Leading by Excellence Since 1983

Certified to ISO 9001:2008

02
01
Custom
Specialty
01
Custom
Specialty
02
Tools
07 for
Cosmetic
Organic &
Peptide
Products Organic
Peptide
Products
Peptide &
Peptides
Synthesis
Synthesis
Technologies Technologies
Synthesis

NEW!
Introducing our latest section, which includes over 4500 new products!

02
01
Custom
02
01
Custom
07Specialty
Cosmetic
01
Custom Organic
Peptide
Products &
Peptide Organic
Peptide Peptides
Synthesis Synthesis
Technologies
Synthesis
Dear Customers:

Throughout its many years of service, the team at Peptides International has maintained a
commitment to offer a continuous stream of innovative products to facilitate ever-expanding
areas of peptide research. In our current catalog you will find hundreds of new products re-
flecting the increased expertise of our staff. These new offerings range from useful tools for
making peptides (e.g. orthogonally protected amino acids and derivativesfor Click chemistry)
to a plethora of biologically active peptides such as Mambalgin-1 and activated KLH (Keyhole
Limpet Hemocynanin) for peptide antigen conjugation. Since publication of a catalog cap -
tures just one point in time, we invite you to look for our latest product additions at PEPNET.
COM under the “New Products” tab.
Investment in additional state-of-the-art automated synthesis equipment now allows us to
produce milligram to kilogram quantities of peptides even more efficiently. All of our produc-
tion and distribution operations have also been certified to the ISO 9001:2008 International
Quality System Standard, reflecting commitment to the quality of our products and the satis-
faction of our customers. New additions to our peptide chemistry team include experts that
can handle all of your discovery and development needs, whether your project involves com-
plex organic chemistry or standard solid-phase techniques. Scale-up and smooth technol -
ogy transfer into drug API products under full-cGMP is also available without any disruption
from our cGMP partner, Peptisyntha.
We thank you for your interest in our products and services and invite you to search for your
peptide needs in our exciting new catalog. Should you require larger quantities than are
listed, additional savings may be available by requesting a “bulk quotation”.
We are confident that you will find all of our products competitively priced while giving you
extraordinary value and quality that will lead to success in your research.

Sincerely,

Peptides International

Michael W. Pennington, Ph.D. Jackie B. Spatola

President and Chief Executive Officer Chair, Board of Directors
Since 1983, Peptides International, Inc. has been an established provider of
catalog products and custom chemistry services, supporting peptide research and
development around world. Built on a passion for excellence, the company has
become recognized as a trusted source of high purity , quality products, and cost
effective custom chemistry services.
The company’s Louisville facility consists of multiple self-contained laboratory
suites, a kilo-scale pilot plant, fully equipped quality control laboratories, and
supporting quality assurance and business departments. Peptides International
is now Certified to ISO 9001:2008, reflecting its commitment to the quality of its
products and satisfaction of its customers.
Peptides International specializes in biologically active peptides and peptide-related
products, glyco-conjugates, defined-length PEGylations, enzyme substrates and
inhibitors, amino acid derivatives, combinatorial peptide libraries, and a variety
of resins and reagents. Purification of custom-produced products is carried out
by conventional techniques such as solvent-solvent extractions, crystallizations,
and by preparative chromatograph ic instrumentations – column sizes to 110mm
diameter – suitable for ion-exchange, flash-chromatography and reverse phase
HPLC methodologies.
Whether it is milligram or kilogram scale-up quantities, Peptides International has
the expertise and technology to support your drug discovery , development, and
manufacturing objectives.

Peptides International, Inc.

Physical Address 11621 Electron Drive
Louisville, Kentucky 40299
Mailing Address P. O. Box 99703
Louisville, Kentucky 40269-0703

Phone 1-502-266-8787 (Local and International Callers)

1-800-777-4779 (Toll-free USA and Canada only)
Fax 502-267-1329
Email peptides@pepnet.com
Website

Social Media
 Table of Contents
Subsections in Bold
Introduction
Peptide Institute............................................................................................................................vii
Distributors...................................................................................................................................viii
cGMP............................................................................................................................................ ix
Quality............................................................................................................................................ x
Product Information...................................................................................................................... xi
Product Packaging........................................................................................................................xii
Communication............................................................................................................................xix
Purchasing................................................................................................................................... xx
Using the Catalog.......................................................................................................................xxii
Terms and Conditions................................................................................................................xxiii
Custom Peptide Synthesis...................................................................................................... xxviii
Technology Platforms................................................................................................................ xxx
Biologically Active Peptides......................................................................................1
Adrenomedullins and Related Peptides.......................................................................................2
Amylins...........................................................................................................................................9
Amyloid β-Protein Related Peptides.............................................................................................9
Angiotensin and Related Peptides..............................................................................................13
Arg-Gly-Asp "RGD" Peptides......................................................................................................20
Bradykinin and Related Peptides................................................................................................27
Defensin Peptides........................................................................................................................39
Endothelins..................................................................................................................................47
Enkephalins..................................................................................................................................51
Experimental Autoimmune Encephalomyelitis Products............................................................54
Galanins and Related Peptides..................................................................................................57
Ghrelin and Related Peptides.....................................................................................................59
Growth Hormone Releasing Factor (GRF, GH-RH)
and Growth Hormone Related Peptides.....................................................................................64
Guanylins and Uroguanylins ......................................................................................................65
Hepcidin.......................................................................................................................................67
Kisspeptins/Metasins...................................................................................................................72
Melanin-Concentrating Hormone and Related Peptides ..........................................................77
Neuroendocrine Regulatory Peptides.........................................................................................82
Parathyroid Hormone (PTH) and Related Peptides...................................................................93
Protease-Activated Receptor (PAR) Peptides..........................................................................101
RF Amide Related Peptides......................................................................................................107
Stresscopins / Urocortin and Related Peptides........................................................................ 110
Substance P and Related Peptides.......................................................................................... 111
Toxins......................................................................................................................................... 114
Urotensin II and Related Peptides............................................................................................133
Vasoactive Intestinal Peptide (VIP)...........................................................................................134
Vasopressin, Vasotocin, and Related Peptides........................................................................135

ii Order Hotline 1-800-777-4779 502-266-8787

 Table of Contents (cont.)
Enzyme Inhibitors and Substrates
Assay Methods Substrates ......................................................................................................137
Enzyme Inhibitors........................................................................................................................143
Angiotensin I Converting Enzyme Inhibitors.............................................................................145
Caspase Inhibitors.....................................................................................................................147
Cathepsin and Thiol Protease Inhibitors...................................................................................151
Chymotrypsin and Chymotrypsin-like Inhibitors.......................................................................154
Collagenase / MMP / Stromelysin Inhibitors.............................................................................155
Elastase Inhibitors......................................................................................................................157
Ubiquitin Proteasome System Inhibitors...................................................................................161
Examples of Proteolytic Enzymes and Their Inhibitors............................................................163
Enzyme Substrates & Related Compounds.............................................................................164
ADAM-17 Substrates......................................................................................................................164
Aminopeptidases Substrates.........................................................................................................165
Calpain Substrates.........................................................................................................................169
Caspase Substrates.......................................................................................................................170
Cathepsin and Thiol Protease Substrates.....................................................................................172
Chymotrypsin and Chymotrypsin-like Protease Substrates.........................................................174
Coagulation Factor Substrates......................................................................................................175
Collagenase / MMP / Stromelysin Substrates...............................................................................178
Elastase Substrates.......................................................................................................................181
Furin and Carboxyl Side of Paired Basic Residue Cleaving Enzyme Substrates ......................183
Ubiquitin Proteasome System Substrates.....................................................................................196
FRETs Peptides Library.................................................................................................................199
Polypeptides...................................................................................................................................205
Oligopeptides..................................................................................................................................205
Dipeptides................................................................................................................................205
Tripeptides...............................................................................................................................206
Tetrapeptides...........................................................................................................................207

Specialty Products and Services

Click Chemistry............................................................................................................................209
Specialty Biologically Active Peptides...................................................................................... 211
Derivatizable Cell Penetrating Peptides (CCPs)...................................................................... 211
Other Specialty Peptides........................................................................................................... 211
Carbohydrates..............................................................................................................................212
Glycosidase Inhibitors................................................................................................................212
Endotoxins (Synthetic)...............................................................................................................216
Antiproliferative Factor...............................................................................................................217
Maleimide activated-KLH...........................................................................................................219
Specialty Tools for Peptide Synthesis..................................................................................221
mini-PEG™................................................................................................................................221
CLEAR-OXTM.............................................................................................................................222
CLEARTM....................................................................................................................................226
Peptide Antisera...........................................................................................................................228
Antisera of Amyloid β-Protein Related Peptides......................................................................229
Endothelin Antisera....................................................................................................................233

Order Hotline 1-800-777-4779 502-266-8787 iii

 Table of Contents (cont.)
Tools for Peptide Synthesis
Amino Acids..................................................................................................................................240
Click Chemistry Amino Acids.....................................................................................................240
l-Amino Acids.............................................................................................................................245
d-Amino Acids............................................................................................................................244
Amino Acid Esters......................................................................................................................245
Side Chain Derivatives of Amino Acids.....................................................................................246
Boc-Protected l-Amino Acids....................................................................................................247
Boc-Protected d-Amino Acids...................................................................................................250
Unusual Boc-Amino Acids.........................................................................................................251
Boc-N-Methyl Amino Acids........................................................................................................258
Boc-Amino Acid Esters..............................................................................................................258
Fmoc-Protected l-Amino Acids.................................................................................................259
Fmoc-Protected d-Amino Acids.................................................................................................263
Unusual Fmoc-Amino Acids......................................................................................................264
Fmoc-N-Methyl Amino Acids.....................................................................................................270
Z-Protected l-Amino Acids........................................................................................................271
Unusual Amino Acids.................................................................................................................273
Resins............................................................................................................................................274
Unsubstituted Resins for Solid Phase Synthesis.....................................................................274
Chlorotrityl Resins......................................................................................................................276
Boc-Amino Acid-Pam Resins....................................................................................................279
Fmoc-Amino Acid-Wang Resins...............................................................................................281
Fmoc-Amino Acid-Rink-Amide MBHA Resins..........................................................................283
TentaGel Resins.........................................................................................................................285
Reagents........................................................................................................................................291
Condensation Reagents, Additives, Linkers, and Other Reagents for Peptide Synthesis .....291
Boc-Amino Acid-Pam Linker Reagents....................................................................................293
Protein Ligation Synthesis Reagents........................................................................................294
PyClocK®. ..................................................................................................................................295
dPEG®........................................................................................................................................296
Laboratory Equipment................................................................................................................. 311
Tubing and Connectors............................................................................................................. 311
Specialty Glassware.................................................................................................................. 311
Replacement Screw Caps and Septa.......................................................................................313
HF Apparatus and Parts............................................................................................................313
Recombinant Proteins
Cytokines and Growth Factors..................................................................................................314
Clusterins...................................................................................................................................320
Defensins...................................................................................................................................323
GH (Growth Hormone).............................................................................................................. 368
IFI30 (γ-Interferon-Inducible Lysosomal Thiol Reductase)...................................................... 379
Interlukins . .........................................................................................................................388-429
IL1F7 (Human Interleukin Family 1, Member 7)...................................................................... 429
IL1F10 (Human Interleukin Family 1, Member 10) .................................................................. 430
Insulin......................................................................................................................................... 431

iv Order Hotline 1-800-777-4779 502-266-8787

 Table of Contents (cont.)
Recombinant Proteins (continued)
Leptin.......................................................................................................................................... 433
Midkines..................................................................................................................................... 445
Pleiotrophin................................................................................................................................ 462
Prolactin..................................................................................................................................... 465
RBP1 (Recombinant Human Retinol Binding Protein-1)......................................................... 474
SCF (Stem Cell Factor)............................................................................................................. 477.
TNF (Tumor Necrosis Factor)................................................................................................... 489
Chemokines.................................................................................................................................. 510
Hormones...................................................................................................................................... 556
Enzymes........................................................................................................................................ 562
Protein Kinases............................................................................................................................ 614
Recombinant and Natural Proteins........................................................................................... 629
Heat Shock Proteins.................................................................................................................... 753
Allergy Proteins............................................................................................................................ 758
Maleria Proteins............................................................................................................................ 758
Mumps Protein.............................................................................................................................. 758
Shiga Like Pprotein...................................................................................................................... 758
Viral Antigens SARS Proteins.................................................................................................... 758
Viral Antigens SARS Proteins Borrelia Protein....................................................................... 759
Viral Antigens - Chagas Protein................................................................................................. 760
Viral Antigens - Herpes Simplex Virus...................................................................................... 760
Viral Antigens - Chlamydia Trachomatis.................................................................................. 761
Viral Antigens - Hepatitis C Virus............................................................................................... 762
Viral Antigens - Hepatitis A Virus............................................................................................... 767
Viral Antigens - Hepatitis B Virus............................................................................................... 768
Viral Antigens - Hantaan Virus................................................................................................... 768
Viral Antigens -Feline Leukemia Virus...................................................................................... 768
Viral Antigens - Hepatitis D Virus............................................................................................... 768
Viral Antigens - Hepatitis E Virus............................................................................................... 768
Viral Antigens - Hepatitis B Surface Antigens......................................................................... 769
Viral Antigens - Cytomegalo Virus............................................................................................. 770
Viral Antigens - Varizella Zoster Virus....................................................................................... 771
Viral Antigens - Toxoplasma Gondii Proteins.......................................................................... 771
Viral Antigens - Treponema Pallidum Proteins........................................................................ 771
Viral Antigens - Human Immunodeficiency Virus................................................................... 772
Viral Antigens - Human T-Lymphotrophic Virus...................................................................... 775
Viral Antigens - Human Papillomavirus Virus.......................................................................... 776
Viral Antigens - Epstein-Barr Virus............................................................................................ 776
Viral Antigens - Encephalitis Virus............................................................................................ 777
Viral Antigens - Measles Virus.................................................................................................. 778
Viral Antigens - Rubella Virus..................................................................................................... 778
Viral Antigens - Chikungunya Virus.......................................................................................... 778
Viral Antigens - Parvovirus......................................................................................................... 778
Viral Antigens - Influenza Virus................................................................................................. 778
Viral Antigens - West-Nile Virus................................................................................................. 781
Viral Antigens - Dengue Virus.................................................................................................... 781

Order Hotline 1-800-777-4779 502-266-8787 v

 Table of Contents (cont.)
Recombinant Proteins (continued)
Anti - Human Cytokines.............................................................................................................. 784
Monoclonal Antibodies, Anti-Human Chemokines................................................................. 789
Monoclonal Antibodies, Anti-Human Lymphocytes................................................................ 790
Monoclonal Antibodies, Anti-Mouse Cytokines....................................................................... 792
Monoclonal Antibodies, Anti-Mouse Lymphocytes................................................................ 793
Monoclonal Antibodies, Anti-Viral............................................................................................. 794
Polyclonal Antibodies, Anti-Human........................................................................................... 795
Monoclonal Antibodies, Anti-Human Heat Shock Proteins................................................... 797
Monoclonal Antibodies, Anti-Human Enzymes....................................................................... 797
Monoclonal / Polyclonal Antibodies, Miscellaneous Antibodies.......................................... 804

vi Order Hotline 1-800-777-4779 502-266-8787

From its very inception, Peptides International has been proud to distribute
the superb products manufactured by the Peptide Institute of Osaka, Japan.
The biologically active peptides synthesized by the Peptide Institute are well
known for their excellent quality . In addition to its historic link with the Peptide
Institute, Peptides International works with other key suppliers around the world
to supplement its own manufact ured products to provide a complete portfolio of
peptides and related products, as well as tools for peptide synthesis and research.

The Peptide Institute is a leading supplier of biologically active peptides, enzyme

substrates and inhibitors, and peptide antisera. Customers in Japan may wish to
contact this company directly.
Peptide Institute, Inc.
4-1-2 Ina Minoh-Shi
Osaka 562 Japan
Phone (0727) 29-4121
Fax (0727) 29-4124
http://www.peptide.co.jp

Order Hotline 1-800-777-4779 502-266-8787 vii

 Distributors

In Japan:
http://www.peptide.co.jp

Osaka, Japan
Email: info@peptide.co.jp
http://www.peptide.co.jp

In Switzerland:

Lucerne, Switzerland
Email: info@lubio.ch
http://www.lubio.ch/

In Benelux:

Huissen, The Netherlands

Email: info@bio-connect.nl
http://www.bio-connect.nl/

In Europe, Latin America,

Australia, and New Zealand:

San Diego, CA USA

Email: axxora-usa@axxora.com
http://www.axxora.com/index.php

viii Order Hotline 1-800-777-4779 502-266-8787

 cGMP Partner

Expertise & Reliability for YOUR cGMP Peptides

Peptides International and Peptisyntha have partnered to create a seamless

stream of technology and expertise, allowing you to focus on the project, not project
management.

Order Hotline 1-800-777-4779 502-266-8787 ix

 Quality

Now Certified to ISO 9001:2008

Quality Policy
It is Peptides International's goal is to achieve complete customer satisfaction by
addressing customer needs and delivering what we promise.
The company is committed to the Quality Management Sysyem and through review of
quality objectives and metrics, is working towards its improvement and effectiveness.
Specifications and Purity Assays
Each product is accompanied by a detailed lot-specific analytical data sheet contain -
ing all specifications. In addition to specification data, additional test results can be
made available upon customer request. Product integrity is assured using techniques
that include thin layer chromatography, high performance liquid chromatography, opti-
cal rotation, nuclear magnetic resonance, IR spectroscopy, and mass spectrometry.

Peptide Institute
Products from the Peptide Institute of Osaka, Japan are manufactured under strict
quality control standards and are accompanied by analytical data sheets directly
from the Institute. Peptide International products are designated by a -PI suffix to
distinguish them from those produced by the Peptide Institute.

x Order Hotline 1-800-777-4779 502-266-8787

 Product Information

Net Peptide Weight

Some products from the Peptide Institute are distributed in premeasured vials. These
are indicated by the suffix -s, or -v in their catalog number. The net peptide weight is
precisely determined by amino acid analysis after acid hydrolysis, HPLC, and/or UV
absorption, and the value is indicated clearly on the vial label. The indicated weight is
only for the net peptide molecule, and the weights of any constituents (water or acetic
acid) are excluded from the quantity. The amount of usable peptide meets and may
exceed its advertised quantity.

Stability and Storage

Complex peptides and antisera should generally be kept dry and frozen to prevent
unnecessary deterioration, although they are stable at ambient temperature for sev -
eral days. Almost all biologically active peptides are readily soluble in water or any
suitable buffer solution. Stability of peptides in solution is relatively low even below
-20 °C. Therefore a peptide solution, once prepared, should be used as soon as
possible. If the solution must be stored overnight, it should be kept in a freezer at
temperatures lower than -20 °C. When prolonged storage has occured, homogene -
ity of the peptide in the solution should be reconfirmed prior to use. Please refer to
the following table and to our website for additional information regarding stability and
storage conditions.

Order Hotline 1-800-777-4779 502-266-8787 xi

 Product Information

Product Storage Conditions

Product Series Number Storage Condition
L- & D-Amino Acids 2700 & 2800 RT
Boc-Amino Acids 2000 & 5000 4 °C
Fmoc-Amino Acids 1700, 1800, & 5000 4 °C
Unusual Amino Acids 5000 4 °C
Reagents 1000 Varies:
RT,
4 °C,
or
-20 °C
Unsubstituted Resins 1000 & 9000 RT
Substituted Resins 1000, 10000, 1100, 11000, 4 °C
1200, 12000, 1300, 1400,
& 9000
All CLEAR Resins 1200, 12000 4 °C
Peptides 3000 & 4000 -20 °C
Inhibitors 3000 & 4000 -20 °C
Substrates 3000 -20 °C
Antisera 8000, 80000, & 14000 -20 °C
Carbohydrates 24000 -20 °C

RT = Room Temperature4 4 °C = Refrigerator -20 °C = Freezer

All products (except RT) are stored in freezers for inventory purposes.

xii Order Hotline 1-800-777-4779 502-266-8787

 Product Information

All of the products listed in this catalog are rigorously tested and the purity of the
products is guaranteed according to the following criteria:
1000 Series
These reagent grade chemicals are of a quality confirmed by our chemists in
Japan and the USA to be acceptable for peptide synthesis.
1100, 1200, 1300,1400, 10000, 11000 and 12000 Series
These substituted resins are manufactured in our Louisville, Kentucky facility .
The parameters, described on the analytical data sheet included with each
resin, are substitution, percent racemization (where appropriate), bead size, and
percent cross-linking.
1700 Series
Fmoc-Amino Acids of the 1700 Series: No free amino acid is detectable by
TLC when 100 micrograms is applied to the plate. Purity determined by HPLC
analysis is higher than 98%.
2000 Series
Amino acids of the 2000 Series: The homogeneity of the amino acids is moni -
tored by thin layer chromatography (TLC) and is guaranteed to yield a single
spot when 50 micrograms is applied to the plate. The optical purity of amino
acids is higher than 99.9% except in the case of serine, which is frequently con -
taminated by more than 1% enantiomeric serine; data are available on request.
Optical purity is determined by Reversed-Phase High-Performance Liquid
Chromatography (RP-HPLC) using chiral derivatizing reagents.

Order Hotline 1-800-777-4779 502-266-8787 xiii

 Product Information

Amino Acid Esters and Side Chain Derivatives of the 2000 Series: The following
letters are used to designate the different grades:
AA: A single spot is always detectable by two dif ferent TLC systems when
200 micrograms is applied to the plate. Homogeneity higher than 99%
as determined by paper electrophoresis is guaranteed.
A: A trace of impurity might be detectable by TLC, but the maximum
range is less than 2%.
B: Contamination of less than 3% might be detectable.
Boc- and Z-Amino Acids of the 2000 Series:
The optical purity of the component amino acids is always higher than 99.9%,
and contamination by the sec-butyl group is guaranteed to be less than 0.05%.
The following letters are used to designate the dif ferent grades:
AA: A single spot is detectable by TLC when 200 micrograms is applied to
the plate. The amount of contamination detectable by HPLC, if any, is
less than 0.5%.
A: A trace of impurity might be detectable by TLC, but the maximum
range determined by HPLC is less than 1%.
B: Contamination of less than 2% might be detectable by HPLC.
AA-A: This compound is synthesized as material of grade AA, but may gradu-
ally decompose to grade A within one year, even under cold storage
conditions.
A-B: This compound is synthesized as material of grade A, but may gradu-
ally decompose to grade B within one year, even under cold storage
conditions.

xiv Order Hotline 1-800-777-4779 502-266-8787

 Product Information

3000 Series
Amino Acids and Peptide Derivatives of the 3000 Series: The following letters
are used to designate the different grades:
AA: A single spot is detectable by TLC when 100 micrograms is applied to
the plate. The amount of contamination detectable by HPLC is less
than 1%.
A: A trace of impurity might be detectable by TLC when 100 micrograms
is applied to the plate. The amount of contamination detectable by
HPLC is less than 2%.
B: Contamination of less than 4% might be detectable by HPLC.
A-B: This compound is synthesized as material of grade A, but may gradu-
ally decompose to grade B within one year, even under cold storage
conditions.
4000 Series
Biologically Active Peptides of the 4000 Series: All of these peptides are
chemically synthesized using carefully selected amino acid derivatives from our
products, and strictly purified to come up to our quality standards. Impurities
detectable by ordinary gradient HPLC systems are less than 1% and a single
TLC spot upon application of 50 micrograms is detected in almost all of our
peptides, except Met-containing peptides. Some additional minor peaks on
HPLC or minor spots on TLC are detectable with Met-containing peptides since
they may be easily oxidized to Met-sulfoxide even during analysis. The peptides
which are followed by the words “Purity Information” and letter symbols, such as
“Purity Information: QP in this catalog”, can be explained as follows:

Order Hotline 1-800-777-4779 502-266-8787 xv

 Product Information

QP: These compounds have some inherent instability. During storage,

even under freezer conditions, a trace of impurity may become visible
by TLC analysis. The amount of impurity determined by HPLC is less
than 1%.
QE: These compounds have some inherent instability. Their purity is guar-
anteed to be higher than 97% by HPLC.
QX: The purity of these compounds is guaranteed to be higher than 97% by
HPLC.
QZ: The purity of these compounds is guaranteed to be higher than 95% by
HPLC.
5000, 6000, and 53000 Series
These unusual amino acids, amino acid derivatives, and other of ferings rep-
resent an expansion of quality products from Peptides International and are
synthesized under appropriately high purity criteria.
14000 Series
Peptide Antisera are sold in vials as amorphous powders which are obtained
after lyophilization from 0.001 M Phosphate Buffer (pH 7.0). The specificity and
sensitivity are determined by the enzyme immunoassay technique specified; the
data for each vial are given on an attached sheet.
Bacterial Enzyme Inhibitors
The microbial enzyme inhibitors (Microbial Products) listed in this catalog are
isolated from cultured media of microorganisms. Many of these compounds are
inherently unstable and thus difficult to categorize using our normal standards of
purity. The homogeneity of these compounds cannot be guaranteed except for
their specific inhibitory activities. Additional data for these series of compounds
are available upon request.

xvi Order Hotline 1-800-777-4779 502-266-8787

 Product Packaging

The biologically active peptides listed in this catalog are sold primarily as
amorphous powders which have been lyophilized from aqueous or dilute acetic
acid solutions. They are available in two package forms: screw-capped bottles
(indicated as “Bulk”) and injection vials (indicated with a -v or –s suffix at the end
of each catalog code number).
Screw-capped Bottles
The amorphous powder of each peptide is thoroughly dried over desiccant in
vacuo and then weighed in a bottle. The weight indicated on the label represents
the gross weight of the amorphous powder, which includes the peptide as well as
the accompanying water and acetic acid, if any. The amount of water and acetic
acid in each amorphous powder is precisely determined by elemental analysis,
Karl Fischer titration or gas chromatography . In some cases, peptides contain
hydrochloride or ammonia instead of acetic acid. The observed values of such
accompanying constituents are given in the structural formula of the respective
peptide described in this catalog. For example, code PBK-4002 Bradykinin is
described as follows:
PBK-4002 Bradykinin Bulk 100 mg
Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg • 2AcOH • 3H2O
(M.W. 1060.2 • 120.10 • 54.05)
The total molecular weight of this amorphous powder is calculated to be 1234.4,
which consists of 1060.2 for the net bradykinin molecule, 120.10 for two mol -
ecules of acetic acid and 54.05 for three molecules of water. This means that
100 mg of this powder contains a net weight of 85.9 mg of bradykinin molecules.
Amounts of the accompanying water and acetic acid vary with the lot; the exact
value in the purchased peptide is available on request.

Order Hotline 1-800-777-4779 502-266-8787 xvii

 Product Packaging

Vials
Peptides with constant weights are lyophilized and sealed under nitrogen in indi-
vidual vials. Net peptide weights are precisely determined by amino acid analy -
sis after acid hydrolysis, HPLC analysis and/or UV absorption measurement,
and is clearly indicated on the label of each vial. The indicated weight is only
the net peptide molecule and does not include the weight of any additional con -
stituents (water, acetic acid, etc.). For example, code PBK-4002-v Bradykinin is
described as follows:
PBK-4002-v Bradykinin Vial 0.5 mg
Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg
(M.W. 1060.2)
This indicates that each vial contains ca. 0.5 mg of Bradykinin and the exact
weight is indicated on the label (for example, 0.53 mg) and the analytical data
sheet (for example, 0.53 mg, 0.50 micromol). The weight is precisely determined
by quality control, insuring the quantity in each vial even if the content seems
to be quite small. A peptide solution of a known concentration can be easily
prepared by injecting a given volume of a suitable solvent into the vial using a
calibrated syringe and dissolving the contents thoroughly . The peptide content
in each vial is relatively small and accurately measured, and the peptide should
not be taken out of the vial to prepare a solution with a guaranteed concentration.

xviii Order Hotline 1-800-777-4779 502-266-8787

 Communication

PEPNET Newsletter
Peptide chemistry is constantly changing. The PEPNET newsletter
A News
P.O. Box letter
Louisv 99703 from
Pepti
USA ille, KY 40224
-0658
Enzyme des Intern
Enzyme s Gone
ation
Addres al
s Servic
e Reque
PRESO
STAND RTED Enzym
inhibitors Wild!
sted ARD modula es are essentia continue Inhibito
to gene rs to the
U.S. Postag
tion of l
PAID e inhibito enzyme in almost all Volum
major rs represent functio biologic Rescue
PEPTID rate stron e 23,
INTERN ES focus almost n represe al process No. 1, 2010
articles of half nts es and !
devoted pharmaceutica the drugs a well-researche
ATIONA
aberrat g rese
and custom
L
to proteas l researc in clinical d route
ion of
enzyme
arch inter
synthes ome h. use today. for drug activity
is services and MMP Therefore, est...

will keep you abreast of many of the exciting new developments

inhibito this issue Design develop is implica
20 th Amer valuabl ment,
e for your rs. We hope of PEPNE, development a point ted in many
Enzym
e inhibi
ican
Pepti Peptid tors innova you will T highlig and study underscored disease states.
de Symp in the es International and relate tions in hts
this area.find our compre this importaof enzyme inhibito by the
fact thatTherefore
osium area of d produ hensive nt
On behalf
thetic
and microb enzym has long had cts collecti area of researc rs continue
enzyme
examp e inhibit a on of reagent h and to
ors that strong produ include be a
of the

CU
we are American
TAPI-1 le, popula Aial-der s for enzyme
pleased Peptide
r matrix ived materi ct focus
Custo s key
In Th letter als. includes both
News

Sp OM
, TAPI-2

ST
jubilee to invite Society, m servic
of the alsoyouoffer metall As a researc
20th ), ubenim from These h
to the
is

ec Iss
Symposiu American
other oprote includ syn- Interna compl
es to
Issue m, "Peptidesnal,
leupep Peptide key ex,
produ and actino inhibitors
ase Peptides ement
stimu

ial ue
• Going held in
e, for late inhibi
distrib tin structu tional also to these
Montreal for Youth"
to be and cts, such nin. In (TAPI-
• Malem
Beyon
d Custom
30, 2007.
remember This symposiu
, Canada
These from ution
are availab Grow
June 26 relatio epoxom
nship icin, as chymo addition,
Intern
0, ation Peptid al ral require provides custom catalog
tor innov
offerin ations
• New
Protein
P.O.
ide-AcBox 99703 Synthe
Louisv tivated
ille, KY KLH Carrier
sis members
the accomplis
since
offermconsid
hments
will serve
to
to
erable
ing Ac
le in multip with the through our statin, elastatwe know- es Interna ments of specifi synthe
Peptid long-st i- how especia tional
has c enzym
gs,
sis service Peptides
40269 This issue for Youth" Boris
Weinstein
Professors
Saul Lande
of society
PI Debu
CUST
saving le vials
or
e Institu
te
anding of compl
ex lly applica a wealth e or diseases to meet

arising in the expanded field of peptide chemistry. PEPNET has

s.ts
Produc
New in bulk quantiof Osaka. cyclic compoenzyme inhibit of
-0703
increase of PEPNE recognizes will strive
ble to chemical Volum
Institut American organized
targets
• Addres
Emplo
e
s Servic
ts from
the Peptid
e this PEPNE
and highlightsto attract
scientific T highligh
d capabili
ties program,
and
edition.ment offering
Tentertain
ts Peptides
Young
their achieveme Investiga
Universit Peptide Symposiu the First
y in 1968. PRESO m
and

OMed Technolo ties that peptide

gy Platf (TAPIs), alkylat aldehy
unds
(BQ-12 ors and substra
the design expert e 24,
and
ise and No.
.
yee Spotlig
e Reque
ht(s)sted Coming
Building Soon! Cell
time of Weinlook
featured

the Montreal forward

s. in
Montreal We ahope
Internat
vibrant
nts, and
youcity,
ional's
tors to
incites
participa
recently te
Moreover atRTED
STAND
Yale
, "Peptides
a meetingARD
The ‘custom
moditi orm... to Ne
des (Ac-LL 3), compl
ing moieti N), hydroxex mimet
tes. Thesesynthesis
includ
1, 2011
It's a
Tradition
mixing Penetra
Blocks/S quality
ynthetic tingGrand
Science
are to

PeptidesPrix
hearing
world
renown
enjoy
from
Montreal

Montreal you!
and by
their interests inU.S.
perusing
. The
night
with a
Postag
PAID e
stimulati
that
turnar
’ peptid
quick zed in recent e busine
Yet researc ound years as more ss has Custo
w Chall
es and
others
amic
.
ics (BQ-78 e
acid deriva 8),
As in
a Kentuc years
past,
: The
2011
cultural
entertain
and Tools and
ment
safe,
centers
with fast , and
Montreal much
HDAC
motorcar
more….
offers
Product
racing,
holding

great s, New participa

life PEPTID
and
INTERNqualityESof
Jazz Festival, the Meeting
ATIONA
around
ng

the L
opmen
t
structu projects
hers pursui source
ng
s appear and •more e com-
around
becomm
low-co
Peptide
Synth
esis
enges
Servic
tives

we are for a memorabl outstandi music

increas peptide-base st,
nts can
glass ky Derby and fun.
res and the world.
with Derby comm including
e meeting. ng facilities, Bilingual enjoyInterna
aldehyd es
Glass tional, bilities of service ingly seek •d Cyclic es, ketones
These orders emora
hotels, , multi-
just compl many drug compou
restauran
with s devel- nds:
and areglasses are of $500 or of these that often more , hydroxy
tive See You Penni
that will eted a a long history
Emanuel ts and
highly more.
Escher Co-chairs
service exceed
• Biotin, compl Peptid
termini ngton
-isoster
visits often Universit : major ex es es
deman allow it
Soon... é de Sherbrooke Joins
comm of provid the aminoh ly annou Interna
/ side
seen display collect provid
to custom The 22 nd Custom capa-
chain PI Team
ding researcto satisfy ing custom• ers. nces thetional
exanoic
This year's able itment Peptid
/ disulfid
proud-
ers' ed during Diego, APS will Dr. acid, defined
William
hers andthe custom in personnel • peptid
as CTO
edition labs and es d FRETMicha
e
additio Universit D. Lubell Additi designe
additio
Califo CA at the be held June on of es, compa el
substra Pennington
For More
length
n of

been published regularly since 1987.

n (or
start) will make
offices é Crystal
“comp their ever chemis andDabcyl has
Information

CL
miss out! . rnia.. Sherat
20thAPS@ de Montréal
the equipm Chief ny’s tes
PEGyla
on Hotel25 - 30, 2011 TAPI-2 structure lex custom new resour increas try needs
, Dabsyl
execut to thetions
Please

to your a nice Intern umontre Contact

ent , Dansyl
ationa Peptides
of PEPNE • of Techni andive
(No additio

IC Iss
Peptides(TNF-a Protease TACE
ing challenCouma team
al.ca
By request collect there l and Coordinat
inor:beautif T
(TNF-a peptidA ces has the most tive , EDANS cal
libraries
(514)Marina Inhibitor- Vol. Decem , Farnes Officer as
nal charge ion. Order In Th will Internatio
nalcompa
News

K ue
es”
rin
and Source: Convertin
22 No. resulte
in San ul San ges.
Susan derivati
please. and while can stop we hope be under ny-wid g Enzyme) as letter PI’s d in the • Glycos ves, Rhodam ber effec-
Seaman
MSD http://ww 2). TAPIs
2). This Backg ines, 1 , 2010.
st yl

Ch
in complex newes
343-6111

quantit for shippi soon is Diego, staff at the w.ebi.ac.u synthelicense frome effort
are proprieta from
and don't Issue by and you tic needs, t TechnoPepti •designation
ext 3907 ylated,
ies last. • ng.) "hello" Europeank/pdbe-srv
analyti /view/ima Patents:that ry TACE
US design

em
ation
with logy
Phosph round TAMRA
LimitMeet "The ! say Bioinform
cal testing but 5,387,610 not only inhibitors inhibitor
provid
des Isotopic
Platfor of Dr.orylated
atics Institute can Pennin, Sulfate
ges/entry/ Intern
offer; 5,616,605 meets es an mally-lab

ist
one per Clicka A compr 2ddf600.p sold by (see
Leadin , techno years gton has
http://ww ng additio
ation eled 20
• The laborat bles" ; 5686,422. custom Peptid integra d (Ser,
inhibit ehensi
by alderivati

ry
ory,
PEPNET. g this logy/pw.ebi.ac.uJ. Swaminanalthan ers immed ted,
e Intern in researc spentThr, Tyr)
ors (“Theindust ve list effort service opmen ves:
Clicka rocess h and over
COM 13
ry expert
of Peptidis Dr. Micha
k/
develo & s in• areas t manag C, 15N
• NEW bles: RGD → What's
This issue substr
Meet Explora iate
ationa

"T
News New →
ates challen
Enzym withesover pment Bachem l speci ement devel-
Feedin
into the ofLook gese Inhibito el Pennin suchtory compou

he Clic
Group
Peptid PEPNEfor Peptides literatu (“The Interna ,•and alizes with the
teamEnzym (see scale-u as recentl
and Note • New g & Regula es T Internatio of researc inset). 20 yearstionalof gton, a well-k
penetrat exciting area highligh us via re are availab r Pept Presid and was
y and in provid
Guide”ides Multi-g
p. to
nd sets
email Chauhleanfrom e Substr
Items
of Click ts Peptides h, ate Joining of Bachem
nal at
Peptid s • Advan from tory Peptid
Look you ing peptides the APS ), compl enzym
experie nown
ram
ent mosting: Volum
and Dr. produc tion, Dr. ement
Inter Bioscie and COO
libraries
Chemist Internat
2011
peptide ence meetin develo pilot-sc e 24,

kables
the
es es who's enjoy
perusing , building breadt Guide” Pennin natio peptid compa
emplo International h and www.p
Dr. Michael
ced Equipm Peptide ry, ional's pment No. 2,
entry and s@pepn e and diagnony’s
ale prepar
• Emplo ing
this PEPNEblocks and as well as its Romm
Whatelom )and ary
gton nal g just nce Inc.,
experieepnet.c andQC
yees
Literatu
Institut
ere citation from you!
citing He is stics King
Chief Penningt
expand et.com scienti and PI’s
would related Introduce such ations
the
Technica 2011
have with yee Spotlig ent InstallePI product
nce toisTalan
on
us! or the
T edition. RGD peptidesuse in cell ed in or by by (see has served author of Prussia
Peptides l Officer,
had contac whom like to sts Please
for
are Dr. existing s New
"
Coming Click contac
2007, phone
s of Internatio
acknow
d s & service
We look Produ this team. Chem pageting of
over thesmany custom
. We
on the nearly 100 (Pennsylvani
1,200 contac
t New more….s! Soon! Toxins, are now800-77
ht(s)
2), who
nal
lege and countin forward ct hope istry? needs Satend journaProd
• Dr. 7-4779 and to t our
Quali PI. labora bring ra technic ls, and uct
DeAnn and Note
years: ers and two former Enzyme to hear- ty and further numbe editori technic a)
tories, unique
service is on Line al boards al publicfacility.
g... Selectienhanc
Develo a APS Inhibito learn al expert
hats, haspmentstoppe
W. Long, Wrap s researchers They will rs &TMSubstra
Value
• Strict been
ve orthog ed with s. update
onal labelin d
about a co-prin
our
r of drugs to discus
develo
the Scienti
fic Adviso
of severa ations,
, but d by who future be missed tes and Peptides Internat limited with serves cost cipal spment l indust
Up:
Thank Confiamine effectiv
ShK
Internaduring and was state- your
moved Directos to endeav and we much dentia
lity • by PI Debuts... g of peptid as an investi e and specifi
compa ry ry
• Lisa on tional hertook ors! with groups
the gator c nies. Boards of a
see
all those in the need, page of Chemi
es has stryadjunct faculty
ional,
boothtenure time to r of wish value
Civello gratulato a new on severa
Inc.
Busine both maleim Proac to 3use added
positio , right,tions to role in at
in San PI wore visit the Peptid who
ss Lastly, PI CTO of them of the target
ido, halo-ac Proje
tive peptid thiol and
wife
MichelPRA=P at Villano memb l NIH He is also
n in theatwho
Linker
was ProducDr. Aleksa academ Diego. many please well in peptid
P.O. Box
24658desired cte to are le haveroparg vayl-Gly er grants
non-pr who
giveaw ia. Also, es @ NP2 Louisvi than one thiol labelin etyl enjoyin molecu
interac Univer in the Depart and
note our
D (tran their e, it lle,
was t Manag ndr Mana
g molecuand NHS-e geme
Biotin
Rabino con- using is KY 40224 t nt gtype lerecentl sity.
) while
succes ayofit sector the
there. winne recent special difficult to or amine
Phone: their new (e.g. Azido-
y moved Mike ment
in marke er, rhas sters • Frien proper PEG).to using the
P.O. Box 502-266 le.
sful meetinIt was mailin
USA
of strateg
taken vich, Louisv 99703 NP Click Chan
Peptide , by allting.
of our
Kindle
a
g addresPeptid slation chemi protecting
get selectiv is presen
Fax: 502-267 -8787When
more ges incorp
oration
dly ty in horseThe
y allow Kentuc andother his
s Internat g. See accoun s es Dr. stry, groups e incorp t in Dr.
Servi ky
possib with
TechnichangeIntern below) Barry a specifi assortm
ille, and
CA Repre you at ts, USA KY 40224 the -1329
to minim oration impact Pennin . Peptid for almost
ce countr ilities a labelin
Numb a veryOur : the incorpSharpless name popula
ional,
that PI c 1-800-77ent es Interna y. limitle employing
Pennincal Office ational's gton's g
Inc.
sentat
withouE-mail: the of these
rized ize side reactio
-0658
Smita has a busine Speaki
ion: er 23! physic groups oration of the Scripp tat PI. peptideapplica additio ss selectiv
Along tion nof hastypes of
7-4779
r, Dr. tional this
Yadav, ss
P.O.ng
of 99703 al locatio speake gton, is slated Chief
thatArg-1 of s ResearFITC by Nobel empha ns.sis, many Click now e label
le, tant San Diego,
at left, consul
Box
n addres 2D Micha wise Clicka s@pepn with aet.com buildin
r at proced broade had
Louisvil
s remain Drugs th the Naturato be a keynotel do not other- ch Institu Laurea chemis antryimmed g block offers a
conven KY dedica
40224-0
ted
please
be 5 biolog occur te, the
involv teures have new ble Cell-P
initiati ned to tools new
area, has iently locatedUSA custom many
Phone:
aware s theheld l ical same Cell-pe been ves, iate
to Califor Advanc from Internationa Peptides e into both molecu in to aid
658 Alkyne-C
enetra
same. ing thees time, produc peptid different
502-266
ing ShK
ontainin
Dr. netrati introdu ting in
peptid many years in the nia. Dr.
Peptide Zermatt, December l Congr To
Fax: 502-267 -8787
-1329 Sclerosis, les interes ced or ts, Peptid e system
tions, company's tChann ng peptid and quality
g Labeling
and the
e,
She wouldchemistry of experie
San Diego has particu Switze 4 - 7, ess, labelin peptide for drug a Basava esimplem es s.
Molecule
ShK (Sticho 1-800-77Into the has
lar 7-4779 Clinic for rland. produc expand technical discov (CPP) ented.
Lys-22
2011,ShK - ecules. g mol- , who
(or future) love to and biolognce in the toxins dactyl peptide topical in A 35 amino These ed and ery had been have At
O

sales ts and techno his

E-mail:
a Toxin Treatm His topic, then react
Peptide
efforts commapplica receive
s@pepn ity for
Azido-TA
peptid discuss youry fields. offerin groups
TMR
in the ercial organi tionslead- d consid
C CH
She can a "Conod gs. (PSK-42 et.com Peptid ent of the Caribbe acid peptide
- or
CH CH
2C and marke T Peptide
logies, (TAT-373 becaus
Multip achiev isolated
e ays" eventFollowing ing high "click", e of theirerable
2

syadav be reache projects curren es Interna CH ting manag busine 4-PI) areas
NH
please 87-s)) le of special tyza-
an sea
is
2

@pepne d directl and needs.t an look Decem the confereone of PI's tional: tivity ss to
selec- ement. development memb ty permeate abili-
anemo from + N
361-41 in-dep up Peptid condit under
75. If t.com, or by y by email
Alkyne
extens
ne, Stichod
the ways ber the cell
es Interna 7 - 9. If nce, there N N
Produ mild
Compon
, and rane
peptid Peptid please you are phone at PEPNE th review will be
ive ct Quali ions. actyla ent
for payloa and allow
you are
e project es Internacontact Dr. located in of peptid
helianth
at 858- T newsle tional ty and d or
Azido
e toxins while there! attending,
us
molecu
Not only RKKRRQR

s. tional Yadav Califor tter. Clicka Value our scientis

Compon
is PI able RR NH
les to cargo
can create today to nia, PEPNET. in the Look Block ble Buildi• Strict
ent O 2
ered into be deliv-
next edition
to synthes
PEPNET. COM → and FITC) ts can
value discuss NP2D.COCOM →
Stichodact
of the
for Tools ng Confi
dentia or Biotinalso attach native ShK
ize
These the cytoso
for your yla
M → Stichodactyla Toxin (PSK-428 The most CLICK initiall peptides werel.
lity • with mini-PE labels and custom
Benef Invited Toxin such
of Click popular y discov
its of Speakers (PSK-428 7-s) Proac as fluoroph analogs
Peptid from
tive Proje G TM spacers
7-s) use ores (TAMRA
biolog chemistry the venomered
Being ,but
annou an up-to- es Intern Social ct Mana + , as shown.
wasps
ical molecu for
[Cu]
nceme ationa : The
Interna nts, offers, where the-mi l involv geme (Trans and the of
tional you'll nute page is tion
es a cyclo-a les nt • Friend -Activ TAT

Our web site of fers online ordering, new products, and other use -
and the and find resour Scan reactio ddi- ly ServicTranscription) ator of
field of events related all the ce here an azido- n using derive protein
peptid latest a speci for compo contai
e d from
e chemis to Peptid al offer! ning They
alkyn nent and typical HIV.
Peptide
s Internat try. es high
conten ly have a
O

compo e-con taininan

ional,
N nine
residu t of argi-
Inc.
in the nent that reactg
O
Peptide
C CH RKKRRQR
can be es.
presen functio CPPs
P.O. Box
Cu (I)
CH CH RR NH
Louisvil 99703
to ce NH 2
N with alkyne nalized
disubs form a of
2
le, KY 2
2

groups s or azido
40269-0
703 USA Phone: 502-266 N
triazol tituted 1,2,3 1,4
for the which allow
Fax: 502-267 -8787
e
numbe (see figure). "Click
cargo transp
molecu ort of
-1329 ed" TAT
1-800-77 one of r of possib For peptid as cytoto les such
the respec ilities e
can be chemistry
E-mail: 7-4779
peptide
tive compo siRNA xic drugs,
s@pepn increas applica
et.com nents ed tions, or kinase molec
within by incorp the
sequen
ules
a peptid orating inhibit
Intern ces. Peptid or

ful information. There are also scientific references, and links to

Produ e chain HIV, TAT
(e.g. (49-57) please ationa l es
ct Quali
ty and (TAT-37 d to offer is
33-PI,
TAT-37 CPP derive
Value a new
• Strict 34-PI,
Confi and TAT-37d from
dentia 35-PI).
lity •
Proac Meet...,see
tive Proje page
3
ct Mana
geme
nt • Friend
ly Servic
e

industry organizations.

Social Media
Just as peptide chemistry is ever-changing, Peptides International knows the
way it conveys these changes will also vary over time. Look for us on Facebook,
Google+, LinkedIn, Twitter, and other new outlets as they appear.
If you wish to receive your own copy of this catalog or to be entered onto the
subscription list for the newsletter , please place a request by contacting the
company via telephone, fax, or email ( peptides@pepnet.com).

Order Hotline 1-800-777-4779 502-266-8787 xix

 Purchasing

Peptides International's customer service representatives are prepared to help

process your orders, assist with product information, and answer technical questions.
Orders can be placed by mail, telephone, fax, or email.

Address:
Mailing Address Physical Address
Peptides International or Peptides International
P. O. Box 99703 11621 Electron Drive
Louisville, Kentucky Louisville, Kentucky
40269-0703 40299-3861
USA USA

Telephone:
1-502-266-8787 (Local and International Callers)
1-800-777-4779 Toll-free (USA and Canada)
Customer service representatives are available during the following times to
assist you:
Monday through Thursday - 8:30 AM - 6:00 PM (EST / EDT time)
Friday - 8:30 AM - 5:00 PM (EST / EDT time)

Fax:
1-502-267-1329
Email:
peptides@pepnet.com

Web site:

xx Order Hotline 1-800-777-4779 502-266-8787

 Purchasing

Orders Confirming Orders

When placing an order please Please mark all confirming orders
specify: clearly to avoid duplication.
• Customer ID Number Back Orders
• Company or Institution Should an item be temporarily out
• Billing Address of stock, this will be indicated in
• Shipping Address the “back order” column of the
• Purchase Order Number or customer’s invoice. Mo st back
Credit Card information order are shipped within two weeks.
• Catalog Code Number
• Quantity and Product
Description
• Quote Number, if applicable
• Telephone Number
• Fax Number
• Email Address
• Shipping Requirements
• VAT, if applicable
Minimum Orders
Peptides International does not
require a minimum order but
encourages repeat customers
to combine small orders, w hen
possible, to minimize handling and
shipping costs.

Order Hotline 1-800-777-4779 502-266-8787 xxi

 Using the Catalog

Catalog Key
• This catalog has been designed to provide unique, concise information for
each product, with the intention of enabling easy navigation and ordering.
• For further information or specific questions regarding a product, please
contact a Peptide International customer service representative.
1 Biologically Active Peptides (All Are Acetate Form Unless Otherwise Indicated)
2 Toxins
3 w-Agatoxins
B.M. Olivera, G.P. Miljanich, J. Ramachandran, and M.E. Adams, Annu. Rev. Biochem., 63, 823 (1994). (Review)
O.D. Uchitel, Toxicon, 35, 1161 (1997). (Review)

4 ω-Agatoxin IVA 5 PAG-4256-s 6 0.1 mg 7 380

8 ω-Aga-IVA 9 -20 °C vial
10 (Funnel Web Spider, Agelenopsis aperta)
11 Lys-Lys-Lys-Cys-Ile-Ala-Lys-Asp-Tyr-Gly-Arg-Cys-Lys-Trp-Gly-Gly-Thr-Pro-Cys-Cys-Arg-Gly-Arg-Gly-Cys-Ile-
Cys-Ser-Ile-Met-Gly-Thr-Asn-Cys-Glu-Cys-Lys-Pro-Arg-Leu-Ile-Met-Glu-Gly-Leu-Gly-Leu-Ala
(Disulfide bonds between Cys 4-Cys20, Cys12-Cys25, Cys19-Cys36 and Cys27-Cys34)
12 (M.W. 5202.2) C217H360N68O60S10
13 P-type Ca2+ Channel Selective Blocker
14 I.M. Mintz, V.J. Venema, K.M. Swiderek, T.D. Lee, B.P. Bean, and M.E. Adams, Nature, 355, 827 (1992). (Original)
T.J. Turner, M.E. Adams, and K. Dunlap, Science, 258, 310 (1992). (Pharmacol.)
H. Nishio, K.Y. Kumagaye, S. Kubo, Y.-N. Chen, A. Momiyama, T. Takahashi, T. Kimura, and S. Sakakibara,
Biochem. Biophys. Res. Commun., 196, 1447 (1993). (Chem. Synthesis & Biological Activity)
• This compound is distributed exclusively through Peptides International under license agreement with the
University of Utah.

1. Major Product Section, designated as Biologically Active 8. Alternate Name (when applicable)
Peptides, Enzyme Inhibitors & Substrates, Specialty 9. Storage Temperature (see page for key)
Products & Technologies, or Tools for Peptide Synthesis. 10. Synthetic, Originally From... (when applicable)
2. Subsection Heading 11. Sequence (when applicable/available)
3. Product Section (may include article and / or references) 12. Molecular Weight, Formula, and CAS Number (when
4. Product Name available)
5. Product Code 13. Description (when applicable/available)
6. Unit Size 14. References (when available)
7. Price (in US Dollars)
Peptides International strives to give accurate content, including product information, quantities, and pricing. Policies,
pricing, and item availability are subject to change without notice. While Peptides International makes a good faith effort
to ensure that the information displayed is accurate, we are not responsible for typographical errors or technical inac-
curacies.

xxii Order Hotline 1-800-777-4779 502-266-8787

 Terms and Conditions
Applicable Terms
These Terms and Conditions of Sale
shall become part of every order , sale,
and purchase agreement between
buyer and Peptides International.
With the placement of an order , the
buyer agrees to accept the Terms
and Conditions of Sale. Peptides
International shall not be bound by the
purchasing conditions of the buyer, even
if not explicitly stated. Orders containing
addenda or statements that are worded
differently or provide for further condi -
tions will not be accepted unless spe -
cifically agreed to in writing by Peptides
International.
The UN Convention on the International
Sale of Goods shall not apply.
Order Hotline 1-800-777-4779 502-266-8787 xxiii
Quotations
Quotations must be requested for the
following special situations:
• Custom synthesis of materials not
listed in Peptides International’s website
or catalog (custom quotations)
• Quantities of specific materials
that exceed those listed in Peptides
International’s website or catalog (bulk
quotations)
• Packaging alternatives, such as
custom vialing, that are not of fered in
website or catalog listings
• Large purchases of multiple items
where a discount is requested (core
quotations)
Unless otherwise stated, quotations are
valid for 30 days from date of issue.
Quotation prices are valid only for indi -
cated product(s) in the quantity , quality,
salt form, and lead time specified in the
quotation.
Lead times for custom quotations are
from date of receipt of an approved
purchase order. Lead times for catalog
products are subject to inventory status
on date of receipt of an approved pur -
chase order.
Quotations are considered confidential
 Terms and Conditions
and are specific to the product(s) and
customer. If appropriate, Non Disclosure
Agreements may also be requested.
Quotations are not transferable to other
parties without express permission from
Peptides International.
Purchases based on accepted quota-
tions remain subject to all other Terms
and Conditions of Sale.
Prices
All prices are quoted in US Dollars and
do not include value-added and/or sales
tax, which may be invoiced separately as
required. Prices include inner and outer
packaging unless specifically noted oth -
erwise.
If the prices in Peptides International’ s
printed literature vary from the prices
published on the Peptides International
website (www.pepnet.com), then the
prices on the website shall prevail.
Shipping and handling charges apply to
all shipments and Peptides International
reserves the right to add a surcharge for
any special shipment requirements ( e.g.
dry ice, inert gas).
All product prices are subject to change
without notice prior to confirmation of an
order, but no product will be shipped at
increased prices without prior notifica -
tion.
Peptides International reserves the right
to charge a re-assaying and restocking
fee on returned goods.
Order Placement
Orders may be placed by telephone,
fax, email, letter or online using Peptides
International’s website ( www.pepnet.
com).
xxiv Order Hotline 1-800-777-4779 502-266-8787
Orders resulting from a prior quotation
must reference the specific quotation
number.
Orders placed verbally or by electronic
transmission shall become legally bind -
ing only if they have been confirmed
by receipt of an invoice number from
Peptides International.
Orders received by Peptides International
are firm and binding upon the buyer and
do not release the parties from their
obligation(s) to deliver or to accept deliv-
ery, nor release them from their financial
obligations to Peptides International.
Custom orders should be reviewed
carefully for structures, sequences, and
other particulars before placing orders.
Peptides International may at its discre -
tion accept change orders under condi -
tions that provide for recovery of already
incurred costs and any additional costs
arising from the agreed upon changes.
Delivery and Acceptance
Agreed upon delivery deadlines refer
to the shipment date of the goods. If
the delivery deadline is extended by
buyer, buyer shall specify an appropri -
ate period for acceptable late delivery
of the shipment. If the delivery deadline
is extended by Peptides International,
buyer will be notified of such extension
prior to the original shipment deadline.
Peptides International reserves the right
to decline orders in the event the product
can no longer be made or the customer
is in arrears with any commitments or
payments.
Buyer is responsible for complying with
national or international laws or regula -
tions applicable to shipment, delivery ,
storage, processing or trading of any
 Terms and Conditions
specifically designated products.
Force majeure of any kind, unforesee -
able operational disruptions, short-
falls or failures in delivery by Peptides
International’s suppliers, shortages of
raw materials, power supplies and/or
manpower, strikes, lockouts, problems
in procuring means of transport, traf fic
obstructions, war, political unrest, acts
of terrorism, natural disasters and order
of higher authorities exempt the party
concerned from the obligation to deliver
or to accept delivery for the duration of
the disruption and for any consequential
damages arising therefrom, but shall not
exempt such party from any financial
obligations arising from any goods or
services already supplied.
Warranty and Warranty Disclaimer
All Peptides International biochemicals
are extensively tested for purity . Each
shipment is accompanied by a detailed
lot-specific “Analytical Data Sheet”
(ADS). Peptides International warrants
the purity, identity and content of its prod-
ucts at the time of sale in accordance
with the results listed in the ADS.
The buyer shall visually inspect and
test products immediately upon receipt
to determine whether the condition and
quantity of the goods conforms to the
ADS and the applicable contractual
agreement. All claims must be received
in writing within 14 days from date of
delivery of the product to the customer
and failure to do so shall constitute a
waiver by buyer for any and all such
claims. Claims must include proof of
non-compliance, specifically naming the
product, the lot number, and the invoice
number.
Order Hotline 1-800-777-4779 502-266-8787 xxv
Peptides International shall ship replace-
ment product for claims for which proof is
submitted and which are received within
the time period specified above. If the
replacement delivery is also non-con -
forming to the contractual agreement,
then the buyer has the right to cancel the
order or contract.
Products that are the subject of com -
plaint may be sent back only with
Peptide International’s agreement and
shipping arrangements for the return
must be agreed upon by both parties in
advance.
Peptides International’s sole obligation
is to replace material up to the extent of
the purchase price, or provide a refund
or credit. Peptides International makes
no other warranties, express or implied,
including, but not limited to, any implied
warranty of merchantability or fitness for
a particular purpose or implied warranty
arising out of a course of dealing, cus -
tom, or usage of trade.
Use and Limitation of Liability
All products sold by Peptides
International are intended solely for
laboratory and research use and
should not be used in or on human
subjects. Peptides International sup -
plies such products only for the pur -
poses of public research as conducted
at experimental and teaching institutes,
technical facilities and commercial enti -
ties.
It is the responsibility of the buyer to
determine the adequacy of all materials
for any intended or specific purpose or
use. Peptides International makes no
warranties as to use for an intended or
specific purpose.
 Terms and Conditions
Peptides International expressly forbids
the distribution of dangerous substances
to private individuals and draws atten -
tion to the fact that the absence of a
hazard warning sign does not indicate
that the product concerned is harmless.
Peptides International shall therefore not
accept any liability for damage that could
arise from the inappropriate handling or
from any use in household applications
or in humans and animals. Peptides
International shall not be liable for any
damage as a result of improper use or
storage of its products. This limitation
of liability also includes products that
have been tampered with or altered by
accident or negligence.
Peptide International’s liability with
respect to non-fulfillment or delay of
delivery shall be limited to the invoice
amount of the goods.
All information contained in catalogs,
brochures, publications and other printed
or electronic media is compiled to the
best of Peptide International’ s knowl-
edge. Peptides International hereby
disclaims any liability for any possible
errors or misprints.
Peptides International shall not under
any circumstances be liable to buyer for
any direct, indirect, special, incidental, or
consequential loss or damages (includ -
ing, but not limited to, loss of profits,
revenue, business, research, research
results, opportunity or goodwill) aris -
ing from or in any way related to the
products or Peptides International’s sale
of products, regardless of the legal or
equitable theory under which such loss
or damages are sought, including breach
of warranty or contract, negligence, or
strict liability.
xxvi Order Hotline 1-800-777-4779 502-266-8787
Title and Proprietary Rights
Until full payment of the purchase price,
including all secondary claims, the sup -
plied products remain the property of
Peptides International ( reservation of
title).
If the buyer fails to pay for products
despite receipt of late notices, Peptides
International reserves the right to with -
hold any further deliveries to the buyer
and to require the return of the unpaid
goods, unused and in original packag -
ing, at the buyer’s expense.
Terms of Payment
Terms of payment are net 30 days for
qualified buyers. A service charge of
1.5% per month (18% ANNUAL RATE)
will be added to all balances which are
30 or more days past due.
Discount deductions on invoices are
not allowed. Reductions in Peptides
International’s invoices may not be made
without a credit invoice or note and if
made without such, shall be considered
a late or short payment.
Peptides International reserves the right
to change the terms of payment to
payment in full or in part in advance of
shipment.
After an order is accepted or a sale com-
mitment is made, any increase in, and
all new taxes, excises, duties, or other
governmental charges (except taxes
on income) imposed on the production,
sale, transportation, import or export of
products sold to buyer which Peptides
International is required to pay will be
added to the price paid by customer for
products.
 Terms and Conditions
Payment may be made by one of the
following methods:
• Check: Send a check, including
any clearing, processing, or other
bank charges or fees to:
Peptides International, Inc.
P.O. Box 99703
Louisville, KY 40269
• Wire Transfer: If not already in US
dollars, arrange for conversion of
the currency to US dollars, includ -
ing shipping and handling charges
(included on all invoices). Wire
the total amount to the following
account:
Bank ABA # 083900680
Account # 5183479840
SWIFT # BRBTUS33
BB&T
401 West Main St.
Louisville, KY 40202 USA
Contact: Nell Prince
Phone (502)-562-7902
• Credit Card: Peptides International
accepts MasterCard, V isa, and
American Express.
Important: After completing one of the
steps above please email or fax a con -
firming note to Peptides International
indicating the date and amount of your
payment. You should also include your
invoice number or purchase order num -
ber to insure proper credit.
Order Hotline 1-800-777-4779 502-266-8787 xxvii
Patent Claims, Protection Rights,
Consultancy
With any purchase, the buyer acquires
the product but no other rights asso -
ciated with the product. Peptides
International remains in possession of
all intellectual property rights related to
the manufacturing and composition of
the product.
The use of trademarks in offers does not
provide for the use of such trademarks.
Permission for such use must always be
obtained from Peptides International in
advance and in writing.
Peptides International makes no guaran-
tee that the use or resale of its products
will not violate the protection or patent
rights of third parties.
Peptides International agrees to of fer
its customers technical support to the
best of its knowledge. All comments
or proposals for the use, application, or
suitability of the products shall not be
interpreted as an explicit guarantee of
success.
Applicable Laws
Any legal dispute involving these Terms
and Conditions will be governed by the
laws of the Commonwealth of Kentucky.
If a provision in these conditions of
sale or a provision in the context of
other agreements are or become legally
unenforceable, only that provision shall
become null and void and all remaining
provisions shall remain enforceable and
in effect.
 Custom Peptide Synthesis

Custom Products and Services

If peptides or other products you need are not listed in this catalog, we invite you to
try our custom synthesis services. Peptides International has earned the reputation of
providing exceptionally high quality custom peptide synthesis products to the research
community. We specialize in 5 to 100 mg quantities (or greater) with purity levels of at
least 95%. Amino acid analysis ratios, mass spectral data, and analytical HPLC chro-
matograms are provided with custom peptides. Areas of expertise include:
Multi-Disulfide Peptides
Interested in mini-proteins with multiple disulfide bonds? Peptides International
researchers have extensive experience folding these highly complicated molecules
to their biologically active forms. Examples include native molecules and analogs of
conotoxins, defensins, hepcidins, chemokines, ion channel blockers (ShK, HwTX4,
charybdotoxin, iberiotoxin, margatoxin, ProTx-II, mu-conotoxins, etc). They can also
customize with labels such as TAMRA, FITC or Biotin using a mini-PEG™ spacer.
Peptide-Protein Conjugates
Peptide-protein conjugates have a variety of applications, including the stimulation of
antibodies for immunization. These conjugates can be customized as needed, includ -
ing combinations with proteins such as Albumin, Ovalbumin, and Ferritin. Selective het-
erobifunctional crosslinkers allow for selective attachment of a Cys-containing peptide
to the protein of your choice. Using KLH-MCC will help streamline this reaction, and the
product (KLH-6000-PI) is conveniently kept in stock at all times.
Peptide Derivatives
Fluorescence resonance energy transfer (FRET) occurs when excitation energy is
transferred from an excited fluorescent donor to a quenching acceptor in a distance-
dependent manner. Cleavage of a scissile peptide bond within a fluorescence
quenched substrate leads to separation of the intramolecular donor-acceptor pair, thus
allowing an increase in fluorescence. The fluorescence increase is proportional to the
amount of peptide hydrolyzed. To design a substrate for a newly discovered enzyme

xxviii Order Hotline 1-800-777-4779 502-266-8787

Custom Peptide Synthesis

or application, contact our specialists to begin a customized Substrates by Design™

project.
Post Translation Modification
Including: Glycosylation, Phosphorylation, Fatty Acid Acylation, Pegylation, Cyclization,
and Disulfide Bonds
Peptide Synthesis
Including: Classical/Solution, Solid-Phase, Native Chemical Ligation, and Dendrimeric
RGD Platforms
Peptidomimetics
Including: Hydroxyethylene Isostere, Reduced Peptide Bonds, Aldehydes, Chloro-
methylketones, Depsipeptides, and Phosphonates
Multi-step Organic Synthesis
Including: Novel Amino Acid Derivatives, Stereo Selective Synthesis, Special Protecting
Groups
Other Services
Peptides International is an excellent source for production of unusual amino acids
and offers rapid, thorough, and cost effective hydrogen fluoride (HF) cleavage proce-
dures. Please inquire for additional analytical services.
Confidentiality
All customer requests will be treated with strict confidentiality and non-disclosure
agreements can easily be put in place. W e offer molecular design consultations,
project management and technology transfer for scale-up production.

Order Hotline 1-800-777-4779 502-266-8787 xxix

 Technology Platforms

As additional value, Peptides International has developed technology platforms that

assure an intergrated company-wide effort that not only meets researcher's immedi-
ate synthetic needs, but can of fer additional services in such areas as analytical
testing, technology/process development, and scale-up.
Peptides International's RGD Technology Platform, is a natural outgrowth of its
extensive catalog offerings, custom RGD experience, and technological expertise.

Defined-Length Multimers
PEGylations Conjugates

RGD
Complex Technology
Industry Leading
Organic Platform Catalog Portfolio
Derivatives

Process Scale-up
Multi-gram Synthesis

Applications and Potential Benefits to Researchers:

• Integrin related RGD research • Tumor targeting, imaging and diagnostics
• NCEs and cancer drug development • Novel biomaterial research & development
• Useful to prepare radiolabeled agents • Tissue repair and wound healing studies

Order Hotline 1-800-777-4779 502-266-8787 xxx

 Technology Platforms

The Custom Services Portfolio Platform spans a wide range of technologies rang-
ing from traditional solution and solid phase synthesis to peptidomimetics as illus -
trated by depsi-peptide bond formation and HET isostere incorporation. Expertise in
multi-step organic synthesis and peptide modi -
fication offer a virtually limitless range
of custom options extending from
glycosylation to fluorescent and Peptide
Peptidomimetics
isotopic labeling, cycliz ation, Synthesis
phosphorylation, and more.
Post
Translational Multi-disulfide
Modifications Peptides

Multi-step
Peptide Organic
Derivatives Synthesis
Peptide-
Protein
Conjugates

xxxi Order Hotline 1-800-777-4779 502-266-8787

PRODUCT CODE QTY PRICE
Biologically Active Peptides

BIOLOGICALLY ACTIVE PEPTIDES

(All Are Acetate Form Unless Otherwise Indicated)

Ac-Asp-Glu
Ac-Asp-Glu • H2O (Bulk) PDE-4167 25 mg 55
(M.W. 304.26 • 18.02) C11H16N2O8 • H2O [3106-85-2] -20 °C 100 mg 155
Endogenous Excitatory Neurotransmitter
K.L. Reichert and F. Fonnum, J. Neurochem., 16, 1409 (1969). (Original)
K.J. Koller and J.T. Coyle, Eur. J. Pharm., 98, 193 (1984). (Characterization of Receptor)
K.J. Koller, R. Zaczek, and J.T. Coyle, J. Neurochem., 43, 1136 (1984). (Localization in Brain)
J.H. Neale, T. Bzdega, and B. Wroblewska, J. Neurochem. 75, 443 (2000). (Review)

ACV (Delta-(l-Alpha aminoadipyl)-l-Cysteinyl-Bis-d-Valine)

Bis-ACV PAC-3860-PI 25 mg 395
Delta-(l-a-aminoadipyl)-l-Cysteinyl-Bis-d-Valine -20 °C 100 mg 995
(M.W. 724.86) C28H48N6O12S2
Precursor for Biosynthesis of Penecillin

Adjuvant Peptide
Adjuvant Peptide PAD-4031-v 0.5 mg 45
N-Ac-Mur-Ala-d-Glu-NH2 (Mur: Muramic acid) -20 °C vial
(M.W. 492.48) C19H32N4O11 [53678-77-6]

Adjuvant Peptide (Bulk) PAD-4031 25 mg 850

N-Ac-Mur-Ala-d-Glu-NH2 • 2H2O (Mur: Muramic acid) -20 °C
(M.W. 492.48 • 36.03 ) C19H32N4O11 • 2H2O [53678-77-6]
Muramyl Dipeptide

PEPTIDES INTERNATIONAL
F. Ellouz, A. Adam, R. Ciorbaru, and E. Lederer, Biochem. Biophys. Res. Commun., 59, 1317 (1974). (Original)
S. Kotani, Y. Watanabe, F. Kinoshita, T. Shimono, I. Morisaki, T. Shiba,
S. Kusumoto, Y. Tarumi, and K. Ikenaka, Biken J., 18, 105 (1975). (Chem. Synthesis and Immun. Activity)

Adrenocorticotropic Hormone (ACTH)

ACTH (Human, 1-24) PAC-4109-v 0.5 mg 275
Adrenocorticotropic Hormone (Human, 1-24) -20 °C vial
Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-
Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro
(M.W. 2933.4) C136H210N40O31S [16960-16-0]
B. Riniker, P. Sieber, W. Rittel, and H. Zuber, Nature (New Biol.), 235, 114 (1972).
(Original; Structure)

Order Hotline 1-800-777-4779 502-266-8787 1

 PRODUCT CODE QTY PRICE
BIOLOGICALLY ACTIVE PEPTIDES

Adrenomedullins and Related Peptides

K. Kitamura, K. Kangawa, H. Matsuo, and T. Eto, Drugs, 49, 485 (1995). (Review)
D.A. Schell, R.C. Vari, and W.K. Samson, Trends Endocrinol. Metab., 7, 7 (1996). (Review)
M. Julián, M. Cacho, M.A. Garcia, S. Martin-Santamaria, B. de Pascual-Teresa, A. Ramos, A. Martinez, and F. Cuttitta,
Eur. J. Med. Chem., 40, 737 (2005). (Review)

Adrenomedullin (Human)* PAD-4278-s 0.1 mg 350

Tyr-Arg-Gln-Ser-Met-Asn-Asn-Phe-Gln-Gly-Leu-Arg-Ser-Phe- -20 °C vial
Gly-Cys-Arg-Phe-Gly-Thr-Cys-Thr-Val-Gln-Lys-Leu-Ala-
His-Gln-Ile-Tyr-Gln-Phe-Thr-Asp-Lys-Asp-Lys-Asp-Asn-
Val-Ala-Pro-Arg-Ser-Lys-lle-Ser-Pro-Gln-Gly-Tyr-NH2
(Disulfide bond between Cys16-Cys21)
(M.W. 6028.7) C264H406N80O77S3 [148498-78-6]
Hypotensive Peptide
K. Kitamura, K. Kangawa, M. Kawamoto, Y. Ichiki, S. Nakamura, H. Matsuo, and T. Eto,
Biochem. Biophys. Res. Commun., 192, 553 (1993). (Original)
K. Kitamura, J. Sakata, K. Kangawa, M. Kojima, H. Matsuo, and T. Eto, Biochem. Biophys. Res. Commun.,
194, 720 (1993). (Original; cDNA)
• This product is distributed under the license of Shionogi & Co., Ltd.
Its use for any purpose other than research is strictly prohibited.
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

Adrenomedullin (Human, 1-25)* PAD-4325-v 0.5 mg 305

Tyr-Arg-Gln-Ser-Met-Asn-Asn-Phe-Gln-Gly-Leu-Arg-Ser- -20 °C vial
Phe-Gly-Cys-Arg-Phe-Gly-Thr-Cys-Thr-Val-Gln-Lys
(Disulfide bond between Cys16-Cys21)
(M.W. 2927.3) C125H192N40O36S3
PEPTIDES INTERNATIONAL

Vasopressor Fragment of Human Adrenomedullin

T.X. Watanabe, Y. Itahara, T. Inui, K. Yoshizawa-Kumagaye, K. Nakajima, and S. Sakakibara,
Biochem. Biophys. Res. Commun., 219, 59 (1996). (Original)

Adrenomedullin (Human, 22-52) PAD-4302-v 0.5 mg 380

Thr-Val-Gln-Lys-Leu-Ala-His-Gln-Ile-Tyr-Gln-Phe-Thr-Asp- -20 °C vial
Lys-Asp-Lys-Asp-Asn-Val-Ala-Pro-Arg-Ser-Lys-Ile-Ser-
Pro-Gln-Gly-Tyr-NH2
(M.W. 3576.0) C159H252N46O48 [159899-65-7]
Adrenomedullin Antagonist
S. Eguchi, Y. Hirata, H. Iwasaki, K. Sato, T.X. Watanabe, T. Inui, K. Nakajima, S. Sakakibara, and F. Marumo,
Endocrinology, 135, 2454 (1994). (Original)

Adrenomedullin (Rat)* PAD-4281-s 0.1 mg 340

Tyr-Arg-Gln-Ser-Met-Asn-Gln-Gly-Ser-Arg-Ser-Thr-Gly-Cys- -20 °C vial
Arg-Phe-Gly-Thr-Cys-Thr-Met-Gln-Lys-Leu-Ala-His-Gln-
Ile-Tyr-Gln-Phe-Thr-Asp-Lys-Asp-Lys-Asp-Gly-Met-
Ala-Pro-Arg-Asn-Lys-Ile-Ser-Pro-Gln-Gly-Tyr-NH2
(Disulfide bond between Cys14-Cys19)
(M.W. 5729.4) C242H381N77O75S5
Hypotensive Peptide
J. Sakata, T. Shimokubo, K. Kitamura, S. Nakamura, K. Kangawa, H. Matsuo, and T. Eto,
Biochem. Biophys. Res. Commun., 195, 921 (1993). (Original; cDNA and Biological Activity)

2 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT CODE QTY PRICE
Adrenomedullin 2 (Human) PAD-4421-s 0.1 mg 290

BIOLOGICALLY ACTIVE PEPTIDES

Intermedin (Human) -20 °C vial
Thr-Gln-Ala-Gln-Leu-Leu-Arg-Val-Gly-Cys-Val-Leu-Gly-
Thr-Cys-Gln-Val-Gln-Asn-Leu-Ser-His-Arg-Leu-Trp-
Gln-Leu-Met-Gly-Pro-Ala-Gly-Arg-Gln-Asp-Ser-Ala-
Pro-Val-Asp-Pro-Ser-Ser-Pro-His-Ser-Tyr-NH2
(Disulfide bond between Cys10 and Cys15)
(M.W. 5100.7) C219H349N69O66S3
Cardiovascular and Renal Regulator / Suppressor for Food Intake and Gastric Emptying
M. Ogoshi, K. Inoue, and Y. Takei, Biochem. Biophys. Res. Commun., 311, 1072 (2003).
(Takifugu rubripes Adrenomedullins)
Y. Takei, K. Inoue, M. Ogoshi, T. Kawahara, H. Bannai, and S. Miyano, FEBS Lett., 556, 53 (2004).
(Original; Adrenomedullin 2)
J. Roh, C.L. Chang, A. Bhalla, C. Klein, and S.Y.T. Hsu, J. Biol. Chem., 279, 7264 (2004). (Original; Intermedin)
Y. Fujisawa, Y. Nagai, A. Miyatake, Y. Takei, K. Miura, T. Shoukouji, A. Nishiyama, S. Kimura, and Y. Abe,
Eur. J. Pharmacol., 497, 75 (2004). (Pharmacol.)
M.M. Taylor, S.L. Bagley, and W.K. Samson, Am. J. Physiol. Regul. Integr. Comp. Physiol., 288, R919 (2005).
(Pharmacol.)
K. Takahashi, K. Kikuchi, Y. Maruyama, T. Urabe, K. Nakajima, H. Sasano, Y. Imai, O. Murakami, and K. Totsune,
Peptides, 27, 1383 (2006). (Histochem.)
D. Bell and B.J. McDermott, Br. J. Pharmacol., 153, S247 (2008). (Review)

Adrenomedullin 2 (Rat) PAD-4422-s 0.1 mg 290

Intermedin (Rat) -20 °C vial
Pro-His-Ala-Gln-Leu-Leu-Arg-Val-Gly-Cys-Val-Leu-Gly-Thr-Cys-Gln-
Val-Gln-Asn-Leu-Ser-His-Arg-Leu-Trp-Gln-Leu-Val-Arg-Pro-Ser-Gly-
Arg-Arg-Asp-Ser-Ala-Pro-Val-Asp-Pro-Ser-Ser-Pro-His-Ser-Tyr-NH2
(Disulfide bond between Cys10-Cys15)

PEPTIDES INTERNATIONAL
(M.W. 5216.9) C226H361N75O64S2
Potent Cardiovascular and Renal Regulator / Suppressor for Food Intake and Gastric Emptying
M. Ogoshi, K. Inoue, and Y. Takei, Biochem. Biophys. Res. Commun., 311, 1072 (2003).
(Takifugu rubripes Adrenomedullins)
Y. Takei, K. Inoue, M. Ogoshi, T. Kawahara, H. Bannai, and S. Miyano, FEBS Lett., 556, 53 (2004).
(Original; Adrenomedullin 2)
J. Roh, C.L. Chang, A. Bhalla, C. Klein, and S.Y.T. Hsu, J. Biol. Chem., 279, 7264 (2004). (Original; Intermedin)
Y. Fujisawa, Y. Nagai, A. Miyatake, Y. Takei, K. Miura, T. Shoukouji, A. Nishiyama, S. Kimura, and Y. Abe,
Eur. J. Pharmacol., 497, 75 (2004). (Pharmacol.)
M.M. Taylor, S.L. Bagley, and W.K. Samson, Am. J. Physiol. Regul. Integr. Comp. Physiol., 288, R919 (2005).
(Pharmacol.)
K. Takahashi, K. Kikuchi, Y. Maruyama, T. Urabe, K. Nakajima, H. Sasano, Y. Imai, O. Murakami, and K. Totsune,
Peptides, 27, 1 383 (2006). (Histochem.)
D. Bell and B.J. McDermott, Br. J. Pharmacol., 153, S247 (2008). (Review)

Order Hotline 1-800-777-4779 502-266-8787 3

 PRODUCT CODE QTY PRICE
BIOLOGICALLY ACTIVE PEPTIDES

PAMP (Human) PAM-4291-v 0.5 mg 250

Proadrenomedullin N-terminal 20 Peptide (Human) -20 °C vial
Ala-Arg-Leu-Asp-Val-Ala-Ser-Glu-Phe-Arg-Lys-Lys-Trp-Asn-
Lys-Trp-Ala-Leu-Ser-Arg-NH2
(M.W. 2460.8) C112H178N36O27 [150238-87-2]
Hypotensive Peptide
K. Kitamura, J. Sakata, K. Kangawa, M. Kojima, H. Matsuo, and T. Eto, Biochem. Biophys. Res. Commun.,
194, 720 (1993). (Original; cDNA)
H. Washimine, K. Kitamura, Y. Ichiki, Y. Yamamoto, K. Kangawa, H. Matsuo, and T. Eto,
Biochem. Biophys. Res. Commun., 202, 1081 (1994). (Distribution in Human Tissue)
K. Kitamura, K. Kangawa, Y. Ishiyama, H. Washimine, Y. Ichiki, M. Kawamoto, N. Minamino, H. Matsuo,
and T. Eto, FEBS Lett., 351, 35 (1994). (Pharmacol.)
F. Katoh, K. Kitamura, H. Niina, R. Yamamoto, H. Washimine, K. Kangawa, Y. Yamamato, H. Kobayashi,
T. Eto, and A. Wada, J. Neurochemistry, 64, 459 (1995). (Pharmacol.)
• This product is distributed under the license of Shionogi & Co., Ltd.
Its use for any purpose other than research is strictly prohibited.

PAMP (Rat) PAM-4292-v 0.5 mg 250

Proadrenomedullin N-terminal 20 Peptide (Rat) -20 °C vial
Ala-Arg-Leu-Asp-Thr-Ser-Ser-Gln-Phe-Arg-Lys-Lys-Trp-Asn-
Lys-Trp-Ala-Leu-Ser-Arg-NH2
(M.W. 2477.8) C111H177N37O28
Hypotensive Peptide
J. Sakata, T. Shimokubo, K. Kitamura, S. Nakamura, K. Kangawa, H. Matsuo, and T. Eto,
Biochem. Biophys. Res. Commun., 195, 921 (1993). (Original; cDNA)

PAMP-12 (Human) PAM-4339-v 0.5 mg 110

Proadrenomedullin N-terminal 20 Peptide (Human, 9-20) -20 °C
PEPTIDES INTERNATIONAL

Phe-Arg-Lys-Lys-Trp-Asn-Lys-Trp-Ala-Leu-Ser-Arg-NH2
(M.W. 1618.9) C77H119N25O14
Hypotensive Peptide / Major Endogenous Form of PAMP
K. Kuwasato, K. Kitamura, Y. Ishiyama, H. Washimine, J. Kato,
K. Kangawa, and T. Eto, FEBS Lett., 414, 105 (1997). (Original)

4 Order Hotline 1-800-777-4779 502-266-8787

 PRODUCT CODE QTY PRICE
Adropin

BIOLOGICALLY ACTIVE PEPTIDES

Adropin (Human, 34-76 ) PAP-4456-s 0.1 mg 340
(Rat, Mouse) -20 °C vial
Cys-His-Ser-Arg-Ser-Ala-Asp-Val-Asp-Ser-Leu-Ser-Glu-Ser-Ser-
NEW!
Pro-Asn-Ser-Ser-Pro-Gly-Pro-Cys-Pro-Glu-Lys-Ala-Pro-Pro-
Pro-Gln-Lys-Pro-Ser-His-Glu-Gly-Ser-Tyr-Leu-Leu-Gln-Pro
(Disulfide bond between Cys1-Cys23)
(M.W. 4499.8) C190H293N55O68S2
Synthetic Product
Regulatory Factor in Energy Homeostasis
K.G. Kumar, J.L. Trevaskis, D.D. Lam, G.M. Sutton, R.A. Koza, V.N. Chouljenko, K.G. Kousoulas, P.M. Rogers,
R.A. Kesterson, M. Thearle, A.W. Ferrante, Jr., R.L. Mynatt, T.P. Burris, J.Z. Dong, H.A. Halem, M.D. Culler,
L.K. Heisler, and J.M. Stephens, Cell Metab., 8, 468 (2008). (Original: Primary Structure/Pharmacol.)

Peptides secreted from peripheral organs regulate lipid metabolism in key insulin-
target tissues and are important for energy homeostasis and maintaining insulin sen-
sitivity. Much attention has been given to adipokines secreted by adipocytes. While
receiving less attention, liver-secreted factors are also critical for energy homeostasis.
Adropin, initially identified during microarray analysis of liver gene expression in
mouse models of obesity, is a 76-residue peptide encoded by the energy homeostasis
associated gene Enho1). Bioinformatics analysis suggested adropin (34-76) being a
secreted form of adropin with high probability. Thus disulfide-linked adropin (34-76)
was chemically synthesized for biological tests; glucose homeostasis and hepatic
lipid metabolism were improved in mouse with 90 or 900 nmol/kg/day through intra-
peritoneal administration. These effects were independent of adiposity or food intake.

PEPTIDES INTERNATIONAL
Considering the alteration of adropin mRNA level associated with obesity, adropin
(34-76) may be a powerful peptide in the study of obesity-associated hepatosteatosis
and hyperinsulinemia.
K.G. Kumar, J.L. Trevaskis, D.D. Lam, G.M. Sutton, R.A. Koza, V.N. Chouljenko, K.G. Kousoulas, P.M. Rogers,
R.A. Kesterson, M. Thearle, A.W. Ferrante, Jr., R.L. Mynatt, T.P. Burris, J.Z. Dong, H.A. Halem, M.D. Culler,
L.K. Heisler, J.M. Stephens, and A.A. Butler, Cell Metab., 8, 468 (2008). (Original: Primary Structure / Pharmacol.)

Agelenin
Agelenin PAG-4247-s 0.1 mg 380
(Spider, Agelena opulenta) -20 °C vial
Gly-Gly-Cys-Leu-Pro-His-Asn-Arg-Phe-Cys-Asn-Ala-Leu-
Ser-Gly-Pro-Arg-Cys-Cys-Ser-Gly-Leu-Lys-Cys-Lys-
Glu-Leu-Ser-Ile-Trp-Asp-Ser-Arg-Cys-Leu-NH2
(Disulfide bonds between Cys3-Cys19, Cys10-Cys24 and Cys18-Cys34)
(M.W. 3818.4) C160H254N52O45S6
Presynaptic Ca2+ Channel Antagonist
K. Hagiwara, T. Sakai, A. Miwa, N. Kawai, and T. Nakajima, Biomedical Res., 11, 181 (1990). (Original)
T. Inui, K. Hagiwara, K. Nakajima, T. Kimura, T. Nakajima, and S. Sakakibara, Pept. Res., 5, 140 (1992).
(Chem. Synthesis, S-S Bond and Amide)
N. Yamaji, K. Sugase, T. Nakajima, T. Miki, M. Wakamori, Y. Mori, and T. Iwashita, FEBS Lett., 581, 3789 (2007).
(Solution Structure)

Order Hotline 1-800-777-4779 502-266-8787 5

 PRODUCT CODE QTY PRICE
BIOLOGICALLY ACTIVE PEPTIDES

AG30/5C
Peptides with antimicrobial activity, in addition to angiogenic properties are good
candidates for wound-healing drugs. One such peptide lead, AG30 (AG: Angiogenic
Peptide) was identified in 2009 by the group of Drs. Nakagami and Kaneda of Osaka
University.1 Actually, AG30 is predicted by in silico analysis of an angiogenic cDNA
clone p3743.2 Through feasibility study and the subsequent clinical investigation of
AG30, AG30/5C has just been discovered from the structure-activity relationship study
of AG30. In AG30/5C the cationic residues of Arg and Lys replace five neutral amino
acids.3 This modification in the primary structure revealed that i) the helical structure
is maintained even in the lower extent than that of parental AG30, ii) the potencies are
significantly improved in the migration and tube forming ability of human endothelial
cells as well as in the antimicrobial activity against P. aeruginosa, Candida, and S.
aureus, and iii) wound healing effects are observed in a diabetic mouse model and in
a porcine model (100 μg/ml).
In this study, AG30/5C is produced applying the conventional solution method compat-
ible to Good Manufacturing Practice (GMP) guidelines. The structure and character-
istics of AG30/5C are similar to those of LL-37, which is known as an antimicrobial
peptide with angiogenic properties. AG30/5C, which may facilitate the discovery of
novel therapeutic agents, is available now from Peptides International.
AG30: MLSLIFLHRLKSMRKRLDRKLRLWHRKNYP
AG30/5C: MLKLIFLHRLKRMRKRLKRKLRLWHRKRYK
1. T. Nishikawa, H. Nakagami, A. Maeda, R. Morishita, N. Miyazaki, T. Ogawa, Y. Tabata, Y. Kikuchi, H. Hayashi,
PEPTIDES INTERNATIONAL

Y. Tatsu, N. Yumoto, K. Tamai, K. Tomono, and Y. Kaneda, J. Cell. Mol. Med., 13, 535 (2009).
(Original; AG30 & Pharmacol.)
2. T. Nishikawa, H. Nakagami, A. Matsuki, A. Maeda, C.Y. Yo, T. Harada, R. Morishita, K. Tamai, and Y. Kaneda,
Hum. Gene Ther., 17, 470 (2006). (Angiogenic cDNA Clone p3743)
3. H. Nakagami, T. Nishikawa, N. Tamura, A. Maeda, H. Hibino, M. Mochizuki, T. Shimosato, T. Moriya, R. Morishita,
K. Tamai, K. Tomono, and Y. Kaneda, J. Cell. Mol. Med., doi: 10.1111/j.1582-4934.2011.01406.x
(Original; AG30/5C & Pharmacol.)

AG30/5C AGP-4469-s 0.1 mg 110

Met-Leu-Lys-Leu-Ile-Phe-Leu-His-Arg-Leu-Lys- -20 °C vial
NEW!
Arg-Met-Arg-Lys-Arg-Leu-Lys-Arg-Lys-Leu-
Arg-Leu-Trp-His-Arg-Lys-Arg-Tyr-Lys
(M.W. 4103.2) C189H330N66O32S2
Antimicrobial Peptide with Angiogenic Properties
• This product is distributed through Peptide Institute, Inc. under the license of AnGes MG, Inc.
Its use for any purpose other than research is strictly prohibited.

6 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT CODE QTY PRICE
Agouti-Related Protein

BIOLOGICALLY ACTIVE PEPTIDES

A gene encoding agouti-related protein (AGRP) was isolated in 1997 during a
search of the proteins related to agouti protein which was known to affect pigmentation
through the melanocortin receptor 1 (MC-1). AGRP shows some sequence similarity
to agouti protein, including the distribution of the 10 cysteine residues in the C-terminal
domain. However, AGRP and agouti protein bind to distinct types of melanocortin
receptors. The receptors for AGRP are reported to be MC-3 and MC-4, which are
known to participate in the regulation of feeding, whereby the binding of an antagonist
like AGRP stimulates food intake. Some groups have attempted to identify the active
domain of a 132 amino acid precursor protein, one of which is AGRP(86-132).1 IC50
values of this peptide in the competitive binding assay for MC-3 and MC-4, expressed
in human embryonic kidney cells, were 2 nM and 19 nM, respectively. Competitive
inhibition of α-MSH-stimulated cAMP production was also detected for MC-3 and
MC-4, but not for MC-1 and MC-5, indicating the selective nature of the action of
AGRP(86-132) with respect to melanocortin receptors.
R.D. Rosenfeld, L. Zeni, A.A. Welcher, L.O. Narhi, C. Hale, J. Marasco, J. Delaney, T. Gleason, J.S. Philo, V. Katta,
J. Hui, H. Baumgartner, M. Graham, K.L. Stark, and W. Karbon, Biochemistry, 37, 16041 (1998). (Original)
E.J. Bures, J.O. Hui, Y. Young, D.T. Chow, V. Katta, M.F. Rohde, L. Zeni, R.D. Rosenfeld, K.L. Stark, and M. Haniu,
Biochemistry, 37, 12172 (1998). (Structure; S-S Bond)
J.R. Shutter, M. Graham, A.C. Kinsey, S. Scully, R. Lüthy, and K.L. Stark, Genes Dev., 11, 593 (1997).
(Agouti-Related Transcript Sequence)
D.M. Dinulescu and R.D. Cone, J. Biol. Chem., 275, 6695 (2000). (Review)
A.M. Wilczynski, C.G. Joseph, and C. Haskell-Luevano, Med. Res. Rev., 25, 545 (2005). (Review)
O. Ilnytska and G. Argyropoulos, Cell. Mol. Life Sci., 65, 2721 (2008). (Review)

Agouti-Related Protein (Human, 86-132) PAR-4366-s 0.1 mg 360

PEPTIDES INTERNATIONAL
AGRP (Human, 86-132) -20 °C vial
Arg-Cys-Val-Arg-Leu-His-Glu-Ser-Cys-Leu-Gly-Gln-Gln-Val-
Pro-Cys-Cys-Asp-Pro-Cys-Ala-Thr-Cys-Tyr-Cys-Arg-Phe-
Phe-Asn-Ala-Phe-Cys-Tyr-Cys-Arg-Lys-Leu-Gly-Thr-Ala-Met-
Asn-Pro-Cys-Ser-Arg-Thr
(Reported disulfide bonds between Cys87-Cys102, Cys94-Cys108, Cys101-Cys119, Cys105-Cys129,
and Cys110-Cys117)
(M.W. 5347.2) C223H339N69O63S11
Melanocortin Receptor-3/4 Antagonist, Appetite Boosting Peptide

Alarin
Alarin (Human) PAL-4449-s 0.1 mg 115
Ala-Pro-Ala-His-Arg-Ser-Ser-Thr-Phe-Pro-Lys-Trp-Val-Thr- -20 °C vial
NEW!
Lys-Thr-Glu-Arg-Gly-Arg-Gln-Pro-Leu-Arg-Ser
APAHRSSTFPKWVTKTERGRQPLRS
(M.W. 2894.3) C127H205N43O35 [909409-86-5]
Splice Variant of Galanin-Like Peptide
Synthetic Product
R. Lang, A.L. Gundlach, and B. Kofler, Pharmacol. Ther., 115, 177 (2007). (Review)
R. Santic, K. Fenninger, K. Graf, R. Schneider, C. Hauser-Kronberger, F.H. Schilling, P. Kogner, M. Ratschek,
N. Jones, W. Sperl, and B. Kofler, J. Mol. Neurosci., 29, 145 (2006). (Original)
R. Santic, S.M. Schmidhuber, R. Lang, I. Rauch, E. Voglas, N. Eberhard, J.W. Bauer, S.D. Brain, and B. Kofler,
Proc. Natl. Acad. Sci. U.S.A., 104, 10217 (2007). (Original)

Order Hotline 1-800-777-4779 502-266-8787 7

 PRODUCT CODE QTY PRICE
BIOLOGICALLY ACTIVE PEPTIDES

AMP-IBP5
Dr. Minamino and his colleagues of the National Cerebral and Cardiovascular Center
Research Institute have been performing the proteomics approach to unveil the
endogenous peptides. His group has now identified a novel antimicrobial peptide,
AMP-IBP5 [named after an antimicrobial peptide derived from insulin-like growth
factor-binding protein 5 (IGFBP-5)] using human pancreatic neuroendocrine tumor cell
QGP-1.1 AMP-IBP5 is actually a 22 amino acid residue peptide with dual post-transla-
tional modifications: C-terminal amidation and intramolecular disulfide bond formation,
the latter of which is a distinct finding because the disulfide linkage of IGFBP-5 has
been differently predicted previously. The primary structure of AMP-IBP5 is conserved
among many mammals including human, mouse, rat, pig, and cow. AMP-IBP5 is
characterized to have a highly basic nature and exerts broad spectra of antimicrobial
activity against Gram-positive bacteria, Gram-negative bacteria, and fungi (IC50 = μM
range), the potency of which were comparable to LL-37 (Code 4445-s) and even higher
than those of human β-defensin-2 (Code 4338-s). Interestingly, this function is missing
in parental IGFBP-5. Major location sites of immunoreactive AMP-IBP5 in rats are
clarified as being the pituitary gland, brain, and small intestine.
This newly discovered AMP-IBP5 has the potential to become an essential peptide
with antimicrobial activity, along with existing antimicrobial peptides such as defensins
and LL-37.
1. T. Osaki, K. Sasaki, and N. Minamino, J. Proteome Res., 10, 1870 (2011). (Original; Primary Structure & Pharmacol.)

AMP-IBP5 (Human) AMP-4468-s 0.1 mg 110

Insulin-Like Growth Factor-Binding Protein 5
PEPTIDES INTERNATIONAL

-20 °C vial
(Human, 193-214 Amide)
(Porcine, Rat, Mouse, Bovine)
Ala-Val-Tyr-Leu-Pro-Asn-Cys-Asp-Arg-Lys-Gly-Phe-Tyr-Lys-Arg-Lys-Gln-Cys-Lys-Pro-Ser-Arg-NH2
(Disulfide bond between Cys7-Cys18)
(M.W. 2655.1) C117H188N38O29S2
Antimicrobial Peptide

8 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT CODE QTY PRICE

BIOLOGICALLY ACTIVE PEPTIDES

Amylins
G.J.S. Cooper, Endocrinol. Rev., 15, 163 (1994). (Review)
J.W.M. Höppener, B. Ahrén, and C.J.M. Lips, N. Engl. J. Med., 343, 411 (2000). (Review)
S.A. Jayasinghe and R. Langen, Biochim. Biophys. Acta, 1768, 2002 (2007). (Review)
L. Haataja, T. Gurlo, C.J. Huang, and P.C. Butler, Endocr. Rev., 29, 303 (2008). (Review)

Amylin (Human) PAM-4219-v 0.5 mg 505

IAPP: Islet Amyloid Polypeptide -20 °C vial
DAP: Diabetes-Associated Peptide
(Trifluoroacetate Form)
Lys-Cys-Asn-Thr-Ala-Thr-Cys-Ala-Thr-Gln-Arg-Leu-Ala-Asn-Phe-Leu-Val-His-Ser-Ser-
Asn-Asn-Phe-Gly-Ala-Ile-Leu-Ser-Ser-Thr-Asn-Val-Gly-Ser-Asn-Thr-Tyr-NH2
(Disulfide bond between Cys2 and Cys7)
(M.W. 3903.3) C165H261N51O55S2 [122384-88-7]
Purity Information: Qx See page xiv
P. Westermark, et al., Proc. Natl. Acad. Sci. USA, 84, 3881 (1987). (Original; 36th A.A. Unknown)
G.J.S. Cooper, et al., Proc. Natl. Acad. Sci. U.S.A., 84, 8628 (1987). (Original; Complete Sequence)
A. Clark, et al., Lancet, 2, 231 (1987). (Pharmacol; May be Pathogenic)
• U.S. Patent No. 5,367,052. This product is made under license from Amylin Pharmaceuticals, Inc. for sale for noncom-
mercial research use only. For other information and information about licenses for commercial research use may be
obtained from Amylin Pharmaceuticals, Inc. at (858) 552-2200.

Amylin (Rat) PAM-4220-v 0.5 mg 470

IAPP: Islet Amyloid Polypeptide -20 °C vial
DAP: Diabetes-Associated Peptide
Lys-Cys-Asn-Thr-Ala-Thr-Cys-Ala-Thr-Gln-Arg-Leu-Ala-Asn-Phe-Leu-Val-Arg-Ser-Ser-
Asn-Asn-Leu-Gly-Pro-Val-Leu-Pro-Pro-Thr-Asn-Val-Gly-Ser-Asn-Thr-Tyr-NH2
(Disulfide bond between Cys2 and Cys7)

PEPTIDES INTERNATIONAL
(M.W. 3920.4) C167H272N52O53S2 [124447-81-0]
J.D. Leffert, C.B. Newgard, H. Okamoto, J.L. Milburn, and K.L. Luskey,
Proc. Natl. Acad. Sci. USA, 86, 3127 (1989). (Original; cDNA)
J. Asai, M. Nakazato, K. Kangawa, S. Matsukura, and H. Mastuo,
Biochem. Biophys. Res. Commun., 164, 400 (1989). (Original; Isolation and Structure)

Amyloid b-Protein Related Peptides

Amyloid b-Protein (Human, 1-40) PAM-4307-v 0.5 mg 220
(Trifluoroacetate Form) -20 °C vial
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-
Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-
Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val
(M.W. 4329.8) C194H295N53O58S [131438-79-4]
Peptide Deposited in the Brain of Alzheimer’s Disease Patient
Purity Information: Qz See page xiv
B.A. Yankner, L.K. Duffy, and D.A. Kirschner, Science, 250, 279 (1990). (Original)

Amyloid b-Protein (Human, 1-40) [HCI Form] PAB-4379-v 0.5 mg 250

Lyophilized from Dilute HCI Solution -20 °C vial
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-
Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-
Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val
(M.W. 4329.8) C194H295N53O58S [131438-79-4]
Specific Form Easily Transferrable to β-Structure
Purity Information: Qz See page xiv
I. Kaneko, N. Yamada, Y. Sakuraba, M. Kamenosono, and S. Tutumi, J. Neurochem., 65, 2585 (1995). (Original)
I. Kaneko, S. Tutumi, J. Neurochem., 68, 438 (1997). (Facile b-Structure Formation)

Order Hotline 1-800-777-4779 502-266-8787 9

 PRODUCT CODE QTY PRICE
BIOLOGICALLY ACTIVE PEPTIDES

Amyloid b-Protein (Human, 1-42) PAM-4349-v 0.5 mg 360

(Trifluoroacetate Form) -20 °C vial
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-
Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-
Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala
(M.W. 4514.0) C203H311N55O60S [107761-42-2]
Purity Information: Qz See page xiv
D. Goldgaber, M.I. Lerman, O.W. McBride, U. Saffiotti, and D.C. Gajdusek, Science, 235, 877 (1987). (Original; cDNA)
A.E. Roher, Jet al., Proc. Natl. Acad. Sci. USA, 90, 10836 (1993). (Pathophysiology)
N. Suzuki, et al., Science, 264, 1336 (1994). (Pathophysiology)
M. Citron, et al., Proc. Natl. Acad. Sci. USA, 93, 13170 (1996). (Biosynthesis)

Amyloid b-Protein (Human, 1-43) PAB-4370-v 0.5 mg 425

(Trifluoroacetate Form) -20 °C vial
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-
Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-
Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-Thr
(M.W. 4615.1) C207H318N56O62S [134500-80-4]
Major Plaque Component in Alzheimer’s Disease
Purity Information: Qz See page xiv
A. Tamaoka, et al., Biochem. Biophys. Res. Commun., 205, 834 (1994). (Pharmacol.)
K. Hsiao, et al., Science, 274, 99 (1996). (Pharmacol.)
K. Duff, et al., Nature, 383, 710 (1996). (Pharmacol.)
T. Kawarabayashi, et al., Brain. Res., 765, 343 (1997). (Pharmacol.)

Amyloid b-Protein (Human, 1-16) PAB-4359-v 0.5 mg 120

Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val- -20 °C vial
PEPTIDES INTERNATIONAL

His-His-Gln-Lys
(M.W. 1955.0) C84H119N27O28 [131580-10-4]
Blocker for Plaque-Induced Microgliosis / Reducer for Brain
Inflammation
D. Giulian, et al., J. Biol. Chem., 273, 29719 (1998). (Original; Pharmacol.)
M. Nakamura, et al., Biochemistry, 46, 12737 (2007). (Pharmacol.)

Amyloid β-Protein (Human, 1-28) PAB-4481-v 0.5 mg 150

SP-28 (Human) -20 °C via
(Trifluoroacetate Form)
NEW!
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-
Ser-Asn-Lys
(M.W. 3262.5) C145H209N41O46 [109770-29-8]
Synthetic Product
Amyloidogenic Segment of Amyloid β-Protein
Purity Information: Qp See page xiv
D.A. Kirschner, et al., Proc. Natl. Acad. Sci. U.S.A., 84, 6953 (1987). (Original; Amyloid-Like Fibril Formation)
B. Klajnert, et al., Biochem. Biophys. Res. Commun., 345, 21 (2006). (Amyloid Fibril Formation)
A. Perálvarez-Marin, et al., J. Mol. Biol., 379, 589 (2008). (Amyloid Fibril Formation)
N.G.N. Milton and J.R. Harris, Micron, 40, 800 (2009). (Amyloid Fibril Formation)
T. Wasiak, et al., Mol. Pharm., 9, 458 (2012). (Amyloid Fibril Formation & Neurotoxity)
J.S. Whitson, et al., Science, 243, 1488 (1989). (Pharmacol.)
B.A. Yankner, et al., Science, 250, 279 (1990). (Pharmacol.)

10 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT CODE QTY PRICE
Amyloid β-Protein (Human, 1-38) PAB-4484-v 0.5 mg 170

BIOLOGICALLY ACTIVE PEPTIDES

NEW! (Trifluoroacetate Form) -20 °C via
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-
Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-
Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly
(M.W. 4131.5) C184H277N51O56S [131438-74-9]
Purity Information: Qz See page xiv
Endogenous Form of Amyloid β-Protein in Cerebrospinal Fluid
M. Okochi, et al., Cell Rep., 3, 42 (2013). (γ-Secretase-Mediated Generation)
N. Matsumura, et al., J. Biol. Chem., 289, 5109 (2014). (γ-Secretase-Mediated Generation)
J.M. Maler, et al., Proteomics, 7, 3815 (2007). (Quantitation in Human Plasma)
4) M.E. Lame, et al., Anal. Biochem., 419, 133 (2011). (Quantitation in Human Cerebrospinal Fluid)
5) M.P. Mattson, et al., J. Neurosci., 12, 376 (1992). (Pharmacol.: Enhancement of Glutamate Neurotoxicity)

Amyloid b-Protein (Human, 25-35) PAM-4309-v 0.5 mg 55

(Trifluoroacetate Form) -20 °C vial
Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met
(M.W. 1060.3) C45H81N13O14S [131602-53-4]
Neurotrophic / Neurodegenerative Peptide
B.A. Yankner, et al., Science, 250, 279 (1990). (Original)
L. Meda, et al., Nature, 374, 647 (1995). (Pharmacol.)
L. Millucci, et al., Curr. Protein Pept. Sci., 11, 54 (2010). (Review)

[Pyr3]-Amyloid b-Protein (Human, 3-42) PAB-4367-v 0.5 mg 360

(Trifluoroacetate Form) -20 °C vial
Pyr-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-
Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-
Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala

PEPTIDES INTERNATIONAL
(M.W. 4309.9) C196H299N53O55S [183449-57-2]
Major Neuritic Plaque Component in Alzheimer’s Disease
Purity Information: Qz See page xiv
T.C. Saido, et al., Neuron, 14, 457 (1995). (Pharmacol.; Dominant Deposition in Senile Plaques)
T. Iwatsubo, et al., Am. J. Pathol., 149, 1823 (1996). (Histochem.; Distribution in Brains of Patients)
Y.-M. Kuo, et al., Biochem. Biophys. Res. Commun., 237, 188 (1997).
(Pharmacol.; Form in Neuritic Plaques and Vascular Amyloid Deposits)

Amyloid b-Protein (40-1) PAB-4413-s 0.1 mg 120

Peptide with Reversed Sequence of Amyloid b-Protein -20 °C vial
(Human, 1-40)
(Trifluoroacetate Form)
Val-Val-Gly-Gly-Val-Met-Leu-Gly-Ile-Ile-Ala-Gly-Lys-Asn-Ser-Gly-Val-Asp-Glu-Ala-Phe-
Phe-Val-Leu-Lys-Gln-His-His-Val-Glu-Tyr-Gly-Ser-Asp-His-Arg-Phe-Glu-Ala-Asp
(M.W. 4329.8) C194H295N53O58S [144409-99-4]
Negative Control Peptide for Amyloid β-Protein (Human, 1-40)
Purity Information : QZ See page xiv

Amyloid b-Protein (42-1) PAB-4420-s 0.1 mg 225

Peptide with Reversed Sequence of Amyloid b-Protein -20 °C vial
(Human, 1-42)
(Trifluoroacetate Form)
Ala-Ile-Val-Val-Gly-Gly-Val-Met-Leu-Gly-Ile-Ile-Ala-Gly-Lys-Asn-Ser-Gly-Val-Asp-Glu-Ala-
Phe-Phe-Val-Leu-Lys-Gln-His-His-Val-Glu-Tyr-Gly-Ser-Asp-His-Arg-Phe-Glu-Ala-Asp
(M.W. 4514.0) C203H311N55O60S [317366-82-8]
Negative Control Peptide for Amyloid β-Protein (Human, 1-42)
Purity Information : Qz See page xiv

Order Hotline 1-800-777-4779 502-266-8787 11

 PRODUCT CODE QTY PRICE
BIOLOGICALLY ACTIVE PEPTIDES

Ac-Leu-Pro-N-Me-Phe-Phe-Asp-NH2 PAB-3637-PI 5 mg 95
b-Sheet Breaker Peptide iAb5p-A1 -20 °C
(M.W. 692.82) C36H48N6O8
Aβ (1-42) Fibrillogenesis Inhibitor, iAβ5p-A1
C. Adessi, et al., J. Biol. Chem., 278, 13905, (2003).

Ac-Leu-Pro-Phe-Phe-Asp-NH2 PAB-3632-PI 5 mg 85
b-Sheet Breaker Peptide iAb5p -20 °C
(M.W. 678.89) C35H46N6O8
Aβ (1-42) Fibrillogenesis Inhibitor, iAβ5p
C. Soto, et al., Nature Medicine, 4, 822 (1998).
B. Permanne, et al., FASEB Journal, 16, 862, (2002).

Ac-Lys-N-Me-Leu-Val-N-Me-Phe-Phe-NH2 PAB-3631-PI 1 mg 65
(M.W. 721.95) C39H59N7O6 -20 °C 5 mg 245
Membrane Permeable Inhibitor of Aβ (1-40) Fibrillogenesis
D.J. Gordon, K.L. Sciarretta, and S.C. Meredith, Biochemistry, 40, 8237 (2001).
D.J. Gordon, R. Tappe, and S.C. Meredith, J. Pep. Res., 60(1), 37-55 (2002).

b-Sheet Breaker Peptide iAβ5 PAB-4358-v 5 mg 190

Leu-Pro-Phe-Phe-Asp -20 °C vial
(M.W. 637.72) C33H43N5O8 [182912-74-9]
Inhibitor of Amyloid Deposition
C. Soto, et al., Nat. Med., 4, 822 (1998). (Original, Pharmacol.)

b-Sheet Breaker Peptide iAβ5 (Bulk) PAB-3615-PI 5 mg 85

Leu-Pro-Phe-Phe-Asp • AcOH • 4H2O -20 °C 25 mg 340
PEPTIDES INTERNATIONAL

(M.W. 637.74) C33H43N5O8

Inhibitor of Amyloid Deposition
C. Soto, E.M. Sigurdsson, L. Morelli, R.A. Kumar, E.M. Castano, and B. Frangione, Nat. Med., 4, 822 (1998). (Original)

Amphipathic Peptide Antibiotic

KKALLALALHHLAHLALHLALALKKA PHR-3642-PI 1 mg 125
H-Lys-Lys-Ala-Leu-Leu-Ala-Leu-Ala-Leu-His-His-Leu-Ala-His- -20 °C 5 mg 495
Leu-Ala-Leu-His-Leu-Ala-Leu-Ala-Leu-Lys-Lys-Ala-OH
(M.W. 2779.53) C132H228N38O27
Amphipathic Peptide Antibiotic, LAH4
A. Kichler, C. Leborgne, J. März, O. Danos, and B. Bechinger, Proc. Natl. Acad. Sci. USA, 100 (4), 1564 (2003).

12 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT CODE QTY PRICE
Angiotensin and Related Peptides

BIOLOGICALLY ACTIVE PEPTIDES

I.H. Page and F.M. Bumpus (eds.), Angiotensin, Handbook of Experimental Pharmacology,
Vol. 37, Springer-Verlag, Berlin, 1974. (Review)
M.J. Peach, Physiol. Rev., 57, 313 (1997). (Review)

Ang II is part of the renin-angiotensin system which is responsible for the regulation of
blood pressure and fluid balance. It is processed in a series of steps that begins with
enzymatic activity of renin on angiotensinogen. Ang II produces many potent effects
including vasoconstriction and release of aldosterone which increases reabsorption of
electrolytes. Nagata et al. recently isolated a new angiotensinogen-derived peptide
with an antibody that binds to the N-terminus of Ang II. The 12 amino acid peptide
was named proangiotensin-12 (PAN-4439-v) and may be a precursor to Ang II.1 It was
detected in significant concentrations in a number of rat tissues and demonstrated to
have constrictive effects, though its activity was not as potent as Ang II. Its discovery
suggests an alternative processing method for Ang II that may be independent of
renin.
1. S. Nagata, J. Kato, K. Sasaki, N. Minamino, T. Eto, and K. Kitamura, Biochem. and Biophys. Res. Commun., 350,
1026 (2006). (Original; Primary Structure & Pharmacol.)

H-Ala-Arg-Val-Tyr-Ile-His-Pro-Phe-OH PAN-3921-PI 1 mg 45
Des-Asp1-[Ala1]-Angiotensin II (Human) -20 °C 5 mg 195
ARVYIHPF
(M.W. 1002.19) C49H71N13O10
Vasoconstrictive Peptide / Angiotensin Peptide
V. Jankowski, R. Vanholder, M. van der Giet, M. Tölle, S. Karadogan, J. Gobom, J. Furkert, A. Oksche, E. Krause,
T.N.A. Tran, M. Tepel, M. Schuchardt, H. Schlüter, A. Wiedon, M. Beyermann, M. Bader, M. Todiras, W. Zidek,

PEPTIDES INTERNATIONAL
and J. Jankowski, Arteriosclerosis, Thrombosis, and Vascular Biology, 27, 297 ( 2007).

Angiotensin I (Human) (0.5 mg vial) PAN-4007-v 0.5 mg 35

(Porcine, Canine, Rat, Rabbit, Guinea pig) -20 °C vial
Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu
(M.W. 1296.5) C62H89N17O14 [484-42-4]

Angiotensin I (Human) (Bulk) PAN-4007 25 mg 525

(Porcine, Canine, Rat, Rabbit, Guinea pig) -20 °C
Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu
(M.W. 1296.5) C62H89N17O14 [484-42-4]
K. Arakawa, M. Nakatani, A. Minohara, and M. Nakamura, Biochem. J., 104, 900 (1967). (Original; Human)
H. Akagi, T. Hayashi, T. Nakayama, T. Nakajima, T.X. Watanabe, and H. Sokabe, Chem. Pharm. Bull., 30, 2498 (1982).
(Original; Porcine etc.)

Angiotensin II (Human)* (0.5 mg vial) PAN-4001-v 0.5 mg 35

Asp-Arg-Val-Tyr-Ile-His-Pro-Phe -20 °C vial
(M.W. 1046.2) C50H71N13O12 [4474-91-3]

Angiotensin II (Human)* (Bulk) PAN-4001 25 mg 476

Asp-Arg-Val-Tyr-Ile-His-Pro-Phe • AcOH • 4H2O -20 °C
(M.W. 1046.2 • 60.05 • 72.06) C50H71N13O12 • CH3COOH •
4H2O

K. Arakawa, M. Nakatani, A. Minohara, and M. Nakamura, Biochem. J., 104, 900 (1967). (Original)

[N-Me-Asp1]-Angiotensin II PAN-3949-PI 1 mg 55
H-N-Me-Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-OH 229
-20 °C 5 mg
Vasoconstrictive Peptide / Angiotensin Peptide
(M.W. 1060.23) C51H73N13O12
R.J. Kokje, W.L. Wilson, T.E. Brown, V.T. Karamyan, J.W. Wright, and R.C. Speth, Hypertension, 49, 1328 (2007).

Order Hotline 1-800-777-4779 502-266-8787 13

 PRODUCT CODE QTY PRICE
BIOLOGICALLY ACTIVE PEPTIDES

Angiotensin III (Human)* PAN-4028-v 0.5 mg 35

Arg-Val-Tyr-Ile-His-Pro-Phe -20 °C vial
(M.W. 931.09) C46H66N12O9 [13602-53-4]

Angiotensin III (Human)* (Bulk) PAN-4028 25 mg 390

Arg-Val-Tyr-lle-His-Pro-Phe • 2AcOH • 4H2O -20 °C 100 mg 990
(M.W. 931.09 • 120.11 • 72.06) C46H66N12O9 • 2CH3COOH •
4H2O [100900-06-9]
W.B Campbell, S.N. Brooks, and W.A. Pettinger, Science, 184, 994 (1974). (Original)

Angiotensin IV (Human)* PAN-4331-v 0.5 mg 35

Angiotensin (Human, 3-8) -20 °C vial
Val-Tyr-Ile-His-Pro-Phe
(M.W. 774.91) C40H54N8O8 [23025-68-5]
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

Angiotensin IV (Human)* (Bulk) PAN-4331 25 mg 365

Angiotensin (Human, 3-8) -20 °C
Val-Tyr-Ile-His-Pro-Phe • ½ AcOH • 3H2O
(M.W. 774.91 • 30.03 • 54.05) C40H54N8O8 • ½ CH3COOH •
3H2O
R.L. Haberl, P.J. Decker, and K.M. Einhäupl, Circ. Res., 68, 1621 (1991). (Biological Activity)
J.W. Harding, et al., Brain Res., 583, 340 (1992). (Specific Binding Site in Brain)
J.M. Hanesworth, et al., J. Pharmacol. Exp. Ther., 266, 1036 (1993). (Specific Binding Site in Heart)
M. de Gasparo, et al., Hypertension, 25, 924 (1995). (AT4 Receptor; Non AT½ Recognition, Nomenclature)

* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

[Val5]-Angiotensin I (Bovine)* PAN-4069-v 0.5 mg 40

PEPTIDES INTERNATIONAL

Asp-Arg-Val-Tyr-Val-His-Pro-Phe-His-Leu -20 °C vial

(M.W. 1282.4) C61H87N17O14 [484-43-5]
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

[Val5]-Angiotensin I (Bovine)* (Bulk) PAN-4069 25 mg 595

Asp-Arg-Val-Tyr-Val-His-Pro-Phe-His-Leu • AcOH • 5H2O -20 °C
(M.W. 1282.4 • 60.05 • 90.08) C61H87N17O14 • CH3COOH •
5H2O
D.F. Elliott and W.S. Peart, Biochem. J., 65, 246 (1957). (Original; Heterogenous Renin)
H. Akagi, et al., Chem. Pharm. Bull., 30, 2498 (1982). (Original; Homologous Renin)
M. Takai, Y. Kurano, T. Kimura, and S. Sakakibara, Peptide Chemistry, 1979, 187 (1980). (Chem. Synthesis)
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

[Asn1, Val5]-Angiotensin II* PAN-4036-v 0.5 mg 35

Asn-Arg-Val-Tyr-Val-His-Pro-Phe -20 °C vial
(M.W. 1031.2) C49H70N14O11 [53-73-6]

[Asn1, Val5]-Angiotensin II* (Bulk) PAN-4036 25 mg 550

Asn-Arg-Val-Tyr-Val-His-Pro-Phe • AcOH • 4H2O -20 °C
(M.W. 1031.2 • 60.05 • 72.06) C49H70N14O11 • CH3COOH •
4H2O
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

Angiotensin (Human, 1-7)* PAN-4332-v 0.5 mg 35

(Canine, Rat) -20 °C vial
Asp-Arg-Val-Tyr-Ile-His-Pro
(M.W. 899.00) C41H62N12O11 [51833-78-4]
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

14 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT CODE QTY PRICE
[Sar1]-Angiotensin II PAN-3948-PI 1 mg 45

BIOLOGICALLY ACTIVE PEPTIDES

H-Sar-Arg-Val-Tyr-Ile-His-Pro-Phe-OH -20 °C 5 mg 195
(M.W. 1002.19) C49H71N13O10
Vasoconstrictive Peptide / Angiotensin Peptide
R.J. Kokje, W.L. Wilson, T.E. Brown, V.T. Karamyan, J.W. Wright, and R.C. Speth, Hypertension, 49, 1328 (2007).

Angiotensin (Human, 1-7)* (Bulk) PAN-4332 25 mg 365

(Canine, Rat) -20 °C
Asp-Arg-Val-Tyr-Ile-His-Pro • AcOH • 4H2O
(M.W. 899.00 • 60.05 • 72.06) C41H62N12O11 • CH3COOH •
4H2O
M.T. Schiavone, R.A.S. Santos, K.B. Brosnihan, M.C. Khosla, and C.M. Ferrario,
Proc. Natl. Acad. Sci. U.S.A., 85, 4095 (1988). (Original)
C.M. Ferrario, K.B. Brosnihan, D.I. Diz, N. Jaiswal, M.C. Khosla, A. Milsted, and E.A. Tallant,
Hypertension, 18 (Suppl. III), III-126 (1991). (Review)
R.A.S. Santos, K.B. Brosnihan, D.W. Jacobsen, P.E. DiCorleto, and C.M. Ferrario,
Hypertension, 19 (Suppl. II), II-56 (1992). (Metabolic Pathway)
A. DelliPizzi, S.D. Hilchey, and C.P. Bell-Quilley, Br. J. Pharmacol., 111, 1 (1994). (Pharmacol.)
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

[Sar1, Ala8]-Angiotensin II PAN-4035-v 0.5 mg 35

Sar-Arg-Val-Tyr-Ile-His-Pro-Ala -20 °C vial
(M.W. 926.07) C43H67N13O10 [38027-95-11]

[Sar1, Ala8]-Angiotensin II (Bulk) PAN-4035 25 mg 455

Sar-Arg-Val-Tyr-Ile-His-Pro-Ala • AcOH • 4H2O -20 °C
(M.W. 926.07 • 60.05 • 72.06) C43H67 N13O10 • CH3COOH • 4H2O
Angiotensin II Selective Antagonist

PEPTIDES INTERNATIONAL
D.T. Pals, F.D. Masucci, G.S. Denning, Jr., F. Sipos, and D.C. Fessler, Circ. Res., 29, 673 (1971). (Original)
F.M. Bumpus, S. Sen, R.R. Smeby, C. Sweet, C.M. Ferrario, and M.C. Khosla, Circ. Res., 32 and 33 (Suppl. I),
1-150 (1973). (Pharmacol.)

[Sar1, Ile8]-Angiotensin II PAN-4016-v 0.5 mg 35

Sar-Arg-Val-Tyr-Ile-His-Pro-Ile -20 °C vial
(M.W. 968.15) C46H73N13O10 [37827-06-8]

[Sar1, Ile8]-Angiotensin II (Bulk) PAN-4016 25 mg 455

Sar-Arg-Val-Tyr-Ile-His-Pro-Ile • AcOH • 4H2O -20 °C
(M.W. 968.15 • 60.05 • 72.06) C46H73N13O10 • CH3COOH •
4H2O
Angiotensin II Selective Antagonist
F.M. Bumpus, et al. Circ. Res., 32 and 33 (Suppl. I), 1-150 (1973).
R.K. Türker, M.M. Hall, M. Yamamoto, C.S. Sweet, and F.M. Bumpus, Science, 177, 1203 (1972).

[Sar1, Thr8]-Angiotensin II PAN-4102-v 0.5 mg 35

Sar-Arg-Val-Tyr-Ile-His-Pro-Thr -20 °C vial
(M.W. 956.10) C44H69N13O11 [53632-49-8]

[Sar1, Thr8]-Angiotensin II (Bulk) PAN-4102 25 mg 550

Sar-Arg-Val-Tyr-Ile-His-Pro-Thr • 2AcOH • 4H2O -20 °C
(M.W. 956.101 • 120.10 • 72.06) C44H69N13O11 • 2CH3COOH • 4H2O
Angiotensin II Selective Antagonist
M.C. Khosla, M.M. Hall, R.B. Smeby, and F.M. Bumpus, J. Med. Chem., 17, 1156 (1974). (Original; Chem. Synthesis)

Order Hotline 1-800-777-4779 502-266-8787 15

 PRODUCT CODE QTY PRICE
BIOLOGICALLY ACTIVE PEPTIDES

[Sar1, Val5, Ala8]-Angiotensin II* PAN-4071-v 0.5 mg 35

Sar-Arg-Val-Tyr-Val-His-Pro-Ala -20 °C vial
(M.W. 912.05) C42H65N13O10 [34273-10-4]
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

[Sar1, Val5, Ala8]-Angiotensin II* (Bulk) PAN-4071 25 mg 550

Sar-Arg-Val-Tyr-Val-His-Pro-Ala • AcOH • 4H2O -20 °C
(M.W. 912.05 • 60.05 • 72.06) C42H65N13O10 • CH3COOH •
4H2O
Angiotensin II Selective Antagonist
D.T. Pals, F.D. Masucci, G.S. Denning, Jr., F. Sipos, and D.C. Fessler, Circ. Res., 29, 673 (1971). (Original)
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

[Val5]-Angiotensin II* PAN-4034-v 0.5 mg 35

Asp-Arg-Val-Tyr-Val-His-Pro-Phe -20 °C vial
(M.W. 1032.2) C49H69N13O12 [58-49-1]
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

[Val5]-Angiotensin II* (Bulk) PAN-4034 25 mg 455

Asp-Arg-Val-Tyr-Val-His-Pro-Phe • AcOH • 4H2O -20 °C
(M.W. 1032.2 • 60.05 • 72.06) C49H69N13O12 • CH3COOH •
4H2O [5649-07-0]
D.F. Elliot and W.S. Peart, Nature, 177, 527 (1956). (Original; Heterogenous Renin)
H. Akagi, et al., Chem. Pharm. Bull., 30, 2498 (1982). (Original; Homologous Renin)
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

Des-Asp1-[Ile8]-Angiotensin II PAN-4037-v 0.5 mg 35

PEPTIDES INTERNATIONAL

Arg-Val-Tyr-Ile-His-Pro-Ile -20 °C vial

(M.W. 897.08) C43H68N12O9 [52498-25-6]

Des-Asp1-[Ile8]-Angiotensin II (Bulk) PAN-4037 25 mg 400

Arg-Val-Tyr-Ile-His-Pro-Ile • 2AcOH • 4H2O -20 °C
(M.W. 897.08 • 120.10 • 72.06) C43H68N12O9 • 2CH3COOH •
4H2O [102029-49-2]
Angiotensin III Selective Antagonist
T. Kono, F. Ikeda, F. Oseko, H. Imura, and J. Endo, J. Clin. Endocrinol. Metab., 52, 354 (1981). (Pharmacol.)

CGP 42112 PAN-4296-v 0.5 mg 75

Nic-Tyr-Lys(Z-Arg)-His-Pro-Ile -20 °C vial
(Nic-Nicotinoyl, Z-: Benzyloxycarbonyl)
(M.W. 1052.2) C52H69N13O11 [127060-75-7]
Angiotensin AT2 Receptor Agonist
S.E. Whitebread, et al., Biochem. Biophys. Res. Commun.,
181, 1365 (1991).
B. Buisson, S.P. Bottari, M. de Gasparo, N. Gallo-Payet, and M.D. Payet, FEBS Lett., 309, 161 (1992). (Pharmacol.)
G. Koike, et al., Biochem. Biophys. Res. Commun., 203,
1842 (1994). (Pharmacol.)

Proangiotensin-12 (Rat) PAN-4439-v 0.5 mg 55

Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-Leu-Tyr -20 °C vial
(M.W. 1572.8) C77H109N19O17 [914910-73-9]
New Member of Angiotensin Family
S. Nagata, et al., Biochem. and Biophys. Res. Commun., 350, 1026 (2006). (Original; Primary Structure & Pharmacol.)
• This compound is distributed through Peptide Institute, Inc. under the license of University of Miyazaki.

16 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT CODE QTY PRICE

BIOLOGICALLY ACTIVE PEPTIDES

A-Type (Atrial) Natriuretic Peptides (ANP) and Related Peptides
P. Needleman, E.H. Blaine, J.E. Greenwald, M.L. Michener, C.B. Saper, P.T. Stockmann, and H.E. Tolunay,
Annu. Rev. Pharmacol. Toxicol., 29, 23 (1989). (Review)
A. Rosenzweig and C.E. Seidman, Annu. Rev. Biochem., 60, 229 (1991). (Review)

ANP (Human, 1-28)* PAF-4135-s 0.1 mg 130

A-Type (Atrial) Natriuretic Peptide (Human, 1-28) -20 °C vial
(Porcine, Bovine, Canine)
Ser-Leu-Arg-Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Met-Asp-Arg-Ile-Gly-
Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr
(Disulfide bond between Cys7-Cys23)
(M.W. 3080.4) C127H203N45O39S3 [91917-63-4]
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

ANP (Human, 1-28)* PAF-4135-v 0.5 mg 455

A-Type (Atrial) Natriuretic Peptide (Human, 1-28) -20 °C vial
(Porcine, Bovine, Canine)
K. Kangawa and H. Matsuo, Biochem. Biophys. Res. Commun., 118, 131 (1984). (Original)
T.X. Watanabe, Y. Noda, N. Chino, Y. Nishiuchi, T. Kimura, S. Sakakibara, and M. Imai, Eur. J. Pharmacol.,
147, 49 (1988). (Pharmacol.)
• This compound is distributed under the license of Suntory Ltd. Its use or sale for diagnostics is strictly prohibited.
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

[Met(O)12]-ANP (Human, 1-28)* PAF-4145-v 0.5 mg 490

[Met(O)12]-A-Type (Atrial) Natriuretic Peptide (Human, 1-28) -20 °C vial
Ser-Leu-Arg-Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Met(O)-Asp-Arg-
Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr

PEPTIDES INTERNATIONAL
(Disulfide bond between Cys7-Cys23)
(M.W. 3096.4) C127H203N45O40S3
T.X. Watanabe, Y. Noda, N. Chino, Y. Nishiuchi, T. Kimura, S. Sakakibara, and M. Imai, Eur. J Pharmacol.,
147, 49 (1988). (Pharmacol.)
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

ANP (Human, 5-27)* PAF-4138-v 0.5 mg 445

A-Type (Atrial) Natriuretic Peptide (Human, 5-27) -20 °C vial
Ser-Ser-Cys-Phe-Gly-Gly-Arg-Met-Asp-Arg-Ile-Gly-
Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg
(Disulfide bond between Cys7-Cys23)
(M.W. 2404.7) C97H154N34O32S3
T.X. Watanabe, Y. Noda, N. Chino, Y. Nishiuchi, T. Kimura, S. Sakakibara, and M. Imai, Eur. J. Pharmacol.,
147, 49 (1988). (Pharmacol.)
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

ANP (Human, 5-28)* PAF-4137-v 0.5 mg 455

A-Type (Atrial) Natriuretic Peptide (Human, 5-28) -20 °C vial
Ser-Ser-Cys-Phe-Gly-Gly-Arg-Met-Asp-Arg-Ile-Gly-Ala-
Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr
(Disulfide bond between Cys7-Cys23)
(M.W. 2567.8) C106H163N35O34S3
S. Ueda, T. Sudoh, K. Fukuda, K. Kangawa, N. Minamino, and H. Matsuo, Biochem. Biophys. Res. Commun.,
149, 1055, (1987). (Original)
T.X. Watanabe, Y. Noda, N. Chino, Y. Nishiuchi, T. Kimura, S. Sakakibara, and M. Imai, Eur. J. Pharmacol., 147, 49
(1988). (Pharmacol.)
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

Order Hotline 1-800-777-4779 502-266-8787 17

 PRODUCT CODE QTY PRICE
BIOLOGICALLY ACTIVE PEPTIDES

ANP (Human, 7-28)* PAF-4139-v 0.5 mg 445

A-Type (Atrial) Natriuretic Peptide (Human, 7-28) -20 °C vial
Cys-Phe-Gly-Gly-Arg-Met-Asp-Arg-Ile-Gly-Ala-Gln-
Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr
(Disulfide bond between Cys7-Cys23)
(M.W. 2393.7) C100H153N33O30S3
T.X. Watanabe, Y. Noda, N. Chino, Y. Nishiuchi, T. Kimura, S. Sakakibara, and M. Imai, Eur. J. Pharmacol.,
147, 49 (1988).
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

b-ANP (Human)* PAF-4168-s 0.1 mg 360

b-A-Type (Atrial) Natriuretic Peptide -20 °C vial
Antiparallel Dimer of ANP (Human,1 1-28)
Ser-Leu-Arg-Arg-Ser-Ser-Cys -Phe-Gly-Gly-Arg-Met-Asp-Arg-lle-Gly-Ala-Gln-Ser-Gly-
7
1 1
Leu-Gly-Cys23 -Asn-Ser-Phe-Arg-Tyr-Tyr-Arg-Phe-Ser-Asn-Cys23 -Gly-Leu-Gly-Ser-
71
Gln-Ala-Gly-lle-Arg-Asp-Met-Arg-Gly-Gly-Phe-Cys -Ser-Ser-Arg-Arg-Leu-Ser
1 1 1
(Disulfide bonds betwen Cys7-Cys23 and Cys7 -Cys23 )
(M.W. 6160.9) C254H406N90O78S6
K. Kangawa, A. Fukuda, and H. Matsuo, Nature, 313, 397 (1985). (Original)
N. Chino, K. Yoshizawa-Kumagaye, Y. Noda, T.X. Watanabe, T. Kimura, and S. Sakakibara,
Biochem. Biophys. Res. Commun., 141, 665 (1986). (Chem. Synthesis and Pharmacol.)
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

ANP (Rat, 1-28)* PAF-4151-s 0.1 mg 130

A-Type (Atrial) Natriuretic Peptide (Rat, 1-28) -20 °C vial
(Rabbit, Mouse)
Ser-Leu-Arg-Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Ile-Asp-Arg-Ile-
PEPTIDES INTERNATIONAL

Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr
(Disulfide bond between Cys7-Cys23)
(M.W. 3062.4) C128H205N45O39S2 [88898-17-3]
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

ANP (Rat, 1-28)* PAF-4151-v 0.5 mg 455

A-Type (Atrial) Natriuretic Peptide (Rat, 1-28 -20 °C vial
(Rabbit, Mouse))
T.G. Flynn, M.L. DeBold, and A.J. DeBold, Biochem. Biophys. Res. Commun., 117, 859 (1983). (Original)
T.X. Watanabe, Y. Noda, N. Chino, Y. Nishiuchi, T. Kimura, S. Sakakibara, and M. Imai, Eur. J. Pharmacol., 147, 49
(1988). (Pharmacol.)

* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

ANP (Rat, 3-28)* PAF-4159-v 0.5 mg 455

A-Type (Atrial) Natriuretic Peptide (Rat, 3-28) -20 °C vial
Arg-Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Ile-Asp-Arg-Ile-Gly-
Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr
(Disulfide bond between Cys7-Cys23)
(M.W. 2862.2) C119H189N43O36S2 [90984-99-9]
N.G. Seidah, et al., Proc. Natl. Acad. Sci. USA, 81, 2640 (1984). (Original)
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

18 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT CODE QTY PRICE
Apamin

BIOLOGICALLY ACTIVE PEPTIDES

Apamin PAP-4257-v 0.5 mg 225
(Honeybee, Apis mellifera) -20 °C vial
Cys-Asn-Cys-Lys-Ala-Pro-Glu-Thr-Ala-Leu-Cys-
Ala-Arg-Arg-Cys-Gln-Gln-His-NH2
(Disulfide bond between Cys1-Cys11 and Cys3-Cys15)
(M.W. 2027.3) C79H131N31O24S4 [24345-16-2]
Small Conductance Ca2+-Activated K+ Channel Blocker
E. Haberman, Pharmacol. Ther., 25, 255 (1984). (Review)
A.L. Blatz and K.L. Magleby, Nature, 323, 718 (1986). (Pharmacol.)
M.L. Garcia, A. Galvez, M. Garcia-Calvo, V.F. King, J. Vazquez, and
G.J. Kaczorowski, J. Bioenerg. Biomembr., 23, 615 (1991). (Review)

Apelins
S.C. Sorli, L. van den Berghe, B. Masri, B. Knibiehler, and Y. Audigier, Drug Discov. Today, 11, 1100 (2006). (Review)
C. Carpene, C. Dray, C. Attane, P. Valet, M.P. Portillo, I. Churruca, F.I. Milagro, and I. Castan-Laure,
J. Physiol. Biochem., 63, 359 (2007 (Review)
I. Falcao-Pires, R. Ladeiras-Lopes, and A.F. Leite-Moreira, Expert Opin. Ther. Targets, 14, 633 (2010). (Review)

Apelin-36 (Human) PAP-4362-s 0.1 mg 180

Leu-Val-Gln-Pro-Arg-Gly-Ser-Arg-Asn-Gly-Pro-Gly-Pro- -20 °C vial
Trp-Gln-Gly-Gly-Arg-Arg-Lys-Phe-Arg-Arg-Gln-Arg-
Pro-Arg-Leu-Ser-His-Lys-Gly-Pro-Met-Pro-Phe
(M.W. 4195.8) C184H297N69O43S [252642-12-9]
Ligand for APJ Receptor
K. Tatemoto, M. Hosoya, Y. Habata, R. Fujii, T. Kakegawa, M.-X. Zou, Y. Kawamata, S. Fukusumi, S. Hinuma, C. Kitada,

PEPTIDES INTERNATIONAL
T. Kurokawa, H. Onda, and M. Fujino, Biochem. Biophys. Res. Commun., 251, 471 (1998). (Original; Human and Bovine)
M.-X. Zou, H.-Y. Liu, Y. Haraguchi, Y. Soda, K. Tatemoto, and H. Hoshino, FEBS Lett., 473, 15 (2000). (Pharmacol.)
M. Hosoya, Y. Kawamata, S. Fukusumi, R. Fujii, Y. Habata, S. Hinuma, C. Kitada, S. Honda, T. Kurokawa, H. Onda,
O. Nishimura, and M. Fujino, J. Biol. Chem., 275, 21061 (2000). (Pharmacol.)
• This compound is distributed through Peptide Institute, Inc. under license of Takeda Chemical Industries, Ltd.

[Pyr1]-Apelin-13 (Human, Bovine) PAP-4361-v 0.5 mg 85

(Rat) -20 °C vial
Pyr-Arg-Pro-Arg-Leu-Ser-His-Lys-Gly-Pro-Met-Pro-Phe
(M.W. 1533.8) C69H108N22O16S [217082-60-5]
Ligand for APJ Receptor
K. Tatemoto, M. Hosoya, Y. Habata, R. Fujii, T. Kakegawa, M.-X. Zou, Y. Kawamata, S. Fukusumi, S. Hinuma, C. Kitada,
T. Kurokawa, H. Onda, and M. Fujino, Biochem. Biophys. Res. Commun., 251, 471 (1998). (Original; Human and Bovine)
M.-X. Zou, H.-Y. Liu, Y. Haraguchi, Y. Soda, K. Tatemoto, and H. Hoshino, FEBS Lett., 473, 15 (2000). (Pharmacol.)
M. Hosoya, Y. Kawamata, S. Fukusumi, R. Fujii, Y. Habata, S. Hinuma, C. Kitada, S. Honda, T. Kurokawa, H. Onda,
O. Nishimura, and M. Fujino, J. Biol. Chem., 275, 21061 (2000). (Pharmacol.)
D.K. Lee, R. Cheng, T. Nguyen, T. Fan, A.P. Kariyawasam, Y. Liu, D.H. Osmond, S.R. George, and B.F. O'Dowd,
J. Neurochem., 74, 34 (2000). cDNA Seq.; Rat)
N. De Mota, A.R.-L. Goazigo, S.E. Messari, N. Chartrel, D. Roesch, C. Dujardin, C. Kordon, H. Vaudry, F. Moos,
and C. Llorens-Cortes, Proc. Natl. Acad. Sci. U.S.A., 101, 10464 (2004). (Endogenous Apelin 13 in Rat)
• This compound is distributed through Peptide Institute, Inc. under license of Takeda Chemical Industries, Ltd.

Order Hotline 1-800-777-4779 502-266-8787 19

 PRODUCT CODE QTY PRICE
BIOLOGICALLY ACTIVE PEPTIDES

Arg-Gly-Asp "RGD" Peptides.

The extracellular matrix (ECM) is central to cell recognition, adhesion and migration.
ECM proteins have an arg-gly-asp (RGD) core that allows for receptor recognition.
Synthetic peptides containing RGD can compete with ECM protein ligands for receptor
binding. GRGDNP (PCI-3909-PI) binds to vitronectin and fibronectin receptors and
block interaction to their perspective ligands, though it is a more active inhibitor of
fibronectin receptor.1 GRGDNP was found to induce caspase 3 mediated apoptosis
in cells and block tumor invasion, implicating fibronectin and vitronectin in tumor
metastasis.2,3 In addition, these ECM proteins may influence cardiac function as well.4,5
1. M.D. Pierschbacher and E. Ruoslahti, 3. K.R. Gehlsen, et al., J. Cell Biol., 106, 925 (1988).
J. Biol. Chem., 262, 17294 (1987). 4. V. Sarin, et al., J. Physiol., 564.2, 603 (2005).
2. C.D. Buckley, et al., Nature, 397, 534 (1999). 5. J.E. Mogford, et al., J. Clin. Invest., 100, 1647 (1997).

cyclo (Arg-Gly-Asp-d-Phe-Cys) PCI-3686-PI 1 mg 59

c(RGDfC) -20 °C 5 mg 175
(M.W. 578.65) C24H34N8O7S
RGD Tumor Targeting Peptide (linker additions via Cys) 25 mg 695
(Requires further derivatization before use)
C. Pattillo, F. Sari-Sarraf, R. Nallamothu, B. Moore, G. Wood, and M. Kiani, Experim. Clin.Therapeutics,
Radiation Research Society Meeting (2005)

cyclo (Arg-Ala-Asp-d-Phe-Cys) PCI-3960-PI 1 mg 59

c(RADfC) -20 °C 5 mg 175
(M.W. 592.68) C25H36N8O7S
Negative Control Peptide for PCI-3686-PI 25 mg 695
cyclo (Arg-Gly-Asp-d-Phe-Glu)
PEPTIDES INTERNATIONAL

PCI-3687-PI 1 mg 49
c(RGDfE) -20 °C 5 mg 149
(M.W. 604.63) C26H36N8O9
RGD Peptide for Radiolabeling and Imaging 25 mg 595
(Requires further derivatization before use)
G. Thumshirn, U. Hersel, S.L. Goodman, and H. Kessler, Chem. Eur. J., 9, 2717 (2003).
T. Poethko, M. Schottelius, G. Thumshirn, U. Hersel, M. Herz, G. Henriksen, H. Kessler, M. Schwaiger,
and H.J. Wester, J. Nucl. Med., 45, 892 (2004).

cyclo [Arg-Ala-Asp-d-Phe-Lys(Biotin-PEG- PCI-3808-PI 1 mg 69

PEG)] -20 °C 5 mg 225
c(RADfK(Biotin-PEG-PEG)]
(M.W. 1134.33 C50H79N13O15S
Negative control peptide for PCI-3697-PI

cyclo (Arg-Gly-Asp-d-Phe-Lys) PCI-3661-PI 1 mg 49

c(RGDfK) -20 °C 5 mg 149
(M.W. 603.68) C27H41N9O7
αv β3 Integrin Binding RGD Peptide 25 mg 595
RGD Tumor Targeting Peptide
(Requires further derivatization before use)
M. Kantlehner, et al., Chembiochem., 1, 107 (2000).
R.J. Kok, et al., Bioconjug. Chem., 13, 128 (2002).

cyclo (Arg-Gly-Asp-d-Phe-Lys) PCI-3919-PI 1 mg 49

c(RGDfK) -20 °C 5 mg 149
(Trifluoroacetate Form)
(M.W. 603.68) C27H41N9O7 25 mg 595
M. Kantlehner, et al., Chembiochem., 1, 107 (2000).
R.J. Kok, et al., Bioconjug. Chem., 13, 128 (2002).

20 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT CODE QTY PRICE
cyclo (Arg-Ala-Asp-d-Phe-Lys) PCI-3883-PI 1 mg 49

BIOLOGICALLY ACTIVE PEPTIDES

c(RADfK) -20 °C 5 mg 149
(M.W. 617.71) C28H43N9O7
Negative Control RGD Peptide for PCI-3661-PI 25 mg 595
P.K. Dubey, et al., J. Drug Targeting, 12, 257 (2004).

cyclo [Arg-Gly-Asp-d-Phe-Lys (PEG-PEG- PCI-3759-PI 1 mg 280

Azide)] one of The Clickables -20 °C 5 mg 1120
(Trifluoroacetate Form)
(M.W. 920.00) C39H61N13O13
Clickable RGD for Dendrimer Constructs

cyclo [Arg-Gly-Asp-d-Phe-Lys (Azide)] RGD-3749-PI 1 mg 75

one of The Clickables -20 °C 5 mg 225
(Trifluoroacetate Form)
(M.W. 629.68) C27H39N11O7
Clickable RGD for Dendrimer Constructs

cyclo [Arg-Gly-Asp-D-Phe-Lys(Mal)] RGD-3795-PI 1 mg 59

(Trifluoroacetate Form) -20 °C 5 mg 175
(M.W. 754.81) C34H46N10O10
RGD peptide with 3-maleimide propionic acid functional group 25 mg 795
cyclo [Arg-Gly-Asp-d-Phe-Lys(PEG- PCI-3977-PI 1 mg 69
COCH2CH2SH)] -20 °C 5 mg 225
where PEG = 8-Amino-3,6-Dioxaoctanoic Acid
(M.W. 836.97) C36H56N10O11S

PEPTIDES INTERNATIONAL
cyclo [Arg-Gly-Asp-d-Phe-Lys(PEG-PEG)] PCI-3696-PI 1 mg 59
c(RGDfK(PEG-PEG)) -20 °C 5 mg 175
where PEG = 8-Amino-3,6-Dioxaoctanoic Acid
(M.W. 894.00) C39H63N11O13 25 mg 695
RGD Peptide equipped with PEG spacers for more efficient binding to lipid surfaces
(Requires further derivatization before use)
P. Holig, et al., Protein Engin. Design Selection, 17, 433 (2004).

cyclo [Arg-Ala-Asp-d-Phe-Lys(PEG-PEG)] PCI-3954-PI 1 mg 59

c[RADfK(PEG-PEG)] -20 °C 5 mg 175
(M.W. 908.03) C40H65N11O13
Negative Control Peptide for PCI-3696-PI 25 mg 695
cyclo (Arg-Gly-Asp-d-Phe-Lys(Biotin-PEG- PCI-3697-PI 1 mg 69
PEG)) -20 °C 5 mg 225
c(RGDfK(Biotin-PEG-PEG))
where PEG = 8-Amino-3,6-Dioxaoctanoic Acid
(Trifluoroacetate Form)
(M.W. 1120.30) C49H77N13O15S
RGD Peptide equipped with a biotin reporting tag and PEG spacers
for more efficient binding to lipid surfaces
(Requires further derivatization before use)
C. Dolce, et al., J. Dent. Res., 82, 682 (2003).
P. Holig, et al., Protein Engin. Design Selection, 17, 433 (2004).

Order Hotline 1-800-777-4779 502-266-8787 21

 PRODUCT CODE QTY PRICE
BIOLOGICALLY ACTIVE PEPTIDES

cyclo [Arg-Gly-Asp-d-Phe-Lys(Ac-SCH2CO)] PCI-3699-PI 1 mg 59

c[RGDfK (Ac-SCH2CO)] -20 °C 5 mg 175
(M.W. 719.82) C31H45N9O9S
25 mg 795
RGD Peptide equipped with thioacetyl group for linking to liposomes
(Requires further derivatization and deprotection before use)
R.J. Kok, et al., Bioconjug. Chem., 13, 128 (2002).
R.M. Schiffelers, et al., J. of Controlled Release, 91, 115 (2003).
K. Darlak, et al., J. Biol. Chem., 265, 5199 (1990).

cyclo (Arg-Ala-Asp-d-Phe-Lys(Ac-SCH2CO)) PCI-3959-PI 1 mg 59

c(RADfK(Ac-SCH2CO)) -20 °C 5 mg 175
(M.W. 733.85) C32H47N9O9S
Negative Control Peptide for PCI-3699-PI 25 mg 795
Galactosyl-cyclo (Arg-Gly-Asp-d-Phe-Lys) RGD-3736-PI 1 mg 375
Cyclo(-Arg-Gly-Asp-d-Phe-Lys(SAA)) -20 °C 5 mg 1500
(M.W. 792.85) C34H52N10O12 [922175-70-0]
Glycosylated RGD for radiolabelling
Haubner, et al., Bioconjugate Chem., 15, 1, (2004).

Galacto-RGD2 RGD-3782-PI 1 mg 200

(M.W> 2149.24) C91H137N29O32, -20 °C 5 mg 600
Galacto RGD dimer
S. Ji, Al Czerwinski, Y. Zhou, Gl Shao, F. Valenzuela, P. Sowinski, S. Chauhan, M. Pennington, and S. Liu,
Mol. harmaceutics, in press

H-Glu[cyclo (Arg-Ala-Asp-d-Phe-Lys)]2 PCI-3979-PI 1 mg 69

PEPTIDES INTERNATIONAL

(Trifluoroacetate Form) -20 °C 5 mg 225

Negative Control Peptide for PCI-3651-PI
25 mg 795
H-Glu[cyclo (Arg-Gly-Asp-d-Phe-Lys)]2 PCI-3651-PI 1 mg 69
E-[c(RGDfK)2] -20 °C 5 mg 225
(M.W. 1318.47) C59H87N19O16
αv β3 Integrin Binding RGD Peptide 25 mg 795
RGD Tumor Targeting Peptide
(Requires further derivatization before use)
M.L. Janssen, et al., Cancer. Res., 62, 6146 (2002).
Y. Wu, et al., J. Nucl. Med., 46, 1707 (2005).

H-Glu{Glu[cyclo (Arg-Gly-Asp-d-Phe-Lys)]2}2 PCI-3975-PI 1 mg 225

(Trifluoroacetate Form) -20 °C 5 mg 400
H-E{E[cRGDfK]2}2
(M.W. 2748.04) C123H179N39O34 25 mg 1600
Tetrameric RGD Peptide
S. Liu, et al., Bioconjugate Chem., 17, 1499 (2006).
S. Liu, et al.,Bioconjugate Chem., 18, 438 (2007).

cyclo (Arg-Gly-Asp-d-Phe-Val) ICA-4304-v 0.5 mg 85

c(RGDfV) -20 °C vial
(M.W. 574.63) C26H38N8O7 [137813-35-5]
Angiogenesis Inhibitor
P.C. Brooks, et al., Cell, 79, 1157 (1994). (Original)
M. Friedlander, et al., Proc. Natl. Acad. Sci. USA, 93, 9764 (1996). (Pharmacol.)

22 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT CODE QTY PRICE
cyclo (Arg-Gly-Asp-d-Phe-Val) • AcOH • 2H2O ICA-4304 25 mg 700

BIOLOGICALLY ACTIVE PEPTIDES

(Bulk) -20 °C
c(RGDfV)
(M.W. 574.63 • 60.25 • 36.03) • C26H38N8O7 • CH3COOH • 2H2O
Angiogenesis Inhibitor

cyclo (Arg-Ala-Asp-d-Phe-Val) PCA-3618-PI 1 mg 49

c(RADfV) -20 °C 5 mg 149
(M.W. 588.67) C27H40N8O7
Negative Control Peptide for ICA-4304 25 mg 595
M. Friedlander, et al., PNAS, 93, 9764 (1996).

cyclo (Arg-Gly-Asp-d-Tyr-Cys) PCI-3912-PI 1 mg 59

c(RGDyC) -20 °C 5 mg 175
(M.W. 594.65) C24H34N8O8S

cyclo (Arg-Ala-Asp-d-Tyr-Cys) PCI-3917-PI 1 mg 59

c(RADyC) -20 °C 5 mg 175
(M.W. 608.68) C25H36N8O8S
Negative Control Peptide for PCI-3912-PI

cyclo (Arg-Gly-Asp-d-Tyr-Glu) PCI-3688-PI 1 mg 49

c(RGDyE) -20 °C 5 mg 149
RGD Peptide for Radiolabeling
(Requires further derivatization before use) 25 mg 595
(M.W. 620.62) C26H36N8O10

cyclo (Arg-Gly-Asp-d-Tyr-Lys) PCI-3662-PI 1 mg 49

c(RGDyK)

PEPTIDES INTERNATIONAL
-20 °C 5 mg 149
(M.W. 619.68) C27H41N9O7
αv β3 Integrin Binding RGD Peptide 25 mg 595
RGD Tumor Targeting and Tumor Imaging Peptide
(Requires further derivatization before use)
R. Haubner, et al., J. Nuclear Med., 42, 326 (2001).
X. Chen, et al., Nucl. Med. Biol., 31, 179 (2004).
X. Chen, et al., Cancer Res., 641, 8009 (2004).
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

H-Glu[cyclo (Arg-Gly-Asp-d-Tyr-Lys)]2 PCI-3899-PI 1 mg 69

H-E[c(RGDyK)]2 -20 °C 5 mg 225
(M.W. 1350.47) C59H87N19O18
RGD Tumor Targeting and Tumor Imaging Peptide 25 mg 795
(Requires further derivatization before use)
Y. Wu, et al., J. Nucl. Med., 46, 1707 (2005).
X. Chen, et al., Mol. Imaging Biol., 6, 350 (2004).
X. Chen, et al., J. Med. Chem., 48, 1098 (2005).
X. Chen, et al., Mol. Imaging, 3, 96 (2004).

H-AEEEA-Glu[cyclo (Arg-Gly-Asp-D-Tyr-Lys)]2 RGD-3766-PI 1 mg 89

PEG3-c(RGDyK)2 -20 °C 5 mg 285
(Trifluoroacetate Form)
(M.W. 1539.68) C67H102N20O22 25 mg 975
Byclic RGD peptide for imaging
E. Chang, et al., European Journal of Nuclear Medicine and Molecular Imaging, 38, 722 (2010).
F.T. Chin, et al., Molecular Imaging and Biology, 14, 88 (2011).

Order Hotline 1-800-777-4779 502-266-8787 23

 PRODUCT CODE QTY PRICE
BIOLOGICALLY ACTIVE PEPTIDES

cyclo [Arg-Gly-Asp-d-Phe-Lys(dPEG™4)] PCI-3790-PI 1 mg 59

(Trifluoroacetate Form) -20 °C 5 mg 175
(M.W. 850.98) C38H62N10O12
GD Tumor Targeting (and With Radiolabeling, A Tumor 25 mg 695
Imaging Peptide)

cyclo (Arg-Gly-Glu-d-Phe-Lys) PCI-3953-PI 1 mg 49

c(RGEfK) -20 °C 5 mg 149
(M.W. 617.71) C28H43N9O7
25 mg 595
Arg-Gly-Asp (RGD) for Cell Adhesion of Biomaterials
NEW! Integrins, such as fibronectin, are involved in mediating cell to cell interactions and cell to
extracellular matrix interactions. They play a central role in cell adhesion, chemotaxis,
cell growth, tissue repair, and tumor development among others. A peptide containing
the fibronectin active fragment or cell binding domain was first developed to increase cell
attachment to biomaterial or plastic surfaces.1 Ac-GrGDSPASSKGGGGSrLLLLLLr-
NH2 also contains a hydrophobic region, SPASSK which acts as a spacer between the
NEW! cell attachment and biomaterial domains for improved cell attachment to nonbiological
surfaces. Additional leucine residues were incorporated to obtain saturated binding.
D-arginines were introduced and the N- and C- termini were protected to prevent
degradation by endoproteases and exopeptidases respectively.
Ac-GrGDSPASSKGGGGSrLLLLLLr-NH2 has been used as a research application
for studying mechanochemical transduction and contractile forces by coating the
peptide to magnetic microbeads. This has allowed for the study of contractile forces
PEPTIDES INTERNATIONAL

of airway smooth muscle cells and their role with asthma and mechanical study of the
elasticity of alveolar epithelial cells.2,3 Besides its role in understanding cytoskeletal
remodeling, the peptide has also been employed to block C. albicans adherence
by binding to a fibronectin-like receptor on the yeast cells, reducing the number of
pathogens in vitro and in vivo.4 This peptide could also prove useful in cell attachment
to nonbiological surfaces for tissue regeneration and implantation associated with
therapeutic applications.
1. W.S. Craig, S. Cheng, D.G. Mullen, J. Blevitt, and M.D. Pierschbacher, Biopolymers Peptide Science, 37, 157 (1995).
2. S.S. An, B. Fabry, X. Trepat, N. Wang, and J.J. Fredberg, Am. J. Resp. Cell and Molec. Biol., 35, 55 (2006).
3. X. Trepat, M. Grabulosa, F. Puig, G.N. Maksym, D. Navajas, and R. Farre, Am. J. Physiol. Lung Cell Mol. Physiol.,
287, L1025 (2004).
4. S.A. Klotz, R.L. Smith, and B.W. Stewart, Antimicrob. Agents and Chemother., 36, 132 (1992).

Ac-Gly-D-Arg-Gly-Asp-Ser-Pro-Ala-Ser-Ser- PFA-3924-PI 1 mg 75
Lys-(Gly)4-Ser-d-Arg-(Leu)6-d-Arg-NH2 -20 °C 5 mg 245
Ac-GrGDSPASSKGGGGSrLLLLLLr-Amide
(Trifluoroacetate Form)
(M.W. 2308.69) C98H174N34O30

H-Arg-Gly-Asp-Ser-Lys-OH PCI-3929-PI 1 mg 75
RGDSK -20 °C 5 mg 275
(M.W. 561.60) C21H39N9O9
RGD Tumor Targeting Peptide
S. Jasseron, et al., Bioorganic & Medicinal Chemistry Letters, 12, 7, (2002).
S. Jasseron, et al., Eur J Med Chem, 38, 9, (2003).

24 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT CODE QTY PRICE
H-Arg-Ala-Asp-Ser-Lys-OH PCI-3930-PI 1 mg 75

BIOLOGICALLY ACTIVE PEPTIDES

RADSK -20 °C 5 mg 275
(M.W. 575.63) C22H41N9O9
Negative Control Peptide for PLI-3929-PI

H-[Cys-Arg-Gly-Asp-Arg-Gly-Pro-Asp-Cys]- RGD-3762-PI 1 mg 160

NH2 -20 °C 5 mg 640
H-[CRGDRGPDC]-NH2
(Trifluoroacetate Form)
(M.W. 975.08) C35H58N16O13S2
(Disulfide bond between Cys1-Cys9)
RGD Tumor Targeting Peptide
K Sugahara, et al., Science, 328, 1031 (2010).
Y. Ye, et al., Bioorg Med Chem Lett., 21, 1146 (2011).

H-[Cys-Arg-Gly-Asp-Lys-Gly-Pro-Asp-Cys]- RGD-3761-PI 1 mg 160

NH2 -20 °C 5 mg 640
H-[CRGDKGPDC]-NH2
(Trifluoroacetate Form)
(M.W. 947.07) C35H58N14O13S2
(Disulfide bond between Cys1-Cys9)
RGD Tumor Targeting Peptide
K Sugahara, et al., Science, 328, 1031 (2010).
Y. Ye, et al., Bioorg Med Chem Lett., 21, 1146 (2011).

Fibronectin Active Fragment (RGDS) PFA-4171-v 0.5 mg 35

Arg-Gly-Asp-Ser -20 °C vial

PEPTIDES INTERNATIONAL
(M.W. 433.42) C15H27N7O8 [91037-65-9]

Fibronectin Active Fragment (RGDS) (Bulk) PFA-4171 25 mg 285

Arg-Gly-Asp-Ser • ½AcOH • 2H2O -20 °C 100 mg 910
(M.W. 433.42 • 30.03 • 36.03) C15H27N7O8 • ½CH3COOH • 2H2O
Purity Information: Qp See page xiv
M.D. Piershbacher and E. Ruoslahti, Nature, 309, 30 (1984). (Original)
D.M. Haverstick, J.F. Cowan, K.M. Yamada, and S.A. Santoro, Blood, 66, 946 (1985). (Pharmacol.)

Fibronectin Active Fragment (GRGDS) PFA-4189-v 0.5 mg 35

Gly-Arg-Gly-Asp-Ser -20 °C vial
(M.W. 490.47) C17H30N8O9 [96426-21-0]

Fibronectin Active Fragment (GRGDS) (Bulk) PFA-4189 25 mg 340

Gly-Arg-Gly-Asp-Ser • ½AcOH • 2H2O -20 °C 100 mg 910
(M.W. 490.47 • 30.03 • 36.03) C17H30N8O9 • ½CH3COOH • 2H2O
S.K. Akiyama and K.M. Yamada, J. Biol. Chem., 260, 10402 (1985).
K. Olden, S. Mohia, S.A. Newton, S.L. White, and M.J. Humphries, Ann. N.Y. Acad. Sci., 551, 421 (1988).

H-Gly-Arg-Ala-Asp-Ser-Pro-OH PCI-3910-PI 1 mg 45
GRADSP -20 °C 5 mg 175
(M.W. 601.62) C23H39N9O10
Negative Control Peptide for Fibronectin Inhibitors
D.G. Hoyt, J.M. Rusnak, R.J. Mannix, R.A. Modzelewski, C.S. Johnson, and J.S. Lazo, Cancer Res., 56, 4146 (1996).

Order Hotline 1-800-777-4779 502-266-8787 25

 PRODUCT CODE QTY PRICE
BIOLOGICALLY ACTIVE PEPTIDES

H-Gly-Arg-Gly-Glu-Ser-OH PFA-3907-PI 5 mg 50
GRGES -20 °C 25 mg 225
(M.W. 504.50) C18H32N8O9
Negative Control Peptide for PFA-4189-v
C.D. Buckley, et al., Nature, 397, 534 (1999)

H-Gly-Arg-Gly-Asp-Asn-Pro-OH PCI-3909-PI 5 mg 75
GRGDNP -20 °C 25 mg 295
(M.W. 614.62) C23H38N10O10
Inhibitor of Cell Adhesion to Fibronectin.
M.D. Pierschbacher and E. Ruoslahti, J. Biol. Chem., 262, 17294 (1987)

H-Gly-Gly-Gly-Gly-Arg-Gly-Asp-Ser-Pro-OH PCI-3965-PI 5 mg 85
H-Gly-Gly-Gly-Gly-Arg-Gly-Asp-Ser-Pro-OH -20 °C 25 mg 245
GGGGRGDSP
(M.W. 758.75) C28H46N12O13

Fibronectin Adhesion-Promoting Peptide FAP-3758-PI 1 mg 45

H-Trp-Gln-Pro-Pro-Arg-Ala-Arg-Ile-OH -20 °C 5 mg 180
(Trifluoroacetate Form)
(M.W. 1023.22) C47H74N16O10 [125720-21-0]
D.L.Mooradian, et al., Invest. Ophthalmol. Vis. Sci., 34, 153 (1993).
A.Woods, et al., Mol. Biol. Cell, 4, 605 (1993).
K.L.Hines, et al., Proc. Natl. Acad. Sci. USA, 91, 5187 (1994).

Bivalirudin
Bivalirudin BIV-3767-PI 1 mg 44
PEPTIDES INTERNATIONAL

(Trifluoroacetate Form) -20 °C 5 mg 200

d-Phe-Pro-Arg-Pro-Gly-Gly-Gly-Gly-Asn-Gly-Asp-Phe-Glu-
NEW!

Glu-Ile-Pro-Glu-Glu-Tyr-Leu-OH
(M.W. 2180.33) C98H138N24O33
Specific, Reversible, Direct Thrombin Inhibitor; Anti-coagulant
C. Michael, and G. Mckendall, Am. J. Health-System Pharma., 60, 18 (2003).
T.E. Warkentin, Thromb. Haemost. 99, 830, 18 (2010).
• This is a FDA-regulated product. It is the customer's responsibility to ensure complaince with Federal rules.
Peptides International cannot be liable for any infringement of rights made by the user.

BQ-123, BQ-610, and BQ-788 See page 55 and Endothelin Antagonists.

Bovine Adrenal Medulla Dodecapeptide (BAM-12P)

BAM-12P PBM-4119-v 0.5 mg 80
Bovine Adrenal Medulla Dodecapeptide -20 °C vial
Tyr-Gly-Gly-Phe-Met-Arg-Arg-Val-Gly-Arg-Pro-Glu
(M.W. 1424.6) C62H97N21O16S [75513-71-2]
K. Mizuno, N. Minamino, K. Kangawa, and H. Matsuo, Biochem. Biophys. Res. Commun., 95, 1482 (1980). (Original)

Bombesin
Bombesin* PBM-4086-v 0.5 mg 65
(Frog, Bombina bombina) -20 °C vial
Pyr-Gln-Arg-Leu-Gly-Asn-Gln-Trp-Ala-Val-Gly-His-Leu-Met-
NH2
(M.W. 1619.8) C71H110N24O18S [31362-50-2]

26 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT CODE QTY PRICE
Bombesin* PBM-4086 25 mg 1200

BIOLOGICALLY ACTIVE PEPTIDES

(Bulk)
(Frog, Bombina bombina) -20 °C vial
Pyr-Gln-Arg-Leu-Gly-Asn-Gln-Trp-Ala-Val-Gly-His-
Leu-Met-NH2 • AcOH • 7H2O
(M.W. 1619.8 • 60.05 • 126.11) C71H110N24O18S • CH3COOH • 7H2O
A. Anastasi, V. Erspamer, and M. Bucci, Experientia, 27, 166 (1971). (Original)
V. Erspamer and P. Melchiorri, Trends Pharmacol. Sci., 1, 391 (1980). (Review)
J.G. McCoy and D.D. Avery, Peptides, 11, 595 (1990). (Review)
L.K. Malendowicz, Horm. Metab Res., 30, 374 (1998). (Review)
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

Bradykinin and Related Peptides

E.G. Erdös (ed.) Bradykinin, Kallidin and Kallikrein, Handbook of Experimental Pharmacology,
Vol. 25, Springer-Verlag, Berlin, 1970. (Review)
E.G. Erdös (ed.) Bradykinin, Kallidin and Kallikrein, Handbook of Experimental Pharmacology,
Vol. 25, Suppl., Springer-Verlag, Berlin, 1979. (Review)

Bradykinin* PBK-4002-v 0.5 mg 32

(Human, Bovine, Rat, Mouse) -20 °C vial
Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg
(M.W. 1060.2) C50H73N15O11 [58-82-2]

Bradykinin* (Bulk) PBK-4002 25 mg 330

(Human, Bovine, Rat, Mouse) -20 °C 100 mg 860
Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg • 2AcOH • 3H2O
(M.W. 1060.2 • 120.10 • 54.05) C50H73N15O11 • 2CH3COOH • 3H2O
D.F. Elliott, G.P. Lewis, and E.W. Horton, Biochem. J., 76, 16P (1960). (Original; Bovine)

PEPTIDES INTERNATIONAL
E.D. Nicolaides and H.A. DeWald, J. Org. Chem., 26, 3872 (1961). (Chem. Synthesis)
J.V. Pierce and M.E. Webster, Biochem. Biophys. Res. Commun., 5, 353 (1961). (Original; Human)

d-Arginyl-[Hyp3,Thi5,d-Tic7,Oic8]-Bradykinin PKB-4293-v 0.5 mg 145

Hoe 140, Icatibant -20 °C vial
d-Arg-Arg-Pro-Hyp-Gly-Thi-Ser-d-Tic-Oic-Arg
(Thi: l-Thienylalanine, Tic: 1,2,3,4-Tetrahydroisoquinoline-3-Carboxylic Acid,
Oic: (3aS,7aS)-Octahydroindolyl-2-Carboxylic Acid)
(M.W. 1304.5) C59H89N19O13S [130308-48-4]

d-Arginyl-[Hyp3,Thi5,d-Tic7,Oic8]-Bradykinin PKB-4293 25 mg 1800

(Bulk) -20 °C
Hoe 140, Icatibant
d-Arg-Arg-Pro-Hyp-Gly-Thi-Ser-d-Tic-Oic-Arg • 2AcOH • 4H2O
(Thi: l-Thienylalanine, Tic: 1,2,3,4-Tetrahydroisoquinoline-3-Carboxylic Acid,
Oic: (3aS,7aS)-Octahydroindolyl-2-Carboxylic Acid) (M.W. 1304.5 • 120.10 • 72.06) C59H89N19O13S •
2CH3COOH • 4H2O [138614-30-9]
Bradykinin B2-Receptor Antagonist
F.J. Hock, et al., Br. J. Pharmacol., 102, 769 (1991). (Original; Pharmacol.; in vitro)
K. Wirth, et al., Br. J. Pharmacol., 102, 774 (1991). (Original; Pharmacol.; in vivo)
A.R. Baydon and B. Woodward, Br. J. Pharmacol., 103, 1829 (1991). (Pharmacol.)
G. Wiener, et al., Brain Res., 638 261 (1994). (Pharmacol.; Icatibant)

d-Arginyl-[Hyp3, Thi5,8, d-Phe7]-Bradykinin PBK-4202-v 0.5 mg 60

d-Arg-Arg-Pro-Hyp-Gly-Thi-Ser-d-Phe-Thi-Arg -20 °C vial
(Thi: l-Thienylalanine)
(M.W. 1294.5) C56H83N19O13S2 [103412-42-6]

Order Hotline 1-800-777-4779 502-266-8787 27

 PRODUCT CODE QTY PRICE
BIOLOGICALLY ACTIVE PEPTIDES

d-Arginyl-[Hyp3,Thi5,8,d-Phe7]-Bradykinin PBK-4202 25 mg 730

(Bulk) -20 °C
d-Arg-Arg-Pro-Hyp-Gly-Thi-Ser-d-Phe-Thi-Arg • 2AcOH •
4H2O
(Thi: l-Thienylalanine)
(M.W. 1294.5 • 120.11 • 72.06) C56H83N19O13S2 • 2CH3COOH • 4H2O
Bradykinin B2-Receptor Antagonist
M. Schachter, et al., Br. J. Pharmacol., 92, 851 (1987). (Original)
J.M. Stewart and R.J. Vavrek, Adv. Biosci., 65, 73 (1987). (Pharmacol.; pA2)
D.C. Perry, Pharmacol. Biochem. Behav., 28, 15 (1987). (Pharmacol.; CNS)

Bradykinin-Potentiator B IAB-4009-v 0.5 mg 35

(Mamushi, Agkistrodon halys blomhoffii) -20 °C vial
Pyr-Gly-Leu-Pro-Pro-Arg-Pro-Lys-Ile-Pro-Pro
(M.W. 1182.4) C56H91N15O13 [30892-86-5]
Inhibitor for Peptidyl-Dipeptidase A, Kininase II, and ACE (Angiotensin Converting Enzyme)
H. Kato and T. Suzuki, Biochemistry, 10, 972 (1971). (Original)
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

Bradykinin-Potentiator C IAC-4010-v 0.5 mg 30

(Mamushi, Agkistrodon halys blomhoffii) -20 °C vial
Pyr-Gly-Leu-Pro-Pro-Gly-Pro-Pro-Ile-Pro-Pro
(M.W. 1052.2) C51H77N11O13 [30953-20-9]
Inhibitor for Peptidyl-Dipeptidase A, Kininase II, and ACE (Angiotensin Converting Enzyme)
H. Kato and T. Suzuki, Biochemistry, 10, 972 (1971). (Original)

Des-Arg9-Bradykinin PBK-4067-v 0.5 mg 35

Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe
PEPTIDES INTERNATIONAL

-20 °C
(M.W. 904.02) C44H61N11O10 [15958-92-6]

Des-Arg9-Bradykinin (Bulk) PBK-4067 25 mg 515

Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe • AcOH • 3H2O -20 °C
(M.W. 904.02 • 60.05 • 54.05) C44H61N11O10 • CH3COOH •
3H2O
Bradykinin B1-Receptor Agonist
D. Regoli, J. Barabe, and W.K. Park, Can. J. Physiol. Pharmacol., 55, 855 (1977). (Original)

Des-Arg10-Kallidin PBK-4303-v 0.5 mg 45

Lysyl-Des-Arg9-Bradykinin -20 °C vial
Lys-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe
(M.W. 1032.2) C50H73N13O11 [71800-36-7]
Bradykinin B1-Receptor Agonist

Des-Arg10-Kallidin (Bulk) PBK-4303 25 mg 630

Lysyl-Des-Arg9-Bradykinin -20 °C
Lys-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe • 2AcOH • 4H2O
(M.W. 1032.2 • 120.10 • 72.06) C50H73N13O11 • 2CH3COOH • 4H2O
Bradykinin B1-Receptor Agonist
J.P. Galizzi, et al., Br. J. Pharmacol., 113, 389 (1994). (Original)
J.G. Menke, et al., J. Biol. Chem., 269, 21583 (1994). (Pharmacol.)
J.S. Zuzack, et al., J. Pharmacol. Exp. Ther., 277, 1337 (1996). (Pharmacol.)

Des-Arg9-[Leu8]-Bradykinin PBK-4065-v 0.5 mg 35

Arg-Pro-Pro-Gly-Phe-Ser-Pro-Leu -20 °C vial
(M.W. 870.01) C41H63N11O10 [64695-06-3]

28 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT CODE QTY PRICE
Des-Arg9-[Leu8]-Bradykinin PBK-4065 25 mg 515

BIOLOGICALLY ACTIVE PEPTIDES

(Bulk)
Arg-Pro-Pro-Gly-Phe-Ser-Pro-Leu • AcOH • 3H2O -20 °C
(M.W. 870.01 • 60.05 • 54.05) C41H63N11O10 • CH3COOH •
3H2O [115035-45-5]
Bradykinin B1-Receptor Antagonist
D. Regoli, J. Barabe, and W.K. Park, Can. J. Physiol. Pharmacol., 55, 855 (1977). (Original; pA2 )

Des-Pro2-Bradykinin IBK-4097-v 0.5 mg 35

Arg-Pro-Gly-Phe-Ser-Pro-Phe-Arg -20 °C vial
(M.W. 963.09 ) C45H66N14O10 [80943-05-1]

Des-Pro2-Bradykinin (Bulk) IBK-4097 25 mg 520

Arg-Pro-Gly-Phe-Ser-Pro-Phe-Arg • 2AcOH • 3H2O -20 °C
(M.W. 963.09 • 120.10 • 54.05) C45H66N14O10 • 2CH3COOH • 3H2O
Inhibitor for Peptidyl-Dipeptidase A, Kininase II, and ACE (Angiotensin Converting Enzyme)
Purity Information: Qp See page xiv
M. Naruse, S. Tamanami, K. Shuto, S. Sakakibara, and T. Kimura, Chem. Pharm. Bull., 29, 3369 (1981).

[Hyp3]-Bradykinin (Human)* PBK-4193-v 0.5 mg 40

Arg-Pro-Hyp-Gly-Phe-Ser-Pro-Phe-Arg -20 °C vial
(M.W. 1076.2) C50H73N15O12 [37642-65-2]
H. Kato, Y. Matsumura, and H. Maeda, FEBS Lett., 232, 252 (1988). (Original)
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

Isoleucyl-Seryl-Bradykinin* PBK-4130-v 0.5 mg 40

T-Kinin (Rat) -20 °C vial
Ile-Ser-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg

PEPTIDES INTERNATIONAL
(M.W. 1260.4) C59H89N17O14 [86030-63-9]
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

Isoleucyl-Seryl-Bradykinin* (Bulk) PBK-4130 25 mg 570

T-Kinin (Rat) -20 °C
Ile-Ser-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg • 2AcOH •
5H2O
(M.W. 1260.4 • 120.10 • 90.08) C59H89N17O14 • 2CH3COOH • 5H2O
H. Okamoto and L.M. Greenbaum, Biochem. Biophys. Res. Commun., 112, 701 (1983). (Original)

Lysyl-Bradykinin* PBK-4008-v 0.5 mg 40

Kallidin (Human, Bovine) -20 °C vial
Lys-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg
(M.W. 1188.4) C56H85N17O12 [342-10-9]
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

Lysyl-Bradykinin* (Bulk) PBK-4008 25 mg 465

Kallidin (Human, Bovine) -20 °C
Lys-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg • 3AcOH • 4H2O
(M.W. 1188.4 • 180.16 • 72.06) C56H85N17O12 • 3CH3COOH • 4H2O [100900-38-7]
J.V. Pierce and M.E. Webster, Biochem. Biophys. Res. Commun., 5, 353 (1961). (Original; Human)
D.F. Elliott and G.P. Lewis, Biochem. J., 95, 437 (1965). (Seq.; Bovine)
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

Lysyl-[Hyp3]-Bradykinin (Human) PBK-4191-v 0.5 mg 345

Lys-Arg-Pro-Hyp-Gly-Phe-Ser-Pro-Phe-Arg -20 °C vial
(M.W. 1204.4) C56H85N17O13
M. Sasaguri, M. Ikeda, M. Ideishi, and K. Arakawa, Biochem. Biophys. Res. Commun., 150, 511 (1988). (Original)

Order Hotline 1-800-777-4779 502-266-8787 29

 PRODUCT CODE QTY PRICE
BIOLOGICALLY ACTIVE PEPTIDES

Methionyl-Lysyl-Bradykinin (Human, Bovine) PBK-4012-v 0.5 mg 40

Met-Lys-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg -20 °C vial
(M.W. 1319.6) C61H94N18O13S [550-19-6]

Methionyl-Lysyl-Bradykinin (Human, Bovine) PBK-4012 25 mg 515

(Bulk) -20 °C
Met-Lys-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg • 3AcOH • 2H2O
(M.W. 1319.6 • 180.16 • 36.03) C61H94N18O13S • 3CH3COOH • 2H2O
D.F. Elliott and G.P. Lewis, Biochem. J., 95, 437 (1965). (Original; Bovine)
I. Ohkubo, K. Kurachi, T. Takasawa, H. Shiokawa, and M. Sasaki, Biochemistry, 23, 5691 (1984). (cDNA Seq.; Human)

[Thi5,8, d-Phe7]-Bradykinin PBK-4175-v 0.5 mg 50

Arg-Pro-Pro-Gly-Thi-Ser-d-Phe-Thi-Arg -20 °C vial
(Thi: l-Thienylalanine)
(M.W. 1122.3) C50H71N15O11S2 [97825-07-5]
Bradykinin B2-Receptor Antagonist
R.J. Vavrek and J.M. Stewart, Peptides, 6, 161 (1985). (Original)

[Tyr ]-Bradykinin
8 PBK-4075-v 0.5 mg 45
Arg-Pro-Pro-Gly-Phe-Ser-Pro-Tyr-Arg -20 °C vial
(M.W. 1076.2) C50H73N15O12 [32222-00-7]
For Radioimmunoassay
M.D. Nielsen, F. Nielsen, A.M. Kappelgaard, and J. Giese, Clinica Chimica Acta, 125, 145 (1982). (Radioimmunoassay)
M.J. Fredrick, F.C. Abel, W.A. Rightsel, E.E. Muirhead, and C.E. Odya, Life Sci., 37, 331 (1985). (Radioimmunoassay)

Tyrosyl-Bradykinin PBK-4056-v 0.5 mg 40

Tyr-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg -20 °C vial
PEPTIDES INTERNATIONAL

(M.W. 1223.4) C59H82N16O13 [33289-76-8]

For Radioimmunoassay
R.E. Lewis, S.R. Childers, and M.I. Phillips, Brain Res., 346, 263 (1985). (Radioimmunoassay)
M.J. Fredrick, F.C. Abel, W.A. Rightsel, E.E. Muirhead, and C.E. Odya, Life Sci., 37, 331 (1985). (Radioimmunoassay)

B-Type (Brain) Natriuretic Peptides (BNP)

A. Rosenzweig and C.E. Seidman, Annu. Rev. Biochem., 60, 229 (1991). (Review)

BNP-32 (Human)* PBN-4212-v 0.5 mg 490

B-Type (Brain) Natriuretic Peptide-32 (Human) -20 °C vial
Ser-Pro-Lys-Met-Val-Gln-Gly-Ser-Gly-Cys-Phe-Gly-Arg-Lys-Met-Asp-
Arg-Ile-Ser-Ser-Ser-Ser-Gly-Leu-Gly-Cys-Lys-Val-Leu-Arg-Arg-His
(Disulfide bond between Cys10-Cys26)
(M.W. 3464.0) C143H244N50O42S4 [124584-08-03]
T. Sudoh, et al., Biochem. Biophys. Res. Commun., 159, 1427 (1989). (Original; cDNA)
Y. Kambayashi, et al., FEBS Lett., 259, 341 (1990). (Original; Isolation and Structure)
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

Tyrosyl-BNP-32 (Human)* PBN-4230-v 0.5 mg 580

Tyrosyl-B-Type (Brain) Natriuretic Peptide-32 (Human) -20 °C vial
Tyr-Ser-Pro-Lys-Met-Val-Gln-Gly-Ser-Gly-Cys-Phe-Gly-Arg-Lys-Met-Asp-
Arg-Ile-Ser-Ser-Ser-Ser-Gly-Leu-Gly-Cys-Lys-Val-Leu-Arg-Arg-His
(Disulfide bond between Cys10-Cys26)
(M.W. 3627.2) C152H253N51O44S4
Purity Information: Qx See page xiv
For Radioimmunoassay
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

30 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT CODE QTY PRICE
BNP-26 (Porcine)* PBN-4200-v 0.5 mg 490

BIOLOGICALLY ACTIVE PEPTIDES

B-Type (Brain) Natriuretic Peptide-26 (Porcine) -20 °C vial
Asp-Ser-Gly-Cys-Phe-Gly-Arg-Arg-Leu-Asp-Arg-lle-Gly-
Ser-Leu-Ser-Gly-Leu-Gly-Cys-Asn-Val-Leu-Arg-Arg-Tyr
(Disulfide bond between Cys4-Cys20)
(M.W. 2869.2) C120H198N42O36S2 [114547-28-3]
T. Sudoh, K. Kangawa, N. Minamino, and H. Matsuo, Nature, 332, 78 (1988). (Original)
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

BNP-32 (Rat)* PBN-4213-v 0.5 mg 490

B-Type (Brain) Natriuretic Peptide-32 (Rat) -20 °C vial
Asn-Ser-Lys-Met-Ala-His-Ser-Ser-Ser-Cys-Phe-Gly-Gln-Lys-Ile-Asp-
Arg-Ile-Gly-Ala-Val-Ser-Arg-Leu-Gly-Cys-Asp-Gly-Leu-Arg-Leu-Phe
(Disulfide bond between Cys10-Cys26)
(M.W. 3452.9) C146H239N47O44S3 [133448-20-1]
M. Kojima, et al., Biochem. Biophys. Res. Commun, 159, 1420 (1989). (Original; cDNA)
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

BNP-45 (Rat)* PBN-4218-s 0.1 mg 170

B-Type (Brain) Natriuretic Peptide-45 (Rat) -20 °C vial
Ser-Gln-Asp-Ser-Ala-Phe-Arg-Ile-Gln-Glu-Arg-Leu-Arg-Asn-
Ser-Lys-Met-Ala-His-Ser-Ser-Ser-Cys-Phe-Gly-Gln-Lys-Ile-
Asp-Arg-Ile-Gly-Ala-Val-Ser-Arg-Leu-Gly-Cys-Asp-Gly-Leu-
Arg-Leu-Phe
(Disulfide bond between Cys23-Cys39)
(M.W. 5040.7) C213H349N71O65S3 [123337-89-3]

PEPTIDES INTERNATIONAL
M. Aburaya, et al., Biochem. Biophys. Res. Commun., 163, 226 (1989). (Original)
Y. Kambayashi, et al., Biochem. Biophys. Res. Commun., 163, 233 (1989). (Original)
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

C Peptide
C-Peptide (Human) PCP-3725-PI 1 mg 195
-20 °C 5 mg 780
H-Glu-Ala-Glu-Asp-Leu-Gln-Val-Gly-Gln-Val-Glu-Leu-Gly-Gly-Gly-Pro-
Gly-Ala-Gly-Ser-Leu-Gln-Pro-Leu-Ala-Leu-Glu-Gly-Ser-Leu-Gln-OH
(M.W. 3020.33) C129H211N35O48 [33017-11-7]
Insulin Precursor (57-87) (Human)
A.S.C.Ko and D.G.Smyth, Eur. J. Biochem., 20, 190 (1971).
P.E.Oyer, et al., J. Biol. Chem., 246, 1375 (1971).
K.Igano, et al., Bull. Chem. Soc. Jpn., 54, 3088 (1981).
J.Wahren, et al., Exp. Diabesity Res., 5, 15 (2004).
J.P.Palmer, et al., Diabetes, 53, 250 (2004).

[Tyr0]-C-Peptide (Human) PCP-3724-PI 1 mg 650

tyrosyl human C-peptide -20 °C 5 mg 2600
H-Tyr-Glu-Ala-Glu-Asp-Leu-Gln-Val-Gly-Gln-Val-Glu-Leu-Gly-Gly-Gly-Pro-
Gly-Ala-Gly-Ser-Leu-Gln-Pro-Leu-Ala-Leu-Glu-Gly-Ser-Leu-Gln-OH
(M.W. 3183.50) C138H220N36O50 [57327-90-9]
C-Peptide derivative for radioimmunoassay.
V.K. Naithani, et al., Hoppe Seylers Z. Physiol. Chem., 356, 1305 (1975)
N. Yanaihara, et al., Hoppe Seylers Z. Physiol. Chem., 362, 775 (1981)
H. Sun, et al., Appl. Biochem. Biotechnol., 55, 167 (1995)
V.K. Naithani, et al., Hoppe Seylers Z. Physiol. Chem., 356, 1305 (1975)

Order Hotline 1-800-777-4779 502-266-8787 31

 PRODUCT CODE QTY PRICE
BIOLOGICALLY ACTIVE PEPTIDES

Calcitonin
Calcitonin (Human) PCL-4051-s 0.1 mg 130
Cys-Gly-Asn-Leu-Ser-Thr-Cys-Met-Leu-Gly-Thr- -20 °C vial
Tyr-Thr-Gln-Asp-Phe-Asn-Lys-Phe-His-Thr-Phe-
Pro-Gln-Thr-Ala-Ile-Gly-Val-Gly-Ala-Pro-NH2
(Disulfide bond between Cys1-Cys7)
(M.W. 3417.8) C151H226N40O45S3 [21215-62-3]

Calcitonin (Human) PCL-4051-v 0.5 mg 425

R. Neher, et al., Helv. Chim. Acta, 51, 1900 (1968). (Original) -20 °C vial
Y. Nakagawa, T. Morikawa, and S. Sakakibara,
Peptide Chemistry 1977, 189 (1978). (Chem. Synthesis)

CART Peptides
P.J. Larsen and R.G. Hunter, Peptides, 27, 1981 (2006). (Review)
A. Vicentic and D.C. Jones, J. Pharmacol. Exp. Ther., 320, 499 (2007). (Review)

CART (Human, 55-102) PCA-4350-s 0.1 mg 360

Cocaine-and Amphetamine-Regulated Transcript (Human, -20 °C vial
55-102)
Ile-Pro-Ile-Tyr-Glu-Lys-Lys-Tyr-Gly-Gln-Val-Pro-Met-Cys-Asp-Ala-Gly-Glu-Gln-Cys-Ala-Val-Arg-Lys-Gly-
Ala-Arg-Ile-Gly-Lys-Leu-Cys-Asp-Cys-Pro-Arg-Gly-Thr-Ser-Cys-Asn-Ser-Phe-Leu-Leu-Lys-Cys-Leu
(Disulfide bonds between Cys68-Cys86, Cys74-Cys94, and Cys88-Cys101)
(M.W. 5245.2) C225H365N65O65S7 [214050-22-3]
Food-Intake Inhibitor
P. Kristensen, et al., Nature, 393, 72 (1998). (Pharmacology; New Anorectic Peptide)
PEPTIDES INTERNATIONAL

J. Douglass and S. Daoud, Gene, 169, 241 (1996). (Original, cDNA)

A.J. Kastin and V. Akerstrom, Am. J. Physiol., 277, E901 (1999). (Pharmacol.; across BBB)
M.J. Kuhar, L.D. Adams, R.G. Hunter, S. Dall Vechia, and Y. Smith, Regul. Pept., 89, 1 (2000). (Review)

CART (Rat, 55-102) PCA-4351-s 0.1 mg 360

Cocaine-and Amphetamine-Regulated Transcript (Rat, 55-102) -20 °C vial
Ile-Pro-Ile-Tyr-Glu-Lys-Lys-Tyr-Gly-Gln-Val-Pro-Met-Cys-Asp-Ala-Gly-Glu-Gln-Cys-Ala-Val-Arg-Lys-Gly-
Ala-Arg-Ile-Gly-Lys-Leu-Cys-Asp-Cys-Pro-Arg-Gly-Thr-Ser-Cys-Asn-Ser-Phe-Leu-Leu-Lys-Cys-Leu
(Disulfide bonds between Cys68-Cys86, Cys74-Cys94, and Cys88-Cys101)
(M.W. 5259.2) C226H367N65O65S7 [209615-79-2]
Food-Intake Inhibitor
P. Kristensen, et al., Nature, 393, 72 (1998). (Pharmacology: New Anorectic Peptide)
J. Douglass, A.A. McKinzie, and P. Couceyro, J. Neurosci., 15, 2471 (1995). (Original: cDNA)
L. Thim, et al., FEBS Lett., 428, 263 (1998). (Biochem. & Pharmacol.)
M.J. Kuhar, L.D. Adams, R.G. Hunter, S. Dall Vechia, and Y. Smith, Regul. Pept., 89, 1 (2000). (Review)

b-Casomorphins
b-Casomorphin-5 (Bovine) PEK-4079-v 0.5 mg 30
Tyr-Pro-Phe-Pro-Gly -20 °C vial
(M.W. 579.64) C30H37N5O7 [72122-63-5]

b-Casomorphin-5 (Bovine) (Bulk) PEK-4079 25 mg 190

Tyr-Pro-Phe-Pro-Gly • 2H2O -20 °C 100 mg 570
(M.W. 579.64 • 36.03) C30H37N5O7 • 2H2O [72122-63-5]
V. Brantl, et al., Hoppe-Seyler’s Z. Physiol. Chem., 360, 1211 (1979). (Original; Isolation)
A. Henschen, et al., Hoppe-Seyler’s Z. Physiol. Chem., 360, 1217 (1979). (Original; Structure)

32 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT CODE QTY PRICE
b-Casomorphin-7 (Bovine) PEK-4078-v 0.5 mg 35

BIOLOGICALLY ACTIVE PEPTIDES

Tyr-Pro-Phe-Pro-Gly-Pro-Ile -20 °C vial
(M.W. 789.92) C41H55N7O9 [72122-62-4]
V. Brantl, et al., Hoppe-Seyler’s Z. Physiol. Chem., 360, 1211 (1979). (Original; Isolation)
A. Henschen, et al., Hoppe-Seyler’s Z. Physiol. Chem., 360, 1217 (1979). (Original; Structure)

Catestatin See Pancreastatins.

CCK See Cholecystokinin and Related Peptides.

CEP1
CEP1 CEP-4487-s 0.1 mg 70
C-Terminally Encoded Peptide 1 -20 °C vial
(Plant, Arabidopsis)
Asp-Phe-Arg-Hyp-Thr-Asn-Pro-Gly-Asn-Ser-Hyp-Gly-Val-Gly-His
(M.W. 1583.6) C66H98N22O24
Mediator of Systemic N-Demand Signaling in Plant
S. Endo, S. Betsuyaku, and H. Fukuda, Curr. Opin. Plant Biol., 21, 140 (2014). (Review)
Y. Matsubayashi, Annu. Rev. Plant Biol., 65, 385 (2014). (Review)
K. Ohyama, M. Ogawa, and Y. Matsubayashi, Plant J., 55, 152 (2008). (Original)
R. Tabata, K. Sumida, T.Yoshii, K.Ohyama, H. Shinohara, and Y. Matsubayashi, Science, 346, 343 (2014). (Pharmacol.)

CGP 42112 See Code PAN-4296-v.

CGRP
CGRP (Human)* PCG-4160-s 0.1 mg 135
Calcitonin Gene Related Peptide (Human) -20 °C vial

PEPTIDES INTERNATIONAL
a-CGRP (Human)
Ala-Cys-Asp-Thr-Ala-Thr-Cys-Val-Thr-His-Arg-Leu-Ala-Gly-Leu-Leu-Ser-Arg-Ser-
Gly-Gly-Val-Val-Lys-Asn-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Lys-Ala-Phe-NH2
(Disulfide bond between Cys 2-Cys7)
(M.W. 3789.3) C163H267N51O49S2 [90954-53-3]
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

CGRP (Human)* PCG-4160-v 0.5 mg 425

Calcitonin Gene Related Peptide (Human) -20 °C vial
a-CGRP (Human)
H.R. Morris, M. Panico, T. Etienne, J. Tippins, S.l. Girgis, and I. Maclntyre, Nature, 308, 746 (1984). (Original)
• This compound is distributed through Peptide Institute, Inc. under the license of The Salk Institute. However, it is no
longer available in the United Kingdom due to patent rights held by Celltech. Ltd.
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

CGRP (Human, 8-37)* PCG-4232-v 0.5 mg 280

Calcitonin Gene Related Peptide (Human, 8-37) -20 °C vial
a-CGRP (Human, 8-37)
Val-Thr-His-Arg-Leu-Ala-Gly-Leu-Leu-Ser-Arg-Ser-Gly-Gly-Val-Val-Lys-
Asn-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Lys-Ala-Phe-NH2
(M.W. 3125.6) C139H230N44O38 [119911-68-1]
Calcitonin Gene Related Peptide (CGRP) Antagonist
T. Chiba, et al., Am. J. Physiol., 256, E331 (1989). (Original)
S.-P. Han, L. Naes, and T.C. Westfall, Biochem. Biophys. Res. Commun., 168, 786 (1990). (Pharmacol.)
T. Dennis, et al., J. Pharmacol. Exp. Ther., 254, 123 (1990). (Pharmacol.)
S.M. Gardiner, et al., Biochem. Biophys. Res. Commun., 171, 938 (1990). (Pharmacol.)
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

Order Hotline 1-800-777-4779 502-266-8787 33

 PRODUCT CODE QTY PRICE
BIOLOGICALLY ACTIVE PEPTIDES

CGRP (Rat)* PCG-4163-s 0.1 mg 135

Calcitonin Gene Related Peptide (Rat) -20 °C vial
a-CGRP (Rat)
Ser-Cys-Asn-Thr-Ala-Thr-Cys-Val-Thr-His-Arg-Leu-Ala-Gly-Leu-Leu-Ser-Arg-Ser-
Gly-Gly-Val-Val-Lys-Asp-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Glu-Ala-Phe-NH2
(Disulfide bond between Cys2-Cys7)
(M.W. 3806.2) C162H262N50O52S2 [83651-90-5]
• This compound is distributed through Peptide Institute, Inc. under the license of the Salk Institute.

CGRP (Rat)* PCG-4163-v 0.5 mg 395

Calcitonin Gene Related Peptide (Rat) -20 °C vial
a-CGRP (Rat)
S.G. Amara, V. Jonas, M.G. Rosenfeld, E.S. Ong, and R.M. Evans, Nature, 298, 240 (1982). (Original)
M.G. Rosenfeld, J.-J. Mermod, S.G. Amara, L.W. Swanson, P.E. Sawchenko, J. Rivier, W.W. Vale,
and R.M. Evans, Nature, 304, 129 (1983). (Processing and Distribution in Neural Tissue)
• This compound is distributed through Peptide Institute, Inc. under the license of the Salk Institute.

Charybotoxin See Code PCB-4227-s in the Toxins subsection.

Chemotactic Peptide
Chemotactic Peptide PCT-4066-v 0.5 mg 30
For-Met-Leu-Phe -20 °C vial
FMLP
(M.W. 437.55) C21H31N3O5S [59880-97-6]

Chemotactic Peptide (Bulk) PCT-4066 25 mg 99

For-Met-Leu-Phe
PEPTIDES INTERNATIONAL

-20 °C 100 mg 290

FMLP
(M.W. 437.55) C21H31N3O5S [59880-97-6]
L.T. Williams, R. Snyderman, M.C. Pike, and R.J. Lefkowitz, Proc. Natl. Acad. Sci. USA, 74, 1204 (1977).
(Receptor Site on Human Leukocyte)

Chlorotoxin See PCN-4282-v in the Toxins subsection.

Cholecystokinin (CCK) Related Peptides

J.E. Jorpes and V. Mutt (eds.) Secretin, Cholecystokinin, Pancreozymin and Gastrin, Handbook of Experimental
Pharmacology, Vol. 34, Springer-Verlag, Berlin, 1973. (Review)

CCK-Tetrapeptide (30-33)* PCK-4083-v 0.5 mg 30

CCK-4 -20 °C vial
(Hydrochloride Form)
Trp-Met-Asp-Phe-NH2
(M.W. 596.70) C29H36N6O6S
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

CCK-Tetrapeptide (30-33)* (Bulk) PCK-4083 25 mg 120

CCK-4 -20 °C 100 mg 360
Trp-Met-Asp-Phe-NH2 • HCI • H2O
(M.W. 596.70 • 36.46 • 18.02) C29H36N6O6S • HCI • H2O [5609-49-4]
J.F. Rehfeld, L.l. Larsson, N.R. Goltermann, T.W. Schwartz, J.J. Holst, S.L. Jensen,
and J.S. Morley, Nature, 284, 33 (1980). (Neural Pharmacol.)
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

34 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT CODE QTY PRICE
CCK-Octapeptide (26-33) (Non-Sulfated PCK-4087-v 0.5 mg 60

BIOLOGICALLY ACTIVE PEPTIDES

Form)* vial
2
CCK-8 (Non-Sulfated Form)
(Ammonium Form) -20 °C
Asp-Tyr-Met-Gly-Trp-Met-Asp-Phe-NH
(M.W. 1063.2) C49H62N10O13S2 [25679-24-7]
M.A. Ondetti, J. Pluscec, E.F. Sabo, J.T. Sheehan, and N. Williams, J. Am. Chem. Soc., 92, 195 (1970).
(Chem. Synthesis)
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

CCK-Octapeptide (26-33) (Sulfated Form)* PCK-4100-v 0.5 mg 150

CCK-8 (Sulfated Form) -20 °C vial
(Ammonium Form)
Asp-Tyr(SO3H)-Met-Gly-Trp-Met-Asp-Phe-NH2
(M.W. 1143.3) C49H62N10O16S3 [25126-32-3]
M.A. Ondetti, J. Pluscec, E.F. Sabo, J.T. Sheehen, and N. Williams, J. Am. Chem. Soc., 92, 195 (1970).
(Chem. Synthesis)
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

CCK-33 (Human)* PCK-4201-s 0.1 mg 515

Lys-Ala-Pro-Ser-Gly-Arg-Met-Ser-Ile-Val-Lys-Asn-Leu- -20 °C vial
Gln-Asn-Leu-Asp-Pro-Ser-His-Arg-Ile-Ser-Asp-Arg-
Asp-Tyr(SO3H)-Met-Gly-Trp-Met-Asp-Phe-NH2
(M.W. 3945.4) C167H263N51O52S4 [96827-04-2]
Y. Takahashi, K. Kato, Y. Hayashizaki, and K. Matsubara, Proc. Natl. Acad. Sci. U.S.A., 82, 1931 (1987).
(Original; Nucleotide Seq.)

PEPTIDES INTERNATIONAL
Y. Kurano, T. Kimura, and S. Sakakibara, In, Peptides, Proceedings of the 10th American Peptide Symposium,
(G.R. Marshall, ed.), ESCOM Science Publishers B.V. 1988, pp. 162-165. (Chem. Synthesis)
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

CCK-33 (Porcine)* PCK-4176-s 0.1 mg 515

Lys-Ala-Pro-Ser-Gly-Arg-Val-Ser-Met-Ile-Lys-Asn-Leu- -20 °C vial
Gln-Ser-Leu-Asp-Pro-Ser-His-Arg-Ile-Ser-Asp-Arg-
Asp-Tyr(SO3H)-Met-Gly-Trp-Met-Asp-Phe-NH2
(M.W. 3918.4) C166H262N50O52S4 [67256-27-3]
V. Mutt and J.E. Jorpes, Eur. J. Biochem., 6, 156 (1968). (Original; Partial Structure)
V. Mutt and J.E. Jorpes, Biochem. J., 125, 57P (1971). (Original)
Y. Kurano, T. Kimura, and S. Sakakibara, J. Chem. Soc. Chem. Commun., 5, 323 (1987). (Chem. Synthesis)
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

CD36 Binding Peptide

H-Gly-Asp-Gly-Val-d-Ile-Thr-Arg-Ile-Arg-OH PCI-3964-PI 1 mg 55
(M.W. 986.15) C41H75N15O13 -20 °C 5 mg 195
CD36 Binding Peptide
J.S. Isenberg, Y. Jia, J. Fukuyama, C.H. Switzer, D.A. Wink, and D.D. Roberts, J. Biol. Chem., 282, 15404 (2007).

Chromagranin A (Human, 286-301 Amide) See Code PCR-4214-v.

Order Hotline 1-800-777-4779 502-266-8787 35

 PRODUCT CODE QTY PRICE
BIOLOGICALLY ACTIVE PEPTIDES

CINC-1/gro
CINC-1/gro (Rat) PIL-4233-v 20 µg 365
Cytokine-Induced Neutrophil Chemoattractant-1/ -20 °C vial
growth-related oncogene (Rat)
Ala-Pro-Val-Ala-Asn-Glu-Leu-Arg-Cys-Gln-Cys-Leu-Gln-Thr-Val-Ala-Gly-Ile-His-Phe-Lys-Asn-Ile-Gln-Ser-
Leu-Lys-Val-Met-Pro-Pro-Gly-Pro-His-Cys-Thr-Gln-Thr-Glu-Val-Ile-Ala-Thr-Leu-Lys-Asn-Gly-Arg-Glu-
Ala-Cys-Leu-Asp-Pro-Glu-Ala-Pro-Met-Val-Gln-Lys-Ile-Val-Gln-Lys-Met-Leu-Lys-Gly-Val-Pro-Lys
(Disulfide bonds between Cys9-Cys35 and Cys11-Cys51)
(M.W. 7845.3) C343H572N98O97S7
K. Watanabe, K. Konishi, M. Fujioka, S. Kinoshita, and H. Nakagawa, J. Biol. Chem., 264, 19559 (1989). (Original)
Y. Nishiuchi, M. Tsunemi, S. Kumagaye, S. Kubo, H. Nishio, K. Watanabe, T. Kinoshita, and S. Sakaibara, In,
(J.A. Smith and J.E Rivier eds.) Peptides: Chemistry and Biology
(Proceeding of the 12th American Peptide Symposium), Escom, Lieden, 1992, pp. 911-913. (Chem. Synthesis)
H. Nakagawa, N. Komorita, F. Shibata, A. Ikesue, K. Konishi, M. Fujioka, and H. Kato, Biochem. J., 301, 545 (1994).
(CINC Family)

Colivelin
Colivelin PHN-3901-PI 0.5 mg 249
H-Ser-Ala-Leu-Leu-Arg-Ser-Ile-Pro-Ala-Gly-Ala-Ser-Arg- -20 °C 1.0 mg 475
Leu-Leu-Leu-Leu-Thr-gly-Glu-Ile-Asp-Leu-Pro-OH
SALLRSIPAPAGASRLLLLTGEIDLP
(M.W. 2645.16) C119H206N32O35
Neuroprotective Peptide in Alzheimer’s Disease Research
T. chiba, M. Yamada, Y. Hashimoto, M. Sato, J. Sasabe, Y. Kita, K. Terashita, S. Aiso, I. Nishimoto, and M. Matsuka,
J. Neuroscience, 25 10252 (2005).
PEPTIDES INTERNATIONAL

Corticotropin-Releasing Factor / Hormones (CRF/CRH)

C.L. Rivier and P.M. Plotsky, Annu. Rev. Physiol., 48, 475 (1986). (Review)
F.A. Antoni, Endocrinol. Rev., 7, 351 (1986). (Review)
M.J. Owens and C.B. Nemeroff, Pharmacol. Rev., 43, 425 (1991). (Review)
M. Schaefer, S.A. Mousa, and C. Stein, Eur. J. Pharmacol., 323, 1 (1997). (Review)

CRF (Human, Rat) PCR-4136-s 0.1 mg 145

Corticotropin-Releasing Factor (Human, Rat) -20 °C vial
Ser-Glu-Glu-Pro-Pro-Ile-Ser-Leu-Asp-Leu-Thr-Phe-His-Leu-Leu-Arg-Glu-Val-Leu-Glu-Met-
Ala-Arg-Ala-Glu-Gln-Leu-Ala-Gln-Gln-Ala-His-Ser-Asn-Arg-Lys-Leu-Met-Glu-Ile-Ile-NH2
(M.W. 4757.5) C208H344N60O63S2 [86784-80-7]

CRF (Human, Rat) PCR-4136-v 0.5 mg 490

Corticotropin-Releasing Factor (Human, Rat) -20 °C vial
J. Spiess, J. Rivier, and W. Vale, Biochemistry, 22, 4341 (1983). (Original; Rat)
S. Shibahara, Y. Morimoto, Y. Furutani, M. Notake, H. Takahashi, S. Shimizu, S. Horikawa, and S. Numa,
The EMBO Journal, 2, 775 (1983). (Original; Human)
• This compound is distributed through Peptide Institute, Inc. under the license of The Salk Institute.

CRF (Ovine) PCR-4111-s 0.1 mg 145

Corticotropin-Releasing Factor (Ovine) -20 °C vial
Ser-Gln-Glu-Pro-Pro-Ile-Ser-Leu-Asp-Leu-Thr-Phe-His-Leu-
Leu-Arg-Glu-Val-Leu-Glu-Met-Thr-Lys-Ala-Asp-Gln-Leu-Ala-
Gln-Gln-Ala-His-Ser-Asn-Arg-Lys-Leu-Leu-Asp-Ile-Ala-NH2
(M.W. 4670.3) C205H339N59O63S [79804-71-0]

36 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT CODE QTY PRICE
CRF (Ovine) PCR-4111-v 0.5 mg 490

BIOLOGICALLY ACTIVE PEPTIDES

Corticotropin-Releasing Factor (Ovine) -20 °C vial
W. Vale, J. Spiess, C. Rivier, and J. Rivier, Science, 213, 1394 (1981). (Original)
• This compound is distributed through Peptide Institute, Inc. under the license of The Salk Institute.

Tyrosyl-CRF (Human, Rat) PCR-4141-s 0.1 mg 165

Tyrosyl-Corticotropin-Releasing Factor (Human, Rat) -20 °C vial
Tyr-Ser-Glu-Glu-Pro-Pro-Ile-Ser-Leu-Asp-Leu-Thr-Phe-His Leu-Leu-
Arg-Glu-Val-Leu-Glu-Met-Ala-Arg-Ala-Glu-Gln-Leu-Ala-Gln-Gln-
Ala-His-Ser-Asn-Arg-Lys-Leu-Met-Glu-Ile-Ile-NH2
(M.W. 4920.6) C217H353N61O65S2 [100513-58-4]
For Radioimmunoassay
Purity Information: Qx: See page xiv
P.C. Wynn, G. Aguilera, J. Morell, and K.J. Catt, Biochem. Biophys. Res. Commun., 110, 602 (1983). (Biochem.)
• This compound is distributed through Peptide Institute, Inc. under the license of The Salk Institute.

Cortistatin
Cortistatin (Rat) PCN-4329-v 0.5 mg 180
CST-14 (Rat) -20 °C vial
Pro-Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Ser-Ser-Cys-Lys
(Disulfide bond between Cys2-Cys13)
(M.W. 1721.0) C81H113N19O19S2
Neuronal Depressant and Sleep-Modulating Peptide
L. De Lecea, et al., Nature, 381, 242 (1996). (Original)
L. De Lecea, et al., J. Neurosci., 17, 5868 (1997). (Biochem.)
M. Connor, S.L. Ingram, and M.J. Christie, Br. J. Pharmacol., 122, 1567 (1997) (Pharmacol.)

PEPTIDES INTERNATIONAL
A.D. Spier and L. de Lecea, Brain Res. Rev., 33, 228 (2000). (Review)

C-Type Natriuretic Peptide (CNP)

A. Rosenzweig and C.E. Seidman, Annu. Rev. Biochem., 60, 229 (1991). (Review)

CNP-22 (Human)* PCT-4229-v 0.5 mg 435

C-Type Natriuretic Peptide-22 (Human) -20 °C vial
(Porcine, Rat, Mouse)
Gly-Leu-Ser-Lys-Gly-Cys-Phe-Gly-Leu-Lys-Leu-Asp-Arg-Ile-Gly-Ser-Met-Ser-Gly-Leu-Gly-Cys
(Disulfide bond between Cys6-Cys22)
(M.W. 2197.6) C93H157N27O28S3 [127869-51-6]
T. Sudoh, et al., Biochem. Biophys. Res. Commun., 168, 863 (1990). (Original; Porcine)
Y. Tawaragi, et al., Biochem. Biophys. Res. Commun., 175, 645 (1991). (cDNA Seq.; Human)
M. Kojima, N. Minamino, K. Kangawa, and H. Matsuo, FEBS Lett., 276, 209 (1990). (cDNA Seq.; Rat)
Y. Ogawa, et al., Genomics, 24, 383 (1994). (Nucleotide Seq.; Mouse)
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

CNP-53 (Human)* PCT-4241-s 0.1 mg 335

C-Type Natriuretic Peptide-53 (Human) -20 °C vial
Asp-Leu-Arg-Val-Asp-Thr-Lys-Ser-Arg-Ala-Ala-Trp-Ala-Arg-Leu-
Leu-Gln-Glu-His-Pro-Asn-Ala-Arg-Lys-Tyr-Lys-Gly-Ala-Asn-
Lys-Lys-Gly-Leu-Ser-Lys-Gly-Cys-Phe-Gly-Leu-Lys-Leu-
Asp-Arg-Ile-Gly-Ser-Met-Ser-Gly-Leu-Gly-Cys
(Disulfide bond between Cys37-Cys53)
(M.W. 5801.7) C251H417N81O71S3 [141294-77-1]
Y. Tawaragi, K. Fuchimura, S. Tanaka, N. Minamino, K. Kangawa, and H. Matsuo, Biochem. Biophys. Res. Commun.,
175, 645 (1991). (Original)
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

Order Hotline 1-800-777-4779 502-266-8787 37

 PRODUCT CODE QTY PRICE
BIOLOGICALLY ACTIVE PEPTIDES

CNP-53 (Porcine, Rat)* PCT-4240-s 0.1 mg 335

C-Type Natriuretic Peptide-53 (Porcine, Rat) -20 °C vial
Asp-Leu-Arg-Val-Asp-Thr-Lys-Ser-Arg-Ala-Ala-Trp-Ala-Arg-
Leu-Leu-His-Glu-His-Pro-Asn-Ala-Arg-Lys-Tyr-Lys-Gly-Gly-
Asn-
Lys-Lys-Gly-Leu-Ser-Lys-Gly-Cys-Phe-Gly-Leu-Lys-Leu-
Asp-Arg-Ile-Gly-Ser-Met-Ser-Gly-Leu-Gly-Cys
(Disulfide bond between Cys37-Cys53)
(M.W. 5796.7) C251H414N82O70S3
N. Minamino, K. Kangawa, and H. Matsuo, Biochem. Biophys. Res. Commun., 170, 973 (1990). (Original; Porcine)
Y. Tawaragi, et al., Biochem. Bipophys. Res. Commun., 172, 627 (1990). (Original; Porcine Nucleotide Seq.)
M. Kojima, N. Minamino, K. Kangawa, and H. Matsuo, FEBS Lett., 276, 209 (1990). (Original; Rat cDNA)
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

Tyrosyl-CNP-22 (Human)* PCT-4251-v 0.5 mg 515

Tyrosyl-C-Type Natriuretic Peptide-22 (Human) -20 °C vial
Tyr-Gly-Leu-Ser-Lys-Gly-Cys-Phe-Gly-Leu-Lys-Leu-
Asp-Arg-Ile-Gly-Ser-Met-Ser-Gly-Leu-Gly-Cys
(Disulfide bond between Cys6-Cys22)
(M.W. 2360.8) C102H166N28O30S3 [142878-79-3]
For Radioimmunoasay
J. Brown and Z. Zuo, Am. J. Physiol., 266, R1383 (1994). (Pharmacol.)
J. Zhao, N. Ardaillou, C.-Y. Lu, S. Placier, P. Pham, L. Badre, J. Cambar, and R. Ardaillou, Kidney Int., 46, 717 (1994).
(Pharmacol.)
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

cyclo (Arg-Gly-Asp) Peptides See Arg-Gly-Asp Peptides.

PEPTIDES INTERNATIONAL

cyclo (d-Trp-d-Asp-Pro-d-Val-Leu) See BQ -123 Sodium Salt.

DAP (Diabetes-Associated Peptide) See Amylin.

d-, l-Peptide with Antitumor Activity

KL-d-Leu-RLL-d-Lys-d-Lys-L-d-Leu-RL-d-Leu- PDL-3643-PI 1 mg 115

LK-NH2 -20 °C 5 mg 475
Lys-Leu-d-Leu-Arg-Leu-Leu-d-Lys-d-Lys-Leu-d-Leu-Arg-Leu-d-Leu-Leu-Lys-NH2
(M.W. 1860.56) C90H174N26O15
d-,l- Peptide with Antitumor Activity

N. Papo, M. Shahar, L. Eisenbach, and Y. Shai, J. Biol. Chem., 278, 21018 (2003).

Deamino-Dicarba-Arginine-Vasopressin See Code PVP-4026-v [Asu1,6, Arg8]-Vasopressin.

Deamino-Dicarba-Arginine-Vasotocin See Code PVP-4027-v [Asu1,6, Arg8] Vasotocin.
Deamino-Dicarba-Oxytocin See Code POX-4025-v [Asu1,6]-Oxytocin.

Decorsin
Decorsin PDC-4269-s 0.1 mg 300
(Leech, Macrobdella decora) -20 °C vial
Ala-Pro-Arg-Leu-Pro-Gln-Cys-Gln-Gly-Asp-Asp-Gln-Glu-Lys-Cys-Leu-Cys-Asn-Lys-Asp-
Glu-Cys-Pro-Pro-Gly-Gln-Cys-Arg-Phe-Pro-Arg-Gly-Asp-Ala-Asp-Pro-Tyr-Cys-Glu
(Disulfide bonds between Cys7-Cys15, Cys17-Cys27, and Cys22-Cys38)
(M.W. 4377.8) C179H271N55O62S6
Glycoprotein IIb / IIIa Antagonist, Platelet Aggregation Inhibitor
J.L. Seymour, W.J. Henzel, B. Nevins, J.T. Stults, and R.A. Lazarus, J. Biol. Chem., 265, 10143 (1990).
A.M. Krezel, G. Wagner, J. Seymour-Ulmer, and R.A. Lazarus, Science, 264, 1944 (1994). (S-S Bond)

38 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT CODE QTY PRICE
Defensin Peptides

BIOLOGICALLY ACTIVE PEPTIDES

R.I. Lehrer and T. Ganz, Ann. N.Y. Acad. Sci., 797, 228 (1996). (Review)
M. Zasloff, Nature, 415, 389 (2002). (Review)
T. Hirsch, F. Jacobsen, H.-U. Steinau, and L. Steinstraesser, Protein Pept. Lett., 15, 238 (2008). (Review)
M. Pazgier, X. Li, W. Lu, and J. Lubkowski, Curr. Pharm. Des., 13, 3096 (2007). (Review)
Y.P. Lai and R.L. Gallo, Trends Immunol., 30, 131 (2009). (Review)

a-Defensin-1 (Human) PDF-4271-s 0.1 mg 265

HNP-1 (HNP: Human Neutrophil Peptide) -20 °C vial
Ala-Cys-Tyr-Cys-Arg-Ile-Pro-Ala-Cys-Ile-Ala-Gly-Glu-Arg-
Arg-Tyr-Gly-Thr-Cys-Ile-Tyr-Gln-Gly-Arg-Leu-Trp-Ala-Phe-
Cys-Cys
(Disulfide bonds are formed between Cys2-Cys30, Cys4-Cys19, and Cys9-Cys29)
(M.W. 3442.0) C150H222N44O38S6
Antimicrobial Peptide / Chemoattractant for Monocytes
T. Ganz, M.E. Selsted, D. Szklarek, S.S.L. Harwig, K. Daher , D.F. Bainton, and R.I. Lehrer, J. Clin. Invest., 76, 1427
(1985). (Original; Isolation)
M.E. Selsted, S.S.L. Harwig, T. Ganz, J.W. Schilling, and R.I. Lehrer, J. Clin. Invest., 76, 1436 (1985). (Original; Structure)

α-Defensin -2 (Human) PDF-4428-s 0.1 mg 240

HNP-2 (Human Neutrophil Peptide-2) -20 °C vial
Cys-Tyr-Cys-Arg-Ile-Pro-Ala-Cys-Ile-Ala-Gly-Glu-Arg-Arg-Tyr-
Gly-Thr-Cys-Ile-Tyr-Gln-Gly-Arg-Leu-Trp-Ala-Phe-Cys-Cys
(Disulfide bonds between Cys1-Cys29, Cys3-Cys18, and Cys8-Cys28)
(M.W. 3371.0) C147H217N43O37S6
Antimicrobial Peptide
Human α-defensins are composed of 6 peptides: 4 human neutrophil peptides [HNP-
1 (PDF-4271-s), HNP-2, HNP-3 (PDF-4416-s), and HNP-4 (PDF-4431-s)] and 2 human

PEPTIDES INTERNATIONAL
defensins [HD-5 (PDF-4415-s) and HD-6 (PDF-4458-s)]. Among them, the primary
structures of HNP-1, HNP-2 and HNP-3 differ only at the amino-terminal residue, in
which the first residue is Ala for HNP-1 and Asp for HNP-3, whereas HNP-2 lacks this
position, resulting in the 29-residue peptide.1,2 Recent studies by mass spectroscopic
analysis clarified that HNP-2 is the second major component in squamous cell
carcinoma of human tongue 3 and gingival crevicular fluid from periodontitis patients
and healthy controls4, where HNP-1 is the most abundant and HNP-3 is the
least. Taking this fact into account, it is speculated that HNP-2 is produced post-
translationally from HNP-3. Concerning the activity, HNP-2 is revealed to be as active
as HNP-1 in neutralizing anthrax lethal toxin5 and blocking papillomavirus infection 6,
although some differences were pointed out in the candidacidal activity among HNPs7.
1. T. Ganz, M.E. Selsted, D. Szklarek, S.S.L. Harwig, K. Daher , D.F. Bainton, and R.I. Lehrer, J. Clin. Invest.,
76, 1427 (1985).
2. M.E. Selsted, S.S.L. Harwig, T. Ganz, J.W. Schilling, and R.I. Lehrer, J. Clin. Invest., 76, 1436 (1985).
3. F.T. Lundy, D.F. Orr, J.R. Gallagher, P. Maxwell, C. Shaw, S.S. Napier, C.G. Cowan, P.-J. Lamey,
and J.J. Marley, Am. J. Pathol., 160, 1311 (2002).
4. F.T. Lundy, D.F. Orr, C. Shaw, P.-J. Lamey, and G.J. Linden, Oral Oncol., 40, 139 (2004).
5. C. Kim, N. Gajendran, H.-W. Mittrüker, M. Weiwad, Y-H. Song, R. Hurwitz, M. Wilmanns, G. Fischer,
and S.H.E. Kaufmann, Proc. Natl. Acad. Sci., U.S.A., 102, 4830 (2005).
6. C.B. Buck, P.M. Day, C.D. Thompson, J. Lubkowski, W. Lu, D.R. Lowy, and J.T. Schiller,
Proc. Natl. Acad. Sci., U.S.A., 103, 1516 (2006).
7. R.I. Lehler, T. Ganz, D. Szklarek, and M.E. Selsted, J. Clin. Invest., 81, 1829 (1988).
(Pharmacol.; Activity difference in HNP)

Order Hotline 1-800-777-4779 502-266-8787 39

 PRODUCT CODE QTY PRICE
BIOLOGICALLY ACTIVE PEPTIDES

α−Defensin-3 (Human) PDF-4416-s 0.1 mg 240

HNP-3 (Human Neutrophil Peptide-3) -20 °C vial
Asp-Cys-Tyr-Cys-Arg-Ile-Pro-Ala-Cys-Ile-Ala-Gly-Glu-Arg-Arg-
Tyr-Gly-Thr-Cys-Ile-Tyr-Gln-Gly-Arg-Leu-Trp-Ala-Phe-Cys-Cys
(Disulfide bonds between Cys2-Cys30, Cys4-Cys19, and Cys9-Cys29)
(M.W. 3486.0) C151H222N44O40S6
Antimicrobial Peptide
HNP-1 to HNP-3 are the major components in azophilic granules of human neu-
trophils.1, 2 The primary structures of HNP-1 to HNP-3 differ by only one amino
acid residue at position 1; HNP-2 corresponds to positions 2 through 30 of HNP-1
(des-Ala1-HNP-1) while HNP-3 is Asp1-HNP-1. Interesting publications using HNP
include: i) HNP-1 to HNP-3 may show anti-HIV-1 activity3, and ii) HNP-1 to HNP-3
are overexpressed in squamous cell carcinomas of the human tongue, representing a
possible role in innate host defense against tumor invasion4. It has been reported that
expression of HNP-1 to HNP-3 is not upregulated by lipopolysaccharide5, while they
locate in intestinal epithelial cells in cases of inflammatory bowel disease6.
1. T. Ganz, et al., J. Clin. Invest., 76, 1427 (1985). (Original; Isolation of HNP 1-3)
2. M.E. Selsted, et al., J. Clin. Invest., 76, 1436 (1985). (Original; Structure of HNP 1-3)
3. C.E. Mackewicz, et al., AIDS, 17, F23 (2003). (Pharmacol.; Anti–HIV–1 Activity)
4. F.T. Lundy, et al., Oral Oncol., 40, 139 (2004). (Pharmacol.; Role in Tumor Invasion)
5. X.-M. Fang, et al., Eur. J. Clin. Invest., 33, 82 (2003). (Histochem.; Regulation of Expression)
6. R.N. Cunliffe, Mol. Immunol., 40, 463 (2003). (Histochem.; α-Defensin in Gastrointestinal Tract)

α-Defensin-4 (Human) PDF-4431-s 0.1 mg 295

HNP-4 (Human Neutrophil Peptide-4) -20 °C vial
Val-Cys-Ser-Cys-Arg-Leu-Val-Phe-Cys-Arg-Arg-Thr-Glu-Leu-Arg-Val-Gly-
PEPTIDES INTERNATIONAL

Asn-Cys-Leu-Ile-Gly-Gly-Val-Ser-Phe-Thr-Tyr-Cys-Cys-Thr-Arg-Val
(Disulfide bonds between Cys2-Cys30, Cys4-Cys19, and Cys9-Cys29)
(M.W. 3709.40) C157H255N49O43S6
Synthetic Product
Antimicrobial Peptide
Four α-defensins in neutrophils are called human neutrophil peptide-1 (HNP-1) to
HNP-4, in which primary structures of HNP-1 to HNP-3 are similar; Ala and Asp are the
first residue of HNP-1 (PDF-4271) and HNP-3 (PDF-4416), respectively, whereas HNP-
2 (PDF-4428) lacks the corresponding amino acid residue at position 1. In contrast to
these HNPs, α-defensin-4 (HNP-4) shows marked difference in its primary structure
although all six Cys residues are conserved.1,2 Activities of HNP-4 reported so far
include: i) inhibition of the ACTH action in rat adrenal cell suspension (ID50 = 7.0 X 10-7
M)1, ii) distinct antimicrobial activity3,4, iii) antiviral activity against X4 and R5 HIV-1
strains5, and iv) inhibition of Bacillus anthracis lethal factor (IC50 = 811 nM)6. In the
HIV-1 inhibition, it is proposed that HNP-4 exerts the activity by the lectin-independent
property with CD4 and/or gp120, which is different from that of HNP-1 to HNP-35).
Although the research using HNP-4 seems to be proceeding relatively slowly at the
moment, partly because HNP-4 is a minor component in the granulocytes HNPs, our
synthetic HNP-4 will contribute significantly to clarify the total activity of HNPs in the
body.
1. A. Singh, et al., Biochem. Biophys. Res. Commun., 155, 524 (1988). (Original; Primary Structure / Anti-ACTH Activity)
2. C.G. Wilde, et al., J. Biol. Chem., 264, 11200 (1989). (Original; Structure / HNP-4 / Antimicrobial Activity)
3. Z. Wu, et al., J. Pept. Res., 64, 118 (2004). (Pharmacol; Antimicrobial Activity)
4. B. Ericksen, et al., Antimicrob. Agents Chemother., 49, 269 (2005). (Pharmacol; Antimicrobial Activity)
5. Z. Wu, et al., FEBS Lett., 579, 162 (2005). (Pharmacol.; HIV-1 Inhibitory Activity)
6. G. Wei, et al., J. Biol. Chem., 284, 29180 (2009). (Pharmacol.;Iinhibition of Bacillus anthracis Lethal Factor)

40 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT CODE QTY PRICE
α-Defensin-5 (Human) PDF-4415-s 0.1 mg 265

BIOLOGICALLY ACTIVE PEPTIDES

HD-5 (Human Defensin-5) -20 °C vial
Ala-Thr-Cys-Tyr-Cys-Arg-Thr-Gly-Arg-Cys-Ala-Thr-Arg-Glu-Ser-Leu-
Ser-Gly-Val-Cys-Glu-Ile-Ser-Gly-Arg-Leu-Tyr-Arg-Leu-Cys-Cys-Arg
(Disulfide bonds between Cys3-Cys31, Cys5-Cys20, and Cys10-Cys30)
(M.W. 3582.1) C144H238N50O45S6
Antimicrobial Peptide in Paneth Cells
HD-5 is expressed in Paneth cells in intestinal epithelium, thus, falls into a distinct
subclass of human α-defensin.1, 2 The in vivo role of HD-5 was studied in transgenic
mouse models injected by an HD-5 minigene, confirming that HD-5 expression was
specific to Paneth cells and resulted in resistance to bacterial challenge.3 In patients
with HIV-related cryptosporidiosis, HD-5 immunoreactivity was reduced in associa-
tion with Paneth cell granule depletion.4 In inflammatory bowel disease, HD-5 was
expressed in metaplastic Paneth cells in the colon.5 These evidences together point
to HD-5 as being an essential factor in the defense against intestinal inflammation.
1. D.E. Jones and C.L. Bevins, J. Biol. Chem., 267, 23216 (1992). (Original; Human Defensin-5)
2. E.M. Porter, M.A. Poles, J.S. Lee, J. Naitoh, C.L. Bevins, amd T. Ganz, FEBS Lett., 434, 272 (1998).
(Pharmacol.; Endogenous Form)
3. N.H. Salzman, D. Ghosh, K.M. Huttner, Y. Paterson, and C.L. Bevins, Nature, 422, 522 (2003). (Pharmacol.)
4. P. Kelly, R. Feakins, P. Domizio, J. Murphy, C. Bevins, J. Wilson, G. Mcphail, R. Poulsom, and W. Dhaliwal,
Clin. Exp. Immunol., 135, 303 (2004). (Histochem.; Location in AIDS Patients)
5. R.N. Cunliffe, Mol. Immunol., 40, 463 (2003). (Histochem.; α-Defensin in Gastrointestinal Tract)

α-Defensin-6 (Human) PDF-4458-s 0.1 mg 295

[HD-6 (Human Defensin-6)] -20 °C vial
Ala-Phe-Thr-Cys-His-Cys-Arg-Arg-Ser-Cys-Tyr-Ser-Thr-Glu-Tyr-Ser-

PEPTIDES INTERNATIONAL
Tyr-Gly-Thr-Cys-Thr-Val-Met-Gly-Ile-Asn-His-Arg-Phe-Cys-Cys-Leu
(Disulfide bonds between Cys4-Cys31, Cys6-Cys20, and Cys10-Cys30)
(M.W. 3708.2) C156H228N46O46S7
Antimicrobial Peptide in Paneth Cells
Six α-defensins have been identified in the human; four of which are found in
neutrophiles and thus named human neutrophil peptide-1, HNP-1 (PDF-4271-s), HNP-
2 (PDF-4428-s), HNP-3 (PDF-4416-s) and HNP-4 (PDF-4431-s). The remaining two are
called human defensin-5 (HD-5, PDF-4415-s) and human defensin-6 (HD-6)1, which are
identified in intestinal Paneth cells. HD-6 was isolated from ileal neobladder urine as a
32-residue peptide.2 It appeared in the initial study that HD-6 was practically inactive
against some bacteria and fungi.3 However, the experimental results proving HD-6 to
be an antimicrobial peptide have been accumulating: i) Helicobacter pylori infection
increases HD-6 expression in the fundus4, ii) HD-6 inhibits herpes simplex virus
infection5, iii) HD-6 has influenza A virus neutralizing ability6, and iv) the HD-6 level is
reduced in small intestinal Crohn’s disease7. In contrast to these positive effects in the
host defense system, Neisseria gonorrhoeae-induced HD-6 enhances HIV infectivity,
showing how complex HD-6 activity may be.8 Anyhow, these specific characteristics
observed in HD-6 are attractive in the study of human innate immunity.
1. D.E. Jones and C.L. Bevins, FEBS Lett., 315,187 (1993). (Original; mRNA Seq.)
2. E.M. Porter, et al., FEBS Lett., 434, 272 (1998). (Endogenous Form)
3. B. Ericksen, et al., Antimicrob. Agents Chemother., 49, 269 (2005). (Pharmacol.; No Antibacterial Activity)
4. J. Wehkamp, et al., J. Clin. Pathol., 56, 352 (2003). (Pharmacol.; Enhanced Expression in Helicobacter pylori Infection)
5. E. Hazrati, et al., J. Immunol., 177, 8658 (2006). (Pharmacol.; Inhibition of Herpes Simplex Virus Infection)
6. M. Doss, et al., J. Immunol., 182, 7878 (2009). (Pharmacol.; Influenza A Virus Neutralizing Activity)
7. M.J. Koslowski, et al., Int. J. Med. Microbiol., 300, 34 (2010).
(Minireview; Antimicrobial Host Defense in Small Intestinal Crohn’s Disease)
8. M.E. Klotman, et al., J. Immunol., 180, 6176 (2008). (Pharmacol.; Enhancement of HIV Infectivity)

Order Hotline 1-800-777-4779 502-266-8787 41

 PRODUCT CODE QTY PRICE
BIOLOGICALLY ACTIVE PEPTIDES

β-Defensin-1 (Human) PDF-4337-s 0.1 mg 260

hBD-1 -20 °C vial
Asp-His-Tyr-Asn-Cys-Val-Ser-Ser-Gly-Gly-Gln-Cys-Leu-
Tyr-Ser-Ala-Cys-Pro-Ile-Phe-Thr-Lys-Ile-Gln-Gly-Thr-
Cys-Tyr-Arg-Gly-Lys-Ala-Lys-Cys-Cys-Lys
(Disulfide bonds between Cys5-Cys34, Cys12-Cys27, and Cys17-Cys35)
(M.W. 3928.5) C167H256N48O50S6
Antimicrobial Peptide
K.W. Bensch, M. Raida, H-J. Mägert, P. Schulz-Knappe, and W.-G. Forssmann, FEBS Lett., 368, 331 (1995). (Original)
M.J. Goldman, et al., Cell, 88, 553 (1997). (Pharmacol.; Inactivated in Cystic Fibrosis)
T. Hiratsuka, et al., Nephron, 85, 34 (2000). (Pharmacol.)

β-Defensin-2 (Human) PDF-4338-s 0.1 mg 280

hBD-2 -20 °C vial
Gly-Ile-Gly-Asp-Pro-Val-Thr-Cys-Leu-Lys-Ser-Gly-Ala-Ile-Cys-
His-Pro-Val-Phe-Cys-Pro-Arg-Arg-Tyr-Lys-Gln-Ile-Gly-Thr-
Cys-Gly-Leu-Pro-Gly-Thr-Lys-Cys-Cys-Lys-Lys-Pro
(Disulfide bonds between Cys8-Cys37, Cys15-Cys30, and Cys20-Cys38)
(M.W. 4328.2) C188H305N55O50S6
Antibacterial Peptide Specific for Gram-Negative Bacteria / Also Effective for Candida albicans
J. Harder, J. Bartels, E. Christophers, and J.-M. Schroder, Nature, 387, 861 (1997). (Original)
T. Hiratsuka, et al., Biochem. Biophys. Res. Commun., 249, 943 (1998). (Pharmacol.)
D.M. Hoover, et al., J. Biol. Chem., 275, 32911 (2000). (S-S Bond)
T. Hiratsuka, et al., Thorax, 58, 425 (2003). (Pharmacol.; Activity against Pseudomonas aeruginosa)
S. Yanagi, et al., Respiratory Res., 6, 130 (2005). (Pharmacol. & Immunohistochem.)
PEPTIDES INTERNATIONAL

42 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT CODE QTY PRICE
β-Defensin-3 (Human) PDF-4382-s 0.1 mg 290

BIOLOGICALLY ACTIVE PEPTIDES

hBD-3 -20 °C vial
Gly-Ile-Ile-Asn-Thr-Leu-Gln-Lys-Tyr-Tyr-Cys-Arg-Val-Arg-Gly-Gly-
Arg-Cys-Ala-Val-Leu-Ser-Cys-Leu-Pro-Lys-Glu-Glu-Gln-Ile-Gly-
Lys-Cys-Ser-Thr-Arg-Gly-Arg-Lys-Cys-Cys-Arg-Arg-Lys-Lys
(Disulfide bonds between Cys11-Cys40, Cys18-Cys33, and Cys23-Cys41)
(M.W. 5155.1) C216H371N75O59S6
Antimicrobial Peptide / Staphylococcus aureus-Killing Factor
The human defensins represent an important family of antimicrobial peptides. They
are composed of two subclasses: α-defensins and β-defensins (hBD), which are
characterized by their distinct arrangement of three disulfide bonds. Following the dis-
covery of hBD-1 (PDF-4337-s) and hBD-2 (PDF-4338-s) in 1995 and 1997, respectively,
hBD-3 was included in 2001. 1 hBD-3 was identified in lesional psoriatic scales, from
which hBD-2 was also isolated. Peptide and DNA chemistry revealed hBD-3 to be a 45
amino acid residue peptide. The antimicrobial activity of hBD-3 is characterized by: i)
a broad spectrum of antimicrobial activity against many pathogenic microbes such as
multi-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus fae-
cium without hemolytic activity, ii) salt-insensitivity up to 200 mM NaCl, iii) expression
of activity through cell wall perforation, and iv) regulation by TNF-α and contact with
bacteria.1 Later, although the data was obtained using the amino-terminally truncated
peptide, hBD-3 (6-45), the following interesting findings were reported: i) hBD-3 is
stimulated by interferon-γ, and ii) hBD-3 has monocyte activating function and elicits
ion channel activity.2 It is also reported that unlike hBD-1 and hBD-2, hBD-3 mRNA
expression is inhibited by corticosteroids.3 Significant amounts of these peptides are
distributed in the following tissues: skin, tonsil, trachea, placenta, testis, thymus, and

PEPTIDES INTERNATIONAL
heart.1,2,4 With respect to the structural aspects of hBD-3, an amphipathic dimeric
structure was proposed in solution, which is different from those of hBD-1 and hBD-2.
This might be responsible for the bactericidal activity against Staphylococcus aureus.5
Thus, the hBD-3, as well as the other defensins, are useful tools for understanding
their defense mechanisms against various microorganisms.
1. J. Harder, J. Bartels, E. Christophers, and J.-M. Schröder, J. Biol. Chem., 276, 5707 (2001). (Original)
2. J.-R.C. García, et al., Cell Tissue Res., 306, 257 (2001). (Original; Amino-Terminally Truncated Peptide)
3. L.A. Duits, et al., Biochem. Biophys. Res. Commun., 280, 522 (2001). (Pharmacol.)
4. H.P. Jia, et al., Gene, 263, 211 (2001). (DNA Seq/Tissue Distribution)
5. D.J. Schibli, et al., J. Biol. Chem., 277, 8279 (2002). (Solution Structure)
6. S. Yanagi, et al., Respiratory Res., 6, 130 (2005). (Pharmacol. & Immunohistochem.)

Order Hotline 1-800-777-4779 502-266-8787 43

 PRODUCT CODE QTY PRICE
BIOLOGICALLY ACTIVE PEPTIDES

β-Defensin-4 (Human) PDF-4406-s 0.1 mg 260

hBD-4 -20 °C vial
Prepro hBD-4 (Human, 25-61)
Glu-Leu-Asp-Arg-Ile-Cys-Gly-Tyr-Gly-Thr-Ala-Arg-Cys-Arg-Lys-Lys-Cys-Arg-Ser-
Gln-Glu-Tyr-Arg-Ile-Gly-Arg-Cys-Pro-Asn-Thr-Tyr-Ala-Cys-Cys-Leu-Arg-Lys
(Disulfide bonds between Cys6-Cys33, Cys13-Cys27, and Cys17-Cys34)
(M.W. 4366.0) C180H295N63O52S6
Antimicrobial Peptide / Chemoattractant for Monocytes
28 Human β-defensins were predicted in five gene clusters using a computational
search approach.1 Among others, hBD-4, was proposed based on the cDNA sequence
analysis, the precursor of which is composed of 72 amino acid residues. Although
natural hBD-4, as far as we know, has not yet been isolated, hBD-4 was tentatively
designed as the peptide corresponding to the positions between 25 and 61 in the
precursor sequence [hereafter the term “hBD-4” is used for this peptide. Chemically
synthesized hBD-4 was confirmed to share the conserved disulfide connectivity of the
β-defensin family of peptides by the combination of enzymatic digestions and Edman
degradation reaction2). Using this chemically synthesized hBD-4, the following obser-
vations were reported2): i) hBD-4 elicits salt-sensitive antimicrobial activities against
both Gram-positive and Gram-negative bacteria in human respiratory epithelial cells;
ii) the most active antimicrobial activity is detected against Pseudomonas aeruginosa
at 4.1 μg/ml; and iii) hBD-4 is a chemoattractant for human blood monocytes at 10
nM, but not for neutrophiles and eosinophiles. Interestingly, antimicrobial activities in
the lungs were inducible by the infection and subsequent activation of protein kinase
C, thus differing from the activation mechanism from hBD-2 and hBD-3, which are
induced in response to the stimulation by TNF-α, IL-1α, IL-6 or interferon α. hBD-4
PEPTIDES INTERNATIONAL

mRNA was expressed abundantly in testis and the stomach, and to a lesser extent
but significantly in the uterus, neutrophiles thyroid, lungs, and kidney. hBD-4, which
is regulated by specific stimulation that differs from those in hBD-2 and hBD-3, should
be an essential component in clarifying the host defense mechanism in humans. Later,
the existence of the immunoreactive hBD-4 in the body was reported3). Also, hBD-4
induces mast cell degranulation, prostaglandin D2 production, intracellular Ca2+
mobilization and chemotaxis4).
1. B.C. Schutte, et al., Proc. Natl. Acad. Sci., USA, 99, 2129 (2002). ( β-Defensin Family Peptides)
2. J.R.C. García, et al., FASEB J., 15, 1819 (2001). (Original: hBD-4 & S-S Bond)
3. S. Yanagi, et al., Respiratory Res., 6, 130 (2005). (Pharmacol. & Immunohistochem.)
4. X. Chen, et al., Eur. J. Immunol., 37, 434 (2007). (Pharmacol.)

Delta Sleep-Inducing Peptide (DSIP)

Delta Sleep-Inducing Peptide (DSIP) PDS-4054-v 0.5 mg 55
Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu -20 °C vial
(M.W. 848.81) C35H48N10O15 [62568-57-4]

Delta Sleep-Inducing Peptide (DSIP) (Bulk) PDS-4054 25 mg 595

Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu • 4H2O -20 °C
(M.W. 848.81 • 72.06) C35H48N10O15 • 4H2O [62568-57-4]
G.A. Schoenenberger and M. Monnier, Proc. Natl. Acad. Sci., USA., 74, 1282 (1977). (Original)
M. Monnier, et al., Experientia, 33, 548 (1977). (Pharmacol.)

44 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT CODE QTY PRICE
Dermcidin- 1L / DCD

BIOLOGICALLY ACTIVE PEPTIDES

Dermcidin- 1L (Human) PDL-4454-s 0.1 mg 270
DCD-1L (Human) -20 °C vial
Ser-Ser-Leu-Leu-Glu-Lys-Gly-Leu-Asp-Gly-Ala-Lys-Lys-Ala-Val-Gly-Gly-
Leu-Gly-Lys-Leu-Gly-Lys-Asp-Ala-Val-Glu-Asp-Leu-Glu-Ser-Val-Gly-
Lys-Gly-Ala-Val-His-Asp-Val-Lys-Asp-Val-Leu-Asp-Ser-Val-Leu
(M.W. 4818.4) C210H359N57O71
Synthetic Product
Antimicrobial Peptide in Sweat Glands
Dermcidin is a constitutively secreted antimicrobial peptide in human sweat.1 Dermcidin
is revealed to be a 110-residue protein by cDNA analysis, which is proteolytically
processed to several components with variable charges. Dermcidin-1L is one of such
processed peptides with anionic property, which corresponds to the carboxyl-terminal
48-residues of the precursor protein. 1,2 Studies using dermcidin-1L reported so far
include: i) dermcidin-1L is active against Gram-positive and negative bacteria and
fungus (1-100 μg/ml) 1, ii) in patients with atopic dermatitis the amounts of dermicidin-
1L and other dermcidin-derived peptides are reduced 3, and iii) dermcidin-1L activates
human keratinocytes, inducing the generation of cytokines and chemokines (2.5-20
μg/ml).4 Dermcidin-1L does not show membrane permeability, thus, the mechanism
exerting antimicrobial activity of dermcidin-1L is distinct from that of other antimicrobial
peptide, LL-37 (PLL-4445-s).5 Dermcidin-1L in sweat may be essential for the battle
with infectious pathogens on the human body surface, therefore it will be an important
tool in the host defense research.

PEPTIDES INTERNATIONAL
1. B. Schittek, et al., Nat. Immunol., 2, 1133 (2001). (Original; Antimicrobial Peptide)
2. S. Rieg, et al., J. Immunol., 174, 8003 (2005). (Endogenous Form)
3. H. Steffen, et al., Antimicrob. Agents Chemother., 50, 2608 (2006). (Pharmacol.)
4. F. Niyonsaba, et al.,Br. J. Dermatol.,160,243 (2009). (Pharmacol.)
5. I. Senyurek, et al., Antimicrob. Agents Chemother., 53, 2499 (2009). (Pharmacol.)

Diabetes-Associated Peptide (DAP) See Codes PAM-4219-v Amylin (Human) and

PAM-4220-v Amylin (Rat).

Dynorphins
J. Hughes, Br. Med. Bull., 39, 17 (1983). (Review)
A.P. Smith and N.M. Lee, Annu. Rev. Pharmacol. Toxicol., 28, 123 (1988). (Review)
M. Simonato and P. Romualdi, Prog. Neurobiol., 50, 557 (1996). (Review)

Dynorphin A (Human, 1-13) PDY-4080-v 0.5 mg 80

(Porcine, Rat, Bovine) -20 °C vial
Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Ile-Arg-Pro-Lys-Leu-Lys
(M.W. 1604.0) C75H126N24O15 [72957-38-1]
A. Goldstein, et al., Proc. Natl. Acad. Sci. U.S.A., 76, 6666 (1979). (Original; Porcine)
S. Horikawa, T. Takai, M. Toyosato, H. Takahashi, M. Noda, H. Kakidani, T. Kubo, T. Hirose, S. Inayama, H. Hayashida,
T. Miyata, and S. Numa, Nature, 306, 611 (1983). (Nucleotide Seq.; Human)

Dynorphin A (Human) PDY-4108-v 0.5 mg 150

(Porcine, Rat, Bovine) -20 °C vial
Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Ile-Arg-Pro-Lys-Leu-Lys-Trp-Asp-Asn-Gln
(M.W. 2147.5) C99H155N31O23 [80448-90-4]
S. Tachibana, et al., The 1981 International Narcotic Research Conference, Kyoto, July 1981. (Original)
A. Goldstein, et al., Proc. Natl. Acad. Sci. USA, 78, 7219 (1981). (Original; Porcine)
S. Horikawa, et al., Nature, 306, 611 (1983). (Nucleotide Seq.; Human)
O. Civelli, et al., Proc. Natl. Acad. Sci. U.S.A., 82, 4291 (1985). (Nucleotide Seq.; Rat)

Order Hotline 1-800-777-4779 502-266-8787 45

 PRODUCT CODE QTY PRICE
BIOLOGICALLY ACTIVE PEPTIDES

Echistatin See Code ECT-3760-PI in the Toxins subsection.

Elafin
Elafin (Human) PEL-4243-v 20 mg 375
Ala-Gln-Glu-Pro-Val-Lys-Gly-Pro-Val-Ser-Thr-Lys-Pro-Gly- -20 °C vial
Ser-Cys-Pro-Ile-Ile-Leu-Ile-Arg-Cys-Ala-Met-Leu-Asn-Pro-
Pro-Asn-Arg-Cys-Leu-Lys-Asp-Thr-Asp-Cys-Pro-Gly-Ile-Lys-
Lys-Cys-Cys-Glu-Gly-Ser-Cys-Gly-Met-Ala-Cys-Phe-Val-
Pro-Gln
(Disulfide bonds between Cys16-Cys45, Cys23-Cys49, Cys32-Cys44, and Cys38-Cys53)
(M.W. 5999.1) C254H416N72O75S10
Elastase-Specific Inhibitor from Human Skin / Innate Immune Factor
O. Wiedow, J.-M. Schröder, H. Gregory, J.A. Young, and E. Christophers, J. Biol. Chem., 265, 14791 (1990). (Original)
O. Wiedow, et al., J. Biol. Chem., 266, 3356 (1991). (Correction of Sequence)
M. Tsunemi, H. Kato, Y. Nishiuchi, S. Kumagaye, and S. Sakakibara, Biochem. Biophys. Res. Commun., 185, 967
(1992). (Chem. Synthesis & Biochem.)
M. Tsunemi, H. Kato, Y. Nishiuchi, S. Kumagaye, and S. Sakakibara, Biochem. Biophys. Res. Commun., 185, 967
(1992). (Chem. Synthesis & Biochem.)
M. Tsunemi, et al., Biochemistry, 35, 11570 (1996). (Biochem.; Crystal Structure of Elafin-Pancreatic Elastase Complex)
L. Marischen, et al., Scand. J. Immunol., 70, 547 (2009). (Pharmacol.)
S.M. Iqbal, et al., AIDS, 23, 1669 (2009). (Pharmacol.)

Eledoisin Related Peptide

Eledoisin Related Peptide PEL-4003-v 0.5 mg 32
Lys-Phe-Ile-Gly-Leu-Met-NH2 -20 °C vial
(M.W. 706.94) C34H58N8O6S [2990-43-4]

Eledoisin Related Peptide PEL-4003 25 mg 290

PEPTIDES INTERNATIONAL

(Bulk)
Lys-Phe-Ile-Gly-Leu-Met-NH2 • 2AcOH • 3H2O -20 °C 100 mg 860
(M.W. 706.94 • 120.10 • 54.05) C34H58N8O6S •
2CH3COOH • 3H2O
S. Sakakibara and M. Fujino, Bull. Chem. Soc. Japan, 39, 947 (1966). (Chem. Synthesis)

Endokinins
Endokinin C (Human) PND-4411-v 0.5 mg 99
Lys-Lys-Ala-Tyr-Gln-Leu-Glu-His-Thr-Phe-Gln-Gly-Leu-Leu- -20 °C vial
NH2
(M.W. 1674.9) C78H123N21O20
Peptide in α-Tachykinin Precursor 4
N.M. Page, et al., Proc. Natl. Acad. Sci. USA, 100, 6245 (2003). (Original)
J.N. Pennefather, et al., Life Sci., 74, 1445 (2004). (Review)
N.M. Page, Cell. Mol. Life Sci.; 61, 1652 (2004). (Review)
R. Naono, et al., Brain Res., 1165, 71 (2007). (Pharmacol.)
Y. Yang and S. Dong, Peptides, 31, 94 (2010). (Pharmacol.)

Endokinin D (Human) PND-4412-v 0.5 mg 99

Val-Gly-Ala-Tyr-Gln-Leu-Glu-His-Thr-Phe-Gln-Gly-Leu-Leu- -20 °C vial
NH2
(M.W. 1574.8) C73H111N19O20
Peptide in β-Tachykinin Precursor 4
N.M. Page, et al., Proc. Natl. Acad. Sci. USA, 100, 6245 (2003). (Original)
J.N. Pennefather, et al., Life Sci., 74, 1445 (2004). (Review)
N.M. Page, Cell. Mol. Life Sci.; 61, 1652 (2004). (Review)
R. Naono, et al., Brain Res., 1165, 71 (2007). (Pharmacol.)
Y. Yang and S. Dong, Peptides, 31, 94 (2010). (Pharmacol.)

46 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT CODE QTY PRICE

BIOLOGICALLY ACTIVE PEPTIDES

Endorphins
A. Goldstein, Ann. N.Y. Acad. Sci., 311, 49 (1978). (Review)
F. Bloom, et al., Adv. Biochem. Psychopharm., 22, 619 (1980). (Review)
P.A. Berger, H. Akil, S.J. Watson, and J.D. Barchas, Annu. Rev. Med., 33, 397 (1982). (Review)
F.E. Bloom, Annu. Rev. Pharmacol. Toxicol., 23, 151 (1983). (Review)

a-Endorphin PEN-4055-v 0.5 mg 115

b-Lipotropin (61-76) -20 °C vial
Tyr-Gly-Gly-Phe-Met-Thr-Ser-Glu-Lys-Ser-Gln-Thr-Pro-Leu-Val-Thr
(M.W. 1745.9) C77H120N18O26S [59004-96-5]
N. Ling, R. Burgus, and R. Guillemin, Proc. Natl. Acad. Sci. USA, 73, 3942 (1976). (Original; Porcine)

b-Endorphin (Human) PEN-4060-v 0.5 mg 230

b-Lipotropin (Human, 61-91) -20 °C vial
Tyr-Gly-Gly-Phe-Met-Thr-Ser-Glu-Lys-Ser-Gln-Thr-Pro-Leu-Val-Thr-
Leu-Phe-Lys-Asn-Ala-Ile-Ile-Lys-Asn-Ala-Tyr-Lys-Lys-Gly-Glu
(M.W. 3465.0) C158H251N39O46S [61214-51-5]
C.H. Li and D. Chung, Nature, 260, 622 (1976). (Original; Human)
C.H. Li, et al., J. Med. Chem., 20, 325 (1977). (Chem. Synthesis & Biological Activity)

g-Endorphin PEN-4089-v 0.5 mg 135

b-Lipotropin (61-77) -20 °C vial
Tyr-Gly-Gly-Phe-Met-Thr-Ser-Glu-Lys-Ser-Gln-Thr-Pro-Leu-Val-Thr-Leu
(M.W. 1859.1) C83H131N19O27S
N. Ling, R. Burgus, and R. Guillemin, Proc. Natl. Acad. Sci. USA, 73, 3942 (1976). (Original; Porcine)

Endothelins

PEPTIDES INTERNATIONAL
M. Yanagisawa and T. Masaki, Trends Pharmacol. Sci., 10, 374 (1989). (Review)
T. Sakurai, M. Yanagisawa, and T. Masaki, Trends Pharmacol. Sci., 13, (1992). (Review)
A.F. James, et al., and M. Takai, Cardiovasc. Drug Rev., 11, 253 (1993). (Review)

Endothelin-1 (Human)* PED-4198-s 0.1 mg 185

(Porcine, Canine, Rat, Mouse, Bovine) -20 °C vial
Cys-Ser-Cys-Ser-Ser-Leu-Met-Asp-Lys-Glu-Cys-
Val-Tyr-Phe-Cys-His-Leu-Asp-Ile-Ile-Trp
(Disulfide bonds between Cys1-Cys15 and Cys3-Cys11)
(M.W. 2491.9) C109H159N25O32S5 [117399-94-7]
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

Endothelin-1 (Human)* PED-4198-v 0.5 mg 540

(Porcine, Canine, Rat, Mouse, Bovine) -20 °C vial
M. Yanagisawa, et al., Nature, 332, 411 (1988). (Original)
A. Inoue, et al., Proc. Natl. Acad. Sci. U.S.A., 86, 2863 (1989). (Naming)
T.X. Wantanabe, et al., J. Cardiovasc, Pharmocal., 17 (Suppl. 7), S5 (1991). (Pharmacol.)
• This compound is distributed through Peptide Institute, Inc., under the license of Takeda Chemical Industries, Ltd.
and the National Institute of Advanced Industrial Science and Technology (AIST).
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

Order Hotline 1-800-777-4779 502-266-8787 47

 PRODUCT CODE QTY PRICE
BIOLOGICALLY ACTIVE PEPTIDES

Endothelin-1 (1-31) (Human)* PED-4360-s 0.1 mg 230

Cys-Ser-Cys-Ser-Ser-Leu-Met-Asp-Lys-Glu-Cys- -20 °C vial
Val-Tyr-Phe-Cys-His-Leu-Asp-Ile-Ile-Trp-Val-
Asn-Thr-Pro-Glu-His-Val-Val-Pro-Tyr
(Disulfide bonds between Cys1-Cys15 and Cys3-Cys11)
(M.W. 3628.2) C162H236N38O47S5 [133972-52-8]
A. Nakao, et al., J. Immunol., 159, 1987 (1997). (Original; New Endogenous Form)
F. Kishi, et al., Biochem. Biophys. Res. Commun., 248, 387 (1998). (Pharmacol.)
M. Yoshizumi, et al., Eur. J. Pharmacol., 348, 305 (1998). (Pharmacol.)
M. Yoshizumi, et al., Br. J. Pharmacol., 125, 1019 (1998). (Pharmacol.)
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

Endothelin-2 (Human)* PED-4209-s 0.1 mg 180

(Canine) -20 °C vial
Cys-Ser-Cys-Ser-Ser-Trp-Leu-Asp-Lys-Glu-Cys-
Val-Tyr-Phe-Cys-His-Leu-Asp-Ile-Ile-Trp
(Disulfide bonds between Cys1-Cys15 and Cys3-Cys11)
(M.W. 2546.9) C115H160N26O32S4 [123562-20-9]
A. Inoue, M. Yanagisawa, S. Kimura, Y. Kasuya, T. Miyauchi, K. Goto, and T. Masaki,
Proc. Natl. Acad. Sci. U.S.A., 86, 2863 (1989). (Original; Human Nucleotide Seq.)
Y. Itoh, C. Kimura, H. Odna, and H. Fujino, Nucleic Acids Res., 17, 5386 (1989). (Original; Canine cDNA)
• This compound is distributed through Peptide Institute, Inc., under the license of Takeda Chemical Industries, Ltd.
and the National Institute of Advanced Industrial Science and Technology (AIST).

Endothelin-3 (Human)* PED-4199-s 0.1 mg 180

(Porcine, Rat, Rabbit, Mouse) -20 °C vial
Cys-Thr-Cys-Phe-Thr-Tyr-Lys-Asp-Lys-Glu-Cys-
Val-Tyr-Tyr-Cys-His-Leu-Asp-Ile-Ile-Trp
PEPTIDES INTERNATIONAL

(Disulfide bonds between Cys1-Cys15 and Cys3-Cys11)

(M.W. 2643.0) C121H168N26O33S4 [117399-93-6]
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

Endothelin-3 (Human)* PED-4199-v 0.5 mg 530

(Porcine, Rat, Rabbit, Mouse) -20 °C vial
M. Yanagisawa, A. Inoue, T. Ishikawa, Y. Kasuya, S. Kimura, S. Kumagaye, K. Nakajima, T.X. Watanabe, S. Sakakibara,
K. Goto, and T. Masaki, Proc. Natl. Acad. Sci., U.S.A., 85, 6964 (1988). (Original)
A. Inoue,et al. Proc. Natl. Acad. Sci. U.S.A., 86, 2863 (1989). (Naming)
K. Nakajima, S. Kumagaye, H. Nishio, H. Kuroda, T.X. Watanabe, Y. Kobayashi, H. Tamaoki, T. Kimura, and S.
Sakakibara, J. Cardiovasc. Pharmacol., 13, (Suppl. 5), S8 (1989). (Chem. Synthesis and S-S Bond)
K. Saida, et al., Peptide Chemistry 1996, 133 (1997). (cDNA Seq.; Mouse)
• This compound is distributed through Peptide Institute, Inc., under the license of Takeda Chemical Industries, Ltd. and
the Agency of Industrial Science and Tech.
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

Big-Endothelin-1 (Human, 1-38)* PED-4208-s 0.1 mg 255

Cys-Ser-Cys-Ser-Ser-Leu-Met-Asp-Lys-Glu-Cys-Val-Tyr- -20 °C vial
Phe-Cys-His-Leu-Asp-Ile-Ile-Trp-Val-Asn-Thr-Pro-Glu-
His-Val-Val-Pro-Tyr-Gly-Leu-Gly-Ser-Pro-Arg-Ser
(Disulfide bonds between Cys1-Cys15 and Cys3-Cys11)
(M.W. 4282.9) C189H282N48O56S5 [120796-97-6]
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

48 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT CODE QTY PRICE
Big Endothelin-1 (Human, 1-38)* PED-4208-v 0.5 mg 670

BIOLOGICALLY ACTIVE PEPTIDES

Y. ltoh, et al., FEBS Lett., 231, 440 (1988). (Original) -20 °C vial
T. Kashiwabara, et al., FEBS Lett., 247, 73 (1989). (Pharmacol.)
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

Big Endothelin-1 (Porcine, 1-39)* PED-4207-s 0.1 mg 250

Cys-Ser-Cys-Ser-Ser-Leu-Met-Asp-Lys-Glu-Cys-Val-Tyr-Phe- -20 °C vial
Cys-His-Leu-Asp-Ile-Ile-Trp-Val-Asn-Thr-Pro-Glu-His-Ile-
Val-Pro-Tyr-Gly-Leu-Gly-Ser-Pro-Ser-Arg-Ser
(Disulfide bonds between Cys1-Cys15 and Cys3-Cys11)
(M.W. 4384.0) C193H289N49O58S5 [120796-99-8]
Y. Itoh, et al., FEBS Letters, 231, 440 (1988). (Original)
T. Kashiwabara, et al., FEBS Letters, 247, 73 (1989). (Pharmacol.)
• This compound is distributed through Peptide Institute, Inc., under the license of Takeda Chemical Industries, Ltd.
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

Big Endothelin-1 (Porcine, 1-39)* PED-4207-v 0.5 mg 675

M. Yanagisawa, et al., Nature, 332, 411 (1988).(Original) -20 °C vial
T. Kashiwabara, et al., FEBS Letters, 247, 73 (1989). (Pharmacol.)
• This compound is distributed through Peptide Institute, Inc., under the license of Takeda Chemical Industries, Ltd.
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

Big Endothelin-1 (Rat, 1-39)* PED-4266-s 0.1 mg 270

Cys-Ser-Cys-Ser-Ser-Leu-Met-Asp-Lys-Glu-Cys-Val-Tyr-Phe- -20 °C vial
Cys-His-Leu-Asp-Ile-Ile-Trp-Val-Asn-Thr-Pro-Glu-Arg-
Val-Val-Pro-Tyr-Gly-Leu-Gly-Ser-Pro-Ser-Arg-Ser
(Disulfide bonds between Cys1-Cys15 and Cys3-Cys11)

PEPTIDES INTERNATIONAL
(M.W. 4389.0) C192H292N50O58S5
T. Sakurai, M. Yanagisawa, A. Inoue, U.S. Ryan, S. Kimura, Y. Mitsui, K. Goto, and T. Masaki,
Biochem. Biophys. Res. Commun., 175, 44 (1991). (Original; cDNA)
• This compound is distributed through Peptide Institute, Inc., under the license of Takeda Chemical Industries, Ltd.
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

Big-Endothelin-2 (Human, 1-37)* PED-4222-s 0.1 mg 250

Cys-Ser-Cys-Ser-Ser-Trp-Leu-Asp-Lys-Glu-Cys-Val-Tyr-Phe- -20 °C vial
Cys-His-Leu-Asp-Ile-Ile-Trp-Val-Asn-Thr-Pro-Glu-Gln-
Thr-Ala-Pro-Tyr-Gly-Leu-Gly-Asn-Pro-Pro
(Disulfide bonds between Cys1-Cys15 and Cys3-Cys11)
(M.W. 4183.7) C188H269N45O56S4 [132699-72-0]
S. Ohkubo, K.Ogi, et al., FEBS Lett., 274, 136 (1990). (Original; cDNA)
• This compound is distributed through Peptide Institute, Inc., under the license of Takeda Chemical Industries, Ltd.
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

Big-Endothelin-2 (Human, 1-38)* PED-4253-s 0.1 mg 270

Cys-Ser-Cys-Ser-Ser-Trp-Leu-Asp-Lys-Glu-Cys-Val-Tyr- -20 °C vial
Phe-Cys-His-Leu-Asp-Ile-Ile-Trp-Val-Asn-Thr-Pro-Glu-
Gln-Thr-Ala-Pro-Tyr-Gly-Leu-Gly-Asn-Pro-Pro-Arg
(Disulfide bonds between Cys1-Cys15 and Cys3-Cys11)
(M.W. 4339.9) C194H281N49O57S4
T. Kosaka, N. Suzuki, Y. Ishibashi, H. Matsumato, Y. Itoh, S. Ohkubo, K. Ogi, C. Kitada, H. Onda, and M. Fujino,
J. Biochem., 116, 443 (1994). (Biosynthesis.)
S. Ohkubo, K. Ogi, M. Hosoya, H. Matsumoto, N. Suzuki, C. Kimura, H. Onda, and M. Fujino,
FEBS Lett., 274, 136 (1990). (Original; cDNA)
• This compound is distributed through Peptide Institute Inc., under the license of Takeda Chemical Industries, Ltd.

Order Hotline 1-800-777-4779 502-266-8787 49

 PRODUCT CODE QTY PRICE
BIOLOGICALLY ACTIVE PEPTIDES

Big-Endothelin-3 (Human, 1-41 Amide)* PED-4223-s 0.1 mg 260

Cys-Thr-Cys-Phe-Thr-Tyr-Lys-Asp-Lys-Glu-Cys-Val-Tyr-Tyr- -20 °C vial
Cys-His-Leu-Asp-Ile-Ile-Trp-Ile-Asn-Thr-Pro-Glu-Gln-Thr-Val-
Pro-Tyr-Gly-Leu-Ser-Asn-Tyr-Arg-Gly-Ser-Phe-Arg-NH2
(Disulfide bonds between Cys1-Cys15 and Cys3-Cys11)
(M.W. 4923.5) C223H322N56O63S4
K.D. Bloch, R.L. Eddy, T.B. Shows, and T. Quertermous, J. Biol. Chem., 264, 18156 (1989). (Original; cDNA)
T. Kosaka, N. Suzuki, Y. Ishibashi, H. Matsumato, Y. Itoh, S. Ohkubo, K. Ogi, C. Kitada, H. Onda, and M. Fujino,
J. Biochem., 116, 443 (1994). (Original; Biosynthesis.)
• This compound is distributed through Peptide Institute Inc., under the license of Takeda Chemical Industries, Ltd.
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

Big Endothelin-3 (Rat, 1-41 Amide)* PED-4267-s 0.1 mg 270

Cys-Thr-Cys-Phe-Thr-Tyr-Lys-Asp-Lys-Glu-Cys-Val-Tyr-Tyr- -20 °C vial
Cys-His-Leu-Asp-Ile-Ile-Trp-Ile-Asn-Thr-Pro-Glu-Gln-Thr-Val-
Pro-Tyr-Gly-Leu-Ser-Asn-His-Arg-Gly-Ser-Leu-Arg-NH2
(Disulfide bonds between Cys1-Cys15 and Cys3-Cys11)
(M.W. 4863.5) C217H322N58O62S4
R. Shiba, T. Sakural, G. Yamada, H. Morimoto, A. Salto, T. Masaki, and K. Goto,
Biochem. Biophys. Res. Commun., 186, 588 (1992). (Original; cDNA)
• This compound is distributed through Peptide Institute, Inc., under the license of Takeda Chemical Industries, Ltd.
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

Suc-[Glu9, Ala11,15]-Endothelin-1 (8-21)* PED-4285-v 0.5 mg 155

IRL 1620 -20 °C vial
Suc-Asp-Glu-Glu-Ala-Val-Tyr-Phe-Ala-His-Leu-Asp-Ile-Ile-Trp
(Suc: Succinyl)
PEPTIDES INTERNATIONAL

(M.W. 1820.9) C86H117N17O27 [142569-99-1]

ETb Receptor Selective Agonist
M. Takai, et al.a, Biochem. Biophys. Res. Commun., 184, 953 (1992). (Original)
S.S. Shetty, et al., Biochem. Biophys. Res. Commun., 191, 459 (1993). (Pharmacol.)
W.G. Haynes, A.P. Davenport, and D.J. Webb, Trends Pharmacol. Sci., 14, 225 (1993). (Report; 3rd Int. Conf. Endothelin)
A.F. James, et al., Cardiovasc. Drug Rev., 11, 253 (1993). (Review)
• This product is distributed under the technical and scientific advices of International Research Laboratories of Novartis
Pharma K.K.
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

VIC (Mouse)* PED-4211-s 0.1 mg 180

Vasoactive Intestinal Contractor (Mouse) -20 °C vial
Cys-Ser-Cys-Asn-Ser-Trp-Leu-Asp-Lys-Glu-Cys-
Val-Tyr-Phe-Cys-His-Leu-Asp-Ile-Ile-Trp
(Disulfide bonds between Cys1-Cys15 and Cys3-Cys11)
(M.W. 2573.9) C116H161N27O32S4
N. Ishida, K. Tsujioka, M. Tomoi K. Saida, and Y. Mitsui, FEBS Lett., 247, 337 (1989). (Original)
K. Saida, Y. Mitsui, and N. Ishida, J. Biol. Chem., 264, 14613 (1989). (Original; Nucleotide Seq.)
• This compound is distributed through Peptide Institute, Inc., under the license of Takeda Chemical Industries, Ltd.
and the Agency of Industrial Science and Tech.
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

50 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT CODE QTY PRICE
Endothelin Inhibitors Also see the Enzyme Inhibitors and Substrates section.

BIOLOGICALLY ACTIVE PEPTIDES

BQ-123 PED-3512-PI 1 mg 65
(Sodium Salt) -20 °C 5 mg 195
cyclo (d-Trp-d-Asp-Pro-d-Val-Leu)
Endothelin Antagonist 25 mg 795
(M.W. 610.72) C31H42N6O7

BQ-610 PED-3610-PI 1 mg 75
(Sodium Salt) -20 °C 5 mg 275
Homopiperdinyl-CO-Leu-d-Trp(CHO)-d-Trp-OH
(M.W. 656.79) C36H44N6O6
ETA-Selective Antagonist

BQ-788 PED-3788-PI 1 mg 140

(Sodium Salt) -20 °C 5 mg 495
N-cis-2,6-Dimethylpiperidinocarbonyl-l-γ-Me-Leu-d-
Trp(COOCH3)-d-Nle
(M.W. 663.80) C34H50N5O7Na
ETB-Selective Antagonist

Enfuviritide (Alternative names: Fuzeon; T20; Pentafuside)

Enfuviritide ENF-3787-PI 1 mg 110
TAc-Tyr-Thr-Ser-Leu-Ile-His-Ser-Leu-Ile-Glu-Glu-Ser-Gln- -20 °C 5 mg 450
NEW!
Asn-Gln-Gln-Glu-Lys-Asn-Glu-Gln-Glu-Leu-Leu-Glu-Leu-Asp-
Lys-Trp-Ala-Ser-Leu-Trp-Asn-Trp-Phe-NH2
(M.W. 4491.98) C204H301N51O64 [159519-65-0]

PEPTIDES INTERNATIONAL
Note: Bolar Exemption applies. This is a FDA-regulated product. It is the responsibility of the customer
to ensure that he/she is complying with Federal rules. PI cannot be liable for infringement of rights made
by the user. (US patent ended in Jun 2013)
H.B.Fung and Y.Guo, Clin. Ther., 26, 352 (2004).
R.Manfredi and S.Sabbatani, Curr. Med. Chem., 13, 2369 (2006).
J.Ruof, et al., Clin. Drug Investig., 27, 469 (2007).
A.Streinu-Cercel, et al., HIV Clin. Trials, 9, 375 (2008).

Enkephalins
Leucine-Enkephalin PEK-4043-v 0.5 mg 30
(Human, Porcine, Bovine, Rat, Mouse) -20 °C vial
Tyr-Gly-Gly-Phe-Leu
(M.W. 555.62) C28H37N5O7 [58822-25-6]

Leucine-Enkephalin (Bulk) PEK-4043 25 mg 130

(Human, Porcine, Bovine, Rat, Mouse) -20 °C 100 mg 370
Tyr-Gly-Gly-Phe-Leu • H2O
(M.W. 555.62 • 18.02) C28H37N5O7 • H2O [58822-25-6]
J. Hughes, T.W. Smith, H.W. Kosterlitz, L.A. Fothergill, B.A. Morgan, and H.R. Morris,
Nature, 258, 577 (1975). (Original; Porcine)
M. Comb, P.H. Seeburg, J. Adelman, L. Eiden, and E. Herbert, Nature, 295, 663 (1982). (cDNA Seq.; Human)
M. Noda, Y. Furutani, H. Takahashi, M. Toyosato, T. Hirose, S. Inayama, S. Nakanishi, and S. Numa, Nature,
295, 202 (1982). (cDNA Seq.; Bovine)
K. Yoshikawa, C. Williams, and S.L. Sabol, J. Biol. Chem., 259, 14301 (1984). (cDNA Seq.; Rat)

Leucine-Enkephalin (Sulfated Form) PEK-4118-v 0.5 mg 55

Tyr(SO3H)-Gly-Gly-Phe-Leu -20 °C vial
(M.W. 635.69) C28H37N5O10S [80632-52-6]
C.D. Unsworth and J. Hughes, Nature, 295, 519 (1982). (Original)

Order Hotline 1-800-777-4779 502-266-8787 51

 PRODUCT CODE QTY PRICE
BIOLOGICALLY ACTIVE PEPTIDES

Methionine-Enkephalin PEK-4042-v 0.5 mg 30

(Human, Porcine, Bovine, Rat, Mouse) -20 °C vial
Tyr-Gly-Gly-Phe-Met
(M.W. 573.66) C27H35N5O7S [58569-55-4]

Methionine-Enkephalin (Bulk) PEK-4042 25 mg 180

(Human, Porcine, Bovine, Rat, Mouse) -20 °C 100 mg 515
Tyr-Gly-Gly-Phe-Met • H2O
(M.W. 573.66 • 18.02) C27H35N5O7S • H2O [58569-55-4]
J. Hughes, et al., Nature, 258, 577 (1975). (Original; Porcine)
M. Comb, P.H. Seeburg, J. Adelman, L. Eiden, and E. Herbert, Nature, 295, 663 (1982). (cDNA Seq.; Human)
M. Noda, et al., Nature, 295, 202 (1982). (cDNA Seq.; Bovine)
K. Yoshikawa, C. Williams, and S.L. Sabol, J. Biol. Chem., 259, 14301 (1984). (cDNA Seq.; Rat)

(Met(O)5)-Enkephalin PEK-3807-PI 5 mg 195

H-Tyr-Gly-Gly-Phe-Met(O)-OH -20 °C 25 mg 780
(M.W. 589.67) C27H35N5O8S [60283-51-4]
Enkephalin Analog

[d-Ala2, d-Leu5]-Enkephalin PEK-4115-v 0.5 mg 30

Tyr-d-Ala-Gly-Phe-d-Leu -20 °C vial
(M.W. 569.65) C29H39N5O7 [63631-40-3]

[d-Ala2, d-Leu5]-Enkephalin (Bulk) PEK-4115 25 mg 280

Tyr-d-Ala-Gly-Phe-d-Leu • AcOH • H2O -20 °C 100 mg 785
(M.W. 569.65 • 60.05 • 18.02) C29H39N5O7 • CH3COOH • H2O
[94825-57-7]
E.T. Wei, L.F. Tseng, H.H. Loh, and C.H. Li, Life Sci., 21, 321 (1977). (Original)
PEPTIDES INTERNATIONAL

[d-Ala2, Met5]-Enkephalin PEK-4116-v 0.5 mg 30

Tyr-d-Ala-Gly-Phe-Met -20 °C vial
(M.W. 587.69 ) C28H37N5O7S [61370-87-4]

[d-Ala2, Met5]-Enkephalin (Bulk) PEK-4116 25 mg 280

Tyr-d-Ala-Gly-Phe-Met • AcOH • H2O -20 °C
(M.W. 587.69 • 60.05 • 18.02 ) C28H37N5O7S • CH3COOH •
H2O [100929-62-6]
D.H. Coy, A.J. Kastin, A.V. Schally, O. Morin, N.G. Caron, F. Labrie, J.M. Walker, R. Fertel, G.G. Berntson,
and C.A. Sandman, Biochem. Biophys. Res. Commun., 73, 632 (1976). (Original; Chem. Synthesis)

[d-Ala2, Met5]-Enkephalinamide PEK-4117-v 0.5 mg 30

Tyr-d-Ala-Gly-Phe-Met-NH2 -20 °C vial
(M.W. 586.70) C28H38N6O6S [61090-95-7]
D.H. Coy, A.J. Kastin, A.V. Schally, O. Morin, N.G. Caron, F. Labrie, J.M. Walker, R. Fertel, G.G. Berntson,
and C.A. Sandman, Biochem. Biophys. Res. Commun., 73, 632 (1976). (Original; Chem. Synthesis)
C.B. Pert, A. Pert, J.-K. Chang, and B.T.W. Fong, Science, 194, 330 (1976). (Original)

Epitope Tag Peptide (Flag Peptide)

H-Asp-Tyr-Lys-Asp-Asp-Asp-Asp-Lys-OH PTG-3976-PI 5 mg 95
DYKDDDDK -20 °C
(M.W. 1012.99) C41H66N10O20
Epitope Tag Peptide
F. Coussen, et al. J. Biol. Chem., 276, 27881 (2001).
M. Zhao, et al., Mol. Cell. Biol., 23, 8982 (2003).
S. Da Cruz, et al., J. Biol. Chem., 278, 4156 (2003).
J. Carrillo, et al., J. Biol. Chem., 278, 42578 (2003).
M. Hiromura, et al., J. Biol. Chem., 279, 53407 (2004).

52 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT CODE QTY PRICE
Eptifibatide

BIOLOGICALLY ACTIVE PEPTIDES

Eptifibatide EPT-3786-PI 1 mg 48
(M.W. 831.98) C35H49N11O9S2 [188627-80-7] -20 °C 5 mg 150
NEW!
Note: Bolar Exemption applies. This is a FDA-regulated product. It is the responsibility of the customer
to ensure that he/she is complying with Federal rules. PI cannot be liable for infringement of rights made
by the user. (Bolar Exemption applies until May 5, 2015)
G.L. Plosker, , et al., Pharmacoeconomics, 21, 885 (2003).
Shea and Tcheng, Expert Opin.Pharmacother., 3, 1199 (2002).

Exendin
Exendin (5-39) PEX-4345-v 0.5 mg 355
(Lizard, Heloderma horridum) -20 °C vial
Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-
Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-
Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2
(M.W. 3806.2) C169H262N44O54S
GLP-1 Receptor Antagonist
C. Montrose-Rafizadeh, H. Yang, B.D. Rodgers, A. Beday, L.A. Pritchette, and J. Eng,
J. Biol. Chem., 272, 21201 (1997). (Original; Potent Antagonist)
J.-I. Oka, E. Suzuki, and Y. Kondo, Brain Res., 878, 194 (2000). (Pharmacol.)

Exendin-4 PEX-3784-PI 1 mg 450

H-His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln- -20 °C 5 mg 1800
NEW!
Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-
Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2
(M.W. 4186.66) C184H282N50O60S [141758-74-9]

PEPTIDES INTERNATIONAL
GLP-1 (Glucagon-Like Peptide-1) Receptor
Note: Bolar Exemption applies. This is a FDA-regulated product. It is the responsibility of the customer
to ensure that he/she is complying with Federal rules. PI cannot be liable for infringement of rights made
by the user.
R Göke, et al., J Biol Chem., 26, 19650 (1993).
B. Thorens, et al., Diabetes, 42, 1678, (1993).
A. Alcántara, et al., Arch Biochem Biophys.341: 1, 1997

Order Hotline 1-800-777-4779 502-266-8787 53

 PRODUCT CODE QTY PRICE
BIOLOGICALLY ACTIVE PEPTIDES

Experimental Autoimmune Encephalomyelitis Products

Experimental autoimmune encephalomyelitis (EAE) has been used as a model for
studying multiple sclerosis (MS) due to the clinical and histopathological similarities
of the inflammatory diseases affecting the central nervous system. Both Myelin PLP
(PLP-3602-PI) and MOG (PMG-3660-PI) are antigenic peptides that induce EAE by
binding to MHC-II molecules on antigen presenting cells where they are recognized
by class-II restricted T cells.
PI expands its line of antigenic peptides to now include: MOG (40-54) (PMG-3962-PI)
and vesicular stomatitis virus octopeptide (52-59) or VS-8 (PVS-3961-PI).1 This antigen
binds to Kb MHC-1 where the antigen is presented to T cells. It has been used in the
past to study vacuolar processing of exogenous Ag and the role of TAP (transporter
associated with antigen processing) during this event. 2 An understanding of events
accompanying the processing and presentation of viral Ags can help assist in vaccine
design and in the study of inflammatory-related diseases.
Bulk quantities and other EAE peptides are available, please inquire.
1. G.M. van Bleek and S.G. Nathenson, Nature (Lond.), 348, 213 (1990).
2. P.J. Chefalo and C.V. Harding, J. Immunol., 167, 1274 (2001).

Acetyl-Myelin Basic Protein (Mouse, 1-11) PMB-3657-PI 1 mg 95

Ac-MBP (1-11) -20 °C 5 mg 375
Ac-Ala-Ser-Gln-Lys-Arg-Pro-Ser-Gln-Arg-Ser-Lys-OH
(M.W. 1314.48) C53H95N21O18
Encephalitogenic Determinant
PEPTIDES INTERNATIONAL

S.D. Wolf, B.N. Dittel, F. Hardardottir, and C.A. Janeway, J. Exp. Med., 184, 2271 (1996).

Acetyl-Myelin Basic Protein (Human, Rat, PMB-3658-PI 1 mg 95

1-11) -20 °C 5 mg 375
Ac-MBP (Human, Porcine, Rat 1-11)
Ac-Ala-Ser-Gln-Lys-Arg-Pro-Ser-Gln-Arg-His-Gly-OH
(M.W. 1293.42) C52H88N22O17
Encephalitogenic Determinant
J.E. Fenyk-Melody, A.E. Garrison, S.R. Brunnert, J.R. Weidner, F. Shen, B.A. Shelton, and J.S. Mudgett,
J. Immunol., 160, 2940 (1998).

Myelin Basic Protein (1-20) PMB-3972-PI 1 mg 95

MBP (1-20) 395
-20 °C 5 mg
ASQKRPSQRSKYLATASTMD
H-Ala-Ser-Gln-Lys-Arg-Pro-Ser-Gln-Arg-Ser-Lys-Tyr-Leu-Ala-Thr-Ala-Ser-Thr-Met-Asp-OH
(M.W. 2226.51) C92H156N30O32S
Immunogenic Peptide

Myelin Basic Protein (87-99) PMB-3973-PI 1 mg 75

MBP (87-99) 295
-20 °C 5 mg
VHFFKNIVTPRTP
H-Val-His-Phe-Phe-Lys-Asn-Ile-Val-Thr-Pro-Arg-Thr-Pro-OH
(M.W. 1555.86) C74H114N20O17
Encephalitogenic Determinant

54 Order Hotline 1-800-777-4779 502-266-8787

 PRODUCT CODE QTY PRICE
Myelin Basic Protein (111-129) PMB-3974-PI 1 mg 85

BIOLOGICALLY ACTIVE PEPTIDES

MBP (111-129) 325
-20 °C 5 mg
LSRFSWGAEGQRPGFGYGG
H-Leu-Ser-Arg-Phe-Ser-Trp-Gly-Ala-Glu-Gly-
Gln-Arg-Pro-Gly-Phe-Gly-Tyr-Gly-Gly-OH
(M.W. 2029.22) C92H129N27O26
Encephalitogenic Determinant

MOG (40-54) PMG-3962-PI 1 mg 60

Myelin Oligodendrocyte Protein (40-54) 225
-20 °C 5 mg
YRSPFSRVVHLYRNG
H-Tyr-Arg-Ser-Pro-Phe-Ser-Arg-Val-Val-His-
Leu-Tyr-Arg-Asn-Gly-OH
(M.W. 1851.12) C84H127N27O21
D. Sun, et al., Int. Immunol., 15, 261 (2003)

MOG (92-106) PMG-3968-PI 1 mg 75

Myelin Oligodendrocyte Protein (92-106) 295
-20 °C 5 mg
DEGGYTCFFRDHSYQ
H-Asp-Glu-Gly-Gly-Tyr-Thr-Cys-Phe-Phe-Arg-Asp-His-Ser-Tyr-Gln-OH
(M.W. 1823.91) C80H104N21O27S
Encephalitogenic Determinant

MOG (Rat, Mouse, 35-55) PMG-3660-PI 1 mg 125

Myelin Oligodendrocyte Protein (35-55) -20 °C 5 mg 495
H-Met-Glu-Val-Gly-Trp-Tyr-Arg-Ser-Pro-Phe-Ser-Arg-Val-Val-His-Leu-Tyr-Arg-Asn-Gly-Lys-OH
(M.W. 2582.01) C118H177N35O29S
Encephalitogenic Determinant

PEPTIDES INTERNATIONAL
M Ichikawa, T.G. Johns, J. Liu, and C.C. Bernard, J. Immunol. 157, 919-926 (1996).
H.-C. von Büdingen, et al., J. Clin. Immunol., 21, 155 (2001).

Myelin PLP (57–70) PLP-3970-PI 1 mg 85

Myelin Proteolipid Protein (57-70) 325
-20 °C 5 mg
YEYLINVIHAFQYV
H-Tyr-Glu-Tyr-Leu-Ile-Asn-Val-Ile-His-Ala-Phe-Gln-Tyr-Val-
OH
(M.W. 1772.05) C87H122N18O22
Encephalitogenic Determinant

Myelin PLP (139-151) PLP-3602-PI 1 mg 75

Myelin Proteolipid Protein (139-151) -20 °C 5 mg 295
(Acetate Form)
H-His-Ser-Leu-Gly-Lys-Trp-Leu-Gly-His-Pro-Asp-Lys-Phe-OH
(M.W. 1521.76) C72H104N20O17
Encephalitogenic Determinant
V.K. Kuchroo, et al., J. Immunol., 153, 3326 (1994).

Myelin PLP (139-151) PLP-3812-PI 1 mg 75

Myelin Proteolipid Protein (139-151) -20 °C 5 mg 295
(Trifluoroacetate Form)
H-His-Ser-Leu-Gly-Lys-Trp-Leu-Gly-His-Pro-Asp-Lys-Phe-OH
NEW!

(M.W. 1521.76) C72H104N20O17

Encephalitogenic Determinant
V.K. Kuchroo, et al., J. Immunol., 153, 3326 (1994).

Order Hotline 1-800-777-4779 502-266-8787 55

 PRODUCT CODE QTY PRICE
BIOLOGICALLY ACTIVE PEPTIDES

Myelin PLP (178-191) PLP-3967-PI 1 mg 75

Myelin Proteolipid Protein (178-191) 275
-20 °C 5 mg
NTWTTCQSIAFPSK
H-Asn-Thr-Trp-Thr-Thr-Cys-Gln-
Ser-Ile-Ala-Phe-Pro-Ser-Lys-OH
(M.W. 1583.80) C 70H106N18O22S
Encephalitogenic Determinant

Myelin PLP (180-199) PLP-3966-PI 1 mg 95

Myelin Proteolipid Protein (180-199) 395
-20 °C 5 mg
WTTCQSIAFPSKTSASIGSL
H-Trp-Thr-Thr-Cys-Gln-Ser-Ile-Ala-Phe-Pro-Ser-Lys-Thr-Ser-Ala-Ser-Ile-Gly-Ser-Leu-OH
(M.W. 2805.38) C 92H145N23O30S
Encephalitogenic Determinant

H-Arg-Gly-Tyr-Val-Tyr-Gln-Gly-Leu-OH PVS-3961-PI 1 mg 55
RGYVYQGL -20 °C 5 mg 195
(M.W. 955.09) C 44H66N12O12
Vesicular Stomatitis Virus (VSV)Nucleoprotein (52 - 59),
VSV - 8

VP2 (70-86) PVP-3971-PI 1 mg 75

Viral Protein 2 (70-86) 295
-20 °C 5 mg
WTTSQEAFSHIRIPLPH
H-Trp-Thr-Thr-Ser-Gln-Glu-Ala-Phe-Ser-His-Ile-Arg-Ile-Pro-Leu-Pro-His-OH
(M.W. 2020.30) C 93H138N26O25
Encephalitogenic Determinant
Richard K. Burt, Josette Padilla, Mauro C. Dal Canto, and Stephen D. Miller , Blood, 94, 2915 (1999).
PEPTIDES INTERNATIONAL

FMRF-Amide See Code PFM-4142 Molluscan Cardioexitatory Neuropeptide.

Fibronectin Active Fragment See Code PFA-4171 Arg-Gly-Asp-Ser.
and Code PFA-4189 Gly-Arg-Gly-Asp-Ser.

Fibrinopeptide B
[Glu1]-Fibrinopeptide B PFB-3742-PI 1 mg 130
Glu-fibrinopeptide B -20 °C 5 mg 520
H-Glu-Gly-Val-Asn-Asp-Asn-Glu-Glu-Gly-Phe-Phe-Ser-Ala-Arg-OH
(Trifluoroacetate Form)
(M.W. 1570.60) C66H95N19O26 [103213-49-6]
Mass Spec Standard for Proteomic Research
C. Fu, C. Wu, et al., Mol. Cell. Proteomics, 8, 1674, (2009).
J.B. Young and L Li, Anal Chem, 79, 5927 (2007).
G.M. Janini, et al., Anal Chem, 75, 1615 (2003).

56 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT CODE QTY PRICE

BIOLOGICALLY ACTIVE PEPTIDES

Galanins and Related Peptides
J.N. Crawley and G.L. Wenk, Trends Neurosci., 12, 278 (1989). (Review)
T. Bartfai, G. Fisone, and Ü. Langel, Trends Pharmacol. Sci., 13, 312 (1992). (Review)
R. Lang, A.L. Gundlach, and B. Kofler, Pharmacol. Ther., 115, 177 (2007). (Review)
I. Mechenthaler, Cell. Mol. Life Sci., 65, 1826 (2008). (Review)

Galanin [PGA-4245-v (human) and PGA-4244-v (rat)] is one of the brain-gut peptides
having various biological activities including feeding regulation. This peptide is known
to be a food intake stimulator which interacts with both of the galanin receptor sub -
types 1 and 2 (GalR1 and GalR2, respectively) in a relatively non-selective manner.
GalR1 is primarily expressed in the central nervous system (CNS), whereas GalR2
is expressed in both peripheral tissue and the CNS. In 1999, scientists at Takeda
Pharmaceutical Company Limited discovered the GalR2-selective ligand in porcine
hypothalamus. At the same time, they proposed the primary structures of the rat and
human orthologues from the corresponding cDNA sequences.1 This newly identified
peptide, known as galanin-like peptide (GALP), is composed of 60 amino acid resi-
dues. GALP (9-21) is identical to galanin (1-13) and the sequence homology among
the species is high. When 125I-labeled rat galanin is used as a ligand, porcine GALP
interacts with GalR2 with an IC50 value of 0.24 nM, while the corresponding value
for GalR1 is 4.3 nM, clearly indicating the receptor selectivity of GALP. Since then,
additional data concerning the role of rat GALP in feeding have been reported dealing
with: i) stimulation of food intake in rats 2,3, ii) control of its expression by leptin4), and
iii) crossing the blood brain barrier.5 Recently review articles concerning the function
of GALP in relation to galanin and the galanin receptor have also been published.6-8

PEPTIDES INTERNATIONAL
1. T. Ohtaki, et al., J. Biol. Chem., 274, 37041 (1999). (Original)
2. Y. Matsumoto, et al., Neurosci. Lett., 322, 67 (2002). (Stimulation of Food Intake)
3. H.-M. Tan, et al., Neuropeptides, 39, 333 (2005). (Pharmacol.; Exaggerated Feeding Response)
4. A. Juréus, et al., Endocrinology, 141, 2703 (2000). (Pharmacol.)
5. A.J. Kastin, V. Akerstrom, and L. Hackler, Neuroendocrinology, 74, 423 (2001). (Brain Entry)
6. A.L. Gundlach, Eur. J. Pharmacol., 440, 255 (2002). (Review)
7. P.S. Man and C.B. Lawrence, Neuropharmacology, 55, (2008). (Review)
8. C.B. Lawrence, Physiol. Behav., 97, 515 (2009). (Review)
• This compound is distributed through Peptide Institute, Inc. under the license of Takeda Chemical Industries, Ltd

Galanin (Human)* PGA-4245-v 0.5 mg 420

Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly- -20 °C vial
Pro-His-Ala-Val-Gly-Asn-His-Arg-Ser-Phe-Ser-
Asp-Lys-Asn-Gly-Leu-Thr-Ser
(M.W. 3157.4) C139H210N42O43 [119418-04-1]
M. Bersani, A.H. Johnsen, P. Højrup, B.E. Dunning, J.J. Andreasen, and J.J. Holst,
FEBS Lett., 283, 189 (1991). (Original)
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

Galanin (Rat)* PGA-4244-v 0.5 mg 420

(Mouse) -20 °C vial
Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-His-
Ala-Ile-Asp-Asn-His-Arg-Ser-Phe-Ser-Asp-Lys-His-Gly-Leu-
Thr-NH2
(M.W. 3164.4) C141H211N43O41 [114547-31-8]
M.E. Vrontakis,et al., J. Biol. Chem., 262, 16755 (1987). (Original; cDNA-Pituitary Tumor)
L.M. Kaplan, et al., Proc. Natl. Acad. Sci. USA, 85, 1065 (1988). (Original; cDNA-Hypothalamus)
J. Lundkvist, et al., Neurosci. Lett., 200, 121 (1995). (Original; Mouse Hypothalamic cDNA)
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

Order Hotline 1-800-777-4779 502-266-8787 57

 PRODUCT CODE QTY PRICE
BIOLOGICALLY ACTIVE PEPTIDES

Galanin-like Peptide (Human, 1-60) PGL-4391-s 0.1 mg 355

GALP (Human, 1-60) -20 °C vial
Ala-Pro-Ala-His-Arg-Gly-Arg-Gly-Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-
Tyr-Leu-Leu-Gly-Pro-Val-Leu-His-Leu-Pro-Gln-Met-Gly-Asp-Gln-
Asp-Gly-Lys-Arg-Glu-Thr-Ala-Leu-Glu-Ile-Leu-Asp-Leu-Trp-Lys-
Ala-Ile-Asp-Gly-Leu-Pro-Tyr-Ser-His-Pro-Pro-Gln-Pro-Ser
(M.W. 6500.3) C292H451N83O84S
Ligand for Galanin Receptor 2 / Target Peptide for Feeding Regulation by Leptin

Gastrins and Related Peptides

J.E. Jorpes and V. Mutt (eds.) Secretin, Cholecystokinin, Pancreozymin and Gastrin,
Handbook of Experimental Pharmacology, Vol. 34, Springer-Verlag, Berlin, 1973. (Review)

Big Gastrin (Human) PGR-4183-s 0.1 mg 155

(Ammonium Form) -20 °C vial
Pyr-Leu-Gly-Pro-Gln-Gly-Pro-Pro-His-Leu-Val-Ala-Asp-
Pro-Ser-Lys-Lys-Gln-Gly-Pro-Trp-Leu-Glu-Glu-Glu-
Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2
(M.W. 3849.2) C176H251N43O53S [60675-77-6]
A.M. Choudhury, et al., Hoppe-Seyler’s Z. Physiol. Chem., 361, 1719 (1980). (Original; Chem. Synthesis)

Gastrin I (Human) PGR-4143-v 0.5 mg 310

(Ammonium Form) -20 °C vial
Pyr-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-
Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2
(M.W. 2098.2) C97H124N20O31S [10047-33-3]
H. Gregory, P.M. Hardy, D.S. Jones, G.W. Kenner, and R.C. Sheppard, Nature, 204, 931 (1964). (Original)
PEPTIDES INTERNATIONAL

J.C. Anderson, et al., Nature, 204, 933 (1964). (Chem. Synthesis)

Gastrin Related Peptide (Bulk) PGR-4004 25 mg 115

Aoc-Trp-Met-Asp-Phe-NH2 -20 °C 100 mg 295
(Aoc: t-Amyloxycarbonyl)
(M.W. 710.84) C35H46N6O8S
Y. Ishii and H. Shinozaki, Japan J. Pharmacol., 18, 93 (1968). (Pharmacol.)
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

GIP (Human) PGR-4178-s 0.1 mg 145

Gastric Inhibitory Polypeptide (Human) -20 °C vial
Glucose-dependent Insulinotropia Polypeptide (Human)
Tyr-Ala-Glu-Gly-Thr-Phe-lle-Ser-Asp-Tyr-Ser-lle-Ala-Met-Asp-Lys-lle-His-Gln-Gln-Asp-Phe-
Val-Asn-Trp-Leu-Leu-Ala-Gln-Lys-Gly-Lys-Lys-Asn-Asp-Trp-Lys-His-Asn-lle-Thr-Gln
(M.W. 4983.5) C226H338N60O66S [100040-31-1]

GIP (Human) PGR-4178-v 0.5 mg 490

Gastric Inhibitory Polypeptide (Human) -20 °C vial
Glucose-dependent Insulinotropia Polypeptide (Human)
A.J. Moody, L. Thim, and I. Valverde, FEBS Lett.,172, 142 (1984). (Original)
N. Fujii, et al., Chem. Pharm. Bull., 34, 2397 (1986). (Glucose-dependent Insulinotropic Polypeptide)

GRP (Human) PGR-4164-v 0.5 mg 390

Gastrin Releasing Peptide (Human) -20 °C vial
Val-Pro-Leu-Pro-Ala-Gly-Gly-Gly-Thr-Val-Leu-Thr-Lys-Met-
Tyr-Pro-Arg-Gly-Asn-His-Trp-Ala-Val-Gly-His-Leu-Met-NH2
(M.W. 2859.4) C130H204N38O31S2 [93755-85-2]
E.R. Spindel, et al. , Proc. Natl. Acad. Sci. USA, 81, 5699 (1984). (Original; cDNA)

58 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT CODE QTY PRICE

BIOLOGICALLY ACTIVE PEPTIDES

GIF See Code PSI-4023 Somatostatin.

Ghrelin and Related Peptides

Ghrelin was discovered in 1999 as the endogenous ligand of growth-hormone
secretagogue receptor1: i) ghrelin is a 28 residue peptide with an n-octanoyl group
on Ser3 and ii) the major ghrelin producing organ is the stomach. Since then, many
researches have been carried out using synthetic ghrelin, clarifying that ghrelin
is a multifunctional peptide. These functions include i) regulation of appetite, ii)
cardiovascular functions, and more. 3-12
1. M. Kojima, H. Hosoda, Y. Date, M. Nakazato, H. Matsuo, and K. Kangawa, Nature, 402, 656 (1999). (Original)
2. P.L. Jeffery,et al., Endocrinology, 146, 432 (2005). (Mouse RNA Seq.)
3. C. Dieguez and F.F. Casanueva, Eur. J. Endocrinol., 142, 413 (2000). (Review)
4. G.Muccioli, et al., Eur. J. Pharmacol., 440, 235 (2002). (Review)
5. G. Wang, H.-M. Lee, E. Englander, and G.H. Greeley, Jr., Regul. Pept., 105, 75 (2002). (Review)

Ghrelin (Human) PGH-4372-s 0.1 mg 270

(Trifluoro3618 Form) -20 °C vial
Gly-Ser-Ser(n-Octanoyl)-Phe-Leu-Ser-Pro-Glu-His-Gln-Arg-Val-Gln-
Gln-Arg-Lys-Glu-Ser-Lys-Lys-Pro-Pro-Ala-Lys-Leu-Gln-Pro-Arg
(M.W. 3370.9) C149H249N47O42 [258279-04-8]
Appetite Stimulating Peptide with Energy Homeostasis Regulation
• This compound is distributed through Peptide Institute under license agreement with Dr. Kangawa.

Ghrelin (Rat) PGH-4373-s 0.1 mg 270

(Mouse) -20 °C vial
(Trifluoroacetate Form)

PEPTIDES INTERNATIONAL
Gly-Ser-Ser(n-Octanoyl)-Phe-Leu-Ser-Pro-Glu-His-Gln-Lys-Ala-Gln-
Gln-Arg-Lys-Glu-Ser-Lys-Lys-Pro-Pro-Ala-Lys-Leu-Gln-Pro-Arg
(M.W. 3314.8) C147H245N45O42 [258338-12-4]
Appetite Stimulating Peptide with Energy Homeostasis Regulation
M. Kojima, H. Hosoda, Y. Date, M. Nakazato, H. Matsuo, and K. Kangawa, Nature, 402, 656 (1999). (Original)
C. Dieguez and F.F. Casanueva, Eur. J. Endocrinol., 142, 413 (2000). (Review)
G. Muccioli, et al., Eur. J. Pharmacol., 440, 235 (2002). (Review)
G. Wang, H.-M. Lee, E. Englander, and G.H. Greeley, Jr., Regul. Pept., 105, 75 (2002). (Review)
• This compound is distributed through Peptide Institute under license agreement with Dr. Kangawa.

Des-Acyl Ghrelin (Human) PGH-4436-s 0.1 mg 130

Des-n-Octanoyl Ghrelin (Human) -20 °C vial
(Trifluoroacetate Form)
Gly-Ser-Ser-Phe-Leu-Ser-Pro-Glu-His-Gln-Arg-Val-Gln-Gln-
Arg-Lys-Glu-Ser-Lys-Lys-Pro-Pro-Ala-Lys-Leu-Gln-Pro-Arg
(M.W. 3244.7) C141H235N47O41
Des-Octanoylated Ghrelin with Distinct Effect on Food Intake

Des-Acyl Ghrelin (Rat) PGH-4437-s 0.1 mg 130

Des-n-Octanoyl Ghrelin (Rat) -20 °C vial
(Trifluoroacetate Form)
Gly-Ser-Ser-Phe-Leu-Ser-Pro-Glu-His-Gln-Lys-Ala-Gln-Gln-
Arg-Lys-Glu-Ser-Lys-Lys-Pro-Pro-Ala-Lys-Leu-Gln-Pro-Arg
(M.W. 3188.6) C139H231N45O41
Des-Octanoylated Ghrelin with Distinct Effect on Food Intake

Order Hotline 1-800-777-4779 502-266-8787 59

 PRODUCT CODE QTY PRICE
BIOLOGICALLY ACTIVE PEPTIDES

Des-n-Octanoyl-[Ser3]-Ghrelin (Human) PGH-3653-PI 0.5 mg 145

Non-Acylated Ghrelin (Human) -20 °C vial
H-Gly-Ser-Ser-Phe-Leu-Ser-Pro-Glu-His-Gln-Arg-Val-Gln-
Gln-Arg-Lys-Glu-Ser-Lys-Lys-Pro-Pro-Ala-Lys-Leu-Gln-Pro-
Arg-OH
(M.W. 3244.74) C141H235N47O41
Counteracts Metabolic Effects of Acylated Ghrelin
F. Broglio, et al., J. Clin. Endoc. and Metabolism, 89, 3062 (2004).
C. Gauna, et al.,, J. Clin. Endoc. and Metabolism, 89, 5035 (2004).
A. Asakawa, et al., Gut, 54, 18 (2005).

Des-n-Octanoyl-[Ser3]-Ghrelin (Rat) PGH-3654-PI 0.5 mg 145

Non-Acylated Ghrelin (Rat) -20 °C vial
H-Gly-Ser-Ser-Phe-Leu-Ser-Pro-Glu-His-Gln-Lys-Ala-Gln-Gln-Arg-
Lys-Glu-Ser-Lys-Lys-Pro-Pro-Ala-Lys-Leu-Gln-Pro-Arg-OH
(M.W. 3188.67) C139H231N45O41
Counteracts Metabolic Effects of Acylated Ghrelin
H Hosoda, M Kojima, H Matsuo, and K Kangawa, Biochem. Biophys. Res. Commun., 279, 909 (2000).
F. Broglio,et al., J. Clin. Endoc. and Metabolism, 89, 3062 (2004).
C. Gauna, et al., J. Clin. Endoc. and Metabolism, 89, 5035 (2004).
A. Asakawa, et al., Gut, 54, 18 (2005).

H-His-d-Trp-d-Lys-Trp-d-Phe-Lys-NH2 PGH-3656-PI 1 mg 25
[D-Lys3]-Growth Hormone Releasing Peptide-6 (GHRP-6) -20 °C 5 mg 49
(M.W. 930.13) C49H63N13O6
Ghrelin Antagonist
K. Fujino, A. Inui, A. Asakawa, N. Kihara, M. Fujimura, and M. Fujimiya, J. Physiol., 550, 227 (2003).
PEPTIDES INTERNATIONAL

H-His-d-Trp-Ala-Trp-d-Phe-Lys-NH2 PGH-3694-PI 1 mg 25
[His1,Lys6]-Growth Hormone Releasing Peptide (GHRP-6) -20 °C 5 mg 65
(M.W. 873.04) C46H56N12O6
C.Y. Bowers, F.A. Monamy, G.A. Renolds, and A. Hong, Endocrinol., 114, 1537 (1984).

Ghrelin (Human, 1-18) PGH-3625-PI 1 mg 95

H-Gly-Ser-Ser(n-Octanoyl)-Phe-Leu-Ser-Pro-Glu- -20 °C 5 mg 285
His-Gln-Arg-Val-Gln-Gln-Arg-Lys-Glu-Ser-NH2
(M.W. 2225.51) C96H157N31O30
M.A. Bednarek, et al., J. Med. Chem., 43, 4370 (2000).

Ghrelin (Human, 1-14) PGH-3626-PI 1 mg 75

H-Gly-Ser-Ser(n-Octanoyl)-Phe-Leu-Ser- -20 °C 5 mg 225
Pro-Glu-His-Gln-Arg-Val-Gln-Gln-OH
(M.W. 1725.94) C76H121N22O24
M.A. Bednarek, et al., J. Med. Chem., 43, 4370 (2000).

Ghrelin (Human, Rat, 1-10) PGH-3627-PI 1 mg 60

H-Gly-Ser-Ser(n-Octanoyl)-Phe-Leu-Ser-Pro-Glu-His-Gln- -20 °C 5 mg 180
NH2
(M.W. 1213.37) C55H84N14O17
M.A. Bednarek, et al., J. Med. Chem., 43, 4370 (2000).

Ghrelin (Human, Rat, 1-5) PGH-3628-PI 1 mg 45

H-Gly-Ser-Ser(n-Octanoyl)-Phe-Leu-NH2 -20 °C 5 mg 135
(M.W. 634.78) C31H50N6O8
M.A. Bednarek, et al.,, J. Med. Chem., 43, 4370 (2000).

60 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT CODE QTY PRICE
Des-n-Octanoyl-[Ser3]-Ghrelin (Human, 1-18) PGH-3645-PI 1 mg 65

BIOLOGICALLY ACTIVE PEPTIDES

H-Gly-Ser-Ser-Phe-Leu-Ser-Pro-Glu-His-Gln-Arg-Val- -20 °C 5 mg 195
Gln-Gln-Arg-Lys-Glu-Ser-NH2
(M.W. 2099.31) C88H143N31O29
Non-acylated Analog of Ghrelin (Human, 1-18)

Des-n-Octanoyl-[Ser3]-Ghrelin (Human, 1-14) PGH-3646-PI 1 mg 55

H-Gly-Ser-Ser-Phe-Leu-Ser-Pro-Glu-His- -20 °C 5 mg 155
Gln-Arg-Val-Gln-Gln-OH
(M.W. 1599.74) C68H106N22O23
Non-acylated Analog of Ghrelin (Human, 1-14)

Des-n-Octanoyl-[Ser3]-Ghrelin PGH-3647-PI 1 mg 45
(Human, Rat, 1-10) -20 °C 5 mg 125
H-Gly-Ser-Ser-Phe-Leu-Ser-Pro-Glu-His-Gln-NH2
(M.W. 1087.17) C47H70N14O16
Non-acylated Analog of Ghrelin (Human, 1-10)

Des-n-Octanoyl-[Ser3]-Ghrelin (Human, Rat, PGH-3648-PI 1 mg 35

1-5) -20 °C 5 mg 95
H-Gly-Ser-Ser-Phe-Leu-NH2
(M.W. 508.58) C23H36N6O7
Non-acylated Analog of Ghrelin (Human, 1-5)

[Dap3]-Ghrelin (Human, Rat, 1-5) PGH-3681-PI 1 mg 55

H-Gly-Ser-Dap(n-Octanoyl)-Phe-Leu-NH2 -20 °C 5 mg 190
Dap = 2,3-diaminopropionic acid
(M.W. 633.79) C31H51N7O7

PEPTIDES INTERNATIONAL
Growth-Hormone Releasing Peptide Ghrelin Analog Active Fragment
M.A. Bednarek, et al., J. Med. Chem., 43, 4370-4376 (2000).

[Dap3]-Ghrelin (Rat) PGH-3680-PI 0.5 mg 165

H-Gly-Ser-Dap(n-Octanoyl)-Phe-Leu-Ser-Pro-Glu-His-Gln- -20 °C vial
Lys-Ala-Gln-Gln-Arg-Lys-Glu-Ser-Lys-Lys-Pro-Pro-Ala-Lys-
Leu-Gln-Pro-Arg-OH
Dap = 2, 3-diaminopropionic acid
(M.W. 3313.88) C147H246N46O41
Growth-Hormone Releasing Peptide / Ghrelin Analog
M.A. Bednarek, et al., J. Med. Chem., 43, 4370 (2000).

[Trp , Arg5]-Ghrelin (1-5)

3 PGH-3902-PI 1 mg 35
H-Gly-Ser-Trp-Phe-Arg-OH -20 °C 5 mg 95
M.W. 651.73) C31H41N9O7
Growth-Hormone Secretogue (GHS) Receptor Agonist / Stimulates Food-Intake
K. Ohinata, K. Kobayashi, M. Yoshikawa, Peptides, 27, 1632 (2006).

Glucagon
Glucagon (Human) PGL-4098-s 0.1 mg 145
His-Ser-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Lys-Tyr-Leu- -20 °C vial
Asp-Ser-Arg-Arg-Ala-Gln-Asp-Phe-Val-Gln-Trp-Leu-Met-
Asn-Thr
(M.W. 3482.7) C153H225N43O49S [16941-32-5]
P.J. Lefebvre and R.H. Unger (eds.), Glucagon, Pergamon Press, Oxford, 1972. (Review)

Order Hotline 1-800-777-4779 502-266-8787 61

 PRODUCT CODE QTY PRICE
BIOLOGICALLY ACTIVE PEPTIDES

Glucagon-Like Peptides
E. Blázquez, et al., Mol. Neurobiol., 18, 157 (1998). (Review)
G. van Dijk and T.E. Thiele, Neuropeptides, 33, 406 (1999). (Review)
D.J. Drucker, Gut, 50, 428 (2002). (Review)

Glucagon-like Peptide 1 (Human, 7-36 Amide) PGL-4344-v 0.5 mg 350

GLP-1 (Human, 7-36 Amide) -20 °C vial
(Bovine, Canine, Rat, Guinea pig)
His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-
Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg-NH2
(M.W. 3297.6) C149H226N40O45 [107444-51-9]
M.D. Turton, et al., Nature, 379, 69 (1996). (Orginial-CNS Effect on Feeding)
M. Tang-Christensen, et al., Am. J. Physiol., 271, R848 (1996). (Original, CNS Effect on Drinking)
G. van Dijk, T.E. Thiele, R.J. Seeley, S.C. Woods, and I.L. Bernstein, Nature, 385, 214 (1997). (Correspondence)

Glucagon-like Peptide 1 (Human, 7-37) PGP-4280-v 0.5 mg 350

GLP-1 (Human, 7-37) -20 °C vial
(Bovine, Canine, Rat, Guinea pig)
His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-
Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg-Gly
(M.W. 3355.7) C151H228N40O47 [106612-94-6]
G.G. Holz IV, W.M. Kühtreiber, and J.F. Habener, Nature, 361, 362 (1993). (Original)
G.S. Meneilly, et al., Diabetes Care, 24, 964 (2001). (Pharmacol.)

Glucagon-like Peptide 1 (Human, PGL-3723-PI 1 mg 400

7-36)-Lys(Biotinyl)-Amide -20 °C 5 mg 1600
GLP-1 (7-36)-Lys(Biotin)-amide
H-His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-
PEPTIDES INTERNATIONAL

Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg-Lys(biotinyl)-NH2
(M.W. 3652.18) C165H252N44O48S
H. John, E. Maronde, W.G. Forssmann, M. Meyer, K. Adermann, Eur. J. Med Res., 13, 73 (2008).
B. Ahrén, et al., Diabetes Care, 25, 869 (2002).
C.F. Deacon, A. Plamboeck, S. Møller, J.J. Holst, Am. J. Physiol. Endocrinol. Metab., 282, E873 (2002).
B. Rolin, C.F. Deacon, R.D. Carr, B.Ahrén, Eur. J. Pharmacol., 494, 283 (2004).
D. Elahi, J.M. Egan, R.P. Shannon, G.S. Meneilly, A. Khatri, J.F. Habener, and D.K. Andersen, Obesity, 16, 1501 (2008).

Glucagon-like Peptide 1 (Human, 9-36 Amide) PGL-3722-PI 1 mg 290

GLP-1 metabolite; GLP-1 (Human, 9-36 amide) -20 °C 5 mg 1160
H-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-
Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg-NH2
(M.W. 3089.48) C140H214N36O43 [161748-29-4]

62 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT CODE QTY PRICE
Glucagon-like Peptide 2 (Human) PGL-4376-v 0.5 mg 370

BIOLOGICALLY ACTIVE PEPTIDES

GLP-2 (Human) -20 °C vial
His-Ala-Asp-Gly-Ser-Phe-Ser-Asp-Glu-Met-Asn-Thr-Ile-Leu-Asp-Asn-
Leu-Ala-Ala-Arg-Asp-Phe-Ile-Asn-Trp-Leu-Ile-Gln-Thr-Lys-Ile-Thr-Asp
(M.W. 3766.1) C165H254N44O55S [223460-79-5]
D.J. Drucker, Gut, 50, 4289 (2002). (Review)
B. Hartmann, A.H. Johnsen, C. Ørskov, K. Adelhorst, L. Thim, and J.J. Holst, Peptides, 21, 73 (2000). (Pharmacol.)
M. Tang-Christensen, P.J. Larsen, J. Thulesen, J. Rømer, and N. Vrang, Nat. Med., 6, 802 (2000). (Pharmacol.)

The proglucagon gene encodes glucagon, glucagon-like peptide 1 (GLP-1) and

GLP-2 tandemly. Among these, the location and function of GLP-1 have long been
studied, showing that GLP-1 is one of the typical brain-gut peptides and has pleiotro-
pic functions, including stimulation of insulin gene expression, regulation of food and
water intake, etc. The chemical structure of GLP-2 in human ileum was reported to
be identical to the 33 amino acid residue peptide corresponding to proglucagon (126-
158).1 GLP-2 is present in human plasma, the concentration of which was shown
to be elevated 3- to 4-fold after ingestion of a meal. 1 Further studies revealed that
GLP-2’s immunoreactivity was distributed in rat brain, especially in the ventral part of
the dorsomedial hypothalamic nucleus (DMH) (and also found in the paraventricular
and arcuate nuclei). Central administration of GLP-2 decreases food intake in ad
libitum-fed rats at concentrations above 5 μg.2 This inhibition is effective for a short-
duration. Surprisingly the GLP-1 receptor antagonist, exendin (9-39), reverses the
GLP-2 induced anorexia, although the GLP-2 receptor is expressed in the compact
part of the DMH. In addition, GLP-2 decreases NPY-induced food intake by 40%, but
this peptide does not affect angiotensin II-induced drinking behavior.2

PEPTIDES INTERNATIONAL
1. B. Hartmann, A.H. Johnsen, C.Ørskov, K. Adelhorst, L. Thim, and J.J. Holst, Peptides, 21, 73 (2000). (Pharmacol.)
2. M. Tang-Christensen, P.J. Larsen, J. Thulesen, J. Rømer, and N. Vrang, Nat. Med., 6, 802 (2000). (Pharmacol.)
3. D.J. Drucker, Gut, 50, 428 (2002). (Review)
4. K. Wallis, J.R.F. Walters, and A. Forbes, Aliment. Pharmacol. Ther., 25, 365 (2007). (Review)
5. P.E. Dube ´and P.L. Brubaker, Am. J. Physiol. Endocrinol, Metab., 293, E460 (2007). (Review)
6. K.J. Rowland and P.L. Brubaker, Mol. Cell. Endocrinol., 288, 63 (2008). (Review)
7. R. Yazbeck, G.S. Howarth, and C.A. Abbott, Cytokine Growth Factor Rev., 20, 175 (2009). (Review)
8. R. Yazbeck, C.A. Abbott, and G.S. Howarth, Curr. Opin. Investig. Drugs, 11, 440 (2010). (Review)

Glutathione Disulfide (GSSG) Methyl Ester GLU-3809-PI 5 mg 65

(M.W. 668.75) C24H40N6O12S2 -20 °C 25 mg 250
H.A. Park, et al., Cell Death Differ.,16,1167 (2009).

GO-CoA-Tat (Rat, Mouse) PGH-3792-PI 0.5 mg 825

H-Gly-Ser-α-Dap-β-(2-CoA-Octanoyl)-Phe-Leu-Ser-Pro-Glu- -20 °C 1 mg 1500
His-Gln-Ahx-Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-OH
(M.W. 3633.92) C146H245N54O47P3S
Inhibitor of Ghrelin O-Acyltransferase (GOAT)

Order Hotline 1-800-777-4779 502-266-8787 63

 PRODUCT CODE QTY PRICE
BIOLOGICALLY ACTIVE PEPTIDES

Growth Hormone Releasing Factor (GRF, GH-RH) and Growth Hormone

Related Peptides
Growth hormone releasing peptide-2 or H- d-Ala-d-Nal(2’)-Ala-Trp-d-Phe-Lys-NH2
(GHRP-2) (PGH-3911-PI) is part of the growth hormone secretagogue (GHS) family
first identified nearly 20 years ago. Ghrelin was later isolated and like GHRPs, were
found to stimulate release of growth hormone. 1,2 Ghrelin and GHRPs act on growth
hormone secretagogue receptor type 1a (GSR1a) in a synergistic manner, and both
can stimulate increase of food intake in humans.3-6 Besides its role in energy balance,
GHRP-2 has been implicated to have anti inflammatory effects in arthritic rats due
to its ability to decrease IL-6 in serum, a major mediator of tissue destruction in this
disease.7 Cardio protective functions have been observed as well.8
GSR1a was found to exhibit high basal activity independent of ghrelin activation.9
Constitutive, ligand independent activation of GSR1a is physiologically important,
and inverse agonists would be helpful in studies focused on such activity. [d-Arg1,d-
Phe5,d-Trp7,9,Leu11]-substance P (PGH-3652-PI) is a selective inverse agonist for
GSR1a with low antagonist activity.10 The pentapeptide core required for inverse
agonist activity was determined to be wFwLL.11 Addition of a positive charged amino
acid led to a novel peptide KwFwLL (PGH-3908-PI); the most potent and shortest
inverse agonist for GSR1a.
http://pepnet.com/products/ghrelin_obestatin.pdf

GRF (Human) PGR-4127-s 0.1 mg 145

Growth Hormone Releasing Factor (Human) -20 °C vial
PEPTIDES INTERNATIONAL

Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-
lle-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu-NH2
(M.W. 5039.7) C215H358N72O66S [83930-13-6]
• This product is distributed through Peptide Institute, Inc. under license of The Salk Institute.

GRF (Human) PGR-4127-v 0.5 mg 490

Growth Hormone Releasing Factor (Human) -20 °C vial
R. Guillemin, et al., Science, 218, 585 (1982). (Original; Pancreatic Tumor)
N. Ling, et al., Proc. Natl. Acad. Sci. USA, 81, 4302 (1984). (Original; Hypothalamus)
• This product is distributed through Peptide Institute, Inc. under the license of The Salk Institute.

H-d-Ala-d-Nal(2’)-Ala-Trp-d-Phe-Lys-NH PGH-3911-PI 1 mg 45
GHRP-2 -20 °C 5 mg 185
(M.W. 818) C45H55N9O6
Growth Hormone Releasing Peptide / Food Intake Stimulator

H-Lys-d-Trp-Phe-d-Trp-Leu-Leu-NH2 PGH-3908-PI 1 mg 45
KwFwLL -20 °C 5 mg 185
(M.W. 891.14) C49H66N10O6
Potent Full Inverse Agonist for Ghrelin Receptor

Phytosulfokine PGR-4477-s 0.1 mg 50

PSK -20 °C vial
Tyr(SO3H)-Ile-Tyr(SO3H)-Thr-Gln
(Ammonium Form)
(M.W. 846.88) C33H46N6O16S2 [179667-62-0]
Potent Mitogenic Factor in Plants
Y. Matsubayashi and Y. Sakagami, Proc. Natl. Acad. Sci. U.S.A., 93, 7623 (1996). (Original)
Y. Matsubayashi, M. Ogawa, A. Morita, and Y. Sakagami, Science, 296, 1470 (2002). (Pharmacol.)
H. Motose, et al., Plant Physiol., 150, 437 (2009). (Pharmacol.)

64 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT CODE QTY PRICE

BIOLOGICALLY ACTIVE PEPTIDES

Guanylins and Uroguanylins
L.R. Forte and M.G. Currie, FASEB J., 9, 643 (1995). (Review)
L.R. Forte, X.H. Fan, and F.K. Hamra, Am. J. Kidney Dis., 28, 296 (1996). (Review)
L.R. Forte, Jr., Pharmacol. Ther., 104, 137 (2004). (Review)

Guanylin (Human) PGN-4274-s 0.1 mg 130

Pro-Gly-Thr-Cys-Glu-Ile-Cys-Ala-Tyr-Ala- -20 °C vial
Ala-Cys-Thr-Gly-Cys
(Disulfide bonds between Cys4-Cys12 and Cys7-Cys15)
(M.W. 1458.7) C58H87N15O21S4 [183200-12-6]
Guanylate Cyclase C Activator
R.C. Wiegand, et al., FEBS Lett., 311, 150 (1992). (Original; cDNA)
F.J. de Sauvage, et al., Proc. Natl. Acad. Sci. USA, 89, 9089 (1992). (Original; cDNA)
M. Kuhn, et al., FEBS Lett., 318, 205 (1993). (Circulating Form)
O. Hill, et al., Proc. Natl. Acad. Sci. U.S.A., 92, 2046 (1995). (Immunohistochem.)

Guanylin (Rat, Mouse) PGN-4275-s 0.1 mg 130

Pro-Asn-Thr-Cys-Glu-Ile-Cys-Ala-Tyr- -20 °C vial
Ala-Ala-Cys-Thr-Gly-Cys
(Disulfide bonds between Cys4-Cys12 and Cys7-Cys15)
(M.W. 1515.7) C60H90N16O22S4
Guanylate Cyclase C Activator
M.G. Currie, et al., Proc. Natl. Acad. Sci. USA, 89, 947 (1992). (Original; Rat)
R.C. Wiegand, J. Kato, and M.G. Currie, Biochem. Biophys. Res. Commun., 185, 812 (1992). (Original; Rat cDNA)
S. Schults, T.D. Chrisman, and D.L. Garbers, J. Biol. Chem. 267, 16019 (1992). (Tissue distribution)
F.J. de Sauvage, et al., Proc. Natl. Acad. Sci. USA, 89, 9089 (1992). (Original; Mouse cDNA)

Uroguanylin (Rat) PUG-4354-s 0.1 mg 120

PEPTIDES INTERNATIONAL
-20 °C vial
Thr-Asp-Glu-Cys-Glu-Leu-Cys-Ile-Asn-Val-Ala-Cys-Thr-Gly-Cys
(Disulfide bonds between Cys4-Cys12 and Cys7-Cys15)
(M.W. 1569.8) C60H96N16O25S4
Guanylate Cyclase C Activator / Natriuretic Factor M. Nakazato, et al., Endocrinology, 139, 5247 (1998). (Original)
H. Ieda, S. Naruse, M. Kitagawa, H. Ishiguro, and T. Hayakawa, Regul. Pept., 79, 165 (1999). (Pharmacol.)
M. Kikuchi, et al, J. Am. Soc. Nephrol., 16, 392 (2005). (Pharmacol.; Natriuretic Activity)

Uroguanylin (Human) PUG-3772-PI 1 mg 550

(Trifluoroacetate Form) -20 °C 5 mg 2200
H-Asn-Asp-Asp-Cys-Glu-Leu-Cys-Val-Asn-Val-Ala-Cys-Thr-Gly-Cys-Leu-OH
(Disulfide bonds between Cys4-Cys12 and Cys7-Cys15)
(M.W. 1667.89) C64H102N18O26S4 [154525-25-4]
T. Kita, et al., Am. J. Physiol., 266, F342 (1994).
J. Beltowski, et al., 52, 351 (2001).
LR Forte, et al., J. Clin. Invest., 112, 1138 (2003).

Uroguanylin Isomer A (Human) PUG-4295-s 0.1 mg 135

(Trifluoroacetate Form) -20 °C vial
Asn-Asp-Asp-Cys-Glu-Leu-Cys-Val-Asn-Val-Ala-Cys-Thr-Gly-Cys-Leu
(Disulfide bonds between Cys4-Cys12 and Cys7-Cys15)
(M.W. 1667.9) C64H102N18O26S4 [154525-25-4]
Guanylate Cyclase C Activator
Purity Information: Qz See page xiv
T. Kita, et al., Am. J. Physiol., 266, F342 (1994). (Original)
M. Nakazato, et al., Biochem. Biophys. Res. Commun., 220, 586 (1996). (Biologically Active/Inactive Isomer)
H. Kinoshita, et al., Kidney Int., 52, 1028 (1997). (Urine/Plasma Level; Renal Disease)
N. Chino, S. Kubo, et al., FEBS Lett., 421, 27 (1998). (Biochem.; Topological Isomers)
N.G. Moss, et al., Hypertension, 53, 867 (2009). (Natriuretic Activity of Topological Isomers)

Order Hotline 1-800-777-4779 502-266-8787 65

 PRODUCT CODE QTY PRICE
BIOLOGICALLY ACTIVE PEPTIDES

Uroguanylin Isomer B (Human) PUG-4463-s 0.1 mg 105

(Trifluoroacetate Form) -20 °C vial
Asn-Asp-Asp-Cys-Glu-Leu-Cys-Val-Asn-Val-Ala-Cys-Thr-Gly-Cys-Leu
(Disulfide bonds between Cys4-Cys12 and Cys7-Cys15)
(M.W. 1667.9) C64H102N18O26S4
Natriuretic Factor
Uroguanylin is a well-known activator of guanylyl cyclase-C (GC-C) in the intestine.
Regulation of natriuresis in the kidney postprandial is another important function of this
peptide.1 In the case of human uroguanylin,2 the so-called topological isomers ( iso-
mer A and isomer B in this catalog) are generated because of the carboxyl-terminal
extension of Leu residue from the core structure formed by two disulfide bonds in a
1-3/2-4 pattern resulting in the stabilization of two topological stereoisomers. Isomer
A (PUG-4295-s) stimulates GC-C, whilst isomer B is a weak agonist in this assay.3
What is the biological role of isomer B? The answer was obtained that isomer B
possesses natriuretic activity4 with a sigmoidal dose-response curve (ED 50 = 20 nmol/
kg in rats). It is of interest that isomer A also shows natriuretic activity at 25 nmol/kg,
however, a distinct bell-shaped dose-response curve was observed. Furthermore,
co-administration of isomer A (100 nmol/kg) and isomer B (35 nmol/kg) induced almost
as efficient natriuretic response as that of a mere administration of isomer A, indicat-
ing that a large amount of coexisting isomer A antagonize, even in part, the natriuretic
activity of isomer B. Considering the report that uroguanylin and guanlylin exert natri-
uretic activity in mice even lacking the GC-C receptor,5 the natriuresis of uroguanylin
might be mediated by a novel receptor other than GC-C. The availability of synthetic
human uroguanylin isomer A and isomer B should allow for more precise research to
help clarify the complicated biological response of the individual topological isomers.
PEPTIDES INTERNATIONAL

Please note: It has been reported that isomer A and isomer B of human uroguanylin
are interconvertible in solution. 6 Keeping the prepared solution at low temperature
(below 4 °C) should help avoid this possible interconversion.
1. L.R. Forte, J. Clin. Invest., 112. 1138 (2003). (Review: Natriuretic Factor)
2. T. Kita, et al., Am. J. Physiol., 266, F342 (1994). (Original)
3. M. Nakazato, et al., Biochem. Biophys. Res. Commun., 220, 586 (1996).
(GC-C Stimulating Activity of Topological Isomers)
4. N.G. Moss, et al., Hypertension, 53, 867 (2009). (Natriuretic Activity of Topological Isomers)
5. S.L. Carrithers, et al., Kidney Int., 65, 40 (2004). (GC-C-Independent Natriuretic Activity)
6. N. Chino, et al., FEBS Lett., 421, 27 (1998). (Interconversion of Topological Isomers)

Gurmarin GUR-3810-PI 1 mg 650

(Acetate Form) -20 °C 5 mg 2600
Pyr-Gln-Cys-Val-Lys-Lys-Asp-Glu-Leu-Cys-Ile-Pro-Tyr-Tyr-
Leu-Asp-Cys-Cys-Glu-Pro-Leu-Glu-Cys-Lys-Lys-Val-Asn-Trp-Trp-Asp-His-Lys-Cys-Ile-Gly-OH
(M.W. 4208.95) C187H276N46O53S6
J.I. Fletcher, et al., Eur. J. Biochem., 264, 525 (1999). Y. Ninomiya, et al., Am J Physiol., 274, R1324 (1998).
M. Sigoillot, et al., Appl. Microbiol. Biotechnol., 96, 619 (2012). A. Shiyovich, et al., Am. J. Med. Sci., 340, 514 (2010).

66 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT CODE QTY PRICE
Hepcidin

BIOLOGICALLY ACTIVE PEPTIDES

Hepcidin is an antimicrobial peptide and negative regulator of iron homeostasis. 1
Both iron loading and inflammation can stimulate hepcidin production in the liver .2,3
Humans have one copy of the hepcidin gene while mice contain 2 copies; hepcidin
1 and 2. Overexpression of hepcidin 1 but not 2 in mice led to anemia, suggesting
the former is the predominant regulator of iron metabolism. 4 In addition, disruption of
hepcidin 1 in mice caused severe multivisceral iron overload and hemochromatosis. 5
1. C.H. Park, et al., J. Biol. Chem., 276, 7806 (2001). 4. D.-Q. Lou, et al., Blood, 103, 2816 (2004).
2. C. Pigeon, et al., J. Biol. Chem., 276, 7811 (2001). 5. J.-C. Lesbordes-Brion, et al., Blood, 108, 1402 (2006).
3. G. Nicholas, et al., J. Clin. Invest., 110, 1037 (2002).

[13C18,15N3]-Hepcidin (Human) PLP- 3405-v 0.02 mg 260

(Trifluoroacetate Form) -20 °C vial
Asp-Thr-His-[13C9,15N]Phe-Pro-Ile-Cys-Ile-[13C9,15N]Phe-Cys-Cys-
[15N]Gly-Cys-Cys-His-Arg-Ser-Lys-Cys-Gly-Met-Cys-Cys-Lys-Thr
(Reported disulfide bonds between Cys7-Cys23, Cys10-Cys13, Cys11-Cys19, and Cys14-Cys22)
(M.W. 2810.20) C9513C18H170N3115N3O31S9
Stable Isotope-Labeled Peptide for Mass Spectrometric Detection of Hepcidin (Human)
N. Murao, M. Ishigai, H. Yasuno, Y. Shimonaka, and Y. Aso, Rapid Commun. Mass Spectrom., 21, 4033 (2007).
T. Hosoki, et al., Proteomics Clin. Appl., 3, 1256 (2009).

Hepcidin (Baboon) PLP-3745-PI 1 mg 625

(Trifluoroacetate Form) -20 °C 5 mg 2500
Liver-Expressed Antimicrobial Peptide (Baboon)
H-Asp-Thr-His-Phe-Pro-Ile-Cys-Ile-Phe-Cys-Cys-Gly-Cys-
Cys-His-Arg-Ser-Lys-Cys-Gly-Met-Cys-Cys-Arg-Thr-OH
(Disulfide bonds between Cys7-Cys23, Cys10-Cys13, Cys11-Cys19, and Cys14-Cys22)

PEPTIDES INTERNATIONAL
(M.W. 2817.41) C113H170N36O31S9
G.M. Morrison, et al., Mol Biol Evol., 20, 460 (2003).

Hepcidin (Crocodile) PLP-3789-PI 1 mg 700

Liver-Expressed Antimicrobial Peptide (Crocodile) -20 °C 5 mg 2800
H-Asn-Ser-His-Phe-Pro-Ile-Cys-Ser-Tyr-Cys-Cys-Asn-Cys-
Cys-Arg-Asn-Lys-Gly-Cys-Gly-Leu-Cys-Cys-Arg-Thr-OH
(Disulfide bonds between Cys7-Cys23, Cys10-Cys13, Cys11-Cys19, and Cys14-Cys22)
(M.W. 2778.27) C100H165N37O33S8
Iron Homestasis Regulator

Hepcidin (Dog) PLP-3785-PI 1 mg 625

Liver-Expressed Antimicrobial Peptide (Dog) -20 °C 5 mg 2500
H-Asp-Thr-His-Phe-Pro-Ile-Cys-Ile-Phe-Cys-Cys-Gly-Cys-
Cys-Lys-Thr-Pro-Lys-Cys-Gly-Leu-Cys-Cys-Lys-Thr-OH
(Disulfide bonds between Cys7-Cys23, Cys10-Cys13, Cys11-Cys19, and Cys14-Cys22)
Iron Homestasis Regulator
M.M. Fry, et al., Vet. Clin. Pathol., 33, 223 (2004).

Hepcidin 1 (Mouse) PLP-4434-s 0.1 mg 260

Liver-Expressed Antimicrobial Peptide 1 (Mouse) -20 °C vial
Asp-Thr-Asn-Phe-Pro-Ile-Cys-Ile-Phe-Cys-Cys-Lys-Cys-
Cys-Asn-Asn-Ser-Gln-Cys-Gly-Ile-Cys-Cys-Lys-Thr
(Disulfide bonds undetermined)
(M.W. 2754.2) C111H169N31O35S8
Iron-Regulatory Hormone-

Order Hotline 1-800-777-4779 502-266-8787 67

 PRODUCT Code Qty PRICE
Biologically Active Peptides

Hepcidin (Mouse) (Bulk) PLP-3773-PI 1 mg 1500

(Trifluoroacetate Form) -20 °C 5 mg 6750
Liver-Expressed Antimicrobial Peptide 1 (Mouse)
Asp-Thr-Asn-Phe-Pro-Ile-Cys-Ile-Phe-Cys-Cys-Lys-Cys-Cys-
Asn-Asn-Ser-Gln-Cys-Gly-Ile-Cys-Cys-Lys-Thr
(Disulfide bonds undetermined)
(M.W. 2754.2) C111H169N31O35S8
Iron-Regulatory Hormone
Hepcidin-9 (Mouse) PLP-3858-PI 1 mg 225
NEW!
(Trifluoroacetate Form) -20 °C 5 mg 900
H-Asp-Thr-Asn-Phe-Pro-Ile-Cys-Ile-Phe-NH2
(M.W.1068.27) C50H73N11O13S

Hepcidin (Rat) (50 µg vial) PLP-4467-v 0.05 mg 365

Liver-Expressed Antimicrobial Peptide (Rat) -20 °C vial
H-Asp-Thr-Asn-Phe-Pro-Ile-Cys-Leu-Phe-Cys-Cys Lys-Cys-
Cys-Lys-Asn-Ser-Ser-Cys-Gly-Leu-Cys-Cys-Ile-Thr
(Disulfide bonds undetermined)
(M.W. 2712.2) C111H169N31O35S8
Synthetic Product
Iron-Regulatory Hormone C. Pigeon, et al., J. Biol. Chem., 276, 7811 (2001). (Primary structure: GenBank accession
No. AF344185)

Hepcidin (Rat) (Bulk) PLP-3769-PI 1 mg 1500

(Trifluoroacetate Form) -20 °C 5 mg 6750
Liver-Expressed Antimicrobial Peptide (Rat)
H-Asp-Thr-Asn-Phe-Pro-Ile-Cys-Leu-Phe-Cys-Cys Lys-Cys-
PEPTIDES INTERNATIONAL

Cys-Lys-Asn-Ser-Ser-Cys-Gly-Leu-Cys-Cys-Ile-Thr
(Disulfide between Cys7-Cys23, Cys10-Cys13, Cys11-Cys19, Cys14-Cys22)
(M.W. 2712.2) C111H169N31O35S8
Synthetic Product
Iron-Regulatory Hormone

Biotinyl-PEG3-Hepcidin (Rat) PLP-3768-PI 0.5 mg 1200

-20 °C 1 mg 4800
Biotin-PEG3-Asp-Thr-Asn-Phe-Pro-Ile-Cys-Leu-Phe-Cys-Cys-Lys-
Cys-Cys-Lys-Asn-Ser-Ser-Cys-Gly-Leu-Cys-Cys-Ile-Thr-OH
(Disulfide bonds between Cys7-Cys23, Cys10-Cys13, Cys11-Cys19, and Cys14- Cys22)
(M.W. 3127.80) C129H200N32O40S9

Phe4,9 [Ring D5]-Hepcidin (Rat) PLP-3780-PI 0.1 mg 280

H-Asp-Thr-Asn-Phe(D5)-Pro-Ile-Cys-Leu-Phe(D5)-Cys-Cys- -20 °C vial
Lys-Cys-Cys-Lys-Asn-Ser-Ser-Cys-Gly-Leu-Cys-Cys-Ile-Thr-OH
(Disulfide bonds between Cys -Cys , Cys -Cys , Cys -Cys , and Cys14-Cys22)
7 23 10 13 11 19

(M.W. 2722.37) C111H161D10N29O34S8

Deuterium Stable Isotope-Labeled Hepcidin for Internal Standard

68 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE
Hepcidin/LEAP-1 (Human) contains 8 Cys residues, disulfide connectivity of which was

Biologically Active Peptides

first determined to be Cys7-Cys23, Cys10-Cys22, Cys11-Cys19, and Cys13-Cys14 based on the
results from NMR analysis of the synthetic peptide. Recently, this connectivity has been
revised to be Cys7-Cys23, Cys10-Cys13, Cys11-Cys19, and Cys14-Cys22 using the natural
peptide from urine, two recombinant peptides expressed in CHO cells or E. coli, and
the chemically synthesized peptide.5 Methods applied to determine this newly reported
connectivity include: NMR, X-ray crystallography of the anti-hepcidin/LEAP-1 antibody
Fab complex, and disulfide mapping by partial reduction/alkylation procedure. Based on
these experimental facts, we have now changed the disulfide connectivity of our hepcidin/
LEAP-1 (Human) to the newly reported one, that is, (Reported disulfide bonds between
Cys7-Cys23, Cys10-Cys13, Cys11-Cys19, and Cys14-Cys22).
1. A. Krause, et al., FEBS Lett., 480, 147 (2000). (Original; LEAP-1)
2. C.H. Park, et al., J. Biol. Chem., 276, 7806 (2001). (Original; Hepcidin)
3. T. Ganz and E. Nemeth, Am. J. Physiol., 290, G199 (2006). (Review)
4. H.N. Hunter, et al., J. Biol. Chem., 277, 37597 (2002). (Previously published S-S Bond Connectivity)
5. J.B. Jordan, et al., J. Biol. Chem., 284, 24155 (2009). (Newly published S-S Bond Connectivity)

Hepcidin/LEAP-1 (Human) PLP-4392-s 0.1 mg 225

Liver-Expressed Antimicrobial Peptide -20 °C vial
Asp-Thr-His-Phe-Pro-Ile-Cys-Ile-Phe-Cys-Cys-Gly-Cys-
Cys-His-Arg-Ser-Lys-Cys-Gly-Met-Cys-Cys-Lys-Thr
(Disulfide bonds between Cys7-Cys23, Cys10-Cys13, Cys11-Cys19, and Cys14- Cys22)
(M.W. 2789.4) C113H170N34O31S9
Liver-Specific Antimicrobial Peptide / Iron-Regulatory Hormone
M. Zasloff, Nature, 475, 389 (2002). (Review)
A. Krause, et al., FEBS Lett., 480, 147 (2000). (Original; LEAP-1)

PEPTIDES INTERNATIONAL
C.H. Park, et al., J. Biol. Chem., 276, 7806 (2001). (Original; Hepcidin)
H.N. Hunter, et al., J. Biol. Chem., 277, 37597 (2002). (S-S Bond)
R.E. Fleming and W.S. Sly, Proc. Natl. Acad. Sci. USA, 98, 8160 (2001). (Regulation of Iron Homeostasis)

Hepcidin/LEAP-1 (Human) (Bulk) PLP-3771-PI 1 mg 700

Liver-Expressed Antimicrobial Peptide -20 °C 5 mg 2800
(Trifluoroacetate Form)
Asp-Thr-His-Phe-Pro-Ile-Cys-Ile-Phe-Cys-Cys-Gly-Cys-Cys-His-Arg-Ser-Lys-Cys-Gly-Met-Cys-Cys-Lys-Thr
(Disulfide bonds between Cys7-Cys23, Cys10-Cys13, Cys11-Cys19, and Cys14- Cys22)
(M.W. 2789.4) C113H170N34O31S9 [342790-21-0]
Liver-Specific Antimicrobial Peptide / Iron-Regulatory Hormone
A. Krause, et al., FEBS Lett., 480, 147 (2000). (Original; LEAP-1) H.N. Hunter, et al., J. Biol. Chem.,
C.H. Park, et al., J. Biol. Chem., 276, 7806 (2001). (Original; Hepcidin) 277, 37597 (2002). (S-S Bond)
T Gan, et al., J. Physiol. Gastrointest. Liver Physiol, 290, G199 (2006). JB Jordan, et al., J. Biol. Chem., 284, 24155 (2009).

LEAP-2 (Human) PLP-4405-s 0.1 mg 260

Liver-Expressed Antimicrobial Peptide 2 (Human) -20 °C vial
Prepro-LEAP-2 (Human, 38-77)
Met-Thr-Pro-Phe-Trp-Arg-Gly-Val-Ser-Leu-Arg-Pro-Ile-Gly-Ala-Ser-Cys-Arg-Asp-Asp-
Ser-Glu-Cys-Ile-Thr-Arg-Leu-Cys-Arg-Lys-Arg-Arg-Cys-Ser-Leu-Ser-Val-Ala-Gln-Glu
(Disulfide bonds between Cys17-Cys28 and Cys23-Cys33)
(M.W. 4581.3) C191H316N64O57S5
Antimicrobial Peptide
A. Krause, et al., Protein Sci., 12, 143 (2003). (Original & S-S Bond).

Order Hotline 1-800-777-4779 502-266-8787 69

 PRODUCT CODE QTY PRICE
BIOLOGICALLY ACTIVE PEPTIDES

LEAP-2 (Human) PLP-4405-s 0.1 mg 260

Liver-Expressed Antimicrobial Peptide 2 (Human) -20 °C vial
Prepro-LEAP-2 (Human, 38-77)
Met-Thr-Pro-Phe-Trp-Arg-Gly-Val-Ser-Leu-Arg-Pro-Ile-Gly-Ala-Ser-Cys-Arg-Asp-Asp-
Ser-Glu-Cys-Ile-Thr-Arg-Leu-Cys-Arg-Lys-Arg-Arg-Cys-Ser-Leu-Ser-Val-Ala-Gln-Glu
(Disulfide bonds between Cys17-Cys28 and Cys23-Cys33)
(M.W. 4581.3) C191H316N64O57S5
Antimicrobial Peptide
A. Krause, et al., Protein Sci., 12, 143 (2003). (Original & S-S Bond).

Hepcidin-20 (Human) PLP-3777-PI 1 mg 600

(Trifluoroacetate Form) -20 °C 5 mg 2400
H-Ile-Cys-Ile-Phe-Cys-Cys-Gly-Cys-Cys-His-Arg-Ser-Lys-Cys-Gly-Met-Cys-Cys-Lys-Thr-OH
(Disulfide bonds between C7-C23, C10-C13, C11-C19, and C14-C22
(M.W. 2191.77) C85H135N27O23S9

Hepcidin-22 (Human) PLP-3776-PI 1 mg 600

(Trifluoroacetate Form) -20 °C 5 mg 2400
H-Phe-Pro-Ile-Cys-Ile-Phe-Cys-Cys-Gly-Cys-Cys-His-Arg-Ser-Lys-Cys-Gly-Met-Cys-Cys-Lys-Thr-OH
(Disulfide bonds between C7-C23, C10-C13, C11-C19, and C14-C22
(M.W. 2436.06) C99H151N29O25S9

Hepcidin-24 (Human) PLP-3779-PI 1 mg 600

Des-Asp Hepcidin-24 -20 °C 5 mg 2400
(Trifluoroacetate Form)
H-Thr-His-Phe-Pro-Ile-Cys-Ile-Phe-Cys-Cys-Gly-Cys-Cys-
His-Arg-Ser-Lys-Cys-Gly-Met-Cys-Cys-Lys-Thr-OH
PEPTIDES INTERNATIONAL

(Disulfide bonds between Cys6- Cys22, Cys9-Cys12, Cys10- Cys18, and Cys13-Cys21
(M.W. 2674.31) C109H165N33O28S9
An internal standard for hepcidin assays
D.W. Swinkels, et al., PLoS ONE, 3: e2706 (2008).

Lys [(AEEA)2-5-FITC]-Hepcidin (Human)

18 PLP-3793-PI 0.5 mg 585
H-Asp-Thr-His-Phe-Pro-Ile-Cys-Ile-Phe-Cys-Cys-Gly-Cys- -20 °C 1 mg 910
Cys-His-Arg-Ser-Lys(AEEA-AEEA-5-FITC)-Cys-Gly-Met-Cys-
Cys-Lys-Thr-OH
(Disulfide bonds between Cys7-Cys23, Cys10-Cys13, Cys11-Cys19, and Cys14-Cys22)
(M.W. 3469.11) C146H203N37O42S10
FITC-Labeled Hepcidin

Histatin
Histatin 5 (Human) PHS-4270-s 0.1 mg 170
Asp-Ser-His-Ala-Lys-Arg-His-His-Gly-Tyr-Lys-Arg-Lys- -20 °C vial
Phe-His-Glu-Lys-His-His-Ser-His-Arg-Gly-Tyr
(M.W. 3036.3) C133H195N51O33 [104339-66-4]
Parotid Histidine-rich Protein / Salivary Antimicrobial Peptide
F.G. Oppenheim, T. Xu, F.M. McMillian, S.M. Levitz, R.D. Diamond, G.D. Of fner,
and R.F. Troxier, J. Biol. Chem., 263, 7472 (1988). (Original)
P.A. Raj, M. Edgerton, and M.J. Levine, J. Biol. Chem., 265, 3898 (1990). (Pharmacol.)
Y. Murakami, T. Takeshita, S. Shizukuishi, A. Tsunemitsu, and S. Aimoto, Arch. Oral Biol., 35, 775 (1990). (Pharmacol.)
M. Nishikata, et al., Biochem. Biophys. Res. Commun., 174, 625 (1991). (Pharmacol.)

70 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT CODE QTY PRICE

BIOLOGICALLY ACTIVE PEPTIDES

Humanin
I. Nishimoto, M. Matsuoka, and T. Niikura, Trends Mol. Med., 10, 102 (2004). (Review)
T. Arakawa, Y. Kita, and T. Niikura, Curr. Med. Chem., 15, 2086 (2008). (Review)

Humanin PHN-4384-v 0.5 mg 305

(Trifluoroacetate Form) -20 °C vial
Met-Ala-Pro-Arg-Gly-Phe-Ser-Cys-Leu-Leu-Leu-Leu-Thr-Ser-Glu-Ile-Asp-Leu-Pro-Val-Lys-Arg-Arg-Ala
(M.W. 2687.2) C119H204N34O32S2 [330936-69-1]
Endogenous Rescue Factor Abolishing Neuronal Cell Death
Purity Information: Qz See page xiv

[Gly14]-Humanin PHN-4385-v 0.5 mg 130

(Trifluoroacetate Form) -20 °C vial
Met-Ala-Pro-Arg-Gly-Phe-Ser-Cys-Leu-Leu-Leu-Leu-Thr-Gly-
Glu-Ile-Asp-Leu-Pro-Val-Lys-Arg-Arg-Ala
(M.W. 2657.2) C118H202N34O31S2 [330936-70-4]
Potent Rescue Factor Abolishing Neuronal Cell Death
Purity Information: Qz See page xiv
Y. Hashimoto, et al., Proc. Natl. Acad. Sci. USA, 98, 6336 (2001). (Original)
Y. Hashimoto, et al., Biochem. and Biophys. Res. Comm., 283, 460 (2001). (Pharmacol.)
T. Mamiya and M. Ukai, Br. J. Pharmacol., 134, 1597 (2001). (Pharmacol.)
S. Kariya, et al., Neurochemistry, 13, 903 (2002). (Pharmacol.)
S.S. Jung and W.E. Van Nostrand, J. Neurochem., 84, 266 (2003). (Pharmacol.)

Insulin
E. Dorzbach (ed.), Insulin I, Handbook of Experimental Pharmacology, Vol. 32 (1),
Springer-Verlag, Berlin, 1971. (Review)

PEPTIDES INTERNATIONAL
A. Hasselblatt and F.V. Bruchhausen (eds.), Insulin II, Handbook of Experimental Pharmacology,
Vol. 32 (2), Springer-Verlag, Berlin, 1975. (Review)

4-[D10]Leu-Insulin (Human) See Code PLP-3404-s on page 221.

Insulin (Human) PlN-4088-s 0.1 mg 155

Enzymatically Derived from Porcine Insulin -20 °C vial
A-chain:
Gly-Ile-Val-Glu-Gln-Cys-Cys-Thr-Ser-Ile-Cys-Ser-Leu-Tyr-Gln-Leu-Glu-Asn-Tyr-Cys-Asn
B-chain:
Phe-Val-Asn-Gln-His-Leu-Cys-Gly-Ser-His-Leu-Val-Glu-Ala-Leu-Tyr-Leu-Val-
Cys-Gly-Glu-Arg-Gly-Phe-Phe-Tyr-Thr-Pro-Lys-Thr
(Disulfide bonds between CysA6-CysA11,CysA7-CysB7, and CysA20-CysB19)
(M.W. 5807.6) C257H383N65O77S6 [11061-68-0]

Insulin (Human) PlN-4088-v 0.5 mg 525

Enzymatically Derived from Porcine Insulin -20 °C vial
Purity Information: QE See page xiv
K. Morihara, T. Oka, and H. Tsuzuki, Nature, 280, 412 (1979). (Semi-Synthesis)
K. Morihara, et al., Biochem. Biophys. Res. Commun., 92, 396 (1980). (Semi-Synthesis)

Joining Peptides
Joining Peptide (Rat) PJP-4288-v 0.5 mg 240
Ala-Glu-Glu-Glu-Thr-Ala-Gly-Gly-Asp-Gly-Arg- -20 °C vial
Pro-Glu-Pro-Ser-Pro-Arg-Glu-NH2
(M.W. 1882.9) C75H119N25O32
Pivotal Neuropeptide in Cardiovascular Regulation
T. Hamakubo, et al., Am. J. Physiol., 265, R1184 (1993). (Original)
M. Yoshida, T. Hamakubo, and T. Inagami, Am. J. Physiol., 266, R802 (1994). (Pharmacol.)

Order Hotline 1-800-777-4779 502-266-8787 71

 PRODUCT CODE QTY PRICE
BIOLOGICALLY ACTIVE PEPTIDES

Kallidin See Code PBK-4008 Lysyl-Bradykinin on page 30.

Kisspeptins/Metasins
Metastasis suppressor gene KiSS-1 encodes a peptide with multiple biological
functions such as inhibition of cancer metastasis, vasoconstriction, reproduction, and
so on. In human and rat, the encoded mature peptide is composed of 54 and 52 amino
acid residues, respectively, which is named metastin or kisspeptin.1,2,3 Kisspeptin-10
(Human) / Metastin (Human, 45-54) is an active segment of the human peptide from
the C-terminal portion and is already available from our catalog (PMT-4389-v). Very
recently, in collaboration with Dr. Tsukamura and her colleagues in Nagoya University,
Ihe Peptide Institute has successfully clarified that the corresponding rat 10-residue
peptide, Kisspeptin-10 (Rat) / Metastin (Rat, 43-52), exerts the luteinizing hormone
(LH) releasing activity in male rats4). Actually, intracerebroventricular or intravenously
administration at a dose of 1 nmol/kg or 10 nmol/kg stimulates LH release and
significantly increases plasma LH level in male rats. Now the precise experiment
using Kisspeptin-10 (Rat) / Metastin (Rat, 43-52) is possible in rat studies.
T. Ohtaki, et al., Nature, 411, 613 (2001). (Metastin)
M. Kotani, et al., J. Biol. Chem., 276, 34631 (2001). (Kisspeptin)
Y. Terao, et al., Biochim. Biophys. Acta, 1678, 102 (2004). (Original; Rat Metastin)
V. Pheng, et al., J. Reprod. Dev., 55, 378 (2009). (Pharmacol.)
M.L. Gottsch, et al., Peptides, 30, 4 (2009). (Review)

Kisspeptin-10 (Human) / Metastin (Human, PMT-4389-v 0.5 mg 90

45-54) -20 °C vial
Former Name Metastin (Human, 45-54)
PEPTIDES INTERNATIONAL

Kp-10 (Human) / KiSS-1 Gene Product (Human, 112-121 Amide)

Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Phe-NH2
(M.W. 1302.4) C63H83N17O14 [374675-21-5]
Ligand for hOT7T175 / GPR54
T. Ohtaki, et al., Nature, 411, 613 (2001). (Original; Metastin)
A.I. Muir, et al., J. Biol. Chem., 276, 28969 (2001). (Original; Kisspeptin)
M. Kotani, et al., J. Biol. Chem., 276, 34631 (2001). (Original; Kisspeptin)
A. Hori, et al., Biochem. Biophys. Res. Commun., 286, 958 (2001). (Pharmacol.)
M. Kinoshita, et al., Endocrinology, 146, 4431 (2005). (Pharmacol.)
S. Ramaswamy, et al. Endocrinology, 148, 3364 (2007). (Pharmacol.)
S.B. Seminara and U.B. Kaiser, Endocrinology, 146, 1686 (2005). (Minireview)
K.I. Maeda, et al., Rev. Endocrinol. Metab. Disord., 8, 21 (2007). (Review)
• This compound is distributed through Peptide Institute, Inc. under the license of Takeda Pharmaceutical Company
Limited.

Kisspeptin-54 (Human) / Metastin (Human, PMT-4446-v 0.5 mg 295

1-54) -20 °C vial
[Kp-54 (Human) / KiSS-1 Gene Product (Human, 68-121 Amide)]
Gly-Thr-Ser-Leu-Ser-Pro-Pro-Pro-Glu-Ser-Ser-Gly-Ser-Arg-Gln-Gln-Pro-Gly-Leu-Ser-Ala-Pro-His-Ser-Arg-
Gln-Ile-Pro-Ala-Pro-Gln-Gly-Ala-Val-Leu-Val-Gln-Arg-Glu-Lys-Asp-Leu-Pro-Asn-Tyr-Asn-Trp-Asn-Ser-Phe-
Gly-Leu-Arg-Phe-NH2
(M.W. 5857.4) C258H401N79O78
Stimulator of Hypothalamic-Pituitary Gonadal Axis

72 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT CODE QTY PRICE
Kisspeptin-52 (Human) / Metastin (Human, PMT-4447-s 0.1 mg 375

BIOLOGICALLY ACTIVE PEPTIDES

1-52) -20 °C vial
Kp-52 (Rat) / KiSS-1 Gene Product (Rat, 68-119 Amide)
Thr-Ser-Pro-Cys-Pro-Pro-Val-Glu-Asn-Pro-Thr-Gly-His-Gln-Arg-Pro-Pro-Cys-
Ala-Thr-Arg-Ser-Arg-Leu-Ile-Pro-Ala-Pro-Arg-Gly-Ser-Val-Leu-Val-Gln-Arg-
Glu-Lys-Asp-Met-Ser-Ala-Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Tyr-NH2
(Disulfide bond between Cys4-Cys18)
(M.W. 5836.6) C254H398N80O73S3
Stimulator of Hypothalamic-Pituitary Gonadal Axis
Y. Terao, S. Kumano, Y. Takatsu, M. Hattori, A. Nishimura, T. Ohtaki, and Y. Shintani,
Biochim. Biophys. Acta.,1678,102 (2004). (Original; Rat Metastin)

Kisspeptin-10 (Rat) / Metastin (Rat, 43-52) PKS-4453-v 0.5 mg 85

Kp-10 (Rat) / KiSS-1 Gene Product (Rat, 110-119 Amide) -20 °C vial
Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Tyr-NH2
(M.W. 1318.4) C63H83N17O15
Ligand for hOT7T175 / GPR54

Laminin
Laminin Pentapeptide YIGSR-NH2 PLP-4194-v 0.5 mg 35
Tyr-lle-Gly-Ser-Arg-NH2 -20 °C vial
(M.W. 593.68) C26H43N9O7 [110590-65-3]

Laminin Pentapeptide YIGSR-NH2 (Bulk) PLP-4194 25 mg 275

Tyr-lle-Gly-Ser-Arg-NH2 • 2AcOH • 2H2O -20 °C 100 mg 770
(M.W. 593.68 • 120.10 • 36.03) C26H43N9O7 •

PEPTIDES INTERNATIONAL
2CH3COOH • 2H2O
Y. Iwamoto, F.A. Robey, J. Graf, M. Sasaki, H.K. Kleinman, Y. Yamada,
and G.R. Martin, Science, 238, 1132 (1987). (Original)

Leu-Pro-Leu-Arg-Phe-NH2 • 2AcOH • 2H2O* PBC-4144 25 mg 305

(M.W. 643.82 • 120.11 • 36.03) C32H53N9O5 • 2CH3COOH • -20 °C 100 mg 830
2H2O
Chicken Brain Peptide
G.J. Dockray, J.R. Reeve Jr., J. Shively, R.J. Gayton, and C.S. Barnard, Nature, 305, 328 (1983). (Original)

Linaclotide
Linaclotide LIN-3796-PI 1 mg 625
NEW!
Linzess or Constella -20 °C 5 mg 2500
(Trifluoroacetate Form)
H-Cys-Cys-Glu-Tyr-Cys-Cys-Asn-Pro-Ala-Cys-Thr-Gly-Cys-Tyr-OH;
(Disulfide bonds between Cys1-Cys6, Cys2-Cys10, Cys5-Cys13)
(M.W. 1526.76) C59H79N15O21S6 [851199-59-2]
Peptide Agonist of Gaunylate Cyclase 2c
Note: Bolar Exemption applies. This is a FDA-regulated product. It is the responsibility of the customer
to ensure that he/she is complying with Federal rules. PI cannot be liable for infringement of rights made
by the user.
W.D. Chey, et al., Am. J. Gastroenterol., 107, 1702 (2012).
S. Rao, et al., Am. J. Gastroenterol., 107, 1714 ((2012).
J.M. Johnston, et al., The Amer. J. of Gastroent., 104, 125 (2009).
A.J. Lembo, et al., N. Eng. J. Med., 365, 527 (2011).
G.F. Longstreth, et al., Gastroenterology, 130, 1480 (2006).

Order Hotline 1-800-777-4779 502-266-8787 73

 PRODUCT CODE QTY PRICE
BIOLOGICALLY ACTIVE PEPTIDES

Liraglutide PGL-3781-PI 1 mg 225

NEW!
(Lys(γ-Glu-palmitoyl)26,Arg34)-GLP-1 (7-37) -20 °C 5 mg 900
H-His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-
Gly-Gln-Ala-Ala-Lys(γ-Glu-palmitoyl)-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-Gly-OH
(M.W. 3751.29) C17H265N43O51
Glucagon-Like-Peptide-1 (GLP-1) Receptor Agonist
J.J.Neumiller, J. Am. Pharm. Assoc., 49, S16 (2009)
M.C.Rossi and A.Nicolucci, Acta Biomed., 80, 93 (2009)
C.F.Deacon, Vasc. Health Risk Manag., 5, 199 (2009)

Liraglutide is a long-acting analog of GLP-1 that has been developed for type-2
diabetes. Palmitoylation of a side chain elongated Lys residue facilitates bind to
albumin. Circulating plasma albumin serves as a central slow-release reservoir for the
noncovalently-bound Liraglutide which improves its half-life by reducing degradation
by DPP IV and neutral endopeptidase (NEP). This GLP-1 agonist acts in a glucose-
dependent manner and has been shown in studies to decrease appetite and maintain
body weight. It may play an important role in the treatment of type 2 diabetes.
Please note: This product is offered and sold solely for uses reasonably related to the development and submission of information
under a Federal law which regulates the manufacture, use or sale of drugs (the “ Bolar Exemption”). Peptides International cannot
be made liable for any infringement of intellectual property rights. It is the sole and only responsibility of the purchaser or user of
this product to comply with the relevant national rules and regulations.

Liver-Cell Growth Factor

* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

Liver-Cell Growth Factor (Bulk) PLC-4022 25 mg 90

PEPTIDES INTERNATIONAL

Gly-His-Lys • AcOH • H2O -20 °C 100 mg 190

(M.W. 340.38 • 60.05 • 18.02) C14H24N6O4 • CH3COOH • H2O
[72957-37-0]
L. Pickart, L. Thayer, and M.M. Thaler, Biochem. Biophys. Res. Commun., 54, 562 (1973). (Original)

Lixisenatide
Lixisenatide LIX-3799-PI 1 mg 450
NEW!
H-His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys- -20 °C 5 mg 1800
Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-
Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Ser-Lys-Lys-Lys-Lys-Lys-Lys-NH2
H-HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPSKKKKKK-NH2
(M.W. 4858.49) C215H347N61O65S [827033-10-3]
GLP-1 receptor agonist
M. Christensen, et al., IDrugs, 12, 503 (2009).
Please note: This product is offered and sold solely for uses reasonably related to the development and submission of information
under a Federal law which regulates the manufacture, use or sale of drugs (the “ Bolar Exemption”). Peptides International cannot
be made liable for any infringement of intellectual property rights. It is the sole and only responsibility of the purchaser or user of
this product to comply with the relevant national rules and regulations.

LL-37 Cathelicidin Antimicrobial Peptide

LL-37 (Human) PLL-4445-s 0.1 mg 140
Leu-Leu-Gly-Asp-Phe-Phe-Arg-Lys-Ser-Lys-Glu-Lys-Ile- -20 °C vial
Gly-Lys-Glu-Phe-Lys-Arg-Ile-Val-Gln-Arg-Ile-Lys-Asp-
Phe-Leu-Arg-Asn-Leu-Val-Pro-Arg-Thr-Glu-Ser
(M.W. 4493.30) C205H340N60O53
Cathelicidin Antimicrobial Peptide
See next page for article

74 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT CODE QTY PRICE
Antimicrobial peptides (often abbreviated as AMPs) play essential roles in self-defense

BIOLOGICALLY ACTIVE PEPTIDES

systems. Defensins are potential protecting factors against microbial infection and
members of AMPs in human: we have been offering α-defensin-1 (PDF-4271), -2
(PDF-4428), -3 (PDF-4416), -4 (PDF-4431), -5 (PDF-4415), and -6 (PDF-4458), as well
as β-defensin-1 (PDF-4337), -2 (PDF-4338), -3 (PDF-4382), and -4 (PDF-4406) as our
catalog items. Another member of AMP in human is LL-37, the so-called cathelicidin
AMP.1,2 Cathelicidins are one family of multifunctional AMPs, characterized by con-
served pro-peptide sequences that have been identified in several mammalian spe-
cies. On the contrary to disulfide cross-linked defensins, LL-37 is a linear, amphipathic
peptide with α-helical structure. LL-37 is reported to exert not only antimicrobial activ-
ity but also immunomodulatory activity.2,3 Recent papers describe the involvement of
LL-37 in toll-like receptor (TLR) activation: i) vitamin D receptor-mediated induction of
LL-37 through TLR2/1L activation was observed in human monocyte4 and ii) LL-37
interacts to self-DNA in psoriasis, after which the complex formed triggers TLR9,
resulting in the induction of interferon-α production.5 In the latter special case, LL-37
might be the pathogenic factor of psoriasis, one of the autoimmune diseases, although
LL-37, together with β-defensin-2, is reported to be highly expressed in psoriasis to
protect the infection with Staphylococcus aureus.6 Thus, LL-37 should be valuable in
the research of human defense systems, especially to clarify the mechanism of innate
immunity and LL-37’s role in autoimmunity and cancer.7
1. G.H. Gudmundsson, B. Agerberth, J. Odeberg, T. Bergman, B. Olsson, and R. Salcedo,
Eur. J. Biochem., 238, 325 (1996). (Original)
2. R. Bals and J.M. Wilson, Cell. Mol. Life Sci., 60, 711 (2003). (Review)
3. M. Zanetti, J. Leukoc. Biol., 75, 39 (2004). (Review)
4. P.T. Liu, S. Stenger, H. Li, L.Wenzel, B.H. Tan, S.R. Krutzik, M.T. Ochoa, J. Schauber, K. Wu, C. Meinken,

PEPTIDES INTERNATIONAL
D.L. Kamen, M. Wagner, R. Bals, A. Steinmeyer, U. Zügel, R.L. Gallo, D. Eisenberg, M. Hewison, B.W. Hollis,
J.S. Adams, B.R. Bloom, and R.L. Modlin, Science, 311, 770 (2006). (Pharmacol.)
5. R. Lande, J. Gregorio, V. Facchinetti, B. Chatterjee, Y.-H.Wang, B. Homey, W. Cao, Y.-H.Wang, B. Su, F.O.Nestle,
T. Zal, I. Mellman, J.-M. Schröder, Y.-J. Liu, and M. Gilliet, Nature, 449, 564 (2007). (Pharmacol.)
6. P.Y. Ong, T. Ohtake, C. Brandt, I. Strickland, M. Boguniewicz, T. Ganz, R.L. Gallo, and, D.Y.M. Leung,
New Engl. J. Med., 347, 1151 (2002). (Pharmacol.)
7. D.W. Hoskin and A. Ramamoorthy, Biochim. Biophys. Acta, 1778, 357 (2008). (Review)
8. Y.P. Lai and R.L. Gallo, Trends Immunol., 30, 131 (2009). (Review)
9. M.F. Burton and P.G. Steel, Nat. Prod. Rep., 26, 1572 (2009). (Review)

Luteinizing Hormone-Releasing Hormone (LH-RH)

LH-RH (Human) PLR-4013-v 0.5 mg 32
Luteinizing Hormone Releasing Hormone (Human) -20 °C vial
(GnRH (Gonadotropin-Releasing Hormone) (Human)
(Porcine, Rat)
Pyr-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2
(M.W. 1182.3) C55H75N17O13 [33515-09-2]

LH-RH (Human) (Bulk) PLR-4013 25 mg 435

Luteinizing Hormone Releasing Hormone (Human) -20 °C 100 mg 1150
(GnRH (Gonadotropin-Releasing Hormone) (Human)
(Porcine, Rat)
Pyr-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2 • 2AcOH • 4H2O
(M.W. 1182.3 • 120.10 • 72.06) C55H75N17O13 • 2CH3COOH • 4H2O [71447-49-9]
H. Matsuo, Y. Baba, R.M.G. Nair, A. Arimura, and A.V. Schally, Biochem. Biophys. Res. Commun,
43, 1334 (1971). (Original)

Order Hotline 1-800-777-4779 502-266-8787 75

 PRODUCT CODE QTY PRICE
BIOLOGICALLY ACTIVE PEPTIDES

b-Lipotropin (61-76) See Code PEN-4055-v a-Endorphin.

b-Lipotropin (61-77) See Code PEN-4089-v g-Endorphin.
b-Lipotropin (Human, 61-91) See Code PEN-4060-v b-Endorphin (Human).

Magainin
Magainin 1 PMG-4196-v 0.5 mg 310
(Frog, Xenopus laevis) -20 °C vial
Gly-Ile-Gly-Lys-Phe-Leu-His-Ser-Ala-Gly-Lys-Phe-
Gly-Lys-Ala-Phe-Val-Gly-Glu-Ile-Met-Lys-Ser
(M.W. 2409.8) C112H177N29O28S [108433-99-4]
Antimicrobial Peptide
M. Zasloff, Proc. Natl. Acad. Sci. USA, 84, 5449 (1987). (Original)
Mambalgin-1 See Code MAM-3778-PI.

Mastoparan
Mastoparan PMS-4107-v 0.5 mg 75
(Wasp, Vespula lewisii) -20 °C vial
Ile-Asn-Leu-Lys-Ala-Leu-Ala-Ala-Leu-Ala-Lys-Lys-Ile-Leu-NH2
(M.W. 1478.9) C70H131N19O15 [72093-21-1]

Mastoparan (Bulk) PMS-4107 25 mg 1325

(Wasp, Vespula lewisii) -20 °C
Ile-Asn-Leu-Lys-Ala-Leu-Ala-Ala-Leu-Ala-Lys-Lys-Ile-Leu-NH2 • 4AcOH • 6H2O
(M.W. 1478.9 • 240.21 • 108.09) C70H131N19O15 • 4CH3COOH • 6H2O
Y. Hirai, et al., Chem. Pharm. Bull., 27, 1942 (1979). (Original; Chem. Synthesis)
PEPTIDES INTERNATIONAL

a-Mating Factor
a-Mating Factor PMF-4076-v 0.5 mg 95
(Yeast, Saccharomyces cerevisiae) -20 °C vial
Trp-His-Trp-Leu-Gln-Leu-Lys-Pro-Gly-Gln-Pro-Met-Tyr
(M.W. 1684.0) C82H114N20O17S [59401-28-4]
D. Stöetzler, H.-H. Kilts, and W. Duntze, Eur. J. Biochem., 69, 397 (1976). (Original)
T. Tanaka, H. Kita, T. Murakami, and K. Narita, J. Biochem., 82, 1681 (1977). (Original)
Y. Masui, N. Chino, S. Sakakibara, T. Tanaka, T. Murakami, and H. Kita, Biochem. Biophys. Res. Commun., 78, 534
(1977). (Chem. Synthesis)
• This compound is distributed through Peptide Institute Inc., under the license of Suntory Limited.

Mast Cell Degranulating Peptide (MCD)

MCD-Peptide* PMC-4258-v 0.5 mg 320
Mast Cell Degranulating Peptide -20 °C vial
(Honeybee, Apis mellifera)
Ile-Lys-Cys-Asn-Cys-Lys-Arg-His-Val-Ile-Lys-Pro-His-Ile-Cys-Arg-Lys-Ile-Cys-Gly-Lys-Asn-NH2
(Disulfide bonds between Cys3-Cys15 and Cys5-Cys19)
(M.W. 2587.2) C110H192N40O24S4 [32908-73-9]
Voltage-Dependent K+ Channel Blocker
E. Haberman, Science, 177, 314 (1972). (Review)
M.R. Ziai, S. Russek, H.-C. Wang, B. Beer, and A.J. Blume, J. Pharm. Pharmacol., 42, 457 (1990). (Review)
• This compound is distributed through Peptide Institute, Inc. under the license of The Salk Institute.
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

76 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT CODE QTY PRICE
Melanin-Concentrating Hormone and Related Peptides

BIOLOGICALLY ACTIVE PEPTIDES

Melanin-Concentrating Hormone (Human) PMC-4369-v 0.5 mg 180
MCH (Human) -20 °C vial
(Rat, Mouse)
Asp-Phe-Asp-Met-Leu-Arg-Cys-Met-Leu-Gly-Arg-Val-Tyr-Arg-Pro-Cys-Trp-Gln-Val
(Disulfide bond between Cys7-Cys16)
(M.W. 2386.8) C105H160N30O26S4 [128315-56-0]
Appetite Boosting Peptide
• This compound is distributed through Peptide Institute, Inc. under the license of The Salk Institute.

Melanin-Concentrating Hormone (MCH) was isolated from salmon pituitary and was
found to induce aggregation of melanin granules in melanophores. Later,a mammalian
homolog was identified in rat hypothalamus as a 19 amino acid peptide with a single
disulfide bond [Endocrinology, 125, 1660 (1989)]. Subsequently, the human MCH
sequence was found to be the same as that of the rat peptide.1 Interestingly, the MCH
of hypothalamus was reported in 1996 to be involved in the regulation of body weight.2
Actually, the injection of MCH into the lateral ventricles increased food consumption in
rats. Further evidence in the literature indicates that MCH-deficient mice are lean due
to hypophagia.3
1 K.M. Knigge, D. Baxter-Grillo, J. Speciale, and J. Wagner, Peptides, 17, 1063 (1996). (Review)
2. D. Qu, et al., Nature, 380, 243 (1996). (Pharmacol.)
3. M. Shimada, N.A. Tritos, B.B. Lowell, J.S. Flier, and E. Maratos-Flier, Nature, 396, 670 (1998). (Pharmacol.)
4. J. Chambers, et al., Nature, 400, 261 (1999). (Pharmacol.; Ligand for Orphan SLC-1 Receptor)
5. Y, Saito, et al., Nature, 400, 265 (1999). (Pharmacol.; Ligand for Orphan SLC-1 Receptor)
• This compound is distributed through Peptide Institute, Inc. under the license of The Salk Institute.

PEPTIDES INTERNATIONAL
Ac-Arg-[Cys-Met-Ava-Arg-Val-Tyr-Ava-Cys]- PMC-3881-PI 1 mg 79
NH2 -20 °C 5 mg 299
Disulfide bond between Cys2 and Cys9
(M.W. 1167.49) C49H82N16O11S3
Ava = Aminovaleric acid
Melanin Concentrating Hormone Receptor 1 Antagonist.
M.A. Bednarek, et al., Biochemistry, 41, 6383 (2002)

Ac-d-Arg-[Cys-Met-Leu-Asn-Arg-Val-Tyr-Arg- PMC-3886-PI 1 mg 79
Pro-Cys]-NH2 -20 °C 5 mg 299
Disulfide bond between Cys2 and Cys11
(M.W. 1449.80) C60H100N22O14S3
Melanin Concentrating Hormone Receptor 1 Agonist
M.A. Bednarek, et al., J. Biol. Chem., 277, 13821 (2002).

Melanocyte Stimulating Hormone (MSH) and Related Peptides

a-MSH PMR-4057-v 0.5 mg 70
a-Melanocyte Stimulating Hormone -20 °C vial
(Human, Porcine, Bovine, Rat, Mouse)
Ac-Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-
Trp-Gly-Lys-Pro-Val-NH2
(M.W. 1664.9) C77H109N21O19S [581-05-5]
T.H. Lee and A.B. Lerner, J. Biol. Chem., 221, 943 (1956). (Original; Porcine)
R.A. Boissonnas, et al., Helv. Chim. Acta, 41, 1867 (1958). (Chem. Synthesis)
R. Schwyzer, A. Costpanagiotis, and P. Sieber, Helv. Chim. Acta, 46, 870 (1963). (Chem. Synthesis)
A.C.Y. Chang, M. Cochet, S.N. Cohen, Proc. Natl. Acad. Sci. U.S.A., 77, 4890 (1980). (Nucleotide Seq.; Human)

Order Hotline 1-800-777-4779 502-266-8787 77

 PRODUCT CODE QTY PRICE
BIOLOGICALLY ACTIVE PEPTIDES

MSH-Release Inhibiting Factor (Bulk) PMI-4024 25 mg 30

(MIF) -20 °C 100 mg 60
Pro-Leu-Gly-NH2 • ½H2O
(M.W. 284.35 • 9.01) C13H24N4O3 • ½ H2O [2002-44-0]
A. Vivas and M.E. Celis, J. Endocrinol., 78, 1 (1978). (Pharmacol.)
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

[Nle4, d-Phe7]-b-MSH-Amide PMC-3669-PI 1 mg 25

Ac-Ser-Tyr-Ser-Nle-Glu-His-d-Phe-Arg-Trp-Gly-Lys-Pro-Val- -20 °C 5 mg 95
NH2
(M.W. 1646.88) C78H111N21O19
Melanocyte Stimulating Hormone Agonist / Melanocortin 1, 3, 4, and 5 Receptor Agonist
T.K. Sawyer, et al., Proc. Natl. Acad. Sci., 77, 5754 (1980).

Ac-His-d-Phe(p-Iodo)-Arg-Trp-NH2 PMC-3684-PI 1 mg 68
(M.W. 811.69) C34H42N11O5I -20 °C 5 mg 195
Melanocortin Receptor 1/4/5 Agonist / Receptor 3 Antagonist
J.R. Holder, R.M. Bauzo, Z. Xiang, and C. Haskell-Luevano, J. Med. Chem., 45, 3073-3081 (2002).

Ac-Nle-cyclo [Asp-His-d-Phe-Arg-Trp-Lys]- PMC-3683-PI 1 mg 49

NH2 -20 °C 5 mg 195
Melanotan II, MT-II
(M.W. 1024.2) C50H69N15O9
Potent Melanocortin 1, 3, 4 and 5 Receptor Agonist
F. Al-Obeidi,V.J. Hruby, A.M. Castrucci, and M.E. Hadley, J. Med. Chem., 32, 174 (1989).

Ac-Tyr-Val-Nle-Gly-His-d-Phe-Arg-Trp-Asp- PMC-3685-PI 1 mg 49
PEPTIDES INTERNATIONAL

Arg-Phe-Gly-NH2 -20 °C 5 mg 195

(M.W. 1593.83) C77H104N22O16
Melanocortin 1, 3, 4 and 5 Receptor Agonist
M. Cai, A.V. Mayorov, C. Cabello, KM. Stankova, D. Trivedi, and V.J. Hruby, J. Med. Chem., 48, 1839 (2005).

cyclo [CO-(CH2)2-CO-d-Nal(2’)-Arg-Trp-Lys]- PMC-3887-PI 1 mg 49

NH2 -20 °C 5 mg 195
(M.W. 766.88) C40H48N9O7
Melanocortin 4 Receptor Antagonist
M.A. Bednarek, et al., J. Med. Chem., 44, 3665 (2001).

78 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT CODE QTY PRICE
Metastin See Kisspeptin.

BIOLOGICALLY ACTIVE PEPTIDES

MHC-class I-restricted epitope in hgp100
Cytotoxic T cells or CD8+ T cells play an important role in the immune defense and
destruction of tumor and infected cells. They are capable of recognizing antigen (Ag)
associated with major histo compatibility complex (MHC) class I molecules on these
target cells. Following Ag stimulation, T cells are selected to undergo clonal selection
and proliferation in the thymus if they have low autoreactivity to self antigens, leading
to an appropriate immune response. Recognition of tumor antigens by T cells has
prompted interest and research in antigen-based cancer vaccines. Progress was
initially hampered by the lack of responsiveness to tumor antigens in clinical trials by
T cells, probably because these Ags are expressed on normal as well as tumor cells;
therefore the level of autoreactivity is too high to lead to clonal selection of specific T
cells.
One of these candidate Ags is gp100; an antigen expressed on normal melanocytes
as well as malignant melanomas. Later studies observed that xenogeneic immuniza-
tion of mice with human gp100 (hgp100) could activate gp100 specific T cells, while
mouse gp100 (mgp100) could not. 1 In addition, in vivo studies found that reactive
gp100 specific T cells followed by recombinant IL-2 treatment dramatically reduced
pulmonary metastases.1 Further investigation determined Db to be the MHC class
I molecule restricting gp100 recognition and its epitope to be hgp100 (25-33). 1 The
peptide epitope hgp100 (25-33) was observed to have stronger binding affinity to Db
than mgp100 (25-33) and could be used to activate T cells for adoptive therapy in the
syngeneic mouse melanoma model.1,2 The peptide epitope can be referred to as a

PEPTIDES INTERNATIONAL
heteroclitic epitope or an altered peptide that is more efficient at inducing T cell activa-
tion. Immunization of mice with a minigene encoding the heteroclitic epitope produced
specific T cells that protected mice challenged with B16 melanoma, just as effectively
as mice immunized with full length hgp100 DNA.
1. W.W. Overwijk, A. Tsung, K.R. Irvine, M.R. FParkhust, T.J. Goletz, K. Tsung, M.W. Carroll, C. Liu, B. Moss,
S.A. Rosenber, and N.P. Restifo, J. Exper. Med., 188, 277 (1998).
2. J.S. Gold, C.R. Ferrone, Jj.A. G.-Patino, W.G. Hawkins, R. Dyall, M.E. Engelhorn, J.D. Wolchok, J.J. Lewis,
and A.N. Houghton, J. Immunol., 170, 5188 (2003).

H-Lys-Val-Pro-Arg-Asn-Gln-Asp-Trp-Leu-OH PCP-3922-PI 1 mg 55
KVPRNQDWL -20 °C 5 mg 195
Human GP 100 (25–33)
(M.W. 1155.33) C52H82N16O14
MHC-class I-restricted epitope in hgp100
Heteroclitic MHC class I epitope in hgp100.
W.W. Overwijk, A. Tsung, K.R. Irvine, M.R. Parkhurst, T.J. Goletz, K. Tsung, M.W. Carroll,
C. Liu, B. Moss, S.A. Rosenberg, and N.P. Restifo, J. Exp. Med., 188, 277 (1998).
J.S. Gold, C.R. Ferrone, J.A.G.-Patino, W.G. Hawkins, R. Dyall, M.E. Engelhorn, J.D. Wolchok,
J.J. Lewis, and A.N. Houghton, J. Immunol., 170, 5188 (2003)

Order Hotline 1-800-777-4779 502-266-8787 79

 PRODUCT CODE QTY PRICE
BIOLOGICALLY ACTIVE PEPTIDES

Midkines
Midkine (Human) PMK-4298-v 50 µg 400
Lys-Lys-Lys-Asp-Lys-Val-Lys-Lys-Gly-Gly-Pro-Gly-Ser-Glu- -20 °C vial
Cys-Ala-Glu-Trp-Ala-Trp-Gly-Pro-Cys-Thr-Pro-Ser-Ser-Lys-
Asp-Cys-Gly-Val-Gly-Phe-Arg-Glu-Gly-Thr-Cys-Gly-Ala-Gln-
Thr-Gln-Arg-Ile-Arg-Cys-Arg-Val-Pro-Cys-Asn-Trp-Lys-Lys-
Glu-Phe-Gly-Ala-Asp-Cys-Lys-Lys-Phe-Glu-Asn-Trp-Gly-
Ala-Cys-Asp-Gly-Gly-Thr-Gly-Thr-Lys-Val-Arg-Gln-Gly-Tyr-
Thr-Leu-Lys-Lys-Ala-Arg-Tyr-Asn-Ala-Gln-Cys-Gln-Glu-Thr-
Ile-Arg-Val-Thr-Lys-Pro-Cys-Thr-Pro-Lys-Thr-Lys-Ala-Lys-
Ala-Lys-Ala-Lys-Lys-Gly-Lys-Gly-Lys-Asp
(Disulfide bonds between Cys15-Cys39,Cys23-Cys48, Cys30-Cys52,Cys62-Cys94, and Cys72-Cys104)
(M.W. 13240.1) C570H915N177O167S10 [170138-17-7]
Heparin-Binding Growth/Differentiation Factor
(Neurotrophic Factor, Neurite Outgrowth-Promoting Factor)
Plasminogen Activator Activity Enhancer
J.-I. Tsutsui, et al., Biochem. Biophys. Res. Commun., 176, 792 (1991).
H. Muramatsu, et al., Biochem. Biophys. Res. Commun., 203, 1131 (1994).
T. Inui, et al., J. Peptide Sci., 2, 28 (1996). (Chem. Synthesis)
G.S.P. Yu, J.Hu, and H. Nakagawa, Neurosci. Lett., 254, 128 (1998). (Pharmacol.; Inhibition of b-amyloid cytotoxicity)
• This product is distributed under the license of Prof. Takashi Muramatsu. Its use for any purpose other than research is
strictly prohibited.
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

Midkine (Human, 60-121) PMK-4299-s 0.1 mg 400

Ala-Asp-Cys-Lys-Tyr-Lys-Phe-Glu-Asn-Trp-Gly-Ala-Cys-Asp- -20 °C vial
Gly-Gly-Thr-Gly-Thr-Lys-Val-Arg-Gln-Gly-Thr-Leu-Lys-Lys-
PEPTIDES INTERNATIONAL

Ala-Arg-Tyr-Asn-Ala-Gln-Cys-Gln-Glu-Thr-Ile-Arg-Val-
Thr-Lys-Pro-Cys-Thr-Pro-Lys-Thr-Lys-Ala-Lys-Ala-
Lys-Ala-Lys-Lys-Gly-Lys-Gly-Lys-Asp
(Disulfide bonds between Cys62-Cys94 and Cys72-Cys104)
(M.W. 6788.8) C292H483N91O87S4
Heparin-Binding Growth/Differentiation Factor Active-Domain (Neurite Outgrowth-Promoting Factor)
Plasminogen Activator Activity Enhancer
J.-i. Tsutsui, et al., Biochem. Biophys. Res. Commun., 176, 792 (1991). (Original)
H. Muramatsu, et al., Biochem. Biophys. Res. Commun., 203, 1131 (1994).
T. Inui, et al., J. Peptide Sci., 2, 28 (1996). (Chem. Synthesis)
G.S.P. Yu, J. Hu, and H. Nakagawa, Neurosci. Lett., 254, 128 (1998). (Pharmacol.; Inhibition of β-amyloid cytotoxicity)
• This product is distributed under the license of Prof. Takashi Muramatsu. Its use for any purpose other than research
is strictly prohibited.

Molluscan Cardioexcitatory Neuropeptide

FMRF-Amide* PFM-4142-v 0.5 mg 30
Molluscan Cardioexcitatory Neuropeptide -20 °C vial
Phe-Met-Arg-Phe-NH2
(M.W. 598.76) C29H42N8O4S [64190-70-1]
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

FMRF-Amide* (Bulk) PFM-4142 25 mg 275

Molluscan Cardioexcitatory Neuropeptide -20 °C 100 mg 790
Phe-Met-Arg-Phe-NH2 • 1½ AcOH • 2H2O
(M.W. 598.76 • 90.08 • 36.03) C29H42N8O4S • 1 ⁄2CH3COOH • 2H2O
1

D.A. Price and M.J. Greenberg, Science, 197, 670 (1977). (Original)
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

80 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT CODE QTY PRICE
Morphine Tolerance Peptide

BIOLOGICALLY ACTIVE PEPTIDES

Morphine Tolerance Peptide (Bulk) PMT-4070 25 mg 50
cyclo (Leu-Gly) -20 °C 100 mg 130
(M.W. 170.21 ) C8H14N2O2 [5845-67-0]
R. Walter, R. Ritzmann, H.N. Bhargava, and L.B. Flexner, Proc. Natl. Acad. Sci. USA, 76, 518 (1979). (Original)

Motilin
Motilin (Human, Porcine) PML-4147-v 0.5 mg 350
Phe-Val-Pro-Ile-Phe-Thr-Tyr-Gly-Glu-Leu-Gln-Arg- -20 °C vial
Met-Gln-Glu-Lys-Glu-Arg-Asn-Lys-Gly-Gln
(M.W. 2699.0) C120H188N34O35S [52906-92-0]
J.C. Brown, M.A. Cook, and J.R. Dryburgh, Can. J. Biochem., 51, 533 (1973). (Original; Porcine)
H. Schubert and J.C. Brown, Can. J. Biochem., 52, 7 (1974). (Correction of Sequence; Gln14)
Y. Seino, K. Tanaka, H. Takahashi, T. Mitani, M. Kurono, T. Kayano, G. Koh, H. Fukumoto, H. Yano, J. Fujita,
N. Inagaki, Y. Yamada, and H. Imura, FEBS Lett., 223, 74 (1987). (Original; Human-cDNA)
C.H.S. McIntosh and J.C. Brown, Adv. Metab. Dis., 11, 439 (1988). (Review)

MSH See Code PMI-4024 MSH-Release Inhibiting Factor.

Muramyl Dipeptide See Code PAD-4031 Adjuvant Peptide.

PEPTIDES INTERNATIONAL

Order Hotline 1-800-777-4779 502-266-8787 81

 PRODUCT CODE QTY PRICE
BIOLOGICALLY ACTIVE PEPTIDES

Neuroendocrine Regulatory Peptides

“Peptidome”, one of the principle research fields in the post-genome era, is a power-
ful method to discover novel peptides. One such study has been reported recently
from the collaboration of several groups including National Cardiovascular Center
Research Institute and University of Miyazaki. The peptides disclosed are neuroendo-
crine regulatory peptide-1 and -2 (abbreviated as NERP-1 and NERP-2, respectively).
Both peptides were isolated either from medullary thyroid carcinoma TT cells or rat
brain applying modern techniques of peptide chemistry / biochemistry. Human and rat
NERP-1 are composed of 26 and 25 amino acid residues, respectively, and NERP-2
of both species are composed of 38 amino acid residues, all contain the carboxyl-
terminal amide functionality. Interestingly, these peptides were the segments of the
neurosecretory protein VGF, suggesting a unique processing signal for NERP-2.
NERP-1 (Human): RPESALLGGSEAGERLLQQGLAQVEA-NH2
NERP-1 (Rat): LEGSFLGGSEAGERLLQQGLAQVEA-NH2
NERP-2 (Human): <EAEATRQAAAQEERLADLASDLLLQYLLQGGARQRGLG-
NH2
NERP-2 (Rat): <EAEATRQAAAQEERLADLASDLLLQYLLQGGARQRDLG-NH2
Biological activity reported is: i) suppression of vasopressin release induced by
intracerebroventricular administration of angiotensin II in rat and ii) suppression of
basal and angiotensin II-induced vasopressin secretion from the paraventricular and
supraoptic nuclei of rat hypothalamus in vitro. Considering the fact that NERPs coexist
with vasopressin in the hypothalamus, these newly identified peptides may be “potent
PEPTIDES INTERNATIONAL

endogenous suppressor of vasopressin release”, thus implying an essential role in

body fluid homeostasis.
1. H. Yamaguchi, et al., J. Biol., Chem., 282, 26354 (2007). (Original)
2. E. Mishiro-Sato, et al., J. Neurochem., 114, 1097 (2010). (Processing & Histochem.)
• These compounds are distributed through Peptide Institute, Inc. under the license of Takeda Pharmaceutical Co. Ltd.

Neuroendocrine Regulatory Peptide-1 PNR-4441-s 0.1 mg 105

(Human) -20 °C vial
NERP-1 (Human)
RPESALLGGSEAGERLLQQGLAQVEA-NH2
H-Arg-Pro-Glu-Ser-Ala-Leu-Leu-Gly-Gly-Ser-Glu-Ala-Gly-
Glu-Arg-Leu-Leu-Gln-Gln-Gly-Leu-Ala-Gln-Val-Glu-Ala-NH2
(M.W. 2679.0) C113H192N36O39 [954420-50-9]
Endogenous Suppressor of Vasopressin Release
H. Yamaguchi, et al., J. Biol. Chem., 282, 26354 (2007). (Original)

Neuroendocrine Regulatory Peptide-1 (Rat) PNR-4442-s 0.1 mg 105

NERP-1 (Rat) -20 °C vial
LEGSFLGGSEAGERLLQQGLAQVEA-NH2
H-Leu-Glu-Gly-Ser-Phe-Leu-Gly-Gly-Ser-Glu-Ala-Gly-Glu-
Arg-Leu-Leu-Gln-Gln-Gly-Leu-Ala-Gln-Val-Glu-Ala-NH2
(M.W. 2558.8) C110H180N32O38
Endogenous Suppressor of Vasopressin Release
H. Yamaguchi, et al., J. Biol. Chem., 282, 26354 (2007). (Original)

82 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT CODE QTY PRICE
Neuroendocrine Regulatory Peptide-2 PNR-4443-s 0.1 mg 150

BIOLOGICALLY ACTIVE PEPTIDES

(Human) -20 °C vial
NERP-2 (Human)
EAEATRQAAAQEERLADLASDLLLQYLL
QGGARQRGLG-NH2
Pyr-Ala-Glu-Ala-Thr-Arg-Gln-Ala-Ala-Ala-Gln-Glu-Glu-Arg-
Leu-Ala-Asp-Leu-Ala-Ser-Asp-Leu-Leu-Leu-Gln-Tyr-Leu-
Leu-Gln-Gly-Gly-Ala-Arg-Gln-Arg-Gly-Leu-Gly-NH2
(M.W. 4064.5) C173H288N56O57
Endogenous Suppressor of Vasopressin Release
H. Yamaguchi, et al., J. Biol. Chem., 282, 26354 (2007). (Original)

Neuroendocrine Regulatory Peptide-2 (Rat) PNR-4444-s 0.1 mg 150

NERP-2 (Rat) -20 °C vial
EAEATRQAAAQEERLADLASDLLLQYLLQGGARQRDLG-NH2
Pyr-Ala-Glu-Ala-Thr-Arg-Gln-Ala-Ala-Ala-Gln-Glu-Glu-Arg-Leu-Ala-Asp-Leu-Ala-Ser-Asp-Leu-Leu-Leu-Gln-
Tyr-Leu-Leu-Gln-Gly-Gly-Ala-Arg-Gln-Arg-Asp-Leu-Gly-NH2
(M.W. 4122.5) C175H290N56O59
Endogenous Suppressor of Vasopressin Release
H. Yamaguchi, et al., J. Biol. Chem., 282, 26354 (2007). (Original)

Neo-Endorphins
a-Neo-Endorphin (Porcine) PEN-4090-v 0.5 mg 80
Tyr-Gly-Gly-Phe-Leu-Arg-Lys-Tyr-Pro-Lys -20 °C vial
(M.W. 1228.4) C60H89N15O13
K. Kangawa, et al., Biochem. Biophys. Res. Commun., 99, 871 (1981). (Original)

PEPTIDES INTERNATIONAL
b-Neo-Endorphin (Porcine) PEN-4091-v 0.5 mg 80
Tyr-Gly-Gly-Phe-Leu-Arg-Lys-Tyr-Pro -20 °C vial
(M.W. 1100.3) C54H77N13O12 [77739-21-0]
N. Minamino, K. Kangawa, N. Chino, S. Sakakibara, and H. Matsuo,
Biochem. Biophys. Res. Commun., 99, 864 (1981). (Original)

Neurokinins
Neurokinin A* PNK-4154-v 0.5 mg 50
Neuromedin L, Substance K -20 °C vial
(Human, Porcine, Rat, Mouse)
His-Lys-Thr-Asp-Ser-Phe-Val-Gly-Leu-Met-NH2
(M.W. 1133.3) C50H80N14O14S [86933-74-6]
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

Neurokinin A* (Bulk) PNK-4154 25 mg 710

Neuromedin L, Substance K -20 °C
(Human, Porcine, Rat, Mouse)
His-Lys-Thr-Asp-Ser-Phe-Val-Gly-Leu-Met-NH2 • 2AcOH • 5H2O
(M.W. 1133.3 • 120.10 • 90.08) C50H80N14O14S • 2CH3COOH • 5H2O
NK2 Receptor Selective Agonist
S. Kimura, et al., Proc. Jpn. Acad., 59 (B), 101 (1983). (Original; Porcine Neurokinin A)
K. Kangawa, et al., Peptide Chemistry 1983, 309 (1984). (Original; Porcine Neuromedin L)
H. Nawa, et al., Nature, 306, 32 (1983). (Original; Porcine Substance K)
A.J. Harmar, et al., FEBS Lett., 208, 67 (1986). (cDNA Seq.; Human)

Order Hotline 1-800-777-4779 502-266-8787 83

 PRODUCT CODE QTY PRICE
BIOLOGICALLY ACTIVE PEPTIDES

Neurokinin B (Neuromedin K)
Neurokinin B PNP-4317-v 0.5 mg 50
Neuromedin K -20 °C vial
(Human, Porcine, Bovine, Rat, Mouse)
Asp-Met-His-Asp-Phe-Phe-Val-Gly-Leu-Met-NH2
(M.W. 1210.4) C55H79N13O14S2 [86933-75-7]

Neurokinin B (Bulk) PNP-4317 25 mg 710

Neuromedin K -20 °C
(Human, Porcine, Bovine, Rat, Mouse)
Asp-Met-His-Asp-Phe-Phe-Val-Gly-Leu-Met-NH2 • 1/2AcOH • 4H2O
(M.W. 1210.4 • 30.03 • 72.06) C55H79N13O14S2 • 1/2CH3COOH • 4H2O
NK3 Receptor Selective Agonist
S. Kimura, et al., Proc. Jpn. Acad., 59 (B), 101 (1983). (Original; Porcine Neurokinin B)
K. Kangawa, et al., Biochem. Biophys. Res. Commun., 114, 533 (1983). (Original; Porcine Neuromedin K)
M.K. et al., J. Comp. Neurol., 384, 429 (1997). (Neurokinin B Nucleotide Seq.; Human)
T.I. Bonner., H.-U. Affolter, A.C. Young, and W.S. Young III, Mol. Brain Res., 2, 243 (1987). (cDNA Seq.; Rat)

Neuromedins
Neuromedin B* PNM-4152-v 0.5 mg 50
(Human, Porcine, Rat) -20 °C vial
Gly-Asn-Leu-Trp-Ala-Thr-Gly-His-Phe-Met-NH2
(M.W. 1132.3) C52H73N15O12S [87096-84-2]
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

Neuromedin B* (Bulk) PNM-4152 25 mg 710

PEPTIDES INTERNATIONAL

(Human, Porcine, Rat) -20 °C

Gly-Asn-Leu-Trp-Ala-Thr-Gly-His-Phe-Met-NH2
• AcOH • 5H2O
(M.W. 1132.3 • 60.05 • 90.08) C52H73N15O12S • CH3COOH • 5H2O
N. Minamino, K. Kangawa, and H. Matsuo, Biochem. Biophys. Res. Commun., 114, 541 (1983). (Original; Porcine)
I.M. Krane, et al., J. Biol. Chem., 263, 13317 (1988). (cDNA Seq.; Human)
E. Wada, J. Way, A.M. Lebacq-Verheyden, and J.F. Battey, J. Neurosci., 10, 2917 (1990). (cDNA Seq.; Rat)
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

Neuromedin C* PNM-4153-v 0.5 mg 50

Gastrin Releasing Peptide (Human, 18-27) -20 °C vial
GRP (18-27)
(Human, Porcine, Canine)
Gly-Asn-His-Trp-Ala-Val-Gly-His-Leu-Met-NH2
(M.W. 1120.3) C50H73N17O11S [81608-30-2]
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

Neuromedin C* (Bulk) PNM-4153 25 mg 710

Gastrin Releasing Peptide (Human, 18-27) -20 °C
GRP (18-27)
(Human, Porcine, Canine)
Gly-Asn-His-Trp-Ala-Val-Gly-His-Leu-Met-NH2 • 2AcOH • 5H2O
(M.W. 1120.3 • 120.11 • 90.08) C50H73N17O11S • 2CH3COOH • 5H2O
K.A. Roth, et al., Biochem. Biophys. Res. Commun., 112, 528 (1983). (Original; GRP (18-27))
N. Minamino, et al., Biochem. Biophys. Res. Commun., 119, 14 (1984). (Original; Porcine Neuromedin C)
M.S. Orloff, J.R. Reeve, Jr., C.M. Ben-Avram, J.E. Shively, and J.H. Walsh, Peptides, 5, 865 (1984). (Seq.; Human)
J.R. Reeve, Jr., Het al., J. Biol. Chem., 258, 5582 (1983). (Isolation & Seq.; Canine Bombesin-like Peptide)
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

84 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT CODE QTY PRICE
Neuromedin S (Human) PNM-4426-s 0.1 mg 135

BIOLOGICALLY ACTIVE PEPTIDES

NMS (Human) -20 °C vial
Ile-Leu-Gln-Arg-Gly-Ser-Gly-Thr-Ala-Ala-Val-Asp-Phe-
Thr-Lys-Lys-Asp-His-Thr-Ala-Thr-Trp-Gly-Arg-Pro-
Phe-Phe-Leu-Phe-Arg-Pro-Arg-Asn-NH2
(M.W. 3791.3) C173H265N53O44
Food Intake Suppressor / Regulator of Circadian Rhythm
• This compound is distributed through Peptide Institute, Inc. under the license of National Cardiovascular Center and
Takeda Pharmaceutical Company Limited.

Neuromedin S (Rat) PNM-4427-s 0.1 mg 145

NMS (Rat) -20 °C vial
Leu-Pro-Arg-Leu-Leu-His-Thr-Asp-Ser-Arg-Met-Ala-Thr-Ile-
Asp-Phe-Pro-Lys-Lys-Asp-Pro-Thr-Thr-Ser-Leu-Gly-Arg-
Pro-Phe-Phe-Leu-Phe-Arg-Pro-Arg-Asn-NH2
(M.W. 4241.9) C193H307N57O49S
Food Intake Suppressor / Regulator of Circadian Rhythm
• This compound is distributed through Peptide Institute, Inc. under the license of National Cardiovascular
Center and Takeda Pharmaceutical Company Limited

Neuromedin U (Rat) PNM-4377-v 0.5 mg 250

NMU-23 (Rat) -20 °C vial
Tyr-Lys-Val-Asn-Glu-Tyr-Gln-Gly-Pro-Val-Ala-Pro-Ser-
Gly-Gly-Phe-Phe-Leu-Phe-Arg-Pro-Arg-Asn-NH2
(M.W. 2643.0) C124H180N34O31 [117505-80-3]
Food Intake Suppressor
J.M. Conlon, et al., J. Neurochem., 51, 988 (1988). (Original; Primary Structure)

PEPTIDES INTERNATIONAL
N. Minamino, et al., Biochem. Biophys. Res. Commun., 156, 355 (1988). (Original; Primary Structure)
A.D. Howard, et al., Nature, 406, 70 (2000). (Pharmacol.)
M. Nakazato, et al., Biochem. Biophys. Res. Commun., 277, 191 (2000). (Pharmacol.)

H-Tyr-Phe-Leu-Phe-Arg-Pro-Arg-Asn-NH2 PNM-3698-PI 1 mg 35
Neuromedin U8 Porcine -20 °C 5 mg 139
YFLFRPRN-Amide
(M.W. 1111.32) C54H78N16O10
Neuropeptide
N. Minamino, K. Kangawa, and H. Matsuo, Biochem. Biophys. Res. Commun., 130, 1078 (1985).

Order Hotline 1-800-777-4779 502-266-8787 85

 PRODUCT CODE QTY PRICE
BIOLOGICALLY ACTIVE PEPTIDES

Neuronostatin
Neuronostatin-13 (Human) PNS-4452-v 0.5 mg 105
Neuronostatin-13 (Human) -20 °C vial
(Chimpanzee, Porcine, Canine, Ovine, Bovine, Chicken)
Leu-Arg-Gln-Phe-Leu-Gln-Lys-Ser-Leu-Ala-Ala-Ala-Ala-NH2
(M.W. 1415.7) C64H110N20O16
Brain/Gut Hormone in Pro-Somatostatin with Neuronal/Neuroendocrine/Cardiovascular Activity
In the post-genome era, a novel peptide called neuronostatin-13 has been predicted in
pro-somatostatin gene sequence based on bioinformatics method. Neuronostatin-13
was purified from porcine tissue by immuno-affinity procedure and then confirmed
to be an endogenous peptide. Actually, neuronostatin-13 is a 13 amino acid residue
peptide with carboxyl-terminal amidation, the primary structure of which is conserved
in human, chimpanzee and some other mammals.
The biological functions of neuronostatin-13 reported so far include: i)
intracerebroventricular administration of neuronostatin-13 in rats increased blood
pressure but suppressed food intake and water drinking (0.3 nmol per rat)1), ii) in
both brain and gastric cells, neuronostatin-13 stimulates c-Fos expression and cell
proliferation/migration1, and iii) this peptide depresses cardiac contractile function. 2
Thus, neuronostatin-13 might be a new member of brain/gut hormones. In addition,
the function of neuronostatin-13 is not mediated by somatostatin receptors.
Neuronostatin-13 with "diverse neuronal, neuroendocrine, and cardiovascular actions"
could be of interest in the research field of hormonal regulation of the body.
1. W.K. Samson, et al., J. Biol. Chem., 283, 31949 (2008). (Original; Structure & Pharmacol.)
PEPTIDES INTERNATIONAL

2. Y. Hua, H. Ma, W.K. Samson, and J. Ren, Am. J. Physiol. Regul. Integr. Comp. Physiol., 297, 682 (2009). (Pharmacol.)

Neuropeptides
Neuropeptide B-29 (Rat) (Non-Brominated PNP-4459-v 0.5 mg 445
Form) -20 °C vial
NPB-29 (Rat) (Non-brominated)
Trp-Tyr-Lys-Pro-Ala-Ala-Gly-Ser-His-His-Tyr-Ser-Val-Gly-Arg-
Ala-Ala-Gly-Leu-Leu-Ser-Ser-Phe-His-Arg-Phe-Pro-Ser-Thr
(M.W. 3188.5) C147H211N43O38
Synthetic Product
Ligand of NPBWR1 (GPR7)
R. Fujii, et al., J. Biol. Chem., 277, 34010 (2002). (Original; cDNA Sequence)
H. Tanaka, et al., Proc. Natl. Acad. Sci. U.S.A., 100, 6251 (2003). (Pharmacol.)
S. Aikawa, et al., Regul. Pept.,151,147 (2008). (Pharmacol.; Food Intake Regulatory Activity)
N. Hirashima, et al., Sleep, 1, 31 (2011). (Pharmacol.; Slow Wave Sleep Induction Activity)

86 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT CODE QTY PRICE
Neuropeptide S (Human) PNP-4425-v 0.5 mg 255

BIOLOGICALLY ACTIVE PEPTIDES

NPS (Human) -20 °C vial
Ser-Phe-Arg-Asn-Gly-Val-Gly-Thr-Gly-Met-Lys-
Lys-Thr-Ser-Phe-Gln-Arg-Ala-Lys-Ser
(M.W. 2187.5) C93H155N31O28S [412938-67-1]
Novel Modulator of Arousal and Anxiety / Food Intake Suppressor
Y.L. Xu, et al., Neuron, 43, 487 (2004). (Original)
R.K. Reinscheid and Y.-L. Xu, FEBS J., 272, 5689 (2005). (Minireview)
B. Beck, B. Fernette, and A. Stricker-Krongrad, Biochem. Biophys. Res. Commun., 332, 859 (2005). (Pharmacol.)
K.L. Smith, et al., Endocrinology, 147, 3510 (2006). (Pharmacol.)
A. Fedeli, et al., Eur. J. Neurosci., 30, 1594 (2009). (Pharmacol.)

Neuropeptide W-30 (Human) PNP-4403-v 0.5 mg 395

NPW30 (Human) hL8C -20 °C vial
Trp-Tyr-Lys-His-Val-Ala-Ser-Pro-Arg-Tyr-His-Thr-
Val-Gly-Arg-Ala-Ala-Gly-Leu-Leu-Met-Gly-
Leu-Arg-Arg-Ser-Pro-Tyr-Leu-Trp
(M.W. 3543.1) C165H249N49O37S [383415-80-3]
Food Intake-Regulating Peptide / GPR7 / GPR8 Ligand
Neuropeptide W-30 (Rat) PNP-4404-v 0.5 mg 395
NPW30 (Rat), rL8C -20 °C vial
Trp-Tyr-Lys-His-Val-Ala-Ser-Pro-Arg-Tyr-His-Thr-
Val-Gly-Arg-Ala-Ser-Gly-Leu-Leu-Met-Gly-
Leu-Arg-Arg-Ser-Pro-Tyr-Leu-Trp
(M.W. 3559.1) C165H249N49O38S [383415-90-5]
Food Intake-Regulating Peptide / GPR7 / GPR8 Ligand

PEPTIDES INTERNATIONAL
Y. Shimomura, et al., J. Biol. Chem., 277, 35826 (2002). (Original; NPW)
S. Brezillon, et al., J. Biol. Chem., 278, 776 (2003). (Original; hL8C)
H. Tanaka, et al., Proc. Natl. Acad. Sci. USA, 100, 6251 (2003). (cDNA)
M.S. Mondal, et al., Endocrinology, 144, 4729 (2003). (Pharmacol.)
F. Takenoya, et al., Regul. Pept., 145, 159 (2008) (Pharmacol.)
•This compound is distributed through Peptide Institute, Inc. under license of Takeda Chemical Industries, Ltd.
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

Neuropeptide Y (NPY) and Related Peptides

Y. Dumont, J.-C. Martel, A. Fournier, S. St-Pierre, and R. Quirion, Progr. Neurobiol., 38, 125 (1992). (Review).
C. Wahlestedt and D.J. Reis, Annu. Rev. Pharmacol. Toxicol., 32, 309 (1993). (Review)

NPY (Human, Rat)* PNP-4158-s 0.1 mg 145

Neuropeptide Y (Human, Rat) -20 °C vial
Tyr-Pro-Ser-Lys-Pro-Asp-Asn-Pro-Gly-Glu-Asp-Ala-Pro-
Ala-Glu-Asp-Met-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-
Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-NH2
(M.W. 4271.7) C189H285N55O57S [90880-35-6]

NPY (Human, Rat)* PNP-4158-v 0.5 mg 490

Neuropeptide Y (Human, Rat) -20 °C vial
Purity Information: Qp See page xiv
C.D. Minth, et al., Proc. Natl. Acad. Sci. U.S.A., 81, 4577 (1984). (Original; Human cDNA)
D. Larhammer, et al., Proc. Natl. Acad. Sci. U.S.A., 84, 2068 (1987). (Original; Rat Nucleotide Seq.)

Order Hotline 1-800-777-4779 502-266-8787 87

 PRODUCT CODE QTY PRICE
BIOLOGICALLY ACTIVE PEPTIDES

NPY (Porcine, Bovine)* PNP-4162-s 0.1 mg 145

Neuropeptide Y (Porcine, Bovine) -20 °C
Tyr-Pro-Ser-Lys-Pro-Asp-Asn-Pro-Gly-Glu-Asp-Ala-Pro-Ala-
Glu-Asp-Leu-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-
Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-NH2
(M.W. 4253.6) C190H287N55O57 [83589-17-7]
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

NPY (Porcine, Bovine)* PNP-4162-v 0.5 mg 490

Neuropeptide Y (Porcine, Bovine) -20 °C vial
Purity Information: Qp See page xiv
K. Tatemoto, Proc. Natl. Acad. Sci. USA, 79, 5485 (1982). (Original)
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

[Leu31,Pro34]-NPY (Porcine) PNP-4314-s 0.1 mg 145

[Leu31,Pro34]-Neuropeptide Y (Porcine) (Bovine) -20 °C vial
Tyr-Pro-Ser-Lys-Pro-Asp-Asn-Pro-Gly-Glu-Asp-Ala-Pro-Ala-
Glu-Asp-Leu-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-
Ile-Asn-Leu-Leu-Thr-Arg-Pro-Arg-Tyr-NH2
(M.W. 4222.6) C190H286N54O56 [125580-28-1]
NPY Y1-Receptor Selective Agonist
Purity Information: Qp See page xiv
J. Fuhlendorff, et al., Proc. Natl. Acad. Sci. USA, 87, 182 (1990). (Original)
S.P. Sheikh, Am. J. Physiol., 261, G701 (1991). (Pharmacol.)

NPY (Porcine, 13-36) PNP-4315-s 0.1 mg 75

Neuropeptide Y (Porcine, 13-36) -20 °C vial
PEPTIDES INTERNATIONAL

(Bovine)
Pro-Ala-Glu-Asp-Leu-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-
His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-NH2
(M.W. 2982.4) C135H209N41O36 [113662-54-7]
NPY Y2-Receptor Selective Agonist
M.W. Walker and R.J. Miller, Mol. Pharmacol., 34, 779 (1988). (Pharmacol.)
J. Fuhlendorff, et al., Proc. Natl. Acad. Sci. USA, 87, 182 (1900). (Pharmacol.)
S.P. Sheikh, Am. J. Physiol., 261, G701 (1991). (Pharmacol.)

Neurotensin
Neurotensin PNT-4029-v 0.5 mg 40
(Human, Bovine, Canine, Mouse) -20 °C vial
Pyr-Leu-Tyr-Glu-Asn-Lys-Pro-Arg-Arg-Pro-Tyr-Ile-Leu
(M.W. 1672.9) C78H121N21O20 [55508-42-4]

Neurotensin (Bulk) PNT-4029 25 mg 595

(Human, Bovine, Canine, Mouse) -20 °C
Pyr-Leu-Tyr-Glu-Asn-Lys-Pro-Arg-Arg-Pro-Tyr-Ile-Leu • 2AcOH • 6H2O
(M.W. 1672.9 • 120.10 • 108.09) C78H121N21O20 • 2CH3COOH • 6H2O
R. Carraway and S.E. Leeman, J. Biol. Chem., 248, 6854 (1973). (Original; Bovine)
R.A. Hammer, S.E. Leeman, R. Carraway, and R.H. Williams, J. Biol. Chem., 255, 2476 (1980). (Original; Human)
P.R. Dobner, D.L. Barber, L. Villa-Komaroff, and C. McKiernan, Proc. Natl. Acad. Sci. U.S.A., 84, 3516 (1987).
(cDNA Seq.; Canine)
P.R. Dobner, J. Fadel, N. Deitemeyer, R.E. Carraway, and A.Y. Deutch, Proc. Natl. Acad. Sci. U.S.A., 98, 8048 (2001).
(cDNA Seq.; Mouse)

88 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT CODE QTY PRICE
Nociceptin

BIOLOGICALLY ACTIVE PEPTIDES

Nociceptin (Human) PNO-4318-v 0.5 mg 180
Orphanin FQ (Human) -20 °C vial
(Rat, Mouse, Bovine, Porcine)
Phe-Gly-Gly-Phe-Thr-Gly-Ala-Arg-Lys-Ser-Ala-Arg-Lys-Leu-Ala-Asn-Gln
(M.W. 1809.0) C79H129N27O22 [170713-75-4]
Agonist of Opioid Receptor-Like-1 (ORL1) Receptor
J.-C. Meunier, et al., Nature, 377, 532 (1995). (Original; Nociceptin-ORL1 Receptor Agonist)
R.K. Reinscheid, et al., Science, 270, 792 (1995). (Original; Orphanin FQ)
C. Mollereau, et al., Proc. Natl. Acad.Sci. U.S.A., 93, 8666 (1996).
(Original; Human, Rat, & Mouse Nociceptin-Nucleotide Seq.)
J.C. Meunier, Eur. J. Pharmacol., 340, 1 (1997). (Review)
G. Csaba and K. Tekes, Brain Dev., 27, 465 (2005). (Review)
Z.S. Zadori, N. Shujaa, L. Koeles, K.P. Kiraly, K. Tekes, and K. Gyires, Peptides, 29, 2257 (2008). (Pharmacol.)

Nocistatins
Nocistatin (Human) PNO-4355-v 0.5 mg 360
Met-Pro-Arg-Val-Arg-Ser-Leu-Phe-Gln-Glu-Gln- -20 °C vial
Glu-Glu-Pro-Glu-Pro-Gly-Met-Glu-Glu-Ala-
Gly-Glu-Met-Glu-Gln-Lys-Gln-Leu-Gln
(M.W. 3561.9) C149H238N42O53S3
Endogenous Allodynia / Hyperalgesia-Blocking Peptide
Nociceptin Action Blocking Peptide
T. Minami, et al., Br. J. Pharmacol., 124, 1016 (1998). (Original; Pharmacol.)
C. Mollereau, M.-J. Simons, P. Soularue, F. Liners, G. Vassart, J.-C. Meunier, and M. Parmentier,
Proc. Natl. Acad. Sci. U.S.A., 93, 8666 (1996). (Original; Prepronociceptin Nucleotide Seq.)

PEPTIDES INTERNATIONAL
T.-L. Lee, et al., NeuroReport, 10,1537 (1999). (Original; Identification in Human)
Z.S. Zadori, N. Shujaa, L. Koeles, K.P. Kiraly, K. Tekes, and K. Gyires, Peptides, 29, 2257 (2008). (Pharmacol.)

Nocistatin (Bovine) PNO-4336-v 0.5 mg 240

(Ammonium Form) -20 °C vial
Thr-Glu-Pro-Gly-Leu-Glu-Glu-Val-Gly-Glu-Ile-
Glu-Gln-Lys-Gln-Leu-Gln
(M.W. 1927.1) C82H135N21O32
Endogenous Allodynia / Hyperalgesia-Blocking Peptide
Nociceptin Action Blocking Peptide
E. Okuda-Ashitaka, et al., Nature, 392, 286 (1998). (Original)
B. Nicol, D.J. Lambert, D.J. Rowbothan, E. Okuda-Ashitaka, S. Ito, D. Smart,
and A.T. McKnight, Eur. J. Pharmacol., 356, R1 (1998). (Pharmacol.)
T. Nakagawa, M. Kaneko, S. Inamura, and M. Satoh, Neurosci. Lett., 265, 64 (1999). (Pharmacol.)
H. Nakano, et al., J. Pharmacol. Exp. Ther., 292, 331 (2000). (Pharmacol.)
M. Fantin, C. Fischetti, C. Trapella, and M. Morari, Br. J. Pharmacol., 152, 549 (2007). (Pharmacol.)

Obestatin and Related Analogs

Obestatin (Human) PGH-3890-PI 1 mg 79
(Human, Monkey) -20 °C 5 mg 299
H-Phe-Asn-Ala-Pro-Phe-Asp-Val-Gly-Ile-Lys-Leu-Ser-Gly-Val-Gln-Tyr-Gln-Gln-His-Ser-Gln-Ala-Leu-NH2
FNAPFDVGIKLSGVQYQQHSQAL-NH2
(M.W. 2546.89) C116H176N32O33
Suppressor of Food Intake and Gastric Emptying
J.V. Zhang, P. Ren, O. Avsian-Kretchmer, C. Luo, R. Rauch, C. Klein, and A.J.W. Hsueh, Science, 310, 996 (2005).
M. Kojima, H. Hosoda, Y. Date, M. Nakazato, H. Matsuo, and K. Kangawa, Nature, 402, 656 (1999).

Order Hotline 1-800-777-4779 502-266-8787 89

 PRODUCT CODE QTY PRICE
BIOLOGICALLY ACTIVE PEPTIDES

Obestatin (Rat, Mouse) PGH-3891-PI 1 mg 79

H-Phe-Asn-Ala-Pro-Phe-Asp-Val-Gly-Ile-Lys-Leu-Ser- -20 °C 5 mg 299
Gly-Ala-Gln-Tyr-Gln-Gln-His-Gly-Arg-Ala-Leu-NH2
FNAPFDVGIKLSGAQYQQHGRAL-NH2
(M.W. 2516.87) C114H174N34O31
Suppressor of Food Intake and Gastric Emptying
J.V. Zhang, P. Ren, O. Avsian-Kretchmer, C. Luo, R. Rauch, C. Klein, and A.J.W. Hsueh, Science, 310, 996 (2005).
M. Kojima, H. Hosoda, Y. Date, M. Nakazato, H. Matsuo, and K. Kangawa, Nature, 402, 656 (1999).

Des 1-10 Obestatin (Human) PGH-3892-PI 1 mg 59

Obestatin (Human, 11-23) -20 °C 5 mg 229
H-Leu-Ser-Gly-Val-Gln-Tyr-Gln-Gln-His-Ser-Gln-Ala-Leu-NH2
H-LSGVQYQQHSQAL-NH2
(M.W. 1457.62) C63H100N20O20
Truncated Analog of Obestatin
J.V. Zhang, P. Ren, O. Avsian-Kretchmer, C. Luo, R. Rauch, C. Klein, and A.J.W. Hsueh, Science, 310, 996 (2005).
M. Kojima, H. Hosoda, Y. Date, M. Nakazato, H. Matsuo, and K. Kangawa, Nature, 402, 656 (1999).

Des 1-10 Obestatin (Rat, Mouse) PGH-3893-PI 1 mg 59

Obestatin (Rat, Mouse, 11-23) -20 °C 5 mg 229
H-Leu-Ser-Gly-Ala-Gln-Tyr-Gln-Gln-His-Gly-Arg-Ala-Leu-NH2
H-LSGAQYQQHGRAL-NH2
(M.W. 1427.60) C61H98N22O18
Truncated Analog of Obestatin
J.V. Zhang, P. Ren, O. Avsian-Kretchmer, C. Luo, R. Rauch, C. Klein, and A.J.W. Hsueh, Science, 310, 996 (2005).
M. Kojima, H. Hosoda, Y. Date, M. Nakazato, H. Matsuo, and K. Kangawa, Nature, 402, 656 (1999).

Orexins
PEPTIDES INTERNATIONAL

T. Sakurai, Regul. Pept., 85, 25 (1999). (Review)

J.M. Siegel, Cell, 98, 409 (1999). (Review)
L. De Lecea and J.G. Sutcliffe, Cell. Mol. Life Sci., 56, 473 (1999). (Review)
R.J. Rodgers, Y. Ishii, J.C.G. Halford, and J.E. Blundell, Neuropeptides, 36, 303 (2002). (Review)
N. Tsujino and T. Sakurai, Pharmacol. Rev., 61, 162 (2009). (Review)
M. Mieda and T. Sakurai, CNS Neurol. Disord. Drug Targets, 8, 281 (2009). (Review)
B.C. Baccari, Curr. Protein Pept. Sci., 11, 148 (2010). (Review)

Orexin-A (Human) POR-4346-s 0.1 mg 250

(Rat, Mouse, Bovine) -20 °C vial
Pyr-Pro-Leu-Pro-Asp-Cys-Cys-Arg-Gln-Lys-Thr-Cys-Ser-Cys-Arg-Leu-Tyr-
Glu-Leu-Leu-His-Gly-Ala-Gly-Asn-His-Ala-Ala-Gly-Ile-Leu-Thr-Leu-NH2
(Disulfide bonds between Cys6-Cys12 and Cys7-Cys14)
(M.W. 3561.1) C152H243N47O44S4 [205640-90-0]
Appetite-Boosting Peptide / Sleep-Wakefulness State Regulator
T. Sakurai, et al., Cell, 92, 573 (1998). (Original)
L. de Lecea, et al., Proc. Natl. Acad. Sci. U.S.A., 95, 322 (1998). (cDNA; Same Sequence [Hypocretin])
N. Takahashi, et al., Biochem. Biophys. Res. Commun., 254, 623 (1999). (Pharmacol.)
T. Ida, et al. Biochem. Biophys. Res. Commun., 270, 318 (2000). (Pharmacol.)

Orexin-A (Human, 17-33) (0.1 mg vial) POR-4482-s 0.1 mg 80

OXA (17-33) -20 °C vial
NEW! Tyr-Glu-Leu-Leu-His-Gly-Ala-Gly-Asn-His-Ala-Ala-Gly-Ile-Leu-Thr-Leu-NH2
(M.W.1749.0) C79H125N23O22 [343268-91-7]
Orexin-1 Receptor Selective Agonist
N.A. German, et al., ACS Med. Chem. Lett., 4, 1224 (2013). (Original; Structure-Activity Relationship & Pharmacol.)
S. Asahi, et al., Bioorg. Med. Chem. Lett., 13, 111 (2003). (Original; Structure-Activity Relationship & Pharmacol.)
J. Putura, et al., Neurosci. Lett., 494, 57 (2011). (Pharmacol.)

90 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT CODE QTY PRICE
Orexin-B (Human) POR-4348-s 0.1 mg 125

BIOLOGICALLY ACTIVE PEPTIDES

Arg-Ser-Gly-Pro-Pro-Gly-Leu-Gln-Gly-Arg-Leu- -20 °C vial
Gln-Arg-Leu-Leu-Gln-Ala-Ser-Gly-Asn-
His-Ala-Ala-Gly-Ile-Leu-Thr-Met-NH2
(M.W. 2899.3) C123H212N44O35S [205640-91-1]
Appetite-Boosting Peptide / Sleep-Wakefulness State Regulator
T. Sakurai, et al., Cell, 92, 573 (1998). (Original)
L. de Lecea, et al., Proc. Natl. Acad. Sci. U.S.A., 95, 322 (1998). (cDNA; Same Sequence [Hypocretin])
N. Takahashi, et al., Biochem. Biophys. Res. Commun., 254, 623 (1999). (Pharmacol.)

Orexin-B (Rat, Mouse) POR-4347-s 0.1 mg 125

Hypocretin 2 (Rat, Mouse) -20 °C vial
Arg-Pro-Gly-Pro-Pro-Gly-Leu-Gln-Gly-Arg-Leu-Gln-Arg-Leu-
Leu-Gln-Ala-Asn-Gly-Asn-His-Ala-Ala-Gly-Ile-Leu-Thr-Met-
NH2
(M.W. 2936.4) C126H215N45O34S [202801-92-1]
Appetite-Boosting Peptide / Sleep-Wakefulness State
Regulator
Purity Information: Qp See page xiv
T. Sakurai, et al., Cell, 92, 573 (1998). (Original)
L. de Lecea, et al., Proc. Natl. Acad. Sci. U.S.A., 95, 322 (1998). (cDNA; Same Sequence [Hypocretin])
N. Takahashi, et al., Biochem. Biophys. Res. Commun., 254, 623 (1999). (Pharmacol.)
M.S. Mondal, et al., Biochem. Biophys. Res. Commun., 256, 495 (1999). (Distribution)

[Ala11, D-Leu15]-Orexin B (Human) POR-4483-s 0.1 mg 100

Arg-Ser-Gly-Pro-Pro-Gly-Leu-Gln-Gly-Arg-Ala-Gln- -20 °C vial
Arg-Leu-D-Leu-Gln-Ala-Ser-Gly-Asn-His-Ala-Ala-
Gly-Ile-Leu-Thr-Met-NH2

PEPTIDES INTERNATIONAL
(M.W. 2857.3) C120H206N44O35S [532932-99-3]
Orexin-2 Receptor Selective Agonist
N.A. German, et al., ACS Med. Chem. Lett., 4, 1224 (2013). (Original; Structure-Activity Relationship & Pharmacol.)
S. Asahi, et al., Bioorg. Med. Chem. Lett., 13, 111 (2003). (Original; Structure-Activity Relationship & Pharmacol.)
J. Putura, et al., Neurosci. Lett., 494, 57 (2011). (Pharmacol.)

Osteocalcins
Gla17,21,24-Osteocalcin (Human) POS-4262-s 0.1 mg 1520
Osteocalcin (Human, Gla17,21,24) -20 °C vial
(Ammonium Form)
Tyr-Leu-Tyr-Gln-Trp-Leu-Gly-Ala-Pro-Val-Pro-Tyr-Pro-Asp-Pro-Leu-Gla-Pro-Arg-Arg-Gla-Val-Cys-Gla-Leu-
Asn-Pro-Asp-Cys-Asp-Glu-Leu-Ala-Asp-His-Ile-Gly-Phe-Gln-Glu-Ala-Tyr-Arg-Arg-Phe-Tyr-Gly-Pro-Val
(Gla: l-g-Carboxyglutamic acid)
(Disulfide bond between Cys23-Cys29)
(M.W. 5929.4) C269H381N67O82S2 [136461-80-8]
Bone Gla Protein
Purity Information: Qx See page xiv
J.W. Poser, et al., J. Biol. Chem., 255, 8685 (1980). (Original)
M. Nakao, Y. Nishiuchi, M. Nakata, T. Kimura, and S. Sakakibara, Pept. Res., 7, 171 (1994). (Chem. Synthesis)
P.V. Hauschka, et al., Physiol. Rev., 69, 990 (1989). (Review)
• This compound is produced by Peptide Institute, Inc., under the license of Mitsubishi Chemical Corporation and is
distributed exclusively through Mitsubishi Chemical Corporation.

Order Hotline 1-800-777-4779 502-266-8787 91

 PRODUCT CODE QTY PRICE
BIOLOGICALLY ACTIVE PEPTIDES

Glu17,Gla21,24-Osteocalcin (Human) POS-4261-s 0.1 mg 1520

Osteocalcin (Human, Glu17,Gla21,24) -20 °C vial
(Ammonium Form)
Tyr-Leu-Tyr-Gln-Trp-Leu-Gly-Ala-Pro-Val-Pro-Tyr-Pro-Asp-Pro-Leu-Glu-Pro-Arg-Arg-Gla-Val-Cys-Gla-Leu-
Asn-Pro-Asp-Cys-Asp-Glu-Leu-Ala-Asp-His-Ile-Gly-Phe-Gln-Glu-Ala-Tyr-Arg-Arg-Phe-Tyr-Gly-Pro-Val
(Gla: l-g-Carboxyglutamic acid)
(Disulfide bond between Cys23-Cys29)
(M.W. 5885.4) C268H381N67O80S2
Bone Gla Protein
Purity Information: Qx See page xiv
J.W. Poser, et al., J. Biol. Chem., 255, 8685 (1980). (Original)
M. Nakao, Y. Nishiuchi, M. Nakata, T. Kimura, and S. Sakakibara, Pept. Res., 7, 171 (1994). (Chem. Synthesis)
P.V. Hauschka, et al., Physiol. Rev., 69, 990 (1989). (Review)
• This compound is produced by Peptide Institute, Inc. under the license of Mitsubishi Chemical Corporation and is
distributed exclusively through Mitsubishi Chemical Corporation.

OVA Peptide Fragment Also see MOG and Ac-MBP Fragments.

OVA Peptide (257-264) POV-3659-PI 1 mg 50
Chicken ovalbumin fragment (257-264) -20 °C 5 mg 195
H-Ser-Ile-Ile-Asn-Phe-Glu-Lys-Leu-OH
(M.W. 963.15) C45H74N10O13
T-cell Activating Peptide
F.R. Carbone, S.J. Sherry, J. Butler, S. Rodda, and M.W. Moore, Int. Immunol. 4, 861 (1992).

OVA Peptide (323-339) POV-3636-PI 1 mg 95

Chicken ovalbumin fragment (323-339) -20 °C 5 mg 375
PEPTIDES INTERNATIONAL

H-Ile-Ser-Gln-Ala-Val-His-Ala-Ala-His-Ala-Glu-Ile-Asn-Glu-Ala-Gly-Arg-OH
(M.W. 1773.94) C74H120N26O25
T-cell Activating Peptide
F. De Mattia, et al., J. Immunol., 163, 5929, (1999).
S.-J. Sung, C.E. Rose, and S.M. Fu, J. Immunol., 166, 1261, (2001).
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

Oxytocins
B. Berde (ed.), Neurohypophysial Hormones and Similar Polypeptides, Handbook of Experimental Pharmacology,
Vol. 23, Springer-Verlag, Berlin, 1968. (Review)

Oxytocin* POX-4084-v 0.5 mg 50

(Human, Porcine, Bovine, Rat, Ovine) -20 °C vial
Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2
(Disulfide bond between Cys1-Cys6)
(M.W. 1007.2) C43H66N12O12S2 [50-56-6]
V. Du Vigneaud, C. Ressler, and S. Trippett, J. Biol. Chem., 205, 949 (1953). (Original)
R.A. Boissonnas, St. Guttmann, P.-A. Jaquenoud, and J.-P. Waller, Helv. Chim. Acta, 38, 1491 (1955). (Chem. Synthesis)
M. Zaoral and J. Rudinger, Collection Czech. Chem. Commun., 20, 1183 (1955). (Chem. Synthesis)
A. Light and V. Du Vigneaud, Proc. Soc. Exp. Biol. Med., 98, 692 (1958). (Original; Human)
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

92 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT CODE QTY PRICE
[Asu1,6]-Oxytocin* POX-4025-v 0.5 mg 60

BIOLOGICALLY ACTIVE PEPTIDES

(Deamino-Dicarba-Oxytocin) -20 °C vial
cyclo (Tyr-lle-Gln-Asn-Asu)-Pro-Leu-Gly-NH2
(cyclic form between Asu w-Carboxyl group and Tyr a-amino group)
(Asu: l-a-Aminosuberic acid)
(M.W. 956.10) C45H69N11O12 [14317-68-1] T. Yamanaka, et al., Mol. Pharmacol., 6, 474 (1970). (Original)
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

Pancreastatins
Catestatin (Human) (0.5 mg vial) CHR-4470-v 0.5 mg 180
Chromogranin A (Human, 352-372) -20 °C vial
Ser-Ser-Met-Lys-Leu-Ser-Phe-Arg-Ala-Arg-Ala-Tyr-Gly-Phe-
Arg-Gly-Pro-Gly-Pro-Gln-Leu
(M.W. 2326.70) C104H164N32O27S
Antimicrobial Peptide/Regulator of Blood Pressure/Cardiac Function Synthetic Product
D.S. Konecki, et al., J. Biol. Chem., 262, 17026 (1987). (Original; Chromogranin A cDNA)
J. Briolat, et al., Cell. Mol. Life Sci., 62, 377 (2005). (Pharmacol.)
B.S. Sahu, et al., Cell. Mol. Life Sci., 67, 861 (2010). (Review)
S.K. Mahata, et al., Regul. Pept.,162,33 (2010). (Review)

Chromogranin A (Human, 286-301 Amide) PCR-4214-v 0.5 mg 135

(Hydrochloride Form) -20 °C vial
Glu-Glu-Glu-Glu-Glu-Met-Ala-Val-Val-Pro-Gln-Gly-Leu-Phe-
Arg-Gly-NH2
(M.W. 1819.0) C78H123N21O27S [133605-57-9]
Purity Information: Qe See page xiv

PEPTIDES INTERNATIONAL
D.S. Konecki, U.M. Benedum, H.H. Gerdes, and W.B. Huttner, J. Biol. Chem., 262, 17026 (1987). (Original; cDNA)

[Pyr ]-Pancreastatin (Porcine, 33-49)

33 PPP-4186-v 0.5 mg 140
Pyr-Glu-Glu-Glu-Glu-Glu-Thr-Ala-Gly-Ala-Pro- -20 °C vial
Gln-Gly-Leu-Phe-Arg-Gly-NH2
(M.W. 1829.9) C77H116N22O30
K. Tatemoto, S. Efendic, V. Mutt, G. Makk, G.J. Feistner, and J.D. Barchas, Nature, 324, 476 (1986). (Original)

Parathyroid Hormone (PTH) and Related Peptides

Parathyroid Hormone (Human, 1-84) PTH-4134-v 20 µg 240
PTH (Human, 1-84) -20 °C vial
Ser-Val-Ser-Glu-Ile-Gln-Leu-Met-His-Asn-Leu-Gly-Lys-His-Leu-
Asn-Ser-Met-Glu-Arg-Val-Glu-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-
Val-His-Asn-Phe-Val-Ala-Leu-Gly-Ala-Pro-Leu-Ala-Pro-Arg-Asp-
Ala-Gly-Ser-Gln-Arg-Pro-Arg-Lys-Lys-Glu-Asp-Asn-Val-Leu-Val-
Glu-Ser-His-Glu-Lys-Ser-Leu-Gly-Glu-Ala-Asp-Lys-Ala-Asp-
Val-Asn-Val-Leu-Thr-Lys-Ala-Lys-Ser-Gln
(M.W. 9424.6) C408H674N126O126S2 [68893-82-3]
G.N. Hendy, et al., Proc. Natl. Acad. Sci. U.S.A., 78, 7365 (1981). (Original; cDNA Sequence)
T. Kimura, et al., Biochem. Biophys. Res. Commun., 114, 493 (1983). (Chem. Synthesis)
H. Takasu, et al., Endocrinology, 137, 5537 (1996). (Pharmacol.)

Order Hotline 1-800-777-4779 502-266-8787 93

 PRODUCT CODE QTY PRICE
BIOLOGICALLY ACTIVE PEPTIDES

Parathyroid Hormone (Human, 1-37) PTH-3753-PI 1 mg 336

PTH (Human, 1-37) -20 °C 5 mg 1344
(Trifluoroacetate Form)
H-Ser-Val-Ser-Glu-Ile-Gln-Leu-Met-His-Asn-Leu-Gly-Lys-His-
Leu-Asn-Ser-Met-Glu-Arg-Val-Glu-Trp-Leu-Arg-Lys-Lys-
Leu-Gln-Asp-Val-His-Asn-Phe-Val-Ala-Leu-OH
(M.W. 4401.18) C195H316N58O54S2 [136799-54-7]
C.P. Schmitt, et al., Kidney Int., 57, 1484 (2000).

Parathyroid Hormone (Human, 1-34) PTH-4068-s 0.1 mg 85

PTH (Human, 1-34) -20 °C vial
Ser-Val-Ser-Glu-Ile-Gln-Leu-Met-His-Asn-Leu-Gly-Lys-
His-Leu-Asn-Ser-Met-Glu-Arg-Val-Glu-Trp-Leu-Arg-
Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Phe
(M.W. 4117.7) C181H291N55O51S2 [52232-67-4]

Parathyroid Hormone (Human, 1-34) PTH-4068-v 0.5 mg 370

PTH (Human, 1-34) -20 °C vial
M. Takai, Y. Kurano, T. Kimura, and S. Sakakibara, Peptide Chemistry 1979, 187 (1980). (Chem. Synthesis)

Parathyroid Hormone (Human, 1-31 Amide) PTH-4324-v 0.5 mg 360

PTH (Human, 1-31 Amide) -20 °C vial
Ser-Val-Ser-Glu-Ile-Gln-Leu-Met-His-Asn-Leu-Gly-Lys-
His-Leu-Asn-Ser-Met-Glu-Arg-Val-Glu-Trp-Leu-Arg-
Lys-Lys-Leu-Gln-Asp-Val-NH2
(M.W. 3718.3) C162H270N50O46S2
Adenylate Cyclase- / Bone Growth Stimulating Peptide
PEPTIDES INTERNATIONAL

R.H. Rixon, et al., J. Bone Miner. Res., 9, 1179 (1994) (Original)

W. Neugebauer, J.-R. Barbier, W.L. Sung, J.F. Whitfield, and G.E. Willick, Biochemistry, 34, 8835 (1995). (Biochem.)
J.F. Whitfield, and P. Morley, Trends Pharmacol. Sci., 16, 382 (1995). (Review)
J.F. Whitfield, et al., Calcif. Tissue Int., 58, 81 (1996). (Pharmacol.)

Parathyroid Hormone (Human, 1-44) PTH-4094-v 0.5 mg 490

PTH (Human, 1-44) -20 °C vial
Ser-Val-Ser-Glu-lle-Gln-Leu-Met-His-Asn-Leu-Gly-Lys-His-Leu-
Asn-Ser-Met-Glu-Arg-Val-Glu-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-
Val-His-Asn-Phe-Val-Ala-Leu-Gly-Ala-Pro-Leu-Ala-Pro-Arg
(M.W. 5063.9) C225H366N68O61S2 [85568-24-7]
Purity Information: Qx See page xiv
T. Kimura, M. Takai, Y. Masui, T. Morikawa, and S. Sakakibara, Biopolymers, 20, 1823 (1981). (Chem. Synthesis)

Parathyroid Hormone (Human, 13-34) PTH-4106-v 0.5 mg 260

PTH (Human, 13-34) -20 °C vial
Lys-His-Leu-Asn-Ser-Met-Glu-Arg-Val-Glu-Trp-Leu-
Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Phe
(M.W. 2808.2) C125H199N39O33S [81306-64-1]
R. Nakamura, H. Sokabe, T. Kimura, and S. Sakakibara, Endocrinol. Jpn., 28, 547 (1981). (Pharmacol.; Hypotension)
K. Sakaguchi, et al., J. Bone Miner. Res., 2, 83 (1987). (Pharmacol.)

94 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT CODE QTY PRICE
Parathyroid Hormone (Human, 39-68) PTH-4124-v 0.5 mg 435

BIOLOGICALLY ACTIVE PEPTIDES

PTH (Human, 39-68) -20 °C vial
(Hydrochloride Form)
Ala-Pro-Leu-Ala-Pro-Arg-Asp-Ala-Gly-Ser-Gln-Arg-Pro-Arg-Lys-
Lys-Glu-Asp-Asn-Val-Leu-Val-Glu-Ser-His-Glu-Lys-Ser-Leu-Gly
(M.W. 3285.6) C139H234N46O46
Purity Information: Qx See page xiv
P. D’Amour, F. Labelle, R. Wolde-Giorghis, and L. Hamel, J. Immunoass., 10, 191 (1989). (Radioimmunoassay)
T. Yamaguchi, M. Arao, and M. Fukase, Acta Endocrinol., 127, 267 (1992). (Biochem.; PTH Degradation)
T. Yamaguchi, et al., Life Sci., 54, 381 (1994). (Biochem.; PTH Degradation)

Parathyroid Hormone (Human, 39-84) PTH-4169-v 0.5 mg 490

PTH (Human, 39-84) -20 °C vial
Ala-Pro-Leu-Ala-Pro-Arg-Asp-Ala-Gly-Ser-Gln-Arg-Pro-Arg-Lys-Lys-
Glu-Asp-Asn-Val-Leu-Val-Glu-Ser-His-Glu-Lys-Ser-Leu-Gly-Glu-
Ala-Asp-Lys-Ala-Asp-Val-Asn-Val-Leu-Thr-Lys-Ala-Lys-Ser-Gln
(M.W. 4984.5) C211H357N67O72 [90880-43-6]
P. D’Amour, et al., J. Immunoass., 10, 191 (1989). (Biochem.; Presence in Circuration)
T. Yamaguchi, M. Arao, and M. Fukase, Acta Endocrinol., 127, 267 (1992). (Biochem.; PTH Degradation)
T. Yamaguchi, et al., Life Sci., 54, 381 (1994). (Biochem.; PTH Degradation)

Parathyroid Hormone (Human, 69-84) PTH-4170-v 0.5 mg 150

PTH (Human, 69-84) -20 °C vial
(Hydrochloride Form)
Glu-Ala-Asp-Lys-Ala-Asp-Val-Asn-Val-
Leu-Thr-Lys-Ala-Lys-Ser-Gln
(M.W. 1716.9) C72H125 N21O27
Purity Information: QE See page xiv

PEPTIDES INTERNATIONAL
P. D’Amour, F. Labelle, R. Wolde-Giorghis, and L. Hamel, J. Immunoass., 10, 191 (1989). (Radioimmunoassay)
H. Takasu, et al., Endocrinology, 137, 5537 (1996). (Pharmacol.)

[Nle8,18,Tyr34]-Parathyroid Hormone (Human, PTH-4129-v 0.5 mg 445

1-34) -20 °C vial
[Nle8,18,Tyr34]-PTH (Human, 1-34)
Ser-Val-Ser-Glu-Ile-Gln-Leu-Nle-His-Asn-Leu-Gly-Lys-His-Leu-Asn-Ser-
Nle-Glu-Arg-Val-Glu-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Tyr
(Nle: l-Norleucine)
(M.W. 4097.6) C183H295N55O52
T. Noda, et al., The 41st Annual Meeting of Chemical Society of Japan, Osaka, April 1980, Abstr. No 4S12. (Original)

[Nle ,Tyr34]-Parathyroid Hormone (Human, 18

8,18 PTH-4180-v 0.5 mg 435
1-34 Amide) -20 °C vial
[Nle8,18,Tyr34]-PTH (Human, 1-34 Amide)
Ser-Val-Ser-Glu-Ile-Gln-Leu-Nle-His-Asn-Leu-Gly-Lys-His-Leu-Asn-Ser-Nle-
Glu-Arg-Val-Glu-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Tyr-NH2
(Nle: l-Norleucine)
(M.W. 4096.7) C183H296N56O51
M. Rosenblatt, et al. J. Biol. Chem., 251, 159 (1976). (Chem. Synthesis & Biological Activity)
M.L. Thomas and L.R. Forte, Comp. Biochem. Physiol., 73A, 691 (1982). (Biological Activity)
I. Yamamoto, C. Shigeno, J.T. Potts, Jr., and G.V. Segre, Endocrinology, 122, 1208 (1988). (Radioimmunoassay)

Order Hotline 1-800-777-4779 502-266-8787 95

 PRODUCT CODE QTY PRICE
BIOLOGICALLY ACTIVE PEPTIDES

[Nle8,18,Tyr34]-Parathyroid Hormone (Human, PTH-4181-v 0.5 mg 435

3-34 Amide) -20 °C vial
[Nle8,18,Tyr34]-PTH (Human, 3-34 amide)
Ser-Glu-Ile-Gln-Leu-Nle-His-Asn-Leu-Gly-Lys-His-Leu-Asn-Ser-Nle-Glu-
Arg-Val-Glu-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Tyr-NH2
(Nle: l-Norleucine)
(M.W. 3910.4) C175H282N54O48
S.R. Goldring, et al., J. Endocrinol. Metab., 48, 655 (1979). (Pharmacol.)
T.C. Chen, M. Rosenblatt, and J.B. Puschett, Biochem. Biophys. Res. Commun., 94, 1227 (1980). (Pharmacol.)
D.A. Gray, et al., Br. J. Pharmacol., 76, 259 (1982). (Pharmacol.)

[Tyr34]-Parathyroid Hormone (Bovine, 1-34 PTH-4179-v 0.5 mg 435

Amide) -20 °C vial
[Tyr34]-PTH (Bovine, 1-34 Amide)
Ala-Val-Ser-Glu-Ile-Gln-Phe-Met-His-Asn-Leu-Gly-Lys-His-Leu-Ser-Ser-Met-
Glu-Arg-Val-Glu-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Tyr-NH2
(M.W. 4123.7) C183H289N55O50S2
M. Rosenblatt, Pathobiol. Annu., 11, 53 (1981). (Review)

[Tyr ]-Parathyroid Hormone (Bovine, 7-34

34 PTH-4185-v 0.5 mg 435
Amide) -20 °C vial
[Tyr34]-PTH (Bovine, 7-34 Amide)
Phe-Met-His-Asn-Leu-Gly-Lys-His-Leu-Ser-Ser-Met-Glu-Arg-Val-
Glu-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Tyr-NH2
(M.W. 3496.0) C156H244N48O40S2 [86292-93-5]
PTH Antagonist
N. Horiuchi, M.F. Holick, J.T. Potts, Jr., and M. Rosenblatt, Science, 220, 1053 (1987). (Original)
PEPTIDES INTERNATIONAL

PTH-rP(Human, 1-34 Amide) PTH-4205-v 0.5 mg 370

Parathyroid Hormone Related Protein (Human, 1-34 Amide) -20 °C vial
(Rat, Mouse)
Ala-Val-Ser-Glu-His-Gln-Leu-Leu-His-Asp-Lys-Gly-Lys-Ser-Ile-Gln-Asp-Leu-
Arg-Arg-Arg-Phe-Phe-Leu-His-His-Leu-Ile-Ala-Glu-Ile-His-Thr-Ala-NH2
(M.W. 4016.6) C180H288N58O47 [112955-31-4]
L.J. Suva, et al., Science, 237, 893 (1987). (Original; cDNA)
N. Horiuchi, et al., Science, 238, 1566 (1987). (Pharmacol.; Synthetic PTH-rP Amide)
B.E. Kemp, et al., Science, 238, 1568 (1987). (Pharmacol.; Synthetic PTH-rP Amide)

PTH-rP(Human, 7-34 Amide) PTH-4215-v 0.5 mg 370

Parathyroid Hormone Related Protein (Human, 7-34 Amide) -20 °C vial
Leu-Leu-His-Asp-Lys-Gly-Lys-Ser-Ile-Gln-Asp-Leu-Arg-Arg-
Arg-Phe-Phe-Leu-His-His-Leu-Ile-Ala-Glu-Ile-His-Thr-Ala-NH2
(M.W. 3364.9) C153H247N49O37 [115695-30-2]
PTH-rP Antagonist
K. Nagasaki, et al., Biochem. Biophys. Res. Comun., 158, 1036 (1989). (Original)
L.J. Suva, et al., Science, 237, 893 (1987). (Original; cDNA)

Peptide 234 PPT-4460-v 0.5 mg 99

Ac-D-Ala-Asn-Trp-Asn-Gly-Phe-Gly-D-Trp-Arg-Phe-NH2 vial
-20 °C
(M.W. 1295.4) C63H78N18O13
Synthetic Kisspeptin Antagonist
A.K. Roseweir, et al., J. Neurosci., 29, 3920 (2009). (Pharmacol.)
X.-F. Li, et al. PLoS One., 4, e8334 (2009). (Pharmacol.)
R. Pineda, et al., Endocrinology, 151, 722 (2010). (Pharmacol.)

96 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT CODE QTY PRICE
Peptide Histidine-Methionine (PHM)

BIOLOGICALLY ACTIVE PEPTIDES

PHM-27(Human) PPM-4177-v 0.5 mg 400
Peptide Histidine-Methionine -20 °C vial
His-Ala-Asp-Gly-Val-Phe-Thr-Ser-Asp-Phe-Ser-Lys-Leu-Leu-
Gly-Gln-Leu-Ser-Ala-Lys-Lys-Tyr-Leu-Glu-Ser-Leu-Met-NH2
(M.W. 2985.4) C135H214N34O40S [87403-73-4]
N. Itoh, K. Obata, N. Yanaihara, and H. Okamoto, Nature, 304, 547 (1983). (Original)

Peptide T
Peptide T PPT-4188-v 0.5 mg 35
Ala-Ser-Thr-Thr-Thr-Asn-Tyr-Thr -20 °C vial
(M.W. 857.86) C35H55N9O16

Peptide T (Bulk) PPT-4188 25 mg 640

Ala-Ser-Thr-Thr-Thr-Asn-Tyr-Thr • 4H2O -20 °C
(M.W. 857.86 • 72.06) C35H55N9O16 • 4H2O
M.R. Ruff, B.M. Martin, E.l. Ginns, W.L. Farrar, and C.B. Pert, FEBS Lett., 211, 17 (1987). (Pharmacol.)
C.B. Pert, et al., Proc. Natl. Acad. Sci. USA, 83, 9254 (1986). (Original)

Peptide YY
Peptide YY (Dog, Mouse, Porcine, Rat, 3-36) PYY-3726-PI 1 mg 260
PYY (Dog, Mouse, Porcine, Rat, 3-36) -20 °C 5 mg 1040
H-Ala-Lys-Pro-Glu-Ala-Pro-Gly-Glu-Asp-Ala-Ser-Pro-Glu-Glu-Leu-Ser-Arg-Tyr-
Tyr-Ala-Ser-Leu-Arg-His-Tyr-Leu-Asn-Leu-Val-Thr-Arg-Gln-Arg-Tyr-NH2

PEPTIDES INTERNATIONAL
(M.W. 3980.45) C176H272N52O54 [126339-09-1]
Physiological inhibitor for food intake/ Y2-receptor agonist
D.Grandt, M. Schimiczek, et al., Regul. Peptides, 40, 161 (1992).
R.L.Batterham, et al., Nature, 418, 650 (2002).
R.L.Batterham, et al. N. Engl. J. Med., 349, 941 (2003).
Y. Shechter, H. Tsubery, M. Mironchik, M. Rubinstein, M. Fridkin, FEBS Lett., 579, 2439 (2005).
I.G.Halatchev and R.D.Cone, Cell Metab., 1, 159 (2005).
C.Acuna-Goycolea and A.N.van den Pol, J. Neurosci., 25, 10510 (2005).
G.H.Ballantyne, Obes. Surg., 16, 651 (2006)
P.K. Chelikani, A.C. Haver , and R.D. Reidelberger, Am. J Phyiol Regul Integr Comp Physiol, 293, R39 (2007).

Peptide YY (Human, 3-36) PYY-4400-v 0.5 mg 455

PYY (Human, 3-36) -20 °C vial
Ile-Lys-Pro-Glu-Ala-Pro-Gly-Glu-Asp-Ala-Ser-Pro-Glu-Glu-Leu-Asn-
Arg-Tyr-Tyr-Ala-Ser-Leu-Arg-His-Tyr-Leu-Asn-Leu-Val-Thr-Arg-Gln-Arg-Tyr-NH2
(M.W. 4049.5) C180H279N53O54
Physiological Inhibitor for Food Intake / NPY Y2-Receptor Agonist
R.L. Batterham, et al., Nature, 418, 650 (2002). (Original; Inhibition of Food Intake)
G.A. Eberlein, et al., Peptides, 10, 797 (1989). (Original; Endogenous Form)
D.A. Keire, et al., Am. J. Physiol., 279, G126 (2000). (Original; NPY Y2 Receptor Selectivity)
S. Chamorro, et al., Int. J. Obesity., 26, 281 (2002). (Review; Y2 R Selectivity)
A. Sainsbury, et al., Proc. Natl. Acad. Sci. USA, 99, 8938 (2002). (Pharmacol.; Food intake Regulation through Y2R)

Order Hotline 1-800-777-4779 502-266-8787 97

 PRODUCT CODE QTY PRICE
BIOLOGICALLY ACTIVE PEPTIDES

Physalaemin
Physalaemin* PPY-4030-v 0.5 mg 40
(Frog, Physalaemus fuscumaculatus) -20 °C vial
Pyr-Ala-Asp-Pro-Asn-Lys-Phe-Tyr-Gly-Leu-Met-NH2
(M.W. 1265.4) C58H84N14O16S [2507-24-6]
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

Physalaemin* (Bulk) PPY-4030 25 mg 590

(Frog, Physalaemus fuscumaculatus) -20 °C
Pyr-Ala-Asp-Pro-Asn-Lys-Phe-Tyr-Gly-Leu-Met-NH2 • AcOH • 3H2O
(M.W. 1265.4 • 60.05 • 54.06) C58H84N14O16S • CH3COOH • 3H2O
V. Erspamer, A. Anastasi, G. Bertaccini, and J.M. Cei, Experientia, 20, 489 (1964). (Original)
L. Bernardi, G. Bosisio, O. Goffredo, and R. de Castiglione, Experientia, 20, 490 (1964). (Chem. Synthesis)
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

Pituitary Adenylate Cyclase Activating Polypeptide (PACAP)

A. Arimura, Peptides, 28, 1617 (2007). (Review)
J. Watanabe, et al., Peptides, 28, 1713 (2007). (Review)
M. Nakata and T. Yada, Curr. Pharm. Des., 13, 1105 (2007). (Review)
D. Vaudry, A. Falluel-Morel, S. Bourgault, M. Basille, D. Burel, O. Wurtz, A. Fournier, B.K. Chow, H. Hashimoto,
L. Galas, and H. Vaudry, Pharmacol. Rev., 61, 283 (2009). (Review)

PACAP38 (Human)* PPA-4221-v 0.5 mg 390

Pituitary Adenylate Cyclase Activating Polypeptide 38 (Human) -20 °C vial
(Ovine, Rat)
His-Ser-Asp-Gly-lle-Phe-Thr-Asp-Ser-Tyr-Ser-Arg-Tyr-Arg-Lys-Gln-Met-Ala-Val-Lys-
PEPTIDES INTERNATIONAL

Lys-Tyr-Leu-Ala-Ala-Val-Leu-Gly-Lys-Arg-Tyr-Lys-Gln-Arg-Val-Lys-Asn-Lys-NH2
(M.W. 4534.3) C203H331N63O53S
A. Miyata, et al., Biochem Biophys. Res. Commun., 164, 567 (1989). (Original)
• This compound is distributed through Peptide Institute, Inc. under the license of Tulane University.
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

PACAP27 (Human, 1-27 Amide)* PPA-4231-v 0.5 mg 260

Pituitary Adenylate Cyclase Activating Polypeptide 27 -20 °C vial
(Human, 1-27 Amide)
(Ovine, Rat)
His-Ser-Asp-Gly-Ile-Phe-Thr-Asp-Ser-Tyr-Ser-Arg-Tyr-Arg-
Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Ala-Ala-Val-Leu-NH2
(M.W. 3147.6) C142H224N40O39S [127317-03-7]
A. Miyata, et al., Biochem. Biophys. Res. Commun., 170, 643 (1990). (Original)
C. Kimura, et al., Biochem. Biophys. Res. Commun., 166, 81 (1990). (Original; Human and Bovine cDNA)
K. Ogi, et al., Biochem. Biophys. Res. Commun., 173, 1271 (1990). (Original: Rat cDNA)
• This compound is distributed through Peptide Institute, Inc. under the license of Tulane University.
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

98 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT CODE QTY PRICE
PACAP (Human, 6-38) PPA-4286-v 0.5 mg 390

BIOLOGICALLY ACTIVE PEPTIDES

Pituitary Adenylate Cyclase Activating Polypeptide (Human, -20 °C vial
6-38)
(Ovine, Rat)
Phe-Thr-Asp-Ser-Tyr-Ser-Arg-Tyr-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-
Ala-Ala-Val-Leu-Gly-Lys-Arg-Tyr-Lys-Gln-Arg-Val-Lys-Asn-Lys-NH2
(M.W. 4024.7) C182H300N56O45S [143748-18-9]
PACAP Selective Antagonist
P. Robberecht, P. Gourlet, P. De Neef, M-C. Woussen-Colle, M-C. Vandermeers-Piret,
A. Vandermeers, and J. Christophe, Eur. J. Biochem., 207, 239 (1992). (Original)
A. Vandermeers, S. Vandenborre, X. Hou, P. De Neef, P. Robberecht, M-C. Vandermeers-Piret,
and J. Christophe, Eur. J. Biochem., 208, 815 (1992). (Pharmacol.)

Platelet Factor-4 Related Peptide

Platelet Factor-4 (Human, 58-70) IPF-4305-v 0.5 mg 60
Pro-Leu-Tyr-Lys-Lys-Ile-Ile-Lys-Lys-Leu-Leu-Glu-Ser -20 °C vial
(M.W. 1573.0) C76H133N17O18 [82989-21-7]
Angiogenesis Inhibitor
T.E. Maione, G.S. Gray, J. Petro, A.J. Hunt, A.L. Donner, S.I. Bauer,
H.F. Carson, and R.J. Sharpe, Science, 247, 77 (1990). (Original)

Plectasin
Plectasin (PDF-4432-s) is a newly discovered defensin and the first to be isolated
from a fungus, Pseudoplectania nigrella.1 This peptide was shown to cure mice of S.
pneumoniae induced, experimental peritonitis and pneumonia just as well as antibi-
otic treatment. The same concentration of plectasin that alters microbial growth also

PEPTIDES INTERNATIONAL
effectively kills the bacteria, suggesting the process is irreversible. Plectasin is also
effective against antibiotic resistant strains of S. pneumoniae and exhibits low toxic-
ity in mice models. This peptide should prove to be an exciting new addition to our
growing number of antimicrobial products.
1. Mygind, et al., Nature, 437, 975 (2005). (Original ; Structure & Antimicrobial Activity)

Plectasin PDF-4432-s 0.1 mg 275

(Fungus, Pseudoplectania nigrella) -20 °C vial
Gly-Phe-Gly-Cys-Asn-Gly-Pro-Trp-Asp-Glu-Asp-Asp-Met-Gln-
Cys-His-Asn-His-Cys-Lys-Ser-Ile-Lys-Gly-Tyr-Lys-Gly-Gly-
Tyr-Cys-Ala-Lys-Gly-Gly-Phe-Val-Cys-Lys-Cys-Tyr
(M.W. 4401.9) C189H267N53O56S7
Antimicrobial Peptide
P.H. Mygind, et al., Nature, 437, 975 (2005). (Original; Structure & Antimicrobial Activity)
S. Hara, et al., Biochem. Biophys. Res. Commun., 374, 709 (2008). (Pharmacol.)
K. Mandal, et al., Protein Sci., 18, 1146 (2009). (X-ray Structure)
T. Schneider, et al., Science, 328, 1168 (2010). (Pharmacol.)

Order Hotline 1-800-777-4779 502-266-8787 99

 PRODUCT CODE QTY PRICE
BIOLOGICALLY ACTIVE PEPTIDES

Pleiotrophin
Pleiotrophin (Human) PTN-4335-v 50 µg 360
PTN (Human) -20 °C vial
Gly-Lys-Lys-Glu-Lys-Pro-Glu-Lys-Lys-Val-Lys-Lys-Ser-Asp-Cys-Gly-Glu-Trp-Gln-Trp-Ser-Val-Cys-Val-Pro-
Thr-Ser-Gly-Asp-Cys-Gly-Leu-Gly-Thr-Arg-Glu-Gly-Thr-Arg-Thr-Gly-Ala-Glu-Cys-Lys-Gln-Thr-Met-Lys-
Thr-Gln-Arg-Cys-Lys-Ile-Pro-Cys-Asn-Trp-Lys-Lys-Gln-Phe-Gly-Ala-Glu-Cys-Lys-Tyr-Gln-Phe-Gln-Ala-Trp-
Gly-Glu-Cys-Asp-Leu-Asn-Thr-Ala-Leu-Lys-Thr-Arg-Thr-Gly-Ser-Leu-Lys-Arg-Ala-Leu-His-Asn-Ala-Glu-
Cys-Gln-Lys-Thr-Val-Thr-Ile-Ser-Lys-Pro-Cys-Gly-Lys-Leu-Thr-Lys-Pro-Lys-Pro-Gln-Ala-Glu-Ser-Lys-Lys-
Lys-Lys-Lys-Glu-Gly-Lys-Lys-Gln-Glu-Lys-Met-Leu-Asp
(Disulfide bonds between Cys15-Cys44, Cys23-Cys53, Cys30-Cys57, Cys67-Cys99, and Cys77-Cys109)
(M.W. 15302.6) C658H1079N197O198S12
Heparin-Binding Growth Factor (Neurite Outgrowth-Promoting Factor)
Y.-S. Li, et al., Science, 250, 1690 (1990). (Primary Structure)
P.G. Milner, et al., Biochemistry, 31, 12023 (1992). (Nucleotide Seq.; Human)
F. Czubayko, A.M. Schulte, G.J. Berchem, and A. Wellstein, Proc. Natl. Acad. Sci. U.S.A., 93, 14753 (1996). (Pharmacol.)
T. Inui, et al., J. Pept. Res., 55, 384 (2000). (Chem. Synthesis & S-S Bond)

PLTX-II See Code PPL-4300-s in the Toxins section.

Prolactin-Releasing Peptides
B. Sun, K. Fujiwara, S. Adachi, and K. Inoue, Regul. Pept., 126, 27 (2005). (Review)
S. Fukusumi, R. Fujii, and S. Hinuma, Peptides, 27, 1073 (2006). (Review)
D.A. Bechtold and S.M. Luckman, J. Endocrinol., 192, 3 (2007). (Review)

Prolactin-Releasing Peptide (Human) PPR-4352-v 0.5 mg 305

PrRP31 (Human) -20 °C vial
Ser-Arg-Thr-His-Arg-His-Ser-Met-Glu-Ile-Arg-Thr-Pro-Asp-Ile-Asn-
PEPTIDES INTERNATIONAL

Pro-Ala-Trp-Tyr-Ala-Ser-Arg-Gly-Ile-Arg-Pro-Val-Gly-Arg-Phe-NH2
(M.W. 3664.1) C160H252N56O42S
Multifunctional Peptide in Neuroendocrinology
S. Hinuma, et al., Nature, 393, 272 (1998). (Original, cDNA)
F. Satoh, et al., Br. J. Pharmacol., 129, 1787 (2000). (Pharmacol.)
• This compound is distributed through Peptide Institute, Inc. under the license of Takeda Chemical Industries, Ltd.

Prolactin-Releasing Peptide (Rat) PPR-4353-v 0.5 mg 305

PrRP31 (Rat) -20 °C vial
Ser-Arg-Ala-His-Gln-His-Ser-Met-Glu-Thr-Arg-Thr-Pro-Asp-Ile-Asn-
Pro-Ala-Trp-Tyr-Thr-Gly-Arg-Gly-Ile-Arg-Pro-Val-Gly-Arg-Phe-NH2
(M.W. 3594.0) C156H242N54O43S
Multifunctional Peptide in Neuroendocrinology
S. Hinuma, et al., Nature, 393, 272 (1998). (Original; cDNA)
M. Maruyama, et al., Neurosci. Lett., 276, 193 (1999). (Pharmacol.)
F. Satoh, et al., Br. J. Pharmacol., 129, 1787 (2000). (Pharmacol.)
H. Matsumoto, et al., Neurosci. Lett., 285, 234 (2000). (Pharmacol.)
• This compound is distributed through Peptide Institute, Inc. under the license of Takeda Chemical Industries, Ltd.

Prolactin Releasing Hormone See Code PTR-4011 TRH.

Renin Substrate See Code MRP-3110 Suc-Arg-Pro-Phe-His-Leu-Leu-Val-Tyr-MCA in the Enzyme Inhibitors
and Substrates section.
Renin Substrate See Code SDH-4133 Asp-Arg-Val-Tyr-lle-His-Pro-Phe-His-Leu-Val-Ile-His in the Enzyme
Inhibitors and Substrates section.

100 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT CODE QTY PRICE
Protease-Activated Receptor (PAR) Peptides

BIOLOGICALLY ACTIVE PEPTIDES

N. Vergnolle, Br. J. Pharmacol., 141, 1264 (2004). (Review)

Proteinase-activated receptor (PAR) is a unique member of the G protein-coupled

receptor (GPCR) family that is activated primarily by proteases. PAR2 is activated
by trypsin cleavage which can lead to a diverse number of physiological responses.
For example, PARs have been reported to relax tracheal and bronchial smooth
muscle cells and participate in hypotension, arterial vasodilation in diabetes, and
gastric secretions.1-4 PAR participation in tissue repair, cell survival, and inflammation
following injury indicates that it may play an important role in controlling inflammatory-
mediated diseases as well. In addition, PAR2 is expressed by a wide number of tumor
cells including breast and colon cancers, suggesting a role in angiogenesis. 5,6
1. A. Kawabata, et al., J. Pharmacol. Exp. Ther., 311,402 (2004)..
2. Cicala, et al., THE FASEB J., 10, 1996 (2001).
3. F. Roviezzo, et al., Arteriosclerosis, Thrombosis, and Vasc. Biol., 25, 2349 (2005).
4. Kawao, et al., British J. of Pharm., 135, 1292 (2002).
5. D. Darmoul, V. Gratio, H. Devaud, T. Lehy, and M. Laburthe, Am. J. Patho., 162, 1503 (2003).
6. S. Even-Ram, et al., Nat. Med., 4, 909 (1998).

Protease-Activated Receptor 1 (PAR1)

H-Ala-Phe(para-Fluoro)-Arg-Cha-Cit-Tyr-NH2 PAR-3931-PI 1 mg 190
H-Ala-Phe(4-F)-Arg-Cha-Cit-Tyr-Amide -20 °C 5 mg 780
(M.W. 883.04) C42H63N12O8F
Protease-Activated Receptor 1 (PAR1) Agonist
A. Kawabata, M. Saifeedine, B. A-Ani, L. Leblond, and M.D. Hollenberg, J. of Pharm. and Exper. Therap., 288, 358 (1999)

PEPTIDES INTERNATIONAL
H-Phe-Leu-Leu-Arg-Asn-OH PAR-3944-PI 1 mg 35
FLLRN -20 °C 5 mg 139
(M.W. 661.81) C31H51N9O7
Protease-Activated Receptor 1 (PAR1) Antagonist
R.R. Vassallo, Jr, T. Kieber-Emmons, K. Cichowski, and L.F Brass, J. Biol. Chem., 267, 6081 (1992)

H-Ser-Phe-Leu-Leu-Arg-NH2 PAR-3942-PI 1 mg 35
SFLLR-Amide -20 °C 5 mg 139
(M.W. 633.80) C30H51N9O6
Protease-Activated Receptor 1 (PAR1) Antagonist
MD. Hollenberg, S.G. Yang, A.A. Laniyonu, C.J. Moore, and M. Saifeddine, Mol. Pharmacol., 42, 186 (1992).

H-Ser-Phe-Leu-Leu-Arg-OH PAR-3936-PI 1 mg 35
SFLLR -20 °C 5 mg 139
(M.W. 634.78) C30H50N8O7
Acid Form of PAR-3942-PI
H.-S. Ahn, C. Foster, G. Boykow, L. Arik, A.S.-Torhan, D. Hesk, and M. Chatterjee, Mol. Pharmacol., 51, 350 (1997).
M.D. Hollenberg, S.G. Yang, A.A. Laniyonu, C.J. Moore, and M. Saifeddine, Mol. Pharmacol., 42, 186 (1992).

H-Phe-Thr-Leu-Leu-Arg-Asn-Pro- PAR-3926-PI 1 mg 59
Asn-Asp-Lys-NH2 -20 °C 5 mg 225
FTLLRNPNDK-Amide
(M.W. 1216.42) C54H89N17O15
Protease-Activated Receptor 1 (PAR1) Negative Control Peptide for PAR1 Agonist PAR-3925-PI
B.D. Blackhart, K. Emilsson, D. Nguyen, W. Teng, A.J. Martelli, S. Nystedt, J. Sundelin, and R.M. Scarborough,
J. Biol. Chem., 271, 16466 (1996).

Order Hotline 1-800-777-4779 502-266-8787 101

 PRODUCT CODE QTY PRICE
BIOLOGICALLY ACTIVE PEPTIDES

H-Ser-Phe-Leu-Leu-Arg-Asn-OH PAR-3943-PI 1 mg 35
SFLLRN -20 °C 5 mg 139
(M.W. 748.89) C34H56N10O9
Acid Form of PAR-3676-PI
H.-S. Ahn, C.Foster, G. Boykow, L. Arik, A.S.-Torhan, D. Hesk, and M. Chatterjee, Mol. Pharmacol., 51, 350 (1997).
R.R. Vassallo, Jr, T. Kieber-Emmons, K. Cichowski, and L.F. Brass, J. Biol. Chem., 267, 6081 (1992).

H-Ser-Phe-Leu-Leu-Arg-Asn-Pro-OH PAR-3945-PI 1 mg 35
SFLLRNP -20 °C 5 mg 139
(M.W. 846.00) C39H63N11O10
Protease-Activated Receptor 1 (PAR1) Agonist
M.L. Webb, D.S. Taylor, and C.J. Molloy, Biochem. Pharmacol., 45, 1577 (1993).

H-Ser-Phe-Leu-Leu-Arg-Asn-Pro-Asn-Asp- PAR-3935-PI 1 mg 55
Lys-Tyr-Glu-Pro-Phe-NH2 -20 °C 5 mg 220
SFLLRNPNDKYEPF-Amide
(M.W. 1738.98) C81H119N21O22
J.R. Ngaiza and E.A. Jaffe, Biochem. Biophys. Res. Commun., 179, 1656 (1991).
D.M. Feng, D.F. Veber, T.M. Connolly, C. Condra, M.J. Tang, and R.F. Nutt, J. Med. Chem.,38,4125 (1995).

H-Ser-Phe-Leu-Leu-Arg-Asn-Pro-Asn-Asp- PAR-3934-PI 1 mg 55
Lys-Tyr-Glu-Pro-Phe-OH -20 °C 5 mg 220
SFLLRNPNDKYEPF
(M.W. 1739.96) C81H118N20O23
Acid Form of PAR-3935-PI
H.-S. Ahn, C. Foster, G. Boykow, L. Arik, A.S.-Torhan, D. Hesk, and M. Chatterjee, Mol. Pharmacol., 51, 350 (1997).
PEPTIDES INTERNATIONAL

J.R. Ngaiza and E.A. Jaffe, Biochem. Biophys. Res. Commun., 179, 1656 (1991).
D.M. Feng, D.F. Veber, T.M. Connolly, C. Condra, M.J. Tang,and R.F. Nutt, J. Med. Chem.,38, 4125 (1995).

H-Ser-Phe-Leu-Leu-Cit-OH PAR-3941-PI 1 mg 55
SFLLcit -20 °C 5 mg 220
(M.W. 635.77) C30H49N7O8
Protease-Activated Receptor 1 (PAR1) Agonist
T. Sabo, et al., Biochem. Biophys. Res. Commun., 188, 604 (1992).

H-Thr-Phe-Leu-Leu-Arg-Asn- PAR-3925-PI 1 mg 59
Pro-Asn-Asp-Lys-NH2 -20 °C 5 mg 225
TFLLRNPNDK-Amide
(M.W. 1216.42) C54H89N17O15
Protease-Activated Receptor 1 (PAR1) Agonist.
B.D. Blackhart, K. Emilsson, D. Nguyen, W. Teng, A.J. Martelli, S. Nystedt, J. Sundelin,
and R.M. Scarborough, J. Biol. Chem., 271, 16466 (1996)

H-Ser-Phe-Leu-Leu-Arg-Asn-NH2 PAR-3676-PI 1 mg 45
SFLLRN-Amide -20 °C 5 mg 179
(M.W. 747.90) C34H57N11O8
Selective Protease-Activated Receptor 1 (PAR1) Agonist
R.R. Vassallo, Jr., T. Kieber-Emmons, K. Cichowski, and L.F. Brass, J. Biol. Chem., 267, 6081 (1992).

H-Thr-Phe-Leu-Leu-Arg-NH2 PAR-3665-PI 1 mg 65
TFLLR-Amide -20 °C 5 mg 195
(M.W. 647.82) C31H53N9O6
Protease-Activated Receptor 1 (PAR1) Agonist
M.D. Hollenberg, M. Saifeddine, B. al-Ani, and A. Kawabata, Can. J. Physiol. Pharmacol., 75, 832 (1997).

102 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT CODE QTY PRICE
H-Arg-Leu-Leu-Phe-Thr-NH2

BIOLOGICALLY ACTIVE PEPTIDES

PAR-3695-PI 1 mg 65
RLLFT-Amide -20 °C 5 mg 195
(M.W. 647.82) C31H53N9O6
Protease-Activated Receptor 1 (PAR1) Negative Control Peptide
S. Asfaha, V. Brusse, K. Chapman, D.W. Zochodne, and N. Vergnolle, Br. J. Pharmacol., 135, 1101 (2002).
M. Fang, J. K.J. Kovacs, L.L. Fisher, and A.A. Larson, Physiol., 549, 903 (2003).

Protease-Activated Receptor 2 (PAR2)

2-Furoyl-Orn-Leu-Arg-Gly-Ile-Leu-NH2 PAR-3951-PI 1 mg 69
2-Furoyl-OrnLRGIL-Amide -20 °C 5 mg 225
(M.W. 777.97) C36H63N11O8
25 mg 795
Protease-Activated Receptor 2 (PAR2 ) Negative Control Peptide for PAR-3663-PI
J.J. McGuire, M. Saifeddine, C.R. Triggle, K. Sun, and M.D. Hollenberg, J. of Pharm. Exp. Ther., 309, 1124 (2004).

2-Furoyl-Leu-Ile-Gly-Arg-Leu-Orn-NH2 PAR-3663-PI 1 mg 75
2-Furoyl-LIGRLO-Amide -20 °C 5 mg 215
(M.W. 777.97) C36H63N11O8
Potent and Selective Protease-Activated Receptor 2 (PAR2) Agonist
J.J. McGuire, M. Saifeddine, C.R. Triggle, K. Sun, and M.D. Hollenberg, J Pharmacol. Exp. Ther., 309, 1124 (2004).

3-Mercaptopropionyl-Phe-Cha-Cha-Arg-Lys- PAR-3677-PI 1 mg 115

Pro-Asn-Asp-Lys-NH2 -20 °C 5 mg 460
3-Mercaptopropionyl-F-Cha-Cha-RKNDK-Amide
(M.W. 1297.64) C61H100N16O13S.
Protease-Activated Receptor 1 (PAR1) Antagonist / Protease-Activated Receptor 2 (PAR2) Agonist

PEPTIDES INTERNATIONAL
A. Kawabata,et al., J. Pharmacol. and Experim. Therapeutics, 88, 358 (1999).
S.M. Seiler, et al., Biochem. Pharmacol., 49, 519 (1995)

H-Ser-Leu-Ile-Gly-Arg-Leu-NH2 PAR-3664-PI 1 mg 45
SLIGRL-Amide -20 °C 5 mg 179/
(M.W. 656.83) C29H56N10O7
Protease-Activated Receptor 2 (PAR2) Agonist
B. Al-Ani, M. Saifeddine, and M.D. Hollenberg, Can. J. of Physiol. Pharmacol., 73, 1203 (1995).

H-Leu-Ser-Ile-Gly-Arg-Leu-NH2 PAR-3913-PI 1 mg 45
LSIGRL-Amide -20 °C 5 mg 179
(M.W. 656.83) C29H56N10O7
Protease-Activated Receptor 2 (PAR2) Negative Control for PAR-3664-PI
H. Nishikawa, et al., J. Pharm. and Experim. Therap., 312, 324 (2005).

H-Ser-Leu-Ile-Gly-Arg-Leu-OH PAR-3940-PI 1 mg 35
SLIGRL -20 °C 5 mg 139
(M.W. 657.82) C29H55N9O8
Acid Form of PAR-3664-PI
A. Bhattacharya, G.F. Smith, and M.L. Cohen, J. Pharmacol. Exp. Ther., 297, 573 (2001).
B. Al-Ani, M. Saifeddine, and M.D. Hollenberg, Can. J. of Physiol. Pharmacol., 73, 1203 (1995).

H-Ser-Leu-Ile-Gly-Arg-NH2 PAR-3743-PI 1 mg 45
SLIGR-Amide -20 °C 5 mg 179
(Trifluoroacetate Form)
(M.W. 543.67) C23H45N9O6
PAR2 Agonist
R.M. Scarborough, Curr. Med. Chem., 1, 73 (2003).
B. Al-Ani, et al., J. Pharmacol. And Experim Therapm., 290, 753 (1999).

Order Hotline 1-800-777-4779 502-266-8787 103

 PRODUCT CODE QTY PRICE
BIOLOGICALLY ACTIVE PEPTIDES

H-Phe-Ser-Leu-Leu-Arg-Tyr-NH2 PAR-3888-PI 1 mg 35
FSLLRY-Amide -20 °C 5 mg 139
(M.W. 796.98) C39H60N10O8
Selective Antagonist for Protease-Activated Receptor 2 (PAR2) Agonist
FSLLRY-NH2 blocks trypsin but not SLIGRL-NH2 activation of PAR2 in receptor-expressing KNRK cells.
B. Al-Ani, M. Saifeddine, S.J. Wijesuriya, and M.D. Hollenberg, J. Pharmacol. Exp. Ther., 300, 702 (2002).
S.Wilson, B. Greer, J. Hooper, A. Zijlstra, B. Walker, J. Quigley, and S. Hawthorne, Biochem. J., 388, 967 (2005).

H-Ser-Leu-Ile-Gly-Lys-Val-NH2 PAR-3889-PI 1 mg 35
SLIGKV-Amide -20 °C 5 mg 139
(M.W. 614.79) C25H54N8O7
PAR2 Tethered Ligand (Human) / Protease-Activated Receptor 2 (PAR2) Agonist
S.K. Bohm, et al., Biochem. J., 314, 1009 (1996).

H-Leu-Ser-Ile-Gly-Lys-Val-NH2 PAR-3920-PI 1 mg 45
LSIGKV-Amide -20 °C 5 mg 175
(M.W. 614.79) C28H54N8O7
Protease-Activated Receptor 2 (PAR2) Negative Control Peptide for PAR-3889-PI
I.A. Akers, et al., Am. J. Physiol. Lung Cell. Mol. Physiol., 278, L193 (2000).
S. Miyata, N. Koshikawa, H. Yasumitsu, and K. Miyazaki, J. Biol. Chem., 275, 4592 (2000).
S. Miike, A.S. McWilliam, and H. Kita, J. Immunol., 167, 6615 (2001).

H-Ser-Leu-Ile-Gly-Lys-Val-OH PAR-3938-PI 1 mg 35
SLIGKV -20 °C 5 mg 139
(M.W. 615.78) C28H53N7O8
Acid Form of PAR-3889-PI
S.K. Bohm,et al., Biochem. J., 314, 1009 (1996).
PEPTIDES INTERNATIONAL

W.R. Ferrell, et al., J. Clin. Invest., 111, 35 (2003)..

Protease-Activated Receptor 3 PAR3

H-Thr-Phe-Arg-Gly-Ala-Pro-NH2 PAR-3689-PI 1 mg 45
TFRGAP-Amide -20 °C 5 mg 179
(M.W. 646.75) C29H46N10O7
PAR3 Tethered Ligand (Human) / Activates PAR1 and PAR2
K.K. Hansen, M. Saifeddine, and M.D. Hollenberg, Immunology, 112, 183 (2004).

H-Ser-Phe-Asn-Gly-Gly-Pro-NH2 PAR-3691-PI 1 mg 45
SFNGGP-Amide -20 °C 5 mg 179
(M.W. 576.61) C25H36N8O8
PAR3 Tethered Ligand (Murine) / Activates PAR1 and PAR2
K.K. Hansen, M. Saifeddine, and M.D. Hollenberg, Immunology, 112, 183 (2004).

Protease-Activated Receptor 4 (PAR4)

H-Gly-Tyr-Pro-Gly-Lys-Phe-NH2 PAR-3672-PI 1 mg 45
GYPGKF-Amide -20 °C 5 mg 179
(M.W. 666.78) C33H46N8O7
PAR4 Tethered Ligand (Murine) / Protease-Activated Receptor 4 (PAR4) Agonist
M.L. Kahn, et al., Nature, 394, 690 (1998).
M.L. Kahn, M. Nakanishi-Matsui, M. J. Shapiro, H. Ishihara, and S.R. Coughlin, J. Clin. Invest., 103, 879 (1999).
M.D. Hollenberg, M Saifeddine, B Al-Ani, and Y. Gui, Can. J. Physiol. Pharmacol., 77, 458 (1999).

104 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT CODE QTY PRICE
H-Gly-Tyr-Pro-Gly-Gln-Val-NH2

BIOLOGICALLY ACTIVE PEPTIDES

PAR-3673-PI 1 mg 45
GYPGQV-Amide -20 °C 5 mg 179
(M.W. 618.70) C28H42N8O8
PAR4 Tethered Ligand (Human) / Protease-Activated Receptor 4 (PAR4) Agonist
W. Xu, et al., Proc. Nat’l. Acad. Sci. U.S.A., 95, 6642 (1998).
M.D. Hollenberg, M. Saifeddine, B. Al-Ani, and Y. Gui, Can. J. Physiol. Pharmacol., 77, 458 (1999).

H-Ala-Tyr-Pro-Gly-Lys-Phe-OH PAR-3939-PI 1 mg 35
AYPGKF -20 °C 5 mg 135
(M.W. 681.80) C34H47N7O8
Acid form of PAR-3674-PI
E.A. Lidington, R. Steinberg, A.R. Kinderlerer, R.C. Landis, M. Ohba, A. Samarel, D.O. Haskard, and J.C. Mason,
Am J Physiol Cell Physiol, 289, C1437 (2005).
M.D. Hollenberg, M. Saifeddine, S. Sandhu, S. Houle, and N. Vergnolle, Br. J. Pharmacol., 143, 443 (2004)

H-Ala-Phe(para-Fluoro)-Arg-Cha-homo PAR-3932-PI 1 mg 195

Arg-Tyr-NH2 -20 °C 5 mg 780
H-Ala-Phe(4-F)-Arg-Cha-homoArg-Tyr-Amide
Thrombin Receptor Activating Peptide
D.M. Feng, D.F. Veber, T.M. Connolly, C. Condra, M.J. Tang, and R.F. Nutt, J. Med. Chem.,38 4125 (1995).
H.-S. Ahn, C.Foster, G. Boykow, L. Arik, A. S.-Torhan, D. Hesk, and M. Chatterjee, Mol. Pharmacol., 51, 350 (1997).

H-Ala-Tyr-Pro-Gly-Lys-Phe-NH2 PAR-3674-PI 1 mg 45
AYPGKF-Amide -20 °C 5 mg 179
(M.W. 680.81) C34H48N8O7
Selective Protease-Activated Receptor 4 (PAR4) Agonist.
M.D. Hollenberg, M. Saifeddine, B. Al-Ani, and Y. Gui, Can. J. Physiol. Pharmacol., 77, 458 (1999).

PEPTIDES INTERNATIONAL
T.R. Faruqi, E.J. Weiss, M.J. Shapiro, W. Huang, and S.R. Coughlin, J. Biol. Chem., 275, 19728 (2000).
M.D. Hollenberg, M. Saifeddine, S. Sandhu, S. Houle, and N. Vergnolle, Br. J. Pharmacol., 143, 443 (2004)

H-Tyr-Ala-Pro-Gly-Lys-Phe-NH2 PAR-3933-PI 1 mg 35
YAPGKF-Amide -20 °C 5 mg 139
(M.W. 680.81) C34H48N8O7
Protease-Activated Receptor 4 (PAR4) Negative Control Peptide for PAR-3674-PI
M.D. Hollenberg, M. Saifeddine, S. Sandhu, S. Houle, and N. Vergnolle, Br. J. Pharmacol., 143, 443 (2004).

trans-Cinnamoyl-Tyr-Pro-Gly-Lys-Phe-NH2 PAR-3675-PI 1 mg 65
trans-Cinnamoyl-YPGKF-Amide -20 °C 5 mg 195
(M.W. 739.88) C40H49N7O7
Selective Protease-Activated Receptor 4 (PAR4) Agonist
L. Ma, M.D. Hollenberg, and J.L. Wallace, Br. J. Pharmacol., 134, 701 (2001).
M.D. Hollenberg and M. Saifeddine, Can. J. Physiol. Pharmacol., 79, 439 (2001).

Order Hotline 1-800-777-4779 502-266-8787 105

 PRODUCT CODE QTY PRICE
BIOLOGICALLY ACTIVE PEPTIDES

Pyroglutamylated RFamide Peptide

The group of Takeda Pharmaceutical Company Limited has long been involved in
discovering orphan receptor ligands and identified a novel peptide in human utiliz -
ing the recently established gene database. Actually, they searched the database
to detect peptides with the carboxyl-terminal Arg-Phe-NH2 (RFamide) moiety in the
mature peptide. As a result, the peptide termed Pyroglutamylated RFamide pep-
tide (QRFP) was identified by analyzing the expressed peptide in Chinese hamster
ovary cells as a 43 amino acid residue peptide.1 The peptide corresponding to the
carboxyl-terminal 26 amino acid residues of QRFP was also predicted by another
group using a similar approach and then termed P518.2 Both of these peptides were
found to interact with an orphan receptor (AQ27/SP9155/GPR103; all of these denote
the same orphan receptor of interest). Human 26RFa was proposed by another
group based on the primary structure of their determined frog peptide in which 26RFa
is identical to P518.3 The biological activities of QRFP and 26RFa reported are: i)
upon intravenous administration in rats at doses between 40 and 400 nmol/kg, QRFP
induced aldosterone secretion in a dose-dependent manner, ii) intracerebroventricular
administration of 26RFa in mice (after partial food deprivation for 18 h) stimulated food
intake at doses of 100 and 1000 ng/mouse, iii) central QRFP (rat QRFP is used in
this report) administration evoked feeding, behavioral arousal, and elevation of blood
pressure in mice4, and iv) intracerebroventricular infusion of QRFP increased fat mass
and decreased rectal temperature in mice.5 QRFP might have variable activities other
than those identified, thus, it should serve as an essential member of the RFamide
family peptides in humans.
PEPTIDES INTERNATIONAL

1. S. Fukusumi, et al., J. Biol. Chem., 278, 46387 (2003). (Original: QRFP)

2. Y. Jiang, et al., J. Biol. Chem., 278, 27652 (2003). (Orphan Receptor Ligand / 26-Residue Peptide, P518)
3. N. Chartrel, et al., Proc. Natl. Acad. Sci. U.S.A., 100, 15247 (2003). (26-Residue Peptide, 26RFa)
4. S. Takayasu, et al. Proc. Natl. Acad, Sci. U.S.A., 103, 7438 (2006). (Pharmacol.)
5. R. Moriya, et al., Endocrinology, 147, 2916 (2006). (Pharmacol.)
6. S. Fukusumi, R. Fujii, and S. Hinuma, Peptides, 27, 1073 (2006). (Review)
7. D.A. Bechtold and S.M. Luckman, J. Endocrinol., 192, 3 (2007). (Review)

Pyroglutamylated RFamide Peptide (Human) PRF-4419-s 0.1 mg 160

QRFP (Human) -20 °C vial
Pyr-Asp-Glu-Gly-Ser-Glu-Ala-Thr-Gly-Phe-Leu-Pro-Ala-Ala-Gly-Glu-
Lys-Thr-Ser-Gly-Pro-Leu-Gly-Asn-Leu-Ala-Glu-Glu-Leu-Asn-Gly-
Tyr-Ser-Arg-Lys-Lys-Gly-Gly-Phe-Ser-Phe-Arg-Phe-NH2
(M.W. 4503.8) C199H301N55O65
Endogenous Ligand for AQ27 / SP9155 / GPR103
Pyr-Lys-Arg-Pro-Ser-Gln-Arg-Ser-Lys-Tyr-Leu See Code SKL-4237-v.
QRFP (Human) See Code PRF-4419-s Pyroglutamylated RFamide Peptide (Human).
Renin Substrate See Code MRP-3110.
Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-Val-Ile-His See Code SDH-4133-v.

106 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT CODE QTY PRICE
RF Amide Related Peptides

BIOLOGICALLY ACTIVE PEPTIDES

RFamide-Related Peptide-1 (Human) PRF-4380-s 0.1 mg 150
RFRP-1 (Human) -20 °C vial
Ser-Leu-Asn-Phe-Glu-Glu-Leu-Lys-Asp-Trp-Gly-Pro-Lys-Asn-Val-Ile-
Lys-Met-Ser-Thr-Pro-Ala-Val-Asn-Lys-Met-Pro-His-Ser-Phe-Ala-Asn-Leu-Pro-Leu-Arg-Phe-NH2
(M.W. 4256.9) C195H304N52O51S2
Endogenous Ligand for OT7T022 / FF1
D.A. Price and M.J. Greenberg, Science, 197, 670 (1977). (Original: FMRF-Amide)
S. Fukusumi, et al., Biochim. Biophys. Acta, 1540, 221 (2001). (Endogenous Form)
S. Hinuma, et al., Nat. Cell Biol., 2, 703 (2000). (Original: cDNA & Pharmacol. of RFRP-1)
Q. Liu, et al., . Biol. Chem., 276, 36961 (2001). (Original: NPSF)
T. Yano, N. Iijima, K. Kakihara, S. Hinuma, M. Tanaka, and Y. Ibata, Brain Res., 982, 156 (2003). (Histochem.)
A. Pertovaara, et al., Neuroscience, 134, 1023 (2005). (Pharmacol.)
S. Fukusumi, R. Fujii, and S. Hinuma, Peptides, 27, 1073 (2006). (Review)
D.A. Bechtold and S.M. Luckman, J. Endocrinol., 192, 3 (2007). (Review)
• This compound is distributed through Peptide Institute, Inc. under the license of Takeda Chemical Industries, Ltd.

RFamide-Related Peptide-3 (RFRP-3)

RFamide-Related Peptide-3 (RFRP-3) was discovered from the cDNA sequences, in
which two other family peptides, RFRP-1 (Code 4380-s for one of the endogenous
forms) and RFRP-2 are encoded.1,2 Endogenous forms of human and rat RFRP-
3 were determined to be an 8- and 18-residue peptide, respectively.3,4 Biological
activities of RFRP-3 include:
• function as gonadotropin inhibitory hormone (GnIH), resulting in the reduction
in LH secretion
• increase in food intake and growth hormone secretion

PEPTIDES INTERNATIONAL
• no effect on Kiss-1 mRNA expression.5,6
RFRP-3 should be especially valuable research tools in reproduction and puberty
studies.
1. S. Hinuma, et al., Nat.Cell Biol., 2, 703 (2000). 4. K. Ukena, et al.,, FEBS Lett., 512, 255 (2002).
(Original: Human & Rat cDNA) (Endogenous Form: Rat RFRP-3)
2. I.J. Clarke, et al., Endocrinology, 149, 5811 (2008). 5. I.J. Clarke, et al., Front.Neuroendocrinol., 30, 371 (2009).
(Original: Ovine cDNA) (Review: Pharmacol.)
3. T. Ubuka, et al., PLoS One., 4, e8400 (2009). 6. M.A. Johnson and G.S. Fraley, Neuroendocrinology, 88,
(Endogenous Form: Human RFRP-3) 305 (2008). (Pharmacol.)

RFamide-Related Peptide-3 (Human) PRF-4461-v 0.5 mg 80

RFRP-3 (Human) -20 °C vial
(Ovine)
Val-Pro-Asn-Leu-Pro-Gln-Arg-Phe-NH2
(M.W. 969.14) C45H72N14O10
Gonadotropin-Inhibitory Hormone

RFamide-Related Peptide-3 (Rat) PRF-4462-v 0.5 mg 110

RFRP-3 (Rat) -20 °C vial
Ala-Asn-Met-Glu-Ala-Gly-Thr-Met-Ser-His-
Phe-Pro-Ser-Leu-Pro-Gln-Arg-Phe-NH2
(M.W. 2020.30) C88H134N26O25S2
Gonadotropin-Inhibitory Hormone
S. Hinuma, et al., Endocrinology, 149, 5811 (2008). (Original: Ovine cDNA)
T. Yamamoto, et al., Nat. Cell Biol., 2, 703 (2000). (Original: cDNA)
K. Ukena, et al., FEBS Lett., 512, 255 (2002). (Identification of RERP-3 in Rat Hypothalamus)
M.A. Johnson, K. Tsutsui, and G.S. Fraley, Horm. Behav., 51,171 (2007). (Pharmacol.)
M.A. Johnson and G.S. Fraley, Neuroendocrinology, 88,305 (2008). (Pharmacol.)
E. Ducret, G.M. Anderson, and A.E. Herbison,Endocrinology, 150, 2799 (2009). (Pharmacol.)

Order Hotline 1-800-777-4779 502-266-8787 107

 PRODUCT CODE QTY PRICE
BIOLOGICALLY ACTIVE PEPTIDES

Salusins
Salusin-a (Human) PSL-4417-s 0.1 mg 150
Ser-Gly-Ala-Leu-Pro-Pro-Ala-Pro-Ala-Ala-Pro-Arg-Pro-Ala- -20 °C vial
Leu-Arg-Ala-Gln-Arg-Ala-Gly-Pro-Ala-Gly-Pro-Gly-Ala-Lys-
NH2
(M.W. 2603.0 ) C114H192N40O30
Hypotensive / Mitogenic Peptide

Salusin-b (Human) PSL-4418-s 0.1 mg 120

Ala-Ile-Phe-Ile-Phe-Ile-Arg-Trp-Leu-Leu-Lys-Leu-Gly-His-His- -20 °C vial
Gly-Arg-Ala-Pro-Pro
(M.W. 2342.8 ) C115H176N32O21
Hypotensive / Mitogenic Peptide
M. Shichiri, S. Ishimaru, T. Ota, T. Nishikawa, T. Isogai, and Y. Hirata, Nat. Med., 9, 1166 (2003). (Original)

Schizophrenia Related Peptide

Schizophrenia Related Peptide (Bulk) PSC-4061 25 mg 99
Thr-Val-Leu -20 °C 100 mg 205
(M.W. 331.41) C15H29N3O5
C.E. Frohman, Chem. Eng. News, 1977, 35. (Original)
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

Secretin
J.E. Jorpes and V. Mutt (eds.) Secretin, Cholecystokinin, Pancreozymin and Gastrin,
Handbook of Experimental Pharmacology, Vol. 34, Springer-Verlag, Berlin, 1973. (Review)
PEPTIDES INTERNATIONAL

Secretin (Human) PSE-4165-v 0.5 mg 350

His-Ser-Asp-Gly-Thr-Phe-Thr-Ser-Glu-Leu-Ser-Arg-Leu-Arg- -20 °C vial
Glu-Gly-Ala-Arg-Leu-Gln-Arg-Leu-Leu-Gln-Gly-Leu-Val-NH2
(M.W. 3039.4) C130H220N44O40 [108753-74-8]
M. Carlquist, H. Jörnvall, W.G. Forssmann, L. Thulin, C. Johansson, and V. Mutt,
IRCS Med. Sci., 13, 217 (1985). (Original)
K. Iguchi, T. Mochizuki, T. Inoue, C. Yanaihara, S. Naruse, K. Nokihara, W.G. Forssmann, V. Mutt, T. Kanno,
and N. Yanaihara, Peptide Chemistry 1985, 191 (1986). (Chem. Synthesis and Biological Activity)

Secretin (Porcine) PSE-4112-v 0.5 mg 350

His-Ser-Asp-Gly-Thr-Phe-Thr-Ser-Glu-Leu-Ser-Arg-Leu-Arg- -20 °C vial
Asp-Ser-Ala-Arg-Leu-Gln-Arg-Leu-Leu-Gln-Gly-Leu-Val-NH2
(M.W. 3055.4) C130H220N44O41 [17034-35-4]

Serum Thymic Factor

Serum Thymic Factor PST-4058-v 0.5 mg 45
Pyr-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn -20 °C vial
(M.W. 858.85) C332H54N12O15 [63958-90-7]

Serum Thymic Factor (Bulk) PST-4058 25 mg 595

Pyr-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn • AcOH • 2H2O -20 °C
(M.W. 858.85 • 60.05 • 36.03) C33H54N12O15 • CH3COOH •
2H2O
J.F. Bach, M. Dardenne, J.M. Pleau, and J. Rosa, Nature, 266, 55 (1977). (Original)

108 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Biologically Active Peptides

SNX-482 See Code PCB-4363-s in the Toxins subsection.

Sodium Potassium ATPase Inhibitor-1 (SPAI-1)

SPAI-1 (Porcine) PSP-4216-s 0.1 mg 275
Sodium Potassium ATPase Inhibitor-1 (Porcine) -20 °C vial
Na+, K+-ATPase Inhibitor-1 (Porcine)
Leu-Leu-Ser-Lys-Arg-Gly-His-Cys-Pro-Arg-Ile-Leu-Phe-Arg-Cys-Pro-Leu-Ser-Asn-Pro-Ser-Asn-Lys-Cys-
Trp-Arg-Asp-Tyr-Asp-Cys-Pro-Gly-Val-Lys-Lys-Cys-Cys-Glu-Gly-Phe-Cys-Gly-Lys-Asp-Cys-Leu-Tyr-Pro-Lys
(Disulfide bonds are between Cys8-Cys37, Cys15-Cys41, Cys24-Cys36, and Cys30-Cys45)
(M.W. 5628.6) C245H378N72O65S8
K. Araki, et al., Biochem. Biophys. Res. Commun., 164, 496 (1989). (Original)
K. Araki, et al., Biochem. Biophys. Res. Commun., 172, 42 (1990). (S-S Bond)
H. Nishio, et al., Pept. Res., 5, 227 (1992). (Chem. Synthesis)
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

Somatostatin (SRIF) and Related Peptides

Octreotide PCI-3738-PI 1 mg 70
NEW!
Phe-Cys-Phe-Trp-Lys-Thr-Cys-Thr-ol -20 °C 5 mg 280
(Disulfide bond between Cys2-Cys7)
(M.W. 1019.24) C49H66N10O10S2 [83150-76-9]
Somatostatin Analog
Note: Bolar Exemption applies. This is a FDA-regulated product. It is the responsibility of the customer
to ensure that he/she is complying with Federal rules. PI cannot be liable for infringement of rights made
by the user.

Somatostatin PSI-4023-v 0.5 mg 110

PEPTIDES INTERNATIONAL
SRIF: (Somatotropin Release Inhibiting Factor) -20 °C vial
GIF: (Growth Hormone Release Inhibiting Factor)
(Human, Ovine, Porcine, Rat, Mouse)
Ala-Gly-Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Thr-Ser-Cys
(Disulfide bond between Cys3-Cys14)
(M.W. 1637.9) C76H104N18O19S2 [38916-34-6]

Somatostatin (Bulk) PSI-4023 25 mg 1150

Ala-Gly-Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Thr-Ser-Cys -20 °C
• 2AcOH • 6H2O
(Disulfide bond between Cys -Cys )
3 14

(M.W. 1637.9 • 120.10 • 108.09) C76H104N18O19S2 • 2CH3COOH • 6H2O

P. Brazeau, et al., Science, 179, 77 (1973). (Original; Ovine)
A. Arimura, et al., Science, 189, 1007 (1975). (Pharmacol.)
L.-P. Shen, et al., Proc. Natl. Acad. Sci. U.S.A., 79, 4575 (1982). (cDNA Seq.; Human)
D.J. Koerker, et al., Science, 184, 482 (1974). (Pharmacol.)

Somatostatin-28 PSI-3747-PI 1 mg 425

(Trifluoroacetate Form) -20 °C 5 mg 1700
H-Ser-Ala-Asn-Ser-Asn-Pro-Ala-Met-Ala-Pro-Arg-Glu-Arg-Lys-
Ala-Gly-Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Thr-Ser-Cys
(Disulfide bond Cys17-Cys­28)
(M.W. 3148.62) C137H207N41O39S3 [73032-94-7]

[d-Trp8]-Somatostatin PSI-4101-v 0.5 mg 145

Ala-Gly-Cys-Lys-Asn-Phe-Phe-d-Trp-Lys-Thr-Phe-Thr-Ser-Cys -20 °C vial
(Disulfide bonds between Cys3-Cys14)
(M.W. 1637.9) C76H104N18O19S2 [58976-46-8]
J. Rivier, H. Brown, and W. Vale, Biochem. Biophys. Res. Commmun., 65, 746 (1975). (Original)

Order Hotline 1-800-777-4779 502-266-8787 109

 PRODUCT CODE QTY PRICE
BIOLOGICALLY ACTIVE PEPTIDES

[Tyr1]-Somatostatin PSI-4038-v 0.5 mg 130

Tyr-Gly-Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Thr-Ser-Cys -20 °C vial
(Disulfide bonds between Cys3-Cys14)
(M.W. 1730.0) C82H108N18O20S2
For Radioimmunoassay
Purity Information: Qx See page xiv
A. Arimura, H. Sato, D.H. Coy, and A.V. Schally, Proc. Soc. Exp. Biol. Med., 148, 784 (1975). (Original)

Spantide See Code PSP-4173 (d-Arg1,d-Trp7,9, Leu11)-Substance P.

Src Homology 2 Domain Ligand

Src Homology 2 Domain Ligand SRC-3737-PI 1 mg 485
(Biotinylated) -20 °C 5 mg 1940
Biotinyl-ε-aminocaproyl-Glu-Pro-Gln-Tyr(PO3H2)-Glu-Glu-Ile-
Pro-Ile-Tyr-Leu-
(M.W. 1813.01) C82H122N15O27SP [215876-01-0]
Src Homology 2 Domain Ligand
L.M.Sonatore, et al., Anal Biochem, 240, 289 (1996).
R-H Yeh, T.R. Lee, and D.S. Lawrence, J. Biol Chem, 276, 12235 (2001).
X. Liu, et al., Bull Korean Chem Soc, 27, 1353 (2006).
S.-H. Park, J. Wona, and K.-H. Lee, J. Med. Chem., 43, 1173 (2000).

Substance K See Code PNK-4154 Neurokinin A.

Stresscopins / Urocortin and Related Peptides

Stresscopin (Human) PST-4387-s 0.1 mg 190
PEPTIDES INTERNATIONAL

Thr-Lys-Phe-Thr-Leu-Ser-Leu-Asp-Val-Pro-Thr-Asn-Ile- -20 °C vial

Met-Asn-Leu-Leu-Phe-Asn-Ile-Ala-Lys-Ala-Lys-Asn-Leu-Arg-
Ala-Gln-Ala-Ala-Ala-Asn-Ala-His-Leu-Met-Ala-Gln-Ile-NH2
(M.W. 4367.1) C195H326N56O53S2
Selective Ligand for Type 2 CRF Receptors
S.Y. Hsu and A.J.W. Hsueh, Nat. Med., 7, 605 (2001). (Original)
F.M. Dautzenberg and R.L. Hauger, Trends Pharmacol. Sci., 23, 71 (2002). (Review)
V. Martínez, L. Wang, J.E. Rivier, W. Vale, and Y. Taché, J. Pharmacol. Exp. Ther., 301, 611 (2002). (Pharmacol.)
A. Chanalaris, et al., J. Mol. Cell. Cardiol., 35, 1295 (2003). (Pharmacol.)

Stresscopin-Related Peptide (Human) PST-4388-s 0.1 mg 220

(Hydrochloride Form) -20 °C vial
His-Pro-Gly-Ser-Arg-Ile-Val-Leu-Ser-Leu-Asp-Val-Pro-Ile-Gly-Leu-
Leu-Gln-Ile-Leu-Leu-Glu-Gln-Ala-Arg-Ala-Arg-Ala-Ala-Arg-Glu-Gln-
Ala-Thr-Thr-Asn-Ala-Arg-Ile-Leu-Ala-Arg-Val-NH2
(M.W. 4687.5) C205H358N68O57
Selective Ligand for Type 2 CRF Receptors
S.Y. Hsu and A.J.W. Hsueh, Nat. Med., 7, 605 (2001). (Original)
F.M. Dautzenberg and R.L. Hauger, Trends Pharmacol. Sci., 23, 71 (2002). (Review)
V. Martínez, L. Wang, J.E. Rivier, W. Vale, and Y. Taché, J. Pharmacol. Exp. Ther., 301, 611 (2002). (Pharmacol.)
A. Chanalaris, et al., J. Mol. Cell. Cardiol., 35, 1295 (2003). (Pharmacol.)

110 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT CODE QTY PRICE
Urocortin (Human) PUC-4328-s 0.1 mg 165

BIOLOGICALLY ACTIVE PEPTIDES

Asp-Asn-Pro-Ser-Leu-Ser-Ile-Asp-Leu-Thr-Phe-His-Leu-Leu- -20 °C vial
Arg-Thr-Leu-Leu-Glu-Leu-Ala-Arg-Thr-Gln-Ser-Gln-Arg-Glu-
Arg-Ala-Glu-Gln-Asn-Arg-Ile-Ile-Phe-Asp-Ser-Val-NH2
(M.W. 4696.2) C204H337N63O64 [176591-49-4]
Ligand for Type 1 / Type-2 CRF Receptors
C.J. Donaldson, et al., Endocrinology, 137, 2167 (1996). (Original; cDNA & Pharmacol.)
D.P. Behan, et al., Brain Res., 725, 263 (1996). (Biochem.)
Y. Murakami, et al., Endocr. J., 44, 627 (1997). (Pharmacol.)
K. Takahashi, et al., Peptides, 19, 643 (1998). (Immunohistochem.)

Urocortin (Rat) PUC-4327-s 0.1 mg 165

(Mouse) -20 °C vial
Asp-Asp-Pro-Pro-Leu-Ser-Ile-Asp-Leu-Thr-Phe-His-Leu-Leu-
Arg-Thr-Leu-Leu-Glu-Leu-Ala-Arg-Thr-Gln-Ser-Gln-Arg-Glu-
Arg-Ala-Glu-Gln-Asn-Arg-Ile-Ile-Phe-Asp-Ser-Val-NH2
(M.W. 4707.3) C206H338N62O64 [171543-83-2]
Ligand for Type 1 / Type-2 CRF Receptors
J. Vaughan, C. Donaldson, J. Bittencourt, M.H. Perrin, K. Lewis, S. Sutton, R. Chan, A.V. Turnbull, D. Lovejoy,
C. Rivier, J. Rivier, P.E. Sawchenko, and W. Vale, Nature, 378, 278 (1995). (Original, cDNA & Pharmacol.)
A.V. Turnbull, W. Vale, and C. Rivier, Eur. J. Pharmacol., 03, 213 (1996). (Pharmacol.; Inhibition of Edema)
M. Spina, et al., Science, 273, 1561 (1996). (Pharmacol.; Suppresion of Appetite)
L.Y. Zhao, C.J. Donaldson, G.W. Smith, and W.W. Vale, Genomics, 50, 23 (1998). (Nucleotide Seq.; Mouse)

Urocortin II (Mouse) PUC-4383-s 0.1 mg 170

Val-Ile-Leu-Ser-Leu-Asp-Val-Pro-Ile-Gly-Leu-Leu-Arg-Ile-Leu- -20 °C vial
Leu-Glu-Gln-Ala-Arg-Tyr-Lys-Ala-Ala-Arg-Asn-Gln-Ala-
Ala-Thr-Asn-Ala-Gln-Ile-Leu-Ala-His-Val-NH2

PEPTIDES INTERNATIONAL
(M.W. 4152.9) C187H320N56O50
Selective Ligand for Type 2 CRF Receptors
C.J. Donaldson, et al., Endocrinology, 137, 2167 (1996). (Original; Human Urocortin)
T.M. Reyes, et al., Proc. Natl. Acad. Sci. USA, 98, 2834 (2001). (Original; Urocortin II)
K. Lewis, C. et al., Proc. Natl. Acad. Sci. USA, 98, 7570 (2001). (Original; Urocortin II)
S.Y. Hsu and A.J.W. Hsueh, Nat. Med., 7, 605 (2001). (Original; Stresscopin & Stresscopin Related Peptides)
F.M. Dautzenberg and R.L. Hauger, Trends Pharmacol. Sci., 23, 71 (2002). (Review)
M. Million, C. Maillot, P. Saunders, J. Rivier, W. Vale, and Y. Taché, Am. J. Physiol., 282, G34 (2002). (Pharmacol.)
C. Li, J. Vaughan, P.E. Sawchenko, and W.W. Vale, J. Neurosci., 22, 991 (2002). (Histochem.)
V. Martínez, L. Wang, J.E. Rivier, W. Vale, and Y. Taché, J. Pharmacol. Exp. Ther., 301, 611 (2002). (Pharmacol.)

Substance P and Related Peptides

D. Regoli, A. Boudon, and J.-L. Fauchere, Pharmacol. Rev., 46, 551 (1994). (Review)

Substance P* PSP-4014-v 0.5 mg 40

(Human, Bovine, Rat, Mouse) -20 °C vial
Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2
(M.W. 1347.6) C63H98N18O13S [33507-63-0]
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

Substance P* (Bulk) PSP-4014 25 mg 595

(Human, Bovine, Rat, Mouse) -20 °C
Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2 • 3AcOH • 5H2O
(M.W. 1347.6 • 180.16 • 90.08) C63H98N18O13S • 3CH3COOH • 5H2O
Purity Information: Qp See page xiv
U.S. von Euler and J.H. Gaddum, J. Physiol., 72, 74 (1931). (Naming)
M.M. Chang, S.E. Leeman, and H.D. Niall, Nature New Biol., 232, 86, (1971). (Original; Bovine)
A.J. Harmar, et al., FEBS Lett., 208, 67 (1986). (cDNA Seq.; Human)
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

Order Hotline 1-800-777-4779 502-266-8787 111

 PRODUCT CODE QTY PRICE
BIOLOGICALLY ACTIVE PEPTIDES

[d-Arg1,d-Pro2,d-Trp7,9,Leu11]-Substance P PSP-4172-v 0.5 mg 55

(Hydrochloride Form) -20 °C vial
d-Arg-d-Pro-Lys-Pro-Gln-Gln-d-Trp-Phe-d-Trp-Leu-Leu-NH2
(M.W. 1497.8) C75H108N20O13 [84676-91-5]

[d-Arg1,d-Phe5,d-Trp7,9,Leu11]-Substance P PGH-3652-PI 1 mg 55
d-Arg-Pro-Lys-Pro-d-Phe-Gln-d-Trp-Phe-d-Trp-Leu-Leu-NH2 -20 °C 5 mg 195
(M.W. 1516.87) C79H109N19O12
Ghrelin Antagonist / Potent Ghrelin Inverse Agonist Bombesin Antagonist
P.J. Woll and E. Rozengurt, Proc. Natl. Acad. Sci. USA, 85, 1859 (1988). (Original: Bombesin Antagonist)
B. Holst, et al., Mol. Endocrin. In Press. (2003). (Original: Ghrelin Antagonist)

[d-Arg1,d-Pro2,d-Trp7,9,Leu11]-Substance P PSP-4172 25 mg 1570

(Bulk) -20 °C
d-Arg-d-Pro-Lys-Pro-Gln-Gln-d-Trp-Phe-d-Trp-Leu-Leu-NH2
• 3HCl • 8H2O
(M.W. 1497.8 • 109.38 • 144.12) C75H108N20O13 • 3HCI • 8H2O
Bombesin Receptor Antagonist
Purity Information: Qp See page xiv
R.T. Jensen, S.W. Jones, K. Folkers, and J.D. Gardner, Nature, 309, 61 (1984). (Original; Bombesin Antagonist)

[d-Arg1,d-Trp7,9,Leu11]-Substance P PSP-4173-v 0.5 mg 55

Spantide -20 °C vial
(Hydrochloride Form)
d-Arg-Pro-Lys-Pro-Gln-Gln-d-Trp-Phe-d-Trp-Leu-Leu-NH2
(M.W. 1497.8) C75H108N20O13 [91224-37-2]

[d-Arg1,d-Trp7,9,Leu11]-Substance P (Bulk) PSP-4173 25 mg 1570

PEPTIDES INTERNATIONAL

Spantide -20 °C
d-Arg-Pro-Lys-Pro-Gln-Gln-d-Trp-Phe-d-Trp-Leu-Leu-NH2 • 3HCl • 8H2O
(M.W. 1497.8 • 109.38 • 144.12) C75H108N20O13 • 3HCI • 8H2O
Substance P Antagonist
Purity Information: Qp See page xiv
K. Folkers, R. Hákanson, J. Hörig, X. Jie-Cheng, and S. Leander, Br. J. Pharmacol., 83, 449 (1984). (Original)

[d-Pro2,d-Trp7,9]-Substance P PSP-4113-v 0.5 mg 55

(Hydrochloride Form) -20 °C vial
Arg-d-Pro-Lys-Pro-Gln-Gln-d-Trp-Phe-d-Trp-Leu-Met-NH2
(M.W. 1515.8) C74H106N20O13S [80434-86-2]

[d-Pro2,d-Trp7,9]-Substance P* (Bulk) PSP-4113 25 mg 1570

Arg-d-Pro-Lys-Pro-Gln-Gln-d-Trp-Phe-d-Trp-Leu-Met-NH2 • -20 °C
3HCI • 6H2O
(M.W. 1515.8 • 109.38 • 108.12) C74H106N20O13S • 3HCI •
6H2O
Substance P Antagonist
Purity Information: Qp See page xiv
G. Engberg, T.H. Svensson, S. Rosell, and K. Folkers, Nature, 293, 222 (1981). (Original)
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

[d-Pro4,d-Trp7,9]-Substance P (4-11) PSP-4114-v 0.5 mg 50

d-Pro-Gln-Gln-d-Trp-Phe-d-Trp-Leu-Met-NH2l -20 °C via
(M.W. 1134.4) C57H75N13O10S [81039-85-2]
Substance P Antagonist
S. Caranikas, J. Mizrahi, P. D’Orleans-Juste, and D. Regoli, Eur. J. Pharmacol., 77, 205 (1982). (Original)

112 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT CODE QTY PRICE
[Tyr8]-Substance P* PSP-4059-v 0.5 mg 60

BIOLOGICALLY ACTIVE PEPTIDES

Arg-Pro-Lys-Pro-Gln-Gln-Phe-Tyr-Gly-Leu-Met-NH2 -20 °C vial
(M.W. 1363.6) C63H98N18O14S [55614-10-3]
For Radioimmunoassay
Purity Information: Qx See page xiv

[D-Leu7]-(-)-Ternatin
Professor Uemura of Nagoya University isolated (-)-ternatin from the mushroom
Coriolus versicolor and determined its structure by the combination of NMR analysis
and total chemical synthesis.1 The inhibitory effects of this highly N-methylated cyclic
7-peptide, (-)-ternatin, in both adipogenesis and lipid metabolism, have been clarified
in vitro as well as in vivo. 2,3 These include: i) a fat accumulation inhibitory effect and
cell viability in 3T3-L1 murine adipocytes (IC50 = 0.027 μM and 0.28 μM, respectively)
and ii) suppression of body weight gain and fat accumulation in C57BL/6J mice at a
dose of 5 mg/kg/day, together with iii) mechanism for exerting these inhibitory activity.
Later, his group found [D-Leu7]-(-)-ternatin as a useful derivative of (-)-ternatin during
a structure-activity relationship study. Actually, this peptide, a deletion analog of β-OH
group from the 7th amino acid, β-OHD-Leu, maintains not only fat accumulation inhibi-
tory activity with only an 8-fold-lower potency, but also the structural integrity of the
parent molecule.4,5 This specific analog, [D-Leu7]-(-)-ternatin, may be an alternative to
(-)-ternatin in the study to combat metabolic diseases in the modern world. [D-Leu7]-
(-)-Ternatin is now available from Peptides International, Inc. under an agreement with
Professor Uemura.
1. K. Shimokawa, I. Mashima, A. Asai, K. Yamada, M. Kita, and D. Uemura, Tetrahedron Lett., 47, 4445 (2006).

PEPTIDES INTERNATIONAL
((-)-Ternatin; Structure Determination / Biological Activity in vitro)
2. K. Shimokawa, K. Yamada, M. Kita, and D. Uemura, Bioorg. Med. Chem. Lett., 17, 4447 (2007).
((-)-Ternatin; Biological Activity in vivo)
3. M. Ito, J. Ito, H. Kitazawa, K. Shimamura, T. Fukami, S. Tokita, K. Shimokawa, K. Yamada, A. Kanatani,
and D. Uemura, Peptides, 30, 1074 (2009). ((-)-Ternatin; Mechanism of Inhibitory Activity)
4. K. Shimokawa, Y. Iwase, K. Yamada, and D. Uemura, Org. Biomol. Chem., 6, 58 (2008).
(D-Leu7-(-)-Ternatin; Biological Activity in vivo)
5. K. Shimokawa, R. Miwa, K. Yamada, and D. Uemura, Org. Biomol. Chem., 7, 777 (2009).
(D-Leu7-(-)-Ternatin; Conformation-Biological Activity Relationship)
• This compound is distributed through Peptide Institute, Inc. under the license of Nagoya University

[D-Leu7]-(-)-Ternatin TNN-4464-v 1 mg 330

cyclo(-d-aIle-MeAla-MeLeu-Leu-MeAla-D-MeAla-d-Leu-) -20 °C vial
(M.W. 721.97)) C37H67N7O7
Fat Accumulation Inhibitor against 3T3-L1 Adipocytes
T-Kinin See Code PBK-4130 Isoleucyl-Seryl-Bradykinin.
Thrombin Receptor Activating Peptide See Code PAR-3932-PI H-Ala-Tyr-Pro-Gly-Lys-Phe-OH.

Thyrotropin Releasing Hormone (TRH)

TRH PTR-4011-v 0.5 mg 25
Thyrotropin Releasing Hormone -20 °C vial
(Human, Ovine, Porcine, Rat)
Pyr-His-Pro-NH2
(M.W. 362.38) C16H22N6O4 [24305-27-9]

Order Hotline 1-800-777-4779 502-266-8787 113

 PRODUCT CODE QTY PRICE
BIOLOGICALLY ACTIVE PEPTIDES

TRH (Bulk) PTR-4011 25 mg 55

Thyrotropin Releasing Hormone -20 °C 100 mg 150
(Human, Ovine, Porcine, Rat)
Pyr-His-Pro-NH2 • H2O
(M.W. 362.38 • 18.02) C16H22N6O4 • H2O
R. Burgus, T.F. Dunn, D. Desiderio, and R. Guillemin, C.R. Acad. Sci. Paris, 269, 1870 (1969). (Original; Ovine)
J. Bøler, et al., Biochem. Biophys. Res. Commun., 37, 705 (1969). (Original; Porcine)
M. Yamada, et al., Mol. Endocrinol., 4, 551 (1990). (cDNA Seq.; Human)
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

TMRIA-K4
TMRIA-K4 PTM-3401-v 0.5 mg 185
S-[2-({4-[3,6-Bis(dimethylamino)xanthylium-9-yl]-3-carboxy- -20 °C vial
phenyl}amino)-2-oxoethyl]-Cys-(Lys-Ile-Ala-Ala-Leu-Lys-Glu)4
(Trifluoroacetate Form)
(M.W. 3578.40) C169H282N40O42S
Fluorophore Peptide in Coiled-Coil Tag-Probe Labeling System
Y. Yano, et al., ACS Chem. Biol., 3, 341 (2008). (TMR-K4; Reference Paper to TMRIA-K4)

Toxins
Toxin Libraries
Atheris Laboratories, a world leader in venomics, venom-related research and ana -
lytical services, has partnered with Peptides International to offer a unique library of
synthetic peptides derived from animal venoms for high-throughput screening against
PEPTIDES INTERNATIONAL

known key therapeutic targets, orphan receptors and ion channels. The libraries
contain peptides which have been refolded and desalted around known structural
scaffolds. These unique collections are constructed from 3 sources:
• Public domain peptides, sequences available in public databases (SwissProt/
UniProt, GeneBank, etc.).
• Proprietary peptides of natural sequence identified by Atheris using NextGen
venom gland transcriptomics (RNAseq) and/or peptidomic/proteomic techniques.
• Proprietary peptides designed by Atheris using algorithms of its proprietary lead
optimization bioinformatics platform.
δ-melusineTM Synthetic Venom Library DML-8000-PI Please
Synthetic venom libraries -20 °C Inquire
These libraries can be ordered in either a 96 or 384 well format to conveniently fit any screening
platform, designed to achieve a high hit rate and, most importantly, unprecedented success
rates in lead generation. Please contact Peptides International for details.

μ-SLPTX-Ssm6a STX-3791-v 0.5 mg 750

(Centipede, Scolopendra subspinipes mutilans) -20 °C 1 mg 1200
H-Ala-Asp-Asn-Lys-Cys-Glu-Asn-Ser-Leu-Arg-Arg-Glu-Ile-
Ala-Cys-Gly-Gln-Cys-Arg-Asp-Lys-Val-Lys-Thr-
Asp-Gly-Tyr-Phe-Tyr-Glu-Cys-Cys-Thr-Ser-Asp-Ser-Thr-
Phe-Lys-Lys-Cys-Gln-Asp-Leu-Leu-His-OH
(Folded to the most thermodynamically stable isomer)
S.Yang,Y. Xiao, D. Kang,J. Liu,Y. Li, E.A.B.Undheim, J.K. Klint,M. Rong,R. Lai, and G.F. King, PNAS, published online
before print2013 Sep 30, doi:10.1073/pnas.1306285110

114 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT CODE QTY PRICE

BIOLOGICALLY ACTIVE PEPTIDES

w-Agatoxins
B.M. Olivera, G.P. Miljanich, J. Ramachandran, and M.E. Adams, Annu. Rev. Biochem., 63, 823 (1994). (Review)
O.D. Uchitel, Toxicon, 35, 1161 (1997). (Review)

w-Agatoxin IVA PAG-4256-s 0.1 mg 380

w-Aga-IVA -20 °C vial
(Funnel Web Spider, Agelenopsis aperta)
Lys-Lys-Lys-Cys-Ile-Ala-Lys-Asp-Tyr-Gly-Arg-Cys-Lys-Trp-Gly-Gly-Thr-Pro-Cys-Cys-Arg-Gly-Arg-Gly-Cys-
Ile-Cys-Ser-Ile-Met-Gly-Thr-Asn-Cys-Glu-Cys-Lys-Pro-Arg-Leu-Ile-Met-Glu-Gly-Leu-Gly-Leu-Ala
(Disulfide bonds between Cys4-Cys20, Cys12-Cys25, Cys19-Cys36 and Cys27-Cys34)
(M.W. 5202.2) C217H360N68O60S10
P-type Ca2+ Channel Selective Blocker
I.M. Mintz, V.J. Venema, K.M. Swiderek, T.D. Lee, B.P. Bean, and M.E. Adams, Nature, 355, 827 (1992). (Original)
T.J. Turner, M.E. Adams, and K. Dunlap, Science, 258, 310 (1992). (Pharmacol.)
H. Nishio, et al., Biochem. Biophys. Res. Commun., 196, 1447 (1993). (Chem. Synthesis & Biological Activity)
• This compound is distributed exclusively through Peptides International under license agreement with the
University of Utah.

w-Agatoxin TK PAG-4294-s 0.1 mg 450

w-Aga-TK, w-Aga-IVB -20 °C vial
(Funnel Web Spider, Agelenopsis aperta)
Glu-Asp-Asn-Cys-Ile-Ala-Glu-Asp-Tyr-Gly-Lys-Cys-Thr-Trp-Gly-Gly-Thr-Lys-Cys-Cys-Arg-Gly-Arg-Pro-
Cys-Arg-Cys-Ser-Met-Ile-Gly-Thr-Asn-Cys-Glu-Cys-Thr-Pro-Arg-Leu-Ile-Met-Glu-Gly-Leu-d-Ser-Phe-Ala
(Disulfide bonds between Cys4-Cys20, Cys12-Cys25,Cys19-Cys36 and Cys27-Cys34)
(M.W. 5273.0) C215H337N65O70S10 [145017-83-0]
P-type Ca2+ Channel Selective Blocker
Purity Information: QE See page xiv

PEPTIDES INTERNATIONAL
M. Kuwada, et al., Mol. Pharmacol., 46, 587 (1994). (Original)
Y. Shikata, et al., J. Biol. Chem., 270, 16719 (1995). (l-Ser to d-Ser Isomerase)
M.E. Adams, I.M. Mintz, M.D. Reily, V. Thanabal, and B.P. Bean, Mol. Pharmacol., 38, 681 (1990). (Original; ω-Aga-IVB)
S.D. Heck, et al., J. Am. Chem. Soc., 116, 10426 (1994). (S-S Bond; ω-Aga-IVB)
T. Teramoto, et al., Brain Res., 756, 225 (1997). (Pharmacol.)
S.P. Lieske and J.-M. Ramirez, J. Neurophysiol., 95, 1323 (2006). (Pharmacol.)
• This product is distributed under the license of Eisai Co., Ltd. Its use for any purpose other than research is strictly
prohibited.

Biotinyl-ω-Agatoxin IVA PAG-3402-s 0.1 mg 401

Biotinyl-ω-Aga-IVA -20 °C vial
(Trifluoroacetate Form)
Biotinyl-Lys-Lys-Lys-Cys-Ile-Ala-Lys-Asp-Tyr-Gly-Arg-Cys-Lys-Trp-Gly-Gly-Thr-Pro-Cys-Cys-Arg-Gly-Arg-
Gly-Cys-Ile-Cys-Ser-Ile-Met-Gly-Thr-Asn-Cys-Glu-Cys-Lys-Pro-Arg-Leu-Ile-Met-Glu-Gly-Leu-Gly-Leu-Ala
(Disulfide bonds between Cys4-Cys20, Cys12-Cys25, Cys19-Cys36 and Cys27-Cys34)
(M.W. 5428.5) C227H374N70O62S11
Reagent for Localization Study of ω-Agatoxin IVA Binding Site
H. Nishio, et al.,Biochem. Biophys. Res. Commun., 196, 1447 (1993). (Chem. Synthesis & Biological Activity)
S. Nakanishi, et al., J. Neurosci. Res., 41, 532 (1995). (Biochem.: Distribution of Binding Sites)

Order Hotline 1-800-777-4779 502-266-8787 115

 PRODUCT CODE QTY PRICE
BIOLOGICALLY ACTIVE PEPTIDES

Calcicludine (CaC)* PCC-4310-s 0.1 mg 355

(Green Mamba, Dendroaspis angusticeps) -20 °C vial
Trp-Gln-Pro-Pro-Trp-Tyr-Cys-Lys-Glu-Pro-Val-Arg-Ile-Gly-Ser-Cys-
Lys-Lys-Gln-Phe-Ser-Ser-Phe-Tyr-Phe-Lys-Trp-Thr-Ala-Lys-Lys-Cys-
Leu-Pro-Phe-Leu-Phe-Ser-Gly-Cys-Gly-Gly-Asn-Ala-Asn-Arg-Phe-
Gln-Thr-Ile-Gly-Glu-Cys-Arg-Lys-Lys-Cys-Leu-Gly-Lys
(Disulfide bonds between Cys7-Cys57, Cys16-Cys40, and Cys32-Cys53)
(M.W. 6980.1) C321H476N86O78S6
Neuronal L-type Ca2+ Channel Blocker
H. Schweitz, et al., Proc. Natl. Acad. Sci. USA, 91, 878 (1994). (Original)
H. Nishio, et al., Peptide Chemistry 1995, 113 (1996). (Chem. Synthesis & Pharmacol.)
O.D. Uchitel, Toxicon, 35, 1161 (1997). (Review)
J. Santos-Torres, et al., J. Neurosci. Res., 85, 634 (2007). (Pharmacol.)
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

Calciseptine* PCL-4255-s 0.1 mg 380

(Black mamba, Dendroaspis polylepis polylepis) -20 °C vial
Arg-Ile-Cys-Tyr-Ile-His-Lys-Ala-Ser-Leu-Pro-Arg-Ala-Thr-Lys-Thr-
Cys-Val-Glu-Asn-Thr-Cys-Tyr-Lys-Met-Phe-Ile-Arg-Thr-Gln-Arg-
Glu-Tyr-Ile-Ser-Glu-Arg-Gly-Cys-Gly-Cys-Pro-Thr-Ala-Met-Trp-
Pro-Tyr-Gln-Thr-Glu-Cys-Cys-Lys-Gly-Asp-Arg-Cys-Asn-Lys
(Disulfide bonds are between Cys3-Cys22, Cys17-Cys39, Cys41-Cys52, and Cys53-Cys58)
(M.W. 7036.1) C299H468N90O87S10 [134710-25-1]
L-type Ca 2+ Channel Blocker
J.R. De Weille, H. Schweitz, P. Maes, A. Tartar, and M. Lazdunski, Proc. Natl. Acad. Sci. USA, 88, 2437 (1991). (Original)
H. Kuroda, Y.-N. Chen, T.X. Watanabe, T. Kimura, and S. Sakakibara, Pept. Res., 5, 265 (1992). (Chem. Synthesis)
T.X. Watanabe, et al., Jpn. J. Pharmacol., 68, 305 (1995). (Pharmacol.)
PEPTIDES INTERNATIONAL

N. Teramoto, et al., Pflügers Arch., 432 (1996). (Pharmacol.)

* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

Charybdotoxin
M.L. Garcia, H.-G. Knaus, P. Munujos, R.S. Slaughter, and G.J. Kaczorowski, Am. J. Physiol., 269, C1 (1995). (Review)

Charybdotoxin (ChTX)* PCB-4227-s 0.1 mg 270

(Scorpion, Leiurus quinquestriatus hebraeus) -20 °C vial
Pyr-Phe-Thr-Asn-Val-Ser-Cys-Thr-Thr-Ser-Lys-Glu-Cys-
Trp-Ser-Val-Cys-Gln-Arg-Leu-His-Asn-Thr-Ser-Arg-Gly-
Lys-Cys-Met-Asn-Lys-Lys-Cys-Arg-Cys-Tyr-Ser
(Disulfide bonds between Cys7-Cys28, Cys13-Cys33, and Cys17-Cys35)
(M.W. 4295.9) C176H277N57O55S7 [95751-30-7]
Ca2+-Activated K + Channel Blocker
G. Gimenez-Gallego, et al., Proc. Natl. Acad. Sci. USA, 85, 3329 (1988). (Original)
P. Lambert, et al., Biochem. Biophys. Res. Commun., 170, 684 (1990). (Chem. Synthesis & Pharmacol.)
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

116 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT CODE QTY PRICE
Chlorotoxin PCN-4282-v 0.5 mg 645

BIOLOGICALLY ACTIVE PEPTIDES

(Scorpion, Leiurus quinquestriatus) -20 °C vial
Met-Cys-Met-Pro-Cys-Phe-Thr-Thr-Asp-His-Gln-Met-Ala-Arg-
Lys-Cys-Asp-Asp-Cys-Cys-Gly-Gly-Lys-Gly-Arg-Gly-Lys-Cys-
Tyr-Gly-Pro-Gln-Cys-Leu-Cys-Arg-NH2
(Reported Disulfide bonds between Cys2-Cys19,Cys5-Cys28,Cys16-Cys33 and Cys20-Cys35)
(M.W. 3995.7) C158H249N53O47S11 [163515-35-3]
Small-Conductance Cl - Channel Blocker
J.A. DeBin, J.E. Maggio, and G.R. Strichartz, Am. J. Physiol., 264, C361 (1993). (Original)
J. Najib, P. Sautiere, et al., In, Innovation and Perspective in Solid Phase Synthesis, (R. Epton, ed.),
Mayflower Worldwide, Birmingham, 1994, pp. 615-618. (Original; Amide)
G. Lippens, J. Najib, S.J. Wodak, and A. Tartar, Biochemistry, 34, 13 (1995). (NMR Structure)
L. Soroceanu, Y. Gillespie, M.B. Khazaeli, and H. Sontheimer, Cancer Res., 58, 4871 (1998). (Pharmacol.)
D.B. Jacoby, et al., Anticancer Res., 30, 39 (2010). (Review)
K. Kesavan, et al., J. Biol. Chem., 285, 4366 (2010). (Review)

Conantokins
W.R. Gray and B.M. Olivera, Annu. Rev. Biochem., 57, 665 (1998). (Review)

Conantokin G PCO-4265-v 0.5 mg 225

(Marine Snail, Conus geographus) -20 °C vial
Gly-Glu-Gla-Gla-Leu-Gln-Gla-Asn-Gln-
Gla-Leu-Ile-Arg-Gla-Lys-Ser-Asn-NH2
(Gla: l-g-Carboxyglutamic acid)
(M.W. 2264.2) C88H138N26O44 [93438-65-4]
Sleeper Peptide, N-Methyl-d-Aspartate (NMDA) Receptor Antagonist
Purity Information: Qx See page xiv

PEPTIDES INTERNATIONAL
J.M. McIntosh, B.M. Olivera, L.J. Cruz, and W.R. Gray, J. Biol. Chem., 259, 14343 (1984). (Original)
L.G. Hammerland, B.M. Olivera, and D. Yoshikami, Eur. J. Pharmacol., 226, 239 (1992). (Pharmacol.)
Y. Nishiuchi, et al., Int. J. Pept. Protein Res, 42, 533 (1993). (Chem. Synthesis)

Conantokin T PCO-4264-v 0.5 mg 250

(Marine Snail, Conus tulipa) -20 °C vial
Gly-Glu-Gla-Gla-Tyr-Gln-Lys-Met-Leu-Gla-Asn-Leu-
Arg-Gla-Ala-Glu-Val-Lys-Lys-Asn-Ala-NH2
(Gla: l-g-Carboxyglutamic acid)
(M.W. 2683.8) C110H175N31O45S
Sleeper Peptide, N-Methyl-d-Aspartate (NMDA) Receptor Antagonist
Purity Information: Qx See page xiv
J.A. Haack, J. Rivier, T.N. Parks, E.E. Mena, L.J. Cruz, and B.M. Olivera, J. Biol. Chem., 265, 6025 (1990). (Original)
Y. Nishiuchi, M. Nakao, M. Nakata, T. Kimura, and S. Sakakibara, Int. J. Pept. Protein Res., 42, 533 (1993).
(Chem. Synthesis)
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

Conotoxins ‡
B.M. Olivera, et al., Science, 230, 1338 (1985). (Review)
W.R. Gray, B.M. Olivera, and L.J. Cruz, Annu. Rev. Biochem., 57, 665 (1988). (Review)
R.A. Myers, L.J. Cruz, J.E. Rivier, and B.M. Olivera, Chem. Rev., 93, 1923 (1993). (Review)
B.M. Olivera, G.P. Miljanich, J. Ramachandran, and M.E. Adams, Annu. Rev. Biochem., 63, 823 (1994). (Review)

Order Hotline 1-800-777-4779 502-266-8787 117

 PRODUCT CODE QTY PRICE
BIOLOGICALLY ACTIVE PEPTIDES

a-Conotoxin GI*‡ PCN-4126-v 0.5 mg 320

(Marine Snail, Conus geographus) -20 °C vial
(Hydrochloride Form)
Glu-Cys-Cys-Asn-Pro-Ala-Cys-Gly-Arg-His-Tyr-Ser-Cys-NH2
(Disulfide bonds between Cys2-Cys7 and Cys3-Cys13)
(M.W. 1437.6) C55H80N20O18S4 [76862-65-2]
Blocker for Nicotinic Acetylcholine Receptor
Purity Information: QE See page xiv
W.R. Gray, A. Luque, B.M. Olivera, J. Barrett, and L.J. Cruz, J. Biol. Chem., 256, 4734 (1981). (Original)
Y. Nishiuchi and S. Sakakibara, FEBS Lett., 148, 260 (1982). (Chem. Synthesis)
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

a-Conotoxin ImI‡ PCN-4311-v 0.5 mg 330

(Marine Snail, Conus imperialis) -20 °C vial
Gly-Cys-Cys-Ser-Asp-Pro-Arg-Cys-Ala-Trp-Arg-Cys-NH2
(Disulfide bonds between Cys -Cys and Cys -Cys )
2 8 3 12

(M.W. 1351.6) C52H78N20O15S4 [156467-85-5]

Blocker for Nicotinic Acetylcholine Receptor in Central Nervous System
J.M. McIntosh, et al., J. Biol. Chem., 269, 16733 (1994). (Original)
D.S. Johnson, et al., Mol. Pharmacol., 48, 194 (1995). (Pharmacol.)
E.F.R. Pereira, et al., J. Pharmacol. Exp. Ther., 278, 1472 (1996). (Pharmacol.; Competitive Antagonist)

a-Conotoxin MI*‡ PCN-4140-v 0.5 mg 330

(Marine Snail, Conus magus) -20 °C vial
Gly-Arg-Cys-Cys-His-Pro-Ala-Cys-Gly-Lys-Asn-Tyr-Ser-Cys-NH2
(Disulfide bonds between Cys3-Cys8 and Cys4-Cys14)
(M.W. 1493.7) C58H88N22O17S4
PEPTIDES INTERNATIONAL

Blocker for Nicotinic Acetylcholine Receptor

M. Mclntosh, et al., Arch. Biochem. Biophys., 218, 329 (1982). (Original)
Y. Nishiuchi and S. Sakakibara, Peptide Chemistry 1983, 191, (1984). (Chem. Synthesis)
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

a-Conotoxin SI*‡ PCN-4228-v 0.5 mg 330

(Marine Snail, Conus striatus) -20 °C vial
Ile-Cys-Cys-Asn-Pro-Ala-Cys-Gly-Pro-Lys-Tyr-Ser-Cys-NH2
(Disulfide bonds between Cys2-Cys7 and Cys3-Cys13)
(M.W. 1353.6) C55H84N16O16S4
Blocker for Nicotinic Acetylcholine Receptor
G.C. Zafaralla, C. Ramilo, W.R. Gray, R. Karlstrom, B.M. Olivera, and L.J. Cruz, Biochemistry, 27, 7102 (1988). (Original)
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.
‡P
 LEASE NOTE: For shipping within the United States, please contact Peptides International for important information regard-
ing the CDC Select Agent Transfer Program and additional requirements for placing orders. Conotoxin peptides are not avail-
able for export without a license from the US Department of Commerce.

118 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT CODE QTY PRICE
m-Conotoxin GIIIB*‡ PCN-4217-v 0.5 mg 470

BIOLOGICALLY ACTIVE PEPTIDES

(Marine Snail, Conus geographus) -20 °C vial
Arg-Asp-Cys-Cys-Thr-Hyp-Hyp-Arg-Lys-Cys-Lys-Asp-
Arg-Arg-Cys-Lys-Hyp-Met-Lys-Cys-Cys-Ala-NH2
(Disulfide bonds between Cys3-Cys15, Cys4-Cys20, and Cys10-Cys21)
(M.W. 2640.2) C101H175N39O30S7 [140678-12-2]
Na+ Channel Blocker: Specific for Skeletal Muscle
S. Sato, H. Nakamura, Y. Ohizumi, J. Kobayashi, and Y. Hirata, FEBS Lett., 155, 277 (1983). (Original)
L.J. Cruz, et al., J. Biol. Chem., 260, 9280 (1985). (Naming)
Y. Ohizumi, H. Nakamura, J. Kobayashi, and W.A. Catterall, J. Biol. Chem., 261, 6149 (1986). (Pharmacol.)
S. Kubo, et al., Pept. Res., 6, 66 (1993). (Chem. Synthesis and Pharmacol.)
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

m-Conotoxin GS‡ PCN-4263-v 0.5 mg 480

(Marine snail, Conus geographus) -20 °C vial
Ala-Cys-Ser-Gly-Arg-Gly-Ser-Arg-Cys-Hyp-Hyp-Gln-Cys-
Cys-Met-Gly-Leu-Arg-Cys-Gly-Arg-Gly-Asn-Pro-Gln-Lys-Cys-
Ile-Gly-Ala-His-Gla-Asp-Val (Gla: l-g-Carboxyglutamic acid)
(Disulfide bonds between Cys2-Cys14, Cys9-Cys19, and Cys13-Cys27)
(M.W. 3618.1) C139H226N52O48S7
Na+ Channel Blocker
Y. Yanagawa, T. Abe, M. Satake, S. Odani, J. Suzuki, and K. Ishikawa, Biochemistry, 27, 6256 (1988). (Original)
M. Nakao, et al., Lett. Pept. Sci., 2, 17 (1995). (Chem. Synthesis and S-S Bond)

μ-Conotoxin SIIIA‡ PCN-4440-v 0.5 mg 360

(Marine Snail, Conus striatus) -20 °C vial
Pyr-Asn-Cys-Cys-Asn-Gly-Gly-Cys-Ser-Ser-Lys-

PEPTIDES INTERNATIONAL
Trp-Cys-Arg-Asp-His-Ala-Arg-Cys-Cys-NH2
(Reported disulfide bonds between Cys3-Cys13, Cys4-Cys19, and Cys8-Cys20)
(M.W. 2207.5) C83H123N33O27S6
Tetrodotoxin-Resistant Na+ Channel Blocker with Analgesic Activity
G. Bulaj, et al., Biochemistry, 44, 7259 (2005). (Original; Primary Structure & Pharmacol.)
S. Yao, et al., Biochemistry, 47, 10940 (2008). (Solution Structure & Pharmacol.)
C.-Z. Wang, et al., Toxicon, 47, 122 (2006). (Pharmacol.)
B.R. Green, et al., Chem. Biol., 14, 399 (2007). (Pharmacol.)

w-Conotoxin GVIA*‡ PCN-4161-v 0.5 mg 455

(Marine Snail, Conus geographus) -20 °C vial
Cys-Lys-Ser-Hyp-Gly-Ser-Ser-Cys-Ser-Hyp-Thr-Ser-Tyr-Asn-
Cys-Cys-Arg-Ser-Cys-Asn-Hyp-Tyr-Thr-Lys-Arg-Cys-Tyr-NH2
(Disulfide bonds between Cys1-Cys16, Cys8-Cys19, and Cys15-Cys26)
(M.W. 3037.3) C120H182N38O43S6 [106375-28-4]
N-type Ca2+ Channel Blocker
B.M. Olivera, J.M. Mclntosh, L.J. Cruz, F.A. Luque, and W.R. Gray, Biochemistry, 23, 5087 (1984). (Original)
Y. Nishiuchi, et al., Biopolymers, 25, S61 (1986). (Chem. Synthesis and S-S Bond)
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

Order Hotline 1-800-777-4779 502-266-8787 119

 PRODUCT CODE QTY PRICE
BIOLOGICALLY ACTIVE PEPTIDES
‡P
 LEASE NOTE: For shipping within the United States, please contact Peptides International for important information regard-
ing the CDC Select Agent Transfer Program and additional requirements for placing orders. Conotoxin peptides are not avail-
able for export without a license from the US Department of Commerce.

w-Conotoxin MVIIA*‡ PCN-4289-v 0.5 mg 375

(Marine Snail, Conus magus) -20 °C vial
Cys-Lys-Gly-Lys-Gly-Ala-Lys-Cys-Ser-Arg-Leu-Met-Tyr-Asp-
Cys-Cys-Thr-Gly-Ser-Cys-Arg-Ser-Gly-Lys-Cys-NH2
(Disulfide bonds between Cys1-Cys16,Cys8-Cys20,and Cys15-Cys25)
(M.W. 2639.1) C102H172N36O32S7 [107452-89-1]
Reversible N-type Ca2+ Channel Blocker
B.M. Olivera, et al., Biochemistry, 26, 2086 (1987). (Original)
K. Valentino, et al., Proc. Natl. Acad. Sci. USA, 90, 7894 (1993). (Pharmacol.)
J.A. Fox, Pflügers Arch., 429, 873 (1995). (Pharmacol.)
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

w-Conotoxin MVIIC‡ PCN-4283-s 0.1 mg 190

(Marine Snail, Conus magus) -20 °C vial
Cys-Lys-Gly-Lys-Gly-Ala-Pro-Cys-Arg-Lys-Thr-Met-Tyr-Asp-
Cys-Cys-Ser-Gly-Ser-Cys-Gly-Arg-Arg-Gly-Lys-Cys-NH2
(Disulfide bonds between Cys1-Cys16,Cys8-Cys20,
and Cys15-Cys26)
(M.W. 2749.3) C106H178N40O32S7 [147794-23-8]

w-Conotoxin MVIIC‡ PCN-4283-v 0.5 mg 425

(Marine Snail, Conus magus) -20 °C vial
P/Q-type Ca2+ Channel Blocker
D.R. Hillyard, Vet al., Neuron, 9, 69 (1992). (Original; cDNA and Pharmacol.)
PEPTIDES INTERNATIONAL

M.E. Adams, R.A. Myers, J.S. Imperial, and B.M. Olivera, Biochemistry, 32, 12566 (1993). (Pharmacol.)
W.A. Sather, T. Tanabe, J.-F. Zhang, Y. Mori, M.E. Adams, and R.W. Tsien, Neuron, 11, 291 (1993). (Pharmacol.)
D.B. Wheeler, A. Randall, and R.W. Tsien, Science, 264, 107 (1994). (Pharmacol.)

w-Conotoxin SVIB*‡ PCN-4284-v 0.5 mg 375

(Marine Snail, Conus striatus) -20 °C vial
Cys-Lys-Leu-Lys-Gly-Gln-Ser-Cys-Arg-Lys-Thr-Ser-Tyr-Asp-
Cys-Cys-Ser-Gly-Ser-Cys-Gly-Arg-Ser-Gly-Lys-Cys-NH2
(Reported disulfide bonds between Cys1-Cys16,Cys8-Cys20, and Cys15-Cys26)
(M.W. 2739.1) C105H176N38O36S6 [150433-82-2]
N-type Ca 2+ Channel Blocker
C.A. Ramilo, et al., Biochemistry, 31, 9919 (1992). (Original.)
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.
‡P
 LEASE NOTE: For shipping within the United States, please contact Peptides International for important information regard-
ing the CDC Select Agent Transfer Program and additional requirements for placing orders. Conotoxin peptides are not avail-
able for export without a license from the US Department of Commerce.

120 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT CODE QTY PRICE
Dendrotoxin I PDN-4330-s 0.1 mg 360

BIOLOGICALLY ACTIVE PEPTIDES

(Black mamba, Dendroaspis polylepis polylepis) -20 °C vial
Pyr-Pro-Leu-Arg-Lys-Leu-Cys-Ile-Leu-His-Arg-Asp-Pro-Gly-Arg-Cys-
Tyr-Gln-Lys-Ile-Pro-Ala-Phe-Tyr-Tyr-Asn-Gln-Lys-Lys-Lys-Gln-Cys-
Glu-Gly-Phe-Thr-Trp-Ser-Gly-Cys-Gly-Gly-Asn-Ser-Asn-Arg-Phe-
Lys-Thr-Ile-Glu-Glu-Cys-Arg-Arg-Thr-Cys-Ile-Arg-Lys
(Disulfide bonds between Cys7-Cys57, Cys16-Cys40, and Cys32-Cys53)
(M.W. 7133.2) C312H487N97O84S6 [107950-33-4]
Voltage-Dependant K+ Channel Blocker
D.J. Strydom, Nature New Biol., 243, 88 (1973). (Original)
J.-N. Bidard, C. Mourre, and M. Lazdunski, Biochem. Biophys. Res. Commun., 143, 383 (1987). (Pharmacol.)
A.L. Harvey, et al., Biochem. Biophys. Res. Commun., 163, 394 (1989). (Pharmacol.)
H. Nishio, et al., J. Pept. Res., 51, 355 (1998). (Chem. Synthesis & Correction of Sequence; Asp12)

Echistatin
Echistatin ECT-3760-PI 1 mg 1200
(Trifluoroacetate Form) -20 °C 5 mg 5000
H-Glu-Cys-Glu-Ser-Gly-Pro-Cys-Cys-Arg-Asn-Cys-Lys-Phe-
Leu-Lys-Glu-Gly-Thr-Ile-Cys-Lys-Arg-Ala-Arg-Gly-Asp-
Asp-Met-Asp-Asp-Tyr-Cys-Asn-Gly-Lys-Thr-Cys-Asp-
Cys-Pro-Arg-Asn-Pro-His-Lys-Gly-Pro-Ala-Thr-OH
(Disulfide bonds between Cys2-Cys11, Cys7-Cys32, Cys8-Cys37, and Cys20-Cys39)
(M.W. 5417.14) C217H341N71O74S9 [154303-05-6]
αVβ3 Integrin Antagonist
J. Musial, et al., Circulation, 82, 261 (1990).
M. Sato, et al., J. Cell.Biol., 111, 1713 (1990).

PEPTIDES INTERNATIONAL
C.C. Kumar, et al., J. Pharmacol.Exp.Ther., 283, 843 (1997).
V. Garsky, et al., Proc Nat Acad of Sciences, 86, 4022 (1989).

Enterotoxin
Enterotoxigenic E.coli are able to produce several toxic peptides which may
cause acute diarrhea in humans and domestic animals. The E.coli heat-stable
Enterotoxin STp is syntheszied in vivo as a 72 amino acid precursor consisting of
pre-, pro-, and mature region. Mature STp is composed of 18 amino acids containing
three intramolecular disulfide bonds, which seem to be important for the correct
conformation of the biologically active structure.
K.Okamoto, et al., Infect. Immun., 55, 2121 (1987). H.Ozaki, et al., J. Biol. Chem., 266, 5934 (1991).
K.Okamoto and M.Takahara, J. Bacteriol., 172, 5260 H.Yamanaka, et al., Microbiol. Immunol., 37, 195 (1993).
(1990). H.Yamanaka, et al., J. Bacteriol., 176, 2906 (1994).

Enterotoxin STp ENT-3744-PI 1 mg 625

(Trifluoroacetate Form) -20 °C 5 mg 2500
H-Asn-Thr-Phe-Tyr-Cys-Cys-Glu-Leu-Cys-Cys-Asn-
Pro-Ala-Cys-Ala-Gly-Cys-Tyr-OH
(Disulfide bonds between Cys5-Cys10, Cys6-Cys14, and Cys9-Cys17)
(M.W. 1972.28) C81H110N20O26S6 [115474-04-9]
Mature Heat-stable Enterotoxin
K.Okamoto, et al., Infect. Immun., 55, 2121 (1987).
K.Okamoto and M.Takahara, J. Bacteriol., 172, 5260 (1990).
H.Ozaki, et al., J. Biol. Chem., 266, 5934 (1991).
H.Yamanaka, et al., Microbiol. Immunol., 37, 195 (1993).
H.Yamanaka, et al., J. Bacteriol., 176, 2906 (1994).

Order Hotline 1-800-777-4779 502-266-8787 121

 PRODUCT CODE QTY PRICE
BIOLOGICALLY ACTIVE PEPTIDES

GsMTx-4 PCB-4393-s 0.1 mg 260

(Chilean Rose Tarantula, Grammostola spatulata) -20 °C vial
Gly-Cys-Leu-Glu-Phe-Trp-Trp-Lys-Cys-Asn-Pro-Asn-Asp-
Asp-Lys-Cys-Cys-Arg-Pro-Lys-Leu-Lys-Cys-Ser-Lys-
Leu-Phe-Lys-Leu-Cys-Asn-Phe-Ser-Phe-NH2
(Reported disulfide bonds between Cys2-Cys17, Cys9-Cys23, and Cys16-Cys30)
(M.W. 4095.8) C185H273N49O45S6
Inhibitor for Cation-Selective Stretch-Activated Channels / Atrial Fibrillation Inhibiting Peptide

Guangxitoxin
Recent efforts for identifying new drugs for Type II Diabetes have focused on inhibitors
that target the delayed-rectifier K+ current (I DR), found in insulin secreting β-cells
and believed to aide in repolarizing action potentials. 1 Such inhibitors may increase
cytosolic calcium levels and insulin secretion.2,3 A novel peptide toxin, guangxitoxin
(GxTX)-1E (PGX-4433-s), was found to inhibit mouse IDR by 90%, selectively
block Kv2.1/Kv2.2 channels (IC50 ~1 nmol/l), and shift the voltage-dependence for
channel activation to more positive potentials, acting as a gating modifier peptide.4
Furthermore, GxTX-1E was able to increase the duration of action potentials (30%
± 6%), calcium oscillations, and insulin secretion (3.5 fold) in a glucose dependent
manner in β-cell IDR.2,3,4,5 This novel peptide may help determine the mechanism and
role of β-cell IDR in insulin secretion and lead to better glucose-dependent methods for
treatment of Type II Diabetes.
1. P.A. Smith, K. Bokvist, P. Arkhammar, P.O. Berggren, and P. Rorsman, J. Gen. Physiol., 95, 1041 (1990).
2. P.E. MacDonald, et al., J. Biol. Chem., 277, 44938 (2002).
3. P.E. MacDonald, et al., Mol. Endocrinol., 15, 1423 (2001).
PEPTIDES INTERNATIONAL

4. J. Herrington, et al., Diabetes, 55,1034 (2006).

5. L. Yan, et al., Diabetes, 53, 597 (2004).

Guangxitoxin-1E PGX-4433-s 0.1 mg 260

GxTX-1E -20 °C vial
(Tarantula, Pleisiophrictus guangxiensis sp. nov.)
(Trifluoroacetate Form)
Glu-Gly-Glu-Cys-Gly-Gly-Phe-Trp-Trp-Lys-Cys-Gly-Ser-Gly-Lys-Pro-Ala-Cys-Cys-
Pro-Lys-Tyr-Val-Cys-Ser-Pro-Lys-Trp-Gly-Leu-Cys-Asn-Phe-Pro-Met-Pro
(Reported disulfide bonds between Cys4-Cys19, Cys11-Cys24 and Cys18-Cys31)
(M.W. 3948.6) C178H248N44O45S7
Kv2.1/Kv2.2 Channel Blocker / Enhancer of Glucose-Dependent Insulin Secretion
Purity Information: QE See page xiv
J. Herrington, et al., 55, 1034-1042 (2006).
P.E. MacDonald, et al., J. Biol. Chem., 277, 44938 (2002).
(Pharmacol.; Role of Kv2.1 in Glucose-Dependent Insulin Secretion)
N.A. Tamarina, et al., Am. J. Physiol. Endocrinol. Metab., 289,E578 (2005).
(Pharmacol.; Role of Kv2.1 in Glucose-Dependent Ca2+ response)
J. Herrington,Toxicon, 49, 231 (2007). (Review)
S. Lee, et al., Biochemistry, 49, 5134 (2010). (Solution Structure & S-S Bond)

122 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT CODE QTY PRICE
Huwentoxin- IV PLL-4455-s 0.1 mg 295

BIOLOGICALLY ACTIVE PEPTIDES

HWTX-IV -20 °C vial
Chinese Bird Spider, (Ornithoctonus huwena)
(Trifluoroacetate Form)
Glu-Cys-Leu-Glu-Ile-Phe-Lys-Ala-Cys-Asn-Pro-Ser-Asn-Asp-Gln-Cys-Cys-Lys-Ser-Ser-Lys-Leu-Val-Cys-
Ser-Arg-Lys-Thr-Arg-Trp-Cys-Lys-Tyr-Gln-Ile-NH2
(Disulfide bonds between Cys2-Cys17, Cys9-Cys24, and Cys16-Cys31)
(M.W. 4106.8) C174H278N52O51S6
Neuronal Tetrodotoxin-Sensitive Na+- Channel Blocker
K. Peng, Q. Shu, Z. Liu, and S. Liang, J. Biol. Chem., 277, 47564 (2002). (Original)
J. Diao, Y. Lin, J. Tang, and S. Liang, Toxicon, 42, 715 (2003). (cDNA Seq)
Y. Xiao, et al., J. Biol. Chem., 283, 27300 (2008). (Pharmacol.)
Y. Xiao, X. Luo, F. Kuang, M. Deng, M. Wang, X. Zeng, and S. Liang, Toxicon, 51, 230 (2008). (Pharmacol.)

Huwentoxin-IV was isolated from the venom of the Chinese bird spider Ornithoctonus
huwena. Its structure was elucidated to be a 35-residue peptide with three disulfide
linkages which are arranged to form the inhibitor cystine knot.1,2 Huwentoxin-IV is a
potent inhibitor of neuronal tetrodotoxin-sensitive Na+ channels with IC50 = 30 nM.1
Further studies clarified that i) among neuronal voltage-gated Na + channels, human
Nav1.7 is most sensitive to huwentoxin-IV where site 4 of the channel is the interacting
site (IC50 = 26 nM)3), and ii) huwentoxin-IV interacts with central Na+ channel isoforms
from rat hippocampus neurons, while the affinity is low (IC50 = ~ 0.4 μM).4 Interestingly,
huwentoxin-IV fails to partition into the artificial membrane bilayers, indicating that the
mechanism for blocking Na+ channels by huwentoxin-IV is distinct from that of ProTx-
II (4450-s), another Na+ channel blocker isolated from the tarantula. 4
1. K. Peng, et al., J. Biol. Chem., 277, 47564 (2002). (Original)

PEPTIDES INTERNATIONAL
2. J. Diao, et al., Toxicon, 42, 715 (2003). (cDNA Seq.)
3. Y. Xiao, et al., J. Biol. Chem., 283, 27300 (2008). (Pharmacol.)
4. Y. Xiao, et al., Toxicon, 51, 230 (2008). (Pharmacol.)

Iberiotoxin* PIB-4235-s 0.1 mg 280

IbTX -20 °C vial
(Scorpion, Buthus tamulus)
Pyr-Phe-Thr-Asp-Val-Asp-Cys-Ser-Val-Ser-Lys-Glu-Cys-Trp-Ser-Val-Cys-Lys-Asp-
Leu-Phe-Gly-Val-Asp-Arg-Gly-Lys-Cys-Met-Gly-Lys-Lys-Cys-Arg-Cys-Tyr-Gln
(Disufide bonds between Cys7-Cys28, Cys13-Cys33, and Cys17-Cys35).
(M.W. 4230.8) C179H274N50O55S7 [129203-60-7]
Ca2+-Activated K+ Channel Blocker (Maxi-K+ Channel Blocker)
A. Galvez, et al., J. Biol. Chem., 265, 11083 (1990). (Original)
M.L. Garcia, et al., J. Bioenerg. Biomembr., 23, 615 (1991). (Review)
K.M. Giangiacomo, M.L. Garcia, and O.B. McManus, Biochemistry, 31, 6719 (1992). (Pharmacol.)
G.J. Kaczorowski, et al., J. Bioenerg. Biomembr., 28, 255 (1996). (Review)
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

Iberiotoxin PIB-3813-PI 1 mg 700

IbTX -20 °C 5 mg 2800
(Trifluoroacetate Form)
NEW!
Pyr-Phe-Thr-Asp-Val-Asp-Cys-Ser-Val-Ser-Lys-Glu-Cys-Trp-Ser-Val-Cys-Lys-Asp-Leu-
Phe-Gly-Val-Asp-Arg-Gly-Lys-Cys-Met-Gly-Lys-Lys-Cys-Arg-Cys-Tyr-Gln-OH
(Disulfide bonds between Cys7-Cys28, Cys13-Cys33, and Cys17-Cys35)
(M.W. 4230.8) C179H274N50O55S7 [129203-60-7]
Ca2+-Activated K+ Channel Blocker (Maxi-K+ Channel Blocker)
A. Galvez, et al., J. Biol. Chem., 265, 11083 (1990). (Original)
M.L. Garcia, et al., J. Bioenerg. Biomembr., 23, 615 (1991). (Review)
K.M. Giangiacomo, et al., Biochemistry, 31, 6719 (1992). (Pharmacol.)
G. J. Kaczorowski, et al., J. Bioenerg. Biomembr., 28, 255 (1996). (Review)

Order Hotline 1-800-777-4779 502-266-8787 123

 PRODUCT CODE QTY PRICE
BIOLOGICALLY ACTIVE PEPTIDES

Imperatoxin A PIM-4343-s 0.1 mg 270

IpTXa -20 °C vial
(Scorpion, Pandinus imperator)
Gly-Asp-Cys-Leu-Pro-His-Leu-Lys-Arg-Cys-Lys-Ala-Asp-Asn-Asp-Cys-Cys-
Gly-Lys-Lys-Cys-Lys-Arg-Arg-Gly-Thr-Asn-Ala-Glu-Lys-Arg-Cys-Arg
(Disulfide bonds between Cys3-Cys17, Cys10-Cys21, and Cys16-Cys32)
(M.W. 3758.4) C148H254N58O45S6 [172451-37-5]
Purity: greater than 94% by HPLC
Activator of Ca2+ Release Channels/Ryanodine Receptors
H.H. Valdivia, et al., Proc. Natl. Acad. Sci. U.S.A., 89, 12185 (1992). (Pharmacol.)
R. El-Hayek, et al., J. Biol. Chem., 270, 28696 (1995). (Pharmacol.)
F.Z. Zamudio, et al., FEBS Lett., 405, 385 (1997). (Original; Structure)
K. Takeuchi, et al., Peptide Science, 1999, 307 (2000). (S-S Bond)

Kaliotoxin (1-37)* PKL-4259-s 0.1 mg 295

(Scorpion, Androctonus mauretanicus mauretanicus) -20 °C vial
Gly-Val-Glu-Ile-Asn-Val-Lys-Cys-Ser-Gly-Ser-Pro-Gln-Cys-Leu-Lys-Pro-Cys-Lys-
Asp-Ala-Gly-Met-Arg-Phe-Gly-Lys-Cys-Met-Asn-Arg-Lys-Cys-His-Cys-Thr-Pro
(Reported disulfide bonds between Cys8-Cys28, Cys14-Cys33, and Cys18-Cys35)
(M.W. 4021.8) C165H271N53O48S8
High Conductance Ca2+-Activated K + Channel Blocker
M. Crest, et al., J. Biol. Chem., 267, 1640 (1992). (Original)
R. Romi, et al., J. Biol. Chem., 268, 26302 (1993). (Chem. Synthesis & Pharmacol.)
F.R. Romi, et al., Biochemistry, 33, 14256 (1994). (Unique Structure)
A.L. Harvey, et al., Toxicon, 33, 425 (1995). (Pharmacol.)
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

Kurtoxin PKT-4375-s 0.1 mg 370

PEPTIDES INTERNATIONAL

(Scorpion, Parabuthus transvaalicus) -20 °C vial

Lys-Ile-Asp-Gly-Tyr-Pro-Val-Asp-Tyr-Trp-Asn-Cys-Lys-Arg-Ile-Cys-
Trp-Tyr-Asn-Asn-Lys-Tyr-Cys-Asn-Asp-Leu-Cys-Lys-Gly-Leu-Lys-
Ala-Asp-Ser-Gly-Tyr-Cys-Trp-Gly-Trp-Thr-Leu-Ser-Cys-Tyr-Cys-
Gln-Gly-Leu-Pro-Asp-Asn-Ala-Arg-Ile-Lys-Arg-Ser-Gly-Arg-Cys-Arg-Ala
(Disulfide bonds between Cys12-Cys61Cys16-Cys37, Cys23-Cys44, and Cys27-Cys46)
(M.W. 7386.4) C324H478N94O90S8
T-type Ca2+ Channel Blocker
Purity Information: Qp See page xiv
R.S-I. Chuang, et al., Nat. Neurosci., 1, 668 (1998). (Original)
S.S. Sidach and I.M. Mintz, J. Neurosci., 22, 2023 (2002). (Pharmacol.; Specificity for Ca2+ Channel Blocking Activity)
T. Olamendi-Portugal, et al., Biochem. Biophys. Res. Commun., 299, 562 (2002). (Pharmacol.)
I. López-González, et al., Biochem. Biophys. Res. Commun., 300, 408 (2003). (Pharmacol.)
H. Nishio, et al., Lett. Pept. Sci., in press. (Chem. Synthesis & S-S Bond)

Leiurotoxin I See Code PSC-4260-s Scyllatoxin.

Mambalgin-1 MAM-3778-PI 1 mg 1700

(Black Mamba, Dendrooaspis polylepis) -20 °C 5 mg 3000
(Trifluoroacetate Form)
H-Leu-Lys-Cys-Tyr-Gln-His-Gly-Lys-Val-Val-Thr-Cys-His-Arg-Asp-
Met-Lys-Phe-Cys-Tyr-His-Asn-Thr-Gly-Met-Pro-Phe-Arg-Asn-Leu-
Lys-Leu-Ile-Leu-Gln-Gly-Cys-Ser-Ser-Ser-Cys-Ser-Glu-Thr-Glu-
Asn-Asn-Lys-Cys-Cys-Ser-Thr-Asp-Arg-Cys-Asn-Lys-OH
(Disulfide bonds Cys3-Cys19, Cys12-Cys37, Cys41-Cys49, and Cys50-Cys55)
(M.W. 6554.61) C272H429N85O84S10
S. Diochot, et al., Nature, 490, 552 (2012).

124 Order Hotline 1-800-777-4779 502-266-8787

 PRODUCT CODE QTY PRICE
Margatoxin (MgTX) PAR-4290-s 0.1 mg 270

BIOLOGICALLY ACTIVE PEPTIDES

(Scorpion, Centruroides margaritatus) -20 °C vial
Thr-Ile-Ile-Asn-Val-Lys-Cys-Thr-Ser-Pro-Lys-Gln-Cys-
Leu-Pro-Pro-Cys-Lys-Ala-Gln-Phe-Gly-Gln-Ser-Ala-Gly-
Ala-Lys-Cys-Met-Asn-Gly-Lys-Cys-Lys-Cys-Tyr-Pro-His
(Reported disulfide bonds between Cys7-Cys29,Cys13-Cys34, and Cys17-Cys36)
(M.W. 4178.9) C178H286N52O50S7 [145808-47-5]
Volgate-Dependent K+ Channel Blocker
(Specific for Kv1.3 Channel)
R.J. Leonard, et al., Proc. Natl. Acad. Sci. U.S.A., 89, 10094 (1992). (Pharmacol.)
M. Garcia-Calvo, et al., J. Biol. Chem., 268, 18866 (1993). (Original)
M.A. Bednarek, et al., Biochem. Biophys. Res. Commun., 198, 619 (1994). (Chem. Synthesis & S-S Bond)
H.G. Knaus, et al., Biochemistry, 34,13627 (1995). (Pharmacol.)

Martentoxin I MAR-3811-PI 1 mg 700

(Scorpion, Buthus martensi Karsch) -20 °C 5 mg 2800
H-Gly-Leu-Ile-Asp-Val-Lys-Cys-Phe-Ala-Ser-Ser-Glu-Cys-
NEW! Trp-Thr-Ala-Cys-Lys-Lys-Val-Thr-Gly-Ser-Gly-Gln-Gly-Lys-
Cys-Gln-Asn-Asn-Gln-Cys-Arg-Cys-Tyr-OH
(D-sulfide Bonded)
(M.W. 3911.50) C162H253N49O52S6
Inhibitor of Calcium-Activated K+ Channels.
J. Tao, et al., PLOS one, 6e, 15896 (2011).
Y. Ji, et al., J. Neurochem., 84, 325 (2003).
J. Shi, et al., Biophy. Journal., 94, 3706 (2008).
Z. Cao, et al., J. Peptides Res,. 62, 252 (2003).

Muscarinic Toxins

PEPTIDES INTERNATIONAL
K.N. Bradley, Pharmacol. Ther., 85, 87 (2000). (Review)
L.T. Potter, Life Sci., 68, 2541 (2001). (Review)
D. Servent and C. Fruchart-Gaillard, J. Neurochem., 109, 1193 (2009). (Review)
E. Karlsson, et al., 82, 793 (2000). (Review)

List of Muscarinic Toxins

Code Compound Specificity Quantity Page
PMT-4341-s Muscarinic Toxin 1 M1/4 0.1 mg vial below
(MT1, MTX1)
PMT-4410-s Muscarinic Toxin 3 M4 0.1 mg vial 134
(MT3, MTX3, m4-toxin)
PMT-4340-s Muscarinic Toxin 7 M1 0.1 mg vial 134
(MT7, MTX7, m1-toxin1)
PMT-4424-s Muscarinic Toxin α (MTα) M3/4/5 0.1 mg vial 134

Order Hotline 1-800-777-4779 502-266-8787 125

 PRODUCT CODE QTY PRICE
BIOLOGICALLY ACTIVE PEPTIDES

Muscarinic Toxin 1 PMT-4341-s 0.1 mgt 360

MTX1, MT1 -20 °C vial
(Green Mamba, Dendroaspis angusticeps)
Leu-Thr-Cys-Val-Thr-Ser-Lys-Ser-Ile-Phe-Gly-Ile-Thr-Thr-Glu-Asn-Cys-Pro-Asp-Gly-Gln-Asn-Leu-
Cys-Phe-Lys-Lys-Trp-Tyr-Tyr-Ile-Val-Pro-Arg-Tyr-Ser-Asp-Ile-Thr-Trp-Gly-Cys-Ala-Ala-Thr-Cys-
Pro-Lys-Pro-Thr-Asn-Val-Arg-Glu-Thr-Ile-Arg-Cys-Cys-Glu-Thr-Asp-Lys-Cys-Asn-Glu
(Disulfide bonds between Cys3-Cys24, Cys17-Cys42, Cys46-Cys58, and Cys59-Cys64)
(M.W. 7509.5) C326H499N87O101S8
Agonist for Muscarinic Acetylcholine Receptor-1 (M1 / M4 )
(Non-Specific Ligand)
Purity Information: Qp See page xiv
M. Jolkkonen, A. Adem, U. Hellman, C. Wernstedt, and E. Karlsson, Toxicon, 33, 399 (1995). (Original-Structure)
D. Jerusalinsky and A.L. Harvey, Trends Pharmacol. Sci., 15, 424 (1994). (Review; Toxin for Muscarinic Receptor)
A. Adem and E. Karlsson, Life Sci., 60, 1069 (1997). (Pharmacol.)
H.Nishio, Y. Nishiuchi, T. Inui, K.N. Bradley, A.L. Harvey, and T. Kimura, Peptide Science, 1999, 125 (2000). (S-S Bond )

Muscarinic Toxin 3 PMT-4410-s 0.1 mg 360

MT3, MTX3, m4-toxin -20 °C vial
(Green Mamba, Dendroaspis angusticeps)
Leu-Thr-Cys-Val-Thr-Lys-Asn-Thr-Ile-Phe-Gly-Ile-Thr-Thr-Glu-Asn-Cys-Pro-Ala-Gly-Gln-Asn-Leu-
Cys-Phe-Lys-Arg-Trp-His-Tyr-Val-Ile-Pro-Arg-Tyr-Thr-Glu-Ile-Thr-Arg-Gly-Cys-Ala-Ala-Thr-
Cys-Pro-Ile-Pro-Glu-Asn-Tyr-Asp-Ser-Ile-His-Cys-Cys-Lys-Thr-Asp-Lys-Cys-Asn-Glu
(Disulfide bonds between Cys3- Cys24, Cys17- Cys42, Cys46- Cys57, and Cys58- Cys63)
(M.W. 7379.4) C319H489N89O97S8
Specific Ligand for Muscarinic Acetylcholine Receptor-4 (M4)
M. Jolkkonen, et al., FEBS Lett., 352, 91 (1994). (Original; MT3)
J.-S. Liang, et al., Toxicon, 34, 1257 (1996). (Original; m4-toxin)
A. Adem and E. Karlsson, Life Sci., 60, 1069 (1997). (Pharmacol.; Muscarinic Receptor Subtype Specificity)
PEPTIDES INTERNATIONAL

S. Katayama, et al., Peptide Science 2004, 161 (2005). (S-S Bond)

Muscarinic Toxin 7 PMT-4340-s 0.1 mg 360

MTX7, MT7, m1-toxin 1 -20 °C vial
(Green Mamba, Dendroaspis angusticeps)
Leu-Thr-Cys-Val-Lys-Ser-Asn-Ser-Ile-Trp-Phe-Pro-Thr-Ser-Glu-Asp-Cys-Pro-Asp-Gly-Gln-Asn-Leu-
Cys-Phe-Lys-Arg-Trp-Gln-Tyr-Ile-Ser-Pro-Arg-Met-Tyr-Asp-Phe-Thr-Arg-Gly-Cys-Ala-Ala-Thr-
Cys-Pro-Lys-Ala-Glu-Tyr-Arg-Asp-Val-Ile-Asn-Cys-Cys-Gly-Thr-Asp-Lys-Cys-Asn-Lys
(Disulfide bonds between Cys3-Cys24, Cys17-Cys42, Cys46-Cys57, and Cys58-Cys63)
(M.W. 7472.4) C322H484N90O98S9
Specific Ligand for Muscarinic Acetylcholine Receptor-1 (M1)
A. Adem and E. Karlsson, Life Sci., 60, 1069 (1997). (Original)
H. Nishio, Y. Nishiuchi, T. Inui, K.N. Bradley, A.L. Harvey, and T. Kimura, Peptide Science, 1999, 125 (2000). (S-S Bond)
J.M. Carsi and L.T. Potter, Toxicon, 38, 187 (2000). (Original; m1-toxin1)
Z. Gu, P. Zhong, and Z. Yan, J. Biol. Chem., 278, 17546 (2003). (Pharmacol; Inhibition of β-Amyloid signaling)

Muscarinic Toxin α PMT-4424-s 0.1 mg 360

MTα -20 °C vial
(Black Mamba, Dendroaspis polylepis)
Leu-Thr-Cys-Val-Thr-Ser-Lys-Ser-Ile-Phe-Gly-Ile-Thr-Thr-Glu-Asn-Cys-Pro-Asp-Gly-Gln-Asn-Leu-
Cys-Phe-Lys-Lys-Trp-Tyr-Tyr-Leu-Asn-His-Arg-Tyr-Ser-Asp-Ile-Thr-Trp-Gly-Cys-Ala-Ala-Thr-
Cys-Pro-Lys-Pro-Thr-Asn-Val-Arg-Glu-Thr-Ile-His-Cys-Cys-Glu-Thr-Asp-Lys-Cys-Asn-Glu
(Disulfide bonds between Cys3-Cys24, Cys17-Cys42, Cys46-Cys58, and Cys59-Cys64)
(M.W. 7545.4) C326H491N89O102S8
Ligand for Muscarinic Acetylcholine Receptor-3/4/5 (M3/M4/M5) (Non-specific Ligand)

126 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT CODE QTY PRICE
Muscarinic acetylcholine receptors have been classified into five subtypes (M1 to M5).

BIOLOGICALLY ACTIVE PEPTIDES

These receptors are involved in various biological functions, which can be studied using
specific ligands to each receptor subtype, including the peptidic "muscarinic toxin"
(abbreviated as MT in this short description). Muscarinic toxins are isolated from the
venom of the mamba species and are composed of 65 to 66 amino acid residues with
four intramolecular disulfide linkages.1 It is indicated that the activation of muscarinic
acetylcholine receptors can regulate the metabolism of amyloid precursor protein, and
that muscarinic agonists led to a reduction of amyloid β-protein production2,3,. For
example, synthetic MT7 (PMT-4340-s) has been used to study M1 receptor's role in
amyloid β-protein-induced signaling.4
We offer two muscarinic toxins bearing different receptor subtype selectivity. These
are muscarinic toxin 3 (MT3) and muscarinic toxin α (MTα). We determined the
disulfide arrangement of synthetic MT35 and MTα, although the experimental details
have not yet published for MTα. MT3 was isolated from the green mamba Dendroaspis
angusticeps and is composed of 65 amino acid residues. This peptide shows selectivity
for the M 4 receptor with low affinity to M1 receptor, and no binding to M 2, M3, andM5
receptors.6-9 Another 66-residue peptide toxin, MTα is reported to be a component
of the venomous toxins of the black mamba Dendroaspis polylepis. This peptide
possesses high affinity to all five subtypes; inhibition constants for M1 through M5 are
23 nM, 44 nM, 3 nM, 5 nM, and 8 nM, respectively.8, 10, 11 As far as we know, a specific
ligand to M3 and M5 does not exist, thus, MTα is attractive for this reason although the
subtype selectivity is rather low.
Combined utilization with already commercially available MT1 (PMT-4341-s) and MT7,

PEPTIDES INTERNATIONAL
the research concerning biological functions elicited through muscarinic acetylcholine
receptors should advance significantly, using these chemically synthesized MT3 and
MTα.
1. K.N. Bradley, Pharmacol. Ther., 85, 87 (2000). (Review)
2. T.G. Beach, D.G. Walker, P.E. Potter, L.I. Sue, and A. Fisher, Brain Res., 905, 220 (2001). (Pharmacol.)
3. C. Hock, et al., J. Protein Folding Disord., 10, 1 (2003). (Pharmacol.)
4. Z. Gu, P. Zhong, and Z. Yan, J. Biol. Chem., 278, 17546 (2003). (Pharmacol.; Role in Aβ -Induced Signaling)
5. S. Katayama, et al., Peptide Science 2004, 161 (2005). (S-S Bond of MT3)
6. M. Jolkkonen, et al., FEBS Lett., 352, 91 (1994). (Original; MT3)
7. J.-S. Liang, et al., Toxicon, 34, 1257 (1996). (Original; m4-toxin)
8. A. Adem and E. Karlsson, Life Sci., 60, 1069 (1997). (Pharmacol.; Muscarinic Receptor Subtype Specificity)
9. M. C. Olianas, et al., Eur. J. Pharmacol., 357, 235 (1998). (Pharmacol.; cAMP-Coupled M4 Receptor)
10. M. Jolkkonen, et al., Eur. J. Biochem., 234, 579 (1995). (Original; MTα)
11. M. Jolkkonen, et al., Toxicon, 39, 377 (2001). (Pharmacol.; Mechanism of Receptor Binding)

Neurotoxin NSTX-3 PNT-4195-s 0.1 mg 115

(Papua New Guinean Spider, Nephila maculata) -20 °C vial
2,4-Dihydroxyphenylacetyl-l-Asparaginyl-N1-
(l-Arginyl-Putreanyl)-Cadaverine
(M.W. 664.80) C30H52N10O7
Y. Aramaki, et al., Proc. Japan Acad., 62 (B), 359 (1986). (Original)
T. Teshima, et al., Tetrahedron Letters, 28, 3509 (1987). (Chem. Synthesis, Preliminary)
T. Teshima, et al., Tetrahedron, 47, 3305 (1991). (Chem. Synthesis; Total Synthesis)
• This compound is distributed through Peptide Institute, Inc. under the license of Takeda, Chemical Industries, Ltd.
and the Tokyo Metropolitan Institute for Neurosciences.

Order Hotline 1-800-777-4779 502-266-8787 127

 PRODUCT CODE QTY PRICE
BIOLOGICALLY ACTIVE PEPTIDES

PLTX-II PPL-4300-s 0.1 mg 455

(spider, Plectreurys tristes) -20 °C vial
Ala-Asp-Cys-Ser-Ala-Thr-Gly-Asp-Thr-Cys-Asp-His-Thr-Lys-
Lys-Cys-Cys-Asp-Asp-Cys-Tyr-Thr-Cys-Arg-Cys-Gly-
Thr-Pro-Trp-Gly-Ala-Asn-Cys-Arg-Cys-Asp-Tyr-Tyr-
Lys-Ala-Arg-Cys-Asp-Thr(Palmitoyl)-NH2
(Disulfide bonds undetermined)
(M.W. 5108.7) C208H313N61O70S10
Presynaptic Ca2+ Channel Blocker
W.D. Branton, L. Kolton, Y.N. Jan, and L.Y. Jan, J. Neurosci., 7, 4195 (1987). (Original)
H.-T. Leung, W.D. Branton, H.S. Phillips, L. Jan, and L. Byerly, Neuron, 3, 767 (1989). (Pharmacol.)
W.D. Branton, et al., Nature, 365, 496 (1993). (Thr(Pal)amide)
J. Bódi, et al., Pept. Res., 8, 228 (1995). (Chem. Synthesis & Biological Activity)
G.F. King, Toxicon, 49, 513 (2007). (Review)

ProTx-I and ProTx-II

ProTx-I and ProTx-II were first isolated and characterized from the venom of taran -
tula Thrixopelma pruriens.1-3 These peptide toxins belong to the inhibitory cystine
knot (ICK) family, which is known to interact with voltage-gated ion channels. They
are unique because they alter the rate of activation rather than inactivation of chan-
nels. Otherwise, there is no sequence homology between ProTx-I and Pro-Tx-II.
ProTx-II is the newest toxin currently offered by Peptides International and produced
by the Peptide Institute in Japan. It was shown to be at least 100-fold selective for
Nav1.7 channel with an IC50 of 0.3 nM.4 Sodium channel subtype Nav1.7 has a role
in modulating neuronal signaling for pain, and recent studies indicate loss-of-function
mutations in Nav1.7 cause insensitivity to pain.5 Others have identified gain-of-function
PEPTIDES INTERNATIONAL

mutations in Nav1.7 as the cause of certain pain disorders. 6-8 Thus Nav1.7 is a poten-
tial target for the development of analgesics.
The highly sensitive nature of ProTx-II for Nav1.7 is believed to be due to the presence
of a unique phenylalanine residue (F813) present in the C-terminal domain II S3 of the
channel, which makes it different than the other sodium channel subtypes. Indeed,
mutation of the F813 residue to glycine or serine reduced the sensitivity of ProTx-II
significantly.4
Evidence indicates ProTx-II may not be able to cross the blood-nerve barrier since
intravenous administration in rats did not significantly block acute pain response. In
addition, the toxin can block C-fiber action potential propagation in desheathed but not
intact nerves.4 While this may limit the use of ProTx-II, the toxin should still act as an
important tool for locating novel inhibitors for Na v1.7.
1. R.E. Middleton, et al., Biochemistry, 41, 14734 5. S.D. Dib-Hajj, et al., Trends Neurosci, 30, 555
(2002). (Original) (2007).
2. B.T. Priest, et al., Toxicon, 49, 194 (2007). (Review) 6. C.R. Fertleman, et al., Neuron, 52, 767 (2006).
3. J.J. Smith, et al., J. Biol. Chem.,282, 12687 (2007). 7. C. Han, et al., Ann Neurol., 59, 553 (2006).
(Pharmacol.; Novel Toxin Binding Site Coupled to 8. Y. Yang,et al., Journal of Med. Genetics, 41171
Nav Activation) (2004).
4. W.A. Schmalhofer, et al., Mol. Pharmacol., 74,1476
(2008).

128 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT CODE QTY PRICE
ProTx-I PTX-4409-s 0.1 mg 265

BIOLOGICALLY ACTIVE PEPTIDES

(Tarantula, Thrixopelma pruriens) -20 °C vial
Glu-Cys-Arg-Tyr-Trp-Leu-Gly-Gly-Cys-Ser-Ala-Gly-Gln-
Thr-Cys-Cys-Lys-His-Leu-Val-Cys-Ser-Arg-Arg-His-
Gly-Trp-Cys-Val-Trp-Asp-Gly-Thr-Phe-Ser
(Disulfide bonds between Cys2-Cys16, Cys9-Cys21, and Cys15- Cys28)
(M.W. 3987.5) C171H245N53O47S6
T-Type Ca2+ Channel / Na+ Channel / K+ Channel Blocker (Gating Modifier)
R.E. Middleton, V.A. Warren, R.L. Kraus, J.C. Hwang, C.J. Liu, G. Dai, R.M. Brochu, M.G. Kohler, Y.D. Gao, V.M. Garsky,
M.J. Bogusky, J.T. Mehl, C.J. Cohen, and M.M. Smith, Biochemistry, 41, 14734 (2002). (Original)
T. Ohkubo, J. Yamazaki, and K. Kitamura, J. Pharmacol. Sci., 112, 452 (2010). (Pharmacol.)
B.T. Priest, K.M. Blumenthal, J.J. Smith, V.A. Warren, and M.M. Smith, Toxicon, 49, 194 (2007). (Review)

ProTx-II PTX-4450-s 0.1 mg 250

(Tarantula, Thrixopelma pruriens) -20 °C vial
YCQKWMWTCDSERKCCEGMVCRLWCKKKLW
Tyr-Cys-Gln-Lys-Trp-Met-Trp-Thr-Cys-Asp-Ser-Glu-Arg-Lys-Cys-Cys-
Glu-Gly-Met-Val-Cys-Arg-Leu-Trp-Cys-Lys-Lys-Lys-Leu-Trp
(Disulfide bonds between Cys2-Cys16, Cys9- Cys21, and Cys15-Cys25)
(M.W. 3826.60) C168H250N46O41S8
Na+ Channel (Especially Nav1.7) / Ca2+ Channel Blocker (Gating Modifier)
R.E. Middleton, et al., Biochemistry, 41, 14734 (2002). (Original)
J.J. Smith, et al., J. Biol. Chem., 282, 12687 (2007). (Pharmacol.; Novel Toxin Binding Site Coupled to Nav Activation)
W.A. Schmalhofer, et al., Mol. Pharmacol, 74, 1476 (2008). (Pharmacol.; Inhibition of Nav1.7 Channels)
S.D. Dib-Hajj, et al., Trends Neurosci., 30, 555 (2007). (Review)
B.T. Priest, et al., Toxicon, 49, 194 (2007). (Review)
S. Sokolov, et al., Mol. Pharmacol., 73, 1020 (2008). (Pharmacol.)

PEPTIDES INTERNATIONAL

Order Hotline 1-800-777-4779 502-266-8787 129

 PRODUCT CODE QTY PRICE
BIOLOGICALLY ACTIVE PEPTIDES

Psalmotoxin
The acid-sensing ion channel (ASIC) family is involved with pain perception, learning,
and memory. In addition, the ion channels may contribute to brain injury and neuronal
death. ASIC is stimulated by H+ ligand, and activation is calcium dependent. 1,2
Peptide toxins have been invaluable tools for inhibition of ion conductance pathways
and in functional/structural studies of channels. Psalmotoxin 1 (PTX-4435-s), isolated
from the venom of tarantula Psalmopoeus cambridgei, is the first potent peptide
blocker shown to inhibit ASIC1a by increasing affinity of the channel for H+, leading
to receptor desensitization.4,5,6 This toxin showed promise as a neuroprotective agent
for ASIC1a mediated ischemic brain injury (100 ng/ml) and could selectively inhibit
malignant glioma (IC50 = 36 pM) Na+ channels (both inward and outward). 7,8 Further
studies of Psalmotoxin ASIC1a interaction could lead to potential diagnosis and
therapy of these and other ASIC1a-related diseases.
1. E.L. Bässler, et. al., J. Biol. Chem., 276, 33782 5. M. Salinas, et. al., J. Physiol., 570, 339 (2005).
(2001). 6. X. Chen, et. al., J. Gen. Physiol., 126, 71 (2005).
2. E. Babini, et. al., J.Biol. Chem., 277, 41597 (2002). 7. G. Pignataro, et. al., Brain, 10, 1093 (2006).
3. V.I. Pidoplichko and J.A. Dani, PNAS, 203, 11376 8. J.K. Bubien, et. al., Am. J. Physiol. Cell Physiol.,
(2006). 287, C1282 (2004).
4. P. Escoubas, et. al., J. Biol. Chem., 275, 25116
(2000).

Psalmotoxin 1 PTX-4435-s 0.1 mg 280

PcTX1 -20 °C vial
(South American Tarantula, Psalmopoeus cambridgei)
(Trifluoroacetate Form)
PEPTIDES INTERNATIONAL

Glu-Asp-Cys-Ile-Pro-Lys-Trp-Lys-Gly-Cys-Val-Asn-Arg-His-Gly-Asp-Cys-Cys-Glu-Gly-
Leu-Glu-Cys-Trp-Lys-Arg-Arg-Arg-Ser-Phe-Glu-Val-Cys-Val-Pro-Lys-Thr-Pro-Lys-Thr
(Disulfide bonds between Cys3-Cys18, Cys10-Cys23, and Cys17-Cys33)
(M.W. 4689.40) C200H312N62O57S6
Selective Blocker for Acid-Sensitive Ion Channel, ASIC1a
Purity Information: QE See page xiv
P. Escoubas, et al., J. Biol. Chem., 275, 25116 (2000). (Original; Primary Structure & ASIC Blocking Selectivity)
P. Escoubas, et al., Protein Sci., 12, 1332 (2003). (Three-dimensional Solution Structure)
X. Chen, et al., J. Gen. Physiol., 127, 267 (2006). (Pharmacol.; State-Dependent Function)
X. Chen, et al., J. Gen. Physiol., 126, 71 (2005). (Pharmacol.; Mechanism of Channel Inhibition)
J.K. Bubien, et al., Am. J. Physiol. Cell Physiol., 287, C1282 (2004).
(Pharmacol.; Inhibition of Malignant Glioma Na+ Channels)
Z.-G. Xiong, et al., Cell, 118, 687 (2004). (Pharmacol.; Neuroprotection in Ischemia)
S. Diochot, et al., Toxicon, 49, 271 (2007). (Review)
Y.J. Qadri, et al., J. Biol. Chem., 284, 17625 (2009). (Pharmacol.)

Purotoxin-1 PPT-4457-v 0.1 mg 295

(Wolf Spider, Geolycosa sp.) -20 °C vial
Gly-Tyr-Cys-Ala-Glu-Lys-Gly-Ile-Arg-Cys-Asp-Asp-Ile-
His-Cys-Cys-Thr-Gly-Leu-Lys-Cys-Lys-Cys-Asn-
Ala-Ser-Gly-Tyr-Asn-Cys-Val-Cys-Arg-Lys-Lys
(Reported disulfide bonds between Cys3-Cys16, Cys10-Cys21, Cys15-Cys32, and Cys23-Cys30)
(M.W. 3836.50) C155H248N50O48S8
Inhibitor of P2X3 Purinoreceptors
E.V. Grishin, et al., Ann. Neurol., 67, 680 (2010). (Original; Structure & Pharmacol.)

Sarafotoxins
E. Kochva, A. Bdolah, and Z. Wollberg, Toxicon, 31, 541 (1993). (Review)
F. Ducancel, Toxicon, 40, 1541 (2002). (Review)
F. Ducancel, Cell. Mol. Life Sci., 62, 2828 (2005). (Review)

130 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT CODE QTY PRICE
Sarafotoxin S6b* PSF-4206-s 0.1 mg 180

BIOLOGICALLY ACTIVE PEPTIDES

(Snake, Atractaspis engaddensis) -20 °C vial
Cys-Ser-Cys-Lys-Asp-Met-Thr-Asp-Lys-Glu-Cys-
Leu-Tyr-Phe-Cys-His-Gln-Asp-Val-Ile-Trp
(Disulfide bonds between Cys1-Cys15 and Cys3-Cys11)
(M.W. 2563.9) C110H159N27O34S5 [120972-53-4]
Endothelin Related Peptide
C. Takasaki, et al., Toxicon, 26, 543 (1988). (Original; Chem. Structure)
Y. Kloog, et al., Science, 242, 268 (1988). (Original; Biochem.)
K. Nakajima, et al., J. Cardiovasc. Pharmacol., 13 (Suppl. 5), 58 (1989). (Chem. Synthesis and Biological Activity)
T.X. Watanabe, et al., J. Cardiovasc. Pharmacol., 17, S5 (1991). (Pharmacol.)
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

Sarafotoxin S6c* PSF-4246-s 0.1 mg 180

(Snake, Atractaspis engaddensis) -20 °C vial
Cys-Thr-Cys-Asn-Asp-Met-Thr-Asp-Glu-Glu-Cys-
Leu-Asn-Phe-Cys-His-Gln-Asp-Val-Ile-Trp
(Disulfide bonds between Cys1-Cys15 and Cys3-Cys11)
(M.W. 2515.8) C103H147N27O37S5 [121695-87-2]
Selective ETB Receptor Agonist
C. Takasaki, et al., Toxicon, 26, 543 (1988). (Original; Chem. Structure)
W.G. Nayler, et al., Biochem. Biophys. Res. Commun., 161, 89 (1989). (Pharmacol.)
D.L. Williams, Jr., et al. Biochem. Biophys. Res. Commun., 175, 556 (1991). (Pharmacol.)
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

Scyllatoxin PSC-4260-s 0.1 mg 260

Leiurotoxin I -20 °C vial

PEPTIDES INTERNATIONAL
(Scorpion, Leiurus quinquestriatus hebraeus)
Ala-Phe-Cys-Asn-Leu-Arg-Met-Cys-Gln-Leu-Ser-Cys-Arg-Ser-Leu-Gly-
Leu-Leu-Gly-Lys-Cys-Ile-Gly-Asp-Lys-Cys-Glu-Cys-Val-Lys-His-NH2
(Reported disulfide bonds betwen Cys3-Cys21, Cys8-Cys26, and Cys12-Cys28)
(M.W. 3423.1) C142H237N45O39S7 [142948-19-4]
Small Conductance Ca2+-Activated K+ Channel Blocker
G.G. Chicchi, et al., J. Biol. Chem., 263, 10192 (1988). (Original)
P. Auguste, M. Hugues, C. Mourre, D. Moinier, A. Tartar, and M. Lazdunski, Biochemistry, 31, 648 (1992). (Pharmacol.)
J.C. Martins, F.J.M. Van de Ven, and F.A.M. Borremans, J. Mol. Biol., 253, 590 (1995). (S-S Bond)

SNX-482 PCB-4363-s 0.1 mg 380

(Tarantula, Hysterocrates gigas) -20 °C vial
Gly-Val-Asp-Lys-Ala-Gly-Cys-Arg-Tyr-Met-Phe-Gly-Gly-Cys-Ser-Val-
Asn-Asp-Asp-Cys-Cys-Pro-Arg-Leu-Gly-Cys-His-Ser-Leu-Phe-Ser-
Tyr-Cys-Ala-Trp-Asp-Leu-Thr-Phe-Ser-Asp
(Reported disulfide bonds between Cys7-Cys21, Cys14-Cys26, and Cys20-Cys33)
(M.W. 4495.0 ) C192H274N52O60S7 [203460-30-4]
Class-E (R-Type) Ca2+ Channel Blocker
R. Newcomb, et al., Biochemistry, 37, 15353 (1998). (Original)
L. Ürge, et al., In, Peptides 1998, Proceedings of 25th European Peptide Symposium (S. Bajusz and F. Hudecz, eds.),
Akadémiai Kiadó Butapest, 1998, 748-749 (1998). (S-S Bond)
A. Tottene, et al., J. Neurosci., 20, 171 (2000). (Pharmacol.)
G. Wang, G. Dayanithi, R. Newcomb, and J.R. Lemos, J. Neurosci., 19, 9235 (1999). (Pharmacol.)
D. Sochivko, et al., J. Physiol., 542, 699 (2002). (Pharmacol.)
X. Jing, et al., J. Clin. Invest., 115, 146 (2005). (Pharmacol.)

Order Hotline 1-800-777-4779 502-266-8787 131

 PRODUCT CODE QTY PRICE
BIOLOGICALLY ACTIVE PEPTIDES

Stichodactyla Toxin (ShK) PSK-4287-s 0.1 mg 275

(Sea Anemone, Stichodactyla helianthus) -20 °C vial
Arg-Ser-Cys-Ile-Asp-Thr-Ile-Pro-Lys-Ser-Arg-Cys-Thr-Ala-
Phe-Gln-Cys-Lys-His-Ser-Met-Lys-Tyr-Arg-Leu-Ser-
Phe-Cys-Arg-Lys-Thr-Cys-Gly-Thr-Cys
(Disulfide bonds between Cys3-Cys35, Cys12-Cys28, and Cys17-Cys32)
(M.W. 4054.8) C169H274N54O48S7
Voltage Dependent K + Channel (A Channel) Blocker
E. Karlsson, et al., Toxicon, 31, 504 (1993). (Original; in Abstract)
J. Pohl, F. Hubalek, M.E. Byrnes, K.R. Nielsen, A. Woods, and M.W. Pennington,
Lett. Pept. Sci., 1, 291 (1994). (S-S Bond)
O. Castañeda, et al., Toxicon, 33, 603 (1995). (Pharmacol.)

Stichodactyla Toxin (ShK) (Amide) SHK-3770-PI 1 mg 1000

(Sea Anemone, Stichodactyla helianthus) -20 °C 5 mg 4000
H-Arg-Ser-Cys-Ile-Asp-Thr-Ile-Pro-Lys-Ser-Arg-Cys-Thr-Ala-Phe-Gln-
Cys-Lys-His-Ser-Met-Lys-Tyr-Arg-Leu-Ser-Phe-Cys-Arg-Lys-Thr-Cys-
Gly-Thr-Cys-NH2
(Disulfide bonds between Cys3-Cys35, Cys12-Cys28, and Cys17-Cys32)
(M.W. 4053.86) C169H275N55O47S7
Voltage Dependent K + Channel (A Channel) Blocker
E. Karlsson,et al., Toxicon, 31, 504 (1993). (Original; in Abstract)
O. Castañeda, et al., Toxicon, 33, 603 (1995). (Pharmacol.)

5-Fam-ShK SHK-3746-PI 1 mg 1500

(Sea Anemone, Stichodactyla helianthus) -20 °C
(Trifluoroacetate Form)
Fluorescein-5-carbonyl-AEEAc-Arg-Ser-Cys-Ile-Asp-Thr-
PEPTIDES INTERNATIONAL

Ile-Pro-Lys-Ser-Arg-Cys-Thr-Ala-Phe-Gln-Cys-Lys-His-Ser-
Met-Lys-Tyr-Arg-Leu-Ser-Phe-Cys-Arg-Lys-Thr-Cys-Gly-Thr-
Cys-NH2
(Disulfide bonds between Cys3-Cys35, Cys12-Cys28, and Cys17-Cys32)
(M.W. 4557.33) C196H296N56O56S7
C. Beeton, et al., J. Biol. Chem., 278, 9928 (2003)
R.S. Norton, et al., Curr. Med. Chem., 11, 3141 (2004)

Tertiapin PTK-4364-s 0.1 mg 180

(Honey Bee, Apis mellifera) -20 °C vial
Ala-Leu-Cys-Asn-Cys-Asn-Arg-Ile-Ile-Ile-Pro-His-
Met-Cys-Trp-Lys-Lys-Cys-Gly-Lys-Lys-NH2
(Disulfide bonds between Cys3-Cys14 and Cys5-Cys18)
(M.W. 2455.1) C106H176N34O23S5
Inward Rectifier K+ Channel Blocker
W. Jin and Z. Lu, Biochemistry, 37, 13291 (1998). (Original; Pharmacol.)
X. Xu and J.W. Nelson, Proteins Struct. Funct. Genet., 17, 124 (1993). (Structure; S-S Bond)
H. Kitamura, et al., J. Pharmacol. Exp.Ther., 293, 196 (2000). (Pharmacol.)
M.-D. Drici, et al., Br. J. Pharmacol., 131, 569 (2000). (Pharmacol.)

132 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT CODE QTY PRICE
Tityustoxin Kα PTT-4313-s 0.1 mg 360

BIOLOGICALLY ACTIVE PEPTIDES

(TsTX-Kα) -20 °C vial
(Scorpion, Tityus serrulatus)
Val-Phe-Ile-Asn-Ala-Lys-Cys-Arg-Gly-Ser-Pro-Glu-Cys-Leu-Pro-Lys-Cys-Lys-Glu-
Ala-Ile-Gly-Lys-Ala-Ala-Gly-Lys-Cys-Met-Asn-Gly-Lys-Cys-Lys-Cys-Tyr-Pro
(Reported disulfide bonds between Cys7-Cys28, Cys13-Cys33, and Cys17-Cys35)
(M.W. 3941.7) C168H275N49O46S7
Voltage-Dependent K+ Channel (A Channel) Blocker
T.R.Werkman, et al., Mol. Pharmacol., 44, 430 (1993). (Original)
R.S. Rogowski, et al., Proc. Natl. Acad. Sci. U.S.A., 91, 1475 (1994). (Pharmacol.)
W.F. Hopkins, J. Pharmacol. Exp. Ther., 285, 1051 (1998). (Pharmacol.)
K.C. Ellis, et al., Biochemistry, 40, 5942 (2001). (S-S Bond)

Tuftsin
Tuftsin PTF-4020-v 0.5 mg 35
Thr-Lys-Pro-Arg -20 °C vial
(M.W. 500.59) C21H40N8O6 [9063-57-4]

Tuftsin (Bulk) PTF-4020 25 mg 145

Thr-Lys-Pro-Arg • 2AcOH • 4H2O -20 °C 100 mg 430
(M.W. 500.59 • 120.10 • 72.06) C21H40N8O6 • 2CH3COOH •
4H2O [72103-53-8]
Phagocytosis-Stimulating Peptide
K. Nishioka, et al., Biochem. Biophys. Res. Commun., 47, 172 (1972). (Original)
K. Nishioka, et al., Biochim. Biophys. Acta, 310, 230 (1973). (Chem. Synthesis & Pharmacol.)

Urantide™ See Code PUT-3639-PI Urotensin Related Products.

PEPTIDES INTERNATIONAL
Urocortin See Stresscopins / Urocortin and Related Peptides.

Urotensin II and Related Peptides

Urotensin II is one of the most potent vasoconstrictors known, and Urantide has been
reported to be the most potent antagonist of urotensin II - until now .1,2 Recent stud -
ies replacing the Asp amino acid in Urantide led to the discovery of a new urotensin
II antagonist, H-Tic-[Pen-Phe-d-Trp-Orn-Tyr-Cys]-Val-OH. It was found to be more
potent than Urantide at inducing contractions in isolated rat thoracic aorta, with a pA 2
value of 9.0 compared to a pA 2 value of 8.3 for Urantide. 3
1. R.S. Ames, et al., Nature, 401, 282 (1999).
2. R. Patacchini, et al., Br. J. Pharmacol., 140, 1155 (2003).
3. Patent N. FI2007A000032. Patent N. FI2006A000340

Urotensin II (Human) PUT-4365-v 0.5 mg 240

(Hydrochloride Form) -20 °C vial
Glu-Thr-Pro-Asp-Cys-Phe-Trp-Lys-Tyr-Cys-Val
(Disulfide bonds between Cys5-Cys10)
(M.W. 1388.6) C64H85N13O18S2 [251293-28-4]
Potent Vasoconstrictor
Purity Information: QE See page xiv
Y. Coulouarn, et al., Proc. Natl. Acad. Sci. U.S.A., 95, 15803 (1998). (Original)
R.S. Ames, et al., Nature, 401, 282 (1999). (Pharmacol.)
M.R. MacLean, et al., Br. J. Pharmacol., 130, 201 (2000). (Pharmacol.)

Order Hotline 1-800-777-4779 502-266-8787 133

 PRODUCT CODE QTY PRICE
BIOLOGICALLY ACTIVE PEPTIDES

Urotensin II (Rat) PUT-4371-v 0.5 mg 240

[Pyr110]-Prepro-Urotensin II (Rat, 110-123) -20 °C vial
Pyr-His-Gly-Thr-Ala-Pro-Glu-Cys-Phe-Trp-Lys-Tyr-Cys-Ile
(Disulfide bonds between Cys8-Cys13)
(M.W. 1663.9) C77H102N18O20S2
Vasoconstrictor
Y. Coulouarn, S. Jégou, H. Tostivint, H. Vaudry, and I. Lihrmann, FEBS Lett., 457, 28 (1999). (Original)
S.M. Gardiner, J.E. March, P.A. Kemp, A.P. Davenport, and T. Bannett, Br. J. Pharmacol., 132, 1625 (2001). (Pharmacol.)

Urotensin II-Related Peptide (Human, Rat, PUT-4408-v 0.5 mg 150

Mouse) -20 °C vial
Ala-Cys-Phe-Trp-Lys-Tyr-Cys-Val
(Disulfide bond between Cys2 - Cys7)
(M.W. 1017.2) C49H64N10O10S2 [342878-90-4]
Endogenous Hypotensive Peptide
Y. Coulouarn, et al., FEBS Lett., 457, 28 (1999). (Original; Rat Urotensin Precursor Sequence)
T. Sugo, et al., Biochem. Biophys. Res. Commun., 310, 860 (2003). (Original: Urotensin II-Related Peptide)

Urantide™ PUT-3639-PI 1 mg 125

H-Asp-[Pen-Phe-d-Trp-Orn-Tyr-Cys]-Val-OH -20 °C
(Trifluoroacetate Form)
[Pen5, D-Trp7, Orn8]-Urotensin II (Human, 4-11)
(Disulfide bond between Pen2-Cys7)
(M.W. 1075.28) C51H66N10O12S2
Potent Urotensin II Antagonist
R. Patacchini, et al., Br. J. Pharmacol., 140, 1155 (2003). (Urantide™)
• This product is sold under exclusive license.
PEPTIDES INTERNATIONAL

H-Asp-[Pen-Phe-Trp-Lys-Tyr-Cys]-Val-OH PUT-3640-PI 1 mg 125

(Disulfide bond between Pen2-Cys7) -20 °C
(M.W. 1089.31) C52H68N10O12S2
Potent Urotensin II Agonist
P. Grieco, A. Carotenuto, P. Campiglia, E. Zampelli, R. Patacchini, C.A. Maggi, E. Novellino, and P. Rovero,
J. Med. Chem., 45, 4391 (2002). (Urotensin Agonist)

H-Tic-[Pen-Phe-d-Trp-Orn-Try-Cys]-Val-OH PUT-3928-PI 1 mg 125

(M.W. 1119.38) C57H70N10O10S2 -20 °C
Potent Urotensin II Antagonist
M. Sala, et al., Poster Presentation at the 20th American Peptide Symposium, Montreal, Canada (2007).
Patent N. FI2007A000032. Patent N. FI2006A000340

Vasoactive Intestinal Peptide (VIP)

VIP (Human, Porcine)* PVA-4110-s 0.1 mg 115
Vasoactive Intestinal Peptide (Human, Porcine) -20 °C vial
(Bovine, Rat, Canine)
His-Ser-Asp-Ala-Val-Phe-Thr-Asp-Asn-Tyr-Thr-Arg-Leu-Arg-Lys-
Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Asn-Ser-Ile-Leu-Asn-NH2
(M.W. 3325.8) C147H238N44O42S [40077-57-4]

134 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT CODE QTY PRICE
VIP (Human, Porcine)* PVA-4110-v 0.5 mg 395

BIOLOGICALLY ACTIVE PEPTIDES

Vasoactive Intestinal Peptide (Human, Porcine) -20 °C vial
(Bovine, Rat, Canine)
[40077-57-4]
V. Mutt and S.I. Said, Eur. J. Biochem., 42, 581 (1974). (Original; Porcine)
N. Itoh, K. Obata, N. Yanaihara, and H. Okamoto, Nature, 304, 547 (1983). (cDNA Seq.; Human)
R. Dimaline, J.R. Reeve, Jr., J.E. Shively, and D. Hawke, Peptides, 5, 183 (1984). (Original; Rat)
S.C. Wang, et al., Life Sci., 37, 979 (1985). (Original; Canine)

Vasopressin, Vasotocin, and Related Peptides

B. Berde (ed.), Neurohypophysial Hormones and Similar Polypeptides,
Handbook of Experimental Pharmacology, Vol. 23, Springer-Verlag, Berlin, 1968. (Review)

[Arg8]-Vasopressin* PVP-4085-v 0.5 mg 60

(Human, Bovine, Ovine, Rat, Mouse) -20 °C vial
Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Arg-Gly-NH2
(Disulfide bond between Cys1-Cys6)
(M.W. 1084.2) C46H65N15O12S2 [113-79-1]
E.A. Popenoe and V. Du Vigneaud, J. Biol. Chem., 205, 133 (1953). (Original; Bovine)
A. Light and V. Du Vigneaud, Proc. Soc. Exp. Biol. Med., 98, 692 (1958). (Original; Human)
H. Schmale, S. Heinsohn, and D. Richter, EMBO J., 2, 763 (1983). (Nucleotide Seq.; Rat)
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

[Asu1,6,Arg8]-Vasopressin* PVP-4026-v 0.5 mg 70

Deamino-Dicarba-Arginine-Vasopressin -20 °C vial
cyclo (Tyr-Phe-Gln-Asn-Asu)-Pro-Arg-Gly-NH2
(Asu: l-a-Aminosuberic Acid)

PEPTIDES INTERNATIONAL
(Cyclic form between Asu w-carboxl group and Tyr a-amino group)
(M.W. 1033.1) C48H68N14O12 [40944-53-4]
Purity Information: Qx See page xiv
S. Hase, S. Sakakibara, et al., J. Amer. Chem. Soc., 94, 3590 (1972). (Original)
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

[Pmp1,Tyr(Me)2]-Arg8-Vasopressin* PVP-4203-v 0.5 mg 130

Pmp-Tyr(Me)-Phe-Gln-Asn-Cys-Pro-Arg-Gly-NH2 -20 °C vial
(Pmp: b-Mercapto-b,b-Cyclopentamethylene Propionic Acid)
(Tyr(Me): O-Methyl-l-Tyrosine)
(Disulfide bond between Cys1-Cys6)
(M.W. 1151.4) C52H74N14O12S2 [73168-24-8]
Potent Arginine Vasopressin V1 Antagonist
M. Kruszynski, B. Lammerk, M. Manning, J. Seto, J. Halder, and W.H. Sawyer, J. Med. Chem., 23, 364 (1980). (Original)
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

[Arg8]-Vasotocin* PVP-4192-v 0.5 mg 60

(Frog, Chicken) -20 °C vial
Cys-Tyr-lle-Gln-Asn-Cys-Pro-Arg-Gly-NH2
(Disulfide bond between Cys1-Cys6)
(M.W. 1050.2) C43H67N15O12S2 [74927-14-3]
R. Acher, J. Chauvet, M.T. Lenci, F. Morel, and J. Maetz, Biochim. Biophys. Acta, 42, 379 (1960). (Original; Frog)
J. Chauvet, M.T. Lenci, and R. Acher, Biochim. Biophys. Acta, 38, 571 (1960). (Original; Chicken)
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

Order Hotline 1-800-777-4779 502-266-8787 135

 PRODUCT CODE QTY PRICE
BIOLOGICALLY ACTIVE PEPTIDES

[Asu1,6,Arg8]-Vasotocin* PVP-4027-v 0.5 mg 70

Deamino-Dicarba-Arginine-Vasotocin -20 °C vial
cyclo (Tyr-lle-Gln-Asn-Asu)-Pro-Arg-Gly-NH2
(Asu: l-a-Aminosuberic Acid)
(Cyclic form between Asu w-carboxl group and Tyr a-amino group)
(M.W. 999.12) C45H70N14O12 [35375-13-4]
S. Hase, S. Sakakibara, et al., J. Am. Chem. Soc., 94, 3590 (1972). (Original)
* The biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

Virus Replication Inhibiting Peptide

Virus Replication Inhibiting Peptide (Bulk) PVI-4092 25 mg 95
Z-d-Phe-Phe-Gly -20 °C 100 mg 190
(Z: Benzyloxcarbonyl)
(M.W. 503.55) C28H29N3O6 [75539-79-6]
C.D. Richardson, A. Scheid, and P.W. Choppin, Virology, 105, 205 (1980). (Original)

Xenin
Xenin 25 (Human) PXN-4279-v 0.5 mg 350
Met-Leu-Thr-Lys-Phe-Glu-Thr-Lys-Ser-Ala-Arg-Val-Lys- -20 °C vial
Gly-Leu-Ser-Phe-His-Pro-Lys-Arg-Pro-Trp-Ile-Leu
(M.W. 2971.6) C139H224N38O32S
Xenopsin Related Peptide
G.E. Feurle, G. Hamscher, R. Kusiek, H.E. Meyer, and J.W. Metzger, J. Biol. Chem., 267, 22305 (1992). (Original)
PEPTIDES INTERNATIONAL

136 Order Hotline 1-800-777-4779 502-266-8787

Assay Methods Using Peptidyl-MCA Substrates (1)

ENZYME INHIBITORS AND SUBSTRATES

Principle

Enzyme
O O + H2O Peptide + N2H O O
Peptidyl-NH

CH3 CH3

Peptidyl-MCA AMC

The initial rate of increase in the AMC concentration can be monitored 1) fluorometrically at λex = 380
nm and λem = 460 nm (Fig. 1a) or 2) photometrically at 370 nm (Fig. 1b).

Reagents
1) Substrate stock solution: Vial, in DMSO at 10 mM

PEPTIDES INTERNATIONAL
2) AMC stock solution: Content of vial (Code MCA-3099-v AMC), in DMSO at 1 mM
3) Buffer
4) Enzyme solution
Procedure
Choose the proper conditions for the measurement, such as substrate concentration and sensitivity setting,
depending on the purpose of the experiment and the instrument available. Described here is one of the
recommended procedures for the fluorometric method (initial-rate method).
1) Set a fluorescence spectrophotometer at λex = 380 nm and λem = 460 nm at 25 °C (1.0 Relative
fluorescence unit at 10-6 M of AMC)
2) Pipette 2940 µL of buffer and 30 µL of substrate stock solution into the cuvette
3) Incubate in the fluorescence spectrophotometer for 3-4 min (for temperature equilibration)
4) Add 30 µL of enzyme solution
5) Record the increase of the fluorescence intensity for 3-4 min
6) Calculate the amount of AMC released using the following equation

* Photometric measurement can be carried out by the same procedure as that of the fluorometric method using a
UV spectrophotometer. Set the wavelength at 370 nm (ε 7700).

Order Hotline 1-800-777-4779 502-266-8787 137

 Assay Methods Using Peptidyl-MCA Substrates (2)
ENZYME INHIBITORS AND SUBSTRATES

(Measurement on an Auto-Fluorescence Spectrophotometer for Multiplate)

Reagents
1) Substrate stock solution: Content of vial, in DMSO at 10 mM
2) AMC standard solution: Content of vial (Code MCA-3099-v AMC), in DMSO at 1 mM
3) Buffer
4) Enzyme solution

Instrument: Auto-fluorescence spectrophotometer

Selection of filter:
380 nm, 390 nm or 355 nm filter will be recommended for measurement.
In using 355 nm filter, observe caution for overlapping of fluorescence of the substrate itself.

Ex = 330 nm
Ex = 340 nm Ex = 350 nm
Ex= 350 nm Ex = 380 nm
Ex = 360 nm
Ex= 370 nm
Fluorescence

Fluorescence
Ex = 380 nm

350 400 450 500 550 400 450 500 550

PEPTIDES INTERNATIONAL

Wavelength (nm) Wavelength (nm)

F ig. 2a F luorescence S pectra of P eptidyl-MC A (S ubstrate) F ig. 2 b F luorescence S pectra of A MC (P roduct)

Procedure
Choose the proper conditions for the measurement, such as substrate, enzyme concentration and other reaction
conditions, depending on the purpose of the experiment.

1) Set the auto-fluorescence spectrophotometer at λex = 380 nm, λem = 460 nm at 25 °C

(1.0 Relative fluorescence unit at 10-6 M of AMC)
2) Pipette 160 µL of buffer and 20 µL of substrate solution in well for final concentration of 100 µM
3) Incubate the plate in the fluorescence spectrophotometer for 3-4 min (for temperature equilibration)
4) Take the multiplate out and add 20 µL of enzyme solution in each well
5) Mount the plate in the fluorescence spectrophotometer
6) Record the increase in fluorescence intensity for 30 min with a premixing time of 3 sec
7) Calculate the amount of released AMC

138 Order Hotline 1-800-777-4779 502-266-8787

 Assay Methods Using Peptidyl-MCA Substrates (3)

ENZYME INHIBITORS AND SUBSTRATES

(Example for Caspase-7 using an Auto-fluorescence Spectrophotometer for Multiplate)
Reagents
1) Substrate stock solution: Content of vial (Code SAP-3171-v Ac-DEVD-MCA), in DMSO at
10 mM
2) AMC standard solution: Content of vial (Code MCA-3099-v AMC), in DMSO at 1 mM
3) Buffer: ICE standard buffer (100 mM HEPES-KOH, pH 7.5, 10% sucrose (w/v), 0.1%
CHAPS (w/v) ,10 mM DTT, 0.1 mg/ml ovalbumin)
4) Enzyme solution: reconstitute Caspase-7 in buffer
Instrument: Fluoroskan Ascent (Labsystems)
This instrument can be used for both initial rate assay and end point assay
Procedure
a) Initial rate assay for 30 min at lex = 390 nm, lem = 460 nm
b) End-point (30 min) assay at 5 different substrate
concentrations at lex = 355 nm or 380 nm, lem = 460 nm
1) Set a fluorescence spectrophotometer at lex =
390 nm ( or 380 nm, 355 nm), lem = 460 nm.
Relative fluorescence is determined with 10-6 M of
AMC at each condition
2) Substrate: Dilute the stock solution with the
buffer (×10, ×20, ×40, ×80, ×160)
3) Caspase-7: Dissolve in buffer
4) Pipette 160 μl of buffer and 20 μl of substrate
solutions (1, 1/2, 1/4, 1/8, 1/16 mM) in each well

PEPTIDES INTERNATIONAL
5) Incubate in the fluorescence spectrophotometer
for 3-4 min for temperature equilibration
6) Take the multiplate out and add 20 μl of enzyme
solution to each well
7) Mount the plate in the fluorescence spectrophotometer
8) Calculate the amount of released AMC
Results

a) Initial rate assay

(Ex 390 nm) b1) End-point assay
b2) End-point assay
300 (Ex 380 nm)
(Ex 355 nm) 250
4000
250
Fluorescence (Em 460 nm)

3500
200
Fluorescence (Em 460 nm)
Fluorescence (Em 460 nm)

200 3000

2500 150
150
2000
100 100
1500

50 1000 50
X X X
X X 500
0
0
0 5 10 15 20 25 30 35 0 20 60 80 100 120
0 40
Reaction Time (min) 0 20 40 60 80 100 120
Substrate conc. (µM) Substrate conc. (µM)
100 X 12.5
0 min Reaction Time 0 min
Substrate conc. (µM) 50 6.25 Reaction Time
30 min 30 min
25

Order Hotline 1-800-777-4779 502-266-8787 139

 Assay Method Using MOCAc/Dnp type Fluorescence-Quenching Substrates
ENZYME INHIBITORS AND SUBSTRATES

(Example using MOC-3163-v MOCAc-Pro-Leu-Gly-Leu-A2pr(Dnp)-Ala-Arg-NH2)

Principle
The highly fluorescent (7-methoxycoumarin-4-yl)acetyl (MOCAc) group in the substrate such as Code MOC-3163-v
is efficiently quenched by the 2,4-dinitrophenyl (Dnp) group. When metalloenzyme cleaves to the Gly-Leu bond, the
fluorescence at λex = 328 nm and λem = 393 nm increases 190-fold.1

Ex Spectrum Em Spectrum
Em=393 nm Ex=328 nm
Fluorescence

300 350 400 450

Wavelength (nm)

Fig. Fluorescence Spectra of MOCAc-Pro-Leu-Gly-OH

Reagents
1) Substrate stock solution: Code MOC-3163-v in DMSO at 2 • 10-4 M
2) MOCAc-Pro-Leu-Gly (reference compound) stock solution: Code MOC-3164-s in 10 ml of DMSO (2 • 10-5
M)
PEPTIDES INTERNATIONAL

3) Buffer: 0.1 M-Tris • HCl, pH 7.5 containing 0.1 M NaCl, 10 mM CaCl2 and 0.05% Brij-35
4) Enzyme solution
Procedure
Choose the proper conditions for the measurement, such as substrate concentration and sensitivity setting,
depending on the purpose of the experiment and the instrument available. Described here is one of the
recommended procedures for the fluorometric method (initial-rate method).
1) Set a fluorescence spectrophotometer at λex = 328 nm and λem = 393 nm at 25 °C (1.0 Relative
fluorescence unit at 10-7 M of the reference compound)
2) Pipette 2900 µl of buffer and 50 µl of substrate stock solution into the cuvette
3) Incubate in the fluorescence spectrophotometer for 3-4 min (for temperature equilibration)
4) Add 50 µl of enzyme solution
5) Record the increase of the fluorescence intensity for 3-4 min
6) Calculate the amount of reference compound released using the following equation

100
100 nM = 100 pmol/ml
Reference Compound

Amount (pmol) of the reference compound released/min

100 pmol X dF % X 3 ml
=
1 ml X 100 % X 1 min
50
dF = 3 X dF pmol/min
Enzyme

60 sec
0
Time

1) C.G. Knight, F. Willenbrock, and G. Murphy, FEBS Lett., 296, 263 (1992).

140 Order Hotline 1-800-777-4779 502-266-8787

Assay Method Using Nma/Dnp type Fluorescence-Quenching Substrates

ENZYME INHIBITORS AND SUBSTRATES

Principle
The highly fluorescent 2-(N-methylamino)benzoyl (Nma) group in the substrates such as Code SFQ-3217-v and
SFR-3224-v is efficiently quenched by the 2,4-dinitrophenyl (Dnp) group. When an enzyme of interest cleaves any
peptide bond between Nma- and Dnp-containing amino acid residues in the substrate, the fluorescence at λex =
340 nm and λem = 440 nm increases in proportion to the release of the Nma fluorophore from the internal Dnp
quencher.1,2

Ex Spectrum Em Spectrum
Fluorescence Em=440 nm Ex=340 nm

300 350 400 450 500

Wavelength (nm)
Fig. Fluorescence Spectra of a 1:1 mixture of D-A2pr(Nma)-Gly and Ala-Phe-Pro-Lys(Dnp)-D-Arg-D-Arg
Reagents
1) Substrate stock solution: 100 μM-10 μM in an appropriate solvent
2) Reference compounds stock solution: a 1:1 mixture of two solutions of Code STD-3720-v and
STD-3721-v, each of which is reconstituted by dissolving peptides in 0.5 ml of DMSO at the
concentration of 2 mM (1 mM, each reference compound)
3) Enzyme solution: an enzyme of interest in an appropriate buf fer

PEPTIDES INTERNATIONAL
4) Buffer
Procedure
Choose the proper conditions for the measurement, such as substrate concentration and sensitivity
setting, depending on the purpose of the experiment and the instrument available. Described here is
one of the recommended procedures for the fluorometric method (initial-rate method).
1) Set a fluorescence spectrometer at λex = 340 nm and λem = 440 nm (1.0 Relative fluorescence unit at 1
µM of the reference compound)
2) Pipette 160 µl of buffer and 2-20 µl of substrate solution in well for final concentration of 1 µM.
3) Incubate in the fluorescence spectrophotometer for 3-4 min for temperature equilibration
4) Add 20 µl of enzyme solution prepared at an appropriate concentration
5) Record the increase of the fluorescence intensity
6) Calculate the amount of the cleaved substrate using the following equation
100
Relative Fluorescence (%)
Reference Compound

Amount (pmol) of the cleaved substrate/min

1 µM = 1 nmol/ml

1000 pmol X dF % X 0.2 ml

=
1 ml X 100 % X 1 min
50
= 2 X dF pmol/min
dF
Enzyme

60 sec
0
Time

1) D.M. Bickett, M.D. Green, J. Berman, M. Dezube, A.S. Howe, P.J. Brown, J.T. Roth, and G.M. McGeehan, Anal. Biochem.,
212, 58 (1993).
2) S. Tanskul, K. Oda, H. Oyama, N. Noparatnaraporn, M. Tsunemi, and K. Takada, Biochem. Biophys. Res. Commun., 309, 547
(2003).

Order Hotline 1-800-777-4779 502-266-8787 141

 Assay Method Using Peptidyl-pNA Substrates
ENZYME INHIBITORS AND SUBSTRATES

Principle
A protease with limited specificity hydrolyzes a peptidyl-pNA substrate, releasing p-nitroaniline (pNA) as follows:
H
Peptidyl-N- -NO2 Peptide + H2N - - NO2

Peptidyl-pNA pNA

The initial rate of increase in the pNA concentration can be monitored photometrically at 405 nm.

e X 103
15 Peptidyl-pNA pNA

10

405 nm
300 400 500
Wavelength (nm)
Fig. UV-Aborption Spectra

Reagents
1) Substrate stock solution: 10 mM (DMSO or distilled water)
2) Buffer
3) Enzyme solution
PEPTIDES INTERNATIONAL

Procedure
Choose the proper conditions for the measurement, such as substrate concentration and sensitivity setting,
depending on the purpose of the experiment and the instrument available. Described here is one of the
recommended procedures for the photometric method (initial-rate method).
1) Set a spectrophotometer at λ= 405 nm at 25˚ C (ε405 nm=9920)*
2) Pipette 2940 µl of buffer and 30 µl of substrate stock solution into the cuvette
3) Incubate in the spectrophotometer for 3-4 min (for temperature equilibration)
4) Add 30 µl of enzyme solution
5) Record the increase of the absorption intensity for 3-4 min
6) Calculate the amount of pNA released using the following equation
OD 405 nm
1.0
pNA 1/9920 M=0.101 mmol/ml

Amount (mmol) of pNA released/min

0.5 1 mmol X dA X 3 ml
=
dA
1 ml X 9.992 x 1 min
Enzyme
= 0.32 X dA mmol/min

60 sec

0
Time

*R. Lottenberg, U. Christensen, C.M. Jackson, and P.L. Coleman, In, Proteolytic Enzymes Part C, Methods in Enzymolology,
Vol. 80, (L. Lorand, ed.) Academic Press, New York, 1981, pp. 341-361.

142 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT CODE QTY PRICE

ENZYME INHIBITORS AND SUBSTRATES

Enzyme Inhibitors IAC-4157-PI

Aminopeptidase
Actinonin IAC-4157-PI 25 mg 342
3-[[1-[[2-(hydroxymethyl)-1-pyrrolidinyl]-carbonyl]- -20 °C 100 mg 1140
2-methylpropyl]-carbamoyl]-octanohydroxamic
4095-v acid OH
(M.W. 385.51) C19H35N3O5 [13434-13-4]
CH3 O

Synthetic Product H3C N

Inhibitor for Aminopeptidase M and Leucyl Aminopeptidase

O NH
O
OH
H3C N
H

Amastatin IAM-4095-v 0.5 mg 80

[(2S,3R)-3-Amino-2-hydroxy-5-methylhexanoyl]-l-valyl-l- -20 °C vial
valyl-l-aspartic acid
(M.W. 474.55) C21H38N4O8 [67655-94-1]
OH O O
H H
Synthetic Product
N N
N OH
H
O O OH
NH2
O

Amastatin (Bulk) IAM-4095 25 mg 1150

[(2S,3R)-3-Amino-2-hydroxy-5-methylhexanoyl]-l-valyl-l- -20 °C
valyl-l-aspartic acid
(M.W. 474.55) C21H38N4O8
Synthetic Product
Inhibitor for Aminopeptidase A/PS and Leucyl Aminopeptidase
Arphamenine A 4148 IAR-4148-v 0.5 mg 40

PEPTIDES INTERNATIONAL
(Sulfate Form) -20 °C
NH2 O
vial
(2R,5S)-5-Amino-8-guanidino-4-oxo-2-phenylmethyloctanoic acid OH

(M.W. 320.39) C16H24N4O3 [96551-81-4] HN NH2 O

4149-v
Microbial Product NH

H. Umezawa, T. Aoyagi, S. Ohuchi, A. Okuyama, H. Suda, T. Takita, M. Hamada, and T. Takeuchi,

J. Antibiotics, 36, 1572 (1983). (Original with IC50)
S. Ohuchi, H. Suda, H. Naganawa, T. Takita, T. Aoyagi, H. Umezawa, H. Nakamura, and Y. Iitaka,
J. Antibiotics, 36, 1576 (1983). (Original; Chem. Structure)
• This compound is distributed through Peptide Institute, Inc. under the technical and scientific advices of the Microbial
Chemistry Research Foundation.

Arphamenine B IAR-4149-v 0.5 mg 45

(Sulfate Form) -20 °C vial
(2R, 5S)-5-Amino-8-Guanidino-4-Oxo-2-p- NH2 O

hydroxyphenylmethyloctanoic Acid OH

(M.W. 336.39) C16H24N4O4 [103900-19-2] HN NH2 O

Microbial Product NH
OH

Order Hotline 1-800-777-4779 502-266-8787 143

 PRODUCT CODE QTY PRICE
Arphamenine B IAR-4149 25 mg 275
ENZYME INHIBITORS AND SUBSTRATES
(Bulk)
(2R, 5S)-5-Amino-8-Guanidino-4-Oxo-2-p- -20 °C 100 mg 995
hydroxyphenylmethyloctanoic Acid • hemisulfate monohydrate
(M.W. 336.39 • 49.04 • 18.02) C16H24N4O4 • ½H2SO4 • H2O [144110-38-3]
Microbial Product
Inhibitor for Aminopeptidase B
H. Umezawa, T. Aoyagi, S. Ohuchi, A. Okuyama, H. Suda, T. Takita, M. Hamada, and T. Takeuchi, J. Antibiotics, 36,
1572, (1983). (Original with IC50)
Aoyagi, H. Umezawa, H. Nakamura, and Y. Iitaka, J. Antibiotics, 36, 1576
S. Ohuchi, H. Suda, H. Naganawa, T. Takita, T.4155
(1983). (Original; Chem. Structure)
• This compound is distributed through Peptide Institute, Inc. under the technical and scientific advices of the Microbial
Chemistry Research Foundation.

Ebelactone A (Bulk) IEB-4155 25 mg 1150

3,11-Dihydroxy-2,4,6,8,10,12-hexamethyl- 9-oxo-(E)-6-tetra- -20 °C
decen-3-olide
(M.W. 338.48) C20H34O4 [76808-16-7]
Microbial Product
Inhibitor for Esterase, Lipase, and N-Formylmethionine O
O O OH

Aminopeptidase
H. Umezawa, T. Aoyagi, K. Uotani, M. Hamada, T. Takeuchi, and S. Takahashi, J. Antibiotics, 33, 1594 (1980).
K. Uotani, H. Naganawa, S. Kondo, T. Aoyagi, and H. Umezawa, J. Antibiotics, 35, 1495 (1982).
K. Uotani, H. Naganawa, T. Aoyagi, and H. Umezawa, J. Antibiotics., 35, 1670 (1982).
• This compound is distributed exclusively through Peptide Institute, Inc. under the license of the Microbial Chemistry
4249-v
Research Foundation.

Leuhistin ILH-4249-v 0.5 mg 45

(2R,3S)-3-Amino-2-hydroxy-2-(1H-imidazol-4-ylmethyl)-5- -20 °C vial
PEPTIDES INTERNATIONAL

methylhexanoic acid
(M.W. 241.29) C11H19N3O3 [129085-76-3] H2N OH OH

Microbial Product O
Inhibitor for Aminopeptidase M N

N
H
T. Aoyagi, S. Yoshida, N. Matsuda, T. Ikeda, N. Hamada, and T. Takeuchi, J. Antibiotics, 44, 573 (1991). (Original; IC50)
S. Yoshida, H. Nagasawa, T. Aoyagi, T. Takeuchi, Y. Takeuchi, Y. Kodama, J. Antibiotics, 44, 579 (1991).
(Original; Chem. Structure)
S. Yoshida, T. Aoyagi, and T. Takeuchi, J. Antibiotics, 44, 683 (1991). (Original; Biosynthesis)
4342-v
• This compound is distributed exclusively through Peptide Institute, Inc.
under the license of the Microbial Chemistry Research Foundation.

Phebestin IPH-4342-v 5 mg 115

(2S,3R)-3-Amino-2-hydroxy-4-phenylbutanoyl-l-valyl-l- -20 °C vial
phenylalanine
(M.W. 441.53) C24H31N3O5
Synthetic Product OH O
Inhibitor for Aminopeptidase N
H
N OH
IBS-4093-PI N
H
M. Nagai, F. Kojima, H. Naganawa, M. Hamada, T. Aoyagi, and T. Takeuchi, J. Antibiotics, 50, 82 (1997). (Original)
NH2 O O

• This compound is distributed exclusively through Peptide Institute, Inc. under the license of the Microbial Chemistry
Research Foundation.

Ubenimex (Bestatin) (Bulk) IBS-4093-PI 25 mg 120

[(2S,3R)-3-Amino-2-hydroxy-4-Phenyl-Butanoyl]-l-Leu -20 °C 100 mg 360
(M.W. 308.38) C16H24N2O4 [58970-76-6]
H. Umezawa, T. Aoyagi, H. Suda, M. Hamada, and T. Takeuchi, NH O COOH CH3
J. Antibiotics, 29, 97 (1976).
N CH3
H
OH

144 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT CODE QTY PRICE
Angiotensin I Converting Enzyme Inhibitors

ENZYME INHIBITORS AND SUBSTRATES

Bradykinin-Potentiator B IAB-4009-v 0.5 mg 35
Pyr-Gly-Leu-Pro-Pro-Arg-Pro-Lys-lle-Pro-Pro -20 °C vial
(M.W. 1182.4) C56H91N15O13 [30892-86-5]
Synthetic Product
Bradykinin-Potentiator B (Bulk) IAB-4009 25 mg 539
Pyr-Gly-Leu-Pro-Pro-Arg-Pro-Lys-Ile-Pro-Pro • AcOH • 4H2O -20 °C
(M.W. 1182.4 • 60.05 • 72.06) C56H91N15O13 • CH3COOH •
4H2O
Synthetic Product
Inhibitor for Peptidyl-Dipeptidase A, Kininase II, and ACE (Angiotensin I Converting Enzyme)
H. Kato and T. Sazuki, Biochemistry, 10, 972 (1971). (Original)

Bradykinin-Potentiator C IAC-4010-v 0.5 mg 30

Pyr-Gly-Leu-Pro-Pro-Gly-Pro-Pro-Ile-Pro-Pro -20 °C vial
(M.W. 1052.2) C51H77N11O13 [30953-20-9]
Synthetic Product
Cpp-AAF-pAb IAP-3754-PI 1 mg 105
N-[(RS)-1-Carboxy-3-phenyl-propyl]-Ala-Ala-Phe-4-Abz-OH -20 °C 420
5 mg
(M.W. 89.67) C32H37N4O7
Inhibitor of ACE
M.Orlowski, et al., Biochemistry, 27, 597 (1988)
D.T.O.Martins, et al., Br. J. Pharmacol., 103, 1851 (1991)
C.H.Williams, et al.., Biochem. J., 294, 681 (1993)
R.Yamin, et al., J. Biol. Chem., 274, 18777 (1999)

PEPTIDES INTERNATIONAL
Des-Pro2-Bradykinin IBK-4097-v 0.5 mg 35
Arg-Pro-Gly-Phe-Ser-Pro-Phe-Arg -20 °C vial
(M.W. 963.09) C45H66N14O10 [80943-05-1]
Synthetic Product
Des-Pro2-Bradykinin (Bulk) IBK-4097 25 mg 520
Arg-Pro-Gly-Phe-Ser-Pro-Phe-Arg • 2AcOH • 3H2O -20 °C
(M.W. 963.09 • 120.10 • 54.05) C45H66N14O10 • 2CH3COOH
• 3H2O
Synthetic Product
Inhibitor for Peptidyl-Dipeptidase A, Kininase II, and ACE (Angiotensin I Converting Enzyme)
M. Naruse, S. Tamanami, K. Shuto, S. Sakakibara, and T. Kimura, Chem. Pharm. Bull., 29, 3369 (1981). (Original)

Foroxymithine IFR-4190-v 0.5 mg 75

(3S,6S)-3-(3-{N-[N-(Na-Acetyl-Nd-Formyl-Nd-hydroxy-l- -20 °C vial
Ornithyl)-l-Seryl]-N-(Hydroxy)Amino}Propyl)-6-[3-(N-Formyl-
N-Hydroxyamino)Propyl]-2,5-Piperazinedione
(M.W. 575.57) C22H37N7O11 [100157-28-6]
Microbial Product

Order Hotline 1-800-777-4779 502-266-8787 145

 PRODUCT 4190-v
CODE QTY PRICE
Foroxymithine IFR-4190 25 mg 1050
ENZYME INHIBITORS AND SUBSTRATES
(Bulk)
(3S,6S)-3-(3-{N-[N-(N -Acetyl-N -Formyl-N -hydroxy-l-
a d d
-20 °C
Ornithyl)-l-Seryl]-N-(Hydroxy)Amino}Propyl)-6-[3-(N-Formyl- OH O
N-Hydroxyamino)Propyl]-2,5-Piperazinedione OH OH

(M.W. 575.57) C22H37N7O11 [100157-28-6]

O HN N
H
N N NH
Microbial Product N O H
H
O O O
Inhibitor for ACE (Angiotensin I Converting Enzyme)
3223-v N OH
H. Umezawa, T. Aoyagi, K. Ogawa, T. Obata, H. Iinuma, H.
Naganawa, M. Hamada, and T. Takeuchi, J. Antibiotics, 38, 1813 H O

(1985). (Original; Chem. Structure with IC50)

d-Aspartyl Endopeptidase Inhibitor

Bz-Arg-His-d-Asp-CH2Cl ICL-3223-v 5 mg 240
(Trifluoroacetate Form) -20 °C vial
[Bz-RHd-CMK]
(Benzoyl-l-arginyl-l-histidyl-d-aspart-1-yl) chloromethane N NH

(M.W. 563.01) C24H31N8O6Cl H

O
H
O

Synthetic Product
N N CI
N
H
Selective Inhibitor for D-Aspartyl Endopeptidase O O O

OH
T. Kinouchi, S. Ishiura, Y. Mabuchi, Y. Urakami-Manaka, H. Nishio, HN

Y. Nishiuchi, M. Tsunemi, K. Takada, M. Watanabe, M. Ikeda, H. HN NH2

Matsui, S. Tomioka, H. Kawahara, T. Hamamoto, K. Suzuki, and Y.
Kagawa, Biochem. Biophys. Res. Commun., 314, 730 (2004).
• This compound is produced by Peptide Institute, Inc. under the
license of Japan Science and Technology Agency.
Bestatin See Code IBS-4093-PI Ubenimex
BQ-123, BQ-610, and BQ-788
PEPTIDES INTERNATIONAL

3671-PI

CA-074 See Code IEC-4322-v

CA-074 Me See Code IEC-4323-v

Calpain Inhibitors
Ac-Leu-Leu-Nle-H (aldehyde) IAL-3671-PI 5 mg 46
ALLN, MG 101 -20 °C
Acetyl-l-leucyl-l-leucyl-l-norleucinal
(M.W. 383.54) C20H37N3O4 O
H
O

Inhibitor for Calpain I and Proteasome N

N
N
H

T. Sasaki, M. Kishi, M. Saito, T. Tanaka, N. Higuchi, E. Kominami, N. Katunuma,

H H
O O

and T. Murachi, J. Enzyme Inhib., 3, 195 (1990).

Ac-Leu-Leu-Met-H (aldehyde) IAL-3678-PI 5 mg 46

ALLM 3678-PI
-20 °C
Acetyl-l-leucyl-l-leucyl-l-methioninal S
(M.W. 401.57) C19H35N3O4S
Inhibitor for Calpain II and Proteasome O
H
O
N H
T. Sasaki, M. Kishi, M. Saito, T. Tanaka, N. Higuchi, E. Kominami,
N N
H H
O O
N. Katunuma, and T. Murachi, J. Enzyme Inhib., 3, 195 (1990).

E-64-c and E-64-d See page 156.

146 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT CODE QTY PRICE

ENZYME INHIBITORS AND SUBSTRATES

Z-Leu-Leu-H (aldehyde) IZL-3178-v 5 mg 50
Benzyloxycarbonyl-l-leucyl-l-leucinal -20 °C vial
(M.W. 362.46) C20H30N2O4 O O
Synthetic Product
H
N
3221-v O N H
Inhibitor for Calpain* H
O

Y. Saito, S. Tsubuki, H. Ito, and S. Kawashima, Neurosci. Lett., 120, 1 (1990).

S. Tsubuki, Y. Saito, M. Tomioka, H. Ito, and S. Kawashima, J. Biochem., 119, 572 (1996).
*This compound does not inhibit Proteasome at the level of 10 -6 M concentration.

Caspase Inhibitors
Ac-Asp-Asn-Leu-Asp-H (aldehyde) ICA-3221-v 5 mg 240
Acetyl-l-aspartyl-l-asparaginyl-l-leucyl-l-aspart-1-al -20 °C vial
(M.W. 501.49) C20H31N5O10
O

Synthetic Product O OH
H
O
H
O
N
Selective Inhibitor for Caspase-3 Designed by in silico
N
N N H
H H

Screening System 3194-v

O NH2 O OH

O O
A. Yoshimori, R. Takasawa, and S. Tanuma, BMC Pharmacol., 4, 7 (2004).
A. Yoshimori, R. Takasawa, and S. Tanuma, Bio. Pharm. Bull., 27, 968 (2004).
• This compound is produced by Peptide Institute, Inc. under the license of the Institute for Theoretical Medicine, Inc.

Ac-Asp-Gln-Thr-Asp-H (aldehyde) ICA-3194-v 5 mg 290

Acetyl-l-aspartyl-l-glutaminyl-l-threonyl-l-aspart-1-al -20 °C vial
(M.W. 503.46) C19H29N5O11 O
Synthetic Product OH OH
Inhibitor for Caspase-7/3
O O O
H H
N N
(Deduced from the Cleavage Site of Focal Adhesion N
H
N
H
H

PEPTIDES INTERNATIONAL
Kinase and Gelsolin)
O O OH

3172-v
L.-P. Wen, J.A. Fahrni, S. Troie, J.-L. Guan, K. Orth, and G.D. Rosen, O NH2 O

J. Biol. Chem., 272, 26056 (1997).

S. Kothakota, T. Azuma, C. Reinhard, A. Klippel, J. Tang, K. Chu, T.J. McGarry, M.W. Kirschner,
K. Koths, D.J. Kwiatkowski, and L.T. Williams, Science, 278, 294 (1997).

Ac-Asp-Glu-Val-Asp-H (aldehyde) IAP-3172-v 5 mg 225

Acetyl-l-aspartyl-l-glutamyl-l-valyl-l-aspart-1-al -20 °C vial
(M.W. 502.47) C20H30N4O11 [184179-08-6]
O

Synthetic Product O OH
H
O
H
O
3192-v
Inhibitor for Caspase-3/7/8 N
N
N
N
H
H H
O O
D.W. Nicholson, A. Ali, N.A. Thornberry, J.P. Vaillancourt, C.K. Ding, OH

M. Gallant, Y. Gareau, P.R. Griffin, M. Labelle, Y.A. Lazebnik, O OH O

N.A. Munday, S.M. Raju, M.E. Smulson, T.-T. Yamin, V.L. Yu, and
D.K. Miller, Nature, 376, 37 (1995).
M. Enari, R.V. Talanian, W.W. Wong, and S. Nagata, Nature, 380, 723 (1996).
N.A. Thornberry, T.A. Rano, E.P. Peterson, D.M. Rasper, T. Timkey, M. Garcia-Calvo, V.M. Houtzager, P.A. Nordstrom,
S. Roy, J.P. Vaillancourt, K.T. Chapman, and D.W. Nicholson, J. Biol. Chem., 272, 17907 (1997).

Ac-Asp-Met-Gln-Asp-H (aldehyde) ICA-3192-v 5 mg 350

Acetyl-l-aspartyl-l-methionyl-l-glutaminyl-l-aspart-1-al -20 °C vial
(M.W. 533.55) C20H31N5O10S [259199-63-8] O O NH2

Synthetic Product O OH
O O
Inhibitor for Caspase-3
H H
N N
N N H
H H
O O OH
S
O

A. Takahashi, H. Hirata, S. Yonehara, Y. Imai, K.-K. Lee, R.W. Moyer, P.C. Turner, P.W. Mesner, T. Okazaki,
H. Sawai, S. Kishi, K. Yamamoto, M. Okuma, and M. Sasada, Oncogene, 14, 2741 (1997).
H. Hirata, A. Takahashi, S. Kobayashi, S. Yonehara, H. Sawai, T. Okazaki, K. Yamamoto, and M. Sasada,
J. Exp. Med., 187, 587 (1998).

Order Hotline 1-800-777-4779 502-266-8787 147

 PRODUCT CODE QTY PRICE
Ac-Ile-Glu-Thr-Asp-H (aldehyde) ICA-3196-v 5 mg 230
ENZYME INHIBITORS AND SUBSTRATES

Acetyl-l-isoleucyl-l-glutamyl-l-threonyl-l-aspart-1-al -20 °C vial

(M.W. 502.52) C21H34N4O10 [191338-86-0]
Synthetic Product
Inhibitor for Caspase-8/6 and Granzyme B
OH
O O O
H H
3199-v
(Deduced from the Cleavage Site of Procaspase-3) N
N
N
N
H
H H
O O
Z. Han, E.A. Hendrickson, T. A. Bremner, and J.H. Wyche, OH

J. Biol. Chem., 272, 13432 (1997). O OH O

M. Garcia-Calvo, E.P. Peterson, B. Leiting, R. Ruel, D.W.
Nicholson, and N.A. Thornberry, J. Biol. Chem., 273, 32608 (1998).

Ac-Leu-Glu-His-Asp-H (aldehyde) ICA-3199-v 5 mg 290

(Trifluoroacetate Form) -20 °C vial
Acetyl-l-leucyl-l-glutamyl-l-histidyl-l-aspart-1-al N
NH
(M.W. 538.55) C23H34N6O9 O O O
H
Synthetic Product
H
N N
N N H
Inhibitor for Caspase-9 H
O
H
O OH
3187-v
N.A. Thornberry, T.A. Rano, E.P. Peterson, D.M. Rasper, O OH O
T. Timkey, M. Garcia-Calvo, V.M. Houtzager, P.A. Nordstrom,
S. Roy, J.P. Vaillancourt, K.T. Chapman, and D.W. Nicholson,
J. Biol. Chem., 272, 17907 (1997).

Ac-Trp-Glu-His-Asp-H (aldehyde) ICA-3187-v 5 mg 230

Acetyl-l-tryptophyl-l-glutamyl-l-histidyl-l-aspart-1-al -20 °C vial
(M.W. 611.60) C28H33N7O9 [189275-71-6] 3180-v
Synthetic Product
Inhibitor for Caspase-1
N
NH
T.A. Rano, T. Timkey, E.P. Peterson, J. Rotonda,
NH
PEPTIDES INTERNATIONAL

O O O
D.W. Nicholson, J.W. Becker, K.T. Chapman, and H
N
H
N
N.A. Thornberry, Chem. Biol., 4, 149 (1997). N
H
N
H
H

M. Garcia-Calvo, E.P. Peterson, B. Leiting, R. Ruel, D.W. Nicholson,

O O OH

and N.A. Thornberry, J. Biol. Chem., 273, 32608 (1998). O OH O

Ac-Tyr-Val-Ala-Asp-CH2Cl ICL-3180-v 5 mg 230

(Acetyl-l-tyrosyl-l-valyl-l-alanyl-l-aspart-1-yl)chloromethane -20 °C vial
(M.W. 540.99) C24H33N4O8Cl [178603-78-6]
Synthetic Product OH

Inhibitor for Caspases O O O

H H
Y.A. Lazebnik, S.H. Kaufmann, S. Desnoyers, G.G. Poirier, N N CI
N N
and W.C. Earnshaw, Nature, 371, 346 (1994). H H O
O OH
M. Enari, H. Hug, and S. Nagata, Nature, 375, 78 (1995). O
C.E. Milligan, D. Prevette, H. Yaginuma, S. Homma, C. Cardwell, L.C. Fritz, K.J. Tomaselli,
R.W. Oppenheim, and L.M. Schwartz, Neuron, 15, 385 (1995).
E. Fujita, T. Mukasa, T. Tsukahara, K. Arahata, S. Omura, and T. Momoi,
Biochem. Biophys. Res. Commun., 224, 74 (1996).

148 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT CODE QTY PRICE

ENZYME INHIBITORS AND SUBSTRATES

Ac-Tyr-Val-Ala-Asp-H (aldehyde) IAT-3165-v 5 mg 225
Acetyl-l-tyrosyl-l-valyl-l-alanyl-l-aspart-1-al -20 °C vial
(M.W. 492.52) C23H32N4O8 [143313-51-3]
Synthetic Product OH

Inhibitor for Caspase-1 3165-v

O O
H O
H
N.A. Thornberry, H.G. Bull, J.R. Calaycay, K.T. Chapman, N
N
N
H
N
A.D. Howard, M.J. Kostura, D.K. Miller, S.M. Molineaux, H
O
H O OH
J.R. Weidner, J. Aunins, K.O. Elliston, J.M. Ayala, F.J. Casano,
J. Chin, G.J.-F. Ding, L.A. Egger, E.P. Gaffney, G. Limjuco, O

O.C. Palyha, S.M. Raju, A.M. Rolando, J.P. Salley,

T.-T. Yamin, T.D. Lee, J.E. Shively, M. MacCross, R.A. Mumford, J.A. Schmidt, and M.J. Tocci, Nature, 356, 768 (1992).
S.M. Molineaux, F.J. Casano, A.M. Rolando, E.P. Peterson, G. Limjuco, J. Chin, P.R. Griffin, J.R. Calaycay,
G.J.-F. Ding, T.-T. Yamin, O.C. Palyha, S. Luell, D. Fletcher, D.K. Miller, A.D. Howard, N.A. Thornberry,
and M.J. Kostura, Proc. Natl. Acad. Sci. USA, 90, 1809 (1993).
M. Enari, R.V. Talanian, W.W. Wong, and S. Nagata, Nature, 380, 723 (1996).
M. Garcia-Calvo, E.P. Peterson, B. Leiting, R. Ruel, D.W. Nicholson, and N.A. Thornberry, J. Biol. Chem., 273, 32608
(1998).

Ac-Tyr-Val-Lys-Asp-H (aldehyde) IAT-3166-v 5 mg 225

Acetyl-l-tyrosyl-l-valyl-l-lysyl-l-aspart-1-al -20 °C vial
(M.W. 549.62) C26H39N5O8 NH2

Synthetic Product
OH
Inhibitor for Caspase-1, Affinity Ligand for Caspase-1
3204-v
3166-v O
N.A. Thornberry, H.G. Bull, J.R. Calaycay, K.T. Chapman, H
O
H
O

A.D. Howard, M.J. Kostura, D.K. Miller, S.M. Molineaux,

N N
N N H
H
J.R. Weidner, J. Aunins, K.O. Elliston, J.M. Ayala, F.J. Casano,
H O
O OH
J. Chin, G.J.-F. Ding, L.A. Egger, E.P. Gaffney, G. Limjuco, O
O.C. Palyha, S.M. Raju, A.M. Rolando, J.P. Salley, T.-T. Yamin,
T.D. Lee, J.E. Shively, M. MacCross, R.A. Mumford, J.A. Schmidt, and M.J. Tocci, Nature, 356, 768 (1992).

PEPTIDES INTERNATIONAL
T.L. Graybill, R.E. Dolle, C.T. Helaszek, R.E. Miller, and M.A. Ator, Int. J. Pept. Protein Res., 44, 173 (1994).

Ac-Val-Asp-Val-Ala-Asp-H (aldehyde) IVD-3204-v 5 mg 350

Acetyl-l-valyl-l-aspartyl-l-valyl-l-alanyl-l-aspart-1-al -20 °C vial
(M.W. 543.57) C23H37N5O10 [194022-51-0] O
Synthetic Product O O
O OH
Inhibitor for Caspase-2 H
N
H
N H
N N N
R.V. Talanian, C. Quinlan, S. Trautz, M.C. Hackett, H
H H
O OH O O
J.A. Mankovich, D. Banach, T. Ghayur, K.D. Brady,
3182-v
and W.W. Wong, J. Biol. Chem., 272, 9677 (1997). O

Ac-Val-Glu-Ile-Asp-H (aldehyde) IVA-3182-v 5 mg 250

Acetyl-l-valyl-l-glutamyl-l-isoleucyl-l-aspart-1-al -20 °C vial
(M.W. 500.54) C22H36N4O9
Synthetic Product
Inhibitor for Caspase-6
H. Hirata, A. Takahashi, S. Kobayashi, S. Yonehara,
O O
H O
H
H. Sawai, T. Okazaki, K. Yamamoto, and M. Sasada,
N N
N NH H
J. Exp. Med., 187, 587 (1998).
H O
O OH

O
O OH

Order Hotline 1-800-777-4779 502-266-8787 149

 PRODUCT 3173-v
CODE QTY PRICE
Biotinyl-Asp-Glu-Val-Asp-H (aldehyde) IBA-3173-v 1 mg 115
ENZYME INHIBITORS AND SUBSTRATES

Biotinyl-l-aspartyl-l-glutamyl-l-valyl-l-aspart-1-al -20 °C vial

(M.W. 686.73) C28H42N6O12S [178603-73-1] O
Synthetic Product
Inhibitor for Caspase-3/7/8 O H
N O
OH
O O
H H
D.W. Nicholson, A. Ali, N.A. Thornberry, HN
3174-v N
N
N
N
H
J.P. Vaillancort, C.K. Ding, M. Gallant,
H H
S O O OH
Y. Gareau, P.R. Griffin, M. Labelle, Y.A. Lazebnik, O
N.A. Munday, S.M. Raju, M.E. Smulson,T.-T. Yamin, O OH

V.L. Yu, and D.K. Miller, Nature, 376, 37 (1995).

Z-Asp-CH2-DCB ICE-3174-v 5 mg 225

(Benzyloxycarbonyl-l-aspart-1-yl)[(2,6-dichlorobenzoyl)oxy] -20 °C vial
methane
(M.W. 454.26) C20H17NO7Cl2 [153088-73-4] O
Synthetic Product O OH O CI
Inhibitor for Caspases
O N O
H
R.E. Dolle, D. Hoyer, C.V.C. Prasad, S.J. Schmidt, C.T. Helaszek, O
CI
3189-v 37, 563 (1994).
R.E. Miller, and M.A. Ator, J. Med. Chem.,
T. Mashima, M. Naito, S. Kataoka, H. Kawai, and T. Tsuruo, Biochem. Biophys. Res. Commun., 209, 907 (1995).

Z-Glu-Lys(Biotinyl)-Asp-CH2-DMB ICA-3189-v 1 mg 115

[Benzyloxycarbonyl-l-glutamyl-(N e-biotinyl-l-lysyl)-l-aspart-1- -20 °C vial
yl]-[(2,6-dimethylbenzoyl)oxy]methane O
(M.W. 897.00) C43H56N6O13S
OH
O

Synthetic Product O
H
O OH O
Affinity Ligand for Caspases O N
N
N O
H H
O O
L.M. Martins, T. Kottke, P.W. Mesner,
PEPTIDES INTERNATIONAL

G.S. Basi, S. Shinha, N. Frigon, Jr.,

S
E. Tatar, J.S. Tung, K. Bryant, A. Takahashi, HN NH
P.A. Svingen, B.J. Madden, D.J. McCormick, W.C. Earnshaw,
and S.H. Kaufmann, J. Biol. Chem., 272, 7421 (1997).
HN
O O
L.M. Martins, P.W. Mesner, T.J. Kottke, G.S. Basi, S. Sinha,
J.S. Tung, P.A. Svingen, B.J. Madden, A. Takahashi, D.J. McCormick,
W.C. Earnshaw, and S. H. Kaufmann, Blood, 90, 4283 (1997).

Z-Val-Ala-Asp(OMe)-CH2F ICA-3188-v 1 mg 130

[Z-VAD-FMK] -20 °C vial
{Benzyloxycarbonyl-l-valyl-l-alanyl-[(2S)-2-amino-3- O

(methoxycarbonyl)propionyl]} fluoromethane O O OCH3

(M.W. 467.49) C22H30N3O7F
H
N
O N N F
Synthetic Product H
O
H
O
Inhibitor for Caspases
E.A. Slee, H. Zhu, S.C. Chow, M. MacFarlane, D.W. Nicholson, and G.M. Cohen, Biochem. J., 315, 21 (1996).
H. Zhu, H.O. Fearnhead, and G.M. Cohen, FEBS Lett., 374, 303 (1995).
3188-v

150 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT 4062-v
CODE QTY PRICE
Cathepsin and Thiol Protease Inhibitors

ENZYME INHIBITORS AND SUBSTRATES

Antipain IAP-4062-v 0.5 mg 45
(Hydrochloride Form) -20 °C vial
[(S)-1-Carboxy-2-Phenylethyl]-
Carbamoyl-l-arginyl-l-valylargininal H H
O
H
N
O

(M.W. 604.70) C27H44N10O6 [37691-11-5]

N N
N H
H
O O
Microbial Product HO O
NH NH

HN NH2 HN NH2

Antipain (Bulk) IAP-4062 25 mg 120

[(S)-1-Carboxy-2-phenylethyl]-carbamoyl-l-arginyl-l- -20 °C 100 mg 315
valylargininal • monohydrochloride dihydrate
(M.W. 604.70 • 36.46 • 36.03) C27H44N10O6 • HCI • 2H2O
Microbial Product
Inhibitor for Trypsin, u-PA, Papain, and Cathepsin A/B
H. Suda, T. Aoyagi, M. Hamada, T. Takeuchi, and H. Umezawa, J. Antibiotics, 25, 263 (1972). (Original)
S. Umezawa, K. Tatsuta, K. Fujimoto, T. Tsuchiya, H. Umezawa, and H. Naganawa,
J. Antibiotics, 25, 267 (1972). (Original; Chem. Structure)
J. Chau, J. Biol. Chem., 258, 4434 (1983). (Inhibitory Activity)
4322-v
• This compound is distributed through Peptide Institute, Inc. under the technical and scientific advices of the Microbial
Chemistry Research Foundation.

CA-074 IEC-4322-v 5 mg 170

[(2 S, 3S)-3-Propylcarbamoyloxirane-2-carbonyl]-l-isoleucyl- -20 °C vial
l-proline methyl ester
(M.W. 383.44) C18H29N3O6 [134448-10-5]

PEPTIDES INTERNATIONAL
Synthetic Product
Inhibitor for Cathepsin B O
O
H N
M. Murata, S. Miyashita, C. Yokoo, M. Tamai, K. Hanada, K.
N N
H
O OH
Hatayama, T. Towatari, T. Nikawa, and N. Katunuma, FEBS Lett., O O
280, 307 (1991). 4323-v
(Original; IC50)
T. Towatari, T. Nikawa, M. Murata, C. Yokoo, M. Tamai, K. Hanada, and N. Katunuma,
FEBS Lett., 280, 311 (1991). (Original; Pharmacol.)
T. Inubushi, H. Kakegawa, Y. Kishino, and N. Katunuma, J. Biochem., 116, 282 (1994). (Biochem.)

CA-074 Me IEC-4323-v 5 mg 170

[(2 S, 3S)-3-Propylcarbamoyloxirane-2-carbonyl]-l-isoleucyl- -20 °C vial
l-proline methyl ester
(M.W. 397.47) C19H31N3O6 [147859-80-1]
Synthetic Product
O
O
H N
Proinhibitor for Intracellular Cathepsin B N N
H
O
Membrane Permeable Analog of CA-074
O
O O

D.J. Buttle, M. Murata, C.G. Knight, and A.J. Barrett, Arch. Biochem. Biophys., 299, 377 (1992). (Original)
• This compound is distributed through Peptide Institute, Inc. under the license of Taisho Pharmaceutical Co., Ltd.

Order Hotline 1-800-777-4779 502-266-8787 151

 PRODUCT CODE QTY PRICE
E-64 IES-4096-v 0.5 mg 45
ENZYME INHIBITORS AND SUBSTRATES

[(2 S, 3S)-3-Carboxyoxiran-2-carbonyl]-l-leucine (4-guanidi- -20 °C vial

nobutyl)amide
(M.W. 357.41) C15H27N5O5 • ½H2O [66701-25-5]
Synthetic Product
E-64 (Bulk) 4096-v IES-4096 25 mg 150
[(2 S, 3S)-3-Carboxyoxiran-2-carbonyl]-l-leucine (4-guanidi- -20 °C 100 mg 350
nobutyl)amide hemihydrate
(M.W. 357.41 • 9.01) C15H27N5O5 • ½H2O [66701-25-5]
Synthetic Product
O
O H
N
Inhibitor fof Thiol Proteases
HO N
H
O
O NH
K. Hanada, M. Tamai, M. Yamagishi, S. Ohmura, J. Sawada, and
I. Tanaka, Agric. Biol. Chem., 42, 523 (1978). (Original)
N NH2
H

K. Hanada, M. Tamai, S. Ohmura, J. Sawada, T. Seki, and I. Tanaka,

4320-v
Agric. Biol. Chem., 42, 529 (1978). (Structure & Chem. Synthesis)
Y. Shoji-Kasai, M. Senshu, S. Iwashita, and K. Imahori,
Proc. Natl. Acad. Sci. USA, 85, 146 (1988). (Pharmacol.)

E-64-c IEC-4320-v 5 mg 115

[(2 S, 3S)-3-Carboxyoxirane-2-carbonyl]-l-leucine (3-meth- -20 °C vial
ylbutyl)amide
(M.W. 314.38) C15H26N2O5 [76684-89-4]
Synthetic Product O
Inhibitor for Thiol Protease (Cathepsin B/H/L and Calpain) HO
O
N
H
N
H
S. Hashida, T. Towatari, E. Kominami, and N. Katunuma, J. Biochem, 88, 1805
O (1980).
O

M. Tamai, K. Hanada, T. Adachi, K. Oguma, K. Kashiwagi, S. Omura, and M. Ohzeki, J. Biochem, 90, 255 (1981).
A.J. Barrett, A.A. Kembhavi, M.A. Brown, H. Kirschke, C.G. Knight, M. Tamai, and K. Hanada, Biochem. J.,
PEPTIDES INTERNATIONAL

4321-v
201, 189 (1982).
K. Suzuki, J. Biochem., 93, 1305 (1983).

E-64-d IED-4321-v 5 mg 115

[(2 S, 3S)-3-Ethoxycarbonyloxirane-2-carbonyl]-l-leucine -20 °C vial
(3-methylbutyl)amide
(M.W. 342.43) C17H30N2O5 [88321-09-9]
Synthetic Product O
H
Inhibitor for Thiol Protease (Cathepsin B/H/L and Calpain)
O
N
O N
Membrane Permeable Analog of E-64-c
H
O
O

M. Tamai, K. Matsumoto, S. Omura, I. Koyama, Y. Ozawa, and K. Hanada,

J. Pharmacobio-Dyn., 9, 672 (1986). (Original)
M. Tamai, C. Yokoo, M. Murata, K. Oguma, K. Sota, E. Sato, and Y. Kanaoka,
Chem. Pharm. Bull., 35, 1098 (1987). (Chem. Synthesis & Biochem.)

Leupeptin ILP-4041-v
4041-v 0.5 mg 40
(Sulfate Form) -20 °C vial
Acetyl-l-leucyl-l-leucyl-l-argininal
(M.W. 426.55) C20H38N6O4 [55123-66-5] H
O
H
O

Microbial Product
N N
N H
H
O O

NH

HN HN2

152 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT CODE QTY PRICE

ENZYME INHIBITORS AND SUBSTRATES

Leupeptin (Bulk) ILP-4041 25 mg 70
Acetyl-l-leucyl-l-leucyl-l-argininal hemisulfate monohydrate -20 °C 100 mg 170
(M.W. 426.55 • 49.04 • 18.02) C20H38N6O4 • ½H2O
[103476-89-7] 1g 1247
Microbial Product
Inhibitor for Trypsin, Plasmin, Papain, and Cathepsin B
S. Kondo, K. Kawamura, J. Iwanaga, M. Hamada, T. Aoyagi, K. Maeda, T. Takeuchi, and H. Umezawa,
Chem. Pharm. Bull., 17, 1896 (1969). (Biological Activity)
T. Aoyagi, T. Takeuchi, A. Matsuzaki, K. Kawamura, S. Kondo, M. Hamada, K. Maeda, and H. Umezawa,
J. Antibiotics, 22, 283 (1969). (Original)
T. Aoyagi, S. Miyata, M. Nanbo, F. Kojima, M. Matsuzaki, M. Ishizuka, T. Takeuchi, and H. Umezawa, J. Antibiotics,
22, 558 (1969). (Biological Activity)
R.M. McConnell, J.L. York, D. Frizzell, and C. Ezell, J. Med. Chem., 36, 1084 (1993). (Inhibitory Activity)
• This compound is distributed through Peptide Institute, Inc.under the technical and scientific advice of the
Microbial Chemistry Research Foundation.

N-(4-Biphenylacetyl)-Cys(Me)-d-Arg-Phe-N- IEC-3644-PI 5 mg 65
Phenylethylamide -20 °C
(M.W. 735.96) C41H49N7O4S 4397-v
Inhibitor for Cathepsin
S.F. Chowdhury,et al., J. Med. Chem., 45, (2002).

Pepstatin A IPA-4397-v 0.5 mg 50

Purity: higher than 90% (HPLC) -20 °C vial
Isovaleryl-l-valyl-l-valyl[(3S,4S)-4-amino-3-hydroxy-6-
methylheptanoyl]-l-alanyl O
H
O
H
O

[(3S,4S)-4-Amino-3-hydroxy-6- N
N
N
N
N
OH

methylheptanoic acid]
H H H
O OH O OH O

PEPTIDES INTERNATIONAL
• This compound is distributed through Peptide Institute, Inc. under the technical and scientific advice of the Institute of
Microbial Chemistry Research Foundation.

Pepstatin A IPA-4397 25 mg 85
Purity: higher than 90% (HPLC) -20 °C 100 mg 200
Isovaleryl-l-valyl-l-valyl[(3S,4S)-4-amino-3-hydroxy-6-
methylheptanoyl]-l-alanyl [(3S,4S)-4-Amino-3-hydroxy-6-methylheptanoic acid]
(M.W. 685.89) C34H63N5O9 [26305-03-3]
Microbial Product 3175-v
Inhibitor for Pepsin, Cathepsin D/E and Renin
H. Umezawa, et al., J. Antibiotics, 23, 259 (1970). (Original)
T. Aoyagi, et al., J. Antibiotics, 25, 689 (1972). (Biological Activity)
• This compound is distributed through Peptide Institute, Inc. under the technical and scientific advice of the Institute of
Microbial Chemistry Research Foundation.

Z-Leu-Leu-Leu-H (aldehyde) IZL-3175-v 5 mg 50

[MG-132] -20 °C vial
Benzyloxycarbonyl-l-leucyl-l-leucyl-l-leucinal
(M.W. 475.62) C26H41N3O5 [133407-82-6] O O
Synthetic Product
H H
N
O N NH
Inhibitor for Proteasome and Cathepsin K H
O O

Y. Saito, et al., Neurosci. Lett., 120, 1 (1990).

T.J. Jensen, et al., Cell, 83, 129 (1995).
B.J. Votta, et al., J. Bone Miner. Res., 12, 1396 (1997)
• This compound is distributed through Peptide Institute, Inc. under the license of Dr. H. Ito.

Order Hotline 1-800-777-4779 502-266-8787 153

 PRODUCT CODE QTY PRICE
ENZYME INHIBITORS AND SUBSTRATES

Chymotrypsin and Chymotrypsin-like Inhibitors

Ala-Ala-Phe-CH2Cl See Code IAA-3202-v

Aprotinin (Bulk) IAT-3830-PI 25 mg 195

Arg-Pro-Asp-Phe-Cys-Leu-Glu-Pro-Pro-Tyr-Thr-Gly-Pro- -20 °C 100 mg 575
Cys-Lys-Ala-Arg-Ile-Ile-Arg-Tyr-Phe-Tyr-Asn-Ala-Lys-
Ala-Gly-Leu-Cys-Gln-Thr-Phe-Val-Tyr-Gly-Gly-Cys-
Arg-Ala-Lys-Arg-Asn-Asn-Phe-Lys-Ser-Ala-Glu-
Asp-Cys-Met-Arg-Thr-Cys-Gly-Gly-Ala
(Disulfide bonds between Cys 5-Cys55, Cys14-Cys38, and Cys30-Cys51)
(M.W. 6511.57) C284H432N84O79S7
I. Trautschold, E. Werle and G. Zickgraf-Rudel, Biochem. Pharm., 16, 59 (1967).

Chymostatin* ICY-4063-v 0.5 mg 40

A Mixture of Type A, B, and C -20 °C vial
[(S)-1-Carboxy-2-phenylethyl]carbamoyl-a-[2-iminohexahydro-4(S)-
pyrimidyl]-(S)-glycyl-X-phenylalaninal
X: l-leucyl (Type A), l-valyl (Type B), l-isoleucyl (Type C) [9076-44-2]
Microbial Product
Chymostatin* (Bulk) ICY-4063 25 mg 200
A Mixture of Type A, B, and C -20 °C 100 mg 595
[(S)-1-Carboxy-2-phenylethyl]carbamoyl-a-[2-iminohexa-
hydro-4(S)-pyrimidyl]-(S)-glycyl-X-phenylalaninal
X: l-leucyl (Type A), l-valyl (Type B), l-isoleucyl (Type C) [9076-44-2]
Microbial Product
Inhibitor for Chymotrypsin, Chymase, Papain, and Cathepsin B/G
PEPTIDES INTERNATIONAL

H. Umezawa, et al., J. Antibiotics, 23, 425 (1970). (Original)

K. Tatsuta, et al.,, J. Antibiotics, 26, 625 (1973). (Chem. Structure)
R.L. Stein and A.M. Strimpler, Biochemistry, 26, 2611 (1987). (Inhibitory Activity)
L.A. Johnson, K.E. Moon, and M. Eisenberg, Biochim. Biophys. Acta, 953, 269 (1988). (Inhibitory Activity)
• This compound is distributed through Peptide Institute, Inc. under the technical and scientific advice of the Microbial
Chemistry Research Foundation.

Coagulation Factors Inhibitors

Also see IAP-4062-v and IAP-4062 Antipain; ILP-4041-v and ILP-4041 Leupeptin.

H-Gly-Pro-Arg-Pro-OH INH-3797-PI 5 mg 35
(Trifluoroacetate Form) -20 °C 25 mg 130
GPRP
(M.W. 425.49) C18H31N7O5 [67869-62-9]
Fibrinolysis Inhibiting Factor

154 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT CODE QTY PRICE

ENZYME INHIBITORS AND SUBSTRATES

Collagenase / MMP / Stromelysin Inhibitors .

Galardin TM

Peptides International is now offering GalardinTM, an addition to other widely used

enzyme inhibitors.1 Galardin or GM6001 is a potent, broad-spectrum matrix metal -
loproteinase (MMP) inhibitor and is a member of the hydroxamate class of inhibitors.
We are pleased to add galardin to complement our popular line of TAPI MMP inhibi-
tors.2
1. J. Gordon, et al., Nature. 195, 701 (1962).
2. K. Darlak, R.B. Miller, M.S. Stack, A.F. Spatola, and R.D. Grey, J. Biol. Chem., 265, 5199 (1990).

GalardinTM INH-3927-PI 5 mg 175

GM6001, Ilomastat -20 °C
N-[(2R)-2-(Hydroxamidocarbonylmethyl)-4-methylpentanoyl]-
l-tryptophan methylamide
(M.W. 388.47) C20H28N4O4 ISN-3821-PI Ac-SIMP-1
Inhibitor for Collagenases and MMPs
D. Grobelny, et al., Biochemistry, 31, 7152 (1992).

Ac-SIMP-1 ISN-3821-PI 5 mg 75
Ac-S-CH2-(R)-CH(CH2CH(CH3)2)-CO-Phe-Ala-NH2
-20 °C
(2R)-S-Acetyl-2-mercaptomethyl-4-methylpentanoyl-l-
phenylalanyl-l-alanine amide
(M.W. 421.56) C21H31N3O4S O O
H
O

(Protected precursor) S N
N
NH2
Collagenase Inhibitor
H
O

PEPTIDES INTERNATIONAL
ISN-3831-PI
• Product produced under license from Research Corporation Technologies

Ac-SIMP-2 ISN-3831-PI 5 mg 95
(Protected Precursor)
-20 °C
Ac-S-CH2-(R)-CH(CH2CH(CH3)2)-CO-Nal-Ala-NH2
(2R)-S-Acetyl-2-mercaptomethyl-4-methylpentanoyl-l-b-(2-
O O
H O
N
naphthyl)alanyl-l-alanine amide S N
H
O
NH2

(M.W. 471.62) C25H33N3O4S

Collagenase Inhibitor ISN-3835-PI SIMP-2

• Product produced under license from Research Corporation Technologies.

SIMP-2 ISN-3835-PI 5 mg 110

(Free thiol form)
-20 °C
HS-CH2-(R)-CH(CH2CH(CH3)2)-CO-Nal-Ala-NH2
(2R)-2-mercaptomethyl-4-methylpentanoyl-l-b-(2-naphthyl)
alanyl-l-alanine amide O
(M.W. 429.59) C23H31N3O3S H O
N
3850 HS N NH2
Collagenase Inhibitor H
O

• Product produced under license from Research Corporation Technologies.

TAPI-O INH-3850-PI 1 mg 125

HONHCOCH2CH(CH2CH(CH3)2)CO-Nal-Ala-NH2 -20 °C 5 mg 495
N-(R)-(2-(Hydroxyaminocarbonyl)methyl)-4-methylpentanoyl-
l-3-(2'-naphthyl)alanyl-l-alanine amide O O

(M.W. 456.53) C24H32N4O5

H
HO N NH2
N N
Inhibitor for Matrix Metalloproteases (MMP) H
O
H
O

K.M. Mohler, et al., Nature, 370, 218 (1984).

A.F. Spatola, et al., Peptides: Chemistry & Biology, J.A. Smith & J.E. Rivier (Eds.),
ESCOM, Leiden, 1992, p. 820.
K. Darlak, R.B. Miller, M.S. Stack, A.F. Spatola, and R.D. Grey, J. Biol. Chem., 265, 5199 (1990).

Order Hotline 1-800-777-4779 502-266-8787 155

 PRODUCT CODE QTY PRICE
ENZYME INHIBITORS AND SUBSTRATES
TAPI-1 INH-3855-PI 1 mg 125
HONHCOCH2CH(CH2CH(CH3)2)CO-Nal-Ala-NHCH2CH2NH2 -20 °C 5 mg 495
N-(R)-(2-(Hydroxyaminocarbonyl)methyl)-4-methylpentanoyl-
l-3-(2'-naphthyl)alanyl-l-alanine 2-aminoethyl amide O O
(M.W. 499.60) C26H37N5O5 H H
HO N N
N N NH2
Inhibitor for Matrix Metalloproteases (MMP) H
O
H
O

K. Darlak, R.B. Miller, M.S. Stack, A.F. Spatola, and3852-v

R.D. Grey,
J. Biol. Chem., 265, 5199 (1990).
A.F. Spatola, et al., Peptides: Chemistry & Biology, J.A. Smith & J.E. Rivier (Eds.), ESCOM, Leiden, 1992, p. 820.
K.M. Mohler, et al., Nature, 370, 218 (1984).

TAPI-2 INH-3852-PI 1 mg 125

HONHCOCH2CH(CH2CH(CH3)2)CO-t-butyl-Gly-Ala- -20 °C 5 mg 495
NHCH2CH2NH2
N-(R)-(2-(Hydroxyaminocarbonyl)methyl)-4-methylpentanoyl-
l-t-butyl-glycyl-l-alanine 2-aminoethyl amide O
H
O
H
(M.W. 415.53) C19H37N5O5 HO
N
N
N
N
NH2
H H
Inhibitor for Metalloproteases (MMP) O O

J. Arribas, et al., J. Biol. Chem., 271, 11376 (1996).

N.M. Hooper, et al, Biochem. J., 321, 265 (1997).

CXCR4 Inhibitor
BKT140 ICX-3806-PI 1 mg 175
4-Fluorobenzoyl-Arg-Arg-Nal-[Cys-Tyr-Cit-Lys-D-Lys-Pro-Tyr-
NEW! -20 °C 5 mg 665
Arg-Cit-Cys]-Arg-NH2
(M.W. 2159.57) C97H144N33O19S2F
CXCR4 Inhibitor
PEPTIDES INTERNATIONAL

D. Fahham, et al., The Journal of Thoracic and Cardiovascular Surgery, 144, 1167 (2012).
K. Beider et al., Experimental Haematology, 39, 282 (2011).
F. de Nigris, et al., Recent Pat Anticancer Drug Discov., 7, 251 (2012).
J.A. Burger, et al., Expert Rev Anticancer Ther., 11, 621 (2011).
J.A. Burger and D.J. Stewart, Expert Opin Investig Drugs., 18, 481 (2009)

Dipeptidyl Peptidase II (DPP II) Inhibitors

H-Dab-Pip IDP-3655-PI 5 mg
(Trifluoroacetate Form) -20 °C
L-2,4-Diaminobutyrylpiperidinamide
NH2

(M.W. 185.27) C9H19N3O

Inhibitor for Dipeptidyl Peptidase II (DPP II) H2N
N

O
K. Senten, et al, Bioorg. Med. Chem. Lett. 12, 2825 (2002).

Diprotin A IDP-4132-v 0.5 mg 22

Ile-Pro-Ile -20 °C vial
(M.W. 341.45) C17H31N3O4 [90614-48-5]
H-Dab-Pip

Diprotin A IDP-4132
Dipeptidyl Peptidase 25 mgII) Inhibitor 75
IDP-3655-PI
(Bulk) II (DPP

Ile-Pro-Ile • H2O -20 °C 100 mg 170

Synthetic Product
Inhibitor for Dipeptidyl-Aminopeptidase IV
H. Umezawa, et al, J. Antibiotics, 37, 422 (1984). (Original; IC50 & Chem. Structure)
• This compound is distributed exclusively through Peptide Institute, Inc. under the license of the Microbial Chemistry
Research Foundation.

E-64 See page 156.

156 Order Hotline 1-800-777-4779 502-266-8787

 4146-v
PRODUCT CODE QTY PRICE

ENZYME INHIBITORS AND SUBSTRATES

Elastase Inhibitors
Cl-Ac-(OH)Leu-Ala-Gly-NH2 ICL-4146-v 0.5 mg 35
N-Chloroacetyl-N-hydroxy-l-leucyl-l-alanylglycine amide -20 °C vial
(M.W. 350.80) C13H23N4O5Cl
Synthetic Product
Cl-Ac-(OH)Leu-Ala-Gly-NH2 (Bulk) ICL-4146 25 mg 230
N-Chloroacetyl-N-hydroxy-l-leucyl-l-alanylglycine amide -20 °C 100 mg 595
N. Nishino and J.C. Powers, J. Biol. Chem., 255, 3482 (1980). OH O
H
O

(Original)
N N
CI N NH2
H
O O

Elafin (Human) PEL-4243-v 20 µg 375

Ala-Gln-Glu-Pro-Val-Lys-Gly-Pro-Val-Ser-Thr-Lys-Pro-Gly- -20 °C vial
Ser-Cys-Pro-Ile-Ile-Leu-Ile-Arg-Cys-Ala-Met-Leu-Asn-Pro-
Pro-Asn-Arg-Cys-Leu-Lys-Asp-Thr-Asp-Cys-Pro-Gly-Ile-Lys-
Lys-Cys-Cys-Glu-Gly-Ser-Cys-Gly-Met-Ala-Cys-Phe-Val-
Pro-Gln
(Disulfide bonds between Cys 16-Cys45, Cys23-Cys49, Cys32-Cys44 and Cys38-Cys53)
(M.W. 5999.1) C254H416N72O75S10
Synthetic Product
Elastase-Specific Inhibitor from Human Skin
O. Wiedow, J.-M. Schröder, H. Gregory, J.A. Young, and E. Christophers, J. Biol. Chem., 265, 14791 (1990). (Original)
O. Wiedow, et al., J. Biol. Chem., 266, 3356 (1991).
(Correction of Sequence)
M. Tsunemi, et al., Biochem. Biophys. Res. Commun., 185, 967 (1992). (Chem. Synthesis & Biochem.)

PEPTIDES INTERNATIONAL
M. Tsunemi, et al., Biochemistry, 35, 11570 (1996). (Biochem; Crystal Structure of Elafin-Pancreatic Elastase)

Elastatinal IEL-4064-v 0.5 mg 45

Microbial Product -20 °C vial

Elastatinal (Bulk) IEL-4064 25 mg 190

Microbial Product -20 °C 100 mg 660
Inhibitor for Elastase
H. Umezawa, T. Aoyagi, A. Okura, H. Morishima, T. Takeuchi, and Y. Okami, J. Antibiotics, 26, 787 (1973). (Original)
• This compound is distributed exclusively through Peptide Institute, Inc. under the license of the Microbial Chemistry
Research Foundation.

Endothelin A & B Receptors (Antagonists)

BQ-123 Sodium Salt PED-3512-PI 1 mg 65
cyclo (d-Trp-d-Asp-Pro-d-Val-Leu) -20 °C 5 mg 195
(M.W. 610.72) C31H42N6O7
BQ-610 Sodium Salt PED-3610-PI 1 mg 75
Homopiperidinyl-CO-Leu-d-Trp(CHO)-d-Trp-OH -20 °C 5 mg 275
(M.W. 656.79) C36H44N6O6
K. Ishikawa, T. Fukami, T. Nagase, T. Mase, T. Hayama, N-CO-Leu-D-Trp(CHO)-D-Trp-OH
K. Niiyama, K. Fujita, Y. Urakawa, U. Kumagai, T. Fukuroda,
M. Ihara, and M. Yano. in C.H. Schneider, and A.N. Eberle (Eds.),
Peptides, 1992, ESCOM, Leiden, 1993, p. 685.

Order Hotline 1-800-777-4779 502-266-8787 157

 PRODUCT CODE QTY PRICE
ENZYME INHIBITORS AND SUBSTRATES
BQ-788 Sodium Salt PED-3788-PI 1 mg 140
N-cis-2,6-Dimethylpiperidinocarbonyl-l-g-Me-Leu-d- -20 °C 5 mg 495
Trp(COOMe)-d-Nle (Sodium Salt)
(M.W. 663.80) C34H50N5O7Na
Soluble: 2 mg in 1 mL H2O
O O
H
N ONa
N N N
T. Fukuroda, T. Fujikawa, S. Ozaki, K. Ishikawa, M. Yano, and H
O
H
O
M. Nishikibe, Biochem. Biophys Res. Commun., 199, 1461 (1994). N O

3788

d-Glucaro-δ-Lactam See Code CAR-24004-v

4395-v

Gingipain Inhibitors
KYT-1 IRG-4395-v 1 mg 300
(Hydrochloride Form) -20 °C vial
(3S)-N-[(1S)-5-Amino-1-(N,N-dimethylcarbamoyl)
pentyl]-3-[(2S)-6-amino-2-[(benzyloxycarbonyl)amino] H2N NH
NH2
hexanoylamino]-6-guanidino-2-oxohexanamide HN

(M.W. 619.76) C29H49N9O6 O O

Synthetic Product 4396-v O
H
N
N N
N

Inhibitor for Arg-Gingipain

H H
O O O

T. Kadowaki, A. Baba, N. Abe, R. Takii, M. Hashimoto, T. Tsukuba,

S. Okazaki, Y. Suda, T. Asao, and K.Yamamoto, NH2
Mol. Pharmacol., 66, 1599 (2004). (Original)

KYT-36 IKG-4396-v 1 mg 300

(Hydrochloride Form) -20 °C vial
(2S)-N-[(1S)-1-(4-Aminobutyl)-2-oxo-2-(N-benzylcarbamoyl)
PEPTIDES INTERNATIONAL

ethyl]-N'-(N-methylphenylamino)-2-[(benzyloxycarbonyl) NH2
amino]pentane-1,5-diamide
(M.W. 630.73) C34H42N6O6 O O
Synthetic Product O
H
N
N N
Inhibitor for Lys-Gingipain
H H
O O

T. Kadowaki, A. Baba, N. Abe, R. Takii, M. Hashimoto, T. Tsukuba, O NH

S. Okazaki, Y. Suda, T. Asao, and K.Yamamoto, Mol. Pharmacol., N

66, 1599 (2004). (Original)

IDE Inhibitor 6bK IDE-3798-PI 1 mg 400

(Fumaryl-Lys-Cha-d-Bpa)-Lys-NH2 -20 °C 5 mg 1600
J.P. Maianti, et al., Nature, doi: 10.1038/nature13297. [Epub ahead
of print] (2014).

Myr-Ser-Ile-Tyr-Arg-Arg-Gly-Ala-Arg-Arg-Trp-Arg-Lys-Leu See Code PKC-3403-v.

MG-101 See Code IAL-3671-PI Ac-Leu-Leu-Nle-H.
MG-115 See Code IAT-3170-v Z-Leu-Leu-Nva-H (aldehyde).
MG-132 See Code IZL-3175-v Z-Leu-Leu-Leu-H (aldehyde).
MMP Inhibitors See Collagenase Inhibitors and TAPI-O, TAPI-1 and TAPI-2.

158 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT 4082-v
CODE QTY PRICE

ENZYME INHIBITORS AND SUBSTRATES

Neutral Endopeptidase Inhibitors
Phosphoramidon (Sodium Salt) IPO-4082-v 0.5 mg 45
N-(a-Rhamnopyranosyloxyhydroxyphosphinyl)-l-leucyl-l- -20 °C vial
tryptophan (M.W. 543.50) C23H34N3O10P [36357-77-4]
Microbial Product NH

O
HO H
N OH
P N
H
O O
O
H3C
O
HO
HO
OH

Phosphoramidon (Bulk) IPO-4082 25 mg 180

N-(a-Rhamnopyranosyloxyhydroxyphosphinyl)--l-leucyl-l- -20 °C 100 mg 570
tryptophan disodium salt dihydrate
(M.W. 541.49 • 45.98 • 36.03) C23H32N3O10P [119942-99-3]
Microbial Product
Inhibitor for Thermolysin, Neutral Endopeptidase-24.11 (ANP Degradation Enzyme),
and Endothelin converting Enzyme
H. Suda, T. Aoyagi, T. Takeuchi, and H. Umezawa, J. Antibiotics, 26, 621 (1973). (Original)
S.L. Stephenson and A.J. Kenny, Biochem. J., 243, 183 (1987). (Pharmacol.)
B.P. Roques and A. Beaumont, Trends Pharmacol. Sci., 11, 245 (1990). (Review)
Y. Matsumura, K. Hisaki, M. Takaoka, and S. Morimoto, Eur. J. Pharmacol., 185, 103 (1990). (Pharmacol.)
• This compound is distributed exclusively through Peptide Institute, Inc. under the license of the Microbial Chemistry
Research Foundation.
Nojirimycin Bisulfite See Code CAR-24003-v.
Pepsin See Code IPA-4397-v and IPA-4397.

PEPTIDES INTERNATIONAL
Pepstatin A See Code IPA-4397-v and IPA-4397.
PSI See Code IAT-3169-v Z-Ile-Glu(OtBu)-Ala-Leu-H (aldehyde).
Plasmin See ILP-4041-v and ILP-4041 Leupeptin.

Propyl Endopeptidase Inhibitor 3214-v

SUAM-14746 ISU-3214-v 5 mg 180

3-({4-[2-(E)-Styrylphenoxy]butanoyl}-L-4-hydroxyprolyl)- -20 °C vial
thiazolidine
(M.W. 466.59) C26H30N2O4S HO

Synthetic Product N
S
N
Inhibitor for Prolyl Endopeptidase O O
O
M.Saito, M. Hashimoto, N. Kawaguchi, H. Shibata, H. Fukami,
T. Tanaka, and N. Higuchi, J. Enzyme Inhib., 5, 51 (1991) (Assay Method)
• This compound is distributed under license of Suntory Ltd.

Protein Kinase Inhibitor

Lys-Lys-Lys-Leu-Arg-Arg-Gln-Glu-Ala-Phe-Asp- IKK-4374-v 0.5 mg 115
Ala-Tyr -20 °C vial
[Lys3, Phe10, Try13]-Autocamtide-2-Related Inhibitory
Peptide (AIP)
(M.W. 1652.9) C74H121N23O20
Synthetic Product
Inhibitor for Calmodulin-Dependent Protein Kinase II
A. Ishida and H. Fujisawa, J. Biol. Chem., 270, 2163 (1995). (AIP; Autocamtide-2-Related Inhibitory Peptide)
A. Ishida, et al., FEBS Lett., 427, 115 (1998). (Original)
• This compound is distributed through Peptide Institute, Inc. under the license of the Agency of Industrial Science &
Technology.

Order Hotline 1-800-777-4779 502-266-8787 159

 PRODUCT CODE QTY PRICE
ENZYME INHIBITORS AND SUBSTRATES

Renin See Code IPA-4397-v and IPA-4397.

Reverse Transcriptase Inhibitor

Doxorubicin-HCl IOX-3765-PI 1g 1000
(M.W. 579.98) C27H29NO11 • HCl [25316-40-9] -20 °C
Inhibitor of Reverse Transcriptase and RNA Polymerase

β-Secretase Inhibitors 4378-v

Lys-Thr-Glu-Glu-Ile-Ser-Glu-Val-Asn-Sta-Val-Ala- IBS-4378-v 1 mg 250

Glu-Phe -20 °C vial
Sta(Statine): (3S,4S)-4-Amino-3-hydroxy-6-methylheptanoic
acid
(M.W. 1651.8) C73H118N16O27
Synthetic Product N
H
Inhibitor for β-Secretase OH O

S. Sinha, et al., Nature, 402, 537 (1999). (Original)

γ-Secretase Inhibitors 3219-v

(3,5-Difluorophenylacetyl)-Ala-Phg-OBut IGS-3219-v 5 mg 125

(3,5-Difluorophenylacetyl)-l-alanyl-l-2-phenylglycine t-butyl -20 °C vial
ester
(M.W. 432.46) C23H26N2O4F2
Synthetic Product H
O

Inhibitor for γ-Secretase F N O

N
H

H.F. Dovey, et al., , J. Neurochem., 76, 173 (2001). O O

PEPTIDES INTERNATIONAL

(Original; Functional γ-Secretase Inhibitor in Brain) F

A.Y. Kornilova, et al., J. Biol. Chem., 278, 16470 (2003).
(Comparison of in Cells and Cell-Free Activity)

(3,5-Difluorophenylacetyl)-Ala-Phg-OtBu IGS-3641-PI 10 mg 150

N-[N-(3,5-Difluorophenacetyl)-l-alanyl)]-l-phenylglycine -20 °C
t-butyl ester
(M.W. 432.47) C23H26N2O4F2
4394-v
Inhibitor for γ-Secretase
H.F. Dovey, et al., J. Neurochem., 76, 173 (2001). (Original; Functional γ-Secretase Inhibitor in Brain)
A.Y. Kornilova, et al., J. Biol. Chem., 278, 16470 (2003). (Comparison of in Cells and Cell-Free Activity)

L-685,458 IGS-4394-v 1 mg 360

[(2R,4R,5S)-2-Benzyl-5-(t-Butyloxycarbonylamino)-4- -20 °C vial
hydroxy-6-phenylhexanoyl]-l-leucyl-l-phenylalanine amide
(M.W. 672.85) C39H52N4O6 OH O

Synthetic Product O
H
N
H
N NH2

Inhibitor for γ-Secretase

N
H
O O O

Y.-M. Li, M. Xu, M.-T. Lai, Q. Huang, J.L. Castro, J. DiMuzio-Mower,

T. Harrison, C. Lellis, A. Nadin, J.G. Neduvelil, R.B. Register, M.K. Sardana, M.S. Shearman, A.L. Smith, X.-P. Shi,
K.-C. Yin, J.A. Shafer, and S.J. Gardell, Nature, 405, 689 (2000). (Biochem.; γ-Secretase Inhibitor)
Y.-M. Li, M.-T. Lai, M. Xu, Q. Huang, J. DiMuzio-Mower, M.K. Sardana, X.-P. Shi, K.-C. Yin, J.A. Shafer, and S.J. Gardell,
Proc. Natl. Acad. Sci. USA, 97, 6138 (2000). (Biochem; γ-Secretase Inhibitor)
M.S. Shearman, D. Beher, E.E. Clarke, H.D. Lewis, T. Harrison, P. Hunt, A. Nadin, A.L. Smith, G. Stevenson,
and J.L. Castro, Biochemistry, 39, 8698 (2000). (Biochem; γ-Secretase Inhibitor)
G. Tian, C.D. Sobotka-Briner, J. Zysk, X. Liu, C. Birr, M.A. Sylvester, P.D. Edwards, C.D. Scott, and B.D. Greenberg,
J. Biol. Chem., 277, 31499 (2002). (Biochem; Inhibition Mechanism)

160 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT CODE QTY PRICE

ENZYME INHIBITORS AND SUBSTRATES

Siastatin B See Code CAR-24002-v.
SIMP Products See Collagenase Inhibitors.

Signal Peptide Peptidase Inhibitor

3218-v

(Z-Leu-Leu-NHCH2)2CO IZL-3218-v 5 mg 90
[(Z-LL)2 Ketone] -20 °C vial
1,3-Bis[(benzyloxycarbonyl-l-leucyl-l-leucyl)amino]acetone
(M.W. 809.00) C43H64N6O9 [313664-40-3]
Synthetic Product
Inhibitor for Signal Peptide Peptidase
A. Weihofen, O
H
O O
H
O

M.K. Lemberg, O N
N
N N
N
N O

H.L. Ploegh,
H H H H
O O O

M. Bogyo, and
B. Martoglio,
J. Biol. Chem., 275, 30951 (2000). (Original)
A. Weihofen, K. Binns, M.K. Lemberg, K. Ashman, and B. Martoglio, Science, 296, 2215 (2002).
(Signal Peptide Peptidase Inhibitor)
A. Weihofen, M.K. Lemberg, E. Friedmann, H. Rueeger, A. Schmitz, P. Paganetti, G. Rovelli, and B. Martoglio,
J. Biol. Chem., 278, 16528 (2003). (Signal Peptide Peptidase Inhibitory Activity)

Sodium Potassium ATPase Inhibitor-1 (Porcine) See Code PSP-4216-s.

3202-v

Tripeptidyl Peptidase II Inhibitor

Ala-Ala-Phe-CH2Cl IAA-3202-v 5 mg 70
(l-alanyl-l-alanyl-l-phenylalanyl)chloromethane -20 °C vial
(M.W. 339.82) C16H22N3O3Cl [102129-66-8]

PEPTIDES INTERNATIONAL
Synthetic Product
Inhibitor for Tripeptidyl Peptidase II (Component of Giant Protease with
Some Proteasome Function), Chymotrypsin, and Chymase O
H
N
R. Glas, M. Bogyo, J.S. McMaster, M. Gaczynska, and H2N N
H
CI
H.L. Ploegh, Nature, 392, 618 (1998). O O

E. Geier, G. Pfeifer, M. Wilm, M. Lucchiari-Hartz, W. Baurmeister, K. Eichmann,

and G. Niedermann, Science, 283, 978 (1999).
L.A. Johnson, K.E. Moon, and M. Eisenberg, Biochem. Biophys. Acta, 953, 269 (1988)
Trypsin and Trypsin-like Protease Inhibitors See Code IAP-4062 Antipain, Code IAT-3830-PI Aprotinin,
and Codes ILP-4041-v and ILP-4041 Leupeptin.

Ubiquitin Proteasome System Inhibitors

Also see Code IAL-3678-PI Ac-Leu-Leu-Met-(aldehyde), Code IAL-3671
4381-v
Ac-Leu-Leu-Nle-H (aldehyde)
[ALLM], and Code IZL-3175-v Z-Leu-Leu-Leu-H (aldehyde) [MG-132] (for Proteasome).
Epoxomicin IEP-4381-v 0.2 mg 250
(2R)-2-[Acetyl-(N-methyl-l-Isoleucyl)-l-isoleucyl-l-threonyl-l- -20 °C vial
Leucyl]-2-Methyloxirane
(M.W. 554.72 ) C28H50N4O7 [134381-21-8] O O
Synthetic Product
H
N N O
N N
Inhibitor for Proteasome O
H
O
H
O
OH
L. Meng, R. Mohan, B.H.B. Kwok, M. Elofsson, N. Sin, and C.M. Crews,
Proc. Natl. Acad. Sci. USA, 96, 10403 (1999). (Proteasome Inhibitor & Antiinflammatory Activity)
N. Sin, et al., Bioorg. Med. Chem. Lett., 9, 2283 (1999). (Proteasome Inhibitor)
K.B. Kim, J. Myung, N. Sin, and C.M. Crews, Bioorg. Med. Chem. Lett., 9, 3335 (1999). (Proteasome Inhibitor)
M. Groll, et al., J. Am.Chem. Soc., 122, 1237 (2000). (Crystal Structure of Proteasome Complex)
T. Aoyagi, et al., J. Appl. Biochem., 7, 388 (1985). (Pharmacol.)
• This compound is distributed exclusively through Peptide Institute, Inc.
under the license of the Microbial Chemistry Research Foundation.

Order Hotline 1-800-777-4779 502-266-8787 161

 PRODUCT 4368-v CODE QTY PRICE
Lactacystin ILC-4368-v 0.2 mg 225
ENZYME INHIBITORS AND SUBSTRATES

N-Acetyl-S-{(2R,3S,4R)-3-hydroxy-2-[(1S)-1-hydroxy-2- -20 °C vial

methylpropyl]-4-methyl-5-oxo-pyrolidine-2-carbonyl}-l-
cysteine
(M.W. 376.43) C15H24N2O7S [133343-34-7] O O OH

Microbial Product NH NH
Inhibitor for Proteasome S
HO O
S. Omura, et al., J. Antibiotics, 44, 113 (1991). (Original) HO
O
S. Omura, et al., J. Antibiotics, 44, 117 (1991). (Original; Chem. Structure)
G. Fenteany, et al., Science, 268, 726 (1995). (Biochem.; Proteasome Inhibition)
S. Imajoh-Ohmi, et al., Biochem. Biophys. Res. Commun., 217, 1070 (1995). (Biochem.; Apoptotic Effect)
• This item is produced by Kyowa Medex Co., Ltd.

Ubiquitin Aldehyde IUB-3207-v 50 mg 250

Met*-Gln-Ile-Phe-Val-Lys-Thr-Leu-Thr-Gly-Lys-Thr-Ile-Thr- -20 °C vial
Leu-Glu-Val-Glu-Pro-Ser-Asp-Thr-Ile-Glu-Asn-Val-Lys-Ala-
Lys-Ile-Gln-Asp-Lys-Glu-Gly-Ile-Pro-Pro-Asp-Gln-Gln-Arg-
Leu-Ile-Phe-Ala-Gly-Lys-Gln-Leu-Glu-Asp-Gly-Arg-Thr-Leu-
Ser-Asp-Tyr-Asn-Ile-Gln-Lys-Glu-Ser-Thr-Leu-His-Leu-Val-
Leu-Arg-Leu-Arg-Gly-Gly-H (aldehyde)
* Met at position 1 is oxidized to Met(O).
(M.W. 8564.70) C378H629N105O118S
Semisynthetic Product
Inhibitor for Deubiquitinating Enzyme
3169-v 35, 10886 (1996).
J.R. Schaeffer and R.E. Cohen, Biochemistry,
F. Melandri, L. Grenier, L. Plamondon, W.P. Huskey, and R.L. Stein, Biochemistry, 35, 12893 (1996).
S.H. Baek, K.S. Choi, Y.J. Yoo, J.M. Cho, R.T. Baker, K. Tanaka, and C.H. Chung, J. Biol. Chem., 272, 25560 (1997).
L.C. Dang, F.D. Melandri, and R.L. Stein, Biochemistry, 37, 1868 (1998)
PEPTIDES INTERNATIONAL

Z-Ile-Glu(OBut)-Ala-Leu-H (aldehyde) IAT-3169-v 5 mg 99

[PSI] -20 °C vial
Benzyloxycarbonyl-l-isoleucyl-[(2S)2-amino-4-
(t-Butyloxycarbonyl)butanoyl]-l-alanyl-l-leucinal
3170-v O O O
(M.W. 618.76) C32H50N4O8 [158442-41-2]
H H
N N
O N N H
Synthetic Product H
O
H
O

Inhibitor for Proteasome

O O
M.E. Figueiredo-Pereira, K.A. Berg, and S. Wilk, J. Neurochem., 63, 1578 (1994).
E.B.-M. Traenckner, S. Wilk, and P.A. Baeuerle, EMBO J., 13, 5433 (1994).
M.E. Figueiredo-Pereira, W-E. Chen, H-M. Yuan, and S. Wilk, Arch. Biochem. Biophys., 317, 69 (1995).

Z-Leu-Leu-Nva-H (aldehyde) IAT-3170-v 5 mg 65

[MG-115] -20 °C vial
Benzyloxycarbonyl-l-leucyl-l-leucyl-l-norvalinal O O
(M.W. 461.59) C25H39N3O5 [133407-86-0] H
N H
Synthetic Product O N
H
N
H
O
O
Inhibitor for Proteasome
Y. Saito, S. Tsubuki, H. Ito, and S. Kawashima, Neurosci. Lett., 120, 1 (1990).
A. Vinitsky, C. Michaud, J.C. Powers, and M. Orlowski, Biochemistry, 31, 9421 (1992).
K.L. Rock, C. Gramm, L. Rothstein, K. Clark, R. Stein, L. Dick, D. Hwang, and A.L. Goldberg, Cell, 78, 761 (1994).
V.J. Palombella, O.J. Rando, A.L. Goldberg, and T. Maniatis, Cell, 78, 773 (1994).
• This compound is distributed through Peptide Institute, Inc. under the license of Dr. H. Ito.

u-PA Urokinase Inhibitor See Code IAP-4062 Antipain.

162 Order Hotline 1-800-777-4779 502-266-8787

Examples of Proteolytic Enzymes and Their Inhibitors

ENZYME INHIBITORS AND SUBSTRATES

Metalloproteases Aspartyl Proteases Seryl Proteases
Inhibitors Inhibitors Inhibitors
Actinonin Pepstatin A Aprotinin
(Aminopeptidase M and Leucyl (Renin, Cathepsin D) (Kallikrein, Trypsin,
Aminopeptidase) Chymotrypsin
Others
Amastatin and Plasmin)
Peptide Renin Inhibitors
(Aminopeptidases) Antipain
Peptide HIV Inhibitors (Trypsin)
Arphamenine A
(Aminopeptidase B) Elastatinal
Arphamenine B (Elastase)
(Aminopeptidase B) Chymostatin
Collagenase Inhibitors (Chymotrypsin)
(Collagen) Leupeptin
Diprotin A (Trypsin, Plasmin)
(Dipeptidyl Aminopeptidase IV) Others
Foroxymithine Organophosphates
(Angiotensin I Converting Enzyme
(ACE)) Peptidyl chloromethanes

Leuhistin Sulfonyl fluorides

(Aminopeptidase M) Peptidyl aldehydes
Phosphoramidon Peptidyl borates
(Collagenase,Thermolysin and
Enkephalinase (24.11))

PEPTIDES INTERNATIONAL
Ubenimex (Bestatin)
(Aminopeptidase B and Leucyl
Aminopeptidase)
Others
EDTA
a-Ketoamides
Divalent metal chelating
reagents
8-Hydroxyisoquinolin
Captopril
Cysteinyl Proteases

Inhibitors
Antipain
(Cathepsin B)
Chymostatin
(Cathepsin B and Papain)
E-64
(Thiol Proteases)
Leupeptin
(Cathepsin B)
Others
Peptidyl chloromethanes
Peptidyl aldehydes
Peptidyl diazomethanes

Order Hotline 1-800-777-4779 502-266-8787 163

 PRODUCT GRADE CODE QTY PRICE
ENZYME INHIBITORS AND SUBSTRATES
Enzyme Substrates & Related Compounds
ADAM-17 Substrates
Abz-Leu-Ala-Gln-Ala-Val-Arg-Ser-Ser-Ser-Arg- SDP-3818-PI 1 mg 75
Dap(Dnp)-NH2 -20 °C 5 mg 285
(Acetate Form)
2-Aminobenzoyl-l-leucyl-l-alanyl-l-glutaminyl-l-alanyl-l-valyl-l-arginyl-l-Seryl-l-Seryl-l-Seryl-l-arginyl-
[Nε (2,4-dinitrophenyl)-l-2,3-Diaminopropionyl] amide
(M.W. 1444.54) C59H93N23O20
Fluorescence-Quenching Substrate for ADAM17 / TNF-α Converting Enzyme
G. Jin, X. Huang, R. Black, M. Wolfson, C. Rauch, H. McGregor,
G. Ellestad, R. Cowling, Anal. Biochem., 302, 269 (2002).

Dabcyl-Leu-Ala-Gln-Ala-Val-Arg-Ser- SFQ-3764-PI 1 mg 235

Ser-Ser-Arg-Edans -20 °C 5 mg 940
(Trifluoroacetate Form) (M.W. 1573.81)
C70H104N22O18S [396716-14-6]
TACE FRET Substrate I
K.M.Mohler et al., Nature, 370, 218 (1994)
A.J.H.Gearing et al., Nature, 370, 555 (1994)
B.F.Becker et al., Biol. Chem., 383, 1821 (2002)

MOCAc-Lys-Pro-Leu-Gly-Leu- A SMO-3226-v 1 mg 105

A2pr(Dnp)-Ala-Arg-NH2 -20 °C vial
(Trifluoroacetate Form)
(7-Methoxycoumarin-4-yl) acetyl-l-lysyl-l-prolyl-l-leucyl-glycyl-l-leucyl-
[Nβ-(2,4-dinitrophenyl)-l-2,3-diaminopropionyl]-l-alanyl-l-arginine amide
PEPTIDES INTERNATIONAL

(M.W. 1221.3) C55H80N16O16

Fluorescence-Quenching Substrate for Matrix Metalloproteinases and
ADAM-17 / Tumor Necrosis Factor Converting Enzyme (TACE)
U. Neumann, H. Kubota, K. Frei, V. Ganu, and D. Leppert, Anal. Biochem., 328, 166 (2004).
A. Trifilieff, C. Walker, T. Keller, G. Kottirsch, and U. Neumann, Br. J. Pharmacol., 135, 1655 (2002).
M.C. Riitano, H. Pfister, P. Engelhardt, U. Neumann, M. Reist, A. Zurbriggen, M. Stoffel, J. Peel, T. Jungi, P. Schawalder,
and D.E. Spreng, Am. J. Vet. Res., 63, 1423 (2002).

MOCAc-Lys-Pro-Leu-Gly-Leu- SMO-3670-PI 1 mg 80
Dap(Dnp)-Ala-Arg-NH2 -20 °C 5 mg 320
(Trifluoroacetate Form)
(M.W. 1221.35) C55H80N16O16
Fluorescence-Quenching Substrate for MMPs,
Cathepsin D and E, ADAM10, and ADAM17/
TACE
U. Neumann , H. Kubota, K. Frei, V. Ganu, and D. Leppert, Anal. Biochem., 328, 166 (2004).

164 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT GRADE CODE QTY PRICE

ENZYME INHIBITORS AND SUBSTRATES

ADAMTS-13 Substrates See page 205 for other FRETS Substrates.
FRETS-VWF73 A SFR-3224-s 0.1 mg 380
(Trifluoroacetate Form) -20 °C vial
Asp-Arg-Glu-A2pr(Nma)-Ala-Pro-Asn- Leu-Val-Tyr-Met-Val-Thr-Gly-
A2pr(Dnp)-Pro-Ala-Ser-Asp-Glu-Ile-Lys-Arg-Leu-Pro-Gly-Asp-Ile-
Gln-Val-Val-Pro-Ile-Gly-Val-Gly-Pro-Asn-Ala-Asn-Val-Gln-Glu-Leu-
Glu-Arg-Ile-Gly-Trp-Pro-Asn-Ala-Pro-Ile-Leu-Ile-Gln-Asp-Phe-
Glu-Thr-Leu-Pro-Arg-Glu-Ala-Pro-Asp-Leu-Val-Leu-Gln-Arg
A2pr(Nma): Nβ-[2-(Methylamino)benzoyl]-2,3-diaminopropionic acid
A2pr(Dnp): Nβ-(2,4-dinitrophenyl)-2,3-diaminopropionic acid
(M.W. 8314.30 ) C370H583N103O113S
Purity: higher than 95% by HPLC
Fluorescence-Quenching Substrate for ADAMTS-13
K. Kokame, M. Matsumoto, Y. Fujimura, and T. Miyata, Blood, 103, 607 (2004). (VWF73 Sequence)
K. Kokame, Y. Nobe, Y. Kokubo, A. Okayama, and T. Miyata, Br. J. Haematol., 129, 93 (2005). (FRETS-VWF73)
• This compound is produced by Peptide Institute, Inc.under license of the National Cardiovascular Center
in Japan

α-Amidating Enzyme Substrates

Ac-Tyr-Val-Gly AA SYG-3146 0.1 g 90
Acetyl-l-tyrosyl-l-valyl-glycine -20 °C 1g 625
(M.W. 379.41) C18H25N3O6
Substrate for a-Amidating Enzyme

Aminopeptidases Substrates

PEPTIDES INTERNATIONAL
Ala-MCA AA MAM-3147-v 5 mg 35
(Tosylate Form) -20 °C vial
l-alanine 4-methylcoumaryl-7-amide
(M.W. 246.26) C13H14N2O3 [77471-41-1]
Substrate for Aminopeptidase.
H. Umetsu, et al., Biosci. Biotechnol. Biochem., 68, 945 (2004).
J.R. McDermott, et al., J. Neurochem., 45, 752 (1985)

Ala-pNA AA SAN-3068 0.1 g 25

l-alanine p-nitroanilide -20 °C 1g 75
(M.W. 209.20) C9H11N3O3 [1668-13-9]
Substrate for Aminopeptidase 5g 315
G. Peleiderer, In, Proteolytic Enzymes, Methods in Enzymology, Vol. 19, (G.E. Perlmann and L. Lorand, Eds.),
Academic Press, New York, 1970, pp. 514-521.

Leu-MCA AA MLM-3091-v 5 mg 35
(Tosylate Form) -20 °C vial
l-Leucine 4-methylcoumaryl-7-amide
(M.W. 288.34) C16H20N2O3
Substrate for Aminopeptidase
K. Saifuku, T. Sekine, T. Namihisa, T. Takahashi, and Y. Kanaoka, Clin. Chim. Acta, 84, 85 (1978).

Order Hotline 1-800-777-4779 502-266-8787 165

 PRODUCT GRADE CODE QTY PRICE
ENZYME INHIBITORS AND SUBSTRATES

Leu-NH2 • HCI AA SLN-3027 0.1 g 25

l-Leucine amide monohydrochloride -20 °C 1g 50
(M.W. 130.19 • 36.46) C6H14N2O • HCI
[10466-61-2]
Substrate for Aminopeptidase
F.H. Carpenter and J.M.Vahl, J. Biol. Chem., 248, 294 (1973).
T. Sopanen and J. Mikola, Plant Physiol., 55, 809 (1975).
H.F.M. Hermes, et al., Applied and Environm. Microbiol., 59, 4330 (1993).

Leu-pNA AA SLN-3014 0.1 g 22

l-leucine p-nitroanilide -20 °C 1g 50
(M.W. 251.28) C12H17N3O3 [4178-93-2]
Substrate for Aminopeptidase 5g 165
G. Peleiderer, In, Proteolytic Enzymes, Methods in Enzymology, Vol. 19, (G.E. Perlmann and L. Lorand, Eds.),
Academic Press, New York, 1970, pp. 514-521.

Lys-MCA A MKM-3132-v 5 mg 50
(Hydrochloride Form) -20 °C vial
l-Lysine 4-methylcoumaryl-7-amide
(M.W. 303.36) C16H21N3O3
Substrate for Aminopeptidase
H. Araki, et al, J. Biochem., 129, 279 (2001).

Met-Leu-pNA SML-3622-PI 5 mg 70
(Hydrochloride Salt) -20 °C 25 mg 260
l-methionyl-l-leucine p-nitroanilide
(M.W. 382.49 • 36.46) C17H26N4O4S • HCl
PEPTIDES INTERNATIONAL

Y. Wei and D. Pei, Anal. Biochem., 250, 29 (1997).

Met-MCA A MMM-3149-v 5 mg 45
(Tosylate Form) -20 °C vial
l-Methionine 4-methylcoumaryl-7-amide
(M.W. 306.38) C15H18N2O3S
Substrate for Aminopeptidase

Phe-MCA AA MFM-3148-v 5 mg 35
(Tosylate Form) -20 °C vial
l-phenylalanine 4-methylcoumaryl-7-amide
(M.W. 322.36) C19H18N2O3 [98516-72-4]
Substrate for Aminopeptidase
Y. Yanigisawa, et al., Biochem. Mol. Med.,59, 161 (1996).

Amyloid A4-Generating Enzyme Substrate

Suc-Ile-Ala-MCA A MIA-3158-v 5 mg 55
Succinyl-l-isoleucyl-l-alanine 4-methylcouma- -20 °C vial
ryl-7-amide
(M.W. 459.49) C23H29N3O7 [126103-95-5]
Substrate for Amyloid A4-Generating Enzyme
S. Ishiura, T. Tsukahara, T. Tabira, T. Shimizu, K. Arahata, and H. Sugita, FEBS Lett., 260, 131 (1990).
S. Ishiura, T. Nishikawa, T. Tsukahara, T. Momoi, H. Ito, K. Suzuki, and H. Sugita, Neurosci. Lett., 115, 329 (1990).

166 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT GRADE CODE QTY PRICE
Z-Val-Lys-Met-MCA

ENZYME INHIBITORS AND SUBSTRATES

A MVM-3156-v 5 mg 70
(Hydrochloride Form) -20 °C vial
Benzyloxycarbonyl-l-valyl-l-lysyl-l-methionine 4-methylcoumaryl-7-amide
(M.W. 667.82) C34H45N5O7S [141223-71-4]
Substrate for Amyloid A4-Generating Enzyme and Proteasome
S. Ishiura, T. Nishikawa, T. Tsukahara, T. Momoi, H. Ito, K. Suzuki, and H. Sugita, Neurosci. Lett., 115, 329 (1990).

Angiotensin I Converting Enzyme I Substrates

Abz-Gly-Phe(NO2)-Pro-OH SFQ-3937-PI 5 mg 45
(M.W. 483.48) C23H25N5O7 [67482-93-3] -20 °C 25 mg 160
Substrate for ACE
(Angiotensin-I Converting Enzyme)
A. Carmel and A. Yaron, Eur. J. Biochem., 87, 265 (1978).

Bz-Gly-Ala-Pro AA SGP-3126 0.1 g 50

[Hippuryl-alanyl-proline] -20 °C 1g 300
Benzoyl-glycyl-l-alanyl-l-proline
(M.W. 347.37) C17H21N3O5 [73167-84-7]
Substrate for ACE (Angiotensin I Converting Enzyme)
H.S Cheung, F.L. Wang, M.A. Ondetti, E.F. Sabo, and D. W. Cushman, J. Biol. Chem., 255, 401 ( 1980).

Bz-Gly-Gly-Gly AA SGG-3128 0.1 g 35

[Hippuryl-glycyl-glycine] -20 °C 1g 160
Benzoylglycylglycylglycine
(M.W. 293.28) C13H15N3O5 [31384-90-4]
Substrate for ACE (Angiotensin l Converting Enzyme)

PEPTIDES INTERNATIONAL
H.Y.T. Yang, E.G. Erdos, and Y. Levin, J. Pharmacol. Exp. Ther., 177, 291 (1971).
T. Nakajima, G. Oshima, H.S.J. Yeh, R. Igic, and E.G. Erdos, Biochim. Biophys. Acta., 315, 430 (1973).
G. Oshima, K. Nagasawa, and J. Kato, J. Biochem. (Tokyo), 80, 477 (1976).

Bz-Gly-His-Leu • H2O AA SGL-3064 0.1 g 50

[Hippuryl-histidyl-leucine] -20 °C 1g 300
Benzoylglycyl-l-histidyl-l-leucine
(M.W. 429.47 • 18.02) C21H27N5O5 • H2O
[31373-65-6]
Substrate for ACE (Angiotensin I Converting Enzyme)
D.W. Cushman and H.S. Cheung, Biochem. Pharmacol., 20, 1637 (1971).

Nma-Phe-His-Lys(Dnp) SNP-3233-v 1 mg 86
[2-(Methylamino)benzoyl-L-phenylalanyl]-L- -20 °C vial
histidyl- Nε-(2,4-dinitrophenyl)-L-lysine
(M.W. 729.74) C35H39N9O9
Fluorescence-Quenching Substrate for Angiotensin I Converting Enzyme and Carboxypeptidase Y

S. Takahashi, H. Ono, T. Gotoh, K. Yoshizawa-Kumagaye, and T. Sugiyama, Biomed. Res., 32, 407 (2011).

Angiotensin I Converting Enzyme II Substrates

Abz-Gly-Phe-Ser-Pro-Tyr(NO2)-OH SFQ-3817-PI 1 mg 45
(M.W. 733.74) C35H39N7O11 -20 °C 5 mg 160
Fluorescence-Quenching Substrate for ACE2 (TBC5180)
Z.-H. Yan, K.-J. Ren, Y. Wang, S. Chen, T.A. Brock, and A. Rege, Anal. Biochem., 312, 141 (2003).

Order Hotline 1-800-777-4779 502-266-8787 167

 PRODUCT GRADE CODE QTY PRICE
ENZYME INHIBITORS AND SUBSTRATES

Abz-Ser-Pro-Tyr(NO2)-OH SFQ-3819-PI 1 mg 45
(M.W. 529.51) C24H27N5O9 -20 °C 5 mg 160
Fluorescence-Quenching Substrate for ACE2 (TBC5182)
Z.-H. Yan, K.-J. Ren, Y. Wang, S. Chen, T.A. Brock, and A. Rege, Anal. Biochem., 312, 141 (2003).

ANP (Rat) Precursor Processing Enzyme Substrate

Boc-Ala-Gly-Pro-Arg-MCA A MAR-3144-v 5m 70
t-Butyloxycarbonyl-l-alanyl-glycyl-l-prolyl-l- -20 °C vial
arginine 4-methylcoumaryl-7-amide
(M.W. 656.73) C31H44N8O8 [118850-78-5]
Substrate for ANP (Rat) Precursor Processing Enzyme
T. Imada, R. Takayanagi, and T. Inagami, Biochem. Biophys. Res. Commun., 143, 587 (1987).
T. Imada, R. Takayanagi, and T. Inagami, Biol. Chem. Hoppe-Seyler Suppl., 369, 113 (1988).

d-Aspartyl Endopeptidase Substrate

Suc-d-Asp-MCA AA MCA-3222-v 5m 80
Succinyl-d-Aspartic acid α-(4-methylcoumaryl- -20 °C vial
7-amide)
(M.W. 390.34) C18H18N2O8
Selective Substrate for d-Aspartyl
Endopeptidase
T. Kinouchi, S. Ishiura, Y. Mabuchi, Y. Urakami-Manaka, H. Nishio, Y. Nishiuchi, M. Tsunemi, K. Takada,
M. Watanabe, M. Ikeda, H. Matsui, S. Tomioka, H. Kawahara, T. Hamamoto, K. Suzuki, and Y. Kagawa,
Biochem. Biophys. Res. Commun., 314, 730 (2004).

dl-BAPA See Code SRN-3013 Benzoyl-dl-arginine p-Nitroanilide Hydrochloride.

PEPTIDES INTERNATIONAL

l-BAPA See Code SRN-3057 Benzoyl-l-arginine p-Nitroanilide Hydrochloride.

Biotinyl-Asp-Glu-Val-Asp-H (aldehyde) See Code IBA-3173-v.

Boc-Glu(OBzl)-Gly-Arg-MCA A MEG-3115-v 5m 65
(Hydrochloride Form) -20 °C vial
t-Butyloxycarbonyl-[(2S)-2-amino-4-(benzyloxycarbonyl)butanoyl]
glycyl-l-arginine 4-methylcoumaryl-7-amide
(M.W. 707.77) C35H45N7O9 [73554-94-6]
S. Iwanaga, T. Morita, H. Kato, T. Harada, N. Adachi, T. Sugo, I. Maruyama, K. Takada, T. Kimura, and S. Sakakibara,
KINlNS-II: Biochemistry, Pathophysiology, and Clinical Aspects, (S. Fujii, H. Moriya, and T. Suzuki, Eds.),
Plenum Publishing Co., 1979, p. 147-163.

Bz-Ala-OMe AA SAM-3084 0.1 g 25

Benzoyl-l-alanine methyl ester -20 °C 1g
(M.W. 207.23) C11H13NO3 [7244-67-9]

Bz-Gly-Arg AA SGR-3059 0.1 g 30

[Hippuryl-arginine] -20 °C 1g 125
Benzoyl-glycyl-l-arginine
(M.W. 335.36) C15H21N5O4 [744-46-7]

Bz-Gly-Lys AA SGK-3047 0.1 g 32

[Hippuryl-lysine] -20 °C 1g 145
Benzoylglycyl-l-lysine
(M.W. 307.34) C15H21N3O4 [740-63-6]

168 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT GRADE CODE QTY PRICE

ENZYME INHIBITORS AND SUBSTRATES

Calpain Substrates
Calpain is a calcium-activated cysteine protease that participates in membrane
remodeling, apoptosis, and signal transduction. Deregulation of calpain activity has
been linked with cell death and tissue damage associated with Alzheimer’s Disease,
myocardial infarction, stroke, and brain trauma.
Current calpain substrates are not optimal, and it has been dif
ficult to determine the best
cleavage sequence due to the broad substrate specificity of calpains. However, Cuerrier,
et al. was able to employ a unique approach in which they designed and digested a
N-terminal acetylated degenerate library to determine substrate specificity at primed
positions for µ-calpain.1 Based on these findings, a second partially degenerate library
was made to determine specificity at unprimed positions. The resulting FRET substrate,
H-Glu(Edans)-Pro-Leu-Phe-Ala-Glu-Arg-Lys(Dabcyl)-OH (SFQ-3914-PI) is more
sensitive to hydrolysis in com-parison to other substrates, including the popular SLY-
MCA. It should prove more sensitive in measuring µ-calpain activity.
1. D. Cuerrier, T. Moldoveanu, P.L. Davies, J. Biol. Chem., 280, 40632 (2005).

Boc-Val-Leu-Lys-MCA A MVL-3104-v 5 mg 75
t-Butyloxycarbonyl-l-valyl-l-leucyl-l-lysine -20 °C vial
4-methylcoumaryl-7-amide
(M.W. 615.76) C32H49N5O7 [73554-84-4]
Substrate for Plasmin and Calpain
H. Kato, N. Adachi, Y. Ohno, S. Iwanaga, K. Takada, and S. Sakakibara, J. Biochem., 88, 183 (1980).
T. Sasaki, T. Kikuchi, N. Yumoto, N. Yoshimura, and T. Murachi, J. Biol. Chem., 259, 12489 (1984).

PEPTIDES INTERNATIONAL
H-Glu(Edans)-Pro-Leu-Phe-Ala-Glu- SFQ-3914-PI 1 mg 129
Arg-Lys(Dabcyl)-OH -20 °C
(Acetate Form)
(M.W. 1488.74) C72H97N17O16S
FRET Substrate for Calpain 1

Suc-Ala-Leu-Pro-Phe-pNA A SAF-3162-v 10 mg 130

Succinyl-l-alanyl-l-leucyl-l-prolyl-l- -20 °C vial
phenylalanine p-nitroanilide
(M.W. 666.72) C33H42N6O9
Substrate for PPlase (Peptidyl-prolyl cis-trans Isomerase)
J.L. Kofron, P. Kuzmic, V. Kishore, E. Colon-Bonilla, and D.H. Rich, Biochemistry, 30, 6127 (1991).

Suc-Leu-Leu-Val-Tyr-MCA A MLL-3120-v 5 mg 80
Succinyl-l-leucyl-l-leucyl-l-valyl-l-tyrosine -20 °C vial
4-methylcoumaryl-7-amide
(M.W. 763.88) C40H53N5O10 [94367-21-2]
Substrate for Chymotrypsin, Ingensin / Proteasome, and Calpain
H. Sawada, H. Yokasawa, M. Hoshi, and S. Ishii, Experientia, 39, 377 (1983).
T. Sasaki, T. Kikuchi, N. Yumoto, N. Yoshimura, and T. Murachi, J. Biol. Chem., 259, 12849 (1984).
S. Ishiura, M. Sano, K. Kamakura, and H. Sugita, FEBS Lett., 189, 119 (1985).
T. Tsukahara, S. Ishiura, and H. Sugita, Eur. J. Biochem., 177, 261, (1988).

Order Hotline 1-800-777-4779 502-266-8787 169

 PRODUCT GRADE CODE QTY PRICE
ENZYME INHIBITORS AND SUBSTRATES

Carboxypeptidase A Substrates
Ac-Phe-Thiaphe-OH STP-3621-PI 5 mg 95
N-Acetyl-l-phenylalanyl-l-3-thiaphenylalanine -20 °C 25 mg 395
Dipeptide Mimetic Substrate for Carboxypeptidase A
(M.W. 372.45) C19H20N2O4S
P. Shamamian, S. Marcus, E. Deutsch, T. Maldonado, A. Liu, J. Stewart, K. Eng, and C. Gilvarg,
Presented at the Annual Meeting of the Society for Surgery of the Alimentary Tract, May 1998.
K.S. Brown, W.D. Kingsbury, N.M. Hall, G.L. Dunn, and C. Gilvarg, Anal. Biochem., 161, 219 (1987).
S.Y. Hwang, W.D. Kingsbury, N.M. Hall, D.R. Jakas, G.L. Dunn, and C. Gilvarg, Anal. Biochem., 154, 552 (1986).

Carnosine Synthase Substrate See Code OAH-3085 β-Ala-His.

Caspase Substrates
(Asp-Glu-Val-Asp)2-Rh110 SDR-3775-PI 1 mg 27
(DEVD)2-Rh110 -20 °C 5 mg 108
(M.W. 1515.48) C72H78N10O27
Substrate for Caspase 3 and Caspase 7
P.D. Sanchez-Gonzalez, et al., Toxicol. Lett, 203, 154 (2011).
V. Gurtu, et al., Anal. Biochem, 251, 98 (1997).
L.M. Martins, et al., J. Biol. Chem., 272, 7421 (1997).
J Biol Chem., 275, 288(2000).
Biochemistry, 38, 13906(1999).

Ac-Asp-Asn-Leu-Asp-MCA A MCA-3220-v 5 mg 90
[Ac-DNLD-MCA] -20 °C vial
Acetyl-L-aspartyl-L-asparaginyl-L-leucyl-L-
aspartic-acid α-(4-methylcoumaryl-7-amide)
PEPTIDES INTERNATIONAL

(M.W. 674.66) C30H38N6O12

Synthetic Product
Selective Substrate for Caspase-3 Designed by in silico Screening System
A. Yoshimori, R. Takasawa, and S. Tanuma, Bio. Pharm. Bull., 27, 968 (2004).
• This compound is produced by Peptide Institute, Inc. under the license of Institute for Theoretical Medicine, Inc.

Ac-Asp-Gln-Thr-Asp-MCA A MCA-3193-v 5 mg 115

[Ac-DQTD-MCA] -20 °C vial
Acetyl-l-aspartyl-l-glutaminyl-l-threonyl-l-
aspartic acid a-(4-methylcoumaryl-7-amide)
(M.W. 676.63) C29H36N6O13
Substrate for Caspase-7/3
(Deduced from the Cleavage Site of Focal Adhesion Kinase and Gelsolin)
L.-P. Wen, et al., Science, 278, 294 (1997).

Ac-Asp-Glu-Val-Asp-MCA A SAP-3171-v 5 mg 90
[Ac-DEVD-MCA] -20 °C vial
Acetyl-l-aspartyl-l-glutamyl-l-valyl-l-aspartic
acid a-(4-methylcoumaryl-7-amide)
(M.W. 675.64) C30H37N5O13 [169332-61-0]
Substrate for Caspase-3/7/8
D.W. Nicholson, et al., Nature, 376, 37 (1995).
N.A. Thornberry, et al., J. Biol. Chem., 272, 17907 (1997).

170 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT GRADE CODE QTY PRICE
Ac-Ile-Glu-Thr-Asp-MCA

ENZYME INHIBITORS AND SUBSTRATES

A MCA-3195-v 5 mg 125
[Ac-IETD-MCA] -20 °C vial
Acetyl-l-isoleucyl-l-glutamyl-l-threonyl-l-aspartic acid
a-(4-methylcoumaryl-7-amide)
(M.W. 675.68) C31H41N5O12 Substrate for Procaspase-3 Cleaving Enzyme
(Caspase-8/6 and Granzyme-B) (Deduced from the Cleavage Site of Procaspase-3)
N.A. Thornberry, et al., J. Biol. Chem., 272, 17907 (1997).

Ac-Leu-Glu-His-Asp-MCA A MCA-3198-v 5 mg 125

[Ac-LEHD-MCA] -20 °C vial
Acetyl-l-leucyl-l-glutamyl-l-histidyl-l-aspartic acid a-
(4-methylcoumaryl-7-amide)
(M.W. 711.72) C33H41N7O11 [292633-16-0]
Substrate for Caspase-9
N.A. Thornberry, et al., J. Biol. Chem., 272, 17907 (1997).

Ac-Val-Asp-Val-Ala-Asp-MCA A MCA-3203-v 5 mg 125

[Ac-VDVAD-MCA] -20 °C vial
Acetyl-l-valyl-l-aspartyl-l-valyl-l-alanyl-l-
aspartic acid a-(4-methylcoumaryl-7-amide)
(M.W. 716.74) C33H44N6O12
Substrate for Caspase-2
R.V. Talanian, C. Quinlan, S. Trautz, M.C. Hackett, J.A. Mankovich, D. Banach, T. Ghayur, K.D. Brady, and W.W. Wong,
J. Biol. Chem. 272, 9677 (1997).

Ac-Val-Glu-Ile-Asp-MCA A MVA-3181-v 5 mg 90
[Ac-VEID-MCA] -20 °C vial

PEPTIDES INTERNATIONAL
Acetyl-l-valyl-l-glutamyl-l-isoleucyl-l-aspartic
acid a-(4-methylcoumaryl-7-amide)
(M.W. 673.71) C32H43N5O11 [219137-97-0]
Substrate for Caspase-6
A. Takahashi, P.J. Goldschmidt-Clermont, E.S. Alnemri, T. Fernandes-Alnemri, K. Yoshizawa-Kumagaye,
K. Nakajima, M. Sasada, G.G. Poirier, and W.C. Earnshaw, Exp. Cell Res., 231, 123 (1997).
A. Takahashi, H. Hirata, S. Yonehara, Y. Imai, K.-K. Lee, R.W. Moyer, P.C. Turner, P.W. Mesner, T. Okazaki, H. Sawai,
S. Kishi, K. Yamamoto, M. Okuma, and M. Sasada, Oncogene, 14, 2741 (1997).

Ac-Trp-Glu-His-Asp-MCA A MCA-3186-v 5 mg 125

[Ac-WEHD-MCA] -20 °C vial
Acetyl-l-tryptophyl-l-glutamyl-l-histidyl-l-
aspartic acid a-(4-methylcoumaryl-7-amide)
(M.W. 784.77) C38H40N8O11 [189275-74-9]
Substrate for Caspase-1/
T.A. Rano, T. Timkey, E.P. Peterson, J. Rotonda, D.W. Nicholson, J.W. Becker, K.T. Chapman, and N.A. Thornberry,
Chem. Biol., 4, 149 (1997).
N.A. Thornberry, T.A. Rano, E.P. Peterson, D.M. Rasper, T. Timkey, M. Garcia-Calvo, V.M. Houtzager, P.A. Nordstrom, S.
Roy, J.P. Vaillancourt, K.T. Chapman, and D.W. Nicholson, J. Biol. Chem., 272, 17907 (1997).
J. Mikolajczyk, F.L. Scott, S. Krajewski, D.P. Sutherlin, and G.S. Salvesen, Biochemistry, 43, 10560 (2004).

Ac-Tyr-Val-Ala-Asp-MCA A MAY-3161-v 5 mg 5 95
[Ac-YVAD-MCA] -20 °C mg

Acetyl-l-tyrosyl-l-valyl-l-alanyl-l-aspartic acid a-(4-methylcoumaryl-7-amide)

(M.W. 665.69) C33H39N5O10 [149231-65-2]
Substrate for Caspase-1
N.A. Thornberry, et al., Nature, 356, 768 (1992).

Order Hotline 1-800-777-4779 502-266-8787 171

 PRODUCT GRADE CODE QTY PRICE
ENZYME INHIBITORS AND SUBSTRATES

MOCAc-Asp-Glu-Val-Asp-Ala-Pro- A MOC-3184-v 1 mg 185

Lys(Dnp)-NH2 -20 °C vial
[MOCAc-DEVDAPK(Dnp)-NH2]
(7-Methoxycoumarin-4-yl) acetyl-l-aspartyl-l-glutamyl-l-valyl-l-aspartyl-l-
alanyl-l-prolyl-[Ne-(2,4-dinitrophenyl)-l-lysine] amide
(M.W. 1154.1) C50H63N11O21
Fluorescence-Quenching Substrate for Caspase-3
M. Enari, R.V. Talanian, W.W. Wong, and S. Nagata, Nature, 380, 723, (1996).

MOCAc-Tyr-Val-Ala-Asp-Ala-Pro- A MOC-3183-v 1 mg 185

Lys(Dnp)-NH2 -20 °C vial
[MOCAc-YVADAPK(Dnp)-NH2]
(7-Methoxycoumarin-4-yl) acetyl-l-tyrosyl-l-valyl-l-alanyl-l-aspartyl-l-
alanyl-l-prolyl-Ne-(2,4-dinitrophenyl)-l-lysine amide
(M.W. 1144.1) C53H65N11O18
Fluorescence-Quenching Substrate for Caspase-1
M. Enari, R.V. Talanian, W.W. Wong, and S. Nagata, Nature, 380, 723, (1996).

(Z-Asp-Glu-Val-Asp)2-Rh110 SDR-3727-PI 1 mg 27
(Z-DEVD)2-Rh110 -20 °C 5 mg 108
(M.W. 1515.48) C72H78N10O27
Substrate for caspase 3 and caspase 7
P.D. Sanchez-Gonzalez et al. Toxicol. Lett, 203, 154 (2011).
V. Gurtu et al, anal. Biochem, 251, 98 (1997).
L.M. Martins et al, J. Biol. Chem. 272, 7421 (1997).

Cathepsin and Thiol Protease Substrates

PEPTIDES INTERNATIONAL

Abz-Glu-Pro-Phe-Trp-Glu-Asp-Gln-EDDnp SFR-3231-v 1 mg 125

[Abz-EPFWEDQ-EDDnp] -20 °C vial
(Ammonium Form)
2-Aminobenzoyl-l-glutamyl-l-prolyl-l-phenylalanyl-l-tryptophyl-l-glutamyl-
l-aspartyl-l-glutamine 2-(2,4-dinitrophenyl)aminoethyl-amide
(M.W. 1277.25) C59H68N14O19
Fluorescence-Quenching Substrate for Human Neutrophil Cathepsin G
S. Attucci, et al., Biochem. J., 366, 965 (2002).
B. Korkmaz, et al., Nat. Protoc., 3, 991(2008).

Arg-MCA AA MAR-3113-v 5 mg 50
(Hydrochloride Form) -20 °C vial
l-arginine 4-methylcoumaryl-7-amide
(M.W. 331.37) C16H21N5O3 [65286-27-3]
Substrate for Cathepsin H
Y. Kanaoka, T. Takahashi, H. Nakayama, K. Takada, T. Kimura, and S. Sakakibara, Chem. Pharm. Bull., 25, 3126 (1977).

172 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT GRADE CODE QTY PRICE
Bz-l-Arg-pNA • HCI

ENZYME INHIBITORS AND SUBSTRATES

AA SRN-3057 0.1 g 30
[l-BAPA] -20 °C 5g 115
Benzoyl-l-arginine p-nitroanilide monohydrochloride
(M.W. 398.42 • 36.46) C19H22N6O4 • HCI [21653-40-7]
Substrate for Trypsin-like Proteases and Papain
K.A. Walsh, In, Proteolytic Enzymes, Methods in Enzymology, Vol. 19, (G.E. Perlmann and L. Lorand, Eds.),
Academic Press, New York, 1970, pp. 41-63.
R. Arnon, In, Proteolytic Enzymes, Methods in Enzymology, Vol. 19, (G.E. Perlmann and L. Lorand, Eds.),
Academic Press, New York, 1970, pp. 226-244.
G.A. Grant, A.Z. Eisen, and R.A. Bradshaw, In, Proteolytic Enzymes Part C, Methods in Enzymology, Vol. 80,
(L. Lorand, ed.), Academic Press, New York, 1981, pp. 722-734.

Gly-Gly-Tyr-Arg • AcOH • 2H2O A OGG-3119 0.1 g 70

Glycyl-glycyl-l-tyrosyl-l-arginine -20 °C 1g 350
(M.W. 451 • 60.05 • 36.03) C19H29N7O6 • CH3COOH • 2H2O [70195-20-9]
Affinity Ligand for Papain
M.O. Funk, Y. Nakagawa, J. Skochdopole, and E.T. Kaiser, Int. J. Peptide Protein Res., 13, 296 (1979).

MOCAc-Gly-Lys-Pro-Ile-Leu-Phe- A SMO-3200-v 1 mg 200

Phe-Arg-Leu-Lys(Dnp)-d-Arg-NH2 -20 °C vial
(7-Methoxycoumarin-4-yl) acetyl-glycyl-l-lysyl-l-Proyl-l-isoleucyl-l-Leucyl-l-phenylalanyl-l-phenylalanyl-l-
arginyl-l-leucyl-[Ne-(2,4-dinitrophenyl)-l-lysyl]-d-arginine amide
(M.W. 1756.0) C85H122N22O19
Fluorescence-Quenching Substrate for Cathepsin D/E
Y. Yasuda, T. Kageyama, A. Akamine, M. Shibata, E. Kominami, Y. Uchiyama, and K. Yamamoto, J. Biochem., 125, 1137
(1999).

PEPTIDES INTERNATIONAL
MOCAc-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 See Code SMO-3670-PI.

MOCAc-Gly-Ser-Pro-Ala-Phe-Leu- A SMO-3225-v 1 mg 135

Ala-Lys(Dnp)-d-Arg-NH2 [KYS-1] -20 °C vial
(Trifluoroacetate Form)
7-Methoxycoumarin-4-yl) acetyl-glycyl-l-seryl-l-prolyl-l-alanyl-l-phenylalanyl-l-
leucyl-l-alanyl-[Nε-(2,4-dinitrophenyl)-l-lysyl]-d-arginine amide
(M.W. 1327.4) C61H82N16O18
Fluorescence-Quenching Substrate for Cathepsin E
K. Yamamoto, Japanese Patent Publication No.2003-246798.
• This compound is produced by Peptide Institute, Inc. under the license of Kyushu TLO Co., Ltd.

Pyr-Phe-Leu-pNA AA SPL-3130 0.1 g 55

l-Pyroglutamyl-l-phenylalanyl-l-leucine-p- -20 °C 1g 340
nitroanilide
(M.W. 509.55) C26H31N5O6 [85901-57-1]
Substrate for Thiol Protease
l.Y. Filippova, E.N. Lysogorskaya, E.S. Oksenoit, G.N. Rudenskaya, and V.M. Stepanov,
Anal. Biochem., 143, 293 (1984).

Z-Arg-Arg-MCA A MRR-3123-v 5 mg 55
(Hydrochloride Form) -20 °C vial
Benzyloxycarbonyl-l-arginyl-l-arginine 4-methylcoumaryl-7-amide
(M.W. 621.69) C30H39N9O6 [88937-61-5]
Substrate for Cathepsin B
A.J. Barrett and H. Kirschke, In, Proteolytic Enzymes Part C, Methods in Enzymology, Vol. 80, (L. Lorand, Ed.),
Academic Press, New York, 1981, pp. 535.

Order Hotline 1-800-777-4779 502-266-8787 173

 PRODUCT GRADE CODE QTY PRICE
ENZYME INHIBITORS AND SUBSTRATES

Z-Gly-Pro-Arg-MCA AA MCA-3208-v 5 mg 65
(Hydrochloride Form) -20 °C vial
Benzyloxycarbonylglycyl-l-prolyl-l-arginine 4-methylcoumaryl-7-amide
(M.W. 619.67) C31H37N7O7 [201928-42-9]
Substrate for Cathepsin K
K. Aibe, H. Yazawa, K. Abe, K. Teramura, M. Kumegawa, H. Kawashima, and K. Honda,
Biol. Pharm. Bull., 19, 1026 (1996).
F. Bühling, A. Gerber, C. Häckel, S. Krüger, T. Köhnlein, D. Brömme, D. Reinhold, S. Ansorge,
and T. Welte, Am. J. Respir. Cell Mol. Biol., 20, 612 (1999).

Z-Glu-Tyr AA SEY-3018 0.1 g 25

Benzyloxycarbonyl-l-glutamyl-l-tyrosine -20 °C 1g 75
(M.W. 444.43) C22H24N2O8 [988-75-0]

Z-Leu-Arg-MCA AA MCA-3210-v 5 mg 65
(Hydrochloride Form) -20 °C vial
Benzyloxycarbonyl-l-leucyl-l-arginine 4-methylcoumaryl-7-amide
(M.W. 578.66) C30H38N6O6
Substrate for Cathepsin K/S/V
D. Brömme, K. Okamoto, B.B. Wang, and S. Biroc, J. Biol. Chem., 271, 2126 (1996).
D. Brömme, Z. Li, M. Barnes, and E. Mehler, Biochemistry, 38, 2377 (1999).

Z-Phe-Arg-MCA AA MFR-3095-v 5 mg 50
(Hydrochloride form) -20 °C vial
Benzyloxycarbonyl-l-phenylalanyl-l-arginine 4-methylcoumaryl-7-amide
(M.W. 612.68) C33H36N6O6 [65147-22-0]
Substrate for Plasma Kallikrein, Cathespin B/L, and Arg-Gingipain
T. Morita, H. Kato, S. Iwanaga, K. Takada, T. Kimura, and S. Sakakibara, J. Biochem., 82, 1495 (1977).
PEPTIDES INTERNATIONAL

A.J. Barret, J. Biochem, 187, 909 (1980).

Z-Val-Val-Arg-MCA AA MCA-3211-v 5 mg 75
(Hydrochloride Form) -20 °C vial
Benzyloxycarbonyl-l-valyl-l-valyl-l-arginine 4-methylcoumaryl-7-amide
(M.W. 663.76) C34H45N7O7
Substrate for Cathepsin S/L
D. Brömme, A. Steinert, S. Friebe, S. Fittkau, B. Wiederanders, and H. Kirschke, Biochem. J., 264, 475 (1989).
H. Kirschke and B. Wiederanders, In, Proteolytic Enzymes: Serine and Cysteine Peptidases, Methods in Enzymology,
Vol. 244, (A.J. Barret, Ed.), Academic Press, New York, 1994, pp. 500-511.

174 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT GRADE CODE QTY PRICE

ENZYME INHIBITORS AND SUBSTRATES

Cellular Prion Protein Substrate
Cellular prion protein (PrP c) in normal brains is found at the cell membrane where it
is cleaved by ADAM10 and TACE between His 111 and Met 112 to produce a secreted
N-terminal (N1) fragment. A recent study developed an original FRETS substrate,
Abz-Thr-Asn-Met-Lys-His-Met-Ala-Gly-Ala-Ala-Gln-EDDnp (SFQ-3916-PI), that
comprises PrPc amino acid sequence 107-116 and contains the His111-Met112 cleav-
age site.1 Hydrolytic cleavage was successfully measured when this new substrate
was incubated with brain homogenates and intact cells, and activity was attenuated by
TACE and ADAM10 inhibitors. Substrate hydrolysis was also attenuated in cells defi -
cient in ADAM10 and TACE while cells overexpressing ADAM10 and TACE exhibited
enhanced substrate hydrolysis. However, TACE and ADAM10 only partially inhibited
Prpc in these studies. Therefore, this novel substrate should prove helpful in identify-
ing additional enzymes involved in normal PrP c metabolism.
1. M.A. Cissé, C. Gandreuil, J.-F. Hernandez, J. Martinez, F. Checler, and B. Vincent,
Biochem. and Biophys. Res. Commun., 347, 254 (2006).

Abz-Thr-Asn-Met-Lys-His-Met-Ala-Gly-Ala- SFQ-3916-PI 1 mg 75
Ala-Gln-EDDnp -20 °C 5 mg 285
(M.W. 1486.66) C61H91N21O19S2
Fluorescence-Quenching Substrate for Cellular Prion Protein
(PrPc)

Chymotrypsin and Chymotrypsin-like Protease Substrates

Ac-Phe-OEt AA SFE-3006 0.1 g 20
Acetyl-l-phenylalanine ethyl ester -20 °C 1g 30

PEPTIDES INTERNATIONAL
(M.W. 235.28) C13H17NO3 [2361-96-8]
5g 60
Ac-Trp-OEt AA SWE-3034 0.1 g 22
Acetyl-l-tryptophan ethyl ester 4 °C 1g 55
(M.W. 274.32) C15H18N2O3 [2382-80-1]

Ac-Tyr-NH2 A SYA-3009 0.1 g 25

Acetyl-l-tyrosine amide -20 °C 1g 40
(M.W. 222.24) C11H14N2O3 [1948-71-6]

Ac-Tyr-OEt • H2O AA SYE-3008 0.1 g 25

Acetyl-l-tyrosine ethyl ester monohydrate -20 °C 1g 30
(M.W. 251.28 • 18.02) C13H17NO4 • H2O [840-97-1]]
Substrate for Chymotrypsin and C1s
P.E. Wilcox, In, Proteolytic Enzymes, Methods in Enzymology, Vol. 19, (G.E. Perlmann and L. Lorand, Eds),
Academic Press, New York, 1970, pp. 64-108.
R.B. Sim, In, Proteolytic Enzymes Part C, Methods in Enzymology, Vol. 80, (L. Lorand, Ed.),
Academic Press, New York, 1981, pp. 26-42.

Bz-Tyr-pNA A SYN-3015 0.1 g 32

Benzoyl-l-tyrosine p-nitroanilide -20 °C 1g 205
(M.W. 405.40) C22H19N3O5 [6154-45-6]
Substrate for Chymotrypsin
G.A. Grant, A.Z. Eisen, and R.A. Bradshaw, In, Proteolytic Enzymes Part C, Methods in Enzymology, Vol. 80,
(L. Lorand, Ed.), Academic Press, New York, 1981, pp. 722-734.

Order Hotline 1-800-777-4779 502-266-8787 175

 PRODUCT GRADE CODE QTY PRICE
ENZYME INHIBITORS AND SUBSTRATES

Bz-Tyr-OEt AA SYE-3010 0.1 g 20

Benzoyl-l-tyrosine ethyl ester -20 °C 1g 30
(M.W. 313.35) C18H19NO4 [3483-82-7]
Substrate for Chymotrypsin
P.E. Wilcox, In, Proteolytic Enzymes, Methods in Enzymology, Vol. 19, (G.E. Perlmann and L. Lorand, Eds.),
Academic Press, New York, 1970, pp. 64-108.

Glt-Ala-Ala-Phe-MCA A MAF-3154-v 5 mg 70
Glutaryl-l-alanyl-l-alanyl-l-phenylalanine -20 °C vial
4-methylcoumaryl-7-amide
(M.W. 578.61) C30H34N4O8
Substrate for Chymotrypsin

MeO-Suc-Arg-Pro-Tyr-MCA SAP-3885-PI 5 mg 95
(Acetate Form) -20 °C 25 mg 395
N-Methoxy-succinyl-l-arginyl-l-prolyl-l-tyrosine-
4-methylcoumaryl-7-amide
(M.W. 668.71) C35H43N7O9
Substrate for Chymotrypsin
B.P. Berdal, O. Olsvik, S. Myhre, and T. Omland, J. Clin. Microb., 16, 452 (1982).

MeO-Suc-Arg-Pro-Tyr-pNA SAP-3882-PI 5 mg 95
N-Methoxy-succinyl-l-arginyl-l-prolyl-l-tyrosine- -20 °C 25 mg 395
p-nitroanilide
(M.W. 705.35) C31H40N8O9
Substrate for Chymotrypsin
B.P. Berdal, O. Olsvik, S. Myhre, and T. Omland, J. Clin. Microb., 16, 452 (1982).
PEPTIDES INTERNATIONAL

Suc-Ala-Ala-Pro-Phe-MCA A MAA-3114-v 5 mg 80
Succinyl-l-alanyl-l-alanyl-l-prolyl-l- -20 °C vial
phenylalanine
4-methylcoumaryl-7-amide
(M.W. 661.70) C34H39N5O9 [88467-45-2]
Substrate for Chymotrypsin
S. Sawada, H. Yokasawa, M. Hoshi and S. Ishii, Experientia, 39, 377 (1983).
Suc-Ala-Leu-Pro-Phe-pNA See Code MLL-3120-v.

Suc-Arg-Pro-Phe-His-Leu-Leu-Val- A MRP-3110-v 1 mg 70
Tyr-MCA -20 °C vial
Succinyl-l-arginyl-l-prolyl-l-phenylalanyl-l-histidyl-l-leucyl-l-
leucyl-l-valyl-l-tyrosine 4-methylcoumaryl-7-amide
(M.W. 1301.5) C66H88N14O14 [76524-84-0]
Substrate for Renin and Proteinase A
K. Murakami, T. Ohsawa, S. Hirose, K. Takada, and S. Sakakibara, Anal. Biochem., 110, 232 (1981).
H. Yokosawa, H. Ito, S. Murata, and S. Ishii, Anal. Biochem., 134, 210 (1983).

Suc-lle-Ile-Trp-MCA A MIW-3150-v 5 mg 80
Succinyl-l-isoleucyl-l-isoleucyl-l-tryptophan -20 °C vial
4-methylcoumaryl-7-amide
(M.W. 687.78) C37H45N5O8 [133525-12-9]

176 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT GRADE CODE QTY PRICE

ENZYME INHIBITORS AND SUBSTRATES

Coagulation Factor Substrates
Boc-Asp(OBzl)-Pro-Arg-MCA AA MDR-3139-v 5 mg 65
t-Butyloxycarbonyl-[(2S)-2-amino-3-benzyloxy- -20 °C vial
carbonyl)propionyl]-l-prolyl-l-arginine
4-methylcoumaryl-7-amide
(M.W. 733.81) C37H47N7O9 [113866-00-5]
Substrate for a-Thrombin
S. Kawabata, T. Miura, T. Morita, H. Kato, K. Fujikawa,
S. Iwanaga, K. Takada, T. Kimura, and S. Sakakibara, Eur. J. Biochem., 172, 17 (1988).

Boc-Gln-Gly-Arg-MCA A MQR-3136-v 5 mg 65
t-Butyloxycarbonyl-l-glutaminyl-glycyl-l-arginine -20 °C vial
4-methylcoumaryl-7-amide
(M.W. 616.67) C28H40N8O8
Substrate for Factor Xlla
S. Kawabata, T. Miura, T. Morita, H. Kato, K. Fujikawa, S. Iwanaga, K. Takada, T. Kimura, and S. Sakakibara,
Eur. J. Biochem., 172, 17 (1988).

Boc-Glu(OBzl)-Ala-Arg-MCA AA MER-3134-v 5 mg 65
t-Butyloxycarbonyl-[(2S)-2-amino-4-(benzyloxycarbonyl) -20 °C vial
butanoyl]-l-alanyl-l-arginine4-methylcoumaryl-7-amide
(M.W. 721.80) C36H47N7O9 [113866-16-3]
Substrate for Factor XIa
S. Kawabata, T. Miura, T. Morita, H. Kato, K. Fujikawa, S. Iwanaga, K. Takada, T. Kimura, and S. Sakakibara,
Eur. J. Biochem., 172, 17 (1988).

Boc-lle-Glu-Gly-Arg-MCA

PEPTIDES INTERNATIONAL
A MlE-3094-v 5 mg 70
t-Butyloxycarbonyl-l-isoleucyl-l-glutamylglycyl- -20 °C vial
l-arginine 4-methylcoumaryl-7-amide
(M.W. 730.81) C34H50N8O10 [65147-06-0]
Substrate for Factor Xa
T. Morita, H. Kato, S. Iwanaga, K. Takada, T. Kimura, and S. Sakakibara, J. Biochem., 82, 1495 (1977).

Boc-Leu-Ser-Thr-Arg-MCA A MLS-3112-v 5 mg 75
t-Butyloxycarbonyl-l-leucyl-l-seryl-l-threonyl-l- -20 °C vial
arginine 4-methylcoumaryl-7-amide
(M.W. 732.82) C34H52N8O10 [73554-93-5]
Substrate for Activated Protein C
Y. Ohno, H. Kato, T. Morita, S. Iwanaga, K. Takada, S. Sakakibara, and J. Stenflo, J. Biochem., 90, 1387 (1981).

Boc-Leu-Ser-Thr-Arg-pNA • AcOH A SLR-3125 25 mg 255

• H2O -20 °C 100 mg 690
t-Butyloxycarbonyl-l-leucyl-l-Seryl-l-threonyl-l-arginine p-nitroanilide
(M.W. 695.76 • 60.05 • 18.02) C30H49N9O10 • CH3COOH • H2O
Substrate for Activated Protein C

Boc-Leu-Thr-Arg-MCA A MLT-3106-v 5 mg 65
t-Butyloxycarbonyl-l-leucyl-l-threonyl-l-arginine -20 °C vial
4-methylcoumaryl-7-amide
(M.W. 645.75) C31H47N7O8
Substrate for Factor VIIa-Tf
Y. Shigematsu, T. Miyata, S. Higashi, T. Miki, J.E. Sadler, and S. Iwanaga, J. Biol. Chem., 267, 21329 (1992).

Order Hotline 1-800-777-4779 502-266-8787 177

 PRODUCT GRADE CODE QTY PRICE
ENZYME INHIBITORS AND SUBSTRATES

Boc-Val-Pro-Arg-MCA AA MVP-3093-v 5 mg 65
t-Butyloxycarbonyl-l-valyl-l-prolyl-l-arginine -20 °C vial
4-methylcoumaryl-7-amide
(M.W. 627.73) C31H45N7O7 [65147-04-8]
Substrate for a-Thrombin
T. Morita, H. Kato, S. Iwanaga, K. Takada, T. Kimura, and S. Sakakibara, J. Biochem., 82, 1495 (1977).
S. Kawabata, T. Morita, S. Iwanaga, and H. Igarashi, J. Biochem., 97, 1073 (1985).

H-Gly-Pro-Arg-Pro-OH INH-3797-PI 5 mg 35
(Trifluoroacetate Form) -20 °C 25 mg 130
GPRP
(M.W. 425.49) C18H31N7O5 [67869-62-9]
Fibrinolysis Inhibiting Factor

Z-Pyr-Gly-Arg-MCA A MPR-3138-v 5 mg 70
(Hydrochloride Form) -20 °C vial
Benzyloxycarbonyl-l-pyroglutamyl-glycyl-l-arginine 4-methylcoumaryl-7-amide
(M.W. 633.65) C31H35N7O8
Substrate for Factor Xa
S. Kawabata, et al., Eur. J. Biochem., 172, 17 (1988).

Collagenase / MMP / Stromelysin Substrates

Also see Code SDP-3818-PI Abz-Leu-Ala-Gln-Ala-Val-Arg-Ser-Ser-Ser-Arg-Dap(Dnp)-NH2
and Code SMO-3226-v MOCAc-Lys-Pro-Leu-Gly-Leu-A2pr(Dnp)-Ala-Arg-NH2.

Dnp-Gln-Gly-Ile-Ala-Gly-Gln-d-Arg B SDQ-3088-v 2.5 mg 105

2,4-dinitrophenyl-l-glutaminyl-glycyl-l-isoleucyl- -20 °C vial
l-alanyl-glycyl-l-glutaminyl-d-arginine
PEPTIDES INTERNATIONAL

(M.W. 894.89 ) C35H54N14O14

Reference Substrate for Collagenase Assay with code SDP-3087-v
Y. Masui, T. Takemoto, S. Sakakibara, H. Hori, and Y. Nagai, Biochem. Med., 17, 215 (1977).

Dnp-Gly-Pro-Leu-Gly-Met-Arg-Gly-Leu-NH2 SDP-3816-PI 1 mg 45
(Trifluoroacetate Form) -20 °C 5 mg 175
2,4-dinitrophenyl-glycyl-l-prolyl-l-leucyl-glycyl-l-methionyl-l-arginyl-glycyl-leucine amide
(M.W. 965.11) C40H64N14O12S
Substrate for Collagenase 3 / MMP-13
S.J. Deng, et al., J. Biol. Chem., 275, 31422-31427 (2000).

Dnp-Pro-Cha-Gly-Cys(Me)-His-Ala- SDP-3815-PI 2.5 mg 165

Lys(NMa)-NH2 -20 °C 5 mg 275
2,4-dinitrophenyl-l-prolyl-l-cyclohexylalanyl-glycyl-S-methyl-l-cysteinyl-l-histidyl-l-alanyl-Ne-methylan-
thranoyl-l-lysine amide
(M.W. 1077.24) C49H68N14O12S
Substrate for Collagenase
J. Berman, et al., J. Biol. Chem., 267, 1434 (1992).

Dnp-Pro-Gln-Gly AA SDP-3089 0.1 g 85

2,4-dinitrophenyl-l-prolyl-l-glutaminyl-glycine -20 °C 1g 495
(M.W. 466.40) C18H22N6O9 [65080-33-3]
Reference Compound to Measure Collagenase Activity with SDP-3087-v

Dnp-Pro-Leu-Gly AA SDP-3082 0.1 g 60

2,4-dinitrophenyl-l-prolyl-l-leucylglycine -20 °C 1g 360
(M.W. 451.43) C19H25N5O8
Reference Compound to Measure Collagenase Activity with SDP-3073-v

178 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT GRADE CODE QTY PRICE
Dnp-Pro-Leu-Gly-Leu-Trp-Ala-d-Arg-NH2

ENZYME INHIBITORS AND SUBSTRATES

SDP-3820-PI 2.5 mg 95
2,4-dinitrophenyl-l-prolyl-l-leucylglycyl-l-leucyl-l-tryptophyl-l- -20 °C 5 mg 175
alanyl-d-arginine amide
(M.W. 977.10) C45H64N14O11
Substrate for Collagenase/Gelatinase
M.S. Stack and R.D. Gray, J. Biol. Chem., 264, 4277 (1989).
K. Darlak, R.B. Miller, M.S. Stack, A.F. Spatola, and R.D. Gray, J. Biol. Chem., 265, 5199 (1990).

Dnp-Pro-Gln-Gly-Ile-Ala-Gly-Gln-d- B SDP-3087-v 2.5 mg 110

Arg -20 °C via
2,4-dinitrophenyl-l-prolyl-l-glutaminylglycyl-l-
lsoleucyl-l-alanyl-glycyl-l-glutaminyl-d-arginine
(M.W. 992.00) C40H61N15O15 [63014-08-4]
Substrate for Animal Collagenase
Y. Masui, T. Takemoto, S. Sakakibara, H. Hori, and Y. Nagai, Biochem. Med., 17, 215 (1977).

Dnp-Pro-Leu-Gly-Ile-Ala-Gly-Arg- A SDP-3073-v 2.5 mg 99

NH2 -20 °C vial
2,4-dinitrophenyl-l-prolyl-l-leucylglycyl-l-
isoleucyl-l-alanyl-glycyl-l-arginine amide
(M.W. 847.92) C36H57N13O11
Substrate for Animal Collagenase
Y. Masui, T. Takemoto, S. Sakakibara, H. Hori, and Y. Nagai, Biochem. Med., 17, 215 (1977).

MOCAc-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 See Code SMO-3670-PI.

MOCAc-Lys-Pro-Leu-Gly-Leu-A2pr(Dnp)-Ala-Arg-NH2 See Code SMO-3226-v.

MOCAc-Pro-Cha-Gly-Nva-His-Ala- SMO-3682-PI 1 mg 65

PEPTIDES INTERNATIONAL
Dap(Dnp)-NH2. -20 °C
(7-Methoxycoumarin-4-yl)acetyl-l-prolyl-l-cyclohexylalanyl-glycyl-l-norvalyl-
l-histidinyl-l-alanyl-Nb-(2,4-dinitrophenyl)-l-2,3-diaminopropionic amide
(M.W. 1100.16) C51H65N13O15
Fluorescence-Quenching Substrate for MMP 13
J.L. Lauer-Fields, T. Broder, T. Sritharan, L. Chung, H. Nagase, and G.B. Fields, Biochemistry, 40, 5795 (2001)

MOCAc-Pro-Leu-Gly-Leu-A2pr(Dnp)- A MOC-3163-v 1 mg 75
Ala-Arg-NH2 -20 °C vial
(7-Methoxycoumarin-4-yl) acetyl-l-prolyl-l-leucyl-glycyl-l-leucyl-[N b-
(2,4-dinitrophenyl)-l-2,3-diaminopropionyl]-l-alanyl-l-arginine amide
(M.W. 1093.1) C49H68N14O15 [140430-53-1]
Fluorescence-Quenching Substrate for Matrix Metalloproteinases
C.G. Knight, F. Willenbrock, and G. Murphy, FEBS Lett., 296, 263 (1992).

MOCAc-Arg-Pro-Lys-Pro-Val-Glu- B SMO-3168-v 1 mg 125

Nva-Trp-Arg-Lys(Dnp)-NH2 -20 °C vial
[NFF-3]
(7-Methoxycoumarin-4-yl) acetyl-l-arginyl-l-prolyl-l-lysyl-l-prolyl-l-valyl-l-glutamyl-l-
norvalyl-l-tryptophyl-l-arginyl-[Ne-(2,4-dinitrophenyl)-l-lysine] amide
(M.W. 1675.8) C78H110N22O20 [158584-09-9]
Fluorescence-Quenching Substrate for Matrix Metalloproteinase-3 (Stromelysin 1)
H. Nagase, C.G. Fields, and G.B. Fields, J. Biol. Chem., 269, 20952 (1994).
• This product is sold under license with the University of Minnesota.

Order Hotline 1-800-777-4779 502-266-8787 179

 PRODUCT GRADE CODE QTY PRICE
ENZYME INHIBITORS AND SUBSTRATES

MOCAc-Arg-Pro-Lys-Pro-Tyr-Ala- B SMO-3167-v 1 mg 125

Nva-Trp-Met-Lys(Dnp)-NH2 -20 °C vial
[NFF-2]
(7-Methoxycoumarin-4-yl) acetyl-l-arginyl-l-prolyl-l-lysyl-l-prolyl-l-tyrosyl-l-alanyl-l-norvalyl-l-
tryptophyl-l-methionyl-[Ne-(2,4-dinitrophenyl)-l-lysine] amide
(M.W. 1656.9) C79H105N19O19S [158584-08-8]
Fluorescence-Quenching Substrate for Matrix Metalloproteinases
H. Nagase, C.G. Fields, and G.B. Fields, J. Biol. Chem., 269, 20952 (1994).
• This product is sold under license with the University of Minnesota.

Suc-Gly-Pro-Leu-Gly-Pro-MCA A MGP-3108-v 5 mg 75
Succinyl-glycyl-l-prolyl-l-leucyl-glycyl-l-proline -20 °C vial
4-methylcoumaryl-7-amide
(M.W. 696.75) C34H44N6O10 [72698-36-3]
Substrate for Collagenase-like Peptidase
K. Kojima, H. Kinoshita, T. Kato, T. Nagatsu, K. Takada, and S. Sakakibara, Anal. Biochem., 100, 43 (1979).

Z-Gly-Pro-Leu-Gly-Pro • H2O • AcOEt AA SGP-3029 0.1 g 90

Benzyloxycarbonylglycyl-l-prolyl-l-leucyl-glycyl- -20 °C 1g 625
l-proline • monohydrate mono (ethyl acetate)
(M.W. 573.64 • 18.02 • 88.11) C28H39N5O8 • H2O • CH3COOC2H5 [2646-61-9]
Crystalline: Substrate for Bacterial Collagenase
Y. Nagai, S. Sakakibara, H. Noda, and S. Akabori, Biochim. Biophys. Acta., 37, 567 (1960).

Z-Phe-Tyr-Leu AA SFL-3131 0.1 g 40

Benzyloxycarbonyl-l-phenylalanyl-l-tyrosyl-l- -20 °C 1g 160
leucine
PEPTIDES INTERNATIONAL

(M.W. 575.65) C32H37N3O7

Substrate for Metalloproteinase

Deformylase Substrates
4-Methoxyphenylazoformyl-Phe B SAA-3197-v 5 mg 40
[AAFP] -20 °C vial
(Potassium Form)
N-(4-Methoxyphenylazoformyl)-l-phenylalanine
(M.W. 327.33) C17H17N3O4 [396717-86-5]
Substrate for Carboxypeptidase A
W.L. Mock, Y. Liu, and D.J. Stanford, Anal. Biochem., 239, 218 (1996).

For-Met-Leu-pNA SFM-3624-PI 5 mg 80
N-Formyl-l-methionyl-l-leucine p-nitroanilide -20 °C 25 mg 295
(M.W. 410.50) C18H26N4O5S
Y. Wei and D. Pei, Anal. Biochem., 250, 29 (1997).

Dengue Fever Virus Protein Substrates

Abz-Lys-Lys-Gln-Arg-Ala-Gly-Val- SFQ-3958-PI 1 mg 45
Leu-Tyr(NO2)-NH2 -20 °C 5 mg 195
Abz-KKQRAGVLY(NO2)-NH2
(M.W. 1225.43) C55H88N18O14
Substrate for for Dengue Virus Non-Structural Protein 3 (NS3) Serine Protease
P. Niyomrattanakit, S. Yahorava, I. Mutule, F. Muturlis, R. Petrovska, P. Prusis, G. Katzenmeier, and J.E.S. Wikberg,
Biochem. J., 397, 203-211 (2006).

180 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT GRADE CODE QTY PRICE
Benzoyl-Nle-Lys-Arg-Arg-MCA

ENZYME INHIBITORS AND SUBSTRATES

MCA-3923-PI 5 mg 95
(M.W.. 833.01) C41H60N12O7 -20 °C
Dengue Fever Virus Protein Substrate
J. Li, et al., J. Biol. Chem., 280, 28766 (2005).

Dengue Virus Non-Structural Protein 3 (NS3) Serine Protease Substrate

Abz-Arg-Arg-Arg-Arg-Ser-Ala-Gly- SFQ-3957-PI 1 mg 45
Tyr(NO2)-NH2 -20 °C 5 mg 195
(M.W. 1184.30) C48H77N23O13
Substrate for NS3 Serine Protease

Dipeptidyl-Amino Peptidase Substrates

Gly-Pro-MCA AA MGP-3090-v 5 mg 40
(Tosylate Form) -20 °C vial
Glycyl-l-proline 4-methylcoumaryl-7-amide
(M.W. 329.35) C17H19N3O4 [67341-42-8]
Substrate for X-prolyl Dipeptidyl-Aminopeptidase
T. Kato, T. Nagatsu, T. Kimura, and S. Sakakibara, Biochem. Med., 19, 351 (1978).

Gly-Pro-pNA • Tos AA SGP-3074-v 10 mg 32

[GPNT] -20 °C vial
Glycyl-l-proline p-nitroanilide monotosylate
(M.W. 292.29 • 172.20) C13H16N4O4 • C7H8O3S [65096-46-0]
Substrate for X-prolyl Dipeptidyl-Aminopeptidase
T. Nagatsu, et al., Anal. Biochem., 74, 466 (1976).

PEPTIDES INTERNATIONAL
K. Fujita, M. Hirano, J. Ochiai, M.M. Funabashi, I. Nagatsu, T. Nagatsu and S. Sakakibara, Clin. Chim. Acta, 88, 15
(1978).

Lys-Ala-MCA A MKA-3124-v 5 mg 50
(Tartarate Form) -20 °C vial
l-Lysyl-l-alanine 4-methylcoumaryl-7-amide
(M.W. 374.43) C19H26N4O4
Substrate for Dipeptidyl-Aminopeptidase II
D. Mantle, M.F. Hardy, B. Lauffart, J.R. McDermott, A.I. Smith, and R.J.T. Pennington, Biochem. J., 211, 567 (1983).

Elastase Substrates
Abz-Ala-Pro-Glu-Glu-Ile-Met-Arg-Arg-Gln- SNE-3230-v 1 mg 110
EDDnp -20 °C vial
[Abz-APEEIMRRQ-EDDnp]
(Trifluoroacetate Form)
2-Aminobenzoyl-l-alanyl-l-prolyl-l-glutamyl-l-glutamyl-l-isoleucyl-l-methionyl-l-arginyl-l-arginyl-l-
glutamine 2-(2,4-dinitrophenyl)aminoethylamide
(M.W. 1456.59) C61H93N21O19S
Fluorescence-Quenching Substrate for Human Neutrophil Elastase
B. Korkmaz, S. Attucci, T. Moreau, E. Godat, L. Juliano, and F. Gauthier, Am. J. Respir. Cell Mol. Biol., 30, 801 (2004).
B. Korkmaz, S. Attucci, M.A. Juliano, T. Kalupov, M.-L. Jourdan, L. Juliano, and F. Gauthier, Nat. Protoc., 3, 991 (2008).

Glt-Ala-Ala-Pro-Leu-pNA • H2O AA SGL-3129 0.1 g 90

Glutaryl-l-alanyl-l-alanyl-l-prolyl-l-leucine-p- -20 °C 1g 625
nitroanilide
(M.W. 604.65 • 18.02) C28H40N6O9 • H2O
Substrate for Pancreatic Elastase
E.G. Del Mar, C. Largman, J.W. Brodrick, M. Fassett, and M.C. Geokas, Biochemistry, 19, 468 (1980).

Order Hotline 1-800-777-4779 502-266-8787 181

 PRODUCT GRADE CODE QTY PRICE
ENZYME INHIBITORS AND SUBSTRATES

Pyr-Pro-Val-pNA SAP-3228-v 5 mg 75
l-Pyroglutamyl-l-prolyl-l-valine p-nitroanilide -20 °C vial
(M.W. 445.47) C21H27N5O6 [83329-36-3]
Selective Substrate for Human Granulocyte Elastase
J.A. Kramps, Ch. van Twisk and A.C. van der Linden, Scand. J. Clin. Lab. Investig., 43, 427 (1983).
L. Persson, J. Bergström, H. Ito, and A. Gustafsson, J. Periodontol., 72, 90 (2001).
I. Groth and S. Alban, Planta Med., 74, 852 (2008).

Suc-Ala-Ala-Ala-MCA AA MAA-3133-v 5 mg 75
Succinyl-l-alanyl-l-alanyl-l-alanine 4-methyl- -20 °C vial
coumaryl-7-amide
(M.W. 488.49) C23H28N4O8 [73617-90-0]
Substrate for Elastase
R.A. Mumford, et. al., J. Biol. Chem., 255, 2227 (1980).

Suc-Ala-Ala-Ala-pNA AA SAA-3071-v 5 mg 25
[STANA] -20 °C vial
Succinyl-l-alanyl-l-alanyl-l-alanine p-nitroan-
ilide
(M.W. 451.43) C19H25N5O8 [52299-14-6]

Suc-Ala-Ala-Ala-pNA (Bulk) AA SAA-3071 0.1 g 50

[STANA] -20 °C 1g 300
Succinyl-l-alanyl-l-alanyl-l-alanine-p-
Nitroanilide
(M.W. 451.43) C19H25N5O8 [52299-14-6]
Substrate for Elastase
PEPTIDES INTERNATIONAL

J. Bieth, B. Spiess, and C.G. Wermuth, Biochem. Med., 11, 350 (1974).

Suc(OMe)-Ala-Ala-Pro-Val-MCA AA MAV-3153-v 5 mg 80
N-Methoxysuccinyl-l-alanyl-l alanyl-l-prolyl- -20 °C vial
l-valine
4-methylcoumaryl-7-amide
(M.W. 627.69) C31H41N5O9 [72252-90-5]
Substrate for Human Leukocyte / Porcine Pancreatic Elastase
M.J. Castrillo, K. Nakajima, M. Zimmerman, and J.C. Powers, Anal. Biochem., 99, 53 (1979).

Suc-Ala-Ala-Pro-Abu-pNA SAP-3667-PI 5 mg 49
(M.W. 562.58) C25H34N6O9 -20 °C 25 mg 195
Substrate for Pancreatic Elastase
C.L. Largman, Biochemistry, 22, 3763 (1983).
E.G. Del Mar, C. Largman, J.W. Brodick, M. Fassett, and M.C. Geokas, Biochemistry, 19, 468 (1980).

Suc-Ala-Ala-Pro-Gly-pNA SAP-3666-PI 5 mg 49
(M.W. 534.53) C23H30N6O9 -20 °C 25 mg 195
Substrate for Pancreatic Elastase
C.L. Largman, Biochemistry, 22, 3763 (1983).
E.G. Del Mar, C. Largman, J.W. Brodick, M. Fassett, and M.C. Geokas, Biochemistry, 19, 468 (1980).

Suc-Ala-Ala-Pro-Trp-pNA SAP-3668-PI 5 mg 49
(M.W. 663.69) C32H37N7O9 -20 °C 25 mg 195
Substrate for Pancreatic Elastase
C.L. Largman, Biochemistry, 22, 3763 (1983).
E.G. Del Mar, C. Largman, J.W. Brodick, M. Fassett, and M.C. Geokas, Biochemistry, 19, 468 (1980).

182 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT GRADE CODE QTY PRICE
Suc-Ala-Pro-Ala-MCA

ENZYME INHIBITORS AND SUBSTRATES

A MAP-3100-v 5 mg 80
Succinyl-l-alanyl-l-prolyl-l-alanine 4-methyl- -20 °C vial
coumaryl-7-amide
(M.W. 514.53) C25H30N4O8 [88467-44-1]
Substrate for Elastase
G. Oshima, K. Akashi, and M. Yamada, Arch. Biochem. Biophys, 233, 212 (1984).

Suc-Ala-Pro-Ala-pNA AA SAP-3118 0.1 g 55

Succinyl-l-alanyl-l-prolyl-l-alanine p-nitroanilide -20 °C 1g 340
(M.W. 477.47) C21H27N5O8
Substrate for Elastase

Furin and Carboxyl Side of Paired Basic Residue Cleaving Enzyme

Substrates
Boc-Gln-Arg-Arg-MCA A MQR-3122-v 5 mg 70
t-Butyloxycarbonyl-l-glutaminyl-l-arginyl-l- -20 °C vial
arginine
4-methylcoumaryl-7-amide
(M.W. 715.80) C32H49N11O8 [109376-05-8]
Substrate for Carboxyl Side of Paired Basic Residue Cleaving Enzyme
K. Mizuno, T. Nakamura, K. Takada, S. Sakakibara, and H. Matsuo, Biochem. Biophys. Res. Commun., 144, 807 (1987).

Pyr-Arg-Thr-Lys-Arg-MCA A MPR-3159-v 5 mg 85
l-Pyroglutamyl-l-arginyl-l-threonyl-l-lysyl- -20 °C vial
l-arginine 4-methylcoumaryl-7-amide
(M.W. 827.93) C37H57N13O9 [155575-02-3]
Substrate for Furin

PEPTIDES INTERNATIONAL
K. Hatsuzawa, M. Nagahama, S. Takahashi, K. Takada, K. Murakami, and K. Nakayama, J. Biol. Chem., 267,
16094 (1992).

Boc-Arg-Val-Arg-Arg-MCA A MRR-3155-v 5 mg 85
t-Butyloxycarbonyl-l-arginyl-l-valyl-l-arginyl-l-arginine -20 °C vial
4-methylcoumaryl-7-amide
(M.W. 842.99) C38H62N14O8
Substrate for Furin
K. Hatsuzawa, K. Murakami, and K. Nakayama, J. Biochem., 111, 296 (1992).
K. Hatsuzawa, M. Nagahara, S. Takahashi, K. Takada, K. Murakami, and K. Nakayama, J. Biol. Chem., 267, 16094,
(1992).

Boc-Gly-Arg-Arg-MCA A MGR-3142-v 5 mg 70
t-Butyloxycarbonyl-glycyl-l-arginyl-l-arginine -20 °C vial
4-methylcoumaryl-7-amide
(M.W. 644.72) C29H44N10O7 [113866-14-1]
Substrate for Carboxyl Side of Paired Basic Residue Cleaving Enzyme
K. Mizuno, T. Nakamura, K. Takada, S. Sakakibara, and H. Matsuo, Biochem. Biophys. Res Commun., 144, 807 (1987).

Boc-Gly-Lys-Arg-MCA A MGK-3143-v 5 mg 70
t-Butyloxycarbonyl-glycyl-l-lysyl-l-arginine -20 °C vial
4-methylcoumaryl-7-amide
(M.W. 616.71) C29H44N8O7 [109358-48-7]
Substrate for Carboxyl Side of Paired Basic Residue Cleaving Enzyme
K. Mizuno, T. Nakamura, K. Takada, S. Sakakibara, and H. Matsuo, Biochem. Biophys. Res. Commun., 144, 807 (1987).

Order Hotline 1-800-777-4779 502-266-8787 183

 PRODUCT GRADE CODE QTY PRICE
ENZYME INHIBITORS AND SUBSTRATES

Boc-Leu-Arg-Arg-MCA A MLR-3140-v 5 mg 70
t-Butyloxycarbonyl-l-leucyl-l-arginyl-l-arginine -20 °C vial
4-methylcoumaryl-7-amide
(M.W. 700.83) C33H52N10O7
Substrate for Carboxyl Side of Paired Basic Residue Cleaving Enzyme and Proteasome
K. Mizuno, T. Nakamura, K. Takada, S. Sakakibara, and H. Matsuo, Biochem. Biophys. Res. Commun., 144, 807 (1987).
M. Aki, N. Shimbara, M. Takashina, K. Akiyama, S. Kagawa, T. Tamura, N. Tanahashi, T. Yoshimura, K. Tanaka,
and A. Ichihara, J. Biochem., 115, 257 (1994).

Boc-Leu-Lys-Arg-MCA A MLK-3141-v 5 mg 70
t-Butyloxycarbonyl-l-leucyl-l-lysyl-l-arginine -20 °C vial
4-methylcoumaryl-7-amide
(M.W. 672.82) C33H52N8O7 [109358-47-6]
Substrate for Carboxyl Side of Paired Basic Residue Cleaving Enzyme
K. Mizuno, T. Nakamura, K. Takada, S. Sakakibara, and H. Matsuo, Biochem. Biophys. Res. Commun., 144, 807 (1987).

GDP-l-Fuc Substrates See Code SGS-23004-s.

Gingipain Substrates
Boc-Phe-Ser-Arg-MCA AA MFS-3107-v 5 mg 65
t-Butyloxycarbonyl-l-phenylalanyl-l-seryl-l- -20 °C vial
arginine 4-methylcoumaryl-7-amide
(M.W. 665.74) C33H43N7O8 [73554-90-2]
Substrate for Trypsin, Tryptase, 73K Protease, and Arg-Gingipain
S. Iwanaga, T. Morita, H. Kato, T. Harada, N. Adachi, T. Sugo, I. Maruyama, K. Takada, T. Kimura and S. Sakakibara,
KININS-II: Biochemistry, Pathophysiology, and Clinical Aspects, (S. Fujii, H. Moriya and T. Suzuki, eds.),
Plenum Publishing Co., 1979. pp. 147-163.
PEPTIDES INTERNATIONAL

M. Muramatsu, T. Itoh, M. Takei, and K. Endo, Biol. Chem. Hoppe-Seyler, 369, 617, (1988).
A. Molla, T. Yamamoto, and H. Maeda, J. Biochem., 104, 616 (1988).

Z-His-Glu-Lys-MCA AA MCA-3215-v 5 mg 80
(Hydrochloride Form) -20 °C vial
Benzyloxycarbonyl-L-histidyl-L-glutamyl-L-lysine 4-methylcoumaryl-7-amide
(M.W. 703.74) C35H41N7O9
Substrate for Lys-Gingipain
N. Abe, A. Baba, T. Kadowaki, K. Okamoto, S. Okazaki, T. Asao, and K. Yamamoto, J. Biochem., 128, 877 (2000).

Z-Phe-Arg-MCA See Code MFR-3095-v.

Glu-Glu A OEE-3080 0.1 g 40

l-glutamyl-l-glutamic acid -20 °C 1g 200
(M.W. 276.24) C10H16N2O7 [3929-61-1]

Glu-pNA • H2O A SEN-3067 0.1 g 30

l-Glutamic acid a-p-nitroanilide -20 °C 1g 90
(M.W. 267.24 • 18.02) C11H13N3O5 • H2O

Glu(Cys-Gly) B OEG-3050 1g 22
[Glutathione; GSH] -20 °C 5g 35
g-l-glutamyl-l-cysteinylglycine
(M.W. 307.32) C10H17N3O6S [70-18-8] 25 g 70
Glutathione See Code OEG-3050 Glu(Cys-Gly) above.

184 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT GRADE CODE QTY PRICE
Gly-Gly

ENZYME INHIBITORS AND SUBSTRATES

AA OGG-3028 5g 25
Glycylglycine -20 °C 25 g 35
(M.W. 132.12) C4H8N2O3 [556-50-3]
100 g 70
Gly-Gly-Gly AA OGG-3061 1g 30
Glycylglycylglycine -20 °C 5g 80
(M.W. 189.17) C6H11N3O4 [556-33-2]
25 g 315
Gly-Gly-His A OGH-3076 0.1 g 50
Glycylglycyl-l-histidine -20 °C 1g 350
(M.W. 269.26) C10H15N5O4 [93404-95-6]
Cu-Binding Peptide
S. Lau, T.P.A. Kruch, and B. Sarkar, J. Biol. Chem., 249, 5878 (1974).

Gly-Leu AA OGL-3022 0.1 g 25

Glycyl-l-leucine -20 °C 1g 40
(M.W. 188.22) C8H16N2O3 [869-19-2]
5g 105
Gly-Phe AA OGF-3053 0.1 g 22
Glycyl-l-phenylalanine -20 °C 1g 40
(M.W. 222.24) C11H14N2O3 [3321-03-7]

Gly-Phe-NH2 • AcOH AA OGF-3023 0.1 g 30

Glycyl-l-phenylalanine amide -20 °C 1g 80
(M.W. 221.26 • 60.05) C11H15N3O2 • CH3COOH
[13467-26-0]

PEPTIDES INTERNATIONAL
Gly-Pro AA OGP-3052 0.1 g 30
Glycyl-l-proline -20 °C 1g 60
(M.W. 172.18) C7H12N2O3 [704-15-4]

γ-Glutamyl Cyclotransferase (GGCT) Substrate

LISA-101 (0.1 mg vial) GLU-3234-s 0.1 mg 100
γ-l-Glutamyl-(2S)-γ-ethyl-γ-[(3-oxo-3H- -20 °C
vial
phenoxazin-7-yl)oxy]carbonyl-2,4-diamino-
butyric acid
M.W. 514.48) C24H26N4O9 [1638785-74-6]
(Fluorogenic Substrate for γ-Glutamyl Cyclotransferase (GGCT)
M. Orlowski, et al., Biochemistry, 8, 1048 (1969). (
Isolation and Identification of GGCT)
A.J. Oakley, et al., J. Biol. Chem., 283, 22031 (2008).
(Isolation and Identification of GGCT)
P. Gromov, et al., J. Proteome Res., 9, 3941 (2010). (Proteomic Profiling of Mammary Carcinomas)
K. Takemura, et al., Human Pathol., 45, 331 (2014). (GGCT as a Diagnostic Marker in Esophageal Tumors)
R. Ran, et al., J. Pham. Sci., 104, 476 (2015). (siRNA for Treatment of Drug-Resistant Breast Cancer)
T. Yoshiya, et al., Org. Biomol. Chem., doi: 10.1039/C5OB00086F (2015). (Development of LISA-101)

γ-Glutamyl Trans-peptidase Substrate

Glu(pNA) • H2O A SEN-3066 0.1 g 25
l-Glutamic acid g-p-nitroanilide -20 °C 1g 55
(M.W. 267.24 • 18.02) C11H13N3O5 • H2O
[122864-94-2] 5g 205
Substrate for g-Glutamyl Transpeptidase

Order Hotline 1-800-777-4779 502-266-8787 185

 PRODUCT GRADE CODE QTY PRICE
ENZYME INHIBITORS AND SUBSTRATES

Glycogen Synthase Kinase 3B Substrates

[Ala353,357]-Presenilin 1 (349-361) SPR-3630-PI 1 mg 59
H-Gly-Pro-His-Arg-Ala-Thr-Pro-Glu-Ala-Arg- -20 °C
Ala-Ala-Val-OH
(M.W. 1332.50) C56H93N21O17
Negative Control of Glycogen Synthase Kinase-3β Substrate
F. Kirschenbaum, S.-C. Hsu, B. Cordell, and J.V. McCarthy, J. Biol. Chem., 276, 7366-7375 (2000).

Presenilin 1 (349-361) SPR-3629-PI 1 mg 59

H-Gly-Pro-His-Arg-Ser-Thr-Pro-Glu-Ser-Arg-Ala-Ala-Val-OH -20 °C
(M.W. 1364.49) C56H93N21O19
Glycogen Synthase Kinase-3β Substrate (GSK-3β Substrate)
F. Kirschenbaum, S.-C. Hsu, B. Cordell, and J.V. McCarthy, J. Biol. Chem., 276, 7366-7375 (2000).

GPNT See Code SGP-3074-v Glycyl-l-proline p-Nitroanilide • Tosylate.

Hepatitis C Protease Substrate

Ac-Asp-Glu-Asp(Edans)-Glu-Glu- SFQ-3730-PI 1 mg 412
Abu-l-Lactoyl-Ser-Lys(Dabcyl)-NH2 -20 °C 5 mg 1648
(M.W. 1548.62) C68H89N15O25S [188530-20-3]
FRET Substrate for Hepatitis C protease
C. Lin, et al., J. Biol. Chem., 10, 1074 (2004).
N. Kakiuchi, et al., J. Virol. Methods, 80, 77 (1999).
Y. Liu, et al., Anal. Biochem., 267, 331 (1999).
M. Taliani, et al., Anal. Biochem., 240, 60 (1996).
PEPTIDES INTERNATIONAL

Hepatocyte Growth Factor-Activator (HGF-A) Substrate

Ac-Lys-Thr-Lys-Gln-Leu-Arg-MCA AA MCA-3185-v 5 mg 150
[Ac-KTKQLR-MCA] -20 °C vial
Acetyl-l-lysyl-l-threonyl-l-lysyl-l-glutaminyl-l-
leucyl-l-arginine 4-methylcoumaryl-7-amide
(M.W. 972.14) C45H73N13O11
Substrate for Hepatocyte Growth Factor-Activator (HGF-A)
K. Mizuno, Y. Tanoue, I. Okano, T. Harano, K. Takada, and T. Nakamura,
Biochem. Biophys. Res. Commun., 198, 1161 (1994).
Hippuryl-alanyl-proline See Code SGP-3126 Bz-Gly-Ala-Pro.
Hippuryl-arginine See Code SGR-3059 Benzoyl-glycyl-l-arginine.
Hippuryl-glycyl-glycine See Code SGG-3128 Bz-Gly-Gly-Gly.
Hippuryl-histidyl-leucine See Code SGL-3064 Benzoyl-glycyl-l-histidyl-l-leucine.
Hippuryl-lysine See Code SGK-3047 Benzoyl-glycyl-l-lysine.

His-Leu AA OHL-3065 0.1 g 30

l-histidyl-l-leucine -20 °C 1g 105
(M.W. 268.31) C12H20N4O3 [7763-65-7]

Histone Deacetylase Substrates

Ac-Arg-Gly-Lys(Ac)-MCA SRK-3728-PI 1 mg 100
Ac-RGK(Ac)-MCA -20 °C 5 mg 400
(Trifluoroacetate Form)
(M.W. 600.68) C28H40N8O7 [660846-97-9]
Substrate for Histone Deacetylase
D. Wegener, et al., Chem. Biol., 10, 61 (2003).

186 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT GRADE CODE QTY PRICE

ENZYME INHIBITORS AND SUBSTRATES

Ac-Arg-Gly-Lys-MCA SHD-3748-PI 1 mg 30
Ac-RGK-MCA -20 °C 5 mg 120
(Trifluoroacetate Form)
(M.W. 558.64) C26H38N8O6 [660846-99-1]
Substrate for Histone Deacetylase
D. Wegener, et al., Chem. Biol., 10, 61 (2003).

HIV-1 Protease Substrates

Dabcyl-γ-Abu-Ser-Gln-Asn-Tyr-Pro- SFQ-3763-PI 1 mg 240
Ile-Val-Gln-Edans -20 °C 5 mg 960
(Trifluoroacetate Form)
(M.W. 1532.75) C73H97N17O18S [127134-13-8]
FRET Substrate for HIV Protease
E.D.Matayoshi, et al., Science, 247, 954 (1990)
M.W. Pennington, et al., Peptides 1992, Proceedings of the 22nd European Peptide Symposium, Interlaken, Switzerland,
p. 936, (C.H.Schneider and A.N.Eberle, eds.) Escom, Leiden, (1993)
U. Nillroth, et al., Antimicrob. Agents Chemother., 41, 2383 (1997)
L.Bannwarth, et al., J. Med. Chem., 49, 4657 (2006)

Ser-Gln-Asn-Tyr-Pro-Ile-Val AA SSV-4236-v 5 mg 175

(M.W. 819.90) C37H57N9O12 vial
-20 °C
Substrate for HIV-1 Protease
S. Billich, M.-T. Knoop, J. Hansen, P. Strop, J. Sedlacek, R. Mertz, and K. Moeliling, J. Biol. Chem., 263, 17905 (1988).
P.L. Darke, et al., Biochem. Biophys. Res. Commun., 156, 297 (1988).
P.L. Darke, et al., J. Biol. Chem., 264, 2307 (1989).

Horseshoe Crab Clotting Enzyme Substrate

PEPTIDES INTERNATIONAL
Boc-Leu-Gly-Arg-MCA AA MLG-3102-v 5 mg 65
(Hydrochloride Form) -20 °C vial
t-Butyloxycarbonyl-l-leucyl-glycyl-l-arginine
4-methylcoumaryl-7-amide
(M.W. 601.69) C29H43N7O7 [65147-09-3]
Substrate for Horseshoe Crab Clotting Enzyme
S. Iwanaga, T. Morita, T.Harada, S. Nakamura, M. Niwa, K. Takada, T. Kimura and S. Sakakibara,
Haemostasis, 7, 183 (1978).

Human Rhino-virus-14 (HRV)3C Protease Substrate

Suc-Glu-Ala-Leu-Phe-Gln-pNA SAP-3693-PI 5 mg 49
Succinyl-l-glutamyl-l-alanyl-l-leucyl-l- -20 °C 25 mg 195
phenylalanyl-l-Glutamine p-Nitroanilide
(M.W. 826.87) C38H50N8O13
Substrate for 3C Human Rhinovirus-14
(HRV14)
Q. M. Wang, R.B. Johnson, G.A. Cox, E.C. Villarreal, and R.J. Loncharich, Anal. Biochem., 252, 238 (1997).
Q.M. Wang, et al,, Antimicrobial Agents and Chemot., 42, 916 (1998).

Kallikrein Substrates
H-D-Val-Leu-Arg-AFC SFC-3774-PI 1 mg 40
(M.W. 597.64) C27H38F3N7O5 -20 °C 5 mg 160
Fluorogenic Substrate for Kallikrein
DK Shori, et al., Biochem. Pharmacol., 43, 1209 (1992).
Z Lojda, et al., Acta Histochem., 98, 215 (1996).
H.T. Johansen, et al., Anal. Biochem., 273, 278 (1999).

Order Hotline 1-800-777-4779 502-266-8787 187

 PRODUCT GRADE CODE QTY PRICE
ENZYME INHIBITORS AND SUBSTRATES

Pro-Phe-Arg-MCA A MPF-3096-v 5 mg 70
(Hydrochloride Form) -20 °C vial
l-prolyl-l-phenylalanyl-l-arginine 4-methylcoumaryl-7-amide
(M.W. 575.66) C30H37N7O5 [115918-56-4]
Substrate for Pancreatic / Urinary Kallikrein and Proteasome
T. Morita, H. Kato, S. Iwanaga, K. Takada, T. Kimura, and S. Sakakibara, J. Biochem., 82, 1495 (1977).
V. Ustrell, G. Pratt, and M. Rechesteiner, Proc. Natl. Acad. Sci. USA, 92, 584 (1995).

Z-Phe-Arg-MCA See Code MFR-3095-v.

Human Kallikrein 6 Substrate

Human kallikrein 6 (hK6) is greatly expressed in the central nervous system. It was
shown to degrade myelin-associated proteins and is expressed in cells localized at
sites of demyelination, suggesting hK6 plays a role in demyelinating diseases such as
multiple sclerosis (MS).1,2 In addition, hK6 is attenuated in brain extracts of Alzheimer
patients.3,4 Discovery of specific hK6 substrates would help to determine the functional
role of this enzyme. Angelo et al. recently screened a number of potential FRETS-
based hK6 substrates that were constructed based on a known hK1 substrate and
found Abz-Ala-Phe-Arg-Phe-Ser-Gln-EEDnp (SFQ-3915-PI) to be the most potent
(kcat = 11.6 s-1, Km = 0.3 µM).5 This substrate may help in studies focused on the
biological role of hK6.
1. Scarisbrick, et al., Brain, 125, 1283 (2002). 4. Ni, et al., Br. J. Cancer, 91, 725 (2004).
2. Blaber, et al., FASEB J., 18, 920 (2004). 5. Angelo, et al., J. Biol. Chem., 281, 3116 (2006)
3. Diamandis, et al., Clin. Biochem., 33, 579 (2000).

Abz-Ala-Phe-Arg-Phe-Ser-Gln-EDDnp SFQ-3915-PI
PEPTIDES INTERNATIONAL

1 mg 50
(M.W. 1082.15) C50H63N15O13 -20 °C 5 mg 195
Substrate for Human Kallikrein 6 (hK6)
Isopeptidase T Substrate See Code MLG-3176-v.

KYS-1 See Code SMO-3225-v.

Legumain Substrate
Z-Ala-Ala-Asn-MCA A MCA-3209-v 5 mg 65
Benzyloxycarbonyl-l-alanyl-l-alanyl-l- -20 °C vial
asparagine-4-methylcoumaryl-7-amide
(M.W. 565.57) C28H31N5O8 [149697-16-5]
Substrate for Legumain
A.A. Kembhavi, D.J. Buttle, C.G. Knight, and A.J. Barret, Arch. Biochem. Biophys., 303, 208 (1993).
J.-M. Chen, et al., J. Biol. Chem., 272, 8090 (1997).
B. Manoury, E.W. Hewitt, N. Morrice, P.M. Dando, A.J. Barret, and C. Watts, Nature, 396, 695 (1998).
S.J. Choi, et al., J. Biol. Chem., 274, 27747 (1999).
P.M. Dando, M. Fortunato, L. Smith, C.G. Knight, J.E. McKendrick, and A.J. Barret, Biochem. J., 339, 743 (1999).

Leu-Gly • ½ H2O AA OLG-3024 0.1 g 25

l-Leucylglycine -20 °C 1g 55
(M.W. 188.22 • 9.01) C8H16N2O3 • ½ H2O
[686-50-0]

Leu-Gly-Gly AA OLG-3025 0.1 g

l-Leucylglycylglycine -20 °C 1g
(M.W. 245.28) C10H19N3O4 [1187-50-4]

188 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT GRADE CODE QTY PRICE

ENZYME INHIBITORS AND SUBSTRATES

Lysine Hydroxylase Substrate
Ala-Arg-Gly-Ile-Lys-Gly-Ile-Arg-Gly- AA SAG-4166 25 mg 525
Phe-Ser-Gly • 3AcOH • 5H2O -20 °C
[lysine Hydroxylase Substrate L-1]
(M.W. 1218.4 • 180.16 • 90.08) C53H91N19O14 • 3CH3COOH • 5H2O
Substrate for lysine Hydroxylase
K.I. Kivirikko, K. Shudo, S. Sakakibara, and D.J. Prockop, Biochemistry, 11, 122 (1972). (Original)

Met-Met A OMM-3152 0.1 g 40

l-methionyl-l-methionine -20 °C 1g 170
(M.W. 280.41) C10H20N2O3S2 [7349-78-2]

MALTI Substrate
Ac-Leu-Arg-Ser-Arg-MCA MCA-3952-PI 5 mg 95
Ac-LRSR-MCA -20 °C
(M.W. 729.84) C33H51N11O8
Substrate for MALTI
P. Niyomrattanakit, S. Yahorava, I. Mutule, F. Muturlis, R. Petrovska, P. Prusis, G. Katzenmeier, and J.E.S. Wikberg,
Biochem. J., 397, 203-211 (2006).

Reference Compound for MOCAc-type Fluorescence-Quenching Substrate

MOCAc-Pro-Leu-Gly AA MOC-3164-s 0.1 mg 30
(7-Methoxycoumarin-4-yl) acetyl-l-prolyl-l-leucyl-glycine -20 °C vial
(M.W. 501.53) C25H31N3O8 [140430-56-4]

PEPTIDES INTERNATIONAL
Reference Compound for MOCAc-type Fluorescence-Quenching Substrate
C.G. Knight, F. Willenbrock, and G. Murphy, FEBS Lett., 296, 263 (1992).

Neprilysin Substrate
Z-Ala-Ala-Leu-pNA AA SAP-3127 0.1 g 50
Benzyloxycarbonyl-l-alanyl-l-alanyl-l-leucine -20 °C 1g 305
p-nitroanilide
(M.W. 527.57) C26H33N5O7 [61043-33-2]
Substrate for Subtilisin A and Serine Protease of Bacillus subtilis IFO3027 / Neprilysin
V.M. Stepanov, et al., Biochem. Biophys. Res. Commun., 77, 298 (1977).
Y. Shimizu, T. Nishino, and S. Murao, Agric. Biol. Chem., 47, 1775 (1983).
Y. Takaki, et al., J. Biochem., 128, 897 (2000).
N. Iwata, Y. Takaki, S. Fukami, S. Tsubuki, and T.C. Saido, J. Neurosci. Res., 70, 493 (2002).

Neutral Endopeptidase Substrates

Z-Gly-Gly-Leu-pNA AA SGL-3111 25 mg 60
Benzyloxycarbonyl-glycylglycyl-l-leucine-p- -20 °C 100 mg 160
nitroanilide
(M.W. 499.52) C24H29N5O7 [53046-98-3] 1g 910
Substrate for Neutral Endopeptidase
M. Orlowski and S. Wilk, In, Peptides, Structure and Biological Functions, (E. Gross and J. Meienhofer, Eds.),
Pierce Chemical Co., 1980, p. 925.

Order Hotline 1-800-777-4779 502-266-8787 189

 PRODUCT GRADE CODE QTY PRICE
ENZYME INHIBITORS AND SUBSTRATES

Abz-Ala-Gly-Leu-Ala-p-Nitro-Benzyl-Amide SAG-3905-PI 5 mg 45
(Trifluoroacetate Form) -20 °C 25 mg 175
2-Aminobenzoyl-l-Alanyl-Glycyl-l-Leucyl-l-Alanyl-para-Nitro-Benzyl-Amide
(M.W. 583.65) C28H37N7O7
Substrate for Thermolysin and Neutral Endopeptidase 24.11 (NEP)
N. Nishino and J.C. Powers, J. Biol. Chem., 255, 3482 (1980).
R.S. Rush, et al., Arch. Biochem. Biophys., 231, 390 (1984).
D.I. Mundy and W.J. Strittmatter, Cell, 40, 645 (1985).

Pepsin Substrate
MOCAc-Ala-Pro-Ala-Lys-Phe-Phe- A SMO-3216-v 1 mg 140
Arg-Leu-Lys(Dnp)-NH2 -20 °C vial
(Trifluoroacetate Form)
(7-Methoxycoumarin-4-yl)Acetyl-l-alanyl-l-prolyl-l-alanyl-l-lysyl-l-phenylalanyl-l-
phenylalanyl-l-arginyl-l-leucyl-[Nε-(2,4-dinitrophenyl)-l-lysine] amide
(M.W. 1458.6) C71H95N17O17
Fluorescence-Quenching Substrate for Proteinase A / Pepsin
H. Kondo, Y. Shibano, T. Amachi, N. Cronin, K. Oda, and B.M. Dunn, J. Biochem., 124, 141 (1998).
• This compound is distributed under the license of Suntory Limited.

Peptidoglutaminase Substrate
Boc-Gln-Pro AA SQP-3151 0.1 g 40
t-Butyloxycarbonyl-l-glutaminyl-l-proline -20 °C 1g 170
(M.W. 343.38) C15H25N3O6 [2419-99-0]
Substrate for Peptidoglutaminase
PEPTIDES INTERNATIONAL

J.S. Hamada and W.E. Marshall, J. Food Sci., 53, 1132 (1988).

Reference Compound for Peptidyl-MCA Substrate

AMC AA MCA-3099-v 5 mg 50
7-Amino-4-methyl-coumarin -20 °C vial
(M.W. 175.18) C10H9NO2 [26093-31-2]
Reference Compound for Analysis with Peptidyl-MCA Substrates

Peptidyl Prolyl cis-trans Isomerase (PPlase) Substrate

Suc-Ala-Glu-Pro-Phe-pNA SAP-3947-PI 1 mg 25
Suc-AEPF-pNA -20 °C 5 mg 65
(Acetate Form)
(M.W. 682.69) C32H38N6O11
Substrate for Peptidyl-prolyl Isomerase (PPIase) Pin1
Z.J. Shen, S. Esnault, and J.S. Malter, Nat. Immunol., 6, 1280 (2005).
S. Esnault, Z.J. Shen, E.Whitesel and J.S. Malter, J. Immunol., 177, 6999 (2006).

Suc-Ala-Leu-Pro-Phe-pNA See Code SAF-3162-v.

Plasmin Substrate
Boc-Glu-Lys-Lys-MCA A MEK-3105-v 5 mg 80
t-Butyloxycarbonyl-l-glutamyl-l-lysyl-l-lysine 4-methylcouma- -20 °C vial
ryl-7-amide
(M.W. 660.76) C32H48N6O9 [73554-85-5]
Substrate for Plasmin
H. Kato, N. Adachi, Y. Ohno, S. Iwanaga, K. Takada, and S. Sakakibara, J. Biochem., 88, 183 (1980).

190 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT GRADE CODE QTY PRICE

ENZYME INHIBITORS AND SUBSTRATES

Boc-Val-Leu-Lys-MCA See Code MVL-3104-v.

Porphyromonas Gingivalis Dipeptidyl-Peptidase Substrates

Met-Leu-MCA (5 mg vial) AA MML-3236-v 5 mg 50
l-Methionyl-l-Leucine 4-methyl-coumaryl- -20 °C
vial
NEW!
7-amide
(M.W. 419.54) C21H29N3O4S [1009549-31-8]
Substrate for Porphyromonas Gingivalis Dipeptidyl-Peptidase 7
A. Banbula, J. Yen, A. Oleksy, P. Mak, M. Bugno, J. Travis, and J. Potempa, J. Biol. Chem., 276, 6299 (2001).
S.M. Rouf, Y. Ohara-Nemoto, T. Hoshino, T. Fujiwara, T. Ono, and T.K. Nemoto, Biochimie, 95, 824 (2013).
S.M. Rouf, Y. Ohara-Nemoto, T. Ono, Y. Shimoyama, S. Kimura, and T.K. Nemoto, FEBS Open Bio, 3, 177 (2013).

Leu-Asp-MCA (0.5 mg vial) AA MLD-3235-v 0.5 mg 50

L-Leucyl-L-aspartic acid α-(4-methylcoumaryl- -20 °C
via
NEW!
7-amide)
(M.W. 403.43) C20H25N3O6
Substrate for Porphyromonas Gingivalis Dipeptidyl-Peptidase 11
Y. Ohara-Nemoto, et al., J. Biol. Chem., 286, 38115 (2011).
S.M. Rouf, et al., Biochimie, 95, 824 (2013).
S.M. Rouf, et al., FEBS Open Bio, 3, 177 (2013).

Prion Proteins See Cellular Prion Protein.

Prolyl Endopeptidase Substrate

Suc-Gly-Pro-MCA AA MGP-3109-v 5 mg 55
Succinyl-glycyl-l-proline 4-methylcoumaryl-7-amide -20 °C vial

PEPTIDES INTERNATIONAL
(M.W. 429.42) C21H23N3O7 [80049-85-0]
Substrate for Propyl Endopeptidase (Post-proline Cleaving Enzyme)
T. Kato, T. Nakano, K. Kojima, T. Nagatsu, and S. Sakakibara, J. Neurochem., 35, 527 (1980).

Proteinase 3 Substrate
Abz-Val-Ala-Asp-Nva-Arg-Asp-Arg-Gln- SNP-3232-v 1 mg 110
EDDnp -20 °C vial
[Abz-VADnVRDRQ-EDDnp], nV = Nva
(Trifluoroacetate Form)
2-Aminobenzoyl-l-valyl-l-alanyl-l-aspartyl-l-norvalyl-l-arginyl-l-aspartyl-l-arginyl-l-glutamine 2-(2,4-dinitrophenyl)
aminoethyl-amide
(M.W. 1285.3) C53H80N20O18
Fluorescence-Quenching Substrate for Human Neutrophil Proteinase 3
B. Korkmaz, et al., J. Biol. Chem., 282, 1989 (2007).
B. Korkmaz, et al., Nat. Protoc., 3, 991 (2008).

Proteinase A Substrates
MOCAc-Ala-Pro-Ala-Lys-Phe-Phe-Arg-Leu-Lys(Dnp)-NH2 See Code SMO-3216-v.
Suc-Arg-Pro-Phe-His-Leu-Leu-Val-Tyr-MCA See Code MRP-3110-v.

Protein Kinase Substrate

Pyr-Lys-Arg-Pro-Ser-Gln-Arg-Ser- A SKL-4237-v 5 mg 290
Lys-Tyr-Leu -20 °C vial
(M.W. 1373.6) C60H100N20O17 [136132-68-8]
Substrate for Protein Kinase C
I. Yasuda, A. Kishimoto, S. Tanaka, M. Tominaga, A. Sakurai, and Y. Nishizuka,
Biochem. Biophys. Res. Commun., 166, 1220 (1990).

Order Hotline 1-800-777-4779 502-266-8787 191

 PRODUCT GRADE CODE QTY PRICE
ENZYME INHIBITORS AND SUBSTRATES

Arg-Arg-Leu-lle-Glu-Asp-Ala-Glu- AA SRG-4184-v 0.5 mg 85

Tyr-Ala-Ala-Arg-Gly -20 °C vial
[RR-SRC]
(M.W. 1519.7) C64H106N22O21 [81156-93-6]
Substrate for Tyrosine Protein-Kinase
J.E. Casnellie, M.L. Harrison, L.J. Pike, K.E. Hellström, and E.G. Krebs, Proc. Natl. Acad. Sci. USA, 79, 282 (1982).

H-Arg-Arg-Leu-Ile-Glu-Asp-Ala-Glu- PTK-3956-PI 1 mg 45
Tyr-Ala-Ala-Arg-Gly-NH2 -20 °C 5 mg 155
(Acetate Form)
RRLIEDAEYAARG
(M.W. 1518.71) C64H107N23O20 [81156-93-6]
Substrate for Protein Tyrosine Kinase (PTK)
J.E. Casnellie, M.L. Harrison, L.J. Pike, K.E. Hellstrom, and E.G. Krebs, Proc. Natl. Acad. Sci. USA, 79, 282 (1982).
S.E. Ramer, D.G. Winker, A. Carrera, T.M. Robets, and C.T. Walsh, Proc. Natl. Acad. Sci. USA, 88, 6254, (1991).
H.S. Earp, K.S. Austin, G.Y. Gillespie, S.C. Buessow, A.A. Davies, and P.J. Parker, J. Biol. Chem., 260, 4351 (1985).

Protein Phosphatase Substrate

H-Arg-Arg-Leu-Ile-Glu-Asp-Ala-Glu- PTP-3955-PI 1 mg 85
Tyr(H2PO3)-Ala-Ala-Arg-Gly-NH2 -20 °C 5 mg 345
RRLIEDAE-pY-AARG
(Acetate Form)
(M.W. 1598.69) C64H108N23O23P
Substrate for Protein Tyrosine Phosphatase (PTP)
K.L. Lim, D.S.Y. Lai, M.B. Kalousek, Y. Wang, and C.J. Pallen, Eur. J. Biochem, 245, 693 (1997).
V. Bhandari, K. Leong Lim, and C.J. Pallen, J. Biol. Chem., 273, 8691 (1998).
PEPTIDES INTERNATIONAL

J.J. Perez-Villar, et al., Molec. Cell. Biol., 19, 2903 (1999).

Pyro-glutamyl Peptidase Substrates

Pyr-Ala AA OVA-3079 0.1 g 32
l-Pyroglutamyl-l-alanine -20 °C 1g 130
(M.W. 200.19) C8H12N2O4 [21282-08-6]
Substrate for Pyroglutamyl Peptidase
R.F. Doolittle, In, Proteolytic Enzymes, Methods in Enzymology, Vol. 19, (G.E. Perlmann and L. Lorand, Eds.),
Academic Press, New York, 1970, pp. 555-569.

Pyr-MCA AA MPX-3101-v 5 mg 50
l-Pyroglutamic acid 4-methylcoumaryl-7-amide -20 °C vial
(M.W. 286.28) C15H14N2O4 [66642-36-2]
Substrate for Pyroglutamyl Peptidase
K. Fujiwara and D. Tsuru, J. Biochem., 83, 1145
(1978).

Renin Substrates
Asp-Arg-Val-Tyr-lle-His-Pro-Phe-His- A SDH-4133-v 0.5 mg 55
Leu-Val-Ile-His -20 °C vial
(M.W. 1645.9) C79H116N22O17 [82048-97-3]
Substrate for Renin
D.A. Tewksbury, R.A. Dart, and J. Travis, Biochem. Biophys. Res. Commun., 99, 1311 (1981).

192 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT GRADE CODE QTY PRICE
Dabcyl-γ-Abu-Ile-His-Pro-Phe-His-

ENZYME INHIBITORS AND SUBSTRATES

SFQ-3731-PI 1 mg 340
Leu-Val-Ile-His-Thr-Edans -20 °C 5 mg 1360
(Trifluoroacetate Form)
(M.W. 1798.16) C90H120N22O16S [142988-22-5]
FRET Substrate for Renin
G.T. Wang, et al., Anal Biochem, 210, 351-9 (1993).
N. Nakamura, et al., J Biochem (Tokyo), 109, 741-5 (1991).
K. Murakami, et al., Anal Biochem, 110, 232-9 (1981).

Nma-Ile-His-Pro-Phe-His-Leu-Val-Ile- SFQ-3229-v 1 mg 175

His-Thr-Lys(Dnp)-D-Arg-D-Arg-NH2 -20 °C vial
(Trifluoroacetate Form)
[2-(Methylamino)benzoyl]-l-isoleucyl-l-histidyl-l-prolyl-l-phenylalanyl-l-histidyl-l-leucyl-l-valyl-l-
isoleucyl-l-histidyl-l-threonyl-[Nε-(2,4-dinitrophenyl)-l-lysyl]-d-arginyl-d-arginine amide
(M.W. 1952.20) C91H134N30O19
Synthetic Product
Fluorescence-Quenching Substrate for Human Renin
S. Takahashi, K. Hori, M. Shinbo, K. Hiwatashi, T. Gotoh, and S. Yamada, Biosci. Biotechnol. Biochem.,72, 3232 (2008).

Suc-Arg-Pro-Phe-His-Leu-Leu-Val-Tyr-MCA See Code MRP-3110-v.

β-Secretase Substrates
MOCAc-Ser-Glu-Val-Asn-Leu-Asp- B SMO-3212-v 1 mg 185
Ala-Glu-Phe-Arg-Lys(Dnp)-Arg-Arg- -20 °C vial
NH2
[MOCAc-SEVNLDAEFRK(Dnp)RR-NH2]
(Trifluoroacetate Form)

PEPTIDES INTERNATIONAL
(7-Methoxycoumarin-4-yl) acetyl-l-seryl-l-glutamyl-l-valyl-l-Asparaginyl-l-leucyl-l-aspartyl-l-alanyl-l-
glutamyl-l-phenylalanyl-l-arginyl-[Ne-(2,4-dinitrophenyl)-l-lysyl]-l-arginyl-l-arginine amide
(M.W. 2001.1) C86H125N27O29
Fluorescence-Quenching Substrate for b-Secretase
H. Koike, H. Seki, Z. Kouchi, M. Ito, T. Kinouchi, S. Tomioka, H. Sorimachi, T.C. Saido, K. Maruyama, K. Suzuki,
and S. Ishiura, J. Biochem., 126, 235 (1999).

H-Arg-Glu(Edans)-Glu-Val-Asn-Leu-Asp-Ala- SFQ-3690-PI 1 mg 129

Glu-Phe-Lys(Dabcyl)-Arg-OH -20 °C
(Trifluoroacetate Form)
H-RE(Edans)-EVNLDAEFK(Dabcyl)R-OH
(M.W. 2005.26) C91H129N25O25S
Fluorescence-Quenching Substrate for Memapsin 2 (β-Secretase)
J. Ermolieff, J.A. Loy, G. Koelsch, and J. Tang, Biochemistry, 39, 12450 (2000). (substrate termed FS-1 this paper)

γ-Secretase Substrate
Nma-Gly-Gly-Val-Val-Ile-Ala-Thr-Val- B SFQ-3217-v 1 mg 185
Lys(Dnp)-d-Arg-d-Arg-d-Arg-NH2 -20 °C vial
(Trifluoroacetate Form)
[2-Methylamino)benzoylglycylglycyl-l-valyl-l-valyl-l-isoleucyl-l-alanyl-l-threonyl-l-
valyl-[Nε-(2,4-dinitrophenyl)-l-lysyl]-d-arginyl-d-arginyl-d-arginine amide
(M.W. 1609.8) C70H116N26O18
Fluorescence-Quenching Substrate for γ-Secretase
M.R. Farmery, et al., J. Biol. Chem., 278, 24277 (2003). (Original)

Order Hotline 1-800-777-4779 502-266-8787 193

 PRODUCT GRADE CODE QTY PRICE
ENZYME INHIBITORS AND SUBSTRATES

Serum Peptidase Substrate

Dnp-Leu-Gly-Ile-Ala-Gly-Arg-NH2 A SDL-3083-v 2.5 mg 95
2,4-dinitrophenyl-l-leucyl-glycyl-l-isoleucyl-l- -20 °C vial
alanyl-glycyl-l-arginine amide
(M.W. 750.80) C31H50N12O10
Substrate for Serum Peptidase
Y. Masui, T. Takemoto, S. Sakakibara, H. Hori, and Y. Nagai, Biochem. Med., 17, 215 (1977).

Site-1 Protease (S1P) Substrate

Ac-Val-Phe-Arg-Ser-Leu-Lys-MCA MCA-3679-PI 1 mg 85
(Trifluoroacetate Form) -20 °C 5 mg 345
Acetyl-l-valyl-l-phenyl-l-arginyl-l-seryl-l-leucyl-
l-lysine 4-methylcoumaryl-7-amide
(M.W. 948.14) C47H69N11O10
Substrate for Site-1 Protease (S1P)
D. Cheng, P.J. Espenshade, C.A. Slaughter, J.C. Jaen, M.S. Brown, and J.L. Goldstein, J. Biol. Chem., 274, 22805
(1999).

Subtilisin A Substrate
Z-Ala-Ala-Leu-pNA See Code SAP-3127.

Suc-Ala-Ala-pNA AA SAA-3117 0.1 g 40

Succinyl-l-alanyl-l-alanine p-nitroanilide -20 °C 1g 180
(M.W. 380.35) C16H20N4O7

Suc-Ala-pNA AA SAN-3116 0.1 g 30

PEPTIDES INTERNATIONAL

Succinyl-l-alanine p-nitroanilide -20 °C 1g 105

(M.W. 309.27) C13H15N3O6

Trans-glutaminase Substrate
Z-Gln-Gly AA SZQ-3190 1g 170
Benzyloxycarbonyl-l-glutaminylglycine -20 °C 5g 515
(M.W. 337.33) C15H19N3O6 [6610-42-0]
Substrate for Transglutaminase
J.E. Folk and P.W. Cole, J. Biol. Chem., 241, 5518 (1966).
H. Ando, M. Adachi, K. Umeda, A. Matsuura, M. Nonaka, R. Uchio, H. Tanaka, and M. Motoki,
Agric. Biol. Chem., 53, 2613 (1989).

Tripeptidyl Peptidase II Substrate

Ala-Ala-Phe-MCA AA MCA-3201-v 5 mg 55
(Hydrochloride Form) -20 °C vial
l-alanyl-l-alanyl-l-phenylalanine 4-methylcoumaryl-7-amide
(M.W. 464.51) C25H28N4O5 [62037-41-6]
Substrate for Tripeptidyl Peptidase II
(Component of Giant Protease with Some Proteasome Function)
R. Glas, M. Bogyo, J.S. McMaster, M. Gaczynska, and H. L. Ploegh, Nature, 392, 618 (1998).
E. Geier, et al., Science, 283, 978 (1999).

194 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT GRADE CODE QTY PRICE

ENZYME INHIBITORS AND SUBSTRATES

Trypsin and Trypsin-like Protease Substrates
Ac-Arg-OMe • HCl B SRM-3078 1g 40
Acetyl-l-arginine methyl ester • -20 °C 5g 105
monohydrochloride
(M.W. 230.26 • 36.46) C9H18N4O3 • HCI [1784-05-0]
Substrate for C1r
R.B. Sim, In, Proteolytic Enzymes Part C, Methods in Enzymology, Vol. 80, (L. Lorand, ed.),
Academic Press, New York, 1981, pp. 26-42.

Ac-Gly-Lys-OMe • AcOH A SGK-3058 0.1 g 30

[AGLME] -20 °C 1g 99
Acetyl-glycyl-l-lysine methyl ester
(M.W. 259.30 • 60.05) C11H21N3O4 • CH3COOH [14752-92-2]
Substrate for u-PA (Urokinase) and C1s
P.L. Walton, Biochim. Biophys. Acta., 132, 104 (1967).
N. Miwa, Y. Obata, and A. Suzuki, Biochem. Biophys. Res. Commun., 112, 754 (1983).
R.B. Sim, In, Proteolytic Enzymes Part C, Methods in Enzymology, Vol. 80, (L. Lorand, Ed.),
Academic Press, New York, 1981, pp. 26-42.

Boc-Gln-Ala-Arg-MCA A MQR-3135-v 5 mg 65
t-Butyloxycarbonyl-l-glutaminyl-l-alanyl-l- -20 °C vial
arginine
4-methylcoumaryl-7-amide
(M.W. 630.69) C29H42N8O8 [113866-20-9]
Substrate for Trypsin
S. Kawabata, T. Miura, T. Morita, H. Kato, K. Fujikawa, S. Iwanaga, K. Takada, T. Kimura, and S. Sakakibara,

PEPTIDES INTERNATIONAL
Eur. J. Biochem., 172, 17 (1988).

Boc-Leu-Gly-Arg-MCA See Code MLG-3102-v.

Boc-Phe-Ser-Arg-MCA See Code MFS-3107-v.

Bz-Arg-MCA A MBR-3092-v 5 mg 45
(Hydrochloride form) -20 °C vial
Benzoyl-l-arginine 4-methylcoumaryl-7-amide
(M.W. 435.48) C23H25N5O4 [83701-04-6]
Substrate for Trypsin
Y. Kanaoka, T. Takahashi, H. Nakayama, K. Takada, T. Kimura, and S. Sakakibara, Chem. Pharm. Bull., 25, 3126 (1977).

Bz-Arg-NH2 • HCl • H2O AA SRA-3002 1g 32

Benzoyl-l-arginine amide monohydrochloride -20 °C 5g 80
monohydrate
(M.W. 277.32 • 36.46 • 18.02) C13H19N5O2 • HCI • H2O [4299-03-0]
Substrate for Trypsin
K.A. Walsh, In, Proteolytic Enzymes, Methods in Enzymology, Vol. 19, (G.E. Perlmann and L. Lorand, Eds.),
Academic Press, New York, 1970, pp. 41-63.

Bz-Arg-OEt • HCl A SRE-3001 1g 30

[BAEE] -20 °C 25 g 55
Benzoyl-l-arginine ethyl ester monohydro-
chloride
(M.W. 306.36 • 36.46) C15H22N4O3 • HCI [2645-08-1]
Substrate for Trypsin K.A. Walsh, In, Proteolytic Enzymes, Methods in Enzymology, Vol. 19, (G.E. Perlmann and
L. Lorand, Eds.), Academic Press, New York, 1970, pp. 41-63.

Order Hotline 1-800-777-4779 502-266-8787 195

 PRODUCT GRADE CODE QTY PRICE
ENZYME INHIBITORS AND SUBSTRATES

Bz-dl-Arg-pNA • HCl A SRN-3013 0.1 g 25

[dl-BAPA] -20 °C 5g 45
Benzoyl-dl-arginine p-nitroanilide monohydrochloride
(M.W. 398.42 • 36.46) C19H22N6O4 • HCl [911-77-3]
Substrate for Trypsin-like Protease
K.A. Thomas and R.A. Bradshaw, In, Proteolytic Enzymes Part C, Methods in Enzymology, Vol. 80, (L. Lorand, Ed.),
Academic Press, New York, 1981, pp. 609-620.
G.A. Grant, A.Z. Eisen, and R.A. Bradshaw, In, Proteolytic Enzymes Part C, Methods in Enzymology, Vol. 80,
(L. Lorand, Ed.), Academic Press, New York, 1981, pp. 722-734.

Bz-L-Arg-pNA See Code SRN-3057.

Tos-Arg-OMe • HCI A STR-3003 5g 35

[TAME] -20 °C 25 g 99
Tosyl-l-arginine methyl ester monohydrochlo-
ride 100 g 272
(M.W. 342.41 • 36.46) C14H22N4O4S • HCI [1784-03-8]
Substrate for Trypsin
K.A. Walsh, In, Proteolytic Enzymes, Methods in Enzymology, Vol. 19, (G.E. Perlmann and L. Lorand, Eds.),
Academic Press, New York, 1970, pp. 41-63.

Tos-Lys-OMe • HCI A STK-3054 0.1 g 25

Tosyl-l-lysine methyl ester monohydrochloride -20 °C 1g 45
(M.W. 314.40 • 36.46) C14H22N2O4S • HCI
[5266-48-8]
Substrate for Trypsin
F. Widmer and J.T. Johansen, Carlsberg Res. Commun., 44, 37 (1979).
PEPTIDES INTERNATIONAL

F. Widmer, K. Breddam, and J.T. Johansen, Proc. 16th European Peptide Symposium (K. Brunfeldt, Ed.),
Scriptor, Copenhagen 1981, pp. 46-55.

Ubiquitin Proteasome System Substrates

Ac-Arg-Leu-Arg-MCA MCA-3729-PI 1 mg 100
Ac-RLR-MCA -20 °C 5 mg 400
(Trifluoroacetate Form)
(M.W. 642.76) C30H46N10O6 [929903-87-7]
Fluorogenic Substrate; Substrate for 20S Proteasome
A.F. Kisselev, et al., J. Biol. Chem., 281 (2006).
A.F. Kisselev and A.L.Goldberg, Meth. Enzy., 398 (2005).
K.J. Rogders and R.T. Dean, Intl. J. Biochem.Cell.Biol., 35 (2003)

Ac-Gly-Pro-Leu-Asp-MCA MCA-3649-PI 5 mg 95
[Ac-GPLD-MCA] -20 °C
(Acetate Form)
Substrate for Caspase-Like Site of
Proteasomes
(M.W. 599.65) C29H37N5O9
A. Kisselev, et al., J. Biol. Chem., 278, 35869 (2003).

Ac-Nle-Pro-Nle-Asp-MCA MCA-3650-PI 5 mg 95
(M.W. 655.75) C33H45N5O9 -20 °C
Substrate for Caspase-Like Site of Proteasomes
A. Kisselev, et al.,, J. Biol. Chem., 278, 35869 (2003).

196 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT GRADE CODE QTY PRICE
Suc-Ala-Glu-MCA

ENZYME INHIBITORS AND SUBSTRATES

A MAE-3160-v 5 mg 55
Succinyl-l-alanyl-l-glutamic acid a-4-methyl- -20 °C vial
coumaryl-7-amide
(M.W. 475.45) C22H25N3O9
Substrate for Ingensin / Proteasome.
S. Ishiura, T. Tsukahara, T. Tabira, and H. Sugita, FEBS Lett., 257, 388 (1980)

Z-Leu-Arg-Gly-Gly-MCA A MLG-3176-v 5 mg 95
Benzyloxycarbonyl-l-leucyl-l-arginyl- -20 °C vial
glycylglycine
4-methylcoumaryl-7-amide
(M.W. 692.76) C34H44N8O8 [167688-68-2]
Substrate for Isopeptidase T
R.L Stein, Z. Chen, and F. Melandri, Biochemistry, 34, 12616 (1995).

Z-Leu-Leu-Glu-MCA A MLG-3179-v 5 mg 75
Benzyloxycarbonyl-l-leucyl-l-leucyl-l-glutamic -20 °C vial
acid
a-(4-methylcoumaryl-7-amide)
(M.W. 664.75) C35H44N4O9 [348086-66-8]
Substrate for Proteasome

Z-Leu-Leu-Leu-MCA A MLL-3177-v 5 mg 65
Benzyloxycarbonyl-l-leucyl-l-leucyl-l-leucine -20 °C vial
4-methylcoumaryl-7-amide
(M.W. 648.79) C36H48N4O7
Substrate for Proteasome
S. Tsubuki, et al., Biochem. Biophys. Res. Commun., 196, 1195 (1993).

PEPTIDES INTERNATIONAL
Boc-Leu-Arg-Arg-MCA See Code MLR-3140-v. Pro-Phe-Arg-MCA See Code MPF-3096-v.
Suc-Leu-Leu-Val-Tyr-MCA See Code MLL-3120-v.

u-PA (Urokinase) Substrates Also see SGK-3058 Ac-Gly-Lys-OMe • AcOH.

Glt-Gly-Arg-MCA A MGG-3097-v 5 mg 55
Glutarylglycyl-l-arginine 4-methylcoumaryl- -20 °C vial
7-amide
(M.W. 502.52) C23H30N6O7 [65147-16-2]
Substrate for u-PA (Urokinase)
T. Morita, et al., J. Biochem., 82, 1495 (1977).
S. Iwanaga, et al., In, KININS-II: Biochemistry, Pathophysiology, and Clinical Aspects, (S. Fujii, H. Moriya, and T. Suzuki,
eds.), Plenum Publishing Co., 1979, pp. 147-163.

Pyr-Gly-Arg-MCA A MPR-3145-v 5 mg 55
l-Pyroglutamyl-glycyl-l-arginine 4-methylcou- -20 °C vial
maryl-7-amide
(M.W. 499.52) C23H29N7O6
Substrate for t-PA and u-PA (Urokinase)

Vascular Processing Enzyme Substrates

Ac-Glu-Ser-Glu-Asn-MCA MCA-3227-v 5 mg 120
[Ac-ESEN-MCA] -20 °C
Acetyl-l-glutamyl-l-seryl-l-glutamyl-l-asparagine α-(4-methylcoumaryl-7-amide)
(M.W. 676.63) C29H36N6O13 Substrate for Vacuolar Processing Enzyme (VPE)
M. Kuroyanagi, M. Nishimura, and I. Hara-Nishimura, Plant Cell Physiol., 43, 143 (2002).
N. Hatsugai, et al., Science, 305, 855 (2004).
M. Kuroyanagi, et al., J. Biol. Chem., 280, 32914 (2005).

Order Hotline 1-800-777-4779 502-266-8787 197

 PRODUCT GRADE CODE QTY PRICE
ENZYME INHIBITORS AND SUBSTRATES

Z-Arg-OBzl(p-NO2) • HBr A SRB-3157 0.1 g 35

Benzyloxycarbonyl-l-arginine p-nitrobenzyl -20 °C 1g 120
ester • Monohydrobromide
(M.W. 443.45 • 80.91) C21H25N5O6 • HBr
[96723-72-7]
Z-Asp-CH2-DCB See Code ICE-3174-v. Z-Glu-Lys(bio)-Asp-aomk See Code ICA-3189-v.
Z-Glu-Lys(Biotinyl)-Asp-CH2-DCB See Code ICA-3189-v.

Z-Gly-Leu AA SGL-3019 0.1 g 25

Benzyloxycarbonylglycyl-l-leucine -20 °C 1g 160
(M.W. 322.36) C16H22N2O5 [1421-69-8]

Z-Gly-Leu-NH2 AA SGL-3037 0.1 g 30

Benzyloxycarbonylglycyl-l-leucine amide -20 °C 1g 80
(M.W. 321.37) C16H23N3O4 [7535-72-0]

Z-Gly-Phe AA SGF-3020 0.1 g 22

Benzyloxycarbonylglycyl-l-phenylalanine -20 °C 1g 55
(M.W. 356.37) C19H20N2O5 [1170-76-9]

Z-Gly-Phe-NH2 AA SGF-3021 0.1 g 30

Benzyloxycarbonylglycyl-l-phenylalanine amide -20 °C 1g 80
(M.W. 355.39) C19H21N3O4 [5513-69-9]

Z-Gly-Pro AA SGP-3055 0.1 g 22

Benzyloxycarbonylglycyl-l-proline -20 °C 1g 55
(M.W. 306.31) C15H18N2O5 [1160-54-9]

Z-Gly-Pro-Leu AA SGL-3039 0.1 g 40

PEPTIDES INTERNATIONAL

Benzyloxycarbonylglycyl-l-prolyl-l-leucine -20 °C 1g 180

(M.W. 419.47) C21H29N3O6 [2646-63-1]

Z-Gly-Pro-Leu-Gly AA SGG-3040 0.1 g 55

Benzyloxycarbonylglycyl-l-prolyl-l-leucyl- -20 °C 1g 340
glycine
(M.W. 476.52) C23H32N4O7
Z-Ile-Glu(OtBu)-Ala-Leu-H (aldehyde) See Code IAT-3169-v. Z-Leu-Leu-H (aldehyde) See Code IZL-3178-v.
Z-Leu-Leu-Leu-H (aldehyde) See Code IZL-3175-v. Z-Leu-Leu-Nva-H (aldehyde) See Code IAT-3170-v.

Z-Phe-Tyr AA SFY-3044 0.1 g 30

Benzyloxycarbonyl-l-phenylalanyl-l-tyrosine -20 °C 1g 80
(M.W. 462.49) C26H26N2O6

Z-Tyr-Glu AA SYE-3069 0.1 g 30

Benzyloxycarbonyl-l-tyrosyl-l-glutamic acid -20 °C 1g 115
(M.W. 444.43) C22H24N2O8 [988-70-5]

Z-Tyr-ONp A-B SYN-3016 0.1 g 25

Benzyloxycarbonyl-l-tyrosine p-nitrophenyl -20 °C 1g 60
ester
(M.W. 436.41) C23H20N2O7 [3556-56-7]

198 Order Hotline 1-800-777-4779 502-266-8787

Frets (Peptide) Library

ENZYME INHIBITORS AND SUBSTRATES

FRETS 25

Nma Dnp

FRETS* - 25Xaa Series

NO2
H
N

* FRETS: Fluorescence Resonance Energy O

Phe
Ala
Pro
Tyr
NO2

Transfer Substrates D-A2pr-Gly- Val

Glu
- Lys
Ile
Asp
- Xaa -Ala-Phe-Pro-Lys-D-Arg-D-Arg

Arg

Zaa Yaa

Design of FRETS-25Xaa
Each substrate (SFA-3701-v - SFV-3719-v) in the FRETS-25Xaa series contains a highly fluorescent
2-(N-methylamino)benzoyl (Nma) group linked to the side chain of the amino-terminal d -2,3-diamino proprionic
acid (D-A 2pr) residue, which is efficiently quenched by a 2,4-dinitrophenyl (Dnp) group linked to the ε-amino
function of Lys. Xaa represents a fixed position of each of the 19 natural amino acids excluding Cys (noted in
product name, code SFA-3701-v - SFV-3719-v). A mixture of 5 amino acid residues (P, Y, K, I, and D) is at the
Yaa position along with a mixture of 5 amino acid residues (F, A, V, E, and R) at the Zaa position for each fixed
Xaa. This provides a peptide mixture of 25 combinations of each Xaa series resulting in a combinatorial library
totaling 475 peptide substrates. Both Nma and Dnp groups are linked to the side chain of the individual residues,
allowing for the determination of the cleavage site by a specific enzyme, through mass spectrometric analysis
and Edman degradation as well.

Principle

PEPTIDES INTERNATIONAL
When an enzyme of interest cleaves any peptide bond between d -A 2pr(Nma) and Lys(Dnp) in the substrate, the
fluorescence at λex = 340 nm and λem = 440 nm increases in proportion to the release of the Nma fluorophore
from the internal Dnp quencher.

Reagents
1) Each substrate stock solutions: each FRETS-25Xaa (Code SFA-3701-v - Code SFV-3719-v) in 1.0 ml of
DMSO (1 mM, total of peptides)
2) Reference compounds stock solution: a 1:1 mixture of two solutions of Code STD-3720-v and Code STD-
3721-v, each of which is reconstituted by dissolving peptides in 0.5 ml of DMSO at the concentration of 2 mM
(1 mM, each reference compound)
3) Enzyme solution: an enzyme of interest in an appropriate buffer
4) Buffer

Procedure for the deduction of the substrate specificity of an enzyme with

unidentified cleavage specificity
Choose the proper conditions for the measurement, such as substrate concentration and sensitivity setting,
depending on the purpose of the experiment and the instrument available. Described here is one of the
recommended procedures for determining the enzymatic cleavage site by the combination of the fluorometric
analysis and liquid chromatography-mass spectrometry (LC-MS) analysis.
Please refer to our complete product brochure for additional experimental details and protocol recommendations.
Please contact our technical specialists or refer to our web site for additional information.

Fluorescence-Quenching Substrate Library

All library products have the general structure:
d-A2pr(Nma)-Gly-[Phe/Ala/Val/Glu/Arg]-[Pro/Tyr/Lys/Ile/Asp]-Gly-Ala-Phe-Pro-Lys(Dnp)-d-Arg-d-Arg
where A2pr(Nma) = Nβ-[2-(N-Methylamino)benzoyl]-2,3-diaminopropionic acid (Lys(Dnp): N ε-(2,4-
dinitrophenyl)lysine)
All substrates are sold as trifluoroacetate form and contain 1 µmol of stated library.

Order Hotline 1-800-777-4779 502-266-8787 199

 ENZYME INHIBITORS AND SUBSTRATES
i) Primary screening: selection of the favored Xaa
• Substrate solution for primary screening (PS solution): Dilute 20 µl of each of the above substrate stock
solution with 1980 µl of an appropriate buffer (10 µM)
• Reference compounds solution for primary screening (PR solution):
Dilute 20 µl of the above reference compounds stock solution with 1980 µl of an appropriate
buffer (10 µM)

1) Set a fluorescence spectrophotometer at λex = 340 nm and λem = 440 nm

2) Mix one of the PS solution and the PR solution in ratios of 10/0, 9/1, 8/2, 5/5 and 0/10
3) Measure the fluorescence of the prepared solutions to obtain the calibration curve for the cleaved products
4) Pipette 200 µl each of all PS solutions into the cells and incubate them in the fluorescence
spectrophotometer for 3 min (temperature equilibration)
5) Measure the fluorescence of each solution (initial fluorescence blank)
6) Add an appropriate volume of enzyme solution
7) Record the increase of the fluorescence intensity
8) Terminate the enzymatic reaction by using a proper inhibitor (leupeptin, E-64, pepstatin, EDTA and so on)
or changing the pH of the reaction medium (using TCA, AcOH, NaOH and so on)
9) Choose the best Xaa-containing substrate for secondary screening
ii) Secondary screening: identification of the specificity of the enzyme (I)
• Substrate solution for secondary screening (SS solution): Dilute 200 µl of the stock solution of the best
Xaa-containing substrate chosen by the above primary screening with 1800 µl of an appropriate buffer
(100 µM)
• Reference compounds solution for secondary screening (SR solution):
Dilute 200 µl of the above reference compounds stock solution with 1800 µl of an
appropriate buffer (100 µM)
1) Set a fluorescence spectrophotometer at λex = 340 nm and λem = 440 nm
2) Mix the SS solution and the SR solution in ratios of 100/0, 95/5, 90/10, 80/20, 50/50 and 0/100
PEPTIDES INTERNATIONAL

3) Measure the fluorescence of the prepared solutions to obtain the calibration curve for the cleaved products
4) Pipette 200 µl of the SS solution into the cells and incubate them in the fluorescence spectrophotometer for
3 min (temperature equilibration)
5) Measure the fluorescence of each solution (initial fluorescence blank)
6) Add an appropriate volume of enzyme solution
7) Record the increase of the fluorescence intensity
8) Terminate the enzymatic reaction by using a proper inhibitor or changing the pH of the reaction medium upon
completion of the reaction at the points of 0%, 5%, 10% and 20% of the total
9) Subject 100 µl aliquots to LC-MS
iii) LC-MS: identification of the specificity of the enzyme (2)
• Analytical conditions
column: ODS
eluant: A) H2O containing 0.05% TFA, B) CH3CN containing 0.05% TFA
gradient: 10% to 40% B) in A) over 50 min
detection: UV at 220 nm and 400 nm or fluorescence

1) Inject 100 µl aliquots of each terminated solution at different stages of the reaction
2) Measure the MW of the cleaved product(s) in the peak(s) with the absorbance at 220 nm but not with 400 nm
[identification of the N-terminal segment(s)]
3) Deduce their structure from the attached list of the theoretical MW for the cleaved products
*Comment 1: If the N-terminal segment has the identical retention time to the C-terminal segment or one of
the starting uncleaved substrates, detection of the products by fluorescence is recommended.
*Comment 2: In the accidental case where the two products with the same MW (ex. Zaa-Yaa=Phe-Asp and
Val-Tyr, Glu-Asp and Phe-Pro) are generated from one of the substrates, their analyses should be carried
out by MS-MS sequencing and/or by Edman degradation.

200 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT CODE QTY PRICE
Usefulness and limitation of FRETS-25Xaa series for screening of substrate

ENZYME INHIBITORS AND SUBSTRATES

specificities of proteases

We have confirmed that FRETS-25Xaa series are effectively used for the assay of numerous proteases such as
trypsin, chymotyrpsin, elastase, thrombin, papain, calpain, pepsin and thermolysin. However, they did not work
well for the assay of caspase-3 and furin, probably because they have only three changeable sites (Zaa-Yaa-
Xaa) in each substrate (deficiency of P4 site). This fact implies that FRETS-25Xaa might not be applicable to the
assay of an enzyme with wide range interacting sites with substrate.

1. K. Takada, M. Tsunemi, Y. Nishiuchi, and T. Kimura, A Fluorescence Resonance Energy Transfer Substrate (FRETS) Library
for Determining Protease Specificity. [Peptide Revolution: Genomic, Proteomics & Therapeutics]
(Proceedings of the 18th American Peptide Symposium) 327 (2003).
2. S. Tanskul, K. Oda, H. Oyama, N. Noparatnaraporn, M. Tsunemi, and K. Takada, Substrate specificity of alkaline serine
proteinase isolated from photosynthetic bacterium, Rubrivivax gelatinosus KDDS1. Biochem. Biophys. Res. Commun., 309,
547 (2003).

PRODUCT CODE QTY PRICE

FRETS (Peptide) Library
Please refer to instructions on page 203-204.

FRETS-25Ala SFA-3701-v 1 µmol 120

(Trifluoroacetate Form) -20 °C vial
d-A2pr(Nma)-Gly-[Phe/Ala/Val/Glu/Arg]-[Pro/Tyr/Lys/Ile/Asp]-
Ala-Ala-Phe-Pro-Lys(Dnp)-d-Arg-d-Arg
A2pr(Nma) : Nβ-[2-(Methylamino)benzoyl]-2,3-diaminopropionic acid

PEPTIDES INTERNATIONAL
(Lys(Dnp): Nε-(2,4-dinitrophenyl)lysine)
Fluorescence-Quenching Substrate Library

FRETS-25Arg SFR-3702-v 1 µmol 120

(Trifluoroacetate Form) -20 °C vial
d-A2pr(Nma)-Gly-[Phe/Ala/Val/Glu/Arg]-[Pro/Tyr/Lys/Ile/Asp]-
Arg-Ala-Phe-Pro-Lys(Dnp)-d-Arg-d-Arg
A2pr(Nma) : Nβ-[2-(Methylamino)benzoyl]-2,3-diaminopropionic acid
(Lys(Dnp): Nε-(2,4-dinitrophenyl)lysine)
Fluorescence-Quenching Substrate Library

FRETS-25Asn SFN-3703-v 1 µmol 120

(Trifluoroacetate Form) -20 °C vial
d-A2pr(Nma)-Gly-[Phe/Ala/Val/Glu/Arg]-[Pro/Tyr/Lys/Ile/Asp]-
Asn-Ala-Phe-Pro-Lys(Dnp)-d-Arg-d-Arg
A2pr(Nma) : Nβ-[2-(Methylamino)benzoyl]-2,3-diaminopropionic acid
(Lys(Dnp): Nε-(2,4-dinitrophenyl)lysine)
Fluorescence-Quenching Substrate Library

FRETS-25Asp SFD-3704-v 1 µmol 120

(Trifluoroacetate Form) -20 °C vial
d-A2pr(Nma)-Gly-[Phe/Ala/Val/Glu/Arg]-[Pro/Tyr/Lys/Ile/Asp]-
Asp-Ala-Phe-Pro-Lys(Dnp)-d-Arg-d-Arg
A2pr(Nma) : Nβ-[2-(Methylamino)benzoyl]-2,3-diaminopropionic acid
(Lys(Dnp): Nε-(2,4-dinitrophenyl)lysine)
Fluorescence-Quenching Substrate Library

Order Hotline 1-800-777-4779 502-266-8787 201

 PRODUCT CODE QTY PRICE
FRETS-25Gln SFQ-3705-v 1 µmol 120
ENZYME INHIBITORS AND SUBSTRATES

(Trifluoroacetate Form) -20 °C vial

d-A2pr(Nma)-Gly-[Phe/Ala/Val/Glu/Arg]-[Pro/Tyr/Lys/Ile/Asp]-
Gln-Ala-Phe-Pro-Lys(Dnp)-d-Arg-d-Arg
A2pr(Nma) : Nβ-[2-(Methylamino)benzoyl]-2,3-diaminopropionic acid
(Lys(Dnp): Nε-(2,4-dinitrophenyl)lysine)
Fluorescence-Quenching Substrate Library
FRETS-25Glu SFE-3706-v 1 µmol 120
(Trifluoroacetate Form) -20 °C vial
d-A2pr(Nma)-Gly-[Phe/Ala/Val/Glu/Arg]-[Pro/Tyr/Lys/Ile/Asp]-
Glu-Ala-Phe-Pro-Lys(Dnp)-d-Arg-d-Arg
A2pr(Nma) : Nβ-[2-(Methylamino)benzoyl]-2,3-diaminopropionic acid
(Lys(Dnp): Nε-(2,4-dinitrophenyl)lysine)
Fluorescence-Quenching Substrate Library

FRETS-25Gly SFG-3707-v 1 µmol 120

(Trifluoroacetate Form) -20 °C vial
d-A2pr(Nma)-Gly-[Phe/Ala/Val/Glu/Arg]-[Pro/Tyr/Lys/Ile/Asp]-
Gly-Ala-Phe-Pro-Lys(Dnp)-d-Arg-d-Arg
A2pr(Nma) : Nβ-[2-(Methylamino)benzoyl]-2,3-diaminopropionic acid
(Lys(Dnp): Nε-(2,4-dinitrophenyl)lysine)
Fluorescence-Quenching Substrate Library

FRETS-25His SFH-3708-v 1 µmol 120

(Trifluoroacetate Form) -20 °C vial
d-A2pr(Nma)-Gly-[Phe/Ala/Val/Glu/Arg]-[Pro/Tyr/Lys/Ile/Asp]-
His-Ala-Phe-Pro-Lys(Dnp)-d-Arg-d-Arg
PEPTIDES INTERNATIONAL

A2pr(Nma) : Nβ-[2-(Methylamino)benzoyl]-2,3-diaminopropionic acid

(Lys(Dnp): Nε-(2,4-dinitrophenyl)lysine)
Fluorescence-Quenching Substrate Library

FRETS-25Ile SFI-3709-v 1 µmol 120

(Trifluoroacetate Form) -20 °C vial
d-A2pr(Nma)-Gly-[Phe/Ala/Val/Glu/Arg]-[Pro/Tyr/Lys/Ile/Asp]-
Ile-Ala-Phe-Pro-Lys(Dnp)-d-Arg-d-Arg
A2pr(Nma) : Nβ-[2-(Methylamino)benzoyl]-2,3-diaminopropionic acid
(Lys(Dnp): Nε-(2,4-dinitrophenyl)lysine)
Fluorescence-Quenching Substrate Library

FRETS-25Leu SFL-3710-v 1 µmol 120

(Trifluoroacetate Form) -20 °C vial
d-A2pr(Nma)-Gly-[Phe/Ala/Val/Glu/Arg]-[Pro/Tyr/Lys/Ile/Asp]-
Leu-Ala-Phe-Pro-Lys(Dnp)-d-Arg-d-Arg
A2pr(Nma) : Nβ-[2-(Methylamino)benzoyl]-2,3-diaminopropionic acid
(Lys(Dnp): Nε-(2,4-dinitrophenyl)lysine)
Fluorescence-Quenching Substrate Library

FRETS-25Lys SFK-3711-v 1 µmol 120

(Trifluoroacetate Form) -20 °C vial
d-A2pr(Nma)-Gly-[Phe/Ala/Val/Glu/Arg]-[Pro/Tyr/Lys/Ile/Asp]-
Lys-Ala-Phe-Pro-Lys(Dnp)-d-Arg-d-Arg
A2pr(Nma) : Nβ-[2-(Methylamino)benzoyl]-2,3-diaminopropionic acid
(Lys(Dnp): Nε-(2,4-dinitrophenyl)lysine)
Fluorescence-Quenching Substrate Library

202 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT CODE QTY PRICE
FRETS-25Met

ENZYME INHIBITORS AND SUBSTRATES

SFM-3712-v 1 µmol 120
(Trifluoroacetate Form) -20 °C vial
d-A2pr(Nma)-Gly-[Phe/Ala/Val/Glu/Arg]-[Pro/Tyr/Lys/Ile/Asp]-
Met-Ala-Phe-Pro-Lys(Dnp)-d-Arg-d-Arg
A2pr(Nma) : Nβ-[2-(Methylamino)benzoyl]-2,3-diaminopropionic acid
(Lys(Dnp): Nε-(2,4-dinitrophenyl)lysine)
Fluorescence-Quenching Substrate Library

FRETS-25Phe SFF-3713-v 1 µmol 120

(Trifluoroacetate Form) -20 °C vial
d-A2pr(Nma)-Gly-[Phe/Ala/Val/Glu/Arg]-[Pro/Tyr/Lys/Ile/Asp]-
Phe-Ala-Phe-Pro-Lys(Dnp)-d-Arg-d-Arg
A2pr(Nma) : Nβ-[2-(Methylamino)benzoyl]-2,3-diaminopropionic acid
(Lys(Dnp): Nε-(2,4-dinitrophenyl)lysine)
Fluorescence-Quenching Substrate Library

FRETS-25Pro SFP-3714-v 1 µmol 120

(Trifluoroacetate Form) -20 °C vial
d-A2pr(Nma)-Gly-[Phe/Ala/Val/Glu/Arg]-[Pro/Tyr/Lys/Ile/Asp]-
Pro-Ala-Phe-Pro-Lys(Dnp)-d-Arg-d-Arg
A2pr(Nma) : Nβ-[2-(Methylamino)benzoyl]-2,3-diaminopropionic acid
(Lys(Dnp): Nε-(2,4-dinitrophenyl)lysine)
Fluorescence-Quenching Substrate Library

FRETS-25Ser SFS-3715-v 1 µmol 120

(Trifluoroacetate Form) -20 °C vial
d-A2pr(Nma)-Gly-[Phe/Ala/Val/Glu/Arg]-[Pro/Tyr/Lys/Ile/Asp]-
Ser-Ala-Phe-Pro-Lys(Dnp)-d-Arg-d-Arg

PEPTIDES INTERNATIONAL
A2pr(Nma) : Nβ-[2-(Methylamino)benzoyl]-2,3-diaminopropionic acid
(Lys(Dnp): Nε-(2,4-dinitrophenyl)lysine)
Fluorescence-Quenching Substrate Library

FRETS-25Thr SFT-3716-v 1 µmol 120

(Trifluoroacetate Form) -20 °C vial
d-A2pr(Nma)-Gly-[Phe/Ala/Val/Glu/Arg]-[Pro/Tyr/Lys/Ile/Asp]-
Thr-Ala-Phe-Pro-Lys(Dnp)-d-Arg-d-Arg
A2pr(Nma) : Nβ-[2-(Methylamino)benzoyl]-2,3-diaminopropionic acid
(Lys(Dnp): Nε-(2,4-dinitrophenyl)lysine)
Fluorescence-Quenching Substrate Library

FRETS-25Trp SFW-3717-v 1 µmol 120

(Trifluoroacetate Form) -20 °C vial
d-A2pr(Nma)-Gly-[Phe/Ala/Val/Glu/Arg]-[Pro/Tyr/Lys/Ile/Asp]-
Trp-Ala-Phe-Pro-Lys(Dnp)-d-Arg-d-Arg
A2pr(Nma) : Nβ-[2-(Methylamino)benzoyl]-2,3-diaminopropionic acid
(Lys(Dnp): Nε-(2,4-dinitrophenyl)lysine)
Fluorescence-Quenching Substrate Library

FRETS-25Tyr SFY-3718-v 1 µmol 120

(Trifluoroacetate Form) -20 °C vial
d-A2pr(Nma)-Gly-[Phe/Ala/Val/Glu/Arg]-[Pro/Tyr/Lys/Ile/Asp]-
Tyr-Ala-Phe-Pro-Lys(Dnp)-d-Arg-d-Arg
A2pr(Nma) : Nβ-[2-(Methylamino)benzoyl]-2,3-diaminopropionic acid
(Lys(Dnp): Nε-(2,4-dinitrophenyl)lysine)
Fluorescence-Quenching Substrate Library

Order Hotline 1-800-777-4779 502-266-8787 203

 PRODUCT CODE QTY PRICE
FRETS-25Val SFV-3719-v 1 µmol 120
ENZYME INHIBITORS AND SUBSTRATES

(Trifluoroacetate Form) -20 °C vial

d-A2pr(Nma)-Gly-[Phe/Ala/Val/Glu/Arg]-[Pro/Tyr/Lys/Ile/Asp]-
Val-Ala-Phe-Pro-Lys(Dnp)-d-Arg-d-Arg
A2pr(Nma) : Nβ-[2-(Methylamino)benzoyl]-2,3-diaminopropionic acid
(Lys(Dnp): Nε-(2,4-dinitrophenyl)lysine)
Fluorescence-Quenching Substrate Library

FRETS-25-STD1 STD-3720-v 1 µmol 30

d-A2pr(Nma)-Gly -20 °C vial
A2pr(Nma) : Ne-[2-(Methylamino)benzoyl]-2,3-diaminopropionic acid
(M.W. 294.31) C13H18N4O4
Standard Compound 1 for Fluorescence-Quenching Substrate Library FRETS-25 Xaa Series

FRETS-25-STD2 STD-3721-v 1 µmol 30

(Trifluoroacetate Form) -20 °C vial
Ala-Phe-Pro-Lys(Dnp)-d-Arg-d-Arg-
(Lys(Dnp): N -(2,4-dinitrophenyl)lysine)
ε

(M.W. 940.02) C41H61N15O11

Standard Compound 2 for Fluorescence-Quenching Substrate Library FRETS-25 Xaa Series
PEPTIDES INTERNATIONAL

204 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT GRADE CODE QTY PRICE
Polypeptides

ENZYME INHIBITORS AND SUBSTRATES

(Pro-Pro-Gly)5 • H2O OPG-4005 25 mg 60
(M.W. 1274.4) C60H87N15O16 -20 °C 100 mg 170
Purity: higher than 97% by HPLC
K. Kivirrikko, K. Suga, Y. Kishida, S. Sakakibara, and D.J. Prockop, Biochem. Biophys. Res. Commun., 45, 1591 (1971).
(Chem. Synthesis and Biochem.)

(Pro-Pro-Gly)10 • H2O OPG-4006 25 mg 85

(M.W. 2530.8) C120H172N30O31 -20 °C 100 mg 250
Purity: higher than 95% by HPLC
S. Sakakibara, Y. Kishida, Y. Kikuchi, R. Sakai, and K. Kakiuchi, Bull. Chem. Soc. Japan, 41, 1273 (1968).
(Chem. Synthesis)

(Pro-Hyp-Gly)5 • H2O OPG-4032 25 mg 400

(M.W. 1354.4) C60H87N15O21 -20 °C
Purity: higher than 96% by HPLC

S. Sakakibara, K. Inouye, K. Shudo, Y. Kishida, Y. Kobayashi, and D.J. Prockop, Biochim. Biophys. Acta.,
303, 198 (1973). (Chem. Synthesis)

(Pro-Hyp-Gly)10 • H2O OPG-4033 25 mg 595

(M.W. 2690.8) C120H172N30O41 -20 °C
Purity: higher than 90% by HPLC

S. Sakakibara, K. Inouye, K. Shudo, Y. Kishida, Y. Kobayashi, and D.J. Prockop,

Biochim. Biophys. Acta., 303, 198 (1973). (Chem. Synthesis)

Poly-l-Glutamic Acid Sodium Salt OEE-3063 0.1 g 47

PEPTIDES INTERNATIONAL
M.W. > 8000 cut off by dialysis, NCA polymer- -20 °C 1g 233
ized product

Poly-l-lysine Hydrobromide OKK-3056 0.1 g 47

M.W. > 8000 cut off by dialysis, NCA polymer- -20 °C 1g 233
ized product

Poly-l-lysine Hydrochloride OKK-3075 0.1 g 47

M.W. > 8000 cut off by dialysis, NCA polymer- -20 °C 1g 233
ized product [26124-78-7]

Oligopeptides
Dipeptides
b-Ala-His AA OAH-3085 1g 35
[Carnosine] -20 °C 5g 80
β-alanyl-l-Histidine
(M.W. 226.23) C9H14N4O3 [305-84-0]

Glu-Glu A OEE-3080 0.1 g 40

l-glutamyl-l-Glutamic Acid -20 °C 1g 200
(M.W. 276.24) C10H16N2O7 [3929-61-1]

Gly-Gly AA OGG-3028 5g 25
Glycyl-glycine -20 °C 25 g 35
(M.W. 132.12) C4H8N2O3 [556-50-3]
100 g 70

Order Hotline 1-800-777-4779 502-266-8787 205

 PRODUCT GRADE CODE QTY PRICE
ENZYME INHIBITORS AND SUBSTRATES

Gly-Leu AA OGL-3022 0.1 g 25

Glycyl-l-leucine -20 °C 1g 40
(M.W. 188.23) C8H16N2O3 [869-19-2]
5g 105
Gly-Phe AA OGF-3053 0.1 g 22
Glycyl-l-phenylalanine -20 °C 1g 40
(M.W. 222.24) C11H14N2O3 [3321-03-7]

Gly-Phe-NH2 • AcOH AA OGF-3023 0.1 g 30

Glycyl-l-phenylalanine amide -20 °C 1g 80
(M.W. 221.26 • 60.05) C11H15N3O2 • CH3COOH
[13467-26-0]

Gly-Pro AA OGP-3052 0.1 g 30

Glycyl-l-proline -20 °C 1g 60
(M.W. 172.18) C7H12N2O3 [704-15-4]

His-Leu AA OHL-3065 0.1 g 30

l-histidyl-l-leucine -20 °C 1g 105
(M.W. 268.31) C12H20N4O3 [7763-65-7]

Leu-Gly • ½ H2O AA OLG-3024 0.1 g 25

l-leucyl-glycine -20 °C 1g 55
(M.W. 188.22 • 9.01] C8H16N2O3 • ½ H2O
[686-50-0]

cyclo (Leu-Gly) PMI-4070 25 mg 50

[Morphine Tolerance Peptide] -20 °C 100 mg 130
PEPTIDES INTERNATIONAL

Cyclo (l-leucyl-l-glycine)
R. Walter, R.F. Ritzmann, H.N. Bhargava, and L.B. Flexner, Proc. Natl. Acad. Sci. USA, 76, 518 (1979). (Original)I

Met-Met A OMM-3152 0.1 g 40

l-methionyl-l-Methionine -20 °C 1g 170
(M.W. 280.41) C10H20N2O3S2 [7349-78-2]

Pyr-Ala AA OVA-3079 0.1 g 32

l-Pyroglutamyl-l-alanine -20 °C 1g 130
(M.W. 200.19) C8H12N2O4 [21282-08-6]
Substrate for Pyroglutamyl Peptidase
R.F. Doolittle, In, Proteolytic Enzymes, Methods in Enzymology, Vol. 19, (G.E. Perlmann and L. Lorand, Eds.),
Academic Press, New York, 1970, pp. 555-569.

Tripeptides
Glu(Cys-Gly) B OEG-3050 1g 22
[Glutathione,GSH] -20 °C 5g 35
g-l-glutamyl-l-Cysteinyl-glycine
(M.W. 307.32) C10H17N3O6S [70-18-8] 25 g 70
Gly-Gly-Gly AA OGG-3061 1g 30
Glycyl-glycyl-glycine -20 °C 5g 80
(M.W. 189.17) C6H11N3O4 [556-33-2]
25 g 315

206 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT GRADE CODE QTY PRICE
Gly-Gly-His

ENZYME INHIBITORS AND SUBSTRATES

A OGH-3076 0.1 g 50
Glycyl-glycyl-l-Histidine -20 °C 1g 350
(M.W. 269.26) C10H15N5O4 [93404-95-06]
Cu-Binding Peptide
S. Lau, T.P.A Kruch, and B. Sarkar, J. Biol. Chem., 249, 5878 (1974).

Gly-His-Lys • AcOH • H2O PLC-4022 25 mg 90

[Liver-Cell Growth Factor] -20 °C 100 mg 190
l-glycyl-l-histidyl-l-lysine • AcOH • H2O

L. Pickart, L. Thayer, and M.M. Thaler, Biochem. Biophys. Res. Commun., 54, 562 (1973). (Original)

Ile-Pro-Ile • H2O IDP-4132 25 mg 75

[Diprotin A] -20 °C 100 mg 170
l-isoleucyl-l-Propyl-l-Isoleucine • H2O
(M.W. 341.45 . 18.02 ) C17H31N3O4 • H2O [90614-48-5]
Inhibitor for Dipeptidyl Aminopeptidase IV
H. Umezawa, T. Aoyagi, K. Ogawa, H. Naganawa, M. Hamada, and T. Takeuchi, J. Antibiotics, 37, 422 (1984).
(Original; IC50 & Chem. Structure)
• This compound is distributed through the Peptide Institute, Inc. under the license of Microbial Chemistry Research
Foundation.

Leu-Gly-Gly AA OLG-3025 0.1 g 30

l-leucyl-glycyl-glycine -20 °C 1g 110
(M.W. 245.28) C10H19N3O4

Pro-Leu-Gly-NH2 • ½H2O PMI-4024 25 mg 30

[MSH-Release Inhibiting Factor; MIF] -20 °C 100 mg 60

PEPTIDES INTERNATIONAL
l-prolyl-l-leucyl-glycine amide • ½H2O
(M.W. 284.35 . 9.01) C13H24N4O3 . ½H2O [2002-44-0]
A. Vivas and M.E. Celis, J. Endocrinol., 78, 1 (1978). (Pharmacol.)

Pyr-His-Pro-NH2 • H2O AA PTR-4011 25 g 55

TRH (Thyrotropin Releasing Hormone) -20 °C 100 g 150
l-Pyroglutamyl-l-histidyl-l-proline amide
(M.W. 362.39 • 18.02) C16H22N6O4 • 4H2O
R. Burgus, T.F. Dunn, D. Desiderio, and R. Guillemin, C.R. Acad. Sci. Paris, 269, 1870 (1969) (Original; Ovine)
J. Bøler, F. Enzman, K. Folkers, C.Y. Bowers, and A.V. Schally, Biochem. Biophys. Res. Commun., 37, 705 (1969).
(Original; Porcine)

Thr-Val-Leu PSC-4061 25 mg 99
[Schizophrenia Related Peptide] -20 °C 100 mg 205
l-threonyl-l-valyl-l-Leuine
(M.W. 331.41) C15H29N3O5
C.E. Frohman, Chem. Eng. News, 55, 35 (1977).
(Original)

Tetrapeptides
Arg-Gly-Asp-Ser • ½AcOH • 2H2O PFA-4171 25 mg 285
[Fibronectin Active Fragment (RGDS)] -20 °C 100 mg 910
l-arginyl-l-glycyl-l-aspartyl-l-Serine
(M.W. 433.42 • 30.03 • 36.03 ) C15H27N7O8 • ½CH3COOH • 2H2O
M.D. Piershbacher and E. Ruoslahti, Nature, 309, 30 (1984). (Original)
D.M. Haverstick, J.F. Cowan, K.M. Yamada, and S.A. Santoro, Blood, 66, 946 (1985). (Pharmacol.)

Order Hotline 1-800-777-4779 502-266-8787 207

 PRODUCT GRADE CODE QTY PRICE
ENZYME INHIBITORS AND SUBSTRATES

Gly-Gly-Tyr-Arg • AcOH • 2H2O OGG-3119 0.1 g 70

Glycyl-glycyl-l-tyrosyl-l-arginine -20 °C 1g 350
(M.W. 451.48 • 60.05 • 36.03) C19H29N7O6 • CH3COOH • 2H2O
Affinity Ligand for Papain
M.O. Funk, Y. Nakagawa, J. Skochdopole, and E.T. Kaiser, Int. J. Peptide Protein Res., 13, 296, (1979).

Phe-Met-Arg-Phe-NH2 • 1½ AcOH • PFM-4142 25 mg 275

2H2O -20 °C 100 mg 790
[FMRF-amide]
l-Phenyl-l-methionyl-l-arginyl-l-phenylalanine
amide 1½AcOH • 2H2O
(M.W. 598.76 • 90.08 • 36.03 ) C29H42N8O4S • 1½CH3COOH • 2H2O
D.A. Price and M.J. Greenberg, Science, 197, 670 (1977). (Original)

Thr-Lys-Pro-Arg • 2AcOH • 4H2O PTF-4020 25 mg 145

[Tuftsin] -20 °C 100 mg 340
l-threonyl-l-lysyl-l-prolyl-l-arginine
(M.W. 500.59 • 120.10 • 72.06 ) C21H40N8O6 • 2CH3COOH • 4H2O [72103-53-8]
Phagocytosis-Stimulating Peptide
K. Nishioka, A. Constantpoulos , P.S. Satoh, and V.A. Najjar, Biochem. Biophys. Res. Commun., 47, 172 (1972). (Original)
K. Nishioka, P.S. Satoh, A. Constantpoulos, and V.A. Najjar, Biochim. Biophys. Acta, 310, 230 (1973). (Chem. Synthesis
& Pharmacol.)

Trp-Met-Asp-Phe-NH2 • HCl • H2O PCK-4083 25 mg 120

[CCK-Tetrapeptide (30-33)] -20 °C 100 mg 360
l-Trptophyl-l-methionyl-l-aspartyl-l-phenylalanine amide
(M.W. 596.70 • 3646 • 18.02 ) C29H36N6O6S • HCI • H2O [5609-49-4]
PEPTIDES INTERNATIONAL

J.F. Rehfeld, L.I. Larsson, N.R. Goltermann, T.W. Schwarz, J.J. Holst, S.L. Jensen, and J.S. Morley, Nature, 284, 33
(1980). (Neural Pharmacol.)

208 Order Hotline 1-800-777-4779 502-266-8787

 SPECIALTY PRODUCTS & TECHNOLOGIES
Click Chemistry
CLICK Chemistry
Click chemistry is the popular term that
R1
describes a class of efficient and selec-
tive reactions that could be used to join N N+ N-
CuI
R1
N
N

molecules together rapidly and in high + N

yield. The Huisgen 1,3-dipolar cycload-
dition,1 in particular the Cu(I)-catalyzed R2
variant, is applied by Meldal2 for the sol- R2

id phase synthesis of peptidotriazoles,

and by Sharpless3 for the creation of covalent links between diverse building blocks.
Click chemistry has been used in peptide cyclization, DNA-peptide conjugation, fluores-
cent dye labeling and surface immobilization of molecules. It has also been used in prob-
ing enzyme activities in cell lysates4 or visualizing biomolecules in fixed cells.5,6 Recently,
Bertozzi7 reported a unique copper-free version of click chemistry to create biomolecular
probes for in vivo studies of live mice.
1. Huisgen, 1,3-Dipolar Cycloaddition Chemistry, Vol. 1, 1984, p. 1.
2. Tornoe, et al., J Org Chem, 67:3057–3064 (2002).
3. Rostovtsev, et al., Angew Chem Int Ed, 41:2596–2599 (2002).
4. Speers, et al., J Am Chem Soc, 125:4686–4687 (2003).
5. Beatty, et al., Angew Chem Int Ed, 45:7364–7367 (2006).
6. Hsu, et al., Proc Natl Acad Sci USA, 104:2614–2619 (2007).
7. Baskin, et al., Proc Natl Acad Sci USA, 104:16793–16797 (2007).

PEPTIDES INTERNATIONAL
Building Blocks for CLICK Chemistry
Peptides International offers a broad selection of reagents for click chemistry including
azido building blocks, azido amino acids, azido-PEGs, and propargyl derivatives. Ap-
plications of these reagents include novel drug design, ligations to modulate bimolecular
function, targeted delivery, nanotechnology, radiotracer attachments, and others.
Please contact us for bulk quantities or custom designed reagents for CLICK chemistry
applications. We also offer cost effective custom chemistry services utilizing these in-
novative reagents.

Protected Azido Acids Azido PEG reagents

N3
R
N3 O
OH O R
Prot N X
H

O Propargyl derivatives

Order Hotline 1-800-777-4779 502-266-8787 209

 PRODUCT CODE QTY PRICE
SPECIALTY PRODUCTS & TECHNOLOGIES

Click Chemistry
Clickable-TAT Alkyne (49-57) TAT-3733-PI 1 mg 225
5-hexynoyl-RKKRRQRRR-NH2 -20 °C 5 mg 900
(Trifluoroacetate Form)
5-hexynoyl-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-NH2
(M.W. 1432.76) C59H113N31O11
Modified HIV TAT Sequence 49-57 for Click Chemistry
S. Brown and D. Graham, Tet Lett, 51, 5032 (2010).

Clickable-TAT Azide (49-57) TAT-3734-PI 1 mg 225

5-azido-pentanoyl-RKKRRQRRR-NH2 -20 °C 5 mg 900
(Trifluoroacetate Form)
5-azido-pentanoyl-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-NH2
(M.W. 1463.78) C58H114N34O11
Modified HIV TAT Sequence 49-57 for Click Chemistry
S. Brown and D. Graham, Tet Lett, 51, 5032 (2010)..

cyclo [Arg-Gly-Asp-d-Phe-Lys (PEG-PEG- RGD-3759-PI 1 mg 280

Azide)] -20 °C 5 mg 1120
(Trifluoroacetate Form)
(M.W. 920.0) C39H61N13O13
Clickable RGD for Dendrimer Constructs

cyclo [Arg-Gly-Asp-d-Phe-Lys (Azide)] RGD-3749-PI 1 mg 75

(Trifluoroacetate Form) -20 °C 5 mg 225
(M.W. 629.68) C27H39N11O7
PEPTIDES INTERNATIONAL

Clickable RGD for Dendrimer Constructs

8-Azido-3,6-Dioxaoctanoic Acid AXX-1905-PI 1g 325

Azido-mini-PEGTM CHA salt 1300
4 °C O
5g

(M.W. 189.17) C6H11N3O4 [88518-90-3]
N3 O
Building Block for Click Chemistry O OH

NH2

5-Azido-Pentanoic Acid AXX-1906-PI 1g 180

δ-Azidovaleric Acid 720
4 °C 5g
(M.W. 143.15) C5H9N3O2 [79583-98-5]
Building Block for Click Chemistry

6-Azido-Hexanoic Acid AHA-1904-PI 1g 180

ε-Azidocaproic Acid 720
4 °C 5g
(M.W. 157.17) C6H11N3O2 [79598-53-1]
Building Block for Click Chemistry 4 °C 4 °C
P. Wu, et al., Angew. Chem. Intl Ed. Engl., 43, 3928 (2004).
C. Grandjean, et al., J. Org. Chem., 70, 7123 (2005).

CHA= Cyclohexylamine

210 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT CODE QTY PRICE

SPECIALTY PRODUCTS & TECHNOLOGIES

Specialty Biologically Active Peptides
Derivatizable Cell Penetrating Peptides (CCPs)
Cys-TAT (49-57) TAT-3735-PI 1 mg 180
H-CRKKRRQRRR-NH2 -20 °C 5 mg 720
(Trifluoroacetate Form)
Cys-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-NH2
(M.W. 1441.79) C56H112N32O11S
Cys- Modified HIV TAT sequence 49-57
L. Santos-Cuevas, et al., Nucl Med Commun., 32, 303 (2011).
P.A. Wender, et al., PNAS, 97, 13003 (2000).
J. Park, et al., J. Gen. Virol., 83, 1173 (2002).

Cys(Npys)-TAT (49-57) TAT-3751-PI 1 mg 225

C(Npys)RKKRKQRRR-NH2 -20 °C 5 mg 900
(Trifluoroacetate Form)
Cys(Npys)-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-NH2
(M.W. 1594.93) C61H113N34O13S2
Cys- Activated TAT for Cargo Conjunction
J. Embury, et al., Diabetes, 50, 1706 (2001).
H. Wang, et al., J. Clin. Invest., 109, 1463 (2002).
Y.-Z. Lin, J. Biol. Chem., 270, 14255 (1995).
D. Holzberg, et al., J. Biol. Chem., 278, 40213 (2003).
E. Williams, et al., J. Biol. Chem., 272, 22349 (1997).
L.A. Kueltzo and C.R. Middaugh, Expert Opinion on Investigational Drugs, 9, 2039 (2000).
A. Mortlock, et al., Nucleic Acids Res., 31, e152 (2003).
S.R. Schwarze, et al., Science. 285:1569-1572 (1999).

PEPTIDES INTERNATIONAL
F. Rabanal, et al., Tetrahedron Letters, 37(9):1347-1350 (1996).

Other Specialty Peptides and Miscellaneous Products

cyclo [Arg-Gly-Asp-d-Phe-Lys (PEG-PEG-Azide)] See Code RGD-3759-PI.

Doxorubicin-HCl IOX-3765-PI 1 mg 1000

(M.W. 579.98 • 36.46) C27H29NO11 • HCl [25316-40-9] -20 °C
Inhibitor of Reverse Transcriptase and RNA Polymerase
[13C18,15N3]-Hepcidin (Human) PLP-3405-v 20 μg 260
[[13C9,15N]Phe4,9, [15N]Gly12]-Hepcidin (Human) -20 °C vial
(Trifluoroacetate Form)
Asp-Thr-His-[13C9,15N]Phe-Pro-Ile-Cys-Ile-[13C9,15N]Phe-Cys-Cys-
[15N]Gly-Cys-Cys-His-Arg-Ser-Lys-Cys-Gly-Met-Cys-Cys-Lys-Thr
(Reported disulfide bonds between Cys7-Cys23, Cys10-Cys13, Cys11-Cys19, and Cys14-Cys22)
(M.W. 2810.2) C9513C18H170N3115N3O31S9
Stable Isotope-Labeled Peptide for Mass Spectrometric Detection of Hepcidin (Human)
N. Murao, M. Ishigai, H. Yasuno, Y. Shimonaka, and Y. Aso, Rapid Commun. Mass Spectrom., 21, 4033 (2007).
T. Hosoki, K. Ikuta, Y. Shimonaka, Y. Sasaki, H. Yasuno, K. Sato, T. Ohtake, K. Sasaki, Y. Torimoto, K. Saito,
and Y. Kohgo, Proteomics Clin. Appl., 3, 1256 (2009).

Order Hotline 1-800-777-4779 502-266-8787 211

 PRODUCT CODE QTY PRICE
SPECIALTY PRODUCTS & TECHNOLOGIES

4-[D10]Leu-Insulin (Human) PLP-3404-s 20 μg 220

[[2H10]LeuB6,B11,B15,B17]-Insulin (Human)
-20 °C vial
(Trifluoroacetate Form)
A-chain:
Gly-Ile-Val-Glu-Gln-Cys-Cys-Thr-Ser-Ile-Cys-Ser-Leu-Tyr-Gln-Leu-Glu-Asn-Tyr-Cys-Asn
B-chain:
Phe-Val-Asn-Gln-His-[2H10]Leu-Cys-Gly-Ser-His-[2H10]Leu-Val-Glu-Ala-[2H10]Leu-Tyr-[2H10]Leu-Val-Cys-
Gly-Glu-Arg-Gly-Phe-Phe-Tyr-Thr-Pro-Lys-Thr
(Disulfide bonds between CysA6-CysA11, CysA7-CysB7, and CysA20-CysB19)
(M.W. 5847.8) C257H343D40N65O77S6
Stable Isotope-Labeled Peptide Useful for Standardization of Insulin Immunoassays
K. Van Uytfanghe, D. Rodríguez-Cabaleiro, D. Stöckl, and L.M. Thienpont,
Rapid Commun. Mass Spectrom., 21, 819 (2007).
D. Rodríguez-Cabaleiro, K. Van Uytfanghe, V. Stove, T. Fiers, and L.M. Thienpont, Clin. Chem., 53, 1462 (2007).
3) W.G. Miller, L.M. Thienpont, K. Van Uytfanghe, P.M. Clark, P. Lindstedt, G. Nilsson, and M.W. Steffes,
Clin. Chem., 55, 1011 (2009).

Myr-Ser-Ile-Tyr-Arg-Arg-Gly-Ala-Arg-Arg-Trp- PKC-3403-v 1 mg 110

Arg-Lys-Leu -20 °C
[Myristoyl-PKC ζ (113-125) TFA
(Trifluoroacetate Form)
Myristoyl-Ser-Ile-Tyr-Arg-Arg-Gly-Ala-Arg-Arg-Trp-Arg-Lys-Leu
(M.W. 1928.40) C90H154N30O17
Myristoylated Cell Permeable PKCζ Pseudosubstrate Inhibitor
C. Laudanna, D. Mochly-Rosen, T. Liron, G. Constantin, and E.C. Butcher,
J. Biol. Chem., 273, 30306 (1998). (Pharmacol.)
S. Lim, J.W. Choi, H.S. Kim, Y.-H. Kim, K. Yea, K. Heo, J.H. Kim, S.-H. Kim, M. Song, J.I. Kim, S.H. Ryu, and P.-G. Suh,
Life Sci., 82, 733 (2008). (Biochem.)
PEPTIDES INTERNATIONAL

T. Hirose, D. Satoh, H. Kurihara, C. Kusaka, H. Hirose, K. Akimoto, T. Matsusaka, I. Ichikawa, T. Noda, and S. Ohno,
PLoS ONE, 4, e4194 (2009). (Pharmacol. & Histochem.)
P.V. Migues, O. Hardt, D.C. Wu, K. Gamache, T.C. Sacktor, Y.T. Wang, and K. Nader, Nat. Neurosci.,13, 630 (2010).
(Pharmacol.)

Carbohydrates
2,3,4,6-Tetra-O-Acetyl-a-d- CAR-22001 1g 175
GlucopyranosylαFluoride -20°C
5g 565
(M.W. 350.29) C14H19O9F
OAc
Glycosyl Donor (Glycosyl Fluoride) O
AcO
AcO
AcO
F

2,3,4,6-Tetra-O-Acetyl-a-d-Galactopyranosyl
22001
CAR-22002 1g 170
Fluoride -20°C 5g 570
(M.W. 350.29) C14H19O9F
AcO
Glycosyl Donor (Glycosyl Fluoride) OAc
O

AcO
AcO

22002

212 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT CODE QTY PRICE
2,3,4,6-Tetra-O-Acetyl-a-d-Mannopyranosyl

SPECIALTY PRODUCTS & TECHNOLOGIES

CAR-22003 1g 170
Fluoride -20°C 5g 570
(M.W. 350.29) C14H19O9F
Glycosyl Donor (Glycosyl Fluoride) OAc
AcO
O
AcO
AcO

2-Deoxy-2-Phthalimido-3,4,6-Tri-O-Acetyl-a-d- CAR-22004 1g 225

Glucopyranosyl Fluoride -20°C 5g 745
(M.W. 437.37) C20H20NO9F
Glycosyl Donor (Glycosyl Fluoride) OAc

O
AcO
AcO
Pht=N

2-Deoxy-2-Phthalimido-3,4,6-Tri-O-Acetyl-a-d- CAR-22005 1g 290

Galactopyranosyl Fluoride -20°C 5g 910
(M.W. 437.37) C20H20NO9F
Glycosyl Donor (Glycosyl Fluoride) AcO OAc

O
22004
AcO
Pht=N

PEPTIDES INTERNATIONAL
Methylα(Methylα5-Acetamido-4,7,8,9-Tetra- CAR-22101 1g 570
O-Acetyl-3,5-Dideoxy-2-Thio-d-Glycero-d- -20°C 5g 2250
Galacto-2-Nonulopyranosid)onate
(M.W. 521.54) C21H31NO12S AcO
COOMe
AcO
Glycosyl Donor (Thioglycoside) AcO
O SMe
AcNH
OAc

Phenyltrifluoroacetimidate Glycosyl Donor CAR-22102 5 mg 560

Synthetic Product -20°C 1g 900
(M.W. 795.92) C29H32N2O14Cl3F3
Glycosyl Donor (Phenyltrifluoroacetimidate)
22101
K. Tanaka, T. Goi, and K. Fukase, Synlett, 2958 (2005). (Original; Synthesis)
S. Tanaka, T. Goi, K. Tanaka, and K. Fukase, J. Carbohydr. Chem., 26, 369 (2007). (Synthesis)

Fmoc-Ser[Ac4Galβ(1- >3)Ac2GalNAcα(1- >O)]- CAR-22103 25 mg 845

OH -20 °C

O-β-2,3,4,6-Tetra-O-Acetyl-d-Galactopyranosyl-(1- >3)-O-α- 4,6- Di-O-Acetyl- 2- Acetamido-

2-Deoxy-d-Galactopyranosyl- (1- >O)-9-Fluorenylmethoxycarbonyl-l-Serine
Synthetic Product
(M.W. 944.88) C44H52N2O21
Reagent for Mucin-Type O-Glycopeptide Synthesis
T. Reipen and H. Kunz, Synthesis, 2487 (2003)

Order Hotline 1-800-777-4779 502-266-8787 213

 PRODUCT CODE QTY PRICE
SPECIALTY PRODUCTS & TECHNOLOGIES

Fmoc-Thr[Ac4Galβ(1- >3)Ac2GalNAcα(1- CAR-22104 25 mg 845

>O)] -OH-O-β-2,3,4,6-Tetra-O-Acetyl-d- -20 °C
Galactopyranosyl-(1- >3)-O-α-4,6-Di-O-Acetyl-
2-Acetamido-2-Deoxy-d-Galactopyranosyl-
(1- >O)-9-Fluorenylmethoxycarbonyl-l-
Threonine
Synthetic Product
(M.W. 958.91) C45H54N2O21
Reagent for Mucin-Type O-Glycopeptide Synthesis
C. Brocke and H. Kunz, Synthesis, 525 (2004)

5-Bromo-4-Chloroindol-3-ylα5-Acetamido-3,5- CAR-23001-v 5 mg 115

Dideoxy-a-d-Glycero-d-Galacto-2-[X-Neu5Ac, -20°C vial
X-Sialic Acid, X-NANA] Nonulopyranosidonic
Acid HO
OH
OH
COOH Cl
(Ammonium Form) O
Br
O
(M.W. 537.74) C19H22N2O9BrCl AcNH
Histochemical Substrate for Neuraminidase HO N
H

2-NBDG CKG-23002-v 0.5 mg 65

2-[N-(7-Nitrobenz-2-Oxa-1,3-Diazol-4-yl)Amino]-2-Deoxy-d- -20 °C vial
Glucose OH

(M.W. 342.26) C12H14N4O8 23001-v HO

O

Reagent for Monitoring Glucose Uptake HO

OH
into Single, Living Cells HN

K. Yoshioka, et al., Biochim. Biophys. Acta, 1289, 5 (1996). (Original) NO2

K. Yamada, et al., J. Biol. Chem., 275, 22278 (2000).
PEPTIDES INTERNATIONAL

(Measurement of Glucose Uptake in Living Mammalian Cells)

K. Yamada, et al., Nature Protocols, 2, 753 (2007). (Chem. Synthesis & Protocols for Measurement) N N

J.V. Rocheleau, et al., Proc. Natl. Acad. Sci. U.S.A., 101, 12899 (2004). O

(Monitoring of Glucose Uptake and NAD(P)H Response in Islet)

2-NBDLG CKG-23003-v 0.5 mg 165

2-[N-(7-Nitrobenz-2-Oxa-1,3-Diazol-4-yl)Amino]-2-Deoxy-l- -20 °C vial
Glucose
(M.W. 342.26) C12H14N4O8
Control Substrate for 2-NBDG
T. Yamamoto, Y. Nishiuchi, T. Teshima, H. Matsuoka, and K. Yamada, Tetrahedron Lett., 49, 6876 (2008). (Original)
K. Yamada, M. Saito, H. Matsuoka, and N. Inagaki, Nature Protocols, 2, 753 (2007). (Protocols for Measurement)
• This compound is distributed through Peptide Institute, Inc. under the license of Hirosaki University Graduate School
of Medicine, Tokyo University of Agriculture and Technology, and the Peptide Institute, Inc.

UDP-β-l-Arabinofuranose CKG-23005-s 0.1 mg 205

UDP-β-L-Araf -20 °C vial
(Triethylammonium Form)
Uridine-5'-Diphospho- β-l-Arabinofuranose
(M.W. 536.28) C14H22N2O16P2
Reagent for Research in Arabinofuranose Biogenesis in Plants
T. Konishi, et al., Plant Physiol., 141,1098 (2006). (Substrate for Arabinofuranosyltransferase)
T. Konishi, et al., Glycobiol., 17, 345 (2007).(Use in Enzymatic Furanose-Pyranose Interconversion)
Q. Zhang and H.-W. Liu, Bioorg. Med. Chem. Lett.,11, 145 (2001). (Chem. Synthesis)

214 Order Hotline 1-800-777-4779 502-266-8787

 PRODUCT CODE QTY PRICE
O-(Acetamido-3,5-Dideoxy-d-Glycero-a-

SPECIALTY PRODUCTS & TECHNOLOGIES

CAR-24001-s 0.1 mg 230
d-Galacto-2-Nonulopyranosylonic Acid)- -20°C vial
(2→3)-O-β-d-Galactopyranosyl-(1→4)-O-β-d-
Glucopyranosyl-(1→1)-2S,3R,4E)-2-N-
(7-Nitrobenz-2-Oxa-1,3-Diazol-4-yl) NO2

Aminooctanamido-4-
N
HO O

Octadecene-1,3-diol
OH N
O
HO
NH

[Gm3 Labelled by NBD]

OH COOH
HO O O
OH HN
O
O O O
HO
(Ammonium Form) AcNH
OH
OH OH
OH

(M.W. 1219.3) C55H90N6O24

Fluorescence Labelled Ganglioside
Sialylglycopeptide CAR-24010 5 mg 300
24001-S

SGP (α2,6) -20°C

NEW!
Lys-Val-Ala-[O-(5-Acetamido-3,5-dideoxy-d-glycero-α-d-galacto-2-nonulopyranosylonic acid)-(2→6)-O-β-
d-galactopyranosyl-(1→4)-O-2-acetamido-2-deoxy-β-D-glucopyranosyl-(1→2)-O-α-d-mannopyranosyl-
(1→3)-[O-(5-acetamido-3,5-dideoxy-d-glycero-α-d-galacto-2-nonulopyranosylonic acid)-(2→6)-O-β-d-
galactopyranosyl-(1→4)-O-2-acetamido-2-deoxy-β-d-glucopyranosyl-(1→2)-O-α-d-mannopyranosyl-
(1→6)]-O-β-d-mannopyranosyl-(1→4)-O-2-acetamido-2-deoxy-β-d-glucopyranosyl-(1→4)-N-2-
acetamido-2-deoxy-β-d-glucopyranosyl]-(1→4)-Asn-Lys-Thr
(M.W. 2865.8) C112H189N15O70 [189035-43-6]
A. Seko, et al., Biochim. Biophys. Acta, 1335, 23 (1997).

Glycosidase Inhibitors PEPTIDES INTERNATIONAL

Siastatin B CAR-24002-v 5 mg 115
(3S,4S,5R,6R)-6-(Acetylamino)-4,5-Dihydroxy-3- -20°C vial
Piperidinecarboxylic Acid
Microbial Product H
N
COOH
(M.W. 218.21) C8H14N2O5
Inhibitor for Sialidase CH3CONH
HO
OH
• This compound is distributed through Peptide Institute, Inc.
under the technical and scientific advice of the Microbial Chemistry Research Foundation.

Nojirimycin Bisulfite CAR-24003-v 5 mg 55

5-amino-5-Deoxy-Glucopyranose Bisulfite -20°C vial
Microbial Product 24002-v
CH2OH H
(M.W. 243.23) C6H13NO7S N
HO
Inhibitor for β-Glucosidase (Apricot Emulsion) HO
SO3H
OH

d-Glucaro-d-Lactam CAR-24004-v 5 mg 75
(2S,3R,4S,5R)-3,4,5-Trihydroxy-6-Oxo-2-Piperidinecarboxylic Acid
(Potassium Salt)
-20°C vial
COO H H
Microbial Product N
HO
(M.W. 191.14) C6H9NO6
HO
Inhibitor for Bovine Liver β-Glucuronidase OH O

24003-v
Order Hotline 1-800-777-4779 502-266-8787 215
 PRODUCT CODE QTY PRICE
SPECIALTY PRODUCTS & TECHNOLOGIES

Endotoxins(Synthetic)
Lipid A (E. coli) CLP-24005-s 0.1 mg 240
Compound 506, LA-15-PP -20°C vial
2-Deoxy-6-O-{2-deoxy-2-[(R)-3-(dodecanoyloxy)
tetradecanoylamino]-3-O-[(R)-3-(tetradecanoyloxy)
tetradecanoyl]-β-D-glucopyranosyl}-3-O-[(R)-3-
hydroxytetradecanoyl]-2-[(R)-3-
hydroxytetradecanoylamino]-α-D-glucopyranose
1,4'-diphosphate
(M.W. 1798.4) C94H178N2O25P2
Synthetic Product
Active Principle of Endotoxin
M. Imoto, S. Kusumoto, T. Shiba, E.Th. Rietschel, C. Galanos,
and O. Lüderitz, Tetrahedron Lett., 26, 907 (1985).
(Original; Chem. Structure)
M. Imoto, H. Yoshimura, T. Shimamoto, N. Sakaguchi,
S. Kusumoto, and T. Shiba, Bull. Chem. Soc. Jpn., 60,
2205 (1987). (Chem. Synthesis)

Lipid IVa CLP-24006-s 0.1 mg 240

Compound 406, LA-14-PP, Precursor la -20°C vial
2-Deoxy-6-O-{2-deoxy-3-O-[(R)-3-hydroxytetradecanoyl]-2-
[(R)-3-hydroxytetradecanoylamino]-β-D-glucopyranosyl}-3-O-
[(R)-3-hydroxytetradecanoyl]-2-[(R)-3-hydroxytetradecanoyl-
PEPTIDES INTERNATIONAL

amino]-α-D-glucopyranose 1,4'-diphosphate
(M.W. 1405.7) C68H130N2O23P2 [91841-27-9]
HO O
HOP O O O
Synthetic Product
2 3
HO
O O
Biosynthetic Precursor of Lipopolysaccharide
O
O O
HO O NH
O O NH
NH OPO3H2
O
M. Imoto, S. Kusumoto, T. Shiba, E.Th. Rietschel, C. Galanos,
O O NH
OPO3H2 O O
O O OH
and O. Lüderitz, Tetrahedron Lett., 26, 907 (1985).
O
O OH O
O
(Original; Chem. Structure)
O O O O
O O
M. Imoto, H. Yoshimura, M. Yamamoto, T. Shimamoto,
O

S. Kusumoto, and T. Shiba,Bull. Chem. Soc. Jpn., 60,

2197 (1987). (Chem. Synthesis)

24008

216 Order Hotline 1-800-777-4779 502-266-8787

 PRODUCT CODE QTY PRICE

SPECIALTY PRODUCTS & TECHNOLOGIES

Lipid A (Salmonella) CLP-24008-s 0.1 230
(Triethylammonium Form) -20 °C mg
2- Deoxy-6-O-[2-deoxy-2-[(R)-3-(dodecanoyloxy) HO O vial
tetradecanoylamino]-3-O-[(R)-3-(tetradecanoyloxy) H O P O 2 3
O O

tetradecanoyl]-β-d-glucopyranosyl]-3-O-[(R)-3-
HO
HO O O
O O
O O
hydroxytetradecanoyl]-2-[(R)-3-(hexadecanoyloxy)
O
HO O NH
O O NH OPO H
NH 3 2

tetradecanoylamino]-β- d-glucopyranose 1,4\’- diphosphate

O O NH O
OPO
3 2 H O O
O O OH
(M.W. 2036.80) C110H208N2O26P2
O
O OH O
O O O O O
O
Synthetic
O Product O
Active Principle of Endotoxin
U. Seydel, B. Lindner, H.-W. Wollenweber, and E.T. Rietschel,
Eur. J. Biochem., 145, 505 (1984). (Original; Chem. Structure)
A.X. Tran, M.E. Lester, C.M. Stead, C.R.H. Raetz, D.J. Maskell,
S.C. McGrath, R.J. Cotter, and M.S. Trent, J. Biol. Chem.,
280, 28186 (2005). (Pharmacol.)
Y. Shi, M.J. Cromie, F.-F. Hsu, J. Turk, and E.A. Groisman,
Mol. Microbiol., 53, 229 (2004). (Pharmacol.)
H.S. Gibbons, S. Lin, R.J. Cotter, and C.R.H. Raetz, J. Biol. Chem.,
275, 32940 (2000). (Pharmacol.)

Antiproliferative Factor 24008

Antiproliferative factor (APF) (CAR-24007) is a low molecular weight, heat stable

sialoglycopeptide that contains the transmembrane segment of Frizzled 8. It is made
and secreted by bladder epithelial cells of patients with a condition known as interstitial
cystitis (IC) which causes chronic pain due to ulcers, hemorrhaging, and thinning of
the bladder epithelium.1,2 APF contributes to the pathology of IC by inhibiting bladder
cell proliferation, and was also shown to regulate proliferation of bladder carcinoma

PEPTIDES INTERNATIONAL
cells.2,3 Recently, CKAP4/p63 was identified as a receptor for APF, but how its activity
is mediated remains unknown.4
APF’s role as a negative regulator makes it a possible target for treatment of disease,
and its unique presence in the urine of IC patients indicates it is a biomarker that
may lead to a diagnostic tool for those suffering with IC. Chemists in the division of
carbohydrate chemistry at the Peptide Institute achieved the total synthesis of this
sialoglycopeptide, APF. In addition to other carbohydrate related products, APF is now
available to aid in IC research.
1. S.K. Keay, Z. Szekely, T.P. Conrads, T. D. Veenstra, J.J. Barchi, Jr., C.-O. Zhang, K.R. Koch, and
C.J. Michejda, Proc. Natl. Acad. Sci.U. S. A., 101, 11803 (2004).
2. S. Keay, M. Kleinberg, C.-O. Zhang, M.K. Hise, and J.W. Warren, J. Urol., 64, 2112 (2000).
3. S. Keay, C.-O. Zhang, M. Hise, A.L. Trifillis, J.R. Hebel, S.C. Jacobs, and J. R. Warren, J. Urol.,
156, 2073 (1996).
4. T.P. Conrads, G.M. Tocci, B.L. Hood, C.-O. Zhang, L. Guo, K.R. Koch, C.J. Michejd,
T.D. Veenstra, and S.K. Keay, J. Biol. Chem., 281, 7836 (2006).
See next page for product

Order Hotline 1-800-777-4779 502-266-8787 217

 PRODUCT CODE QTY PRICE
SPECIALTY PRODUCTS & TECHNOLOGIES

Antiproliferative Factor Sialoglycopeptide CAR-24007-v 50 mg 240

APF Sialoglycopeptide -20°C
Thr[Neu5Acα(2→3)Galβ(1→3)
GalNAcα(1→O)]541-Frizzled 8 (541-549)
(Ammonium Form)
O-(Acetamido-3,5-dideoxy-d-glycero-α-d-galacto-2-nonulopyranosylonic acid)-(2→3)-O-β-d-
galactopyranosyl-(1→3)-O-α-2-acetamido-2-deoxy-d-galactopyranosyl-(1→O)-
Thr-Val-Pro-Ala-Ala-Val-Val-Val-Ala
(M.W. 1482.6) C63H107N11O29
Antiproliferative Factor from Interstitial Cystitis Patients
24007

S.K. Keay, C.-O. Zhang, J. Shoenfelt, D.R. Eirkson, K. Whitmore, J.W. Warren, R. Marvel, and T. Chai,
Urology, 57, 9 (2001). (Original)
S. K. Keay, Z. Szekely, T..P. Conrads, T. D. Veenstra, J. J. Barchi, Jr., C.-O. Zhang, K.R. Koch, and
C.J. and Michejda, Proc. Natl. Acad. Sci.U. S. A., 101, 11803 (2004). (Original; Structure & Pharmacol.)
C.-O. Zhang, Z.-L. Li, and C.-Z. Kong, BioMed Central Urology, 5, 7 (2005). (Pharmacol.)

HO OH
OH COOH OH OH
OH OH
O O
AcNH O
HO O
O
AcNH
OH
O O
O
N O O O O
H H H H
N N N N
NH2 N N N OH
H H H
O O O

Big Angiotensin-25 (Human) CAR-24009-s 0.1 mg 200

Bang-25
PEPTIDES INTERNATIONAL

-20°C vial
(Trifluoroacetate Form)
NEW!
Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-Val-Ile-His-[O-β-d-Galactopyranosyl-(1→4)-O-2-acetamido-2-
deoxy-β-d-glucopyranosyl-(1→2)-O-α-d-mannopyranosyl-(1→3)-[O-β-d-galactopyranosyl-(1→4)-O-2-
acetamido-2-deoxy-β-d-glucopyranosyl-(1→2)-O-α-d-mannopyranosyl-(1→6)]-O-β-d-mannopyranosyl-
(1→4)-O-2-acetamido-2-deoxy-β-d-glucopyranosyl-(1→4)-N-2-acetamido-2-deoxy-β-d-glucopyranosyl-
(1→4)]-Asn-Glu-Ser-Thr-Cys(Cys)-Glu-Gln-Leu-Ala-Lys-Ala-Asn
(M.W. 4677.9) C195H307N43O85S2
Synthetic Product
Glycosylated Novel Endogenous Angiotensin Family Peptide
S. Nagata, K. Hatakeyama, M. Asami, M. Tokashiki, H. Hibino, Y. Nishiuchi, K. Kuwasako, J. Kato, Y. Asada, and
K. Kitamura, Biochem. Biophys. Res. Commun., 441, 757 (2013). (Original; Structure & Enzymatic Generation of
Angiotensin II).
H. Hibino, S. Nagata, K. Hatakeyama, M. Asami, M. Tokashiki, K. Kuwasako, J. Kato, Y. Asada, K. Kitamura,
and Y. Nishiuchi, Peptide Science 2013, 50, 151 (2014). (Chem. Synthesis)

Other Carbohydrate Related Products

Adjuvant Peptide Code PAD-4031.
Phosphoramidon Code IPO-4082.

218 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT CODE QTY PRICE
GDP-l-Fuc: N-Acetyl-β-d-Glucosaminide α1-6Fucosyltransferase Substrate

SPECIALTY PRODUCTS & TECHNOLOGIES

GnGn-bi-Asn-PABA SGS-23004-s 0.1 mg 375
Semisynthetic Product with Enzymatically Derived Bovine -20°C vial
γ-Globulin Sugar Moiety
O-β-2-Acetamido-2-deoxy-d-glucopyranosyl-(1→2)-O-α-d-mannopyranosyl-(1→3)-[O-β-2-acetamido-
2-deoxy-d-glucopyranosyl-(1→2)-O-α-d-mannopyranosyl-(1→6)]-O-β-d-mannopyranosyl-(1→4)-O-β-
2-acetamido-2-deoxy-d-glucopyranosyl-(1→4)-N-β-2-acetamido-2-deoxy-d-glucopyranosyl-(1→4)-L-
asparagine 4-(2-pyridylamino)butylamide
(M.W. 1578.5) C63H103N9O37
Semisynthetic Product
Substrate for GDP-l-Fuc: N-Acetyl-β-d-Glucosaminide α1-6Fucosyltransferase
N. Uozumi, T. Teshima, T. Yamamoto, A. Nishikawa, Y.-EGao, E. Miyoshi, C.-X. Gao, K. Noda, K.N. Islam, Y. Ihara,
S. Fujii, T. Shiba, and N. Taniguchi, J. Biochem., 120, 385 (1996). (Original; Semisynthesis & Assay Method)
K. Noda, E. Miyoshi, J. Gu, C.-X. Gao, S. Nakahara, T. Kitada, K. Honke, K. Suzuki, H. Yoshihara, K. Yoshikawa,
K. Kawano, M. Tonetti, A. Kasahara, M. Hori, N. Hayashi, and N. Taniguchi, Cancer Res., 63, 6282 (2003).
(GDP-l-fucose Levels in Human Hepatocellular Carcinoma)
Y. Shimma, F. Saito, F. Oosawa, and Y. Jigami, Appl. Environ. Microbiol. 72, 7003 (2006).
(Construction of a Library of Human Glycosyltransferases)
K. Matsumoto, H. Yokote, T. Arao, M. Maegawa, K. Tanaka, Y. Fujita C. Shimizu, T. Hanafusa, Y. Fujiwara,
and K. Nishio, Cancer Sci., 99, 1611 (2008). (Effect of Fucosylation on Epidermal Growth Factor Receptor Activity)

PEPTIDES INTERNATIONAL
Maleimide activated-KLH
Maleimide activated-KLH KLH-6000-PI 5 mg 140
Maleimide activated carrier protein for haptens -20°C 10 mg 250
Minimum of 400 moles of sulfhydryl reactive maleimide per
mole of KHL
Larger quantities are available, please inquire.
D.J. Betting, et al., J. Immunol., 181, 4131 (2008).
P. Michon, et al., Infect. Immun., 68, 3164 (2000).
G.L. Toller, et al., PNAS, 101, 15160 (2004).
J.G. Joyce, et al., J. Biol. Chem., 277, 45811 (2002).
See next page for article

Order Hotline 1-800-777-4779 502-266-8787 219

 SPECIALTY PRODUCTS & TECHNOLOGIES

Activated KLH (Keyhole Limpet

Hemocyanin) is a popular choice
to use as a carrier protein for hap-
tens in order to assist in the acti-
vation of an immune response.
Haptens or small peptides are of-
ten limited by their size and can-
not elicit an immune response by
themselves. Activated KLH has a
large molecular mass and high
immunogenic properties that are
ideal for immunogenic stimula-
tion. Small peptides containing free sulfhydryl groups can react with Maleimide groups of
this carrier protein to form stable thioether bonds. Such carrier peptide conjugates can
be used to stimulate antibodies for immunization.
• Convenient Vialing - Offered in single-use vials of 5 or 10 mg, Maleimide-Acti-
vated mKLH is lyophilized and stabilized for easy application.
• Excellent Solubility - Our preparation of mariculture KLH is highly soluble, but
if your research requires even greater hydrophilicity and solubility, a PEGylated
form can be made available.
• Optimized Activation - Specifications require that each lot is activated with >
400 moles of sulfhydryl-reactive maleimide per mole of KLH, ensuring consis-
tently high levels of conjugation.
PEPTIDES INTERNATIONAL

• Sulfhydryl-reactive - Designed for conjugating cysteine-containing peptide an-

tigens to enhance immunogenicity required for high-titer antibody production.
• Very Efficient Procedure - Complete the hapten-carrier conjugation reaction in
two hours to yield sufficient immunogenicity for several injections and booster
immunizations of host animals.
• High-Quality Carrier Protein - KLH is isolated from the mollusk Megathura
crenulata (keyhole limpet); mKLH is a high-quality form of KLH that is harvested
from limpets grown in mariculture.
• Highly Immunogenic - KLH has a high molecular mass (0.5 to 13 million dal-
tons; aggregates of 350 and 390kDa subunits) and elicits a stronger immune
response than BSA or ovalbumin.

220 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT CODE QTY PRICE

SPECIALTY PRODUCTS & TECHNOLOGIES

mini-PEG™ (8-amino-3,6-dioxaoctanoic acid, AEEA) is a hydrophilic bifunctional
spacer used for peptide and peptide nucleic acid (PNA) synthesis.1,2 The popular
solubilizing linker, mini-PEG™ is now available in a slightly longer version. These
hydrophilic amino acids are widely used in both peptide and peptide nucleic acid
(PNA) syntheses.
Linkers, such as mini-PEG, can be used to minimize the adverse effects of bulky
labeling reagents on hybridization properties of PNA oligomers or to enhance binding
to lipid surfaces. Fmoc-mini-PEG™ (FXX-5521-PI) was recently used in tandem
(X-AEEA-AEEA-Y) as a linker for a peptide oligonucleotide conjugate employed
for the construction of peptide chips.3 In another application, Fmoc-mini-PEG was
coupled to a glycopeptide antibiotic, vancomycin, for covalent attachment to titanium
metal, which is reported to yield an implant device with reduced infections.4
In addition to Fmoc-mini-PEG, both Boc- and Fmoc-protected derivatives of 11-amino-
3,6,9-trioxaundecanoic acid are now available as Boc-mini-PEG-3™ (BXX-5523-PI)
and Fmoc-mini-PEG-3™ (FXX-5524-PI), where “3” designates 3 ethylene oxide units.
The original Boc- and Fmoc- mini-PEG™ derivatives of 8-amino-3,6-dioxaoctanoic
acid contain the shortest ether structure possible of poly(ethylene glycol)(PEG) with 2
ethylene oxide units. Please consider coupling more than one mini-PEG for additional
spacer lengths. Please inquire for special bulk pricing.
1. A
 .M.P. Koskinen, et al., Bioorg. Med. Chem. Lett., 3. K. Ohtsuka, et al., Analyst, 131, 55 (2006).
5, 573 (1995). 4. B. Jose, et al., Chemistry & Biology, 12, 1041

PEPTIDES INTERNATIONAL
2. J.W. Trauger, et al., Biochemistry, 40, 7092 (2001). (2005).

Boc-mini-PEG-3™ BXX-5523-PI 1g 150

Boc-11-amino-3,6,9-Trioxaundecanoic Acid • 4 °C 5g 575
DCHA
Boc-AEEEA
tert-Butyloxycarbonyl-11-amino-3,6,9-Trioxaundecanoic Acid • Dicyclohexylamine
(M.W. 307.35 • 181.32) C13H25NO7 • C12H23N Boc-NH O
O O COOH

Boc-mini-PEG ™ BXX-5519-PI 1g 125

Boc-8-amino-3,6-dioxaoctanoic acid • DCHA 4 °C 5g 495
Boc-AEEA
tert-Butyloxycarbonyl-8-amino-3,6-Dioxaoctanoic Acid • Dicyclohexylamine
(M.W. 263.29 • 181.3) C11H21NO6 • C12H23N O
Boc-NH O COOH

Fmoc-mini-PEG-3™ FXX-5524-PI 1g 175

Fmoc-11-amino-3,6,9-Trioxaundecanoic Acid 4 °C 5g 695
(Syrup) Fmoc-NH O
Fmoc-AEEEA O O COOH

9-Fluorenylmethoxycarbonyl-11-Amino-3,6,9-Trioxaundecanoic Acid
(M.W. 429.47) C23H27NO7

Fmoc-mini-PEG™ FXX-5521-PI 1g 130

Fmoc-8-amino-3,6-dioxaoctanoic acid 4 °C 5g 520
Fmoc-AEEA
9-Fluorenylmethoxycarbonyl-8-amino-3,6-Dioxaoctanoic Acid O
Fmoc-NH O COOH
(M.W. 385.42) C21H23NO6

AEEA = [2-(2-amino-ethoxy)-ethoxy]-acetic acid • AEEEA= {2-[2-(2-amino-ethoxy)-ethoxy]-ethoxy}-acetic acid

Order Hotline 1-800-777-4779 502-266-8787 221

 Specialty Resins
SPECIALTY PRODUCTS & TECHNOLOGIES

CLEAR-OXTM

Disulfide Peptides Made Simple.

T
he chemistry used to
oxidize the free thiol (-SH)
bonds to the corresponding
disulfide (-S-S-) bond
in a controlled fashion remains
a significant challenge in spite
of many advances in peptide
chemistry. Peptides International
proudly introduces CLEAR-OXTM, a
polymer-supported oxidant, which
combines the power of solid phase
chemistry with the versatility of
solution-phase reactions.
CLEAR-OXTM is a highly ef fective
polymer-supported reagent for
PEPTIDES INTERNATIONAL

the formation of disulfide-bonds.1,2

CLEAR resin is the polymer of choice
due to its compatibility with both
aqueous and organic environments.
A lysine-preformed cyclic
Ellman’s reagent [5,5’-dithiobis(2-
nitrobenzoic acid) = DTNB] is
covalently attached to a CLEAR
polymeric support with a β-alanine
spacer to yield CLEAR-OX.3,4 Since
the mechanism is based on peptide
capture, sensitive residues such as
Tyr, Trp, and Met are not affected, l eading to increased purity and yield. These improved
synthetic conditions allow for facile r emoval of the oxidant.

222 Order Hotline 1-800-777-4779 502-266-8787

 SPECIALTY PRODUCTS & TECHNOLOGIES
Single disulfide-bridged peptides with constrained amino acids have been successfully
produced using CLEAR-OX with various ring sizes and lengths. Oxidations are performed at
considerably higher concentrations than solution methods, thus leading to reduced solvent
use for larger scale. Furthermore, oxidations are scalable with potential for recycling and
automation using CLEAR-OX. Oxidations can be carried out immediately after cleavage
with as low as two-fold excess of CLEAR-OX to obtain satisfactory yields. Most oxidations
were complete within 1-2 hrs at an optimum pH < 7.
Solubility problems of reduced peptides were overcome by the addition of organic solvents,
such as acetonitrile, to the CLEAR-OX cyclization mixtures. While multiple bond formation
is still under investigation, early reports indicate positive results.5 In CLEAR-OX mediated
oxidations, product yields and purities were better than or comparable to existing oxidation
methods. However, CLEAR-OX is a superior choice when sensitive residues are present
and because the method is so easy to use.
For additional information and references please visit: http://pepnet.com/CLEAR-OX.html.

References
1. CLEAR resins are protected under US Patents 5,910,554 and 5,656,707.
2. K. Darlak, D.W. Long, A. Czerwinski, M. Darlak, F. Valenzuela, A.F. Spatola, and G. Barany, J. Peptide Res.,
63, 303-312 (2004).
3. I. Annis, L. Chen, and G. Barany, J. Am. Chem. Soc., 120, 7226-7238 (1998).
4. CLEAR-OXTM US Patent Application 11/165,609 (June 23, 2005).
5. B.R. Green and G. Bulaj, Protein Peptide Lett., 13, 67-70 (2006)

PRODUCT CODE QTY PRICE

CLEAR-OXTM

PEPTIDES INTERNATIONAL
RCO-1260-PI 1g 49
Polymer-Supported Oxidant for Disulfide Bond Formation -20 °C 5g 195
Application Notes
CLEAR-OXTM Resin Conditioning
Prior to use, swell the appropriate amount of CLEAR-OXTM resin (substitution level 0.17-0.20
meq/g) (3 times excess for the quantity of the peptide) in dichloromethane (DCM) for at least
40 min, then wash with 2 x DCM, 3 x DMF, 3 x MeOH, 3 x deionized water, and finally with
3 x water-acetonitrile (1:1) that has been degassed and purged with nitrogen. Filter the resin
and use directly as a slurry.
Synthesize the linear, reduced peptide according to standard Fmoc/tBu solid-phase synthesis
strategies. Cleave peptides from the resin with TFA: phenol: water: triisopropylsilane
88:5:5:2 v/v/v/v for 2 h at room temperature under inert atmosphere. Extract the peptide
from the cleaved resin and precipitate from cold, diethyl ether. Dry the peptide in vacuo .
Oxidize the crude peptide directly with the preconditioned CLEAR-OX, without further
purification.
(continued next page)

Order Hotline 1-800-777-4779 502-266-8787 223

 CLEAR-OXTM Oxidation
SPECIALTY PRODUCTS & TECHNOLOGIES

General Method
Dissolve the crude, dry peptide dithiol (20-25 mg) in degassed oxidation buffer. Adjust the solution pH
to the desired value with either 50% acetic acid or 8 M ammonium hydroxide. Dilute the solution to the
final concentration of 5-7 mg/ml and add to the pre-conditioned CLEAR-OX resin. Allow the reaction
mixture to stir with gentle agitation (1-2 h) blanketed with inert gas. The start of oxidation can be noted
as the color of the resin changes from yellow to deep orange. Reaction completion must be confirmed
by Ellman’s test (please see G.L. Ellman, Arch. Biochem. Biophys., 82, 70–77 (1959)). If not complete
after 2 hours, extend the reaction time accordingly. Once oxidation is complete, filter the reaction
mixture and wash with the oxidation buffer, CH3CN : H2O (1 : 1, v/v). Combine filtrates, concentrate in
vacuo to remove acetonitrile and lyophilize.
H-[Cys-Trp-Ala-Met-Ala-Cys]-Lys-NH2
Met- and Trp-Containing Peptide Oxidation at pH 4.6
Immediately following cleavage from the resin and precipi-
tate/drying step, dissolve 20 mg of dry, reduced peptide H-
Cys-Trp-Ala-Met-Ala-Cys-Lys-NH2 in degassed 0.1 M am-
monium acetate buffer/acetonitrile (1 : 1, v/v) at 6–7 mg/mL
concentration level. Add the peptide solution to pre-swollen
CLEAR-OX resin (0.2 meq/g; 3 x molar excess over the
amount of peptide, 370 mg of CLEAR-OX). Stir the reaction
mixture at 25 °C for 2 hours at pH 4.6. Adjust pH with 50%
acetic acid. A color change of the resin from yellow to deep
orange indicates oxidation has begun. Ellman’s test should
PEPTIDES INTERNATIONAL

be used to confirm reaction completion (please see G.L. Ell-

man, Arch. Biochem. Biophys., 82, 70–77 (1959)).
Once oxidation is complete, filter the reaction mixture and
wash with a small amount of CH3CN : H2O (1 : 1, v/v). Con-
centrate the filtrate in vacuo to remove CH 3CN then lyophi-
lize. Analyze the final oxidized peptide by reverse-phase A color change of the resin from
(RP)-HPLC and ES-MS to confirm identity. Molecular Weight yellow to deep orange indicates
[M + H]+ oxidized: 808.32 [M + H]+ reduced: 811.34 Crude oxidation has begun.
purity of oxidized peptide by RP-HPLC 50%.
H-Asp-[Pen-Phe-d-Trp-Orn-Tyr-Cys]-Val-OH
Constrained Penicillamine with Tyr- and Trp present. Oxidation at pH 6.8
Immediately following cleavage from the resin and precipitate/drying step, dissolve 2.01 g of dry, re-
duced peptide H-Asp-Pen-Phe-d-Trp-Orn-Tyr-Cys-Val-OH in 280 mL of degassed ammonium acetate
buffer in acetonitrile NH4OAc-CH3CN (1: 1, v/v) at pH 6.8.
Add the pre-conditioned CLEAR-OX resin (29.35 g; Sn = 0.19 meq/g) to the slurry in 60 mL of de-
gassed 0.1 M NH4OAc-CH3CN (1: 1, v/v) to the peptide solution. Stir the reaction mixture at 25 °C
for 1-2 hours at pH 6.8 A color change of the resin from yellow to deep orange indicates oxidation has
begun. Ellman’s test should be used to confirm reaction completion (please see G.L. Ellman, Arch.
Biochem. Biophys., 82, 70–77 (1959)).
Once oxidation is complete, filter the reaction mixture and wash with the oxidation buffer, CH3CN : H2O
(1 : 1, v/v) and water; total volume of the filtrate, 600 mL. Concentrate the filtrate in vacuo to remove
CH3CN then lyophilize. Analyze the final oxidized peptide by reverse-phase (RP)-HPLC and ES-MS
to confirm identity. Yield of the crude oxidized product 1.91 g, 95.6%. Purity by HPLC 63%; ESI-MS:
calc. 1074.43, found 1075.44 [M + H]+.

224 Order Hotline 1-800-777-4779 502-266-8787

 SPECIALTY PRODUCTS & TECHNOLOGIES
Publications That Reference CLEAR-OXTM
Publication
Title Authors Article Highlights
Information
Oxidative Folding of Ji. Zhang, S. Diamond, Biopolymers (Pep- “Folding at pH 4.0 with CLEAR-OXTM also
Hepcidin at Acidic pH T. Arvedson, B.J. Sasu, tide Science), 2010, led to a high quality folding product but had
L.P. Miranda 2, pp 257-264 the advantage of faster folding kinetics
over the oxidation at pH 3.3. Importantly,
we found that correctly folded epcidin
could be obtained from directly folding of
crude (unpurified) linear hepcidin using
CLEAR-OXTM-assisted folding at pH < 5.5.
Utilization of CLEAR- A. Walewska, A. Lesner, Poster, 29th “Two methods DMSO and CLEAR-OXTM
OXTM, Polymer Sup- A. Łęgowska, and K. Rolka European Peptide resulted in high yield of properly folded
ported Oxidant for Symposium peptide. However DMSO oxidation re-
Disulfide Bridge For- quires more time for clean up procedure
mation in Peptides than the of application of CLEAR-OXTM
resin.”
Synthesis of Cysteine- K. Kádár, G. Panyi, and Poster, 30th “The regioselectivity of the isolated isomer
Rich Peptides G.K. Tóth European Peptide was verified with biological measurements.
Symposium For the synthesis of Orexin A we optimized
the folding conditions and, using a poly-
mer-supported oxidant- the CLEAR-OXTM
resin-, within two hours we could isolate
the correctly folded isomer as the major
reaction product.”
Oxidative Folding of B.R. Green and G. Bulaj Protein and Peptide “We tested two alternative oxidation
Conotoxins in Immobi- Letters, strategies to produce conotoxins α-GI

PEPTIDES INTERNATIONAL
lized Systems January 2006, 13 (1) and µ-PIIIA. The peptides were either
pp 67-70 reversibly immobilized on a solid support
and then oxidized, or the immobilized di-
sulfide reagent (CLEAR-OXTM) was used
to oxidize the peptides. Both strategies
appeared more efficient at higher peptide
concentrations, consistent with pseudo-
dilution effects.”
Conantokin-Br from V.D. Twede, R.W. Teichert, Biochemistry, 2009, “Conantokins were oxidized using either
Conus brettinghami C.S. Walker, P. Gruszczynski, 48, pp 4063-4073 CLEAR-OX resin (Peptides International,
and Selectivity Deter- R. Kazmierkiewicz, G. Bulaj, and DOI:10.1021/ Inc.), ...1:1 oxidized/reduced glutathione...
minants for the NR2D B.M. Olivera bi802259a For the CLEAR-OX reaction, 200 nmol of
Subunit of the NMDA peptide per reaction was oxidized for 2h
Receptor in a solution containing 20 mg of the acti-
vated resin and 100 mM Tris HCI.”

Role of Hydroxypro- E. Lopez-Vera, Biochemistry, 2008,

lines in the in Vitro A. Walewska, J.J. Skalicky, 47 (6),
Oxidative Folding and B.M. Olivera, and G. Bulaj pp 1741–1751
Biological Activity of
Conotoxins
Folding of Conotoxins: G. Bulaj, and B.M. Olivera Antioxidants &
Formation of the Na- Redox Signaling,
tive Disulfide Bridges January 2008, 10
During Chemical Syn- (1) pp 141-156,
thesis and Biosynthe- doi:10.1089/
sis of Conus Peptides ars.2007.1856.
For bulk quantities, please inquire

Order Hotline 1-800-777-4779 502-266-8787 225

 Are you using CLEARTM (Cross-Linked Ethoxylate Acrylate Resin)
SPECIALTY PRODUCTS & TECHNOLOGIES
The Future is
as your preferred support for solid-phase synthesis? Do you need
improved synthetic results? If you have encountered a difficult peptide
or need to synthesize a longer sequence, then CLEARTM may be a
solution for you. CLEARTM polymers were introduced by Kempe and
Barany1, 2 and further developed as a commercial product in 1997.3, 4
The degree of synthetic difficulty for a peptide sequence depends on several factors: known
sequence dependent motifs, incomplete coupling reactions, and limited improvement from recoupling
or acetylation (“capping”). This is the result of aggregation of the growing peptide chain due to
secondary structure formation during synthesis (i.e., β-sheet formation), interchain or intrachain
peptide association via hydrogen bonding or hydrophobic interactions, and peptide-polymer matrix
association. This leads to a hindered amino terminus, which results in reduced coupling and
deprotection efficiencies. In more ideal reaction conditions, a well-solvated peptide-polymer matrix
results in faster and more complete coupling reactions. Traditionally, solid-phase peptide synthesis
(SPPS) has been carried out employing cross-linked polystyrene (PS) solid supports. Some of
the newer solid supports, such as PEG-PS™ or TentaGel™ resins, combine a polyethylene glycol
(PEG) appendage with a polymer backbone suitable for manipulation during SPPS. The addition of
polyethylene glycol linkers to polystyrene supports led to improved synthesis of difficult sequences.
This was attributed to the disruption of aggregation of the growing peptide chain. While CLEARTM
resins are highly cross-linked and contain polyethylene glycol, CLEARTM does not possess a
polystyrene core. The entire cross-linked matrix of CLEARTM has the character of PEG and is thus,
hydrophilic. CLEAR resin products retain the highly desirable solvation properties of PEG-grafted
PS supports and aid disruption of secondary structure formation during synthesis. Also, CLEARTM
resins offer better swelling properties than PS-based resins in a wider variety of solvents (i.e., DCM,
PEPTIDES INTERNATIONAL

DMF, and water), leading to better coupling efficiencies and improved yields and purities. Importantly,
CLEARTM resins swell in aqueous systems, which has proven to be useful for on-resin disulfide
oxidations (e.g. K3Fe(CN)6)5 or bio-chemical applications.
Clearly, your own imagination should lead to many other uses for a product as exciting as CLEAR.
Organic Synthesis?5,6,7 Affinity Chromato-graphy? Enzyme Immobilization? Microwave-Assisted
SPPS?8 Trace Analysis? Remote Sensor Applica-tions? Isn’t it CLEARTM what your next solid-phase
support choice should be?
We invite you to try these superior resins. Please contact our technical specialists today.
1. M. Kempe and G. Barany, “CLEAR: A Novel Family of Highly Cross-Linked Polymeric Supports for Solid Phase
Synthesis”, J. Am. Chem. Soc., 118, 7083-7093, (1996).
2. M. Kempe and G. Barany, "Novel Highly Cross-Linked Polymeric Supports for Solid Phase Applications", in Solid
Phase Synthesis (Fourth International Symposium, Edinburg Scotland) R. Epton, Ed., Mayflower (London) 1996, pp.
191-194.
3. CLEAR products are protected under US Patents 5,910,554 and 5,656,707 granted to the Regents of the University
of Minnesota.
4. K. Darlak, I. Romanovska, A.F. Spatola, G. Barany, and M. Kempe, "A New Solid Support for Peptide and Organic
Synthesis", Fifteenth American Peptide Symposium; Nashville, Tennessee, USA; June 1997.
5. K. Darlak, D. Wiegandt Long, A. Czerwinski, M. Darlak, F. Valenzuela, A.F. Spatola, and G. Barrany, "Facile
preparation of disulfide-bridged peptides using the polymer supported oxidant CLEAR-OXTM" J. Peptide Res., 63,
303-312 (2004).
6. N. Chatla, K. Darlak, and A.F. Spatola, "Applications of CLEAR Resin for Solid Phase Organic Synthesis Comparison
with Polystyrene Based Resin" Innovation and Perspectives in Solid Phase Synthesis and Combinatorial Libraries
(Fifth International Symposium, London, England) R. Epton, Ed., Mayflower (London) 1998, pp. 275-276.
7. K. Darlak, M. Darlak, and A.F. Spatola, "Disulfide Oxidation in Water: Investigation of CLEAR Supports for On-Resin
Cyclization" Peptide Science - Present and Future (Proceedings of the 1st International Peptide Symposium, Kyoto,
Japan) Y. Shimonishi, Ed., Kluwer Academic Publishers (Dordrecht) 1997, pp. 584-586.
8. A. Carenbauer, M. Cecil, A. Czerwinski, K. Darlak, M. Darlak, D. Wiegandt Long, F. Valenzuela, and G. Barany,
“Microwave-Assisted Solid-Phase Peptide Synthesis (MW-SPPS) on CLEAR Supports" Nineteenth American Peptide
Symposium, San Diego, California, USA; June, 2005.

226 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT CODE QTY PRICE

SPECIALTY PRODUCTS & TECHNOLOGIES

CLEAR-Base Resin HCI NH2 - CLEAR
Swelling Properties of
CLEAR-Base Resin
O
Solvent Bed Volume (ml)
CLEAR-Acid Resin HO-CH2 OCH2C-Nle -NH- CLEAR of 1 g of resin
Hydroxymethylphenoxyacetyl-norleucyl-CLEAR Resin
CH2Cl2 7.0
O
DMF 6.5
CLEAR-Amide Resin Fmoc-NH-CH OCH2C-Nle-NH- CLEAR
Rink-Amide-CLEAR Resin THF 7.0
CH3O
4-(2,4-dimethoxyphenyl-Fmoc-Aminomethyl) MeOH 6.0
phenoxyacetyl-norleucyl-CLEAR Resin
H2O 5.5
OCH3

Unsubstituted CLEARTM Resins (100-200 mesh)

CLEARTM-Base Resin (HCl) RCB-1210-PI 5g 75
HCl • NH2–CLEAR Resin 4 °C 25 g 275
100 g 995
CLEAR -Acid Resin
TM RCX-1213-PI 5g 135
Hydroxymethylphenoxyacetyl-Norleucyl-CLEAR-Resin 4 °C 25 g 625

CLEARTM-Amide Resin RCY-1250-PI 5g 195

(0.3-0.5 meq/g) 4 °C 25 g 675
Rink-Amide-Nle-CLEAR Resin

General Information for Handling CLEARTM Resins

CLEARTM Resins have been widely used in solid phase synthesis, ranging in applications from
on-resin disulfide formation to solid phase organic syntheses. Unlike other commonly used solid
supports (PEG-PSTM or TentaGelTM), CLEARTM resin particles are highly cross-linked, structurally

PEPTIDES INTERNATIONAL
uniform, and are generated from a large-scale suspension polymerization process (not grafted onto
polystyrene). Attaining the best solvation conditions for solid phase synthesis is highly desirable.
CLEARTM resins by their very nature mimic the solubility properties of polyethylene glycol (PEG) or
PEG-linked products but with greater convenience. CLEARTM particles swell in a variety of solvents,
including water, DCM or DMF. These resin particles are also compatible with relatively non-polar
solvents, such as THF or dioxane.
Recommendation: After completion of synthesis, use hexane or diethyl ether as a final washing
step before drying the resin. If MeOH or EtOH is used in final washing, CLEARTM resins (as well as
other ethylene glycol-containing resins) can become gelatinous and may be more difficult to handle.

Order Hotline 1-800-777-4779 502-266-8787 227

 PRODUCT CODE QTY PRICE
SPECIALTY PRODUCTS & TECHNOLOGIES

Peptide Antisera
Our undiluted antisera are suitable for immunohistochemical use, for application
to radioimmunoassay (RIA), or other non-isotopic immunoassay systems. These
antisera are partially characterized by either of the following two methods: 1) (EIA)
or 2) ELISA. These products are not controlled to the rigorous specifications of
prediluted antisera, which are adjusted to optimum concentrations for RIA and
other immunoassays. These antisera are sold for research and development
purposes only. Each antiserum has been lyophilized from 0.001 M Phosphate
Buffer (pH 7.0).
Storage and Stability:
These Iyophilized antisera are stable for one month at room temperature. For long term
storage, we recommend storing at -20 °C (freezer). After reconstitution with buffer, solu-
tions may be kept at 4 °C for continuous use with a suitable preservative.
For extended storage, the solutions should be frozen at -20 °C.
Adrenomedullin (Human) Antiserum NAD-14278-v 50 µl 390
(Rabbit) -20 °C vial

Antiserum: lyophilized from 0.001 M Phosphate Buffer (pH 7.0) 1

Immunogen: Adrenomedullin (Human, 1-52) (Carrier-free) 14278

Absorbance at 415 nm
Reactivity: Adrenomedullin (Human, 1-52) + 0.75 Antiserum

Adrenomedullin (Rat,1-50) +
Adrenomedullin (Human, 1-25) - 0.5

Adrenomedullin (Human, 22-52) +

Sensitivity*: IC50 = 0.053 pmol/ml (Antiserum Dilution: x 10,000) 0.25
Normal Serum

0
PEPTIDES INTERNATIONAL

10000 100000
Serum Dilution
Adrenomedullin (Human) Antiserum Dilution Curve
• This product is distributed under the license of Shionogi & Co., Ltd. Its use for any purpose other than research(Human)
Adrenomedullin is strictlyAntiserum
prohibited.Dilution Curve

Adrenomedullin 2 (Human, 1-7) Antiserum NAD-14438-v 50 µl 390

(Rabbit) -20 °C vial
Adrenomeduillin 2 (Human) Specific Antiserum 1.4

1.2
Antiserum: lyophilized from 0.001 M Phosphate Buffer (pH 7.0) 1.0
Absorbance at 415 nm

Immunogen: Adrenomedullin 2 (Human, 1-7)-TG Antiserum

0.8
(TG: Bovine Thyroglobulin)
Reactivity:
0.6
Adrenomedullin 2 (Human) +
Adrenomedullin (Human) - 0.4

Calcitonin (Human) - 0.2

Normal Serum

CGRP (Human) - 0.0

10000 100000
Serum Dilution
Adrenomedullin 2 Antiserum Dilution Curve
• This product is distributed under the license of Shionogi & Co., Ltd. Its use for any purpose other than research is strictly prohibited.

228 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT CODE QTY PRICE
Amylin (Rat) Antiserum NAM-14220-v

SPECIALTY PRODUCTS & TECHNOLOGIES

50 µl 390
(Rabbit) -20 °C vial
Antiserum: lyophilized from 0.001 M Phosphate Buffer (pH 7.0)
Immunogen: Amylin (Rat)-BSA (BSA: Bovine Serum Albumin)
Cross-reactions were not observed at higher doses
Specificity: Amylin (Rat) 100%
(1-10 nmol/ml) against the following peptides:
Amylin (Human) 60% CRF (Human)
Calcitonin Gene Related Peptide (Human) 0% Oxytocin
Calcitonin Gene Related Peptide (Rat) 0% Neuropeptide Y
(Human)
Calcitonin (Human) 0% Somatostatin
Sensitivity*: IC50 = 0.80 pmol/ml (Antiserum Dilution: x 20,000) β-Endorphin (Human)

Antisera of Amyloid β-Protein Related Peptides

Amyloid β-Protein (Human, 1-40) Antiserum NAP-14307-v 50 µl 295
(Rabbit) -20 °C vial
Antiserum: lyophilized from 0.001 M Phosphate Buffer (pH 7.0)
Immunogen: Amyloid β-Protein (Human, 1-40) (Carrier-free)
Cross-reactions were not observed at higher doses
Specificity: Amyloid β-Protein (Human, 1-40) 100%
(1-10 nmol/ml) against the following peptides:
Amyloid β-Protein (Human, 1-25) 100% CRF (Human)
Amyloid β-Protein (Human, 1-15 Amide) <1% BNP-32 (Human)
Amyloid β-Protein (Human, 1-16) <1% Endothelin-1 (Human)
Amyloid β-Protein (Human, 26-40) 0% Secretin (Human)
Amyloid β-Protein (Human, 17-25) 0% Substance P

PEPTIDES INTERNATIONAL
Amyloid β-Protein (Human, 24-35) 0%
Sensitivity*: IC50 = 0.60 pmol/ml (Antiserum Dilution: x 20,000)

β-Protein (Human, 1-16) Antiserum NAB-14359-v 50 µl 295

Amyloid β-Protein N-Terminal Specific Antiserum -20 °C vial
(Rabbit)
Antiserum: lyophilized from 0.001 M Phosphate Buffer (pH 7.0)
1

Immunogen: Amyloid β-Protein (Human, 1-16)-KLH Antiserum

Absorbance at 415 nm

(KLH: Keyhole Limpet Hemocyanin)

0.75 14359

Reactivity: Amyloid β-Protein (Human, 1-16) +

Amyloid β-Protein (Human, 1-40) +
0.5

Amyloid β-Protein (Human, 1-42) +

0.25
Normal Serum

0
10000 100000

Serum Dilution

Amyloid β Protein (Human,

Amyloid 1-16)(Human,
β Protein Antiserum Dilution
1-16) CurveDilution Curve
Antiserum

*All sensitivity data are measured by enzyme immunoassay using β-d-galactosidase as a label.

Order Hotline 1-800-777-4779 502-266-8787 229

 PRODUCT CODE QTY PRICE
SPECIALTY PRODUCTS & TECHNOLOGIES

Amyloid β-Protein (Human, 34-40) Antiserum NAB-14356-v 50 µl 295

Amyloid β-Protein (1-40) Specific Antiserum -20 °C vial
(Rabbit)
Antiserum: lyophilized from 0.001 M Phosphate Buffer (pH 7.0)
1

Immunogen: Amyloid β-Protein (Human, 34-40)-KLH Antiserum

Absorbance at 415 nm
(KLH: Keyhole Limpet Hemocyanin) 14356
0.75

Reactivity: Amyloid β-Protein (Human, 1-40) +

Amyloid β-Protein (Human, 1-16) -
0.5

Amyloid β-Protein (Human, 1-42) -

0.25
Normal Serum

0
10000 100000
Serum Dilution
Amloid β Protein (Human, 34-40) Antiserum Dilution Curve

Amyloid β-Protein (Human, 37-42) Antiserum NAB-14357-v 50 µl 295

Amyloid β Protein (Human, 34-40) Antiserum Dilution Curve

Amyloid β-Protein (1-42) Specific Antiserum -20 °C vial

(Rabbit)
1
Antiserum: lyophilized from 0.001 M Phosphate Buffer (pH 7.0)
Immunogen: Amyloid β-Protein (Human, 37-42)-KLH Antiserum

Absorbance at 415 nm
0.75 14357
(KLH: Keyhole Limpet Hemocyanin)
Reactivity: Amyloid β-Protein (Human, 1-42) + 0.5
Amyloid β-Protein (Human, 1-40) -
Amyloid β-Protein (Human, 1-16) - 0.25

Normal Serum
0
10000 100000

Serum Dilution

Amloid β Protein (Human,

Amyloid β37-42)
ProteinAntiserum Dilution Curve Dilution Curve
PEPTIDES INTERNATIONAL

(Human, 37-42) Antiserum

Amyloid β-Protein (Human, 37-43) Antiserum NAB-14414-v 50 µl 300

Amyloid β-Protein (1-43) Specific Antiserum -20 °C vial
(Rabbit)
Antiserum: lyophilized from 0.001 M Phosphate Buffer (pH 7.0)
1.8

1.6
Immunogen: Amyloid β-Protein (Human, 37-43)-KLH
Absorbance at 415 nm

1.4
Antiserum 14414
(KLH: Keyhole Limpet Hemocyanin) 1.2

Reactivity: Amyloid β-Protein (Human, 1-43) + 1.0

Amyloid β-Protein (Human, 1-42) - 0.8

Amyloid β-Protein (Human, 1-40) - 0.6

Amyloid β-Protein (Human, 1-16) - 0.4

0.2 Normal Serum

0.0

Amloid β Protein (Human, 37-43) Antiserum Dilution Curve100000

10000
Serum Dilution

ANP (Human, 1-28) Antiserum NAF-14135-v 50 µl37-43) Antiserum

Amyloid β Protein (Human, 390 Dilution Curve
A-Type (Atrial) Natriuretic Peptide (Human, 1-28) Antiserum -20 °C vial
(Rabbit)
Antiserum: lyophilized from 0.001 M Phosphate Buffer (pH 7.0)
Immunogen: ANP (Human, 1-28)-TG (TG: Bovine Thyroglobulin)
Cross-reactions were not observed at higher doses
(1-10 nmol/ml) against the following peptides:
Specificity: ANP (Human, 1-28) 100%
ANP (Human, 7-28) 100% Oxytocin
[Met(O)12]-ANP (Human,1-28) 150% [Arg8]-Vasopressin
ANP (Rat, 1-28) 55% Somatostatin
β-ANP (Human, 1-28 Dimer) 100% [Met5]-Enkephalin
Sensitivity*: IC50 = 0.28 pmol/ml (Antiserum Dilution: x 10,000) β-Endorphin (Human)

*All sensitivity data are measured by enzyme immunoassay using β-d-galactosidase as a label.

230 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT CODE QTY PRICE
BNP-26 (Porcine) Antiserum NBN-14200-v

SPECIALTY PRODUCTS & TECHNOLOGIES

50 µl 390
B-Type (Brain) Natriuretic Peptide (Porcine, 1-26) -20 °C vial
Antiserum
(Rabbit)
Antiserum: lyophilized from 0.001 M Phosphate Buffer (pH 7.0)
Immunogen: BNP-26 (Porcine)-TG (TG: Bovine Thyroglobulin)
Cross-reactions were not observed at higher doses
(1-10 nmol/ml) against the following peptides:
Specificity: BNP-26 (Porcine) 100%
BNP (Porcine, 20-26) <0.1% Oxytocin
ANP (Human, 1-28) <0.1% Somatostatin
ANP (Rat, 1-28) <0.1% [Met5]-Enkephalin
Sensitivity*: IC50 = 5.5 pmol/ml (Antiserum Dilution: x 20,000) VIP
CRF (Human)

Calcitonin (Human) Antiserum NCL-14051-v 50 µl 390

(Rabbit) -20 °C vial
Antiserum: lyophilized from 0.001 M Phosphate Buffer (pH 7.0)
Cross-reactions were not observed at higher doses
Immunogen: Calcitonin (Human)-TG (TG: Bovine Thyroglobulin)
(1-10 nmol/ml) against the following peptides:
Specificity: Calcitonin (Human) 100% CGRP (Human)
Calcitonin (Human, 11-32) 100% Secretin (Human)
Calcitonin (Rat) 100% Somatostatin
Calcitonin (Salmon) 0% b-Endorphin (Human)
Sensitivity*: IC50 = 3.0 pmol/ml (Antiserum Dilution: x 100,000) Neuropeptide Y (Porcine)

CCK-33 (Porcine) Antiserum NCK-14176-v 50 µl 390

PEPTIDES INTERNATIONAL
(Rabbit) -20 °C vial
Antiserum: lyophilized from 0.001 M Phosphate Buffer (pH 7.0)
Cross-reactions were not observed at higher doses
Immunogen: CCK-33 (Porcine)-TG (TG: Bovine Thyroglobulin)
(1-10 nmol/ml) against the following peptides:
Specificity: CCK-33 (Porcine, Sulfated) 100% CRF (Human)
CCK-33 (Human, Sulfated) 60% VIP
Gastrin l <0.1% Neuropeptide Y (Human)
CCK-8 (Sulfated Form) <0.1% b-Endorphin (Human)
CCK-8 (Nonsulfated Form) <0.1% Somatostatin
Peptide YY <0.1%
Sensitivity*: IC50 = 0.3 pmol/ml (Antiserum Dilution: x 200,000)

CGRP (Human) Antiserum NCG-14160-v 50 µl 390

Calcitonin Gene Related Peptide (Human) Antiserum -20 °C vial
(Rabbit)
Antiserum: lyophilized from 0.001 M Phosphate Buffer (pH 7.0)
Cross-reactions were not observed at higher doses
Immunogen: CGRP (Human)-TG (TG: Bovine Thyroglobulin)
(1-10 nmol/ml) against the following peptides:
Specificity: CGRP (Human) 100% [Met5]-Enkephalin
CGRP II (Human) 20% Oxytocin
CGRP (Rat) 10% Neuropeptide Y (Human)
Sensitivity*: IC50 = 0.45 pmol/ml (Antiserum Dilution: x 20,000) β-Endorphin (Human)
Somatostatin
*All sensitivity data are measured by enzyme immunoassay using β-d-galactosidase as a label.

Order Hotline 1-800-777-4779 502-266-8787 231

 PRODUCT CODE QTY PRICE
SPECIALTY PRODUCTS & TECHNOLOGIES

CINC-1/gro (Rat) Antiserum NIL-14233-v 50 µl 390

Cytokine-Induced Neutrophil Chemoattractant / Growth- -20 °C vial
Related Oncogene (Rat) Antiserum
(Rabbit)
Antiserum: lyophilized from 0.001 M Phosphate Buffer (pH 7.0)
Cross-reactions were not observed at higher doses
Immunogen: CINC/gro (Rat, 1-72) (Carrier-free)
(1-10 nmol/ml) against the following peptides:
Specificity: CINC/gro (Rat, 1-72) 100% Glucagon (Human)
[Cys(Acm)9,11]-CINC/gro (Rat, 1-17) 0% Secretin (Human)
CINC/gro (Rat, 11-34) 0% Gastrin I (Human)
CINC/gro (Rat, 35-50) 0% CCK-8 (Sulfated Form)
CINC/gro (Rat, 51-72) 0% Somatostatin
Sensitivity*: IC50 = 0.19 pmol/ml (Antiserum Dilution: x 100,000)

CNP-22 (Human) Antiserum NCT-14250-v 50 µl 370

C-type Natriuretic Peptide-22 (Human) Antiserum -20 °C vial
(Rabbit)
Antiserum: lyophilized from 0.001 M Phosphate Buffer (pH 7.0)
Cross-reactions were not observed at higher doses
Immunogen: CNP-22 (Human)-TG (TG: Bovine Thyrogloblin)
(1-10 nmol/ml) against the following peptides:
Specificity: CNP-22 (Human) 100% Secretin (Human)
CNP-53 (Porcine, Rat) 100% CRF (Human)
CNP-53 (Human) 100% Substance P
ANP (Human, 1-28) 0% CGRP (Human)
ANP (Rat, 1-28) 0% Endothelin-2 (Human)
BNP-32 (Human) 0%
PEPTIDES INTERNATIONAL

BNP-45 (Human) 0%
BNP-45 (Rat) 0%
Sensitivity*: IC50 = 0.25 pmol/ml (Antiserum Dilution: x 10,000)

CRF (Human) Antiserum NCR-14136-v 50 µl 370

Corticotropin Releasing Factor (Human) Antiserum -20 °C vial
(Rabbit)
Antiserum: lyophilized from 0.001 M Phosphate Buffer (pH 7.0)
Cross-reactions were not observed at higher doses
Immunogen: CRF (Human)-TG (TG: Bovine Thyroglobulin)
(1-10 nmol/ml) against the following peptides:
Specificity: CRF (Human) 100% Oxytocin
CRF (Human, 31-42) 35% [Arg8]-Vasopressin
CRF (Ovine) <0.1% [Met5]-Enkephalin
CRF (Ovine, 31-42) <0.1% β-Endorphin (Human)
Sensitivity*: IC50 = 5.2 pmol/ml (Antiserum Dilution: x 20,000) Somatostatin
*All sensitivity data are measured by enzyme immunoassay using β-d-galactosidase as a label.

232 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT CODE QTY PRICE
β-Defensin-2 (Human) Antiserum

SPECIALTY PRODUCTS & TECHNOLOGIES

NBD-14338-v 50 µl 390
(Rabbit) -20 °C vial
Antiserum: lyophilized from 0.001 M Phosphate Buffer (pH 7.0)
1

Immunogen: β-Defensin-2 (Human)-TG (TG: Bovine Thyroglobulin)

Absorbance at 415 nm
Antiserum
Reactivity:
14338
β-Defensin-2 (Human) +
0.75

β-Defensin-1 (Human) -
a-Defensin-1 (Human) - 0.5

0.25

Normal Serum

0
10000 100000

Serum Dilution
β-Defensin-2 (Human) Antiserum
β-Defensin-2 Dilution
(Human) Curve
Antiserum Dilution Curve

Elafin (Human) Antiserum NEL-14243-v 50 µl 370

(Rabbit) -20 °C vial
Antiserum: lyophilized from 0.001 M Phosphate Buffer (pH 7.0)
Cross-reactions were not observed at higher doses
Immunogen: Elafin (Human, 1-57) (Carrier-free)
(1-10 nmol/ml) against the following peptides:
Specificity: Elafin (Human) 100% Endothelin-1 (Human)
Sensitivity*: IC50 = 0.40 pmol/ml (Antiserum Dilution: x 20,000) ANP (Human 1-28)
CRF (Human)
Substance P
Neuropeptide Y (Human)

Endothelin Antisera
Endothelin-1 (Human) Antiserum NED-14198-v 50 µl 390

PEPTIDES INTERNATIONAL
(Rabbit) -20 °C vial
Antiserum: lyophilized from 0.001 M Phosphate Buffer (pH 7.0)
Cross-reactions were not observed at higher doses
Immunogen: Endothelin-1 (Human, 1-21)-TG (TG: Bovine Thyroglobulin)
(1-10 nmol/ml) against the following peptides:
Specificity: Endothelin 1 (Human) 100% Peptide YY
Endothelin-2 (Human) 60% CGRP (Human)
Endothelin 3 (Human) 40% Secretin (Human)
Big Endothelin-1 (Human, 1-38) <1% β-Endorphin (Human)
Big Endothelin-1 (Porcine, 1-39) <1% Somatostatin
Sensitivity*: IC50 = 1.0 pmol/ml (Antiserum Dilution: x 20,000)

Big Endothelin-1 (Porcine, 22-39) Antiserum NED-14210-v 50 µl 390

(Rabbit) -20 °C vial
Antiserum: lyophilized from 0.001 M Phosphate Buffer (pH 7.0)
Immunogen: Big Endothelin-1 (Porcine, 22-39)-BSA
(BSA: Bovine Serum Albumin)
Cross-reactions were not observed at higher doses
(1-10 nmol/ml) against the following peptides:
Specificity: Big Endothelin-1 (Porcine, 22-39) 100% Glucagon (Human)
Big Endothelin-1 (Porcine, 1-39) 100% Secretin (Human)
Big Endothelin-1 (Human, 1-38) 10% Gastrin I
Big Endothelin-1 (Human, 18-38) 10% CCK-8 (Sulfated Form)
Endothelin-1 (Human) 0% Somatostatin
Endothelin-2 (Human) 0%
Endothelin-3 (Human) 0%
Sensitivity*: IC50 = 0.45 pmol/ml (Antiserum Dilution: x 30,000)
*All sensitivity data are measured by enzyme immunoassay using β-d-galactosidase as a label.

Order Hotline 1-800-777-4779 502-266-8787 233

 PRODUCT CODE QTY PRICE
SPECIALTY PRODUCTS & TECHNOLOGIES

Big Endothelin-1 (Human, 22-38) Antiserum NED-14224-v 50 µl 390

(Rabbit) -20 °C vial
Antiserum: lyophilized from 0.001 M Phosphate Buffer (pH 7.0)
Immunogen: Big Endothelin-1 (Human, 22-38)-BSA
(BSA: Bovine Serum Albumin)
Cross-reactions were not observed at higher doses
(1-10 nmol/ml) against the following peptides:
Specificity: Big Endothelin-1 (Human, 1-38) 100% Peptide YY
Big Endothelin-1 (Human, 22-38) 50% CGRP (Human)
Big Endothelin-2 (Human, 22-38) <0.1% Secretin (Human)
Big Endothelin-3 (Human, 22-41 Amide) <0.1% b-Endorphin (Human)
Endothelin-1 (Human) 0% Somatostatin
Sensitivity*: IC50 = 2.5 pmol/ml (Antiserum Dilution: x 20,000)

Big Endothelin-2 (Human, 22-38) Antiserum NED-14225-v 50 µl 390

(Rabbit) -20 °C vial
Antiserum: lyophilized from 0.001 M Phosphate Buffer (pH 7.0)
Immunogen: Big Endothelin-2 (Human, 22-38)-BSA
(BSA: Bovine Serum Albumin)
Cross-reactions were not observed at higher doses
(1-10 nmol/ml) against the following peptides:
Specificity: Big Endothelin-2 (Human, 1-38) 100% ANP (Human, 1-28)
Big Endothelin-2 (Human, 22-38) 200% BNP-32 (Human)
Big Endothelin-2 (Human, 1-37) 0% CNP-53 (Human)
Big Endothelin-1 (Human, 1-38) 0% Substance P
Big Endothelin-3 (Human, 1-41 Amide) 0% CRF (Human)
Endothelin-1 (Human) 0%
PEPTIDES INTERNATIONAL

Endothelin-2 (Human) 0%
Endothelin-3 (Human) 0%
Sensitivity*: IC50 = 0.25 pmol/ml (Antiserum Dilution: x 40,000)

Big Endothelin-2 (Human, 22-37) Antiserum NED-14238-v 50 µl 390

(Rabbit) -20 °C vial
Antiserum: lyophilized from 0.001 M Phosphate Buffer (pH 7.0)
Immunogen: Big Endothelin-2 (Human, 22-37)-BSA
(BSA: Bovine Serum Albumin)
Cross-reactions were not observed at higher doses
(1-10 nmol/ml) against the following peptides:
Specificity: Big Endothelin-2 (Human, 1-37) 100% Peptide YY
Big Endothelin-2 (Human, 1-38) 0% CGRP (Human)
Big Endothelin-2 (Human, 22-37) 400% Secretin (Human)
Big Endothelin-1 (Human, 1-38) 0% b-Endorphin (Human)
Big Endothelin-3 (Human, 1-41 Amide) 0% Somatostatin
Endothelin-1 (Human) 0%
Endothelin-2 (Human) 0%
Endothelin-3 (Human) 0%
Sensitivity*: IC50 = 1.8 pmol/ml (Antiserum Dilution: x 100,000)
*All sensitivity data are measured by enzyme immunoassay using β-d-galactosidase as a label.

234 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT CODE QTY PRICE
Big Endothelin-3 (Human, 22-41 Amide) NED-14226-v

SPECIALTY PRODUCTS & TECHNOLOGIES

50 µl 390
Antiserum -20 °C vial
(Rabbit)
Antiserum: lyophilized from 0.001 M Phosphate Buffer (pH 7.0)
Immunogen: Big Endothelin-3 (Human, 22-41 Amide)-BSA
(BSA: Bovine Serum Albumin)
Cross-reactions were not observed at higher doses
(1-10 nmol/ml) against the following peptides:
Specificity: Big Endothelin-3 (Human, 1-41 Amide) 100% Peptide YY
Big Endothelin-3 (Human, 22-41 Amide) 35% CGRP (Human)
Big Endothelin-3 (Rat, 1-41 Amide) 100% Secretin (Human)
Big Endothelin-3 (Rat, 1-39) <0.1% b-Endorphin (Human)
Big Endothelin-1 (Human, 1-38) 0% Somatostatin
Big Endothelin-2 (Human, 1-37) 0%
Endothelin-1 (Human) 0%
Endothelin-2 (Human) 0%
Endothelin-3 (Human) 0%
Sensitivity*: IC50 = 0.45 pmol/ml (Antiserum Dilution: x 20,000)

Galanin (Rat) Antiserum NGA-14244-v 50 µl 370

(Rabbit) -20 °C vial
Antiserum: lyophilized from 0.001 M Phosphate Buffer (pH 7.0)
Immunogen: Galanin (Rat)-BSA
(BSA: Bovine Serum Albumin)
Cross-reactions were not observed at higher doses
(1-10 nmol/ml) against the following peptides:
Specificity: Galanin (Rat) 100% Secretin (Human)
Galanin (Rat, 1-16) 0% CRF (Human)

PEPTIDES INTERNATIONAL
Galanin (Human) 0% CGRP (Human)
Sensitivity*: IC50 = 1.2 pmol/ml (Antiserum Dilution: x 30,000) ANP (Human, 1-28)

GRF (Human) Antiserum NGR-14127-v 50 µl 390

Growth Hormone Releasing Factor (Human) Antiserum -20 °C vial
(Rabbit)
Antiserum: lyophilized from 0.001 M Phosphate Buffer (pH 7.0)
Immunogen: GRF (Human)-KLH
(KLH: Keyhole Limpet Hemocyanin)
Cross-reactions were not observed at higher doses
Specificity: GRF (Human) 100%
(1-10 nmol/ml) against the following peptides:
GRF (Porcine) 100% CRF (Human)
GRF (Human, 30-44 Amide) 30% VIP
GRF (Bovine) 5% Neuropeptide Y (Human)
GRF (Ovine) 1% b-Endorphin (Human)
GRF (Rat) <0.1% Somatostatin
GRF (Human 1-29) <0.1%
Sensitivity*: IC50 = 0.35 pmol/ml (Antiserum Dilution: x 20,000)
*All sensitivity data are measured by enzyme immunoassay using β-d-galactosidase as a label.

Order Hotline 1-800-777-4779 502-266-8787 235

 PRODUCT CODE QTY PRICE
SPECIALTY PRODUCTS & TECHNOLOGIES

GRP (Human) Antiserum NGR-14164-v 50 µl 390

Gastrin Releasing Peptide (Human) Antiserum -20 °C vial
(Rabbit)
Antiserum: lyophilized from 0.001 M Phosphate Buffer (pH 7.0)
Immunogen: GRP (Human)-TG (TG: Bovine Thyroglobulin)
Cross-reactions were not observed at higher doses
Specificity: GRP (Human) 100%
(1-10 nmol/ml) against the following peptides:
GRP (Porcine) 75% Glucagon (Human)
GRP (14-27) 55% Secretin (Human)
Neuromedin C (GRP, 18-27) 10% Gastrin I (Human)
Bombesin 10% Somatostatin
Neuromedin B <0.1% CCK-8 (Sulfated Form)
GRP (Human, 1-18) <0.1%
Peptide YY <0.1%
Sensitivity*: IC50 = 0.34 pmol/ml (Antiserum Dilution: x 10,000)

Lysenin Antiserum NLY-14802-v 50 µl 365

(Rabbit) -20 °C vial
1

Antiserum: lyophilized from 0.001 M Phosphate Buffer (pH 7.0)

Absorbance at 415 nm
Immunogen: Lysenin (Carrier-free) 0.75 Antiserum 14802
Reactivity: Lysenin +
For Immunohistochemistry: x 100 - 1,000 dilution 0.5

0.25
Normal Serum

0
PEPTIDES INTERNATIONAL

10000 100000

Serum Dilution
Lysenin Antiserum Dilution Curve
Lysenin Antiserum Dilution Curve

Midkine (Human, 1-59) Antiserum NMK-14319-v 50 µl 400

(Rabbit) -20 °C vial
Antiserum: lyophilized from 0.001 M Phosphate Buffer (pH 7.0)
1

14319
Immunogen: Midkine (Human, 1-59)-TG (TG: Bovine Thyroglobulin)
Absorbance at 415 nm

0.75
Antiserum
Reactivity: Midkine (Human) +
Midkine (Human, 1-59) + 0.5
Midkine (Human, 60-121) -
Pleiotrophin (Human) - 0.25
Normal Serum

0
10000 100000

Serum Dilution

Midkine (Human, 1-59) Antiserum
Midkine Dilution
(Human, 1-59) Curve
Antiserum Dilution Curve

*All sensitivity data are measured by enzyme immunoassay using β-d-galactosidase as a label.

236 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT CODE QTY PRICE
NPY (Human) Antiserum NNP-14158-v

SPECIALTY PRODUCTS & TECHNOLOGIES

50 µl 390
Neuropeptide Y (Human) Antiserum -20 °C vial
(Rabbit)
Antiserum: lyophilized from 0.001 M Phosphate Buffer (pH 7.0)
Immunogen: NPY (Human)-TG (TG: BovineThyroglobulin)
Cross-reactions were not observed at higher doses
NPY (Human) 100%
(1-10 nmol/ml) against the following peptides:
Specificity: NPY (Porcine) 100% Oxytocin
NPY (Human, 1-9) <0.1% [Arg8]-Vasopressin
NPY (Human, 24-36) <0.1% Somatostatin
Pancreatic Polypeptide (Human) <0.1% ANP (Human, 1-28)
Peptide YY <0.1% β-Endorphin (Human)
Sensitivity*: IC50 = 3.0 pmol/ml (Antiserum Dilution: x 50,000)

Orexin-A (Human) Antiserum NOR-14346-v 50 µl 365

(Rabbit) -20 °C vial
Antiserum: lyophilized from 0.001 M Phosphate Buffer (pH 7.0)
1
Antiserum

Absorbance at 415 nm
Immunogen: Orexin-A (Human)-BSA (BSA: Bovine Serum Albumin) 0.75 14346

Reactivity: Orexin-A (Human) +

Orexin-B (Human) + 0.5

Orexin-B (Rat) +
GLP-1 (7-36 Amide) - 0.25
Normal Serum
0
10000 100000

Serum Dilution

Orexin-A (Human) Antiserum Dilution Curve

PEPTIDES INTERNATIONAL
Orexin-A (Human) Antiserum Dilution Curve

Osteocalcin (Human, 38-49) Antiserum NOS-14276-v 50 µl 390

(Rabbit) -20 °C vial
Antiserum: lyophilized from 0.001 M Phosphate Buffer (pH 7.0)
Immunogen: Osteocalcin (Human, 38-49)-BSA
(BSA: Bovine Serum Albumin)
Cross-reactions were not observed at higher doses
(20-2000 pmol/ml): against the following peptides:
Specificity: Gla17,21,24-Osteocalcin (Human, 1-49) 100% Endothelin-1 (Human)
Glu17,Gla21,24-Osteocalcin (Human, 1-49) 100% ANP (Human, 1-28)
Osteocalcin (Human, 38-49) 200% CRF (Human)
Osteocalcin (Human, 1-13) 0% Substance P
Sensitivity*: IC50 = 0.60 pmol/ml (Antiserum Dilution: x 50,000) Secretin (Human)

Proangiotensin-12 (Rat) Antibody NAN-14439-v 50 µl 570

(Rabbit) -20 °C vial
S. Nagata, J. Kato, K. Sasaki, N. Minamino, T. Eto, and K. Kitamura,
Biochem. Biophys. Res. Commun., 350 ,1026 (2006).

*All sensitivity data are measured by enzyme immunoassay using β-d-galactosidase as a label.

Order Hotline 1-800-777-4779 502-266-8787 237

 PRODUCT CODE QTY PRICE
SPECIALTY PRODUCTS & TECHNOLOGIES

[Pyr ]-Pancreastatin (Porcine, 33-49)

33 NPP-14186-v 50 µl 370
Antiserum -20 °C vial
(Rabbit)
Antiserum: lyophilized from 0.001 M Phosphate Buffer (pH 7.0)
Cross-reactions were not observed at higher doses
Immunogen: [Pyr33]-Pancreastatin (Porcine, 33-49)-TG (TG: Bovine Thyroglobulin)
(1-10 nmol/ml) against the following peptides:
Peptide YY
Specificity: [Pyr33]-Pancreastatin (Porcine, 33-49) 100% CGRP (Human)
Pancreastatin (Porcine, 1-49) 100% Somatostatin
Chromogranin A (Human, 286-301 Amide) 100% Secretin (Human)
Sensitivity*: IC50 = 0.27 pmol/ml (Antiserum Dilution: x 50,000) β-Endorphin (Human)

Salusin-β (Human) Antiserum NSL-14418-v 50 µl 390

Salusin-β (Human) Specific Antiserum vial
(Rabbit)
Antiserum: lyophilized from 0.001 M Phosphate Buffer (pH 7.0)

Immunogen: Salusin-β (Human)-TG (TG: Bovine Thyroglobulin)

Specificity: Salusin-β (Human) +

Salusin-α (Human) -

Salusin-β Antiserum Dilution Curve

Secretin (Porcine) Antiserum NSE-14112-v 50 µl 370

PEPTIDES INTERNATIONAL

(Rabbit) -20 °C vial

Antiserum: lyophilized from 0.001 M Phosphate Buffer (pH 7.0)
Cross-reactions were not observed at higher doses
Immunogen: Secretin (Porcine)-TG (TG: Bovine Thyroglobulin)
(1-10 nmol/ml) against the following peptides:
Specificity: Secretin (Porcine) 100% GRP (Human)
Secretin (Human) 100% Gastrin I (Human)
Secretin (Chicken) 0% Neuropeptide Y (Porcine)
Glucagon (Human)
Sensitivity*: IC50 = 0.27 pmol/ml (Antiserum Dilution: x 50,000) Somatostatin

SPAI-1 (Porcine) Antiserum NSP-14216-v 50 µl 370

Sodium Potassium ATPase Inhibitor-1 (Porcine) -20 °C vial
Antiserum
(Na+,K+-ATPase Inhibitor-1 Antiserum)
(Rabbit)
Antiserum: lyophilized from 0.001 M Phosphate Buffer (pH 7.0)
Cross-reactions were not observed at higher doses
Immunogen: SPAI-1 (Porcine, 1-49)-BSA
(100-200 nmol/ml) against the following peptides:
(BSA: Bovine Serum Albumin) Calcitonin (Human)
Specificity: SPAI-1 (Porcine, 1-49) 100% CRF (Human)
SPAl-1 (Porcine, 1-14) 0% Endothelin-1 (Human)
SPAI-1 (Porcine, 25-35) 0% BNP-26 (Porcine)
Ouabain 0% Secretin (Human)
Sensitivity*: IC50 = 0.14 pmol/ml (Antiserum Dilution: x 30,000)
*All sensitivity data are measured by enzyme immunoassay using β-d-galactosidase as a label.

238 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT CODE QTY PRICE
Urotensin II (Human) Antiserum NUT-14365-v

SPECIALTY PRODUCTS & TECHNOLOGIES

50 µl 370
(Rabbit) -20 °C vial
Antiserum: lyophilized from 0.001 M Phosphate Buffer (pH 7.0)
1

Antiserum

Absorbance at 415 nm
0.75
Immunogen: Urotensin II (Human)-BSA (BSA: Bovine Serum Albumin) 14365

Reactivity: Urotensin II (Human) ++ 0.5

Urotensin II (Rat) +
Endothelin-1 - 0.25

Somatostatin - Normal Serum

++: Positive Color Reaction 0

10000 100000
+: Weakly Positive Color Reaction Serum Dilution
-: Negative Color Reaction in 60 min
Urotensin II (Human) Antiserum Dilution Curve
Urotensin II (Human) Antiserum Dilution Curve

VIP Antiserum NVA-14110-v 50 µl 370

Vasoactive Intestinal Peptide Antiserum -20 °C vial
(Rabbit)
Antiserum: lyophilized from 0.001 M Phosphate Buffer (pH 7.0)
Cross-reactions were not observed at higher doses
Immunogen: VIP-TG (TG: Bovine Thyroglobulin)
(1-10 nmol/ml) against the following peptides:
Specificity: VIP 100% CRF (Human)
Secretin (Human) <0.1% Oxytocin
Glucagon (Human) <0.1% Neuropeptide Y (Human)
GRF (Human) <0.1% β-Endorphin (Human)
Sensitivity*: IC50 = 1.2 pmol/ml (Antiserum Dilution: x 10,000) Somatostatin

PEPTIDES INTERNATIONAL
*All sensitivity data are measured by enzyme immunoassay using β-d-galactosidase as a label.

Order Hotline 1-800-777-4779 502-266-8787 239

 PRODUCT Code Qty PRICE
Amino Acids
TOOLS for PEPTIDE SYNTHESIS

Click Chemistry Amino Acids

Boc-Dab(N3)-OH • CHA N3 BLX-53111-PI 1g 360
Boc-(S)-2-amino-4-azidobutanoic acid CHA 4 °C 5g 1106
O
salt
(M.W. 343.4) O N
OH H2N 25 g 3750
[120042-08-2] H
O

Boc-d-Dab(N3)-OH • CHA N3
BDX-53115-PI 1g 544
Boc-(R)-2-amino-4-azidobutanoic acid CHA 4 °C 5g 1680
salt O
(M.W. 343.4) OH H2N
25 g 5625
O N
H
O

Boc-Dap(N3)-OH • CHA BLX-53110-PI 1g 360

Boc-(S)-2-amino-3-azidopropanoic acid CHA 4 °C 5g 1106
salt N3

(M.W. 329.4)
O
25 g 3750
OH H2N
O N
H
O

Boc-d-Dap(N3)-OH • CHA BDX-53114-PI 1g 544

Boc-(R)-2-amino-3-azidopropanoic acid CHA 4 °C 5g 1680
N3
salt O
PEPTIDES INTERNATIONAL

(M.W. 329.4) OH H2N

25 g 5625
O N
H
O

Boc-l-Glutamic Acid bis-Propargyl BGP-3783-PI 100 mg 95

Amide -20°C 500 mg 350
Boc-Glu-bis-Prg-NH2 salt
(M.W. 321.3) C16H23N3O4 1g 600
Specialty Tool for click chemistry dimerization
S. Ji, Al Czerwinski, Y. Zhou, Gl Shao, F. Valenzuela, P. Sowinski, S. Chauhan, M. Pennington, and S. Liu,
Mol. Pharmaceutics, in press

Boc-Lys(N3)-OH • CHA N3 BLK-53113-PI 1g 360

Boc-(S)-2-amino-6-azidohexanoic acid CHA 4 °C 5g 1106
salt
(M.W. 371.5) 25 g 3750
O
[846549-33-5]
OH H2N
O N
H
O

Boc-d-Lys(N3)-OH • CHA N3 BDK-53117-PI 1g 544

Boc-(R)-2-amino-6-azidohexanoic acid CHA 4 °C 5g 1680
salt
(M.W. 371.5) O
25 g 5625
OH H2N
O N
H
O

240 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

TOOLS for PEPTIDE SYNTHESIS

Boc-Orn(N3)-OH • CHA N3 BLO-53112-PI 1g 408
Boc-(S)-2-amino-5-azidopentanoic acid CHA salt 4 °C 5g 1260
(M.W. 357.4) O

OH H2N
25 g 4250
O N
H
O

Boc-d-Orn(N3)-OH • CHA N3 BDO-53116-PI 1g 544

Boc-(R)-2-amino-5-azidopentanoic acid CHA 4 °C 5g 1680
salt O
(M.W. 357.4) OH H2N
25 g 5625
O N
H
O

Fmoc-Azido-Lys-OH N3 FAK-1903-PI 1g 470

Nα-9-Fluorenylmethoxycarbonyl-ε-Azido-l- 4 °C 5g 1880
Lysine
(M.W. 394.43) C21H22N4O4 [159610-89-6]
Building Block for Click Chemistry
O
A. Le Chevalier Isaad, et al.,
J. Pept. Sci., 15, 451 (2009). OH
O N
P.E. Schneggenburger, et al., H
J. Pept. Sci., 16, 10 (2010). O

Fmoc-d-Dab(N3)-OH N3 FDX-53107-PI 1g 544

Fmoc-(R)-2-Amino-4-azidobutanoic acid 4 °C 5g 1680
(M.W. 366.4) O
25 g 5625

PEPTIDES INTERNATIONAL
OH
O N
H
O

Fmoc-Dab(N3)-OH N3 FLX-53103-PI 1g 432

Fmoc-(S)-2-Amino-4-azidobutanoic acid 4 °C 5g 1344
(M.W. 366.4) O
[942518-20-9] 25 g 4500
OH
O N
H
O

Fmoc-d-Dap(N3)-OH FDX-53106-PI 1g 544

Fmoc-(R)-2-Amino-3-Azidopropanoic Acid N3 4 °C 5g 1680
(M.W. 352.3) O
[1016163-79-3] OH 25 g 5625
O N
H
O

Fmoc-Dap(N3)-OH FLX-53102-PI 1g 432

Fmoc-(S)-2-Amino-3-Azidopropanoic Acid N3 4 °C 5g 1344
(M.W. 352.3) O
[684270-46-0] 25 g 4500
OH
O N
H
O

Order Hotline 1-800-777-4779 502-266-8787 241

 PRODUCT Code Qty PRICE
Fmoc-d-Lys(N3)-OH N3 FDK-53109-PI 1g 544
TOOLS for PEPTIDE SYNTHESIS

Fmoc-(R)-2-Amino-6-Azidohexanoic Acid 4 °C 5g 1680

(M.W. 394.4)
[1198791-53-5] 25 g 5625
O

OH
O N
H
O

Fmoc-Orn(N3)-OH N3 FLO-53104-PI 1g 320

Fmoc-(S)-2-Amino-5-azidopentanoic acid 4 °C 5g 1008
(M.W. 380.4)
[1097192-04-5] O 25 g 3375
OH
O N
H
O

Fmoc-d-Orn(N3)-OH N3 FDO-53108-PI 1g 544

Fmoc-(R)-2-Amino-5-Azidopentanoic Acid 4 °C 5g 1680
(M.W. 380.4)
[1176270-25-9] O 25 g 5625
OH
O N
H
O
PEPTIDES INTERNATIONAL

l-Amino Acids

l-Alanine ALA-2701-PI 100 g 62

(M.W. 89.09) C3H7NO2 [56-41-7] 4 °C 500 g 229
l-Arginine • HCI ALR-2702-PI 100 g 29
(M.W. 174.20 • 36.46) C6H14N4O2 • HCI 4 °C 500 g 84
[1119-34-2]

l-Asparagine • H2O ALN-2703-PI 100 g 45

(M.W. 132.12 • 18.02) C4H8N2O3 • H2O 4 °C 500 g 163
[5794-13-18]

l-Aspartic acid ALD-2704-PI 100 g 20

(M.W. 133.10) C4H7NO4 [56-84-8] 4 °C 500 g 48
l-Cysteine • HCI • H2O ALC-2705-PI 100 g 47
(M.W. 121.16 • 36.46 • 18.02) 4 °C 500 g 158
C3H7NO2S • HCI • H2O [7048-04-6]

l-Cystine ALC-2706-PI 100 g 47

(M.W. 240.30) C6H12N2O4S2 [56-89-3] 4 °C 500 g 158
l-Glutamic Acid ALE-2708-PI 100 g 20
(M.W. 147.13) C5H9NO4 [56-86-0] 4 °C 500 g 48
l-Glutamine ALQ-2707-PI 100 g 41
(M.W. 146.15) C5H10N2O3 [56-85-9] 4 °C 500 g 140

242 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

TOOLS for PEPTIDE SYNTHESIS

Glycine ALG-2709-PI 100 g 20
(M.W. 75.07) C2H5NO2 [56-40-6] 4 °C 500 g 48
l-Histidine • HCI • H2O ALH-2710-PI 100 g 45
(M.W. 155.16 • 36.46 • 18.02) 4 °C 500 g 148
C6H9N3O2 • HCI • H2O [5934-29-2]

l-Hydroxyproline ALX-2711-PI 25 g 59
(M.W. 131.13) C5H9NO3 [51-35-4] 4 °C 100 g 188
500 g 720
l-Isoleucine ALI-2712-PI 25 g 41
(M.W. 131.18) C6H13NO2 [73-32-5] 4 °C 100 g 113
500 g 419
l-Leucine ALL-2713-PI 25 g 19
(M.W. 131.18) C6H13NO2 [61-90-5] 4 °C 100 g 45
500 g 163
l-Lysine • HCI ALK-2714-PI 100 g 23
(M.W. 146.19 • 36.46) C6H14N2O2 • H2O [657-27-2] 4 °C 500 g 60
l-Methionine ALM-2715-PI 100 g 38
(M.W. 149.21) C5H11NO2S [63-68-3] 4 °C 500 g 128
l-Norleucine ALU-2728-PI 5g 48

PEPTIDES INTERNATIONAL
(M.W. 131.17) C6H13NO2 [327-57-1] 4 °C 25 g 195
l-Ornithine • HCI ALO-2716-PI 25 g 25
(M.W. 132.16 • 36.46) C5H12N2O2 • HCI [3184-13-2] 4 °C 100 g 61
l-Phenylalanine ALF-2717-PI 100 g 46
(M.W. 165.19) C9H11NO2 [63-91-2] 4 °C 500 g 156
l-Proline ALP-2718-PI 100 g 82
(M.W. 115.13) C5H9NO2 [147-85-3] 4 °C 500 g 300
l-Pyroglutamic Acid ALU-2724-PI 25 g 28
(l-Pyrrolidone carboxylic acid) 4 °C 100 g 62
(M.W. 129.12) C5H7NO3 [98-79-3]

l-Serine ALS-2719-PI 25 g 40
(M.W. 105.09) C3H7NO3 [56-45-1] 4 °C 100 g 120
d-Ser Contamination: 0.5-1.5%

l-Threonine ALT-2720-PI 100 g 63

(M.W. 119.12) C4H9NO3 [72-19-5] 4 °C 500 g 235
l-Tryptophan ALW-2721-PI 25 g 34
(M.W. 204.23) C11H12N2O2 [73-22-3] 4 °C 100 g 87
l-Tyrosine ALY-2722-PI 100 g 36
(M.W. 181.19) C9H11NO3 [60-18-4] 4 °C 500 g 117

Order Hotline 1-800-777-4779 502-266-8787 243

 PRODUCT Code Qty PRICE
l-Valine ALV-2723-PI 100 g 38
TOOLS for PEPTIDE SYNTHESIS

(M.W. 117.15) C5H11NO2 [72-18-4] 4 °C 500 g 128

d-Amino Acids

d-Alanine ADA-2801-PI 5g 31
(M.W. 89.09) C3H7NO2 [338-69-2] 4 °C 25 g 82
d-Arginine ADR-2802-PI 5g 66
(M.W. 174.20) C6H14N4O2 [157-06-2] 4 °C 25 g 238
d-Asparagine • H2O ADN-2815-PI 5g 40
(M.W. 132.12 • 18.02) C4H8N2O3 • H2O [5794-24-1] 4 °C 25 g 124
d-Aspartic acid ADD-2814-PI 5g 33
(M.W. 133.10) C4H7NO4 [1783-96-6] 4 °C 25 g 92
d-Cysteine • HCI • H2O ADC-2817-PI 5g 66
(M.W. 121.16 • 36.46 • 18.02) C3H7NO2S • HCI • H2O 4 °C 25 g 238
[32443-99-5]

d-Glutamic Acid ADE-2804-PI 5 g 28

(M.W. 147.13) C5H9NO4 [6893-26-1] 4 °C 25 g 66
d-Histidine ADH-2805-PI 5g 66
(M.W. 155.16) C6H9N3O2 [351-50-8] 4 °C 25 g 238
d-Isoleucine ADI-2819-PI 1g 255
PEPTIDES INTERNATIONAL

(M.W. 131.17) C6H13NO2 [319-78-8] 4 °C 5g 995

d-Leucine ADL-2806-PI 5g 50
(M.W. 131.17) C6H13NO2 [328-38-1] 4 °C 25 g 170
d-Lysine • HCI ADK-2813-PI 5g 44
(M.W. 146.19 • 36.46) C6H14N2O2 • HCI [7274-88-6] 4 °C 25 g 145
d-Methionine ADM-2807-PI 5g 50
(M.W. 149.21) C5H11NO2S [348-67-4] 4 °C 25 g 170
d-Phenylalanine ADF-2808-PI 5g 30
(M.W. 165.19) C9H11NO2 [673-06-3] 4 °C 25 g 76
d-Proline ADP-2816-PI 5g 66
(M.W. 115.13) C5H9NO2 [344-25-2] 4 °C 25 g 238
d-Serine ADS-2818-PI 5g 40
(M.W. 105.09) C3H7NO3 [312-84-5] 4 °C 25 g 124
d-Threonine ADT-2809-PI 5g 44
(M.W. 119.12) C4H9NO3 [632-20-2] 4 °C 25 g 145
d-Tryptophan ADW-2810-PI 5g 30
(M.W. 204.23) C11H12N2O2 [153-94-6] 4 °C 25 g 76
d-Tyrosine ADY-2812-PI 5g 44
(M.W. 181.19) C9H11NO3 [556-02-5] 4 °C 25 g 145

244 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

TOOLS for PEPTIDE SYNTHESIS

d-Valine ADV-2811-PI 5g 255
(M.W. 117.15) C5H11NO2 4 °C 25 g 995
Amino Acid Esters
Arg(NO2)-OBzl • Tos B EBR-2048 5g 50
Ng-nitro-l-Arginine benzyl ester tosylate 4 °C 25 g 145
(M.W. 309.32 • 172.20) C13H19N5O4 • C7H8O3S
[10342-07-1] 100 g 470

Asp(OBzl)-OBzl • Tos A EBD-2045 5g 32

l-aspartic acid α, β-dibenzyl ester tosylate 4 °C 25 g 80
M.W. 313.35 • 172.20) C18H19NO4 • C7H8O3S
[2886-33-1] 100 g 250
Glu(OBzl)-OBzl • Tos A EBE-2046 5g 32
l-glutamic acid α,γ-dibenzyl ester tosylate 4 °C 25 g 80
M.W. 327.37 • 172.20) C19H21NO4 • C7H8O3S
[2791-84-6] 100 g 250
Gly-OBzl • Tos A EBG-2047 5g 29
Glycine benzyl ester tosylate 4 °C 25 g 73
(M.W. 165.19 • 172.20) C9H11NO2 • C7H8O3S
[1738-76-7] 100 g 230

Gly-OEt • HCI EEG-2037-PI 5g 21

Glycine Ethyl ester hydrochloride 4 °C 25 g 43
(M.W. 103.12 • 36.46) C4H9NO2 • HCI [623-33-6]
100 g 134

PEPTIDES INTERNATIONAL
His-OMe • 2HCl EMH-2038-PI 5g 55
l-histidine methyl ester Dihydrochloride 4 °C 25 g 55
(M.W. 162.18 • 79.92) C7H11N3O2 • 2HCI [7389-87-9]
100 g 172
Ile-OMe • HCI A EMI-2039-PI 5g 27
l-isoleucine methyl ester hydrochloride 4 °C 25 g 70
(M.W. 145.24 • 36.46) C7H15NO2 • HCI
100 g 223
Ile-OBzl • Tos A EBI-2111 5g 35
l-isoleucine benzyl ester tosylate 4 °C 25 g 95
(M.W. 221.30 • 172.20) C13H19NO2 • C7H8O3S
[16652-75-8] 100 g 295
Leu-OBzl • Tos EBL-2112 5g 35
l-Leucine benzyl ester tosylate 4 °C 25 g 95
(M.W. 221.30 • 172.20) C13H19NO2 • C7H8O3S [1738-77-8}
100 g 295
Leu-OEt • HCl EEL-2040-PI 5g 24
l-Leucine ethyl ester hydrochloride 4 °C 25 g 62
(M.W. 159.24 • 36.46) C8H17NO2 • HCI [2743-40-0]
100 g 194
Met-OMe • HCI EMM-2036-PI 5g 27
l-Methionine methyl ester hydrochloride 4 °C 25 g 68
(M.W. 163.24 • 36.46) C6H13NO2S • HCI [2491-18-1]
100 g 218

Order Hotline 1-800-777-4779 502-266-8787 245

 PRODUCT Code Qty PRICE
Phe-OBzl • Tos A EBF-2110 5g 35
TOOLS for PEPTIDE SYNTHESIS

l-phenylalanine benzyl ester tosylate 4 °C 25 g 95

(M.W. 255.31 • 172.20) C16H17NO2 • C7H8O3S
[1738-78-9] 100 g 295
Phe-OEt • HCI EEF-2041-PI 5g 24
l-phenylalanine ethyl ester hydrochloride 4 °C 25 g 62
(M.W. 193.24 • 36.46) C11H15NO2 • HCI [3182-93-2]
100 g 194
Pro-OBzl • HCI B EBP-2049 5g 50
l-proline benzyl Ester Hydrochloride 4 °C 25 g 170
(M.W. 205.25 • 36.45) C12H15NO2 • HCI
[16652-71-4] 100 g 560
Ser-OMe • HCI EMS-2042-PI 5g 27
l-serine methyl ester hydrochloride 4 °C 25 g 75
(M.W. 119.10 • 36.45) C4H9NO3 • HCI [5680-80-8]
100 g 250
Tyr-OEt • HCI EEY-2043-PI 5g 24
l-tyrosine ethyl ester hydrochloride 4 °C 25 g 62
M.W. 209.24 • 36.44) C11H15NO3 • HCI [4089-07-0]
100 g 194
Val-OMe • HCI EMV-2044-PI 5g 24
l-Valine methyl ester hydrochloride 4 °C 25 g 62
(M.W. 131.14 • 36.46) C6H13NO2 • HCI [6306-52-1]
100 g 194
PEPTIDES INTERNATIONAL

Side Chain Derivatives of Amino Acids

Arg(NO2) AA XNR-2005 5g 25
Ng-nitro-l-Arginine 4 °C 25 g 50
(Nω-nitro-l-Arginine)
Y. Kobayashi and K. Hattori, Jpn. J. Pharmacol., 52, 167 (1990). 100 g 140
A. Gibson, S. Mirzazadeh, A.J. Hobbs, and P.K. Moore, Br. J. Pharmacol., 99, 602 (1990).

Arg(Tos) XTR-2101-PI 1g 27
Ng-tosyl-l-arginine 4 °C 5g 81
(M.W. 328.39) C13H20N4O4S [4353-32-6]
25 g 303
Glu(OBzl) A XBE-2003 5g 30
l-glutamic acid γ-benzyl ester 4 °C 25 g 65
(M.W. 237.25) C12H15NO4 [1676-73-9]
100 g 200
Glu(OMe) XME-2001-PI 25 g 95
l-glutamic acid γ-methyl ester 4 °C 100 g 225
(M.W. 161.16) C6H11NO4 [1499-55-4]

Lys(Z) XZK-2006-PI 5g 35
Nε-Carbobenzoxy-l-lysine 4 °C 25 g 117
(M.W. 280.30) C14H20N2O4 [2212-75-1]
100 g 379

246 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

TOOLS for PEPTIDE SYNTHESIS

Boc-Protected l-Amino Acids
Boc-Ala-OH AA BLA-2051 5g 25
t-Butyloxycarbonyl-l-alanine 4 °C 25 g 50
(M.W. 189.21) C8H15NO4 [15761-38-3]
100 g 140
Boc-β-Ala-OH AA BBA-2131 5g 30
t-Butyloxycarbonyl-β-alanine 4 °C 25 g 70
(M.W. 189.21) C8H15NO4 [3303-84-2]
100 g 230
Boc-Arg(NO2)-OH* AA-A BLR-2058 5g 35
Nα-t-Butyloxycarbonyl-Ng-nitro-l-arginine 4 °C 25 g 105
(M.W. 319.32) C11H21N5O6 [2188-18-3]
100 g 350
Boc-Arg(Tos)-OH* AA BLR-2125 5g 60
Nα-t-Butyloxycarbonyl-Ng-tosyl-l-arginine 4 °C 25 g 180
(M.W. 428.50) C18H28N4O5S [13836-37-8]
100 g 630
Boc-Asn-OH AA-A BLN-2060 5g 25
t-Butyloxycarbonyl-l-asparagine 4 °C 25 g 60
(M.W. 232.23) C9H16N2O5 [7536-55-2]
100 g 170
Boc-Asn-ONp B BLN-2077 5g 130
t-Butyloxycarbonyl-l-asparagine-p-nitrophenyl 4 °C 25 g 455
ester

PEPTIDES INTERNATIONAL
(M.W. 353.33) C15H19N3O7 [4587-33-1]

Boc-Asp(OBzl)-OH AA BLD-2059 5g 30
t-Butyloxycarbonyl-l-aspartic acid β-benzyl 4 °C 25 g 85
ester
(M.W. 323.34) C16H21NO6 [7536-58-5] 100 g 285
Boc-Asp(OcHex)-OH AA BLD-2132 5g 30
t-Butyloxycarbonyl-l-aspartic acid β-cyclohexyl 4 °C 25 g 85
ester
(M.W. 315.36) C15H25NO6 [73821-95-1] 100 g 285
J.P. Tam, T.-W. Wong, M.W. Riemen, F.-S. Tjoeng, and R.B. Merrifield, Tetrahedron Lett., 42, 4033 (1979)

Boc-Cys(Acm)-OH AA BLC-2121 5g 50
t-Butyloxycarbonyl-S-acetamidomethyl-l- 4 °C 25 g 150
cysteine
(M.W. 292.35) C11H20N2O5S [19746-37-3] 100 g 510
D.F. Veber, J.D. Milkowski, S.L. Varga, R.G. Denkewalter, and R. Hirschmann, J. Am. Chem. Soc., 94, 5456 (1972).
B. Kamber, A. Hartmann, K. Eisler, B. Riniker, H. Rink, P. Sieber, and W. Rittel, Helv. Chim. Acta, 63, 899 (1980).

Boc-Cys(Bzl)-OH AA BLC-2061 5g 50
t-Butyloxycarbonyl-S-benzyl-l-cysteine 4 °C 25 g 150
(M.W. 311.40) C15H21NO4S [5068-28-0]
100 g 495
* These compounds typically co-crystallize with ¼ - 1 molecule of water and/or ethyl acetate per molecule of amino acid
derivatives. The exact analytical data are provided to customers with each shipment.

Order Hotline 1-800-777-4779 502-266-8787 247

 PRODUCT GRADE Code Qty PRICE
Boc-Cys(tBu)-OH
TOOLS for PEPTIDE SYNTHESIS
AA BLC-2130 5g 60
t-Butyloxycarbonyl-S-t-butyl-l-cysteine 4 °C 25 g 180
(M.W. 277.38) C12H23NO4S [56976-06-8]
100 g 568
Boc-Cys(4-CH3Bzl)-OH AA BLC-2129 5g 50
t-Butyloxycarbonyl-S-4-methylbenzyl-l- 4 °C 25 g 160
cysteine
(M.W. 325.42) C16H23NO4S [61925-77-7] 100 g 545
50W.F. Heath, J.P. Tam, and R.B. Merrifield, Int. J. Pept. Protein Res., 28, 498 (1986)

Boc-Cys(MBzl)-OH AA BLC-2078 5g 50
t-Butyloxycarbonyl-S-p-methoxybenzyl-l- 4 °C 25 g 160
cysteine
(M.W. 341.43) C16H23NO5S [18942-46-6] 100 g 545
M. Platen and E. Steckhan, Liebigs Ann. Chem., 9, 1563 (1984).

Boc-Gln-OH AA-A BLQ-2062 5g 30

t-Butyloxycarbonyl-l-glutamine 4 °C 25 g 70
(M.W. 246.26) C10H18N2O5 [13726-85-7]
100 g 205
Boc-Gln-ONp A-B BLQ-2079 5g 130
t-Butyloxycarbonyl-l-glutamine p-nitrophenyl 4 °C 25 g 455
ester
(M.W. 367.35) C16H21N3O7 [15387-45-8]

Boc-Gln(Xan)-OH BLQ-5349-PI 5g 50
Nα-t-Butyloxycarbonyl-Nγ-xanthenyl-l-glutamine 4 °C 25 g 195
PEPTIDES INTERNATIONAL

(M.W. 426.47) C26H26N2O6 [55260-24-7]

100 g 785
Boc-Glu(OBzl)-OH AA BLE-2103 5g 30
t-Butyloxycarbonyl-l-glutamic acid γ-benzyl 4 °C 25 g 85
ester
(M.W. 337.37) C17H23NO6 [13574-13-5] 100 g 285
Boc-Glu(OcHex)-OH AA BLE-2134 5g 30
t-Butyloxycarbonyl-l-glutamic acid γ-cyclohexyl 4 °C 25 g 85
ester
(M.W. 329.39) C16H27NO6 [73821-97-3] 100 g 285
J.P. Tam, T.-W. Wong, M.W. Riemen, F.-S. Tjoeng, and R.B. Merrifield, Tetrahedron Lett., 42, 4033 (1979).

Boc-Gly-OH AA BLG-2054 5g 25
t-Butyloxycarbonyl-glycine 4 °C 25 g 50
(M.W. 175.18) C7H13NO4 [4530-20-5]
100 g 140
Boc-His(Bom)-OH AA BLH-2138 5g
Nα-t-Butyloxycarbonyl-Nπ-benzyloxymethyl-l- 4 °C 25 g
histidine
(M.W. 375.42) C19H25N3O5 [79950-65-5] 100 g
T. Brown, J.H. Jones, and J.D. Richards, J. Chem. Soc. Perkin Trans I, 1982, 1553.

Boc-His(Tos)-OH A BLH-2109 5g
Nα-t-Butyloxycarbonyl-Nτ-tosyl-l-histidine -20 °C 25 g
(M.W. 409.46) C18H23N3O6S [35899-43-5]

248 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT GRADE Code Qty PRICE

TOOLS for PEPTIDE SYNTHESIS

Boc-Hyp(Bzl)-OH AA BLX-2116 5g 110
t-Butyloxycarbonyl-O-benzyl-l-hydroxyproline 4 °C 25 g 390
(M.W. 321.37) C17H23NO5 [54631-81-1}

Boc-Ile-OH • 1⁄2 H2O AA BLI-2065 5g 25

t-Butyloxycarbonyl-l-isoleucine • hemihydrate 4 °C 25 g 50
(M.W. 231.29 • 9.01) C11H21NO4 • ½ H2O
[13139-16-7] 100 g 140
Boc-Leu-OH • H2O AA BLL-2055 5g 25
t-Butyloxycarbonyl-l-leucine • monohydrate 4 °C 25 g 50
(M.W. 231.29 • 18.02) C11H21NO4 • H2O
[13139-15-6] 100 g 140
Boc-Lys(Boc)-OH • DCHA BLK-5328-PI 5g 20
Nα,Nε,-di-t-butyloxycarbonyl-l-lysine • dicyclohexylamine salt 4 °C 25 g 80
(M.W. 346.43 • 181.32) C16H30N2O6 • C12­H23N [15098-69-8]

Boc-Lys(Fmoc)-OH BLK-5364-PI 1g 30
Nα-t-Butyloxycarbonyl-Nε-9-fluorenylmethoxycarbonyl-l-lysine 4 °C 5g 110
(M.W. 468.55) C26H32N2O6 [84624-27-1]
25 g 440
Boc-Lys(Cl-Z)-OH AA BLK-2135 5g 60
Nα-t-Butyloxycarbonyl-Nε-2- 4 °C 25 g 220
chlorobenzyloxycarbonyl-l-lysine
(M.W. 414.88) C19H27N2O6Cl [54613-99-9] 100 g 665
Boc-Lys(Z)-OH AA BLK-2108 5g 50
Nα-t-Butyloxycarbonyl-Nε-benzyloxycarbonyl-

PEPTIDES INTERNATIONAL
4 °C 25 g 150
l-lysine
(M.W. 380.44) C19H28N2O6 [2389-45-9] 100 g 495
Boc-Met-OH AA BLM-2104 5g 25
t-Butyloxycarbonyl-l-methionine 4 °C 25 g 55
(M.W. 249.33) C10H19NO4S [2488-15-5]
100 g 150
Boc-Phe-OH AA BLF-2068 5g 25
t-Butyloxycarbonyl-l-phenylalanine 4 °C 25 g 50
(M.W. 265.30) C14H19NO4 [13734-34-4]
100 g 140
Boc-Pro-OH AA BLP-2056 5g 25
t-Butyloxycarbonyl-l-proline 4 °C 25 g 50
(M.W. 215.25) C10H17NO4 [15761-39-4]
100 g 140
Boc-Ser(Bzl)-OH AA BLS-2102 5g 50
t-Butyloxycarbonyl-O-benzyl-l-serine 4 °C 25 g 160
(M.W. 295.33) C15H21NO5 [23680-31-1]
100 g 545
Boc-Thr(Bzl)-OH AA BLT-2070 5g 55
t-Butyloxycarbonyl-O-benzyl-l-threonine 4 °C 25 g 170
(M.W. 309.36) C16H23NO5 [15260-10-3]
100 g 515

Order Hotline 1-800-777-4779 502-266-8787 249

 PRODUCT GRADE Code Qty PRICE
Boc-Trp-OH
TOOLS for PEPTIDE SYNTHESIS
A BLW-2057 5g 25
Nα-t-Butyloxycarbonyl-l-tryptophan 4 °C 25 g 60
(M.W. 304.34) C16H20N2O4 [13139-14-5]
100 g 170
Boc-Trp(CHO)-OH AA BLW-2115 5g 80
Nα-t-Butyloxycarbonyl-Nin-formyl-l-tryptophan 4 °C 25 g 250
(M.W. 332.35) C17H20N2O5 [47355-10-2]
100 g 760
M. Ohno, S. Tsukamoto, S. Sato, and N. Izumiya, Bull. Chem. Soc. Jpn., 46, 3280 (1973).

Boc-Trp(Hoc)-OH A BLW-2139 5g 680

Nα-t-Butyloxycarbonyl-Nin- 4 °C
cyclohexyloxycarbonyl-l-tryptophan
(M.W. 430.49) C23H30N2O6
Y. Nishiuchi, H. Nishio, T. Inui, T. Kimura, and S. Sakakibara, Tetrahedron Lett., 37, 7529 (1996).

Boc-Tyr(Bzl)-OH AA BLY-2071 5g 80
t-Butyloxycarbonyl-O-benzyl-l-tyrosine 4 °C 25 g 250
(M.W. 371.43) C21H25NO5 [2130-96-3]
100 g 760
Boc-Tyr(Br-Z)-OH A BLY-2114 5g 80
t-Butyloxycarbonyl-O-2-bromobenzyloxycar- 4 °C 25 g 290
bonyl-l-tyrosine
(M.W. 494.33) C22H24NO7Br [47689-67-8] 100 g 890
Boc-Tyr(Cl2-Bzl)-OH AA BLY-2119 5g 65
t-Butyloxycarbonyl-O-2,6-dichlorobenzyl-l-
PEPTIDES INTERNATIONAL

4 °C 25 g 225
tyrosine
(M.W. 440.32) C21H23NO5CI2 [40298-71-3] 100 g 715
D. Yamashiro and C.H. Li, J. Am. Chem. Soc., 95, 1310 (1980).
Y. Kiso, M. Satomi, K. Ukawa, and T. Akita, J. Chem. Soc. Chem. Commun., 22, 1063 (1980).

Boc-Val-OH AA BLV-2105 5g 25
t-Butyloxycarbonyl-l-valine 4 °C 25 g 50
(M.W. 217.26) C10H19NO4 [13734-41-3]
100 g 140
Boc Amino Acids attached to Pam Resin are listed on page 288.
Boc Amino Acids attached to Merrifield Resin are listed on page 319.

Boc-Protected d-Amino Acids

Boc-d-Ala-OH AA BDA-2606 1g 30
t-Butyloxycarbonyl-d-alanine 4 °C 5g 65
(M.W. 189.21) C8H15NO4 [7764-95-6]
25 g 225
Boc-d-Arg(Tos)-OH* AA BDR-2609 1g 75
Nα-t-Butyloxycarbonyl-Ng-tosyl-d-arginine 4 °C 5g 190
(M.W. 428.50) C18H28N4O6S [61315-61-5]
480
Boc-d-Asn-OH AA-A BDN-2626 1g 55
t-Butyloxycarbonyl-d-asparagine 4 °C 5g 185
(M.W. 232.23) C9H16N2O5 [75647-01-7]
25 g 745

250 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT GRADE Code Qty PRICE

TOOLS for PEPTIDE SYNTHESIS

Boc-d-Asn-ONp B BDN-2620 1g 80
t-Butyloxycarbonyl-d-asparagine-p-nitrophenyl -20 °C 5g 270
ester
(M.W. 353.33) C19H19N3O7 [104199-82-8] 25 g 915
Boc-d-Asn(Xan)-OH BDN-2651-PI 1g 75
Nα-t-Butyloxycarbonyl-Nβ-xanthenyl-d-asparagine -20 °C 5g 295
(M.W. 412.45) C22H24N2O6

Boc-d-Asp(OBzl)-OH AA BDD-2616 1g 50
t-Butyloxycarbonyl-d-aspartic acid β-benzyl 4 °C 5g 170
ester
(M.W. 323.35) C 16H21NO6 [51186-58-4] 25 g 660
Boc-d-Asp(OcHex)-OH AA BDD-2617 1g 50
t-Butyloxycarbonyl-d-aspartic acid β-cyclohexyl 4 °C 5g 170
ester
(M.W. 315.37) C 15H25NO6 [112898-18-7] 25 g 660
Boc-d-Asp-OFm BDD-2618-PI 1g 95
t-Butyloxycarbonyl-d-aspartic acid-α-9-fluorenylmethyl ester 4 °C 5g 395
(M.W. 411.46) C23H25NO6 [123417-19-6]

Boc-d-Ile-OH BDI-5318-PI 1g 225

t-Butyloxycarbonyl-d-isoleucine 4 °C 5g 950
(M.W. 231.29) C11H21NO4 [55721-65-8]

Boc-d-Lys(Fmoc)-OH BDX-5375-PI 1g 65
Nα-t-Butyloxycarbonyl-Nε-9-fluorenylmethoxycarbonyl-d-lysine 4 °C 5g 255

PEPTIDES INTERNATIONAL
(M.W. 468.55) C26H32N2O6 [115186-31-7]

Boc-d-His(Tos)-OH • DCHA A BDH-2605 1g 70

Nα-t-Butyloxycarbonyl-Nim-tosyl-d-histidine • 4 °C 5g 200
dicyclohexylamine
(M.W. 409.46 • 181.32) C18H23N3O6S • C12H23N 25 g 720

Boc-d-Ile • ½ H2O AA BDI-2629 1g 390

t-Butyloxycarbonyl-d-isoleucine hemihydrate 4 °C 5g 1550
(M.W. 231.29 • 9.01) C13H21NO4 • ½H2O

Boc-d-Leu-OH • H2O AA BDL-2603 1g 32

t-Butyloxycarbonyl-d-leucine • monohydrate 4 °C 5g 80
(M.W. 231.29 • 18.02) C11H21NO4 • H2O
[16937-99-8] 25 g 290

Boc-d-Lys(Cl-Z)-OH AA BDK-2628 1g 65
Nα-t-Butyloxycarbonyl-Nε-2-chloro- 4 °C 5g 225
benzyloxycarbonyl-d-lysine
(M.W. 414.88) C19H27N2O6Cl [57096-11-4] 25 g 860
Boc-d-Met-OH A BDM-2608 1g 35
t-Butyloxycarbonyl-d-methionine 4 °C 5g 105
(M.W. 249.33) C10H19NO4S [5241-66-7]
25 g 390
Boc-d-Phe-OH AA BDF-2604 1g 32
t-Butyloxycarbonyl-d-phenylalanine 4 °C 5g 70
(M.W. 265.30) C14H19NO4 [18942-49-9]
25 g 250

Order Hotline 1-800-777-4779 502-266-8787 251

 PRODUCT GRADE Code Qty PRICE
Boc-d-Phe(NO2)-OH
TOOLS for PEPTIDE SYNTHESIS
BDF-5222-PI 1g
t-Butyloxycarbonyl-p-nitro-d-phenylalanine 4 °C 5g
(M.W. 310.31) C14H18N2O6 [61280-75-9]

Boc-d-Pro-OH AA BDP-2610 1g 65
t-Butyloxycarbonyl-d-proline 4 °C 5g 225
(M.W. 215.25) C10H17NO4 [37784-17-1]
25 g 785
Boc-d-Ser(Bzl)-OH AA BDS-2627 5g 190
t-Butyloxycarbonyl-O-benzyl-d-serine 4 °C 25 g 770
(M.W. 295.33) C15H21NO5 [47173-80-8]

Boc-d-Thr(Bzl)-OH AA BDT-2624 5g 190

t-Butyloxycarbonyl-O-benzyl-d-threonine 4 °C 25 g 770
(M.W. 309.36) C16H23NO5 [69355-99-3]

Boc-d-Trp-OH A BDW-2602 5g 32
Nα-t-Butyloxycarbonyl-d-tryptophan 4 °C 25 g 80
(M.W. 304.34) C16H20N2O4 [5241-64-5]
225
Boc-d-Trp(CHO)-OH AA BDW-2614 5g 220
Nα-t-Butyloxycarbonyl-Nin-formyl-d-tryptophan 4 °C 25 g 745
(M.W. 332.35) C17H20N2O5 [64905-10-8]

Boc-d-Tyr(Br-Z)-OH A BDY-2612 5g 225

t-Butyloxycarbonyl-O-2-bromobenzyloxycar- 4 °C 25 g 785
bonyl-d-tyrosine
(M.W. 494.33) C22H24NO7Br [81189-61-9]
PEPTIDES INTERNATIONAL

Boc-d-Tyr(Cl2-Bzl)-OH AA BDY-2622 1g 75
t-Butyloxycarbonyl-O-2,6-dichlorobenzyl-d- 4 °C 5g 270
tyrosine
(M.W. 440.32) C21H23NO5Cl2 [69541-62-4]

Boc-d-Val-OH AA BDV-2619 1g 35
t-Butyloxycarbonyl-d-valine 4 °C 5g 95
(M.W. 217.27) C10H19NO4 [22838-58-0]

Unusual Boc-Amino Acids

Boc-Abu-OH BLX-5362-PI 1g 20
t-Butyloxycarbonyl-l-α-aminobutyric acid 4 °C 5g 60
(M.W. 203.24) C9H17NO4 [34306-42-8]
25 g 240
Boc-d-Abu-OH BDX-5365-PI 1g 20
t-Butyloxycarbonyl-d-α-aminobutyric acid 4 °C 5g 60
(M.W. 203.24) C9H17NO4 [45121-22-0]
25 g 240
Boc-d-Abu-OH • DCHA BDX-5360-PI 5g 45
t-Butyloxycarbonyl-d-α-aminobutyric acid • 4 °C 25 g 180
dicyclohexylamine
(M.W. 203.24 • 181.26) C9H17NO4 • C12H23N 100 g 540

252 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

TOOLS for PEPTIDE SYNTHESIS

Boc-γ-Abu-OH BAB-5363-PI 5g 49
t-Butyloxycarbonyl-γ-aminobutyric acid 4 °C 25 g 75
(M.W. 203.24) C9H17NO4 [57294-38-9]
100 g 225
Boc-Abz-OH ABZ-5014-PI 1g 50
Boc-anthranilic acid 4 °C 5g 200
Boc-2-aminobenzoic acid
(M.W. 237.26) C12H15NO4 [68790-38-5]

Boc-ε-Aca-OH BAC-5352-PI 5g 49
t-Butyloxycarbonyl-ε-aminocaproic acid 4 °C 25 g 195
(M.W. 231.29) C11H21NO4 [6404-29-1]

Boc-p-Aminobenzoic Acid BAB-5403-PI 1g 35

Boc-PABA 4 °C 5g 125
(M.W. 237.26) C12H15NO4
25 g 495
Boc-Asn(Xan)-OH BLN-5351-PI 5g 50
Nα-t-Butyloxycarbonyl-Nβ-xanthenyl-l-asparagine 4 °C 25 g 195
(M.W. 412.45) C22H24N2O6 [65420-40-8]

Boc-Asp(OFm)-OH (Beta Ester) BLD-5662-PI 5g 195

t-Butyloxycarbonyl-l-aspartic acid-β-9-fluorenylmethyl ester 4 °C 25 g 795
(M.W. 411.46) C23H25NO6

Boc-Asp-OFm (Alpha Ester) BLD-5571-PI 5g 195

t-Butyloxycarbonyl-l-aspartic acid-α-9-fluorenylmethyl ester 4 °C 25 g 795
(M.W. 411.46) C23H25NO6

PEPTIDES INTERNATIONAL
Boc-Aib-OH BLX-5340-PI 5g 30
t-Butyloxycarbonyl-α-aminoisobutyric acid 4 °C 25 g 110
(t-Butyloxycarbonyl-α-methylalanine)
(M.W. 203.20) C9H17NO4 [30992-29-1]

Boc-5-Ava-OH BLX-5366-PI 1g 75
t-Butyloxycarbonyl-5-aminovaleric acid 4 °C 5g 295
(M.W. 217.27) C10H19NO4 [27219-07-4]

Boc-Cys(Npys)-OH BCN-5000-PI 1g 110

t-Butyloxycarbonyl-S-(3-nitro-2-pyridylthio)-l-cysteine 4 °C 5g 425
(M.W. 375.42) C13H17N3O6S2 [76880-29-0]

Boc-Dab(Fmoc)-OH BLX-5369-PI 1g 110

Nα-t-Butyloxycarbonyl-Nγ-9-fluorenylmethoxycarbonyl-l-2,4- 4 °C 5g 440
diaminobutyric acid
(M.W. 440.50) C24H28N2O6 [17106-21-5]

Boc-Dap-OH BLX-5378-PI 1g 49
Nα-t-Butyloxycarbonyl-l-2,3-diaminopropionic Acid 4 °C 5g 195
(M.W. 204.23) C8H16N2O4 [73259-81-1]
25 g 695
Boc-d-Dab(Fmoc)-OH BDX-5357-PI 1g 210
Nα-t-Butyloxycarbonyl-Nγ-9-fluorenylmethoxycarbonyl-d-2,4- 4 °C 5g 840
diaminobutyric acid
(M.W. 440.50) C24H28N2O6 [131570-57-5]

Order Hotline 1-800-777-4779 502-266-8787 253

 Boc-Dap(Fmoc)-OH BLX-5359-PI 1g 110
TOOLS for PEPTIDE SYNTHESIS

Nα-t-Butyloxycarbonyl-Nβ-9-fluorenylmethoxycarbonyl-l-2,3- 4 °C 5g 440
diaminopropionic acid
(M.W. 426.47) C23H26N2O6 [122235-70-5]

Boc-d-Dap(Fmoc)-OH BDX-5354-PI 1g 210

Nα-t-Butyloxycarbonyl-Nβ-9-fluorenylmethoxycarbonyl-d-2,3- 4 °C 5g 840
diaminopropionic acid

Boc-Deg-OH BLX-5341-PI 1g 55
t-Butyloxycarbonyl-diethylglycine 4 °C 5g 195
(M.W. 231.29) C11H21NO4
25 g 795
Boc-Dhp-OH BLX-5324-PI 1g 280
t-Butyloxycarbonyl-3,4-dehydro-l-proline 4 °C
(M.W. 197.23) C10H10NO4 [51154-06-4]

Boc-Dip-OH BDF-5528-PI 1g 135

t-Butyloxycarbonyl-l-(3,3-diphenyl)alanine 4 °C 5g 495
(M.W. 341.41) C20H23NO4 [138662-63-2]

Boc-d-Dip-OH BDF-5530-PI 1g 135

t-Butyloxycarbonyl-d-(3,3-diphenyl)alanine 4 °C 5g 495
(M.W. 341.41) C20H23NO4 [117027-46-0]

Boc-Glu(OFm)-OH (Gamma Ester) BLE-5683-PI 5g 195

t-Butyloxycarbonyl-l-glutamic Acid-γ-9-fluorenylmethyl ester 4 °C 25 g 795
(M.W. 425.49) C24H27NO6 [123417-18-5]
PEPTIDES INTERNATIONAL

Boc-Glu-OFm (Alpha Ester) BLE-5591-PI 5g 195

t-Butyloxycarbonyl-l-glutamic Acid-α-9-fluorenylmethyl ester 4 °C 25 g 795
(M.W. 425.48) C24H27NO6

Boc-Homo-Phe-OH BLF-5371-PI 1g 75
t-Butyloxycarbonyl-l-homophenylalanine 4 °C 5g 295
(M.W. 279.34) C15H21NO4 [100564-78-1]

Boc-d-Homo-Phe-OH BDF-5373-PI 1g 75
t-Butyloxycarbonyl-d-homophenylalanine 4 °C 5g 295
(M.W. 279.34) C15H21NO4 [82732-07-8]

Boc-Hydroxy-Tic-OH BLX-5345-PI 1g 425

t-Butyloxycarbonyl-7-hydroxy-l-1,2,3,4-tetrahydroisoquinoline 4 °C
3-carboxylic acid
(M.W. 293.32) C15H19NO5

Boc-d-Hydroxy-Tic-OH BDX-5343-PI 1g 475

t-Butyloxycarbonyl-7-hydroxy-d-1,2,3,4-tetrahydroisoquinoline 4 °C
3-carboxylic acid
(M.W. 293.32) C15H19NO5 [214630-00-9]

Boc-allo-Ile-OH BLX-5342-PI 1g 195

t-Butyloxycarbonyl-allo-isoleucine 4 °C 5g 795
(M.W. 231.29) C11H21NO4 [35264-07-4]

Boc-d-lle-OH BDI-5318-PI 1g 225

t-Butyloxycarbonyl-d-isoleucine 4 °C 5g 950
(M.W. 231.29) C11H21NO4 [55721-65-8]

254 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

TOOLS for PEPTIDE SYNTHESIS

Boc-mini-PEG™ BXX-5519-PI 1g 125
Boc-8-Amino-3,6-Dioxaoctanoic Acid • DCHA 4 °C 5g 495
tert-butyloxycarbonyl-8-amino-3,6-dioxaoctanoic acid • dicyclohexylamine
(M.W. 263.29 • 181.3) C11H21NO6 • C12­H23N
Boc-AEEA

Boc-mini-PEG-3™ BXX-5523-PI 1g 150

Boc-11-Amino-3,6,9-Trioxaundecanoic Acid • 4 °C 5g 575
DCHA
tert-butyloxycarbonyl-11-Amino-3,6,9-trioxaundecanoic acid • dicyclohexylamine
(M.W. 307.35 • 181.32) C13H25NO7 • C12­H23N
Boc-AEEEA

Boc-Nal(2')-OH BLX-5327-PI 1g 60
t-Butyloxycarbonyl-l-(2-naphthyl)alanine 4 °C 5g 240
(M.W. 315.37) C18H21NO4 [58438-04-3]

Boc-d-Nal(2')-OH BDX-5319-PI 1g 80
t-Butyloxycarbonyl-d-(2-naphthyl)alanine 4 °C 5g 320
(M.W. 315.37) C18H21NO4 [76985-10-9]

Boc-Nal(1')-OH BLX-5379-PI 1g 80
t-Butyloxycarbonyl-l-(1-naphthyl)alanine 4 °C 5g 320
(M.W. 315.37) C18H21NO4 [55447-00-2]

Boc-d-Nal(1')-OH BDX-5381-PI 1g 80
t-Butyloxycarbonyl-d-(1-naphthyl)alanine 4 °C 5g 320
(M.W. 315.37) C 18H21NO4 [76932-48-4]

PEPTIDES INTERNATIONAL
Boc-Norleucine (syrup) BLX-5325-PI 5g 95
t-Butyloxycarbonyl-l-norleucine 4 °C 25 g 380
(M.W. 231.29) C11H21NO4 [6404-28-0]

Boc-Norvaline (syrup) BLX-5320-PI 5g 85

t-Butyloxycarbonyl-l-norvaline 4 °C 25 g 330
(M.W. 217.27) C10H19NO4 [53308-95-5]

Boc-Orn-OH BLO-5321-PI 1g 50
t-Butyloxycarbonyl-l-ornithine 4 °C 5g 175
(M.W. 232.28) C10H20N2O4 [21887-64-9]
25 g 700
Boc-Orn(Cl-Z)-OH BLO-5326-PI 5g 149
Nα-t-Butyloxycarbonyl-Nδ-2-chlorobenzyloxycarbonyl-l- 4 °C 25 g 595
ornithine
(M.W. 400.86) C18H25N2O6CI [118554-00-0]

Boc-Orn(Boc)-OH BLO-5361-PI 1g 20
Nα, Nδ,-di-t-Butyloxycarbonyl-l-ornithine 4 °C 5g 70
(M.W. 332.40) C15H28N2O6 [57133-29-6]
25 g 275
Boc-Orn(Fmoc)-OH BLX-5368-PI 1g 50
Nα-t-Butyloxycarbonyl-Nδ-9-fluorenylmethoxycarbonyl-l- 4 °C 5g 200
ornithine
(M.W. 454.53) C25H30N2O6 [150828-96-9]

Order Hotline 1-800-777-4779 502-266-8787 255

 PRODUCT Code Qty PRICE
Boc-d-Orn(Fmoc)-OH BDX-5355-PI 1g 125
TOOLS for PEPTIDE SYNTHESIS

Nα-t-Butyloxycarbonyl-Nδ-9-fluorenylmethoxycarbonyl-d- 4 °C 5g 495
ornithine
(M.W. 454.53) C25H30N2O6

Boc-3-Pal-OH BLX-5331-PI 1g 135

t-Butyloxycarbonyl-l-(3-pyridyl)alanine 4 °C 5g 495
(M.W. 266.30) C13H18N2O4 [117142-26-4]

Boc-d-3-Pal-OH BDX-5339-PI 1g 135

t-Butyloxycarbonyl-d-(3-pyridyl)alanine 4 °C 5g 495
(M.W. 266.30) C13H18N2O4 [98266-33-2]

Boc-4-Pal-OH BLX-5532-PI 1g 145

t-Butyloxycarbonyl-l-(4-pyridyl)alanine 4 °C 5g 580
(M.W. 266.30) C13H18N2O4 [37535-57-2]

Boc-d-4-Pal-OH BDX-5533-PI 1g 145

t-Butyloxycarbonyl-d-(4-pyridyl)alanine 4 °C 5g 580
(M.W. 266.30) C13H18N2O4 [37535-58-3]

Boc-Pen(Meb)-OH • DCHA BLX-5221-PI 1g 95

t-Butyloxycarbonyl-S-p-methylbenzyl-l-penicillamine • 4 °C 5g 380
Dicyclohexylamine
(M.W. 353.48 • 181.32) C18H27NO4S • C12H23N [198474-61-2]

Boc-d-Pen(Meb)-OH • DCHA BDX-5220-PI 1g 40

t-Butyloxycarbonyl-S-d-methylbenzyl-d-penicillamine • 4 °C 5g 135
Dicyclohexylamine
25 g 480
PEPTIDES INTERNATIONAL

(M.W. 353.48 • 181.32) C18H27NO4S • C12H23N [198470-36-9]

Boc-Pen(Mob)-OH BLX-5828-PI 1g 120

t-Butyloxycarbonyl-S-p-methoxybenzyl-l-penicillamine 4 °C 5g 480
(M.W. 369.48) C18H27NO5S [120944-75-4]

Boc-d-Pen(Mob)-OH BDX-2615-PI 1g 70
t-Butyloxycarbonyl-S-p-methoxybenzyl-d-penicillamine 4 °C 5g 280
(M.W. 369.48) C18H27NO5S [106306-57-4]

Boc-Pentafluoro-Phe-OH BLF-5383-PI 1g 80
t-Butyloxycarbonyl-pentafluoro-l-phenylalanine 4 °C 5g 320
(M.W. 355.26) C14H14NO4F5 [34702-60-8]

Boc-d-Pentafluoro-Phe-OH BDF-5385-PI 1g 80
t-Butyloxycarbonyl-pentafluoro-d-phenylalanine 4 °C 5g 320
(M.W. 355.26) C14H18NO4F5 [136207-26-6]

Boc-p-Cl-Phe-OH BLF-5315-PI 1g 60
t-Butyloxycarbonyl-p-chloro-l-phenylalanine 4 °C 5g 240
(M.W. 299.76) C14H18NO4Cl [68090-88-0]

Boc-p-Cl-d-Phe-OH BDF-5316-PI 1g 60
t-Butyloxycarbonyl-p-chloro-d-phenylalanine 4 °C 5g 240
(M.W. 299.76) C14H18NO4Cl [57292-44-1]

Boc-p-F-Phe-OH BLF-5329-PI 1g 60
t-Butyloxycarbonyl-p-fluoro-l-phenylalanine 4 °C 5g 240
(M.W. 283.30) C14H18NO4F [41153-30-4]

256 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

TOOLS for PEPTIDE SYNTHESIS

Boc-p-F-d-Phe-OH BDF-5335-PI 1g 60
t-Butyloxycarbonyl-p-fluoro-d-phenylalanine 4 °C 5g 240
(M.W. 283.30) C14H18NO4F [57292-45-2]

Boc-Phe(NO2)-OH BLF-5333-PI 1g 20
t-Butyloxycarbonyl-p-nitro-l-phenylalanine 4 °C 5g 85
(M.W. 309.31) C14H18N2O6 [33305-77-0]

Boc-Phe(NH2)-OH BLF-5337-PI 1g 50
t-Butyloxycarbonyl-p-amino-l-phenylalanine 4 °C 5g 195
(M.W. 280.33) C14H20N2O4 [55533-24-9]

Boc-Phe(NH-Z)-OH BLX-5230-PI 1g 70
Nα-t-Butyloxycarbonyl-l-phenylalanine 4 °C 5g 275
(p-amino-carbobenzoxy)
(M.W. 414.46) C22H26N2O6

Boc-Phg-OH BFG-5323-PI 1g 35
t-Butyloxycarbonyl-l-phenylglycine 4 °C 5g 140
(M.W. 251.28) C13H17NO4 [2900-27-8]

Boc-d-Phg-OH BDP-2600-PI 1g 30
t-Butyloxycarbonyl-d-phenylglycine 4 °C 5g 110
(M.W. 251.28) C13H17NO4 [33125-05-2]

Boc-Sar-OH BSR-2120 5g 35
t-Butyloxycarbonyl-sarcosine AA 4 °C 25 g 105
(M.W. 189.21) C8H15NO4 [13734-36-6]
100 g 340

PEPTIDES INTERNATIONAL
Boc-2-Thienylalanine BBX-5387-PI 1g 80
t-Butyloxycarbonyl-l-2-Thienylalanine 4 °C 5g 320
(M.W. 271.34) C12H17NO4S [56675-37-7]

Boc-d-2-Thienylalanine BDX-5389-PI 1g 80
t-Butyloxycarbonyl-d-2-Thienylalanine 4 °C 5g 320
(M.W. 271.34) C12H17NO4S [78452-55-8]

Boc-Tic-OH BLX-5347-PI 1g 75
t-Butyloxycarbonyl-l-1,2,3,4-Tetrahydroisoquinoline-3- 4 °C 5g 315
carboxylic acid
(M.W. 277.32) C15H19NO4 [78879-20-6]

Boc-d-Tic-OH BDX-5346-PI 1g 95
t-Butyloxycarbonyl-d-1,2,3,4-tetrahydroisoquinoline-3- 4 °C 5g 394
carboxylic acid
(M.W. 277.32) C15H19NO4 [115962-35-1]

Boc-Tyr(Me)-OH BLY-5332-PI 1g 55
t-Butyloxycarbonyl-O-methyl-l-tyrosine 4 °C 5g 220
(t-Butyloxycarbonyl-p-methoxy-l-phenylalanine)
(M.W. 295.34) C15H21NO5 [53267-93-9]

Boc-d-Tyr(Me)-OH BDY-5336-PI 1g 125

t-Butyloxycarbonyl-O-methyl-d-tyrosine 4 °C 5g 495
(t-Butyloxycarbonyl-p-methoxy-d-phenylalanine)
(M.W. 295.34) C15H21NO5 [68856-96-2]

Order Hotline 1-800-777-4779 502-266-8787 257

 PRODUCT Code Qty PRICE
Boc-Tyr(Et)-OH BLY-5334-PI 1g 45
TOOLS for PEPTIDE SYNTHESIS

t-Butyloxycarbonyl-O-Ethyl-l-tyrosine 4 °C 5g 180
(M.W. 309.40) C16H23NO5 [76757-91-0]

Boc-d-Tyr(Et)-OH BDY-5338-PI 1g 105

t-Butyloxycarbonyl-O-ethyl-d-tyrosine 4 °C 5g 415
(M.W. 309.40) C16H23NO5 [76757-92-1]

Boc-11-Aminoundecanoic Acid BAM-5454-PI 5g 65

t-Butyloxycarbonyl-II-aminoundecanoic acid 4 °C 25 g 260
(M.W. 301.43) C16H31NO4

Boc-N-Methyl Amino Acids

Boc-N-Me-Leu-OH BML-5313-PI 1g 67
t-Butyloxycarbonyl-N-methyl-l-leucine 4 °C 5g 260
(M.W. 245.32) C12H23NO4 [53363-89-6]

Boc-N-Me-Phe-OH BXF-5322-PI 1g 67
t-Butyloxycarbonyl-N-methyl-l-phenylalanine 4 °C 5g 260
(M.W. 279.34) C15H21NO4 [37553-65-4]

Boc-N-Me-Ser-OH BMS-5310-PI 1g 67
t-Butyloxycarbonyl-N-methyl-l-serine 4 °C 5g 260
(M.W. 219.24) C9H17NO5 [101772-29-6]

Boc-N-Me-Tyr-OH • DCHA BMY-5311-PI 1g 67

t-Butyloxycarbonyl-N-methyl-l-tyrosine • dicyclohexylamine 4 °C 5g 260
(M.W. 295.34 •181.32) C15H21NO5 • C12H23N [95105-25-2]
PEPTIDES INTERNATIONAL

Boc-N-Me-Val-OH BMV-5312-PI 1g 67
t-Butyloxycarbonyl-N-methyl-l-valine 4 °C 5g 260
(M.W. 231.29) C11H21NO4 [45170-31-8]

Boc-Amino Acid Esters

Boc-Leu-OEt BEL-5540-PI 1g 36
t-Butyloxycarbonyl-l-leucine ethyl ester 4 °C 5g 126
(M.W. 259.35)
25 g 405
Boc-Phe-OEt BEF-5841-PI 5g 36
t-Butyloxycarbonyl-l-phenylalanine ethyl ester 4 °C 25 g 126
100 g 405
Fmoc-Protected l-Amino Acids
Fmoc Protecting Group O
We are pleased to of fer a carefully selected list of stable,
high purity fluorenylmethyloxycarbonyl (Fmoc) amino acid O N
H
derivatives. The temporary, base labile, Fmoc protecting
group is usually removed by 20% piperidine in dimeth -
ylformamide (DMF), and is ideal in applications involving
orthogonal synthesis.
Fmoc-Ala-OH • H2O FLA-1706-PI 5g
FMOC Group 11
9-Fluorenylmethoxycarbonyl-l-alanine • H2O 4 °C 25 g 44
(M.W. 311.34 • 18.02) C18H17NO4 • H2O [35661-39-3]
100 g 132

258 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

TOOLS for PEPTIDE SYNTHESIS

Fmoc-β-Ala-OH FLX-1744-PI 1g 25
9-Fluorenylmethoxycarbonyl-β-alanine 4 °C 5g 49
(M.W. 311.34) C18H17NO4 [35737-10-1]
25 g 169
Fmoc-Arg-OH FLR-1708-PI 5g 50
9-Fluorenylmethoxycarbonyl-l-arginine 4 °C 25 g 179
(M.W. 396.45) C21H24N4O4 [91000-69-0]

Fmoc-Arg(Pbf)-OH FLR-1746-PI 5g 48
Nα-9-Fluorenylmethoxycarbonyl-Ng-2,2,4,6,7- 4 °C 25 g 185
pentamethyldihydrobenzofuran-5-sulfonyl-l-arginine
100 g 645
Fmoc-Arg(Pbf)-OH FLR-53012-PI 1 kg 2200
N-Fmoc-l-Arginine(Pbf) 4 °C
(M.W. 648.77) C21H23N5O6 [154445-77-9]

Fmoc-Arg(Tos)-OH FLR-1710-PI 1g 35
Nα-9-Fluorenylmethoxycarbonyl-Ng-tosyl-l-arginine 4 °C 5g 140
(M.W. 550.60) C28H30N4O6S [83792-47-6]
25 g 565
Fmoc-Arg(Z)2-OH FRC-1902-PI 1g 150
N-α-9-Fluorenylmethoxycarbonyl-N-γ-bis-carbobenzoxy-L- 4 °C 5g 600
arginine
(M.W. 664.72) C37H36N4O8 [207857-35-0]

Fmoc-Asn-OH FLN-1704-PI 5g 25
9-Fluorenylmethoxycarbonyl-l-asparagine

PEPTIDES INTERNATIONAL
4 °C 25 g 70
(M.W. 354.37) C19H18N2O5 [71989-16-7]
100 g 255
Fmoc-Asn(Trt)-OH FLN-1754-PI 5g 55
Nα-9-Fluorenylmethoxycarbonyl-Nβ-trityl-l-asparagine 4 °C 25 g 150
(M.W. 596.69) C38H32N2O5 [132388-59-1]
100 g 495
Fmoc-Asp(Edans)-OH FDE-1900-PI 1g 560
(M.W. 603.66) C31H29N3O8S [182253-73-2] 4 °C 5g 2240
Building Blocks for FRETs

Fmoc-Asp(OBzl)-OH FLD-1712-PI 1g 35
9-Fluorenylmethoxycarbonyl-l-aspartic acid β-benzyl ester 4 °C 5g 159
(M.W. 445.46) C26H23NO6 [86060-84-6]
25 g 625
Fmoc-Asp(OtBu)-OH FLD-1713-PI 5g 28
9-Fluorenylmethoxycarbonyl-l-aspartic acid β-t-butyl ester 4 °C 25 g 92
(M.W. 411.46) C23H25NO6 [129460-09-9]
100 g 256
Fmoc-Cys(Acm)-OH FLC-1714-PI 5g 55
9-Fluorenylmethoxycarbonyl-S-acetamidomethyl-l-cysteine 4 °C 25 g 195
(M.W. 414.48) C21H22N2O5S [86060-81-3]

Fmoc-Cys(Ddm)-OH FCP-2330-PI 1g 130

9-Fluorenylmethoxycarbonyl-S-4,4'-dimethoxydiphenylmethyl- 4 °C
l-cysteine
(M.W. 569.67) C33H31NO6S

Order Hotline 1-800-777-4779 502-266-8787 259

 PRODUCT Code Qty PRICE
Fmoc-Cys(Dpm) FCP-2329-PI 5g 141
TOOLS for PEPTIDE SYNTHESIS

9-Fluorenylmethoxycarbonyl-S-diphenylmethyl-l-cysteine 4 °C
(M.W. 509.62) C31H27NO4S
M. Góngora-Benítez, et al., Org. Lett.,14, 5472 (2012).

Fmoc-Cys(tBu)-OH FLC-1741-PI 5g 79
9-Fluorenylmethoxycarbonyl-S-t-butyl-l-cysteine 4 °C 25 g 275
(M.W. 399.50) C22H25NO4S [67436-13-9]

Fmoc-Cys(pMeOBzl)-OH FLC-1717-PI 5g 116

9-Fluorenylmethoxycarbonyl-S-p-methoxybenzyl-l-cysteine 4 °C 25 g 495
(M.W. 463.51) C26H25NO5S [141892-41-3]

Fmoc-Cys(Pam)2-OH FCP-5001-PI 1g 1200

Fmoc-Cys((R,S)-2,3-di(palmitoyloxy)-propyl)-OH 4 °C 5g 4800
(M.W. 894.32) C53H83NO8S [210532-98-2]

Fmoc-Cys(Trt)-OH FLC-1718-PI 5g 35
9-Fluorenylmethoxycarbonyl-S-trityl-l-cysteine 4 °C 25 g 95
(M.W. 585.71) C37H31NO4S [103213-32-7]
100 g 275
Fmoc-Cys(Xan)-OH FLC-5358-PI 5g 99
9-Fluorenylmethoxycarbonyl-S-xanthenyl-l-cysteine 4 °C 25 g 395
(M.W. 523.61) C31H25NO5S

Fmoc-Cys(Xan)-OPfp FLC-5374-PI 1g 75
9-Fluorenylmethoxycarbonyl-S-xanthenyl-l-cysteine pentaf- 4 °C 5g 245
luorophenyl ester
PEPTIDES INTERNATIONAL

(M.W. 689.66) C37H24NO5SF5

Fmoc-Dap(Octanoyl)-OH FDO-1909-PI 1g 325

N-α-9-Fluorenylmethoxycarbonyl-N-β-octanoyl-L-2,3- 5g 1300
4 °C
diaminopropionic acid
(M.W. 452.56) C26H32N2O5
Building Blocks for FRETs

Fmoc-Glu(OtBu)-OH FLE-1720-PI 5g 40
9-Fluorenylmethoxycarbonyl-l-glutamic Acid γ-t-butyl ester 4 °C 25 g 140
(M.W. 425.49) C24H27NO6
100 g 445
Fmoc-Gln-OH FLQ-1721-PI 5g 20
9-Fluorenylmethoxycarbonyl-l-glutamine 4 °C 25 g 70
(M.W. 368.39) C20H20N2O5 [71989-20-3]
100 g 255
Fmoc-Gln(Trt)-OH FLQ-1755-PI 5g 55
Nα-9-Fluorenylmethoxycarbonyl-Nγ-trityl-l-glutamine 4 °C 25 g 150
(M.W. 610.72) C39H34N2O5 [132327-80-1]
100 g 495
Fmoc-Glu-OH FLG-1701-PI 5g 10
9-Fluorenylmethoxycarbonyl-Glycine 4 °C 25 g 30
(M.W. 297.31) C17H15NO4 [ 29022-11-5]
100 g 95

260 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

TOOLS for PEPTIDE SYNTHESIS

Fmoc-His(Bzl)-OH FLH-1742-PI 1g 23
Nα-Fluorenylmethoxycarbonyl-Nim-benzyl-l-histidine 4 °C 5g 89
(M.W. 467.53) C28H25N3O4
25 g 375
Fmoc-His(Fmoc)-OH FLH-1702-PI 1g 23
Nα,Nim-di-9-Fluorenylmethoxycarbonyl-l-histidine 4 °C 5g 79
(M.W. 599.65) C36H29N3O6 [98929-98-7]
25 g 349
Fmoc-His(MBom) FCP-2328 1g 130
Nα-9-Fluorenylmethoxycarbonyl-Nπ-4- 4 °C 5g 585
methoxybenzyloxymethyl-l-histidine
(M.W. 527.57) C30H29N3O6
H. Hibino, and Y. Nishiuchi, Tetrahedron Lett., 52 ,4947 H. Hibino, et al., J. Pept. Sci., 18, 763 (2012).
(2011). K. Sakamoto, et al., J. Org. Chem., 77, 6948 (2012).

Fmoc-His(Trt)-OH FLH-1740-PI 5g 35
Nα-9-Fluorenylmethoxycarbonyl-Nim-trityl-l-histidine 4 °C 25 g 95
(M.W. 619.73) C40H33N3O4 [128545-09-5]
100 g 275
Fmoc-Ile-OH FLI-1724-PI 5g 10
9-Fluorenylmethoxycarbonyl-l-isoleucine 4 °C 25 g 30
(M.W. 353.42) C21H23NO4 [71989-23-6]
100 g 95
Fmoc-Leu-OH FLL-1725-PI 5g 10
9-Fluorenylmethoxycarbonyl-l-leucine 4 °C 25 g 30

PEPTIDES INTERNATIONAL
(M.W. 353.42) C21H23NO4 [35661-60-0]
100 g 95
Fmoc-Lys(Boc)-OH FLK-1726-PI 5g 35
Nα-9-Fluorenylmethoxycarbonyl-Nε-t-butyloxycarbonyl-l- 4 °C 25 g 110
lysine
(M.W. 468.55) C26H32N2O6 [71989-26-9] 100 g 350
Fmoc-Lys-(Dabcyl)-OH FKD-1908-PI 1g 600
N-alpha-9-Fluorenylmethoxycarbonyl-N-ε-(4,4- 4 °C
dimethylazobenzene-4’carbonyl)-L-lysine
(M.W. 619.73) C36H37N5O5 [146998-27-8]

Fmoc-Lys(Fmoc)-OH FLK-1750-PI 1g 20
Nα,Nε-di-9-Fluorenylmethoxycarbonyl-l-lysine 4 °C 5g 49
(M.W. 590.68) C36H34N2O6 [78081-87-5]
25 g 195
Fmoc-Lys(ivDde)-OH FLK-1759-PI 1g 190
(M.W. 574.72) C34H42N2O6 [204777-78-6] 4 °C 5g 760
Useful For Synthesis Of Lipidated Peptides
Fmoc-Lys(Palmitoyl)-OH FLK-1955-PI 1g 225
Fmoc-Lys(Pam)-OH; N-α-Fmoc-N-ε-palmitoyl-l-Lysine 4 °C 5g 900
Useful For Synthesis Of Lipidated Peptides
Fmoc-Lys(Z)-OH FLK-1727-PI 1g 22
Nα-Fluorenylmethoxycarbonyl-Nε-benzyloxycarbonyl-l-lysine 4 °C 5g 89
(M.W. 502.57) C29H30N2O6 [86060-82-4]
25 g 373

Order Hotline 1-800-777-4779 502-266-8787 261

 PRODUCT Code Qty PRICE
Fmoc-Met-OH FLM-1703-PI 5g 20
TOOLS for PEPTIDE SYNTHESIS

9-Fluorenylmethoxycarbonyl-l-methionine 4 °C 25 g 33
(M.W. 371.46) C20H21NO4S [71989-28-1]
100 g 95
Fmoc-Phe-OH FLF-1730-PI 5g 10
9-Fluorenylmethoxycarbonyl-l-phenylalanine 4 °C 25 g 30
(M.W. 387.44) C24H21NO4 [35661-40-6]
100 g 95
Fmoc-Pro-OH FLP-1731-PI 5g 10
9-Fluorenylmethoxycarbonyl-l-proline 4 °C 25 g 30
(M.W. 337.38) C20H19NO4 [71989-31-6]
100 g 95
Fmoc-Ser(Bzl)-OH FLS-1732-PI 1g 25
Nα-9-Fluorenylmethoxycarbonyl-O-benzyl-l-serine 4 °C 5g 99
(M.W. 417.46) C25H23NO5 [83792-48-7]
25 g 425
Fmoc-Ser(tBu)-OH FLS-1733-PI 5g 35
Nα-9-Fluorenylmethoxycarbonyl-O-t-butyl-l-serine 4 °C 25 g 130
(M.W. 383.45) C22H25NO5 [71989-33-8]
100 g 395
Fmoc-Ser(Trt)-OH FLS-1756-PI 5g 90
Nα-9-Fluorenylmethoxycarbonyl-O-trityl-l-serine 4 °C 25 g 350
(M.W. 569.66) C37H31NO5 [111061-56-4]

Fmoc-Thr(Bzl)-OH FLT-1734-PI 1g 44
PEPTIDES INTERNATIONAL

9-Fluorenylmethoxycarbonyl-O-benzyl-l-threonine 4 °C 5g 179
(M.W. 431.49) C26H25NO5 [47872-75-0]
25 g 700
Fmoc-Thr(tBu)-OH FLT-1700-PI 5g 35
9-Fluorenylmethoxycarbonyl-O-t-butyl-l-threonine 4 °C 25 g 130
(M.W. 397.48) C23H27NO5 [71989-35-0]
100 g 395
Fmoc-Thr(Trt)-OH FLT-1768-PI 1g 22
Nα-9-Fluorenylmethoxycarbonyl-O-trityl-l-Threorine 4 °C 5g 99
(M.W. 583.69) C38H33NO5 [133180-01-5]
25 g 450
Fmoc-Trp-OH FLW-1735-PI 5g 10
Nα-9-Fluorenylmethoxycarbonyl-l-tryptophan 4 °C 25 g 30
(M.W. 426.48) C26H22N2O4 [35737-15-6]
100 g 95
Fmoc-Trp(Boc)-OH FLW-1769-PI 5g 95
Nα-9-Fluorenylmethoxycarbonyl-Nin-t-butyloxycarbonyl-l- 4 °C 25 g 245
tryptophan
(M.W. 526.59) C31H30N2O6 [143824-78-6] 100 g 795
Fmoc-Tyr(Bzl)-OH FLY-1736-PI 1g 40
9-Fluorenylmethoxycarbonyl-O-benzyl-l-tyrosine 4 °C 5g 157
(M.W. 493.56) C31H27NO5 [71989-40-7]
25 g 625

262 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

TOOLS for PEPTIDE SYNTHESIS

Fmoc-Tyr(tBu)-OH FLY-1737-PI 5g 55
9-Fluorenylmethoxycarbonyl-O-t-butyl-l-tyrosine 4 °C 25 g 130
(M.W. 459.55) C28H29NO5 [71989-38-3]
100 g 395
Fmoc-Tyr(Cl2-Bzl)-OH FLY-1738-PI 1g 44
Nα-9-Fluorenylmethoxycarbonyl-O-2,6-dichlorobenzyl-l- 4 °C 5g 179
tyrosine
(M.W. 562.45) C31H25NO5Cl2 [112402-12-7] 25 g 747
Fmoc-Val-OH FLV-1739-PI 5g 10
9-Fluorenylmethoxycarbonyl-l-valine 4 °C 25 g 30
(M.W. 339.39) C20H21NO4 [68858-20-8]
100 g 95
Fmoc Amino Acids attached to CLEAR Resins are listed on page 299, Rink-Amide MBHA Resins on page 292, and Wang
Resins on page 290.

Fmoc-Protected d-Amino Acids

Fmoc-d-Gln(Trt)-OH FDQ-1809-PI 1g 50
Nα-9-Fluorenylmethoxycarbonyl-Nγ-trityl-d-glutamine 4 °C 5g 190
(M.W. 610.72) C39H34N2O5 [200623-62-7]

Fmoc-d-Glu(OtBu)-OH FDE-1810-PI 1g 40
9-Fluorenylmethoxycarbonyl-d-glutamic acid γ-t-butyl ester 4 °C 5g 145
(M.W. 425.49) C24H27NO6 [104091-08-9]

Fmoc-d-His(Trt)-OH FDH-1812-PI 1g 30
Nα-9-Fluorenylmethoxycarbonyl-Nim-trityl-d-histidine 4 °C 5g 120

PEPTIDES INTERNATIONAL
(M.W. 619.73) C40H33N3O4 [135610-90-1]

Fmoc-d-lle-OH FDI-1856-PI 1g 230

9-Fluorenylmethoxycarbonyl-d-isoleucine 4 °C 5g 925
(M.W. 353.42) C21H23NO4 [143688-83-9]

Fmoc-d-Leu-OH FDL-1814-PI 1g 15
9-Fluorenylmethoxycarbonyl-d-leucine 4 °C 5g 55
(M.W. 353.42) C21H23NO4 [14360-54-2]

Fmoc-d-Lys(Boc)-OH FDK-1815-PI 1g 35
Nα-9-Fluorenylmethoxycarbonyl-Nε-t-butyloxycarbonyl-d- 4 °C 5g 155
lysine
(M.W. 468.55) C26H32N2O6 [92122-45-7]

Fmoc-d-Lys(Mtt)-OH FDK-1898-PI 1g 95
Nα-9-Fluorenylmethoxycarbonyl-Nε-4-methyltrityl-d-lysine 4 °C 5g 380
(M.W. 624.79) C41H40N2O4

Fmoc-d-Met-OH FDM-1816-PI 1g 15
9-Fluorenylmethoxycarbonyl-d-Methionine 4 °C 5g 50
(M.W. 371.45) C20H21NO4S [112883-40-6]

Fmoc-d-Orn(Boc)-OH FDX-1818-PI 1g 15
Nα-9-Fluorenylmethoxycarbonyl-Nδ-t-butyloxycarbonyl-d- 4 °C 5g 50
ornithine
(M.W. 454.52) C25H30N2O6 [118476-89-4]

Order Hotline 1-800-777-4779 502-266-8787 263

 PRODUCT Code Qty PRICE
Fmoc-d-Phe-OH FDF-1830-PI 1g 15
TOOLS for PEPTIDE SYNTHESIS

9-Fluorenylmethoxycarbonyl-d-phenylalanine 4 °C 5g 45
(M.W. 387.44) C24H21NO4 [86123-10-6]

Fmoc-d-Pro-OH FDP-1826-PI 1g 19
9-Fluorenylmethoxycarbonyl-d-proline 4 °C 5g 76
(M.W. 337.38) C20H19NO4 [101555-62-8]

Fmoc-d-Ser(tBu)-OH FDS-1831-PI 1g 35
9-Fluorenylmethoxycarbonyl-O-t-butyl-d-serine 4 °C 5g 135
(M.W. 383.45) C22H25NO5 [128107-47-1]

Fmoc-d-Ser(Trt)-OH FDS-1869-PI 1g 35
9-Fluorenylmethoxycarbonyl-O-trityl-d-serine 4 °C 5g 145
(M.W. 569.66) C37H31NO5

Fmoc-d-Thr(tBu)-OH FDT-1828-PI 1g 67
9-Fluorenylmethoxycarbonyl-O-t-butyl-d-threonine 4 °C 5g 265
(M.W. 397.48) C23H27NO5 [138797-71-4]

Fmoc-d-Trp-OH FDW-1832-PI 1g 18
Nα-9-Fluorenylmethoxycarbonyl-d-tryptophan 4 °C 5g 76
(M.W. 426.47) C26H22N2O4 [86123-11-7]

Fmoc-d-Trp(Boc)-OH FDW-1829-PI 1g 59
Nα-Fluorenylmethoxycarbonyl-Nin-t-butyloxycarbonyl-d- 4 °C 5g 230
tryptophan
(M.W. 526.59) C31H30N2O6 [163619-04-3]

Fmoc-d-Tyr(tBu)-OH FDY-1833-PI 1g 49
PEPTIDES INTERNATIONAL

9-Fluorenylmethoxycarbonyl-O-t-butyl-d-tyrosine 4 °C 5g 185
(M.W. 459.55) C28H29NO5 [118488-18-9]

Fmoc-d-Val-OH FDV-1834-PI 1g 15
9-Fluorenylmethoxycarbonyl-d-valine 4 °C 5g 50
(M.W. 339.39) C20H21NO4 [84624-17-9]

Unusual Fmoc-Amino Acids

Fmoc-Abu-OH FLX-1753-PI 1g 35
9-Fluorenylmethoxycarbonyl-l-α-aminobutyric acid 4 °C 5g 125
(M.W. 325.13 • 18.01) C19H19NO4 • H2O [135112-27-5]
25 g 495
Fmoc-d-Abu-OH FDX-1860-PI 1g 35
9-Fluorenylmethoxycarbonyl-d-α-aminobutyric acid 4 °C 5g 125
(M.W. 325.13 • 18.01) C19H19NO4 • H2O [170642-27-0]
25 g 495
Fmoc-γ-Abu-OH FAB-1773-PI 5g 130
9-Fluorenylmethoxycarbonyl-γ-aminobutyric acid 4 °C 25 g 520
(M.W. 325.37) C19H19NO4 [116821-47-7]

Fmoc-ε-Aca-OH FLX-1775-PI 1g 25
9-Fluorenylmethoxycarbonyl-ε-aminocaproic acid 4 °C 5g 100
9-Fluorenylmethoxycarbonyl-6-Aminohexanoic Acid
(M.W. 353.42) C21H23NO4 [88574-06-5] 25 g 400

264 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

TOOLS for PEPTIDE SYNTHESIS

Fmoc-Adp-OH FAP-1907-PI 1g 190
N-α-9-Fluorenylmethoxycarbonyl-3-amino-2,2-Dimethyl- 4 °C 5g 760
Propionic Acid
(M.W. 339.39) C20H21NO4

Fmoc-Aib-OH FLX-1749-PI 1g 30
9-Fluorenylmethoxycarbonyl-α-aminoisobutyric acid 4 °C 5g 110
(M.W. 325.37) C19H19NO4 [94744-50-0]
25 g 440
Fmoc-Ala-Cys(Trt)-OH FCP-2350 1g 270
9-Fluorenylmethoxycarbonyl-l-Alanyl-S-Trityl-Cysteine 4 °C
(M.W. 656.79) C40H36N2O5S
Component of Cysteinyl Prolyl Ester (CPE) Autoactivation Unit
T. Kawakami and S. Aimoto, Chem. Lett., 36, 76 (2007). T. Kawakami and S. Aimoto, Tetrahedron, 65, 3871
T. Kawakami and S. Aimoto, Tetrahedron Lett., 48, 1903 (2007). (2009).
• This compound is produced by Peptide Institute, Inc. under the license of Osaka University and Osaka Foundation

Fmoc-11-Aminoundecanoic Acid FAA-1707-PI 1g 23

9-Fluorenylmethoxycarbonyl-11-aminoundecanoic acid 4 °C 5g 92
(M.W. 423.56) C26H33NO4 [88574-07-6]
25 g 360
Fmoc-5-Ava-OH FLX-5518-PI 1g 75
9-Fluorenylmethoxycarbonyl-5-aminovaleric acid 4 °C 5g 295
(M.W. 339.39) C20H21NO4 [123622-48-0]

Fmoc-Asp-OAll (Alpha Ester) FLD-5536-PI 1g 49

9-Fluorenylmethoxycarbonyl-l-aspartic acid-α-Allyl ester 4 °C 5g 195

PEPTIDES INTERNATIONAL
(M.W. 395.42) C22H21NO6 [146982-24-3]

Fmoc-Cha-OH FLX-5545-PI 1g 45
9-Fluorenylmethoxycarbonyl-β-cyclohexyl-l-alanine 4 °C 5g 180
(M.W. 393.49) C24H27NO4 [135673-97-1]

Fmoc-d-Cha-OH FDX-1879-PI 1g 56
9-Fluorenylmethoxycarbonyl-β-cyclohexyl-d-alanine 4 °C 5g 210
(M.W. 393.50) C24H27NO4 [144701-25-7]

Fmoc-Cpg-OH FPG-1901-PI 1g 485

N-α-9-Fluorenylmethoxycarbonyl-Cyclopentyl-l-Glycine 4 °C 5g 1940
(M.W. 365.43) C22H23NO4 [220497-61-0]

Fmoc-hCys(Trt)-OH FCT-5004-PI 1g
Fmoc-hCys(Trt)-OH -20 °C 5g
N-α-(9-Fluorenylmethyloxy-carbonyl)-S-trityl-l-homocysteine
(M.W. 599.76) C38H33NO4S [167015-23-8]
Fmoc Unusual Amino Acid
S. Lindman, et al., Bioorg. Med. Chem., 9, 763 (2001) S. Lindman, et al., Bioorg. Med. Chem., 11, 2974 (2003)
J. Liang and K. Burgess, Tetrahedron, 58, 8743 (2002) A. Saporito, et al., Biopolymers, 83, 508 (2006)

Fmoc-Dab(Boc)-OH FLX-5522-PI 1g 110

Nα-9-Fluorenylmethoxycarbonyl-Nγ-t-butyloxycarbonyl-l-2,4- 4 °C 5g 440
diaminobutyric acid
(M.W. 440.50) C24H28N2O6 [125238-99-5]

Order Hotline 1-800-777-4779 502-266-8787 265

 PRODUCT Code Qty PRICE
Fmoc-d-Dab(Boc)-OH FDX-5541-PI 1g 210
TOOLS for PEPTIDE SYNTHESIS

Nα-9-Fluorenylmethoxycarbonyl-Nγ-t-butyloxycarbonyl-d-2,4- 4 °C 5g 840
diaminobutyric acid
(M.W. 440.50) C24H28N2O6 [114360-56-4]

Fmoc-Dap(Boc)-OH FLX-5526-PI 1g 110

Nα-9-Fluorenylmethoxycarbonyl-Nβ-t-butyloxycarbonyl-l-2,3- 4 °C 5g 440
diaminopropionic acid
(M.W. 426.47) C23H26N2O6 [162558-25-0]

Fmoc-d-Dap(Boc)-OH FDX-5525-PI 1g 210

Nα-9-Fluorenylmethoxycarbonyl-Nβ-t-butyloxycarbonyl-d-2,3- 4 °C 5g 840
diaminopropionic acid
(M.W. 426.47) C23H26N2O6 [198544-42-2]

Fmoc-Dap(Dnp)-OH FDD-5019-PI 1g 200

Fmoc-Dpa-OH 4 °C 5g 800
(M.W. 492.45) C24H20N4O8 [140430-54-2]
Building Block for FRET Substrates

Fmoc-Deg-OH FLX-1799-PI 1g 75
9-Fluorenylmethoxycarbonyl-diethylglycine 4 °C 5g 295
(M.W. 353.42) C21H23NO4

Fmoc-3,5-Diiodo-l-Tyr-OH FDY-5009-PI 1g 50
Nα-9-Fluorenylmethoxycarbonyl-3,5-diiodo-L-tyrosine 4 °C 5g 200
(M.W. 655.23) C24H19I2NO5 [103213-31-6]

Fmoc-3,3-Dip-OH FLX-5529-PI 1g 175

PEPTIDES INTERNATIONAL

9-Fluorenylmethoxycarbonyl-l-3,3-diphenylalanine 4 °C 5g 745
(M.W. 463.54) C30H25NO4

Fmoc-d-3,3-Dip-OH FDX-5531-PI 1g 175

9-Fluorenylmethoxycarbonyl-d-3,3-diphenylalanine 4 °C 5g 745
(M.W. 463.54) C30H25NO4

Fmoc-Glu-OAll (α Ester) FLE-5538-PI 1g 49

9-Fluorenylmethoxycarbonyl-l-glutamic acid-α-allyl ester 4 °C 5g 195
(M.W. 409.44) C23H23NO6

Fmoc-Glu(OBzl)-OH FLE-1719-PI 1g 22
9-Fluorenylmethoxycarbonyl-l-glutamic Acid γ-benzyl ester 4 °C 5g 75
(M.W. 459.50) C27H25NO6 [123639-61-2]
25 g 300
Fmoc-Gly-Cys(Trt)-OH FCP-2351 1g 270
9-Fluorenylmethoxycarbonyl-Glycyl-S-Trityl-Cysteine 4 °C
(M.W. 642.76) C39H34N2O5S
Component of Cysteinyl Prolyl Ester (CPE) Autoactivation Unit
T. Kawakami and S. Aimoto, Chem. Lett., 36, 76 (2007). T. Kawakami and S. Aimoto, Tetrahedron Lett., 48, 1903 (2007).
T. Kawakami and S. Aimoto, Tetrahedron, 65, 3871 (2009).
• This compound is produced by Peptide Institute, Inc. under the license of Osaka University and Osaka Foundation

Fmoc-Har(Pbf)-OH FHP-5005-PI 1g 250

Nα-(9-Fluorenylmethyloxy-carbonyl)-Nγ-(2,2,4,6,7- 4 °C 5g 1000
Pentamethyldihydrobenzofuran-5-Sulfonyl)-l-Homoarginine
(M.W. 662.81) C35H42N4O7S [15445-77-9]

266 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

TOOLS for PEPTIDE SYNTHESIS

Fmoc-Hyp(tBu)-OH FLX-1771-PI 1g 55
9-Fluorenylmethoxycarbonyl-O-t-butyl-l-hydroxyproline 4 °C 5g 210
(M.W. 409.49) C24H27NO5 [122996-47-8]

Fmoc-allo-Ile-OH FLI-1757-PI 1g 295

9-Fluorenylmethoxycarbonyl-l-allo-isoleucine 4 °C 5g 995
(M.W. 353.42)

Fmoc-3,Iodo-l-Tyr-OH FDY-5043-PI 1g 100

Fmoc-3-iodo-Tyr-OH; Fmoc-3-iodo-l-tyrosine 4 °C 5g 400
(M.W. 529.34) C24H20I2NO5 [134486-00-3]

Fmoc-Leu-Cys(Trt)-OH FCP-2352 1g 270

9-Fluorenylmethoxycarbonyl-l-Leucyl-S-Trityl-Cysteine 4 °C
(M.W. 698.87) C43H42N2O5S
Component of Cysteinyl Prolyl Ester (CPE) Autoactivation Unit
T. Kawakami and S. Aimoto, Chem. Lett., 36, 76 (2007). T. Kawakami and S. Aimoto, Tetrahedron Lett., 48, 1903 (2007).
T. Kawakami and S. Aimoto, Tetrahedron, 65, 3871 (2009).
• This compound is produced by Peptide Institute, Inc. under the license of Osaka University and Osaka Foundation

Fmoc-Lys(Alloc)-OH FLK-1776-PI 5g 85
N-α-Fmoc-N-ε-Alloc-l-Lysine 4 °C 25 g 335
(M.W. 452.51) C21H23NO4 [146982-27-6]
Aide in the Synthesis of Branched, Cyclic Peptides

Fmoc-Lys(Mtt)-OH FLK-1798-PI 1g 49
Nα-9-Fluorenylmethoxycarbonyl-Nε-4-methyltrityl-l-lysine 4 °C 5g 195
(M.W. 624.79) C41H40N2O4 [167393-62-6]
25 g 780

PEPTIDES INTERNATIONAL
Fmoc-Lys(Palmitoyl-Glu-OtBu)-OH KEP-1957-PI 1g 500
NEW! N-α-(9-Fluorenylmethyloxycarbonyl)-N-ε-(N-α'-Palmitoyl-L- 4 °C 5g 2000
Glutamic-Acid α'-t-Butyl Ester)-L-lysine
(M.W. 792.08) C46H69N3O8

Fmoc-Lys(Dnp)-OH FKD-5018-PI 1g 500

N-α-(9-Fluorenylmethylcarbonyl)-N-ε-(2,4-Dinitrophenyl)-l- 4 °C 5g 2000
Lysine
(M.W. 534.53) C27H26N4O8 [148083-64-1]
Building Block for FRET Substrates

Fmoc-mini-PEGTM FXX-5521-PI 1g 130

Fmoc-8-Amino-3,6-Dioxaoctanoic Acid 4 °C 5g 520
9-Fluorenylmethoxycarbonyl-8-amino-3,6-dioxaoctanoic acid
(M.W. 385.42) C21H23NO6
Fmoc-AEEA

Fmoc-mini-PEG-3TM FXX-5524-PI 1g 195

Fmoc-11-Amino-3,6,9-Trioxaundecanoic Acid (Syrup) 4 °C 5g 695
9-Fluorenylmethoxycarbonyl-8-amino-3,6,9-trioxaundecanoic acid
(M.W. 429.47) C23H27NO7
Fmoc-AEEEA

Fmoc-Nal(2')-OH FLX-1758-PI 1g 80
9-Fluorenylmethoxycarbonyl-l-(2-naphthyl)alanine 4 °C 5g 320
(M.W. 437.50) C28H23NO4 [112883-43-9]

Order Hotline 1-800-777-4779 502-266-8787 267

 PRODUCT Code Qty PRICE
Fmoc-d-Nal(2')-OH FDX-1859-PI 1g 80
TOOLS for PEPTIDE SYNTHESIS

9-Fluorenylmethoxycarbonyl-d-(2-naphthyl)alanine 4 °C 5g 320
(M.W. 437.50) C28H23NO4 [138774-94-4]

Fmoc-Nal(1')-OH FLX-1778-PI 1g 135

9-Fluorenylmethoxycarbonyl-l-(1-Naphthyl)alanine 4 °C 5g 495
(M.W. 437.50) C28H23NO4 [96402-49-2]

Fmoc-d-Nal(1')-OH FDX-1780-PI 1g 135

9-Fluorenylmethoxycarbonyl-d-(1-naphthyl)alanine 4 °C 5g 495
(M.W. 437.50) C28H23NO4

Fmoc-Nle-OH FLU-1728-PI 1g 22
9-Fluorenylmethoxycarbonyl-l-norleucine 4 °C 5g 89
(M.W. 353.42) C21H23NO6 [77284-32-3]
25 g 319
Fmoc-Nva-OH FLX-1785-PI 5g 79
9-Fluorenylmethoxycarbonyl-l-norvaline 4 °C 25 g 299
(M.W. 339.39) C20H21NO4 [135112-28-6]

Fmoc-Orn(Boc)-OH FLO-1729-PI 1g 19
Nα-9-Fluorenylmethoxycarbonyl-Nδ-t-butyloxycarbonyl- 4 °C 5g 76
l-ornithine
(M.W. 454.52) C25H30N2O6 [109425-55-0] 25 g 295
Fmoc-d-Orn(Boc)-OH FDX-1818-PI 1g 55
Nα-9-Fluorenylmethoxycarbonyl-Nδ-t-butyloxycarbonyl- 4 °C 5g 220
d-ornithine
PEPTIDES INTERNATIONAL

(M.W. 454.52) C25H30N2O6 [118476-89-4]

Fmoc-Orn(Fmoc)-OH FLO-1788-PI 1g 27
Nα,Nδ-di-9-Fluorenylmethoxycarbonyl-l-ornithine 4 °C 5g 99
(M.W. 576.65) C35H32N2O6
25 g 395
Fmoc-Orn(Mtt)-OH FLO-1747-PI 1g 5
Nα-9-Fluorenylmethoxycarbonyl-Nδ-4-methyltrityl-l-ornithine 4 °C 5g 220
(M.W. 610.76) C40H38N2O4

Fmoc-d-Orn(Mtt)-OH FDO-1897-PI 1g 69
Nα-9-Fluorenylmethoxycarbonyl-Nδ-4-methyl-trityl-d-ornithine 4 °C 5g 275
(M.W. 610.79) C40H36N2O4

Fmoc-3-Pal-OH FLX-1766-PI 1g 195

9-Fluorenylmethoxycarbonyl-l-(3-pyridyl)alanine 4 °C 5g 875
(M.W. 388.42) C23H20N2O4 [175453-07-3]

Fmoc-d-3-Pal-OH FDX-1772-PI 1g 195

9-Fluorenylmethoxycarbonyl-d-(3-pyridyl)alanine 4 °C
(M.W. 388.42) C23H20N2O4 [142994-45-4]

Fmoc-4-Pal-OH FLX-5534-PI 1g 195

9-Fluorenylmethoxycarbonyl-l-(4-pyridyl)alanine 4 °C 5g 875
(M.W. 388.43) C23H20N2O4 [169555-95-7]

Fmoc-d-4-Pal-OH FDX-5535-PI 1g 195

9-Fluorenylmethoxycarbonyl-d-(4-pyridyl)alanine 4 °C 5g 875
(M.W. 388.43) C23H20N2O4 [20528-30-9]

268 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

TOOLS for PEPTIDE SYNTHESIS

Fmoc-Pen(Meb)-OH FLX-1760-PI 1g 195
9-Fluorenylmethoxycarbonyl-S-p-methylbenzyl-l- 4 °C 5g 795
penicillamine
(M.W. 475.64) C28H29NO4S

Fmoc-d-Pen(Acm)-OH FDX-1827-PI 1g 120

9-Fluorenylmethoxycarbonyl-S-acetamidomethyl-d- 4 °C 5g 480
penicillamine
(M.W. 442.54) C23H26N2O5S [201531-77-3]

Fmoc-d-Pen(Meb)-OH FDX-1861-PI 1g 100

9-Fluorenylmethoxycarbonyl-S-p-methylbenzyl-d- 4 °C 5g 400
penicillamine
(M.W. 475.64) C28H29NO4S

Fmoc-Pen(Acm)-OH FLX-1711-PI 1g 120

9-Fluorenylmethoxycarbonyl-S-acetamidomethyl-l- 4 °C 5g 480
penicillamine
(M.W. 442.54) C23H26N2O5S [201531-76-2]

Fmoc-Phe-OH (ring-D5) FFD-5007-PI 1g 360

N-(9-Fluorenylmethoxycarbonyl)-L-phenylalanine-2,3,4,5,6-D5 4 °C 5g 1440
(M.W. 392.48) C24H26D5NO4

Fmoc-p-F-Phe-OH FLF-1770-PI 1g 95
9-Fluorenylmethoxycarbonyl-p-Fluoro-l-phenylalanine 4 °C 5g 380
(M.W. 405.40) C24H20NO4F [169243-86-1]

Fmoc-d-p-F-Phe-OH FDF-1774-PI 1g 95

PEPTIDES INTERNATIONAL
9-Fluorenylmethoxycarbonyl-p-fluoro-d-phenylalanine 4 °C 5g 380
(M.W. 405.40) C24H20NO4F [177966-64-2]

Fmoc-p-Cl-Phe-OH FLF-1762-PI 1g 95
9-Fluorenylmethoxycarbonyl-l-p-chloro-l-phenylalanine 4 °C 5g 380
(M.W. 421.88) C24H20NO4Cl [175453-08-4]

Fmoc-d-p-Cl-Phe-OH FDF-1863-PI 1g 95
9-Fluorenylmethoxycarbonyl-p-Chloro-d-phenylalanine 4 °C 5g 380
(M.W. 421.88) C24H20NO4Cl [142994-19-2]

Fmoc-Phe(NO2)-OH FLF-1781-PI 1g 30
9-Fluorenylmethoxycarbonyl-p-nitro-l-phenylalanine 4 °C 5g 110
(M.W. 432.40) C24H20N2O6 [95753-55-2]

Fmoc-d-Phe(NO2)-OH FDF-1783-PI 1g 55
9-Fluorenylmethoxycarbonyl-p-nitro-d-phenylalanine 4 °C 5g 220
(M.W. 432.40) C24H20N2O6 [177966-63-1]

Fmoc-Phg-OH FFG-1789-PI 1g 30
9-Fluorenylmethoxycarbonyl-l-phenylglycine 4 °C 5g 110
(M.W. 373.40) C23H19NO4 [102410-65-1]

Fmoc-d-Phg-OH FDX-1862-PI 1g 25
9-Fluorenylmethoxycarbonyl-d-phenylglycine 4 °C 5g 95
(M.W. 373.41) C23H19NO4 [111524-95-9]

Order Hotline 1-800-777-4779 502-266-8787 269

 PRODUCT Code Qty PRICE
Fmoc-Pra-OH PRA-5010-PI 1g 175
TOOLS for PEPTIDE SYNTHESIS

9-Fluorenylmethoxycarbonyl-propargyl-l-glycine 4 °C 5g 700
(S)-2-(Fmoc-amino)-4-pentynoic acid
(M.W. 335.36) C20H17NO4
R.A. Turner, et al., Org. Lett., 9, 5011 (2007) A. Le Chevalier Isaad, et al., J. Pept. Sci., 15, 451 (2009)
L. Garcia, et al., Org. Biomol. Chem., 7, 5020 (2009)

Fmoc-Tic-OH FLX-1767-PI 1g 95
9-Fluorenylmethoxycarbonyl-l-1,2,3,4-tetrahydroisoquinoline- 4 °C 5g 395
3-carboxylic acid
(M.W. 399.40) C25H21NO4 [136030-33-6]

Fmoc-d-Tic-OH FDX-1846-PI 1g 125

9-Fluorenylmethoxycarbonyl-d-1,2,3,4-tetrahydroisoquinoline- 4 °C 5g 495
3-carboxylic acid
(M.W. 399.40) C25H21NO4 [130309-33-0]

Fmoc-N-Methyl Amino Acids

Fmoc-N-Me-Ala-OH FMA-1791-PI 1g 55
9-Fluorenylmethoxycarbonyl-N-methyl-l-alanine 4 °C 5g 245
(M.W. 325.37) C19H19NO4 [84000-07-7]

Fmoc-N-Me-d-Ala-OH FMA-1790-PI 1g 95
9-Fluorenylmethoxycarbonyl-N-methyl-d-alanine 4 °C 5g 380
(M.W. 325.37) C19H19NO4 [138774-92-2]

Fmoc-N-Me-Asp(OBzl)-OH FMD-1792-PI 1g 350

9-Fluorenylmethoxycarbonyl-N-Methyl-l-aspartic acid
PEPTIDES INTERNATIONAL

4 °C 5g 1400
β-benzyl ester
(M.W. 459.50) C27H25NO6

Fmoc-N-Me-d-Asp(OBzl)-OH FMD-1890-PI 1g 220

9-Fluorenylmethoxycarbonyl-N-Methyl-d-aspartic acid 4 °C 5g 880
β-benzyl ester
(M.W. 459.50) C27H25NO6

Fmoc-N-Me-Glu(OBzl)-OH FME-1782-PI 1g 145

9-Fluorenylmethoxycarbonyl-N-Methyl-l-glutamic acid 4 °C 5g 580
γ-benzyl ester
(M.W. 473.53) C28H27NO7

Fmoc-Sar-OH FLX-1751-PI 5g 52
Fmoc-N-Me-Gly-OH 4 °C 25 g 195
9-Fluorenylmethoxycarbonyl-sarcosine
9-Fluorenylmethoxycarbonyl-N-methyl-glycine
(M.W. 311.34) C18H17NO4 [77128-70-2]

Fmoc-N-Me-Ile-OH FMI-1793-PI 1g 55
9-Fluorenylmethoxycarbonyl-N-methyl-l-isoleucine 4 °C 5g 245
(M.W. 367.45) C22H25NO4 [138775-22-1]

Fmoc-N-Me-Leu-OH FML-1794-PI 1g 55
9-Fluorenylmethoxycarbonyl-N-methyl-l-leucine 4 °C 5g 245
(M.W. 367.40) C22H25NO4 [103478-62-2]

Fmoc-N-Me-d-Leu-OH FML-1784-PI 1g 95
9-Fluorenylmethoxycarbonyl-N-methyl-d-leucine 4 °C 5g 380
(M.W. 367.40) C22H25NO4 [103478-63-3]

270 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

TOOLS for PEPTIDE SYNTHESIS

Fmoc-N-Me-Phe-OH FMF-1795-PI 1g 55
9-Fluorenylmethoxycarbonyl-N-methyl-l-phenylalanine 4 °C 5g 245
(M.W. 401.47) C25H23NO4 [77128-73-5]

Fmoc-N-Me-d-Phe-OH FMF-1896-PI 1g 145

9-Fluorenylmethoxycarbonyl-N-methyl-d-phenylalanine 4 °C 5g 495
(M.W. 401.47) C25H23NO4 [138775-05-0]

Fmoc-N-Me-Val-OH FMV-1796-PI 1g 55
9-Fluorenylmethoxycarbonyl-N-methyl-l-valine 4 °C 5g 245
(M.W. 353.40) C21H23NO4 [84000-11-3]

Fmoc-N-Me-d-Val-OH FMV-1787-PI 1g 95
9-Fluorenylmethoxycarbonyl-N-methyl-d-valine 4 °C 5g 380
(M.W. 353.40) C21H23NO4 [103478-58-6]

Z-Protected l-Amino Acids

Z-Ala-OH ZLA-2007-PI 5g 21
Benzyloxycarbonyl-l-alanine 4 °C 25 g 45
(M.W. 223.20) C11H13NO4 [1142-20-7]
100 g 143
Z-Arg-OH ZLR-2008-PI 5g 21
Benzyloxycarbonyl-l-arginine 4 °C 25 g 45
(M.W. 308.30) C14H20N4O4 [1234-35-1]
100 g 143
Z-Arg(NO2)-OH ZLR-2009-PI 5g 34
Nα-benzyloxycarbonyl-Ng-nitro-l-arginine 4 °C 25 g 112

PEPTIDES INTERNATIONAL
(M.W. 353.30) C14H19N5O6 [2304-98-5]
100 g 359
Z-Asn-OH ZLN-2010-PI 5g 21
Benzyloxycarbonyl-l-asparagine 4 °C 25 g 45
(M.W. 266.30) C12H14N2O5 [2304-96-3]
100 g 143
Z-Asp-OH ZLD-2011-PI 5g 20
Benzyloxycarbonyl-l-aspartic acid 4 °C 25 g 42
(M.W. 267.20) C12H13NO6 [1152-61-0]
100 g 127
Z-Cys(Bzl)-OH ZLC-2014-PI 5g 21
Benzyloxycarbonyl-S-benzyl-l-cysteine 4 °C 25 g 50
(M.W. 345.40) C18H19NO4S [3257-18-9]
100 g 158
Z-Gln-OH ZLQ-2017-PI 5g 21
Benzyloxycarbonyl-l-glutamine 4 °C 25 g 45
(M.W. 280.30) C13H16N2O5 [2650-64-8]
100 g 143
Z-Glu-OH ZLE-2015-PI 5g 21
Benzyloxycarbonyl-l-glutamic acid 4 °C 25 g 45
(M.W. 281.26) C13H15NO6 [1155-62-0]
100 g 143
Z-Gly-OH ZLG-2018-PI 5g 20
Benzyloxycarbonyl-glycine 4 °C 25 g 43
(M.W. 209.20) C10H11NO4 [1138-80-3]
100 g 135

Order Hotline 1-800-777-4779 502-266-8787 271

 PRODUCT Code Qty PRICE
Z-Ile-OH ZLI-2028-PI 5g 21
TOOLS for PEPTIDE SYNTHESIS

Benzyloxycarbonyl-l-isoleucine (Syrup) 4 °C 25 g 45
(M.W. 265.40) C14H19NO4 [3160-59-6]
100 g 143
Z-Leu-OH ZLL-2029-PI 5g 21
Benzyloxycarbonyl-l-leucine (Syrup) 4 °C 25 g 45
(M.W. 265.30) C14H19NO4 [2018-66-8]
100 g 143
Z-Lys(Z)-OH ZLK-2019-PI 5g 31
Nα,Nε-di-benzyloxycarbonyl-l-lysine 4 °C 25 g 95
(M.W. 414.50) C22H26N2O6 [405-39-0]
100 g 295
Z-Met-OH ZLM-2020-PI 5g 31
Benzyloxycarbonyl-l-methionine 4 °C 25 g 95
(M.W. 283.40) C13H17NO4S [1152-62-1]
100 g 295
Z-Phe-OH ZLF-2021-PI 5g 21
Benzyloxycarbonyl-l-phenylalanine 4 °C 25 g 45
(M.W. 299.30) C17H17NO4 [1161-13-3]
100 g 143
Z-Pro-OH ZLP-2022-PI 5g 21
Benzyloxycarbonyl-l-proline 4 °C 25 g 45
(M.W. 249.27) C13H15NO4 [1148-11-4]
100 g 143
Z-Pyr-OH
PEPTIDES INTERNATIONAL

ZLU-2117 5g 105
Benzyloxycarbonyl-l-pyroglutamic acid 4 °C 25 g 255
(N-benzyloxycarbonyl-l-pyrrolidone carboxylic acid)
(M.W. 263.20) C13H13NO5 [32159-21-0] 100 g 795
Z-d-Pyr-OH ZDU-2613 1g 60
Benzyloxycarbonyl-d-pyroglutamic acid 4 °C 5g 200
(N-benzyloxycarbonyl-d-pyrrolidone carboxylic acid)
(M.W. 263.20) C13H13NO5 [78339-57-8] 25 g 745
Z-Ser-OH ZLS-2023-PI 5g 21
Benzyloxycarbonyl-l-serine 4 °C 25 g 45
(M.W. 239.20) C11H13NO5 [1145-80-8]
Z-Thr-OH ZLT-2024-PI 5g 21
Benzyloxycarbonyl-l-threonine 4 °C 25 g 45
(M.W. 253.30) C12H15NO5 [19728-63-3]
Z-Trp-OH ZLW-2025-PI 5g 21
Benzyloxycarbonyl-l-tryptophan 4 °C 25 g 45
(M.W. 338.40) C19H18N2O4 [7432-21-5]

Z-Tyr-OH ZLY-2026-PI 5g 49
Benzyloxycarbonyl-l-tyrosine 4 °C 25 g 95
(M.W. 315.30) C17H17NO5 [1164-16-5]
Z-Val-OH ZLV-2027-PI 5g 32
Benzyloxycarbonyl-l-valine 4 °C 25 g 80
(M.W. 251.28) C13H17NO4 [1149-26-4]

272 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

TOOLS for PEPTIDE SYNTHESIS

Unusual Amino Acids
Diethylglycine (Deg) ALX-5041-PI 1g 55
(M.W. 131.18) C6H13NO2 [2566-29-2] 4 °C 5g 195
Palmitoyl-Cys((RS)-2,3-di(palmitoyloxy)- PAC-5002-PI 1g 1200
propyl)-OH 4 °C 5g 4800
Pam3-Cys-OH
(M.W. 910.49) C54H103NO7S [87420-41-5]
K.-H.Wiesmueller, et al., Hoppe-Seyler’s Z. Physiol. Chem., 364, W.Zeng, et al., J. Immunol., 169, 4905 (2002).
593 (1983). D.C.Jackson, et al., Proc. Natl. Acad. Sci. USA, 101,
G.Jung, et al., Angew. Chem. Int. Ed. Engl., 24, 872 (1985). 15440 (2004).
K.-H.Wiesmueller, et al., Vaccine, 7, 29 (1989). S.J.Keding and S.J.Danishefsky, Proc. Natl. Acad. Sci.
W.Zeng, et al., J. Pept. Sci., 2, 66 (1996). USA, 101, 11937 (2004).

Fmoc-Ala-OH (2,3,3,3,-D4) FAD-5008-PI 1g 360

N-(9-Fluorenylmethoxycarbonyl)-l-alanine-2,3,3,3-D4 4 °C 5g 1440
(M.W. 315.37) C18H13D4NO4 [225101-69-9]

cis-4-Hydroxy-l-proline ALX-5330-PI 1g 265

(M.W. 131.13) C5H9NO3 [618-27-9] 4 °C 5g 1060
l-Pen AXL-5021-PI 1g 20
(M.W. 149.21) C5H11NO2S [1113-41-3] -20 °C 5g 80
d-Pen AXP-5020-PI 5g 25
(M.W. 149.21) C5H11NO2S [52-67-5] 4 °C 25 g 100

PEPTIDES INTERNATIONAL
l-Pen(p-Me-Bzl) XLM-5121-PI 1g 75
l-penicillamine (S-p-methylbenzyl-l-penicillamine) 4 °C 5g 195
(M.W. 253.20) C13H19NO2S

d-Pen(p-Me-Bzl) XDM-5120-PI 1g 75
d-penicillamine (S-p-methylbenzyl-d-penicillamine) 4 °C 5g 195
(M.W. 253.20) C13H19NO2S
l-Tic ALX-5029-PI 1g 65
l-1,2,3,4-Tetrahydroisoquinoline-3-carboxylic acid 4 °C 5g 265
(M.W. 177.20) C10H11NO2 [74163-81-8]

d-Tic ADX-5028-PI 1g 95
d-1,2,3,4-Tetrahydroisoquinoline-3-carboxylic acid 4 °C 5g 395
(M.W. 177.20) C10H11NO2 [103733-65-9]

Hydroxy-Tic ALX-5027-PI 1g 269

7-Hydroxy-l-1,2,3,4-Tetrahydroisoquinoline-3-carboxylic acid 4 °C
(M.W. 193.20) C10H11NO3
d-Hydroxy-Tic ADX-5026-PI 1g 309
7-Hydroxy-d-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid 4 °C
M.W. 193.20) C10H11NO3 [152286-30-1]

Order Hotline 1-800-777-4779 502-266-8787 273

 Cleavage Reagent
PRODUCT Cleavage Product Code Qty PRICE
Resins
TOOLS for PEPTIDE SYNTHESIS

Unsubstituted Resins for Solid Phase Synthesis

Aminomethylated Polystyrene Resin • HCl RAM-1440-PI 5g 39
Divinylbenzene 1%, 100-200 mesh 4 °C 25 g 155
NH2: 0.3-0.8 meq/g

Aminomethylated Polystyrene (smaller RAM-1049-PI 5g 45

Resin • HCl beads)
4 °C 25 g 180
Divinylbenzene 1%, 200-400 mesh

Aminomethylated Polystyrene RAM-1051-PI 5g 113

Resin • HCI 4 °C 25 g 433
Divinylbenzene 1%, 100-200 mesh
NH2: 0.1-0.3 meq/g

Benzhydrylamine Resin • HCl RBH-1046-PI 5g 55

(BHA) 4 °C 25 g 220
Divinylbenzene 1%, 100-200 mesh
NH2: 0.3-1.0 meq/g

Benzhydrylamine Resin • HCl HF RBH-1048-PI 5g 55

(BHA) RCONH2
4 °C 25 g 220
Divinylbenzene 1%, 200-400 mesh
NH2: 0.3-1.0 meq/g

Benzhydrylamine Resin • HCI (BHA) RBH-1028 5g 91

Divinylbenzene 2%, 100-200 mesh 4 °C 25 g 342
PEPTIDES INTERNATIONAL

NH2: 0.3-1.5 meq/g

Chloromethylated Polystyrene Resin RCM-1034-PI 5g 19

Divinylbenzene 1%, 100-200 mesh 4 °C 25 g 65
Cl: 0.3-1.5 meq/g

Chloromethylated Polystyrene Resin RCM-1017-PI 5g 19

Divinylbenzene 2%, 200-400 mesh 4 °C 25 g 65
Cl: 1.0 meq/g

Chloromethylated Polystyrene Resin RCM-1052-PI 5g 25

p-substituted, Divinylbenzene 1%, 100-200 mesh 4 °C 25 g 79
Cl: 0.7-1.1 meq/g

Chloromethylated Polystyrene Resin RCM-1054-PI 5g 25

p-substituted, Divinylbenzene 1%, 200-400 mesh 4 °C 25 g 79
Cl: 0.7-1.1 meq/g

HMBA-MBHA Resin NH3/MeOH

NH2NH2/
RHM-1079-PI 1g 45
Hydroxymethylbenzoyl-MBHA Resin 4 °C 5g 175
DMF
Divinylbenzene 1%, 200-400 mesh NaOH (aq)
For preparation of various C-modified peptides MeOH/Et3N
NaBH4/
EtOH
RCONH2
RCONHNH2
RCO2H
RCOOCH3
RCH2OH

274 Order Hotline 1-800-777-4779 502-266-8787

 Cleavage Reagent
PRODUCT Cleavage Product Code Qty PRICE

TOOLS for PEPTIDE SYNTHESIS

HMPB-MBHA Resin 1% TFA/
CH2Cl2
RHM-1077-PI 1g 45
4-(4-hydroxymethyl-3-methoxyphenoxy)-
butyryl-MBHA Resin (smaller 4 °C 5g 175
Divinylbenzene 1%, 200-400 mesh beads)
For preparation of protected peptide fragments, acid RCO2H
sensitive resin
(cleavage =1%TFA)

Hydroxymethyl Polystyrene Resin HF RFR-1069-PI 5g 50

HO-CH2-Phenyl-Polymer NaBH4 4 °C 25 g 200
Divinylbenzene 1%, 100-200 mesh RCO2H
For the preparation of peptide acids ROH

Hydroxymethyl Polystyrene Resin RFR-1072-PI 5g 50

Divinylbenzene 2%, 200-400 mesh 4 °C 25 g 200
p-Methyl-Benzhydrylamine Resin • HCl RMB-1045-PI 5g 49
(MBHA) 4 °C 25 g 189
Divinylbenzene 1%, 100-200 mesh
NH2: 0.3-1.0 meq/g

p-Methyl-Benzhydrylamine Resin • HCI RMB-1039 5g 95

(MBHA) 4 °C 25 g 420
Divinylbenzene 2%,100-200 mesh
NH2: 0.3-1.5 meq/g

p-Methyl-Benzhydrylamine Resin • HF RMB-2100-PI 5g 49

HCI (MBHA) 4 °C 25 g 189
Divinylbenzene 1%, 200-400 mesh RCONH2
100 g 549

PEPTIDES INTERNATIONAL
NH2: 0.3-1.5 meq/g
(Please be sure to specify the preferred milliequivalents/gram when ordering)

Rink-Amide-AM Resin TFA RHM-1073-PI 5g 169

4-(2’,4’-Dimethoxyphenyl-Fmoc-Aminomethyl) RCONH2 4 °C 25 g 549
Phenoxyacetylnorleucyl Aminomethyl Resin
Divinylbenzene 1%, 200-400 mesh
NH2: 0.3-0.6 meq/g
For the preparation of peptide amides

Rink-Amide-MBHA Resin TFA RFR-1063-PI 5g 169

4-(2’,4’-Dimethoxyphenyl-Fmoc-Aminomethyl) RCONH2 4 °C 25 g 549
Phenoxyacetyl-MBHA Resin
Divinylbenzene 1%, 100-200 mesh
NH2: 0.3-0.6 meq/g
For the preparation of peptide amides

Rink-Amide-MBHA Resin TFA RFR-1067-PI 5g 169

Divinylbenzene 1%, 200-400 mesh RCONH2 4 °C 25 g 549
NH2: 0.3-0.6 meq/g
For the preparation of peptide amides

Wang Resin TFA

NaBH4
RWN-1399-PI 5g 49
p-Alkoxybenzyl Alcohol Resin 4 °C 25 g 180
Divinylbenzene 1%, 100-200 mesh RCO2H
ROH

Order Hotline 1-800-777-4779 502-266-8787 275

 Cleavage Reagent
PRODUCT Cleavage Product Code Qty PRICE
Wang Resin TFA RWN-1398-PI 5g 45
TOOLS for PEPTIDE SYNTHESIS

NaBH4
p-Alkoxybenzyl Alcohol Resin 4 °C 25 g 180
Divinylbenzene 1%, 200-400 mesh RCO2H
ROH

Chlorotrityl Resins (For preparation of acids, alcohols, thiols, or amines)

Caution: Extremely moisture sensitive. Keep dry and tightly closed. Always warm to room temperature before
opening

2-Chlorotrityl Chloride Resin RCT-1056-PI 5g 65

Divinylbenzene 1%, 100-200 mesh 4 °C 25 g 265
Extremely acid sensitive resin, for preparation of
peptide fragments (Cleavage: AcOH/TFE/CH2Cl2)

2-Chlorotrityl Chloride Resin 0.5%TFA/

DCM
RCT-1083-PI 5g 65
Divinylbenzene 1%, 200-400 mesh 4 °C 25 g 265
AcOH/TFE/
Extremely acid sensitive resin, for prepara- DCM
tion of TFA
peptide fragments (Cleavage: AcOH/TFE/ TFMSA
CH2Cl2) TFA
Cl R
RCO2H
Cl
RSH
RNH2

Chlorotrityl Polystyrene Macrobead RTH-9937-PI 5g 141

Particle size: (500-560 μm) 0.6-1.0 meq/g 4 °C

H-γ-Abu-2-ClTrt-Resin RHX-11048-PI 1g 40
PEPTIDES INTERNATIONAL

Divinylbenzene 1%, 100-200 mesh 4 °C 5g 145

H-e-Aca-2-ClTrt-Resin RHX-11049-PI 1g 40
Divinylbenzene 1%, 100-200 mesh 4 °C 5g 145
H-e-Aca-2-ClTrt-Resin RHX-1059-PI 1g 40
Divinylbenzene 1%, 200-400 mesh 4 °C 5g 145
H-Ala-2-ClTrt-Resin RHA-11050-PI 1g 30
Divinylbenzene 1%, 100-200 mesh 4 °C 5g 115
H-Ala-2-ClTrt-Resin RHA-1081-PI 1g 30
Divinylbenzene 1%, 200-400 mesh 4 °C 5g 115
H-β-Ala-2-ClTrt-Resin RHX-11055-PI 1g 40
Divinylbenzene 1%, 100-200 mesh 4 °C 5g 145
H-β-Ala-2-ClTrt-Resin RHX-1078-PI 1g 40
Divinylbenzene 1%, 200-400 mesh 4 °C 5g 145
H-d-Ala-2-ClTrt-Resin RHA-11077-PI 1g 60
Divinylbenzene 1%, 100-200 mesh 4 °C 5g 230
H-Arg(Pbf)-2-ClTrt-Resin RHX-11051-PI 1g 50
Divinylbenzene 1%, 100-200 mesh 4 °C 5g 195

276 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

TOOLS for PEPTIDE SYNTHESIS

H-Arg(Pbf)-2-ClTrt-Resin RHR-1082-PI 1g 50
Divinylbenzene 1%, 200-400 mesh 4 °C 5g 195
H-Asn(Trt)-2-ClTrt-Resin RHN-11053-PI 1g 40
Divinylbenzene 1%, 100-200 mesh 4 °C 5g 145

H-Asn(Trt)-2-ClTrt-Resin RHN-1062-PI 1g 40
Divinylbenzene 1%, 200-400 mesh 4 °C 5g 145

H-Asn-2-ClTrt-Resin RHN-1080-PI 1g 30
Divinylbenzene 1%, 200-400 mesh 4 °C 5g 115
H-Asp(OtBu)-2-ClTrt-Resin RHD-11054-PI 1g 40
Divinylbenzene 1%, 100-200 mesh 4 °C 5g 145
H-Asp(OtBu)-2-ClTrt-Resin RHD-1086-PI 1g 40
Divinylbenzene 1%, 200-400 mesh 4 °C 5g 145
H-Cys(Trt)-2-ClTrt-Resin RHC-11056-PI 1g 40
Divinylbenzene 1%, 100-200 mesh 4 °C 5g 145
H-Gln(Trt)-2-ClTrt-Resin RHQ-11058-PI 1g 40
Divinylbenzene 1%, 200-400 mesh 4 °C 5g 145
H-Gln(Trt)-2-ClTrt-Resin RHQ-1064-PI 1g 40
Divinylbenzene 1%, 200-400 mesh 4 °C 5g 145

PEPTIDES INTERNATIONAL
H-Gln-2-ClTrt-Resin RHQ-1092-PI 1g 30
Divinylbenzene 1%, 200-400 mesh 4 °C 5g 115
H-Glu(OtBu)-2-ClTrt-Resin RHE-11059-PI 1g 40
Divinylbenzene 1%, 100-200 mesh 4 °C 5g 145
H-Glu(OtBu)-2-ClTrt-Resin RHE-1093-PI 1g 40
Divinylbenzene 1%, 200-400 mesh 4 °C 5g 145
H-Gly-2-ClTrt-Resin RHG-11060-PI 1g 30
Divinylbenzene 1%, 100-200 mesh 4 °C 5g 115
H-Gly-2-ClTrt-Resin RHG-1085-PI 1g 30
Divinylbenzene 1%, 200-400 mesh 4 °C 5g 115
H-His(Trt)-2-ClTrt-Resin RHH-11061-PI 1g 40
Divinylbenzene 1%, 100-200 mesh 4 °C 5g 145
H-His(Trt)-2-ClTrt-Resin RHH-1087-PI 1g 40
Divinylbenzene 1%, 200-400 mesh 4 °C 5g 145
H-Ile-2-ClTrt-Resin RHI-11062-PI 1g 30
Divinylbenzene 1%, 100-200 mesh 4 °C 5g 115
H-Ile-2-ClTrt-Resin RHI-1088-PI 1g 30
Divinylbenzene 1%, 200-400 mesh 4 °C 5g 115

Order Hotline 1-800-777-4779 502-266-8787 277

 PRODUCT Code Qty PRICE
H-Leu-2-ClTrt-Resin RHL-11063-PI 1g 30
TOOLS for PEPTIDE SYNTHESIS

Divinylbenzene 1%, 100-200 mesh 4 °C 5g 115

H-Leu-2-ClTrt-Resin RHL-1094-PI 1g 30
Divinylbenzene 1%, 200-400 mesh 4 °C 5g 115
H-Lys(Boc)-2-ClTrt-Resin RHK-11064-PI 1g 40
Divinylbenzene 1%, 100-200 mesh 4 °C 5g 145
H-Lys(Boc)-2-ClTrt-Resin RHK-1091-PI 1g 40
Divinylbenzene 1%, 200-400 mesh 4 °C 5g 145
H-mini-PEG -2-ClTrt-Resin
TM
RHM-11074-PI 1g 99
Divinylbenzene 1%, 100-200 mesh 4 °C 5g 396
H-Met-2-ClTrt-Resin RHM-11065-PI 1g 30
Divinylbenzene 1%, 100-200 mesh 4 °C 5g 115
H-Met-2-ClTrt-Resin RHM-1074-PI 1g 30
Divinylbenzene 1%, 200-400 mesh 4 °C 5g 115
H-Nle-2-ClTrt-Resin RHX-11040-PI 1g 40
Divinylbenzene 1%, 200-400 mesh 4 °C 5g 145

H-Phe-2-ClTrt-Resin RHF-11066-PI 1g 30
Divinylbenzene 1%, 100-200 mesh 4 °C 5g 115
PEPTIDES INTERNATIONAL

H-Phe-2-ClTrt-Resin RHF-1095-PI 1g 30
Divinylbenzene 1%, 200-400 mesh 4 °C 5g 115
H-Pro-2-ClTrt-Resin RHP-11067-PI 1g 30
Divinylbenzene 1%, 100-200 mesh 4 °C 5g 115
Excellent resin for synthesis of peptides containing
C-terminal Pro without DKP formation.

H-Pro-2-ClTrt-Resin RHP-1089-PI 1g 30
Divinylbenzene 1%, 200-400 mesh 4 °C 5g 115
Excellent resin for synthesis of peptides containing
C-terminal Pro without DKP formation.

H-Ser(tBu)-2-ClTrt-Resin RHS-11068-PI 1g 40
Divinylbenzene 1%, 100-200 mesh 4 °C 5g 145
H-Ser(tBu)-2-ClTrt-Resin RHS-1096-PI 1g 40
Divinylbenzene 1%, 200-400 mesh 4 °C 5g 145
H-Thr(tBu)-2-ClTrt-Resin RHT-11069-PI 1g 40
Divinylbenzene 1%, 100-200 mesh 4 °C 5g 145
H-Thr(tBu)-2-ClTrt-Resin RHT-1097-PI 1g 40
Divinylbenzene 1%, 200-400 mesh 4 °C 5g 145
H-Trp(Boc)-2-ClTrt-Resin RHW-11070-PI 1g 50
Divinylbenzene 1%, 100-200 mesh 4 °C 5g 195

278 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

TOOLS for PEPTIDE SYNTHESIS

H-Trp(Boc)-2-ClTrt-Resin RHW-1099-PI 1g 50
Divinylbenzene 1%, 200-400 mesh 4 °C 5g 195
H-Trp-2-ClTrt-Resin RHW-11071-PI 1g 30
Divinylbenzene 1%, 100-200 mesh 4 °C 5g 115
H-Trp-2-ClTrt-Resin RHW-1098-PI 1g 30
Divinylbenzene 1%, 200-400 mesh 4 °C 5g 115
H-Tyr(tBu)-2-ClTrt-Resin RHY-11072-PI 1g 40
Divinylbenzene 1%, 100-200 mesh 4 °C 5g 145
H-Tyr(tBu)-2-ClTrt-Resin RHY-1075-PI 1g 40
Divinylbenzene 1%, 200-400 mesh 4 °C 5g 145
H-Val-2-ClTrt-Resin RHV-11073-PI 1g 30
Divinylbenzene 1%, 100-200 mesh 4 °C 5g 115
H-Val-2-ClTrt-Resin RHV-1076-PI 1g 30
Divinylbenzene 1%, 200-400 mesh 4 °C 5g 115
CLEAR-OX are found in the Specialty Products and Services Section on page 232.
TM

Fmoc-Amino Acid-Wang Resins

p-Alkoxybenzyl Alcohol Resin
Fmoc-amino acid resins are supplied with their exact substitution levels. Fmoc- D-amino acids,
or unusual Fmoc amino acids attached to the W ang resin are available upon request. .

PEPTIDES INTERNATIONAL
Unsubstituted Resin HO CH2 O CH2 P

Fmoc-Ala-Wang Resin RFA-1306-PI 1g 20

FmocL-Alanine-p-Alkoxybenzyl
9-Fluorenylmethoxycarbonyl- Amino Wang Resin 4 °C 4 °C 5g 80
Alcohol Resin; Divinylbenzene 1%, 100-200 mesh

Fmoc-β-Ala-Wang Resin RFX-1344-PI 1g 20

9-Fluorenylmethoxycarbonyl-β-Alanine- p-Alkoxybenzyl 4 °C 5g 80
Alcohol Resin
(0.4-0.7 meq/g) [Higher
Divinylbenzene 1%, 100-200 mesh Substitution]

Fmoc-β-Ala-Wang Resin RFX-1345-PI 1g 20

9-Fluorenylmethoxycarbonyl-β-Alanine- p-Alkoxybenzyl 4 °C 5g 80
Alcohol Resin (0.1-0.2 meq/g)
Divinylbenzene 1%, 100-200 mesh [Lower
Substitution]

Fmoc-Asn(Trt)-Wang Resin RFN-1354-PI 1g 40

Nα-9-Fluorenylmethoxycarbonyl-Nβ-Trityl- L-Asparagine-p- 4 °C 5g 160
Alkoxybenzyl Alcohol Resin
Divinylbenzene 1%, 100-200 mesh

Fmoc-Asp(OtBu)-Wang Resin RFD-1313-PI 1g 40

9-Fluorenylmethoxycarbonyl-L-Aspartic Acid- β-t-Butyl Ester- 4 °C 5g 160
p-Alkoxybenzyl Alcohol Resin
Divinylbenzene 1%, 100-200 mesh

Order Hotline 1-800-777-4779 502-266-8787 279

 PRODUCT Code Qty PRICE
Fmoc-Cys(tBu)-Wang Resin RFC-1341-PI 1g 75
TOOLS for PEPTIDE SYNTHESIS

9-Fluorenylmethoxycarbonyl- S-t-Butyl-L-Cysteine-p- 4 °C 5g 225

Alkoxybenzyl Alcohol Resin
Divinylbenzene 1%, 100-200 mesh

Fmoc-Cys(Trt)-Wang Resin RFC-1318-PI 1g 40

9-Fluorenylmethoxycarbonyl-S-Trityl- L-Cysteine-p- 4 °C 5g 160
Alkoxybenzyl Alcohol Resin
Divinylbenzene 1%, 100-200 mesh

Fmoc-Cys(Xan)-Wang Resin RFC-1319-PI 1g 60

9-Fluorenylmethoxycarbonyl-S-Xanthyl-L-Cysteine- p-Alkoxy- 4 °C 5g 240
benzyl Alcohol Resin
Divinylbenzene 1%, 100-200 mesh

Fmoc-Glu(OtBu)-Wang Resin RFE-1320-PI 1g 40

9-Fluorenylmethoxycarbonyl-L-Glutamic Acid- γ-t-Butyl Ester- 4 °C 5g 160
p-Alkoxybenzyl Alcohol Resin
Divinylbenzene 1%, 100-200 mesh

Fmoc-d-Glu(OtBu)-Wang Resin RFE-1358-PI 1g 90

Divinylbenzene 1%, 100-200 mesh 4 °C 5g 360
Fmoc-Gln(Trt)-Wang Resin RFQ-1355-PI 1g 40
Nα-9-Fluorenylmethoxycarbonyl-Nγ-Trityl-L-Glutamine-p- 4 °C 5g 160
Alkoxybenzyl Alcohol Resin
Divinylbenzene 1%, 100-200 mesh

Fmoc-Gly-Wang Resin RFG-1301-PI 1g 20

PEPTIDES INTERNATIONAL

9-Fluorenylmethoxycarbonyl-Glycine-p-Alkoxybenzyl Alcohol 4 °C 5g 80
Resin; Divinylbenzene 1%, 100-200 mesh

Fmoc-His(Trt)-Wang Resin RFH-1340-PI 1g 40

Nα-9-Fluorenylmethoxycarbonyl-Nim-Trityl-L-Histidine-p- 4 °C 5g 160
Alkoxybenzyl Alcohol Resin
Divinylbenzene 1%, 100-200 mesh

Fmoc-lle-Wang Resin RFI-1324-PI 1g 20

Nim-9-Fluorenylmethoxycarbonyl-L-lsoleucine-p-Alkoxybenzyl 4 °C 5g 80
Alcohol Resin; Divinylbenzene 1%, 100-200 mesh

Fmoc-Leu-Wang Resin RFL-1325-PI 1g 20

9-Fluorenylmethoxycarbonyl-L-Leucine-p-Alkoxybenzyl 4 °C 5g 80
Alcohol Resin; Divinylbenzene 1%, 100-200 mesh

Fmoc-Lys(Alloc)-Wang Resin RFK-1304-PI 1g 65

Divinylbenzene 1%, 100-200 mesh 4 °C 5g 230
Fmoc-Lys(Boc)-Wang Resin RFK-1326-PI 1g 40
9-Fluorenylmethoxycarbonyl-Nε-t-Butyloxycarbonyl-L-Lysine- 4 °C 5g 160
p-Alkoxybenzyl Alcohol Resin
Divinylbenzene 1%, 100-200 mesh

Fmoc-Lys(ivDde)-Wang Resin RFK-1307-PI 1g

Divinylbenzene 1%, 100-200 mesh 4 °C 5g
Fmoc-Met-Wang Resin RFM-1303-PI 1g 20
9-Fluorenylmethoxycarbonyl-L-Methionine-p-Alkoxybenzyl 4 °C 5g 80
Alcohol Resin; Divinylbenzene 1%, 100-200 mesh

280 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

TOOLS for PEPTIDE SYNTHESIS

Fmoc-Nva-Wang Resin RFU-1308-PI 1g
Divinylbenzene 1%, 100-200 mesh 4 °C 5g
Fmoc-Phe-Wang Resin RFF-1330-PI 1g 20
9-Fluorenylmethoxycarbonyl-L-Phenylalanine-p-Alkoxybenzyl 4 °C 5g 80
Alcohol Resin ;Divinylbenzene 1%, 100-200 mesh

Fmoc-Pro-Wang Resin RFP-1331-PI 1g 20

9-Fluorenylmethoxycarbonyl-L-Proline-p-Alkoxybenzyl 4 °C 5g 80
Alcohol Resin; Divinylbenzene 1%, 100-200 mesh

Fmoc-Ser(tBu)-Wang Resin RFS-1333-PI 1g 40

9-Fluorenylmethoxycarbonyl-O-t-Butyl-L-Serine-p- 4 °C 5g 160
Alkoxybenzyl Alcohol Resin
Divinylbenzene 1%, 100-200 mesh

Fmoc-Thr(tBu)-Wang Resin RFT-1300-PI 1g 40

9-Fluorenylmethoxycarbonyl-O-t-Butyl-L-Threonine-p- 4 °C 5g 160
Alkoxybenzyl Alcohol Resin
Divinylbenzene 1%, 100-200 mesh

Fmoc-Trp(Boc)-Wang Resin RFW-1342-PI 1g 60

Nα-9-Fluorenylmethoxycarbonyl-Nin­-t-Butyloxycarbonyl-l- 4 °C 5g 240
Tryptophan-Alkoxybenzyl Alcohol Resin
Divinylbenzene 1%, 100-200 mesh

Fmoc-Trp-Wang Resin RFW-1335-PI 1g 20

9-Fluorenylmethoxycarbonyl-l-Tryptophan-p-Alkoxybenzyl 4 °C 5g 80
Alcohol Resin, Divinylbenzene 1%, 100-200 mesh

PEPTIDES INTERNATIONAL
Fmoc-Tyr(tBu)-Wang Resin RFY-1337-PI 1g 40
9-Fluorenylmethoxycarbonyl-O-t-Butyl-L-Tyrosine-p- 4 °C 5g 160
Alkoxybenzyl Alcohol Resin
Divinylbenzene 1%, 100-200 mesh

Fmoc-Val-Wang Resin RFV-1339-PI 1g 20

9-Fluorenylmethoxycarbonyl-L-Valine-p-Alkoxybenzyl Alcohol 4 °C 5g 80
Resin, Divinylbenzene 1%, 100-200 mesh

Fmoc-Amino Acid-Rink-Amide MBHA Resins

Substitution range 0.2 meq/g - 0.6 meq/g

Fmoc-Ala-Rink-Amide MBHA Resin RFA-10010-PI 1g 20

Divinylbenzene 1%, 100-200 mesh 4 °C 5g 80
Fmoc-b-Ala-Rink-Amide MBHA Resin RFX-10011-PI 1g 20
Divinylbenzene 1%, 100-200 mesh 4 °C 5g 80
Fmoc-Arg(Pbf)-Rink-Amide MBHA Resin RFR-10012-PI 1g 60
Divinylbenzene 1%, 100-200 mesh 4 °C 5g 240
Fmoc-Asn(Trt)-Rink-Amide MBHA Resin RFN-10013-PI 1g 40
Divinylbenzene 1%, 100-200 mesh 4 °C 5g 160
Fmoc-Asp(OtBu)-Rink-Amide MBHA Resin RFD-10014-PI 1g 40
Divinylbenzene 1%, 100-200 mesh 4 °C 5g 160

Order Hotline 1-800-777-4779 502-266-8787 281

 PRODUCT Code Qty PRICE
Fmoc-Cys(Trt)-Rink-Amide MBHA Resin RFC-10015-PI 1g 40
TOOLS for PEPTIDE SYNTHESIS

Divinylbenzene 1%, 100-200 mesh 4 °C 5g 160

Fmoc-Gln(Trt)-Rink-Amide MBHA Resin RFQ-10019-PI 1g 40
Divinylbenzene 1%, 100-200 mesh 4 °C 5g 160
Fmoc-Glu(OtBu)-Rink-Amide MBHA Resin RFE-10020-PI 1g 40
Divinylbenzene 1%, 100-200 mesh 4 °C 5g 160
Fmoc-Gly-Rink-Amide MBHA Resin RFG-10021-PI 1g 20
Divinylbenzene 1%, 100-200 mesh 4 °C 5g 80
Fmoc-His(Trt)-Rink-Amide MBHA Resin RFH-10022-PI 1g 40
Divinylbenzene 1%, 100-200 mesh 4 °C 5g 160
Fmoc-Ile-Rink-Amide MBHA Resin RFI-10023-PI 1g 20
Divinylbenzene 1%, 100-200 mesh 4 °C 5g 80
Fmoc-Leu-Rink-Amide MBHA Resin RFL-10024-PI 1g 20
Divinylbenzene 1%, 100-200 mesh 4 °C 5g 80
Fmoc-Lys(Boc)-Rink-Amide MBHA Resin RFK-10025-PI 1g 40
Divinylbenzene 1%, 100-200 mesh 4 °C 5g 160
Fmoc-Met-Rink-Amide MBHA Resin RFM-10026-PI 1g 20
Divinylbenzene 1%, 100-200 mesh 4 °C 5g 80
Fmoc-Phe-Rink-Amide MBHA Resin
PEPTIDES INTERNATIONAL

RFF-10027-PI 1g 20
Divinylbenzene 1%, 100-200 mesh 4 °C 5g 80
Fmoc-Pro-Rink-Amide MBHA Resin RFP-10029-PI 1g 20
Divinylbenzene 1%, 100-200 mesh 4 °C 5g 80
Fmoc-Ser(tBu)-Rink-Amide MBHA Resin RFS-10030-PI 1g 40
Divinylbenzene 1%, 100-200 mesh 4 °C 5g 160
Fmoc-Thr(tBu)-Rink-Amide MBHA Resin RFT-10031-PI 1g 40
Divinylbenzene 1%, 100-200 mesh 4 °C 5g 160
Fmoc-Trp-Rink-Amide MBHA Resin RFW-10032-PI 1g 45
Divinylbenzene 1%, 100-200 mesh 4 °C 5g 175
Fmoc-Trp(Boc)-Rink-Amide MBHA Resin RFW-10033-PI 1g 60
Divinylbenzene 1%, 100-200 mesh 4 °C 5g 240
Fmoc-Tyr(tBu)-Rink-Amide MBHA Resin RFY-10034-PI 1g 40
Divinylbenzene 1%, 100-200 mesh 4 °C 5g 160
Fmoc-Val-Rink-Amide MBHA Resin RFV-10035-PI 1g 20
Divinylbenzene 1%, 100-200 mesh 4 °C 5g 80

282 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

TOOLS for PEPTIDE SYNTHESIS

TentaGel Resins from Rapp Polymere, Germany
TentaGel is a gelatinous resin, an important support for solid phase synthesis. TentaGel resins
are constructed with a backbone of low crosslinked polystyrene grafted with polyoxyethylene
(polyethylene glycol) as shown below . The typical chain length of POE (n) is approximately
68 ethylene oxide units or an average MW of 3000. This long chain creates a spacer that effec-
tively separates the reactive site (X) from the crosslinked backbone matrix.

What is the dif ference between TentaGel R and TentaGel S? TentaGel S is the base resin;
it is available in a variety of functional groups and in 90 μm or 130 μm sizes. TentaGel R is
specially modified with an optimized ratio of PEG attached to the polystyrene core. This results
in improved swelling properties and its structure helps overcome peptide aggregation problems.
For this reason TentaGel R (“Research” grade) is often used for the synthesis of long or dif -
ficult peptide sequences. TentaGel R is a softer gel than TentaGel S. While it can be used in
continuous flow synthesizers, a lower flow rate (10-15 mL/min) is recommended. Both resins
are appropriate for Fmoc-chemistry.
This polystyrene-based support with polyoxyethylene arms is an excellent resin for preparation
of peptide organic libraries on a solid support. The highly uniform beads and compatible oxy -

PEPTIDES INTERNATIONAL
ethylene spacer make this support quite useful for testing mixtures directly on the solid support.
The water compatibility permits use in numerous biological applications. Resins are available in
two bead sizes (90 and 130 microns).
Please inquire for additional products of Rapp Polymere.

Table: TentaGel Characteristics vs. Bead Size

Capacity/ Bead Capacity/ Bead
Substitution
[nmol] [nmol]
Resin Functional Beads/g
(for Polystyrene, (for TentaGel
Group
= 1 mmol/g) S = 0.28 mmol/g)

TentaGel S Resin -O-CH2-CH2-NH2 2.86 x 106 0.4 0.1

NH2 90 μm

TentaGel S Resin -O-CH2-CH2-NH2 782,770 1.3 0.35

NH2 130 μm
Please note: The above resin choices have been especially selected for combinatorial chemistry or solid phase
organic synthesis applications.

Order Hotline 1-800-777-4779 502-266-8787 283

 PRODUCT Code Qty PRICE
TentaGel S - Base Resins
TOOLS for PEPTIDE SYNTHESIS

The typical capacity range for our TentaGel base resins is 0.2-0.3 meq/g.
The TentaGel S base resins are available with several dif ferent derivative choices. Please
inquire for further information.

TentaGel S Br Resin RTS-9901-PI 1g 53

(90 μm) -O-CH2-CH2-Br 4 °C 5g 131
25g 493
TentaGel S NH2 Resin RTS-9902-PI 1g 531
(90 μm) -O-CH2-CH2-NH2 4 °C 5g 109
25g 437
TentaGel S COOH RTS-9903-PI 1g 66
Resin -NH-CO-CH2-CH2-COOH 4 °C 5g 148
(90 μm)
25g 598
TentaGel S SH Resin RTS-9904-PI 1g 45
(90 μm) -CH2-CH2-SH 4 °C 5g 129
25g 424
TentaGel HL (High Load) Resins TentaGel HL (High Load)
(mean particle size 75 μm: capacity 0.4-0.6 meq/g)
PEPTIDES INTERNATIONAL

TentaGel HL-OH -O-CH2-CH2-OH

RTH-9330-PI 1g 66
Resin 4 °C 5g 129
TentaGel HL-Br Resin -O-CH2-CH2-Br
RTH-9331-PI 1g 66
4 °C 5g 129
TentaGel HL-NH2 -O-CH2-CH2-NH2
RTH-9332-PI 1g 66
Resin 4 °C 5g 129
TentaGel HL-COOH -NH-CO-CH2-CH2-COOH
RTH-9333-PI 1g 82
Resin 4 °C 5g 188
TentaGel HL-SH -CH2-CH2-SH
RTH-9334-PI 1g 45
Resin 4 °C 5g 148
TentaGel HL (High Load) (mean particle size 110 μm: capacity 0.4-0.6 meq/g)
TentaGel HL-OH -O-CH2-CH2-OH
RTH-9335-PI 1g 66
Resin 4 °C 5g 129
TentaGel HL-Br Resin -O-CH2-CH2-Br
RTH-9336-PI 1g 66
4 °C 5g 129
TentaGel HL-NH2 -O-CH2-CH2-NH2
RTH-9337-PI 1g 59
Resin 4 °C 5g 168
TentaGel HL-COOH -NH-CO-CH2-CH2-COOH
RTH-9338-PI 1g 82
Resin 4 °C 5g 188

284 Order Hotline 1-800-777-4779 502-266-8787

TentaGel HL-SH RTH-9339-PI 5g 255

TOOLS for PEPTIDE SYNTHESIS

-CH2-CH2-SH
Resin 4 °C 25 g 1018
TentaGel HL (High Load) with Handles mean particle size 75 μm: capacity 0.3-0.4 meq/g
TentaGel HL PHB Resin RTH-9340-PI 1g 69
4 °C 5g 173
TentaGel HL HMBA Resin RTH-9341-PI 1g 86
4 °C 5g 235
TentaGel HL RAM Resin RTH-9342-PI 1g 86
4 °C 5g 203
TentaGel Macrobeads
These resins are designed for single bead synthesis and single bead analysis.
(mean particle size 280-320 μm: capacity 0.2-0.3 meq/g)

TentaGel Macrobead- -O-CH2-CH2-OH

TMB-9343-PI 1g 69
OH Resin 4 °C 5g 173
TentaGel Macrobead- -O-CH2-CH2-Br
TMB-9344-PI 1g 69
Br Resin 4 °C 5g 173
TentaGel Macrobead- TMB-9908-PI 1g 66
NH2 4 °C 5g 165
TentaGel Macrobead- -O-CH2-CH2-NH2
TMB-9345-PI 1g 69
NH2 Resin 4 °C 5g 173
TentaGel Macrobead- TMB-9346-PI 1g 86

PEPTIDES INTERNATIONAL
-NH-CO-CH2-CH2-COOH
COOH Resin 4 °C 5g 197
TentaGel Macrobead- -CH2-CH2-SH
TMB-9347-PI 1g 47
SH Resin 4 °C 5g 155
TentaGel Macrobead Resins with Handles
Particle size 280-320 μm; capacity: 0.2-0.3 meq/g. Additional particle sizes available, please inquire.

TentaGel Macrobead PHB Resin TMB-9348-PI 1g 69

4 °C 5g 173
TentaGel Macrobead HMBA Resin TMB-9349-PI 1g 86
4 °C 5g 235
TentaGel Macrobead RAM Resin TMB-9350-PI 1g 86
4 °C 5g 311

Order Hotline 1-800-777-4779 502-266-8787 285

 PRODUCT Code Qty PRICE
TOOLS for PEPTIDE SYNTHESIS

TentaGels Microsphere
TentaGel RTM-9401-PI 1g 120
Microsphere NH2 -O-CH2-CH2-NH2 4 °C 5g 311
Resin
Particle size 30 μm monosized; capacity: 0.2-0.3 meq/g. 25 g 1242

TentaGel S NH2 Resin -O-CH2-CH2-NH2

RTS-9932-PI 1g 54
4 °C 5g 115
Particle size 130 μm; capacity: 0.2-0.35 meq/g
25 g 459
This resin is used in combinatorial chemistry.

TentaGel R NH2 Resin RTS-9992-PI 1g 55

Particle size 90 μm; capacity: 0.18-0.22 meq/g 4 °C 5g 138
This resin is specially designed for difficult & long sequences.
25 g 517
Peptide Synthesis - for preparation of peptide acids
TentaGel S PHB RTS-9913-PI 1g 54
Resin TentaGel O CH2 OH 4 °C
5g 115
Particle size 90 μm; capacity: 0.2-0.3 meq/g 25 g 459
TentaGel R PHB Resin RTS-9993-PI 1g 55
Particle size 90 μm; capacity: 0.18-0.23 meq/g 4 °C 5g 138
This resin is specially designed for difficult & long sequences.
25 g 517
PEPTIDES INTERNATIONAL

TentaGel S PHB Resin RTS-9913-PI

Peptide Synthesis-for preparation of peptide amides
TentaGel S RAM Resin RTS-9923-PI 1g 69
(Rink-type) (90 μm) 0.2-0.27 meq/g 4 °C 5g 135
25 g 540

TentaGel R RAM RTS-9995-PI 1g 86

Resin 4 °C 5g 203
(Rink-type)
(90 μm) 0.18-0.22
O NH Fmoc
fmo 25 g 608
C CH2 O CH OMe
meq/g 100 g 1695
This resin is specially
designed for difficult &
long sequences.
OMe

Immunization & Antibodies

TentaGel PAP Resin PS POE-CH 2-CH2-NH2 RTS-9002-PI 1g 69
(90 μm) 0.2-0.25 meq/g 4 °C 5g 173
Using this resin, cleav-
age yields the POE-
tentagel r ram resin 25 g 587
peptide conjugates. Even less soluble peptides may be completely solubilized with this linker .

286 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

TOOLS for PEPTIDE SYNTHESIS

TentaGel B Resins (Bifunctional)
TentaGel B Particle size 90 μm; capacity: 0.2-0.3 meq/g
inside outside
TentaGel B NH2 / Boc RTS-9321-PI 1g 270
Resin NH2 Boc 4 °C 5g 1080
(90 μm)

TentaGel B Boc / NH2 RTS-9312-PI 1g 257

Resin Boc NH2 4 °C 5g 1029
(90 μm)

TentaGel B Resin Particle size 130 μm; Capacity: 0.2-0.3 meq/g

TentaGel B NH2 / Boc RTS-9311-PI 1g 270
Resin NH2 Boc 4 °C 5g 1080
(130 μm)

TentaGel B NH2 / Boc RTS-9312-PI 1g 270

Resin NH2 Boc 4 °C 5g 1080
(90 μm)

*TentaGel B resins represent a line of bifunctional resins that are useful for orthogonal synthesis.
References
E. Bayer, W. Rapp, In, Peptide Chemistry 1987, Ed. T. Shiba and S.Sakakibara, Protein Research

PEPTIDES INTERNATIONAL
Foundation, Osaka 1988, 263.
W. Bessler, et al., J. Immunol. 135, 1900-1905 (1985).
W. Rapp, et al., Innovations and Perspectives in Solid Phase Synthesis, R. Epton, Ed., SPCC(UK) Ltd.,
Birmingham, 1991.
Please inquire for additional products of Rapp Polymere.

MAPS (Multiple Antigen Peptide Systems) Resins

In 1988, James P. Tam introduced the Multiple Antigenic Peptides (MAPs) concept
to enhance antibody generation against a synthetic peptide multiplet and to avoid
the need for conjugation to carrier protein.* Since then, researchers have found even
more uses for these branched lysine cores to generate peptide tetramers, octamers
or other novel species. Orthogonally branched analogs ( RBL-1433-PI) are especially
useful for preparing sequences with multiple epitopes.
*J.P. Tam, Proc. Natl. Acad. Sci. USA, 85, 5409-5413 (1988).

Base MAP Cores

Fmoc-b-Ala-Wang Resin RFX-1345-PI 1g 20
Divinylbenzene 1%, 100-200 mesh 4 °C 5g 80
NH2: 0.1-0.2 meq/g

4 Branch MAP Cores

Fmoc4-Lys2-Lys-b-Ala-CLEAR Acid Resin CFM-1214-PI 1g 99
100-200 mesh 4 °C 5g 396

Order Hotline 1-800-777-4779 502-266-8787 287

 PRODUCT Code Qty PRICE
Fmoc4-Lys2-Lys-b-Ala-Wang Resin RFX-1390-PI 1g 195
TOOLS for PEPTIDE SYNTHESIS

Divinylbenzene 1%, 100-200 mesh 4 °C 5g 695

NH2: 0.2-0.6 meq/g

(Boc-Lys(Fmoc))2-Lys-b-Ala-Pam Resin RBL-1433-PI 1g 175

Divinylbenzene 1%, 200-400 mesh 4 °C 5g 450
NH2: 0.2-0.6 meq/g

Boc4-Lys2-Lys-b-Ala-Pam Resin RBL-1437-PI 1g 175

Divinylbenzene 1%, 200-400 mesh 4 °C 5g 450
NH2: 0.2-0.6 meq/g

Boc4-Lys2-Lys-Cys(Acm)-b-Ala-Pam Resin RBL-1443-PI 1g 175

Divinylbenzene 1%, 200-400 mesh 4 °C 5g 450
NH2: 0.2-0.6 meq/g

8 Branch MAP Cores

Fmoc8-Lys4-Lys2-Lys-b-Ala-CLEAR Acid CFM-1218-PI 1g 125
Resin 4 °C
100-200 mesh

Fmoc8-Lys4-Lys2-Lys-b-Ala-Wang Resin RFX-1395-PI 1g 275

Divinylbenzene 1%, 100-200 mesh 4 °C 5g 945
NH2: 0.4-0.8 meq/g

Boc8-Lys4-Lys2-Lys-b-Ala-Pam Resin RBL-1439-PI 1g 195

Divinylbenzene 1%, 200-400 mesh 4 °C 5g 585
NH2: 0.4-0.8 meq/g
PEPTIDES INTERNATIONAL

Boc8-Lys4-Lys2-Lys-Cys(Acm)-b-Ala-Pam RBL-1441-PI 1g 195

Resin 4 °C 5g 585
Divinylbenzene 1%, 200-400 mesh
NH2: 0.4-0.8 meq/g

Resins for Protein Ligation

S-Trityl-β-Mercaptopropionyl-AM Resin RAM-1055-PI 5g 79
Divinylbenzene 1%, 100-200 mesh 4 °C 25 g 279
S-Trityl-β-Mercaptopropionyl-Leu-Pam Resin RPL-1458-PI 1g 45
Divinylbenzene 1%, 100-200 mesh 4 °C 5g 139

288 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

TOOLS for PEPTIDE SYNTHESIS

Reagents
Condensation Reagents, Additives, Linkers, and Other Reagents for Peptide
Synthesis
Biotin-ONp BDN-6004-PI 1g 125
Biotin 4-Nitrophenyl Ester 4 °C 5g 500
(M.W. 365.41) C16H19N3O5S [33755-53-2]
D. Baumeister, Intl J of Peptide Res and Ther, 11,139 (2005).
D.F. Winkler and P.L. McGeer, Proteomics, 8, 961 (2008).

Biotin-OSu BOS-6003-PI 1g 125

d-Biotin-N-hydroxysuccinimide Ester 4 °C 5g 500
(M.W. 341.39) C14H19N3O5S [35013-72-0]
D.F. Winkler and P.L. McGeer, Proteomics, 8, 961 (2008).

BOP Reagent N KBP-1060-PI 5g 25

Benzotriazol-1-yl-oxy-tris N
75
4 °C 25 g
(dimethylamino) phosphonium N
hexafluorophosphate O 100 g 175
(M.W. 442.29) C12H22N6OF6P2 + PF6-
P
[56602-33-6]

DCCD BOP KBP-1060-PI KDC-1001 100 g 45

Dicyclohexylcarbodiimide 185
4 °C 500 g
(M.W. 206.33) C13H22N2 [538-

PEPTIDES INTERNATIONAL
75-0]
Crystalline Mass
N C N
J.C. Sheehan and G.P. Hess, J.
Amer Chem. Soc., 77, 1065 (1955).

EDDNP EDP-5012-PI 1g 140

N-(2,4-Dintrophenyl)-ethylenediamine DCCD KDC-1001-PI
NEW! 4 °C 5g 560
(M.W. 226.19) C8H10N4O4 [28767-75-1]

EEDQ KEE-1024 25 g 25
N-Ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline 4 °C 100 g 70
(M.W. 247.29) C14H17NO3 [16357-59-8]
B. Belleau and G. Malek, J. Am. Chem. Soc., 90, 1651 (1968).
H. Yajima and H. Kawatani, Chem. Pharm. Bull., 19, 1905 (1971).

Order Hotline 1-800-777-4779 502-266-8787 289

 PRODUCT Code Qty PRICE
Fmoc-OSu KFS-1042-PI 5g 25
TOOLS for PEPTIDE SYNTHESIS

9-Fluorenylmethoxycarbonyl-N- 4 °C 75
25 g
succinimide ester O
M.W. 337.33) C19H15NO5 O O 100 g 195
[82911-69-1] N
O
A. Paquet, Can. J. Chem., 60, 976 O
(1982).

HBTU Reagent KHB-1065-PI 5g 25

N-HBTU N Fmoc-OSu KFS-1042-PI
55
N
4 °C 25 g
1-[bis(Dimethylamino)
methylene]-1H-benzotriazolium N+ 100 g 125
hexafluorophosphate 3-oxide N
-
(M.W. 379.25) C11H16N5OPF6 N PF6
+
[94790-37-1] -
O

HCTU Reagent KHC-1018-PI 5g 25

1H-Benzotriazolium-1- N
55
N
4 °C 25 g
[bis(dimethylamino)methylene]- HBTU KHB-1065-PI
5-chloro-hexafluorophosphate- N+ 100 g 125
(1-),3-oxide N
-
(M.W. 413.69) C11H15N5OClPF6 N PF6
Cl +
[330645-87-9] -
O
Coupling Reagent

6-Cl-HOBt Reagent KCH-1009-PI 25 g 55

PEPTIDES INTERNATIONAL

1-Hydroxy-6- OH
HCTU KHC-1018-PI 4 °C 100 g 125
chlorobenzotriazole N
(M.W. 169.57) C6H4N3OCI N
[2619-18-96] N
Efficient reagent to suppress Cl
racemization and to enhance
coupling in peptide synthesis

HOSu KSU-1011 25 g 45
N-Hydroxysuccinimide 115
O
RT 100 g
(M.W. 115.09) C4H5NO3
[6066-82-6]
G.W. Anderson, J.E. 6-Cl--HOBt,
N OH KHC-1009-PI
Zimmerman, and F.M.
Callahan, J. Amer. Chem. Soc., O
86, 1839 (1964)

Marfey’s Reagent KMF-3870-PI 25 mg 20

N-(2,4-Dinitro-5-fluorophenyl)-l-alaninamide 4 °C 45
100 mg
P. Marfey, Carlsberg Res. Commun., 49, 591 (1984).
500 mg 145
Nefken’s Reagent N-HOSU, KSU-1011-PI KNF-1033 25 g 30
N-Carboethoxy phthalimide 70
4 °C 100 g
(M.W. 219.19) C11H9NO4 [22509-74-6]
500 g 245
G.H.L. Nefkens, Nature, 185, 309 (1960).

290 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

TOOLS for PEPTIDE SYNTHESIS

OxymaPure ® OXY-1050-PI 25 g 27
Ethyl (hydroxyimino)cyanoacetate 79
NEW! 4 °C 100 g
(M.W. 142.12) C5H6N2O3
[3849-21-6]
Considered as a replacement for HOBt , HOAT , HOOBt,
HOPO , Cl-HOBT and other analogues
OxymaPure® is a registered Trade Mark of Luxembourg Bio Technologies Ltd.
J.M. Collins, et al., Org. Lett., 16, 940 (2014). N. Babu Palakurthy, et al., Eur. J. Org. Chem., 2627 (2013).
S.N. Khattab, et al., Eur. J. Org. Chem., 3275 (2010). R.Subiros-Funosas, et al., PeptideScience, 98, Vol. 2
R. Subiros-Funosas, et al., Chem. Eur. J., 15, 9394 S.N. Khattab, Bull. Chem. Soc. Jpn., 83, No. 11, 1374 (2010).
(2009).

TBTU Reagent KTB-1066-PI 25 g 35

1-[bis(Dimethylamino) N
95
N
4 °C 100 g
Methylene]-1H-benzotriazolium
tetrafluoroborate 3-oxide N+ 500 g 195
(M.W. 321.13) C11H16N5OBF4 N
[125700-67-6] N BF4-
+
-
O

TCTU Reagent KTC-1010-PI 25 g 55

1-H-Benzotriazolium-1- N
125
N
4 °C 100 g
[bis(dimethylamino)methylene]- TBTU KTB-1066-PI
5-chloro-tetrafluoroborate-(1-), N +
3-oxide N BF4-
(M.W. 355.57) C11H15BClF4N5O N
Cl +
[330641-16-2] -

PEPTIDES INTERNATIONAL
O

WSCD • HCl KWS-1030 5g 45

Water-Soluble Carbodiimide 135
4 °C 25 g
hydrochloride N TCTU KTC-1010-PI
• N C N
HCl

Boc-Amino Acid-Pam Linker Reagents

WSCD.HCl KWS-1030-PI
Boc-Glu(OBzl)-Pam Acid BEP-5482-PI 1g 36
4-(t-Butyloxycarbonyl-(g-benzyl)-glutamyloxymethyl]- 4 °C 144
5g
phenylacetic acid
Useful Reagent for Pam Resin Preparation
(M.W. 485.54) C16H21NO8

Boc-Gly-Pam Acid BGP-5484-PI 1g 30

4-(t-Butyloxycarbonyl-glycyloxymethyl)-phenylacetic acid 4 °C 115
5g
(M.W. 323.35) C16H21NO6
Useful Reagent for Pam Resin Preparation

Boc-Leu-Pam Acid BLP-5487-PI 1g 30

4-(t-Butyloxycarbonyl-Leucyloxymethyl)-phenylacetic acid 4 °C 115
5g
(M.W. 379.46) C20H29NO6
Useful Reagent for Pam Resin Preparation

Boc-Val-Pam Acid BVP-5499-PI 1g 30

4-(t-Butyloxycarbonyl-valyloxymethyl)-phenylacetic acid 4 °C 115
5g
(M.W. 365.43) C19H27NO6
Useful Reagent for Pam Resin Preparation

Order Hotline 1-800-777-4779 502-266-8787 291

 PRODUCT Code Qty PRICE
COMU
TOOLS for PEPTIDE SYNTHESIS

(1-[1-(Cyano-2-ethoxy-2-Oxoethylideneaminooxy)-Dimethylamino-Morpholino]-
Uronium Hexafluorophosphate) allows for the use of one equivalent of base during
the coupling protocol, thus contributing to the reduction of potential racemization in
the growing peptide chain without impairing the reaction rate or the overall yield of the
coupling process. Additionally, COMU is highly soluble in DMF and NMP , safe, and
non-allergenic, which makes it a compelling reagent alternative.
COMU Reagent KCM-1015-PI 5g 40
1-[1-(Cyano-2-ethoxy-2-Oxoethylideneaminooxy)- 4 °C 150
25 g
dimethylamino-Morpholino]-Uronium hexafluorophosphate
(M.W. 428.27) C12H19N4O4PF6 [1075198-30-9] 100 g 450
Coupling Reagent
COMU allows for the use of one equivalent of base during C2H5OOC CN
the coupling protocol, thus contributing to the reduction of
potential racemization in the growing peptide chain without N
O
impairing the reaction rate or the overall yield of the coupling
process. N
+
N
A. El-Faham and F.Albericio, J. Org. Chem., 73, 2731 (2008). PF6- O
A.El-Faham, et al., Poster P10103-039 presented at the 30th EPS,
Helsinki, 2008).

Protein Ligation Synthesis Reagents

Ac-S-Mpa-OPfp ASX-5049-PI 1g 39
Acetyl-S-β-mercaptopropionic acid pentafluorophenyl ester 4 °C 5g 159
(M.W. 314.23) C11H7O3SF5
PEPTIDES INTERNATIONAL

S-Acm-β-Mercaptopropionic Acid K?CM-1015-PI SAM-5510-PI 1g 30

S-acetamidomethyl-β-mercaptopropionic acid 4 °C 5g 125
(M.W. 177.22) C6H11NO3S [52574-08-0]

Maleimidopropionic Acid MPA-5011-PI 1g 110

(M.W. 169.14) C7H7NO4 [7423-55-4] 4 °C 5g 475
S-p-Me-Bzl-β-Mercaptopropionic Acid AXP-5030-PI 5g 30
S-p-methylbenzyl-β-mercaptopropionic acid 4 °C 25 g 120
(M.W. 210.29) C11H14O2S [78981-22-3]

S-trityl-β-Mercaptopropionic Acid ASX-5047-PI 1g 49

(M.W. 348.47) C22H20O2S [27144-18-9] 4 °C 5g 195
S-trityl-Mercaptoacetic Acid ASX-5048-PI 1g 49
(M.W. 334.44) C21H18O2S [68-11-1] 4 °C 5g 195
S-Acm-Pmp ASX-5045-PI 1g 125
S-acetamidomethyl-β-mercapto-β, 4 °C 5g 495
β-Cyclopentamethylenepropionic acid
(M.W. 245.34) C11H19NO3S

S-p-Me-Bzl-Pmp ASX-5042-PI 1g 65
β-(S-4-methylbenzylmercapto)-β, 4 °C 5g 260
β-Cyclopentamethylenepropionic acid
(M.W. 278.40) C16H22SO2

292 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

TOOLS for PEPTIDE SYNTHESIS

PyClocK ®

HCTU and TCTU, based on Cl-HOBt, are good alternatives to HBTU/TBTU. The
presence of the Cl atom results in a better leaving group since it is more acidic than
HOBt (pKa: 3.35 for Cl-HOBt and 4.60 for HOBt); therefore the active esters are more
reactive than OBt esters. 1 PI proudly introduces a new coupling reagent, PyClocK,
the phosphonium salt of Cl-HOBt. PyClocK® has been reported to be faster than
PyBOP® in activating hindered amino acids such as Fmoc-Aib-OH; and in some cases
its reactivity was close to the most active reagent, PyAOP ®.
PyClocK® can not react with the free amine function and therefore does not terminate
the growing peptide as the aminium salts do, through the formation of guanidine
derivatives. Thus, PyClocK is especially useful for slow coupling reactions and could
be used in excess to assure complete activation of the carboxylic function.
1. O. Marder. F. Albericio, Chimica Oggi, 21, 6 (2003).
PyClocK® is a proprietary product of Luxembourg Industries Ltd.
PyBOP® is a registered trademaek of Merck Biosciences AG.
PyAOP® is a registered trademaek of Applied BioSystems.

Synthesis on Hindered Derivatives of Leu-Enkephalinalinamide

PyClocK® PyBOP® PyAOP®
H-Tyr-Aib-Aib-Phe-Leu-NH2 97.24 85.11 99.47
Impurity: H-Tyr-Aib-Phe-Leu-
2.76 14.89 0.53
NH2

PEPTIDES INTERNATIONAL
Stability: PyBOP® > PyClocK® > PyAOP®
Reactivity: PyAOP® > PyClocK® > PyBOP®

PyClocK® KPC-1016-PI 5g 30
6-Chloro-benzotriazole-1-yl-oxy-tris-pyrrolidino-phosphonium 4 °C 95
25 g
hexafluorophosphate
(M.W. 554.85) C18H27N6OF6ClP2
Coupling Reagent for Peptide Synthesis

N
N
N N
Cl +
O P N
-
PF6 N

PyClocK KPC-1016-PI

Order Hotline 1-800-777-4779 502-266-8787 293

 PRODUCT Code Qty PRICE
dPEG ®
TOOLS for PEPTIDE SYNTHESIS

dPEG® Biotinylation Reagents

• Very water soluble, hydrophilic and eliminates non-specific binding.
• Non-antigenic and non-immunogenic spacer arm
• The dPEG® pegylation spacer and its properties eliminates aggregation and precipitation when
labeling antibodies and other biological materials, and will also significantly increase S/N in
analytical applications as well.

Reference:
Greg T. Hermanson, Bioconjugate Techniques, 2nd Ed, Academic Press, Inc., San Diego, CA, (2008).

Protocol:
See Hermanson pg. 728 for a typical protocol for a antibody or protein biotinylation
using an in situ activated form of DPG-5706-PI. Generally customers use this when
they have their favorite way of activating the acid, as opposed to using our dPEG ®12
pegylation spacer containing biotin reagent. The reagent can be pre-dissolved in
an organic solvent or can be directly dissolved in your reaction medium based on its
inherent water solubility.
NHS-dPEG®4 Biotin DPG-5701-PI 50 mg 100
Chain length from amide to terminal carbonyl is 19.2 -20 °C 1g 750
Angstroms and 16 atoms spacer
Ideal spacer length for binding streptavidin conjugates
(M.W. 588.67)
Amine reactive biotinylation reagent with a dPEG® pegylation
spacer arm; activate in situ
PEPTIDES INTERNATIONAL

• The dPEG® pegylation spacer and its properties eliminate

aggregation and precipitation when labeling antibodies
and other biological materials, and will also signific antly
increase S/N in analytical applications as well.
O
O H O
O
N
O O N
HN N O O O
H O
S

10200
NHS-dPEG®12 Biotin DPG-5703-PI 50 mg 150
47.6 Angstrom and 40 atoms spacer -20 °C 1g 1250
(M.W. 941.09)
Amine reactive biotinylation reagent with a dPEG® pegylation
spacer arm; activate in situ
O
O H O
O
N
O O O O O O N
HN N O O O O O O O
H
S O

10198

294 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

TOOLS for PEPTIDE SYNTHESIS

NHS-dPEG Biotinidase-Resistant Biotin
®
4
DPG-5702-PI 100 mg 150
Amine reactive biotinylation pegylation reagent with a dPEG ®4 -20 °C 1g 1200
spacer
(M.W. 673.78)
Amine Reactive Biotinylation Reagent
D. Scott Wilbur, et al., Bioconjugate Chemistry, 17(6), 1514-1522
(2006). O H
N O O
H
N O O O
HN N O O N
H
S O O
O

• Amine reactive biotinylation pegylation reagent with a dPEG ® spacer, the perfect length for most
applications. 10202
• Biotindase resistant - vital especially for in vivo work or clinical analysis.
• This reagent gives the spacer length with the pegylation arm for optimal biotin binding with
streptavidin conjugates; chain length from amide to terminal carbonyl is 19.2 Angstroms.
• Designed to be the same length as the LC-LC spacer , which is ideal for the streptavidin binding
pocket.
• Eliminates non-specific binding issues, things like aggregation and precipitation when labeling
antibodies and other biological materials (a problem with conventional biotinylation reagents).
Fmoc-Amido-(dPEG®4 Biotin) Acid DPG-5704-PI 50 mg 150
Spacer properties: 18.1 Angstrom and 17 atoms spacer -20 °C 100 mg 250
(M.W. 827.98)
O
S 1g 1250
N HN NH
O H
O O O
O O

PEPTIDES INTERNATIONAL
O
N O
H
N
10602
OH
O

Biotinylation reagent in peptide synthesis, with built-in pegylation spacer arm for optimal Streptavidin
binding
• An N-Fmoc protected hydrophilic, non-immunogenic biotinylation pegylation reagent for peptide syn-
thesis.
• Useful for incorporating the powerful dPEG®4-biotin directly into the peptide synthesis, without having
to label a side chain or label the N-terminus.
• Incorporation of the dPEG®4 spacer with the biotin will increase water solubility and reduce or eliminate
aggregation, while having the length in the spacer to optimize the interaction with the avidin conjugate
of your choice.

Order Hotline 1-800-777-4779 502-266-8787 295

 PRODUCT Code Qty PRICE
dPEG® Biotin Acid
TOOLS for PEPTIDE SYNTHESIS

• Imparted physical properties are the biotin same as the dPEG ®X NHS esters (DPG-5701-PI,
DPG-5703-PI); the labeled compound becomes very hydrophilic because of the dPEG ® pegylation
spacer, making the biotin very available for streptavidin binding in the capture/binding step.
• The DPG-5705-PI pegylation spacer is the same length as DPG-5701-PI and DPG-5703-PI,
respectively, and its length is optimal for rapid and tight avidin/SA binding properties.
• Very water soluble, hydrophilic and eliminates non-specific binding.
• DPG-5703-PI has a longer 47.6 Angstrom spacer: the longer pegylation arm gives ready accessibility
to the biotin by the streptavidin/avidin conjugate binding; also where the amine of the biotinylation site
may be buried, the longer arm is ideal for giving accessibility to the binding conjugates.
• Non-antigenic and non-immunogenic spacer arm.
• The dPEG® pegylation spacer and its properties eliminates aggregation and precipitation when
labeling antibodies and other biological materials, and will also significantly increase S/N in analytical
applications as well.
dPEG®4 Biotin Acid DPG-5705-PI 100 mg 100
Chain length from amide to terminal carbonyl is 19.2 -20 °C 1g 600
Angstroms and 16 atoms spacer
O
(M.W. 491.60) H
N O O
O O
HN N O O
H
OH
S

dPEG®12 Biotin Acid DPG-5706-PI

10199
100 mg 150
47.6 Angstrom and 40 atoms spacer -20 °C 1g 975
(M.W. 844.02)
Amine Reactive Biotinylation Reagent; Activate in situ
O O O
PEPTIDES INTERNATIONAL

NH
O O O O O O
NH N O O O O O O OH
H
S

NHS-Biotin
10197 DPG-5707-PI 100 mg 50
(M.W. 341.38) -20 °C 1g 150
Amine Reactive Label with Aliphatic Spacer
O
Greg T. Hermanson, Bioconjugate Techniques, 2nd Ed, Academic NH

Press, Inc., San Diego, CA, (2008). HN

O
O

S
O N
• Efficient label for certain peptides and nucleic acids.
• Permeates cell membranes.. O

10205

296 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

TOOLS for PEPTIDE SYNTHESIS

Carbonyl / Carboxyl Reactive Reagents
• A carboxy protected dPEG ®x amino acid pegylation reagent
• dPEG® pegylation spacer and modifier with a reactive amine and a t-butyl protected carboxylic acid.
• dPEG® pegylation spacer is extremely hydrophilic, will enhance the water solubility of a compound in
which it is incorporated and reduce non-specific binding where applicable. The spacer is also non-
immunogenic. The ester is both water soluble, as well as in common used organic solvents of moder-
ate prolarity.
• t-Butyl group:
– Is easily removed with TFA (25% TFA in CH2Cl2, ice bath/0° C, takes about 5 h).
– Provides a potentially powerful purification handle due to its hydrophobicity . Subsequently it is
removed to perform additional chemistry. This applies best when using normal phase ( e.g., silica gel)
chromatography.
– Neutralizes the zwitterion of the amino acid for better reactivity at the amine.
– Reacts with carboxylic acids and other carbonyls.
Amino-dPEG®2 t-Butyl Ester DPG-5709-PI 100 mg 100
10.9 Angstroms and 10 atoms spacer (nitrogen to carbonyl -20 °C 1g 200
carbon)
(M.W. 233.30) O
5g 600
Carboxy-Protected dPEG®2 Amino Acid O
H2N O O

Amino-dPEG®4 t-Butyl Ester DPG-5711-PI 100 mg 135

10264
18.0 Angstroms and 16 atoms spacer (nitrogen to carbonyl -20 °C 1g 400
carbon)
(M.W. 321.41) O

Carboxy-Protected dPEG®4 Amino Acid H2N

O
O
O
O O

Amino-dPEG®4 Methyl Ester Kit DPG-5712-PI 100 mg 150

PEPTIDES INTERNATIONAL
18.0 Angstroms and 16 atoms spacer (nitrogen to carbonyl -20 °C 1g 800
carbon) 10221
O
(M.W. 279.33) H2N
O
O
O
O OCH3
Carboxy-Protected dPEG®4 Amino Acid
Methyl protected dPEG amino acid:
®
10330
dPEG® pegylation spacer and modifiercontaining a reactive amine
Note: The amino-dPEG® methyl esters are not stable upon prolonged storage. There are kits developed
in order to make these valuable pegylation compounds available in a pure form in situ.
Each kit contains three component parts:
a) 1 eq. of amino-dPEG ® acid;
b) 1.5 eq. of p-toluene sulfonic acid;
c) sufficient dry methanol for the package size.
• Methyl group is removed with mild base once the amine is reacted.
• dPEG® pegylation spacer is hydrophilic, highly water soluble and non-immunogenic. The ester is
water soluble, as well as being soluble in a variety of organic solvents especially methylene chloride.
• Contrasting the t-butyl group, the methyl group can be easily removed with base, either KOH or with
a carbonate base, e.g., potassium carbonate in aqueous methanol. This can be done in an aqueous
or combination aqueous organic solvent system. The specific conditions are going to be dictated by
the stability of the system into which the methyl ester is being introduced.
• Methyl group can also, like the t-Butyl group provide a potential purification handle due to its hydropho-
bicity. Subsequently it is removed to perform additional chemistry. This applies best when using
normal phase (e.g., silica gel) chromatography. The methyl group neutralizes the zwitterion of the
amino acid for better reactivity at the amine.

Order Hotline 1-800-777-4779 502-266-8787 297

 PRODUCT Code Qty PRICE
Amino-dPEG Acids ®
TOOLS for PEPTIDE SYNTHESIS

• Soluble and non-immunogenic.

• Zwitterionic, extremely water soluble, and soluble in methylene chloride.
• Unprotected amino acid for those who prefer the potential simplicity of not having to remove one more
protecting group. Pegylation reagent reacts selectively as the amine with NHS and other active esters
in the presence of a 3º amine, e.g., TEA.
• The dPEG® amino acids can also be used in situ to make the methyl ester, which is generally not stable
for extended periods of storage (see DPG-5712-PI for kit and protocol).
• Spacer will minimize or eliminate aggregation problems with its incorporation into peptides and related
compounds.
Application:
Surface and particle modification with terminal carboxyl functionality.
• GREAT for coating beads in order to reduce non-specific binding problems.
• Reacts like common amino acids. The amine can be reacted selectively in the presence of an appropri-
ate base with an activated ester.
• Can be reacted in solvents as non-polar as methylene chloride.

Amino-dPEG®4 Acid DPG-5710-PI 100 mg 100

18.0 Angstrom and 16 atoms spacer -20 °C O 1g 500
(M.W. 265.30) O O
H2N O O OH
Unprotected amino acid

Amino-dPEG®8 Acid DPG-5713-PI 100 mg 175

32.2 Angstroms and 28 atoms spacer (nitrogen to carbonyl -20 °C 1g 500
carbon) H2N O O O O OH
(M.W. 441.51) O O 10244 O O

Unprotected dPEG 8 Amino Acid

® O
PEPTIDES INTERNATIONAL

Amino-dPEG®12 Acid DPG-5715-PI 100 mg 195

46.5 Angstroms and 40 atoms spacer 10277
-20 °C 1g 800
(M.W. 617.72) HO O

Unprotected dPEG®12 Amino Acid

H2N O O O O O O
O O O O O O

Amino-dPEG®24 Acid DPG-5717-PI

10287
100 mg 250
89 Angstroms and 76 atoms spacer -20 °C 1g 950
(M.W. 1146.35)
Unprotected amino acid
H2N O O O O O O O O O O O O OH
O O O O O O O O O O O O
O

Fmoc-Amidooxy dPEG®12 Acid DPG-5795-PI 100 mg 175

47.6 Angstroms and 41 atoms spacer -20 °C 1g 850
(M.W. 1855.96) 10317
Unprotected amino acid

298 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

TOOLS for PEPTIDE SYNTHESIS

Amino-dPEG t-Butyl Esters
®

• A carboxy protected dPEG ®x amino acid pegylation reagent.

• dPEG® pegylation spacer and modifier with a reactive amine and a t-butyl protected carboxylic acid.
• dPEG® pegylation spacer is extremely hydrophilic, will enhance the water solubility of a compound
in which it is incorporated and reduce non-specific binding where applicable. The spacer is also non-
immunogenic. The ester is both water soluble, as well as in common used organic solvents of moder-
ate prolarity.
• t-Butyl group:
– Is easily removed with TFA (25% TFA in CH2Cl2, ice bath/0° C, takes about 5 h).
– Provides a potentially powerful purification handle due to its hydrophobicity . Subsequently it is
removed to perform additional chemistry . This applies best when using normal phase ( e.g., silica
gel) chromatography .
– Neutralizes the zwitterion of the amino acid for better reactivity at the amine.
– Reacts with carboxylic acids and other carbonyls.
Amino-dPEG®8 t-Butyl Ester DPG-5714-PI 100 mg 175
32.2 Angstroms and 28 atoms spacer (nitrogen to carbonyl -20 °C 1g 600
carbon)
(M.W. 497.62)
Carboxy-Protected dPEG®8 Amino Acid
H2N O O O O O
O O O O
O

Amino-dPEG ®
12 t-Butyl Ester DPG-5716-PI
10271
100 mg 225
46.5 Angstroms and 40 atoms spacer (nitrogen to carbonyl -20 °C 1g 700
carbon)
(M.W. 673.83)

PEPTIDES INTERNATIONAL
Carboxy-Protected dPEG®12 Amino Acid
H2N O O O O O O O
O O O O O O
O

Amino-dPEG®24 t-Butyl Ester DPG-5718-PI

10281 100 mg 250
89 Angstroms and 76 atoms spacer (nitrogen to carbonyl -20 °C 1g 1000
carbon)
(M.W. 1202.46)
A carboxy protected dPEG®x amino acid pegylation reagent, dPEG® pegylation spacer and modifier with a
reactive amine and a t-butyl protected carboxylic acid
H2N O O O O O O O O O O O O O
O O O O O O O O O O O O
O

10311

Order Hotline 1-800-777-4779 502-266-8787 299

 PRODUCT Code Qty PRICE
Methoxy Terminated Amine Reactive Reagents
TOOLS for PEPTIDE SYNTHESIS

• Makes discrete MW pegylation modification possible with our unique range of m-dPEG ® pegylation
NHS esters.
• m-dPEG® pegylation produces compounds with increased water solubility and reduced aggregation,
also reduces immunogenicity and potentially even toxicity .
• Can be used in conjunction with amino protected amino dPEG ® acids for the pegylation of surfaces for
produce hydrophilic and reactive surfaces with no non-specific binding issues.
• Allows for low MW discrete pegylation of small molecule drugs and other related compounds for
increased water solubility and reduced aggregation, or of surfaces to reduce non-specific binding; may
even be useful for “dusting” enzymes and other proteins to increase chemical stability .
• Amine reactive.
• Produces stable amide bond.
m-dPEGTM 2-NHS Ester(MW = 245) DPG-5719-PI 100 mg 100
Methoxy-dPEGTM-N-hydroxysuccinimide (MW=245) -20 °C 1g 265
8.5 Angstroms and 8 atoms spacer O
(M.W. 245.23) O O
CH3O N
Can be used in conjunction with amino protected amino O
dPEG® acids for the pegylation of surfaces for produce O

hydrophilic and reactive surfaces with no non-specific binding

issues 10327

m-dPEG -NHS Ester (MW = 333)

®
4
DPG-5720-PI 100 mg 100
Methoxy-dPEGTM-N-hydroxysuccinimide (MW=333) -20 °C 1g 330
15.6 Angstroms and 14 atoms spacer O
O O O
(M.W. 333.33) H CO 3
O N
O
O
PEPTIDES INTERNATIONAL

10211

m-dPEG -NHS Ester(MW = 509)

®
8
DPG-5723-PI 100 mg 175
Methoxy-dPEGTM-N-hydroxysuccinimide (MW=509) 500
-20 °C 1g
29.8 Angstroms and 26 atoms spacer O
(M.W. 509.54) CH3O
O
O
O
O
O
O
O O
N
Amine Reactive O
O
Makes discrete MW pegylation modification possible with a
unique range of m-dPEG® pegylation NHS esters
10260

m-dPEG®12-NHS Ester (MW = 685) DPG-5725-PI 100 mg 175

Methoxy-dPEGTM-N-hydroxysuccinimide (MW=685) -20 °C 1g 600
44.0 Angstroms and 38 atoms spacer
(M.W. 685.75)
Amine Reactive O
O
CH3O O O O O O N
O O O O O O O
O

10262

300 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

TOOLS for PEPTIDE SYNTHESIS

m-dPEG®24-NHS Ester (MW = 1214) DPG-5727-PI 100 mg 225
Methoxy-dPEGTM-N-hydroxysuccinimide (MW=1214) -20 °C 1g 850
86.2 Angstroms and 74 atoms spacer
(M.W. 1214.39)
Amine Reactive
Makes discrete MW pegylation modification possible with a unique range of m-dPEG® pegylation NHS esters
O
O
O O O O O O O O O O O O N
CH3O O O O O O O O O O O O O O
O

m-dPEGTM -Acids
• Acid form of the corresponding m-dPEG® NHS esters
• Can activate the acid in situ using standard activation methods, e.g., with EDC and NHS in methylene
10304
chloride
• Pegylation spacer is water soluble, non-immunogenic and non-toxic, so can be used to modulate the
properties of the m-dPEG ® pegylation modified compounds.
m-dPEGTM4 -Acid (MW = 236) DPG-5721-PI 100 mg 100
Methoxy-dPEGTM (MW=236) -20 °C 1g 265
15.6 Angstroms and 14 atoms spacer
(M.W. 236.26) O O OH
5g 530
H3CO O
Acid form of NHS Ester, DPG-5720-PI O

m-dPEG -Acid (MW = 148)

®
2 10234
DPG-5722-PI 100 mg 100
8.5 Angstroms and 8 atoms spacer 4 °C 1g 230
(M.W. 148.16)
Acid form of NHS Ester, DPG-5719-PI 5g 460
O

PEPTIDES INTERNATIONAL
CH3O
O OH

m-dPEG®8-Acid (MW = 412) DPG-5724-PI 100 mg 175

29.8 Angstroms and 26 atoms spacer -20 °C 10326
1g 400
(M.W. 412.47)
Acid form of NHS Ester, DPG-5723-PI
O O O O OH
CH3O O O O
O

m-dPEG®24 acid (MW = 1117)

10324
DPG-5728-PI 100 mg 225
Methoxy-dPEGTM-N-hydroxysuccinimide (MW=1117) -20 °C 1g 800
86.2 Angstroms and 74 atoms spacer
(M.W. 1117.31)
Acid form of NHS Ester, DPG-5727-PI

Order Hotline 1-800-777-4779 502-266-8787 301

 PRODUCT Code Qty PRICE
Carboxyl-dPEG -(m-dPEG ) Ester ® ® DPG-5730-PI 100 mg 250
TOOLS for PEPTIDE SYNTHESIS

4 12 3
(M.W. 2323.73) -20 °C 1g 1300
Amine reactive pegylation reagent with a tribranched dPEG®4
branch; activate carboxylic acid in situ H
CH3O O O O O O N O
O O O O O O

O O
O O O O O O O
CH3O O O O
O O O O N O O O
H N O O N OH
H H
O
H
CH3O O O O O O N
O O O O O O
O

• Single compound; made synthetically from 99.5% pure tetraethylene glycol.

• Imparts significant and surprising water solubility, and the modifier itself is non-immunogenic and
non-toxic. 10402

• Potentially very useful as a drug modifier with high hydrodynamic volume.

• Produces compounds with reduced aggregation, or surfaces with reduced non-specific binding.
• Produces stable amide bond.
• Activate in situ with EDC/NHS.
TFP-dPEG®4-(m-dPEG®11)3-Ester DPG-5794-PI 100 mg 250
(M.W. 2420.80) -20 °C 1g 1300
Reference:
Greg T. Hermanson, Bioconjugate Techniques, 2nd Ed, Elsevier Inc., Burlington, MA 01803, April, 2008 (ISBN-13: 978-0-
12-370501-3; ISBN-10: 0-12-370501-0)., Ch. 18, pp. 711-742.

• Increase water solubility…potential to increase hydrodynamic volume

• Amine reactive, activated ester, a dPEG® based tribranched pegylation reagent
• Each is a single compound made synthetically from 99.5% pure tetraethylene glycol
PEPTIDES INTERNATIONAL

• Imparts incredible water solubility, and the pegylation reagent itself is non-immunogenic and non-toxic,
passing these properties to the modified agent
• Potentially very useful as a drug/protein modifier to specifically increase hydrodynamic volume
• Produces compounds with reduced aggregation, or surfaces with reduced non-specific bindings in
diagnostic applications
• Produces very stable amide bonds
Note: This product can be used a a replacement for NHS-dPEG4-(m-dPEG12)3-ester (DPG-5729-PI),
which has been discontinued

302 Order Hotline 1-800-777-4779 502-266-8787

 PRODUCT Code Qty PRICE

TOOLS for PEPTIDE SYNTHESIS

Methoxy Terminated Carbonyl / Carboxyl Reactive Reagents
• Carbonyl/carboxyl reactive dPEG®; this unique pegylation reagent reacts with
acids, active esters and aldehydes.
• Each is a single compound; made from 99.5% pure tetraethylene glycol.
• In modification reactions: Pegylation arm imparts significant and surprising water
solubility, and the modifier itself is non-immunogenic and non-toxic, so can
decrease these properties in the modified application.
• For surface applications: m-dPEG ® amine pegylation reagent will react on surfaces
to significantly reduce or eliminate non-specific interactions and create a monolayer
surface structure. Can be used in conjunction with the amino dPEG ® acids or
amino dPEG® esters to protect the surface as well as to impart functionality back to
a carboxylated surface.
Reference:
Greg T. Hermanson, Bioconjugate Techniques, 2nd Ed, Elsevier Inc., Burlington, MA 01803, April, 2008 (ISBN-13: 978-
0-12-370501-3; ISBN-10: 0-12-370501-0). Specifically, see pp. 726-729, Chapter 18, on discrete PEG compounds for
pegylation applications.

m-dPEG®4 Amine DPG-5731-PI 100 mg 250

15.5 Angstroms and 14 atoms spacer -20 °C 1g 650
(M.W. 207.27)
Carbonyl/carboxyl reactive dPEG®; this unique pegylation CH3O
O
O
O
NH2
reagent reacts with acids, active esters and aldehydes.

m-dPEG®8 Amine DPG-5732-PI 100 mg 175

29.7 Angstroms and 26 atoms spacer -20 °C 1g 450
10175
(M.W. 383.48)

PEPTIDES INTERNATIONAL
Carbonyl/carboxyl reactive dPEG®; this unique pegylation reagent reacts with acids, active esters and
aldehydes.
CH3O O O O NH2
O O O O

m-dPEG®12 Amine 10278 DPG-5733-PI 100 mg 200

43.9 Angstroms and 38 atoms spacer -20 °C 1g 600
(M.W. 559.69)
Carbonyl/carboxyl reactive dPEG®; this unique pegylation
reagent reacts with acids, active esters and aldehydes.
CH3O O O O O O NH2
O O O O O O

m-dPEG®24 Amine10288 DPG-5734-PI 100 mg 250

86.1 Angstroms and 74 atoms spacer -20 °C 1g 900
(M.W. 1088.32)
Carbonyl/carboxyl reactive dPEG®; this unique pegylation
reagent reacts with acids, active esters and aldehydes
CH3O O O O O O O O O O O O NH2
O O O O O O O O O O O O

10318

Order Hotline 1-800-777-4779 502-266-8787 303

 PRODUCT Code Qty PRICE
Surface Reactive and Thiophilic Reagents
TOOLS for PEPTIDE SYNTHESIS

• Thiol is reactive with metal surfaces, other thiols, disulfides, maleimides, vinyl sulfones,and haloacet-
amides and incorporates the pegylation spacer into all of these various functionality .
• dPEG® pegylation spacer is hydrophilic, highly water soluble, and non-immunogenic.

Thiol-dPEG®4 Acid5787 DPG-5735-PI 100 mg 200

18.3 Angstroms and 16 atoms spacer -20 °C 1g 450
(M.W. 282.35)
Bifunctional thiol acids with dPEG® pegylation spacer
HS O O OH
O O
O
10247
Thiol-dPEG®8 Acid DPG-5737-PI 100 mg 250
32.5 Angstroms and 28 atoms spacer -20 °C 1g 700
(M.W. 458.57)
Bifunctional thiol acids with dPEG® pegylation spacer O
• Incorporates O O O O
HS O O O O OH
the dPEG®
carboxylic acid.
• Once functionalized, the carboxylic acid moiety can be
activated for further reaction, e.g. with EDC/NHS.
10183
• Potentially activatable carboxylic acid moiety.

Hydroxy-dPEG®8 t-Butyl Ester DPG-5796-PI 100 mg 150

32.1 Angstroms and 29 atoms spacer -20 °C 1g 275
(M.W. 498.60)
Surface Modification Reagent with Free Alcohol
PEPTIDES INTERNATIONAL

304 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

TOOLS for PEPTIDE SYNTHESIS

Heterobifunctional dPEG Crosslinkers ®

Our dPEG® pegylation version of the popular SATA reagent, providing a method for converting the amino
group to a thiol with the incorporation of the pegylation unit
• Adds the properties of dPEG ®, including added pegylation spacer distance, a spacer that is highly
hydrophilic, non-antigenic, non-immunogenic and non-toxic
• Greater accessibility of reaction/modification site, i.e., spacer distance makes the amine, now thiol,
much more accessible, e.g., a maleimide, vinyl sulfone or a α-haloketo functionalize reaction partner.
MAL-dPEG®4-Acid DPG-5763-PI 100 mg 100
Mol. Wt.: 416.42; single compound -20 °C 1g 125
17.5 Angstromsand 16 atomsspacer
Pegylation Crosslinker Reagent with Amine and Sulfhydryl /
Thiol Reactivity
• Activate the carboxyl in situ with EDC/NHS or other acti-
vation chemistry of the carboxylic acid
O O O
O O
N N O O OH
H
O

S-Acetyl-dPEG®4 Acid (dPEG®4 SATA Acid) DPG-5741-PI 100 mg 215

18.3 Angstroms and 16 atoms10338
spacer -20 °C 1g 1175
(M.W. 324.39) O O
O O
S O O OH

S-Acetyl-dPEG®8 Acid (dPEG®8 SATA Acid) DPG-5742-PI 100 mg 215

PEPTIDES INTERNATIONAL
32.5 Angstroms and 28 atoms spacer
10180
-20 °C 1g 1175
(M.W. 500.60)
• This acid form needs to be activated in sita to some form
of active ester.O O
O O O O
S O O O O OH

S-Acetyl-dPEG®4 NHS Ester (dPEG®4 SATA) DPG-5740-PI 100 mg 235

18.3 Angstroms and 16 atoms spacer
10182
-20 °C 1g 1250
(M.W. 421.46)
O
O O
O O N
S O O O
O

S-Acetyl-dPEG®8 NHS Ester (dPEGTM8 SATA) DPG-5743-PI 100 mg 350

10181
32.5 Angstroms and 28 atoms spacer -20 °C 1g 1250
(M.W. 597.67) O
O O
O O O O N
S O O O O O
O

10184

Order Hotline 1-800-777-4779 502-266-8787 305

 PRODUCT Code Qty PRICE
Mono-N-t-Boc-Amido-dPEG®
TOOLS for PEPTIDE SYNTHESIS

• Convenient mono-protected dPEG diamine for pegylation -- selectively react just one end, then
subsequently deprotect with TFA to make other amine available for reaction
• Hydrophilic, non-immunogenic dPEG® pegylyation spacer
• Water soluble with pegylation spacer
Mono-N-t-Boc-Amido-dPEG®3 Amine DPG-5744-PI 1g 200
15 Angstroms and 16.9 atoms spacer O -20 °C
(M.W. 320.43) O
O N O O NH2
H

Mono-N-t-Boc-Amido-dPEG®11 Amine DPG-5745-PI 100 mg 235

42.8 Angstroms and 37 atoms spacer 10225
-20 °C 1g 1050
(M.W. 644.79)
H
O N O O O O O NH2
O O O O O O
O

Mono-N-Cbz-Amido-dPEG®3 Amine DPG-5747-PI 1g 375

16.9 Angstroms and 15 atoms spacer -20 °C
O
(M.W. 354.44) 10172
O
Introduces a 15 atom and 16.9 O N
H
O O NH2
Angstrom
hydrophilic, non-immunogenic
dPEG® pegylation spacer
10269

dPEG® Peptide Synthesis Reagents with Spacers

Fmoc-Based Solid Phase Synthesis
PEPTIDES INTERNATIONAL

Fmoc-Amido-dPEG®2 Acid DPG-5748-PI 1g 150

10.9 Angstroms and 10 atoms spacer -20 °C 5g 400
(M.W. 399.44)
H
Peptide pegylation reagent, Fmoc protected dPEG® O N
O
O OH

amino acids O O

10243
Fmoc-Amido-dPEG®4 Acid DPG-5749-PI 100 mg 100
18.1 Angstroms and 17 atoms spacer -20 °C 500 g 250
(M.W. 487.54)
1g 650
H
O N O O OH
O O
O O

Fmoc-Amido-dPEG®6 Acid DPG-5750-PI 100 mg 125

25.1 Angstroms and 22 atoms spacer
(M.W. 575.65)
-20 °C 500 g 350
10213
N-Fmoc protected hydrophilic, 1g 950
non-immunogenic spacer

H
O N O O O OH
O O O
O O

10063

306 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

TOOLS for PEPTIDE SYNTHESIS

Fmoc-Amido-dPEG®8 Acid DPG-5751-PI 100 mg 150
32.2 Angstroms and 28 atoms spacer -20 °C 1g 425
(M.W. 663.75)
N-Fmoc protected 5g 1050
hydrophilic, H
non-immunogenic O N
O
O
O
O
O
O
O
O OH

spacer O O

Fmoc-Amido-dPEG®12 Acid DPG-5752-PI 10273 100 mg 150

46.5 Angstroms and 40 atoms spacer -20 °C 1g 600
(M.W. 839.96)
N-Fmoc protected hydrophilic, non-immunogenic spacer

H
O N O O O O O O OH
O O O O O O
O O

Fmoc-Amido-dPEG®24 Acid DPG-5753-PI 100 mg

10283 250
89 Angstroms and 76 atoms spacer -20 °C 1g 850
(M.W. 1368.59)
N-Fmoc protected hydrophilic, non-immunogenic spacer
Peptide pegylation reagent, Fmoc protected dPEG® amino acids, Useful for incorporating all of the properties
of a dPEG®, either as a spacer in or terminating group of the peptide sequence
H O O O O O
O O O O O OH
O N O O O O O O O
O O O O O O O
O
O

Cbz-Based Solid Phase Synthesis

PEPTIDES INTERNATIONAL
Cbz-Amido-dPEG®4 Acid DPG-5754-PI 100 mg 125
19.2 Angstroms
10313and 17 atoms spacer -20 °C 1g 200
(M.W. 399.44)
N-Cbz protected hydrophilic, non-immunogenic spacer
H
O N O O OH
O O
O O

Cbz-Amido-dPEG®6 Acid DPG-5755-PI 100 mg 150

25.1 Angstroms and 22 atoms spacer 10268 -20 °C 1g 300
(M.W. 487.54)
N-Cbz protected hydrophilic, non-immunogenic spacer O
O
O O O
O N O O O OH
H

Cbz-Amido-dPEG®8 Acid DPG-5756-PI 100 mg 150

32.2 Angstroms and 28 atoms spacer
10066 -20 °C 1g 600
(M.W. 575.65)
N-Cbz Protected Hydrophilic, Non-Immunogenic Spacer
H
O N O O O O OH
O O O O
O O

10276

Order Hotline 1-800-777-4779 502-266-8787 307

 PRODUCT Code Qty PRICE
Cbz-Amido-dPEG®12 Acid DPG-5757-PI 100 mg 150
TOOLS for PEPTIDE SYNTHESIS

46.5 Angstroms and 40 atoms spacer -20 °C 1g 650

(M.W. 751.86)
N-Cbz Protected Hydrophilic, Non-Immunogenic Spacer

H
O N O O O O O O OH
O O O O O O
O O

Cbz-Amido-dPEG®24 Acid DPG-5758-PI 100 mg 250

88.5 Angstroms and 76 atoms spacer -20 °C 1g 750
(M.W. 1280.49) 10286

N-CBZ protected dPEG® amino acid pegylation reagents for

peptide synthesis

H
O N O O O O OH
O O O O O O O O
O O O O O O O
O O O O O

O O

Merrifield Boc-Based Solid Phase Synthesis

t-Boc-Amido-dPEG®4 Acid DPG-5759-PI 100 mg 100
10316
19.2 Angstroms and 17 atoms spacer -20 °C 500 g 275
(M.W. 365.42)
N-t-Boc Protected Hydrophilic, Non-Immunogenic Spacer 1g 775
• N-t-boc protected dPEG® amino acid pegylation reagents for peptide synthesis.
H
O N O O OH
O O
O O
PEPTIDES INTERNATIONAL

Thiol Modifiers 10220

• Useful pegylation reagents for incorporating the sulfhydryl moiety into a peptide, that contains the
dPEG® pegylation unit.
• Potentially a significant alternative to cysteine for incorporating the sulfydryl into peptides.
• Bulk pricing available, please inquire.

Methoxytrityl-S-dPEG®4 Acid DPG-5761-PI 100 mg 150

18.3 Angstroms and 16 atoms spacer -20 °C 1g 550
(M.W. 554.70)
S O O OH
O O
O

10301
OCH3

Methoxytrityl-S-dPEG®8 Acid DPG-5762-PI 100 mg 200

32.5 Angstroms and 28 atoms spacer -20 °C 900
(M.W. 730.91) 1g
O

O O O O
O O O O OH
S

CH3O

10166

308 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

TOOLS for PEPTIDE SYNTHESIS

Laboratory Equipment
Tubing and Connectors
Teflon Tubing 1 ⁄8” (10 feet) STB-21018-PI 10 feet 25
The 1⁄8” diameter Teflon tubing is ideal for connecting a
semi-automated synthesis assembly. Use this tubing with
the available Teflon connectors (STC • 22900-PI) to connect
¼” glass tubing of a reaction vessel. Typically, solid phase
assemblies connect to valves, stopcocks, aspirators, pumps,
nitrogen tanks, and reagent bottles through a variety of
configurations. Purchase this tubing in ample lengths and let
your imagination and creativity be your guide.

Teflon Connectors STC-22902-PI 1 each 49

(for attaching ¼” glass tubing to ¼” Teflon tubing)
(Two required for each reaction vessel)

Specialty Glassware
Manual Reaction Vessel
This glass reaction vessel features an inert Teflon lined screw cap, a Teflon stopcock
and a coarse glass frit. The vessel can be matched to many 180° shakers, and its
large diameter opening allows easy access for the addition of reagents, resins, and
solvents.
5 mL Manual Reaction Vessel SHG-20205-PI 1 each 110
10 mL Manual Reaction Vessel SHG-20210-PI 1 each 110

PEPTIDES INTERNATIONAL
15 mL Manual Reaction Vessel SHG-20215-PI 1 each 110
30 mL Manual Reaction Vessel SHG-20230-PI 1 each 130
60 mL Manual Reaction Vessel SHG-20260-PI 1 each 150
90 mL Manual Reaction Vessel SHG-20290-PI 1 each 165

Manual Reaction Vessels with Baffles

For better mixing action with larger vessel sizes
200 mL Manual Reaction Vessel with Baffles SHG-20295-PI 1 each 225
300 mL Manual Reaction Vessel with Baffles SHG-20300-PI 1 each 245
400 mL Manual Reaction Vessel with Baffles SHG-20400-PI 1 each 260
600 mL Manual Reaction Vessel with Baffles SHG-20600-PI 1 each 295
Manual Reaction Vessels with Jacket
Same design as SHG-20215-PI listed above but comes with an external water jacket
and ribbed entry port. This vessel is perfect for solid phase reactions where precise
temperature control, above or below room temperature, is important.
15 mL Manual Reaction Vessel with Jacket SHG-22215-PI 1 each 195
30 mL Manual Reaction Vessel with Jacket SHG-22230-PI 1 each 195
60 mL Manual Reaction Vessel with Jacket SHG-22260-PI 1 each 235
90 mL Manual Reaction Vessel with Jacket SHG-22290-PI 1 each 210

Order Hotline 1-800-777-4779 502-266-8787 309

 PRODUCT Code Qty PRICE
Manual Reaction Vessels with 3-way Teflon Stopcock with Two ¼” Outlets
TOOLS for PEPTIDE SYNTHESIS

15 mL Manual Reaction Vessel with 3-way SHG-22315-PI 1 each 145

Teflon Stopcock
30 mL Manual Reaction Vessel with 3-way SHG-22330-PI 1 each 175
Teflon Stopcock
60 mL Manual Reaction Vessel with 3-way SHG-22360-PI 1 each 195
Teflon Stopcock
90 mL Manual Reaction Vessel with 3-way SHG-22390-PI 1 each 210
Teflon Stopcock
30 mL Manual Reaction Vessel with 24/40 SHG-22630-PI 1 each 155
Vacuum Adapter Joint
60 mL Manual Reaction Vessel with 24/40 SHG-22660-PI 1 each 190
Vacuum Adapter Joint
90 mL Manual Reaction Vessel with 24/40 SHG-22690-PI 1 each 205
Vacuum Adapter Joint
200 mL Manual Reaction Vessel with 24/40 SHG-22695-PI 1 each 240
Vacuum Adapter Joint
600 mL and Larger Septum (Teflon-coated SEP-22845-PI 1 each 4
Silicone Rubber)
PEPTIDES INTERNATIONAL

Other Manual Reaction Vessels

Reaction Vessel for PS-3 Synthesizer SHG-21003-PI 1 each 156

Replacement Screw Caps and Septa

To order the screw caps for Manual Reaction V essel & Manual Reaction Vessel with Jacket, please use
the codes given below:

Screw Cap for 5, 10, and 15 mL Manual CAP-22201-PI 1 each 4

Reaction Vessels
Screw Cap for 30 mL - 400 mL Manual CAP-22203-PI 1 each 6
Reaction Vessels
Screw Cap for 600 mL and Larger Manual CAP-22205-PI 1 each 8
Reaction Vessels
Screw Cap for PS-3 Reaction Vessel SHG-20003-PI 1 pack 1
(package of 3 each) of 3

Extra Septa (Teflon-coated Silicone Rubber)

Septum for the cap on 10 and 15 mL Manual SEP-22825-PI 1 each 2
Reaction Vessels
Septum for the cap on 30 mL - 400 mL SEP-22832-PI 1 each 2
Manual Reaction Vessels

310 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

TOOLS for PEPTIDE SYNTHESIS

Replacement Screw Cap (open) plus Septum for:
Open Screw Cap (10 and 15 mL) with Teflon- CAP-22225-PI 1 each 4
coated Septum
Open Screw Cap (30 mL and larger) with CAP-22232-PI 1 each 6
Teflon-coated Septum
Tubing and Connectors
Teflon Tubing 1 ⁄8” (10 feet) STB-21018-PI 10 feet 25
The 1⁄8” diameter Teflon tubing is ideal for connecting a
semi-automated synthesis assembly. Use this tubing with
the available Teflon connectors (STC • 22900-PI) to connect
¼” glass tubing of a reaction vessel. Typically, solid phase
assemblies connect to valves, stopcocks, aspirators, pumps,
nitrogen tanks, and reagent bottles through a variety of
configurations. Purchase this tubing in ample lengths and let
your imagination and creativity be your guide.

Teflon Connectors STC-22902-PI 1 each 49

(for attaching ¼” glass tubing to ¼” Teflon tubing)
(Two required for each reaction vessel)

General Laboratory Glassware

Evaporator Trap 200 mL (Splash Guard Adapter) SHG-20200-PI 1 each 75
This is an especially well-made, thick walled glass evapora -
tor trap (also known as a “splash-guard”).

PEPTIDES INTERNATIONAL
Its standard 24/40 joints and optimal size makes it a popular
choice for any laboratory.

HF Apparatus and Parts

Parts are still available for the HF appartatus by special order . Please inquire with
Peptides International Customer Service Representatives for more information..

Order Hotline 1-800-777-4779 502-266-8787 311

 Recombinant proteins

Cytokines and Growth Factors

Activin A CYT-569 2 µg 50
Recombinant Human Activin-A -20 °C 10 µg 130
Activin β-A chain, Erythroid differentiation Protein, EDF, FRP, 1 mg 3,900
Activin-A, Inhibin-B, Inihibin-β A chain
Activin-A Human Recombinant also called Inhibin-β A chain produced in E.Coli is a single monomeric,
non-glycosylated, polypeptide chain containing 116 amino acids fragment (311-426) and having an
amino-terminal hexa-histidine tag, having a total molecular weight of 17.47 kDa.

Activin A Plant-Active CYT-414 1 µg 50

Recombinant Human Activin-A Active -20 °C 5 µg 130
Inhba, Inhibin β A, FSH releasing Protein 100 µg 1,500
HHHHHHGLECDGKVNICCKKQFFVSFKDIGWNDWIIAPSGY HANYCEGECPS HIAGTSGSSLSFHSTVI
NHYRMRGHSPFANLKSCCVPTKLRPMSMLYYDDGQNIIKKDIQNMIVEECGCS
Active form Activin-A Human Recombinant produced in Plant is a homodimeric, glycosylated, polypeptide
chain containing 2 x 116 amino acids and having a molecular weight of 27.4kDa.
The Active form Activin-A is fused to a 6-His tag at N-terminus and purified by standard chromatographic
techniques.

Activin A HEK-Active CYT-078 1 µg 50

Recombinant Human Activin-A HEK-Active -20 °C 5 µg 130
Inhba, Inhibin β A, FSH releasing Protein 50 µg 1,100
The specific activity was determined by the dose-dependent inhibition of proliferation
of the MPC-11 cell line (mouse plasmocytoma cell line) and is typically 0.5-5ng/ml.
PEPTIDES INTERNATIONAL

Activin A Plant CYT-052 2 µg 50

Recombinant Human Activin-A, Plant -20 °C 10 µg 130
C600H911N173O174S13 1 mg 4,800
Activin A human Recombinant produced in Nicotiana benthamiana plant is a disulfide-linked homodimers
of two β A chains, each containing 116 amino residues and 6-His-tag at the N-terminal having the total
molecular mass of 27.4kDa.

Activin B Active CYT-057 2 µg 50

Recombinant Human Activin-B Active -20 °C 10 µg 130
Inhibin β B (activin AB β polypeptide), Inhibin, β-2, Activin β-B 1 mg 5,200
chain, MGC157939.
HHHHHHHHHHGLECDGRTNL CCRQQFFIDF RLIGWNDWII APTGYYGNYC EGSCPAYLAG
VPGSASSFHT AVVNQYRMRGLNPGTVNSCC IPTKLSTMSM LYFDDEYNIV KRDVPNMIVEECG
C615H910N178O177S12
Activin B human Recombinant produced in Nicotiana benthamiana plant is a β-B single chain (aa 293-
406) containing 123 amino acids. Activin B is fused to a 10-His-tag at the N-terminal having the total
molecular mass of 14kDa and purified by standard chromatographic techniques

Activin B CYT-058 2 µg 50
Recombinant Human Activin-B -20 °C 10 µg 130
Inhibin β B (activin AB β polypeptide), Inhibin, β-2, Activin β-B 1 mg 4,800
chain, MGC157939.
HHHHHHHHHHGLECDGRTNLCCRQQFFIDF RLIGWNDWII APTGYYGNYC EGSCPAYLAG
VPGSASSFHT AVVNQYRMRG LNPGTVNSCC IPTKLSTMSM LYFDDEYNIV KRDVPNMIVE ECG
C615H910N178O177S12
Activin B human Recombinant produced in Nicotiana benthamiana plant is a β-B single chain (aa 293-
406) containing 123 amino acids. Activin B is fused to a 10-His-tag at the N-terminal having the total
molecular mass of 14kDa and purified by standard chromatographic techniques.

312 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
Activin A, Active CYT-145 2 µg 50
Recombinant Human Activin-A, Active -20 °C 10 µg 130
Inhba, Inhibin β A, FSH releasing Protein 1 mg 5,200
MGLECDGKVN ICCKKQFFVS FKDIGWNDWI IAPSGYHANY CEGECPSHIA GT SGSSLSFH
STVINHYRMR GHSPFANLKS CCVPTKLRPM SMLYYDDGQN IIKK DIQNMI VEECGCS

mActivin A CYT-146 2 µg 50
Recombinant Mouse Activin-A -20 °C 10 µg 130
Inhba, Inhibin β A, FSH releasing Protein 1 mg 4,680
MGLECDGKVN ICCKKQFFVS FKDIGWNDWI IAPSGYHANYCEGECPSHIAGTSGSS
LSFH STVINHYRMR GHSPFANLKS CCVPTKLRPM SMLYYDDGQN IIKKDIQNMI VEECGCS
Active form Activin-A Murine Recombinant produced in E.Coli is a homodimeric, non-glycosylated,
polypeptide chain containing 2 x 117 amino acids and having a molecular weight of 26.2kDa.

rActivin A CYT-147 2 µg 50
Recombinant Rat Activin-A -20 °C 10 µg 130
Inhba, Inhibin β A, FSH releasing Protein 1 mg 4,680
MGLECDGKVN ICCKKQFFVS FKDIGWNDWI IAPSGYHANY CEGECPSHIA GTSGSSLSFH
STVINHYRMR GHSPFANLKS CCVPTKLRPM SMLYYDDGQN IIKKDIQNMI VEECGCS
Active form Activin-A Rat Recombinant produced in E.Coli is a homodimeric, non-glycosylated,
polypeptide chain containing 2 x 117 amino acids and having a molecular weight of 26.2kDa.

AIF1 CYT-697 2 µg 50
Recombinant Human Allograft Inflammatory Factor 1 -20 °C 10 µg 130
AIF-1, Allograft inflammatory factor 1, Em:AF129756.17, G1, 1 mg 4,680
IBA1, Ionized calcium-binding adapter molecule 1, IRT-1,
Protein G1, AIF1

PEPTIDES INTERNATIONAL
MKHHHHHHASQTRDLQGGKAF­GLLKAQQEERLDE­INKQFLDDPKYSSDED­LPSKLEGFKEKYMEF­
DLNGNGDIDIMSLKRMLEK­LGVPKTHLELKKLI­GEVSSGSGETFSYP­DFLRMMLGKRSAIL­
KMILMYEEKAREKEK­PTGPPAKKAISELP
The AIF1 Human Recombinant contains a total of 155 amino acids having a molecular Mass of 17.7kDa.
The Human AIF1 is fused to a 9 amino acid long N-terminal His tag.

AIF1L CYT-007 5 µg 50
Recombinant Human Allograft Inflammatory Factor 1 Like -20 °C 20 µg 130
Allograft Inflammatory Factor 1-like, IBA2, FLJ12783, Ionized 1 mg 2,700
calcium-binding adapter molecule 2, C9orf58, chromosome 9
open reading frame 58, MGC29466
MGSSHHHHHH SSGLVPRGSH MSGELSNRFQ GGKAFGLLKA RQERRLAEIN REFLCDQKYS
DEENLPEKLT AFKEKYMEFD LNNEGEIDLM SLKRMMEKLG VPKTHLEMKK MISEVTGGVS
DTISYRDFVN MMLGKRSAVL KLVMMFEGKA NESSPKPVGP PPERDIASLP
AIF1L produced in E.Coli is a single, non-glycosylated polypeptide chain containing 170 amino acids
(1-150a.a.) and having a molecular mass of 19.2kDa. AIF1L is fused to a 20 amino acid His-tag at
N-terminus.

AITRL CYT-076 5 µg 50
Recombinant Human AITRL -20 °C 20 µg 130
Osteostat, TNFSF18, Activation-induced TNFR member Ligand, 1 mg 2,700
GITRL,TL6, AITRL, Glucocorticoid-induced TNF-related ligand,
hGITRL, Tumor necrosis factor ligand superfamily member 18,
MGC138237
MQLETAKEPC MAKFGPLPSK WQMASSEPPC VNKVSDWKLE ILQNGLYLIY GQVAPNANYN
DVAPFEVRLY KNKDMIQTLT NKSKIQNVGG TYELHVGDTI DLIFNSEHQV LKNNTYWGII LLANPQFIS
AITRL Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing
129 amino acids (72-199) and having a molecular mass of 14.6 kDa.

Order Hotline 1-800-777-4779 502-266-8787 313

 Recombinant proteins

AITRL His CYT-317 5 µg 50

Recombinant Human AITRL, His Tag -20 °C 20 µg 130
Osteostat, TNFSF18, Activation-induced TNFR member Ligand, 1 mg 4,680
GITRL,TL6, AITRL, Glucocorticoid-induced TNF-related ligand, hGITRL,
Tumor necrosis factor ligand superfamily member 18, MGC138237
MRGSHHHHHH GMASTAKEPC MAKFGPLPSK WQMASSEPPC VNKVSDWKLE ILQNGLYLIY
GQVAPNANYNDVAPFEVRLY KNKDMIQTLT NKSKIQNVGG TYELHVGDTI DLIFNSEHQV
LKNNTYWGII LLANPQFIS
The Human AITRL His-Tagged Recombinant Protein, produced in E. coli, is 15.7 kDa (calculated) protein
containing 125 amino acid residues of the human AITRL and 14 additional amino acid residues - HisTag.
The amino acid sequence of the recombinant human Osteostat is homologous to the extracellular domain
of the human TNF18, Thr53-Ser177.

ANGPT1 CYT-074 5 µg 50
Recombinant Human Angiopoietin-1 -20 °C 20 µg 130
Angiopoietin 1, KIAA0003, ANG-1, AGP1, AGPT 1 mg 2,700
MSNQRRSPEN SGRRYNRIQH GQCAYTFILP EHDGNCREST TDQYNTNALQ RDAPHVEPDF
SSQKLQHLEH VMENYTQWLQ KLENYIVENM KSEMAQIQQN AVQNHTATML EIGTSLLSQT
AEQTRKLTDV ETQVLNQTSR LEIQLLENSL STYKLEKQLL QQTNEILKIH EKNSLLEHKI
LEMEGKHKEE LDTLKEEKEN LQGLVTRQTY IIQELEKQLN RATTNNSVLQ KQQLELMDTV
HNLVNLCTKE GVLLKGGKRE EEKPFRDCAD VYQAGFNKSG IYTIYINNMP EPKKVFCNMD
VNGGGWTVIQ HREDGSLDFQ RGWKEYKMGF GNPSGEYWLG NEFIFAITSQ RQYMLRIELM
DWEGNRAYSQ YDRFHIGNEK QNYRLYLKGH TGTAGKQSSL ILHGADFSTK DADNDNCMCK
CALMLTGGWW FDACGPSNLN GMFYTAGQNH GKLNGIKWHY FKGPSYSLRS TTMMIRPLDF
ANGPT1 Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain
containing 480 amino acids (20-498) and having a molecular mass of 55.6 kDa.
PEPTIDES INTERNATIONAL

ANGPTL2 CYT-765 2 µg 50
Recombinant Human Angiopoietin-like Protein 2 -20 °C 10 µg 130
Angiopoietin-related Protein 2, Angiopoietin-like Protein 2, 1 mg 5,200
ANGPTL2, ARP2, HARP
MKHHHHHHASQEDGFEGTEE GSPREFIYLN RYKRAGESQD KCTYTFIVPQ QRVTGAICVN
SKEPEVLLEN RVHKQELELL NNELLKQKRQ IETLQQLVEV DGGIVSEVKL LRKESRNMNS
RVTQLYMQLL HEIIRKRDNA LELSQLENRI LNQTADMLQL ASKYKDLEHK YQHLATLAHN QSEIIAQLEE
HCQRVPSARP VPQPPPAAPP RVYQPPTYNR IINQISTNEI QSDQNLKVLP PPLPTMPTLT
SLPSSTDKPS GPWRDCLQAL EDGHDTSSIY LVKPENTNRL MQVWCDQRHD PGGWTVIQRR
LDGSVNFFRN WETYKQGFGN IDGEYWLGLE NIYWLTNQGN YKLLVTMEDW SGRKVFAEYA
SFRLEPESEY YKLRLGRYHG NAGDSFTWHN GKQFTTLDRD HDVYTGNCAH YQKGGWWYNA
CAHSNLNGVW YRGGHYRSRY QDGVYWAEFR GGSYSLKKVV MMIRPNPNTF H
ANGPTL2 Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain
containing 481 amino acids including a 10 a.a N-terminal His tag. The total molecular mass is 56kDa
(calculated).

ANGPTL3 CYT-248 2 µg 50
Recombinant Human Angiopoietin-like Protein 3 -20 °C 10 µg 130
Angiopoietin 5, ANGPT5, ANGPTL3, Angiopoietin Like Protein 3 1 mg 4,800
MRGSHHHHHH GMASHMSRID QDNSSFDSLS PEPKSRFAML DDVKILANGL LQLGHGLKDF
VHKTKGQIND IFQKLNIFDQ SFYDLSLQTS EIKEEEKELR RTTYKLQVKN EEVKNMSLEL
NSKLESLLEE KILLQQKVKY LEEQLTNLIQ NQPETPEHPE VTSLKTFVEK QDNSIKDLLQ
TVEDQYKQLN QQHSQIKEIE NQLRRTSIQE PTEISLSSKP RAP
The ANGPTL3 Human Recombinant is produced with N-terminal fusion of His-Tag.
The Angiopoietin-like protein 3 His Tagged Fusion Protein is 26kDa containing 207 amino acid residues of
the ANGPTL3 Human and 16 additional amino acid residues – His-Tag

314 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
ANGPTL3 HEK CYT-766 2 µg 50
Recombinant Human Angiopoietin-like Protein 3, HEK -20 °C 10 µg 130
Angiopoietin 5, ANGPT5, ANGPTL3, Angiopoietin Like 100 µg 1,200
Protein 3.
SRIDQDNSSF DSLSPEPKSR FAMLDDVKIL ANGLLQLGHG LKDFVHKTKG QINDIFQKLN
IFDQSFYDLS LQTSEIKEEE KELRRTTYKL QVKNEEVKNM SLELNSKLES LLEEKILLQQ
KVKYLEEQLT NLIQNQPETP EHPEVTSLKT FVEKQDNSIK DLLQTVEDQY KQLNQQHSQI
KEIENQLRRT SIQEPTEISL SSKPRAPRTT PFLQLNEIRN VKHDGIPAEC TTIYNRGEHT SGMYAIRPSN
SQVFHVYCDV ISGSPWTLIQ HRIDGSQNFN ETWENYKYGF GRLDGEFWLG LEKIYSIVKQ
SNYVLRIELE DWKDNKHYIE YSFYLGNHET NYTLHLVAIT GNVPNAIPEN KDLVFSTWDH
KAKGHFNCPE GYSGGWWWHD ECGENNLNGK YNKPRAKSKP ERRRGLSWKS QNGRLYSIKS
TKMLIHPTDS ESFEHHHHHH
ANGPTL3 Human Recombinant produced in HEK cells is a single, glycosylated, polypeptide chain (a.a
17-460) containing a total of 450 amino acids, having a molecular mass of 52.6kDa (calculated) and
fused to a 6 aa His tag at C-Terminus.

ANGPTL4 CYT-249 2 µg 50
Recombinant Human Angiopoietin-like Protein 4 -20 °C 10 µg 130
ANGPTL4, NL2, ARP4, FIAF, PGAR, HFARP, pp1158, ANGPTL2, 1 mg 4,800
Fasting- Induced Adipose Factor, Hepatic Fibrinogen/
Angiopoietin-Related Protein, PPARG Angiopoietin-Related
Protein
MRGSHHHHHH GMASHMGPVQ SKSPRFASWD EMNVLAHGLL QLGQGLREHA ERTRSQLSAL
ERRLSACGSA CQGTEGSTDL PLAPESRVDP EVLHSLQTQL KAQNSRIQQL FHKVAQQQRH
LEKQHLRIQH LQSQFGLLDH KHLDHEVAKP ARRKRLPEMA QPVDPAHNVS RLHRLPRDCQ
ELFQVGERQS GLFEIQPQGS PPFLVNCKMT SDGGWTVIQR
The ANGPTL4 Human Recombinant is manufactured with N-terminal fusion of His Tag.

PEPTIDES INTERNATIONAL
The Angiopoietin-like Protein 4 His -Tagged Fusion Protein is 25 kDa protein containing 204 amino acid
residues of the Angiopoietin-like Protein 4 and 16 additional amino acid residues - His Tag.

ANGPTL4 HEK CYT-698 2 µg 50

Recombinant Human Angiopoietin-like Protein 4, HEK -20 °C 10 µg 130
ANGPTL4, NL2, ARP4, FIAF, PGAR, HFARP, pp1158, ANGPTL2, 1 mg 4,800
Fasting- Induced Adipose Factor, Hepatic Fibrinogen/
Angiopoietin-Related Protein, PPARG Angiopoietin-Related
Protein
GPVQSKSPRF ASWDEMNVLA HGLLQLGQGL REHAERTRSQ LSALERRLSA CGSACQGTEG
STDLPLAPES RVDPEVLHSL QTQLKAQNSR IQQLFHKVAQ QQRHLEKQHL RIQHLQSQFG
LLDHKHLDHE VAKPARRKRL PEMAQPVDPA HNVSRLHRLP RDCQELFQVG ERQSGLFEIQ
PQGSPPFLVN CKMTSDGGWT VIQRRHDGSV DFNRPWEAYK AGFGDPHGEF WLGLEKVHSI
TGDRNSRLAV QLRDWDGNAE LLQFSVHLGG EDTAYSLQLT APVAGQLGAT TVPPSGLSVP
FSTWDQDHDL RRDKNCAKSL SGGWWFGTCS HSNLNGQYFR SIPQQRQKLK KGIFWKTWRG
RYYPLQATTM LIQPMAAEAA SAAADYKDDDDK
The ANGPTL4 Human Recombinant is manufactured with C-terminal fusion of 11 amino acid FLAG Tag.
The ANGPTL4 Flag -Tagged Fusion Protein is a 44.2kDa protein containing 392 amino acid residues of
the Angiopoietin-like Protein 4 and 11 additional amino acid residues - Flag Tag.

Order Hotline 1-800-777-4779 502-266-8787 315

 PRODUCT Code Qty PRICE
Recombinant proteins

APOA1 CYT-750 20 µg 50
Recombinant Human ApolipoProtein A-I -20 °C 100 µg 130
ApolipoProtein A-I, Apo-AI, ApoA-I, APOA1, MGC117399 1 mg 990
MDEPPQSPWD RVKDLATVYV DVLKDSGRDY VSQFEGSALG KQLNLKLLDN WDSVTSTFSK
LREQLGPVTQ EFWDNLEKET EGLRQEMSKD LEEVKAKVQP YLDDFQKKWQ EEMELYRQKV
EPLRAELQEG ARQKLHELQE KLSPLGEEMR DRARAHVDAL RTHLAPYSDE LRQRLAARLE
ALKENGGARL AEYHAKATEH LSTLSEKAKP ALEDLRQGLL PVLESFKVSF LSALEEYTKK LNTQ
Apolipoprotein A-I Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide
chain containing 244 amino acids and having a molecular mass of 28.2kDa.

APOA1, His CYT-661 20 µg 50

Recombinant Human ApolipoProtein A-I, His Tag -20 °C 100 µg 130
ApolipoProtein A-I, Apo-AI, ApoA-I, APOA1, MGC117399 1 mg 1,000

MGSSHHHHHH SSGLVPRGSH MDEPPQSPWD RVKDLATVYV DVLKDSGRDY VSQFEGSALG

KQLNLKLLDN WDSVTSTFSK LREQLGPVTQ EFWDNLEKET EGLRQEMSKD LEEVKAKVQP
YLDDFQKKWQ EEMELYRQKV EPLRAELQEG ARQKLHELQE KLSPLGEEMR DRARAHVDAL
RTHLAPYSDE LRQRLAARLE ALKENGGARL AEYHAKATEH LSTLSEKAKP ALEDLRQGLL
PVLESFKVSF LSALEEYTKK LNTQ
APOA1 Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain
containing 264 amino acids (25-267 a.a.) and having a molecular mass of 30.3kDa. APOA1 is fused to 20
a.a. His-Tag at N-terminus.

APOA1 CYT-037 20 µg 50
Human ApolipoProtein A-I -20 °C 100 µg 130
ApolipoProtein A-I, Apo-AI, ApoA-I, APOA1, MGC117399 1 mg 600
APOA1 Human isolated from Human HDL is a single, glycosylated, polypeptide chain having a molecular
PEPTIDES INTERNATIONAL

mass of 28.3kDa. APOA1 is purified using delipidation and gel permeation chromatographic technique

APOA2 CYT-038 20 µg 50
Human ApolipoProtein A-II -20 °C 100 µg 130
ApolipoProtein A-II, Apo-AII, ApoA-II, APOA2 1 mg 900
APOA2 Human isolated from Human HDL is a single, glycosylated, polypeptide chain having a molecular
mass of 17.38kDa. APOA2 is purified using delipidation and gel permeation chromatographic technique.

APOA5 HEK CYT-025 2 µg 50

Recombinant Human ApolipoProtein A-V, HEK -20 °C 10 µg 130
ApolipoProtein A-V, Apo-AV, ApoA-V, ApolipoProtein A5, 1 mg 5,200
Regeneration-associated Protein 3, APOA5, RAP3, APOAV
RKGFWDYFSQ TSGDKGRVEQ IHQQKMAREP ATLKDSLEQD LNNMNKFLEK LRPLSGSEAP
RLPQDPVGMR RQLQEELEEV KARLQPYMAE AHELVGWNLE GLRQQLKPYT MDLMEQVALR
VQELQEQLRV VGEDTKAQLL GGVDEAWALL QGLQSRVVHH TGRFKELFHP YAESLVSGIG
RHVQELHRSV APHAPASPAR LSRCVQVLSR KLTLKAKALH ARIQQNLDQL REELSRAFAG
TGTEEGAGPD PQMLSEEVRQ RLQAFRQDTY LQIAAFTRAI DQETEEVQQQ LAPPPPGHSA
FAPEFQQTDS GKVLSKLQAR LDDLWEDITH SLHDQGHSHL GDPAAADYKD DDDK
APOA5 Human Recombinant Flag-Tagged Fusion Protein is 40.1 kDa protein containing 354 amino acid
residues of the APOA5 Human and 11 additional amino acid residues of flagTag.

316 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
APOA5 CYT-767 2 µg 50
Recombinant Human ApolipoProtein A-V -20 °C 10 µg 130
ApolipoProtein A-V, Apo-AV, ApoA-V, ApolipoProtein A5, 1 mg 5,200
Regeneration-associated Protein 3, APOA5, RAP3, APOAV
MGSSHHHHHH SSGLVPRGSH MGSRKGFWDY FSQTSGDKGR VEQIHQQKMA REPATLKDSL
EQDLNNMNKF LEKLRPLSGS EAPRLPQDPV GMRRQLQEEL EEVKARLQPY MAEAHELVGW
NLEGLRQQLK PYTMDLMEQV ALRVQELQEQ LRVVGEDTKA QLLGGVDEAW ALLQGLQSRV
VHHTGRFKEL FHPYAESLVS GIGRHVQELH RSVAPHAPAS PARLSRCVQV LSRKLTLKAK
ALHARIQQNL DQLREELSRA FAGTGTEEGA GPDPQMLSEE VRQRLQAFRQ DTYLQIAAFT
RAIDQETEEV QQQLAPPPPG HSAFAPEFQQ TDSGKVLSKL QARLDDLWED ITHSLHDQGH SHLGDP
APOA5 Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain
containing 366 amino acids (24-366 a.a.) and having a molecular mass of 41.3kDa. APOA5 is fused to a
23 amino acid His-tag at N-terminus.

APOL4 CYT-785 2 µg 50
Recombinant Human ApolipoProtein L 4 -20 °C 10 µg 130
APOL-IV, APOLIV, ApolipoProtein L4, ApoL-IV 100 µg 1,200
MGSSHHHHHH SSGLVPRGSH MGSMGSWVQL ITSVGVQQNH PGWTVAGQFQ EKKRFTEEVI
EYFQKKVSPV HLKILLTSDE AWKRFVRVAE LPREEADALY EALKNLTPYV AIEDKDMQQK
EQQFREWFLK EFPQIRWKIQ ESIERLRVIA NEIEKVHRGC VIANVVSGST GILSVIGVML APFTAGLSLS
ITAAGVGLGI ASATAGIASS IVENTYTRSA ELTASRLTAT STDQLEALRD ILRDITPNVL SFALDFDEAT
KMIANDVHTL RRSKATVGRP LIAWRYVPIN VVETLRTRGA PTRIVRKVAR NLGKATSGVL
VVLDVVNLVQ DSLDLHKGAK SESAESLRQW AQELEENLNE LTHIHQSLKA G
APOH Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing
371 amino acids (1-348 a.a.) and having a molecular mass of 41.1kDa. APOH is fused to a 23 amino
acid His-tag at N-terminus..

PEPTIDES INTERNATIONAL
AREG CYT-041 10 µg 50
Recombinant Human Amphiregulin -20 °C 50 µg 130
Schwannoma-derived growth factor, Colorectum cell-derived 1 mg 1,350
growth factor, AR, CRDGF, SDGF, AREGB, MGC13647
SVRVEQVVKP PQNKTESENT SDKPKRKKKG GKNGKNRRNR KKKNPCNAEF QNFCIHGECK
YIEHLEAVTC KCQQEYFGER CGEKSMKTHS MIDSSLSK
Amphiregulin (AREG) Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide
chain containing 98 amino acids and having a molecular mass of 11.3 KDa.

Order Hotline 1-800-777-4779 502-266-8787 317

 PRODUCT Code Qty PRICE
Recombinant proteins

Clusterins
Clusterin, also named Apolipoprotein J (APO-J), is a 75-80 kD disulfide-linked
heterodimeric protein containing about 30% of N-linked carbohydrate rich in sialic acid
but truncated forms targeted to the nucleus have also been identified.
The precursor polypeptide chain is cleaved proteolytically to remove the 22-mer
secretory signal peptide and subsequently between residues 227/228 to generate the
a and b chains. These are assembled in anti-parallel to give a heterodimeric molecule
in which the cysteine-rich centers are linked by five disulfide bridges and are flanked by
two predicted coiled-coil a-helices and three predicted amphipathic a-helices.
Across a broad range of species clusterin shows a high degree of sequence homology
ranging from 70% to 80%. It is nearly ubiquitously expressed in most mammalian
tissues and can be found in plasma, milk, urine, cerebrospinal fluid and semen.
It is able to bind and form complexes with numerous partners such as immunoglobulins,
lipids, heparin, bacteria, complement components, paraoxonase, beta amyloid, leptin
and others. Clusterin has been ascribed a plethora of functions such as phagocyte
recruitment, aggregation induction, complement attack prevention, apoptosis inhibition,
membrane remodeling, lipid transport, hormone transport and/or scavenging, matrix
metalloproteinase inhibition.
A genuine function of clusterin has not been defined. One tempting hypothesis says
that clusterin is an extracellular chaperone protecting cells from stress induced insults
caused by degraded and misfolded protein precipitates.
PEPTIDES INTERNATIONAL

Clusterin is up- or down regulated on the mRNA or protein level in many pathological
and clinically relevant situations including cancer, organ regeneration, infection,
Alzheimer disease, retinitis pigmentosa, myocardial infarction, renal tubular damage,
autoimmunity and others.

Clusterin CYT-278 2 µg 50
Recombinant Human ApolipoProtein-J -20 °C 10 µg 130
CLI, AAG4, KUB1, SGP2, SGP-2, SP-40, TRPM2, MGC24903, 1 mg 5,200
Clusterin, ApolipoProtein J, Apo-J
DQTVSDNELQ EMSNQGSKYV NKEIQNAVNG VKQIKTLIEK TNEERKTLLS NLEEAKKKKE
DALNETRESE TKLKELPGVC NETMMALWEE CKPCLKQTCM KFYARVCRSGS
GLVGRQLEE FLNQSSPFYF WMNGDRIDSL LENDRQQTHM LDVMQDHFSRA SSIIDELFQ
DRFFTREPQD TYHYLPFSLP HRRPHFFFPK SRIVRSLMPF SPYEPLNFHA MFQPFLEMIH
EAQQAMDIHF HSPAFQHPPT EFIREGDDDR TVCREIRHNS TGCLRMKDQC DKCREILSVD
CSTNNPSQAKLRRELDESLQ VAERLTRKYN ELLKSYQWKM LNTSSLLEQL NEQFNWVSRL
ANLTQGEDQYYLRVTTVASH TSDSDVPSGV TEVVVKLFDS DPITVTVPVE VSRKNPKFME
TVAEKALQEY RKKHREEAAA DYKDDDDK
The Clusterin Human contains a total 438 amino acids and a calculated molecular mass of 51.27kDa
(calculated). The AA sequence (AA 1-427) is identical to Swiss-Prot-P10909 (AA 23-449, secreted Human
Clusterin). C-terminal Flag-tag 11 extra AA (underlined).
G.S. Griffiths, et. al., Biology of Reproduction, 81, 3 (2009).
J. Chen, et al., Molecular Neurodegeneration, 7, 41 (2012).

318 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
Clusterin CYT-548 2 µg 50
Human ApolipoProtein-J -20 °C 10 µg 130
CLI, AAG4, KUB1, SGP2, SGP-2, SP-40, TRPM2, MGC24903, 1 mg 4,800
Clusterin, ApolipoProtein J, Apo-J

rClusterin CYT-437 2 µg 50
Recombinant Rat ApolipoProtein-J -20 °C 10 µg 130
CLI, AAG4, KUB1, SGP2, SGP-2, SP-40, TRPM2, 1 mg 3,600
MGC24903, Complement-associated Protein SP-40,40,
Complement cytolysis inhibitor, NA1/NA2, ApolipoProtein
J, Apo-J, Testosterone-repressed prostate message 2,
TRPM-2
MASMTGGQQM GRDPNSSSPF YFWMNGDRID SLLESDRQQS QVLDAMQDSF TRASGIIDTL
FQDRFFTHEPQDIHHFSPMG FPHKRPHLLY PKSRLVRSLM PLSHYGPLSF HNMFQPFFDM
IHQAQQAMDV QLHSPALQFPDVDFLKEGED DRTVCKEIRH NSTGCLKMKG QCEKCQEILS
VDCSTNNPAQ ANLRQELNDS LQVAERLTQQYNELLHSLQS KMLNTSSLLE QALEHHHHHH
The Clusterin Rat was constructed as a recombinant protein with N-terminal fusion of T7-Tag (16AA) and
C-terminal fusion of His-Tag (9AA). The Clusterin Rat His-Tagged Fusion Protein, produced in E.Coli,
is 26.5 kDa protein containing 215 amino acid residues of the APO-J Rat and 25 additional amino acid
residues – His-Tag, T7-Tag.

k9Clusterin CYT-549 2 µg 50
Recombinant Canine ApolipoProtein-J -20 °C 10 µg 130
CLI, AAG4, KUB1, SGP2, SGP-2, SP-40, TRPM2, MGC24903, 1 mg 5,200
GlycoProtein 80, Gp80, CLU, Clusterin, ApolipoProtein J, Apo-J
MKHHHHHHAS DQAVSDTELQ EMSTEGSKYI NKEIKNALKG VKQIKTLIEQ TNEERKSLLS

PEPTIDES INTERNATIONAL
NLEEAKKKKE DALNDTKDSE TKLKASQGVC NDTMMALWEE CKPCLKQTCM KFYARVCRSG
SGLVGHQLEE FLNQSSPFYF WMNGDRIDSL LENDRQQTHA LDVMQDSFNR ASSIMDELFQ
DRFFTREPQD TYHYSPFSLF QRRPFFNPKF RIARNIIPFP RFQPLNFHDM FQPFFDMIHQ
AQQAMDVNLH RIPYHFPIEF PEEDNRTVCK EIRHNSTGCL KMKDQCEKCQ EILSVDCSSN
NPAQVQLRQE LSNSLQIAEK FTKLYDELLQ SYQEKMFNTS SLLKQLNEQF SWVSQLANLT
QSEDPFYLQV TTVGSQTSDS NVPVGFTKVV VKLFDSDPIT VMIPEAVSRN NPKFMETVAE
KALQEYRQKHREE
Apolipoprotein-J canine Recombinant produced in E.Coli is a single, non-glycosylated, Polypeptide chain
containing 433 amino acids and having a molecular mass of 50.6 kDa. The protein is fused to His tag at
N-Terminus. The sequence is identical to UniProtKB/Swiss-Prot entry P25473 amino acids 23–445.

k9Clusterin HEK CYT-618 2 µg 50

Recombinant Canine ApolipoProtein-J, HEK -20 °C 10 µg 130
CLI, AAG4, KUB1, SGP2, SGP-2, SP-40, TRPM2, MGC24903, 1 mg 5,200
Clusterin, GlycoProtein 80, Gp80, CLU
PGDYKDDDDK PAGDQAVSDT ELQEMSTEGS KYINKEIKNA LKGVKQIKTL IEQTNEERKS
LLSNLEEAKK KKEDALNDTK DSETKLKASQ GVCNDTMMAL WEECKPCLKQ TCMKFYARVC
RSGSGLVGHQ LEEFLNQSSP FYFWMNGDRI DSLLENDRQQ THALDVMQDS FNRASSIMDE
LFQDRFFTRE PQDTYHYSPF SLFQRRPFFN PKFRIARNII PFPRFQPLNF HDMFQPFFDM
IHQAQQAMDV NLHRIPYHFP IEFPEEDNRT VCKEIRHNST GCLKMKDQCE KCQEILSVDC
SSNNPAQVQL RQELSNSLQI AEKFTKLYDE LLQSYQEKMF NTSSLLKQLN EQFSWVSQLA
NLTQSEDPFY LQVTTVGSQT SDSNVPVGFT KVVVKLFDSD PITVMIPEAV SRNNPKFMET
VAEKALQEYRQKHREE
Clusterin Canine Recombinant produced in HEK293 cells is a glycosylated, Polypeptide chain containing
436 amino acids and having a molecular mass of 50.72 kDa. The protein is fused with 13 amino acid
Flag tag at N-Terminus.

Order Hotline 1-800-777-4779 502-266-8787 319

 PRODUCT Code Qty PRICE
Recombinant proteins

APOD CYT-547 2 µg 50
Recombinant Human ApolipoProtein-D -20 °C 10 µg 130
ApolipoProtein D, Apo-D, ApoD 1 mg 5,200
FHLGKCPNPP VQENFDVNKY PGRWYEIEKI PTTFENGRCI QANYSLMENG KIKVLNQELR
ADGTVNQIEG EATPVNLTEP AKLEVKFSWF MPSAPYHILA TDYENYALVY SCTSISQSFH
VDFAWILARN VALPPETVDS LKNILTSNNI DVKKMTVTDQ VNCPKLSAHHHHHH
Apolipoprotein-D Human Recombinant His Tag fusion protein at C-terminus (7 highlighted a.a.) produced
in E.Coli is a single, non-glycosylated, Polypeptide chain containing 174 amino acids and having a
molecular mass of 19.82kDa. The protein a.a sequence corresponds to the UniProtKB/Swiss-Prot entry
P05090. The Following gene modifications were made:
Trp99His, Cys116Ser, Ile118Ser, Leu120Ser amino acids exchanges were introduced at the surface of
Apolipoprotein-D to enhance the protein’s solubility and another three Leu23Pro, Pro133Val, Asn134Ala
amino acids exchanges which facilitate its genetic manipulation.

APOD, HEK CYT-768 2 µg 50

Recombinant Human ApolipoProtein-D, HEK -20 °C 10 µg 130
ApolipoProtein D, Apo-D, ApoD 1 mg 5,200
QAFHLGKCPN PPVQENFDVN KYLGRWYEIE KIPTTFENGR CIQANYSLME NGKIKVLNQE
LRADGTVNQI EGEATPVNLT EPAKLEVKFS WFMPSAPYWI LATDYENYAL VYSCTCIIQL
FHVDFAWILA RNPNLPPETV DSLKNILTSN NIDVKKMTVT DQVNCPKLSH HHHHH
Apolipoprotein-D Human Recombinant produced in HEK cells is a single, glycosylated, polypeptide chain
(aa 21-189) containing a total of 175 amino acids, having a molecular mass of 20.1kDa (calculated) and
fused to a 6 aa His tag at C-Terminus.

APOD GST CYT-652 2 µg 175

Recombinant Human APO-D GST Tag -20 °C 5 µg 270
ApolipoProtein D, Apo-D, Apo 10 µg 490
PEPTIDES INTERNATIONAL

APO-D Human Recombinant full length protein expressed in E.Coli, shows a 48 kDa band on SDS-
PAGE.

APOH CYT-189 2 µg 50
Recombinant Human ApolipoProtein-H -20 °C 10 µg 130
β-2-glycoProtein 1, APC inhibitor, Activated Protein C-binding 1 mg 5,200
Protein, Anticardiolipin cofactor, ApolipoProtein H, Apo-H, β-2-
glycoProtein I, B2GPI, β(2)GPI, APOH, B2G1, BG, B2GP1
MGSSHHHHHH SSGLVPRGSH MGSGRTCPKP DDLPFSTVVP LKTFYEPGEE ITYSCKPGYV
SRGGMRKFIC PLTGLWPINT LKCTPRVCPF AGILENGAVR YTTFEYPNTI SFSCNTGFYL
NGADSAKCTE EGKWSPELPV CAPIICPPPS IPTFATLRVY KPSAGNNSLY RDTAVFECLP
QHAMFGNDTI TCTTHGNWTK LPECREVKCP FPSRPDNGFV NYPAKPTLYY KDKATFGCHD
GYSLDGPEEI ECTKLGNWSA MPSCKASCKV PVKKATVVYQ GERVKIQEKF KNGMLHGDKV
SFFCKNKEKK CSYTEDAQCI DGTIEVPKCF KEHSSLAFWK TDASDVKPC
APOH Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing
349 amino acids (20-345 a.a.) and having a molecular mass of 38.6kDa. APOH is fused to a 23 amino
acid His-tag at N-terminus.

APOm CYT-715 2 µg 50
Recombinant Human ApolipoProtein-m -20 °C 10 µg 130
G3a, HSPC336, NG20, ApolipoProtein M, APOM, Apo-M, 1 mg 5,200
MGC22400
MGSSHHHHHH SSGLVPRGSH MCPEHSQLTT LGVDGKEFPE VHLGQWYFIA GAAPTKEELA TFD-
PVDNIVF NMAAGSAPMQ LHLRATIRMK DGLCVPRKWI YHLTEGSTDL RTEGRPDMKT ELFSSSCPGG
IMLNETGQGY QRFLLYNRSP HPPEKCVEEF KSLTSCLDSK AFLLTPRNQE ACELSNN
APOM Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing
187 amino acids (23-188 a.a.) and having a molecular mass of 20.9 kDa. APOM protein is fused to a 21
amino acid His-Tag at N-terminus and purified by standard chromatography.

320 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
APOm HEK CYT-026 2 µg 50
Recombinant Human ApolipoProtein-m, HEK -20 °C 10 µg 130
G3a, HSPC336, NG20, ApolipoProtein M, APOM, Apo-M, 1 mg 5,200
MGC22400
HVDYKDDDDK PAGCPEHSQL TTLGVDGKEF PEVHLGQWYF IAGAAPTKEE LATFDPVDNI VFN-
MAAGSAP MQLHLRATIR MKDGLCVPRK WIYHLTEGST DLRTEGRPDM KTELFSSSCP GGIMLNETGQ
GYQRFLLYNR SPHPPEKCVE EFKSLTSCLD SKAFLLTPRN QEACELSNN
APOM HEK Human Recombinant Protein is 20 kDa protein containing 179 amino acid residues of the
APOM Human and 13 additional amino acid residues of flag Tag.

Artemin CYT-306 5 µg 50
Recombinant Human Artemin -20 °C 20 µg 130
ART, ARTN , EVN, NBN 1 mg 2,700
The sequence of the first five N-terminal amino acids was determined and was found to be Ala-Gly-Gly-
Pro-Gly
Artemin Human Recombinant produced in E.Coli is a disulfide-linked homodimer, non-glycosylated, poly-
peptide chain containing 2 x 113 amino acids and having a total molecular mass of 24205 Dalton.

Defensins
The Defensin family are highly similar in their protein sequence and are microbicidal
and cytotoxic peptides made by neutrophils. β Defensin-1 is an antimicrobial peptide
having the resistance of epithelial surfaces to microbial colonization. β Defensin-1 has
close proximity to Defensin α-1 and has been implicated in the pathogenesis of cystic
fibrosis. Skin of patients having atopic dermatitis patients and mycosis fungoides (non-
lesional and lesional) show lower human β Defensin-1 mRNA expression and higher

PEPTIDES INTERNATIONAL
human β Defensin-2 and human β Defensin-3 mRNA expression.
β Defensin is highly expressed by epithelial cells. β-defensin 1 may play a role in
the pathogenesis of severe sepsis. V ariation in human β Defensin-1 contributes to
asthma diagnosis, with apparent gender-specific effects. Human β Defensin-3 is
a dimer, while Human BD-1 and Human BD-2 are monomeric. The expression of
Human BD1 is correlated with induction profiles in gingival keratinocytes. The level
of expression of human DEFB1 mRNA is lower than that of human BD3 and human
BD-2 in reconstructed epidermis. Human BD1 is down-regulated in human prostatic
and renal carcinomas.

BD 1 CYT-564 5 µg 50
Recombinant Human β Defensin -1 -20 °C 20 µg 130
Beta-defensin 1, BD-1, Defensin beta 1, hBD-1, HBD1, HBP1, 1 mg 2,700
DEFB1, HBD-1, HBP-1, DEFB101, DEFB-1, MGC51822
GNFLTGLGHR SDHYNCVSSG GQCLYSACPI FTKIQGTCYR GKAKCCK
Beta Defensin-1 Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain
containing 47 amino acids and having a molecular mass of 5 kDa.

mBD 1 CYT-044 5 µg 50
Recombinant Mouse Β Defensin -1 -20 °C 20 µg 130
Beta-defensin 1, BD-1, Defensin beta 1, hBD-1, HBD1, HBP1, 1 mg 2,700
DEFB1, HBD-1, HBP-1, DEFB101, DEFB-1, MGC51822
DQYKCLQHGG FCLRSSCPSN TKLQGTCKPD KPNCCKS
BD 1 Mouse Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing
37 amino acids and having a molecular mass of 4.1 KDa.

Order Hotline 1-800-777-4779 502-266-8787 321

 PRODUCT Code Qty PRICE
Recombinant proteins

rBD 1 CYT-062 5 µg 50
Recombinant Rat Β Defensin -1 -20 °C 20 µg 130
Beta-defensin 1, BD-1, rBD-1, Defensin beta 1, Defb1 1 mg 2,700
DQYRCLQNGG FCLRSSCPSH TKLQGTCKPD KPNCCRS
BD-1 Rat Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 37
amino acids and having a molecular mass of 4.1kDa.

BD 2 CYT-571 5 µg 50
Recombinant Human Β Defensin -2 -20 °C 20 µg 130
BD-2, hBD-2, Defensin beta 2, Skin-antimicrobial peptide 1, 1 mg 2,700
SAP1, DEFB4, DEFB102, DEFB2, DEFB4P, Beta-defensin 2
GIGDPVTCLK SGAICHPVFC PRRYKQIGTC GLPGTKCCKK P
Beta Defensin-2 Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain
containing 41 amino acids and having a molecular mass of 4.3 kDa.

mBD 2 CYT-035 5 µg 50
Recombinant Mouse Β Defensin -2 -20 °C 20 µg 130
Beta-defensin 2, BD-2, mBD-2, Defensin beta 2, Defb2, 1 mg 2,700
MGC129140, MGC129141
AVGSLKSIGY EAELDHCHTN GGYCVRAICP PSARRPGSCF PEKNPCCKYM K
Beta Defensin-2 Mouse Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain
containing 51 amino acids and having a molecular mass of 5.5kDa.

BD 3 CYT-461 5 µg 50
Recombinant Human Β Defensin -3 -20 °C 20 µg 130
HBD3, HBP3, DEFB3, HBD-3, HBP-3, DEFB103 1 mg 1,400
PEPTIDES INTERNATIONAL

GIINTLQKYY CRVRGGRCAV LSCLPKEEQI GKCSTRGRKC CRRKK

Beta Defensin-3 Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain
containing 45 amino acids and having a molecular mass of 5161.2 Dalton.

mBD 3 CYT-036 5 µg 50
Recombinant Mouse Β Defensin -3 -20 °C 20 µg 130
Beta-defensin 3, BD-3, mBD-3, Defensin beta 3, Defb3, Bd3, 1 mg 2,700
MGC129397
KKINNPVSCL RKGGRCWNRC IGNTRQIGSC GVPFLKCCKR K
Beta Defensin-3 Mouse Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain
containing 41 amino acids and having a molecular mass of 4.6kDa.

rBD 3 CYT-063 5 µg 50
Recombinant Rat Β Defensin -3 -20 °C 20 µg 130
Beta-defensin 3, BD-3, Defensin beta 3, Defb3 1 mg 2,700
KKVYNAVSCM TNGGICWLKC SGTFREIGSC GTRQLKCCKK K
BD-3 Rat Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 41
amino acids and having a molecular mass of 4.5kDa.

BD 4 CYT-599 5 µg 50
Recombinant Human Β Defensin -4 -20 °C 20 µg 130
HBD-4, DEFB-4, HBD4, DEFB104B, Beta-defensin 4, BD-4 1 mg 2,700
EFELDRICGY GTARCRKKCR SQEYRIGRCP NTYACCLRKW DESLLNRTKP
Beta Defensin-4 Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain
containing 50 amino acids and having a molecular mass of 6 kDa.

322 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
rBD 4 CYT-066 5 µg 50
Recombinant Rat Β Defensin -4 -20 °C 20 µg 130
Beta-defensin 4, BD-4, BD-2, Defensin, beta 4, RBD-2, RBD-4, 1 mg 2,700
Defb4, Defb2, Defb3
QSINNPITCL TKGGVCWGPC TGGFRQIGTC GLPRVRCCKK K
BD-4 Rat Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 41
amino acids and having a molecular mass of 4.4kDa.

BDNF CYT-207 2 µg 50
Recombinant Human Brain-Derived Neurotrophic Factor -20 °C 10 µg 130
Brain-Derived Neurotrophic Factor, BDNF, MGC34632 1 mg 4,680
The sequence of the first five N-terminal amino acids of BDNF was determined and found to be Met-His-
Ser-Asp-Pro
Brain-Derived Neurotrophic Factor Human Recombinant produced in E.Coli is a homodimer, non-glyco-
sylated, polypeptide chain containing 2 x 119 amino acids and having a total molecular mass of 26,984
Dalton..
A.-Y. Jo, et al., Stem Cells, 27, 9, 2238 (2009).

proBDNF CYT-014 2 µg 50
Recombinant Human Precursor Brain-Derived Neurotrophic -20 °C 10 µg 130
Factor, proBDNF, Precursor Form Brain-derived Neurotrophic 1 mg 5,200
Factor
The sequence of the first five N-terminal amino acids was determined and was found to be Met-Ala-Pro-
Met-Lys
proBDNF Human Recombinant produced in E.Coli is a single, non-glycosylated, non-covalently linked ho-
modimer with each polypeptide chain containing 229 amino acids and having a molecular mass of 52kDa.

PEPTIDES INTERNATIONAL
BAFF (B Cell-Activating Factor)
B cell-activating factor (BAFF) enhances B-cell survival in vitro and is a regulator of the
peripheral B-cell population. Overexpression of Baf f in mice results in mature B-cell
hyperplasia and symptoms of systemic lupus erythematosus (SLE). Also, some SLE
patients have increased levels of BAFF in serum. Therefore, it has been proposed that
abnormally high levels of BAFF may contribute to the pathogenesis of autoimmune
diseases by enhancing the survival of autoreactive B cells. The protein encoded by
this gene is a receptor for BAFF and is a type III transmembrane protein containing a
single extracellular cysteine-rich domain. It is thought that this receptor is the principal
receptor required for BAFF-mediated mature B-cell survival.
BAFF CYT-307 5 µg 50
Recombinant Human BAFF (BLyS) -20 °C 20 µg 130
BAFF, BLYS, CD257, TALL1, THANK, ZTNF4, TALL-1, TNFSF20, 1 mg 4,680
TNFSF13B, B-cell Activating Factor
MAVQGPEETV TQDCLQLIAD SETPTIQKGS YTFVPWLLSF KRGSALEEKE NKILVKETGY FFIYGQV-
LYT DKTYAMGHLI QRKKVHVFGD ELSLVTLFRC IQNMPETLPN NSCYSAGIAK LEEGDELQLA
IPRENAQISL DGDVTFFGAL KLL
BAFF Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing
153 amino acids and having a molecular mass of 17007 Dalton.

Order Hotline 1-800-777-4779 502-266-8787 323

 PRODUCT Code Qty PRICE
Recombinant proteins

BAFF His CYT-545 5 µg 50

Recombinant Human BAFF (BLyS), His Tag -20 °C 20 µg 130
BAFF, BLYS, CD257, TALL1, THANK, ZTNF4, TALL-1, TNFSF20, 1 mg 3,600
TNFSF13B, B-cell Activating Factor
MRGSHHHHHH GMASMTGGQQ MGRDLYDDDD KDRWGSHMAV QGPEETVTQDCLQLIADSET
PTIQKGSYTF VPWLLSFKRG SALEEKENKI LVKETGYFFI YGQVLYTDKT YAMGHLIQRK KVHVFG-
DELS LVTLFRCIQN MPETLPNNSC YSAGIAKLEE GDELQLAIPR ENAQISLDGD VTFFGALKLL
BLyS Human Recombinant fused to His tag at N-terminus produced in E.Coli is a single, non-glycosylated
polypeptide chain containing 190 amino acids and having a molecular mass of 21 kDa.

BAFF Plant CYT-054 1 µg 50

Recombinant Human BAFF (BLyS), Plant -20 °C 5 µg 130
BAFF, BLYS, CD257, TALL1, THANK, ZTNF4, TALL-1, TNFSF20, 100 µg 1,500
TNFSF13B, B-cell Activating Factor
HHHHHHHHHH AVQGPEETVT QDCLQLIADS ETPTIQKGSY TFVPWLLSFK RGSALEEKEN
KILVKETGYF FIYGQVLYTD KTYAMGHLIQ RKKVHVFGDE LSLVTLFRCI QNMPETLPNN SCYSAGIAKL
EEGDELQLAI PRENAQISLD GDVTFFGALK LL
BAFF human Recombinant produced in Nicotiana benthamiana plant is a single glycosilated polypeptide
chain containing 151 amino acids fragment (134-285). BAFF (C830H1277N223O242S5) is fused to
a 10-His-tag at the N-terminal having the total molecular mass of 18-20kDa and purified by standard
chromatographic techniques.
Note: For long term storage it is recommended to add a carrier protein (0.1% HSA or BSA).
Please prevent freeze-thaw cycles.

BAFF R CYT-429 10 µg 50
Recombinant Human BAFF (BLyS) Receptor -20 °C 50 µg 130
PEPTIDES INTERNATIONAL

TNFRSF13C, CD268, BAFF-R, MGC138235, B cell-activating 1 mg 1,350

factor receptor
MRRGPRSLRGRDAPAPTPCVPAECFDLLVRHCVACGLLRTPRPKPAG
ASSPAPRTALQPQESVGAGAGEAALPLPG
B Lymphocyte Stimulator Receptor Human Recombinant extracellular produced in E.Coli is a single, non-
glycosylated polypeptide chain containing 76 amino acids and having a molecular mass of 7.7 kDa.

BMPs (Bone Morphogenetic Proteins)

The bone morphogenetic proteins (BMPs) are a family of secreted signaling mole -
cules, which can induce ectopic bone growth. V arious BMPs are part of the trans -
forming growth factor-beta (TGFB) superfamily. BMPs were initially identified by an
ability of demineralized bone extract to induce endochondral osteogenesis in vivo in
an extraskeletal site. Based upon its expression early in embryogenesis, BMP6 has
a suggested role in early development. M oreover , the fact that the BMP6 is closely
related to BMP5 and BMP7 leads to an assumption of possible bone inductive activity.
BmPR1A CYT-380 2 µg 50
Recombinant Human Bone Morphogenetic Protein Receptor-1A -20 °C 10 µg 130
BMPR-1A, BMP-R1A, BMPR1A, BMR1A, CD292, CD-292, Serine/ 1 mg 4,000
threonine-Protein kinase receptor R5, SKR5, Activin receptor-
like kinase 3, ALK-3, ACVRLK3, EC 2.7.11.30, CD292 antigen
BMPR1A Human Recombinant extracellular domain produced in baculovirus is a monomeric, glycosylated,
Polypeptide chain fused with 6xHis tag at C-terminus and having a molecular mass of 23 kDa.

324 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
BmP 2 CYT-261 2 µg 50
Recombinant Human Bone Morphogenetic Protein-2 -20 °C 10 µg 130
BMP-2, BMP2A 1 mg 4,680
MQAKHKQRKR LKSSCKRHPL YVDFSDVGWN DWIVAPPGYH AFYCHGECPF PLADHLNSTN
HAIVQTLVNS VNSKIPKACC VPTELSAISM LYLDENEKVV LKNYQDMVVE GCGCR
Bone Morphogenetic Protein-2 Human Recombinant produced in E.Coli is a homodimeric, non-glycosylat-
ed polypeptide chain containing 2x115 amino acids and having a molecular mass of 26kDa.
Y. Chen, et al.., J. of Biol. Chem., 282, 526 (2007).

BmP 2 HEK CYT-080 2 µg 50

Recombinant Human Bone Morphogenetic Protein-2, HEK -20 °C 10 µg 130
BMP-2, BMP2A 100 µg 1,100
BMP-2 Human Recombinant produced in HEK cells is a glycosylated disulfide-linked homodimer, having a molecular
weight range of 30-38kDa due to glycosylation.

BmP 2 Mono CYT-627 5 µg 50

Recombinant Human Bone Morphogenetic Protein-2 Monomer -20 °C 20 µg 130
BMP-2, BMP2A, Bone morphogenetic Protein 2, BMP-2A, BMP2 1 mg 2,100

MQAKHKQRKR LKSSCKRHPL YVDFSDVGWN DWIVAPPGYH AFYCHGECPF PLADHLNSTN HAIVQTLVNS VNSKIP-

KACC VPTELSAISMLYLDENEKVV LKNYQDMVVE GCGCR
Bone Morphogenetic Protein-2 Human Recombinant produced in E.Coli is a monomeric, non-glycosylated,
Polypeptide chain containing 115 amino acids (283-396) and having a molecular mass of 13009 Dalton.

Pro BmP 2 CYT-427 2 µg 50

Recombinant Human Pro Bone Morphogenetic Protein-2 -20 °C 10 µg 130
ProBMP-2 100 µg 1,000

PEPTIDES INTERNATIONAL
Pro Bone Morphogenetic Protein -2 Human Recombinant is the precursor of BMP-2 which has 3 intramolecular cystein
bridges is a homodimer, non-glycosylated, polypeptide chain containing 377 amino acids and having a molecular mass of
85,476 Dalton. .

BmP 4 CYT-361 2 µg 50
Recombinant Human Bonemorphogenetic Protein-4 -20 °C 10 µg 130
BMP4, ZYME, BMP2B, BMP2B1 1 mg 2,900
SPKHHSQRAR KKNKNCRRHS LYVDFSDVGW NDWIVAPPGY QAFYCHGDCP FPLADHLNST NHAIVQTLVN SVNS-
SIPKAC CVPTELSAIS MLYLDEYDKV VLKNYQEMVV EGCGCR
Bone Morphogenetic Protein-4 Human Recombinant produced in E.Coli is a monomeric, non-glycosylated,
Polypeptide chain containing 116 amino acids and having a molecular mass of 13kDa.

BmP 4 Active CYT-081 2 µg 50

Recombinant Human Bonemorphogenetic Protein-4 Active -20 °C 10 µg 130
BMP4, ZYME, BMP2B, BMP2B1 100 µg 1,100

BMP-4 Human Recombinant produced in HEK cells is a glycosylated disulfide linked homodimer, having a
total molecular weight of 34kDa.

BmP 5 CYT-660 5 µg 50
Recombinant Human Bonemorphogenetic Protein-5 20 µg 130
Bone morphogenetic Protein 5, BMP-5, BMP5, MGC34244 1 mg 3,000
MAANKRKNQN RNKSSSHQDS SRMSSVGDYN TSEQKQACKK HELYVSFRDL GWQDWIIAPE GYAAF-
YCDGE CSFPLNAHMN ATNHAIVQTL VHLMFPDHVP KPCCAPTKLN AISVLYFDDS SNVILKKYRN
MVVRSCGCH
BMP-5 Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing
139 amino acids (317-454 a.a.) and having a total molecular mass of 15.7 kDa.

Order Hotline 1-800-777-4779 502-266-8787 325

 PRODUCT Code Qty PRICE
Recombinant proteins

BmP6 CYT-754 2 µg 50
Recombinant Human Bonemorphogenetic Protein-6 -20 °C 10 µg 130
Bone morphogenetic Protein 6, BMP-6, VG-1-related Protein, 100 µg 950
VG-1-R, VGR-1, BMP6, VGR, VGR1
MGSSHHHHHH SSGLVPRGSH MGSHMSASSR RRQQSRNRST QSQDVARVSS ASDYNSSELK
TACRKHELYV SFQDLGWQDW IIAPKGYAAN YCDGECSFPL NAHMNATNHA IVQTLVHLMN PEYVPK-
PCCA PTKLNAISVL YFDDNSNVIL KKYRNMVVRA CGCH
BMP6 Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing
164 amino acids (375-513) and having a molecular mass of 18kDa. BMP6 is fused to a 25 amino acid
His-tag at N-terminus.

BmP 7 CYT-333 2 µg 50
Recombinant Human Bonemorphogenetic Protein-7 -20 °C 10 µg 130
Osteogenic Protein 1, BMP-7 1 mg 3,600
The sequence of the first five N-terminal amino acids was determined and was found to be Ser-Thr-Gly-
Ser-Lys
Bone Morphogenetic Protein-7 Human Recombinant produced in E.Coli is a monomeric, non-glycosylated,
polypeptide chain containing 139 amino acids and having a molecular mass of 15679.97 Dalton. .
L.A. da Silva, et al., Journal of Dentistry for Children 75, 1 (2008).

BmP 7 His CYT-629 10 µg 50

Recombinant Human Bonemorphogenetic Protein-7 His Tag -20 °C 50 µg 130
Osteogenic Protein 1, OP-1, BMP-7, Bone morphogenetic 1 mg 1,800
Protein 7, BMP7, OP1
MSTGSKQRSQ NRSKTPKNQE ALRMANVAEN SSSDQRQACK KHELYVSFRD LGWQDWIIAP
EGYAAYYCEG ECAFPLNSYM NATNHAIVQTLVHFINPETV PKPCCAPTQL NAISVLYFDD SSNVILKKYR
PEPTIDES INTERNATIONAL

NMVVRACGCH LEHHHHHH
BMP7 Human Recombinant produced in E.Coli is a monomeric, non-glycosylated, polypeptide chain
containing 148 amino acids (293-431) and having a molecular mass of 16.8 kDa. The BMP-7 is fused to 8
amino acid His Tag at C-terminus.

BmP 7 CHO CYT-276 2 µg 50

Recombinant Human Bonemorphogenetic Protein-7, CHO -20 °C 10 µg 130
Osteogenic Protein 1, BMP-7 1 mg 7,000
N-TERMINAL---Human BMP-2 (Met 1 – Arg 282) Human BMP-7 (Ser 293 – Arg 431)---C-TERMINAL.
The DNA sequence encoding the human BMP-2 signal peptide and propeptide (1~282 amino acid) fused
to the human rhBMP-7 mature chain (293~431 amino acid) was expressed in a Chinese hamster ovary
cell line. The mature recombinant BMP-7 generated by the proteolytic removal of the signal peptide and
propetide contains 139 amino acid residues. The glycosylation of BMP-7 increases the molecular mass
and the glycosylated proteins migrate as 25 ~ 40 kDa in SDS-PAGE under non-reducing conditions. .
Y.-R. Na, et al., Cancer Science, 100, 11, (2009).
R.S. Radhakrishnan, et al., Shock, 30, 5 (2008).
C.L. Flanagan, et al., Tissue Engineering and Regenerative Medicine International Society, EU Meeting (2010).

BmP 7 Plant CYT-039 2 µg 50

Recombinant Human Bonemorphogenetic Protein-7, Plant -20 °C 10 µg 130
Osteogenic Protein 1, BMP-7 1 mg 7,000
HHHHHHSTGSKQRSQNRSKTPKNQEALRMANVAENSSSDQRQACKKHELYVSFRDLGWQDWIIAPEG-
YAAY YCEGECAFPLNSYMNATNHAIVQTLVHFINPETVPKPCCAPTQLNAISVLYFDDSSVILKKYRNMV-
VRACGCH
Bone Morphogenetic Protein-7 Human Recombinant produced in Nicotiana benthamiana is a monomeric,
glycosylated, polypeptide chain containing 144 amino acids and having a molecular mass of 16.5kDa, and
fused to a 6xHis-tag at the N-terminus.

326 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
BmP 7 HEK CYT-082 1 µg 50
Recombinant Human Bonemorphogenetic Protein-7, HEK -20 °C 5 µg 130
Osteogenic Protein 1, BMP-7 50 µg 1,100
BMP-7 Human Recombinant produced in HEK cells is a glycosylated disulfide-linked homodimer, having a
molecular weight range of 30-38kDa due to glycosylation.

NGF-β (Nerve Growth Factor-β)

NGF-β has nerve growth stimulating activity and the complex is involved in the regu-
lation of growth and the dif ferentiation of sympathetic and certain sensory neurons.
Mutations in this gene have been associated with hereditary sensory and autonomic
neuropathy, type 5 (HSAN5), and dysregulation of this gene's expression is associated
with allergic rhinitis. Nerve Growth Factor was the 1 st protein found from the family of
neurotrophic factors that influence the growth and differentiation of sympathetic and
sensory neurons. NGF consists of 3 different subunits: α, β, and γ. The β subunit is
accountable for its growth stimulating activity . The synthesis of NGF in astrocytes is
enhanced by a range of cytokines such as IL1, TNF-α, PDGF and TGF-β.

b NGF CYT-579 5 µg 30
Recombinant Human β Nerve Growth Factor -20 °C 20 µg 50
β Polypeptide, NGF, NGFB, HSAN5, β-NGF, MGC161426, 1 mg 990
MGC161428
MSSSHPIFHRG EFSVCDSVSV WVGDKTTATD IKGKEVMVLG EVNINNSVFK QYFFETKCRD PNPVDS-
GCRG IDSKHWNSYC TTTHTFVKAL TMDGKQAAWR FIRIDTACVC VLSRKAVRRA
Nerve Growth Factor-β Human Recombinant produced in E.Coli is a non-covalently disulfide-linked

PEPTIDES INTERNATIONAL
homodimer, non-glycosylated, polypeptide chain containing 2 identical 121 amino acids with a molecular
weight of two 13.6 kDa polypeptide monomers.

b NGF CHO CYT-246 5 µg 50

Recombinant Human β Nerve Growth Factor, CHO -20 °C 20 µg 130
β Polypeptide, NGF, NGFB, HSAN5, Beta-NGF, MGC161426, 1 mg 2,700
MGC161428
Nerve Growth Factor-β Human Recombinant produced in CHO is a noncovalently disulfide linked homodi-
mer, glycosylated, polypeptide chain containing 2 identical 118 amino acids and having a molecular mass
of 26.5 kDa. .

b NGF HEK CYT-079 5 µg 50

Recombinant Human β Nerve Growth Factor, HEK -20 °C 20 µg 130
β Polypeptide, NGF, NGFB, HSAN5, β-NGF, MGC161426, 1 mg 3,600
MGC161428
β-NGF Human Recombinant produced in HEK cells is a non-glycosylated non-disulfide linked homodimer,
having a total molecular weight of 13kDa.

mb NGF CYT-581 5 µg 50
Recombinant Mouse β Nerve Growth Factor, β Polypeptide, -20 °C 20 µg 130
NGF, NGFB, HSAN5, β-NGF, MGC161426, MGC161428 1 mg 2,700
Recombinant Mouse β-NGF produced in E.Coli is a noncovalently disulfide-linked homodimer, non-
glycosylated, polypeptide chain containing 2 identical chains of 120 amino acids each and having a
molecular mass of 13,471 Dalton each. The Recombinant Mouse-β-NGF is purified by advanced biology
purification technology.

Order Hotline 1-800-777-4779 502-266-8787 327

 PRODUCT Code Qty PRICE
Recombinant proteins

mb NGF CYT-440 5 µg 50
Mouse β Nerve Growth Factor, β Polypeptide, NGF, NGFB, -20 °C 20 µg 130
HSAN5, Beta-NGF, MGC161426, MGC161428 1 mg 2,700
SSTHPVFHMGEF SVCDSVSVWV GDKTTATDIK GKEVTVLAEV NINNSVFRQY FFETKCRASN PVES-
GCRGID SKHWNSYCTT THTFVKALTT DEKQAAWRFI RIDTACVCVL SRKATRRG
NGF β Mouse produced in Submaxillary Gland of Grown Mouse is a homodimer, non-glycosylated, poly-
peptide chain containing 2 identical 120 amino acids and having a molecular mass of 13,471 Dalton each.
The NGF β Mouse is purified by advanced biology purification technology.

ProNGF CYT-426 2 µg 50
Recombinant Human Pro-Nerve Growth Factor -20 °C 10 µg 130
Human Pro-NGF, ProNGF, NGFB 100 µg 1,000

MEPHSESNVPAGHTIPQVHWTKLQHSLDTALRRARSAPAAAIAARVAGQTRNITVDPRLFKKRRLRSPRV-
LFSTQPPREAADTQDLDFEVGGAAPFNRTHRSKRSSSHPIFHRGEFSVCDSVSVWVGKTTATDIKG-
KEVMVLGEVNINNSVFKQYFFETKCRDPNPVDSGCRGIDSKHWNSYCTTTHTFVKALTMDGKQAAW-
RFIRIDTACVCVLSRKAVRRA
Pro NGF is the pro-form of the neurotrophin nerve growth factor. Like the mature protein pro NGF is
characterized by the cysteine knot motif consisting of three cysteine bridges. The protein predominantly
exists as a non-covalently linked homodimer.Pro-Nerve Growth Factor Human Recombinant produced in
E.Coli is a non-glycosylated, polypeptide chain containing 224 amino acids and having a molecular mass
of 50KDa.

BNP CYT-327 2 µg 50
Recombinant Human B-type Natriuretic Protein -20 °C 10 µg 130
NPPB, Natriuretic Peptide Precursor B, BNP, B-type Natriuretic 1 mg 4,680
Peptide
PEPTIDES INTERNATIONAL

SPKMVQGSGCFGRKMDRISSSSGLGCKVLRRH
B-type Natriuretic Peptide Human Recombinant produced in E.Coli is a single, non-glycosylated, polypep-
tide chain containing 32 amino acids and having a molecular mass of 3464 Dalton.

BNP His CYT-605 2 µg 50

Recombinant Human B-type Natriuretic Protein His Tag -20 °C 10 µg 130
NPPB, Natriuretic Peptide Precursor B, BNP, B-type Natriuretic 1 mg 4,680
Peptide
MGSSHHHHHH SSGLVPRGSH MHPLGSPGSA SDLETSGLQE QRNHLQGKLSELQVEQTSLE
PLQESPRPTG VWKSREVATE GIRGHRKMVL YTLRAPRSPK MVQGSGCFGR KMDRISSSSG LGCK-
VLRRH
BNP Recombinant Human fused with 20 amino acid His tag at N-terminus produced in E.Coli is a single,
non-glycosylated, polypeptide chain containing 129 amino acids (27-134 a.a) and having a molecular mass
of 14 kDa.  

BNP CYT-369 10 mg 300

Human B-type Natriuretic Protein -20 °C 25 mg 500
NPPB, Natriuretic Peptide Precursor B, BNP, B-type Natriuretic 100 mg 1,500
Peptide
SPKMVQGSGCFGRKMDRISSSSGLGCKVLRRH
C143H244N50O42S4
B-type Natriuretic Peptide Human is a polypeptide chain containing 32 amino acids and having a molecular
mass of 3464 Dalton.

328 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
BST2 CYT-059 2 µg 50
Recombinant Human Bone Marrow Stromal Cell Antigen 2 -20 °C 10 µg 130
Bone marrow stromal cell antigen 2, CD317 antigen, BST-2, 1 mg 5,200
HM1.24 antigen, Tetherin, NPC-A-7
MGSSHHHHHH SSGLVPRGSH MSEACRDGLR AVMECRNVTH LLQQELTEAQ KGFQDVEAQA
ATCNHTVMAL MASLDAEKAQ GQKKVEELEG EITTLNHKLQ DASAEVERLR RENQVLSVRI ADK-
KYYPSSQ DSS
BST2 Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing
133 amino acids (50-161) and having a molecular mass of 14.8 kDa. The BST2 is fused to a 21 amino
acid His-Tag at N-terminus.

BTC CYT-330 5 µg 50
Recombinant Human Βetacellulin -20 °C 20 µg 130
1 mg 2,700
The sequence of the first five N-terminal amino acids was determined
and was found to be Asp-Gly-Asn-Ser-Thr
Betacellulin Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain
containing 80 amino acids and having a molecular mass of 9 kDa.

BTC His CYT-077 2 µg 50

Recombinant Human Βcellulin, His Tag -20 °C 10 µg 130
Betacellulin, Probetacellulin 1 mg 5,200
MGSSHHHHHH SSGLVPRGSH MDGNSTRSPE TNGLLCGDPE ENCAATTTQS KRKGHFSRCP
KQYKHYCIKG RCRFVVAEQT PSCVCDEGYI GARCERVDLF Y
BTC Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing
101 amino acids (32-111) and having a molecular mass of 11.3 kDa. BTC is fused to a 21 amino acid

PEPTIDES INTERNATIONAL
His-tag at N-terminus.

mBTC CYT-131 5 µg 50
Recombinant Mouse Βcellulin -20 °C 20 µg 130
Betacellulin, Probetacellulin 1 mg 2,700

DGNTTRTPET NGSLCGAPGE NCTGTTPRQK VKTHFSRCPK QYKHYCIHGR CRFVVDEQTP SCICEK-

GYFG ARCERVDLFY
BTC Mouse Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 80
amino acids and having a molecular mass of 9.0kDa.

bBTC CYT-406 5 µg 50
Recombinant Bovine Βcellulin -20 °C 20 µg 130
1 mg 3,600
The sequence of the first five N-terminal amino acids was determined and was found
to be Asp-Gly-Asn-Ser-Thr
Betacellulin Bovine Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain
containing 80 amino acids and having a molecular mass of 9003 Dalton.

Order Hotline 1-800-777-4779 502-266-8787 329

 PRODUCT Code Qty PRICE
Recombinant proteins

CD4
CD4 is a cell-surface glycoprotein found on the mature helper T cells and immature
thymocytes, as well as on monocytes and macrophages. (Some cytotoxic T cells have
CD4 protein as well.) Normally, about 65% of T cells in the blood are CD4+ (have CD4
protein protruding from their membrane). A mature T cell with either have CD4 or CD8,
but not both. During one stage of development T cells develop CD4 and CD8 recep -
tors, but they eventually are differentiated in the thymus and become more specialized.

sCD4 Human CYT-304 2 µg 50

Recombinant Human Soluble CD4; gp55, HLA-2, L3 / T4, Ly-4, T -20 °C 10 µg 130
cell antigen T4/LEU3, T4, sCD4, CD4mut 1 mg 4,950

KKVVL GKKGDTVELT CTASQKKSIQ FHWKNSNQIK ILGNQGSFLT KGPSKLNDRA DSRRSLWDQG

NFPLIIKNLK IEDSDTYICE VEDQKEEVQL LVFGLTANSD THLLQGQSLT LTLESPPGSS PSVQCRSPRG
KNIQGGKTLS VSQLELQDSG TWTCTVLQNQ KKVEFKIDIV VLAFQKASSI VYKKEGEQVE FSF-
PLAFTVE KLTGSGELWWQAERASSSKS WITFDLKNKE VSVKRVTQDP KLQMGKKLPL HLTLPQALPQ
YAGSGNLTLALEAKTGKLHQ EVNLVVMRAT QLQKNLTCEV WGPTSPKLML SLKLENKEAK VSKREKA-
VWV LNPEAGMWQC LLSDSGQVLL ESNIKVLPTW
sCD4 Human Recombinant produced in Baculovirus is a single, glycosylated polypeptide chain containing
365 amino acids and having a non glycosilated molecular mass of 45 kDa. As a result of glycosilation the
sCD4 migrates as a 46 kDa protein on standard SDS-PAGE. Detected By Western Imunno Blots anti CD4
monoclonal antibody.

CD4 (26-226) CYT-313 2 µg 175

Recombinant Human CD4 (26-226) -20 °C 5 µg 270
gp55, HLA-2, L3 / T4, Ly-4, T cell antigen T4/LEU3, T4, sCD4 10 µg 500
PEPTIDES INTERNATIONAL

D-4 Human Recombinant encoding amino acids 26-226

CD4, a single chain transmembrane glycoprotein, is found on a T cell subset (helper/inducer) represent-
ing 45% of peripheral blood lymphocytes. It is also present on 80% of thymocytes and at a lower level on
monocytes. It is involved in recognition of antigen presented along with MHC class II by APCs. It serves as
receptor for HIV. Antibody to CD4 recognizes T-helper cells required for recognition of class II antigens. It
reacts with ~60% of peripheral blood E rosette-positive (E+) cells while showing negligible reactivity with
E- cells, monocytes, granulocytes, EBV-transformed B cell lines, and mouse splenocytes.

CD4 (125-202) CYT-315 5 µg 50

Recombinant Human CD4 (125-202) -20 °C 20 µg 130
gp55, HLA-2, L3 / T4, Ly-4, T cell antigen T4/LEU3, T4, sCD4 1 mg 2,400

CD-4 Human Recombinant is fused with a 4kDa His Tag and encoding amino acids 125-202, having a total
molecular weight of 19 kDa.
L.J. Matthias, et al., Journal of Biological Chemistry, 285, 52 (2010).

CD4 (203-317) CYT-316 5 µg 50

Recombinant Human CD4 (203-317) -20 °C 20 µg 130
gp55, HLA-2, L3 / T4, Ly-4, T cell antigen T4/LEU3, T4, sCD4 1 mg 2,400

CD-4 Human Recombinant His Tag protein encoding 203-317 amino acids.

330 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
sCD40L CYT-245 10 µg 50
Recombinant Human Soluble CD40 Ligand/TRAP -20 °C 50 µg 130
CD40-L, Tumor necrosis factor ligand superfamily member 1 mg 1,350
5, TNF-related activation Protein, TRAP, T cell antigen Gp39,
CD154 antigen, sCD40, IGM, IMD3, HIGM1, T-BAM, TNFSF5,
hCD40L
sCD40 Human Recombinant produced in E.Coli is a non-glycosylated, Polypeptide chain containing 149
amino acids and having a molecular mass of 16308 Dalton.

sCD40L His CYT-670 5 µg 50

Recombinant Human Soluble CD40 Ligand/TRAP His Tag -20 °C 20 µg 130
CD40-L, Tumor necrosis factor ligand superfamily member 1 mg 2,700
5, TNF-related activation Protein, TRAP, T cell antigen Gp39,
CD154 antigen, sCD40, IGM, IMD3, HIGM1, T-BAM, TNFSF5,
hCD40L, CD40LG
MGSSHHHHHH SSGLVPRGSH MQKGDQNPQI AAHVISEASS KTTSVLQWAE KGYYTMSNNL VT-
LENGKQLT VKRQGLYYIY AQVTFCSNRE ASSQAPFIAS LCLKSPGRFE RILLRAANTH SSAKPCGQQS
IHLGGVFELQ PGASVFVNVT DPSQVSHGTG FTSFGLLKL
CD40LG Human Recombinant fused with a 20 amino acid His tag at N-terminus produced in E.Coli is
a single, non-glycosylated, polypeptide chain containing 169 amino acids (113-261 a.a.) and having a
molecular mass of 18.3kDa.

msCD40L CYT-472 5 µg 50
Recombinant Mouse Soluble CD40 Ligand/TRAP; CD40-L, -20 °C 25 µg 130
Tumor necrosis factor ligand superfamily member 5, TNF- 1 mg 2,700
related activation Protein, TRAP, T cell antigen Gp39, CD154

PEPTIDES INTERNATIONAL
antigen, sCD40, IGM, IMD3, HIGM1, T-BAM, TNFSF5, hCD40L
The sequence of the first five N-terminal amino acids was determined and was found to be Met-Gln-Arg-
Gly-Asp
sCD40 Mouse Recombinant produced in E.Coli is a non-glycosylated, Polypeptide chain containing 149
amino acids and having a molecular mass of 16409 Dalton.

CDFN (Cerebral Dopamine Neurotrophic Factor)

CDNF is a member of the ARMET family and acts as a trophic factor for dopamine
neurons. CDNF inhibits the 6-hydroxydopamine (6-OHDA)-induced degeneration of
dopaminergic neurons. When CDNF controlled after 6-OHDA-lesioning, it reestablish-
es the dopaminergic function and inhibits the degeneration of dopaminergic neurons
in substantia nigra. CDNF is universally expressed in neuronal and non-neuronal tis -
sues. The highest levels in the brain are found in the optic nerve and corpus callosum.
CDNF CYT-167 5 µg 50
Recombinant Human Cerebral Dopamine Neurotrophic Factor -20 °C 20 µg 130
Cerebral dopamine neurotrophic factor, arginine-rich, mutated 1 mg 2,700
in early stage tumors-like 1, Conserved dopamine neurotrophic
factor, ARMET-like Protein 1, ARMETL1
QEAGGRPGAD CEVCKEFLNR FYKSLIDRGV NFSLDTIEKE LISFCLDTKG KENRLCYYLG ATK-
DAATKIL SEVTRPMSVH MPAMKICEKL KKLDSQICEL KYEKTLDLAS VDLRKMRVAE LKQILHSWGE
ECRACAEKTD YVNLIQELAP KYAATHPKTE L
CDNF Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing
161 amino acids and having a molecular mass of 18.5kDa.

Order Hotline 1-800-777-4779 502-266-8787 331

 PRODUCT Code Qty PRICE
Recombinant proteins

mCDNF CYT-729 5 µg 50
Recombinant Mouse Cerebral Dopamine Neurotrophic Factor -20 °C 20 µg 130
Cerebral dopamine neurotrophic factor, ARMET-like Protein 1 mg 2,700
1, Conserved dopamine neurotrophic factor, Cdnf, Armetl1,
9330140G23
QGLEAGVGPR ADCEVCKEFL DRFYNSLLSR GIDFSADTIE KELLNFCSDA KGKENRLCYY
LGATTDAATK ILGEVTRPMS VHIPAVKICE KLKKMDSQIC ELKYGKKLDL ASVDLWKMRV AELKQ-
ILQRW GEECRACAEK SDYVNLIREL APKYVEIYPQ TEL
CDNF Mouse Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing
163 amino acids and having a molecular mass of 18.5kDa.

rCDNF CYT-730 5 µg 50
Recombinant Rat Cerebral Dopamine Neurotrophic Factor -20 °C 20 µg 130
Cerebral dopamine neurotrophic factor, ARMET-like Protein 1 mg 2,700
1, Arginine-rich Protein mutated in early stage tumors-like 1,
Conserved dopamine neurotrophic factor, Cdnf, Armetl1
QGLEAGVRSR ADCEVCKEFL NRFYNSLLTR GIDFSVDTIE EELISFCADT KGKENRLCYY LGAT-
KDSATK ILGEVTRPMS VHMPTVKICE KLKKMDSQIC ELKYEKKLDL ESVDLWKMRV AELKQILHSW
GEECRACAEK HDYVNLIKEL APKYVETRPQ TEL
CDNF Rat Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 163
amino acids and having a molecular mass of 18.8kDa.

CLCF1 CYT-071 5 µg 50
Recombinant Human Cardiotrophin-Like Cytokine Factor 1 -20 °C 20 µg 130
Cardiotrophin-like cytokine factor 1, B-cell-stimulating factor 3, 1 mg 2,700
BSF-3, Novel neurotrophin-1, NNT-1, CLCF1, BSF3, CLC, NNT1,
PEPTIDES INTERNATIONAL

NR6, CISS2
GSSHHHHHH SSGLVPRGSH MLNRTGDPGP GPSIQKTYDL TRYLEHQLRS LAGTYLNYLG PPFNEP-
DFNP PRLGAETLPR ATVDLEVWRS LNDKLRLTQN YEAYSHLLCY LRGLNRQAAT AELRRSLAHF
CTSLQGLLGS IAGVMAALGY PLPQPLPGTE PTWTPGPAHS DFLQKMDDFW LLKELQTWLW RSAKDF-
NRLK KKMQPPAAAV TLHLGAHGF
CLCF1 Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing
219 amino acids (28-225 a.a) and having a molecular mass of 24.6kDa. CLCF1 is fused to a 21 amino
acid His-tag at N-terminus.

CNTF CYT-272 5 µg 50
Recombinant Human Ciliary Neurotrophic Factor -20 °C 20 µg 130
HCNTF, CNTF, Ciliary Neurotrophic Factor 1 mg 2,700
The sequence of the first five N-terminal amino acids was determined and was found to be Met-Ala-Phe-
Thr-Glu
Ciliary Neurotrophic Factor Recombinant Human produced in E.Coli is a single, non-glycosylated polypep-
tide chain containing 199 amino acids and having a molecular mass of 22706 Dalton.

CNTF His CYT-573 5 µg 50

Recombinant Human Ciliary Neurotrophic Factor, His Tag -20 °C 20 µg 130
HCNTF, CNTF, Ciliary Neurotrophic Factor 1 mg 3,600
MGSSHHHHHH SSGLVPRGSH MAFTEHSPLT PHRRDLCSRS IWLARKIRSDLTALTESYVK
HQGLNKNINL DSADGMPVAS TDQWSELTEA ERLQENLQAY RTFHVLLARL LEDQQVHFTP TEGDF-
HQAIH TLLLQVAAFA YQIEELMILL EYKIPRNEAD GMPINVGDGG LFEKKLWGLK VLQELSQWTV
RSIHDLRFIS SHQTGIPARG SHYIANNKKM
Ciliary Neurotrophic Factor Recombinant Human produced in E.Coli is a single, non-glycosylated polypep-
tide chain containing 220 amino acids and having a molecular mass of 25 kDa. The CNTF protein is fused
to His Tag at N-terminus.

332 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
mCNTF CYT-139 5 µg 50
Recombinant Mouse Ciliary Neurotrophic Factor -20 °C 25 µg 130
HCNTF, CNTF, Ciliary Neurotrophic Factor 1 mg 2,700
MAFAEQSPLT LHRRDLCSRS IWLARKIRSD LTALMESYVK HQGLNKNISL DSVDGVPVAS TDRWSEM-
TEA ERLQENLQAY RTFQGMLTKL LEDQRVHFTP TEGDFHQAIH TLTLQVSAFA YQLEELMALL EQKV-
PEKEAD GMPVTIGDGG LFEKKLWGLK VLQELSQWTV RSIHDLRVIS SHHMGISAHE SHYGAKQM
Ciliary Neurotrophic Factor Recombinant Mouse produced in E.Coli is a single, non-glycosylated polypep-
tide chain containing 198 amino acids and having a molecular mass of 22.6kDa.

rCNTF CYT-654 5 µg 50
Recombinant Rat Ciliary Neurotrophic Factor -20 °C 25 µg 130
HCNTF, CNTF, Ciliary Neurotrophic Factor 1 mg 2,700
AFAEQTPLTL HRRDLSSRSIWLARKIRSDLTALMESYVKHQGLNKNINLDSVDGVPVASTDRWSEM-
TEAERLQENLQAYRTFQGMLTKLLEDQRVHFTPTEGDFHQAIHTLMLQVSAFAYQLEELMVLLEQKIPE-
NEADGMPATVGDGGLFEKKLWGLKVLQELSQWTVRSIHDLRVISSHQMGISALESHYGAKDKQM
CNTF Recombinant Rat produced in E.Coli is a single, non-glycosylated polypeptide chain containing 200
amino acids and having a molecular mass of 22834 Dalton.

CSFR2 CYT-796 5 µg 50
Recombinant Human Gm-CSF Receptor α -20 °C 20 µg 130
CD116, CDw116, CSF2R, GM-CSF-R-α, GMCSFR, GMR, 1 mg 2,700
SMDP4, GMR-α, CD116 Antigen, CSF2RAX, CSF2RY, CSF2RAY,
CSF2RX, Colony Stimulating Factor 2 Receptor α Subunit,
GM-CSF Receptor α Subunit, Granulocyte-Macrophage Colony-
Stimulating Factor Receptor α Chain, Granulocyte-Macrophage
Colony-Stimulating Factor Receptor Subunit α

PEPTIDES INTERNATIONAL
CSFR2 Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing
324 amino acids (20-320 a.a) and having a molecular mass of 37.2kDa. CSFR2 is fused to a 23 amino
acid His-tag at N-terminus.

CT 1 CYT-436 2 µg 50
Recombinant Human Cardiotrophin-1 -20 °C 10 µg 130
CTF1, CT1, CT-1, Cardiophin 1 1 mg 4,680

MRGSHHHHHH GSSRREGSLE DPQTDSSVSL LPHLEAKIRQ THSLAHLLTK YAEQLLQEYV QLQG-

DPFGLPSFSPPRLPVA GLSAPAPSHA GLPVHERLRL DAAALAALPP LLDAVCRRQA ELNPRAPRLL
RRLEDAARQA RALGAAVEAL LAALGAANRG PRAEPPAATA SAASATGVFP AKVLGLRVCG LYREWL-
SRTE GDLGQLLPGG SA
The Cardiotrophin His-Tagged Fusion Protein Human, produced in E. coli, is 22.5 kDa protein containing
200 amino acid residues of the human Cardiotrophin and 12 additional amino acid residues – His Tag
(underlined).

mCT 1 CYT-151 2 µg 50
Recombinant Mouse Cardiotrophin-1 -20 °C 10 µg 130
CTF1, CT1, CT-1, Cardiophin 1 1 mg 4,680
SQREGSLEDH QTDSSISFLP HLEAKIRQTH NLARLLTKYA EQLLEEYVQQ QGEPFGLPGF SPPRLPLA-
GL SGPAPSHAGL PVSERLRQDA AALSVLPALL DAVRRRQAEL NPRAPRLLRS LEDAARQVRA LGAA-
VETVLA ALGAAARGPG PEPVTVATLF TANSTAGIFS AKVLGFHVCG LYGEWVSRTE GDLGQLVPGG VA
CT 1 Mouse Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing
202 amino acids and having a molecular mass of 21.3kDa.

Order Hotline 1-800-777-4779 502-266-8787 333

 PRODUCT Code Qty PRICE
Recombinant proteins

rCT 1 CYT-199 2 µg 50
Recombinant Rat Cardiotrophin-1 -20 °C 10 µg 130
Cardiotrophin-1, CT-1, Ctf1 1 mg 4,680

MSQREGSLED HQTDSSFSFL PHLEAKIRQT HNLARLLTKY ADQLLEEYVQ QQGEPFGLPG FSP-

PRLPLAG LSGPAPSHAG LPVSERLRQD AAALSALPAL LDAVRRRQAE LNPRAPRLLR SLEDAARQVR
ALGAAVETVL AALGAAARGP VPEPVATSAL FTSNSAAGVF SAKVLGLHVC GLYGEWVSRT EGDL-
GQLVPG GVA
Cardiotrophin-1 Rat Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain
containing 203 amino acids and having a molecular mass of 21.4kDa.

CTGF CYT-541 5 µg 50
Recombinant Human Connective Tissue Growth Factor -20 °C 20 µg 130
CCN2, NOV2, HCS24, IGFBP8, MGC102839, CTGF, Connective 1 mg 3,510
Tissue Growth Factor
MGKKCIRTPK ISKPIKFELS GCTSMKTYRA KFCGVCTDGR CCTPHRTTTL PVEFKCPDGE VMK-
KNMMFIK TCACHYNCPG DNDIFESLYY RKMYGDMA
CTGF Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing
98 amino acids and having a molecular mass of 11.2 kDa.

CTGF His CYT-438 2 µg 50

Recombinant Human Connective Tissue Growth Factor, -20 °C 10 µg 130
His Tag, CCN2, NOV2, HCS24, IGFBP8, MGC102839, CTGF, 1 mg 3,510
Connective Tissue Growth Factor
MGHHHHHHHH HHSSGHIEGR HMRQNCSGPC RCPDEPAPRC PAGVSLVLDG CGCCRVCAKQ
LGELCTERDPCDPHKGLFCD FGSPANRKIG VCTAKDGAPC IFGGTVYRSG ESFQSSCKYQ CT-
PEPTIDES INTERNATIONAL

CLDGAVGC MPLCSMDVRLPSPDCPFPRR VKLPGKCCEE WVCDEPKDQT VVGPALAAYR LEDT-

FGPDPT MIRANCLVQT TEWSACSKTCGMGISTRVTN DNASCRLEKQ SRLCMVRPCE ADLEEN-
IKKG KKCIRTPKIS KPIKFELSGC TSMKTYRAKF CGVCTDGRCCTPHRTTTLPV EFKCPDGEVM
KKNMMFIKTC ACHYNCPGDN DIFESLYYRK MYGDMA
The Connective Tissue Growth Factor His-Tagged Fusion Protein, produced in E. coli, is 38.3 kDa protein
containing 323 amino acid residues of the CTGF human and 23 additional amino acid residues - HisTag,
Xa - cleavage site (underlined).

CTGF (182-250 a.a.) CYT-526 4 µg 50

Recombinant Human Connective Tissue Growth Factor 182- -20 °C 20 µg 130
250 a.a., CCN2, NOV2, HCS24, IGFBP8, MGC102839, CTGF, 1 mg 2,400
Connective Tissue Growth Factor
The Connective Tissue Growth Factor amino acids 182-250, produced in E.Coli, is a fusion protein with His
Tag (4 kDa), having a total molecular mass of 15 kDa.

CTGF HEK CYT-687 2 µg 50

Recombinant Human Connective Tissue Growth Factor, HEK -20 °C 10 µg 130
CCN2, NOV2, HCS24, IGFBP8, MGC102839, CTGF 1 mg 5,200
QNCSGPCRCP DEPAPRCPAG VSLVLDGCGC CRVCAKQLGE LCTERDPCDP HKGLFCHFGS
PANRKIGVCT AKDGAPCIFG GTVYRSGESF QSSCKYQCTC LDGAVGCMPL CSMDVRLPSP DCPF-
PRRVKL PGKCCEEWVC DEPKDQTVVG PALAAYRLED TFGPDPTMIR ANCLVQTTEW SACSKTCGMG
ISTRVTNDNA SCRLEKQSRL CMVRPCEADL EENIKKGKKC IRTPKISKPI KFELSGCTSM KTYRAK-
FCGV CTDGRCCTPH RTTTLPVEFK CPDGEVMKKN MMFIKTCACH YNCPGDNDIF ESLYYRKMYG
DMA HHHHHH
he CTGF Human Recombinant produced in HEK293 cells, is 36kDa protein containing a total of 329 amino
acid residues (aa 27-349) including a C-terminal 6×His tag.

334 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
CTLA 4 CYT-366 5 µg 50
Recombinant Human Cytotoxic T-Lymphocyte Associated -20 °C 25 µg 130
Antigen-4, GSE, CD152, IDDM12, CELIAC3, CTLA-4 1 mg 2,700
MGSSHHHHHH SSGLVPRGSH MGSKAMHVAQ PAVVLASSRG IASFVCEYAS PGKATEVRVT VLRQA-
DSQVT EVCAATYMMG NELTFLDDSI CTGTSSGNQV NLTIQGLRAM DTGLYICKVE LMYPPPYYLG
IGNGTQIYVI DPEPCPDSD
CTLA 4 Human Recombinant produced in E. coli is a single polypeptide chain containing 149 amino
acids (36-161) and having a molecular mass of 15.9 kDa. CTLA 4 is fused to a 23 amino acid His-tag at
N-terminus.

CYR61 CYT-164 5 µg 50
Recombinant Human Cysteine-Rich Angiogenic Inducer 61 -20 °C 20 µg 130
CYR61, Protein CYR61, Cysteine-rich angiogenic inducer 61, 1 mg 3,510
Insulin-like growth factor-binding Protein 10, IGF-binding
Protein 10, IGFBP-10, IBP-10, Protein GIG1, CCN family
member 1, CCN1, GIG1, IGFBP10
TCPAACHCPL EAPKCAPGVG LVRDGCGCCK VCAKQLNEDC SKTQPCDHTK GLECNFGASS TALK-
GICRAQ SEGRPCEYNS RIYQNGESFQ PNCKHQCTCI DGAVGCIPLC PQELSLPNLG CPNPRLVKVT
GQCCEEWVCD EDSIKDPMED QDGLLGKELG FDASEVELTR NNELIAVGKG SSLKRLPVFG MEPRI-
LYNPL QGQKCIVQTT SWSQCSKTCG TGISTRVTND NPECRLVKET RICEVRPCGQ PVYSSLKKGK
KCSKTKKSPE PVRFTYAGCL SVKKYRPKYC GSCVDGRCCTPQLTRTVKMR FRCEDGETFS KNVM-
MIQSCK CNYNCPHANE AAFPFYRLFN DIHKFRD
CYR61 Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain contain-
ing 357 amino acids and having a molecular mass of 39.5kDa.

CYTL1 CYT-775 2 µg 50

PEPTIDES INTERNATIONAL
Recombinant Human Cytokine-Like 1 -20 °C 10 µg 130
Cytokine-like Protein 1, Protein C17, CYTL1, C4orf4, C17 1 mg 5,200
MKHHHHHHASTPPTCYSRMR ALSQEITRDF NLLQVSEPSE PCVRYLPRLY LDIHNYCVLD KLRD-
FVASPP CWKVAQVDSL KDKARKLYTI MNSFCRRDLV FLLDDCNALE YPIPVTTVLP DRQR
CYTL1 Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain (aa
23-136) containing 124 amino acids including a 10 a.a N-terminal His tag. The total molecular mass is
14.6kDa (calculated).

DEFB116 CYT-713 2 µg 50
Recombinant Human β Defensin 116, β-Defensin 16, DEFB-16, -20 °C 10 µg 130
Beta 16, defensin, β-Defensin 116, Defensin, β 16, DEFB16 1 mg 5,200
MGSSHHHHHH SSGLVPRGSH MGSGLFRSHN GKSREPWNPC ELYQGMCRNA CREYEIQYLT
CPNDQKCCLK LSVKITSSKN VKEDYDSNSN LSVTNSSSYS HI
DEFB116 Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain contain-
ing 102 amino acids (24-102 a.a) and having a molecular mass of 11.5kDa. DEFB116 is fused to a 23
amino acid His-tag at N-terminus.

Order Hotline 1-800-777-4779 502-266-8787 335

 PRODUCT Code Qty PRICE
Recombinant proteins

DHH (Desert Hedgehog)

DHH is part of the Hedgehog family which encodes signaling molecules that are in -
volved in regulating morphogenesis. DHH protein is a precursor that is autocatalyti -
cally cleaved, the N-terminal portion is soluble and contains the signalling activity while
the C-terminal portion is involved in precursor processing. Additionally, the C-terminal
product covalently attaches a cholesterol moiety to the N-terminal product, restrict -
ing the N-terminal product to the cell surface and preventing it from freely dif fusing
throughout the organism. Defects in DHH protein have been associated with partial go-
nadal dysgenesis (PGD) accompanied by minifascicular polyneuropathy. DHH plays a
role both male gonadal differentiation and perineurial development.
DHH plays a role in intercellular signaling which is essential for a variety of patterning
events during development. DHH functions as a spermatocyte survival factor in the
testes & is essential for testes development.

DHH Human CYT-467 5 µg 50

Recombinant Human Desert HedgeHog; HHG-3, Desert -20 °C 25 µg 130
Hedgehog homolog, MGC35145, Desert hedgehog Protein 1 mg 2,900

MGSSHHHHHH SSGLVPRGSH MCGPGRGPVG RRRYARKQLV PLLYKQFVPG VPERTLGASG PAE-

GRVARGS ERFRDLVPNY NPDIIFKDEE NSGADRLMTE RCKERVNALA IAVMNMWPGV RLRVTEG-
WDE DGHHAQDSLH YEGRALDITT SDRDRNKYGL LARLAVEAGF DWVYYESRNH VHVSVKADNS
LAVRAGG
DHH Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing
197 amino acids (23-198) and having a molecular mass of 22 kDa. DHH is fused to His-tag (20 a.a.) at
PEPTIDES INTERNATIONAL

N-terminus.

DHH (C23II) CYT-362 5 µg 50

Recombinant Human Desert HedgeHog (C23II) -20 °C 25 µg 130
HHG-3, Desert Hedgehog homolog, MGC35145, Desert 1 mg 2,700
hedgehog Protein, DHH
IIGPGRGPVG RRRYARKQLV PLLYKQFVPG VPERTLGASG PAEGRVARGS ERFRDLVPNY NPDIIFK-
DEE NSGADRLMTE RCKERVNALA IAVMNMWPGV RLRVTEGWDE DGHHAQDSLH YEGRALDITT
SDRDRNKYGL LARLAVEAGF DWVYYESRNH VHVSVKADNS LAVRAGG
DHH (C23II) Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain
containing 177 amino acids and having a molecular mass of 19.9kDa.

DHH (C23II) His CYT-763 5 µg 50

Recombinant Human Desert HedgeHog (C23II), His Tag -20 °C 25 µg 130
HHG-3, Desert Hedgehog homolog, MGC35145, Desert 1 mg 2,700
hedgehog Protein, DHH.
MGSSHHHHHH SSGLVPRGSH MGSMIIGPGR GPVGRRRYAR KQLVPLLYKQ FVPGVPERTL GAS-
GPAEGRV ARGSERFRDL VPNYNPDIIF KDEENSGADR LMTERCKERV NALAIAVMNM WPGVRL-
RVTE GWDEDGHHAQ DSLHYEGRAL DITTSDRDRN KYGLLARLAV EAGFDWVYYE SRNHVHVSVK
ADNSLAVRAG G
DHH (C23II) His Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain
containing 201 amino acids (23-198) and having a molecular mass of 22.4kDa. DHH (C23II) His is fused
to a 24 amino acid His-tag at N-terminus.

336 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
mDHH (C23II) CYT-773 5 µg 50
Recombinant Mouse Desert HedgeHog (C23II) -20 °C 25 µg 130
Desert hedgehog Protein, DHH, HHG-3, C78960 1 mg 2,700

IIGPGRGPVG RRRYVRKQLV PLLYKQFVPS MPERTLGASG PAEGRVTRGS ERFRDLVPNY NPDIIFK-

DEE NSGADRLMTE RCKERVNALA IAVMNMWPGV RLRVTEGWDE DGHHAQDSLH YEGRALDITT
SDRDRNKYGL LARLAVEAGF DWVYYESRNH IHVSVKADNS LAVRAGG
DHH (C23II) Mouse Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain
containing 177 amino acids and having a molecular mass of 20kDa.

EBI3 CYT-367 2 µg 50
Recombinant Human Epstein Barr Virus Induced 3 -20 °C 10 µg 130
Interleukin-27 subunit beta, IL-27 subunit beta, IL-27B, 1 mg 5,200
Epstein-Barr virus-induced gene 3 Protein, EBV-induced gene
3 Protein, EBI3, IL27B
RKGPPAALTLPRVQCRASRYPIAVDCSWTLPPAPNSTSPVSFIATYRLGMAARGHSWPCLQQTPTSTSC-
TITDVQLFSMAPYVLNVTAVHPWGSSSSFVPFITEHIIKPDPPEGVRLSPLAERQLQVQWEPPGSWPFPEI-
FSLKYWIRYKRQGAARFHRVGPIEATSFILRAVRPRARYYVQVAAQDLTDYGELSDWSLPATATMSLGK
EBI3 Human Recombinant produced in E.Coli is a single, non-glycosylated, Polypeptide chain containing
209 amino acids fragment (21-229) having a molecular weight of 23.3kDa.

EBI3 His CYT-668 2 µg 50

Recombinant Human Epstein Barr Virus Induced 3, His Tag -20 °C 10 µg 130
Interleukin-27 subunit β, IL-27 subunit β, IL-27B, Epstein-Barr 1 mg 4,800
virus-induced gene 3 Protein, EBV-induced gene 3 Protein,
EBI3, IL27B

PEPTIDES INTERNATIONAL
EBI3 Human Recombinant produced in E.Coli is a single, non-glycosylated, Polypeptide chain containing
209 amino acids fragment (21-229) having a molecular weight of 34kDa and fused with a 4.5kDa amino-
terminal hexahistidine tag.

mEBI3 CYT-621 2 µg 50
Recombinant Mouse Epstein Barr Virus Induced 3 -20 °C 10 µg 130
IL-27B, IL27B, IL 27-B, EBI-3, Interleukin-27 β, IL-27 subunit 1 mg 5,200
beta, Epstein-Barr virus-induced gene 3 Protein homolog, EBI3
MALVALSQPR VQCHASRYPV AVDCSWTPLQ APNSTRSTSF IATYRLGVAT QQQSQPCLQR SPQA-
SRCTIP DVHLFSTVPY MLNVTAVHPG GASSSLLAFV AERIIKPDPP EGVRLRTAGQ RLQVLWHPPA
SWPFPDIFSL KYRLRYRRRG ASHFRQVGPI EATTFTLRNS KPHAKYCIQV SAQDLTDYGK PSDWSLP-
GQV ESAPHKP
EBI3 Mouse Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing
207 amino acids and having a molecular mass of 22.9kDa.

EG VEGF CYT-338 5 µg 50
Recombinant Human Endocrine Gland Vacular Endothelial -20 °C 20 µg 130
Growth Factor, PK1, PRK1, Prokineticin 1, EG-VEGF 1 mg 2,700
The sequence of the first five N-terminal amino acids was determined and was found to be Ala-Val-Ile-Thr-
Gly
EG-VEGF Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain
containing 86 amino acids and having a molecular mass of 9605 Dalton.

Order Hotline 1-800-777-4779 502-266-8787 337

 PRODUCT Code Qty PRICE
Recombinant proteins

EGF (Epidermal Growth Factor)

Epidermal growth factor has a profound effect on the differentiation of specific cells in
vivo and is a potent mitogenic factor for a variety of cultured cells of both ectodermal
and mesodermal origin. The EGF precursor is believed to exist as a membrane-bound
molecule which is proteolytically cleaved to generate the 53-amino acid peptide hor -
mone that stimulates cells to divide. EGF stimulates the growth of various epidermal
and epithelial tissues in vivo and in vitro and of some fibroblasts in cell culture.
EGF CYT-217 100 µg 50
Recombinant Human Epidermal Growth Factor -20 °C 0.5 mg 130
Urogastrone, URG, EGF 1 mg 225

(NSDSECPLSH DGYCLHDGVC MYIEALDKYA CNCVVGYIGE RCQYRDLKWW ELR

Epidermal Growth Factor Human Recombinant produced in E.Coli is a single, non-glycosylated, polypep-
tide chain containing 53 amino acids and having a molecular mass of 6222 Dalton. .

S.Z. Rush, et al., Neuro Oncol., 12, 8 (2010). H. Kallio, et al., PLoS ONE, 6, 11 (2011).
A. Mechaly, et al., mBio,. 3, 3 (2012). G. Chen, et al., Developmental Dynamics, 239, 12 (2010)
H. Kallio, et al., Journal of Cancer Molecules, 5, A. Higuchi, et al., Sen’i Gakkaishi, 67, 8 (2011).
3 (2010).

EGF Pichia CYT-332 100 µg 50

Recombinant Human Epidermal Growth Factor, Pichia -20 °C 0.5 mg 130
Urogastrone, URG, EGF 1 mg 250
PEPTIDES INTERNATIONAL

The sequence of the first five N-terminal amino acids was determined and was found to be Asn-Ser-
Asp-Ser-Glu, which agrees with the sequence of native EGF human. N-terminal methionine has been
completely removed enzymatically.
Epidermal Growth Factor Human Recombinant produced in Pichia Pastoris is a single, glycosylated,
polypeptide chain containing 51 amino acids and having a molecular mass of 6KDa.

EGF (Leu 21) CYT-466 20 µg 50

Recombinant Human Epidermal Growth Factor 21-Leu -20 °C 100 µg 130
Urogastrone, URG, EGF 1 mg 925

The sequence of the first five N-terminal amino acids was determined and was found to be Asn-Ser-Asp-
Ser-Glu.
EGF 21-Leu Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain
containing 53 amino acids and having a molecular mass of 6205 Dalton.

EGF Long CYT-798 20 µg 50

Recombinant Human Epidermal Growth Factor Long -20 °C 100 µg 130
Urogastrone, URG, EG 1 mg 990
MFPAMPLSSL FANAVLRAQH LHQLAADTYK EFERAYIPEG QRYSIQVNFA HYGNSDSECP LSHDGY-
CLHD GVCMYIEALD KYACNCVVGY IGERCQYRDL KWWELR
Recombinant Human EGF Long produced in E.Coli cells is a single non-glycosylated, polypeptide chain
containing 106 amino acids and having a molecular mass of 12.3kDa.

338 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
mEGF CYT-326 100 µg 50
Recombinant Mouse Epidermal Growth Factor -20 °C 0.5 mg 130
Urogastrone, URG, EGF 1 mg 225

The sequence of the first five N-terminal amino acids was determined and was found to be Asn-Ser-Tyr-
Pro-Gly, which agrees with the sequence of native Epidermal Growth Factor human.
Epidermal Growth Factor Mouse Recombinant produced in E.Coli is a single, non-glycosylated, polypep-
tide chain containing 53 amino acids including 3 intramolecular disulfide-bonds and having a molecular
mass of 6 kDa.

mEGF CYT-554 10 µg 50
Mouse Epidermal Growth Factor -20 °C 50 µg 130
Urogastrone, URG, EGF 1 mg 2,050
Epidermal Growth Factor Mouse purified from submaxillary gland is a single, glycosylated, polypeptide
chain having a molecular mass of 6.1 kDa.

mEGF, His CYT-138 2 µg 50

Recombinant Mouse Epidermal Growth Factor, His -20 °C 10 µg 130
Urogastrone, URG, EGF 100 µg 1,200

MGSSHHHHHH SSGLVPRGSH MGSMNSYPGC PSSYDGYCLN GGVCMHIESL DSYTCNCVIG

YSGDRCQTRD LRWWELR
EGF mouse Recombinant produced in E. coli is a single polypeptide chain containing 77 amino acids (977-
1029) and having a molecular mass of 8.6kDa. EGF is fused to a 24 amino acid His-tag at N-terminus.

rEGF CYT-556 2 µg 175

Rat Epidermal Growth Factor -20 °C 5 µg 270
10 µg 490

PEPTIDES INTERNATIONAL
Urogastrone, URG, EGF
Epidermal Growth Factor Rat purified from submandibular gland is a single, glycosylated, polypeptide
chain having a molecular mass of 6.15 kDa.

rEGF CYT-669 20 µg 50
Recombinant Rat Epidermal Growth Factor -20 °C 100 µg 130
Urogastrone, URG, EGF 1 mg 990
NSNTGCPPSY DGYCLNGGVC MYVESVDRYV CNCVIGYIGE RCQHRDLRWW KLR
Epidermal Growth Factor Rat Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide
chain containing 53 amino acids and having a molecular mass of 6151 Dalton.

EmAP II CYT-607 5 µg 50
Recombinant Human Endothelial-monocyte Activating -20 °C 20 µg 130
Polypeptide II, AIMP1, EMAP2, EMAP-2, EMAPII, SCYE1, 1 mg 3,510
Multisynthetase complex auxiliary component p43, Endothelial
monocyte-activating polypeptide 2, EMAP-II, p43
SKPIDVSRLD LRIGCIITAR KHPDADSLYV EEVDVGEIAP RTVVSGLVNH VPLEQM QNRM VILLCNLKPA
KMRGVLSQAM VMCASSPEKI EILAPPNGSV PGDRITFDAF PGEPDKELNP KKKIWEQIQP DLHTN-
DECVA TYKGVPFEVK GKGVCRAQTM SNSGIK
EMAP-II Recombinant Human produced in E.Coli is a single, non-glycosylated polypeptide chain contain-
ing 166 amino acids and having a molecular mass of 18.3 kDa.

Order Hotline 1-800-777-4779 502-266-8787 339

 PRODUCT Code Qty PRICE
Recombinant proteins

AImP1 CYT-021 1 µg 50
Recombinant Human Aminoacyl tRNA Synthetase Complex- -20 °C 5 µg 130
Interacting Multifunctional Protein 1 50 µg 1,200
Aminoacyl tRNA synthase complex-interacting multifunctional
Protein 1, Multisynthase complex auxiliary component p43,
AIMP1, EMAP2, SCYE1, p43, EMAPII
MGSSHHHHHH SSGLVPRGSH MLPAVAVSEP VVLRFMIFCR LLAKMANNDA VLKRLEQKGA
EADQIIEYLK QQVSLLKEKA ILQATLREEK KLRVENAKLK KEIEELKQEL IQAEIQNGVK QIPFPSGTPL
HANSMVSENV IQSTAVTTVS SGTKEQIKGG TGDEKKAKEK IEKKGEKKEK KQQSIAGSAD SKPID-
VSRLD LRIGCIITAR KHPDADSLYV EEVDVGEIAP RTVVSGLVNH VPLEQMQNRM VILLCNLKPA KM-
RGVLSQAM VMCASSPEKI EILAPPNGSV PGDRITFDAF PGEPDKELNP KKKIWEQIQP DLHTNDECVA
TYKGVPFEVK GKGVCRAQTM SNSGIK
AIMP1 Human Recombinant fused with a 20 amino acid His tag at N-terminus produced in E.Coli is a
single, non-glycosylated, polypeptide chain containing 356 amino acids (1-336 a.a.) and having a molecu-
lar mass of 39.2kDa (Molecular size on SDS-PAGE will appear higher).

Endoglin Sf9 CYT-389 2 µg 50

Recombinant Human Endoglin, Sf9 -20 °C 10 µg 130
CD105, ENG, END, ORW, HHT1, ORW1, FLJ41744, Endoglin 100 µg 990

MDRGTLPLAVALLLASCSLSPTSLAETVHCDLQPVGPERGEVTYTTSQVSKGCVAQAPNAILEVHVLFLE-
FPTGPSQLELTLQASKQNGTWPREVLLVL SVNSSVFLHLQALGIPLHLAYNSSLVTFQEPPGVNTTELPS-
FPKTQILEWAAERGPITSAAELNDPQSILLRLGQAQGSLSFCMLEASQDMGRTLEWRPRTPALVRGCHLE
GVAGHKEAHILRVLPGHSAGPRTVTVKVELSCAPGDLDAVLILQGPPYVSWLIDANHNMQIWTT-
GEYSFKIFPEKNIRGFKLPDTPQGLLGEARMLNASIVASFVELPL ASIVSLHASSCGGRLQTSPAPIQTTP-
PKDTCSPELLMSLIQTKCADDAMTLVLKKE LVAHLKCTITGLTFWDPSCEAEDRGDKFVLRSAYS-
PEPTIDES INTERNATIONAL

SCGMQVSASMISNEAVVNILSSSSPQRKKVHCLNMDSLSFQLGLYLSPHFLQASNTIEPGQQS-
FVQVRVSPSVSEFLLQLDSCHLDLGPEGGTVELIQGRAAKGNCVSLLSPSPEGDPRFSFLLHFYTVPI
PKTGTLSCTVALRPKTGS
CD105 Human Recombinant extracellular domain produced in baculovirus is a homodimeric, glycosyl-
ated, Polypeptide containing 586 amino acids and having a molecular mass of 61 kDa but as a result
of glycosylation, migrates at 90 kDa under reducing conditions in SDS-PAGE. The CD105 is fused to a
C-terminal His-tag (6xHis).

Endoglin CYT-525 2 µg 175

Recombinant Human Endoglin -20 °C 5 µg 270
CD105, ENG, END, ORW, HHT1, ORW1, FLJ41744, Endoglin 10 µg 490
Endoglin Human Recombinant extracellular domain produced in E.Coli is a single, glycosylated, Polypep-
tide containing 151 amino acids (26-176) and having a molecular mass of 43 kDa.

340 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
mEndoglin CYT-424 2 µg 50
Recombinant Mouse Endoglin, CD105, ENG, END, ORW, HHT1, -20 °C 10 µg 130
ORW1, FLJ41744, Cell surface MJ7/18 antigen, Endoglin 100 µg 990

MDRGVLPLPITLLFVIYSFVPTTGLAERVGCDLQPVDPTRGEVT FTTSQVSEGCVAQAANAVREVHVL-
FLDFPGMLSHLELTLQASKQNGTETQEVF LVLVSNKNVFVKFQAPEIPLHLAYDSSLVIFQGQPRVNIT-
VLPSLTSRKQILDWA ATKGAITSIAALDDPQSIVLQLGQDPKAPFLCLPEAHKDMGATLEWQPRAQTP
VQSCRLEGVSGHKEAYILRILPGSEAGPRTVTVMMELSCTSGDAILILHGPPYVS WFIDINHSMQILTT-
GEYSVKIFPGSKVKGVELPDTPQGLIAEARKLNASIVTSFV ELPLVSNVSLRASSCGGVFQTTPAPV-
VTTPPKDTCSPVLLMSLIQPKCGNQVMT LALNKKHVQTLQCTITGLTFWDSSCQAEDTDDHLVLSSAYS-
SCGMKVTAHVV SNEVIISFPSGSPPLRKKVQCIDMDSLSFQLGLYLSPHFLQASNTIELGQQAFVQV
SVSPLTSEVTVQLDSCHLDLGPEGDMVELIQSRTAKGSCVTLLSPSPEGDPRFSF LLRVYMVPTP-
TAGTLSCNLALRPSTLSQEVYKTVSMRLNIVSPDLS
CD105 Mouse Recombinant extracellular domain produced in baculovirus is a homodimeric, glycosylated,
Polypeptide containing 581 amino acids and having a molecular mass of 61 kDa but as a result of glyco-
sylation, migrates at 75-85 kDa under reducing conditions in SDS-PAGE. Based on N-terminal sequence
analysis, the primary structure of recombinant mature Endoglin starts at Glu 26. The CD105 is fused to a
C-terminal His-tag (6xHis).

EPGN CYT-601 5 µg 50
Recombinant Human Epigen; EPG, Epigen, PRO9904, -20 °C 25 µg 130
ALGV3072, FLJ75542, EPGN, Epithelial mitogen 1 mg 2,700
AVTVTPPITA QQADNIEGPI ALKFSHLCLE DHNSYCINGA CAFHHELEKA ICRCFTGYTG ERCEHLTLTS
YA
Epigen Recombinant Human produced in E.Coli is a single, non-glycosylated, polypeptide chain containing
72 amino acids and having a molecular mass of 7.9 kDa.

PEPTIDES INTERNATIONAL
EPGN His CYT-794 5 µg 50
Recombinant Human Epigen, His Tag; EPG, Epigen, PRO9904, -20 °C 20 µg 130
ALGV3072, FLJ75542, EPGN, Epithelial mitogen 1 mg 2,700

MGSSHHHHHH SSGLVPRGSH MGSAAVTVTP PITAQQGNWT VNKTEADNIE GPIALKFSHL CLEDHN-

SYCI NGACAFHHEL EKAICRCFTG YTGERCEHLT LTSYAVDSYE K
EPGN Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing
111 amino acids (23-110 a.a) and having a molecular mass of 12.1kDa. EPGN is fused to a 23 amino acid
His-tag at N-terminus.

EREG CYT-609 5 µg 50
Recombinant Human Epiregulin, EREG, Epiregulin, ER -20 °C 25 µg 130
1 mg 2,700
MVAQVSITKC SSDMNGYCLH GQCIYLVDMS QNYCRCEVGY TGVRCEHFFL
Epiregulin Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain
containing 50 amino acids and having a molecular mass of 6 kDa.

Order Hotline 1-800-777-4779 502-266-8787 341

 PRODUCT Code Qty PRICE
Recombinant proteins

EPO a CYT-201 5 µg 50
Recombinant Human Erythropoietin-α, Erythropoietin-Alpha, -20 °C 50 µg 130
EPO-a, EPO-alpha, Epoetin, EP, MGC138142 1 mg 1,500
APPRLICDSR VLERYLLEAK EAENITTGCA EHCSLNENIT VPDTKVNFYA WKRMEVGQQA
VEVWQGLALL SEAVLRGQAL LVNSSQPWEP LQLHVDKAVS GLRSLTTLLR ALGAQKEAIS PPDAAS-
AAPL RTITADTFRK LFRVYSNFLR GKLKLYTGEA CRTGDR
Erythropoietin-alpha Human Recombinant is produced in Chinese hamster ovary (CHO) cells by recom-
binant DNA technology is a single, polypeptide chain containing 166 amino acids and having a predicted
molecular mass of 21,000 Dalton and apparent glycosylated molecular mass of 36-40kDa. L.M. Yamaleyeva,
et al., Stem Cells Trans Med., 1, 5 (2012).
M.I. Ransome and A.M. Turnley, J. of Neurochemistry, 102, 6 (2007).
M.-S. Ryu, et al., J. Nutr., 138, 11 (2008).
M.-S. Ryu, Zinc Transporter Expression in Mature Red Blood Cells and Differentiating Erythoid Progenitor Cells,
University of Florida (2007).

EPO a Fc CYT-325 2 µg 50
Recombinant Human Erythropoietin-α Fc/Chimera -20 °C 10 µg 130
EPO-a, EPO-α, Epoetin, EP, MGC138142 1 mg 4,800
Erythropoietin-α Fc-Chimera Human Recombinant is produced in Chinese hamster ovary (CHO) cells by
recombinant DNA technology is a dimeric, glycosilated, polypeptide chain consisting of two mature human
EPO molecules linked to the Fc portion of human IgG1. The Fc component contains the CH2 domain, the
CH3 domain and hinge region, but not the CH1 domain of IgG1. As a result of glycosylation, the recombi-
nant protein migrates with an apparent molecular mass of 140 kDa in non-reducing SDS-PAGE.

EPO a HEK CYT-083 2 µg 50

Recombinant Human Erythropoietin-α, HEK -20 °C 10 µg 130
Erythropoietin-α, EPO-a, EPO-α, Epoetin, EP, MGC138142 1 mg 5,200
PEPTIDES INTERNATIONAL

EPO-a Human Recombinant produced in HEK cells is a glycosylated monomer, having a total molecular
weight of 36kDa.

EPO a His CYT-791 2 µg 50

Recombinant Human Erythropoietin-α, His Tag -20 °C 10 µg 130
Erythropoietin, EP, INN=Epoetin, EPO α, Erythropoietin-α, EPO 1 mg 4,800
MGSSHHHHHH SSGLVPRGSH MGSAPPRLIC DSRVLERYLL EAKEAENITT GCAEHCSLNE NITVP-
DTKVN FYAWKRMEVG QQAVEVWQGL ALLSEAVLRG QALLVNSSQP WEPLQLHVDK AVSGLRSLTT
LLRALRAQKE AISPPDAASA APLRTITADT FRKLFRVYSN FLRGKLKLYT GEACRTGDR
EPO a Human Recombinant produced in E.Coli, is a single, non-glycosylated polypeptide chain containing
189 amino acids (28-193a.a.) and having a molecular mass of 20.9kDa. EPO a is fused to a 23 amino
acid His-tag at N-terminus.

FAS CYT-125 5 µg 50
Recombinant Human sFas Receptor -20 °C 20 µg 130
Tumor necrosis factor receptor superfamily member 6, Apo-1 1 mg 3,510
antigen, Apoptosis-mediating surface antigen FAS, FASLG
receptor, CD95, FAS, APT1, FAS1, APO-1, FASTM, ALPS1A,
TNFRSF6
MRLSSKSVNA QVTDINSKGL ELRKTVTTVE TQNLEGLHHD GQFCHKPCPP GERKARDCTV NGDEP-
DCVPC QEGKEYTDKA HFSSKCRRCR LCDEGHGLEV EINCTRTQNT KCRCKPNFFC NSTVCEHCDP
CTKCEHGIIK ECTLTSNTKC KEEGSRS
sFas Receptor Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain
containing 157 amino acids and having a molecular mass of 17.6kDa.

342 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
FASLG CYT-031 5 µg 50
Recombinant Human FAS Ligand, Tumor necrosis factor ligand -20 °C 20 µg 130
superfamily member 6, Apoptosis antigen ligand, APTL, CD95 1 mg 2,700
ligand, CD95-L, Fas antigen ligand, Fas ligand, FasL, CD178,
FASLG, APT1LG1, CD95L, TNFSF6, ALPS1B
MGSSHHHHHH SSGLVPRGSH MQIGHPSPPP EKKELRKVAH LTGKSNSRSM PLEWEDTYGI VLLS-
GVKYKK GGLVINETGL YFVYSKVYFR GQSCNNLPLS HKVYMRNSKY PQDLVMMEGK MMSYCTT-
GQM WARSSYLGAV FNLTSADHLY VNVSELSLVN FEESQTFFGL YKL
FASLG Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing
173 amino acids (130-281 a.a.) and having a molecular mass of 19.6kDa. FASLG is fused to a 21 amino
acid His-tag at N-terminus.

FASLG HEK CYT-051 2 µg 50

Recombinant Human FAS Ligand, HEK, Fas ligand (TNF -20 °C 10 µg 130
superfamily, member 6), APT1LG1, FASL, TNFSF6, CD178, 1 mg 3,800
tumor necrosis factor (ligand) superfamily member 6,
Apoptosis antigen ligand, Fas antigen ligand, APTL, CD95-L
Recombinant Human FAS Ligand produced in HEK293 cells is a polypeptide chain containing 147 amino
acids (134-281a.a). FASLG is fused to a 6 amino acid His-tag at N-terminus.

FGF (Fibroblast Growth Factor)

The FGFs are a family of more than 20 small (~17–26 kDa) secreted peptides. The
initial characterization of these proteins focused on their ability to stimulate fibroblast
proliferation. This mitogenic activity was mediated through FGF receptors (FGFRs) 1,
2, or 3. A fourth closely related tyrosine kinase receptor (FGFR4) was able to bind the

PEPTIDES INTERNATIONAL
FGFs but did not lead to a mitogenic response.
FGFs modulate cellular activity via at least 5 distinct subfamilies of high-affinity FGF
receptors (FGFRs): FGFR-1, -2, -3, and -4, all with intrinsic tyrosine kinase activity and,
except for FGFR-4, multiple splice isoforms, and FGFR-5, which lacks an intracellular
kinase domain. There is growing evidence that FGFRs can be important for regulation
of glucose and lipid homeostasis. The overexpression of a dominant negative form of
FGFR-1 in ? cells leads to diabetes in mice, which thus implies that proper FGF signal-
ing is required for normal ? cell function and glycemia maintenance. FGFR-2 appears
to be a key molecule during pancreatic development. Moreover , FGFR-4 has been
implicated in cholesterol metabolism and bile acid synthesis.
FGF-19, has been shown to cause resistance to diet-induced obesity and insulin
desensitization and to improve insulin, glucose, and lipid profiles in diabetic rodents.
Since these effects, at least in part, are mediated through the observed changes in
metabolic rates, FGF-19 can be considered as a regulator of energy expenditure.
FGF-21 is preferentially expressed in liver, but an exact knowledge of FGF-21 bioactiv-
ity and its mode of action have been lacking to date. FGF-21 is a potent activator of
glucose uptake on adipocytes, protects animals from diet-induced obesity when over-
expressed in transgenic mice, and lowers blood glucose and triglyceride levels when
therapeutically administered to diabetic rodents.

Order Hotline 1-800-777-4779 502-266-8787 343

 PRODUCT Code Qty PRICE
Recombinant proteins

FGF 1 CYT-264 10 µg 50
Recombinant Human Fibroblast Growth Factor-acidic -20 °C 50 µg 130
HBGF-1, ECGF-beta, FIBP, FGFIBP, FIBP-1, ECGF, ECGFA, 1 mg 1,350
GLIO703, FGF1, FGF-a
MFNLPPGNYK KPKLLYCSNG GHFLRILPDG TVDGTRDRSD QHIQLQLSAE SVGEVYIKST ETGQYL-
AMDT DGLLYGSQTP NEECLFLERL EENHYNTYIS KKHAEKNWFV GLKKNGSCKR GPRTHYGQKA
ILFLPLPVSS D
Fibroblast Growth Factor-acidic Human Recombinant (FGF-1) produced in E.Coli is a single, non-
glycosylated, polypeptide chain containing 140 amino acids and having a molecular mass of approximately
15.8kDa. .

FGF 1 Sf9 CYT-364 2 µg 50

Recombinant Human Fibroblast Growth Factor-acidic, Sf9 -20 °C 10 µg 130
HBGF-1, ECGF-β, FIBP, FGFIBP, FIBP-1, ECGF, ECGFA, 1 mg 5,200
GLIO703, FGF1, FGF-a
The sequence of the first five N-terminal amino acids as determined and was found to be Met-Phe-Asn-
Leu-Pro
Fibroblast Growth Factor-1 Human Recombinant (FGF-1) produced in Sf9 insect cells is a single, glycosyl-
ated, polypeptide chain containing 140 amino acids and having a molecular mass of 15803 Dalton.

mFGF 1 CYT-528 10 µg 50
Recombinant Mouse Fibroblast Growth Factor-acidic -20 °C 50 µg 130
HBGF-1, ECGF-β, FIBP, FGFIBP, FIBP-1, ECGF, ECGFA, 1 mg 1,350
GLIO703, FGF1, FGF-a
MFNLPLGNYK KPKLLYCSNG GHFLRILPDG TVDGTRDRSD QHIQLQLSAE SAGEVYIKGT ETGQYL-
AMDT EGLLYGSQTP NEECLFLERL EENHYNTYTS KKHAEKNWFV GLKKNGSCKR GPRTHYGQKA
PEPTIDES INTERNATIONAL

ILFLPLPVSS D
Fibroblast Growth Factor-acidic Mouse Recombinant (FGF-1) produced in E.Coli is a single, non-glycosyl-
ated, polypeptide chain containing 141 amino acids and having a molecular mass of 15.9 kDa.

mFGF 1 His CYT-072 5 µg 50

Recombinant Mouse Fibroblast Growth Factor-acidic, His Tag -20 °C 20 µg 130
HBGF-1, ECGF-β, FIBP, FGFIBP, FIBP-1, ECGF, ECGFA, 1 mg 2,700
GLIO703, FGF1, FGF-a
MGSSHHHHHH SSGLVPRGSH MFNLPLGNYK KPKLLYCSNG GHFLRILPDG TVDGTRDRSD
QHIQLQLSAE SAGEVYIKGT ETGQYLAMDT EGLLYGSQTP NEECLFLERL EENHYNTYTS
KKHAEKNWFV GLKKNGSCKR GPRTHYGQKA ILFLPLPVSS D
FGF-1 Mouse Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing
161 amino acids (16-155 a.a) and having a molecular mass of 18kDa (Molecular weight on SDS-PAGE will
appear higher). FGF-1 is fused to a 21 amino acid His-tag at N-terminus.

rFGF 1 CYT-075 10 µg 50
Recombinant Rat Fibroblast Growth Factor-acidic -20 °C 50 µg 130
Fibroblast growth factor 1, FGF-1, Acidic fibroblast growth 1 mg 1,350
factor, aFGF, Heparin-binding growth factor 1, HBGF-1, Fgf1,
Fgfa, HBGF1
MFNLPLGNYK KPKLLYCSNG GHFLRILPDG TVDGTRDRSD QHIQLQLSAE SAGEVYIKGT ETGQYL-
AMDT EGLLYGSQTP NEECLFLERL EENHYNTYTS KKHAEKNWFV GLKKNGSCKR GPRTHYGQKA
ILFLPLPVSS D
Fibroblast Growth Factor-acidic Rat Recombinant (FGF-1) produced in E.Coli is a single, non-glycosylated,
polypeptide chain containing 141 amino acids and having a molecular mass of 15.9 kDa.

344 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
baFGF CYT-613 1 µg 50
Bovine Fibroblast Growth Factor-acidic -20 °C 5 µg 130
HBGF-1, ECGF-beta, FIBP, FGFIBP, FIBP-1, ECGF, ECGFA, 100 µg 1880
GLIO703, FGF1, FGF-a
Fibroblast Growth Factor-acidic Bovine (FGF-1) purified from Bovine Brain contains a 17 kDa and a 20
kDa polypeptide chain. The 17 kDa peptide is derived from the 20K peptide by restricted proteolysis.

FGF 2 CYT-218 10 µg 50
Recombinant Human Fibroblast Growth Factor-basic -20 °C 50 µg 130
Prostatropin, HBGH-2, HBGF-2, FGF-2, FGF-b 1 mg 720
MAAGSITTLP ALPEDGGSGA FPPGHFKDPK RLYCKNGGFF LRIHPDGRVD GVREKSDPHI KLQLQA-
EERG VVSIKGVCAN RYLAMKEDGR LLASKCVTDE CFFFERLESN NYNTYRSRKY TSWYVALKRT
GQYKLGSKTG PGQKAILFLP MSAKS
Fibroblast Growth Factor-2 Human Recombinant (FGF-2) produced in E.Coli is a single, non-glycosylated,
polypeptide chain containing 155 amino acids and having a molecular mass of 17353 Dalton.

S.Z. Rush, et al., Neuro. Oncol., 12, 8 (2010). A.J. Robinson, et al., Cell Transplantation, 19, 8 (2010).
M. Inada, et al., J Cell Sci ,121, 7 (2008). A. Arthur, et al., Stem Cells, 26, 7 (2008).

FGF 2 Sf9 CYT-365 2 µg 50

Recombinant Human Fibroblast Growth Factor-basic, Sf9 -20 °C 10 µg 130
Prostatropin, HBGH-2, HBGF-2, FGF-2, FGF-b 1 mg 5,200
The sequence of the first five N-terminal amino acids was determined and was found to be Ala-Ala-Gly-
Ser-Ile
Fibroblast Growth Factor-2 Human Recombinant (FGF-2) produced in Sf9 insect cells is a single, glycosyl-

PEPTIDES INTERNATIONAL
ated, polypeptide chain containing 155 amino acids and having a molecular mass of 17353 Dalton. .

FGF 2 (147 a.a.) CYT-557 10 µg 50

Recombinant Human Fibroblast Growth Factor-basic (147 a.a) -20 °C 50 µg 130
Prostatropin, HBGH-2, HBGF-2, FGF-2, FGF-b 1 mg 1,080
MPALPEDGGS GAFPPGHFKD PKRLYCKNGG FFLRIHPDGR VDGVREKSDP HIKLQLQAEE RGV-
VSIKGVC ANRYLAMKED GRLLASKCVT DECFFFERLE SNNYNTYRSR KYTSWYVALK RTGQYKLGSK
TGPGQKAILF LPMSAKS
Fibroblast Growth Factor-2 Human Recombinant (FGF-2) produced in E.Coli is a single, non-glycosylated,
polypeptide chain containing 147 amino acids and having a molecular mass of 16539 Dalton.

FGF 2 293 Cells CYT-085 2 µg 50

Recombinant Human Fibroblast Growth Factor-basic, 293 Cells -20 °C 10 µg 130
Prostatropin, HBGH-2, HBGF-2, FGF-2, FGF-b 1 mg 4,200

FGF-2 Human Recombinant produced in HEK cells is a non-glycosylated monomer, having a total molecu-
lar weight of 17kDa.

FGF2 Plant CYT-123 10 µg 50

Recombinant Human Fibroblast Growth Factor-basic, Plant -20 °C 50 µg 130
Prostatropin, HBGH-2, HBGF-2, FGF-2, FGF-b, Fibroblast 1 mg 1,260
growth factor 2, Basic fibroblast growth factor, Heparin-binding
growth factor 2
FGF-2 Human Recombinant produced in rice is a single, non-glycosylated polypeptide chain containing
146 amino acids and having a molecular mass of ~17kDa.

Order Hotline 1-800-777-4779 502-266-8787 345

 PRODUCT Code Qty PRICE
Recombinant proteins

bFGF 2 CYT-288 10 µg 50
Recombinant Bovine Fibroblast Growth Factor-basic -20 °C 50 µg 130
HBGH-2, HBGF-2, Prostatropin, FGF-2, FGB-b 1 mg 1,260
The sequence of the first five N-terminal amino acids was determined and was found to be Met-Ala-Ala-
Gly-Ser
FGF-2 Bovine Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing
155 amino acids and having a molecular mass of 17250 Dalton.

bFGF 2 CYT-560 2 µg 110

Bovine Fibroblast Growth Factor-basic -20 °C 5 µg 190
HBGH-2, HBGF-2, Prostatropin, FGF-2, FGB-b 10 µg 290
FGF-2 Bovine purified from bovine pituitary is a single, glycosylated, polypeptide chain having a molecular
mass of 16kDa. .

mFGF 2 CYT-386 10 µg 50
Recombinant Mouse Fibroblast Growth Factor-basic -20 °C 50 µg 130
HBGH-2, HBGF-2, Prostatropin, FGF-2, FGB-b 1 mg 1,260
MPALPEDGGA AFPPGHFKDP KRLYCKNGGF FLRIHPDGRV DGVREKSDPH VKLQLQAEER GVVSIK-
GVCA NRYLAMKEDG RLLASKCVTE ECFFFERLES NNYNTYRSRK YSSWYVALKR TGQYKLGSKT
GPGQKAILFL PMSAKS
Fibroblast Growth Factor-basic Mouse Recombinant (FGF-2) produced in E.Coli is a single, non-glycosyl-
ated, polypeptide chain containing 146 amino acids and having a molecular mass of 16.3kDa.

rFGF 2 CYT-608 10 µg 50
Recombinant Rat Fibroblast Growth Factor-basic -20 °C 50 µg 130
HBGH-2, HBGF-2, Prostatropin, FGF-2, FGB-b, Fibroblast 1 mg 1,260
PEPTIDES INTERNATIONAL

Growth Factor-basic, Basic fibroblast growth factor, bFGF,

Heparin-binding growth factor 2
PALPEDGGGA FPPGHFKDPK RLYCKNGGFF LRIHPDGRVD GVREKSDPHV KLQLQAEERG VVSIK-
GVCAN RYLAMKEDGR LLASKCVTEE CFFFERLESN NYNTYRSRKY SSWYVALKRT GQYKLGSKTG
PGQKAILFLP MSAKS
bFGF Rat Recombinant (FGF-2) produced in E.Coli is a single, non-glycosylated, polypeptide chain
containing 145 amino acids and having a molecular mass of 16.3 kDa.

FGF 4 CYT-312 5 µg 50
Recombinant Human Fibroblast Growth Factor-4 -20 °C 25 µg 130
HBGF4, FGF-4, FGF4, KFGF, HSTF1 1 mg 2,700
GRGGAAAPTA PNGTLEAELE RRWESLVALS LARLPVAAQP KEAAVQSGAG DYLLGIKRLR RLYC-
NVGIGF HLQALPDGRI GGAHADTRDS LLELSPVERG VVSIFGVASR FFVAMSSKGK LYGSPFFTDE
CTFKEILLPN NYNAYESYKY PGMFIALSKN GKTKKGNRVS PTMKVTHFLP RL
FGF4 Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing
182 amino acids and having a molecular mass of 19.8kDa.

FGF 4 HEK CYT-084 2 µg 50

Recombinant Human Fibroblast Growth Factor-4, HEK -20 °C 10 µg 130
HBGF4, FGF-4, FGF4, KFGF, HSTF1 1 mg 5,200
FGF-4 Human Recombinant produced in HEK cells is a glycosylated monomer, having a molecular weight
range of 17-27kDa due to glycosylation.

346 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
mFGF 8 CYT-070 5 µg 50
Recombinant Mouse Fibroblast Growth Factor-8 -20 °C 25 µg 130
Fibroblast growth factor 8, FGF-8, Androgen-induced growth 1 mg 2,700
factor, AIGF, Heparin-binding growth factor 8, HBGF-8, Fgf8
QVRSAAQKRG PGAGNPADTL GQGHEDRPFG QRSRAGKNFT NPAPNYPEEG SKEQRDSVLP
KVTQRHVREQ SLVTDQLSRR LIRTYQLYSR TSGKHVQVLA NKRINAMAED GDPFAKLIVE TDTFG-
SRVRV RGAETGLYIC MNKKGKLIAK SNGKGKDCVF TEIVLENNYT ALQNAKYEGW YMAFTRKGRP
RKGSKTRQHQ REVHFMKRLP RGHHTTEQSL RFEFLNYPPF TRSLRGSQRT WAPEPR
FGF-8 Mouse Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing
246 amino acids and having a molecular mass of 28.1kDa.

FGF8 CYT-087 2 µg 50
Recombinant Human Fibroblast Growth Factor-8, HEK -20 °C 10 µg 130
FGF8B, FGF-8B, FGF8-B, KAL6, HBGF-8, HBGF8, AIGF, HBGF- 1 mg 5,200
8, MGC149376, fibroblast growth factor 8
FGF-8 Human Recombinant produced in HEK cells is a glycosylated monomer, having a molecular weight
range of 30-45kDa due to glycosylation.

FGF 9 CYT-415 5 µg 50
Recombinant Human Fibroblast Growth Factor-9; GAF (Glia- -20 °C 20 µg 130
activating factor), HBGF-9, MGC119914, MGC119915, FGF-9 1 mg 3,510
APLGEVGNYF GVQDAVPFGN VPVLPVDSPV LLSDHLGQSE AGGLPRGPAV TDLDHLKGIL RRRQLY-
CRTG FHLEIFPNGT IQGTRKDHSR FGILEFISIA VGLVSIRGVD SGLYLGMNEK GELYGSEKLT QECV-
FREQFE ENWYNTYSSN LYKHVDTGRR YYVALNKDGT PREGTRTKRH QKFTHFLPRP VDPDKVPELY
KDILSQS

PEPTIDES INTERNATIONAL
Fibroblast Growth Factor-9 Human Recombinant produced in E.Coli is a single, non-glycosylated, polypep-
tide chain containing 207 amino acids and having a molecular mass of 23.4 kDa.

mFGF 9 CYT-349 2 µg 50
Recombinant Mouse Fibroblast Growth Factor-9, GAF (Glia- -20 °C 10 µg 130
activating factor), HBGF-9, MGC119914, MGC119915, FGF-9 1 mg 3,510
The sequence of the first five N-terminal amino acids was determined and was found to be Pro-Leu-Gly-
Glu-Val
Fibroblast Growth Factor-9 Mouse Recombinant produced in E.Coli is a single, non-glycosylated, polypep-
tide chain containing 205 amino acids and having a molecular mass of 23308 Dalton.

rFGF 9 CYT-558 2 µg 50
Recombinant Rat Fibroblast Growth Factor-9, GAF (Glia- -20 °C 10 µg 130
activating factor), HBGF-9, MGC119914, MGC119915, FGF-9 1 mg 3,510

MPLGEVGSYFG VQDAVPFGNV PVLPVDSPVL LNDHLGQSEA GGLPRGPAVT DLDHLKGILR

RRQLYCRTGF HLEIFPNGTI QGTRKDHSRF GILEFISIAV GLVSIRGVDS GLYLGMNEKG ELYGSEKLTQ
ECVFREQFEE NWYNTYSSNL YKHVDTGRRY YVALNKDGTP REGTRTKRHQ KFTHFLPRPV DPD-
KVPELYK DILSQS
Rat FGF9 Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 207
amino acids and having a molecular mass of 23.3kDa.

Order Hotline 1-800-777-4779 502-266-8787 347

 PRODUCT Code Qty PRICE
Recombinant proteins

FGF12 CYT-620 2 µg 50
Recombinant Human Fibroblast Growth Factor 12 -20 °C 10 µg 130
FGF-12, FGF12, FGF12B, FHF1, Fibroblast growth factor 12, 1 mg 5,200
Fibroblast growth factor homologous factor 1, FHF-1, Myocyte-
activating factor
MSSHHHHHH SSGLVPRGSH MESKEPQLKG IVTRLFSQQG YFLQMHPDGT IDGTKDENSD YTLF-
NLIPVG LRVVAIQGVK ASLYVAMNGE YLYSSDVFT PECKFKESVF ENYYVIYSST LYRQQESGRA
WFLGLNKEGQ IMKGNRVKKT KPSSHFVPKP IEVCMYREQS LHEIGEKQGR RKSSGTPTM NGGKV-
VNQDS T
The FGF-12 Human recombinant protein is a single, non-glycosylated polypeptide chain produced in E.
coli, having a molecular weight of 22.6kDa and containing 201 amino acids (1-181). The FGF12 is fused
to a 20 amino acid His tag at the N-terminus.

FGF13 CYT-121 5 µg 50
Recombinant Human Fibroblast Growth Factor 13 -20 °C 25 µg 130
Fibroblast growth factor 13, FGF-13, Fibroblast growth factor 1 mg 2,700
homologous factor 2, FHF-2, FGF13, FHF2
MAAAIASSLI RQKRQARERE KSNACKCVSS PSKGKTSCDK NKLNVFSRVK LFGSKKRRRR RPEP-
QLKGIV TKLYSRQGYH LQLQADGTID GTKDEDSTYT LFNLIPVGLR VVAIQGVQTK LYLAMNSEGY
LYTSELFTPE CKFKESVFEN YYVTYSSMIY RQQQSGRGWY LGLNKEGEIM KGNHVKKNKP AAHFLPK-
PLK VAMYKEPSLH DLTEFSRSGS GTPTKSRSVS GVLNGGKSMS HNEST
FGF13 Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing
245 amino acids and having a molecular mass of 27.6kDa.

FGF14 CYT-756 2 µg 50
Recombinant Human Fibroblast Growth Factor 14 -20 °C 10 µg 130
1 mg 5,200
PEPTIDES INTERNATIONAL

Fibroblast growth factor 14, FGF-14, Fibroblast growth factor

homologous factor 4, FHF-4, FGF14, FHF4, SCA27, bA397O8.2
MGSSHHHHHH SSGLVPRGSH MGSHMAAAIA SGLIRQKRQA REQHWDRPSA SRRRSSPSKN
RGLCNGNLVD IFSKVRIFGL KKRRLRRQDP QLKGIVTRLY CRQGYYLQMH PDGALDGTKD DSTN-
STLFNL IPVGLRVVAI QGVKTGLYIA MNGEGYLYPS ELFTPECKFK ESVFENYYVI YSSMLYRQQE
SGRAWFLGLN KEGQAMKGNR VKKTKPAAHF LPKPLEVAMY REPSLHDVGE TVPKPGVTPS KSTSA-
SAIMN GGKPVNKSKT T
FGF14 Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing
271 amino acids (1-247 a.a) and having a molecular mass of 30kDa. FGF14 is fused to a 24 amino acid
His-tag at N-terminus.

mFGF-15 CYT-027 2 µg 50
Recombinant Mouse Fibroblast Growth Factor-15 -20 °C 10 µg 130
Fibroblast Growth Factor 15, FGF19 1 mg 5,200
MKHHHHHHAS RPLAQQSQSV SDEDPLFLYG WGKITRLQYL YSAGPYVSNC FLRIRSDGSV
DCEEDQNERN LLEFRAVALK TIAIKDVSSV RYLCMSADGK IYGLIRYSEE DCTFREEMDC LGYN-
QYRSMK HHLHIIFIQA KPREQLQDQK PSNFIPVFHR SFFETGDQLR SKMFSLPLES DSMDPFRMVE
DVDHLVKSPS FQK
FGF-15 takes part in the suppression of bile acid biosynthesis by down-regulation of CYP7A1 expression.
FGF-15 is expressed in the developing brain. FGF-15 Protein is 23.78 kDa protein containing 203 amino
acid residues including a 10 a.a. N-Terminal His-tag.

348 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
FGF17 CYT-755 5 µg 50
Recombinant Human Fibroblast Growth Factor 17 -20 °C 25 µg 130
Fibroblast growth factor 17, FGF-17, FGF17, FGF-13, HH20 1 mg 2,700
MGSSHHHHHH SSGLVPRGSH MGSHMTQGEN HPSPNFNQYV RDQGAMTDQL SRRQIREYQL
YSRTSGKHVQ VTGRRISATA EDGNKFAKLI VETDTFGSRV RIKGAESEKY ICMNKRGKLI GKPSGK-
SKDC VFTEIVLENN YTAFQNARHE GWFMAFTRQG RPRQASRSRQ NQREAHFIKR LYQGQLPFPN
HAEKQKQFEF VGSAPTRRTK RTRRPQPLT
FGF17 Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing
219 amino acids (23-216 a.a) and having a molecular mass of 25.2kDa. FGF17 is fused to a 25 amino
acid His-tag at N-terminus.

FGF-18 CYT-120 5 µg 50
Recombinant Human Fibroblast Growth Factor-18, Fgf18, -20 °C 25 µg 130
Fibroblast growth factor 18, FGF-18, zFGF5, D130055P09Rik 1 mg 2,700

mFGF-18 CYT-064 5 µg 50
Recombinant Mouse Fibroblast Growth Factor-18, Fgf18, -20 °C 25 µg 130
Fibroblast growth factor 18, FGF-18, zFGF5, D130055P09Rik 1 mg 2,700

EENVDFRIHV ENQTRARDDV SRKQLRLYQL YSRTSGKHIQ VLGRRISARG EDGDKYAQLL VETDT-

FGSQV RIKGKETEFY LCMNRKGKLV GKPDGTSKEC VFIEKVLENN YTALMSAKYS GWYVGFTKKG
RPRKGPKTRE NQQDVHFMKR YPKGQAELQK PFKYTTVTKR SRRIRPTHPG
FGF-18 Mouse Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing
180 amino acids and having a molecular mass of 21kDa.

rFGF-18 CYT-176 5 µg 50
Recombinant Rat Fibroblast Growth Factor-18 -20 °C 25 µg 130
1 mg 2,700

PEPTIDES INTERNATIONAL
Fibroblast growth factor 18, FGF-18, zFGF5, Fgf18,
D130055P09Rik
EENVDFRIHV ENQTRARDDV SRKQLRLYQL YSRTSGKHIQ VLGRRISARG EDGDKYAQLL VETDT-
FGSQV RIKGKETEFY LCMNRKGKLV GKPDGTSKEC VFIEKVLENN YTALMSAKYS GWYVGFTKKG
RPRKGPKTRE NQQDVHFMKR YPKGQTELQK PFKYTTVTKR SRRIRPTHPG
FGF18 Rat Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing
180 amino acids and having a molecular mass of 21.0kDa.
Please prevent freeze-thaw cycles.

FGF 19 CYT-700 5 µg 50
Recombinant Human Fibroblast Growth Factor-19 -20 °C 25 µg 130
Fibroblast growth factor 19, FGF-19, FGF19 1 mg 2,700
FGF19 Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing
195 amino acids and having a molecular mass of 21.8 kDa.

FGF 19 His CYT-279 5 µg 50

Recombinant Human Fibroblast Growth Factor-19 His Tag -20 °C 25 µg 130
Fibroblast growth factor 19, FGF-19 1 mg 2,950
MRGSHHHHHH GMASLAFSDA GPHVHYGWGD PIRLRHLYTS GPHGLSSCFL RIRADGVVDC AR-
GQSAHSLLEIKAVALRTV AIKGVHSVRY LCMGADGKMQ GLLQYSEEDC AFEEEIRPDG YNVYRSEKHR
LPVSLSSAKQ RQLYKNRGFL PLSHFLPMLP MVPEEPEDLR GHLESDMFSS PLETDSMDPF GLVT-
GLEAVR SPSFEK
Fibroblast Growth Factor -19 Human Recombinant produced in E.Coli is a single, non-glycosylated,
polypeptide chain containing 206 amino acids and having a molecular mass of 23 kDa. The amino acid
sequence of the recombinant human FGF19 is 100% homologous to the amino acid sequence of the
human FGF19 without signal sequence and contains his tag at N-terminal.

Order Hotline 1-800-777-4779 502-266-8787 349

 PRODUCT Code Qty PRICE
Recombinant proteins

FGF 21 CYT-474 5 µg 50
Recombinant Human Fibroblast Growth Factor-21 -20 °C 20 µg 130
Fibroblast growth factor 21, FGF-21 1 mg 2,700

MHPIPDS SPLLQFGGQV RQRYLYTDDA QQTEAHLEIR EDGTVGGAAD QSPESLLQLK ALKPGVIQIL

GVKTSRFLCQ RPDGALYGSL HFDPEACSFR ELLLEDGYNV YQSEAHGLPL HLPGNKSPHR DPAPRG-
PARF LPLPGLPPAP PEPPGILAPQ PPDVGSSDPL SMVGPSQGRS PSYAS
Fibroblast Growth Factor -21 Human Recombinant produced in E.Coli is a single, non-glycosylated,
polypeptide chain containing 181 amino acids and an N-terminal Methionin (bold), having a molecular
weight of 19.5 kDa.

FGF 21 His CYT-281 10 µg 50

Recombinant Human Fibroblast Growth Factor-21, His Tag -20 °C 50 µg 130
Fibroblast growth factor 21, FGF-21 1 mg 1,800
MGSSHHHHHH SSGLVPRGSH MHPIPDSSPL LQFGGQVRQR YLYTDDAQQT EAHLEIREDG
TVGGAADQSP ESLLQLKALK PGVIQILGVKTSRFLCQRPD GALYGSLHFD PEACSFRELL LEDGYN-
VYQS EAHGLPLHLP GNKSPHRDPA PRGPARFLPL PGLPPAPPEP PGILAPQPPD VGSSDPLSMV
GPSQGRSPSY AS
Fibroblast Growth Factor -21 Human Recombinant produced in E.Coli is a single, non-glycosylated,
polypeptide chain containing 202 amino acids (29-209) and having a molecular mass of 21.6 kDa. The
FGF-21 is fused to 20 amino acid His Tga at N-terminus.

mFGF 21 CYT-339 2 µg 50
Recombinant Mouse Fibroblast Growth Factor-21 -20 °C 10 µg 130
Fibroblast growth factor 21, FGF-21 1 mg 3,600

MAY PIPDSSPLLQ FGGQVRQRYL YTDDDQDTEA HLEIREDGTV VGAAHRSPES LLELKALKPG VIQIL-

GVKAS RFLCQQPDGA LYGSPHFDPE ACSFRELLLE DGYNVYQSEA HGLPLRLPQK DSPNQDATSW
PEPTIDES INTERNATIONAL

GPVRFLPMPG LLHEPQDQAG FLPPEPPDVG SSDPLSMVEP LQGRSPSYAS

Fibroblast Growth Factor -21 Mouse Recombinant produced in E.Coli is a single, non-glycosylated,
polypeptide chain containing 183 amino acids including N-terminal Methionin and having a molecular mass
of 20.1 kDa.

mFGF 21 His CYT-516 2 µg 50

Recombinant Mouse Fibroblast Growth Factor-21, His Tag -20 °C 10 µg 130
Fibroblast growth factor 21, FGF-21 1 mg 4,800
MKHHHHHHAS AYPIPDSSPL LQFGGQVRQR YLYTDDDQDT EAHLEIREDG TVVGAAHRSP ESL-
LELKALKPGVIQILGVK ASRFLCQQPD GALYGSPHFD PEACSFRELL LEDGYNVYQS EAHGLPLRLP
QKDSPNQDATSWGPVRFLPM PGLLHEPQDQ AGFLPPEPPD VGSSDPLSMV EPLQGRSPSY AS
Fibroblast Growth Factor -21 Mouse Recombinant produced in E.Coli is a single, non-glycosylated,
polypeptide chain containing 192 amino acids and having a molecular mass of 21.2 kDa. The amino acid
sequence of the recombinant human FGF21 is 100% homologous to the amino acid sequence of the
Mouse FGF21 without signal sequence and contains 10 a.a. His tag at N-terminal.

350 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
rFGF 21 CYT-130 5 µg 50
Recombinant Rat Fibroblast Growth Factor-21 -20 °C 20 µg 130
Fibroblast growth factor 21, FGF-21 1 mg 2,700

AYPISDSSPL LQFGGQVRQR YLYTDDDQDT EAHLEIREDG TVVGTAHRSP ESLLELKALK PGVIQ-

ILGVK ASRFLCQQPD GTLYGSPHFD PEACSFRELL LKDGYNVYQS EAHGLPLRLP QKDSQDPATR
GPVRFLPMPG LPHEPQEQPG VLPPEPPDVG SSDPLSMVEP LQGRSPSYAS
FGF 21 Rat Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing
180 amino acids and having a molecular mass of 19.7kDa.

bFGF 21 CYT-657 2 µg 50
Recombinant Bovine Fibroblast Growth Factor-21 -20 °C 10 µg 130
Fibroblast growth factor 21, FGF-21, FGF21 1 mg 5,200
The sequence of the first five N-terminal amino acids was determined and was found to be Ala-His-Pro-Ile-
Pro
Fibroblast Growth Factor -21 Bovine Recombinant produced in E.Coli is a single, non-glycosylated, poly-
peptide chain containing 182 amino acids, having a molecular weight of 19.5 kDa.

FGF 22 CYT-428 2 µg 50
Recombinant Human Fibroblast Growth Factor-22 -20 °C 10 µg 130
Fibroblast growth factor 22, FGF-22 1 mg 5,200
MTPSASRGPR SYPHLEGDVR WRRLFSSTHF FLRVDPGGRV QGTRWRHGQD SILEIRSVHV GVVVI-
KAVSS GFYVAMNRRG RLYGSRLYTV DCRFRERIEE NGHNTYASQR WRRRGQPMFL ALDRRGGPRP
GGRTRRYHLS AHFLPVLVS
Fibroblast Growth Factor-22 Human Recombinant produced in E.Coli is a single, non-glycosylated poly-
peptide chain containing 149 amino acids and having a molecular mass of 17.3 kDa.

PEPTIDES INTERNATIONAL
FGF-23 is a member of the fibroblast growth factor (FGF) family. FGF family members pos-
sess broad mitogenic and cell survival activities and are involved in a variety of biological
processes including embryonic development, cell growth, morphogenesis, tissue repair ,
tumor growth and invasion. FGF-23 inhibits renal tubular phosphate transport. The FGF-
23 gene was identified by its mutations associated with autosomal dominant hypophos-
phatemic rickets (ADHR), an inherited phosphate wasting disorder. Abnormally high level
expression of FGF-23 was found in oncogenic hypophosphatemic osteomalacia (OHO), a
phenotypically similar disease caused by abnormal phosphate metabolism. FGF-23 muta-
tions have also been shown to cause familial tumoral calcinosis with hyperphosphatemia.
FGF 23 CYT-020 5 µg 50
Recombinant Human Fibroblast Growth Factor-23, FGF-23, -20 °C 20 µg 130
Tumor-derived hypophosphatemia-inducing factor, HYPF, 1 mg 3,510
ADHR, HPDR2, PHPTC, FGF23, Fibroblast Growth Factor-23
MYPNASPLLG SSWGGLIHLY TATARNSYHL QIHKNGHVDG APHQTIYSAL MIRSEDAGFV VITGVM-
SRRY LCMDFRGNIF GSHYFDPENC RFQHQTLENG YDVYHSPQYH FLVSLGRAKR AFLPGMNPPP
YSQFLSRRNE IPLIHFNTPI PRRHTRSAED DSERDPLNVL KPRARMTPAP ASCSQELPSA EDNSP-
MASDP LGVVRGGRVN THAGGTGPEG CRPFAKFI
Fibroblast Growth Factor-23 Human Recombinant produced in E.Coli is a single, non-glycosylated poly-
peptide chain containing a total of 228 amino acids and having a molecular mass of 22.5kDa.

Order Hotline 1-800-777-4779 502-266-8787 351

 PRODUCT Code Qty PRICE
Recombinant proteins

FGF 23 His CYT-374 2 µg 50

Recombinant Human Fibroblast Growth Factor-23 His Tag -20 °C 10 µg 130
Tumor-derived hypophosphatemia-inducing factor, HYPF, 100 µg 1,200
ADHR, HPDR2, PHPTC, FGF23, FGF-23, Fibroblast Growth
Factor-23
MLGARLRLWVCALCSVCSMSVLRAYPNASPLLGSSWGGLIHLYTATARNSYHLQIHKNGHVDGAPHQTI-
YSALMIRSEDAGFVVITGVMSRRYLCMDFR GNIFGSHYFDPENCRFQHQTLENGYDVYHSPQYH-
FLVSLGRAKRAFLPGMNPPPYSQFLSRRNEIPLIHFNTPIPRRHTRSAEDDSERDPLNVLKPRAR
MTPAPASCSQELPSAEDNSPMASDPLGVVRGGRVNTHAGGTGPEGCRPFAKFIHHHHHH
Fibroblast Growth Factor-23 Human Recombinant produced in E.Coli is a single, non-glycosylated poly-
peptide chain expressed with a -6xHis tag containing a total of 257 amino acids (251 a.a. FGF23+ 6 a.a.
His tag) and having a molecular mass of 28629.5 Dalton.

FGF 23 C-term CYT-028 2 µg 50

Recombinant Human Fibroblast Growth Factor-23 C-Terminal -20 °C 10 µg 130
Tumor-derived hypophosphatemia-inducing factor, HYPF, 1 mg 5,200
ADHR, HPDR2, PHPTC, FGF23, FGF-23, Fibroblast Growth
Factor-23
MKHHHHHHAS AED­DSERDPL NVLKPRARMT PAPASCSQEL PSAEDNSPMA SDPLGVVRGG RVN-
THAGGTG PEGCRPFAKF I
FGF-23 C-term Protein is 8.67 kDa protein containing 72 amino acid residues and an additional 9 a.a.
His-Tag at N-terminus.

FIBP CYT-758 2 µg 50
Recombinant Human FGF-1 Intracellular-Binding Protein -20 °C 10 µg 130
FGFIBP, FIBP-1, Acidic fibroblast growth factor intracellular- 1 mg 5,200
PEPTIDES INTERNATIONAL

binding Protein, aFGF intracellular-binding Protein, FGF-1

intracellular-binding Protein, FIBP
MGSSHHHHHH SSGLVPRGSH MGSMTSELDI FVGNTTLIDE DVYRLWLDGY SVTDAVALRV
RSGILEQTGA TAAVLQSDTM DHYRTFHMLE RLLHAPPKLL HQLIFQIPPS RQALLIERYY AFDEAF-
VREV LGKKLSKGTK KDLDDISTKT GITLKSCRRQ FDNFKRVFKV VEEMRGSLVD NIQQHFLLSD
RLARDYAAIV FFANNRFETG KKKLQYLSFG DFAFCAELMI QNWTLGAVGE APTDPDSQMD
DMDMDLDKEF LQDLKELKVL VADKDLLDLH KSLVCTALRG KLGVFSEMEA NFKNLSRGLV NVAAK-
LTHNK DVRDLFVDLV EKFVEPCRSD HWPLSDVRFF LNQYSASVHS LDGFRHQALW DRYMGTLRGC
LLRLYHD
FIBP Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing
387amino acids (1-364) and having a molecular mass of 44.3kDa. The FIBP is fused to a 23 amino acid
His-Tag at N-terminus.
Avoid multiple freeze-thaw cycles.

352 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
Flt3 Ligand (FMS-Related Tyrosine Kinase 3 Ligand)
FLT3 ligand is a receptor for the fl cytokine has a tyrosine-protein kinase activity and
a growth factor that regulates proliferation of early hematopoietic cells. Flt3-Ligand
synergizes with other CSFs and interleukins to induce growth and differentiation.
Flt3 Ligand CYT-331 2 µg 50
Recombinant Human Flt3-Ligand -20 °C 10 µg 130
Fms-related tyrosine kinase 3 ligand, FLK2, STK1, CD135, Stem 1 mg 3,510
Cell Tyrosine Kinase 1, FLT3LG, Flt3
The sequence of the first five N-terminal amino acids was determined and was found to be Thr-Gln-Asp-
Cys-Ser
Flt3-Ligand Human Recombinant produced in E.Coli is non-glycosylated, polypeptide chain containing 155
amino acids and having a molecular mass of 17605 Dalton.
E. Heiss, et al., Blood, 108, 5 (2006).
K. Masson, et al., British Journal of Haematology, 146, 193 (2009).

Flt3 Ligand HEK CYT-706 2 µg 50

Recombinant Human Flt3-Ligand, HEK -20 °C 10 µg 130
Fms-related tyrosine kinase 3 ligand, FLK2, STK1, CD135, Stem 100 µg 1,100
Cell Tyrosine Kinase 1, FLT3LG, Flt3
TQDCSFQHSP ISSDFAVKIR ELSDYLLQDY PVTVASNLQD EELCGGLWRL VLAQRWMERL KTVAG-
SKMQG LLERVNTEIH FVTKCAFQPP PSCLRFVQTN ISRLLQETSE QLVALKPWIT RQNFSRCLEL
QCQPDSSTLP PPWSPRPLEA TAPTAPQP
Flt3-Ligand Human Recombinant produced in HEK293 cells is a glycosylated, polypeptide chain, migrates
as a diffuse band on SDS-PAGE due to heterogeneous glycosylation at 30kDa.

PEPTIDES INTERNATIONAL
Flt3 Ligand Sf9 CYT-409 2 µg 50
Recombinant Human Flt3-Ligand, Sf9 -20 °C 10 µg 130
Fms-related tyrosine kinase 3 ligand, FLK2, STK1, CD135, Stem 100 µg 1,100
Cell Tyrosine Kinase 1, FLT3LG, Flt3
The sequence of the first five N-terminal amino acids was determined and was found to be Thr-Gln-Asp-
Cys-Ser
Flt3-Ligand Human Recombinant produced in Sf9 insect cells is a glycosylated, polypeptide chain contain-
ing 155 amino acids and having migrating on SDS-PAGE at 19kDa.

mFlt3 Ligand CYT-340 2 µg 50

Recombinant Mouse Flt3-Ligand -20 °C 10 µg 130
Fms-related tyrosine kinase 3 ligand, FLK2, STK1, CD135, Stem 1 mg 3,500
Cell Tyrosine Kinase 1, FLT3LG, Flt3
MTPDCYFSHS PISSNFKVKF RELTDHLLKD YPVTVAVNLQ DEKHCKALWS LFLAQRWIEQ LKT-
VAGSKMQ TLLEDVNTEI HFVTSCTFQP LPECLRFVQT NISHLLKDTC TQLLALKPCI GKACQNFSRC
LEVQCQPDSS TLLPPRSPIA LEATELPEPR PRQ
Flt3-Ligand Mouse Recombinant produced in E.Coli is non-glycosylated, polypeptide chain containing 163
amino acids and having a molecular mass of 18587 Dalton.

Order Hotline 1-800-777-4779 502-266-8787 353

 PRODUCT Code Qty PRICE
Recombinant proteins

rmFlt3 Ligand CYT-157 2 µg 50

Recombinant Rhesus Macaque Flt3-Ligand -20 °C 10 µg 130
Fms-related tyrosine kinase 3 ligand, FLK2, STK1, CD135, Stem 1 mg 3,510
Cell Tyrosine Kinase 1, FLT3LG, Flt3
TQDCSFQHSP ISSDFAVKIR ELSDYLLQDY PVTVPSNLQD EELCGALWRL VLAQRWMERL KTVAG-
SKMQG LLERVNTEIH FVTKCAFQHP PSCLRFVQTN ISRLLQETSE QLVALKPWIT RQNFSRCLEL
QCQPDSSTLP PPRSPGALEA TALTAPQRP
Flt3 Ligand Rhesus Macaque Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide
chain containing 159 amino acids and having a molecular mass of 18.0kDa. .
Please prevent freeze-thaw cycles.

FST Ligand (Follistatin)

Follistatin is a single-chain gonadal protein that specifically inhibits follicle-stimulating
hormone release. The single FST gene encodes two isoforms, FST317 and FST344
containing 317 and 344 amino acids respectively, resulting from alternative splicing of
the precursor mRNA. In a study in which 37 candidate genes were tested for linkage
and association with polycystic ovary syndrome (PCOS) or hyperandrogenemia in 150
families, evidence was found for linkage between PCOS and follistatin. Follistatin binds
directly to activin and functions as an activin antagonist. specific inhibitor of the biosyn-
thesis and secretion of pituitary follicle stimulating hormone (FSH).
FST CYT-232 5 µg 50
Recombinant Human Follistatin -20 °C 20 µg 130
FST, FS, Activin-binding Protein 1 mg 4,680
PEPTIDES INTERNATIONAL

Follistatin Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain contain-
ing 288 amino acids and having a total molecular mass of 31.5kDa.

FST His CYT-029 2 µg 50

Recombinant Human Follistatin His Tag, -20 °C 10 µg 130
FST, FS, Activin-binding Protein 1 mg 5,200
MKHHHHHHAS GNCWLRQAKN GRCQVLYKTE LSKEECCSTG RLSTSWTEED VNDNTLFKWM IFNG-
GAPNCI PCKETCENVD CGPGKKCRMN KKNKPRCVCA PDCSNITWKG PVCGLDGKTY RNECALLKAR
CKEQPELEVQ YQGRCKKTCR DVFCPGSSTC VVDQTNNAYC VTCNRICPEP ASSEQYLCGN DGV-
TYSSACH LRKATCLLGR SIGLAYEGKC IKAKSCEDIQ CTGGKKCLWD FKVGRGRCSL CDELCPDSKS
DEPVCASDNA TYASECAMKE AACSSGVLLE VKHSGSCNSI SEDTEEEEED EDQDYSFPIS SILEW
FST His Protein is 36.0 kDa protein containing 325 amino acid residues of the FST His and the 10 aa
N-Terminal His-tag.

mFST CYT-124 2 µg 50
Recombinant Mouse Follistatin -20 °C 10 µg 130
Follistatin, FST, FS, Activin-binding Protein, AL033346 1 mg 4,500
MGNCWLRQAK NGRCQVLTKT ELSKEECCST GRLSTSWTEE DVNDNTLFKW MIFNGGAPNC
IPCKETCENV DCGPGKKCRM NKKNKPRCVC APDCSNITWK GPVCGLDGKT YRNECALLKA RCK-
EQPELEV QYQGRCKKTC RDVFCPGSST CVVDQTNNAY CVTCNRICPE PASSEQYLCG NDGVTYS-
SAC HLRKATCLLG RSIGLAYEGK CIKAKSCEDI QCTGGKKCLW DS
Follistatin Mouse Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain contain-
ing 289 amino acids and having a total molecular mass of 31.6kDa.

354 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
FSTL1 CYT-792 2 µg 50
Recombinant Human Follistatin Like 1 -20 °C 10 µg 130
Follistatin-related Protein 1, Follistatin-like Protein 1, FSTL1, 100 µg 1,200
FRP, Follistatin Like 1, FSL1
MGSSHHHHHH SSGLVPRGSH MEEELRSKSK ICANVFCGAG RECAVTEKGE PTCLCIEQCK
PHKRPVCGSN GKTYLNHCEL HRDACLTGSK IQVDYDGHCK EKKSVSPSAS PVVCYQSNRD
ELRRRIIQWL EAEIIPDGWF SKGSNYSEIL DKYFKNFDNG DSRLDSSEFL KFVEQNETAI NITTYPDQEN
NKLLRGLCVD ALIELSDENA DWKLSFQEFL KCLNPSFNPP EKKCALEDET YADGAETEVD CNRCV-
CACGN WVCTAMTCDG KNQKGAQTQT EEEMTRYVQE LQKHQETAEK TKRVSTKEI
FSTL1 Human Recombinant produced in E. coli is a single polypeptide chain containing 309 amino
acids (21-308) and having a molecular mass of 34.9 kDa. FSTL1 is fused to a 21 amino acid His-tag at
N-terminus.
Avoid multiple freeze-thaw cycles.

HB-EGF (Heparin-Binding EGF-Like Growth Factor)

HB-EGF is an EGF related growth factor which signals via the EGF receptor , and
stimulates the proliferation of SMC (smooth muscle cells), fibroblasts, epithelial cells
and keratinocytes. HB-EGF is expressed in various cell types and tissues, including
vascular endothelial cells and SMC, macrophages, skeletal muscle, keratinocytes and
particular tumor cells. HB-EGF’ s ability to explicitly bind heparin and heparin sulfate
proteoglycans is dissimilar from other EGF-like molecules, and might be related to the
enhanced mitogenic activity, relative to EGF, that HB-EGF exerts on smooth muscle
cells.
HB-EGF CYT-119 10 µg 50

PEPTIDES INTERNATIONAL
Recombinant Human Proheparin-Binding EGF-like Growth -20 °C 50 µg 130
Factor, Proheparin-binding EGF-like growth factor, HBEGF, 1 mg 1,350
DTR, DTS, HEGFL, HB-EGF, Heparin-binding EGF-like growth
factor, Diphtheria toxin receptor, DT-R, DTSF
DLQEADLDLL RVTLSSKPQA LATPNKEEHG KRKKKGKGLG KKRDPCLRKY KDFCIHGECK YVKEL-
RAPSC ICHPGYHGER CHGLSL
HB-EGF Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain contain-
ing 86 amino acids and having a molecular mass of 9.7kDa.

mHB-EGF CYT-068 10 µg 50
Recombinant Mouse Proheparin-Binding EGF-like Growth -20 °C 50 µg 130
Factor, Heparin-binding EGF-like growth factor, DTR, HEGFL, 1 mg 1,350
diphtheria toxin receptor (heparin-binding epidermal growth
factor-like growth factor), DTSF, proheparin-binding epidermal
growth factor-like growth factor
DLEGTDLNLF KVAFSSKPQG LATPSKERNG KKKKKGKGLG KKRDPCLRKY KDYCIHGECR YLQE-
FRTPSC KCLPGYHGHR CHGLTL
HB-EGF Mouse Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain contain-
ing 86 amino acids (63-148 a.a.) and having a molecular mass of 9.8 kDa.

Order Hotline 1-800-777-4779 502-266-8787 355

 PRODUCT Code Qty PRICE
Recombinant proteins

rHB-EGF CYT-170 10 µg 50
Recombinant Rat Proheparin-Binding EGF-like Growth Factor -20 °C 50 µg 130
Proheparin-binding EGF-like growth factor, Heparin-binding 1 mg 1,500
EGF-like growth factor, HB-EGF, HBEGF, Dtr, Hegfl, GFHB
DLEGTDLDLF KVAFSSKPQA LATPGKEKNG KKKRKGKGLG KKRDPCLKKY KDYCIHGECR YLKEL-
RIPSC HCLPGYHGQR CHGLTL
HB-EGF Rat Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing
86 amino acids and having a molecular mass of 9.7kDa.

HB-EGF His CYT-761 2 µg 50

Recombinant Human Proheparin-Binding EGF-like Growth -20 °C 10 µg 130
Factor, His Tag, Proheparin-binding EGF-like growth factor, 1 mg 3,500
HBEGF, DTR, DTS, HEGFL, HB-EGF, Heparin-binding EGF-like
growth factor, Diphtheria toxin receptor, DT-R, DTSF
MGSSHHHHHH SSGLVPRGSH MGSDLQEADL DLLRVTLSSK PQALATPNKE EHGKRKKKGK GLGK-
KRDPCL RKYKDFCIHG ECKYVKELRA PSCICHPGYH GERCHGLSL
HB-EGF His Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain
containing 109 amino acids (63-148) and having a molecular mass of 12.1kDa. HB-EGF His is fused to a
23 amino acid His-tag at N-terminus.

Galectins
The galectins are a family of beta-galactoside-binding proteins implicated in modulat-
ing cell-cell and cell-matrix interactions. Galectin-1 is an autocrine negative growth fac-
tor that regulates cell proliferation. Galectin-1 regulates cell apoptosis and cell differen-
tiation. Galectin-1 binds CD45, CD3 and CD4 and inhibits CD45 protein phosphatase
activity and therefore the dephosphorylation of lyn kinase. Galectin-1 and its ligands
PEPTIDES INTERNATIONAL

are one of the master regulators of immune responses as T-cell homeostasis and
survival, T-cell immune disorders, inflammation and allergies as well as host–patho-
gen interactions. Galectin-1 expression or overexpression in tumors and/or the tissue
surrounding them must be considered as a sign of the malignant tumor progression
that is often related to the long-range dissemination of tumoral cells (metastasis), to
their dissemination into the surrounding normal tissue, and to tumor immune-escape.
Galectin-1 in its oxidized form plays a number of important roles in the regeneration
of the central nervous system after injury . The targeted overexpression (or delivery)
of Galectin-1 should be considered as a method of choice for the treatment of some
kinds of inflammation-related diseases, neurodegenerative pathologies and muscular
dystrophies. In contrast, the targeted inhibition of Galectin-1 expression is what should
be developed for therapeutic applications against cancer progression. Galectin-1 is
thus a promising molecular target for the development of new and original therapeutic
tools. There is 88% homology between the human and mouse galectin-1.

356 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
LGALS1 CYT-544 10 µg 50
Recombinant Human Galectin-1 -20 °C 50 µg 130
Galectin-1, GAL1, GAL-1, Lectin galactoside-binding soluble 1, 1 mg 1,350
Beta-galactoside- binding lectin L-14-I, Lactose-binding lectin
1, S-Lac lectin 1, Galaptin, 14 kDa lectin, HPL, HBL, Putative
MAPK-activating Protein PM12, GBP, DKFZp686E23103
ACGLVASNLN LKPGECLRVR GEVAPDAKSF VLNLGKDSNN LCLHFNPRFN AHGDANTIVC NSKDG-
GAWGT EQREAVFPFQ PGSVAEVCIT FDQANLTVKL PDGYEFKFPN RLNLEAINYM AADGDFKIKC
VAFD
LGALS1 Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain contain-
ing 134 amino acids and having a molecular mass of 14.5 kDa.

mLGALS1 CYT-186 5 µg 50
Recombinant Mouse Galectin-1 -20 °C 20 µg 130
Galectin-1, Gal-1, 14 kDa lectin, β-galactoside-binding lectin 1 mg 2,700
L-14-I, Galaptin, Lactose-binding lectin 1, Lectin galactoside-
binding soluble 1, S-Lac lectin 1, Lgals1, Gbp, L14, Galbp,
L-14.5, Lect14, AA410090
MGSSHHHHHH SSGLVPRGSH MGSHMACGLV ASNLNLKPGE CLKVRGEVAS DAKSFVLNLG KD-
SNNLCLHF NPRFNAHGDA NTIVCNTKED GTWGTEHREP AFPFQPGSIT EVCITFDQAD LTIKLPDGHE
FKFPNRLNME AINYMAADGD FKIKCVAFE
LGALS1 mouse Recombinant produced E. coli is a single polypeptide chain containing 159 amino
acids (1-135) and having a molecular mass of 17kDa. LGALS1 is fused to a 24 amino acid His-tag at
N-terminus.

LGALS2 CYT-725 5 µg 50

PEPTIDES INTERNATIONAL
Recombinant Human Galectin-2 -20 °C 25 µg 130
HL14, Gal-2, Beta-galactoside-binding lectin L-14-II, Lactose- 1 mg 2,700
binding lectin 2, S-Lac lectin 2
MGSSHHHHHH SSGLVPRGSH MTGELEVKNM DMKPGSTLKI TGSIADGTDG FVINLGQGTD KLNLH-
FNPRF SESTIVCNSL DGSNWGQEQR EDHLCFSPGS EVKFTVTFES DKFKVKLPDG HELTFPNRLG
HSHLSYLSVR GGFNMSSFKL KE
LGALS2 Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain contain-
ing 152 amino acids (1-132 a.a.) and having a molecular mass of 16.8 kDa. The LGALS2 is fused to a 20
amino acid His-Tag at N-terminus.

mLGALS2 CYT-019 5 µg 50
Recombinant Mouse Galectin-2 -20 °C 25 µg 130
Galectin-2, Gal-2, Lgals2, AI324147, 2200008F12Rik 1 mg 2,700
MGSSHHHHHH SSGLVPRGSH MGSMSEKFEV KDLNMKPGMS LKIKGKIHND VDRFLINLGQ GKETLN-
LHFN PRFDESTIVC NTSEGGRWGQ EQRENHMCFS PGSEVKITIT FQDKDFKVTL PDGHQLTFPN
RLGHNQLHYL SMGGLQISSF KLE
LGALS2 mouse Recombinant produced E. coli is a single polypeptide chain containing 153 amino acids
(1-130) and having a molecular mass of 17.3kDa. LGALS2 is fused to a 23 amino acid His-tag at N-
terminus.

Order Hotline 1-800-777-4779 502-266-8787 357

PRODUCT Code Qty PRICE

Recombinant proteins
LGALS3 CYT-606 10 µg 50
Recombinant Human Galectin-3 -20 °C 50 µg 130
Galectin-3, GAL3, MAC2, CBP35, GALB, GALIG, LGALS2, 1 mg 1,350
LGALS3, Galactose-specific lectin 3, Mac-2 antigen, IgE-
binding Protein, 35 kDa lectin, Carbohydrate-binding Protein
35, CBP 35, Laminin-binding Protein, Lectin L-29, L-31,
Galactoside-binding Protein, GALBP
ADNFSLHDAL SGSGNPNPQG WPGAWGNQPA GAGGYPGASY PGAYPGQAPP GAYPGQAPPG AYP-
GAPGAYP GAPAPGVYPG PPSGPGAYPS SGQPSATGAY PATGPYGAPA GPLIVPYNLP LPGGVVPRML
ITILGTVKPN ANRIALDFQR GNDVAFHFNP RFNENNRRVI VCNTKLDNNW GREERQSVFP FESGKP-
FKIQ VLVEPDHFKV AVNDAHLLQY NHRVKKLNEI SKLGISGDID LTSASYTMI
LGALS3 Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain contain-
ing 249 amino acids and having a molecular mass of 26kDa.

LGALS3 His CYT-693 5 µg 50

Recombinant Human Galectin-3 His Tag -20 °C 25 µg 130
Galectin-3, GAL3, MAC2, CBP35, GALB, GALIG, LGALS2, 1 mg 2,250
LGALS3, Galactose-specific lectin 3, Mac-2 antigen, IgE-
binding Protein, 35 kDa lectin, Carbohydrate-binding Protein
35, CBP 35, Laminin-binding Protein, Lectin L-29, L-31,
Galactoside-binding Protein, GALBP
MGSSHHHHHH SSGLVPRGSH MADNFSLHDA LSGSGNPNPQ GWPGAWGNQP AGAGGYPGAS
YPGAYPGQAP PGAYPGQAPP GAYPGAPGAY PGAPAPGVYP GPPSGPGAYP SSGQPSATGA
YPATGPYGAP AGPLIVPYNL PLPGGVVPRM LITILGTVKP NANRIALDFQ RGNDVAFHFN PRFNEN-
NRRV IVCNTKLDNN WGREERQSVF PFESGKPFKI QVLVEPDHFK VAVNDAHLLQ YNHRVKKLNE
ISKLGISGDI DLTSASYTMI

PEPTIDES INTERNATIONAL
LGALS3 Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain contain-
ing 270 amino acids (1-250 a.a.) and having a molecular mass of 28.3 kDa. The LGALS3 is fused to a 20
amino acid His-Tag at N-terminus.

mLGALS3 CYT-188 2 µg 50
Recombinant Mouse Galectin-3, CBP35, GAL3, GALBP, GALIG, -20 °C 10 µg 130
LGALS2, MAC2, Galectin-3, Lectin, galactose binding, soluble 1 mg 5,200
3, Lectin, galactose binding, soluble 3, isoform CRA_a, Lectin,
galactose binding, soluble 3, isoform CRA_d, Lgals3
MGSSHHHHHH SSGLVPRGSH MGSMADSFSL NDALAGSGNP NPQGYPGAWG NQPGAGGYPG
AAYPGAYPGQ APPGAYPGQA PPGAYPGQAP PSAYPGPTAP GAYPGPTAPG AYPGSTAPGA FPGQP-
GAPGA YPSAPGGYPA AGPYGVPAGP LTVPYDLPLP GGVMPRMLIT IMGTVKPNAN RIVLDFRRGN
DVAFHFNPRF NENNRRVIVC NTKQDNNWGK EERQSAFPFE SGKPFKIQVL VEADHFKVAV NDAHL-
LQYNH RMKNLREISQ LGISGDITLT SANHAMI
LGALS3 Mouse Recombinant produced in E. coli is a single polypeptide chain containing 287 amino
acids (1-264) and having a molecular mass of 29.8 kDa. LGALS3 is fused to a 23 amino acid His-tag at
N-terminus.

Order Hotline 1-800-777-4779 502-266-8787 358

PRODUCT Code Qty PRICE

Recombinant proteins
LGALS4 CYT-686 5 µg 50
Recombinant Human Galectin-4, Galectin-4, Gal-4, Lactose- -20 °C 25 µg 130
binding lectin 4, L-36 lactose-binding Protein, L36LBP, Antigen 1 mg 2,250
NY-CO-27, LGALS4, lectin galactoside-binding soluble 4, GAL4
MGSSHHHHHH SSGLVPRGSH MAYVPAPGYQ PTYNPTLPYY QPIPGGLNVG MSVYIQGVAS
EHMKRFFVNF VVGQDPGSDV AFHFNPRFDG WDKVVFNTLQ GGKWGSEERK RSMPFKKGAA FELV-
FIVLAE HYKVVVNGNP FYEYGHRLPL QMVTHLQVDG DLQLQSINFI GGQPLRPQGP PMMPPYPGPG
HCHQQLNSLP TMEGPPTFNP PVPYFGRLQG GLTARRTIII KGYVPPTGKS FAINFKVGSS GDIAL-
HINPR MGNGTVVRNS LLNGSWGSEE KKITHNPFGP GQFFDLSIRC GLDRFKVYAN GQHLFDFAHR
LSAFQRVDTL EIQGDVTLSY VQI
Galectin-4 produced in E.Coli is a single, non-glycosylated polypeptide chain containing 343 amino acids
(1-323 a.a.) and having a molecular mass of 38.1kDa. Galectin-4 is fused to 20 amino acid His-Tag at
N-terminus.

mLGALS4 CYT-187 2 µg 50
Recombinant Mouse Galectin-4, gal-4 , Galectin-4, Lactose- -20 °C 10 µg 130
binding lectin 4, lectin galactoside-binding soluble 4 1 mg 5,200
MGSSHHHHHH SSGLVPRGSH MGSMAYVPAP GYQPTYNPTL PYKRPIPGGL SVGMSVYIQG
MAKENMRRFH VNFAVGQDDG ADVAFHFNPR FDGWDKVVFN TMQSGQWGKE EKKKSMPFQK GKH-
FELVFMV MPEHYKVVVN GNSFYEYGHR LPVQMVTHLQ VDGDLELQSI NFLGGQPAAA PYPGAMTIPA
YPAGSPGYNP PQMNTLPVMT GPPVFNPRVP YVGALQGGLT VRRTIIIKGY VLPTARNFVI NFKVGSS-
GDI ALHLNPRIGD SVVRNSFMNG SWGAEERKVA YNPFGPGQFF DLSIRCGMDR FKVFANGQHL
FDFSHRFQAF QMVDTLEING DITLSYVQI
LGALS4 Mouse Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain contain-
ing 349 amino acids (1-326a.a) and having a molecular mass of 31.8kDa.LGALS4 is fused to a 23 amino
acid His-tag at N-terminus.

PEPTIDES INTERNATIONAL
LGALS7 CYT-016 2 µg 50
Recombinant Human Galectin-7, Galectin-7, Gal-7, HKL-14, PI7, -20 °C 10 µg 130
p53-induced gene 1 Protein, LGALS7, PIG1, LGALS7B, GAL7, 1 mg 5,200
LGALS7A
The sequence of the first five N-terminal amino acids was determined and was found to be Ser-Asn-Val-
Pro-His.
Galectin-7 Human Recombinant produced in E.Coli is a single, non-glycosylated, Polypeptide chain
containing 135 amino acids and having a molecular mass of 15kDa.

LGALS7 His CYT-617 5 µg 50

Recombinant Human Galectin-7 His Tag -20 °C 20 µg 130
Galectin-7, Gal-7, HKL-14, PI7, p53-induced gene 1 Protein, 1 mg 2,700
LGALS7, PIG1, LGALS7B, GAL7, LGALS7A
MGSSHHHHHH SSGLVPRGSH MSNVPHKSSL PEGIRPGTVL RIRGLVPPNA SRFHVNLLCG EEQGS-
DAALH FNPRLDTSEV VFNSKEQGSW GREERGPGVP FQRGQPFEVL IIASDDGFKA VVGDAQYHHF
RHRLPLARVR LVEVGGDVQL DSVRIF
Galectin-7 Human Recombinant fused with a 20 amino acid His tag at N-terminus produced in E.Coli
is a single, non-glycosylated, polypeptide chain containing 156 amino acids (1-136 a.a.) and having a
molecular mass of 17.2kDa.

Order Hotline 1-800-777-4779 502-266-8787 359

 PRODUCT Code Qty PRICE
Recombinant proteins

mLGALS7 CYT-184 5 µg 50
Recombinant Mouse Galectin-7 -20 °C 20 µg 130
Galectin-7, Gal-7, HKL-14, PI7, p53-induced gene 1 Protein, 1 mg 2,700
LGALS7, PIG1, LGALS7B, GAL7, LGALS7A
MGSSHHHHHH SSGLVPRGSH MGSMSATQHK TSLPQGVRVG TVMRIRGMVP DQAGRFHVNL LCGE-
EQGADA ALHFNPRLDT SEVVFNTKEQ GKWGREERGT GIPFERGQPF EVLLIATEEG FKAVVGDDEY
LHFHHRMPPA RVRLVEVGGD VQLHSVKIF
LGALS7 mouse Recombinant produced E. coli is a single polypeptide chain containing 159 amino acids
(1-136) and having a molecular mass of 17.6kDa. LGALS7 is fused to a 23 amino acid His-tag at N-
terminus.

LGALS8 CYT-017 2 µg 50
Recombinant Human Galectin-8 -20 °C 10 µg 130
Galectin-8, Gal-8, Po66 carbohydrate-binding Protein, Po66- 1 mg 4,500
CBP, Prostate carcinoma tumor antigen 1, PCTA-1, LGALS8
The sequence of the first five N-terminal amino acids was determined and was found to be Met-Met-Leu-
Ser-Leu
Galectin-8 Human Recombinant produced in E.Coli is a single, non-glycosylated, Polypeptide chain
containing 317 amino acids and having a molecular mass of 35.8kDa.

LGALS8 His CYT-727 2 µg 50

Recombinant Human Galectin-8, His Tag -20 °C 10 µg 130
Gal-8, PCTA1, Po66-CBP, Prostate carcinoma tumor antigen 1 1 mg 5,200

MGSSHHHHHH SSGLVPRGSH MMLSLNNLQN IIYNPVIPFV GTIPDQLDPG TLIVIRGHVP

SDADRFQVDL QNGSSMKPRA DVAFHFNPRF KRAGCIVCNT LINEKWGREE ITYDTPFKRE
KSFEIVIMVL KDKFQVAVNG KHTLLYGHRI GPEKIDTLGI YGKVNIHSIG FSFSSDLQST QASSLELTEI
PEPTIDES INTERNATIONAL

SRENVPKSGT PQLRLPFAAR LNTPMGPGRT VVVKGEVNAN AKSFNVDLLA GKSKDIALHL NPRL-

NIKAFV RNSFLQESWG EEERNITSFP FSPGMYFEMI IYCDVREFKV AVNGVHSLEY KHRFKELSSI
DTLEINGDIH LLEVRSW
LGALS8 Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain contain-
ing 337 amino acids (1-317 a.a.) and having a molecular mass of 37.9 kDa. The LGALS8 is fused to a 20
amino acid His-Tag at N-terminus.

360 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
mLGALS8 CYT-185 2 µg 50
Recombinant Mouse Galectin-8, Galectin-8, Gal-8, LGALS-8, -20 °C 10 µg 130
AI326142, D13Ertd524e, 1200015E08Rik 1 mg 5,200
MGSSHHHHHH SSGLVPRGSH MGSMLSLNNL QNIIYNPIIP YVGTITEQLK PGSLIVIRGH VPKDSER-
FQV DFQLGNSLKP RADVAFHFNP RFKRSSCIVC NTLTQEKWGW EEITYDMPFR KEKSFEIVFM
VLKNKFQVAV NGRHVLLYAH RISPEQIDTV GIYGKVNIHS IGFRFSSDLQ SMETSALGLT QINRENIQKP
GKLQLSLPFE ARLNASMGPG RTVVIKGEVN TNARSFNVDL VAGKTRDIAL HLNPRLNVKA FVRN-
SFLQDA WGEEERNITC FPFSSGMYFE MIIYCDVREF KVAINGVHSL EYKHRFKDLS SIDTLSVDGD
IRLLDVRSW
LGALS8 mouse Recombinant produced E. coli is a single polypeptide chain containing 339 amino
acids (1-316) and having a molecular mass of 38kDa. LGALS8 is fused to a 23 amino acid His-tag at
N-terminus.
Activity Assay
1. Mix equal volumes of human blood and Alsever’s solution (pH 7.0).
(Alsever’s solution: NaCl 0.42g, Sodium citric acid 0.8g, Citric acid 0.055g, d-
glucose 2.05g in DW100 ml).
2. Centrifuge at 15000rpm for 10 minutes and wash 4 times with PBS.
3. Dilute packed cells in a 0.5mg/ml trypsin-EDTA solution to give 4% red cell
suspension.
4. Incubate for 1 hour at 37°C and wash 4 times with PBS.
5. Dilute packed cells in PBS to give a 4% red cell suspension.
6. Load 50µl of 0.5%BSA-in-0.15M-NaCl solution and 25µl of 4%-Red-Cell-in-PBS
in U shaped wells.
7. Add 25µl of serial diluted galectin protein in PBS to each well plate (round

PEPTIDES INTERNATIONAL
bottom 96 well plate).
8. Incubate for 30 minutes at room temperature to observe visible agglutination.

LGALS9 CYT-708 2 µg 50
Recombinant Human Galectin-9 -20 °C 10 µg 130
Lectin galactoside-binding soluble 9, Urate transporter/channel 1 mg 5,200
Protein, LGALS9A, MGC125973, HUAT, Ecalectin, Galectin-9,
MGC117375, MGC125974, HOM-HD-21, LGALS9
MGSSHHHHHH SSGLVPRGSH MAFSGSQAPY LSPAVPFSGT IQGGLQDGLQ ITVNGTVLSS SGTRFA-
VNFQ TGFSGNDIAF HFNPRFEDGG YVVCNTRQNG SWGPEERKTH MPFQKGMPFD LCFLVQSSDF
KVMVNGILFV QYFHRVPFHR VDTISVNGSV QLSYISFQ
LGALS9 produced in E.Coli is a single, non-glycosylated polypeptide chain containing 168 amino acids
(1-148 a.a.) and having a molecular mass of 18.5 kDa. Galectin-9 is fused to a 20 amino acid His-Tag at
N-terminus.

mLGALS9 CYT-550 2 µg 50
Recombinant Mouse Galectin-9, Galectin-9, Gal-9, Lgals9, -20 °C 10 µg 130
Lgals5, LGALS35, AA407335, AI194909, AI265545 1 mg 5,200
MGSSHHHHHH SSGLVPRGSH MGSMALFSAQ SPYINPIIPF TGPIQGGLQE GLQVTLQGTT KSFAQR-
FVVN FQNSFNGNDI AFHFNPRFEE GGYVVCNTKQ NGQWGPEERK MQMPFQKGMP FELCFLVQRS
EFKVMVNKKF FVQYQHRVPY HLVDTIAVSG CLKLSFITFQ TQNFRPAHQA PMAQTTIHMV HST-
PGQMFST PGIPPVVYPT PAYTIPFYTP IPNGLYPSKS IMISGNVLPD ATRFHINLRC GGDIAFHLNP
RFNENAVVRN TQINNSWGQE ERSLLGRMPF SRGQSFSVWI ICEGHCFKVA VNGQHMCEYY
HRLKNLQDIN TLEVAGDIQL THVQT
LGALS9 mouse Recombinant produced E. coli is a single polypeptide chain containing 345 amino
acids (1-322) and having a molecular mass of 38kDa. LGALS9 is fused to a 23 amino acid His-tag at
N-terminus..

Order Hotline 1-800-777-4779 502-266-8787 361

 PRODUCT Code Qty PRICE
Recombinant proteins

LGALS13 CYT-004 20 µg 50
Recombinant Human Galectin-13 -20 °C 100 µg 130
Galactoside-binding soluble lectin 13, Galectin-13, Gal-13, 1 mg 1,200
Placental tissue Protein 13, PP13, Placental Protein 13,
LGALS13, PLAC8, GAL13
Recombinant Human LGALS13 produced in E.Coli is a single, non-glycosylated polypeptide chain having
a molecular mass of 16kDa. T he LGALS13 also might appear as a homodimer, having a total Mw of
32kDa. LGALS13 was purified using standard chromatography techniques.

LGALS14 CYT-003 1 µg 50
Recombinant Human Galectin-14 -20 °C 5 µg 130
Placental Protein 13-like, Charcot-Leyden crystal Protein 2, 50 µg 1,100
CLC2, Galectin-14, Gal-14, LGALS14, PPL13, MGC22235
MGSSHHHHHH SSGLVPRGSH MGSMSSLPVP YTLPVSLPVG SCVIITGTPI LTFVKDPQLE VNFYTG-
MDED SDIAFQFRLH FGHPAIMNSR VFGIWRYEEK CYYLPFEDGK PFELCIYVRH KEYKVMVNGQ
RIYNFAHRFP PASVKMLQVL RDISLTRVLI SD
LGALS14 Human Recombinant fused with a 23 amino acid His tag at N-terminus produced in E.Coli
is a single, non-glycosylated, polypeptide chain containing 162 amino acids (1-139 a.a.) and having a
molecular mass of 18.5kDa.

LGALSL CYT-073 5 µg 50
Recombinant Human Galectin-Related Protein -20 °C 20 µg 130
Lectin galactoside-binding-like, galectin-related Protein, GRP, 1 mg 2,700
HSPC159, MGC33751, MGC71953
MGSSHHHHHH SSGLVPRGSH MGSHMAGSVA DSDAVVKLDD GHLNNSLSSP VQADVYFPRL
IVPFCGHIKG GMRPGKKVLV MGIVDLNPES FAISLTCGDS EDPPADVAIE LKAVFTDRQL LRNSCISGER
PEPTIDES INTERNATIONAL

GEEQSAIPYF PFIPDQPFRV EILCEHPRFR VFVDGHQLFD FYHRIQTLSA IDTIKINGDL QITKLG

LGALSL Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain contain-
ing 196 amino acids (1-172) and having a molecular mass of 21.6 kDa. The LGALSL is fused to a 24
amino acid His-Tag at N-terminus.

GDNF CYT-305 2 µg 50
Recombinant Human Glial-Derived Neurotrophic Factor -20 °C 10 µg 130
ATF1, ATF2, HFB1-GDNF, GDNF 1 mg 4,680
The sequence of the first five N-terminal amino acids was determined and was found to be Met-Ser-Pro-
Asp-Lys
Glial derived Neurotrophic Factor Human Recombinant produced in E.Coli is a homodimer, non-glycosylat-
ed, polypeptide chain containing 2 x 135 amino acids and having a total molecular mass of 30,360 Dalton.

mGDNF CYT-243 2 µg 50
Recombinant Mouse Glial-Derived Neurotrophic Factor -20 °C 10 µg 130
ATF1, ATF2, HFB1-GDNF, GDNF 1 mg 4,680
MSPDKQAAL PRRENRNRQAA AASPENSRGK GRRGQRGKNR GCVLTAIHLN VTDLGLGYET KEELI-
FRYCS GSCESAETMY DKILKNLSRS RRLTSDKVGQ ACCRPVAFDD DLSFLDDNLV YHILRKHSAK
RCGCI
Glial derived Neurotrophic Factor Mouse Recombinant produced in E.Coli is a non-glycosylated homodi-
mer containing 2 x 135 amino acids and having a total molecular mass of 30.2kDa.

362 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
rGDNF CYT-403 2 µg 50
Recombinant Rat Glial-Derived Neurotrophic Factor -20 °C 10 µg 130
ATF1, ATF2, HFB1-GDNF, GDNF 1 mg 4,680
MSPDKQAAL PRRENRNRQAA AASPENSRGK GRRGQRGKNR GCVLTAIHLN VTDLGLGYET KEELI-
FRYCS GSCESAETMY DKILKNLSRS RRLTSDKVGQ ACCRPVAFDD DLSFLDDNLV YHILRKHSAK
RCGCI
Glial derived Neurotrophic Factor Rat Recombinant produced in E.Coli is a homodimer, non-glycosylated,
polypeptide chain containing 2 x 135 amino acids and having a total molecular mass of 30.1 kDa.

GDF3 CYT-694 5 µg 50
Recombinant Human Growth and Differentiation factor 3 -20 °C 20 µg 130
VGR2, GDF-2, VGR-2, Vg-Related Gene-2, C78318, ecat9, 1 mg 3,510
Growth/differentiation factor 3, MGC123990, MGC123991, VG-1-
related Protein 2, GDF-3, GDF3
MKHHHHHHAS AAIPVPKLSC KNLCHRHQLF INFRDLGWHK WIIAPKGFMA NYCHGECPFS LTISLNS-
SNY AFMQALMHAV DPEIPQAVCI PTKLSPISML YQDNNDNVIL RHYEDMVVDECGCG
GDF3 Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing
124 amino acids and having a total molecular mass of 14.15 kDa. GDF3 is fused to a 10 amino acid His
Tag at N-terminus.

GDF5 CYT-442 10 µg 50
Recombinant Human Growth and Differentiation factor 5 -20 °C 50 µg 130
Cartilage-derived morphogenetic Protein-1, CDMP-1, 1 mg 1,350
LAP4, SYNS2, GDF-5, Radotermin, CDMP1, GDF5, Growth
differentiation factor 5, BMP-14
APSATRQGKR PSKNLKARCS RKALHVNFKD MGWDDWIIAP LEYEAFHCEG LCEFPLRSHL EPTN-

PEPTIDES INTERNATIONAL
HAVIQT LMNSMDPEST PPTCCVPTRL SPISILFIDS ANNVVYKQYE DMVVESCGCR
Growth Differentiation Factor 5 Human Recombinant produced in E.Coli is a homodimer, non-glycosylated
polypeptide chain containing 2 x 120 amino acids and having a total molecular mass of 27.4kDa. To en-
able bacterial expression the N-terminal sequence of Ala-Pro-Leu-Thr was replaced with a Lys.

GDF5 His CYT-653 5 µg 50

Recombinant Human Growth and Differentiation factor 5 His -20 °C 25 µg 130
Tag, Cartilage-derived morphogenetic Protein-1, CDMP-1, 1 mg 2,700
LAP4, SYNS2, GDF-5, Radotermin, CDMP1, GDF5, Growth
differentiation factor 5, BMP-14
MGSSHHHHHH SSGLVPRGSH MAPLATRQGK RPSKNLKARC SRKALHVNFK DMGWDDWIIA PLE-
YEAFHCE GLCEFPLRSH LEPTNHAVIQ TLMNSMDPES TPPTCCVPTR LSPISILFID SANNVVYKQY
EDMVVESCGC R
GDF5 Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing
141 amino acids (382-501 a.a.) and having a total molecular mass of 15.8 kDa. GDF5 is fused to 20
amino acid His Tag at N-terminus.

GDF10 CYT-659 5 µg 50
Recombinant Human Growth and Differentiation factor 10 -20 °C 20 µg 130
Bone morphogenetic Protein 3b, BMP-3b, Growth/ 1 mg 3,600
differentiation factor 10, GDF-10, Bone-inducing Protein, BIP,
GDF10, BMP3B
MQWDEPRVCS RRYLKVDFAD IGWNEWIISP KSFDAYYCAG ACEFPMPKIV RPSNHATIQS IVRAVGI-
IPG IPEPCCVPDK MNSLGVLFLD ENRNVVLKVY PNMSVDTCAC R
GDF10 Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain contain-
ing 111 amino acids (369-478 a.a.) and having a total molecular mass of 12.5 kDa.

Order Hotline 1-800-777-4779 502-266-8787 363

 PRODUCT Code Qty PRICE
Recombinant proteins

GDF15 His CYT-691 2 µg 50

Recombinant Human Growth and Differentiation factor 15, -20 °C 10 µg 130
His Tag, GDF-15, MIC1, MIC-1, NAG-1, PDF, PLAB, PTGFB, 1 mg 5,200
Growth/differentiation factor 15, Placental bone morphogenetic
Protein, Placental TGF-beta, Macrophage inhibitory cytokine 1,
Prostate differentiation factor, NSAID-activated gene 1 Protein,
NSAID-regulated gene 1 Protein, NRG-1, GDF15
MRGSHHHHHH GMASMTGGQQ MGRDLYDDDD KDRWGSMARA RNGDHCPLGP GRCCRLHTVR
ASLEDLGWAD WVLSPREVQV TMCIGACPSQ FRAANMHAQI KTSLHRLKPD TVPAPCCVPA SYNPMV-
LIQK TDTGVSLQTY DDLLAKDCHC I
Recombinant Human GDF15 produced in E.Coli is a single, non-glycosylated polypeptide chain containing
151 amino acids (195-308) and having a molecular mass of 16.7 kDa(molecular weight on SDS-PAGE will
appear higher). GDF15 is expressed with a 36 amino acid His tag fused at N-Terminus.

GDF15 D CYT-314 5 µg 50
Recombinant Human Growth and Differentiation factor 15 -20 °C 20 µg 130
D-Vairant, GDF-15, MIC1, MIC-1, NAG-1, PDF, PLAB, PTGFB, 1 mg 3,600
Growth/differentiation factor 15, Placental bone morphogenetic
Protein, Placental TGF-beta, Macrophage inhibitory cytokine 1,
Prostate differentiation factor, NSAID-activated gene 1 Protein,
NSAID-regulated gene 1 Protein, NRG-1, GDF15
MARNGDDCPL GPGRCCRLHT VRASLEDLGW ADWVLSPREV QVTMCIGACP SQFRAANMHA QIKT-
SLHRLK PDTVPAPCCV PASYNPMVLI QKTDTGVSLQ TYDDLLAKDC HCI
GDF15 D-variant (His substitutes Asp at position 7) Human Recombinant produced in E.Coli is a homodi-
meric, non-glycosylated, Polypeptide chain containing 2x113 amino acids and having a molecular mass of
24.5kDa.
PEPTIDES INTERNATIONAL

GDF15 CYT-335 5 µg 50
Recombinant Human Growth and Differentiation factor 15 -20 °C 20 µg 130
GDF-15, MIC1, MIC-1, NAG-1, PDF, PLAB, PTGFB, Growth/ 1 mg 3,600
differentiation factor 15, Placental bone morphogenetic Protein,
Placental TGF-beta, Macrophage inhibitory cytokine 1, Prostate
differentiation factor, NSAID-activated gene 1 Protein, NSAID-
regulated gene 1 Protein, NRG-1, GDF15
MARNGDHCPL GPGRCCRLHT VRASLEDLGW ADWVLSPREV QVTMCIGACP SQFRAANMHA QIKT-
SLHRLK PDTVPAPCCV PASYNPMVLI QKTDTGVSLQ TYDDLLAKDC HCI
GDF15 Human Recombinant produced in E.Coli is a homodimeric, non-glycosylated, Polypeptide chain
containing 2x113 amino acids and having a molecular mass of 24.5 kDa.

G CSF CYT-220 2 µg 50
Recombinant Human Granulocyte-Colony Stimulating Factor -20 °C 10 µg 130
CSF-3, MGI-1G, GM-CSF beta, Pluripoietin, Filgrastim, 1 mg 4,680
Lenograstim, G-CSF, MGC45931, GCSF
The sequence of the first five N-terminal amino acids of GCSF was determined and was found to be Met-
Thr-Pro-Leu-Gly
Granulocyte Colony Stimulating Factor Human Recombinant produced in E.Coli is a single, non-glycosylat-
ed, polypeptide chain containing 175 amino acids and having a molecular mass of 18.8 KD.
V. Vas, et al., PLoS ONE, 7, 2 (2012).

364 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
G CSF His CYT-476 2 µg 50
Recombinant Human Granulocyte-Colony Stimulating Factor, -20 °C 10 µg 130
His Tag, CSF-3, MGI-1G, GM-CSF beta, Pluripoietin, Filgrastim, 1 mg 3,200
Lenograstim, G-CSF, MGC45931, GCSF
Granulocyte Colony Stimulating Factor-His Tag Human Recombinant produced in E.Coli is a single, non-
glycosylated, polypeptide chain containing 174 amino acids, fragment (31-204) and having a molecular
mass of 23.19 kDa with an amino-terminal hexahistidine tag.

G CSF CHO CYT-329 2 µg 50

Recombinant Human Granulocyte-Colony Stimulating Factor, -20 °C 10 µg 130
CHO, CSF-3, MGI-1G, GM-CSF beta, Pluripoietin, Filgrastim, 1 mg 5,200
Lenograstim, G-CSF, MGC45931, GCSF

TPLGPASSLP QSFLLKCLEQ VRKIQGDGAA LQEKLCATYK LCHPEELVLL GHSLGIPWAP LSSCP-

SQALQ LAGCLSQLHS GLFLYQGLLQ ALEGISPELG PTLDTLQLDV ADFATTIWQQ MEELGMAPAL
QPTQGAMPAF ASAFQRRAGG VLVASHLQSF LEVSYRVLRH LAQP
Granulocyte Colony Stimulating Factor Human Recombinant produced in CHO cells is a single, glycosyl-
ated, polypeptide chain containing 174 amino acids and having a molecular mass of approximately 18 kDa.

G CSF PEG CYT-018 2 µg 50

Recombinant Human Pegylated Granulocyte-Colony -20 °C 10 µg 130
Stimulating Factor, CSF-3, MGI-1G, GM-CSF beta, Pluripoietin, 1 mg 5,200
Filgrastim, Lenograstim, G-CSF, MGC45931, GCSF
Granulocyte Colony Stimulating Factor Human Recombinant produced in E.Coli is a single, non-glyco-
sylated, polypeptide chain containing 175 amino acids and having a molecular mass of 18.8kDa. The
Pegylated G-CSF is produced by attaching a 20kDa methoxypolyethylene glycol propionaldehyde (mPEG-

PEPTIDES INTERNATIONAL
ALD) to the N-terminal amino acid of G-CSF giving a total molecular mass of 38.8kDa.

G CSF HEK CYT-088 2 µg 50

Recombinant Human Granulocyte-Colony Stimulating Factor, -20 °C 10 µg 130
HEK, CSF-3, MGI-1G, GM-CSF beta, Pluripoietin, Filgrastim, 1 mg 5,200
Lenograstim, G-CSF, MGC45931, GCSF
G-CSF Human Recombinant produced in HEK cells is a glycosylated monomer, having a molecular weight
range of 21-25kDa due to glycosylation. .

mG CSF CYT-410 2 µg 50
Recombinant Mouse Granulocyte-Colony Stimulating Factor -20 °C 10 µg 130
CSF3, MGI-1G, GM-CSF beta, Pluripoietin, G-CSF, GCSF 1 mg 4,680
The sequence of the first five N-terminal amino acids was determined and was found to be Met-Val-Pro-
Leu-Val
Granulocyte Colony Stimulating Factor Mouse Recombinant produced in E.Coli is a single, non-glycosylat-
ed, polypeptide chain containing 179 amino acids and having a molecular mass of 19kDa.

Order Hotline 1-800-777-4779 502-266-8787 365

 PRODUCT Code Qty PRICE
Recombinant proteins

GH (Growth Hormone)
GH is a member of the somatotropin/prolactin family of hormones which play an impor-
tant role in growth control. The gene, along with four other related genes, is located at
the growth hormone locus on chromosome 17 where they are interspersed in the same
transcriptional orientation; an arrangement which is thought to have evolved by a se -
ries of gene duplications. The five genes share a remarkably high degree of sequence
identity. Alternative splicing generates additional isoforms of each of the five growth
hormones, leading to further diversity and potential for specialization. This particular
family member is expressed in the pituitary but not in placental tissue as is the case for
the other four genes in the growth hormone locus. Mutations in or deletions of the gene
lead to growth hormone deficiency and short stature.

GH CYT-202 100 µg 50
Recombinant Human Growth Hormone -20 °C 0.5 mg 130
GH1, GH, GHN, GH-N, hGH-N,Pituitary growth hormone, 1 mg 270
Growth hormone 1, Somatotropin
The sequence of the first five N-terminal amino acids was determined and was found to be Met-Phe-Pro-
Thr-Ile
GH Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing
192 amino acids and having a molecular mass of 22260.01 Dalton.

pGH 22kDa CYT-235 10 µg 50

Recombinant Human Placental Corr Growth Hormone -20 °C 50 µg 130
GHL, GHV, GH-V, hGH-V, PGH 1 mg 2,100
PEPTIDES INTERNATIONAL

The sequence of the first five N-terminal amino acids was determined and was found to be Ala-Phe-Pro-
Thr-Ile
Placental HGH 22kDa Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain
containing 192 amino acids and having a molecular mass of 22367 Dalton. Predicted pI=7.80. Placental
Growth Hormone has dimished lactogenic (prolactin receptor mediated) activity characteristic to pituitary
GHs.
C. Arsene, et al., Anal. Chem., 80, 11 (2008).

GH 20kDa CYT-259 10 µg 50
Recombinant Human Pituitary Growth Hormone 20kDa -20 °C 50 µg 130
GH1, GH, GHN, GH-N, hGH-N,Pituitary growth hormone, 1 mg 2,100
Growth hormone 1, Somatotropin
The sequence of the first five N-terminal amino acids was determined and was found to be Ala-Phe-Pro-
Thr-Ile
Growth Hormone 20KDa Pituitary Human Recombinant produced in E.Coli is a single, non-glycosylated,
polypeptide chain containing 177 amino acids and having a molecular mass of 20322 Dalton.

pGH 20kDa CYT-337 10 µg 50

Recombinant Human Placental Growth Hormone 20kDa -20 °C 50 µg 130
GHL, GHV, GH-V, hGH-V, PGH 1 mg 2,100
The sequence of the first five N-terminal amino acids was determined and was found to be Ala-Phe-Pro-
Thr-Ile
Growth Hormone Placental 20kDa Human Recombinant produced in E.Coli is a single, non-glycosylated,
polypeptide chain containing 177 amino acids and having a molecular mass of 20498 Dalton. Predicted
pI=8.20. Growth Hormone 20K placental is devoid of lactogenic (prolactin receptor mediated) activity
characteristic to pituitary GHs. .

366 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
GH Plant CYT-053 2 µg 50
Recombinant Human Growth Hormone, Plant -20 °C 10 µg 130
1 mg 5,200
HHHHHHFPTI PLSRPFDNAM LRAHRLHQLA FDTYQEFEEA YIPKEQKYSF LQNPQTSLCF SES-
IPTPSNR EETQQKSNLE LLRISLLLIQ SWLEPVQFLR SVFANSLVYG ASDSNVYDLL KDLEEGIQTL
MGRLEDGSPR TGQIFKQTYS KFDTNSHNDD ALLKNYGLLY CFRKDMDKVE TFLRIVQCRS VEGSC-
GFAG
C1025H1570N280O306S7
GH human Recombinant produced in Nicotiana benthamiana plant is a single chain containing 205 amino
acids and 6-His-tag at the N-terminal having the total molecular mass of 22.9kDa.

GH HEK CYT-091 2 µg 50
Recombinant Human Growth Hormone, HEK -20 °C 10 µg 130
GH1, GH, GHN, GH-N, hGH-N,Pituitary growth hormone, 1 mg 5,200
Growth hormone 1, Somatotropin
Growth Hormone Human Recombinant produced in HEK cells is a non-glycosylated monomer, having a
total molecular weight of 22kDa.

GHBP CYT-238 5 µg 50
Recombinant Human Growth Hormone Binding Protein -20 °C 20 µg 130
GHR, GHBP, GH receptor, Somatotropin receptor 1 mg 3,360
afsgseataai lsrapwslqs vnpglktnss kepkftkcrs peretfschw tdevhhgtkn lg-
piqlfytr rntqewtqew kecpdyvsag enscyfnssf tsiwipycik ltsnggtvde kcfsvdeivq
pdppialnwt llnvsltgih adiqvrweap rnadiqkgwm vleyelqyke vnetkwkmmd piltts-
vpvy slkvdkeyev rvrskqrnsg nygefsevly vtlpqmsq
Growth Hormone Binding Protein Human Recombinant produced in E.Coli is a single, non-glycosylated,

PEPTIDES INTERNATIONAL
polypeptide chain containing 237 amino acids and having a molecular mass of 28107.01 Dalton.

oGHBP CYT-470 5 µg 50
Recombinant Ovine Growth Hormone Binding Protein -20 °C 20 µg 130
GHR, GHBP, GH receptor, Somatotropin receptor 1 mg 3,360
The sequence of the first five N-terminal amino acids was determined and was found to be Ala-Phe-Ser-
Gly-Ser
Growth Hormone Binding Protein Ovine Recombinant produced in E.Coli is a single, non-glycosylated,
polypeptide chain containing 237 amino acids and having a molecular mass of 28 kDa.

bGHBP CYT-471 5 µg 50
Recombinant Bovine Growth Hormone Binding Protein -20 °C 20 µg 130
GHR, GHBP, GH receptor, Somatotropin receptor 1 mg 3,360

The sequence of the first five N-terminal amino acids was determined and was found to be Ala-Phe-Ser-
Gly-Ser
Growth Hormone Binding Protein Bovine Recombinant produced in E.Coli is a single, non-glycosylated,
polypeptide chain containing 237 amino acids and having a molecular mass of 28 kDa.

raGHBP CYT-593 5 µg 50
Recombinant Rabbit Growth Hormone Binding Protein -20 °C 20 µg 130
GHR, GHBP, GH receptor, Somatotropin receptor 1 mg 3,360
The sequence of the first five N-terminal amino acids was determined and was found to be Ala-Phe-Ser-
Gly-Ser
Growth Hormone Binding Protein Rabbit Recombinant produced in E.Coli is a single, non-glycosylated,
polypeptide chain containing 248 amino acids and having a molecular mass of 48 kDa.

Order Hotline 1-800-777-4779 502-266-8787 367

 PRODUCT Code Qty PRICE
Recombinant proteins

chGH CYT-430 20 µg 50
Recombinant Chicken Growth Hormone -20 °C 100 µg 130
GH1, GH, GHN, GH-N, hGH-N,Pituitary growth hormone, 1 mg 840
Growth hormone 1, Somatotropin
The sequence of the first five N-terminal amino acids was determined and was found to be Ala-Thr-Phe-
Pro-Ala
Growth Hormone Chicken Recombinant (cGH) produced in E.Coli is a single, non-glycosylated, polypep-
tide chain containing 191 amino acids with an additional Ala at its N-terminus and having a molecular mass
of 22255 Dalton.

oGH CYT-237 20 µg 50
Recombinant Ovine Growth Hormone -20 °C 100 µg 130
GH1, GH, GHN, GH-N, hGH-N,Pituitary growth hormone, 1 mg 525
Growth hormone 1, Somatotropin
The sequence of the first five N-terminal amino acids was determined and was found to be Met-Ala-Phe-
Pro-Ala
Growth Hormone Ovine Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain
containing 200 amino acids and having a molecular mass of 22015 Dalton.

oGH Placental CYT-594 20 µg 50

Recombinant Placental Ovine Growth Hormone -20 °C 100 µg 130
GH1, GH, GHN, GH-N, hGH-N,Pituitary growth hormone, 1 mg 1,050
Growth hormone 1, Somatotropin
The sequence of the first five N-terminal amino acids was determined and was found to be Ala-Thr-Phe-
Pro-Ala
PEPTIDES INTERNATIONAL

Placental Growth Hormone Ovine Recombinant produced in E.Coli is a single, non-glycosylated poly-
peptide chain containing 191 amino acids and having a molecular mass of 21918 Dalton. The GH Ovine
Recombinant is purified by proprietary chromatographic techniques. Placental Growth Hormone differs
from pituitary Ovine Growth Hormone by two amino acids G9R/G63S. Placental Ovine Growth Hormone
possesses higher biological activity as compared to pituitary Ovine GH.

bGH CYT-636 20 µg 50
Recombinant Bovine Growth Hormone -20 °C 100 µg 130
BGH, BST, rBGH, rBST, Bovine Somatotropin, Bovine GH, 1 mg 675
Growth hormone, GH1
afpamslsgl fanavlraqh lhqlaadtfk efertyipeg qrysiqntqv afcfsetmpa ptg-
kneaqqk sdlellrisl lliqswlgpl qflsrvftns lvfgtsdrvy eklkdleegi lalmreledg
tprrgqilkq tydkfdtnmr sddallknyg llscfrkdlh ktetylrvmk crrfgeasca f
Growth Hormone Bovine Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain
containing 191 amino acids and having a molecular mass of 21.8 kDa.

mGH CYT-540 100 µg 400

Recombinant Mouse Growth Hormone -20 °C 200 µg 600
GH1, GH, GHN, GH-N, hGH-N, Pituitary growth hormone, 1 mg 2,400
Growth hormone 1, Somatotropin
The sequence of the first five N-terminal amino acids was determined and was found to be Met-Phe-Pro-
Ala-Met.
Growth Hormone Mouse Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain
containing 191 amino acids and having a molecular mass of 22 kDa.

368 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
rGH CYT-296 100 µg 255
Recombinant Rat Growth Hormone -20 °C 200 µg 340
GH1, GH, GHN, GH-N, hGH-N,Pituitary growth hormone, 1 mg 1,200
Growth hormone 1, Somatotropin
Growth Hormone Rat Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain
containing 190 amino acids and having a molecular mass of 21810 Dalton. .
R. Wu, et al., Ann Surg. 250, 1 (2010).

cGH CYT-297 10 µg 50
Recombinant Carp Growth Hormone -20 °C 50 µg 130
GH1, GH, GHN, GH-N, hGH-N,Pituitary growth hormone, 1 mg 2,100
Growth hormone 1, Somatotropin
The sequence of the first five N-terminal amino acids was determined and found to be Ser-Asp-Asn-Gln-
Arg
Growth Hormone Carp Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain
containing 188 amino acids and having a molecular mass of 21,408 Dalton. .
H. Sun, et al., PLoS ONE, 6 11 (2011).

dGH CYT-498 10 µg 50
Recombinant Denis Growth Hormone -20 °C 50 µg 130
GH1, GH, GHN, GH-N, hGH-N,Pituitary growth hormone, 1 mg 2,100
Growth hormone 1, Somatotropin
Growth Hormone Denis Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain
containing 190 amino acids and having a molecular mass of 21810 Dalton.

PEPTIDES INTERNATIONAL
maiGH CYT-499 10 µg 50
Recombinant Mai Mai Growth Hormone -20 °C 50 µg 130
GH1, GH, GHN, GH-N, hGH-N,Pituitary growth hormone, 1 mg 2,100
Growth hormone 1, Somatotropin
Growth Hormone Mai Mai Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain
containing 190 amino acids and having a molecular mass of 21810 Dalton.

sGH CYT-529 100 µg 255

Recombinant Gilthead Seabream Growth Hormone -20 °C 200 µg 340
GH1, GH, GHN, GH-N, hGH-N, Pituitary growth hormone, 1 mg 1,200
Growth hormone 1, Somatotropin
The sequence of the first five N-terminal amino acids was determined and was found to be Thr-Asp-Gly-
Gln-Arg-Leu
Somatotropin Gilthead Seabream Recombinant Sparus Aurata produced in E.Coli is a single, non-glyco-
sylated polypeptide chain containing 188 amino acids with an additional Ala at the N-terminus and having a
molecular mass of 21.4 kDa.

raGH CYT-514 10 µg 50
Recombinant Rabbit Growth Hormone -20 °C 50 µg 130
GH1, GH, GHN, GH-N, hGH-N,Pituitary growth hormone, 1 mg 2,100
Growth hormone 1, Somatotropin
Growth Hormone Rabbit Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain
containing 190 amino acids and having a molecular mass of 21774 Dalton.

Order Hotline 1-800-777-4779 502-266-8787 369

 PRODUCT Code Qty PRICE
Recombinant proteins

pGH CYT-519 100 µg 50

Recombinant Porcine Growth Hormone -20 °C 0.5 mg 130
GH1, GH, GHN, GH-N, hGH-N,Pituitary growth hormone, 1 mg 270
Growth hormone 1, Somatotropin, pST
The sequence of the first five N-terminal amino acids was determined and was found to be Phe-Pro-Ala-
Met-Pro
Porcine-Somatotropin Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain
containing 190 amino acids and having a molecular mass of 21730 Dalton.

chGH Antagonist CYT-538 20 µg 50

Recombinant Chicken Growth Hormone Anatagonist -20 °C 100 µg 130
GH1, GH, GHN, GH-N, hGH-N, Pituitary growth hormone, 1 mg 840
Growth hormone 1, Somatotropin
The sequence of the first five N-terminal amino acids was determined and was found to be Ala-Thr-Phe-
Pro-Ala
Somatotropin Chicken Antagonist Recombinant mutein G119R produced in E.Coli is a single, non-glyco-
sylated polypeptide chain containing 191 amino acids with an additional Ala at the N-terminus and having a
molecular mass of 22.3 kDa.

oGH Antagonist CYT-215 20 µg 50

Recombinant Ovine Growth Hormone Anatagonist -20 °C 100 µg 130
GH1, GH, GHN, GH-N, hGH-N, Pituitary growth hormone, 1 mg 525
Growth hormone 1, Somatotropin
The sequence of the first five N-terminal amino acids was determined and was found to be Ala-Thr-Phe-
Pro-Ala
Somatotropin Ovine Antagonist Recombinant G119R produced in E.Coli is a single, non-glycosylated
PEPTIDES INTERNATIONAL

polypeptide chain containing 191 amino acids and having a molecular mass of 22 kDa.

zGH CYT-710 10 µg 50
Recombinant Zebrafish Growth Hormone -20 °C 50 µg 130
GH1, GH, GHN, GH-N, hGH-N, Pituitary growth hormone, 1 mg 2,300
Growth hormone 1, Somatotropin
The sequence of the first six N-terminal amino acids was determined and was found to be Ala-Gln-Arg-
Leu-Phe-Asn
Somatotropin Zebrafish Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain
containing 185 amino acids with an additional Ala at the N-terminus and having a molecular mass of 21.18
kDa.
H. Sun, et al., PLoS ONE 6,11 (2011).

zGH Mutant CYT-709 10 µg 50

Recombinant Zebrafish Growth Hormone Mutant -20 °C 50 µg 130
GH1, GH, GHN, GH-N, hGH-N, Pituitary growth hormone, 1 mg 2,300
Growth hormone 1, Somatotropin
The sequence of the first six N-terminal amino acids was determined and was found to be Ala-Gln-Arg-
Leu-Phe-Asn
Somatotropin Zebrafish Mutant G113R Recombinant produced in E.Coli is a single, non-glycosylated poly-
peptide chain containing 185 amino acids with an additional Ala at the N-terminus and having a molecular
mass of 21.18 kDa.

370 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
GM-CSF (Granulocyte Macrophage Colony Stimulating Factor)
Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) was first characterized
as a growth factor that supports the in-vitro colony formation of granulocytes-macro -
phages progenitor cells. It is a pleiotropic cytokine and a member of a family of endog-
enous cytokines of the hematopoietic system. GM-CSF is produced as a response to
immune or inflammatory stimuli by activated cells of the hematopoietic system such as
T cells, B cells, macrophages, mast cells and also fibroblasts and alveolar epithelial
cells. It plays an important role in regulating the proliferation, dif ferentiation, survival
and activation of hematopoietic cells such as granulocytes and monocytes ,neutro -
philes, basophiles and eosonophoiles, erythroid cells, megakaryocytes and T cells.
Human and mouse GM-CSF have about 56% homology and are species specific.
Human GM-CSF is not active on mouse cells and vice versa. It is active on canine
and feline cells.
GMCSF is 144 amino acids, 22kDa glycoprotein. It is composed of four bundles alpha
helices. Its receptor is heterodimers with a ligand-specific alpha subunit and a betac
(?c) subunit that is shared with the interleukin IL-3 and IL-5 receptors. This unusual
form of receptor assembly likely applies also to IL-3 and IL-5 receptors. Cross-linking
the two receptor subunits is required for receptor activation and signaling.
GMCSF has been shown to be involved in maturation, mobilization and antigen pre -
sentation of myeloid dentritic cells (DCs) in-vivo or ex-vivo.This function promotes Th1
immune responses, cytotoxcity, anti-angiogenesis as well as allergic inflammation, and
the development of autoimmunity. Therefore GMCSF can be used in immunotherapy

PEPTIDES INTERNATIONAL
for the treatment of immune suppressed and immune-compromised patients as well as
in veterinary medicine for the same purpose. GM-CSF is also important in regulation
of embryo development and pregnancy and specifically in embryo implantation and
subsequent development.

GM CSF CYT-221 5 µg 50
Recombinant Human Granulocyte Macrophage-Colony -20 °C 20 µg 130
Stimulating Factor, CSF-2, MGI-1GM, GM-CSF, Pluripoietin- 1 mg 2,925
alpha, Molgramostin, Sargramostim, MGC131935, MGC138897
The sequence of the first five N-terminal amino acids was determined and was found to be Ala-Pro-Ala-
Arg-Ser
N-terminal methionine has been completely removed enzymatically.
Granulocyte Macrophage Colony Stimulating Factor Human Recombinant produced in E.Coli is a single,
non-glycosylated, polypeptide chain containing 127 amino acids and having a molecular mass of 14477
Dalton.
L.J. Carreño, et al., Immunology. 128, 3 (2009). R. Pacheco, et al., J Immunol., 177, 10 (2006).
Z. Zhang, et al., PLoS One, 5, 11 (2010). A. Rate, et al., The J. of Immunology, 182, 1 (2009).
E. Kim, et al., J Immunol., 180, 5 (2008). A. Bråve, et al., Molecular Therapy 15, 9 (2007).
C.S. Bonder, et al., Blood, 113, 9 (2009). R. Pacheco, et al., PNAS, 102, 27 (2005).
I. Correa, et al., J. of Leukocyte Bio., 85, 5 (2009). A.S. Hatzfeld-Charbonnier, et al., J. of Leukocyte Bio., 81, 5 (2007).
J.M. Martinez-Navio, et al., J. of Leukocyte Bio., 89, 1 (2010).

Order Hotline 1-800-777-4779 502-266-8787 371

 PRODUCT Code Qty PRICE
Recombinant proteins

GM CSF Pichia CYT-324 2 µg 50

Recombinant Human Granulocyte Macrophage-Colony -20 °C 10 µg 130
Stimulating Factor, Pichia 1 mg 3,600
CSF-2, MGI-1GM, GM-CSF, Pluripoietin-alpha, Molgramostin,
Sargramostim, MGC131935, MGC138897
The sequence of the first five N-terminal amino acids was determined and was found to be Ala-Pro-Ala-
Arg-Ser
Granulocyte Macrophage Colony Stimulating Factor Human Recombinant produced in Yeast is a single,
glycosylated, polypeptide chain containing 127 amino acids and having a molecular mass of 26-32 kDa.
rhGMCSF differs from the natural human GM-CSF by a substitution of leucine at position 23 (R to L), and
the carbohydrate moiety may be different from the native protein.

GM CSF Sf9 CYT-416 2 µg 50

Recombinant Human Granulocyte Macrophage-Colony -20 °C 10 µg 130
Stimulating Factor, Sf9 , CSF-2, MGI-1GM, GMCSF, Pluripoietin- 1 mg 3,600
alpha, Molgramostin, Sargramostim
The sequence of the first five N-terminal amino acids was determined and was found to be Ala-Pro-Ala-
Arg-Ser
GM-CSF Human Recombinant produced in insect cells is a single, glycosylated, polypeptide chain contain-
ing 127 amino acids (18-144) and having a molecular mass of 14.6kDa. GM-CSF is fused to a C-terminal
His -tag (6x His).

GM CSF HEK CYT-089 2 µg 50

Recombinant Human Granulocyte Macrophage-Colony -20 °C 10 µg 130
Stimulating Factor, HEK, 1 mg 5,200
CSF-2, MGI-1GM, GM-CSF, Pluripoietin-alpha, Molgramostin,
PEPTIDES INTERNATIONAL

Sargramostim, MGC131935, MGC138897

GM-CSF Human Recombinant produced in HEK cells is a glycosylated monomer, having a molecular
weight range of 15-36kDa due to glycosylation.

GM CSF His CYT-477 5 µg 50

Recombinant Human Granulocyte Macrophage-Colony -20 °C 20 µg 130
Stimulating Factor, His Tag 1 1 mg 2,400
CSF-2, MGI-1GM, GM-CSF, Pluripoietin-alpha, Molgramostin,
Sargramostim, MGC131935, MGC138897
GMCSF Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing
127 amino acids fragment (18-144) and having a molecular mass of 18.98kDa with an amino-terminal
hexahistidine tag.

372 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
PIXY321
Synergism of IL3 together with GMCSF causes a rapid rise in neutrophils due to
GMCSF and a slower rise in platelets due to IL3 which has strong stimulated effect on
hematopoietic cells.
The analog of GMCSF/IL3 is PIXY321. Results indicate that PIXY321 can stimulate
multilineage hematopoiesis in vivo and enhance neutrophil and platelet recovery fol -
lowing chemotherapy and bone marrow transplantation (BMT). These results sug -
gest that PIXY321 elicits the biological ef fects of both its component cytokines and
represents a novel means of delivering two independent but interactive cytokines in
combination.
PIXY321 CYT-360 2 µg 50
Recombinant Human gm-csf/IL-3 Fusion Protein (PIXY321) -20 °C 10 µg 130
PIXY321, GMCSF/ IL3 1 mg 5,200
GMCSF/IL3 fusion protein Human Recombinant produced in E.Coli is a single, non-glycosylated, polypep-
tide chain having a Mw of 30kDa. .

mGm CSF CYT-222 5 µg 50

Recombinant Mouse Granulocyte Macrophage-Colony -20 °C 20 µg 130
Stimulating Factor, CSF-2, MGI-1GM, GM-CSF, Pluripoietin-α, 1 mg 2,925
Molgramostin, Sargramostim
The sequence of the first five N-terminal amino acids was determined and was found to be Met-Ala-Pro-
Thr-Arg
Granulocyte Macrophage Colony Stimulating Factor Mouse Recombinant produced in E.Coli is a single,

PEPTIDES INTERNATIONAL
non-glycosylated, polypeptide chain containing 125 amino acids and having a molecular mass of 14285.35
Dalton.

rGm CSF CYT-395 5 µg 50

Recombinant Rat Granulocyte Macrophage-Colony Stimulating -20 °C 20 µg 130
Factor, CSF-2, MGI-1GM, GM-CSF, Pluripoietin-α, Molgramostin, 1 mg 2,925
Sargramostim
The sequence of the first five N-terminal amino acids was determined and was found to be Met-Ala-Pro-
Thr-Arg
Granulocyte Macrophage Colony Stimulating Factor Rat Recombinant produced in E.Coli is a single,
non-glycosylated, polypeptide chain containing 128 amino acids and having a molecular mass of 14590.65
Dalton.

pGm CSF CYT-401 2 µg 50

Recombinant Porcine Granulocyte Macrophage-Colony -20 °C 10 µg 130
Stimulating Factor, CSF-2, MGI-1GM, GM-CSF, Pluripoietin-α, 100 µg 1,300
Molgramostin, Sargramostim
The sequence of the first five N-terminal amino acids was determined and was found to be Ala-Pro-Thr-
Arg-Pro
Granulocyte Macrophage Colony Stimulating Factor Porcine Recombinant produced in E.Coli is a single,
non-glycosylated, polypeptide chain containing 127 amino acids and having a molecular mass of 14381
Dalton.

Order Hotline 1-800-777-4779 502-266-8787 373

 PRODUCT Code Qty PRICE
Recombinant proteins

rmGm CSF CYT-720 2 µg 50

Recombinant Rhesus Macaque Granulocyte Macrophage- -20 °C 10 µg 130
Colony Stimulating Factor, 1 mg 2,925
CSF-2, MGI-1GM, GM-CSF, Pluripoietin-α, Molgramostin,
Sargramostim, MGC131935, MGC138897
APARSPSPGT QPWEHVNAIQ EARRLLNLSR DTAAEMNKTV EVVSEMFDLQ EPSCLQTRLE
LYKQGLQGSL TKLKGPLTMM ASHYKQHCPP TPETSCATQI ITFQSFKENL KDFLLVIPFD CWEPVQE
Granulocyte Macrophage Colony Stimulating Factor Monkey Recombinant produced in E.Coli is a single,
non-glycosylated, polypeptide chain containing 127 amino acids and having a molecular mass of 14.4 kDa.

k9Gm CSF CYT-724 2 µg 50

Recombinant Canine Granulocyte Macrophage-Colony -20 °C 10 µg 130
Stimulating Factor 1 mg 2,925
CSF-2, MGI-1GM, GM-CSF, Pluripoietin-α, Molgramostin,
Sargramostim, MGC131935, MGC138897
APTRSPTLVT RPSQHVDAIQ EALSLLNNSN DVTAVMNKAV KVVSEVFDPE
GPTCLETRLQ LYKEGLQGSL TSLKNPLTMM ANHYKQHCPP TPESPCATQN
INFKSFKENL KDFLFNIPFD CWKPVKK
GMCSF k9 Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing
128 amino acids and having a molecular mass of 14.2 kDa.
Please prevent freeze-thaw cycles.

GMF-β (Glia Maturation Factor-β)

Glia Maturation Factor-β (GMF-β) is a 17 kDa protein nerve gorwth factor identified as
a growth and differentiation factor in the vertebrate brain.
PEPTIDES INTERNATIONAL

Glia Maturation Factor-β stimulates differentiation of normal neurons as well as glial

cells. GMFB inhibits the proliferation of the N-18 neuroblastoma line and the C6 glioma
line while promoting their phenotypic expression.
GMF-β inhances the phenotypic expression of glia and neurons thus inhibits the pro-
liferation of their respective tumors when added to cell culture. Although astrocytes
produce GMF-β and stores it inside the cells, they don’t secrete the GMF-β into the
cultured medium. Cell- surface GMFβ acts on the target cells at close range when
cells are in direct contact. GMF-β is produced by thymic epithelial cells and plays an
important role in T cell development in favor of CD4+ T cells.
GMFβ is a brain-specific protein which belongs to the actin-binding proteins (ADF)
family. GMF-β appears to play a role in the differentiation, maintenance, and regenera-
tion of the nervous system. It also supports the progression of certain auto-immune
diseases, possibly through its ability to induce the production and secretion of various
pro-inflammatory cytokines.
GmF b CYT-565 2 µg 50
Recombinant Human Glia Maturation Factor Β -20 °C 10 µg 130
Glia maturation factor β, GMFB, GMF-B, GMF-β, GMF 1 mg 4,680
SESLVVCDVAEDLVEKLRKFRFRKETNNAAIIMKIDKDKRLVVLDEELEGISPD
ELKELPERQPRFIVYSYKYQHDDGRVSYPLCFIFSSPVGCKPEQQMMYAGSKN
KLVQT AELTKVFEIRNTEDLTEEWLREKLGFFH
Glia Maturation Factor-Beta (GMF-Beta) Human Recombinant produced in E.Coli is a signle, non-glycosyl-
ated, polypeptide chain containing 141 amino acids and having a total molecular mass of 16.5 kDa.

374 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
GmF b His CYT-726 5 µg 50
Recombinant Human Glia Maturation Factor Β His Tag -20 °C 20 µg 130
GMF, GMF β 1 mg 2,700
MGSSHHHHHH SSGLVPRGSH MSESLVVCDV AEDLVEKLRK FRFRKETNNA AIIMKIDKDK RLVV-
LDEELE GISPDELKDE LPERQPRFIV YSYKYQHDDG RVSYPLCFIF SSPVGCKPEQ QMMYAGSKNK
LVQTAELTKV FEIRNTEDLT EEWLREKLGF FH
GMFB Human Recombinant produced in E.Coli is a signle, non-glycosylated, polypeptide chain containing
162 amino acids (1-142 a.a.)and having a total molecular mass of 18.8 kDa. GMGB is fused to a 20 amino
acid His Tag at N-terminus.

mGmF b CYT-006 2 µg 50
Recombinant Mouse Glia Maturation Factor Β -20 °C 10 µg 130
Glia maturation factor β, GMFB, GMF-B, GMF-β, GMF, C79176, 1 mg 4,680
AI851627, D14Ertd630e, 3110001H22Rik, 3110001O16Rik
SESLVVCDVA EDLVEKLRKF RFRKETHNAA IIMKIDKDER LVVLDEELEG
VSPDELKDEL PERQPRFIVY SYKYQHDDGR VSYPLCFIFS SPVGCKPEQQ
MMYAGSKNKL VQTAELTKVF EIRNTEDLTE EWLREKLGFF H
Glia Maturation Factor-β (GMF-β) Mouse Recombinant produced in E.Coli is a signle, non-glycosylated,
polypeptide chain containing 141 amino acids and having a total molecular mass of 16.6kDa.

rGmF b CYT-049 2 µg 50
Recombinant Rat Glia Maturation Factor Β -20 °C 10 µg 130
Glia maturation factor β, GMFB, GMF-B, GMF-β, GMF, C79176, 1 mg 4,680
AI851627, D14Ertd630e, 3110001H22Rik, 3110001O16Rik
SESLVVCDVA EDLVEKLRKF RFRKETHNAA IIMKIDKDKR LVVLDEELEG VSPDELKDEL PERQPRFIVY
SYKYQHDDGR VSYPLCFIFS SPLGCKPEQQ MMYAGSKNKL VQTAELTKVF EIRNTEDLTE EWL-

PEPTIDES INTERNATIONAL
REKLGFF H
Glia Maturation Factor-Beta (GMF-β) Rat Recombinant produced in E.Coli is a signle, non-glycosylated,
polypeptide chain containing 141 amino acids and having a total molecular mass of 16.6kDa.

GmFG CYT-632 5 µg 50
Recombinant Human Glia Maturation Factor γ -20 °C 20 µg 130
Glia maturation factor γ, GMF- γ, GMFG, MGC126867. 1 mg 2,700
MSDSLVVCEV DPELTEKLRK FRFRKETDNA AIIMKVDKDR QMVVLEEEFQ NISPEELKME LPER-
QPRFVV YSYKYVHDDG RVSYPLCFIF SSPVGCKPEQ QMMYAGSKNR LVQTAELTKV FEIRTTDDLT
EAWLQEKLSF FR
Glia Maturation Factor-γ (GMF-γ) Human Recombinant produced in E.Coli is a signle, non-glycosylated,
polypeptide chain containing 142 amino acids and having a total molecular mass of 16.8 kDa.

HDGF CYT-681 5 µg 50
Recombinant Human Hepatoma-Derived Growth Factor -20 °C 20 µg 130
High-mobility group Protein 1-like 2, HMG1L2, HMG- 1 mg 3,600
1L2, Hepatoma-derived growth factor, HDGF, FLJ96580,
DKFZp686J1764
MSRSNRQKEY KCGDLVFAKM KGYPHWPARI DEMPEAAVKS TANKYQVFFF GTHETAFLGP KDLFPY-
EESK EKFGKPNKRK GFSEGLWEIE NNPTVKASGY
The HDGF Human recombinant protein is a single, non-glycosylated polypeptide chain produced in E. coli,
having a molecular weight of 11.5kDa and containing 100 amino acids.

Order Hotline 1-800-777-4779 502-266-8787 375

 PRODUCT Code Qty PRICE
Recombinant proteins

HDGF2 CYT-132 5 µg 50
Recombinant Human Hepatoma-Derived Growth Factor-2 -20 °C 20 µg 130
Hepatoma-derived growth factor-related Protein 3, HRP-3, 1 mg 2,700
Hepatoma-derived growth factor 2, HDGF-2, HDGFRP3, HDGF2,
CGI-142
MGSSHHHHHH SSGLVPRGSH MGSHMARPRP REYKAGDLVF AKMKGYPHWP ARIDELPEGA
VKPPANKYPI FFFGTHETAF LGPKDLFPYK EYKDKFGKSN KRKGFNEGLW EIENNPGVKF TGYQAI-
QQQS SSETEGEGGN TADASSEEEG DRVEEDGKGK RKNEKAGSKR KKSYTSKKSS KQSRKSPGDE
DDKDCKEEEN KSSSEGGDAG NDTRNTTSDL QKTSEGT
HDGF2 Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing
227 amino acids (1-203 a.a.) and having a molecular mass of 25.1kDa (Molecular weight on SDS-PAGE
will appear higher). HDGF2 is fused to a 24 amino acid His-tag at N-terminus.

HGF CHO CYT-251 2 µg 50

Recombinant Human Hepatocyte Growth Factor, CHO -20 °C 10 µg 130
Scatter Factor (SF), Hepatopoietin (HPTA), HGF 1 mg 4,400

Agrees with the sequence of native human HGF

Hepatocyte Growth Factor Human Recombinant produced in CHO is a heterodimer, non-glycosylated,
polypeptide chain consisting an a-chain of 463 amino acids and b-chain of 234 having a total molecular
mass of 75kDa.

HGF Sf9 CYT-244 2 µg 50

Recombinant Human Hepatocyte Growth Factor, Sf9 -20 °C 10 µg 130
Scatter Factor (SF), Hepatopoietin (HPTA), HGF, HGFB, F-TCF 1 mg 4,300

QRKRRNTIHEFKKSAKTTLIKIDPALKIKTKKVNTADQCANRCTRNKGLPFTCK AFVFDKARKQCLWFP-
FNSMSSGVKKEFGHEFDLYENKDYIRNCIIGKGRSYKGTVSITKSGIKCQPWSSMIPHEHSYRGKDLQE-
PEPTIDES INTERNATIONAL

NYCRNPRGEEGGPWCFTSNPEVRYEVCDIPQCSEVECMTCNGESYRGLMDHTESGKICQRWDHQT-
PHRHKFLPERYPDKGFDDNYCRNPDGQPRPWCYTLDPHTRWEYCAIKTCADNTMNDTDVPLETTECI
QGQGEGYRGTVNTIWNGIPCQRWDSQYPHEHDMTPENFKCKDLRENYCRNPDG SESPW
CFTTDPNIRVGYCSQIPNCDMSHGQDCYRGNGKNYMGNLSQTRSGLTCSM WDKNMEDLHRHIFWEP
DASKLNENYCRNPDDDAHGPWCYTGNPLIPWDYCPISRCEGDTTPTIVNLDHPVISCAKTKQLRVVN-
GIPTRTNIGWMVSLRYRNKHICGGSLIKESWVLTARQCFPSRDLKDYEAWLGIHDVHGRGDEKCKQVL-
NVSQLVYGPEGSDLVLMKLARPAVLDDFVSTIDLPNYGCTIPEKTSCSVYGWGYTGLINYDGLLRVAHLY-
IMGNEKCSQHHRGKVTLNESEICAGAEKIGSGPCEGDYGGPLVCEQHKMRMVLGVIVPGRGCAIPNRP-
GIFVRVAYYAKWIHKIILTYKVPQS
Hepatocyte Growth Factor Human Recombinant produced in Baculovirus is a heterodimer, non-glycosylat-
ed, polypeptide chain containing 692 a.a and having a total molecular mass of 78.0 KDa.

HGF HEK CYT-090 2 µg 50

Recombinant Human Hepatocyte Growth Factor, HEK -20 °C 10 µg 130
Scatter Factor (SF), Hepatopoietin (HPTA), HGF, HGFB, F-TCF 1 mg 4,800
32-QRKRRNTIHE FKKSAKTTLI KIDPALKIKT KKVNTADQCA NRCTRNKGLP FTCKAFVFDK ARKQ-
CLWFPF NSMSSGVKKE FGHEFDLYEN KDYIRNCIIG KGRSYKGTVS ITKSGIKCQP WSSMIPHEHS
FLPSSYRGKD LQENYCRNPR GEEGGPWCFT SNPEVRYEVC DIPQCSEVEC MTCNGESYRG
LMDHTESGKI CQRWDHQTPH RHKFLPERYP DKGFDDNYCR NPDGQPRPWC YTLDPHTRWE
YCAIKTCADN TMNDTDVPLE TTECIQGQGE GYRGTVNTIW NGIPCQRWDS QYPHEHDMTP ENFKCK-
DLRE NYCRNPDGSE SPWCFTTDPN IRVGYCSQIP NCDMSHGQDC YRGNGKNYMG NLSQTRSGLT
CSMWDKNMED LHRHIFWEPD ASKLNENYCR NPDDDAHGPW CYTGNPLIPW DYCPISRCEG
DTTPTIVNLD HPVISCAKTK QLRVVNGIPT RTNIGWMVSL RYRNKHICGG SLIKESWVLT ARQCFP-
SRDL KDYEAWLGIH DVHGRGDEKC KQVLNVSQLV YGPEGSDLVL MKLARPAVLD DFVSTIDLPN
YGCTIPEKTS CSVYGWGYTG LINYDGLLRV AHLYIMGNEK CSQHHRGKVT LNESEICAGA EKIGSGP-
CEG DYGGPLVCEQ HKMRMVLGVI VPGRGCAIPN RPGIFVRVAY YAKWIHKIIL TYKVPQS-728
HGF Human Recombinant produced in HEK cells is a glycosylated single chain peptide, containing 697
a.a. (Gln-32 to Ser-728) having a total molecular weight of 70kDa.

376 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
HGF-A CYT-664 2 µg 50
Recombinant Human Hepatocyte Growth Factor A Chain -20 °C 10 µg 130
Scatter Factor, SF, Hepatopoietin, HPTA, HGF, HGFB, 1 mg 4,800
F-TCF, DFNB39, Hepatocyte growth factor, Hepatopoeitin-A,
Hepatocyte growth factor α chain
QRKRRNTIHEFKKSAKTTLIKIDPALKIKTKKVNTADQCAN
RCTRNKGLPFTCKAFVFDKARKQCLWFPF-
NSMSSGVKK
EFGHEFDLYENKDYIRNCIIGKGRSYKGTVSITKSGIKCQP
WSSMIPHEHSFLPSSYRG-
KDLQENYCRNPRGEEGGPWC
FTSNPEVRYEVCDIPQCSEVECMTCNGESYRGLMDHTES
GKICQR-
WDHQTPHRHKFLPERYPDKGFDDNYCRNPDGQ
PRPWCYTLDPHTRWEYCAIKTCADNTMNDTDV-
PLETTEC
IQGQGEGYRGTVNTIWNGIPCQRWDSQYPHEHDMTPEN
FKCKDLRENYCRNPDGSESPW-
CFTTDPNIRVGYCSQIPNC
DMSHGQDCYRGNGKNYMGNLSQTRSGLTCSMWDKNME
DLHRHIFWEP-
DASKLNENYCRNPDDDAHGPWCYTGNPLIP
WDYCPISRCEGDTTPTIVNLDHPVISCAKTKQLR
HGF-A Human Recombinant produced in E.Coli is a single, non-glycosylated, Polypeptide chain containing
463 amino acids fragment (32-494) having a total molecular weight of 57.8kDa. The HGF-A is fused with a
4.5kDa amino-terminal hexahistidine tag.

HGF-B CYT-665 2 µg 50
Recombinant Human Hepatocyte Growth Factor B Chain -20 °C 10 µg 130
Scatter Factor, SF, Hepatopoietin, HPTA, HGF, HGFB, F-TCF, 1 mg 4,800
DFNB39, Hepatocyte growth factor, Hepatocyte growth factor
β chain
VVNGIPTRTNIGWMVSLRYRNKHICGGSLIKESWVLTAR QCFPSRDLKDYEAWLGIHDVHGRGDEKCK-
QVLNVSQLV YGPEGSDLVLMKLARPAVLDDFVSTIDLPNYGCTIPEKTS CSVYGWGYTGLINYDGLLR-
VAHLYIMGNEKCSQHHRGK VTLNESEICAGAEKIGSGPCEGDYGGPLVCEQHKMRMV LGVIVPGRG-
CAIPNRPGIFVRVAYYAKWIHKIILTYKVPQS
HGF-B Human Recombinant produced in E.Coli is a single, non-glycosylated, Polypeptide chain contain-

PEPTIDES INTERNATIONAL
ing 234 amino acids fragment (495-728) having a molecular weight of 34kDa and fused with a 4.5kDa
amino-terminal hexahistidine tag. .

pHGF CYT-522 2 µg 50
Porcine Hepatocyte Promoting Growth Factor, Scatter Factor -20 °C 10 µg 130
(SF), Hepatopoietin (HPTA), HGF, HGFB, F-TCF, pHGF 1 mg 3,000
Hepatocyte Growth Factor porcine is extracted from pig liver.

IFI30 (γ-Interferon-Inducible Lysosomal Thiol Reductase)

γ-interferon-inducible lysosomal thiol reductase (IFI30), is a part of the GILT family.
IFI30 is a lysosomal thiol reductase which at low pH is capable of decreasing protein’s
disulfide bonds. IFI30 is expressed constitutively in antigen-presenting cells and in-
duced by gamma-interferon in other cell types. Also, IFI30 plays an important role in
MHC class II-restricted antigen processing. IFI30 facilitates the generation of MHC
class II-restricted epitopes from disulfide bond-containing antigen by the endocytic
reduction of disulfide bonds and also facilitates MHC class I-restricted recognition of
exogenous antigens containing disulfide bonds by CD8+ T-cells or cross-presentation.

Order Hotline 1-800-777-4779 502-266-8787 377

 PRODUCT Code Qty PRICE
Recombinant proteins

IFI30 CYT-183 2 µg 50
Recombinant Human Interferon Gamma-Inducible Protein 30 -20 °C 10 µg 130
Interferon γ-Inducible Protein 30, γ-Interferon-Inducible 1 mg 5,200
Lysosomal Thiol Reductase, Interferon γ-Inducible Protein
30 PreproProtein, γ-Interferon-Inducible Protein IP-30,
Legumaturain, GILT, IP30, IFI-30, MGC32056, EC 1.8
MGSSHHHHHH SSGLVPRGSH MGSMNAPLVN VTLYYEALCG GCRAFLIREL FPTWLLVMEI LNVTLV-
PYGN AQEQNVSGRW EFKCQHGEEE CKFNKVEACV LDELDMELAF LTIVCMEEFE DMERSLPLCL
QLYAPGLSPD TIMECAMGDR GMQLMHANAQ RTDALQPPHE YVPWVTVNGK  PLEDQTQLLT
LVCQLYQGK
IFI30 Human Recombinant produced in E. coli is a single polypeptide chain containing 199 amino acids
(58-232) and having a molecular mass of 22.5 kDa. IFI30 is fused to a 24 amino acid His-tag at N-
terminus.

IFN a 1 CYT-291 5 µg 50
Recombinant Human Interferon-α 1 -20 °C 20 µg 130
IFNA1, IFN-α 1, Interferon -a 1 mg 3,000
MCDLPETHSL DNRRTLMLLA QMSRISPSSC LMDRHDFGFP QEEFDGNQFQ KAPAISVLHE LIQQ-
IFNLFT TKDSSAAWDE DLLDKFCTEL YQQLNDLEAC VMQEERVGET PLMNVDSILA VKKYFRRITL
YLTEKKYSPC AWEVVRAEIM RSLSLSTNLQ ERLRRKE
IFNA1 Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing
167 amino acids (24-189) and having a molecular mass of 19.5 kDa.

IFN a 1a CYT-520 20 µg 50
Recombinant Human Interferon-α 1a -20 °C 100 µg 130
Interferon-α 1a, IFN-a 1a, IFN α 1a 1 mg 900
PEPTIDES INTERNATIONAL

CDLPETHSLD NRRTLMLLAQ MSRISPSSCL MDRHDFGFPQ EEFDGNQFQK APAISVLHEL IQQIF-

NLFTT KDSSAAWDED LLDKFCTELY QQLNDLEACA MQEERVGETP LMNVDSILAV KKYFRRITLY
LTEKKYSPCA WEVVRAEIMR SLSLSTNLQE RLRRKE
Interferon-α 1a Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain
containing 165 amino acids and having a molecular mass of 19.4 kDa. The Interferon-α 1a contains Valine
residue at position 114.

IFN a 1b CYT-283 20 µg 50
Recombinant Human Interferon-α 1b -20 °C 100 µg 130
1 mg 900
The sequence of the first five N-terminal amino acids was determined and was found to be Cys-Asp-Leu-
Pro-Glu
Interferon-α 1b Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain
containing 166 amino acids and having a molecular mass of 19392 Dalton. The Interferon-α 1b gene was
obtained from human leukocytes.

IFN a 2a CYT-204 20 µg 50
Recombinant Human Interferon-α 2a, Leukocyte interferon, B -20 °C 100 µg 130
cell interferon, Type I interferon, IFNA2, IFN-a 2a 1 mg 900

The sequence of the first five N-terminal amino acids was determined and was found to be Cys-Asp-Leu-
Pro-Gln, conforming to the sequence of native human IFN-α. N-terminal methionine has been completely
removed enzymatically.
Interferon α Human 2a Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain
containing 165 amino acids and having a molecular mass of 19241 Dalton. The Interferon-α 2a gene was
obtained from human leukocytes.
E.J. Goetzl, et al., FASEB Journal, 24, 9, (2009).

378 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
IFN a 2a Plant CYT-543 5 µg 50
Recombinant Human Interferon-α 2a, Tobacco -20 °C 25 µg 130
Leukocyte interferon, B cell interferon, Type I interferon, IFNA2, 1 mg 3,000
IFN-a 2a
The sequence of the first twelve N-terminal amino acids was determined and was found to be Cys-Asp-
Leu-Pro-Gln-Thr-His-Ser-Leu-Gly-Ser-Arg
Interferon α Human 2a Recombinant produced in plant is a single, glycosylated, polypeptide chain contain-
ing 165 amino acids and having a molecular mass of 19 kDa. The Interferon-α 2a contains affinity 6xHis
tag on C-terminus.

IFN a 2b CYT-205 20 µg 50
Recombinant Human Interferon-α 2b -20 °C 100 µg 130
Interferon α 2b, IFNA, INFA2, MGC125764, MGC125765 1 mg 900
MCDLPQTHSLGSRRTLMLLAQMRRISLFSCLKDRHDFGFPQEEFGNQFQKAETIPVLHEMIQQIFNLF
STMDSSAAWDETLLDKFYTELYQQLNDLEACVIQGVGVTETPLMKEDSILAVRKYFQRITLYLKEKKYSP
CAWEVVRAEIMRSFSLSTNLQESLRSKE
Interferon-α 2b Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain
containing 166 amino acids and having a molecular mass of 19400 Dalton. The Interferon-α 2b gene was
obtained from human leukocytes.
S. Dedoni, et al., Journal of Neurochemistry, 115, 6 (2010).

IFN a 2b Yeast CYT-460 10 µg 50

Recombinant Human Interferon-α 2b, Saccharomyces -20 °C 50 µg 130
Interferon α 2b, IFNA, INFA2, IFN-α 2b, MGC125764, 1 mg 1,400
MGC125765

PEPTIDES INTERNATIONAL
The sequence of the first five N-terminal amino acids was determined and was found to be Cys-Asp-Leu-
Pro-Gln
Interferon-α 2b Human Recombinant produced in yeast is a single, glycosylated, polypeptide chain con-
taining 165 amino acids and having a molecular mass of approximately 19 kDa. The Interferon-α 2b gene
was obtained from human leukocytes.

IFN a 2b 20kd-PEG CYT-034 2 µg 50

Recombinant Human Interferon-α 2b 20kd-Pegylated -20 °C 10 µg 130
Interferon α 2b, IFNA, INFA2, MGC125764, MGC125765 1 mg 5,200
Interferon-a 2b Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain
containing 165 amino acids and having a molecular mass of 19269 Dalton. The Pegylated IFN-α 2b is
produced by attaching a 20kDa mPEG-aldehyde to the N-terminal IFN α-2b.

IFN a 2b HEK CYT-092 2 µg 50

Recombinant Human Interferon-α 2b, HEK -20 °C 10 µg 130
Interferon alpha 2b, IFNA, INFA2, MGC125764, MGC125765 100 µg 1,100
IFN-α 2b Human Recombinant produced in HEK cells is a glycosylated monomer, having a total molecular
weight of 16kDa.

IFN a 2a HEK CYT-093 2 µg 50

Recombinant Human Interferon-α 2a, HEK: Leukocyte -20 °C 10 µg 130
interferon, B cell interferon, Type I interferon, IFNA2, IFN-a 2a 100 µg 1,100
IFN-α 2a Human Recombinant produced in HEK cells is a glycosylated monomer, having a total molecular
weight of 16kDa. .

Order Hotline 1-800-777-4779 502-266-8787 379

 PRODUCT Code Qty PRICE
Recombinant proteins

IFNA7 CYT-196 2 µg 50
Recombinant Human Interferon-α 7 -20 °C 10 µg 130
Interferon α-7, IFN-α-7, Interferon α-J, LeIF J, Interferon α-J1, 1 mg 5,200
IFN-α-J1, IFNA7, IFNA-J, IFN-αJ
MGSSHHHHHH SSGLVPRGSH MGSHMCDLPQ THSLRNRRAL ILLAQMGRIS PFSCLKDRHE FRF-
PEEEFDG HQFQKTQAIS VLHEMIQQTF NLFSTEDSSA AWEQSLLEKF STELYQQLND LEACVIQEVG
VEETPLMNED FILAVRKYFQ RITLYLMEKK YSPCAWEVVR AEIMRSFSFS TNLKKGLRRK D
IFNA7 Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing
191 amino acids (24-189 a.a) and having a molecular mass of 22.3kDa. IFNA7 is fused to a 25 amino acid
His-tag at N-terminus.

IFNA14 CYT-135 5 µg 50
Recombinant Human Interferon-α 14, -20 °C 20 µg 130
Interferon alpha-14, IFN-α-14, Interferon α-H, LeIF H, Interferon 1 mg 2,700
λ-2-H, IFNA14, LEIF2H, IFN-αH
MGSSHHHHHH SSGLVPRGSH MGSHMCNLSQ THSLNNRRTL MLMAQMRRIS PFSCLKDRHD FEF-
PQEEFDG NQFQKAQAIS VLHEMMQQTF NLFSTKNSSA AWDETLLEKF YIELFQQMND LEACVIQEVG
VEETPLMNED SILAVKKYFQ RITLYLMEKK YSPCAWEVVR AEIMRSLSFS TNLQKRLRRK D
IFNA14 Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing
191 amino acids (24-189 a.a.) and having a molecular mass of 22.4kDa. IFNA14 is fused to a 25 amino
acid His-tag at N-terminus.

IFNB 1a CYT-236 5 µg 50
Recombinant Human Interferon-β 1a -20 °C 20 µg 130
Leukocyte interferon, B cell interferon, Type I interferon, IFNB1, 1 mg 3,510
IFB, IFF, IFNB, IFN-b 1a ,MGC96956
PEPTIDES INTERNATIONAL

Interferon-β 1a Human Recombinant produced in CHO (Chinese Hamster Ovarian) cells is a single, glyco-
sylated polypeptide chain containing 166 amino acids and having a molecular mass of 22500 Dalton.
S. Dedoni, et al., Journal of Neurochemistry, 115, 6 (2010).

IFNB 1b CYT-234 2 µg 50
Recombinant Human Interferon-β 1b -20 °C 10 µg 130
Leukocyte interferon, B cell interferon, Type I interferon, IFNB1, 1 mg 2,700
IFB, IFF, IFNB, IFN-b 1b, MGC96956
The sequence of the first five N-terminal amino acids was determined and was found to be Ser-Tyr-Asn-
Leu-Leu
Interferon β 1b Human Recombinant produced in E.Coli is a single, non-glycosylated mutant (variant form)
of human Interferon β-1b polypeptide chain containing 165 amino acids and having a molecular mass of
18510.86 Dalton. The IFN-β gene was cloned from human fibroblasts and altered to substitute Serine for
the Cysteine residue found at position 17.

mIFNB CYT-651 5 µg 50
Recombinant Mouse Interferon-β -20 °C 25 µg 130
Leukocyte interferon, B cell interferon, Type I interferon, IFNB1, 1 mg 2,700
IFB, IFF, IFNB, IFN-b 1b, MGC96956
MGSSHHHHHH SSGLVPRGSH MINYKQLQLQ ERTNIRKCQE LLEQLNGKIN LTYRADFKIP MEM-
TEKMQKS YTAFAIQEML QNVFLVFRNN FSSTGWNETI VVRLLDELHQ QTVFLKTVLE EKQEERLTWE
MSSTALHLKS YYWRVQRYLK LMKYNSYAWM VVRAEIFRNF LIIRRLTRNF QN
Interferon β Mouse Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain
containing 182 amino acids (22-182 a.a.) and having a molecular mass of 22 kDa. Mouse IFN β is fused
to 20 amino acid at N-terminus.

380 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
IFNG CYT-206 20 µg 50
Recombinant Human Interferon-γ, Immune Interferon, type II -20 °C 100 µg 130
interferon, T cell interferon, MAF, IFNG, IFG, IFI, IFN-γ 1 mg 900
MQDPYVKEAE NLKKYFNAGH SDVADNGTLF LGILKNWKEE SDRKIMQSQI VSFYFKLFKN FKD-
DQSIQKS VETIKEDMNV KFFNSNKKKR DDFEKLTNYS VTDLNVQRKA IHELIQVMAE LSPAAKTGKR
KRSQMLFQGR RASQ
Interferon-gamma Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain
containing 144 amino acids and having a molecular mass of 17kDa.
Y. Shiraki, et al., FEMS Immunology and Medical Microbiology, 54, 1 (2008).

IFNG His CYT-478 10 µg 50

Recombinant Human Interferon-γ His Tag, Immune Interferon, -20 °C 50 µg 130
type II interferon, T cell interferon, MAF, IFNG, IFG, IFI, IFN-γ 1 mg 1,400
Interferon-γ Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain
containing 143 amino acids fragment (24-166) and having a molecular mass of 21.28 kDa with an amino-
terminal hexahistidine tag.

mIFNG CYT-358 20 µg 50
Recombinant Mouse Interferon-γ, Immune Interferon, type II -20 °C 100 µg 130
interferon, T cell interferon, MAF, IFNG, IFG, IFI, IFN-γ 1 mg 990
MHGTVIESLE SLNNYFNSSG IDVEEKSLFL DIWRNWQKDG DMKILQSQII SFYLRLFEVL KDNQAISNNI
SVIESHLITT FFSNSKAKKD AFMSIAKFEV NNPQVQRQAF NELIRVVHQL LPESSLRKRK RSRC
Interferon-γ Mouse Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain
containing 134 amino acids and having a molecular mass of 15.6kDa.

rIFNG CYT-359 20 µg 50

PEPTIDES INTERNATIONAL
Recombinant Rat Interferon-γ, Immune Interferon, type II -20 °C 100 µg 130
interferon, T cell interferon, MAF, IFNG, IFG, IFI, IFN-γ 1 mg 990
The sequence of the first five N-terminal amino acids was determined and was found to be Met-Gln-Gly-
Tyr-Leu
Interferon-γ Rat Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain contain-
ing 135 amino acids and having a molecular mass of 15609 Dalton.

pIFNG CYT-402 10 µg 50
Recombinant Porcine Interferon-γ, Immune Interferon, type II -20 °C 50 µg 130
interferon, T cell interferon, MAF, IFNG, IFG, IFI, IFN-γ 1 mg 2,500
The sequence of the first five N-terminal amino acids was determined and was found to be Ser-Tyr-Cys-
Gln-Ala
Interferon-γ Porcine Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain
containing 146 amino acids and having a molecular mass of 17140 Dalton.

qIFNG CYT-739 5 µg 50
Recombinant Equine Interferon-γ, Interferon gamma, IFN-γ, -20 °C 20 µg 130
IFNG 1 mg 2,700
QAAFFKEIEN LKEYFNASNP DVGDGGPLFL DILKNWKEDS DKKIIQSQIV SFYFKLFENL KDN-
QVIQKSM DTIKEDLFVK FFNSSTSKLE DFQKLIQIPV NDLKVQRKAI SELIKVMNDL SPKANLRKRK
RSQNPFRGRR ALQ
Recombinant Equine Interferon-γ produced in E.Coli is a single, non-glycosylated, polypeptide chain
containing 143 amino acids and having a molecular mass of 16.7kDa.

Order Hotline 1-800-777-4779 502-266-8787 381

 PRODUCT Code Qty PRICE
Recombinant proteins

k9IFNG CYT-404 5 µg 50
Recombinant Canine Interferon-γ, Immune Interferon, type II -20 °C 20 µg 130
interferon, T cell interferon, MAF, IFNG, IFG, IFI, IFN-γ 1 mg 2,700
QAMFFKEIEN LKEYFNASNP DVSDGGSLFV DILKKWREES DKTIIQSQIV SFYLKLFDNF KDNQIIQRSM
DTIKEDMLGK FLNSSTSKRE DFLKLIQIPV NDLQVQRKAI NELIKVMNDL SPRSNLRKRK RSQNLFR-
GRR ASK
Recombinant IFNG Dog produced in E.Coli cells is a non-glycosylated, homodimeric protein containing
143 amino acid chain and having a molecular mass of 16.9kDa. IFNG is purified by proprietary chromato-
graphic techniques.

IFNW1 CYT-040 20 µg 50
Recombinant Human Interferon-ω 1, Interferon ω-1, Interferon -20 °C 100 µg 130
α-II-1, IFNW1 1 mg 990
MCDLPQNHGL LSRNTLVLLH QMRRISPFLC LKDRRDFRFP QEMVKGSQLQ KAHVMSVLHE MLQQ-
IFSLFH TERSSAAWNM TLLDQLHTGL HQQLQHLETC LLQVVGEGES AGAISSPALT LRRYFQGIRV
YLKEKKYSDC AWEVVRMEIM KSLFLSTNMQ ERLRSKDRDL GSS
Interferon-ω 1 Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain
containing 172 amino acids and having a molecular mass of 19.9kDa.

oIFN tau CYT-377 2 µg 50

Recombinant Ovine Interferon-tau, IFN-τ1, Trophoblast -20 °C 10 µg 130
Protein 1, TP-1, Trophoblastin, Antiluteolysin, Trophoblast 1 mg 4,080
antiluteolytic Protein, IFN-τ, Interferon τ-1
The sequence of the first five N-terminal amino acids was determined and was found to be Cys-Tyr-Leu-
Ser-Arg
Interferon-τ Ovine Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain
containing 172 amino acids and having a molecular mass of 19914.7 Dalton.
PEPTIDES INTERNATIONAL

IRF 1 CYT-449 5 µg 50
Recombinant Human Interferon Regulatory Factor-1 -20 °C 20 µg 130
IRF-1, IRF1, MAR 1 mg 2,700
MGSSHHHHHH SSGLVPRGSH MPITRMRMRP WLEMQINSNQ IPGLIWINKE EMIFQIPWKHAAKHG-
WDINK DACLFRSWAI HTGRYKAGEK EPDPKTWKAN FRCAMNSLPD IEEVKDQSRN KGSSAVRVYR
MLPP
Interferon Regulatory Factor-1 Human Recombinant produced in E.Coli is a single, non-glycosylated,
polypeptide chain containing 134 amino acids (1-114) with a His Tag of 20 aa, and having a molecular
mass of 15 kDa.

IRF 2 CYT-534 5 µg 50
Recombinant Human Interferon Regulatory Factor-2, IRF-2, -20 °C 20 µg 130
IRF2, MAR, DKFZp686F0244, Interferon regulatory factor 1 mg 3,600
MGSSHHHHHH SSGLVPRGSH MPVERMRMRP WLEEQINSNT IPGLKWLNKE KKIFQIPWMHAARH-
GWDVEK DAPLFRNWAI HTGKHQPGVD KPDPKTWKAN FRCAMNSLPD IEEVKDKSIKKGNNAFRVYR
MLP
Interferon Regulatory Factor-2 Human Recombinant produced in E.Coli is a single, non-glycosylated,
polypeptide chain containing 133 amino acids (1-113) with a His Tag of 20 aa, and having a molecular
mass of 15 kDa.

382 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
IRF 3 CYT-292 5 µg 50
Recombinant Human Interferon Regulatory Factor-3 -20 °C 20 µg 130
IRF-3, IRF3, Interferon Regulatory Factor 3 1 mg 2,700
MGTPKPRILP WLVSQLDLGQ LEGVAWVNKS RTRFRIPWKH GLRQDAQQED FGIFQAWAEA TGAYVP-
GRDK PDLPTWKRNF RSALNRKEGL RLAEDRSKDP HDPHKIYEFV NS
IRF-3 Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing
111 amino acids (1-112) and having a molecular mass of 13 kDa.

IGF (Insulin-like Growth Factor)

The somatomedins, or insulin-like growth factors (IGFs), comprise a family of peptides
that play important roles in mammalian growth and development. IGF1 mediates many
of the growth-promoting effects of growth hormone (GH; MIM 139250). Early studies
showed that growth hormone did not directly stimulate the incorporation of sulfate into
cartilage, but rather acted through a serum factor, termed ‘sulfation factor,’ which later
became known as ‘somatomedin’ (Daughaday, et al., 1972). Three main somatome-
dins have been characterized: somatomedin C (IGF1), somatomedin A (IGF2; MIM
147470), and somatomedin B (MIM 193190) (Rotwein, 1986; Rosenfeld, 2003).
IGF1 CYT-216 20 µg 50
Recombinant Human Insulin Like Growth Factor-1, IGF-I, IGFI -20 °C 100 µg 130
Somatomedin C, IGF1, IGF-IA, Mechano growth factor, MGF 1 mg 270

GPETLCGAEL VDALQFVCGD RGFYFNKPTG YGSSSRRAPQ TGIVDECCFR SCDLRRLEMY CAPLK-

PAKSA
Insulin-Like Growth Factor-I Human Recombinant produced in E.Coli is a single, non-glycosylated, poly-

PEPTIDES INTERNATIONAL
peptide chain containing 70 amino acids and having a molecular mass of 7.7kDa.

IGF1 GST CYT-690 2 µg 175

Recombinant Human Insulin Like Growth Factor-1, GST-Tag -20 °C 5 µg 270
Somatomedin C, IGF-I, IGFI, IGF1, IGF-IA, Mechano growth 10 µg 490
factor, MGF
IGF1 Human Recombinant produced in E.Coli is a single, non-glycosylated, Polypeptide chain fused to a
GST tag.

IGF1 Des1-3 CYT-518 20 µg 50

Recombinant Human Insulin Like Growth Factor-1 Des (1-3) -20 °C 100 µg 130
Somatomedin C, IGF-I, IGFI, IGF1, IGF-IA, Mechano growth 1 mg 270
factor, MGF, Des(1-3), Des1-3, Des 1-3, Des (1-3), IGF-1 (4-70)
The sequence of the first five N-terminal amino acids was determined and was found to be Thr-Leu-Cys-
Gly-Ala
IGF-I Des(1-3) Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain
containing 67 amino acids (aa 4-70) and having a molecular mass of 7372 Dalton.

Order Hotline 1-800-777-4779 502-266-8787 383

 PRODUCT Code Qty PRICE
Recombinant proteins

Long R3 IGF1 CYT-022 100 µg 50

Recombinant Human LR3 Insulin Like Growth Factor-1 -20 °C 0.5 mg 130
R3 IGF1, R3 IGF-1, R3IGF1, R3IGF-1, LONG IGF1, LONG IGF-1, 1 mg 225
LONG R3 IGF1, LONG R3IGF1, LONG R3 IGF-1, LONG R3IGF-1
MFPAMPLSSLFVNGPRTLCGAELVDALQFVCGDRGFYFNKPTGYGSSSRRAPQTGIV DECCFRSCDLR-
RLEMYCAPLKPAKSA
The LR3 is a long-term analog of human IGF-1, specifically designed and manufactured for mammalian
cell culture to support large-scale manufacturing of recombinant biopharmaceuticals. Recombinant Hu-
man LR3 Insulin Like Growth Factor-1 produced in E.Coli is a single, non-glycosylated, polypeptide chain
containing 83 amino acids and having a molecular mass of 9.1kDa.

IGF1 N15 CYT-128 10 µg 50

Recombinant Human Insulin Like Growth Factor-1 N15 Labeled -20 °C 50 µg 130
Somatomedin C, IGF-I, IGFI, IGF1, IGF-IA, Mechano growth 1 mg 1,900
factor, MGF
GPETLCGAEL VDALQFVCGD RGFYFNKPTG YGSSSRRAPQ TGIVDECCFR SCDLRRLEMY CAPLK-
PAKSA
IGF1 N15 Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain contain-
ing 70 amino acids and having a molecular mass of 7.73kDa.

mIGF1 CYT-229 10 µg 50
Recombinant Mouse Insulin Like Growth Factor-1 -20 °C 50 µg 130
Somatomedin C, IGF-I, IGFIA, IGF1 1 mg 1,260
The sequence of the first five N-terminal amino acids was determined and was found to be Gly-Pro-Glu-
Thr-Leu
Insulin-Like Growth Factor I mouse Recombinant produced in E.Coli is a single, non-glycosylated, polypep-
PEPTIDES INTERNATIONAL

tide chain containing 70 amino acids and having a molecular mass of 7600 Dalton.

rIGF1 CYT-289 10 µg 50
Recombinant Rat Insulin Like Growth Factor-1 -20 °C 50 µg 130
Somatomedin C, IGF-I, IGFIA, IGF 1 mg 1,350
GPETLCGAEL VDALQFVCGP RGFYFNKPTG YGSSIRRAPQ TGIVDECCFR SCDLRRLEMY CAPLK-
PTKSA
Insulin-Like Growth Factor I Rat Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide
chain containing 70 amino acids and having a molecular mass of 7.7kDa.

sIGF1 CYT-295 10 µg 50
Recombinant Gilthead Seabream Insulin Like Growth Factor-1 -20 °C 50 µg 130
Somatomedin C, IGF-I, IGFI 1 mg 2,100
The sequence of the first ten N-terminal amino acids was determined and was found to be Met-Ser-Pro-
Glu-Thr-Leu-Cys-Gly-Ala-Glu
Insulin-Like Growth Factor-IGilthead SeabreamRecombinant produced in E.Coli is a single, non-glyco-
sylated, polypeptide chain containing 68 amino acids and having a molecular mass of 7545.4 Dalton, the
predicted pI=7.72.

IGF2 CYT-265 10 µg 50
Recombinant Human Insulin Like Growth Factor-2; -20 °C 50 µg 130
Somatomedin-A, IGF2, INSIGF, pp9974, C11orf43, FLJ22066, 1 mg 1,260
FLJ44734.
AYRPSETLCG GELVDTLQFV CGDRGFYFSR PASRVSRRSR GIVEECCFRS CDLALLETYC ATPAKSE
Insulin-Like Growth Factor-II Human Recombinant produced in E.Coli is a single, non-glycosylated, poly-
peptide chain containing 67 amino acids and having a molecular mass of 7505 Dalton.

384 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
pro-IGF2 CYT-110 2 µg 50
Recombinant Human Pro-Insulin Like Growth Factor-2 -20 °C 10 µg 130
Pro-Insulin Like Growth Factor-2, pro-IGF2 1 mg 4,800
Pro-IGF2 Human Recombinant produced in HEK cells is a glycosylated monomer, contains 157 a.a. (24-
180) having a total molecular weight of 25kDa. The Pro-IGF2 contains a C-terminal propeptide (E peptide)
Arg92 to Lys180.

IGFBP1 CYT-299 2 µg 175

Human Insulin Like Growth Factor Binding Protein-1; IGFBP-1 -20 °C 10 µg 490
IBP-1, IGF-Binding Protein 1, AFBP, PP12, IGF-BP25, hIGFBP-1, 100 µg 3,500

IGFBP1 native Human is a single, glycosylated, polypeptide chain containing 218 amino acids and having
a molecular mass of 25.3kDa.

IGFBP3 CYT-300 5 µg 50
Recombinant Human Insulin Like Growth Factor Binding -20 °C 25 µg 130
Protein-3; Growth-hormone-dependant binding Protein, IBP3, 1 mg 2,700
BP-53, IGFBP-3
GASSGGLGPV VRCEPCDARA LAQCAPPPAV CAELVREPGC GCCLTCALSE GQPCGIYTER CGSGL-
RCQPS PDEARPLQAL LDGRGLCVNA SAVSRLRAYL LPAPPAPGNA SESEEDRSAG EVESPSVSST
HRVSDPKFHP LHSKIIIIKK GHAKDSQRYK VDYESQSTDT QNFSSESKRE TEYGPCRREM EDTLNHLK-
FL NVLSPRGVHI PNCDKKGFYK KKQCRPSKGR KRGFCWCVDK YGQPLPGYTT KGKEDVHCYS
MQSK
IGFBP3 Human Recombinant produced in E.Coli is a homodimeric, non-glycosylated, polypeptide chain
containing 2x264 amino acids and having a molecular mass of 28806 Dalton.

IGFBP4 CYT-030 5 µg 50

PEPTIDES INTERNATIONAL
Recombinant Human Insulin Like Growth Factor Binding -20 °C 20 µg 130
Protein-4; Insulin-like growth factor-binding Protein 4, IBP-4, 1 mg 3,900
IGF-binding Protein 4, IGFBP-4, IGFBP4, IBP4, BP-4, HT29-
IGFBP
DEAIHCPPCS EEKLARCRPP VGCEELVREP GCGCCATCAL GLGMPCGVYT PRCGSGLRCY
PPRGVEKPLH TLMHGQGVCM ELAEIEAIQE SLQPSDKDEG DHPNNSFSPC SAHDRRCLQK HFA-
KIRDRST SGGKMKVNGA PREDARPVPQ GSCQSELHRA LERLAASQSR THEDLYIIPI PNCDRNGNFH
PKQCHPALDG QRGKCWCVDR KTGVKLPGGL EPKGELDCHQ LADSFRE + His Tag
IGFBP-4 Human Recombinant amino acids Asp22- Glu258, produced in HEK293 cells and fused with
a polyhistidine tag at the C-terminus. IGFBP4 predicted Mw is 27kDa and on SDS-PAGE appears as a
32kDa band under denaturing conditions. .

IGFBP5 CYT-464 5 µg 50
Recombinant Human Insulin Like Growth Factor Binding -20 °C 25 µg 130
Protein-5 1 mg 2,900

IGFBP6 CYT-258 5 µg 50
Recombinant Human Insulin Like Growth Factor Binding -20 °C 20 µg 130
Protein-6; IGFBP-6, IBP-6, IGF-binding Protein 6 1 mg 2,400

IGFBP6 Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain contain-
ing amino acids 148-240 and having a molecular mass of 20 kDa including 4kDa His tag.

Order Hotline 1-800-777-4779 502-266-8787 385

 PRODUCT Code Qty PRICE
Recombinant proteins

IGFBP6 (28-240) CYT-786 2 µg 50

Recombinant Human Insulin Like Growth Factor Binding -20 °C 10 µg 130
Protein-6 (28-240 a.a.); Insulin-like growth factor-binding 100 µg 1,200
Protein 6, IBP-6, IGF-binding Protein 6, IGFBP-6, IGFBP6, IBP6
MGSSHHHHHH SSGLVPRGSH MGSRCPGCGQ GVQAGCPGGC VEEEDGGSPA EGCAEAEGCL
RREGQECGVY TPNCAPGLQC HPPKDDEAPL RALLLGRGRC LPARAPAVAE ENPKESKPQA
GTARPQDVNR RDQQRNPGTS TTPSQPNSAG VQDTEMGPCR RHLDSVLQQL QTEVYRGAQT
LYVPNCDHRG FYRKRQCRSS QGQRRGPCWC VDRMGKSLPG SPDGNGSSSC PTGSSG
IGFBP6 Human Recombinant produced in E. coli is a single polypeptide chain containing 236 amino acids
(28-240) and having a molecular mass of 25.0kDa (Molecular size on SDS-PAGE will appear higher).
IGFBP6 is fused to a 23 amino acid His-tag at N-terminus.

IGFBP7 CYT-788 5 µg 50
Recombinant Human Insulin Like Growth Factor Binding -20 °C 25 µg 130
Protein-7; Insulin-like growth factor-binding Protein 7, IBP-7, 1 mg 2,700
IGF-binding Protein 7, IGFBP-7, IGFBP-rP1, MAC25 Protein,
PGI2-stimulating factor, Prostacyclin-stimulating factor, Tumor-
derived adhesion factor, TAF, IGFBP7, MAC25, PSF, AGM,
FSTL2, RAMSVPS, IGFBP-7v, IGFBPRP1
SSSDTCGPCE PASCPPLPPL GCLLGETRDA CGCCPMCARG EGEPCGGGGA GRGYCAPGME CVK-
SRKRRKG KAGAAAGGPG VSGVCVCKSR YPVCGSDGTT YPSGCQLRAA SQRAESRGEK AITQVSK-
GTC EQGPSIVTPP KDIWNVTGAQ VYLSCEVIGI PTPVLIWNKV KRGHYGVQRT ELLPGDRDNL
AIQTRGGPEK HEVTGWVLVS PLSKEDAGEY ECHASNSQGQ ASASAKITVV DALHEIPVKK GEGAEL
Recombinant Human IGFBP7 produced in E.Coli cells is a non-glycosylated, homodimeric protein contain-
ing 2x256 amino acid chains and having a molecular mass of 26.4kDa.
PEPTIDES INTERNATIONAL

IHH CYT-195 5 µg 50
Recombinant Human Indian Hedgehog -20 °C 25 µg 130
Indian hedgehog Protein, IHH, HHG-2, BDA1 1 mg 2,700
IIGPGRVVGS RRRPPRKLVP LAYKQFSPNV PEKTLGASGR YEGKIARSSE RFKELTPNYN PDIIFK-
DEEN TGADRLMTQR CKDRLNSLAI SVMNQWPGVK LRVTEGWDED GHHSEESLHY EGRAVDITTS
DRDRNKYGLL ARLAVEAGFD WVYYESKAHV HCSVKSEHSA AAKTGG
IHH Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing
176 amino acids and having a molecular mass of 19.8kDa..

IL 1 α CYT-253 2 µg 50
Recombinant Human Interleukin-1 α; Hematopoietin-1, -20 °C 10 µg 130
Lymphocyte-activating factor (LAF), Endogenous Pyrogen 1 mg 4,680
(EP), Leukocyte Endogenous Mediator (LEM), Mononuclear
Cell Factor (MCF), IL-1 α, IL1, IL-1A, IL1F1
SAPFSFLSNVKYNFMRIIKYEFILNDALNQSIIRANDQYLTAAALHNLDEAV KFDMGAYKSSKDDAKITVIL-
RISKTQLYVTAQDEDQPVLLKEMPEIPKTITG SETNLLFFWETHGTKNYFTSVAHPNLFIATKQDYWV-
CLAGGPPSITDFQILE NQA
Interleukin-1 α Human Recombinant produced in E.Coli is single, a non-glycosylated, Polypeptide chain
containing 159 amino acids and having a molecular mass of 18022 Dalton..

386 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
IL 1 α His CYT-479 5 µg 50
Recombinant Human Interleukin-1 α, His Tag; Hematopoietin-1, -20 °C 20 µg 130
Lymphocyte-activating factor (LAF), Endogenous Pyrogen 1 mg 3,200
(EP), Leukocyte Endogenous Mediator (LEM), Mononuclear
Cell Factor (MCF), IL-1 α, IL1, IL-1A, IL1F1
IL-1A Human Recombinant produced in E.Coli is single, a non-glycosylated, Polypeptide chain containing
159 amino acids fragment (113-271) with an amino-terminal hexahistidine tag and having a total molecular
mass of 22.5kDa.

mIL 1 α CYT-523 2 µg 50
Recombinant Mouse Interleukin-1 α -20 °C 10 µg 130
Hematopoietin-1, Lymphocyte-activating factor (LAF), 1 mg 4,680
Endogenous Pyrogen (EP), Leukocyte Endogenous Mediator
(LEM), Mononuclear Cell Factor (MCF), IL-1 α, IL1, IL-1A, IL1F1
The sequence of the first five N-terminal amino acids was determined and was found to be Ser-Ala-Pro-
Tyr-Thr
Interleukin-1A Mouse Recombinant produced in E.Coli is single, a non-glycosylated, Polypeptide chain
containing 156 amino acids and having a molecular mass of 18 kDa.

rIL 1 α CYT-381 2 µg 50
Recombinant Rat Interleukin-1 α; Hematopoietin-1, -20 °C 10 µg 130
Lymphocyte-activating factor (LAF), Endogenous Pyrogen 1 mg 4,680
(EP), Leukocyte Endogenous Mediator (LEM), Mononuclear
Cell Factor (MCF), IL-1 α ,IL1, IL-1A, IL1F1
The sequence of the first five N-terminal amino acids was determined and was found to be Ala-Pro-His-

PEPTIDES INTERNATIONAL
Ser-Phe
Interleukin-1A Rat Recombinant produced in E.Coli is single, a non-glycosylated, Polypeptide chain
containing 155 amino acids and having a molecular mass of 17703 Dalton.

pIL 1 α CYT-396 2 µg 50
Recombinant Porcine Interleukin-1 α; Hematopoietin-1, -20 °C 10 µg 130
Lymphocyte-activating factor (LAF), Endogenous Pyrogen 100 µg 1,300
(EP), Leukocyte Endogenous Mediator (LEM), Mononuclear
Cell Factor (MCF), IL-1 α, IL1, IL-1A, IL1F1
The sequence of the first five N-terminal amino acids was determined and was found to be Ser-Ala-Thr-
Tyr-Ser
Interleukin-1A Porice Recombinant produced in E.Coli is single, a non-glycosylated, Polypeptide chain
containing 158 amino acids and having a molecular mass of 18076 Dalton.

rmIL 1 α CYT-790 2 µg 50
Recombinant Rhesus Macaque Interleukin-1 α; IL-1 α, -20 °C 10 µg 130
IL1, Hematopoietin-1, Lymphocyte-activating factor (LAF), 1 mg 4,680
Endogenous Pyrogen (EP), Leukocyte Endogenous Mediator
(LEM), Mononuclear Cell Factor (MCF), IL-1A, IL1F1
SAPFSFLSNM TYHFIRIIKH EFILNDTLNQ TIIRANDQHL TAAAIHNLDE AVKFDMGAYT SSKDDTKVPV
ILRISKTQLY VSAQDEDQPV LLKEMPEINK TITGSETNFL FFWETHGTKN YFISVAHPNL FIATKHDNWV
CLAKGLPSIT DFQILENQA
Recombinant IL 1 α Rhesus Macaque produced in E.Coli cells is a non-glycosylated, homodimeric protein
containing 159 amino acid chain and having a molecular mass of 18.1kDa..

Order Hotline 1-800-777-4779 502-266-8787 387

 PRODUCT Code Qty PRICE
Recombinant proteins

IL 1 β CYT-208 2 µg 50
Recombinant Human Interleukin-1 β; Catabolin, Lymphocyte- -20 °C 10 µg 130
activating factor (LAF), Endogenous Pyrogen (EP), Leukocyte 1 mg 3,500
Endogenous Mediator (LEM), Mononuclear Cell Factor (MCF),
IL1F2, IL-1 β
The sequence of the first five N-terminal amino acids was determined and was found to be Ala-Pro-Val-
Arg-Ser
Interleukin-1 beta Human Recombinant produced in E.Coli is a non-glycosylated, Polypeptide chain
containing 153 amino acids and having a molecular mass of 17000 Dalton.
G.-Y. Kim, et al., Journal of Immunology, 184, 7 (2010).
D. Kafka, et al., Int. Immunol., 20, 9 (2008).

IL 1 β His CYT-480 5 µg 50
Recombinant Human Interleukin-1 β, His Tag; Catabolin, -20 °C 20 µg 130
Lymphocyte-activating factor (LAF), Endogenous Pyrogen 1 mg 2,500
(EP), Leukocyte Endogenous Mediator (LEM), Mononuclear
Cell Factor (MCF), IL1F2, IL-1 β
Interleukin-1 beta His-Tag Human Recombinant produced in E.Coli is a single, non-glycosylated, Polypep-
tide chain containing 153 amino acids fragment (117-269) and having a total molecular mass of 21.88 kDa
with an amino-terminal hexahistidine tag.

IL 1 β HEK CYT-094 2 µg 50
Recombinant Human Interleukin-1 β, HEK; Catabolin, -20 °C 10 µg 130
Lymphocyte-activating factor (LAF), Endogenous Pyrogen 1 mg 5,200
(EP), Leukocyte Endogenous Mediator (LEM), Mononuclear
Cell Factor (MCF), IL1F2, IL-1 β
PEPTIDES INTERNATIONAL

Interleukin-1 β Human Recombinant produced in HEK cells is a glycosylated monomer, having a molecular
weight range of 18-25kDa due to glycosylation.

mIL 1 β CYT-273 2 µg 50
Recombinant Mouse Interleukin-1 β, Catabolin, Lymphocyte- -20 °C 10 µg 130
activating factor (LAF), Endogenous Pyrogen (EP), Leukocyte 1 mg 4,680
Endogenous Mediator (LEM), Mononuclear Cell Factor (MCF),
IL1F2, IL-1 β
MVPIRQLHYR LRDEQQKSLV LSDPYELKAL HLNGQNINQQ VIFSMSFVQGEPSNDKIPVA LGLKG-
KNLYL SCVMKDGTPT LQLESVDPKQ YPKKKMEKRFVFNKIEVKSK VEFESAEFPN WYISTSQAEH
KPVFLGNNSG QDIIDFTMES VSS
Interleukin-1 β Mouse Recombinant produced in E.Coli is a non-glycosylated, Polypeptide chain containing
153 amino acids and having a molecular mass of 17500 Dalton.

mIL 1 β His CYT-578 5 µg 50

Recombinant Mouse Interleukin-1 β, His Tag; Catabolin, -20 °C 25 µg 130
Lymphocyte-activating factor (LAF), Endogenous Pyrogen 1 mg 2,700
(EP), Leukocyte Endogenous Mediator (LEM), Mononuclear
Cell Factor (MCF), IL1F2, IL-1 beta, Interleukin-1 β.
MRGSHHHHHH GMASMTGGQQ MGRDLYDDDD KDRWGSMVPI RQLHYRLRDE QQKSLVLSDP YEL-
KALHLNG QNINQQVIFS MSFVQGEPSN DKIPVALGLK GKNLYLSCVM KDGTPTLQLE SVDPKQYPKK
KMEKRFVFNK IEVKSKVEFE SAEFPNWYIS TSQAEHKPVF LGNNSGQDII DFTMESVSS
Interleukin-1 beta Mouse Recombinant produced in E.Coli is a non-glycosylated, Polypeptide chain con-
taining 189 amino acids and having a molecular mass of 21 kDa. The IL-1b is fused to His-Tag.

388 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
rIL 1 β CYT-394 2 µg 50
Recombinant Rat Interleukin-1 β; Catabolin, Lymphocyte- -20 °C 10 µg 130
activating factor (LAF), Endogenous Pyrogen (EP), Leukocyte 1 mg 4,680
Endogenous Mediator (LEM), Mononuclear Cell Factor (MCF),
IL1F2, IL-1 β
MVPIRQLHCRLRDEQQKCLVLSDPCELKALHLNGQNISQQVVFSMSF VQGETSNDKIPVALGLKGLN-
LYLSCVMKDGTPTLQLESVDPKQYPKK KMEKRFVFNKIEVKTKVEFESAQFPNWYISTSQAEHRPVFL-
GNSNGRD IVDFTMEPVSS
Interleukin-1b Rat Recombinant produced in E.Coli is a non-glycosylated, Polypeptide chain containing
153 amino acids and having a molecular mass of 17.3 kDa.

rmIL 1 β CYT-718 2 µg 50
Recombinant Rhesus Macaque Interleukin-1 β , Catabolin, -20 °C 10 µg 130
Lymphocyte-activating factor (LAF), Endogenous Pyrogen 1 mg 3,500
(EP), Leukocyte Endogenous Mediator (LEM), Mononuclear
Cell Factor (MCF), IL1F2, IL-1 β
APVRSLHCTL RDAQLKSLVM SGPYELKALH LQGQDLEQQV VFSMSFVQGE ESNDKIPVAL
GLKAKNLYLS CVLKDDKPTL QLESVDPKNY PKKKMEKRFV FNKIEINNKL EFESAQFPNW YISTSQA-
ENM PVFLGGTRGG QDITDFTMQF VSS
Interleukin-1 β Monkey Recombinant produced in E.Coli is a non-glycosylated, Polypeptide chain contain-
ing 153 amino acids and having a molecular mass of 17.3 kDa.

pIL 1 β CYT-400 2 µg 50
Recombinant Porcine Interleukin-1 β, Catabolin, Lymphocyte- -20 °C 10 µg 130
activating factor (LAF), Endogenous Pyrogen (EP), Leukocyte 1 mg 4,680
Endogenous Mediator (LEM), Mononuclear Cell Factor (MCF),

PEPTIDES INTERNATIONAL
IL1F2, IL-1 β
ANVQSMECKL QDKDHKSLVL AGPHMLKALH LLTGDLKREV VFCMSFVQGD DSNNKIPVTL GIKG-
KNLYLS CVMKDNTPTL QLEDIDPKRY PKRDMEKRFV FYKTEIKNRV EFESALYPNW YISTSQAEQK
PVFLGNSKGR QDITDFTMEV LSP
Recombinant IL 1 β Porcine produced in E.Coli cells is a non-glycosylated, homodimeric protein containing
153 amino acid chain and having a molecular mass of 17.6kDa.
Please prevent freeze-thaw cycles.

eIL 1 β CYT-411 2 µg 50
Recombinant Equine Interleukin-1 β, Catabolin, Lymphocyte- -20 °C 10 µg 130
activating factor (LAF), Endogenous Pyrogen (EP), Leukocyte 1 mg 4,680
Endogenous Mediator (LEM), Mononuclear Cell Factor (MCF),
IL1F2, IL-1 β
AAMHSVNCRL RDIYHKSLVL SGACELQAVH LNGENTNQQV VFCMSFVQGE EETDKIPVAL
GLKEKNLYLS CGMKDGKPTL QLETVDPNTY PKRKMEKRFV FNKMEIKGNV EFESAMYPNW YIST-
SQAEKS PVFLGNTRGG RDITDFIMEI TSA
Recombinant IL 1 β Equine produced in E.Coli cells is a non-glycosylated, homodimeric protein containing
153 amino acid chain and having a molecular mass of 17.3kDa..

Order Hotline 1-800-777-4779 502-266-8787 389

 PRODUCT Code Qty PRICE
Recombinant proteins

IL 1RA CYT-203 20 µg 50
Recombinant Human Interleukin-1 Receptor Antagonist -20 °C 100 µg 130
IRAP, IL1F3, IL1RA, IL-1ra3, ICIL-1RA, IL1RN, IL1 inhibitor, 1 mg 990
IL-1ra, MGC10430
The sequence of the first five N-terminal amino acids was determined and was found to be Met-Arg-Pro-
Ser-Gly
IL1ra Human Recombinant produced in E.Coli is a non-glycosylated, N-terminal methionyl form of the
human naturally-occurring polypeptide chain containing 153 amino acids and having a molecular mass of
17000 Dalton. .

IL 1RA His CYT-481 10 µg 150

Recombinant Human Interleukin-1 Receptor Antagonist, His -20 °C 50 µg 500
Tag; IRAP, IL1F3, IL1RA; IL-1ra3, ICIL-1RA, IL1RN, IL1 inhibitor, 1 mg 2,380
IL-1ra, MGC10430
IL1Ra Human Recombinant produced in E.Coli is single, a non-glycosylated, Polypeptide chain containing
152 amino acids fragment (26-177) and having a total molecular mass of 21.63kDa with an amino-terminal
hexahistidine tag. .

IL1RL1 CYT-671 2 µg 50
Recombinant Human Interleukin-1 Receptor Like-1, DER4, ST2, -20 °C 10 µg 130
Interleukin-1 receptor-like 1, Protein ST2, IL1RL1, T1, ST2L, 1 mg 4,800
ST2V, FIT-1, MGC32623
IL1RL1 Human Recombinant produced in E.Coli is a single, non-glycosylated, Polypeptide chain contain-
ing 310 amino acids fragment (19-328) corresponding to the soluble IL1RL1 coding sequence, having a
molecular weight of 39.5kDa and fused with a 4.5kDa amino-terminal hexahistidine tag. .
PEPTIDES INTERNATIONAL

mIL 1RA CYT-658 5 µg 50

Recombinant Mouse Interleukin-1 Receptor Antagonist, IRAP, -20 °C 20 µg 130
IL1F3, IL1RA, IL-1ra3, ICIL-1RA, IL1RN, IL1 inhibitor, IL-1ra, 1 mg 3,000
F630041P17Rik
The sequence of the first six N-terminal amino acids was determined and was found to be Ala-Cys-Arg-
Pro-Ser-Gly
IL1 ra Mouse Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing
153 amino acids and having a molecular mass of 17.4kDa. .

mIL 1RA His CYT-136 5 µg 50

Recombinant Mouse Interleukin-1 Receptor Antagonist, His Tag -20 °C 20 µg 130
IRAP, IL1F3, IL1RA, IL-1ra3, ICIL-1RA, IL1RN, IL1 inhibitor, 1 mg 2,700
IL-1ra, F630041P17Rik
MGSSHHHHHH SSGLVPRGSH MGSHMRPSGK RPCKMQAFRI WDTNQKTFYL RNNQLIAGYL
QGPNIKLEEK IDMVPIDLHS VFLGIHGGKL CLSCAKSGDD IKLQLEEVNI TDLSKNKEED KRFTFIRSEK
GPTTSFESAA CPGWFLCTTL EADRPVSLTN TPEEPLIVTK FYFQEDQ
IL-1RA mouse Recombinant produced E. coli is a single polypeptide chain containing 177 amino acids (27-
178) and having a molecular mass of 20kDa. IL-1RA is fused to a 25 amino acid His-tag at N-terminus.

390 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
rIL 1RA CYT-152 5 µg 50
Recombinant Rat Interleukin-1 Receptor Antagonist, IRAP, -20 °C 20 µg 130
IL1F3, IL1RA, IL-1ra3, ICIL-1RA, IL1RN, IL1 inhibitor, IL-1ra, 1 mg 2,700
MGC10430
HPAGKRPCKM QAFRIWDTNQ KTFYLRNNQL IAGYLQGPNT KLEEKIDMVP IDFRNVFLGI HGG-
KLCLSCV KSGDDTKLQL EEVNITDLNK NKEEDKRFTF IRSETGPTTS FESLACPGWF LCTTLEADHP
VSLTNTPKEP CTVTKFYFQE DQ
IL 1RA Rat Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 152
amino acids and having a molecular mass of 17.5kDa..

hIL 1RA CYT-010 20 µg 50

Recombinant Horse Interleukin-1 Receptor Antagonist -20 °C 100 µg 130
Interleukin-1 receptor antagonist Protein, IL-1RN, IL-1ra, IRAP, 1 mg 990
IL1 inhibitor, IL1RN, IL1RA
HPLGKRPCKM QAFRIWDVNQ KTFYMRNNQL VAGYLQESNT KLQEKIDVVP IEPDALFLGL
HGRKLCLACV KSGDEIRFQL EAVNITDLSK NKEENKRFTF IRSNSGPTTS FESAACPGWF
LCTAQEADRP VSLTNKPKES FMVTKFYLQE DQ
Recombinant Horse Interleukin-1 Receptor Antagonist produced in E.Coli cells is a single, non-glycosylat-
ed, polypeptide chain containing 152 amino acids and having a molecular mass of 17.4kDa. .

pIL 1RA CYT-376 5 µg 50

Recombinant Porcine Interleukin-1 Receptor Antagonist, IRAP, -20 °C 20 µg 130
IL1F3, IL1RA, IL-1ra3, ICIL-1RA, IL1RN, IL1 inhibitor, IL-1ra, 1 mg 2,700
MGC10430
HPLGKRPCRM QAFRIWDVNQ KTFYLRNNQL VAGYLQGPNT KLEEKIDVVP VEPHFVFLGI HGG-
KLCLSCV KSGDEMKLQL DAVNITDLRK NSEQDKRFTF IRSDSGPTTS FESAACPGWF LCTALEADQP

PEPTIDES INTERNATIONAL
VGLTNTPKAA VKVTKFYFQQ DQ
Recombinant IL 1RA Porcine produced in E.Coli cells is a non-glycosylated, homodimeric protein contain-
ing 152 amino acid chain and having a molecular mass of 17.1kDa..
Please prevent freeze-thaw cycles.

IL2 (Interleukin-2)
IL2 is a secreted cytokine that is important for the proliferation of T and B lymphocytes.
The receptor of this cytokine is a heterotrimeric protein complex whose gamma chain
is also shared by interleukin 4 (IL4) and interleukin 7 (IL7). The expression of this gene
in mature thymocytes is monoallelic, which represents an unusual regulatory mode for
controlling the precise expression of a single gene. The targeted disruption of a similar
gene in mice leads to ulcerative colitis-like disease, which suggests an essential role of
this gene in the immune response to antigenic stimuli.

IL 2 CYT-209 10 µg 50
Recombinant Human Interleukin-2 -20 °C 50 µg 130
T-cell growth factor (TCGF), Aldesleukin, Lymphokine, IL-2 1 mg 720
MAPTSSSTKK TQLQLEHLLL DLQMILNGIN NYKNPKLTRM LTFKFYMPKK ATELKHLQCL EEELK-
PLEEV LNLAQSKNFH LRPRDLISNI NVIVLELKGS ETTFMCEYAD ETATIVEFLN RWITFCQSII STLT
Interleukin-2 Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain
containing 134 amino acids and having a molecular mass of 15kDa. .
D.M. Gakamsky, et al., Biophysical Journal, 89, 9 (2005).

Order Hotline 1-800-777-4779 502-266-8787 391

 PRODUCT Code Qty PRICE
Recombinant proteins

IL 2 His CYT-666 2 µg 50
Recombinant Human Interleukin-2 His Tag -20 °C 10 µg 130
T-cell growth factor (TCGF), Aldesleukin, Lymphokine, IL-2, IL2 1 mg 4,800
Interleukin-2 Human Recombinant produced in E.Coli is a single, non-glycosylated, Polypeptide chain con-
taining 133 amino acids fragment (21-153) having a molecular weight of 20kDa and fused with a 4.5kDa
amino-terminal hexahistidine tag. .

IL 2 HEK CYT-095 2 µg 50
Recombinant Human Interleukin 2, HEK -20 °C 10 µg 130
T-cell growth factor (TCGF), Aldesleukin, Lymphokine, IL-2 1 mg 3,900
Interleukin-2 Human Recombinant produced in HEK cells is a glycosylated monomer, having a total
molecular weight of 15kDa. .

mIL 2 CYT-370 5 µg 50
Recombinant Mouse Interleukin-2, Interleukin-2, T-cell growth -20 °C 20 µg 130
factor (TCGF), Aldesleukin, Lymphokine, IL-2 1 mg 2,520
PTSSSTSSST AEAQQQQQQQ QQQQQHLEQL LMDLQELLSR MENYRNLKLP RMLTFKFYLP KQA-
TELKDLQ CLEDELGPLR HVLDLTQSKS FQLEDAENFI SNIRVTVVKL KGSDNTFECQ FDDESATVVD
FLRRWIAFCQ SIISTSPQ
Interleukin-2 Mouse Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain
containing 148 amino acids and having a molecular mass of 17.2kDa. .

mIL 2 His CYT-624 10 µg 50

Recombinant Mouse Interleukin-2, His Tag; Interleukin-2, T-cell -20 °C 50 µg 130
growth factor (TCGF), Aldesleukin, Lymphokine, IL-2, Il2 1 mg 1,800
MGSSHHHHHH SSGLVPRGSH MAPTSSSTSS STAEAQQQQQ QQQQQQQHLE QLLMDLQELL SRME-
PEPTIDES INTERNATIONAL

NYRNLK LPRMLTFKFY LPKQATELKD LQCLEDELGP LRHVLDLTQS KSFQLEDAEN FISNIRVTVV

KLKGSDNTFE CQFDDESATV VDFLRRWIAF CQSVISTSPQ
Interleukin-2 Mouse Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain con-
taining 170 amino acids (21-169 a.a) and having a molecular mass of 19.5kDa. The mouse IL-2 is fused to
a 20 amino acid His tag at N-Terminus.

rIL 2 CYT-382 5 µg 50
Recombinant Rat Interleukin-2 -20 °C 20 µg 130
T-cell growth factor (TCGF), Aldesleukin, Lymphokine, IL-2 1 mg 2,520
Interleukin-2 Rat Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain contain-
ing 134 amino acids and having a molecular mass of 17kDa. .
A. Mendoza-Naranjo, et al., Journal of Immunology, 178, 11 (2007).

pIL 2 CYT-397 2 µg 50
Recombinant Porcine Interleukin-2 -20 °C 10 µg 130
T-cell growth factor (TCGF), Aldesleukin, Lymphokine, IL-2 1 mg 4,680

The sequence of the first five N-terminal amino acids was determined and was found to be Met-Ala-Pro-
Thr-Ser
Interleukin2 Porcine Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain
containing 134 amino acids and having a molecular mass of 15217 Dalton. .

392 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
qIL2 CYT-738 5 µg 50
Recombinant Equine Interleukin-2, Interleukin-2, IL-2, T-cell -20 °C 20 µg 130
growth factor, TCGF, IL2Interleukin-2, IL-2, T-cell growth factor, 1 mg 2,700
TCGF, IL2
APTSSSKRET QQQLKQLQMD LKLLLEGVNN NKNPKLSKML TFKINMPKKA TELKHLQCLE EELKPL-
EEML KNFLSKDIKE LMSNINVTVL GLKGSETRFT CEYDDETGTI VEFLNKWITF SQSIFSTMT
Recombinant Equine Interleukin-2 produced in E.Coli is a single, non-glycosylated, polypeptide chain
containing 129 amino acids (with a substitution of S for C - at position 141 compared with the wild type IL2)
and having a molecular mass of 14.9kDa..

sIL 2R CYT-285 5 µg 50
Recombinant Human Soluble Iinterleukin-2 Receptor α -20 °C 25 µg 130
CD25, IL2R, TCGFR, IL-2RA, sIL-2RA, TAC antigen, sIL-2R, 1 mg 2,600
IDDM10, p55
Interleukin-2R Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain
containing 192 amino acids (22-213) corresponding to the mature IL2-R protein with an amino terminal
hexahistidine tag. .

IL2 Yeast CYT-797 2 µg 50

Recombinant Human Interleukin-2, Yeast, Interleukin-2, T-cell -20 °C 10 µg 130
growth factor (TCGF), Aldesleukin, Lymphokine, IL-2 1 mg 3,900
APTSSSTKKTQLQLEHLLLDLQMILNGINNYKNPKLTRMLTFKFYMPKKATELKHLQCLEEELKPLEEVLN-
LAQSKNFHLRPRDLISNINVIVLELKGSETTFMCEYADETATIVEFLNRWITFCQSIISTLT
Interleukin-2 Human Recombinant produced in yeast is a single, glycosylated polypeptide chain containing
134 amino acids and having a molecular mass of 14 kDa..

PEPTIDES INTERNATIONAL
IL3 (Interleukin-3)
Interleukin-3 is a pleiotropic cytokine produced primarily by activated T cells.
IL-3 is thought to function via specific cell surface receptors to stimulate the prolifera-
tion, differentiation and survival of haematopoietic cell lines. IL-3 has also been shown
to affect the functional activity of a variety of other cell types including mast cells, eo -
sinophils, megakaryocytes and basophils.
IL 3 CYT-210 2 µg 50
Recombinant Human Interleukin-3, MCGF (Mast cell growth -20 °C 10 µg 130
factor), Multi-CSF, HCGF, P-cell stimulation factor, IL-3, 1 mg 2,700
MGC79398, MGC79399
The sequence of the first five N-terminal amino acids was determined and was found to be Ala-Pro-Met-
Thr-Gln
Interleukin-3 Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain
containing 133 amino acids and having a molecular mass of 15000 Dalton. .
X. Han, et al., FASEB Journal, 24, 8, (2010).
K. Hasegawa, et al., Stem Cells, 24, 12 (2006).

Order Hotline 1-800-777-4779 502-266-8787 393

 PRODUCT Code Qty PRICE
Recombinant proteins

IL 3 His CYT-482 10 µg 50
Recombinant Human Interleukin-3, His Tag -20 °C 50 µg 130
MCGF (Mast cell growth factor), Multi-CSF, HCGF, P-cell 1 mg 2,100
stimulation factor, IL-3, MGC79398, MGC79399
MGSSHHHHHH SSGLVPRGSH MAPMTQTTSL KTSWVNCSNM IDEIITHLKQ PPLPLLDFNN
LNGEDQDILM ENNLRRPNLE AFNRAVKSLQ NASAIESILK NLLPCLPLAT AAPTRHPIHI KDGDWNE-
FRR KLTFYLKTLE NAQAQQTTLS LAIF
Interleukin-3 Human Recombinant produced in E.Coli is single, a non-glycosylated, Polypeptide chain
containing 154 amino acids fragment (20-152) and having a total molecular mass of 17.3kDa and fused
with a 20 aa N-terminal His tag. .

IL 3 HEK CYT-096 2 µg 50
Recombinant Human Interleukin 3, HEK -20 °C 10 µg 130
MCGF (Mast cell growth factor), Multi-CSF, HCGF, P-cell 1 mg 5,200
stimulation factor, IL-3, MGC79398, MGC79399
Interleukin-3 Human Recombinant produced in HEK cells is a glycosylated monomer, having a molecular
weight range of 17-45kDa due to glycosylation. .

mIL 3 CYT-371 2 µg 50
Recombinant Mouse Interleukin-3 -20 °C 10 µg 130
MCGF (Mast cell growth factor), Multi-CSF, HCGF, P-cell 1 mg 2,700
stimulation factor, IL-3, MGC79398, MGC79399
Interleukin-3 mouse Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain
containing 135 amino acids and having a molecular mass of 15100 Dalton. .
K. Masson, et al., Biochemical Journal Immediate Publication, BJ20060464 (2006).
PEPTIDES INTERNATIONAL

J. Yang, et al., Journal of Hematology and Oncology, 4, 38 (2011).

E. Heiss, et al., Blood, 108, 5 (2006).

rIL 3 CYT-383 5 µg 50
Recombinant Rat Interleukin-3 -20 °C 20 µg 130
MCGF (Mast cell growth factor), Multi-CSF, HCGF, P-cell 1 mg 2,700
stimulation factor, IL-3, MGC79398, MGC79399
The sequence of the first five N-terminal amino acids was determined and was found to be Met-Ser-Asp-
Arg-Gly
Interleukin-3 Rat Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain contain-
ing 140 amino acids, having a molecular mass of 16 kDa.

IL 3 Sf9 CYT-417 2 µg 50
Recombinant Human Interleukin-3, Sf9 -20 °C 10 µg 130
MCGF (Mast cell growth factor), Multi-CSF, HCGF, P-cell 1 mg 3,600
stimulation factor, IL-3, MGC79398, MGC79399
The sequence of the first five N-terminal amino acids was determined and was found to be Ala-Pro-Ala-
Pro-Thr
Interleukin-3 Human Recombinant produced in insect cells is a single, glycosylated polypeptide chain
containing 133 amino acids and having a molecular mass of 15000 Dalton. The IL-3 CSF is fused to a
C-terminal His-tag (6x His).

394 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
k9 IL 3 CYT-722 2 µg 50
Recombinant Canine Interleukin-3 -20 °C 10 µg 130
MCGF (Mast cell growth factor), Multi-CSF, HCGF, P-cell 1 mg 2,700
stimulation factor, IL-3, MGC79398, MGC79399
RPFSTDLPKQ YFTMINEIME MLNKSPSPSE EPLDSNEKET LLEDTLLRPN LDVFLNASSK FHKNGL-
LIWN NLKEFLPLLP TPTPRGEPIS IMENNWGDFQ RKLKKYLEAL DNFLNFKNKP
Interleukin-3 Canine Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain
containing 120 amino acids and having a molecular mass of 14 kDa..

rmIL3 CYT-156 2 µg 50
Recombinant Rhesus Macaque Interleukin-3 -20 °C 10 µg 130
MCGF (Mast cell growth factor), Multi-CSF, HCGF, P-cell 1 mg 2,700
stimulation factor, IL-3, MGC79398, MGC79399
APMTQTTSLK TSWAKCSNMI DEIITHLNQP PLPSPDFNNL NEEDQTILVE KNLRRSNLEA FSKAVK-
SLQN ASAIESILKN LPPCLPMATA APTRPPIRIT NGDRNDFRRK LKFYLKTLEN EQAQ
IL 3 Rhesus Macaque Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain
containing 124 amino acids and having a molecular mass of 14.0kDa. .
Please prevent freeze-thaw cycles.

IL4 (Interleukin-4)
IL4 is a pleiotropic cytokine produced by activated T cells. IL4 is a ligand for interleukin
4 receptor. The interleukin 4 receptor also binds to IL13, which may contribute to many
overlapping functions of this cytokine and IL13. STAT6, a signal transducer and activa-
tor of transcription, has been shown to play a central role in mediating the immune

PEPTIDES INTERNATIONAL
regulatory signal of this cytokine. This gene, IL3, IL5, IL13, and CSF2 form a cytokine
gene cluster on chromosome 5q, with this gene particularly close to IL13. IL4, IL13 and
IL5 are found to be regulated coordinately by several long-range regulatory elements
in an over 120 kilobase range on the chromosome. Two alternatively spliced transcript
variants of this gene encoding distinct isoforms have been reported.
IL 4 CYT-211 5 µg 50
Recombinant Human Interleukin-4 -20 °C 20 µg 130
BCGF, BCDF, B cell stimulating factor, BSF-1, Lymphocyte 1 mg 2,900
stimulatory factor 1, IL-4, MGC79402, Binetrakin, Pitrakinra
BCGF, BCDF, B cell stimulating factor, BSF-1, Lymphocyte stimulatory factor 1, IL-4, MGC79402, Binetra-
kin, Pitrakinra
Interleukin-4 Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain
containing 130 amino acids and having a molecular mass of 15000 Dalton. .

IL 4 CHO CYT-271 2 µg 50
Recombinant Human Interleukin-4 CHO -20 °C 10 µg 130
BCGF, BCDF, B cell stimulating factor, BSF-1, Lymphocyte 1 mg 4,800
stimulatory factor 1, IL-4, MGC79402, Binetrakin, Pitrakinra
Interleukin-4 Human Recombinant produced in CHO is a single, non-glycosylated polypeptide chain
containing 129 amino acids and having a molecular mass of 14 kDa, the glycosilation of IL-4 migrates as
18 kDa on SDS-PAGE. .
A. Bosco, et al., Journal of Immunology, 182, 10 (2009).

Order Hotline 1-800-777-4779 502-266-8787 395

 PRODUCT Code Qty PRICE
Recombinant proteins

IL 4 His CYT-483 5 µg 50
Recombinant Human Interleukin-4, His Tag -20 °C 20 µg 130
BCGF, BCDF, B cell stimulating factor, BSF-1, Lymphocyte 1 mg 5,200
stimulatory factor 1, IL-4, MGC79402, Binetrakin, Pitrakinra
MGSSHHHHHH SSGLVPRGSH MHKCDITLQE IIKTLNSLTE QKTLCTELTV TDIFAASKNT TEKETF-
CRAA TVLRQFYSHH EKDTRCLGAT AQQFHRHKQL IRFLKRLDRN LWGLAGLNSC PVKEANQSTL
ENFLERLKTI MREKYSKCSS
Interleukin-4 Human Recombinant produced in E.Coli is single, a non-glycosylated, Polypeptide chain
containing 150 amino acids fragment (25-153) and having a total molecular mass of 17.2kDa. The IL-4 is
fused to a 20 amino acid His-Tag at N-terminus.

IL 4 HEK CYT-097 2 µg 50
Recombinant Human Interleukin 4, HEK -20 °C 10 µg 130
BCGF, BCDF, B cell stimulating factor, BSF-1, Lymphocyte 1 mg 5,200
stimulatory factor 1, IL-4, MGC79402, Binetrakin, Pitrakinra
IL-4 Human Recombinant produced in HEK cells is a glycosylated monomer, having a molecular weight
range of 14-19kDa due to glycosylation. .

mIL 4 CYT-282 5 µg 50
Recombinant Mouse Interleukin-4 -20 °C 20 µg 130
BCGF, BCDF, B cell stimulating factor, BSF-1, Lymphocyte 1 mg 2,900
stimulatory factor 1, IL-4, MGC79402, Binetrakin, Pitrakinra
MHIHGCDKNH LREIIGILNE VTGEGTPCTE MDVPNVLTAT KNTTESELVC RASKVLRIFY LKHGKTPCLK
KNSSVLMELQ RLFRAFRCLD SSISCTMNES KSTSLKDFLE SLKSIMQMDY S
Interleukin-4 Mouse Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain
PEPTIDES INTERNATIONAL

containing 120 amino acids and having a molecular mass of 13500 Dalton. .
R Pacheco, et al., PNAS, 102, 27 (2005)..

rIL 4 CYT-385 5 µg 50
Recombinant Rat Interleukin-4 -20 °C 20 µg 130
BCGF, BCDF, B cell stimulating factor, BSF-1, Lymphocyte 1 mg 2,900
stimulatory factor 1, IL-4, MGC79402, Binetrakin, Pitrakinra
MHGCNDSPLR EIINTLNQVT EKGTPCTEMF VPDVLTATRN TTENELICRA SRVLRKFYFP RDVP-
PCLKNK SGVLGELRKL CRGVSGLNSL RSCTVNESTL TTLKDFLESL KSILRGKYLQ SCTSMS
Interleukin-4 Rat Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain contain-
ing 126 amino acids and having a molecular mass of 14kDa. .

pIL 4 CYT-398 2 µg 50
Recombinant Porcine Interleukin-4, Interleukin-4, BCGF, BCDF, -20 °C 10 µg 130
B cell stimulating factor, BSF-1, Lymphocyte stimulatory factor 100 µg 1,300
1, IL-4, MGC79402, Binetrakin, Pitrakinra
The sequence of the first five N-terminal amino acids was determined and was found to be Met-His-Lys-
Cys-Asp
IL-4 Porcine Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing
110 amino acids and having a molecular mass of 12615 Dalton. .

396 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
rmIL4 CYT-172 2 µg 50
Recombinant Rhesus Macaque Interleukin-4 -20 °C 10 µg 130
Interleukin-4, IL-4, B-cell stimulatory factor 1, BSF-1, 1 mg 4,680
Lymphocyte stimulatory factor 1, IL4
HNCHIALREI IETLNSLTEQ KTLCTKLTIT DILAASKNTT EKETFCRAAT VLRQFYSHHE KDTRCLGATA
QQFHRHKQLI RFLKRLDRNL WGLAGLNSCP VKEANQSTLE DFLERLKTIM REKYSKCSS
IL-4 Rhesus Macaque Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain
containing 129 amino acids and having a molecular mass of 14.9kDa. .

IL4 Yeast CYT-712 2 µg 50

Recombinant Human Interleukin-4 , Yeast -20 °C 10 µg 130
BCGF, BCDF, B cell stimulating factor, BSF-1, Lymphocyte 1 mg 3,900
stimulatory factor 1, IL-4, MGC79402, Binetrakin, Pitrakinra
Interleukin-4 Human Recombinant produced in yeast is a single, glycosylated polypeptide chain containing
129 amino acids. .

IL5 (Interleukin-5)
The protein encoded by this gene is a cytokine that acts as a growth and differentiation
factor for both B cells and eosinophils. This cytokine is a main regulator of eosinopoi-
esis, eosinophil maturation and activation. The elevated production of this cytokine is
reported to be related to asthma or hypereosinophilic syndromes. The receptor of this
cytokine is a heterodimer, whose beta subunit is shared with the receptors for inter -
leukine 3 (IL3) and colony stimulating factor 2 (CSF2/GM-CSF). This gene, together
with those for interleukin 4 (IL4), interleukin 13 (IL13), and CSF2, form a cytokine gene

PEPTIDES INTERNATIONAL
cluster on chromosome 5. This cytokine, IL4, and IL13 are found to be regulated
coordinately by long-range regulatory elements spread over 120 kilobases on chromo-
some 5q31.
IL 5 CYT-212 2 µg 50
Recombinant Human Interleukin-5 -20 °C 10 µg 130
EDF, BCDFII, TRF, T-cell replacing factor, Eosinophil 1 mg 3,870
differentiation factor, B cell differentiation factor I, IL-5
The sequence of the first five N-terminal amino acids was determined and was found to be Met-Ile-Pro-
Thr-Glu
Interleukin-5 Human Recombinant produced in E.Coli is a dimeric, non-glycosylated polypeptide chain
containing two 113 amino acids chains, and having a molecular mass of 26522.84 Dalton. .

mIL 5 CYT-689 2 µg 25
Recombinant Mouse Interleukin-5 -20 °C 10 µg 70
EDF, BCDFII, TRF, T-cell replacing factor, Eosinophil 1 mg 2,700
differentiation factor, B cell differentiation factor II, IL-5, BCGF-
II, Cytotoxic T-lymphocyte inducer, Il5
MEIPMSTVVK ETLTQLSAHR ALLTSNETMR LPVPTHKNHQ LCIGEIFQGL DILKNQTVRG GT-
VEMLFQNL SLIKKYIDRQ KEKCGEERRR TRQFLDYLQE FLGVMSTEWA MEG
Interleukin-5 Mouse Recombinant produced in E.Coli is a dimeric, non-glycosylated polypeptide chain
containing 2 x 113 amino acids forming a disulfide linked homodimer and having a molecular mass of 26.2
kDa. .

Order Hotline 1-800-777-4779 502-266-8787 397

 PRODUCT Code Qty PRICE
Recombinant proteins

rIL 5 CYT-387 2 µg 50
Recombinant Rat Interleukin-5 -20 °C 10 µg 130
EDF, BCDFII, TRF, T-cell replacing factor, Eosinophil 1 mg 4,680
differentiation factor, B cell differentiation factor I, IL-5
The sequence of the first five N-terminal amino acids was determined and was found to be Met-Glu-Ile-
Pro-Met
Interleukin-5 Rat Recombinant produced in E.Coli is a dimeric, non-glycosylated polypeptide chain contain-
ing 113 amino acids and having a molecular mass of 13074 Dalton. .

rmIL5 CYT-772 2 µg 50
Recombinant Rhesus Macaque Interleukin-5 -20 °C 10 µg 130
Interleukin-5, IL-5, Eosinophil differentiation factor, T-cell 1 mg 4,680
replacing factor, TRF, IL5
IPTEIPASAL VKETLALLST HRTLLIANET LRIPVPVHKN HQLCTEEIFQ GIGTLESQTV QGGTVERLFK
NLSLIKKYIG GQKKKCGEER RRVNQFLDYL QEFLGVMNTE WIIES
IL5 Rhesus Macaque Recombinant produced in E.Coli is a disulfide-linked homodimeric, non-glycosylated,
polypeptide protein containing 2x115 amino acids chains and having a total molecular mass of 26.1kDa.

IL6 (Interleukin-6)
Il-6 is a cytokine with a wide variety of biological functions: it plays an essential role in
the final differentiation of b-cells into ig-secreting cells, it induces myeloma and plas-
macytoma growth, it induces nerve cells dif ferentiation, and in hepatocytes it induces
acute phase reactants.
IL 6 CYT-213 5 µg 50
PEPTIDES INTERNATIONAL

Recombinant Human Interleukin-6, IFN-b2, B cell differentiation -20 °C 20 µg 130

factor, BCDF, BSF-2, HPGF, HSF, MGI-2, B-cell stimulatory 1 mg 2,700
factor 2, Interferon β-2, Hybridoma growth factor, CTL
differentiation factor, CDF, IL-6, HGF
The sequence of the first five N-terminal amino acids was determined and was found to be Met-Pro-Val-
Pro-Pro
Interleukin-6 Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain
containing 184 amino acids and having a molecular mass of 21000 Dalton.
S. Min-Li Tan, et al., JPET, 334, 1 (2010).
G. Sethi, et al., Clin Cancer Res., 17, 1425 (2011).
J. Yang, et al., Journal of Hematology and Oncology, 4, 38 (2011).
F. Li, et al., British Journal of Pharmacology, 161, 3, (2010).

IL 6 CHO CYT-274 2 µg 50
Recombinant Human Interleukin-6, CHO -20 °C 10 µg 130
IFN-b2, B cell differentiation factor, BCDF, BSF-2, HPGF, HSF, 1 mg 4,680
MGI-2, B-cell stimulatory factor 2, Interferon β-2, Hybridoma
growth factor, CTL differentiation factor, CDF, IL-6, HGF
APVPPGEDSK DVAAPHRQPL TSSERIDKQI RYILDGISAL RKETCNKSNM CESSKEALAE NNLN-
LPKMAE KDGCFQSGFN EETCLVKIIT GLLEFEVYLE YLQNRFESSE EQARAVQMST KVLIQFLQKK
AKNLDAITTP DPTTNASLLT KLQAQNQWLQ DMTTHLILRS FKEFLQSSLR ALRQM
Interleukin-6 Human Recombinant produced in CHO is a single, glycosylated polypeptide chain containing
185 amino acids and migrates at 22 kDa as a glycosilated protein on SDS-PAGE. .

398 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
IL 6 His CYT-484 10 µg 50
Recombinant Human Interleukin-6, His Tag -20 °C 50 µg 130
IFN-b2, B cell differentiation factor, BCDF, BSF-2, HPGF, HSF, 1 mg 2,100
MGI-2, B-cell stimulatory factor 2, Interferon β-2, Hybridoma
growth factor, CTL differentiation factor, CDF, IL-6, HGF
MGSSHHHHHH SSGLVPRGSH MVPPGEDSKD VAAPHRQPLT SSERIDKQIR YILDGISALR KETCNK-
SNMC ESSKEALAEN NLNLPKMAEK DGCFQSGFNE ETCLVKIITG LLEFEVYLEY LQNRFESSEE QA-
RAVQMSTK VLIQFLQKKA KNLDAITTPD PTTNASLLTK LQAQNQWLQD MTTHLILRSF KEFLQSSLRA
LRQM
IL-6 Human Recombinant produced in E.Coli is single, a non-glycosylated, Polypeptide chain containing
204 amino acids fragment (30-212) and having a total molecular mass of 23.1kDa with a 20 aa N-terminal
His tag. .

IL 6 HEK CYT-098 2 µg 50
Recombinant Human Interleukin 6, HEK -20 °C 10 µg 130
IFN-b2, B cell differentiation factor, BCDF, BSF-2, HPGF, HSF, 1 mg 5,200
MGI-2, B-cell stimulatory factor 2, Interferon β-2, Hybridoma
growth factor, CTL differentiation factor, CDF, IL-6, HGF
IL-6 Human Recombinant produced in HEK cells is a glycosylated monomer, having a molecular weight
range of 26-30kDa due to glycosylation. .

mIL 6 CYT-350 2 µg 50
Recombinant Mouse Interleukin-6 -20 °C 10 µg 130
IFN-b2, B cell differentiation factor (BCDF), BSF-2, HPGF, HSF, 1 mg 2,700
MGI-2, IL-6, Interleukin HP-1, B-cell hybridoma growth factor
FPTSQVRRGD FTEDTTPNRP VYTTSQVGGL ITHVLWEIVE MRKELCNGNS DCMNNDDALA

PEPTIDES INTERNATIONAL
ENNLKLPEIQ RNDGCYQTGY NQEICLLKIS SGLLEYHSYL EYMKNNLKDN KKDKARVLQR DTETLI-
HIFN QEVKDLHKIV LPTPISNALL TDKLESQKEW LRTKTIQFIL KSLEEFLKVT LRSTRQT
Interleukin-6 Mouse Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain
containing 187 amino acids and having a molecular mass of 21709 Dalton. .

rIL 6 CYT-388 2 µg 50
Recombinant Rat Interleukin-6 -20 °C 10 µg 130
IFN-b2, B cell differentiation factor (BCDF), BSF-2, HPGF, HSF, 1 mg 4,680
MGI-2, IL-6, Interleukin HP-1, B-cell hybridoma growth factor
The sequence of the first five N-terminal amino acids was determined and was found to be Met-Phe-Pro-
Thr-Ser
Interleukin-6 Rat Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain contain-
ing 187 amino acids and having a molecular mass of 21732 Dalton. .

rmIL 6 CYT-174 2 µg 50
Recombinant Rhesus Macaque Interleukin-6 -20 °C 10 µg 130
IFN-b2, B cell differentiation factor, BCDF, BSF-2, HPGF, HSF, 1 mg 4,680
MGI-2, B-cell stimulatory factor 2, Interferon β-2, Hybridoma
growth factor, CTL differentiation factor, CDF, IL-6, HGF
MAPVLPGEDS KNVAAPHSQP LTSSERIDKH IRYILDGISA LRKETCNRSN MCESSKEALA ENNLN-
LPKMA EKDGCFQSGF NEDTCLVKII TGLLEFEVYL EYLQNRFESS EEQARAVQMS TKVLIQFLQK
KAKNLDAITT PEPTTNASLL TKLQAQNQWL QDMTTHLILR SFKEFLQSNL RALRQM
IL 6 Rhesus Macaque Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain
containing 186 amino acids and having a molecular mass of 21.1kDa. .
Please prevent freeze-thaw cycles.

Order Hotline 1-800-777-4779 502-266-8787 399

 PRODUCT Code Qty PRICE
Recombinant proteins

sIL 6R CYT-286 5 µg 50
Recombinant Human Soluble IL-6 Receptor α -20 °C 20 µg 130
IL6R-α, CD126, IL-6R 1, CD126 antigen, IL6RA, Interleukin 6 1 mg 3,400
receptor, Interleukin 6 receptor alpha subunit, Interleukin-6
receptor α chain precursor, B cell stimulatory factor-2,
Membrane glycoProtein 80, gp80, IL-6R, MGC10499
sIL-6R Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing
338 amino acids (20-357) corresponding to the mature IL-6R protein, having a molecular weight of 42.25
kDa, with an aminoterminal hexahistidine tag. .

IL7 (Interleukin-7)
IL-7 is a cytokine important for B andT cell development. The cytokine and the hepato-
cyte growth factor (HGF) form a heterodimer that functions as a pre-pro-B cell growth-
stimulating factor. This cytokine is found to be a cofactor for V(D)J rearrangement of
the T cell receptor beta (TCRB) during early T cell development. This cytokine can be
produced locally by intestinal epithelial and epithelial goblet cells, and may serve as
a regulatory factor for intestinal mucosal lymphocytes. Knockout studies in mice sug -
gested that this cytokine plays an essential role in lymphoid cell survival.
IL 7 CYT-254 2 µg 50
Recombinant Human Interleukin-7 -20 °C 10 µg 130
Lymphopoietin 1 (LP-1), pre-B cell factor, IL-7 1 mg 4,680
MDCDIEGKDG KQYESVLMVS IDQLLDSMKE IGSNCLNNEF NFFKRHICDA NKEGMFLFRA ARKLRQ-
FLKM NSTGDFDLHL LKVSEGTTIL LNCTGQVKGR KPAALGEAQP TKSLEENKSL KEQKKLNDLC
FLKRLLQEIK TCWNKILMGT KEH
PEPTIDES INTERNATIONAL

Interleukin-7 Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain

containing 153 amino acids and having a molecular mass of 17412 Dalton. .

IL 7 Yeast CYT-298 2 µg 50
Recombinant Human Interleukin-7, Saccharomyces -20 °C 10 µg 130
Lymphopoietin 1 (LP-1), pre-B cell factor, IL-7 1 mg 4,680
The sequence of the first five N-terminal amino acids was determined and was found to be Asp-Cys-Asp-
Ile-Glu
Interleukin-7 Human Recombinant produced in yeast is a single, glycosylated polypeptide chain containing
152 amino acids and having a molecular mass of 17.4 kDa. .

IL 7 His CYT-485 2 µg 50
Recombinant Human Interleukin-7, His Tag -20 °C 10 µg 130
Lymphopoietin 1 (LP-1), pre-B cell factor, IL-7 1 mg 3,400
IL-7 Human Recombinant produced in E.Coli is single, a non-glycosylated, Polypeptide chain containing
152 amino acids fragment (26-177) and having a total molecular mass of 21.97 kDa with an amino-terminal
hexahistidine tag. .

IL 7, HEK CYT-197 2 µg 50
Recombinant Human Interleukin-7, HEK -20 °C 10 µg 130
Lymphopoietin 1 (LP-1), pre-B cell factor, IL-7 0.1 mg 990
IL-7 Human Recombinant produced in HEK cells is a glycosylated monomer, having a molecular weight
range of 19-30kDa due to glycosylation. The IL-7 is purified by proprietary chromatographic techniques.

400 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
mIL 7 CYT-372 2 µg 50
Recombinant Mouse Interleukin-7 -20 °C 10 µg 130
Lymphopoietin 1 (LP-1), pre-B cell factor, IL-7 1 mg 4,680
Interleukin-7 Mouse Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain
containing 130 amino acids and having a molecular mass of 15.0 kDa. .

rIL 7 CYT-163 2 µg 50
Recombinant Rat Interleukin-7 -20 °C 10 µg 130
Lymphopoietin 1 (LP-1), pre-B cell factor, IL-7 1 mg 4,680
DCHIKDKDGK AFGSVLMISI NQLDKMTGTD SDCPNNEPNF FKKHLCDDTK EAAFLNRAAR KLRQFLK-
MNI SEEFNDHLLR VSDGTQTLVN CTSKEEKTIK EQKKNDPCFL KRLLREIKTC WNKILKGSI
IL 7 Rat Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 129
amino acids and having a molecular mass of 15.0kDa.

IL9 (Interleukin-9)
This is the factor that is thought to be a regulator of hematopoiesis. It has been shown
to enhance the growth of human mast cells and megakaryoblastic leukemic cells as
well as murine helper t-cell clones. IL-9 is a glycoprotein with a molecular weight of
32-39 that is derived from T-cells, and maps to human chromosome 5.
IL 9 CYT-348 2 µg 50
Recombinant Human Interleukin-9 -20 °C 10 µg 130
P40, HP40, T-cell growth factor p40, IL-9, P40 cytokine 1 mg 4,680
MQGCPTLAGI LDINFLINKM QEDPASKCHC SANVTSCLCL GIPSDNCTRP CFSERLSQMT NTTMQ-
TRYPL IFSRVKKSVE VLKNNKCPYF SCEQPCNQTT AGNALTFLKS LLEIFQKEKM RGMRGKI

PEPTIDES INTERNATIONAL
Interleukin-9 Human Recombinant produced in E.Coli is a single, non-glycosylated single polypeptide
chain containing 127 amino acids and having a molecular mass of 14,004 Dalton.

IL 9 HEK CYT-099 2 µg 50
Recombinant Human Interleukin 9, HEK -20 °C 10 µg 130
P40, HP40, T-cell growth factor p40, IL-9, P40 cytokine 100 µg 1,100
IL-9 Human Recombinant produced in HEK cells is a glycosylated monomer, having a molecular weight
range of 38-48kDa due to glycosylation.

mIL 9 CYT-373 2 µg 50
Recombinant Mouse Interleukin-9 -20 °C 10 µg 130
P40, HP40, T-cell growth factor p40, IL-9, P40 cytokine 1 mg 4,680
MQRCSTTWGI RDTNYLIENL KDDPPSKCSC SGNVTSCLCL SVPTDDCTTP CYREGLLQLT NATQK-
SRLLP VFHRVKRIVE VLKNITCPSF SCEKPCNQTM AGNTMSFLKS LLGTFQKTEM QRQKSRP
Interleukin-9 Mouse Recombinant produced in E.Coli is a single, non-glycosylated single polypeptide chain
containing 127 amino acids and having a molecular mass of 14.3kDa.

rIL 9 CYT-748 2 µg 50
Recombinant Rat Interleukin-9, Interleukin 9, Protein Il9, Il9 -20 °C 10 µg 130
1 mg 4,680
MQRCSTSWGI QHTSYLIENL KDDPSSKCSC SANVTSCLCL PIPSDDCTTP CFQEGMSQVT
NATQQSKFSP FFFRVKRIVE TLKSNKCQFF SCEKPCNQTT AGNTVSFLKS LLKTFQKTEV QVQRSRA
Interleukin-9 Rat Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain contain-
ing 127 amino acids and having a molecular mass of 14.3kDa.

Order Hotline 1-800-777-4779 502-266-8787 401

 PRODUCT Code Qty PRICE
Recombinant proteins

IL10 (Interleukin-10)
This is the factor that is thought to be a regulator of hematopoiesis. It has been shown
to enhance the growth of human mast cells and megakaryoblastic leukemic cells as
well as murine helper t-cell clones. IL-9 is a glycoprotein with a molecular weight of
32-39 that is derived from T-cells, and maps to human chromosome 5.
IL 10 CYT-500 2 µg 50
Recombinant Human Interleukin-10 -20 °C 10 µg 130
B-TCGF, CSIF, TGIF, IL-10, IL10A, MGC126450, MGC126451, 1 mg 4,680
Cytokine synthesis inhibitory factor
MSPGQGTQSE NSCTHFPGNL PNMLRDLRDA FSRVKTFFQM KDQLDNLLLK ESLLEDFKGY LGCQA-
LSEMI QFYLEEVMPQ AENQDPDIKA HVNSLGENLK TLRLRLRRCH RFLPCENKSK AVEQVKNAFN
KLQEKGIYKA MSEFDIFINY IEAYMTMKIR N
Interleukin-10 Human Recombinant produced in E.Coli is a single non-glycosylated polypeptide chains
containing 161 amino acids each and having a molecular mass of 18.6kDa.

IL 10 His CYT-486 2 µg 50
Recombinant Human Interleukin-10, His Tag -20 °C 10 µg 130
B-TCGF, CSIF, TGIF, IL-10, IL10A, MGC126450, MGC126451, 1 mg 3,400
Cytokine synthesis inhibitory factor
MGSSHHHHHH SSGLVPRGSH MSPGQGTQSE NSCTHFPGNL PNMLRDLRDA FSRVKTFFQM
KDQLDNLLLK ESLLEDFKGY LGCQALSEMI QFYLEEVMPQ AENQDPDIKA HVNSLGENLK TLRLRLR-
RCH RFLPCENKSK AVEQVKNAFN KLQEKGIYKA MSEFDIFINY IEAYMTMKIR N
Interleukin-10 Human Recombinant produced in E.Coli is single, a non-glycosylated, Polypeptide chain
containing 181 amino acids fragment (19-178) and having a total molecular mass of 20.94kDa with a 20
PEPTIDES INTERNATIONAL

amino acids N-Terminal His tag.

IL 10 HEK CYT-100 2 µg 50
Recombinant Human Interleukin 10, HEK -20 °C 10 µg 130
B-TCGF, CSIF, TGIF, IL-10, IL10A, MGC126450, MGC126451, 1 mg 5,200
Cytokine synthesis inhibitory factor
Interleukin-10 Human Recombinant produced in HEK cells is a glycosylated non-disulfide bonded homodi-
mer, having a total molecular weight of 17kDa.

mIL 10 CYT-497 2 µg 50
Recombinant Mouse Interleukin-10 -20 °C 10 µg 130
B-TCGF, CSIF, TGIF, IL-10, IL10A, MGC126450, MGC126451, 1 mg 4,680
Cytokine synthesis inhibitory factor
The sequence of the first five N-terminal amino acids was determined and was found to be Met-Ser-Arg-
Gly-Gln
IL-10 Recombinant Mouse produced in E.Coli is a single, non-glycosylated polypeptide chain containing
161 amino acids and having a molecular mass of 18785 Dalton.

rIL 10 CYT-465 2 µg 50
Recombinant Rat Interleukin-10 -20 °C 10 µg 130
B-TCGF, CSIF, TGIF, IL-10, IL10A, MGC126450, MGC126451, 1 mg 4,680
Cytokine synthesis inhibitory factor
The sequence of the first five N-terminal amino acids was determined and was found to be Met-Ser-Lys-
Gly-His
L-10 Recombinant Rat produced in E.Coli is a single, glycosylated polypeptide chain containing 160 amino
acids and having a molecular mass of 18.7 kDa.

402 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
IL11 (Interleukin-11)
IL11 is a member of the gp130 family of cytokines.These cytokines drive the assembly
of multisubunit receptor complexes, all of which contain at least one molecule of the
transmembrane signaling receptor IL6ST (gp130). IL-1 1 is shown to stimulate the
T-cell-dependent development of immunoglobulin-producing B cells. It is also found
to support the proliferation of hematopoietic stem cells and megakaryocyte progenitor
cells.
IL 11 CYT-214 2 µg 50
Recombinant Human Interleukin-11 -20 °C 10 µg 130
AGIF, Adipogenesis inhibitory factor, Oprelvekin, IL-11 1 mg 4,680

The sequence of the first five N-terminal amino acids was determined and was found to be Gly-Pro-Pro-
Pro-Gly. N-terminal methionine has been completely removed enzymatically
Interleukin-11 Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain
containing 179 amino acids and having a molecular mass of 19256.29 Dalton.

IL 11 Pichia CYT-013 2 µg 50
Recombinant Human Interleukin-11, Pichia, Interleukin-11, IL- -20 °C 10 µg 130
11, Adipogenesis inhibitory factor, AGIF, Oprelvekin, IL11 1 mg 4,680
The sequence of the first five N-terminal amino acids was determined and was found to be Gly-Pro-Pro-
Pro-Gly
IL11 Human Recombinant produced in Pichia Pastoris is a single, non-glycosylated, Polypeptide chain
containing 177 amino acids (it differs from the 178 amino acid length of the native IL11 only in lack of the
N-terminal praline residue) and having a molecular mass of 19kDa.

PEPTIDES INTERNATIONAL
mIL 11 CYT-646 2 µg 50
Recombinant Mouse Interleukin-11, AGIF, Adipogenesis -20 °C 10 µg 130
inhibitory factor, Oprelvekin, IL-11, Interleukin-11, Il11 1 mg 4,680
MPGPPAGSPR VSSDPRADLD SAVLLTRSLL ADTRQLAAQM RDKFPADGDH SLDSLPTLAM SAGTLG-
SLQL PGVLTRLRVD LMSYLRHVQW LRRAGGPSLK TLEPELGALQ ARLERLLRRL QLLMSRLALP
QAAPDQPVIP LGPPASAWGS IRAAHAILGG LHLTLDWAVR GLLLLKTRL
Interleukin-11 Mouse Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain
containing 179 amino acids and having a molecular mass of 19.1kDa.

Order Hotline 1-800-777-4779 502-266-8787 403

 PRODUCT Code Qty PRICE
Recombinant proteins

IL12 (Interleukin-12)
Active IL-12 is a p70 disulphide-linked dimer composed of p35 and p40 subunits. T
he protein is a pleiotropic cytokine produced primarily by antigen presenting cells and
has multiple effects on T lymphocytes and natural killer cells in terms of stimulating
cytotoxicity, proliferation, production of other cytokines and Th1 subset differentiation.
IL 12 CYT-101 2 µg 50
Recombinant Human Interleukin 12 -20 °C 10 µg 130
NKSF, CTL maturation factor (TCMF), Cytotoxic lymphocyte 100 µg 1,100
maturation factor (CLMF), TSF, Edodekin-α, IL-12
IL-12 is a heterodimer of IL-12A and IL-12B linked through a disulfide-bond between cysteines in red in
sequences below.
>IL-12 A
RNLPVATPDPGMFPCLHHSQNLLRAVSNMLQKARQTLEFYPCTSEEIDHEDITKDKTSTVEACLP
LELTKNESCLNSRETSFITNGSCLASRKTSFMMALCLSSIYEDLKMYQVEFKTMNAKLLMDPKRQ
IFLDQNMLAVIDELMQALNFNSETVPQKSSLEEPDFYKTKIKLCILLHAFRIRAVTIDRVMSYLNAS
>IL-12B
IWELKKDVYVVELDWYPDAPGEMVVLTCDTPEEDGITWTLDQSSEVLGSGKTLTIQVKEFGDAG
QYTCHKGGEVLSHSLLLLHKKEDGIWSTDILKDQKEPKNKTFLRCEAKNYSGRFTCWWLTTISTD
LTFSVKSSRGSSDPQGVTCGAATLSAERVRGDNKEYEYSVECQEDSACPAAEESLPIEVMVDAV
HKLKYENYTSSFFIRDIIKPDPPKNLQLKPLKNSRQVEVSWEYPDTWSTPHSYFSLTFCVQVQGK
SKREKKDRVFTDKTSATVICRKNASISVRAQDRYYSSSWSEWASVPCS
Interleukin-12 Human Recombinant produced in HEK cells is a glycosylated heterodimer, having a total
molecular weight of 57kDa.
PEPTIDES INTERNATIONAL

IL 12 p35 His CYT-487 2 µg 50

Recombinant Human Interleukin-12 p35, His Tag -20 °C 10 µg 130
NKSF1, CTL maturation factor (TCMF), Cytotoxic lymphocyte 1 mg 4,320
maturation factor 35 kDa subunit (CLMF p35), TSF, Edodekin-
alpha, IL-12 p35, IL-12A, IL-12 subunit p35, NK cell stimulatory
factor chain 1, SGT2, FLJ39002
Interleukin-12 p35 His Human Recombinant produced in E.Coli is single, a non-glycosylated, polypeptide
chain containing 197 amino acids fragment (57-253) with an amino-terminal hexahistidine tag.

IL 12 p40 Baculovirus CYT-134 2 µg 50

Recombinant Human Interleukin-12 p40, Baculovirus -20 °C 10 µg 130
NKSF2, CTL maturation factor (TCMF), Cytotoxic lymphocyte 1 mg 5,200
maturation factor 40 kDa subunit (CLMF p40), TSF, Edodekin-α,
IL-12 p40, IL-12B, IL-12 subunit p40, NK cell stimulatory factor
chain 2
ADPIWELKKD VYVVELDWYP DAPGEMVVLT CDTPEEDGIT WTLDQSSEVL GSGKTLTIQV KEFG-
DAGQYT CHKGGEVLSH SLLLLHKKED GIWSTDILKD QKEPKNKTFL RCEAKNYSGR FTCWWLTTIS
TDLTFSVKSS RGSSDPQGVT CGAATLSAER VRGDNKEYEY SVECQEDSAC PAAEESLPIE VMV-
DAVHKLK YENYTSSFFI RDIIKPDPPK NLQLKPLKNS RQVEVSWEYP DTWSTPHSYF SLTFCVQVQG
KSKREKKDRV FTDKTSATVI CRKNASISVR AQDRYYSSSW SEWASVPCSH HHHHH
IL 12 p40 Human Recombinant produced in Hi-5 cell using Baculovirus is a single polypeptide chain
containing 315 amino acids (23-328) and having a molecular mass of 29.4kDa.
IL 12 p40 is fused to a 6 amino acid His-tag at C-terminus.
Avoid multiple freeze-thaw cycles.

404 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
IL 12 p40 His CYT-488 2 µg 50
Recombinant Human Interleukin-12 p40, His Tag; NKSF2, CTL -20 °C 10 µg 130
maturation factor (TCMF), Cytotoxic lymphocyte maturation 1 mg 4,320
factor 40 kDa subunit (CLMF p40), TSF, Edodekin-α, IL-12 p40,
IL-12B, IL-12 subunit p40, NK cell stimulatory factor chain 2
Interleukin-12 p40 His Human Recombinant produced in E.Coli is single, a non-glycosylated, polypeptide
chain containing 306 amino acids fragment (23-328) with an amino-terminal hexahistidine tag.

IL 12 p40 Plant CYT-056 1 µg 50

Recombinant Human Interleukin-12 p40, Plant; NKSF2, CTL -20 °C 5 µg 130
maturation factor (TCMF), Cytotoxic lymphocyte maturation 100 µg 1,500
factor 40 kDa subunit (CLMF p40), TSF, Edodekin-α, IL-12 p40,
IL-12B, IL-12 subunit p40, NK cell stimulatory factor chain 2
HHHHHHIWEL KKDVYVVELD WYPDAPGEMV VLTCDTPEED GITWTLDQSS EVLGSGKTLT IQVKE-
FGDAG QYTCHKGGEV LSHSLLLLHK KEDGIWSTDI LKDQKEPKNK TFLRCEAKNY SGRFTCWWLT
TISTDLTFSV KSSRGSSDPQ GVTCGAATLS AERVRGDNKE YEYSVECQED SACPAAEESL PIEVM-
VDAVH KLKYENYTSS FFIRDIIKPD PPKNLQLKPL KNSRQVEVSW EYPDTWSTPH SYFSLTFCVQ
VQGKSKREKK DRVFTDKTSA TVICRKNASI SVRAQDRYYS SSWSEWASVP CS
C1575H2420N424O490S12
L-12 p40 human Recombinant produced in Nicotiana benthamiana plant is a glycosilated polypeptide
chain containing 312 amino acids, 23-328 aa. IL-12 p40 is fused to a 6-His-tag at the N-terminal having
the total molecular mass of 35.5kDa however as a result of potential glycosylation, the molecular mass
could be approximately 40kDa by SDS PAGE under reducing conditions.
Please prevent freeze-thaw cycles.

mIL 12 CYT-144 2 µg 50

PEPTIDES INTERNATIONAL
Recombinant Mouse Interleukin-12 -20 °C 10 µg 130
NKSF, CTL maturation factor (TCMF), Cytotoxic lymphocyte 100 µg 990
maturation factor (CLMF), TSF, Edodekin-α, IL-12
p35 Subunit: RVIPVSGPAR CLSQSRNLLK TTDDMVKTAR EKLKHYSCTA EDIDHEDITR DQTSTLKTCL
PLELHKNESC LATRETSSTT RGSCLPPQKT SLMMTLCLGS IYEDLKMYQT EFQAINAALQ NHNHQQ-
IILD KGMLVAIDEL MQSLNHNGET LRQKPPVGEA DPYRVKMKLC ILLHAFSTRV VTINRVMGYL SSA.
p40 Subunit: MWELEKDVYV VEVDWTPDAP GETVNLTCDT PEEDDITWTS DQRHGVIGSG KTLTIT-
VKEF LDAGQYTCHK GGETLSHSHL LLHKKENGIW STEILKNFKN KTFLKCEAPN YSGRFTCSWL
VQRNMDLKFN IKSSSSSPDS RAVTCGMASL SAEKVTLDQR DYEKYSVSCQ EDVTCPTAEE TL-
PIELALEA RQQNKYENYS TSFFIRDIIK PDPPKNLQMK PLKNSQVEVS WEYPDSWSTP HSYFSLKFFV
RIQRKKEKMK ETEEGCNQKG AFLVEKTSTE VQCKGGNVCV QAQDRYYNSS CSKWACVPCR VRS
Interleukin-12 Mouse Recombinant produced in Sf9 insect cells is a glycosylated disulfide linked heterodi-
meric polypeptide containing 506 amino acids and having a molecular weight of 75 kDa comprised of
disulfide-bonded 35 kDa (p35) and 40 kDa (p40) subunits.

rIL 12 CYT-390 2 µg 50
Recombinant Rat Interleukin-12 -20 °C 10 µg 130
NKSF, CTL maturation factor (TCMF), Cytotoxic lymphocyte 100 µg 990
maturation factor (CLMF), TSF, Edodekin-α, IL-12
The sequence of the first five N-terminal amino acids was determined and found to be Arg-Val-Ile-Pro-Val
at the p35 subunit and Met-Thr-Glu-Leu-Glu at the p40 subunit.
Interleukin-12 Rat Recombinant produced in Sf9 insect cells is a glycosylated disulfide linked heterodimeric
polypeptide containing 503 amino acids and having a molecular weight of 70 kDa comprised of disulfide-
bonded 35 kDa (p35) and 40 kDa (p40) subunits.

Order Hotline 1-800-777-4779 502-266-8787 405

 PRODUCT Code Qty PRICE
Recombinant proteins

IL13 (Interleukin-13)
IL13 is an immunoregulatory cytokine produced primarily by activated Th2 cells. IL-13
is involved in several stages of B-cell maturation and dif ferentiation. It up-regulates
CD23 and MHC class II expression, and promotes IgE isotype switching of B cells.
The cytokine down-regulates macrophage activity , thereby inhibits the production of
pro-inflammatory cytokines and chemokines. This cytokine is found to be critical to
the pathogenesis of allergen-induced asthma but operates through mechanisms in -
dependent of IgE and eosinophils. The gene, along with IL3, IL5, IL4, and CSF2, form
a cytokine gene cluster on chromosome 5q, with this gene particularly close to IL4..
IL 13 CYT-446 2 µg 50
Recombinant Human Interleukin-13, NC30, ALRH, BHR1, P600, -20 °C 10 µg 130
IL-13, MGC116786, MGC116788, MGC116789 1 mg 4,680
GPVPPSTALRELIEELVNITQNQKAPLCNGSMVWSINLTAGMYCAALESLINVSGCSAIEKTQRMLSGF-
CPHKVSAGQFSSLHVRDTKIEVAQFVKDLLLHLKKLFRE GRFN
Interleukin-13 Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain
containing 112 amino acids and having a molecular mass of 12 kDa.

IL 13 Variant CYT-682 2 µg 50
Recombinant Human Interleukin-13 Variant -20 °C 10 µg 130
Interleukin-13, NC30, ALRH, BHR1, P600, IL-13, MGC116786, 1 mg 4,680
MGC116788, MGC116789
SPGPVPPSTA LRELIEELVN ITQNQKAPLC NGSMVWSINL TAGMYCAALE SLINVSGCSA IEK-
TQRMLSG FCPHKVSAGQ FSSLHVRDTK IEVAQFVKDL LLHLKKLFRE GQFN
PEPTIDES INTERNATIONAL

Interleukin-13 Variant Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide

chain containing 114 amino acids, with a substitution of Q for R at position 112 compared with the wild type
IL-13, having a molecular mass of 12.5 kDa.

IL 13 His CYT-489 2 µg 50
Recombinant Human Interleukin-13, His Tag; NC30, ALRH, -20 °C 10 µg 130
BHR1, P600, IL-13, MGC116786, MGC116788, MGC116789 1 mg 3,400

Interleukin-13 His Human Recombinant produced in E.Coli is a single, non-glycosylated, Polypeptide chain
containing 112 amino acids fragment (21-132) having a molecular weight of 12.84kDa with a 4kDa amino-
terminal hexahistidine tag (total weight of 16.84kDa).

mIL 13 CYT-375 2 µg 50
Recombinant Mouse Interleukin-13 -20 °C 10 µg 130
Interleukin-13, NC300, ALRH, BHR1, P600, IL-13, IL13 1 mg 4,680
MPVPRSVSLP LTLKELIEEL SNITQDQTPL CNGSMVWSVD LAAGGFCVAL DSLTNISNCN AIYRTQRILH
GLCNRKAPTT VSSLPDTKIE VAHFITKLLS YTKQLFRHGP F
Interleukin-13 Mouse Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain
containing 111 amino acids and having a molecular mass of 12.3 kDa.

rIL 13 CYT-391 2 µg 50
Recombinant Rat Interleukin-13 -20 °C 10 µg 130
NC300, ALRH, BHR1, P600, IL-13 1 mg 4,680
Interleukin-13 Rat Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain contain-
ing 113 amino acids and having a molecular mass of 12.7 kDa.

406 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
rIL 13 109 a.a. CYT-182 2 µg 50
Recombinant Rat Interleukin-13 109 a.a. -20 °C 10 µg 130
NC300, ALRH, BHR1, P600, IL-13 1 mg 4,680
VRRSTSPPVA LRELIEELSN ITQDQKTSLC NSSIVWSVDI TAGGFCAALE SLTNISSCNA IHRTQRILNG
LCNQKASDVA SSPPDTKIEV AQFISKLLNY SKQLFRYGH
Interleukin-13 Rat Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain contain-
ing 109 amino acids and having a molecular mass of 11.9 kDa.

rmIL 13 CYT-175 2 µg 50
Recombinant Rhesus Macaque Interleukin-13, NC30, ALRH, -20 °C 10 µg 130
BHR1, P600, IL-13, MGC116786, MGC116788, MGC116789 1 mg 4,680

SPSPVPRSTA LKELIEELVN ITQNQKAPLC NGSMVWSINL TAGVYCAALE SLINVSGCSA IEK-

TQRMLNG FCPHKVSAGQ FSSLRVRDTK IEVAQFVKDL LVHLKKLFRE GRFN
IL 13 Rhesus Macaque Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain
containing 114 amino acids and having a molecular mass of 12.6kDa.
Please prevent freeze-thaw cycles.

IL13RA2 CYT-757 5 µg 50
Recombinant Human Interleukin 13 Receptor, Α 2; CD213A2, -20 °C 20 µg 130
CT19, IL-13R, IL13BP, IL-13 receptor subunit α-2, IL-13R subunit 1 mg 2,700
α-2, CD_antigen=CD213a2, Interleukin-13-binding Protein
MGSSHHHHHH SSGLVPRGSH MGSDTEIKVN PPQDFEIVDP GYLGYLYLQW QPPLSLDHFK
ECTVEYELKY RNIGSETWKT IITKNLHYKD GFDLNKGIEA KIHTLLPWQC TNGSEVQSSW AETTY-
WISPQ GIPETKVQDM DCVYYNWQYL LCSWKPGIGV LLDTNYNLFY WYEGLDHALQ CVDYIKADGQ
NIGCRFPYLE ASDYKDFYIC VNGSSENKPI RSSYFTFQLQ NIVKPLPPVY LTFTRESSCE IKLKWSIPLG

PEPTIDES INTERNATIONAL
PIPARCFDYE IEIREDDTTL VTATVENETY TLKTTNETRQ LCFVVRSKVN IYCSDDGIWS EWSDKQC-
WEG EDLSKKTLLR
IL13RA2 Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain contain-
ing 340 amino acids (27-343 a.a.) and having a molecular mass of 39.5kDa. IL13RA2 is fused to a 23
amino acid His-tag at N-terminus.
Avoid multiple freeze-thaw cycles.

IL15 (Interleukin-15)
The protein encoded by this gene is a cytokine that regulates T and natural killer cell
activation and proliferation. This cytokine and interleukine 2 share many biological
activities. They are found to bind common hematopoietin receptor subunits, and may
compete for the same receptor, and thus negatively regulate each other’s activity. The
number of CD8+ memory cells is shown to be controlled by a balance between this
cytokine and IL2. This cytokine induces the activation of JAK kinases, as well as the
phosphorylation and activation of transcription activators STAT3, STAT5, and STAT6.
Studies of the mouse counterpart suggested that this cytokine may increase the ex -
pression of apoptosis inhibitor BCL2L1/BCL-x(L), possibly through the transcription
activation activity of STAT6, and thus prevent apoptosis. Two alternatively spliced tran-
script variants of this gene encoding the same protein have been reported..
IL 15 CYT-230 2 µg 50
Recombinant Human Interleukin-15, IL-15, MGC9721 -20 °C 10 µg 130
1 mg 3,510
MNWVNVISDL KKIEDLIQSM HIDATLYTES DVHPSCKVTA MKCFLLELQV ISLESGDASI HDTVENLIIL
ANNSLSSNGN VTESGCKECE ELEEKNIKEF LQSFVHIVQM FINTS
Interleukin-15 Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain
containing 114 amino acids (and an N-terminal Methionine) and having a molecular mass of 12.8kDa.

Order Hotline 1-800-777-4779 502-266-8787 407

 PRODUCT Code Qty PRICE
Recombinant proteins

IL 15 His CYT-490 2 µg 50
Recombinant Human Interleukin-15, His Tag; IL-15, MGC9721 -20 °C 10 µg 130
1 mg 3,400
MNWVNVISDL KKIEDLIQSM HIDATLYTES DVHPSCKVTA MKCFLLELQV ISLESGDASI HDTVENLIIL
ANNSLSSNGN VTESGCKECE ELEEKNIKEF LQSFVHIVQM FINTSLEHHH HHH
Interleukin-15 His Human Recombinant ?produced in E.Coli is single, a non-glycosylated, Polypeptide
chain containing 123 amino acids fragment (49-162) having a total molecular weight of 13.9 kDa with an
C-terminal hexahistidine tag.

mIL 15 CYT-344 2 µg 50
Recombinant Mouse Interleukin-15, IL-15, MGC9721 -20 °C 10 µg 130
1 mg 3,510
The sequence of the first five N-terminal amino acids was determined and was found to be Met-Asn-Trp-
Ile-Asp
Interleukin-15 Mouse Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain
containing 115 amino acids and having a molecular mass of 13321 Dalton.

mIL 15 His CYT-647 2 µg 50

Recombinant Mouse Interleukin-15, His Tag -20 °C 10 µg 130
IL-15, MGC9721, Interleukin-15, Il15, AI503618 1 mg 4,680

MRGSHHHHHH GMASMTGGQQ MGRDLYDDDD KDRWGSHMNW IDVRYDLEKI ESLIQSIHID

TTLYTDSDFH PSCKVTAMNC FLLELQVILH EYSNMTLNET VRNVLYLANS TLSSNKNVAE SGCK-
ECEELE EKTFTEFLQS FIRIVQMFIN TS
Interleukin-15 Mouse Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain
containing 152 amino acids (49-162 a.a.) and having a molecular mass of 17.6 kDa. The IL-15 is fused to
a 37 amino acid His Tag at N-terminus.
PEPTIDES INTERNATIONAL

rIL 15 CYT-345 2 µg 50
Recombinant Rat Interleukin-15, IL-15, MGC9721 -20 °C 10 µg 130
1 mg 3,510
The sequence of the first five N-terminal amino acids was determined and was found to be Met-Asn-Trp-
Ile-Asp
Interleukin-15 Rat Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain contain-
ing 115 amino acids and having a molecular mass of 13533 Dalton.

IL16 (Interleukin-16)
IL-16 is a pleiotropic cytokine that functions as a chemoattractant, a modulator of T
cell activation, and an inhibitor of HIV replication. The signaling process of IL-16 is
mediated by CD4. The product of this gene undergoes proteolytic processing, which
is found to yield two functional proteins. IL-16 functions exclusively attributed to the
secreted C-terminal peptide, while the N-terminal product may play a role in cell cycle
control. Caspase 3 is reported to be involved in the proteolytic processing of this pro -
tein. Two transcript variants encoding different isoforms have been found for this gene.
IL-16 stimulates a migratory response in cd4+ lymphocytes, monocytes, and eosino-
phils. It also induces t-lymphocyte expression of interleukin 2 receptor, ligand for cd4.

408 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
IL 16, (130 a.a.) CYT-536 2 µg 50
Recombinant Human Interleukin-16, (130 a.a.) -20 °C 10 µg 130
IL16, Interleukin-16, LCF, Lymphocyte Chemoattractant Factor, 1 mg 4,680
prIL-16, IL-16, FLJ16806, FLJ42735, FLJ44234, HsT19289.
The sequence of the first five N-terminal amino acids was determined and was found to be Met-Pro-Asp-
Leu-Asn
Interleukin-16 Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain
containing 130 amino acids and having a molecular mass of 13.5 kDa.

IL 16, (121 a.a.) CYT-142 2 µg 50

Recombinant Human Interleukin-16, (121 a.a.) -20 °C 10 µg 130
IL16, Interleukin-16, LCF, Lymphocyte Chemoattractant Factor, 1 mg 4,680
prIL-16, IL-16, FLJ16806, FLJ42735, FLJ44234, HsT19289
SAASASAASD VSVESTAEAT VCTVTLEKMS AGLGFSLEGG KGSLHGDKPL TINRIFKGAA SEQSET-
VQPG DEILQLGGTA MQGLTRFEAW NIIKALPDGP VTIVIRRKSL QSKETTAAGD S
Interleukin-16 Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain
containing 121 amino acids and having a molecular mass of 12.4 kDa.

IL 16 His CYT-562 5 µg 50
Recombinant Human Interleukin-16, His Tag -20 °C 25 µg 130
IL16, Interleukin-16, LCF, Lymphocyte Chemoattractant Factor, 1 mg 2,700
prIL-16, IL-16, FLJ16806, FLJ42735, FLJ44234, HsT19289
MGSSHHHHHH SSGLVPRGSH MPDLNSSTDS AASASAASDV SVESTAEATV CTVTLEKMSAGLGF-
SLEGGK GSLHGDKPLT INRIFKGAAS EQSETVQPGD EILQLGGTAM QGLTRFEAWN IIKALPDGPV
TIVIRRKSLQ SKETTAAGDS

PEPTIDES INTERNATIONAL
Interleukin-16 Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain
(502-631 a.a) containing 150 amino acids and having a molecular mass of 15.5kDa. The IL-16 is fused to a
20 a.a His-Tag at N-Terminus.

mIL 16 CYT-559 2 µg 50
Recombinant Mouse Interleukin-16 -20 °C 10 µg 130
LCF, Lymphocyte Chemoattractant Factor, prIL-16, KIAA4048, 1 mg 4,680
mKIAA4048, Il16, IL-16, Interleukin-16
MHDLNSSTDS AASASAASDI SVESKEATVC TVTLEKTSAG LGFSLEGGKG SLHGDKPLTI NRIFKG-
DRTG EMVQPGDEIL QLAGTAVQGL TRFEAWNVIK ALPDGPVTIV IRRTSLQCKQ TTASADS
Interleukin-16 Mouse Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain
containing 127 amino acids and having a molecular mass of 13.2 kDa.

maIL 16 CYT-153 2 µg 50
Recombinant Rhesus Macaque Interleukin-16 -20 °C 10 µg 130
IL16, Interleukin-16, LCF, Lymphocyte Chemoattractant Factor, 1 mg 4,680
prIL-16, IL-16, FLJ16806, FLJ42735, FLJ44234, HsT19289

SAASASAASD VSVESSAEAT VYTVTLEKMS AGLGFSLEGG KGSLHGDKPL TINRIFKGAA SEQSET-

IQPG DEILQLAGTA MQGLTRFEAW NIIKALPDGP VTIVIRRKSL QPKETTAAAD S
IL 16 Rhesus Macaque Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain
containing 121 amino acids and having a molecular mass of 12.5kDa.
Please prevent freeze-thaw cycles.

Order Hotline 1-800-777-4779 502-266-8787 409

 PRODUCT Code Qty PRICE
Recombinant proteins

IL17 (Interleukin-17)
IL17 is a proinflammatory cytokine produced by activated T cells. IL-17 regulates the
activities of NF-kappaB and mitogen-activated protein kinases. Interleukin-17 can
stimulate the expression of IL6 and cyclooxygenase-2 (PTGS2/COX-2), as well as
enhance the production of nitric oxide (NO). High levels of IL-17 are associated with
several chronic inflammatory diseases including rheumatoid arthritis, psoriasis and
multiple sclerosis.

IL 17A CYT-250 5 µg 50
Recombinant Human Interleukin-17A, CTLA-8, IL-17, IL-17A, -20 °C 25 µg 130
Cytotoxic T-lymphocyte-associated antigen 8 1 mg 2,700

Interleukin-17A Human Recombinant produced in E.Coli is a homodimeric, non-glycosylated polypeptide

chain containing a total of 264 amino acids (2 chains of 132 aa) and having a molecular mass of 31kDa.

IL 17A His CYT-662 2 µg 50

Recombinant Human Interleukin-17A His Tag -20 °C 10 µg 130
CTLA-8, IL-17, IL-17A, Cytotoxic T-lymphocyte-associated 1 mg 4,800
antigen 8, IL17A
Interleukin-17A Human Recombinant produced in E.Coli is a single, non-glycosylated, Polypeptide chain
containing 132 amino acids fragment (24-155) having a molecular weight of 19.62kDa and fused with a
4.5kDa amino-terminal hexahistidine tag.

IL 17A HEK CYT-102 2 µg 50

Recombinant Human Interleukin 17A, HEK; CTLA-8, IL-17, IL- -20 °C 10 µg 130
PEPTIDES INTERNATIONAL

17A, Cytotoxic T-lymphocyte-associated antigen 8 1 mg 5,200

IL-17 Human Recombinant produced in HEK cells is a glycosylated homodimer, having a molecular weight
range of 30-35kDa due to glycosylation.

IL17B CYT-771 5 µg 50
Recombinant Human Interleukin-17B -20 °C 25 µg 130
Interleukin-17B, IL-17B, Cytokine Zcyto7, Interleukin-20, 1 mg 2,700
Neuronal interleukin-17-related factor, IL20, NIRF, ZCYTO7
MQPRSPKSKR KGQGRPGPLA PGPHQVPLDL VSRMKPYARM EEYERNIEEM VAQLRNSSEL AQRK-
CEVNLQ LWMSNKRSLS PWGYSINHDP SRIPVDLPEA RCLCLGCVNP FTMQEDRSMV SVPVFSQVPV
RRRLCPPPPR TGPCRQRAVM ETIAVGCTCI F
nterleukin-17B Human Recombinant produced in E.Coli is a homodimeric, non-disulfide-linked polypeptide
chain containing a total of 322 amino acids (2 chains of 161aa) and having a molecular mass of 36.5kDa.

IL17B, His CYT-753 5 µg 50

Recombinant Human Interleukin-17B His Tag -20 °C 25 µg 130
Interleukin-17B, IL-17B, Cytokine Zcyto7, Interleukin-20, 1 mg 2,700
Neuronal interleukin-17-related factor, IL20, NIRF, ZCYTO7
MGSSHHHHHH SSGLVPRGSH MGSHMQPRSP KSKRKGQGRP GPLAPGPHQV PLDLVSRMKP YAR-
MEEYERN IEEMVAQLRN SSELAQRKCE VNLQLWMSNK RSLSPWGYSI NHDPSRIPVD LPEARCLCLG
CVNPFTMQED RSMVSVPVFS QVPVRRRLCP PPPRTGPCRQ RAVMETIAVG CTCIF
IL17B Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing
185 amino acids (21-180) and having a molecular mass of 20kDa. IL17B is fused to a 25 amino acid
His-tag at N-terminus.

410 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
IL 17E CYT-583 5 µg 50
Recombinant Human Interleukin-17E -20 °C 25 µg 130
IL-25, IL-17E, IL17E, IL25, Interleukin-25, Interleukin-17E 1 mg 2,700
MYSHWPSCCP SKGQDTSEEL LRWSTVPVPP LEPARPNRHP ESCRASEDGP LNSRAISPWR YEL-
DRDLNRL PQDLYHARCL CPHCVSLQTG SHMDPRGNSE LLYHNQTVFY RRPCHGEKGT HKGYCL-
ERRL YRVSLACVCV RPRVMG
Interleukin-17E Human Recombinant produced in E.Coli is a homodimeric, non-glycosylated polypeptide
chain containing 146 amino acids and having a molecular mass of 33.7 kDa.

IL 17F CYT-587 5 µg 50
Recombinant Human Interleukin-17F, Cytokine ML-1, IL-17F, -20 °C 25 µg 130
Interleukin-17F precursor, IL17F, ML1, ML-1 1 mg 2,700
MRKIPKVGHT FFQKPESCPP VPGGSMKLDI GIINENQRVS MSRNIESRST SPWNYTVTWD PNRYP-
SEVVQ AQCRNLGCIN AQGKEDISMN SVPIQQETLV VRRKHQGCSV SFQLEKVLVT VGCTCVTPVI
HHVQ
Interleukin-17F Human Recombinant produced in E.Coli is a homodimeric, cysteine linked, non-glycosylat-
ed polypeptide chain containing 2 x 134 amino acids and having a total molecular mass of 30.1 kDa.

IL 17F His CYT-762 5 µg 50

Recombinant Human Interleukin-17F, His Tag; Cytokine ML-1, -20 °C 25 µg 130
IL-17F, Interleukin-17F precursor, IL17F, ML1, ML-1 1 mg 2,700
MGSSHHHHHH SSGLVPRGSH MGSHMRKIPK VGHTFFQKPE SCPPVPGGSM KLDIGIINEN
QRVSMSRNIE SRSTSPWNYT VTWDPNRYPS EVVQAQCRNL GCINAQGKED ISMNSVPIQQ ETLV-
VRRKHQ GCSVSFQLEK VLVTVGCTCV TPVIHHVQ
IL 17F His Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain contain-
ing 158 amino acids (31-163) and having a molecular mass of 17.6kDa. IL 17F His is fused to a 25 amino

PEPTIDES INTERNATIONAL
acid His-tag at N-terminus.

IL 17F HEK CYT-103 2 µg 50

Recombinant Human Interleukin 17F, HEK; Cytokine ML-1, -20 °C 10 µg 130
IL-17F, Interleukin-17F precursor, IL17F, ML1, ML- 1 mg 5,200

Interleukin- 17F Human Recombinant produced in HEK cells is a glycosylated homodimer, having a total
molecular weight of 38kDa.

IL 17 A/F CYT-623 2 µg 50
Recombinant Human Interleukin-17 A/F Heterodimer -20 °C 10 µg 130
IL17A/F, IL17 A/F, IL-17A/F, IL-17 A/F, IL17AF, IL-17 AF, 100 µg 900
Interleukin-17 A/F, Interleukin-17 AF
MIVKAGITIP RNPGCPNSED KNFPRTVMVN LNIHNRNTNT NPKRSSDYYN RSTSPWNLHR NED-
PERYPSV IWEAKCRHLG CINADGNVDY HMNSVPIQQE ILVLRREPPH CPNSFRLEKI LVSVGCTCVT
PIVHHVA. MRKIPKVGHT FFQKPESCPP VPGGSMKLDI GIINENQRVS MSRNIESRST SPWNYTVTWD
PNRYPSEVVQ AQCRNLGCIN AQGKEDISMN SVPIQQETLV VRRKHQGCSV SFQLEKVLVT VGCTCVT-
PVI HHVQ
IL-17A/F Human Recombinant produced in E.Coli is a heterodimeric, non-glycosylated polypeptide chain
containing 1 monomeric subunit of each IL-17A and IL-17F. The active dimer contains 271 amino acids and
having a total molecular mass of 30.7 kDa.

Order Hotline 1-800-777-4779 502-266-8787 411

 PRODUCT Code Qty PRICE
Recombinant proteins

mIL 17 CYT-378 5 µg 50
Recombinant Mouse Interleukin-17A, CTLA-8, IL-17, IL-17A, -20 °C 25 µg 130
Cytotoxic T-lymphocyte-associated antigen 8 1 mg 2,700
MAAIIPQSSA CPNTEAKDFL QNVKVNLKVF NSLGAKVSSR RPSDYLNRST SPWTLHRNED PDRYPS-
VIWE AQCRHQRCVN AEGKLDHHMN SVLIQQEILV LKREPESCPF TFRVEKMLVG VGCTCVASIV
RQAA
Interleukin-17 Murine Recombinant produced in E.Coli is a homodimeric, non-glycosylated polypeptide
chain containing a total of 268 (2x134 a.a.) amino acids and having a molecular mass of 30 kDa.

mIL 17E CYT-641 5 µg 50

Recombinant Mouse Interleukin-17E -20 °C 25 µg 130
IL-25, IL-17E, IL17E, IL25, Interleukin-25 1 mg 2,700
Recombinant mouse IL-17E is a non-glycosylated, disulfide-linked homodimer, containing 2x145 amino
acid chains, with a total molecular weight of 35.5 kDa.

mIL 17F CYT-642 5 µg 50

Recombinant Mouse Interleukin-17F, Cytokine ML-1, IL-17F, -20 °C 25 µg 130
Interleukin-17F precursor, IL17F, ML1, ML-1 1 mg 2,700
IL17F Mouse Recombinant produced in E.Coli is a homodimeric, non-glycosylated polypeptide chain
containing a total of 266 amino acids and having a molecular mass of 29.8 kDa.

mIL 17 A/F CYT-640 2 µg 50

Recombinant Mouse Interleukin-17 A/F Heterodimer -20 °C 10 µg 130
IL17A/F, IL17 A/F, IL-17A/F, IL-17 A/F, IL17AF, IL-17 AF, 100 µg 900
Interleukin-17 A/F, Interleukin-17 AF
PEPTIDES INTERNATIONAL

RKNPKAGVPALQKAGNCPPLEDNTVRVDIRIFNQNQGISVPREFQNRSSSP WDYNITRDPHRF-
PSEIAEAQCRHSGCINAQGQEDSTMNSVAIQQEILVLRR EPQGCSNSFRLEKMLLKVGCTCVKPIVHQA-
AAAIIPQSSACPNTEAKDFLQ NVKVNLKVFNSLGAKVSSRRPSDYLNRSTSPWTLHRNEDPDRYPS-
VIWE AQCRHQRCVNAEGKLDHHMNSVLIQQEILVLKREPESCPFTFRVEKMLV GVGCTCVASIVRQAA
Interleukin-17 A/F Mouse Recombinant produced in E.Coli is a heterodimeric, non-glycosylated polypep-
tide comprised of IL17A monomeric subunit and and IL17F monomeric subunit containing a total of 266
amino acids and having a total molecular mass of 29.8kDa.

rIL 17 A/F CYT-677 2 µg 50

Recombinant Rat Interleukin-17 A/F Heterodimer -20 °C 10 µg 130
IL17A/F, IL17 A/F, IL-17A/F, IL-17 A/F, IL17AF, IL-17 AF, 100 µg 900
Interleukin-17 A/F, Interleukin-17 AF
IL-17A: MAVLIPQSSV CPNAEANNFL QNVKVNLKVL NSLSSKASSR RPSDYLNRST SPWTLSRNED
PDRYPSVIWE AQCRHQRCVN AEGKLDHHMN SVLIQQEILV LKREPEKCPF TFRVEKMLVG VGCTCVS-
SIV RHAS.
IL-17F: MARRNPKVGL SALQKAGNCP PLEDNSVRVD IRIFNQNQGI SVPRDFQNRS SSPW-
DYNITR DPDRFPSEIA EAQCRHSGCI NAQGQEDGSM NSVPIQQEIL VLRREPQGCS NSFRLEKMLI
KVGCTCVTPI VHHAA.
IL-17A/F Rat Recombinant produced in E.Coli is a heterodimeric, non-glycosylated polypeptide chain con-
taining 1 monomeric subunit of each IL-17A and IL-17F. The dimer contains 269 amino acids and having a
total molecular mass of 30.7 kDa.

412 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
rIL 17 CYT-542 5 µg 50
Recombinant Rat Interleukin-17A, CTLA-8, IL-17, IL-17A, -20 °C 25 µg 130
Cytotoxic T-lymphocyte-associated antigen 8, Interleukin-17A 1 mg 2,700

MAVLIPQSSV CPNAEANNFL QNVKVNLKVL NSLSSKASSR RPSDYLNRST SPWTLSRNED PDRYPS-

VIWE AQCRHQRCVN AEGKLDHHMN SVLIQQEILV LKREPEKCPF TFRVEKMLVG VGCTCVSSIV
RHAS
Interleukin-17A Rat Recombinant produced in E.Coli is a homodimeric, non-glycosylated polypeptide chain
having a molecular mass of 30 kDa.

rIL 17E CYT-576 5 µg 50

Recombinant Rat Interleukin-17E -20 °C 25 µg 130
IL-25, IL-17E, IL17E, IL25, Interleukin-25 1 mg 2,700
CSHLPRCCPS KQQEFPEEWL KWNPAPVSPP EPLRHTHHPE SCRASKDGPL NSRAISPWSY
ELDRDLNRVP QDLYHARCLC PHCVSLQTGS HMDPMGNSVP LYHNQTVFYR RPCHGEQGAH GRY-
CLERRLY RVSLACVCVR PRMMA
Interleukin-17E Rat Recombinant produced in E.Coli is a homodimeric, non-glycosylated polypeptide chain
containing 145 amino acids and having a molecular mass of 35.5 kDa.

rIL 17F CYT-643 5 µg 50

Recombinant Rat Interleukin-17F, Cytokine ML-1, IL-17F, -20 °C 25 µg 130
Interleukin-17F precursor, IL17F, ML1, ML-1 1 mg 2,700

MARRNPKVGL SALQKAGNCP PLEDNSVRVD IRIFNQNQGI SVPRDFQNRS SSPWDYNITR DPDRF-

PSEIA EAQCRHSGCI NAQGQEDGSM NSVPIQQEIL VLRREPQGCS NSFRLEKMLI KVGCTCVTPI
VHHAA
IL17F Rat Recombinant produced in E.Coli is a homodimeric, non-glycosylated polypeptide chain contain-

PEPTIDES INTERNATIONAL
ing a total of 270 amino acids and having a molecular mass of 30 kDa.

IL19 (Interleukin-19)
IL19 is a cytokine that belongs to the IL10 cytokine subfamily . IL-19 is found to be
preferentially expressed in monocytes. It can bind the IL20 receptor complex and
lead to the activation of the signal transducer and activator of transcription 3 (ST AT3).
A similar cytokine in mouse is reported to up-regulate the expression of IL6 and TNF-
alpha and induce apoptosis, which suggests a role of this cytokine in inflammatory re-
sponses. Alternatively, spliced transcript variants encoding the distinct isoforms have
been described.
IL 19 CYT-363 2 µg 50
Recombinant Human Interleukin-19, Melanoma differentiation -20 °C 10 µg 130
association like Protein, MDA1, NG.1, ZMDA1, IL-10C, IL-19 1 mg 4,680

The sequence of the first five N-terminal amino acids was determined and was found to be Met-Leu-Arg-
Arg-Cys.
Interleukin-19 Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain
containing 155 amino acids and having a molecular mass of 17913 Dalton.

Order Hotline 1-800-777-4779 502-266-8787 413

 PRODUCT Code Qty PRICE
Recombinant proteins

IL20 (Interleukin-20)
IL20 is a cytokine structurally related to interleukin 10 (IL10). IL20 cytokine has been
shown to transduce its signal through signal transducer and activator of transcription 3
(STAT3) in keratinocytes. A specific receptor for this cytokine is found to be expressed
in skin and upregulated dramatically in psoriatic skin, suggesting a role for this protein
in epidermal function and psoriasis.
IL 20 CYT-347 2 µg 50
Recombinant Human Interleukin-20, IL10D, ZCYTO10, IL-20, -20 °C 10 µg 130
MGC96907, Four α helix cytokine Zcyto10 1 mg 4,680

The sequence of the first five N-terminal amino acids was determined and was found to be Met-Leu-Lys-
Thr-Leu
Interleukin-20 Human Recombinant produced in E.Coli is a single, non-glycosylated homodimeric polypep-
tide chain containing 2 x 153 amino acids and having a total molecular mass of 35,212 Dalton.

mIL 20 CYT-379 2 µg 50
Recombinant Mouse Interleukin-20, IL10D, ZCYTO10, IL-20, -20 °C 10 µg 130
MGC96907, Four alpha helix cytokine Zcyto10 1 mg 5,200
The sequence of the first five N-terminal amino acids was determined and was found to be Met-Leu-Lys-
Thr-Leu
Interleukin-20 Mouse Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain
containing 152 amino acids and having a total molecular mass of 17,584 Dalton.

IL21 (Interleukin-21)
PEPTIDES INTERNATIONAL

IL-21 is produced by CD4+ T cells in response to antigenic stimulation. Its action

enhances antigen-specific responses of immune cells. The biological effects of IL-21
include induction of dif ferentiation of T-cells-stimulated B-cells into plasma cells and
memory B-cells, stimulation (in conjuction) with IL-4 of IgG production, and induction of
apoptotic effects in naive B-cells and stimulated B-cells in the absence of T-cell signal-
ing. Additionally, IL-21 promotes the anti-tumor activity of CD8+ T-cells and NK cells.
IL-21 exerts its effect through binding to a specific type I cytokine receptor, IL-21R,
which also contains the γ chain (°C) found in other cytokine receptors including IL-2, IL-
4, IL-7, IL-9 and IL-15. The IL-21/IL-21R interaction triggers a cascade of events which
includes activation of the tyrosine kinases JAK1 and JAK3, followed by activation of the
transcription factors STAT1 and STAT3.
IL 21 CYT-408 2 µg 50
Recombinant Human Interleukin-21, Za11, IL-21 -20 °C 10 µg 130
1 mg 4,680
MQDRHMIRMR QLIDIVDQLK NYVNDLVPEF LPAPEDVETN CEWSAFSCFQ KAQLKSANTG NNERIIN-
VSI KKLKRKPPST NAGRRQKHRL TCPSCDSYEK KPPKEFLERF KSLLQKMIHQ HLSSRTHGSE DS
IL21 Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing
132 amino acids and having a total molecular mass of 15.4kDa.

414 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
mIL 21 CYT-684 2 µg 50
Recombinant Mouse Interleukin-21, Interleukin-21, IL-21, Il21 -20 °C 10 µg 130
1 mg 4,680
The sequence of the first five N-terminal amino acids was determined and was found to be Met-His-Lys-
Ser-Ser
Interleukin-21 Mouse Recombinant produced in E.Coli is a single, non-glycosilated polypeptide chain
containing 130 amino acids and having a total molecular mass of 15kDa.

rIL 21 CYT-033 2 µg 50
Recombinant Rat Interleukin-21, Interleukin-21, IL-21, Il21 -20 °C 10 µg 130
1 mg 4,680
HKSSPQRPDH LLIRLRHLMD IVEQLKIYEN DLDPELLTAP QDVKGQCEHE AFACFQKAKL KPSNT-
GNNKT FINDLLAQLR RRLPAKRTGN KQRHMAKCPS CDLYEKKTPK EFLERLKWLL QKMIHQHLS
Interleukin-21 Rat Recombinant produced in E.Coli is a single, non-glycosilated polypeptide chain contain-
ing 129 amino acids and having a total molecular mass of 15.2kDa.

IL22 (Interleukin-22)
IL-22 is a member of the IL-10 family of regulatory cytokines.Members of this fam -
ily share partial homology in their amino acid sequences, but they are dissimilar in
their biological functions. Produced by T lymphocytes, IL-22 inhibits IL-4 production
by Th2 cells, and induces acute phase reactants in the liver and pancreas. IL-22 sig -
nals through a receptor system consisting of IL-10R-beta/CRF2-4 and IL-22R, both of
which are members of the class II cytokine-receptor family.

IL 22 CYT-328 2 µg 50

PEPTIDES INTERNATIONAL
Recombinant Human Interleukin-22 -20 °C 10 µg 130
IL-TIF, TIFa, IL-10-related T-cell-derived-inducible factor, IL-22, 1 mg 4,680
ILTIF, IL-D110, zcyto18, MGC79382, MGC79384, TIFIL-23
The sequence of the first five N-terminal amino acids was determined and was found to be Met-Ala-Pro-
Ile-Ser
Interleukin-22 Human Recombinant produced in E.Coli is a single, non-glycosylated homodimeric polypep-
tide chain containing 2 x 146 amino acids and having a total molecular mass of 33,607 Dalton.

mIL 22 CYT-539 2 µg 50
Recombinant Mouse Interleukin-22 -20 °C 10 µg 130
IL-TIF, TIFa, IL-10-related T-cell-derived-inducible factor, IL-22, 1 mg 4,680
ILTIF, IL-D110, zcyto18, MGC79382, MGC79384, TIFIL-23
The sequence of the first five N-terminal amino acids was determined and was found to be Met-Leu-Pro-
Val-Asn
Interleukin-22 Mouse Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain
containing 147 amino acids and having a molecular mass of 16.7 kDa.

rIL 22 CYT-173 2 µg 50
Recombinant Rat Interleuikin-22 -20 °C 10 µg 130
IL-TIF, TIFa, IL-10-related T-cell-derived-inducible factor, IL-22, 1 mg 4,680
ILTIF, IL-D110, zcyto18, MGC79382, MGC79384, TIFIL-23
LPINSQCKLE AANFQQPYIV NRTFMLAKEA SLADNNTDVR LIGEELFRGV KAKDQCYLMK QVL-
NFTLEDV LLPQSDRFQP YMQEVVPFLT KLSIHLSPCH ISGDDQNIQK NVRQLKETVQ KLGESGEIKA
IGELDLLFMS LRNACV
IL-22 Rat Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 146
amino acids and having a molecular mass of 16.6kDa.

Order Hotline 1-800-777-4779 502-266-8787 415

 PRODUCT Code Qty PRICE
Recombinant proteins

mIL 22 PEG CYT-701 2 µg 50

Recombinant Mouse Interleukin-22, Pegylated -20 °C 10 µg 130
IL-TIF, TIFa, IL-10-related T-cell-derived-inducible factor, IL-22, 1 mg 5,200
ILTIF, IL-D110, zcyto18, MGC79382, MGC79384, TIFIL-23
Pegylated Interleukin-22 Mouse Recombinant produced in E.Coli is a single, non-glycosylated homodimer-
ic polypeptide chain containing 147 amino acids and an aditional Ala amino acid at N-terminus having a
molecular mass of 36 kDa as determioned by mass spectometry. However due to enlarged hydrodymanic
volume it runs on the SDS-PAGE as a 50 kDa protein and in gel-filtration on Superdex 200 as over 200
kDa protein. The Murine IL-22 is Mono-pegylated (with 20 kDa PEG).

mIL 22A CYT-148 2 µg 50

Recombinant Mouse Interleukin-22 Antagonist (E117A) -20 °C 10 µg 130
IL-TIF, TIFa, IL-10-related T-cell-derived-inducible factor, IL-22, 0.1 mg 1,200
ILTIF, IL-D110, zcyto18, MGC79382, MGC79384, TIFIL-23
The sequence of the first five N-terminal amino acids was determined and was found to be Ala-Leu-Pro-
Val-Asn
Interleukin-22 Antagonist Mouse Recombinant produced in E.Coli is a single, non-glycosylated homodimer-
ic polypeptide chain containing 147 amino acids and having a total molecular mass of 16.7 KDa.

IL23 (Interleukin-23)
IL23 is composed of a subunit of the heterodimeric cytokine IL23 and the p40 subunit
of interleukin 12 (IL12B). Interleukin-23 (IL-23) belongs to the IL-12 family and is pro -
duced by antigen presenting cells. IL-23 using IL12RB1 and IL-23R (specific for IL-23)
can activate STAT and NF-kB pathways and stimulate the production of interferon-
gamma. ). IL-23 is known to take a vital part in the inflammation process and is associ-
PEPTIDES INTERNATIONAL

ated with auto immune diseases. However, unlike IL12, which acts primarily on naive
CD4(+) T cells, IL23 preferentially acts on memory CD4(+) T cells.

IL 23 CYT-050 2 µg 50
Recombinant Human Interleukin-23, Interleukin 23 α subunit -20 °C 10 µg 130
p19, Interleukin-12 subunit β p40, SGRF, IL23P19, IL-23-A, 0.1 mg 1,200
interleukin-six, G-CSF related factor, JKA3 induced upon
T-cell activation, interleukin 12B (natural killer cell stimulatory
factor 2 cytotoxic lymphocyte maturation factor 2 p40), NK cell
stimulatory factor chain 2, Cytotoxic lymphocyte maturation
factor 40 kDa subunit, CLMF2, CLMF p40
IL-23 Human Recombinant produced in HEK cells is a glycosylated disulfide linked homodimer, having a
total molecular weight of 43kDa and 19kDa heterodimer.

416 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
IL 23 His CYT-067 2 µg 50
Recombinant Human Interleukin-23, His Tag; Interleukin 23 α -20 °C 10 µg 130
subunit p19, Interleukin-12 subunit β p40, SGRF, IL23P19, IL- 0.1 mg 1,200
23-A, interleukin-six, G-CSF related factor, JKA3 induced upon
T-cell activation, interleukin 12B (natural killer cell stimulatory
factor 2 cytotoxic lymphocyte maturation factor 2 p40), NK cell
stimulatory factor chain 2, Cytotoxic lymphocyte maturation
factor 40 kDa subunit, CLMF2, CLMF p40
IL23A-His:
RAVPGGSSPAWTQCQQLSQKLCTLAWSAHPLVGHMDLREEGDEETTNDVPHIQCG DGCD-
PQGLRDNSQFCLQRIHQGLIFYEKLLGSDIFTGEPSLLPDSPVGQLHASLLGLS QLLQPEGHHWETQQ-
IPSLSPSQPWQRLLLRFKILRSLQAFVAVAARVFAHGAATLSP HHHHHHHH.
IL12B-Flag:
IWELKKDVYVVELDWYPDAPGEMVVLTCDTPEEDGITWTLDQSSEVLGSGKTLTIQVK
EFGDAGQYTCHKGGEVLSHSLLLLHKKEDGIWSTDILKDQKEPKNKTFLRCEAKNYS GRFTCWWLT-
TISTDLTFSVKSSRGSSDPQGVTCGAATLSAERVRGDNKEYEYSVEC QEDSACPAAEESLPIEVMV-
DAVHKLKYENYTSSFFIRDIIKPDPPKNLQLKPLKNSRQV EVSWEYPDTWSTPHSYFSLTFCVQVQGK-
SKREKKDRVFTDKTSATVICRKNASISVR AQDRYYSSSWSEWASVPCSDYKDDDDK
IL-23 Human Recombinant produced in HEK 293 cells is a heterodimer (IL23A co-transfected with IL12B),
containing one polypeptide chain of IL23 protein (19.77kDa) fused with a C-terminal His tag and one
polypeptide chain of IL12b-Flag (35.69kDa).

IL24 (Interleukin-24)
IL24 is a member of the IL10 family of cytokines. It was identified as a gene induced
during terminal differentiation in melanoma cells. IL-10B encoded can induce apopto-
sis selectively in various cancer cells. Overexpression IL-24 leads to elevated expres-
sion of several GADD family genes, which correlates with the induction of apoptosis.

PEPTIDES INTERNATIONAL
The phosphorylation of mitogen-activated protein kinase 14 (MAPK7/P38), and heat
shock 27kDa protein 1 (HSPB2/HSP27) are found to be induced by this gene in mela-
noma cells, but not in normal immortal melanocytes. Alternatively spliced transcript
variants encoding distinct isoforms have been reported. The glycosylation is essential
for activity of IL-24. Functionally , IL-24 has diverse activities. At low concentrations,
it induces type I proinflammatory cytokines such as IFN-g, IL-1b, IL-12 and TNF-a. At
high concentration, it is a strong inducer of apoptosis in tumor cells, but not normal
cells. mda-7/IL-24 is being hailed as a ‘magic bullet’ for cancer gene therapy.

IL 24 CYT-515 2 µg 50
Recombinant Human Interleukin-24 -20 °C 10 µg 130
C49A, FISP, MDA7, ST16, IL-24, IL10B, Mob-5, MDA-7, 1 mg 3,510
Suppression of tumorigenicity 16 Protein, Melanoma
differentiation-associated gene 7 Protein
Interleukin 24 human recombinant produced in yeast is a single, glycosylated, polypeptide chain containing
158 amino acids and having a molecular mass of 18 kDa. As a result of glycosylation, the protein migrates
at 19.5 kDa on SDS-PAGE.

Order Hotline 1-800-777-4779 502-266-8787 417

 PRODUCT Code Qty PRICE
Recombinant proteins

IL27 (Interleukin-27)
Interleukin-27 protein is related to IL-12A and is one of the subunits of a heterodimeric
cytokine complex. IL-27 interacts with EBV induced gene 3 also called EBI3, and
forms a complex that drives rapid expansion of CD4 (+) T cells. IL-27 complex is syn-
ergizes with IL-12 in order to trigger the cytokine production of IFN-γ of CD4 (+) T cells.
The biological effect of IL-27 is mediated by class-I cytokine receptor (WSX1/TCRR).
The pro-inflammatory activity of IL-27 is mediated through the growing expression of
key molecules involved in the MHC class-I and MHC class-II pathways. Both MHC
class-I and MHC-class-II expression are increased in endothelial cells after Interleu -
kin-27 stimulation which suggests that it may play an important role in conferring the
immune function on vascular endothelium IL-27p28 subunit can be induced by IFN-β
and during LPS-induced maturation of dendritic cells in type-I IFN-dependent man -
ner through IFN regulatory factor-1 activation. Interleukin-27 regulates Interleukin-12
responsiveness of CD4+ T cells through Stat1-dependent and -independent mecha -
nisms. IL-17 and IL-23 play an important IL-17 role in inflammation. Interleukin-27
possesses potent anti-angiogenic activity that plays an important role in its antitumor
and antimetastatic activities. EBV induced gene 3 plays a role, independently from
IL-27, in regulating anti-viral or anti-tumoral immune responses. Interleukin-27 is a
potent inhibitor of HIV -1 replication in macrophages, CD4+ T cells, peripheral blood
mononuclear cells. Interleukin-27 triggers STAT activation and gene transcription.
IL 27 CYT-048 1 µg 50
Recombinant Human Interleukin-27 p28, Il27, Il27a, IL-27p28 -20 °C 5 µg 130
Interleukin-30, IL-30, IL-27/p28, p28, Interleukin-27, IL27-A, 100 µg 1,500
PEPTIDES INTERNATIONAL

Interleukin-27/p28, IL-27, Interleukin-27 subunit α, IL-27 subunit

α
IL-27A (215aa): FPRPPGRPQL SLQELRREFT VSLHLARKLL AEVRGQAHRF AESHLPGVNL YLL-
PLGEQLP DVSLTFQAWR RLSDPERLCF ISTTLQPFHA LLGGLGTQGR WTNMERMQLW AMRLD-
LRDLQ RHLRFQVLAA GFNLPEEEEE EEEEEEEERK GLLPGALGSA LQGPAQVSWP QLLSTYRLLH
SLELVLSRAV RELLLLSKAG HSVWPLGFPT LSPQP.
IL-27B (209aa): RKGPPAALTL PRVQCRASRY PIAVDCSWTL PPAPNSTSPV SFIATYRLGM AARGHSW-
PCL QQTPTSTSCT ITDVQLFSMA PYVLNVTAVH PWGSSSSFVP FITEHIIKPD PPEGVRLSPL AER-
QLQVQWE PPGSWPFPEI FSLKYWIRYK RQGAARFHRV GPIEATSFIL RAVRPRARYY VQVAAQDLTD
YGELSDWSLP ATATMSLGK.
IL-27 Human Recombinant produced in HEK cells is a glycosylated heterodimer, having a molecular
weight range of 25-30kDa due to glycosylation.

mIL 27 CYT-570 2 µg 50
Recombinant Mouse Interleukin-27, Interleukin-30, IL-30, IL-27/ -20 °C 10 µg 130
p28, p28, Interleukin-27, Interleukin-27/p28, IL-27, Interleukin-27 1 mg 5,200
subunit α, IL-27 subunit α, IL27-A, Il27, Il27a, IL-27p28
MFPTDPLSLQ ELRREFTVSL YLARKLLSEV QGYVHSFAES RLPGVNLDLL PLGYHLPNVS LTFQA-
WHHLS DSERLCFLAT TLRPFPAMLG GLGTQGTWTS SEREQLWAMR LDLRDLHRHL RFQVLAAGFK
CSKEEEDKEE EEEEEEEEKK LPLGALGGPN QVSSQVSWPQ LLYTYQLLHS LELVLSRAVR DLLLLSL-
PRR PGSAWDS
Interleukin-27 Mouse Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain
containing 207 amino acids and having a molecular mass of 23.7 kDa.

418 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
IL28 (Interleukin-28)
IL-28A is distantly related to type I interferons and the IL-10 family . Expression of IL-
28A is induced by viral infection which interacts with a heterodimeric class II cytokine
receptor that consists of interleukin 10 receptor, β (IL10RB) and interleukin 28 receptor,
α. IL-28A exhibits common features with type I IFNs such as antiviral activity, antipro-
liferative activity and in vivo antitumour activity.
IL-28A acts similarly to IFNs, but is less ef fective generally and has activity in a more
limited range of cell lines. IFN-λ 1, IFN-λ 2 and IFN-λ 3 are closely positioned genes
on human chromosome 19.
IL-28A induces ELR(-) CXC chemokine mRNA in human peripheral blood mononucle-
ar cells, in an IFN-gamma-independent manner.
IL-28A is able to generate tolerogenic DCs, an activity that could thwart IFN-β func-
tions. IL-28A produced in response to viral infection, activates both monocytes and
macrophages producing a restricted panel of cytokines and therefore is an important
factor in activating innate immune responses at the site of viral infection.
IL 28A CYT-602 5 µg 50
Recombinant Human Interleukin-28A -20 °C 20 µg 130
Interleukin-28A, IL-28A, IFN-Lambda 2, Interferon-Lambda 2, 1 mg 2,700
Cytokine ZCYTO20, IL28A, IFNL2, ZCYTO20
VPVAR LHGALPDARG CHIAQFKSLS PQELQAFKRAKDALEESLLL KDCRCHSRLF PRTWDLRQLQ VR-
ERPMALEA ELALTLKVLE ATADTDPALV DVLDQPLHTL HHILSQFRAC IQPQPTAGPR TRGRLHHWLY

PEPTIDES INTERNATIONAL
RLQEAPKKES PGCLEASVTFNLFRLLTRDL NCVASGDLCV
IL-28A human recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing
175 amino acids and having a molecular mass of 19.6 kDa.

IL 28A HEK CYT-104 2 µg 50

Recombinant Human Interleukin-28A, HEK -20 °C 10 µg 130
Interleukin-28A, IL-28A, IFN-Lambda 2, Interferon-Lambda 2, 1 mg 5,200
Cytokine ZCYTO20, IL28A, IFNL2, ZCYTO20
Interleukin-28A Human Recombinant produced in HEK cells is a non-glycosylated monomer, having a total
molecular weight of 24kDa.

mIL 28A CYT-741 5 µg 50

Recombinant Mouse Interleukin-28A; Interferon λ-2, IFN-λ-2, -20 °C 20 µg 130
Interleukin-28A, IL-28A, Ifnl2, Il28a, EG330496 1 mg 2,700
DPVPRATRLP VEAKDCHIAQ FKSLSPKELQ AFKKAKDAIE KRLLEKDMRC SSHLISRAWD
LKQLQVQERP KALQAEVALT LKVWENMTDS ALATILGQPL HTLSHIHSQL QTCTQLQATA EPKPPSR-
RLS RWLHRLQEAQ SKETPGCLED SVTSNLFRLL TRDLKCVASG DQCV
Recombinant Mouse Interleukin-28A produced in E.Coli is a single, non-glycosylated polypeptide chain
containing 174 amino acids and having a total molecular mass of 19.7kDa.

IL 28B CYT-105 2 µg 50
Recombinant Human Interleukin-28B -20 °C 10 µg 130
Interleukin-28B, IL-28B, Cytokine Zcyto22, Interferon λ-3, 1 mg 5,200
IFN-λ-3, Interferon λ-4, IFN-λ-4, Interleukin-28C, IL-28C, IL28B,
IFNL3, IFNL4, IL28C, ZCYTO22
Interleukin-28B Human Recombinant produced in HEK cells is a non-glycosylated monomer, having a total
molecular weight of 24kDa.

Order Hotline 1-800-777-4779 502-266-8787 419

 PRODUCT Code Qty PRICE
Recombinant proteins

mIL 28B CYT-732 5 µg 50

Recombinant Mouse Interleukin-28B, Interferon λ-3, IFN-λ-3, -20 °C 20 µg 130
Interleukin-28B, IL-28B, Ifnl3, Il28, Il28b, IFL-1, INF-α, INF-λ 1 mg 2,700

DPVPRATRLP VEAKDCHIAQ FKSLSPKELQ AFKKAKGAIE KRLLEKDMRC SSHLISRAWD

LKQLQVQERP KALQAEVALT LKVWENINDS ALTTILGQPL HTLSHIHSQL QTCTQLQATA EPKPPSRRLS
RWLHRLQEAQ SKETPGCLED SVTSNLFQLL LRDLKCVASG DQCV
IL-28B Mouse Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing
174 amino acids and having a molecular mass of 19.6kDa.

IL29 (Interleukin-29)
IL-29 is distantly related to type I interferons and the IL-10 family. Expression of IL-29
is induced by viral infection which interacts with a heterodimeric class II cytokine recep-
tor that consists of interleukin 10 receptor , beta (IL10RB) and interleukin 28 receptor ,
alpha. IL-29 exhibits common features with type I IFNs such as antiviral activity, antip-
roliferative activity and in vivo antitumour activity.
IL-29 acts similarly to IFNs, but is less ef fective generally and has activity in a more
limited range of cell lines. IFN-λ 1, IFN-λ 2 and IFN-λ3 are closely positioned genes on
human chromosome 19.
IL-29 induces ELR(-) CXC chemokine mRNA in human peripheral blood mononuclear
cells, in an IFN-γ-independent manner.
IL-29 is able to generate tolerogenic DCs, an activity that could thwart IFN-β functions.
IL-29 produced in response to viral infection, activates both monocytes and macro-
phages producing a restricted panel of cytokines and therefore is an important factor in
PEPTIDES INTERNATIONAL

activating innate immune responses at the site of viral infection.

IFN-λ 1 antiviral and antiproliferative activity requires Interferon-λ 2 receptor tyrosine
residues.
IL 29 CYT-603 5 µg 50
Recombinant Human Interleukin-29, Interleukin-29, IL-29, IFN-λ -20 °C 20 µg 130
1, Interferon-λ 1, Cytokine ZCYTO21, IL29, IFNL1, ZCYTO21 1 mg 2,700
GPVPTSKPTTT GKGCHIGRFK SLSPQELASF KKARDALEES LKLKNWSCSS PVFPGNWDLR LLQVR-
ERPVA LEAELALTLK VLEAAAGPAL EDVLDQPLHTLHHILSQLQA CIQPQPTAGP RPRGRLHHWL
HRLQEAPKKE SAGCLEASVT FNLFRLLTRD LKYVADGNLC LRTSTHPEST
IL-29 human recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing
181 amino acids and having a molecular mass of 20 kDa.

IL 29 HEK CYT-117 2 µg 50
Recombinant Human Interleukin-29, HEK -20 °C 10 µg 130
Interleukin-29, IL-29, IFN-λ 1, Interferon-λ 1, Cytokine ZCYTO21, 1 mg 5,200
IL-29 Human Recombinant produced in HEK cells is a glycosylated monomer, having a molecular weight
range of 29-35kDa due to glycosylation.

420 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
IL31 (Interleukin-31)
IL-31 produced by activated Th2-type T cells, cooperates with a heterodimeric receptor
consisting of IL-31 Receptor Anatagonist and Onconstatin-M Receptor that is contin -
uesly expressed on epithelial cells and keratinocytes. IL-31 plays a role in the promo-
tion of allergic skin disorders and in regulating other allergic diseases, such as asthma.
IL-31 is involved in the itching sensation and endorses the scratching behavior in NC/
Nga mice with atopic dermatitis. IL-31 expression is connectd with CLA(+) T cells
and contributes to the development of atopic dermatitis-induced skin inflammation and
pruritus. IL-31 is a powerful inducer of proinflammatory mediators in human colonic
SEMFs. IL-31 takes part as a proinflammatory cytokine derived from Th2 cells.
Serum IL-31 level is higher in patients with atopic dermatitis. IL-31 is involved in a
broad range of immune- and non-immune cells and possesses potential pleiotropic
physiological functions, including regulating hematopoiesis and immune response,
causing inflammatory bowel disease, airway hypersensitivity and dermatitis.
IL-29 induces ELR(-) CXC chemokine mRNA in human peripheral blood mononuclear
cells, in an IFN-γ-independent manner.
IL-29 is able to generate tolerogenic DCs, an activity that could thwart IFN-β functions.
IL-29 produced in response to viral infection, activates both monocytes and macro-
phages producing a restricted panel of cytokines and therefore is an important factor in
activating innate immune responses at the site of viral infection.
IFN-λ 1 antiviral and antiproliferative activity requires Interferon-λ 2 receptor tyrosine
residues.

PEPTIDES INTERNATIONAL
IL 31 CYT-625 2 µg 50
Recombinant Human Interleukin-31, Interleukin 31, IL31, IL-31 -20 °C 10 µg 130
1 mg 4,680
SHTLPVRLLR PSDDVQKIVE ELQSLSKMLL KDVEEEKGVL VSQNYTLPCL SPDAQPPNNI
HSPAIRAYLK TIRQLDNKSV IDEIIEHLDK LIFQDAPETN ISVPTDTHEC KRFILTISQQ FSECMDLALK
SLTSGAQQAT T
IL-31 human recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing
141 amino acids (24-164 a.a.) and having a molecular mass of 15.8 kDa.

mIL 31 CYT-604 2 µg 50
Recombinant Mouse Interleukin-31, Interleukin 31, IL31, IL-31 -20 °C 10 µg 130
1 mg 4,680
MTCSLSFGAP ISKEDLRTTI DLLKQESQDL YNNYSIKQAS GMSADESIQL PCFSLDREAL TNISVIIAHL
EKVKVLSENT VDTSWVIRWL TNISCFNPLN LNISVPGNTD ESYDCKVFVL TVLKQFSNCM AELQA-
KDNTT C
IL31 mouse recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing
141 amino acids and having a molecular mass of 15.7 kDa.

Order Hotline 1-800-777-4779 502-266-8787 421

 PRODUCT Code Qty PRICE
Recombinant proteins

IL32 (Interleukin-32)
IL-32 is part of the cytokine family and contains a tyrosine sulfation site, 3 potential
N-myristoylation sites, multiple putative phosphorylation sites, and an RGD cell-attach-
ment sequence. IL-32 expression is elevated after the activation of T-cells by mitogens
or the activation of NK cells by IL-2. IL-32 induces the production of TNF-a from mac-
rophage cells. IL-32 pro-inflammatory pathway is activated in response to influenza
A virus infection. Dysregulation of IL-32 in myelodysplastic syndrome and chronic
myelomonocytic leukemia modulates apoptosis and impairs NK function.
Induction of TNF, IL-1β, and IL-6 by IL-32 is intervened by p38-MAPK. IL-32 induced
monocyte-to-macrophage differentiation is mediated through nonapoptotic, caspase-
3-dependent mechanisms. IL32 plays an important role in the pathogenesis of rheu-
matoid arthritis, and is involved in activation-induced cell death in T cells, through its
intracellular actions. IL-32 is a cell-associated proinflammatory cytokine, which is
particularly stimulated by mycobacteria through a caspase-1- and IL-18-dependent
production of interferon γ.
IL-32 is associated with TNF-a, IL-1β, and IL-18. IL32 is involved in human rheumatoid
arthritis and is a novel target in autoimmune diseases.

IL 32A CYT-584 2 µg 50
Recombinant Human IL-32 α, NK4, TAIF, TAIFa, TAIFb, TAIFc, -20 °C 10 µg 130
TAIFd, IL-32β, IL-32α, IL-32δ, IL-32γ, Interleukin-32, IL-32, 1 mg 5,200
Natural killer cells Protein 4, Tumor necrosis factor α-inducing
factor, IL-32a, IL32a, IL32, Interleukin-32 α
PEPTIDES INTERNATIONAL

MCFPKVLSDD MKKLKARMHQ AIERFYDKMQ NAESGRGQVM SSLAELEDDF KEGYLETVAA

YYEEQHPELT PLLEKERDGL RCRGNRSPVP DVEDPATEEP GESFCDKSYG APRGDKEELT PQKC-
SEPQSS K
Interleukin-32 human recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain
containing 131 amino acids and having a molecular mass of 14.9 kDa.

IL 32A His Tag CYT-648 5 µg 50

Recombinant Human IL-32 α His Tag; NK4, TAIF, TAIFa, TAIFb, -20 °C 20 µg 130
TAIFc, TAIFd, IL-32β, IL-32α, IL-32delta, IL-32γ, Interleukin-32, 1 mg 2,700
IL-32, Natural killer cells Protein 4, Tumor necrosis factor
α-inducing factor, IL-32a, IL32a, IL32, Interleukin-32 α
MRGSHHHHHH GMASMTGGQQ MGRDLYDDDD KDRWGSHMCF PKVLSDDMKK LKARMHQAIE RFY-
DKMQNAE SGRGQVMSSL AELEDDFKEGYLETVAAYYE EQHPELTPLL EKERDGLRCR GNRSPVP-
DVE DPATEEPGES FCDKSYGAPR GDKEELTPQK CSEPQSSK
Interleukin-32 human recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain
containing 168 amino acids (1-131 a.a.) and having a molecular mass of 19.1 kDa. The IL-32 is fused to a
37 amino acid His Tag at N-terminus.

422 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
IL33 (Interleukin-33)
Interleukin 33 (IL-33) is a 32kDa proinflammatory cytokine that may also regulate gene
transcription in producer cells. IL-33 is structurally related to IL-1, which induces helper
T cells to produce type 2 cytokines and acts through the receptor IL1RL-1 (IL1 recep -
tor-like-1), which is known also as ST2. Binding of IL-33 to this receptor activates NF-
kappa-B and MAP kinases and induces in vitro Th2 cells to produce cytokines. In vivo,
IL-33 induces expression of IL-4, IL-5, IL-13 and leads to severe pathological changes
in mucosal organs and in vitro, it can be divided to N-terminal fragment of 12kDa and
C-terminal fragment of 18kDa by cleavage of caspase-1.
IL 33 CYT-425 2 µg 50
Recombinant Human Interleukin-33, Interleukin 33, DVS27, -20 °C 10 µg 130
NF-HEV, NKHEV, C9orf26, Interleukin-1 family member 11, IL- 1 mg 4,680
1F11, Nuclear factor from high endothelial venules, NFEHEV,
DKFZp586H0523, RP11-575C20.2, IL-33
MSITGISPIT EYLASLSTYN DQSITFALED ESYEIYVEDL KKDEKKDKVL LSYYESQHPS NESGDGVDGK
MLMVTLSPTK DFWLHANNKE HSVELHKCEK PLPDQAFFVL HNMHSNCVSF ECKTDPGVFI GVKDNH-
LALI KVDSSENLCT ENILFKLSET
Interleukin33 Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain
containing 160 amino acids and having a molecular mass of 18,125 Dalton.

IL 33 His CYT-667 2 µg 50
Recombinant Human Interleukin-33 His Tag; Interleukin 33, -20 °C 10 µg 130
DVS27, NF-HEV, NKHEV, C9orf26, Interleukin-1 family member 1 mg 4,800
11, IL- 1F11, Nuclear factor from high endothelial venules,

PEPTIDES INTERNATIONAL
NFEHEV, DKFZp586H0523, RP11-575C20.2, IL-33, IL33
Interleukin-33 Human Recombinant produced in E.Coli is a single, non-glycosylated, Polypeptide chain
containing 159 amino acids C-terminal fragment (112-270) having a molecular weight of 20.5kDa and
fused with a 4.5kDa amino-terminal hexahistidine tag.

mIL 33 CYT-655 2 µg 50
Recombinant Mouse Interleukin-33, Interleukin 33, DVS27, -20 °C 10 µg 130
NF-HEV, NKHEV, C9orf26, Interleukin-1 family member 11, IL- 1 mg 4,680
1F11, Nuclear factor from high endothelial venules, Il-33, Il1f11,
9230117N10Rik, Il33
SIQGTSLLTQ SPASLSTYND QSVSFVLENG CYVINVDDSG KDQEQDQVLL RYYESPCPAS QS-
GDGVDGKK LMVNMSPIKD TDIWLHANDK DYSVELQRGD VSPPEQAFFV LHKKSSDFVS FECKNLP-
GTY IGVKDNQLAL VEEKDESCNN IMFKLSKI
Interleukin33 Mouse recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain
containing 158 amino acids and having a molecular mass of 17.5 kDa.

rIL 33 CYT-150 2 µg 50
Recombinant Rat Interleukin-33, Interleukin 33, DVS27, -20 °C 10 µg 130
NF-HEV, NKHEV, C9orf26, Interleukin-1 family member 11, IL- 1 mg 4,680
1F11, Nuclear factor from high endothelial venules, NFEHEV,
DKFZp586H0523, RP11-575C20.2, IL-33
SIQGTSLLTE SCALSTYNDQ SVSFVLENGC YVINVEDCGK NQEKDKVLLR YYESSFPAQS GDGVDG-
KKLM VNMSPIKDTD IWLNANDKDY SVELQKGDVS PPDQAFFVLH KKSSDFVSFE CKNLPGTYIG
VKDNQLALVE ENDESCNNIM FKLSKM
IL 33 Rat Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 156
amino acids and having a molecular mass of 17.4kDa.
Please prevent freeze-thaw cycles.

Order Hotline 1-800-777-4779 502-266-8787 423

 PRODUCT Code Qty PRICE
Recombinant proteins

IL34 (Interleukin-34)
Interleukin 34 (IL34) is a cytokine that promotes the differentiation and viability of
monocytes and macrophages through the colony-stimulating factor-1 receptor and is a
part of a group of cytokines called interleukins. IL34 increases growth or survival of im-
mune cells known as monocytes. IL34 protein obtains its activity by binding the Colony
stimulating factor 1 receptor. Interleukin 34 has also a potential part in viral infection,
the adaptive immune response and bone marrow cell proliferation. Furthermore, IL34
plays an important role in innate immunity and in inflammatory processes.

IL34 CYT-042 2 µg 50
Recombinant Human Interleukin-34 -20 °C 10 µg 130
Interleukin 34, C16orf77, MGC34647, IL34 1 mg 4,680

MRGSHHHHHH GMASMTGGQQ MGRDLYDDDD KDRWGSHMNE PLEMWPLTQN EECTVTGFLR

DKLQYRSRLQ YMKHYFPINY KISVPYEGVF RIANVTRLQR AQVSERELRY LWVLVSLSAT ESVQDVL-
LEG HPSWKYLQEV QTLLLNVQQG LTDVEVSPKV ESVLSLLNAP GPNLKLVRPK ALLDNCFRVM
ELLYCSCCKQ SSVLNWQDCE VPSPQSCSPE PSLQYAATQL YPPPPWSPSS PPHSTGSVRP
VRAQGEGLLP
IL34 Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing
260 amino acids (21-242 a.a) and having a molecular mass of 29.6kDa. IL34 is fused to a 38 amino acid
His-tag at N-terminus & purified by proprietary chromatographic techniques.
Avoid multiple freeze-thaw cycles.

IL36 (Interleukin-36)
Human interleukin family 1, member 5 (IL-1F5 / FIL1-delta) belongs to the interleu -
PEPTIDES INTERNATIONAL

kin 1 cytokine family. IL1F5 is expressed by a variety of cells including monocytes,

Bcells, dendritic cells/Langerhans cells, keratinocytes,and gastric fundus Parietal and
Chief cells. IL1F5 is an antagonist of IL1F9; however IL1F5 activity related to receptor
binding remains unclear. Human and mouse IL1F5 share 90% amino acid sequence
identity.
IL36RN CYT-009 5 µg 50
Recombinant Human Interleukin-36 Receptor Antagonist -20 °C 25 µg 130
Interleukin-36 receptor antagonist Protein, FIL1 δ, IL-1-related 1 mg 2,700
Protein 3, IL-1RP3, Interleukin-1 HY1, IL-1HY1, Interleukin-1
δ, IL-1 δ, Interleukin-1 family member 5, IL-1F5, Interleukin-1
receptor antagonist homolog 1, IL-1ra homolog 1, Interleukin-
1-like Protein 1, IL-1L1, IL36RN, FIL1D, IL1F5, IL1HY1, IL1L1,
IL1RP3, FIL1, PSORP, IL36RA, FIL1(δ)
The sequence of the first five N-terminal amino acids was determined and was found to be Met-Val-Leu-
Ser-Gly
IL1F5 Human Recombinant produced in E.Coli is a single, non-glycosylated, Polypeptide chain containing
155 amino acids and having a molecular mass of 17kDa.

mIL36RN CYT-154 2 µg 50
Recombinant Mouse Interleukin-36 Receptor Antagonist -20 °C 10 µg 130
1 mg 4,680
IL36RN Mouse Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing
154 amino acids and having a molecular mass of 17.0kDa.
Please prevent freeze-thaw cycles.

424 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
PEPTIDES INTERNATIONAL

Order Hotline 1-800-777-4779 502-266-8787 425

 PRODUCT Code Qty PRICE
Recombinant proteins

IL36B CYT-159 2 µg 50
Recombinant Human Interleukin-36 Β, Interleukin 36 β, -20 °C 10 µg 130
interleukin 1 family member 8 (η), Interleukin-1 homolog 2, 1 mg 4,680
IL1F8 (Canonical product IL-1F8a), IL-1F8 (FIL1-η), Interleukin-1
Superfamily e, IL1H2, MGC126880, MGC126882
MNPQREAAPK SYAIRDSRQM VWVLSGNSLI AAPLSRSIKP VTLHLIACRD TEFSDKEKGN MVYL-
GIKGKD LCLFCAEIQG KPTLQLKEKN IMDLYVEKKA QKPFLFFHNK EGSTSVFQSV SYPGWFIATS
TTSGQPIFLT KERGITNNTN FYLDSVE
IL36B Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing
157 amino acids and having a molecular mass of 17.7kDa.
Please prevent freeze-thaw cycles.

IL36B 153 a.a. CYT-180 2 µg 50

Recombinant Human Interleukin-36 Β 153 a.a, Interleukin 36 -20 °C 10 µg 130
β, interleukin 1 family member 8 (η), Interleukin-1 homolog 2, 1 mg 4,680
IL1F8 (Canonical product IL-1F8a), IL-1F8 (FIL1-η), Interleukin-1
Superfamily e, IL1H2, MGC126880, MGC126882
REAAPKSYAI RDSRQMVWVL SGNSLIAAPL SRSIKPVTLH LIACRDTEFS DKEKGNMVYL GIKGK-
DLCLF CAEIQGKPTL QLKEKNIMDL YVEKKAQKPF LFFHNKEGST SVFQSVSYPG WFIATSTTSG
QPIFLTKERG ITNNTNFYLD SVE
IL36B 153 a.a. Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain
containing 153 amino acids (5-157a.a.) and having a molecular mass of 17.2kDa.
Please prevent freeze-thaw cycles.

mIL36B CYT-165 2 µg 50
PEPTIDES INTERNATIONAL

Recombinant Mouse Interleukin-36 Β, Interleukin 36 β, -20 °C 10 µg 130

interleukin 1 family member 8 (η), Interleukin-1 homolog 2, 1 mg 4,680
IL1F8 (Canonical product IL-1F8a), IL-1F8 (FIL1-η), Interleukin-1
Superfamily e, IL1H2, MGC126880, MGC126882
MMAFPPQSCV HVLPPKSIQM WEPNHNTMHG SSQSPRNYRV HDSQQMVWVL TGNTLTAVPA SN-
NVKPVILS LIACRDTEFQ DVKKGNLVFL GIKNRNLCFC CVEMEGKPTL QLKEVDIMNL YKERKAQKAF
LFYHGIEGST SVFQSVLYPG WFIATSSIER QTIILTHQRG KLVNTNFYIE SEK
IL36B Mouse Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing
183 amino acids and having a molecular mass of 21.0kDa.
Please prevent freeze-thaw cycles.

IL36G CYT-160 2 µg 50
Recombinant Human Interleukin-36 γ, Interleukin 36 γ, IL1F9, -20 °C 10 µg 130
interleukin 1 family member 9, Interleukin-1 ε, IL-1RP2, IL-1H1, 1 mg 4,680
IL1E, interleukin 1-related Protein 2, Interleukin-1 homolog 1
MRGTPGDADG GGRAVYQSMC KPITGTINDL NQQVWTLQGQ NLVAVPRSDS VTPVTVAVIT CKY-
PEALEQG RGDPIYLGIQ NPEMCLYCEK VGEQPTLQLK EQKIMDLYGQ PEPVKPFLFY RAKTGRTSTL
ESVAFPDWFI ASSKRDQPII LTSELGKSYN TAFELNIND
IL36G Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing
169 amino acids and having a molecular mass of 18.7kDa.
Please prevent freeze-thaw cycles.

426 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
IL36G 152 a.a. CYT-161 2 µg 50
Recombinant Human Interleukin-36 γ 152 a.a., Interleukin 36 γ, -20 °C 10 µg 130
IL1F9, interleukin 1 family member 9, Interleukin-1 ε, IL-1RP2, 1 mg 4,680
IL-1H1, IL1E, interleukin 1-related Protein 2, Interleukin-1
homolog 1
SMCKPITGTI NDLNQQVWTL QGQNLVAVPR SDSVTPVTVA VITCKYPEAL EQGRGDPIYL GIQN-
PEMCLY CEKVGEQPTL QLKEQKIMDL YGQPEPVKPF LFYRAKTGRT STLESVAFPD WFIASSKRDQ
PIILTSELGK SYNTAFELNI ND
IL36G (152 a.a.) Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain
containing 152 amino acids and having a molecular mass of 17.0kDa.

IL36G His CYT-782 5 µg 50

Recombinant Human Interleukin-36 γ, His Tag; Interleukin 36 γ, -20 °C 20 µg 130
IL1F9, interleukin 1 family member 9, Interleukin-1 ε, IL-1RP2, 1 mg 2,700
IL-1H1, IL1E, interleukin 1-related Protein 2, Interleukin-1
homolog 1
MGSSHHHHHH SSGLVPRGSH MGSMRGTPGD ADGGGRAVYQ SMCKPITGTI NDLNQQVWTL
QGQNLVAVPR SDSVTPVTVA VITCKYPEAL EQGRGDPIYL GIQNPEMCLY CEKVGEQPTL QLKEQ-
KIMDL YGQPEPVKPF LFYRAKTGRT STLESVAFPD WFIASSKRDQ PIILTSELGK SYNTAFELNI ND
IL36G Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing
192 amino acids (1-169) and having a molecular mass of 21.1kDa. IL36G is fused to a 23 amino acid
His-tag at N-terminus.

mIL36G CYT-745 2 µg 50
Recombinant Mouse Interleukin-36 γ, Interleukin-36 γ, -20 °C 10 µg 130
Interleukin-1 family member 9, IL-1F9, Il36g, Il1f9 1 mg 4,680

PEPTIDES INTERNATIONAL
GRETPDFGEV FDLDQQVWIF RNQALVTVPR SHRVTPVSVT ILPCKYPESL EQDKGIAIYL GIQNP-
DKCLF CKEVNGHPTL LLKEEKILDL YHHPEPMKPF LFYHTRTGGT STFESVAFPG HYIASSKTGN
PIFLTSKKGE YYNINFNLDI KS
IL36G Mouse Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing
152 amino acids and having a molecular mass of 17.3kDa.

IL1F7 (Human Interleukin Family 1, Member 7)

Human interleukin family 1, member 7 (IL1F7) belongs to the interleukin 1 cytokine
family. There are 5 alternatively spliced transcript variants encoding distinct isoforms
with distinct expression profiles. The longest IL-1F7 transcript, named IL1F7b or IL1F7
isoform 1, encodes a 218 aa residues proprotein and containing a 45 aa propeptide
which is cleaved to produce a mature protein. IL1F7b binds to IL18 Rb with low af -
finity however it doesn’t exert any IL18 agonistic or antagonistic effects. IL1F7b also
binds IL18BP (interleukin 18 binding protein), which is an inhibitory binding protein of
interleukin 18 (IL18), and afterward forms a complex with IL18 receptor beta subunit,
and through which it inhibits the activity of IL18.

Order Hotline 1-800-777-4779 502-266-8787 427

 PRODUCT Code Qty PRICE
Recombinant proteins

IL37 CYT-011 2 µg 50
Recombinant Human Interleukin 37, Interleukin-37, FIL1 ζ, -20 °C 10 µg 130
IL-1X, Interleukin-1 family member 7, IL-1F7, Interleukin-1 1 mg 4,500
homolog 4, IL-1H, IL-1H4, Interleukin-1 ζ, IL-1 ζ, Interleukin-
1-related Protein, IL-1RP1, Interleukin-23, IL-37, IL37, FIL1Z,
IL1F7, IL1H4, IL1RP1, FIL1, FIL1(ζ)
MKNLNPKKFSIHDQDHKVLVLDSGNLIAVPDKNYIRPEIFFALASSLSSASAEKGSPILLGVSKGEFCLYCD-
KDKGQSHPSLQLKKEKLMKLAAQKESARRPFIFYRAQVGSWNMLESAAHPGWFICTSCNCNEPVGVTD-
KFENRKHIEFSFQPVCKAEMSPSEVSD
Interleukin-37 Human Recombinant produced in E.Coli is a single, non-glycosylated, Polypeptide chain
containing 167 amino acids (Lys27-Asp192)  and having a molecular mass of 18.6kDa.

IL1F10 (Human Interleukin Family 1, Member 10)

Human interleukin family 1, member 10 (IL1F10) belongs to the interleukin 1 cytokine
family. IL1F10 is expressed in the fetal skin, spleen and tonsil, generally in the basal
epithelia of skin and in proliferating B-cells of the tonsil. IL1F10 binds soluble IL1
receptor type 1 and may be implicated in the regulation of adapted and innate immune
responses.
IL1F10 CYT-012 2 µg 50
Recombinant Human Interleukin 1 Family, Member 10, -20 °C 10 µg 130
Interleukin-1 family member 10, IL-1F10, FIL1 θ, Interleukin-1 1 mg 4,500
HY2, IL-1HY2, Interleukin-1 θ, IL-1 θ, IL1F10, FIL1T, IL1HY2,
FKSG75, MGC119831, MGC119832, MGC119833, FIL1-θ
The sequence of the first five N-terminal amino acids was determined and was found to be Met-Cys-Ser-
PEPTIDES INTERNATIONAL

Leu-Pro
IL1F10 Human Recombinant produced in E.Coli is a single, non-glycosylated, Polypeptide chain containing
152 amino acids and having a molecular mass of 17kDa.

IL1F10 His CYT-783 5 µg 50

Recombinant Human Interleukin 1 Family, Member 10 His Tag, -20 °C 20 µg 130
Interleukin-1 family member 10, IL-1F10, FIL1 θ, Interleukin-1 1 mg 2,700
HY2, IL-1HY2, Interleukin-1 θ, IL-1 θ, IL1F10, FIL1T, IL1HY2,
FKSG75, MGC119831, MGC119832, MGC119833, FIL1-θ
MGSSHHHHHH SSGLVPRGSH MCSLPMARYY IIKYADQKAL YTRDGQLLVG DPVADNC-
CAE KICTLPNRGL DRTKVPIFLG IQGGSRCLAC VETEEGPSLQ LEDVNIEELY KGGEEATRFT
FFQSSSGSAF RLEAAAWPGW FLCGPAEPQQ PVQLTKESEP SARTKFYFEQ SW
IL1F10 Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing
172 amino acids (1-152) and having a molecular mass of 19.1kDa. IL1F10 is fused to a 20 amino acid
His-tag at N-terminus.

428 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
Insulin
Insulin decreases blood glucose concentration. It increases cell permeability to mono-
saccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phos-
phate cycle, and glycogen synthesis in liver.

Insulin CYT-270 25 mg 110

Recombinant Human Insulin -20 °C 250 mg 310
1g 1,000
Insulin Human Recombinant produced in E.Coli is a two chain, non-glycosylated polypeptide chain contain-
ing 51 amino acids and having a molecular mass of 5807 Dalton.

Insulin Yeast CYT-614 2 mg 50

Recombinant Human Insulin Yeast -20 °C 10 mg 130
100 mg 600
Insulin Human Recombinant produced in Yeast is a two chain, glycosylated polypeptide chain containing
51 amino acids and having a molecular mass of 5807 Dalton. Zinc content was found to be 0.4%.

pInsulin CYT-468 25 mg 110

Porcine Insulin -20 °C 250 mg 310
1g 1,000
Insulin Porcine is a two chain, glycosylated polypeptide chain containing 51 amino acids and having a
molecular mass of 5777 Dalton.
The a and b chains are joined by two interchain disulfide bonds. The a chain contains an intrachain disul-
fide bond. Insulin regulates the cellular uptake, utilization, and storage of glucose, amino acids, and fatty
acids and inhibits the breakdown of glycogen, protein, and fat.

PEPTIDES INTERNATIONAL
INSR CYT-777 2 µg 50
Recombinant Human Insulin Receptor -20 °C 10 µg 130
Insulin receptor, IR, EC 2.7.10.1, CD220, INSR, HHF5 1 mg 5,200
ASHLYPGEVC PGMDIRNNLT RLHELENCSV IEGHLQILLM FKTRPEDFRD LSFPKLIMIT DYLLLFRVYG
LESLKDLFPN LTVIRGSRLF FNYALVIFEM VHLKELGLYN LMNITRGSVR IEKNNELCYL ATIDWSRILD
SVEDNYIVLN KDDNEECGDI CPGTAKGKTN CPATVINGQF VERCWTHSHC QKVCPTICKS HGCTAE-
GLCC HSECLGNCSQ PDDPTKCVAC RNFYLDGRCV ETCPPPYYHF QDWRCVNFSF CQDLHHKCKN
SRRQGCHQYV IHNNKCIPEC PSGYTMNSSN LLCTPCLGPC PKVCHLLEGE KTIDSVTSAQ ELRGCTV-
ING SLIINIRGGN NLAAELEANL GLIEEISGYL KIRRSYALVS LSFFRKLRLI RGETLEIGNY SFYALD-
NQNL RQLWDWSKHN LTITQGKLFF HYNPKLCLSE IHKMEEVSGT KGRQERNDIA LKTNGDQASC
ENELLKFSYI RTSFDKILLR WEPYWPPDFR DLLGFMLFYK EAPYQNVTEF DGQDACGSNS WTV-
VDIDPPL RSNDPKSQNH PGWLMRGLKP WTQYAIFVKT LVTFSDERRT YGAKSDIIYV QTDATNPSVP
LDPISVSNSS SQIILKWKPP SDPNGNITHY LVFWERQAED SELFELDYCL KGLKLPSRTW SPPFESED-
SQ KHNQSEYEDS AGECCSCPKT DSQILKELEE SSFRKTFEDY LHNVVFVPRP SRKRRSLGDV GN-
VTVAVPTV AAFPNTSSTS VPTSPEEHRP FEKVVNKESL VISGLRHFTG YRIELQACNQ DTPEERCSVA
AYVSARTMPE AKADDIVGPV THEIFENNVV HLMWQEPKEP NGLIVLYEVS YRRYGDEELH LCVSRKH-
FAL ERGCRLRGLS PGNYSVRIRA TSLAGNGSWT EPTYFYVTDY LDVPSNIAKK LHHHHHH
Insulin Receptor Human Recombinant produced in HEK cells is a single, glycosylated, polypeptide chain
(aa 28-944 of the short isoform- HIR-A, Uniprot accession # P06213-2 which includes the whole subunit α
and extracellular domain of subunit β) containing a total of 927 amino acids, having a molecular mass of
105.9kDa (calculated), though it migrates at approximately 160kDa on SDS PAGE, the INSR is fused to a
2 a.a N-terminal linker, a 2 a.a C-terminal linker and fused to a 6 a.a His tag at C-Terminus.

Order Hotline 1-800-777-4779 502-266-8787 429

 PRODUCT Code Qty PRICE
Recombinant proteins

KGF (Keratinocyte Growth Factor)

KGF is a member of the fibroblast growth factor (FGF) family. FGF family members
possess broad mitogenic and cell survival activities, and are involved in a variety of bio
-
logical processes, including embryonic development, cell growth, morphogenesis, tis -
sue repair, tumor growth and invasion. FGF7 is a potent epithelial cell-specific growth
factor, whose mitogenic activity is predominantly exhibited in keratinocytes but not in
fibroblasts and endothelial cells. Studies of mouse and rat homologs of this gene
implicated roles in morphogenesis of epithelium, reepithelialization of wounds, hair de-
velopment and early lung organogenesis..

KGF CYT-219 2 µg 50
Recombinant Human Keratinocyte Growth Factor, HBGF-7, -20 °C 10 µg 130
FGF7, FGF-7 1 mg 4,680

MCNDMTPEQM ATNVNCSSPE RHTRSYDYME GGDIRVRRLF CRTQWYLRID KRGKVKGTQE

MKNNYNIMEI RTVAVGIVAI KGVESEFYLA MNKEGKLYAK KECNEDCNFK ELILENHYNT YASAK-
WTHNG GEMFVALNQK GIPVRGKKTK KEQKTAHFLP MAIT
Keratinocyte Growth Factor-1 Human Recombinant produced in E.Coli is a single, non-glycosylated,
polypeptide chain containing 164 amino acids and having a molecular mass of 18995 Dalton.

mKGF CYT-721 2 µg 50
Recombinant Mouse Keratinocyte Growth Factor, HBGF-7, -20 °C 10 µg 130
FGF7, FGF-7, KGF, Keratinocyte growth factor, Fibroblast 1 mg 4,680
growth factor 7, Heparin-binding growth factor 7
MCNDMSPEQT ATSVNCSSPE RHTRSYDYME GGDIRVRRLF CRTQWYLRID KRGKVKGTQE
PEPTIDES INTERNATIONAL

MKNSYNIMEI RTVAVGIVAI KGVESEYYLA MNKEGKLYAK KECNEDCNFK ELILENHYNT YASAK-

WTHSG GEMFVALNQK GIPVKGKKTK KEQKTAHFLP MAIT
Keratinocyte Growth Factor-1 Mouse Recombinant produced in E.Coli is a single, non-glycosylated,
polypeptide chain containing 164 amino acids and having a molecular mass of 18.9 kDa.

KGF HEK CYT-086 2 µg 50

Recombinant Human Keratinocyte Growth Factor, HEK -20 °C 10 µg 130
HBGF-7, FGF7, FGF-7, KGF 100 µg 1,100
KGF Human Recombinant produced in HEK cells is a glycosylated monomer, having a molecular weight
range of 17-30kDa due to glycosylation.

KGF 2 CYT-303 5 µg 50
Recombinant Human Keratinocyte Growth Factor-2, FGFA, -20 °C 25 µg 130
FGF10, FGF-10, KGF-2, Fibroblast growth factor 10 1 mg 2,700

MLGQDMVSPE ATNSSSSSFS SPSSAGRHVR SYNHLQGDVR WRKLFSFTKY FLKIEKNGKV SGTK-

KENCPY SILEITSVEI GVVAVKAINS NYYLAMNKKG KLYGSKEFNN DCKLKERIEE NGYNTYASFN
WQHNGRQMYV ALNGKGAPRR GQKTRRKNTS AHFLPMVVHS
Keratinocyte Growth Factor-2 Human Recombinant produced in E.Coli is a single, non-glycosylated
polypeptide chain containing 170 amino acids (40-208) and having a molecular mass of 19300 Dalton.
Keratinocyte Growth Factor 2 is highly related to KGF-1(FGF-7), it binds to the same receptor as KGF-1
and shares 57% sequence homology.

430 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
KGF 2 His CYT-129 2 µg 50
Recombinant Human Keratinocyte Growth Factor-2, His Tag -20 °C 10 µg 130
FGFA, FGF10, FGF-10, KGF-2, Fibroblast growth factor 10 1 mg 5,200
MGSSHHHHHH SSGLVPRGSH MGSHMQALGQ DMVSPEATNS SSSSFSSPSS AGRHVRSYNH
LQGDVRWRKL FSFTKYFLKI EKNGKVSGTK KENCPYSILE ITSVEIGVVA VKAINSNYYL AMNKKGKLYG
SKEFNNDCKL KERIEENGYN TYASFNWQHN GRQMYVALNG KGAPRRGQKT RRKNTSAHFL PMV-
VHS
KGF 2 Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing
196 amino acids (38-208) and having a molecular mass of 22.0kDa. KGF 2 is fused to a 25 amino acid
His-tag at N-terminus.

mKGF 2 CYT-126 5 µg 50
Recombinant Mouse Keratinocyte Growth Factor-2 -20 °C 25 µg 130
FGFA, FGF10, FGF-10, KGF-2, Fibroblast growth factor 10 1 mg 2,700

QALGQDMVSQ EATNCSSSSS SFSSPSSAGR HVRSYNHLQG DVRWRRLFSF TKYFLTIEKN GKVS-

GTKNED CPYSVLEITS VEIGVVAVKA INSNYYLAMN KKGKLYGSKE FNNDCKLKER IEENGYNTYA
SFNWQHNGRQ MYVALNGKGA PRRGQKTRRK NTSAHFLPMT IQT
KGF 2 Mouse Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing
173 amino acids and having a molecular mass of 19.5kDa.
Please prevent freeze-thaw cycles.

rKGF CYT-127 5 µg 50
Recombinant Rat Keratinocyte Growth Factor-2 -20 °C 25 µg 130
FGFA, FGF10, FGF-10, KGF-2, Fibroblast growth factor 1 1 mg 2,700
QALGQDMVSP EATNSSSSSS SSSSSSSFSS PSSAGRHVRS YNHLQGDVRW RKLFSFTKYF

PEPTIDES INTERNATIONAL
LKIEKNGKVS GTKKENCPYS ILEITSVEIG VVAVKAINSN YYLAMNKKGK LYGSKEFNND CKLKERIEEN
GYNTYASFNW QHNGRQMYVA LNGKGAPRRG QKTRRKNTSA HFLPMVVHS
KGF 2 Rat Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 179
amino acids and having a molecular mass of 20.0kDa.
Please prevent freeze-thaw cycles.

Leptin
A 16-kDa peptide hormone secreted from white adipocytes and implicated in the regu-
lation of food intake and energy balance, Leptin provides the key af ferent signal from
fat cells in the feedback system that controls body fat stores..

Leptin CYT-228 200 µg 50

Recombinant Human Leptin, OB Protein, Obesity Protein, OBS, -20 °C 1 mg 130
Obesity factor 5 mg 450
Leptin Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing
146 amino acids and having a molecular mass of 16 kDa.
H.-S. Moon, et al., Diabetes Care, 34, 1 (2011).
J. Roa, et al., Endocrinology, 150, 11 (2009).
K Yan, et al., Mol Med., 18, 1 (2012).

Order Hotline 1-800-777-4779 502-266-8787 431

 PRODUCT Code Qty PRICE
Recombinant proteins

Leptin CYT-683 200 µg 50

Human Leptin -20 °C 1 mg 130
OB Protein, Obesity Protein, OBS, Obesity factor, 5 mg 450

Val-Pro-Ile-Gln-Lys-Val-Gln-Asp-Asp-Thr-Lys-Thr-Leu-Ile-Lys-Thr-Ile-Val-Thr-Arg-Ile-Asn-Asp-Ile-Ser-His-
Thr-Gln-Ser-Val-Ser-Ser-Lys-Gln-Lys
Leptin Human produced syntheticaly contains 35 amino acids (22-56 a.a.) having a molecular mass of
3950.6 Dalton.

Leptin His CYT-287 5 µg 50

Recombinant Human Leptin, His Tag -20 °C 25 µg 130
OB Protein, Obesity Protein, OBS, Obesity factor 1 mg 2,400

Leptin Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing
amino acids 48-167 and having a total molecular mass of 19 kDa including the 4 kDa His tag.

mLeptin CYT-351 200 µg 50

Recombinant Mouse Leptin -20 °C 1 mg 130
OB Protein, Obesity Protein, OBS, Obesity factor 5 mg 450
MVPIQKVQDD TKTLIKTIVT RINDISHTQS VSAKQRVTGL DFIPGLHPIL SLSKMDQTLA VYQQVLTSLP
SQNVLQIAND LENLRDLLHL LAFSKSCSLP QTSGLQKPES LDGVLEASLY STEVVALSRL QG-
SLQDILQQ LDVSPEC
Leptin Mouse Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing
147 amino acids and having a molecular mass of 16.2 kDa.

mLeptin PEG CYT-591 5 µg 50

Recombinant Pegylated Mouse Leptin -20 °C 20 µg 130
PEPTIDES INTERNATIONAL

OB Protein, Obesity Protein, OBS, Obesity factor 1 mg 2,850

Leptin Mono-Pegylated Mouse Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide

chain containing 146 amino acids and an additional Ala at N-terminus. Pegylated Mouse Leptin contains
PEG 20 kDa at its N-terminus and having a molecular mass of 35.6 kDa as determined by mass spectrom-
etry.
Since its enlarged hydrodymanic volume Pegylated Leptin runs on SDS-PAGE as A 48 kDa protein and in
gel-filtration on Superdex 200 as over 100 kDa protein.
Pegylated Mouse Leptin half-life in circulation after SC injection was over 20 hours. Mouse Leptin was
purified by proprietary chromatographic techniques according to Salomon et al (2006) Protein Expression
and Purification 47, 128–136 and then pegylated.

rLeptin CYT-227 200 µg 50

Recombinant Rat Leptin -20 °C 1 mg 130
OB Protein, Obesity Protein, OBS, Obesity factor 5 mg 450

The sequence of the first five N-terminal amino acids was determined and was found to be Ala-Val-Pro-Ile-
His
Leptin Rat Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 147
amino acids and having a molecular mass of 16 kDa.
J.M. Castellano, et al., Diabetes, 55, 9 (2006). K. Yan, et al., Mol Med., 18, 1 (2012).
J. Roa, et al., Am J Physiol Endocrinol Metab., 294 (2008). D Amantea, et al., Cell Death and Disease, 2 (2011).

432 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
rLeptin PEG CYT-592 20 µg 50
Recombinant Pegylated Rat Leptin -20 °C 100 µg 130
OB Protein, Obesity Protein, OBS, Obesity factor 1 mg 1,050
Mono-Pegylated Leptin Rat Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide
chain containing 147 amino acids and an additional Ala at N-terminus having a molecular mass of 35.6
kDa (with 20 kDa PEG) as determined by mass spectometry. However due to enlarged hydrodymanic
volume it runs on the SDS-PAGE as 48 kDa protein and in gel-filtration on Superdex 200 as over 100
kDa protein. Its half-life in circulation after SC injection was over 20 hours. Rat Leptin was purified by
proprietary chromatographic techniques (according to Salomon, et al., Protein Expression and Purification
47, 128–136 (2006)), and then pegylated.

oLeptin CYT-239 20 µg 50
Recombinant Ovine Leptin -20 °C 100 µg 130
OB Protein, Obesity Protein, OBS, Obesity factor 1 mg 950
The sequence of the first five N-terminal amino acids was determined and was found to be Ala-Val-Pro-Ile-
Arg
Leptin Ovine Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing
146 amino acids and having a molecular mass of 16 kDa.

oLeptin, MTS CYT-531 20 µg 50

Recombinant Ovine Leptin, MTS tag -20 °C 100 µg 130
OB Protein, Obesity Protein, OBS, Obesity factor 1 mg 1,050
The sequence of the first five N-terminal amino acids was determined and was found to be Ala-Val-Pro-Ile-
Arg
Leptin Ovine MTS tagged Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide
chain containing 157 amino acids and having a molecular mass of 17.5 kDa. The membrane translocating

PEPTIDES INTERNATIONAL
sequence Tag is composed of 10 amino acids Val-Leu-Leu-Pro-Val-Leu-Leu-Ala-Ala-Pro located at the
N-terminus.

bLeptin CYT-502 20 µg 50
Recombinant Bovine Leptin -20 °C 100 µg 130
OB Protein, Obesity Protein, OBS, Obesity factor 1 mg 950
The sequence of the first five N-terminal amino acids was determined and was found to be Ala-Val-Pro-Ile-
Arg
Leptin Bovine Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing
146 amino acids and having a molecular mass of 16 kDa.

pLeptin CYT-503 20 µg 50
Recombinant Porcine Leptin -20 °C 100 µg 130
OB Protein, Obesity Protein, OBS, Obesity factor 1 mg 950
The sequence of the first five N-terminal amino acids was determined and was found to be Ala-Val-Pro-Ile-
Trp
Leptin Porcine Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing
146 amino acids and additional Ala at N-terminus, having a molecular mass of 16kDa.

Order Hotline 1-800-777-4779 502-266-8787 433

 PRODUCT Code Qty PRICE
Recombinant proteins

pfLeptin CYT-530 20 µg 50
Recombinant Pufferfish Leptin -20 °C 100 µg 130
OB Protein, Obesity Protein, OBS, Obesity factor 1 mg 1,050
The sequence of the first five N-terminal amino acids was determined and was found to be Ala-Leu-Pro-
Gly-Ala
Leptin Pufferfish (Takifugu rubripes) Recombinant produced in E.Coli is a single, non-glycosylated,
polypeptide chain having a molecular mass of 16 kDa and was prepared (according to the sequence
published by Kurokawa, et al., Peptides, 26, 745-750 (2005)) in two forms: monomer and covalent dimer.
MS analysis revealed molecular masses of 15,291 and 30,585 Da, close to the theoretical values of 15,270
and 30,540 Da. CD spectra revealed high similarity to mammalian leptins. Other details of its preparation
are published by Yacobovitz, et al., General and Comparative Endocrinology.

sLeptin CYT-704 100 µg 255

Recombinant Salamander Leptin -20 °C 200 µg 340
OB Protein, Obesity Protein, OBS, Obesity factor, Leptin 1 mg 1,200
The sequence of the ten N-terminal amino acids was determined and was found to be Ala-Ile-Met-Val-Asp-
Gln-Leu-Arg-Met-Asp
Leptin Salamander Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain
containing 146 amino and additional Ala at N-terminus acids and having a molecular mass of 16kDa.

hLeptin CYT-504 20 µg 50
Recombinant Horse Leptin -20 °C 100 µg 130
OB Protein, Obesity Protein, OBS, Obesity factor 1 mg 950
The sequence of the first five N-terminal amino acids was determined and was found to be Ala-Val-Pro-Ile-
Gln
Leptin Horse Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing
PEPTIDES INTERNATIONAL

146 amino acids and having a molecular mass of 16 kDa.

chLeptin CYT-505 20 µg 50
Recombinant Chicken Leptin -20 °C 100 µg 130
OB Protein, Obesity Protein, OBS, Obesity factor 1 mg 950

The sequence of the first five N-terminal amino acids was determined and was found to be Ala-Val-Pro-
Cys-Gln
eptin Chicken Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing
145 amino acids and having a molecular mass of 16 kDa.

dLeptin CYT-506 20 µg 50
Recombinant Dog Leptin -20 °C 100 µg 130
OB Protein, Obesity Protein, OBS, Obesity factor 1 mg 950
The sequence of the first five N-terminal amino acids was determined and was found to be Ala-Val-Pro-Ile-
Arg
Leptin Dog Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing
146 amino acids and having a molecular mass of 16 kDa.

raLeptin CYT-507 20 µg 50
Recombinant Rabbit Leptin -20 °C 100 µg 130
OB Protein, Obesity Protein, OBS, Obesity factor 1 mg 950

The sequence of the first five N-terminal amino acids was determined and was found to be Ala-Val-Pro-Ile-
Arg
Leptin Rabbit Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing
146 amino acids and having a molecular mass of 16 kDa.

434 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
Leptin tA CYT-352 10 µg 50
Recombinant Human Leptin Triple Antagonist -20 °C 50 µg 130
1 mg 1,680
The sequence of the first five N-terminal amino acids was determined and was found to be Ala-Val-Pro-Ile-
Gln.
Leptin Antagonist Triple Mutant Human Recombinant is a single non-glycosilated polypeptide chain con-
taining 146 amino and additional Ala at N-terminus acids and having a molecular weight of 16 kDa, Leptin
was mutated, resulting in L39A/D40A/F41A.

Leptin tA PEG CYT-702 5 µg 50

Recombinant Human Leptin Triple Antagonist, Pegylated -20 °C 20 µg 130
1 mg 3,360
Pegylated Leptin Antagonist Triple Mutant Human Recombinant is a single non-glycosilated polypeptide
chain containing 146 amino and additional Ala at N-terminus acids and having a molecular weight of
35.6kDa, Leptin was mutated, resulting in L39A/D40A/F41A. However due to enlarged hydrodymanic
volume it runs on the SDS-PAGE as 48 kDa protein and in gel-filtration on Superdex 200 as over 200 kDa
protein.

Leptin qA CYT-353 10 µg 50
Recombinant Human Leptin Quadruple Antagonist -20 °C 50 µg 130
1 mg 1,680
The sequence of the first five N-terminal amino acids was determined and was found to be Ala-Val-Pro-Ile-
Gln
Leptin Quadruple Mutant Human Recombinant is a single polypeptide chain containing 146 amino and
additional Ala at N-terminus acids and having a Mw of 16 kDa, Human Leptin was mutated, resulting in
L39A/D40A/F41A/I42A.

mLeptin tA CYT-354 10 µg 50

PEPTIDES INTERNATIONAL
Recombinant Mouse Leptin Triple Antagonist -20 °C 50 µg 130
1 mg 1,680
The sequence of the first five N-terminal amino acids was determined and was found to be Ala-Val-Pro-Ile-
Gln
Leptin Antagonist Triple Mutant Mouse Recombinant is a single non-glycosilated polypeptide chain contain-
ing 146 amino and additional Ala at N-terminus acids and having a molecular mass of ~ 16 kDa, LEP was
mutated, resulting in L39A/D40A/F41A mutant.

mLeptin tA PEG CYT-566 5 µg 50

Recombinant Pegylated Mouse Leptin Triple Antagonist, -20 °C 20 µg 130
Pegylated 1 mg 3,360

Leptin Antagonist Triple Mutant Mouse Recombinant is a single non-glycosilated polypeptide chain contain-
ing 146 amino and additional Ala at N-terminus acids and having a molecular mass of ~ 16 kDa.
The Mouse Leptin antagonist was mutated, resulting in L39A/D40A/F41A mutant.
The Mouse Leptin antagonist is bound to 20 kDa mono-PEG at N-terminus, resulting in 35.6 kDa. The
Mouse Leptin triple anatagonist runs as a 48 kDa.

rLeptin tA CYT-355 10 µg 50
Recombinant Rat Leptin Triple Antagonist -20 °C 50 µg 130
1 mg 1,680
The sequence of the first five N-terminal amino acids was determined and was found to be Ala-Val-Pro-Ile-
Gln
Leptin Antagonist Triple Mutant Rat Recombinant is a singly non-glycosilated polypeptide chain containing
146 amino and additional Ala at N-terminus acids and having a molecular mass of ~ 16 kDa, Leptin was
mutated, resulting in L39A/D40A/F41A mutant.

Order Hotline 1-800-777-4779 502-266-8787 435

 PRODUCT Code Qty PRICE
Recombinant proteins

rLeptin tA PEG CYT-567 5 µg 50

Recombinant Pegylated Rat Leptin Triple Antagonist, Pegylated -20 °C 20 µg 130
1 mg 3,360
Leptin Antagonist Triple Mutant Rat Recombinant is a single non-glycosilated polypeptide chain containing
146 amino and additional Ala at N-terminus acids and having a molecular mass of ~ 16 kDa.
The Rat Leptin antagonist was mutated, resulting in L39A/D40A/F41A mutant.
The Rat Leptin antagonist is bound to 20 kDa mono-PEG at N-terminus, resulting in 35.6 kDa. The Rat
Leptin triple anatagonist runs as a 48 kDa.

oLeptin tA CYT-356 10 µg 50
Recombinant Ovine Leptin Triple Antagonist -20 °C 50 µg 130
1 mg 1,680
The sequence of the first five N-terminal amino acids was determined and was found to be Ala-Val-Pro-Ile-
Arg
Leptin Antagonist Triple Mutant Ovine Recombinant is a single non-glycosilated polypeptide chain contain-
ing 146 amino and additional Ala at N-terminus acids and having a molecular mass of ~ 16 kDa, Leptin
was mutated, resulting in L39A/D40A/F41A mutant.

oLeptin tA PEG CYT-703 5 µg 50

Recombinant Ovine Leptin Triple Antagonist, Pegylated -20 °C 20 µg 130
1 mg 3,360
Pegylated Leptin Antagonist Triple Mutant Ovine Recombinant is a single non-glycosilated polypeptide
chain containing 146 amino and additional Ala at N-terminus acids and having a molecular mass of ~ 35.6
kDa, Leptin was mutated, resulting in L39A/D40A/F41A mutant. However due to enlarged hydrodymanic
volume it runs on the SGS-Page as 48 kDa protein and in gel-filtration on Superdex 200 as over 200kDa
protein.

oLeptin qA
PEPTIDES INTERNATIONAL

CYT-357 10 µg 50
Recombinant Ovine Leptin Quadruple Antagonist -20 °C 50 µg 130
1 mg 1,680
The sequence of the first five N-terminal amino acids was determined and was found to be Ala-Val-Pro-Ile-
Arg
Leptin Antagonist Quadruple Mutant Ovine Recombinant is a single non-glycosilated polypeptide chain
containing 146 amino and additional Ala at N-terminus acids and having a molecular mass of ~ 16 kDa,
Leptin was mutated, resulting in L39A/D40A/F41A/I42A mutant.

Leptin Receptor CYT-508 5 µg 50

Recombinant Human Leptin Binding Domain, OB Protein, -20 °C 20 µg 130
Obesity Protein, OBS, Obesity factor, Leptin Receptor 1 mg 3,800

The sequence of the first four N-terminal amino acids was determined and was found to be Ala-Thr-Pro-Val
Biological ActivityBiological Activity is evidenced by high affinity binding of mammalian leptins at 1:1 molar
ratio
Leptin Binding Domain Human Recombinant also called Leptin soluble receptor produced in E.Coli is a
single, non-glycosylated, polypeptide chain containing 208 amino acids and having a molecular mass of
24.5 kDa. Leptin Receptor consists of the cytokine binding domain of leptin receptor amino acids 428-635
of human leptin receptor.

436 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
chLeptin Receptor CYT-509 5 µg 50
Recombinant Chicken Leptin Binding Domain, OB Protein, -20 °C 20 µg 130
Obesity Protein, OBS, Obesity factor, Leptin Receptor 1 mg 3,800
The sequence of the first six N-terminal amino acids was determined and was found to be Ala-Ile-Asp-Val-
Asn-Ile Biological ActivityBiological Activity is evidenced by high affinity binding of mammalian leptins at 1:1
molar ratio.
Leptin Binding Domain Chicken Recombinant also called Leptin Receptor produced in E.Coli is a single,
non-glycosylated, polypeptide chain containing 208 amino acids and having a molecular mass of 24.5 kDa.
Chicken Leptin Receptor consists of the cytokine binding domain of leptin receptor amino acids 420-626 of
chicken leptin receptor.

LFA 3 (Leukocyte Function Associated Antigen-3)

LFA-3 is ligand of the t-lymphocyte cd2 glycoprotein. This interaction is important in
mediating thymocyte interactions with thymic epithelial cells, antigen-independent and
dependent interactions of t-lymphocytes with target cells and antigen- presenting cells
and the t-lymphocyte rosetting with erythrocytes. In addition, the lfa-3/cd2 interaction
may prime response by both the cd2+ and lfa-3+ cells.
LFA 3 Human CYT-423 20 µg 50
Recombinant Human Leukocyte Function Associated Antigen-3 -20 °C 100 µg 130
Fusion Protein , CD58, LFA-3, Ag3, Surface glycoProtein LFA-3 1 mg 850

Lymphocyte Function-Associated Antigen-3 Fusion Protein Recombinant Human is produced by recom-

binant DNA technology in a Chinese Hamster Ovary (CHO) mammalian cell expression system. The
molecular weight is 91.4 kDa.

PEPTIDES INTERNATIONAL
LIF (Leukemia Inhibitory Factor)
Leukemia Inhibitory Factor also called LIF is a lymphoid factor that promotes long-
term maintenance of embryonic stem cells by suppressing spontaneous differentiation.
Leukemia Inhibitory Factor has several functions such as cholinergic neuron dif feren-
tiation, control of stem cell pluripotency, bone & fat metabolism, mitogenesis of factor
dependent cell lines & promotion of megakaryocyte production in vivo. Human and
mouse LIF exhibit a 78% identity in its amino acid sequence.

LIF Human CYT-644 2 µg 30

Recombinant Human Leukemia Inhibitory Factor -20 °C 25 µg 130
CDF, HILDA, D-FACTOR, Differentiation- stimulating factor, 1 mg 2.520
Melanoma-derived LPL inhibitor, MLPLI, Emfilermin, Leukemia
inhibitory factor, LIF, DIA
SPLPITPVNA TCAIRHPCHN NLMNQIRSQL AQLNGSANAL FILYYTAQGE PFPNNLDKLC GPNVTDFP-
PF HANGTEKAKL VELYRIVVYL GTSLGNITRD QKILNPSALS LHSKLNATAD ILRGLLSNVL CRLCSKY-
HVG HVDVTYGPDT SGKDVFQKKK LGCQLLGKYK QIIAVLAQAF
Leukemia Inhibitory Factor (LIF) Human Recombinant produced in E.Coli is a single, non-glycosylated,
polypeptide chain containing 180 amino acids and having a molecular mass of 19.7kDa.

Order Hotline 1-800-777-4779 502-266-8787 437

 PRODUCT Code Qty PRICE
Recombinant proteins

mLIF CYT-645 2 µg 50
Recombinant Mouse Leukemia Inhibitory Factor -20 °C 10 µg 130
CDF, HILDA, D-FACTOR, Differentiation- stimulating factor, 1 mg 5,200
Melanoma-derived LPL inhibitor, MLPLI, Emfilermin, Leukemia
inhibitory factor, LIF, DIA
MSPLPITPVNATCAIRHPCHGNLMNQIKNQLAQLNGSANALFISYYTAQGEPFP NNVEKLCAP
NMTDFPSFHGNGTEKTKLVELYRMVAYLSASLTNITRDQKVLNP TAVSLQVKLNATIDVMRGLLSNVL-
CRLCNKYRVGHVDVPPVPDHSDKEAFQR KKLGCQLLGTYKQVISVVVQAF
Leukemia Inhibitory Factor (LIF) Murine Recombinant produced in E.Coli is a single, non-glycosylated,
polypeptide chain containing 181 amino acids and having a molecular mass of 20 kDa.

LIF GST CYT-001 2 µg 50

Recombinant Human Leukemia Inhibitory Factor, GST tag -20 °C 10 µg 130
D factor, MLPLI, HILDA, Emfilermin, Leukemia Inhibitory factor, 1 mg 5,200
Differentiation-stimulating factor, Melanoma-derived LPL
inhibitor
MHHHHHHMSP ILGYWKIKGL VQPTRLLLEY LEEKYEEHLY ERDEGDKWRN KKFELGLEFP NL-
PYYIDGDV KLTQSMAIIR YIADKHNMLG GCPKERAEIS MLEGAVLDIR YGVSRIAYSK DFETLKVDFL
SKLPEMLKMF EDRLCHKTYL NGDHVTHPDF MLYDALDVVL YMDPMCLDAF PKLVCFKKRI EAIPQ-
IDKYL KSSKYIAWPL QGWQATFGGG DHPPKSDLVP RGSHMSPLPI TPVNATCAIR HPCHNNLMNQ
IRSQLAQLNG SANALFILYY TAQGEPFPNN LDKLCGPNVT DFPPFHANGT EKAKLVELYR IVVYL-
GTSLG NITRDQKILN PSALSLHSKL NATADILRGL LSNVLCRLCS KYHVGHVDVT YGPDTSGKDV
FQKKKLGCQL LGKYKQIIAV LAQAF
LIF produced in E.Coli is a single, non-glycosylated polypeptide chain containing 415 amino acids (23-
202a.a.) and having a molecular mass of 47.2kDa.
PEPTIDES INTERNATIONAL

LIF Yeast CYT-191 5 µg 50

Recombinant Human Leukemia Inhibitory Factor, Yeast -20 °C 25 µg 130
CDF, HILDA, D-FACTOR, Differentiation- stimulating factor, 1 mg 3,600
Melanoma-derived LPL inhibitor, MLPLI, Emfilermin, Leukemia
inhibitory factor, LIF, DIA
SPLPITPVNATCAIRHPCHNNLMNQIRSQLAQLNGSANALFILYYTAQGEPFPNNLDKLCGPNVTDFPPF-
HANGTEKAKLVELYRIVVYLGTSLGNITRDQKILNPSALSLHSKLNATADILRGLLSNVLCRLCSKYHVGH-
VDVTYGPDTSGKDVFQKKKLGCQLLGKYKQIIAVLAQAF
LIF Human Recombinant produced in yeast is a single, glycosylated polypeptide chain containing 180
amino acids and having a molecular mass of 58.5 kDa.
Please prevent freeze-thaw cycles.

rLIF CYT-731 2 µg 50
Recombinant Rat Leukemia Inhibitory Factor, Leukemia -20 °C 10 µg 130
inhibitory factor, Cholinergic neuronal differentiation factor, Lif. 1 mg 5,200

SPLPITPVNA TCAIRHPCHG NLMNQIKSQL AQLNGSANAL FISYYTAQGE PFPNNVDKLC APNMTD-

FPPF HANGTEKTKL VELYRMVTYL GASLTNITWD QKNLNPTAVS LQIKLNATTD VMRGLLSSVL
CRLCNKYHVG HVDVPCVPDN SSKEAFQRKK LGCQLLGTYK QVISVLAQAF
Leukemia Inhibitory Factor (LIF) Rat Recombinant produced in E.Coli is a single, non-glycosylated, poly-
peptide chain containing 180 amino acids and having a molecular mass of 19.8 kDa.

438 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
MANF (Mesencephalic Astrocyte-derived Neurotrophic Factor)
MANF is a 20kDa protein which belongs to the ARMET family. MANF was originally
known as an arginine-rich region protein which was extremely mutated in a large num-
ber of tumors. MANF Expression is induced during ER stress, signifying that MANF
takes part in protein quality control during ER stress.

mANF, His CYT-133 5 µg 50

Recombinant Human Mesencephalic Astrocyte-Derived -20 °C 20 µg 130
Neurotrophic Factor, His Tag; Protein ARMET, ARP, arginine- 1 mg 2,700
rich mutated in early stage tumors, Arginine-rich Protein
MGSSHHHHHH SSGLVPRGSH MGSHMLRPGD CEVCISYLGR FYQDLKDRDV TFSPATIENE
LIKFCREARG KENRLCYYIG ATDDAATKII NEVSKPLAHH IPVEKICEKL KKKDSQICEL KYDKQIDLST
VDLKKLRVKE LKKILDDWGE TCKGCAEKSD YIRKINELMP KYAPKAASAR TDL
MANF Human Recombinant produced in E. coli is a single polypeptide chain containing 183 amino acids
(25-182) and having a molecular mass of 20.8kDa.

mANF CYT-141 5 µg 50
Recombinant Human Mesencephalic Astrocyte-Derived -20 °C 20 µg 130
Neurotrophic Factor; Protein ARMET, ARP, arginine-rich 1 mg 2,700
mutated in early stage tumors, Arginine-rich Protein
LRPGDCEVCI SYLGRFYQDL KDRDVTFSPA TIENELIKFC REARGKENRL CYYIGATDDA ATKIINEVSK
PLAHHIPVEK ICEKLKKKDS QICELKYDKQ IDLSTVDLKK LRVKELKKIL DDWGETCKGC AEKSDYIRKI
NELMPKYAPK AASARTDL
MANF Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing

PEPTIDES INTERNATIONAL
158 amino acids and having a molecular mass of 18.1 kDa.

MCSF (Macrophage Colony Stimulating Factor)

Granulocyte/Macrophage Colony-Stimulating Factors are cytokines that act in hemato-
poiesis by controlling the production, differentiation, and function of 2 related white cell
populations of the blood, the granulocytes and the monocytes-macrophages. MCSF
induces cells of the monocyte/macrophage lineage. MCSF plays a role in immunologi-
cal defenses, bone metabolism, lipoproteins clearance, fertility and pregnancy.
MCSF CYT-308 2 µg 50
Recombinant Human Macrophage Colony Stimulating Factor -20 °C 10 µg 130
Macrophage Colony Stimulating Factor, CSF-1, Lanimostim, 1 mg 4,680
MCSF, MGC31930, M-CSF
The sequence of the first five N-terminal amino acids of MCSF was determined and found to be Met-Glu-
Glu-Val-Ser
Macrophage Colony Stimulating Factor Human Recombinant produced in E.Coli is a disulfide linked ho-
modimer, non-glycosylated, polypeptide chain containing 2 x 159 amino acids and having a total molecular
mass of 36.8 KD.

Order Hotline 1-800-777-4779 502-266-8787 439

 PRODUCT Code Qty PRICE
Recombinant proteins

MCSF Baculovirus CYT-637 2 µg 50

Recombinant Human Macrophage Colony Stimulating Factor, -20 °C 10 µg 130
Baculovirus; CSF-1, Lanimostim, MCSF, MGC31930, M-CSF, 1 mg 4,680
Macrophage colony-stimulating factor 1, CSF1
EEVSEYCSHM IGSGHLQSLQ RLIDSQMETS CQITFEFVDQ EQLKDPVCYL KKAFLLVQDI MEDT-
MRFRDN TPNAIAIVQL QELSLRLKSC FTKDYEEHDK ACVRTFYETP LQLLEKVKNV FNETKNLLDK
DWNIFSKNCN NSFAECSSQ
Macrophage Colony Stimulating Factor Human Recombinant produced in Baculovirus is a disulfide linked
homodimer, glycosylated, polypeptide chain containing 2 x 149 amino acids and having a total molecular
mass of 42 kDa.

MCSF HEK CYT-106 2 µg 50

Recombinant Human Macrophage Colony Stimulating -20 °C 10 µg 130
Factor, HEK, Macrophage Colony Stimulating Factor, CSF-1, 1 mg 5,200
Lanimostim, MCSF, MGC31930, M-CSF
M-CSF Human Recombinant produced in HEK cells is a glycosylated homodimer, having a molecular
weight range of 35-40kDa due to glycosylation.

MCSF His CYT-695 5 µg 50

Recombinant Human Macrophage Colony Stimulating Factor, -20 °C 25 µg 130
His Tag; CSF-1, Lanimostim, MCSF, MGC31930, M-CSF 1 mg 2,250

MGSSHHHHHH SSGLVPRGSH MEEVSEYCSH MIGSGHLQSL QRLIDSQMET SCQITFEFVD QEQLK-

DPVCY LKKAFLLVQD IMEDTMRFRD NTPNAIAIVQ LQELSLRLKS CFTKDYEEHD KACVRTFYET
PLQLLEKVKN VFNETKNLLD KDWNIFSKNC NNSFAECSSQ DVVTKPDCN
Macrophage Colony Stimulating Factor Human Recombinant produced in E.Coli is a single, non-glyco-
PEPTIDES INTERNATIONAL

sylated, polypeptide chain containing 179 amino acids (33-190 a.a.) and having a total molecular mass of
20.7 kDa. MCSF is fused to a 20 amino acid His Tag at N-terminus.

mMCSF CYT-439 2 µg 50
Recombinant Mouse Macrophage Colony Stimulating Factor -20 °C 10 µg 130
CSF-1, Lanimostim, MCSF, M-CSF 1 mg 4,680
MKEVSEHCSH MIGNGHLKVL QQLIDSQMET SCQIAFEFVD QEQLDDPVCY LKKAFFLVQD IIDET-
MRFKD NTPNANATER LQELSNNLNS CFTKDYEEQN KACVRTFHET PLQLLEKIKN FFNETKNLLE
KDWNIFTKNC NNSFAKCSSR DVVTKP
Macrophage Colony Stimulating Factor Mouse Recombinant produced in E.Coli is a disulfide linked ho-
modimer, non-glycosylated, polypeptide chain containing 2 x 156 amino acids and having a total molecular
mass of 36.4 KD.

rMCSF CYT-046 2 µg 50
Recombinant Rat Macrophage Colony Stimulating Factor -20 °C 10 µg 130
CSF-1, Lanimostim, MCSF, MGC31930, M-CSF 1 mg 4,680
MCSF Rat Recombinant produced in HEK-293 cells is a secreted protein (amino acids Glu33-Arg254).
M-CSF is disulfide-linked homodimer containing 2 x 222 a.a chains.

440 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
MIF (Migration Inhibitory Factor)
The cytokine Macrophage migration inhibitory factor (MIF) has been identified to be
secreted by the pituitary gland and the monocyte/macrophage and to play an important
role in endotoxic shock. MIF has the unique property of being released from macro -
phages and T cells in response to physiological concentrations of glucocorticoids. The
secretion of MIF is tightly regulated and decreases at high, anti-inflammatory steroid
concentration.
MIF CYT-575 5 µg 50
Recombinant Human Macrophage Migration Inhibitor Factor -20 °C 25 µg 130
Phenylpyruvate tautomerase, Glycosylation-inhibiting factor, 1 mg 3,600
GIF, MMIF, MIF
MPMFIVNTNV PRASVPDGFL SELTQQLAQA TGKPPQYIAV HVVPDQLMAF GGSSEPCALC SLHSIG-
KIGG AQNRSYSKLL CGLLAERLRI  SPDRVYINYY DMNAANVGWN NSTFA
MIF human Recombinant was cloned into an E. coli expression vector and was purified to apparent homo-
geneity by using conventional column chromatography techniques. Macrophage Inducing Factor Human
Recombinant is a single, non-glycosylated, polypeptide chain containing 115 amino acids and having a
molecular mass of 12 kDa.

MIF (Active) CYT-596 2 µg 50

Recombinant Human Macrophage Migration Inhibitor Factor -20 °C 10 µg 130
Phenylpyruvate tautomerase, Glycosylation-inhibiting factor, 1 mg 4,680
GIF, MMIF, MIF
MPMFIVNTNVPRASVPDGFLSELTQQLAQATGKPPQYIAVHVVPDQLM AFGGSSEPCALCSLHSIGKIG-
GAQNRSYSKLLCGLLAERLRISPDRVY INYYDMNAANVGWNNSTFA

PEPTIDES INTERNATIONAL
MIF human Recombinant was cloned into an E.Coli expression vector and was purified to apparent homo-
geneity by using conventional column chromatography techniques. Macrophage Inducing Factor Human
Recombinant is a single, non-glycosylated, polypeptide chain containing 115 amino acids and having a
molecular mass of 12.5 kDa.

MIF His N CYT-431 5 µg 50

Recombinant Human Macrophage Migration Inhibitor -20 °C 25 µg 130
Factor, His Tag N-Terminus; Phenylpyruvate tautomerase, 1 mg 1,800
Glycosylation-inhibiting factor, GIF, MMIF, MIF
MRGSHHHHHHGMASMTGGQQMGRDLYDDDDKDRWGSMPMFIVNTNV PRASVPDGFL
SELTQQLAQA TGKPPQYIAV HVVPDQLMAF GGSSEPCALC LHSIGKIGGA QNRSYSKLLC GLLAERL-
RIS PDRVYINYYD MNAANVGWNN STFA
MIF human Recombinant, fused to His-tag at N-terminus, was cloned into an E. coli expression vector and
was purified to apparent homogeneity by using conventional column chromatography techniques.
Macrophage Inducing Factor Human Recombinant is a single, non-glycosylated, polypeptide chain having
amino acids from 1-114 and having a molecular mass of 16.6 kDa.

MIF His C CYT-521 5 µg 50

Recombinant Human Macrophage Migration Inhibitor -20 °C 25 µg 130
Factor, His Tag C-Terminus; Phenylpyruvate tautomerase, 1 mg 1,800
Glycosylation-inhibiting factor, GIF, MMIF, MIF
MPMFIVNTNVPRASVPDGFLSELTQQLAQATGKPPQYIAVHVVPDQLMAFGGSSEPCALCSLHSIGKIG-
GAQNRSYSKLLCGLLAERLRISPDRVYINYYDMNAANVGWNNSTFALEHHHHHH
MIF human Recombinant, fused to His-tag at C-terminus, was cloned into an E. coli expression vector and
was purified to apparent homogeneity by using conventional column chromatography techniques.
Macrophage Inducing Factor Human Recombinant is a single, non-glycosylated, polypeptide chaincontain-
ing 123 amino acidsand having a molecular mass of 13.5 kDa.

Order Hotline 1-800-777-4779 502-266-8787 441

 PRODUCT Code Qty PRICE
Recombinant proteins

mMIF CYT-744 5 µg 50
Recombinant Mouse Macrophage Migration Inhibitor Factor -20 °C 20 µg 130
Macrophage migration inhibitory factor, MIF, Delayed early 1 mg 2,700
response Protein 6, DER6, Glycosylation-inhibiting factor,
GIF, L-dopachrome isomerase, L-dopachrome tautomerase,
Phenylpyruvate tautomerase, Glif
MPMFIVNTNV PRASVPEGFL SELTQQLAQA TGKPAQYIAV HVVPDQLMTF SGTNDPCALC SLHSIG-
KIGG AQNRNYSKLL CGLLSDRLHI SPDRVYINYY DMNAANVGWN GSTFA
MIF Mouse Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 115
amino acids and having a molecular mass of 12.5kDa.

rMIF CYT-193 5 µg 50
Recombinant Rat Macrophage Migration Inhibitor Factor -20 °C 25 µg 130
Macrophage migration inhibitory factor, MIF, Glutathione- 1 mg 3,600
binding 13 kDa Protein, L-dopachrome isomerase,
L-dopachrome tautomerase, Phenylpyruvate tautomerase
MPMFIVNTNV PRASVPEGFL SELTQQLAQA TGKPAQYIAV HVVPDQLMTF SGTSDPCALC SLHSIG-
KIGG AQNRNYSKLL CGLLSDRLHI SPDRVYINYY DMNAANVGWN GSTF
MIF Rat Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 115
amino acids and having a molecular mass of 12.5kDa.

MIA (Melanoma Inhibitory Activity Protein)

The Melanoma Inhibitory protein (MIA) was identified as an inhibitor of in vitro growth
of malignant melanoma cells. The protein contains a SH3 domain.
MIA acts as a potent tumor cell growth inhibitor for malignant melanoma cells and
PEPTIDES INTERNATIONAL

some other neuroectodermal tumors, including gliomas, in an autocrine fashion. In a

study of human melanoma cell lines with different metastatic capacity MIA mRNA ex-
pression appeared to be inversely correlated with pigmentation. MIA has been shown
to represent a very sensitive and specific serum marker for systemic malignant mela-
noma that might be useful for staging of primary melanomas, detection of progres -
sion from localized to metastatic disease during follow-up, and monitoring therapy of
advanced melanomas.

MIA Human CYT-310 5 µg 50

Recombinant Human Melanoma Inhibitory Activity Protein -20 °C 20 µg 130
Melanoma-derived growth regulatory Protein precursor, 1 mg 3,800
Cartilage-derived retinoic acid-sensitive Protein, CD-RAP, MIA
MGPMPKLADRKLCADQECSSHPISMAVALQDYMAPDCRFLTIHRGQVV
YVFSLKGRGRFLWGGSVQGDYYGDLAARLGYFPSSIVREDQTLKVDVKT
DKWDFYCQ
Melanoma Inhibitory Activity Human Recombinant produced in E.Coli is a single, non-glycosylated, poly-
peptide chain consisting of 108 amino having a total molecular mass of 12237 Dalton.

442 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
MIA2 CYT-638 5 µg 50
Recombinant Human Melanoma Inhibitory Activity Protein 2 -20 °C 20 µg 130
MIA-2, MIA2, Melanoma Inhibitory Activity 2, FLJ22404 1 mg 2,700
MLESTKLLAD LKKCGDLECE ALINRVSAMR DYRGPDCRYL NFTKGEEISV YVKLAGERED LWAGSKG-
KEF GYFPRDAVQI EEVFISEEIQ MSTKESDFLC L
MIA2 Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain consisting
of 101 amino having a total molecular mass of 11.5 kDa.

Midkines
Midkine (MK) is the product of a retinoic acid responsive gene, MK, and is a member
of a family of heparin binding factors. It contains 121 amino acid residues including 10
conserved cysteine residues, all of which appear to be disulphide linked.
Midkine is expressed during embryogenesis, showing an expression pattern that sug-
gests functions in neurogenesis, cell migration, secondary organogenetic induction,
and mesoderm-epithelial interaction.
The widespread downregulation of MK in the adult human is reverted in a number of
cancers, in which polypeptides are able to act as both transforming growth factors and
promoters of angiogenesis.
Midkine (MK), induces chemotaxis of human neutrophils and was found to trigger mo-
bilization of intracellular calcium of these cells.
Midkine induces histamine release from rat peritoneal mast cells with a rapid response
in a dose dependent manner.

PEPTIDES INTERNATIONAL
Midkine is also a potent stimulator of collagen and glycosaminoglycan synthesis..
Midkine Human CYT-192 5 µg 50
Recombinant Human Midkine, NEGF-2, Neurite Growth- -20 °C 20 µg 130
Promoting Factor 2, MK, Neurite outgrowth-promoting Protein, 1 mg 2,700
Midgestation and kidney Protein, Amphiregulin-associated
Protein, ARAP, Neurite outgrowth-promoting factor 2,
FLJ27379, Midkine, MK1, NEGF2
VAKKKDKVKK GGPGSECAEW AWGPCTPSSK DCGVGFREGT CGAQTQRIRC RVPCNWKKEF
GADCKYKFEN WGACDGGTGT KVRQGTLKKA RYNAQCQETI RVTKPCTPKT KAKAKAKKGK GKD
Midkine Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing
123 amino acids and having a molecular mass of 13.4kDa.

Midkine, His CYT-444 5 µg 50

Recombinant Human Midkine, His Tag; NEGF-2, Neurite -20 °C 20 µg 130
Growth-Promoting Factor 2, MK, Neurite outgrowth-promoting 1 mg 2,700
Protein, Midgestation and kidney Protein, Amphiregulin-
associated Protein, ARAP, Neurite outgrowth-promoting factor
2, FLJ27379, Midkine, MK1, NEGF2
MKHHHHHHHM KKKDKVKKGG PGSECAEWAW GPCTPSSKDC GVGFREGTCG AQTQRIRCRV
PCNWKKEFGA DCKYKFENWG ACDGGTGTKV RQGTLKKARY NAQCQETIRV TKPCTPKTKA KAKAK-
KGKGK D
Midkine Human Recombinant is manufactured with N-terminal fusion of His Tag, having a molecular mass
of 14.6 kDa protein and containing 121 amino acid residues of the Midkine human and 10 additional amino
acid residues – His Tag (underlined).

Order Hotline 1-800-777-4779 502-266-8787 443

 PRODUCT Code Qty PRICE
Recombinant proteins

mMidkine CYT-178 5 µg 50
Recombinant Mouse Midkine, NEGF-2, Neurite Growth- -20 °C 20 µg 130
Promoting Factor 2, MK, Neurite outgrowth-promoting Protein, 1 mg 2,700
Midgestation and kidney Protein, Amphiregulin-associated
Protein, ARAP, Neurite outgrowth-promoting factor 2,
FLJ27379, Midkine, MK1, NEGF2
VAKKKEKVKK GSECSEWTWG PCTPSSKDCG MGFREGTCGA QTQRVHCKVP CNWKKEFGAD
CKYKFESWGA CDGSTGTKAR QGTLKKARYN AQCQETIRVT KPCTSKTKSK TKAKKGKGKD
Midkine Mouse Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing
120 amino acids and having a molecular mass of 13.3kDa.

rMidkine CYT-747 5 µg 50
Recombinant Rat Midkine, Midkine, MK, Mdk -20 °C 20 µg 130
1 mg 2,700
VAKKKDKVKK GSECSEWTWG PCTPSSKDCG MGFREGTCGA QTQRIHCKVP CNWKKEFGAD CKYK-
FESWGA CDGSTGTKAR QGTLKKARYN AQCQETIRVT KPCTSKTKSK AKAKKGKGKD
Midkine Rat Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing
120 amino acids and having a molecular mass of 13.2kDa.

MTPN (Myotrophin)
MTPN is an ankyrin repeat protein, that stimulates protein synthesis and cardiomyo -
cyte growth to commence cardiac hypertrophy by activating the NF-kappaB signaling
cascade. Myotrophin participates in cerebellar morphogenesis and takes part in dif -
ferentiation of cerebellar neurons, particularly of granule cells. High levels of MTPN
are expressed in human dilated cardiomyopathic and ischemic hearts.
PEPTIDES INTERNATIONAL

MTPN CYT-723 5 µg 50
Recombinant Human Myotrophin -20 °C 20 µg 130
Protein V-1, GCDP, Myotrophin, FLJ31098, FLJ99857 1 mg 2,700

MGSSHHHHHH SSGLVPRGSH MCDKEFMWAL KNGDLDEVKD YVAKGEDVNR TLEGGRKPLH

YAADCGQLEI LEFLLLKGAD INAPDKHHIT PLLSAVYEGH VSCVKLLLSK GADKTVKGPD GLTAFEATDN
QAIKALLQ
MTPN Recombinant Human produced in E.Coli is a single, non-glycosylated polypeptide chain containing
138 amino acids (1-118 a.a.) and having a molecular mass of 15 kDa. The MTPN is fused to 20 amino acid
His-Tag at N-terminus.

Myostatin
GDF8 is a member of the bone morphogenetic protein (BMP) family and the TGF-
beta superfamily. This group of proteins is characterized by a polybasic proteolytic
processing site which is cleaved to produce a mature protein containing seven con -
served cysteine residues. The members of this family are regulators of cell growth and
differentiation in both embryonic and adult tissues. This gene is thought to encode a
secreted protein which negatively regulates skeletal muscle growth.
Myostatin Human CYT-418 2 µg 50
Recombinant Human Myostatin, GDF-8, MSTN, Growth -20 °C 10 µg 130
Differentiation Factor 8, MSTN Muscle Hypertrophy 1 mg 4,680
The sequence of the first five N-terminal amino acids was determined and was found to be Asp-Phe-Gly-
Leu-Asp
Myostatin Human Recombinant produced in E.Coli is a homodimer, non-glycosylated polypeptide chain
containing 2 x 109 amino acids and having a total molecular mass of 24814 Dalton.

444 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
Myostatin His CYT-445 2 µg 50
Recombinant Human Myostatin, His-Tag; GDF-8, MSTN, -20 °C 10 µg 130
Growth/Differentiation Factor 8,MSTN Muscle Hypertrophy 1 mg 3,600

MRGSHHHHHH GMASMTGGQQ MGRDLYDDDD KDPSSRSAVR SRRDFGLDCD EHSTESRCCR

YPLTVDFEAFGWDWIIAPKR YKANYCSGEC EFVFLQKYPH THLVHQANPR GSAGPCCTPT KMSPIN-
MLYF NGKEQIIYGKIPAMVVDRCG CS
Total 152AA. M.W. 16.7kDa (calculated). N-terminal His-tag and spacer (43AA – highlighted). The AA
sequence of the human myostatin part of the fusion protein is corresponding to the UniProtKB/Swiss-Prot
entry O14793.

Myostatin Propetide CYT-448 5 µg 50

Recombinant Human Myostatin Propeptide, GDF-8, MSTN, -20 °C 25 µg 130
Growth Differentiation Factor 8, MSTN Muscle Hypertrophy 1 mg 4,680
MNENSEQKE NVEKEGLCNA CTWRQNTKSS RIEAIKIQIL SKLRLETAPN ISKDVIRQLL PKAPPLRELI
DQYDVQRDDS SDGSLEDDDY HATTETIITM PTESDFLMQV DGKPKCCFFK FSSKIQYNKV VKAQL-
WIYLR PVETPTTVFV QILRLIKPMK DGTRYTGIRS LKLDMNPGTG IWQSIDVKTV LQNWLKQPES
NLGIEIKALD ENGHDLAVTF PGPGEDGLNP FLEVKVTDTP KRSRR
Recombinant Human Myostatin Propeptide is a 27.8 kDa protein containing 244 amino acid residues of the
human Myostatin Propeptide

Myostatin Plant CYT-055 2 µg 50

Recombinant Human Myostatin, Plant; GDF-8, MSTN, Growth -20 °C 10 µg 130
Differentiation Factor 8, MSTN Muscle Hypertrophy 1 mg 5,200
HHHHHHDFGL DCDEHSTESR CCRYPLTVDF EAFGWDWIIA PKRYKANYCS GECEFVFLQK
YPHTHLVHQA NPRGSAGPCC TPTKMSPINM LYFNGKEQII YGKIPAMVVD RCGCS
Myostatin Human Recombinant produced in Nicotiana benthamiana plant is a single chain containing 115

PEPTIDES INTERNATIONAL
amino acids (molecular formula C586H865N165O164S12) and 6-His-tag at the N-terminal having the total
molecular mass of 13.2kDa.
Please prevent freeze-thaw cycles.

NENF (Neudesin Neurotrophic Factor)

Neudesin Neurotrophic Factor (NENF) is a member of the cytochrome b5 family ,
MAPR subfamily. NENF contains 1 cytochrome b5 heme-binding domain. NENF ex -
hibits neurotrophic activity and activates phosphorylation of MAPK1/ERK2, MAPK3/
ERK1 and AKT1/AKT in primary cultured neurons. NENF doesn’t have mitogenic ac -
tivity in primary cultured astrocytes. NENF may play a part in neuronal dif ferentiation
and may have a transient influence on neural cell proliferation in neural precursor cells.
NENF neurotrophic activity is increased by binding to heme. NENF is up-regulated
in immortal cells and induced in estrogen receptor positive breast cancer expressing
progesterone receptor.
NENF CYT-778 2 µg 50
Recombinant Human Neudesin Neurotrophic Factor, Neudesin, -20 °C 10 µg 130
Cell immortalization-related Protein 2, Neuron-derived 1 mg 5,200
neurotrophic factor, Secreted Protein of unknown function,
SPUF Protein, NENF, CIR2, SPUF, SCIRP1
MKHHHHHHASGQTPRPAERG PPVRLFTEEE LARYGGEEED QPIYLAVKGV VFDVTSGKEF YGRGA-
PYNAL TGKDSTRGVA KMSLDPADLT HDTTGLTAKE LEALDEVFTK VYKAKYPIVG YTARRILNED
GSPNLDFKPE DQPHFDIKDE F
NENF Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain (aa 32-
172) containing 151 amino acids including a 10 a.a N-terminal His tag.

Order Hotline 1-800-777-4779 502-266-8787 445

 PRODUCT Code Qty PRICE
Recombinant proteins

NGB (Neuroglobin)
Neuroglobin, 151 amino acid residue protein, mainly expressed in vertebrate brain
and retina, is a recently identified member of the globin superfamily. Augmenting O (2)
supply, neuroglobin promotes survival of neurons upon hypoxic injury, potentially limit-
ing brain damage. Moreover, neuroglobin may be a novel oxidative stress-responsive
sensor for signal transduction in the brain. Neuroglobin expression is increased by
neuronal hypoxia in vitro and focal cerebral ischemia in vivo, and neuronal survival
after hypoxia is reduced by inhibiting neuroglobin expression with an antisense oligo-
deoxynucleotide and enhanced by neuroglobin overexpression.
NGB Human CYT-450 2 µg 50
Recombinant Human Neuroglobin; NGB -20 °C 10 µg 130
1 mg 4,680

MERPEPELIR QSWRAVSRSP LEHGTVLFAR LFALEPDLLP LFQYNCRQFS SPEDCLSSPE FLD-

HIRKVML VIDAAVTNVE DLSSLEEYLA SLGRKHRAVG VKLSSFSTVG ESLLYMLEKC LGPAFTPATR
AAWSQLYGAV VQAMSRGWDG E
17kDa protein containing 151 amino acid residues of the Neuroglobin human.

NOV (Nephroblastoma Overexpressed)

Nephroblastoma Overexpressed (NOV) is a member of the CCN family of secreted
cysteine rich regulatory proteins. The full length NOV protein is comprised of 4 struc-
tural domains, which present distinct, and sometimes opposing, biological activities.
An elevated expression of NOV is linked with certain tumors, including Wilm’s tumor
PEPTIDES INTERNATIONAL

and most nephroblastomas. On the other hand, in other tumor types and certain can-
cer cell lines, increased tumorgenicity and proliferation is associated with decreased
NOV expression.

mNOV CYT-171 5 µg 50
Recombinant Mouse Nephroblastoma Overexpressed -20 °C 20 µg 130
Protein NOV homolog, NovH, CCN family member 3, 1 mg 3,500
Nephroblastoma-overexpressed gene Protein homolog, Nov,
Ccn3, C130088N23Rik
QVSASLRCPS RCPPKCPSIS PTCAPGVRSV LDGCSCCPVC ARQRGESCSE MRPCDQSSGL YC-
DRSADPNN QTGICMVPEG DNCVFDGVIY RNGEKFEPNC QYFCTCRDGQ IGCLPRCQLD VLLPG-
PDCPA PRKVAVPGEC CEKWTCGSDE QGTQGTLGGL ALPAYRPEAT VGVEVSDSSI NCIEQTTEWS
ACSKSCGMGV STRVTNRNRQ CEMVKQTRLC IVRPCEQEPE EVTDKKGKKC LRTKKSLKAI
HLQFENCTSL YTYKPRFCGV CSDGRCCTPH NTKTIQVEFQ CLPGEIIKKP VMVIGTCTCY SNCPQN-
NEAF LQDLELKTSR GEI
NOV Mouse Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing
333 amino acids and having a molecular mass of 36.4kDa.

446 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
NRG1 (Neuregulin)
Neuregulin/Heregulin is a family of structurally related polypeptide growth factors which
are stemmed from alternatively spliced genes (NRG1, NRG2, NRG3 and NRG4).Thus
far, there are more than 14 soluble and transmembrane proteins derived from the
NRG1 gene. Proteolytic processing of the extracellular domain of the transmembrane
NRG1 isoforms release soluble growth factors. HRG1-b1 is comprised of an Ig domain
and an EGF-like domain which is necessary for direct binding to receptor tyrosine
kinases erb3 and erb4. This binding stimulates erb3 and erb4 heterodimerization with
erb2, promoting intrinsic kinase activity, which results in tyrosine phosphorylation. Even
though HRG1-b1 biological effects are still unclear, it has been discovered to advance
motility and invasiveness of breast cancer cells which in addition might entail up-reg -
ulation of expression and function of the autocrine motility-promoting factor (AMF).
Neuregulin is a signaling protein for ErbB2/ErbB4 receptor heterodimers on the cardiac
muscle cells, playing an important role in heart structure and function through inducing
ErbB2/ErbB4 receptor phosphorylation and cardiomyocyte dif ferentiation. Research
on molecular level discovered that neuregulin recombinant could make disturbed myo-
cardial cell structure into order and strengthen the connection between myocardial
cells by intercalated discs re-organization. Pharmacodynamic experiments in animals
showed that neuregulin (NRG1) recombinant can reduce the degree of damage on
myocardial cells caused by ischemia, hypoxia and viral infection.
NRG1 CYT-407 10 µg 50
Recombinant Human Neuregulin-1/Heregulin-b2, Neuregulin-1, -20 °C 50 µg 130

PEPTIDES INTERNATIONAL
NRG1, GGF, HGL, HRGA, NDF, SMDF, HRG, ARIA, GGF2, HRG1 1 mg 1,350

shlvkcaekektfcvnggecfmvkdlsnpsrylckcpneftgdrcqnyvmasfykaeelyq
Recombinant Human Neuregulin-1 beta 2 produced in E.Coli is a single, non-glycosylated, polypeptide
chain containing 61 amino acids and having a total molecular mass of 7055 Dalton.

NRG1 B1 CYT-733 10 µg 50
Recombinant Human Neuregulin-1/Heregulin-b1; -20 °C 50 µg 130
SHLVKCAEKE KTFCVNGGEC FMVKDLSNPS RYLCKCPNEF 1 mg 1,350
TGDRCQNYVM ASFYKHLGIE FMEAE
Recombinant Human Neuregulin-1/Heregulin-b1 produced in E.Coli is a single, non-glycosylated, polypep-
tide chain (a.a 177-241) containing 65 amino acids and having a total molecular mass of 7.5kDa.

NRG1 A CYT-736 5 µg 50
Recombinant Human Neuregulin-1/Heregulin Α (EGF Domain) -20 °C 20 µg 130
Neuregulin-1, Heregulin Alpha, NRG1-A, NRG1 A 1 mg 2,700
SHLVKCAEKE KTFCVNGGEC FMVKDLSNPS RYLCKCQPGF TGARCTENVP MKVQNQEKAE ELYQK
Recombinant Human Neuregulin-1/Heregulin Alpha (EGF Domain) produced in E.Coli is a single, non-
glycosylated, polypeptide chain containing 65 amino acids and having a total molecular mass of 7.4kDa.

NRN1 CYT-789 5 µg 50
Recombinant Human Neuritin-1; Neuritin, NRN1, NRN, -20 °C 20 µg 130
dJ380B8.2 1 mg 2,700
AGKCDAVFKG FSDCLLKLGD SMANYPQGLD DKTNIKTVCT YWEDFHSCTV TALTDCQEGA KDMWD-
KLRKE SKNLNIQGSL FELCGSGN
Recombinant Human NRN1 produced in E.Coli cells is a non-glycosylated, homodimeric protein containing
2x88 amino acid chains and having a molecular mass of 19.4kDa.

Order Hotline 1-800-777-4779 502-266-8787 447

 PRODUCT Code Qty PRICE
Recombinant proteins

NT3 (Neurotrophin-3)
NT3 a member of the neurotrophin family , that controls survival and differentiation of
mammalian neurons. This protein is closely related to both nerve growth factor and
brain-derived neurotrophic factor. It may be involved in the maintenance of the adult
nervous system, and may affect development of neurons in the embryo when it is ex -
pressed in human placenta. NTF3-deficient mice generated by gene targeting display
severe movement defects of the limbs. The mature peptide of this protein is identical
in all mammals examined including human, pig, rat and mouse.

NT 3 CYT-257 2 µg 50
Recombinant Human Neurotrophin-3; Neurotrophic factor, -20 °C 10 µg 130
Nerve growth factor-2, NGF-2, HDNF, NT-3 1 mg 4,680
YAEHKSHRGE YSVCDSESLW VTDKSSAIDI RGHQVTVLGE IKTGNSPVKQ YFYETRCKEA
RPVKNGCRGI DDKHWNSQCK TSQTYVRALT SENNKLVGWR WIRIDTSCVC ALSRKIGRT
Neurotrophin-3 Human Recombinant produced in E.Coli is a non-glycosylated and non-covalently linked
homodimer, containing 2x119 amino acid chains, having a total Mw of 27.2 kDa.

proNT3 CYT-015 2 µg 50
Recombinant Human Precursor Neurotrophin-3 -20 °C 10 µg 130
Precursor Form Neurotrophin-3, proNT-3 1 mg 5,200
proNT3 Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain contain-
ing 239 amino acids and having a molecular mass of 27.4kDa.
proNT-3 (the precursor form of neurotrophin-3) functions through p75NTR and sortilin and induces neuro-
nal apoptosis. In contrast, mature NT-3 interacts with Trk receptors and selectively promotes the survival,
PEPTIDES INTERNATIONAL

growth and differentiation of neurons. Since axon retrograde transport is crucial for neurotrophin signaling,
proNT-3 also has an important role in the mechanism of retrograde signaling.

mNT 3 CYT-688 2 µg 50
Recombinant Mouse Neurotrophin-3 -20 °C 10 µg 130
Neurotrophic factor, Nerve growth factor-2, NGF-2, HDNF, NT-3, 1 mg 4,680
Neurotrophin-3, Ntf3, Ntf-3, AI316846, AI835689, Nt3
YAEHKSHRGE YSVCDSESLW VTDKSSAIDI RGHQVTVLGE IKTGNSPVKQ YFYETRCKEA
RPVKNGCRGI DDKHWNSQCK TSQTYVRALT SENNKLVGWR WIRIDTSCVC ALSRKIGRT
Neurotrophin-3 Mouse Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain
containing 119 amino acids and having a molecular mass of 13.6kDa.

NT 4 CYT-626 2 µg 50
Recombinant Human Neurotrophin-4 -20 °C 10 µg 130
NT4, NT5, NTF5, NT-4/5, NTF4, Neurotrophin-4, Neutrophic 1 mg 4,680
factor 4, Neurotrophin-5, NT-5
GVSETAPASR RGELAVCDAV SGWVTDRRTA VDLRGREVEV LGEVPAAGGS PLRQYFFETR
CKADNAEEGG PGAGGGGCRG VDRRHWVSEC KAKQSYVRAL TADAQGRVGW RWIRIDTACV
CTLLSRTGRA
Neurotrophin-4 Human Recombinant produced in E.Coli is a noncovalently linked homodimer, non-
glycosylated polypeptide chain containing 2 x 130 amino acids (81-210 amino acids) and having a total
molecular mass of 28 kDa.
NT-4 is part of the family of neurotrophic factors, neurotrophins, that are in charge for the survival and
differentiation of mammalian neurons. NT-4 expression is dominant and less influenced by environmental
signals. NT-4 deficient mice shows slight cellular deficits and develop normally to adulthood. NT-4 is a
target-derived survival factor for peripheral sensory sympathetic neurons.NT-4 is involved in the prolifera-
tion and differentiation of periodontal ligament cells.

448 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
Noggin
The secreted polypeptide noggin, encoded by the NOG gene, binds and inactivates
members of the transforming growth factor-beta (TGF-beta) superfamily signaling pro-
teins, such as bone morphogenetic protein-4 (BMP4). By diffusing through extracellu-
lar matrices more efficiently than members of the TGF-β superfamily, noggin may have
a principal role in creating morphogenic gradients. Noggin appears to have pleiotropic
effect, both early in development as well as in later stages. It was originally isolated
from Xenopus based on its ability to restore normal dorsal-ventral body axis in embryos
that had been artificially ventralized by UV treatment. The results of the mouse knock-
out of noggin suggest that it is involved in numerous developmental processes, such
as neural tube fusion and joint formation. Recently , several dominant human NOG
mutations in unrelated families with proximal symphalangism (SYM1) and multiple
synostoses syndrome (SYNS1) were identified; both SYM1 and SYNS1 have multiple
joint fusion as their principal feature, and map to the same region (17q22) as NOG. All
NOG mutations altered evolutionarily conserved amino acid residues. The amino acid
sequence of human noggin is highly homologous to that of Xenopus, rat and mouse.

Noggin Human CYT-475 5 µg 50

Recombinant Human Noggin; SYM1, SYNS1, NOG -20 °C 20 µg 130
1 mg 3,510
MQHYLHIRPAPSDNLPLVDLIEHPDPIFDPKEKDLNETLLRSLLGGHYDPGFMATSPP
EDRPGGGGGAAGGAEDLAELDQLLRQRPSGAMPSEIKGLEFSEGLAQGKKQRLSKKLR
RKLQMWLWSQTFCPVLYAWNDLGSRFWPRYVKVGSCFSKRSCSVPEGMVCKPSKSVHL
TVLRWRCQRRGGQRCGWIPIQYPIISECKCSC

PEPTIDES INTERNATIONAL
Noggin Human Recombinant produced in E.Coli is a non-glycosylated, non-disulfide-linked homodimer
consisting of two 206 amino acid polypeptide chains, having a total molecular mass of approximately 46.2
kDa (each chain 23.1 kDa).

Noggin HEK CYT-107 2 µg 50

Recombinant Human Noggin, HEK; SYM1, SYNS1, NOG -20 °C 10 µg 130
1 mg 5,200
Noggin Human Recombinant produced in HEK cells is a glycosylated homodimer, having a total molecular
weight of 65kDa

mNoggin CYT-600 5 µg 50
Recombinant Mouse Noggin; Noggin, SYM1, SYNS1, NOG -20 °C 20 µg 130
1 mg 3,510
MQHYLHIRPAPSDNLPLVDLIEHPDPIFDPKEKDLNETLLRSLLGGHYDPGFMATSPPEDRPGGGGG-
PAGGAEDLAELDQLLRQRPSGAMPSEIKGLEFSEGLAQGKKQRLSKKLRRKLQMWLWSQTFCPV-
LYAWNDLGSRFWPRYVKVGSCFSKRSCSVPEGMVCKPSKSVHLTVLRWRCQRRGQRCGWIPIQYPI-
ISECKCSC
Noggin Mouse Recombinant produced in E.Coli is a non-glycosylated, non-disulfide-linked homodimer
consisting of two 206 amino acid polypeptide chains, having a total molecular mass of approximately 46.2
kDa (each chain 23.1 kDa).

Order Hotline 1-800-777-4779 502-266-8787 449

 PRODUCT Code Qty PRICE
Recombinant proteins

NPPC (Natriuretic Peptide Precursor C)

NPPC is proteolytically managed to create a secreted hormone of the natriuretic pep -
tide family. NPPC is vasoactive and natriuretic and controls the evolution and differen-
tiation of cartilaginous growth plate chondrocytes
NPPC CYT-760 5 µg 50
Recombinant Human Natriuretic Peptide C; Natriuretic Peptide -20 °C 20 µg 130
Precursor C, C-Type Natriuretic Peptide, CNP2, CNP 1 mg 2,700
MGSSHHHHHH SSGLVPRGSH MGSKPGAPPK VPRTPPAEEL AEPQAAGGGQ KKGDKAPGGG
GANLKGDRSR LLRDLRVDTK SRAAWARLLQ EHPNARKYKG ANKKGLSKGC FGLKLDRIGS MSGLGC
NPPC Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing
126 amino acids (24-126) and having a molecular mass of 13.2kDa. NPPC is fused to a 23 amino acid
His-tag at N-terminus.

Omentin
Omentin is a recently recognized gene highly localized to the mental tissue (visceral
adipose tissue). Omentin is present in the stromal vascular cells in the adipose tis -
sue rather than in the adipocytes. Omentin is predominantly expressed in the visceral
adipose tissue than the subcutaneous tissue, with the omentin mRNAbeing 150 times
higher in the visceral adipose tissue. Omentin has also been detected in human blood
using western blot analysis, and seems to increase insulin-stimulated glucose uptake
in 3T3-L1 adipocytes in mice. Omentin seems to increase Akt phosphorylation irre-
spective of insulin presence. Its role in glucose metabolism and obesity remains to be
described; an insulin-sensitizing action is possible.Dif ferences in Omentin expression
PEPTIDES INTERNATIONAL

has been noted in adipose tissue from normals and patients with inflammatory bowel
disease although its significance is unknown.
Omentin Human CYT-301 2 µg 50
Recombinant HumanIATTRGWSTD
MNQLSFLLFL Omentin EANTYFKEWTCSSSPSLPRS CKEIKDECPS 10 µg
-20 °C AFDGLYFLRT ENGVIY- 130
Intelectin-1, HL1, LFR, HL-1, INTL,
QTFC DMTSGGGGWT ITLN, hIntL
LVASVHENDM RGKCTVGDRW SSQQGSKADY PEGDGNWANY 1 mgNTFG- 5,200
SAEAAT SDDYKNPGYY DIQAKDLGIW HVPNKSPMQH WRNSSLLRYR TDTGFLQTLG HNLFGIYQKY
PVKYGEGKCW TDNGPVIPVV YDFGDAQKTA SYYSPYGQRE FNNERAANAL CAGMRVTGCN
TEHHCIGGGG YFPEASPQQC GDFSGFDWSG YGTHVGYSSS REITEAAVLLFYR
Omentin Human Recombinant is produced in E.Coli by recombinant DNA technology is a single, polypep-
tide chain containing 313 amino acids and having a molecular mass of 35 kDa.

Omentin His CYT-551 2 µg 50

Recombinant Human Omentin His Tag -20 °C 10 µg 130
Intelectin-1, HL1, LFR, HL-1, INTL, ITLN, hIntL 1 mg 5,200
MRGSHHHHHH GMASTDEANT YFKEWTCSSS PSLPRSCKEI KDECPSAFDG LYFLRTENGV IYQT-
FCDMTS GGGGWTLVAS VHENDMRGKC TVGDRWSSQQ GSKAVYPEGD GNWANYNTFG SAEAATS-
DDY KNPGYYDIQA KDLGIWHVPN KSPMQHWRNS SLLRYRTDTG FLQTLGHNLF GIYQKYPVKY
GEGKCWTDNG PVIPVVYDFG DAQKTASYYS PYGQREFTAG FVQFRVFNNE RAANALCAGM
RVTGCNTEHH CIGGGGYFPE ASPQQCGDFS GFDWSGYGTH VGYS
Omentin Human Recombinant is produced in E.Coli by recombinant DNA technology is a single, polypep-
tide chain containing 294 amino acids and having a molecular mass of 32.7 kDa. Recombinant Human
Omentin contains His tag fused at N-Terminus.

450 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
Omentin 298 a.a. CYT-061 5 µg 50
Recombinant Human Omentin 298 a.a. -20 °C 20 µg 130
Intelectin-1, HL1, LFR, HL-1, INTL, ITLN, hIntL 1 mg 2,700
MWSTDEANTY FKEWTCSSSP SLPRSCKEIK DECPSAFDGL YFLRTENGVI YQTFCDMTSG GGGWTL-
VASV HENDMRGKCT VGDRWSSQQG SKAVYPEGDG NWANYNTFGS AEAATSDDYK NPGYYDIQAK
DLGIWHVPNK SPMQHWRNSS LLRYRTDTGF LQTLGHNLFG IYQKYPVKYG EGKCWTDNGP VIPV-
VYDFGD AQKTASYYSP YGQREFTAGF VQFRVFNNER AANALCAGMR VTGCNTEHHC IGGGGYFPEA
SPQQCGDFSG FDWSGYGTHV GYSSSREITE AAVLLFYR
Omentin Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain contain-
ing 298 amino acids (17-313) and having a molecular mass of 33.2 kDa.
Avoid multiple freeze-thaw cycles.

OPG (Osteoprotegerin)
Osteoprotegerin, which is a member of the tumor necrosis factor receptor superfamily
and is involved in the regulation of bone metabolism. OPGand its ligand (OPGL) are
cytokines regulating osteoclasto-genesis. OPGL binds to receptors on the surface of
preosteoclasts and stimulates their dif ferentiation into active osteoclasts. This leads
to osteoresorption. OPG inhibits this osteoclasto-genesis (OPG is secreted by osteo -
blasts, and binds to OPGL, thus inhibiting maturation of osteoclasts and osteoresorp -
tion). The degree and activity of osteoresorption depend mainly on the balance be -
tween OPG and its ligand (OPGL); factors increasing OPGLexpression mostly reduce
OPG expression and vice versa.
Osteoprotegerin acts as decoy receptor for rankl and thereby neutralizes its function
in osteoclastogenesis. OPG inhibits the activation of osteoclasts and promotes osteo-

PEPTIDES INTERNATIONAL
clast apoptosis in vitro. Bone homeostasis seems to depend on the local rankl/opg
ratio. Osteoprotegerin may also play a role in preventing arterial calcification. May act
as decoy receptor for trail and protect against apoptosis.Trail binding blocks the inhibi-
tion of osteoclastogenesis..
OPG Fc CYT-266
10 µg 50
Recombinant Human Osteoprotegerin/Fc Chimera 50 µg -20 °C130
1 mg 1,350
AA Sequence: OPG 22-201: ETFPPKYLHYDEETSHQLLCDKCPPGTYLKQHCTAKWKTVCAPCPDHYY
TDSWHTSDECLYCSPVCKELQYVKQECNRTHNRVCECKEGRYLEIEFCL
KHRSCPPGFGVVQAGTPERNTVCKRCPDGFFSNETSSKAPCRKHTNCS
VFGLLLTQKGNATHDNICSGNSESTQKCGIDVTL
Fc232: EPKSSDKTHTCPPCPAPEFEGAPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKF-
NWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPTPIEKTISKAK-
GQREPQVYTLPPSRDELTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLT-
VDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPGK
Recombinant OPG produced in yeast contains 412 amino acid residues, including 180 residues from
mature OPG (a.a 22-201) and 232 residues from the Fc protein of human IgG1, and has a calculated
molecular mass of 46.5 kDa. As a result of glycosylation, the recombinant Osteoprotegrin migrates as a 49
kDa protein in SDS-PAGE under reducing conditions.

Order Hotline 1-800-777-4779 502-266-8787 451

 PRODUCT Code Qty PRICE
Recombinant proteins

OPG Human CYT-177 10 µg 50

Recombinant Human Osteoprotegerin -20 °C 50 µg 130
TNFRSF11B, OPG, OCIF, Osteoclastogenesis inhibitory factor, 1 mg 1,350
Osteoprotegerin, TR1, MGC29565
METFPPKYLH YDEETSHQLL CDKCPPGTYL KQHCTAKWKT VCAPCPDHYY TDSWHTSDEC LYC-
SPVCKEL QYVKQECNRT HNRVCECKEG RYLEIEFCLK HRSCPPGFGV VQAGTPERNT VCKRCP-
DGFF SNETSSKAPC RKHTNCSVFG LLLTQKGNAT HDNICSGNSE STQK
Recombinant Human Osteoprotegerin produced in E.Coli cells is a single, non-glycosylated, polypeptide
chain containing 174 amino acids and having a molecular mass of 20kDa.

OPG His CYT-290 10 µg 50

Recombinant Human Osteoprotegerin, His Tag; TNFRSF11B, -20 °C 50 µg 130
OPG, OCIF, Osteoclastogenesis inhibitory factor, TR1, 1 mg 2,400
MGC29565
Recombinant Human OCIF produced in E.Coli cells is a single, non-glycosylated, polypeptide chain con-
taining amino acids 201-401 and having a molecular mass of 31 kDa which includes a 4 kDa His tag.

OPG Hi-5 CYT-633 2 µg 50

Recombinant Human Osteoprotegerin Hi-5; TNFRSF11B, OPG, -20 °C 10 µg 130
OCIF, Osteoclastogenesis inhibitory factor, Osteoprotegerin, 100 µg 1,200
TR1, MGC29565
ADPETFPPKY LHYDEETSHQ LLCDKCPPGT YLKQHCTAKW KTVCAPCPDH YYTDSWHTSD ECLYC-
SPVCK ELQYVKQECN RTHNRVCECK EGRYLEIEFC LKHRSCPPGF GVVQAGTPER NTVCKRCPDG
FFSNETSSKA PCRKHTNCSV FGLLLTQKGN ATHDNICSGN SESTQKCGID VTLCEEAFFR FAVPT-
KFTPNWLSVLVDNLP GTKVNAESVE RIKRQHSSQE QTFQLLKLWK HQNKDQDIVK KIIQDIDLCE
NSVQRHIGHA NLTFEQLRSL MESLPGKKVG AEDIEKTIKACKPSDQILKL LSLWRIKNGD QDTLKGLMHA
PEPTIDES INTERNATIONAL

LKHSKTYHFP KTVTQSLKKT IRFLHSFTMY KLYQKLFLEM IGNQVQSVKI SCLSGRLVPR GSHHHHHH

Recombinant Osteoprotegerin produced in baculovirus is a signle, glycosylated polypeptide chain
containing 398 amino acid residues (22-401 a.a.), having a calculated molecular mass of 45.6 kDa. The
Osteoprotegerin is fused to 17 amino acid His tag at C-terminus.

OSM (Oncostatin M)
Oncostatin M is a member of a cytokine family that includes leukemia-inhibitory factor,
granulocyte colony-stimulating factor, and interleukin 6. This gene encodes a growth
regulator which inhibits the proliferation of a number of tumor cell lines. It regulates
cytokine production, including IL-6, G-CSF and GM-CSF from endothelial cells.
Osteoprotegerin acts as decoy receptor for rankl and thereby neutralizes its function
in osteoclastogenesis. OPG inhibits the activation of osteoclasts and promotes osteo-
clast apoptosis in vitro. Bone homeostasis seems to depend on the local rankl/opg
ratio. Osteoprotegerin may also play a role in preventing arterial calcification. May act
as decoy receptor for trail and protect against apoptosis.Trail binding blocks the inhibi-
tion of osteoclastogenesis..
OSM Human CYT-231 2 µg 50
Recombinant Human Oncostatin-M -20 °C 10 µg 130
1 mg 4,680
AAIGSCSKEY RVLLGQLQKQ TDLMQDTSRL LDPYIRIQGL DVPKLREHCRERPGAFPSEE TLRGL-
GRRGF LQTLNATLGC VLHRLADLEQ RLPKAQDLERSGLNIEDLEK LQMARPNILG LRNNIYCMAQ
LLDNSDTAEP TKAGRGASQPPTPTPASDAF QRKLEGCRFL HGYHRFMHSV GRVFSKWGES
PNRSRRHSPHQALRKGVRRT RPSRKGKRLM TRGQLPR
Oncostatin-M Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain
containing 227 amino acids and having a molecular mass of 26kDa.

452 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
OSM (209 a.a.) CYT-639 2 µg 50
Recombinant Human Oncostatin-m (209 a.a.) -20 °C 10 µg 130
OSM, MGC20461, Oncostatin M 1 mg 4,680
AAIGSCSKEYRVLLGQLQKQTDLMQDTSRLLDPYIRIQGLDVPKLREHCRERPGAFPSEETLRGLGRRG-
FLQTLNATLGCVLHRLADLEQRLPKAQDLERSGLNIEDLEKLQMARPNILGLRNNIYCMAQLLDNSDTA-
EPTKAGRGASQPPTPTPASDAFQRKLEGCRFLHGYHRFMHSVGRVFKWGESPNRSRRHSPHQALRK-
GVRR
Oncostatin-M (209 a.a.) Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide
chain containing 209 amino acids and having a molecular mass of 23.9kDa.

OSM (195 a.a.) CYT-735 2 µg 50

Recombinant Human Oncostatin-M (195 a.a.) -20 °C 10 µg 130
OSM, MGC20461, Oncostatin M 1 mg 4,680
AAIGSCSKEY RVLLGQLQKQ TDLMQDTSRL LDPYIRIQGL DVPKLREHCR ERPGAFPSEE TLRGL-
GRRGF LQTLNATLGC VLHRLADLEQ RLPKAQDLER SGLNIEDLEK LQMARPNILG LRNNIYCMAQ
LLDNSDTAEP TKAGRGASQP PTPTPASDAF QRKLEGCRFL HGYHRFMHSV GRVFSKWGES PNRSR
Oncostatin-M Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain
containing 195 amino acids and having a molecular mass of 22kDa.

OSm, His CYT-060 5 µg 50

Recombinant Human Oncostatin-m, His Tag -20 °C 20 µg 130
OSM, MGC20461 1 mg 2,700
MGSSHHHHHH SSGLVPRGSH MAAIGSCSKE YRVLLGQLQK QTDLMQDTSR LLDPYIRIQG LD-
VPKLREHC RERPGAFPSE ETLRGLGRRG FLQTLNATLG CVLHRLADLE QRLPKAQDLE RSGL-
NIEDLE KLQMARPNIL GLRNNIYCMA QLLDNSDTAE PTKAGRGASQ PPTPTPASDA FQRKLEGCRF
LHGYHRFMHS VGRVFSKWGE SPNRSRRHSP HQALRKGVRR

PEPTIDES INTERNATIONAL
OSM Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing
230 amino acids (26-234) and having a molecular mass of 25.9 kDa. The OSM is fused to a 21 amino
acid His-Tag at N-terminus.

OSm HEK CYT-108 2 µg 50

Recombinant Human Oncostatin-m, HEK -20 °C 10 µg 130
OSM, MGC20461 1 mg 5,200
Oncostatin-M Human Recombinant produced in HEK cells is a glycosylated monomer, having a total
molecular weight of 30kDa.

mOSm CYT-168 2 µg 50
Recombinant Mouse Oncostatin-m -20 °C 10 µg 130
Oncostatin-M, OSM, OncoM 1 mg 4,680

NRGCSNSSSQ LLSQLQNQAN LTGNTESLLE PYIRLQNLNT PDLRAACTQH SVAFPSEDTL RQL-

SKPHFLS TVYTTLDRVL YQLDALRQKF LKTPAFPKLD SARHNILGIR NNVFCMARLL NHSLEIPEPT
QTDSGASRST TTPDVFNTKI GSCGFLWGYH RFMGSVGRVF REWDDGSTRS R
OSM Mouse Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing
181 amino acids and having a molecular mass of 20.4kDa.

rOSm CYT-169 2 µg 50
Recombinant Rat Oncostatin-m, Oncostatin-M, OSM, OncoM -20 °C 10 µg 130
1 mg 4,680
KRGCSSSSPK LLSQLKSQAN ITGNTASLLE PYILHQNLNT LTLRAACTEH PVAFPSEDML RQLSKPD-
FLS TVHATLGRVW HQLGAFRQQF PKIQDFPELE RARQNIQGIR NNVYCMARLL HPPLEIPEPT QADS-
GTSRPT TTAPGIFQIK IDSCRFLWGY HRFMGSVGRV FEEWGDGSRR SR RHSPLWAW LKGDHRIRPS
RSSQSAMLRS LVPR
OSM Rat Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 214
amino acids and having a molecular mass of 24.3kDa.

Order Hotline 1-800-777-4779 502-266-8787 453

 PRODUCT Code Qty PRICE
Recombinant proteins

OSTF1 CYT-630 10 µg 50
Recombinant Human Osteoclast Stimulating Factor-1 -20 °C 50 µg 130
SH3P2, OSF, OSTF-1, Osteoclast-stimulating factor 1, OSTF1, 1 mg 1,800
FLJ20559, bA235O14.1
MSKPPPKPVK PGEGGQVKVF RALYTFEPRT PDELYFEEGD IIYITDMSDT NWWKGTSKGR TGLIP-
SNYVA EQAESIDNPL HEAAKRGNLSWLRECLDNRV GVNGLDKAGS TALYWACHGG HKDIVEMLFT
QPNIELNQQN KLGDTALHAA AWKGYADIVQ LFLAKGARTD LRNIEKKLAF DMATNAACAS LLKKKQGT-
DA VRTLSNAEDY LDDEDSDLEH HHHHH
OSTF1 Human Recombinant produced in E.Coli is a monomeric, non-glycosylated, polypeptide chain
containing 222 amino acids (1-214) and having a molecular mass of 25.1 kDa. The OSTF1 is fused to 8
amino acid His Tag at C-terminus

OTOR CYT-582 5 µg 50
Recombinant Human Otoraplin; Otoraplin, Fibrocyte-derived -20 °C 20 µg 130
Protein, Melanoma inhibitory activity-like Protein, OTOR, MIAL, 1 mg 3,510
FDP, MIAL1, MGC126737, MGC126739
VHGIFMDRLASKKLCADDECVYTISLASAQEDYNAPDCRFINVKKGQQIYVYSKLVKENGAGEFWAGS-
VYGDGQDEMGVVGYFPRNLVKEQRVYQEATKEVPTTDIDFFCE
Otoraplin Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain contain-
ing 111 amino acids and having a molecular mass of 12.7 kDa.

PDGF AA (Platelet Derived Growth Factor-AA)

PDGF-AA, PDGF-BB and PDGF-AB, are potent mitogens for a variety of cell types
including smooth muscle cells, connective tissue cells, bone and cartilage cells, and
some blood cells. The PDGF is stored in platelet alpha-granules and released upon
PEPTIDES INTERNATIONAL

platelet activation. The PDGF is involved in a number of biological processes, includ-

ing hyperplasia, chemotaxis, embryonic neuron development, and respiratory tubule
epithelial cell development. Two distinct signaling receptors used by PDGF have been
identified and named PDGFR-α and PDGFR-β. PDGFR-α is high-affinity receptor
for each of the three PDGF forms. On the other hand, PDGFR-β interacts with only
PDGF-BB and PDGF-AB
PDGF AA Human CYT-341 2 µg 50
Recombinant Human Platelet Derived Growth Factor-AA -20 °C 10 µg 130
Glioma- growth factor, GDGF, Osteosarcoma-derived Growth 1 mg 3,510
Factor, ODGF, PDGF-AA, PDGF-1
SIEEAVPAVC KTRTVIYEIP RSQVDPTSAN FLIWPPCVEV KRCTGCCNTS SVKCQPSRVH HRSVK-
VAKVE YVRKKPKLKE VQVRLEEHLE CACATTSLNP DYREEDTGRP RESGKKRKRK RLKPT
Platelet-Derived Growth Factor AA Human Recombinant is a homodimeric, non-glycosylated, polypeptide
chain containing 2 x 125 amino acids and having a total molecular mass of 28511 Dalton.

PDGF AA Yeast CYT-568 2 µg 50

Recombinant Human Platelet Derived Growth Factor-AA, Yeast -20 °C 10 µg 130
Glioma-derived growth factor, GDGF, Osteosarcoma-derived 1 mg 4,680
Growth Factor, ODGF, PDGF-AA, PDGF-1
PDGF-AA Human Recombinant produced in Yeast is a homodimeric, glycosilated, polypeptide chain
containing 2 x 110 amino acids and having a total molecular mass of 34 kDa.

454 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
PDGF AA HEK CYT-109 2 µg 50
Recombinant Human Platelet Derived Growth Factor-AA HEK -20 °C 10 µg 130
Glioma-derived growth factor, GDGF, Osteosarcoma-derived 1 mg 5,200
Growth Factor, ODGF, PDGF-AA, PDGF-1
PDGF-AA Human Recombinant produced in HEK cells is a glycosylated homodimer, having a molecular
weight range of 35-45kDa due to glycosylation.

PDGF A Human CYT-491 5 µg 50

Recombinant Human Platelet Derived Growth Factor-A -20 °C 20 µg 130
Glioma-derived growth factor, GDGF, Osteosarcoma-derived 1 mg 2,600
Growth Factor, ODGF, PDGF-A, PDGF-1
Platelet-Derived Growth Factor A Human Recombinant short chain produced in E.Coli is a non-glycosylat-
ed, polypeptide chain containing 110 amino acids fragment (87-196) and having a total Mw of 17.02kDa,
with an amino-terminal hexahistidine tag.

mPDGF AA CYT-590 2 µg 50
Recombinant Mouse Platelet Derived Growth Factor-AA -20 °C 10 µg 130
Glioma-derived growth factor, GDGF, Osteosarcoma-derived 1 mg 3,510
Growth Factor, ODGF, PDGF-AA, PDGF-1
MSIEEAVPAV CKTRTVIYEI PRSQVDPTSA NFLIWPPCVE VKRCTGCCNT SSVKCQPSRV HHRSVK-
VAKV EYVRKKPKLK EVQVRLEEHL ECACATSNLN PDHREEETGR RRESGKNRKR KRLKPT
PDGF-AA Mouse Recombinant is a disulfide linked homodimeric, non-glycosylated, polypeptide chain
containing 2 x 126 amino acids and having a total molecular mass of 28.9 kDa

rPDGF AA CYT-776 2 µg 50
Recombinant Rat Platelet Derived Growth Factor-AA; Platelet- -20 °C 10 µg 130
1 mg 3,510

PEPTIDES INTERNATIONAL
derived growth factor subunit A, PDGF subunit A, PDGF-1,
Platelet-derived growth factor A chain, Platelet-derived growth
factor α polypeptide, Pdgfa, Rpa1
MSIEEAIPAV CKTRTVIYEI PRSQVDPTSA NFLIWPPCVE VKRCTGCCNT SSVKCQPSRV HHRSVK-
VAKV EYVRKKPKLK EVQVRLEEHL ECACATSNLN PDHREEETDV R
Platelet-derived Growth Factor AA Human Recombinant is a disulfide-linked homodimer Consists of two A
chains containing 111 amino acids each and having a total molecular mass of 25.3KDa.

PDGF AB CYT-342 2 µg 50
Recombinant Human Platelet Derived Growth Factor-AB -20 °C 10 µg 130
Glioma-derived growth factor, GDGF, Osteosarcoma-derived 1 mg 3,510
Growth Factor, ODGF, PDGF-AB
The sequence of the first five N-terminal amino acids was determined and was found to be Met-Ser-Ile-
Glu-Glu-alpha chain and Met-Ser-Leu-Gly-Ser-β chain
Platelet-Derived Growth Factor AB Human Recombinant is a heterodimeric, non-glycosylated, polypeptide
chain containing 234 amino acids consisting of 13.3kDa alpha-chain and 12.2 beta-chain having a total
molecular mass of 25.5kDa.

Order Hotline 1-800-777-4779 502-266-8787 455

 PRODUCT Code Qty PRICE
Recombinant proteins

PDGF BB CYT-501 2 µg 50
Recombinant Human Platelet Derived Growth Factor-BB -20 °C 10 µg 130
Glioma-derived growth factor, GDGF, Osteosarcoma-derived 1 mg 3,510
Growth Factor, ODGF, SIS, SSV, PDGF2, c-sis, FLJ12858,
PDGF-BB, PDGF B-chain, Platelet-derived growth factor β
polypeptide, Becaplermin
SLGSLTIAEP AMIAECKTRT EVFEISRRLI DRTNANFLVW PPCVEVQRCS GCCNNRNVQC RPTQVQL-
RPV QVRKIEIVRK KPIFKKATVT LEDHLACKCE TVAAARPVT
Platelet-Derived Growth Factor BB Human Recombinant is a homodimeric, non-glycosylated, polypeptide
chain containing 2x109 amino acids (218 amino acids in total) and having a molecular mass of 24.3 kDa.

PDGF B CYT-492 5 µg 50
Recombinant Human Platelet Derived Growth Factor-B -20 °C 20 µg 130
Glioma-derived growth factor, GDGF, Osteosarcoma-derived 1 mg 2,600
Growth Factor, ODGF, SIS, SSV, PDGF2, c-sis, FLJ12858,
PDGF-BB, PDGF B-chain, Platelet-derived growth factor β
polypeptide, Becaplermin
PDGF-B Human Recombinant mature chain produced in E.Coli is a non-glycosylated, polypeptide chain
containing 109 amino acids fragment (82-190) and having a molecular mass of 16.75 kDa. The PDGF-B is
fused with an amino-terminal hexahistidine tag.

PDGF BB Yeast CYT-242 2 µg 50

Recombinant Human Platelet Derived Growth Factor-BB, Yeast -20 °C 10 µg 130
Glioma-derived growth factor, GDGF, Osteosarcoma-derived 1 mg 3,510
Growth Factor, ODGF, SIS, SSV, PDGF2, c-sis, FLJ12858,
PDGF-BB, PDGF B-chain, Platelet-derived growth factor β
PEPTIDES INTERNATIONAL

polypeptide, Becaplermin
The sequence of the first five N-terminal amino acids was determined and was found to be Ser-Leu-Gly-
Ser-Leu
Platelet-Derived Growth Factor BB Human Recombinant is a glycosylated homodimer produced in Sac-
charomyces cerevisiae, containing 2x109 amino acids and having a molecular mass of 32kDa.

mPDGF BB CYT-412 2 µg 50
Recombinant Mouse Platelet Derived Growth Factor-BB -20 °C 10 µg 130
Glioma-derived growth factor, GDGF, Osteosarcoma-derived 1 mg 3,510
Growth Factor, ODGF, SIS, SSV, PDGF2, c-sis, FLJ12858,
PDGF-BB, PDGF B-chain, Platelet-derived growth factor β
polypeptide, Becaplermin
The sequence of the first five N-terminal amino acids was determined and was found to be Met-Ser-Leu-
Gly-Ser
Platelet-Derived Growth Factor BB Mouse Recombinant produced in E.Coli, is a homodimeric, non-
glycosylated, polypeptide chain containing 2x109 (total of 2 chains 218aa) amino acids and having a total
molecular weight of 24.6 kDa.

456 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
rPDGF BB CYT-740 2 µg 50
Recombinant Rat Platelet Derived Growth Factor-BB; Platelet- -20 °C 10 µg 130
derived growth factor subunit B, PDGF subunit B, PDGF-2, 1 mg 3,510
Platelet-derived growth factor B chain, Platelet-derived growth
factor β polypeptide, Pdgfb, SIS, c-sis
SLGSLAAAEP AVIAECKTRT EVFQISRNLI DRTNANFLVW PPCVEVQRCS GCCNNRNVQC RASQVQM-
RPV QVRKIEIVRK KPVFKKATVT LEDHLACKCE TVVTPRPVT
PDGF-BB Rat Recombinant produced in E.Coli is a disulfide-linked homodimeric, non-glycosylated, poly-
peptide of two B chains containing 2x109 amino acids (218 amino acids in total) and having a molecular
mass of 24.4 kDa.

PDGFD CYT-155 5 µg 50
Recombinant Human Platelet Derived Growth Factor-D -20 °C 20 µg 130
Platelet Derived Growth Factor D, Spinal Cord-Derived Growth 1 mg 2,700
Factor B, Iris-Expressed Growth Factor, SCDGF-B, IEGF,
PDGF-D, MSTP036
MGSSHHHHHH SSGLVPRGSH MGSHMSYHDR KSKVDLDRLN DDAKRYSCTP RNYSVNIREE LKLAN-
VVFFP RCLLVQRCGG NCGCGTVNWR SCTCNSGKTV KKYHEVLQFE PGHIKRRGRA KTMALVDIQL
DHHERCDCIC SSRPPR
PDGFD Human Recombinant produced in E. coli is a single polypeptide chain containing 146 amino
acids (250-370) and having a molecular mass of 16.6 kDa. PDGFD is fused to a 25 amino acid His-tag at
N-terminus.

PDGFRA CYT-065 1 µg 50
Recombinant Human Platelet-Derived Growth Factor Receptor, -20 °C 5 µg 130
Α; Platelet-derived growth factor receptor α polypeptide, 50 µg 1,200

PEPTIDES INTERNATIONAL
PDGFR2, PDGF-R-alpha, CD140 antigen-like family member A,
CD140a antigen, α-type platelet-derived growth factor receptor,
RHEPDGFRA, rearranged-in-hypereosinophilia-platelet
derived growth factor receptor α, PDGFRA/BCR fusion Protein,
MGC74795, EC 2.7.10.1
MGSSHHHHHH SSGLVPRGSH MQLSLPSILP NENEKVVQLN SSFSLRCFGE SEVSWQYPMS EEESS-
DVEIR NEENNSGLFV TVLEVSSASA AHTGLYTCYY NHTQTEENEL EGRHIYIYVP DPDVAFVPLG
MTDYLVIVED DDSAIIPCRT TDPETPVTLH NSEGVVPASY DSRQGFNGTF TVGPYICEAT VKGK-
KFQTIP FNVYALKATS ELDLEMEALK TVYKSGETIV VTCAVFNNEV VDLQWTYPGE VKGKGITMLE
EIKVPSIKLV YTLTVPEATV KDSGDYECAA RQATREVKEM KKVTISVHEK GFIEIKPTFS QLEAVNLHEV
KHFVVEVRAY PPPRISWLKN NLTLIENLTE ITTDVEKIQE IRYRSKLKLI RAKEEDSGHY TIVAQNEDAV
KSYTFELLTQ VPSSILDLVD DHHGSTGGQT VRCTAEGTPL PDIEWMICKD IKKCNNETSW TILANNVSNI
ITEIHSRDRS TVEGRVTFAK VEETIAVRCL AKNLLGAENR ELKLVAPTLR SE
PDGFRa is a cell surface tyrosine kinase receptor for PDGF family members. PDGFRa binds to both A
and B subunits of PDGF. It is known that PDGFRa is vital for kidney development since mice heterozygous
for the receptor display defective kidney phenotypes.
PDGFRA Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain contain-
ing 522 amino acids (24-524) and having a molecular mass of 58.4 kDa. The PDGFRA is fused to a 20
amino acid His-Tag at N-terminus.

Order Hotline 1-800-777-4779 502-266-8787 457

 PRODUCT Code Qty PRICE
Recombinant proteins

PEDF (Pigment Epithelium-Derived Factor)

PEDF is a noninhibitory serpin with neurotrophic, anti-angiogenic, and anti-tumorigenic
properties. PEDF is a 50,000 dalton glycoprotein created and secreted in many tis -
sues all the way through the body . A key component of the anti-angiogenic action
of PEDF is the induction of apoptosis in proliferating endothelial cells. Additionally,
PEDF is capable to inhibit the activity of angiogenic factors such as VEGF and FGF-2.
The neuro-protective effects of PEDF are achieved through suppression of neuronal
apoptosis induced by peroxide, glutamate, or other neurotoxins. The recognition of
a lipase-linked cell membrane receptor for PEDF (PEDF-R) that binds to PEDF with
high affinity should facilitate further elucidation of the underlying mechanisms of this
pluripotent serpin. To date, PEDF-R is the only signaling receptor known tobe used by
a serpin family member. The unique range of PEDF activities associate it as a potential
therapeutic agent for the treatment of vasculature related neurodegenerative diseases
such as age-related macular degeneration (AMD) and proliferative diabetic retinopathy
(PDR). In addition, PEDF has the potential to be functional in the treatment of various
angiogenesis-related diseases including a number of cancers.
PEDF Human CYT-580 5 µg 50
Recombinant Human Pigment Epithelium-Derived Factor -20 °C 20 µg 130
Pigment epithelium-derived factor,PEDF, Serpin-F1, SerpinF1, 1 mg 3,510
EPC-1, EPC1, PIG35
MQNPASPPEE GSPDPDSTGA LVEEEDPFFK VPVNKLAAAV SNFGYDLYRV RSSMSPTTNV LLSPLS-
VATA LSALSLGAEQ RTESIIHRAL YYDLISSPDI HGTYKELLDT VTAPQKNLKS ASRIVFEKKL RIKSS-
FVAPL EKSYGTRPRV LTGNPRLDLQ EINNWVQAQM KGKLARSTKE IPDEISILLL GVAHFKGQWV
PEPTIDES INTERNATIONAL

TKFDSRKTSL EDFYLDEERT VRVPMMSDPK AVLRYGLDSD LSCKIAQLPL TGSMSIIFFL PLKVTQNLTL

IEESLTSEFI HDIDRELKTV QAVLTVPKLK LSYEGEVTKS LQEMKLQSLF DSPDFSKITG KPIKLTQVEH
RAGFEWNEDG AGTTPSPGLQ PAHLTFPLDY HLNQPFIFVL RDTDTGALLF IGKILDPRGP
PEDF Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing
400 amino acids and having a molecular mass of 44.5 kDa.

PEDF His CYT-552 5 µg 50

Recombinant Human Pigment Epithelium-Derived Factor, -20 °C 20 µg 130
His Tag; Pigment epithelium-derived factor, PEDF, Serpin-F1, 1 mg 3,000
SerpinF1, EPC-1, EPC1, PIG35
MGSSHHHHHH SSGLVPRGSH MQNPASPPEE GSPDPDSTGA LVEEEDPFFK VPVNKLAAAV
SNFGYDLYRV RSSMSPTTNV LLSPLSVATA LSALSLGAEQ RTESIIHRAL YYDLISSPDI HGTYKELLDT
VTAPQKNLKS ASRIVFEKKL RIKSSFVAPL EKSYGTRPRV LTGNPRLDLQ EINNWVQAQM KG-
KLARSTKE IPDEISILLL GVAHFKGQWV TKFDSRKTSL EDFYLDEERT VRVPMMSDPK AVLRYGLDSD
LSCKIAQLPL TGSMSIIFFL PLKVTQNLTL IEESLTSEFI HDIDRELKTV QAVLTVPKLK LSYEGEVTKS
LQEMKLQSLF DSPDFSKITG KPIKLTQVEH RAGFEWNEDG AGTTPSPGLQ PAHLTFPLDY HLNQP-
FIFVL RDTDTGALLF IGKILDPRGP
PEDF Human Recombinant produced in E.Coli containing a natural variant M72T is a single, non-glyco-
sylated, polypeptide chain containing 420 amino acids (20-418 a.a.) and having a total molecular mass of
46.7 kDa. PEDF is fused to a 20 amino acid His Tag at N-terminus.

458 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
PEDF HEK CYT-553 2 µg 50
Recombinant Human Pigment Epithelium-Derived Factor, HEK -20 °C 10 µg 130
Pigment epithelium-derived factor, PEDF, Serpin-F1, SerpinF1, 100 µg 1,100
EPC-1, EPC1, PIG35
QNPASPPEEG SPDPDSTGAL VEEEDPFFKV PVNKLAAAVS NFGYDLYRVR SSTSPTTNVL LSPLS-
VATAL SALSLGAEQR TESIIHRALY YDLISSPDIH GTYKELLDTV TAPQKNLKSA SRIVFEKKLR IKSS-
FVAPLE KSYGTRPRVL TGNPRLDLQE INNWVQAQMK GKLARSTKEI PDEISILLLG VAHFKGQWVT
KFDSRKTSLE DFYLDEERTV RVPMMSDPKA VLRYGLDSDL SCKIAQLPLT GSMSIIFFLP LKVTQNLTLI
EESLTSEFIH DIDRELKTVQ AVLTVPKLKL SYEGEVTKSL QEMKLQSLFD SPDFSKITGK PIKLTQVEHR
AGFEWNEDGA GTTPSPGLQP AHLTFPLDYH LNQPFIFVLR DTDTGALLFI GKILDPRGPA AADY-
KDDDDK
PEDF Human Recombinant produced in HEK cells is a single, glycosylated, polypeptide chain containing
a total of 410 amino acids, having a molecular mass of 45.6 kDa and fused to an 11 aa FLAG tag at
C-Terminus.

Periostin
Periostin is a disulfide linked 90 kDa, 811 amino acid protein originally isolated as a
osteoblast-specific factor that functions as a cell adhesion molecule for preosteoblasts
and is thought to be involved in osteoblast recruitment, attachment and spreading. Ad-
ditionally, periostin expression has previously been shown to be significantly increased
by both transforming growth factor beta-1(TGFbeta1) and bone morphogenetic protein
(BMP-2). OSF-2 has a typical signal sequence, followed by a cysteine-rich domain, a
fourfold repeated domain and a C-terminal domain. The fourfold repeated domain of
OSF-2 shows homology with the insect protein fasciclin
Periostin mRNA is expressed in the developing mouse embryonic and fetal heart, and

PEPTIDES INTERNATIONAL
that it is localized to the endocardial cushions that ultimately divide the primitive heart
tube into a four-chambered heart.
Periostin Human CYT-452 2 µg 50
Recombinant Human Periostin, OSF-2, Periostin, Osteoblast -20 °C 10 µg 130
Specific Factor 2, PN OSF-2, PDLPOSTN, POSTN, MGC119510, 1 mg 3,600
MGC119511, PN, RP11-412K4.1
MGHHHHHHHH HHSSGHIEGR HMRNNHYDKI LAHSRIRGRD QGPNVCALQQ ILGTKKKYFS TCK-
NWYKKSI CGQKTTVLYE CCPGYMRMEG MKGCPAVLPI DHVYGTLGIV GATTTQRYSD ASKLREEIEG
KGSFTYFAPS NEAWDNLDSD IRRGLESNVN VELLNALHSH MINKRMLTKD LKNGMIIPSM YNNLGL-
FINH YPNGVVTVNC ARIIHGNQIA TNGVVHVIDR VLTQIGTSIQ DFIEAEDDLS SFRAAAITSD ILEAL-
GRDGH FTLFAPTNEA FEKLPRGVLE RFMGDKVASEALMKYHILNT LQCSESIMGG AVFETLEGNT
IEIGCDGDSI TVNGIKMVNK KDIVTNNGVI HLIDQVLIPD SAKQVIELAG KQQTTFTDLV AQLGLASALR
PDGEYTLLAP VNNAFSDDTL SMVQRLLKLI LQNHILKVKV GLNELYNGQI LETIGGKQLR VFVYR-
TAVCI ENSCMEKGSK QGRNGAIHIF REIIKPAEKS LHEKLKQDKR FSTFLSLLEA ADLKELLTQP
GDWTLFVPTN DAFKGMTSEE KEILIRDKNA LQNIILYHLT PGVFIGKGFE PGVTNILKTT QGSKIFLKEV
NDTLLVNELK SKESDIMTTN GVIHVVDKLL YPADTPVGND QLLEILNKLI KYIQIKFVRG STFKEIPVTV Y
The OSF2 His-Tagged Fusion Protein Human is produced in E. coli, and its molecular weight is 75 kDa
protein containing 648 amino acid residues of the human OSF-2 and 23 additional amino acid residues -
HisTag, Xa - cleavage site.

Order Hotline 1-800-777-4779 502-266-8787 459

 PRODUCT Code Qty PRICE
Recombinant proteins

PGRN (Progranulin)
A 88-kDa progranulin, also called proepithelin and PC cell-derived growth factor , is
a single precursor protein of granulins which are a family of secreted, glycosylated
peptides that are cleaved from a single precursor protein with 7.5 repeats of a highly
conserved 12-cysteine granulin/epithelin motif. Granulins are a variety of active, 6
kDa peptides and named granulin A (epithelin 1), granulin B (epithelin 2), granulin C,
etc. Both the peptides and intact progranulin protein regulate cell growth. However,
different members of the granulin protein family may act as inhibitors, stimulators, or
have dual actions on cell growth. Granulin family members are important in normal
development, wound healing, and tumorigenesis.
PGRN CYT-524 2 µg 50
Recombinant Human Progranulin -20 °C 10 µg 130
GRN, PGRN, granulin, Acrogranin, propithelin, PC cell derived 100 µg 1,200
growth Factor, GEP, GP88, PEPI, PCDGF
Progranulin Human Recombinant fused to FLAG at C-terminus produced in HEK is a single, glycosylated,
polypeptide chain containing 1-593 amino acids and having a molecular mass of 70kDa.
The Progranulin is purified by standard chromatographic techniques.

Pleiotrophin
Pleiotrophin (Osteoblast-Specific Factor-1, OSF-1) contains 136 amino acid residues.
The sequence is very rich in cationic amino acids (24% of the residues); lysine cluster
sequences are found in the N-terminal and C-terminal ends of the structure.
PEPTIDES INTERNATIONAL

The OSF-1 gene was shown by Northern blotting analysis to be expressed in mouse
calvarial osteoblast-enriched cells and in mouse brain tissues, but not in thymus,
spleen, kidney, liver, lung, testis or heart. Pleiotrophin has the ability to promote adhe-
sion, migration, expansion, and differentiation of human osteoprogenitor cells. In addi-
tion to certain types of cancer, the embryonic growth and differentiation factor pleiotro-
phin is found also in adults in inflammatory diseases. In osteoarthritis, pleiotrophin is
especially expressed in early stages, and its concentrations in the synovial fluid could
serve as a marker for the progress of the disease. Pleitrophin might be involved in
cartilage repair in osteoarthritis, in particular, in earlier stages.

Pleiotrophin Human CYT-749 5 µg 50

Recombinant Human Pleiotrophin -20 °C 20 µg 130
PTN, Heparin Affin Regulatory Protein, HARP, Heparin-binding 1 mg 2,700
growth factor-8, HBGF-8, Osteoblast-Specific Factor-1, OSF-1,
Heparin-binding growth-associated molecule, HB-GAM, HBNF-
1 Heparin-binding brain mitogen, Heparin-binding neurite
outgrowth-promoting factor 1, HBBM, NEGF1
GKKEKPEKKV KKSDCGEWQW SVCVPTSGDC GLGTREGTRT GAECKQTMKT QRCKIPCNWK KQF-
GAECKYQ FQAWGECDLN TALKTRTGSL KRALHNAECQ KTVTISKPCG KLTKPKPQAE SKKKKKEGKK
QEKMLD
Pleiotrophin Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain
containing 136 amino acids and having a molecular mass of 15.3kDa.

460 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
Pleiotrophin His CYT-451 5 µg 50
Recombinant Human Pleiotrophin, His Tag; PTN, Heparin Affin -20 °C 20 µg 130
Regulatory Protein, HARP, Heparin-binding growth factor-8, 1 mg 2,700
HBGF-8, Osteoblast-Specific Factor-1, OSF-1, Heparin-binding
growth-associated molecule, HB-GAM, HBNF-1 Heparin-
binding brain mitogen, Heparin-binding neurite outgrowth-
promoting factor 1, HBBM, NEGF1
MKHHHHHHHM LVPRGSGKKE KPEKKVKKSD CGEWQWSVCV PTSGDCGLGT REGTRTGAEC KQT-
MKTQRCK IPCNWKKQFG AECKYQFQAW GECDLNTALK TRTGSLKRAL HNAECQKTVT ISKPCGKLTK
PKPQAESKKK KKEGKKQEKM LD
Pleiotrophin Human Recombinant contains His-Tagged Fusion Protein, produced in E. coli, its molecular
weight is 17.3 kDa protein containing 136 amino acid residues of the OSF-1 human and 16 additional
amino acid residues - HisTag, thrombin cleavage site (underlined).

Pleiotrophin HEK CYT-198 2 µg 50

Recombinant Human Pleiotrophin, HEK; PTN, Heparin Affin -20 °C 10 µg 130
Regulatory Protein, HARP, Heparin-binding growth factor-8, 1 mg 5,200
HBGF-8, Osteoblast-Specific Factor-1, OSF-1, Heparin-binding
growth-associated molecule, HB-GAM, HBNF-1 Heparin-
binding brain mitogen, Heparin-binding neurite outgrowth-
promoting factor 1, HBBM, NEGF1
Pleiotrophin Human Recombinant produced in HEK cells is a non-glycosylated monomer, having a
molecular weight of 18kDa.
Please prevent freeze-thaw cycles.

Placental Lactogen

PEPTIDES INTERNATIONAL
Placental Lactogen is a polypeptide hormone that is produced by the Syncytiotropho -
blasts of the Placenta, also known as chorionic somatomammotropin. It has both
Growth Hormone and Prolactin activities on growth, lactation, and luteal steroid pro -
duction. In women, placental lactogen secretion begins soon after implantation and
increases to 1 g or more a day in late pregnancy. Placental lactogen is also an insulin
antagonist.
Placental Lactogen Bovine is also capable of activating human and other heterologous
GH receptors but not ruminat GH receptors.
Placental Lactogen CYT-656 10 µg 50
Recombinant Human Placental Lactogen -20 °C 50 µg 130
Chorionic Somatomammotropin Hormone 1, CSH1, CSA, 1 mg 2,100
Choriomammotropin, Lactogen, CSH2, PL, CSMT, FLJ75407
The sequence of the first six N-terminal amino acids was determined and was found to be Ala-Val-Gln-Thr-
Val-Pro
Placental Lactogen Human Recombinant, is a single polypeptide chain containing 199 amino acids and an
additional Ala at the N-terminus having a molecular mass of approximately 22.4 kDa.

bPlacental Lactogen CYT-511 50 µg 50

Recombinant Bovine Placental Lactogen -20 °C 200 µg 130
Chorionic Somatomammotropin Hormone 1, CSH1, CSB, CS-1, 1 mg 500
hCS-B, BPL, BPLP-I
The sequence of the first six N-terminal amino acids was determined and was found to be Ala-Glu-Asp-Tyr-
Ala-Pro
Placental Lactogen Bovine Recombinant, is a single polypeptide chain containing 199 amino acids and an
additional Ala at the N-terminus having a molecular mass of 23 kDa.

Order Hotline 1-800-777-4779 502-266-8787 461

 PRODUCT Code Qty PRICE
Recombinant proteins

oPlacental Lactogen CYT-512 50 µg 50

Recombinant Ovine Placental Lactogen; Chorionic -20 °C 200 µg 130
Somatomammotropin Hormone 1, CSH1, CS-1, hCS, PL 1 mg 500
The sequence of the first five N-terminal amino acids was determined and was found to be Ala-Gln-His-
Pro-Pro
Placental Lactogen Ovine Recombinant, is a single polypeptide chain containing 199 amino acids and an
additional Ala at the N-terminus having a molecular mass of 23 kDa.

cPlacental Lactogen CYT-510 50 µg 50

Recombinant Caprine Placental Lactogen; Chorionic -20 °C 200 µg 130
Somatomammotropin Hormone 1, CSH1, CS-1, hCS, PL 1 mg 500
The sequence of the first four N-terminal amino acids was determined and was found to be Ala-Glu-Asn-
Tyr
Placental Lactogen Caprine Recombinant, is a single polypeptide chain containing 199 amino acids and an
additional Ala at the N-terminus having a molecular mass of 23 kDa.

PLGF (Placenta Growth Factor)

PLGF is a growth factor active in angiogenesis, and endothelial cell growth, stimulating
their proliferation and migration. It binds to receptor vegfr-1/flt1.

PLGF 1 CYT-419 2 µg 50
Recombinant Human Placenta Growth Factor-1 -20 °C 10 µg 130
PIGF, PGF, PLGF-1, PlGF-2 1 mg 5,200
The sequence of the first five N-terminal amino acids was determined and was found to be Met-Leu-Pro-
Ala-Val
PEPTIDES INTERNATIONAL

Placenta Growth Factor-1 Human Recombinant produced in insect cells is a homodimer, glycosylated
polypeptide chain containing 2 x 131 amino acids and having a total molecular mass of approximately 34
kDa.

PLGF 2 CYT-420 2 µg 50
Recombinant Human Placenta Growth Factor-2 -20 °C 10 µg 130
PIGF, PGF, PlGF-2, PLGF-2 1 mg 5,200
Placenta Growth Factor-2 Human Recombinant produced in insect cells is a homodimer, glycosylated
polypeptide chain containing 2 x 152 amino acids and having a total molecular mass of 44 kDa.

462 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
PIP (Prolactin-Inducible Protein)
Prolactin Inducible Protein (PIP) is a 17kDa glycoprotein existing in human seminal
plasma. PIP is synthesized as a 146 amino acid long polypeptide exhibiting high se -
quence similarity with mouse submaxillary gland with a single glycosylation site. The
precise biological functions of PIP are still ambiguous but various functions have been
assigned to PIP due its existence at high concentration in biological fluids. PIP binds
to various proteins such as fibrinogen, actin, keratin, myosin and tropomyosin. PIP is
also expressed in pathological conditions of the mammary gland and in some exocrine
tissues, such as the lacrimal, salivary and sweat glands. Due to PIP’s association with
secretory cell differentiation, it has been used in diagnostic evaluation of tumors of
breast, salivary gland, and skin.

PIP CYT-779 5 µg 50
Recombinant Human Prolactin-Induced Protein -20 °C 20 µg 130
Prolactin-inducible Protein, Gross cystic disease fluid Protein 1 mg 2,700
15, GCDFP-15, Prolactin-induced Protein, Secretory actin-
binding Protein, SABP, gp17, PIP, GCDFP15, GPIP4
QDNTRKIIIK NFDIPKSVRP NDEVTAVLAV QTELKECMVV KTYLISSIPL QGAFNYKYTA CLCDDNPKTF
YWDFYTNRTV QIAAVVDVIR ELGICPDDAA VIPIKNNRFY TIEILKVE
The Prolactin-Induced Protein produced from Human Seminal Plasma has a molecular mass of 13.52kDa
(calculated without glycosylation) containing 118 amino acid residues.

Prolactin
Prolactin is a pituitary hormone involved in the stimulation of milk production, salt and

PEPTIDES INTERNATIONAL
water regulation, growth, development and reproduction. The initial step in its action is
the binding to a specific membrane receptor (prolactin receptor) which belongs to the
superfamily of class 1 cytokine receptors. The function of the prolactin receptor is me-
diated, at least in part, by two families of signaling molecules: Janus kinases and signal
transducers and activators of transcription. Prolactin (PRL) is a hormone involved in a
variety of important functions including ion transport and osmoregulation, stimulation
of milk, protein synthesis as well as the regulation of numerous reproductive functions.
PRL exerts its influence on different cell types through a signal transduction pathway
which begins with the binding of the hormone to a transmembrane PRL receptor. Im-
munoreactive PRL receptor, a member of the cytokine receptor family , varies in size
(short and long forms) with tissue source and species, from ~40 kDa to 100 kDa. The
PRL receptor consists of at least three separate domains: an extracellular region with
5 cysteines which contains the prolactin binding site, a single transmembrane domain
and a cytoplasmic region, the length of which appears to influence ligand binding and
regulate cellular function.
Prolactin Human CYT-267 10 µg 50
Recombinant Human Prolactin -20 °C 50 µg 130
Mammotropin, Luteotropic hormone, Luteotropin, PRL 1 mg 1,350
The sequence of the first five N-terminal amino acids was determined and was found to be Met-Leu-Pro-
Ile-Cys
Prolactin Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain contain-
ing 200 amino acids and having a molecular mass of 23007 Dalton.

Order Hotline 1-800-777-4779 502-266-8787 463

 PRODUCT Code Qty PRICE
Recombinant proteins

Prolactin His CYT-493 5 µg 50

Recombinant Human Prolactin, His Tag -20 °C 20 µg 130
Mammotropin, Luteotropic hormone, Luteotropin, PRL 1 mg 1,900
Prolactin-His Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain con-
taining 199 amino acids fragment (29-227) and having a molecular mass of 23 kDa with an amino-terminal
hexahistidine tag.

mProlactin CYT-321 10 µg 50
Recombinant Mouse Prolactin -20 °C 50 µg 130
Mammotropin, Luterotropic hormone, Lutetropin, PRL 1 mg 1,350

The sequence of the first five N-terminal amino acids was determined and was found to be Met-Leu-Pro-
Ile-Cys
Prolactin Mouse Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain contain-
ing 198 amino acids and having a molecular mass of 22.5 kDa.

rProlactin CYT-322 10 µg 50
Recombinant Rat Prolactin -20 °C 50 µg 130
Mammotropin, Luterotropic hormone, Lutetropin, PRL 1 mg 1,350
The sequence of the first five N-terminal amino acids was determined and was found to be Met-Leu-Pro-
Val-Cys
Prolactin Rat Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing
198 amino acids and having a molecular mass of 22.6 kDa.

oProlactin CYT-240 10 µg 50
Recombinant Ovine Prolactin -20 °C 50 µg 130
Mammotropin, Luteotropic hormone, Luteotropin, PRL 1 mg 700
PEPTIDES INTERNATIONAL

The sequence of the first five N-terminal amino acids was determined and was found to be Ala-Thr-Pro-
Val-Cys-Pro
Prolactin Ovine Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing
199 amino acids and having a molecular mass of 23 kDa.
M. Johansson, et al., Endocrinology, 150, 4 (2009).
M. Johansson, et al., Endocrinology, 147, 5 (2006).

raProlactin CYT-513 10 µg 50
Recombinant Rabbit Prolactin -20 °C 50 µg 130
Mammotropin, Luteotropic hormone, Luteotropin, PRL 1 mg 1,350
The sequence of the first five N-terminal amino acids was determined and was found to be Ala-Leu-Pro-
Ile-Cys
Prolactin Rabbit Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing
200 amino acids and having a molecular mass of 23007 Dalton.

Prl R, GST CYT-469 2 µg 175

Recombinant Human Prolactin Receptor , GST Tag -20 °C 5 µg 270
PRL-R, hPRLrI 10 µg 490
Cytoplasmatic Prolactin Receptor Human Recombinant produced in E.Coli is a non-glycosylated, Polypep-
tide chain amino acids 432-623 and having a molecular mass of 45 kDa, the PRLR is fused with a GST
tag.

464 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
Prl R CYT-595 5 µg 50
Recombinant Human Prolactin Receptor -20 °C 20 µg 130
PRL-R, hPRLrI 1 mg 3,360
The sequence of the first six N-terminal amino acids was determined to be Ala-Gly-Lys-Pro-Glu-Ile
Extra Cellular Domain Prolactin Receptor Human Recombinant is produced in E.Coli and is a non-glyco-
sylated, Polypeptide chain containsing 210 amino acids and having a molecular mass of 23.97 kDa. The
Prolactin Receptor is purified by proprietary chromatographic techniques (according to Bignon, et al., JBC,
269, 3318-24 (1994).) and tested (according to Gertler, et al., JBC 271, 24482-91 (1996).).

raPrl R CYT-268 5 µg 50
Recombinant Rabbit Prolactin Soluble Receptor -20 °C 20 µg 130
PRL-R 1 mg 3,360
The sequence of the first five N-terminal amino acids was determined and was found to be Gly-Lys-Pro-
Phe-Ile
Prolactin Receptor Rabbit Extra Celleular Domain Recombinant is produced in E.Coli and is a non-glyco-
sylated, Polypeptide chain containing 207 amino acids and having a molecular mass of 23972 Dalton.
Bignon, et al., JBC, 269, 3318-24 (1994).
Gertler, et al., JBC, 271, 24482-91 (1996).

oPrl R CYT-293 5 µg 50
Recombinant Ovine Prolactin Soluble Receptor -20 °C 20 µg 130
PRL-R, PRLR, OPR, PRLrI 1 mg 3,360
The sequence of the first five N-terminal amino acids was determined and was found to be Gln-Ser-Pro-
Pro-Glu
Prolactin Receptor Ovine Extra Celleular Domain Recombinant is produced in E.Coli and is a non-glycosyl-
ated, Polypeptide chain containing 213 amino acids and having a molecular mass of 24.4 kDa.

PEPTIDES INTERNATIONAL
bPrl R CYT-294 5 µg 50
Recombinant Bovine Prolactin Soluble Receptor -20 °C 20 µg 130
PRL-R, PRLR, OPR, PRLrI 1 mg 3,360
The sequence of the first five N-terminal amino acids was determined and was found to be Gln-Ser-Pro-
Pro-Glu
Prolactin Receptor Bovine Extra Celleular Domain Recombinant is produced in E.Coli and is a non-glyco-
sylated, Polypeptide chain containing 213 amino acids and having a molecular mass of 24.4 kDa.

tPrl R CYT-532 5 µg 50
Recombinant Raibow Trout Prolactin Soluble Receptor; PRL-R -20 °C 20 µg 130
1 mg 3,360
The sequence of the first five N-terminal amino acids was determined and was found to be Ala-Arg-His-
Thr-Pro
Prolactin Receptor Rainbow Trout Extra Celleular Domain Recombinant is produced in E.Coli and is a non-
glycosylated, Polypeptide chain containing 210 amino acids and having a molecular mass of 24034 Dalton.

rPrl R CYT-533 5 µg 50
Recombinant Rat Prolactin Soluble Receptor -20 °C 20 µg 130
PRL-R, Prolactin receptor, Lactogen receptor, Prlr 1 mg 3,360
The sequence of the first five N-terminal amino acids was determined and was found to be Gly-Lys-Pro-
Glu-Ile
Prolactin Receptor Rat Extra Celleular Domain Recombinant produced in E.Coli is a non-glycosylated,
Polypeptide chain containing 206 amino acids and having a molecular mass of 24120 Dalton.

Order Hotline 1-800-777-4779 502-266-8787 465

 PRODUCT Code Qty PRICE
Recombinant proteins

oPrl A CYT-311 10 µg 50
Recombinant Ovine Prolactin Antagonist -20 °C 50 µg 130
Mammotropin, Luteotropic hormone, Luteotropin, PR 1 mg 1,350
The sequence of the first five N-terminal amino acids was determined and was found to be Ala-Thr-Pro-
Val-Cys-Pro
Prolactin Ovine Antagonist Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain
containing 199 amino acids and having a molecular mass of 23kDa.

oPrl A Mutant CYT-705 10 µg 50

Recombinant Ovine Prolactin Antagonist, Mutant; PRL, -20 °C 50 µg 130
Mammotropin, Luteotropic hormone, Luteotropin, Prolactin 1 mg 1,350
The sequence of the first five N-terminal amino acids was determined and was found to be Ala-Thr-Pro-
Val-Cys-Pro
Prolactin Ovine Antagonist Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain
containing 199 amino acids and an additional Ala at N-terminus and having a molecular mass of 23kDa.
The mutant R129G is DES 9 amino acids truncated form from its N-terminus which has higher inhibitory
activity.

RANKL
RANKL binds to tnfrsf1 1b/opg and to tnfrsf1 1a/rank. Osteoclast dif ferentiation and
activation factor. It augments the ability of dendritic cells to stimulate naive t-cell pro -
liferation. RANKL may be an important regulator of interactions between t-cells and
dendritic cells and possibly play a role in the regulation of the t-cell-dependent immune
response. sRANKL may also play an important role in enhanced bone-resorption in
humoral hypercalcemia of malignancy.
PEPTIDES INTERNATIONAL

sRANKL CYT-334 2 µg 50
Recombinant Human Soluble RANK Ligand -20 °C 10 µg 130
Soluble Receptor Activator of NFkB Ligand, TNFSF11, 1 mg 4,680
TRANCE, TNF-related activation-induced cytokine, OPGL, ODF,
Osteoclast differentiation factor, Tumor necrosis factor ligand
superfamily member 11, Receptor activator of nuclear factor
κ B ligand, RANKL, Osteoprotegerin ligand, CD254 antigen,
sRANKL, sOdf, hRANKL2
MEKAMVDGSW LDLAKRSKLE AQPFAHLTIN ATDIPSGSHK VSLSSWYHDR GWAKISNMTF SNG-
KLIVNQD GFYYLYANIC FRHHETSGDL ATEYLQLMVY VTKTSIKIPS SHTLMKGGST KYWSGNSEFH
FYSINVGGFF KLRSGEEISI EVSNPSLLDP DQDATYFGAF KVRDID
sRANKL Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain contain-
ing 176 amino acids and having a molecular mass of 20 kDa.
J.M. Schmit, et al., Journal of Veterinary Internal Medicine, 26, 1 (2012).
B. Zhao, et al., PLoS One, 8, 8 (2013).

466 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
sRANKL His CYT-692 5 µg 50
Recombinant Human Soluble RANK Ligand, His Tag -20 °C 20 µg 130
Soluble Receptor Activator of NFkB Ligand, TNFSF11, 1 mg 2,700
TRANCE, TNF-related activation-induced cytokine, OPGL, ODF,
Osteoclast differentiation factor, Tumor necrosis factor ligand
superfamily member 11, Receptor activator of nuclear factor
κ B ligand, RANKL, Osteoprotegerin ligand, CD254 antigen,
sRANKL, sOdf, hRANKL2
MGSSHHHHHH SSGLVPRGSH MIRAEKAMVD GSWLDLAKRS KLEAQPFAHL TINATDIPSG
SHKVSLSSWY HDRGWAKISN MTFSNGKLIV NQDGFYYLYA NICFRHHETS GDLATEYLQL MVYVT-
KTSIK IPSSHTLMKG GSTKYWSGNS EFHFYSINVG GFFKLRSGEE ISIEVSNPSL LDPDQDATYF
GAFKVRDID
sRANKL Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain contain-
ing 199 amino acids (140-317 a.a) and having a molecular mass of 22.3kDa.
sRANKL is fused to a 21
amino acid His-tag at N-terminus

sRANKL GST CYT-631 2 µg 50

Recombinant Human Soluble RANK Ligand, GST Tag -20 °C 10 µg 130
Soluble Receptor Activator of NFkB Ligand, TNFSF11, 0.1 mg 1,100
TRANCE, TNF-related activation-induced cytokine, OPGL, ODF,
Osteoclast differentiation factor, Tumor necrosis factor ligand
superfamily member 11, Receptor activator of nuclear factor
κ B ligand, RANKL, Osteoprotegerin ligand, CD254 antigen,
sRANKL, sOdf, hRANKL2
RANKL Human Recombinant fused to GST tag produced in E.Coli is a single, non-glycosylated polypep-

PEPTIDES INTERNATIONAL
tide having a molecular mass of 47 kDa.

msRANKL CYT-320 2 µg 50
Recombinant Mouse Soluble RANK Ligand; Soluble Receptor -20 °C 10 µg 130
Activator of NFkB Ligand, TNFSF11, TRANCE, TNF-related 1 mg 4,680
activation-induced cytokine, OPGL, ODF, Osteoclast
differentiation factor, Tumor necrosis factor ligand superfamily
member 11, Receptor activator of nuclear factor κ B ligand,
RANKL, Osteoprotegerin ligand, CD254 antigen, sRANKL, sOdf
PAMMEGSWLD VAQRGKPEAQ PFAHLTINAA SIPSGSHKVT LSSWYHDRGW AKISNMTLSN GKLRVN-
QDGF YYLYANICFR HHETSGSVPT DYLQLMVYVV KTSIKIPSSH NLMKGGSTKN WSGNSEFHFY
SINVGGFFKL RAGEEISIQV SNPSLLDPDQ DATYFGAFKV QDID
sRANKL Mouse Recombinant produced in E.Coli is single, non-glycosylated, polypeptide chain containing
174 amino acids and having a total molecular mass of 19.9kDa.

sRANK Receptor CYT-734 20 µg 50

Recombinant Human Soluble RANK Receptor -20 °C 100 µg 130
Tumor necrosis factor receptor superfamily member 11A, 1 mg 990
Osteoclast differentiation factor receptor, ODFR, Receptor
activator of NF-KB, FEO, OFE, ODFR, OSTS, PDB2, RANK,
CD265, OPTB7, TRANCER, LOH18CR1
QIAPPCTSEK HYEHLGRCCN KCEPGKYMSS KCTTTSDSVC LPCGPDEYLD SWNEEDKCLL HKVCDT-
GKAL VAVVAGNSTT PRRCACTAGY HWSQDCECCR RNTECAPGLG AQHPLQLNKD TVCKPCLAGY
FSDAFSSTDK CRPWTNCTFL GKRVEHHGTE KSDAVCSSSL PARK
sRANK Receptor Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain
containing 174 amino acids and having a molecular mass of 19.1kDa.

Order Hotline 1-800-777-4779 502-266-8787 467

 PRODUCT Code Qty PRICE
Recombinant proteins

RELm α
Bronchoalveolar lavage fluid from mice with experimentally induced allergic pulmonary
inflammation contains a novel 9.4 kDa cysteine-rich secreted protein, RELM-α (FIZZ1,
found in inflammatory zone). RELM-α is a secreted protein that has a restricted tissue
distribution with highest levels in adipose tissue stroma. Murine RELM-α (FIZZ1) is the
founding member of a new gene family including two other murine genes expressed,
respectively, in intestinal crypt epithelium (RELM-β) and white adipose tissue (Resis-
tin), and two related human genes.
RELMα inhibits the differentiation of 3T3-L1 preadipocytes into adipocytes but has no
effect on proliferation of 3T3-L1 preadipocytes. RELMα is able to form heterooligo-
mers with resistin but not RELMβ. Since RELMα is expressed by adipose tissue and it
is a secreted factor, our findings suggest that RELMα may be involved in the control of
the adipogenesis as well as in the process of muscle differentiation.
In the lung, RELM-α is induced by hypoxia and was renamed as hypoxia-induced
mitogenic factor (HIMF). HIMF strongly activated Akt phosphorylation. The phos-
phatidylinositol 3-kinase (PI3K) inhibitor L Y294002 (10 micromol/L) inhibited HIMF-
activated Akt phosphorylation. It also inhibited HIMF stimulated RPSM proliferation.
Thus, the PI3K/Akt pathway, at least in part, mediates the proliferative ef fect of HIMF.
Further studies showed that HIMF had angiogenic and vasoconstrictive properties.
HIMF increased pulmonary arterial pressure and vascular resistance. Further studies
suggest that HIMF regulates apoptosis and may participate in lung alveolarization and
maturation.
PEPTIDES INTERNATIONAL

mRELm a CYT-309 5 µg 50
Recombinant Mouse RELm-α -20 °C 25 µg 130
Resistin-like α, RELMalpha, Cysteine-rich secreted Protein 1 mg 2,700
FIZZ1, Parasite-induced macrophage novel gene 1 Protein,
Cysteine-rich secreted Protein A12-γ, RELM-a
MDETIEIIVE NKVKELLANP ANYPSTVTKT LSCTSVKTMN RWASCPAGMT ATGCACGFAC GSWEIQS-
GDT CNCLCLLVDW TTARCCQLS
Mouse RELM-alpha Recombinant produced in E.Coli is a monomeric, non-glycosylated, polypeptide chain
containing 88 amino acids and having a molecular mass of 10 kDa.

mRELm a His CYT-453 5 µg 50

Recombinant Mouse RELm-α His Tag -20 °C 25 µg 130
Resistin-like α, RELMalpha, Cysteine-rich secreted Protein 1 mg 2,900
FIZZ1, Parasite-induced macrophage novel gene 1 Protein,
Cysteine-rich secreted Protein A12-gamma, RELM-a
MKKLLFAIPL VVPFYSHSTM VNTDETIEII VENKVKELLA NPANYPSTVT TLSCTSVKT MNRWASCPAG
MTATGCACGF ACGSWEIQSG DTCNCLCLLV DWTTARCCQL SLEDYKDDDD K
RELM-alpha Mouse Recombinant is manufactured with a signal sequence of phage fd (20aa) and
C-terminal fusion of flagTag (10aa). The RELM-alpha Flag-Tagged Fusion Protein is a 13.3 kDa protein
containing 91 amino acid residues with 30 additional amino acid residues - signal sequence of phage fd,
flagTag (underlined).

468 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
RELm b His CYT-454 5 µg 50
Recombinant Human RELm-β, His Tag -20 °C 25 µg 130
Resistin-like beta, RELM beta, Cysteine-rich secreted Protein 1 mg 2,900
FIZZ2, Colon and small intestine-specific cysteine-rich
Protein, Cysteine-rich secreted Protein A12-alpha-like 1, Colon
carcinoma-related gene Protein, RELM-b, XCP2, HXCP2
MGSTQCSLDS VMDKKIKDVL NSLEYSPSPI SKKLSCASVK SQGRPSSCPA GMAVTGCACG YGCG-
SWDVQLETTCHCQCSV VDWTTARCCH LTKLRSHHHH HH
RELM-beta Human Recombinant is a His-Tagged Fusion Protein which is 11 kDa protein containing 90
amino acid residues of the RELM-beta human and 12 additional amino acid residues - HisTag (underlined).

RELm b CYT-780 5 µg 50
Recombinant Human RELm-β -20 °C 25 µg 130
Resistin-like beta, RELM beta, Cysteine-rich secreted Protein 1 mg 2,900
FIZZ2, Colon and small intestine-specific cysteine-rich
Protein, Cysteine-rich secreted Protein A12-alpha-like 1, Colon
carcinoma-related gene Protein, RELM-b, XCP2, HXCP2
MQCSLDSVMD KKIKDVLNSL EYSPSPISKK LSCASVKSQG RPSSCPAGMA VTGCACGYGC GSWD-
VQLETT CHCQCSVVDW TTARCCHLT
RELM-b Human Recombinant produced in E.Coli is a disulfide-linked homodimer, non-glycosylated,
polypeptide chain containing 2 x 89 amino acids and having a total molecular mass of 19kDa.

mRELm b CYT-413 5 µg 50
Recombinant Mouse RELm-β -20 °C 25 µg 130
Resistin-like β, RELM β, Cysteine-rich secreted Protein FIZZ2, 1 mg 2,700

PEPTIDES INTERNATIONAL
Colon and small intestine-specific cysteine-rich Protein,
Cysteine-rich secreted Protein A12-α-like 1, Colon carcinoma-
related gene Protein, RELM-b, XCP2, HXCP2
MQCSFESLVD QRIKEALSRQ EPKTISCTSV TSSGRLASCP AGMVVTGCAC GYGCGSWDIR NGNTCH-
CQCS VMDWASARCC RMA
Mouse RELM-b Recombinant produced in E.Coli is a monomeric, non-glycosylated, polypeptide chain
containing 83 amino acids and having a molecular mass of 8.9kDa.

mRELm g CYT-455 5 µg 50
Recombinant Mouse RELm-Gamma -20 °C 25 µg 130
Resistin-like γ, RELMγ,RELM-γ, RELM-g 1 mg 2,900

MRGSHHHHHH GMASHMTLES IVEKKVKELL ANRDDCPSTV TKTFSCTSIT ASGRLASCPS GMTVTG-

CACG YGCGSWDIRD GNTCHCQCST MDWATARCCQ LA
RELM-gamma Mouse Recombinant is a His -Tagged Fusion Protein having a molecular weight of 11 kDa
containing 86 amino acid residues of the RELM-gamma Mouse and 16 additional amino acid residues –
HisTag (underlined).

Order Hotline 1-800-777-4779 502-266-8787 469

 PRODUCT Code Qty PRICE
Recombinant proteins

Resistin
Resistin, a product of the RSTN gene, is a peptide hormone belonging to the class
of cysteine-rich secreted proteins which is termed the RELM family , and is also de -
scribed as ADSF (Adipose Tissue- Specific Secretory Factor) and FIZZ3 (Found in
Inflammatory Zone). Human resistin contains 108 amino acids as a prepeptide, and
its hydrofobic signal peptide is cleaved before its secretion. Resistin circulates in hu-
man blood as a dimeric protein consisting of two 92 amino acid polypeptides, which
are disulfide-linked via Cys26.
Resistin may be an important link between obesity and insulin resistance. Mouse re-
sistin, specifically produced and secreted by adipocyte, acts on skeletal muscle myo-
cytes, hepatocytes and adipocytes themselves so that it reduces their sensitivity to
insulin. Steppan, et al., have suggested that resistin suppresses the ability of insulin
to stimulate glucose uptake. They have also suggested that resistin is present at el -
evated levels in blood of obese mice, and is down regulated by fasting and antidiabetic
drugs. Way et al., on the other hand, have found that resistin expression is severly
suppressed in obesity and is stimulated by several antidiabetic drugs.
Other studies have shown that mouse resistin increases during the dif ferentiation of
adipocytes, but it also seems to inhibit adipogenesis. In contrast, the human adipo -
genic differentiation is likely to be associated with a down regulation of resistin gene
expression.
Resistin CYT-456 5 µg 50
Recombinant Human Resistin -20 °C 25 µg 130
PEPTIDES INTERNATIONAL

Cysteine-rich secreted Protein FIZZ3, Adipose tissue-specific 1 mg 4,680

secretory factor, ADSF, C/EBP-ε-regulated myeloid-specific
secreted cysteine-rich Protein, Cysteine-rich secreted Protein
A12-α-like 2, RSTN, XCP1, RETN1, MGC126603, MGC126609
ASSKTLCSME EAINERIQEV AGSLIFRAIS SIGLECQSVT SRGDLATCPR GFAVTGCTCG SACGSWD-
VRA ETTCHCQCAG MDWTGARCCR VQ
9.9 kDa protein containing 93 amino acid residues.

Resistin His CYT-256 5 µg 50

Recombinant Human Resistin, His Tag -20 °C 25 µg 130
Cysteine-rich secreted Protein FIZZ3, Adipose tissue-specific 1 mg 3,680
secretory factor, ADSF, C/EBP-ε-regulated myeloid-specific
secreted cysteine-rich Protein, Cysteine-rich secreted Protein
A12-α-like 2, RSTN, XCP1, RETN1, MGC126603, MGC126609
Resistin Human Recombinant produced in E.Coli is a single, non-glycosylated, Polypeptide chain contain-
ing a 92 amino acids fragment (17-108) of the mature Human Resistin, having a total molecular mass of
14.23kDa and fused with a 4.5kDa amino-terminal hexahistidine tag.

470 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
Resistin Mutant CYT-585 2 µg 50
Recombinant Human Resistin Mutant -20 °C 10 µg 130
Resistin, Cysteine-rich secreted Protein FIZZ3, Adipose tissue- 1 mg 5,200
specific secretory factor, ADSF, C/EBP-ε-regulated myeloid-
specific secreted cysteine-rich Protein, Cysteine-rich secreted
Protein A12-α-like 2, RSTN, XCP1, RETN1, MGC126603,
MGC126609
MSSKTLCSME EAINERIQEV AGSLIFRAIS SIGLECQSVT SRGDLATCPR GFAVTGCTCG SACGSWD-
VRA ETTCHCQCAG MDWTGARCCR VQP
9.9 kDa protein containing 93 amino acid residues, produced in E.Coli. Mutant-Resistin has had a Cysteine
residue mutated to prevent dimerization and possibly acts as an antagonist.

mResistin CYT-457 5 µg 50
Recombinant Mouse Resistin -20 °C 25 µg 130
Cysteine-rich secreted Protein FIZZ3, Adipose tissue-specific 1 mg 4,680
secretory factor, ADSF, C/EBP-ε-regulated myeloid-specific
secreted cysteine-rich Protein, Cysteine-rich secreted Protein
A12-α-like 2, RSTN, XCP1, RETN1, MGC126603, MGC126609
MKKLLFAIPL VVPFYSHSTM ASMPLCPIDE AIDKKIKQDF NSLFPNAIKN IGLNCWTVSS RGKLASCPEG
TAVLSCSCGS ACGSWDIREE KVCHCQCARI DWTAARCCKL QVASLEDYKD DDDK
Resistin Mouse is manufactured with signal sequence of phage fd (21aa) and C-terminal fusion of flagTag
(10aa). Resistin Mouse Recombinant Flag-Tagged Fusion Protein is 13.7 kDa protein containing 93 amino
acid residues of the Resistin Mouse and 31 additional amino acid residues - signal sequence of phage fd,
flagTag (underlined).

rResistin CYT-458 5 µg 50

PEPTIDES INTERNATIONAL
Recombinant Rat Resistin -20 °C 25 µg 130
Cysteine-rich secreted Protein FIZZ3, Adipose tissue-specific 1 mg 4,680
secretory factor, ADSF, C/EBP-ε-regulated myeloid-specific
secreted cysteine-rich Protein, Cysteine-rich secreted Protein
A12-α-like 2, RSTN, XCP1, RETN1, MGC126603, MGC126609
MRGSHHHHHH GMASHMPSMS LCPMDEAISK KINQDFSSLL PAAMKNTVLH CWSVSSRGRL AS-
CPEGTTVT SCSCGSGCGS WDVREDTMCH CQCGSIDWTA ARCCTLRVGS
Resistin Rat Recombinant is manufactured with N-terminal fusion of His tag. Resistin Rat Recombinant
His-Tagged Fusion Protein is an 11.9 kDa protein containing 94 amino acid residues of the Resistin Rat
and 16 additional amino acid residues – His Tag (underlined).

Order Hotline 1-800-777-4779 502-266-8787 471

 PRODUCT Code Qty PRICE
Recombinant proteins

RBP1 (Recombinant Human Retinol Binding Protein-1)

RBP1 is a member of the calycin superfamily and fatty-acid binding protein (F ABP)
family. RBP1 is the carrier protein which takes part in the transport of retinol (vitamin A
alcohol) from the liver storage site to peripheral tissue. Additionally, RBP1 performs as
a bridging molecule to recruit histone deacetylases (HDACs) which is a forceful regula-
tor of gene expression. RBP1 is found in almost all the tissues with higher expression
in pancreas, adrenal gland and pituitary gland, fetal liver and adult ovary
RBP1 CYT-122 2 µg 50
Recombinant Human Retinol Binding Protein-1; Retinol binding -20 °C 10 µg 130
Protein 1 cellular, CRBP, CRBP1, CRABP-I, RBPC 1 mg 5,200
GSSHHHHHH SSGLVPRGSH MGSMDPPAGF VRAGNPAVAA PQSPLSPEGA HFRAAHHPRS TG-
SRCPGSLQ PSRPLVANWL QSLPEMPVDF TGYWKMLVNE NFEEYLRALD VNVALRKIAN LLKPD-
KEIVQ DGDHMIIRTL STFRNYIMDF QVGKEFEEDL TGIDDRKCMT TVSWDGDKLQ CVQKGEKEGR
GWTQWIEGDE LHLEMRVEGV VCKQVFKKVQ
RBP1 Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing
220 amino acids (1-197 a.a.) and having a molecular mass of 24.7kDa. RBP1 is fused to a 23 amino acid
His-tag at N-terminus.
Avoid multiple freeze-thaw cycles.

RBP2 (Recombinant Human Retinol Binding Protein-2)

Retinol Binding Protein-2 (RBP2) which is present in the small intestinal epithelium
takes part in the uptake and intracellular metabolism of vitamin A. Vitamin A is a fat-
soluble vitamin essential for growth, reproduction, dif ferentiation of epithelial tissues,
PEPTIDES INTERNATIONAL

and vision. RBP2 moderates the supply of retinoic acid to the nuclei of endometrial
cells throughout the menstrual cycle.

RBP2 CYT-751 5 µg 50
Recombinant Human Retinol Binding Protein-2 -20 °C 20 µg 130
CRABP-II, CRBP2, CRBPII, RBPC2, Retinol-binding Protein 2, 1 mg 2,700
Cellular retinol-binding Protein II, RBP2
MGSSHHHHHH SSGLVPRGSH MGSHMTRDQN GTWEMESNEN FEGYMKALDI DFATRKIAVR LTQT-
KVIDQD GDNFKTKTTS TFRNYDVDFT VGVEFDEYTK SLDNRHVKAL VTWEGDVLVC VQKGEKENRG
WKQWIEGDKL YLELTCGDQV CRQVFKKK
RBP2 Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing
158 amino acids (1-134 a.a.) and having a molecular mass of 18kDa. RBP2 is fused to a 24 amino acid
His-tag at N-terminus
Avoid multiple freeze-thaw cycles.

472 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
RBP4 (Recombinant Human Retinol Binding Protein-4)
Retinol binding protein 4(RBP4) belongs to the lipocalin family and is the specific car-
rier for retinol (vitamin A alcohol) in the blood. This protein was found to be expressed
and secreted by adipose tissue, and was strongly associated with insulin resistance.
It delivers retinol from the liver stores to the peripheral tissues. In plasma, the RBP-
retinol complex interacts with transthyretin which prevents its loss by filtration through
the kidney glomeruli.
RBP4 delivers retinol from the liver to the peripheral tissues. In plasma, the rbp-retinol
complex interacts with transthyretin, this prevents its loss by filtration through the kid-
ney glomeruli.

RBP4 CYT-535 5 µg 50
Recombinant Human Retinol Binding Protein-4 -20 °C 20 µg 130
Retinol Binding Protein 4, RBP-4, RBP4, Plasma retinol-binding 1 mg 3,600
Protein, PRBP, RBP
MERDCRVSSF RVKENFDKAR FSGTWYAMAK KDPEGLFLQD NIVAEFSVDE TGQMSATAKGRVRLLN-
NWDV CADMVGTFTD TEDPAKFKMK YWGVASFLQK GNDDHWIVDT DYDTYAVQYS CRLLNLDGTC
ADSYSFVFSR DPNGLPPEAQ KIVRQRQEEL CLARQYRLIV HNGYCDGRSE RNLL
RBP-4 Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain (19-201
a.a.) containing 184 amino acids and having a molecular mass of 21 kDa.

RBP4 His CYT-555 2 µg 50

Recombinant Human Retinol Binding Protein-4 His Tag -20 °C 10 µg 130
Retinol Binding Protein 4 plasma, RBP-4, RBP4, Plasma retinol- 1 mg 5,200

PEPTIDES INTERNATIONAL
binding Protein, PRBP, RBP
RBP-4 Human Recombinant produced in E.Coli is single, a non-glycosylated, Polypeptide chain containing
183 amino acids fragment (19-201) corresponding to the mature Retinol Binding Protein, having a total
molecular mass of 25.57kDa and fused with a 4.5kDa amino-terminal hexahistidine tag.

RBP5 (Recombinant Human Retinol Binding Protein-5)

RBP5 is a member of the Retinol-binding proteins family . Estimation of retinol-bind -
ing protein is used to determine visceral protein mass in nutritional studies related
to health. RBP5 has a higher expression in the adult kidney and liver and to a lesser
extent in the adult and fetal spleen, adult lymph nodes and appendix, and fetal liver and
kidney. RBP5 expression is strongly decreased in hepatocellular carcinoma tissues.
RBP5 CYT-650 2 µg 50
Recombinant Human Retinol Binding Protein-5 -20 °C 10 µg 130
Retinol-binding Protein 5, Cellular retinol-binding Protein III, 1 mg 5,200
CRBP-III, HRBPiso, RBP5, CRBP3, CRBPIII
MGSSHHHHHH SSGLVPRGSH MPPNLTGYYR FVSQKNMEDY LQALNISLAV RKIALLLKPD KEI-
EHQGNHM TVRTLSTFRN YTVQFDVGVE FEEDLRSVDG RKCQTIVTWE EEHLVCVQKG EVPNRG-
WRHW LEGEMLYLEL TARDAVCEQV FRKVR
RBP5 Human Recombinant fused with a 20 amino acid His tag at N-terminus produced in E.Coli is a
single, non-glycosylated, polypeptide chain containing 155 amino acids (1-135 a.a.) and having a molecu-
lar mass of 18.1kDa.

Order Hotline 1-800-777-4779 502-266-8787 473

 PRODUCT Code Qty PRICE
Recombinant proteins

RBP7 (Recombinant Human Retinol Binding Protein-7)

RBP7 is a member of a superfamily of small cytoplasmic proteins which interact with
hydrophobic ligands. RBP7 is cytoplasmic protein which, like CRBP I and CRBP II,
forms ?-barrel structures and participates in the intracellular transport of retinol. RBP7
is a newly identified cellular retinol carrier, which is expressed in the kidney, heart and
transverse colon in humans.
RBP7 CYT-023 5 µg 50
Recombinant Human Retinol Binding Protein-7 -20 °C 20 µg 130
Retinoid-binding Protein 7, Cellular retinoic acid-binding 1 mg 2,700
Protein 4, CRABP4, CRBP4, Cellular retinoic acid-binding
Protein IV, CRABP-IV, RBP7, MGC7064
MGSSHHHHHH SSGLVPRGSH MPADLSGTWT LLSSDNFEGY MLALGIDFAT RKIAKLLKPQ
KVIEQNGDSF TIHTNSSLRN YFVKFKVGEE FDEDNRGLDN RKCKSLVIWD NDRLTCIQKG EKKNRG-
WTHW IEGDKLHLEM FCEGQVCKQT FQRA
RBP7 Human Recombinant fused with a 20 amino acid His tag at N-terminus produced in E.Coli is a
single, non-glycosylated, polypeptide chain containing 154 amino acids (1-134 a.a.) and having a molecu-
lar mass of 17.6kDa.

SAA1 (Serum Amyloid A)

SAA1 protein is an acute phase apolipoprotein reactant which is produced mostly by
hepatocytes and under regulation of inflammatory cytokines. SAA1 (Serum amyloid
A1) protein is produced mainly in the liver and circulates in low levels in the blood. The
SAA1 seems to have a role in the immune system. SAA1 protein levels increase in
the blood and other tissues under conditions of inflammation. SAA1 may facilitate the
PEPTIDES INTERNATIONAL

repair of injured tissues; it also acts as an antibacterial agent, and signals the migration
of germ-fighting cells to sites of infection. SAA1 also functions as an apolipoprotein of
the HDL complex.
Elevated levels of SAA1 ultimately affect secondary amyloidosis, extracellular amass-
ing of amyloid fibrils, resulting from a circulating precursor, in a variety of tissues and
organs. The most widespread type of amyloidosis appears secondary to chronic in -
flammatory disease, mainly rheumatoid arthritis. The SAA1 cleavage produces a des-
ignated amyloid protein A that is deposited systemically as amyloid in vital organs such
as the liver, spleen, and kidneys in chronic inflammatory diseases patients. These
deposits are extremely insoluble and resistant to proteolysis; they disrupt tissue struc-
ture and compromise performance.
SAA1 Human CYT-787 10 µg 50
Recombinant Human Serum Amyloid A (APO-SAA1) -20 °C 50 µg 130
Serum amyloid A Protein, SAA, Amyloid Protein A, Amyloid 1 mg 1,260
fibril Protein AA, SAA1, SAA2, PIG4, TP53I4, MGC111216
RSFFSFLGEA FDGARDMWRA YSDMREANYI GSDKYFHARG NYDAAKRGPG GVWAAEAISD AR-
ENIQRFFG HGAEDSLADQ AANEWGRSGK DPNHFRPAGL PEKY
SAA1 Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing
104 amino acids and having a molecular mass of 11.7kDa.

474 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
SAA1 His CYT-675 10 µg 50
Recombinant Human Serum Amyloid A (APO-SAA1), His Tag -20 °C 50 µg 130
Serum amyloid A Protein, SAA, Amyloid Protein A, Amyloid 1 mg 1,260
fibril Protein AA, SAA1, SAA2, PIG4, TP53I4, MGC111216

MGSSHHHHHH SSGLVPRGSH MRSFFSFLGE AFDGARDMWR AYSDMREANY IGSDKYFHAR GNY-

DAAKRGP GGVWAAEAIS DARENIQRFF GHGAEDSLAD QAANEWGRSG KDPNHFRPAG LPEKY
SAA1 Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing
125 amino acids (19-122 a.a.) and having a total molecular mass of 13.9 kDa. SAA1 is fused to a 20
amino acid His Tag at N-terminus.

rmSAA1 CYT-719 2 µg 50
Recombinant Rhesus Macaque Serum Amyloid A (APO-SAA1) -20 °C 10 µg 130
Serum amyloid A Protein, SAA, Amyloid Protein A, Amyloid 1 mg 3,500
fibril Protein AA, SAA1, SAA2, PIG4, TP53I4, MGC111216
RSWFSFLGEA YDGARDMWRA YSDMKEANYK NSDKYFHARG NYDAAQRGPG GVWAAEVISD
ARENIQKLLG RGAEDTLADQ AANEWGRSGK DPNHFRPAGL PEKY
SAA1 monkey Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing
104 amino acids and having a total molecular mass of 11.8 kDa.

SAA4 CYT-002 2 µg 50
Recombinant Human Serum Amyloid A4 -20 °C 10 µg 130
Serum amyloid A-4 Protein, Constitutively expressed serum 1 mg 5,200
amyloid A Protein, C-SAA, SAA4, CSAA
MGSSHHHHHH SSGLVPRGSH MWRSFFKEAL QGVGDMGRAY WDIMISNHQN SNRYLYARGN
YDAAQRGPGG VWAAKLISRS RVYLQGLIDY YLFGNSSTVL EDSKSNEKAE EWGRSGKDPD RFRP-

PEPTIDES INTERNATIONAL
DGLPKK Y
SAA4 Human Recombinant fused with a 21 amino acid His tag at N-terminus produced in E.Coli is a
single, non-glycosylated, polypeptide chain containing 131 amino acids (21-130 a.a.) and having a molecu-
lar mass of 14.9kDa.

SCF (Stem Cell Factor)

Stem cell factor / KIT ligand (SCF) is a cytokine which binds CD117(c-Kit). SCF is also
known as “steel factor” or “c-kit ligand”. SCF exists in two forms, cell surface bound
SCF and soluble (or free) SCF. Soluble SCF is produced by the cleavage of surface
bound SCF by metalloproteases. SCF is a growth factor important for the survival,
proliferation, and differentiation of hematopoietic stem cells and other hematopoietic
progenitor cells. One of its roles is to change the BFU-E (burst-forming unit-erythroid)
cells, which are the earliest erythrocyte precursors in the erythrocytic series, into the
CFU-E (colony-forming unit-erythroid).
SCF CYT-255 2 µg 50
Recombinant Human Stem Cell Factor -20 °C 10 µg 130
Kit ligand Precursor, C-kit ligand, SCF, Mast cell growth factor, 1 mg 2,700
MGF, SF, KL-1, Kitl, DKFZp686F2250
The sequence of the first five N-terminal amino acids was determined and was found to be Met-Glu-Gly-
Ile-Cys
Stem Cell Factor Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain
containing 165 amino acids and having a molecular mass of 18409 Dalton.
K. Masson, et al., Biochemical Journal, BJ20060464 (2006).
J. Sun, et al., Journal of Biological Chemistry, 284, 17 (2009).
F. Zadjali, et al., The Journal of Biological Chemistry, 286, 1 (2011).

Order Hotline 1-800-777-4779 502-266-8787 475

 PRODUCT Code Qty PRICE
Recombinant proteins

mSCF CYT-275 2 µg 50
Recombinant Mouse Stem Cell Factor; Kit ligand Precursor, -20 °C 10 µg 130
C-kit ligand, SCF, Mast cell growth factor, MGF, SF, KL-1, Kitl, 1 mg 2,700
DKFZp686F2250, Hematopoietic growth factor KL, Steel factor
MKEICGNPVT DNVKDITKLV ANLPNDYMIT LNYVAGMDVL PSHCWLRDMV IQLSLSLTTL LDKFSNISEG
LSNYSIIDKL GKIVDDLVLC MEENAPKNIK ESPKRPETRS FTPEEFFSIF NRSIDAFKDF MVASDTSDCV
LSSTLGPEKD SRVSVTKPFM LPPVA
Stem Cell Factor Mouse Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain
containing 165 amino acids and having a molecular mass of 18309 Dalton.
J. Yang, et al., Journal of Hematology & Oncology, 4, 38 (2011).
V. Vas, et al., PLoS ONE, 7, 2 (2012).

rSCF CYT-323 2 µg 50
Recombinant Rat Stem Cell Factor; Kit ligand Precursor, -20 °C 10 µg 130
C-kit ligand, SCF, Mast cell growth factor, MGF, SF, KL-1, Kitl, 1 mg 2,700
DKFZp686F2250, Hematopoietic growth factor KL
MQEICRNPVT DNVKDITKLV ANLPNDYMIT LNYVAGMDVL PSHCWLRDMV THLSVSLTTL LDKF-
SNISEG LSNYSIIDKL GKIVDDLVAC MEENAPKNVK ESLKKPETRN FTPEEFFSIF NRSIDAFKDF
MVASDTSDCV LSSTLGPEKD SRVSVTKPFM LPPVA
Stem cell factor Rat Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain
containing 164 amino acids (26-189) and having a molecular mass of 18.4 kDa.

SCF Sf9 CYT-421 2 µg 50

Recombinant Human Stem Cell Factor, Sf9; Kit ligand -20 °C 10 µg 130
Precursor, C-kit ligand, SCF, Mast cell growth factor, MGF, SF, 1 mg 4,500
KL-1, Kitl, DKFZp686F2250
PEPTIDES INTERNATIONAL

Stem Cell Factor Human Recombinant produced in insect cells is a single, glycosylated polypeptide
chain containing 165 amino acids and having a molecular mass of 18409 Dalton. The SCF is fused to a
C-terminal His-tag (6x His).

SCF HEK CYT-111 2 µg 50

Recombinant Human Stem Cell Factor, HEK; Kit ligand -20 °C 10 µg 130
Precursor, C-kit ligand, SCF, Mast cell growth factor, MGF, SF, 1 mg 5,200
KL-1, Kitl, DKFZp686F2250
SCF Human Recombinant produced in HEK cells is a glycosylated monomer, having a molecular weight
range of 35-45kDa due to glycosylation.

k9SCF CYT-194 2 µg 50
Recombinant Canine Stem Cell Factor; Kit ligand Precursor, -20 °C 10 µg 130
C-kit ligand, SCF, Mast cell growth factor, MGF, SF, KL-1, Kitl, 1 mg 2,700
DKFZp686F2250
KGICGKRVTD DVKDVTKLVA NLPKDYKIAL KYVPGMDVLP SHCWISVMVE QLSVSLTDLL DKF-
SNISEGL SNYSIIDKLV KIVDDLVECT EGYSFENVKK APKSPELRLF TPEEFFRIFN RSIDAFKDLE
TVASKSSECV VSSTLSPDKD SRVSVTKPFM LPPVA
Stem Cell Factor Canine Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain
containing 165 amino acids and having a molecular mass of 18.4kDa Dalton.

476 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
SCGB1A1 (Secretoglobin Family 1A Member 1)
Uteroglobin (SCGB1A1) which belongs to the Secretoglobin (SCGBs) superfamily ,
is a multifunctional protein that exerts anti-inflammatory and anti-tumorigenic effects
by binding small hydrophobic molecules such as phospholipids and prostaglandins.
Uteroglobin is involved in numerous functions including anti-inflammation, inhibition
of phospholipase A2 and the sequestering of hydrophobic ligands. SCGB1A1 is ex -
pressed by Clara cells, the non-ciliated, non-mucous secretory cells predominant in
lung bronchioles, and by other epithelia which communicate with the external environ-
ment. On top of sequestering pro-inflammatory mediators and carcinogens, Uteroglo-
bin is implicated in the inhibition of cell migration and invasion, platelet aggregation,
and T cell differentiation. SCGB1A1 gene defects are associated with a susceptibility
to asthma.

mSCGB1A1 CYT-746 10 µg 50
Recombinant Mouse Uteroglobin; Uteroglobin, Clara cell 17 -20 °C 50 µg 130
kDa Protein, Clara cell phospholipid-binding Protein, CCPBP, 1 mg 1,350
Clara cells 10 kDa secretory Protein, CC10, PCB-binding
Protein, Secretoglobin family 1A member 1, Scgb1a1, Ugb, Utg,
UG, CC16, CCSP, PCB-BP
Uteroglobin Mouse Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain
containing 75 amino acids and having a molecular mass of 16.7kDa.

SCGB1A1 Human CYT-743 10 µg 50

Recombinant Human Uteroglobin; Uteroglobin, Clara cell -20 °C 50 µg 130

PEPTIDES INTERNATIONAL
phospholipid-binding Protein, CCPBP, Clara cells 10 kDa 1 mg 1,350
secretory Protein, CC10, Secretoglobin family 1A member 1,
Urinary Protein 1, UP-1, UP1, Urine Protein 1, SCGB1A1, CCSP,
UGB, CC16
EICPSFQRVI ETLLMDTPSS YEAAMELFSP DQDMREAGAQ LKKLVDTLPQ KPRESIIKLM EKI-
AQSSLCN
Uteroglobin Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain
containing 70 amino acids and having a molecular mass of 15.8kDa.

SCGB1A1 His CYT-752 2 µg 50

Recombinant Human Uteroglobin, His Tag; Uteroglobin, Clara -20 °C 10 µg 130
cell phospholipid-binding Protein, CCPBP, Clara cells 10 kDa 1 mg 5,200
secretory Protein, CC10, Secretoglobin family 1A member 1,
Urinary Protein 1, UP-1, UP1, Urine Protein 1, SCGB1A1, CCSP,
UGB, CC16
MKHHHHHHASEICPSFQRVI ETLLMDTPSS YEAAMELFSP DQDMREAGAQ LKKLVDTLPQ KPRESII-
KLM EKIAQSSLCN
Uteroglobin Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain
containing 80 amino acids and including a 10 a.a N-terminal His tag. The total molecular mass is 9.2kDa
(calculated).

Order Hotline 1-800-777-4779 502-266-8787 477

 PRODUCT Code Qty PRICE
Recombinant proteins

SF20 CYT-622 10 µg 50
Recombinant Human Chromosome 19 Open Reading Frame 10, -20 °C 50 µg 130
C19orf10, Interleukin-25, IL-25, IL25, IL27, IL-27, IL27w, IL-27w, 1 mg 1,800
Stromal cell-derived growth factor SF20, UPF0556 Protein
C19orf10, chromosome 19 open reading frame 10
SF20 Human Recombinant produced in E.Coli is single, a non-glycosylated, Polypeptide chain containing
162 amino acids fragment (33-173) and having a total molecular mass of 18 kDa. C9orf10 is fused to 20
amino acids His tag at N-terminus. SF20 plays a role in proliferation of lymphoid cells and is considered an
interleukin. SF20 was initially identified as a product of bone marrow-derived stromal cells.

mSF20 CYT-678 2 µg 50
Recombinant Mouse Chromosome 19 Open Reading Frame 10; -20 °C 10 µg 130
UPF0556 Protein C19orf10 homolog, Stromal cell-derived 1 mg 4,680
growth factor SF20, Interleukin-25, IL-25, D17Wsu104e, Il25,
IL27, SF20, IL27w, R33729_1, C19orf10, Chromosome 19 Open
Reading Frame 10
MVSEPTTVPF DVRPGGVVHS FSQDVGPGNK FTCTFTYASQ GGTNEQWQMS LGTSEDSQHF TCTI-
WRPQGK SYLYFTQFKA ELRGAEIEYA MAYSKAAFER ESDVPLKSEE FEVTKTAVSH RPGAFKAELS
KLVIVAKAAR SEL
Chromosome 19 Open Reading Frame 10 Mouse Recombinant produced in E.Coli is a single, non-
glycosylated, polypeptide chain containing 143 amino acids and having a molecular mass of 15.8kDa.
Mouse SF20 is a bone marrow stroma-derived growth factor. SF20 is expressed in the bone marrow,
spleen stroma cells, resting mononuclear cells, resting CD8+ and CD19+ cells and activated CD8+ T cells.
SF20 has been shown to bind to the surface of cells expressing the receptor TSA-1 (Thymic shared Ag-1).
Among SF20’s biological activities is stimulation of the proliferation of FDCP2 cells (a mouse factor-depen-
dent hemopoietic cell line) and mouse lymphoid cells.
PEPTIDES INTERNATIONAL

SHH (Sonic Hedgehog)

Recombinant Human Sonic Hedgehog is part of a small group of secreted proteins
that are vital for development in both vertebrates and invertebrates. Three mamma-
lian hedgehog genes (sonic, desert, Indian) share about 60% homology . The Hu-
man Sonic Hedgehog is 99% homologous to the mouse gene. Sonic HedgeHog is
a protein that is vital in guding the early embryo. It has been associated as the major
inductive signal in patterning of the ventral neural tube, the anterior-posterior limb axis,
and the ventral somites. Sonic HedgeHog binds to the patched receptor , which func-
tions in association with smoothened, to activate the transcription of target genes. In
the absence of sonic HedgeHog, patched receptor represses the constitutive signal -
ing activity of smoothened. Sonic HedgeHog also regulates another factor , the gli
oncogene. Sonic HedgeHog intercellular signal is essential for a various patterning
events during development: signal produced by the notochord that induces ventral
cell fate in the neural tube and somites, and the polarizing signal for patterning of the
anterior-posterior axis of the developing limb bud. S onic HedgeHog exhibits both floor
plate- and motor neuron-inducing activity. Mutations in a long-range Sonic HedgeHog
enhancer located in an intron of the limb region 1 gene result in preaxial polydactyly.

478 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
SHH CYT-676 5 µg 50
Recombinant Human Sonic HedgeHog -20 °C 25 µg 130
SHH, HHG-1, HHG1, Sonic hedgehog Protein, TPT, HLP3, HPE3, 1 mg 2,500
SMMCI, TPTPS, MCOPCB5
MIIGPGRGFG KRRHPKKLTP LAYKQFIPNV AEKTLGASGR YEGKISRNSE RFKELTPNYN PDIIFK-
DEEN TGADRLMTQR CKDKLNALAI SVMNQWPGVK LRVTEGWDED GHHSEESLHY EGRALDITTS
DRDRSKYGML ARLAVEAGFD WVYYESKAHI HCSVKAENSV AAKSGG
Sonic HedgeHog Recombinant Human produced in E.Coli is a single, non-glycosylated polypeptide chain
containing 175 amino acids and having a molecular mass of 19.7kDa.

SHH, His CYT-717 5 µg 50

Recombinant Human Sonic HedgeHog, His Tag -20 °C 25 µg 130
SHH, HHG-1, HHG1, Sonic hedgehog Protein, TPT, HLP3, HPE3, 1 mg 2,250
SMMCI, TPTPS, MCOPCB5
MCGPGRGFGK RRHPKKLTPL AYKQFIPNVA EKTLGASGRY EGKISRNSER FKELTPNYNP DIIFK-
DEENT GADRLMTQRC KDKLNALAIS VMNQWPGVKL RVTEGWDEDG HHSEESLHYE GRAVDITTSD
RDRSKYGMLA RLAVEAGFDW VYYESKAHIH CSVKAENSVA AKSGGLEHHH HHH
Sonic HedgeHog Recombinant Human produced in E.Coli is a single, non-glycosylated polypeptide chain
containing 183 amino acids and having a molecular mass of 20.7kDa. The Sonic HedgeHog is fused to 8
amino acid His-Tag at C-terminus.

mSHH CYT-597 5 µg 50
Recombinant Mouse Sonic HedgeHog -20 °C 25 µg 130
SHH, HHG-1, HHG1, Sonic hedgehog Protein 1 mg 2,520

MIIGPGRGFG KRRHPKKLTP LAYKQFIPNV AEKTLGASGR YEGKITRNSE RFKELTPNYN PDIIFK-

PEPTIDES INTERNATIONAL
DEEN TGADRLMTQR CKDKLNALAI SVMNQWPGVK LRVTEGWDED GHHSEESLHY EGRAVDITTS
DRDRSKYGML ARLAVEAGFD WVYYESKAHI HCSVKAENSV AAKSGG
Sonic Hedgehog Recombinant Mouse produced in E.Coli is a single, non-glycosylated polypeptide chain
containing 176 amino acids and having a molecular mass of 19.8 kDa. The Mouse Sonic Hedgehog is
99% homologous to the human gene. Cysteine at position 25 has been substituted with Ile.

mSHH, His CYT-711 5 µg 50

Recombinant Mouse Sonic HedgeHog, His Tag -20 °C 25 µg 130
SHH, HHG-1, HHG1, Sonic hedgehog Protein, TPT, HLP3, HPE3, 1 mg 2,250
SMMCI, TPTPS, MCOPCB5
MCGPGRGFGK RRHPKKLTPL AYKQFIPNVA EKTLGASGRY EGKITRNSER FKELTPNYNP DIIFK-
DEENT GADRLMTQRC KDKLNALAIS VMNQWPGVKL RVTEGWDEDG HHSEESLHYE GRAVDITTSD
RDRSKYGMLA RLAVEAGFDW VYYESKAHIH CSVKAENSVA AKSGGLEHHH HHH
SHH Mouse Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing
183 amino acids (25-198 a.a.) and having a molecular mass of 20.8 kDa. SHH protein is fused to a 8
amino acid His-Tag at C-terminus and purified by standard chromatography.

Order Hotline 1-800-777-4779 502-266-8787 479

 PRODUCT Code Qty PRICE
Recombinant proteins

SPP1
Osteopontin is a glycoprotein that was first identified in osteoblasts and is involved
in bone remodeling, immune functions in fibroblasts, macrophages, and lymphocytes
during inflammation and wound healing. SPP1 binds tightly to hydroxyapatite. SPP1
forms an integral part of the mineralized matrix. SPP1 is vital to cell-matrix interaction.
Secreted Phosphoprotein-1 protects against cardiac ischemia-reperfusion injury via
late preconditioning. Expression of both Ostepontin and CD44 in hepatocellular carci -
noma is linked with advanced tumor stage and contributes to prognosis information.
SPP1 is the most over-expressed gene in intrahepatic cholangiocarcinoma. Secreted
Phosphoprotein-1 overexpression is related with interstitial lung diseases.

SPP1 Human CYT-635 2 µg 50

Recombinant Human Osteopontin -20 °C 10 µg 130
Secreted PhosphoProtein-1, OPN, BNSP, BSPI, ETA-1, 1 mg 5,200
MGC110940, SPP-1, Osteopontin, Bone sialoProtein 1, Urinary
stone Protein, Nephropontin, Uropontin, SPP1
MGSSHHHHHH SSGLVPRGSH RSMIPVKQAD SGSSEEKQLY NKYPDAVATW LNPDPSQKQN
LLAPQNAVSS EETNDFKQET LPSKSNESHD HMDDMDDEDD DDHVDSQDSI DSNDSDDVDD
TDDSHQSDES HHSDESDELV TDFPTDLPAT EVFTPVVPTV DTYDGRGDSV VYGLRSKSKK FRRP-
DIQYPD ATDEDITSHM ESEELNGAYK AIPVAQDLNA PSDWDSRGKD SYETSQLDDQ SAETHSHKQS
RLYKRKANDE SNEHSDVIDS QELSKVSREF HSHEFHSHED MLVVDPKSKE EDKHLKFRIS HELDSAS-
SEV N
Secreted Phosphoprotein-1 Human Recombinant produced in E.Coli is single, a non-glycosylated, Poly-
peptide chain containing 321 amino acids fragment (17-314) and having a total molecular mass of 36.2
PEPTIDES INTERNATIONAL

kDa (molecular weight on SDS-PAGE will shift up). The SPP1 protein is fused to a 20 amino acid His-Tag
at N-terminus.

SPP1 HEK CYT-047 10 µg 50

Recombinant Human Osteopontin, HEK; Secreted -20 °C 50 µg 130
PhosphoProtein-1, OPN, BNSP, BSPI, ETA-1, MGC110940, SPP- 1 mg 2,000
1, Osteopontin, Bone sialoProtein 1, Urinary stone Protein,
Nephropontin, Uropontin, SPP1
IPVKQADSGSSEEKQLYNKYPDAVATWLNPDPSQKQNLLAPQNAVSSEETNDFKQETLPSKSNESHDH-
MDDMDDEDDDDHVDSQDSIDSNDSDDVDDTDDSHQSDESHHSDESDELVTDFPTDLPATEVFTPV-
VPTVDTYDGRGDSVVYGLRSKSKKFRRPDIQYPDATDEDITSHMESEELNGAYKAIPVAQDLNAPSDWD-
SRGKDSYETSQLDDQSAETHSHKQSRLYKRKANDESNEHSDVIDSQELSKVSREFHSHEFHSHEDMLV-
VDPKSKEEDKHLKFRISHELDSASSEVNVDHHHHHH
Osteopontin Human Recombinant is a single, glycosylated, polypeptide chain produced in HEK293 cells,
is a full length protein (amino acids 17-314) fused with a polyhistidine tag at the C-terminus, having a total
calculated molecular mass of 34.5kDa (The actual molecular mass may be approximately 60-65kDa in
SDS-PAGE under reducing conditions due to glycosylation).

480 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
TACI (TNFRSF13B (Tumor Necrosis Factor Receptor Superfamily, Member
13B))
TNFRSF13B (TACI) is a transmembrane receptor protein found predominantly on the
surface of B cells (a significant part of the immune system). TACI was at first dis-
covered owing to its ability to interact with calcium-modulator and cyclophilin ligand
(CAML). Later on, it was found that TACI plays a key role in humoral immunity by
interacting with two members of theTNF family. Also, TACI controls T cell-independent
B cell antibody responses, isotype switching, and B cell homeostasis.

TACI Human CYT-032 5 µg 50

Recombinant Human Tumor Necrosis Factor Receptor 13B; -20 °C 20 µg 130
CD267, CVID, CVID2, TACI, TNFRSF14B, Tumor necrosis 1 mg 2,700
factor receptor superfamily, member 13B, Tumor necrosis
factor receptor superfamily, member 13B, isoform CRA_a,
TNFRSF13B
MGSSHHHHHH SSGLVPRGSH MGSMSGLGRS RRGGRSRVDQ EERFPQGLWT GVAMRSCPEE
QYWDPLLGTC MSCKTICNHQ SQRTCAAFCR SLSCRKEQGK FYDHLLRDCI SCASICGQHP KQCAYF-
CENK LRSPVNLPPE LRRQRSGEVE NNSDNSGRYQ GLEHRGSEAS PALPGLKLSA DQVALVYS
TACI Human Recombinant fused with a 23 amino acid His tag at N-terminus produced in E.Coli is a single,
non-glycosylated, polypeptide chain containing 188 amino acids (1- 165a.a.) and having a molecular mass
of 20.9kDa.
Avoid multiple freeze-thaw cycles.

TAFA-2

PEPTIDES INTERNATIONAL
TAFA-2 is a 11 kDa secreted protein that belongs to the FAM19/TAFA family of che-
mokine-like proteins. Similar to other F AM19/TAFA family members, mature TAFA-1
contains 10 regularly spaced cysteine residues with the same pattern: CX7CCX13CX-
CX14CX11CX4CX5CX10C (C symbolizes a conserved cysteine residue and X sym -
bolizes any noncysteine amino acid). Human TAFA-2 is 97% aa identical to mouse
TAFA-2 and is expressed in the central nervous system (CNS), colon, heart, lung,
spleen, kidney, and thymus; however its expression in the CNS is 50 to 1000 fold
higher than in other tissues. The biological roles of TAFA family members have not
yet been determined.

TAFA2 CYT-118 5 µg 50
Recombinant Human Family with Sequence Similarity 19 -20 °C 20 µg 130
Member A2; Family with sequence similarity 19 (chemokine 1 mg 2,700
(C-C motif)-like) member A2, Chemokine-like Protein TAFA-2,
Protein FAM19A2
ANHHKAHHVK TGTCEVVALH RCCNKNKIEE RSQTVKCSCF PGQVAGTTRA APSCVDASIV EQKW-
WCHMQP CLEGEECKVL PDRKGWSCSS GNKVKTTRVT H
TAFA2 Human Recombinant produced in E.Coli is a non-glycosylated, Polypeptide chain containing 101
amino acids and having a molecular mass of 11.2kDa.
Avoid multiple freeze-thaw cycles.

Order Hotline 1-800-777-4779 502-266-8787 481

 PRODUCT Code Qty PRICE
Recombinant proteins

TFF(Trefoil Factor Peptides)

The Trefoil Factor peptides (TFF1, TFF2 and TFF3) are stable secretory proteins ex -
pressed in the gastrointestinal tract (gastric mucosa), and are involved in intestinal
mucosal defense and repair. TFF1 is an essential protein for normal dif ferentiation of
the antral and pyloric gastric m ucosa and functions as a gastric-specific tumor sup-
pressor gene. TFF1 is a stabilizer of the mucous gel overlying the gastrointestinal
mucosa that provides a physical barrier against various noxious agents.TFF1 protects
the mucosa from isults, stabilizes the mucus layer, & affects healing of the epithelium.
TFF1 is commonly expressed in tumors. TFF1 is related with the cell membrane of
MCF-7 cells. High levels of TFF1 and TFF2 are found in serum from inflammatory
bowel disease.
Proteins of the TFF family are characterized by obtaining a minimum of 1 copy of the
trefoil motif, a 40-amino acid domain that contains 3 conserved disulfides. Trefoil Fac-
tors are stable secretory proteins expressed in gastrointestinal mucosa which protect
the mucosa from insults, stabilize the mucus layer and affect healing of the epithelium.
TFF2 inhibits gastric acid motility & secretion. TFF2 stabilizes glycoproteins in the
mucus gel through interactions with carbohydrate side chains

TFF1 CYT-586 5 µg 50
Recombinant Human Trefoil Factor-1; TFF-1, TFF1, pS2, BCEI, -20 °C 20 µg 130
HPS, HP1.A, pNR-2, D21S21, pS2 Protein, Trefoil factor 1, 1 mg 2,700
Breast cancer estrogen-inducible Protein
EAQTETCTVAPRERQNCGFPGVTPSQCANKGCCFDDTVRGVPWCFYPNTIDVPPEEECEF
PEPTIDES INTERNATIONAL

TFF-1 Human Recombinant produced in E.Coli is a homodimer, non-glycosylated, polypeptide chain con-
taining 2 x 60 amino acids which includes a 40 amino acid trefoil motif containing 3 conserved interamo-
lecular disulfide bonds and having a total molecular mass of 13.2 kDa.

TFF1 His CYT-610 5 µg 50

Recombinant Human Trefoil Factor-1 His Tag; TFF-1, TFF1, -20 °C 20 µg 130
pS2, BCEI, HPS, HP1.A, pNR-2, D21S21, pS2 Protein, Trefoil 1 mg 3,000
factor 1, Breast cancer estrogen-inducible Protein
MKHHHHHHAS EAQTETCTVA PRERQNCGFP GVTPSQCANK GCCFDDTVRG VPWCFYPNTI DVP-
PEEECEF
TFF-1 Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing
70 amino acids (25-84) which includes a 10 amino acid His Tag and having a total molecular mass of 7.9
kDa.

TFF2 CYT-612 5 µg 50
Recombinant Human Trefoil Factor-2; TFF-2, Spasmolytic -20 °C 20 µg 130
polypeptide, Spasmolysin, SML1, Trefoil factor 2, SP 1 mg 2,700

EKPSPCQCSR LSPHNRTNCG FPGITSDQCF DNGCCFDSSV TGVPWCFHPL PKQESDQCVM EVS-

DRRNCGY PGISPEECAS RKCCFSNFIF EVPWCFFPKSVEDCHY
TFF-2 Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing
106 amino acids (24-129) and having a total molecular mass of 12 kDa. TFF2 Human Recombinant
includes a 40-amino acid trefoil motif containing three conserved intramolecular disulfide bonds

482 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
TFF2 His CYT-611 5 µg 50
Recombinant Human Trefoil Factor-2 His Tag; TFF-2, SP, -20 °C 20 µg 130
Spasmolytic polypeptide, Spasmolysin, SML1, Trefoil factor 2 1 mg 2,900

MKHHHHHHAS EKPSPCQCSR LSPHNRTNCG FPGITSDQCF DNGCCFDSSV TGVPWCFHPL

PKQESDQCVM EVSDRRNCGY PGISPEECAS RKCCFSNFIF EVPWCFFPKSVEDCHY
TFF-2 Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing
116 amino acids (24-129) which includes a 10 amino acid His Tag fused at N-terminus and having a total
molecular mass of 13.2 kDa.

TFF3 CYT-005 5 µg 50
Recombinant Human Trefoil Factor-3; TFF-3, ITF, TFI, HITF, -20 °C 20 µg 130
hP1.B, TFF3, Trefoil factor 3, Intestinal trefoil factor 1 mg 2,700
EEYVGLSANQ CAVPAKDRVD CGYPHVTPKE CNNRGCCFDS RIPGVPWCFKPLQEAECTF
TFF-3 Human Recombinant produced in E.Coli is a homodimeric, non-glycosylated, polypeptide chain
containing 2 x 59 amino acid chains which includes a 40 amino acid trefoil motif containing 3 conserved
interamolecular disulfide bonds and having a total molecular mass of 13.2kDa.

TFF3 His CYT-616 5 µg 50

Recombinant Human Trefoil Factor-3 His Tag; TFF-3, ITF, TFI, -20 °C 20 µg 130
HITF, hP1.B, TFF3, Trefoil factor 3, Intestinal trefoil factor 1 mg 2,900

MKHHHHHHAS EEYVGLSANQ CAVPAKDRVD CGYPHVTPKE CNNRGCCFDS RIPGVPWCFK

PLQEAECTF
TFF3 Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing
69 amino acids (22-80 a.a.) which includes a 10 amino acid His Tag fused at N-terminus and having a total
molecular mass of 7.82 kDa

PEPTIDES INTERNATIONAL
rTFF3 CYT-781 2 µg 50
Recombinant Rat Trefoil Factor-3; Trefoil factor 3, Intestinal -20 °C 10 µg 130
trefoil factor, rITF, Polypeptide P1.B, rP1.B, Tff3, Itf 1 mg 5,200

MQEFVGLSPS QCMVPANVRV DCGYPTVTSE QCNNRGCCFD SSIPNVPWCF KPLQETECT F

DYKDDDDK
The Trefoil Factor-3 Rat was constructed as a recombinant protein with a 9 a.a C-terminal fusion of Flag-
Tag (1 aa N-terminal+8 aa C-terminal). The TFF3 Rat produced in E.Coli, is 7.7kDa protein containing a
total of 68 amino acid residues.

TGFβ (Transforming growth factor β)

Transforming growth factor β (TGFβ) mediate many cell-cell interactions that occur dur-
ing embryonic development. Three TGFβs have been identified in mammals. TGFβ1,
TGFβ2 and TGFβ3 are each synthesized as precursor proteins that are very similar in
that each is cleaved to yield a 112 amino acid polypeptide that remains associated with
the latent portion of the molecule.
TGF b 1 CYT-716 1 µg 50
Recombinant Human Transforming Growth Factor-Β 1 -20 °C 5 µg 130
Transforming growth factor β-1, TGF-β-1, CED, DPD1, TGFB, 100 µg 1,500
TGF-b 1, LAP, TGFB1
ALDTNYCFSS TEKNCCVRQL YIDFRKDLGW KWIHEPKGYH ANFCLGPCPY IWSLDTQYSK VLALYN-
QHNP GASAAPCCVP QALEPLPIVY YVGRKPKVEQ LSNMIVRSCK CS
TGFB1 Human Recombinant produced in Human 293 cells is a homodimeric polypeptide chain containing
2 x 112 amino acids and having a total molecular mass of 25kDa.
P. Huang, et al., FASEB Journal, .23, 8 (2009).
H. Kallio, et al., PLoS ONE, 6, 11 (2011).
H. Kallio, et al., J. Cancer Mol., 5, 3 (2010).

Order Hotline 1-800-777-4779 502-266-8787 483

 PRODUCT Code Qty PRICE
Recombinant proteins

TGF b 1 CYT-561 1 µg 400

Human Transforming Growth Factor-Β 1; Transforming growth -20 °C 2.5 µg 950
factor β-1, TGF-β-1, CED, DPD1, TGFB, TGF-b 1 5 µg 1,800
Human Transforming Growth Factor-beta 1 purified from Human Platelets having a molecular mass of
25kDa.
Do Not Reconstitute With Neutral Buffers. Do Not Use Glass Implements Or Extensive Manipula-
tion. Prevent Freeze Thaw Cycles.

TGF b 1 GST CYT-473 2 µg 50

Recombinant Human Transforming Growth Factor-Β 1, GST tag -20 °C 10 µg 130
Transforming growth factor β-1, TGF-β-1, CED, DPD1, TGFB 100 µg 1,000
The sequence of the first five N-terminal amino acids was determined and was found to be Ala-Leu-Asp-
Thr-Asn
The Recombinant Human TGF-b1 (aa 309-391) is purified by standard chromatographic techniques and
shows a 35kDa band on SDS-PAGE (including GST tag).

TGF b 1 His CYT-672 2 µg 50

Recombinant Human Transforming Growth Factor-Β 1 His Tag -20 °C 10 µg 130
Transforming growth factor β-1, TGF-beta-1, CED, DPD1, TGFB, 1 mg 4,800
TGF-b 1, TGFB1
TGF-b 1 Human Recombinant produced in E.Coli is a single, non-glycosylated, Polypeptide chain contain-
ing 112 amino acids fragment (279-390) having a molecular weight of 17.3kDa and fused with a 4.5kDa
amino-terminal hexahistidine tag.

TGF b 1 (113 a.a.) CYT-679 2 µg 50

10 µg 130
PEPTIDES INTERNATIONAL

Recombinant Human Transforming Growth Factor-Β 1 (113 a.a.) -20 °C

Transforming growth factor β-1, TGF-β-1, CED, DPD1, TGFB, 1 mg 5,200
TGF-b 1
MALDTNYCFS STEKNCCVRQ LYIDFRKDLG WKWIHEPKGY HANFCLGPCP YIWSLDTQYS KVLALYN-
QHN PGASAAPCCV PQALEPLPIVYYVGRKPKVE QLSNMIVRSC KCS
TGF-b 1 Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain contain-
ing 113 amino acids (279-390 a.a.) and having a total molecular mass of 12.9 kDa.

TGF β 2 CYT-441 1 µg 50
Recombinant Human Transforming Growth Factor-Β 2; -20 °C 5 µg 130
Transforming growth factor, β 2, cetermin, Glioblastoma- 100 µg 1,500
derived T-cell suppressor factor, polyergin, G-TSF, TGF-β2,
TGF-β-2, transforming growth factor β-2, BSC-1 cell growth
inhibitor, TGFB-2
HHHHHHALDAAYCFRNVQDNCCLRPLYIDFKRDLGWKWIHEPKGYNANFCAGACPYLWSSDTQHSRV-
LSLYNTINPEASASPCCVSQDLEPLTI LYYIGKTPKIEQLSNMIVKSCKCS
TGFB2 Human Recombinant produced in plants is a homodimeric polypeptide chain containing 2 x
118 amino acids and having a total molecular mass of 27.08kDa. The TGFB2 is fused to 6xHis Tag at
N-terminus.

484 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
TGF β 2 HEK CYT-112 1 µg 50
Recombinant Human Transforming Growth Factor-Β 2, HEK; -20 °C 5 µg 130
Transforming growth factor, β 2, cetermin, Glioblastoma- 100 µg 1,500
derived T-cell suppressor factor, polyergin, G-TSF, TGF-β2,
TGF-β-2, transforming growth factor β-2, BSC-1 cell growth
inhibitor, TGFB-2
TGF-b 2 Human Recombinant produced in HEK cells is a non-glycosylated homodimer, having a total
molecular weight of 25kDa.

TGF β 3 CYT-368 2 µg 50
Recombinant Human Transforming Growth Factor-Β 3; -20 °C 10 µg 130
Transforming Growth Factor-β3, TGFB3, ARVD, FLJ16571, 100 µg 1,000
TGF-β3
ALDTNYCFRN LEENCCVRPL YIDFRQDLGW KWVHEPKGYY ANFCSGPCPY LRSADTTHST VLG-
LYNTLNP EASASPCCVP QDLEPLTILY YVGRTPKVEQ LSNMVVKSCK CS
TGF-β 3 Human Recombinant produced in E.Coli is a disulfide-linked homodimeric, non-glycosylated,
polypeptide chain containing two 112 amino acid chains and having a total molecular mass of 25.5kD The
TGF-b 3 is purified by standard chromatographic techniques.

TGF β 3 CHO CYT-685 2 µg 50

Recombinant Human Transforming Growth Factor-Β 3, CHO; -20 °C 10 µg 130
Transforming Growth Factor-β3, TGFB3, ARVD, FLJ16571, 100 µg 1,000
TGF-β3
The sequence of the first five N-terminal amino acids was determined and was found to be Ala-Leu-Asp-
Thr-Asn

PEPTIDES INTERNATIONAL
TGF-β 3 Human Recombinant produced in CHO is a disulfide-linked homodimeric, glycosylated, polypep-
tide chain containing 112 amino acids and having a molecular mass of 25kDa The TGF-b 3 is purified by
standard chromatographic techniques.

TGF β 3 Plant CYT-588 1 µg 50

Recombinant Human Transforming Growth Factor-Β 3, Plant; -20 °C 5 µg 130
Transforming Growth Factor-β3, TGFB3, ARVD, FLJ16571, 100 µg 1,500
TGF-β3
HHHHHALDTNYCFRNLEENCCVRPLYIDFRQDLGWKWVHEPKGYYANFCSGPCPYLRSADTTHSTVLG-
LYNTLNPEASASPCCVPQDLEPLTILYYVGRTPKVEQLSNMVVKSCKCS
TGFB3 Human Recombinant produced in plant is a disulfide-linked homodimeric, glycosylated, polypep-
tide chain containing 118 amino acids and having a molecular mass of 27.2kDa. The TGFB3 is fused to
6xHis tag at N-terminus and purified by standard chromatographic techniques.

TGF β 3 HEK CYT-113 1 µg 50

Recombinant Human Transforming Growth Factor-Β 3, HEK; -20 °C 5 µg 130
Transforming Growth Factor-β3, TGFB3, ARVD, FLJ16571, 100 µg 1,500
TGF-β3
TGF-b 3 Human Recombinant produced in HEK cells is a non-glycosylated homodimer, having a total
molecular weight of 25kDa.

Order Hotline 1-800-777-4779 502-266-8787 485

 PRODUCT Code Qty PRICE
Recombinant proteins

TGF β 3 (207 a.a.) CYT-319 2 µg 175

Recombinant Human Transforming Growth Factor-Β 3 -20 °C 5 µg 270
(644-850); Transforming Growth Factor-β3, TGFB3, ARVD, 10 µg 500
FLJ16571, TGF-β3
TGFB3 Human Recombinant protein encoding amino acids 644-850 and total molecular mass of 50 kDa
(Including GST Tag).

mTGF β 3 CYT-143 2 µg 50
Recombinant Mouse Transforming Growth Factor-Β 3; -20 °C 10 µg 130
Transforming Growth Factor-β3, TGFB3, ARVD, FLJ16571, 100 µg 1,000
TGF-β3
ALDTNYCFRN LEENCCVRPL YIDFRQDLGW KWVHEPKGYY ANFCSGPCPY LRSADTTHST VLG-
LYNTLNP EASASPCCVP QDLEPLTILY YVGRTPKVEQ LSNMVVKSCK CS
TGF-b3 Mouse Recombinant produced in E.Coli is a disulfide-linked homodimeric, non-glycosylated,
polypeptide chain containing 112 amino acids and having a molecular mass of 25.5kDa. The TGF-b 3 is
purified by standard chromatographic techniques.

TNFSF9 (Tumor Necrosis Factor Receptor Superfamily Member 9 (4 1BBR))

The protein encoded by this gene is a member of the TNF-receptor superfamily. This
receptor contributes to the clonal expansion, survival, and development of T cells. It
can also induce proliferation in peripheral monocytes, enhance T cell apoptosis in -
duced by TCR/CD3 triggered activation, and regulate CD28 co-stimulation to promote
Th1 cell responses. The expression of this receptor is induced by lymphocyte activa -
tion. TRAF adaptor proteins have been shown to bind to this receptor and transduce
PEPTIDES INTERNATIONAL

the signals leading to activation of NF-κB.

4 1BBR CYT-463 5 µg 50
Recombinant Human 4-1BB Receptor; Tumor necrosis factor -20 °C 20 µg 130
receptor superfamily member 9, 4-1BB ligand receptor T-cell, 1 mg 2,700
antigen 4-1BB homolog, T-cell antigen ILA, CD137 antigen,
CDw137, ILA, 4-1BB, MGC2172, 4-1BBR, TNFRSF9
The sequence of the first five N-terminal amino acids was determined and was found to be Met-Glu-Arg-
Thr-Ar
4-1BB Soluble Receptor Recombinant Human also called Tumor necrosis factor receptor superfamily
member 9 produced in E.Coli is a single, non-glycosylated polypeptide chain containing 167 amino acids,
having a molecular mass of 17718 Dalton and containing the cysteine rich TNFR-like extracellular domain
of 4-1BB Receptor.

4 1BBR, His CYT-137 5 µg 50

Recombinant Human 4-1BB Receptor His Tag; Tumor necrosis -20 °C 20 µg 130
factor receptor superfamily member 9, 4-1BB ligand receptor 1 mg 3,600
T-cell, antigen 4-1BB homolog, T-cell antigen ILA, CD137
antigen, CDw137, ILA, 4-1BB, MGC2172, 4-1BBR, TNFRSF9
MGSSHHHHHH SSGLVPRGSH MGSMFERTRS LQDPCSNCPA GTFCDNNRNQ ICSPCPPNSF SSAG-
GQRTCD ICRQCKGVFR TRKECSSTSN AECDCTPGFH CLGAGCSMCE QDCKQGQELT KKGCKDC-
CFG TFNDQKRGIC RPWTNCSLDG KSVLVNGTKE RDVVCGPSPA DLSPGASSVT
PPAPAREPGH SPQ
4-1BBR Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain contain-
ing 193 amino acids (18-186 a.a) and having a molecular mass of 20kDa. 4-1BBR is fused to a 24 amino
acid His-tag at N-terminus.

486 Order Hotline 1-800-777-4779 502-266-8787

 PRODUCT Code Qty PRICE
Recombinant proteins

4 1BBL CYT-149 5 µg 50
Recombinant Human 4-1BB Ligand; CD137L, CD137-L, 4-1BBL, -20 °C 20 µg 130
4-1BB Ligand, TNFSF9, Tumor Necrosis Factor (ligand) 1 mg 2,700
Superfamily Member 9
REGPELSPDD PAGLLDLRQG MFAQLVAQNV LLIDGPLSWY SDPGLAGVSL TGGLSYKEDT KELV-
VAKAGV YYVFFQLELR RVVAGEGSGS VSLALHLQPL RSAAGAAALA LTVDLPPASS EARNSAFGFQ
GRLLHLSAGQ RLGVHLHTEA RARHAWQLTQ GATVLGLFRV TPEIPAGLPS PRSE
4 1BBL Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain contain-
ing 184 amino acids and having a molecular mass of 19.5kDa.
Please prevent freeze-thaw cycles.

4 1BBL, His CYT-649 5 µg 50

Recombinant Human 4-1BB Ligand, His Tag; CD137L, CD137-L, -20 °C 20 µg 130
4-1BBL, 4-1BB Ligand, TNFSF9, Tumor Necrosis Factor (ligand) 1 mg 2,700
Superfamily Member 9
MRGSHHHHHH GMASMTGGQQ MGRDLYDDDD KDRWGSHMRE GPELSPDDPA GLLDLRQGMF
AQLVAQNVLL IDGPLSWYSD PGLAGVSLTGGLSYKEDTKE LVVAKAGVYY VFFQLELRRV VAGEGSGS-
VS LALHLQPLRS AAGAAALALT VDLPPASSEA RNSAFGFQGR LLHLSAGQRL GVHLHTEARA
RHAWQLTQGA  TVLGLFRVTP EIPAGLPSPR SE
TNFSF9 Human Recombinant fused to 37 amino acids His tag at N-terminus produced in E.Coli is a
single, non-glycosylated polypeptide chain containing 222 amino acids (71-254 a.a.) and having a molecu-
lar mass of 23.8 kDa.

TNF (Tumor Necrosis Factor)

Tumor necrosis factor is a cytokine involved in systemic inflammation and is a member
PEPTIDES INTERNATIONAL

of a group of cytokines that all stimulate the acute phase reaction. TNF is mainly
secreted by macrophages.
TNF causes apoptotic cell death, cellular proliferation, differentiation, inflammation,
tumorigenesis and viral replication, TNF is also involved in lipid metabolism, and co -
agulation. TNF’s primary role is in the regulation of immune cells.
Dysregulation and, in particular, overproduction of TNF have been implicated in a vari-
ety of human diseases- autoimmune diseases, insulin resistance, and cancer.

TNF α CYT-223 10 µg 50
Recombinant Human Tumor Necrosis Factor-α; TNF-α, -20 °C 50 µg 130
Tumor necrosis factor ligand superfamily member 2, TNF-a, 1 mg 1,350
Cachectin, DIF, TNFA, TNFSF2
MVRSSSRTPS DKPVAHVVAN PQAEGQLQWL NRRANALLAN GVELRDNQLV VPSEGLYLIY SQV-
LFKGQGC PSTHVLLTHT ISRIAVSYQT KVNLLSAIKS PCQRETPEGA E AKPWYEPIY LGGVFQLEKG
DRLSAEINRP DYLDFAESGQ VYFGIIAL
Tumor Necrosis Factor-a Human Recombinant produced in E.Coli is a single, non-glycosylated, polypep-
tide chain containing 158 amino acids (157 a.a. of the mature human TNF-α and an N-terminal methionine)
and having a molecular mass of 17.5kDa. The TNF-α is purified by standard chromatographic techniques.

487 Order Hotline 1-800-777-4779 502-266-8787

 PRODUCT Code Qty PRICE
Recombinant proteins

TNF α His CYT-494 10 µg 50

Recombinant Human Tumor Necrosis Factor-α, His Tag; TNF-α, -20 °C 50 µg 130
Tumor necrosis factor ligand superfamily member 2, TNF-a, 1 mg 1,500
Cachectin, DIF, TNFA, TNFSF2
Tumor Necrosis Factor-α Human Recombinant His produced in E.Coli is a single, non-glycosylated,
polypeptide chain containing 157 amino acids fragment (77-233) and having a molecular mass of 21.85
kDa with an amino-terminal hexahistidine tag. The TNF-α His is purified by standard chromatographic
techniques.

TNF a HEK CYT-114 2 µg 50

Recombinant Human Tumor Necrosis Factor-α, HEK; TNF-α, -20 °C 10 µg 130
Tumor necrosis factor ligand superfamily member 2, TNF-a, 1 mg 5,200
Cachectin, DIF, TNFA, TNFSF2
VRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFK-
GQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRL-
SAEINRPDYLDFAESGQVYFGIIAL
TNF-α Human Recombinant produced in HEK cells is a glycosylated non-disulfide linked homotrimer,
containing 157 and having total Mw of 17kDa.

mTNF a CYT-252 5 µg 50
Recombinant Mouse Tumor Necrosis Factor-α; TNF-α, -20 °C 20 µg 130
Tumor necrosis factor ligand superfamily member 2, TNF-a, 1 mg 2,700
Cachectin, DIF, TNFA, TNFSF2
MLRSSSQNSS DKPVAHVVAN HQVEEQLEWL SQRANALLAN GMDLKDNQLV VPADGLYLVY SQV-
LFKGQGC PDYVLLTHTV SRFAISYQEK VNLLSAVKSP CPKDTPEGAE LKPWYEPIYL GGVFQLEKGD
QLSAEVNLPK YLDFAESGQV YFGVIAL
PEPTIDES INTERNATIONAL

Tumor Necrosis Factor-a Mouse Recombinant produced in E. coli is a single, non glycosylated, polypep-
tide chain containing 157 amino acids and having a molecular mass of 17301.32 Dalton. The TNF-alpha
is purified by standard chromatographic techniques.
P. Wang, et al., Cell Death and Differentation, 16, 10 (2009).

rTNF a CYT-393 5 µg 50
Recombinant Rat Tumor Necrosis Factor-α; TNF-α, Tumor -20 °C 20 µg 130
necrosis factor ligand superfamily member 2, TNF-a, 1 mg 2,700
Cachectin, DIF, TNFA, TNFSF2
MLRSSSQNSS DKPVVHVVAN HQAEEQLEWL SQRANALLAN GMDLKDNQLV VPADGLYLIY SQV-
LFKGQGC PDYVLLTHTV SRFATSYQEK VSLLSAIKSP CPKDTPEGAE LKPWYEPMYL GGVSQLEKGD
LLSAEVNLPK YLDITESGQV YFGVIAL
Tumor Necrosis Factor-a Rat Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide
chain containing 157 amino acids and having a molecular mass of 17339.44 Dalton. The TNF-α is purified
by standard chromatographic techniques.

rpTNF a CYT-405 5 µg 50
Recombinant Porcine Tumor Necrosis Factor-α -20 °C 20 µg 130
TNF-α, Tumor necrosis factor ligand superfamily member 2, 1 mg 5,200
TNF-α, Cachectin, DIF, TNFA, TNFSF2
The sequence of the first five N-terminal amino acids was determined and was found to be Met-Leu-Arg-
Ser-Ser
Tumor Necrosis Factor-a Porcine Recombinant produced in E.Coli is a single, non-glycosylated, polypep-
tide chain containing 157 amino acids and having a molecular mass of 17,274 Dalton. The TNF-alpha is
purified by standard chromatographic techniques.

488 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
raTNF a CYT-008 5 µg 50
Recombinant Rabbit Tumor Necrosis Factor-α -20 °C 20 µg 130
Tumor necrosis factor, Cachectin, TNF-α, Tumor necrosis 1 mg 2,700
factor ligand superfamily member 2, TNF-a, TNF, TNFA, TNFSF2
The sequence of the first five N-terminal amino acids was determined and was found to be Met-Ser-Ala-
Ser-Arg
Tumor Necrosis Factor-a Rabbit Recombinant consists of three identical polypeptide chains of 158
amino acids combined to form a compact, bell-shaped homotrimer. TNF-α was produced in E.Coli is a
non-glycosylated, polypeptide chain having a molecular mass of 17.4 kDa for the individual subunit. The
TNF-α is purified by standard chromatographic techniques.

rCaTNF a CYT-140 5 µg 50
Recombinant Canine Tumor Necrosis Factor-α -20 °C 20 µg 130
Tumor necrosis factor, Cachectin, TNF-α, Tumor necrosis 1 mg 2,700
factor ligand superfamily member 2, TNF-a, TNF, TNFA, TNFSF2
VKSSSRTPSD KPVAHVVANP EAEGQLQWLS RRANALLANG VELTDNQLIV PSDGLYLIYS QVLFK-
GQGCP STHVLLTHTI SRFAVSYQTK VNLLSAIKSP CQRETPEGTE AKPWYEPIYL GGVFQLEKGD
RLSAEINLPN YLDFAESGQV YFGIIAL
TNF-a Canine Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing
157 amino acids and having a molecular mass of 17.3 kDa.

rmTNF a CYT-737 5 µg 50
Recombinant Rhesus Macaque Tumor Necrosis Factor-α -20 °C 20 µg 130
Tumor necrosis factor, Cachectin, TNF-α, Tumor necrosis 1 mg 2,700
factor ligand superfamily member 2, TNF-a, TNF, TNFA, TNFSF2
VRSSSRTPSD KPVAHVVANP QAEGQLQWLN RRANALLANG VELTDNQLVV PSEGLYLIYS QVLFK-

PEPTIDES INTERNATIONAL
GQGCP SNHVLLTHTI SRIAVSYQTK VNLLSAIKSP CQRETPEGAE AKPWYEPIYL GGVFQLEKGD
RLSAEINLPD YLDFAESGQV YFGIIAL
TNF-a Rhesus Macaque Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain
containing 157 amino acids and having a molecular mass of 17.3kDa.

TNF α Mutant
The clinical use of the potent anti-tumor activity of TNF-a has been limited by the pro-
inflammatory side effects including fever, dose-limiting hypotension, hepatotoxicity,
intravascular thrombosis, and hemorrhage. Designing clinically applicable TNF-α mu-
tants with low systemic toxicity has been an intense pharmacological interest. Human
TNF-α, which binds to the murine TNF-R55 but not to the mouse TNF-R75, exhibits
retained anti-tumor activity and reduced systemic toxicity in mice compared with mu -
rine TNF-α, which binds to both murine TNF receptors. Based on these results, many
TNF-α mutants that selectively bind to TNF-R55 have been designed. These mutants
displayed cytotoxic activities on tumor cell lines in vitro, and exhibited lower systemic
toxicity in vivo.
TNF a Mutant CYT-384 10 µg 50
Recombinant Human Tumor Necrosis Factor-α, Mutant; TNF-α, -20 °C 50 µg 130
Tumor necrosis factor ligand superfamily member 2, TNF-a, 1 mg 1,350
Cachectin, DIF, TNFA, TNFSF2
MRKRKPVAHV VANPQAEGQL QWLNRRANAL LANGVELRDNQLVVPSEGLY LIYSQVLFKG QGCP-
STHVLL THTISRIAVS YQTKVNLLSA IKSPCQRETP EGAEAKPWYE PIYLGGVFQL EKGDRLSAEI
NRPDYLDFAE SGQVYFGIIAF
Tumor Necrosis Factor-a Variant Human Recombinant produced in E.Coli is a single, non-glycosylated,
polypeptide chain containing 151 amino acids and having a molecular mass of 16598 Dalton. The TNF-α
Variant is purified by standard chromatographic techniques.

Order Hotline 1-800-777-4779 502-266-8787 489

 PRODUCT Code Qty PRICE
Recombinant proteins

TNF β
Lymphotoxin α, a member of the tumor necrosis factor family, is a cytokine produced
by lymphocytes. LTA is highly inducible, secreted, and exists as homotrimeric mole -
cule. LTA forms heterotrimers with lymphotoxin-beta which anchors lymphotoxin-alpha
to the cell surface. LTA mediates a large variety of inflammatory, immunostimulatory,
and antiviral responses, is also involved in the formation of secondary lymphoid organs
during development and plays a role in apoptosis.
TNF β CYT-224 5 µg 50
Recombinant Human Tumor Necrosis Factor-β -20 °C 20 µg 130
Lymphotoxin-α, LT-α, TNF-β, Tumor necrosis factor ligand 1 mg 2,700
superfamily member 1, LTA, LT, TNFB, TNFSF1
MLPGVGLTPS AAQTARQHPK MHLAHSTLKP AAHLIGDPSK QNSLLWRANT DRAFLQDGFS LSNNSLL-
VPT SGIYFVYSQV VFSGKAYSPK ATSSPLYLAH EVQLFSSQYP FHVPLLSSQK MVYPGLQEPW
LHSMYHGAAF QLTQGDQLST HTDGIPHLVL SPSTVFFGAF AL
Tumor Necrosis Factor-b Human Recombinant (Lymphotoxin) produced in E.Coli is a single, non-glycosyl-
ated, polypeptide chain containing 172 amino acids and having a molecular mass of 18645 Dalton. The
TNF-b is purified by standard chromatographic techniques.

TNF β His CYT-495 5 µg 50

Recombinant Human Tumor Necrosis Factor-β, His Tag; -20 °C 20 µg 130
Lymphotoxin-α, LT-α, TNF-β, Tumor necrosis factor ligand 1 mg 1,950
superfamily member 1, LTA, LT, TNFB, TNFSF1
Tumor Necrosis Factor -β His Human Recombinant produced in E.Coli is a single, non-glycosylated, poly-
peptide chain containing 171 amino acids fragment (35-205) and having a molecular mass of 23.3kDa with
PEPTIDES INTERNATIONAL

an amino-terminal hexahistidine tag. The TNF-β His is purified by standard chromatographic techniques.

TNFR2
TNFR2 belongs to the TNF-receptor superfamily. TNFR2 is receptor with high affinity
for TNFSF2/TNF-α and approximately 5-fold lower affinity for homotrimeric TNFSF1/
lymphotoxin-α. TNFR2 mediates the majority of the metabolic effects of TNF-alpha.
In addition, knockout studies in mice propose a role for TNFR2 in protecting neurons
from apoptosis by stimulating antioxidative pathways. TNFR2 expression might have
a significant role in the angiogenesis, tumor cell proliferation and metastasis of Invasive
micropapillary carcinoma of the breast.
There are 2 types of soluble TNF receptors: sTNFR-I and sTNFR-II, which act to
neutralize the biological activities of TNF α and TNF β. The levels of these soluble
receptors seem to increase as a result of shedding of the extracellular domains of
the membrane bound receptors. High levels of soluble TNF receptors are found in
the amniotic fluid of pregnant women. TNFR2 and TNFR1 form a heterocomplex
which mediates the recruitment of 2 anti-apoptotic proteins, c-IAP1 and c-IAP2, which
possess E3 ubiquitin ligase activity . IAPs’ function in TNF-receptor signaling is un -
known; nevertheless, c-IAP1 is believed to potentiate TNF-induced apoptosis by the
ubiquitination and degradation of TNF-receptor-associated factor 2, which mediates
anti-apoptotic signals. Oxidative stress promotes TNFR1 and TNFR2 self-interaction,
ligand-independent and enhanced ligand-dependent TNF signaling. TNF-α, TNFR1
and TNFR2 have roles in cellular dif ferentiation. TNFR1 and TNFR2 function in cell
type-specific renal injury.

490 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
TNFR2 CYT-769 5 µg 50
Recombinant Human Tumor Necrosis Factor Receptor Type 2 -20 °C 20 µg 130
Tumor necrosis factor receptor superfamily member 1B, Tumor 1 mg 2,700
necrosis factor receptor 2, TNF-R2, Tumor necrosis factor
receptor type II, TNF-RII, TNFR-II, p75, p80 TNF-α receptor,
TNFRSF1B, TNFBR, TNFR2
MPAQVAFTPY APEPGSTCRL REYYDQTAQM CCSKCSPGQH AKVFCTKTSD TVCDSCEDST YTQL-
WNWVPE CLSCGSRCSS DQVETQACTR EQNRICTCRP GWYCALSKQE GCRLCAPLRK CRPGF-
GVARP GTETSDVVCK PCAPGTFSNT TSSTDICRPH QICNVVAIPG NASMDAVCTS TSPT
TNFR2 Human produced in E.Coli is a single, non-glycosylated polypeptide chain containing 184 amino
acids and having a molecular mass of 20kDa.

TNFR2 His CYT-674 5 µg 50

Recombinant Human Tumor Necrosis Factor Receptor Type 2, -20 °C 20 µg 130
His Tag; Tumor necrosis factor receptor superfamily member 1 mg 4,800
1B, Tumor necrosis factor receptor 2, Tumor necrosis factor
receptor type II, p75, p80 TNF-α receptor, CD120b, Etanercept,
TNF-R2, TNF-RII, TNFR-II, TNFRSF1B, TNFBR, TNFR2, TBPII,
TNFR2, TNFR1B, TNFR80, TNF-R75, p75TNFR, TNF-R-II
LPAQVAFTPYAPEPGSTCRLREYYDQTAQMCCSKCSPGQHAKVFCTKTSDTVCDSCEDSTYTQLWN-
WVPECLSCGSRCSSDQVETQACTREQNRICTCRPGWYCALSKQEGCRLCAPLRKCRPGFGVARPG-
TETSDVVCKPCAPGTFSNTTSSTDICRPHQICNVVAIPGNASMDAVCTSTSPT
TNFR2 Human Recombinant produced in E.Coli is a single, non-glycosylated, Polypeptide chain contain-
ing 184 amino acids fragment (23-206) having a molecular weight of 24.45kDa and fused with a 4.5kDa
amino-terminal hexahistidine tag.

PEPTIDES INTERNATIONAL
mTNFR2 CYT-770 5 µg 50
Recombinant Mouse Tumor Necrosis Factor Receptor Type 2; -20 °C 20 µg 130
Tumor necrosis factor receptor superfamily member 1B, Tumor 1 mg 2,700
necrosis factor receptor 2, TNF-R2, Tumor necrosis factor
receptor type II, TNF-RII, TNFR-II, p75, p80 TNF-α receptor,
CD120b, Tnfrsf1b, Tnfr-2, Tnfr2, TNFBR, TNFR80, TNFRII,
TNF-R75, TNF-R-II, TNF-alphaR2, TNFα-R2
MPAQVAFTPY APEPGSTCRL REYYDQTAQM CCSKCSPGQH AKVFCTKTSD TVCDSCEDST YTQL-
WNWVPE CLSCGSRCSS DQVETQACTR EQNRICTCRP GWYCALSKQE GCRLCAPLRK CRPGF-
GVARP GTETSDVVCK PCAPGTFSNT TSSTDICRPH QICNVVAIPG NASMDAVCTS TSPT
TNFR2 Mouse Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing
184 amino acids and having a molecular mass of 20kDa.

Order Hotline 1-800-777-4779 502-266-8787 491

 PRODUCT Code Qty PRICE
Recombinant proteins

TNFR2 Fc
TNFR binds specifically to tumor necrosis factor (TNF) and blocks its interaction with
cell surface TNF receptors. TNF is a naturally occurring cytokine that is involved in nor-
mal inflammatory and immune responses. It plays an important role in the inflamma-
tory processes of rheumatoid arthritis (RA), polyarticular-course juvenile rheumatoid
arthritis (JRA), and ankylosing spondylitis and the resulting joint pathology. In addition,
TNF plays a role in the inflammatory process of plaque psoriasis. Elevated levels of
TNF are found in involved tissues and fluids of patients with RA, psoriatic arthritis,
ankylosing spondylitis (AS), and plaque psoriasis. Two distinct receptors for TNF (TN-
FRs), a 55 kilodalton protein (p55) and a 75 kilodalton protein (p75), exist naturally as
monomeric molecules on cell surfaces and in soluble forms. Biological activity of TNF
is dependent upon binding to either cell surface TNFR. Recombinant Human TNFR
is a dimeric soluble form of the p75 TNF receptor that can bind to two TNF molecules.
It inhibits the activity of TNF in vitro and has been shown to affect several animal mod-
els of inflammation, including murine collagen-induced arthritis. TNFR inhibits binding
of both TNFα and TNFβ (lymphotoxin alpha [LTα]) to cell surface TNFRs, rendering
TNF biologically inactive. Cells expressing transmembraneTNF that bind to TNFR are
not lysed in vitro in the presence or absence of complement.
TNFR can also modulate biological responses that are induced or regulated by TNF,
including expression of adhesion molecules responsible for leukocyte migration ( i.e.,
E-selectin and to a lesser extent intercellular adhesion molecule-1 [ICAM-1]), serum
levels of cytokines (e.g., IL-6), and serum levels of matrix metalloproteinase-3 (MMP-3
PEPTIDES INTERNATIONAL

or stromelysin).

TNFR2 Fc CYT-422 10 µg 50
Recombinant Human Tumor Necrosis Factor Receptor 2 -20 °C 50 µg 130
Fusion Protein; Tumor necrosis factor receptor superfamily 1 mg 1,200
member 1B,Tumor necrosis factor receptor 2, TNF-R2, Tumor
necrosis factor receptor type II, p75, p80 TNF-α receptor,
CD120b antigen, Etanercept, TBPII, TNFBR, TNFR80, TNF-R75,
p75TNFR, TNF-R-II
Recombinant Human Tumor Necrosis Factor Receptor 2 Fusion Protein produced in CHO is a dimeric,
glycosylated, polypeptide chain consisting of the extracellular ligand-binding portion of the human 75
kilo Dalton (p75) tumor necrosis factor receptor 2 (TNFR2) linked to the Fc portion of human IgG1. The
Fc component of TNFR2 contains the CH2 domain, the CH3 domain and hinge region, but not the CH1
domain of IgG1. It consists of 934 amino acids and has an apparent molecular weight of approximately
150 kilo Daltons. The TNFR2 is purified by standard chromatographic techniques.

492 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
TNFRSF17 (Tumor Necrosis Factor Receptor Superfamily Member 17)
TNFRSF17 is a receptor for tnfsf13b/blys/baff and tnfsf13/april. TNFRSF17 promotes
b-cell survival and plays a role in the regulation of humoral immunity . TNFRSF17
activates nf-κ-b and jnk. TNFRSF17 is a member of the TNF-receptor superfamily,
expressed in mature B lymphocytes, and is invloved in B cell development and au -
toimmune response. TNFRSF17 specifically binds to the tumor TNFSF13B/TALL-1/
BAFF, which causes NF-kappaB and MAPK8/JNK activation. TNFRSF17 binds to a
variety of TRAF family members, and therefore transduces signals for cell survival and
proliferation. TNFRSF17 is a type III membrane protein having 1 extracellular cysteine
rich domain. Within the TNFRSF, it shares the highest homology with TACI. BCMA
and TACI have both been shown to bind to APRIL and BAFF, members of the TNF
ligand superfamily. BCMA expression has been found in immune organs. TNFRSF17
appears to be localized to the Golgi compartment. The binding of BCMA to APRIL
or BAFF has been shown to stimulate IgM production in peripheral blood B cells and
increase the survival of cultured B cells.
TNFRSF17 Human CYT-598 5 µg 50
Recombinant Human B-Cell Maturation Antigen; BCMA, CD269, -20 °C 20 µg 130
Tumor Necrosis Factor Receptor Superfamily Member 17, BCM, 1 mg 4,680
TNFRSF17, B-cell maturation Protein, CD269 antigen
AGQCSQNEYF DSLLHACIPC QLRCSSNTPP LTCQRYCNAS VTNSVKGTN
TNFRSF17 Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain con-
taining 50 amino acids and having a molecular mass of 5.3 kDa. The TNFRSF17 is purified by standard
chromatographic techniques.

PEPTIDES INTERNATIONAL
TNFRSF17, His CYT-190 5 µg 50
Recombinant Human B-Cell Maturation Antigen, His Tag; -20 °C 20 µg 130
BCMA, CD269, Tumor Necrosis Factor Receptor Superfamily 1 mg 2,700
Member 17, BCM, TNFRSF17, B-cell maturation Protein, CD269
antigen
MGSSHHHHHH SSGLVPRGSH MGSRKINSEP LKDEFKNTGS GLLGMANIDL EKSRTGDEII
LPRGLEYTVE ECTCEDCIKS KPKVDSDHCF PLPAMEEGAT ILVTTKTNDY CKSLPAALSA TEIEKSISAR
TNFRSF17 Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain
containing 130 amino acids (78-184 a.a) and having a molecular mass of 14.1kDa. TNFRSF17 is fused to
a 21 amino acid His-tag at N-terminus

Order Hotline 1-800-777-4779 502-266-8787 493

 PRODUCT Code Qty PRICE
Recombinant proteins

TNFR
TNFR1 belongs to the TNF-receptor superfamily. It is a receptor for TNFSF2/TNF-α
and homotrimeric TNFSF1/lymphotoxin-α.
There are 2 types of soluble TNF receptors: sTNFR-I and sTNFR-II, which act to
neutralize the biological activities of TNF α and TNF β. The levels of these soluble
receptors seem to increase as a result of shedding of the extracellular domains of the
membrane bound receptors. TNF-a, TNFR1 and TNFR2 have roles in cellular differen-
tiation. TNFR1 and TNFR2 function in cell type-specific renal injury.
TNFR1 is capable of signaling both cell survival and apoptosis. TNFR1-induced apop-
tosis requires 2 sequential signaling complexes. TNFR1 is capable of activating NF-
κB, mediate apoptosis, and function as a regulator of inflammation. Oxidative stress
promotes TNFR1 and TNFR2 self-interaction, ligand-independent and enhanced
ligand-dependent TNF signaling. TNFR1 contributes to the induction of non-cytocidal
TNF effects including anti-viral state and activation of the acid sphingomyelinase. Hu-
man TNFR1 has a major region which controls cell surface expression. High levels of
soluble TNF receptors are found in the amniotic fluid of pregnant women.
Germline mutations of the extracellular domains of TNFR1 are linked to the autosomal
dominant periodic fever syndrome. The impaired receptor clearance is believed to be
a mechanism of the disease. Familial hibernian fever (FHF) is caused by defects in
TNFRSF1A gene.
TNFR CYT-707 5 µg 50
20 µg 130
PEPTIDES INTERNATIONAL

Recombinant Human Tumor Necrosis Factor Receptor; Tumor -20 °C

necrosis factor receptor superfamily member 1A, Tumor 1 mg 2,700
necrosis factor receptor 1, Tumor necrosis factor receptor
type I, TNF-R1, TNF-RI, TNFR-I, p60, p55, CD120a, TNFRSF1A,
TNFAR, TNFR1, FPF, TBP1, TNF-R, p55-R, TNFR55, TNFR60,
TNF-R-I, TNF-R55, MGC19588
MDSVCPQGKY IHPQNNSICC TKCHKGTYLY NDCPGPGQDT DCRECESSGSF TASENHLRHC LSC-
SKCRKEM GQVEKSSCTV DRDTVCGCRK NQYRHYWSEN LFQCFNCSLC LNGTVHLSCQ EKQNT-
VCTCH AGFFLRENEC VSCSNCKKSL ECTKLCLPQI E
TNFR Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing
162 amino acids and having a total molecular mass of 18.2 kDa. TNFR Human Recombinant is purified by
proprietary chromatographic techniques

TNFR His CYT-673 5 µg 50

Recombinant Human Tumor Necrosis Factor Receptor Type -20 °C 20 µg 130
His Tag; Tumor Necrosis Factor Receptor Superfamily Member 1 mg 4,800
1A, Tumor necrosis factor receptor 1, Tumor necrosis factor
receptor type I, TNF-R1, TNF-RI, TNFR-I, p60, p55, CD120a,
TNFRSF1A, TNFAR, TNFR1, FPF, TBP1, TNF-R, p55-R, TNFR55,
TNFR60, TNF-R-I, TNF-R55, MGC19588
DSVCPQGKYIHPQNNSICCTKCHKGTYLYNDCPGPGQDTDCRECESGSFTASENHLRHCLSCSKCRKE-
MGQVEISSCTVDRDTVCGCRKNQYRHYWSENLFQCFNCSLCLNGTVHLSCQEKQNTVCTCHAGFFL-
RENECVSCSNCKKSLECTKLCLPQIEN
TNFR Human Recombinant produced in E.Coli is a single, non-glycosylated, Polypeptide chain containing
161 amino acids fragment (41-201) having a molecular weight of 22.68kDa and fused with a 4.5kDa
amino-terminal hexahistidine tag.

494 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
mTNFR CYT-774 5 µg 50
Recombinant Mouse Tumor Necrosis Factor Receptor ; Tumor -20 °C 20 µg 130
Necrosis Factor Receptor Superfamily Member 1A, Tumor 1 mg 2,700
necrosis factor receptor 1, TNF-R1, Tumor necrosis factor
receptor type I, TNF-RI, TNFR-I, p55, p60, CD120a, Tnfrsf1a,
Tnfr-1, Tnfr1, FPF, TNF-R, TNFAR, TNFRI, p55-R, TNFR60, Tnfr-
2, TNF-R-I, TNF-R55, TNFRp55, TNF-αR1, TNFα-R1
IHPSGVTGLV PSLGDREKRD SLCPQGKYVH SKNNSICCTK CHKGTYLVSD CPSPGRDTVC RECEK-
GTFTA SQNYLRQCLS CKTCRKEMSQ VEISPCQADK DTVCGCKENQ FQRYLSETHF QCVDCSPCFN
GTVTIPCKET QNTVCNCHAG FFLRESECVP CSHCKKNEEC MKLCLPPPLA NVTNPQDSGT A
TNFR Mouse Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing
191 amino acids and having a molecular mass of 21.1kDa.

TNFSF12 CYT-699 5 µg 50
Recombinant Human TNF Ligand Superfamily Member 12; -20 °C 25 µg 130
TWEAK, TNF-related weak inducer of apoptosis, TNFSF12, 1 mg 4,800
DR3LG, Apo3-Ligand, APO3L, TNFRSF12A, Tumor Necrosis
Factor Receptor Superfamily Member 12, MGC20669,
MGC129581
HVDYKDDDDK PAGSAPKGRK TRARRAIAAH YEVHPRPGQD GAQAGVDGTV SGWEEARINS
SSPLRYNRQI GEFIVTRAGL YYLYCQVHFD EGKAVYLKLD LLVDGVLALR CLEEFSATAA SSLGPQL-
RLC QVSGLLALRP GSSLRIRTLP WAHLKAAPFL TYFGLFQVH
The TWEAK Human Recombinant is manufactured with N-terminal fusion of 13 amino acid FLAG Tag. The
TNFSF12 Flag -Tagged Fusion Protein has a Mw of 18.7kDa containing a total of 169 amino acid residues.

TNFRSF10B CYT-069 10 µg 50

PEPTIDES INTERNATIONAL
Recombinant Human TNF Ligand Receptor Superfamily -20 °C 50 µg 130
Member 10B; Death receptor 5, TNF-related apoptosis- 1 mg 1,350
inducing ligand receptor 2, TRAIL receptor 2, TRAIL-R2,
CD262, TNFRSF10B, DR5, KILLER, TRAILR2, TRICK2, ZTNFR9,
TRICKB, TRICK2A, TRICK2B, KILLER/DR5
ESALITQQD LAPQQRVAPQ QKRSSPSEGL CPPGHHISED GRDCISCKYG QDYSTHWNDL LFCLRC-
TRCD SGEVELSPCT TTRNTVCQCE EGTFREEDSP EMCRKCRTGC PRGMVKVGDC TPWSDIECVH
KES
TNFRSF10B Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain
containing 132 amino acids and having a molecular mass of 14.8kDa.

TNFRSF12A CYT-043 5 µg 50
Recombinant Human TNF Ligand Receptor Superfamily -20 °C 25 µg 130
Member 12A ; FN14, CD266 antigen, TweakR, tweak-receptor, 1 mg 2,700
Fibroblast growth factor-inducible immediate-early response
Protein 14, FGF-inducible 14, type I transmembrane Protein
Fn14
EQAPGTAPCS RGSSWSADLD KCMDCASCRA RPHSDFCLGC AAAPPAPFRL LWP
TNFRSF12A Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain
containing 53 amino acids and having a molecular mass of 5.6 KDa.

Order Hotline 1-800-777-4779 502-266-8787 495

 PRODUCT Code Qty PRICE
Recombinant proteins

TNFAIP8 CYT-759 2 µg 50
Recombinant Human Tumor Necrosis Factor, Α-Induced -20 °C 10 µg 130
Protein 8; GG2-1; MDC-3.13, SCC-S2, SCCS2, Tumor necrosis 1 mg 5,200
factor α-induced Protein 8, TNF α-induced Protein 8, Head and
neck tumor and metastasis-related Protein, NF-κ-B-inducible
DED-containing Protein, NDED, TNF-induced Protein GG2-1,
TNFAIP8
MGSSHHHHHH SSGLVPRGSH MGSMHSEAEE SKEVATDVFN SKNLAVQAQK KILGKMVSKS IATTLID-
DTS SEVLDELYRV TREYTQNKKE AEKIIKNLIK TVIKLAILYR NNQFNQDELA LMEKFKKKVH QLAMTV-
VSFH QVDYTFDRNV LSRLLNECRE MLHQIIQRHL TAKSHGRVNN VFDHFSDCEF LAALYNPFGN
FKPHLQKLCD GINKMLDEEN I
TNFAIP8 Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain contain-
ing 221 amino acids (1-198a.a.) and having a molecular mass of 25kDa. TNFAIP8 is fused to a 23 amino
acid His-tag at N-terminus

TSLP (Thymic Stromal Lymphopoietin)

TSLP protein is a hemopoietic cytokine which signals throughout a heterodimeric re -
ceptor complex composed of the thymic stromal lymphopoietin receptor & the Inter -
leukin-7 receptor alpha chain. TSLP impacts myeloid cells thus induces the discharge
of T cell-attracting chemokines from monocytes & increases the growth of CD1 1c(+)
dendritic cells. TSLP is mainly expressed in the heart, liver and prostate. TSLP is
related in its biological activities with IL-7 and binds with the heterodimeric receptor
complex consisting of the Interleukin-7 receptor alpha chain & the TSLPR. Similar
to IL-7, TSLP enhances phosphorylation of STAT3 and STAT5, though uses kinases
excluding JAKs for its activation. TSLP induces the release of T cell-attracting chemo-
PEPTIDES INTERNATIONAL

kines such asTARC & MDC from monocytes & triggers CD11c(+) dendritic cells. TSLP
activated dendritic cells primes naive T cells to manufacture pro-allergic cytokines such
as Iinterleukin-4, Interleukin-5, Interleukin-13 and TNF-α whereas down-regulating In-
terleukin-10 and IFN-γ play a role in the initiation of allergic inflammation.
TSLP CYT-572 2 µg 50
Recombinant Human Thymic Stromal Lymphopoietin; Thymic -20 °C 10 µg 130
Stromal Lymphopoietin 1 mg 4,680
MYDFTNCDFE KIKAAYLSTI SKDLITYMSG TKSTEFNNTV SCSNRPHCLT EIQSLTFNPT AGCASLAKEM
FAMKTKAALA IWCPGYSETQ INATQAMKKR RKRKVTTNKC LEQVSQLQGL WRRFNRPLLK QQ
TSLP Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing
132 amino acids and having a molecular mass of 15 kDa.

496 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
TSLPR (Thymic Stromal Lymphopoietin Receptor)
Thymic Stromal Lymphopoietin Receptor (TSLPR) is a member of the type I cytokine
receptor family. TSLPR alongside the interleukin 7 receptor (IL7R) activate ST AT3,
STAT5, and JAK2 pathways, which is regulated processes such as cell proliferation
and development of the hematopoietic system. Two transcript variants encoding
dissimilar isoforms have been found for this gene. It is expressed in heart, skeletal
muscle, kidney and adult and fetal liver.
TSLPR CYT-742 5 µg 50
Recombinant Human Thymic Stromal Lymphopoietin Receptor; -20 °C 20 µg 130
CRL2, CRLF2Y, Cytokine receptor-like factor 2, Cytokine 1 mg 2,700
receptor-like 2, IL-XR, ILXR
MGSSHHHHHH SSGLVPRGSH MGSQGGAAEG VQIQIIYFNL ETVQVTWNAS KYSRTNLTFH YRFNG-
DEAYD QCTNYLLQEG HTSGCLLDAE QRDDILYFSI RNGTHPVFTA SRWMVYYLKP SSPKHVRFSW
HQDAVTVTCS DLSYGDLLYE VQYRSPFDTE WQSKQENTCN VTIEGLDAEK CYSFWVRVKA MED-
VYGPDTY PSDWSEVTCW QRGEIRDACA ETPTPPKPKL SK
TSLPR Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing
232 amino acids (23-231 a.a.) and having a molecular mass of 26.6kDa. TSLPR is fused to a 23 amino
acid His-tag at N-terminus

TPO (Thrombopoietin)
Thrombopoietin is a glycoprotein hormone produced mainly by the liver and the kidney
that regulates the production of platelets by the bone marrow. It stimulates the produc-
tion and differentiation of megakaryocytes, the bone marrow cells that fragment into

PEPTIDES INTERNATIONAL
large numbers of platelets.
TPO CYT-302 2 µg 50
Recombinant Human Thrombopoietin; Megakaryocyte -20 °C 10 µg 130
colony-stimulating factor, Myeloproliferative leukemia virus 1 mg 3,900
oncogene ligand, C-mpl ligand, ML, Megakaryocyte growth and
development factor, MGDF, TPO, MKCSF, MPLLG, MGC163194,
THPO
SPAPPACDLR VLSKLLRDSH VLHSRLSQCP EVHPLPTPVL LPAVDFSLGE WKTQMEETKA QDIL-
GAVTLL LEGVMAARGQ LGPTCLSSLL GQLSGQVRLL LGALQSLLGT QLPPQGRTTA HKDPNAIFLS
FQHLLRGKVR FLMLVGGSTL CVRRAPPTTA VPSRTSLVLT LNEL
Thrombopoietin Human Recombinant produced in E.Coli is a single, non-glycosylated soluble polypeptide
chain containing 174 amino acids and having a molecular mass of 18608 Dalton which comprises the
receptor binding domain of the Mpl-ligand protein.

Order Hotline 1-800-777-4779 502-266-8787 497

 PRODUCT Code Qty PRICE
Recombinant proteins

TPO CHO CYT-462 2 µg 50

Recombinant Human Thrombopoietin, CHO ; Megakaryocyte -20 °C 10 µg 130
colony-stimulating factor, Myeloproliferative leukemia virus 1 mg 3,900
oncogene ligand, C-mpl ligand, ML, Megakaryocyte growth and
development factor, MGDF, TPO, MKCSF, MPLLG, MGC163194,
THPO
SPAPPACDLR VLSKLLRDSH VLHSRLSQCP EVHPLPTPVL LPAVDFSLGE WKTQMEETKA QDIL-
GAVTLL LEGVMAARGQ LGPTCLSSLL GQLSGQVRLL LGALQSLLGT QLPPQGRTTA HKDPNAIFLS
FQHLLRGKVR FLMLVGGSTL CVRRAPPTTA VPSRTSLVLT LNELPNRTSG LLETNFTASA RTTGS-
GLLKW QQGFRAKIPG LLNQTSRSLD QIPGYLNRIH ELLNGTRGLF PGPSRRTLGA PDISSGTSDT
GSLPPNLQPG YSPSPTHPPT GQYTLFPLPP TLPTPVVQLH PLLPDPSAPT PTPTSPLLNT SYTH-
SQNLSQ EG
Thrombopoietin Human Recombinant is approximately 80 kDa, consisting of a 332 amino acid residue with
a predicted molecular mass of approximately 35 kDa. As a result of glycosylation, the recombinant protein
migrates with an apparent molecular mass of 80±10 kDa in SDS-PAGE.
V. Vas, et al. PLoS ONE, 7, 2 (2012).

TPO HEK CYT-115 2 µg 50

Recombinant Human Thrombopoietin, HEK; Megakaryocyte -20 °C 10 µg 130
colony-stimulating factor, Myeloproliferative leukemia virus 1 mg 3,900
oncogene ligand, C-mpl ligand, ML, Megakaryocyte growth and
development factor, MGDF, TPO, MKCSF, MPLLG, MGC163194,
THPO
Thrombopoietin Human Recombinant produced in HEK cells is a glycosylated monomer, having a molecu-
lar weight range of 80-85kDa due to glycosylation.

mTPO CYT-346 2 µg 50
PEPTIDES INTERNATIONAL

Recombinant Mouse Thrombopoietin; Megakaryocyte -20 °C 10 µg 130

colony-stimulating factor, Myeloproliferative leukemia virus 1 mg 3,900
oncogene ligand, C-mpl ligand, ML, Megakaryocyte growth and
development factor, MGDF, TPO, MKCSF, MPLLG, MGC163194,
THPO
SPVAPACDPR LLNKLLRDSH LLHSRLSQCP DVDPLSIPVL LPAVDFSLGE WKTQTEQSKA QDIL-
GAVSLL LEGVMAARGQ LEPSCLSSLL GQLSGQVRLL LGALQGLLGT QLPLQGRTTA HKDPNALFLS
LQQLLRGKVR FLLLVEGPTL CVRRTLPTTA VPSSTSQLLT LNKF
Thrombopoietin Mouse Recombinant produced in E.Coli is a single, non-glycosylated soluble polypeptide
chain containing 174 amino acids and having a molecular mass of 18704 Dalton.

498 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
TRAIL (TNF-Related Apoptosis-Inducing Ligand)
TNF-related apoptosis-inducing ligand (TRAIL) is a ligand molecule which induces apoptosis. It is a type II
transmembrane protein with homology to other members of the tumor necrosis factor family.
In humans, the gene that encodes for TRAIL is located at chromosome 3q26. TRAIL binds to the death
receptors, DR4 and DR5. The process of apoptosis is caspase-8-dependent. This protein preferentially
induces apoptosis in transformed and tumor cells, but does not appear to kill normal cells although it is
expressed at a significant level in most normal tissues.

TRAIL CYT-443 10 µg 50
Recombinant Human TNF-Related Apoptosis Inducing Ligand/ -20 °C 50 µg 130
Apo2L; Tumor necrosis factor ligand superfamily member 10, 1 mg 1,350
TNF-related apoptosis-inducing ligand, Protein TRAIL, Apo-2
ligand, Apo-2L, CD253 antigen, TL2, APO2L, TNFSF10
MRERGPQRVA AHITGTRGRS NTLSSPNSKN EKALGRKINS WESSRSGHSF LSNLHLRNGE LVI-
HEKGFYY IYSQTYFRFQ EEIKENTKND KQMVQYIYKY TSYPDPILLM KSARNSCWSK DAEYGLYSIY
QGGIFELKEN DRIFVSVTNE HLIDMDHEAS FFGAFLVG
TRAIL/APO 2 Ligand Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide
chain containing 168 amino acids (Met+Arg115-Gly281) and having a molecular mass of ~21kDa.

TRAIL (114-281 a.a.) CYT-546 10 µg 50

Recombinant Human TNF-Related Apoptosis Inducing Ligand/ -20 °C 50 µg 130
Apo2L (114-281); Tumor necrosis factor ligand superfamily 1 mg 1,800
member 10, TNF-related apoptosis-inducing ligand, Protein
TRAIL, Apo-2 ligand, Apo-2L, CD253 antigen, TL2, APO2L,
TNFSF10

PEPTIDES INTERNATIONAL
MVRERGPQRV AAHITGTRGR SNTLSSPNSK NEKALGRKIN SWESSRSGHS FLSNLHLRNGELVI-
HEKGFY YIYSQTYFRF QEEIKENTKN DKQMVQYIYK YTSYPDPILL MKSARNSCWSKDAEYGLYSI
YQGGIFELKE NDRIFVSVTN EHLIDMDHEA SFFGAFLVG
Soluble TNF-related apoptosis-inducing ligand Human Recombinant produced in E.Coli is a single, non-
glycosylated polypeptide chain containing 169 amino acids (114-281) and having a molecular mass of 19.6
kDa.

Order Hotline 1-800-777-4779 502-266-8787 499

 PRODUCT Code Qty PRICE
Recombinant proteins

Vaspin (Visceral Adipose-Specific SERPIN)

Vaspin (visceral adipose-specific SERPIN), a newly identified adipokine, which is a member of serine prote-
ase inhibitor family. Vaspin is also a unique insulin sensitizing adipocytokine in obesity. A recent publication
indicates that induction of human vaspin mRNA expression in adipose tissue is regulated in a fat depot-spe-
cific manner and could be associated with parameters of obesity, insulin resistance, and glucose metabolism
Excess adiposity is the most important risk in the development of insulin resistance and type 2 diabetes mel-
litus (T2DM). Adipose tissue produces several proteins (adipocytokines) such as leptin, adiponectin, resistin,
tumor necrosis factor-α, and IL-6, that modulate insulin sensitivity and appear to play an important role in the
pathogenesis of insulin resistance, diabetes, dyslipidemia, inflammation, and atherosclerosis. However, the
mechanisms by which fat tissue induces insulin resistance and the role of adipocytokines in the pathogen -
esis of T2DM have not been well established. V isfatin, also known as pre-B cell colony-enhancing factor
(PBEF), is a cytokine that is highly expressed in visceral fat and was originally isolated as a secreted factor
that synergizes with IL-7 and stem cell factors to promote the growth of B cell precursors. Visfatin homologs
have been identified in carp, invertebrate mollusks, and bacteria, as well as in vertebrates, including humans
and the mouse. It has been postulated to play a role in innate immunity.
Visfatin exerts insulin-mimetic effects that are dose-dependent and quantitatively similar to those of insulin
in stimulating muscle and adipocyte glucose transport, and in inhibiting hepatocyte glucose production. In -
travenous injection of recombinant visfatin in mice decreased plasma glucose in a dose-dependent fashion.
In keeping with its insulin-mimetic ef fects, visfatin was as ef fective as insulin in reducing hyperglycemia in
insulin-deficient diabetic mice. Visfatin was also found to be bound to and activate insulin receptor, caus-
ing receptor phosphorylation and the activation of downstream signaling molecules. However , visfatin and
insulin did not compete for binding to the insulin receptor, indicating that the two proteins were recognized by
different regions of the receptor. Thus, visfatin might play a role in glucose homeostasis and dysregulation in
biosynthesis or signal transduction, and might contribute to the pathogenesis of diabetes.

Vaspin Human
PEPTIDES INTERNATIONAL

CYT-459 5 µg 50
Recombinant Human Vaspin; Serpin A12 precursor, Visceral -20 °C 25 µg 130
adipose-specific serpin, Visceral adipose tissue- derived 1 mg 2,700
serine protease inhibitor, Vaspin, OL-64, SERPINA12, Serine
(or cysteine) Proteinase inhibitor, clade A, antitrypsin, α-1
antiProteinase
MGSSHHHHHH SSGLVPRGSH MLKPSFSPRN YKALSEVQGW KQRMAAKELA RQNMDLGFKL LK-
KLAFYNPG RNIFLSPLSI STAFSMLCLG AQDSTLDEIK QGFNFRKMPE KDLHEGFHYI IHELTQKTQD
LKLSIGNTLF IDQRLQPQRK FLEDAKNFYS AETILTNFQN LEMAQKQIND FISQKTHGKI NNLIENIDPG
TVMLLANYIF FRARWKHEFD PNVTKEEDFF LEKNSSVKVP MMFRSGIYQV GYDDKLSCTI LEIPY-
QKNIT AIFILPDEGK LKHLEKGLQV DTFSRWKTLL SRRVVDVSVP RLHMTGTFDL KKTLSYIGVS
KIFEEHGDLT KIAPHRSLKV GEAVHKAELK MDERGTEGAA GTGAQTLPME TPLVVKIDKP YLLLIYSEKI
PSVLFLGKIV NPIGK
Vaspin Human Recombinant produced in E.Coli is a single, non-glycosylated, His Tag, polypeptide chain
containing 415 amino acids and having a molecular mass of 47 kDa.

500 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
VEGF (Vascular Endothelial Growth Factor)
Vascular endothelial growth factor is an important signaling protein involved in both
vasculogenesis and angiogenesis. As its name implies, VEGF activity has been
mostly studied on cells of the vascular endothelium, although it does have effects on a
number of other cell types (e.g. stimulation monocyte/ macrophagemigration, neurons,
cancer cells, kidney epithelial cells ). VEGF mediates increased vascular permeability,
induces angiogenesis, vasculogenesis and endothelial cell growth, promotes cell mi -
gration, and inhibits apoptosis. In vitro, VEGF has been shown to stimulate endothelial
cell mitogenesisand cell migration. VEGF is also a vasodilator and increases micro -
vascular permeability and was originally referred to as vascular permeability factor.
Elevated levels of this protein are linked to POEMS syndrome, also known as Crow-
Fukase syndrome. Mutations in this gene have been associated with proliferative and
nonproliferative diabetic retinopathy.
VEGF Human CYT-241 2 µg 50
Recombinant Human Vascular Endothelial Growth Factor -20 °C 10 µg 130
Vascular endothelial growth factor A, VEGF-A, Vascular 1 mg 3,510
permeability factor, VPF, VEGF, MGC70609
APMAEGGGQN HHEVVKFMDV YQRSYCHPIE TLVDIFQEYP DEIEYIFKPS CVPLMRCGGC CNDE-
GLECVP TEESNITMQI MRIKPHQGQH IGEMSFLQHN KCECRPKKDR ARQENPCGPC SERRKHLFVQ
DPQTCKCSCK NTDSRCKARQ LELNERTCRC DKPRR
Vascular Endothelial Growth Factor Human Recombinant produced in E.Coli is a double, non-glycosylated,
polypeptide chain containing 165 amino acids and having a molecular mass of 38231 Dalton.

PEPTIDES INTERNATIONAL
Y. Tasaki,et al., Journal of Reproduction and Development, 56, 2 (2010).

VEGF His CYT-496 5 µg 50

Recombinant Human Vascular Endothelial Growth Factor, His -20 °C 20 µg 130
Tag; Vascular endothelial growth factor A, VEGF-A, Vascular 1 mg 2,700
permeability factor, VPF, VEGF, MGC70609
MGSSHHHHHH SSGLVPRGSH TEESNITMQI MRIKPHQGQH IGEMSFLQHN KCECRPKKDR ARQEN-
PCGPC SERRKHLFVQ DPQTCKCSCK NTDSRCKARQ LELNERTCRC APMAEGGGQN HHEVVK-
FMDV YQRSYCHPIE TLVDIFQEYP DEIEYIFKPS CVPLMRCGGC CNDEGLECVP DKPRR
Vascular Endothelial Growth Factor Human Recombinant produced in E.Coli is a non-glycosylated, poly-
peptide chain (aa 207-371) containing 185 amino acids and having a molecular mass of 21.3 kDa. The
VEGF is fused to a 20 a.a His-tag at N-terminus.

VEGF CHO CYT-260 2 µg 50

Recombinant Human Vascular Endothelial Growth Factor, -20 °C 10 µg 130
CHO ; Vascular endothelial growth factor A, VEGF-A, Vascular 1 mg 5,100
permeability factor, VPF, VEGF, MGC70609
Vascular Endothelial Growth Factor Human Recombinant produced in CHO cells is a double, glycosylated,
polypeptide chain containing 165 amino acids and migrates as 44 kDa in SDS-PAGE under non-reducing
conditions.

Order Hotline 1-800-777-4779 502-266-8787 501

 PRODUCT Code Qty PRICE
Recombinant proteins

VEGF HEK CYT-225 2 µg 50

Recombinant Human Vascular Endothelial Growth Factor, -20 °C 10 µg 130
HEK; Vascular endothelial growth factor A, VEGF-A, Vascular 100 µg 1,100
permeability factor, VPF, VEGF, MGC70609
APMAEGGGQN HHEVVKFMDV YQRSYCHPIE TLVDIFQEYP DEIEYIFKPS CVPLMRCGGC CNDE-
GLECVP TEESNITMQI MRIKPHQGQH IGEMSFLQHN KCECRPKKDR ARQENPCGPC SERRKHLFVQ
DPQTCKCSCK NTDSRCKARQ LELNERTCRC DKPRR
Vascular Endothelial Growth Factor Human Recombinant produced in HEK293 cells is a double, glycosyl-
ated, polypeptide chain containing 165 amino acids (27-191) and having a molecular mass of 40 kDa.

VEGF Yeast CYT-577 2 µg 50

Recombinant Human Vascular Endothelial Growth Factor, -20 °C 10 µg 130
Yeast; Vascular endothelial growth factor A, VEGF-A, Vascular 1 mg 3,510
permeability factor, VPF, VEGF, MGC70609
Vascular Endothelial Growth Factor Human Recombinant produced in Yeast is a double, glycosylated,
polypeptide chain containing 165 amino acids and having a molecular mass of 42 kDa.

VEGF (121a.a.) CYT-343 2 µg 50

Recombinant Human Vascular Endothelial Growth Factor -20 °C 10 µg 130
(121); Vascular endothelial growth factor A, VEGF-A, Vascular 1 mg 3,500
permeability factor, VPF, VEGF, MGC70609
APMAEGGGQN HHEVVKFMDV YQRSYCHPIE TLVDIFQEYP DEIEYIFKPS CVPLMRCGGC CNDE-
GLECVP TEESNITMQI MRIKPHQGQH IGEMSFLQHN KCECRPKKDR ARQENCDKPR R
Vascular Endothelial Growth Factor-121 Human Recombinant produced in E.Coli is a double, non-
glycosylated, polypeptide chain containing 121 amino acids and having a molecular mass of 28423 Dalton.
PEPTIDES INTERNATIONAL

VEGF121 circulates more freely than other VEGF forms, which bind more tightly with vascular heparin
sulfates.

VEGF (121a.a.) Sf9 CYT-200 2 µg 50

Recombinant Human Vascular Endothelial Growth Factor (121), -20 °C 10 µg 130
Sf9; Vascular endothelial growth factor A, VEGF-A, Vascular 1 mg 5,100
permeability factor, VPF, VEGF, MGC70609
APMAEGGGQNHHEVVKFMDVYQRSYCHPIETLVDIFQEYPDEIEYIFKPSCVPLMRCGGCCNDEGLECV
PTEESNITMQIMRIKPHQGQHIGEMSFLQHNKCECRPKKDRARQEKCDKPR
Vascular Endothelial Growth Factor-121 Human Recombinant produced in insect cells as an 18kDa
homodimer, is a glycosylated, polypeptide chain containing 121 amino acids and having a molecular mass
of approximately 36kDa. VEGF121 circulates more freely than other VEGF forms, which bind more tightly
with vascular heparin sulfates.

VEGF (121a.a.) His CYT-619 2 µg 50

Recombinant Human Vascular Endothelial Growth Factor -20 °C 10 µg 130
(121), His Tag; Vascular endothelial growth factor A, VEGF-A, 1 mg 4,500
Vascular permeability factor, VPF, VEGF, MGC70609
MGSSHHHHHH SSGLVPRGSH MAPMAEGGGQ NHHEVVKFMD VYQRSYCHPI ETLVDIFQEY PDEI-
EYIFKP SCVPLMRCGG CCNDEGLECV PTEESNITMQ IMRIKPHQGQ HIGEMSFLQH NKCECRPKKD
RARQEKCDKP RR
Vascular Endothelial Growth Factor-121 Human Recombinant produced in E.Coli is a double, non-glyco-
sylated, polypeptide chain (aa 207-327) containing a total of 142 amino acids and having a molecular mass
of 16.3 kDa. The VEGF-121 is fused to a 20 amino acid His tag at N-terminus.

502 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
VEGF (121a.a.) HEK CYT-116 2 µg 50
Recombinant Human Vascular Endothelial Growth Factor (121), -20 °C 10 µg 130
HEK; Vascular endothelial growth factor A, VEGF-A, Vascular 1 mg 5,200
permeability factor, VPF, VEGF, MGC70609
Recombinant Human VEGF 121 amino acids, produced in HEK cells is a glycosylated 37kDa homodimer
and 50kDa homotrimer.

rmVEGF CYT-336 2 µg 50
Recombinant Mouse Vascular Endothelial Growth Factor -20 °C 10 µg 130
Vascular endothelial growth factor A, VEGF-A, Vascular 1 mg 3,510
permeability factor, VPF, VEGF, MGC70609
MAPTTEGEQK SHEVIKFMDV YQRSYCRPIE TLVDIFQEYP DEIEYIFKPS CVPLMRCAGC
CNDEALECVP TSESNITMQI MRIKPHQSQH IGEMSFLQHS RCECRPKKDR TKPEKHCEPC
SERRKHLFVQ DPQTCKCSCK NTDSRCKARQ LELNERTCRC DKPRR
Vascular Endothelial Growth Factor Mouse Recombinant produced in E.Coli is a double, non-glycosylated,
polypeptide chain containing 165 amino acids and having a molecular mass of 39035 Dalton.

mVEGF Sf9 CYT-226 2 µg 50

Recombinant Mouse Vascular Endothelial Growth Factor-Sf9 -20 °C 10 µg 130
Vascular endothelial growth factor A, VEGF-A, Vascular 1 mg 5,100
permeability factor, VPF, VEGF, MGC70609
Vascular Endothelial Growth Factor Mouse Recombinant produced in Sf9 insect cells is a double, glycosyl-
ated, polypeptide chain containing 164 amino acids and having a molecular mass of 48 kDa.

rmVEGF (121a.a.) CYT-574 2 µg 50

Recombinant Mouse Vascular Endothelial Growth Factor (121) -20 °C 10 µg 130

PEPTIDES INTERNATIONAL
Vascular endothelial growth factor A, VEGF-A, Vascular 1 mg 3,510
permeability factor, VPF, VEGF, MGC70609
MAPTTEGEQK SHEVIKFMDV YQRSYCRPIE TLVDIFQEYP DEIEYIFKPS CVPLMRCAGC
CNDEALECVP TSESNITMQI MRIKPHQSQH IGEMSFLQHS RCECRPKKDR TKPEKCDKRPR R
Vascular Endothelial Growth Factor-121 Mouse Recombinant produced in E.Coli is a homodimer, non-
glycosylated, polypeptide chain containing 121 amino acids and having a molecular mass of 28.4 kDa.
Recombinant Mouse VEGF-121 is a truncated version of Murine VEGF-165. .
M.R. Saban, et al., BMC Physiology, 11, 16 (2011).

rmVEGF His CYT-680 2 µg 50

Recombinant Mouse Vascular Endothelial Growth Factor, His -20 °C 10 µg 130
Tag; Vascular endothelial growth factor A, VEGF-A, Vascular 1 mg 5,200
permeability factor, VPF, VEGF, Vegf120, Vegf164, Vegf188,
Vegfa
MGSSHHHHHH SSGLVPRGSH MAPTTEGEQK SHEVIKFMDV YQRSYCRPIE TLVDIFQEYP DEIEY-
IFKPS CVPLMRCAGC CNDEALECVP TSESNITMQI MRIKPHQSQH IGEMSFLQHS RCECRPKKDR
TKPEKCDKPR R
VEGF Mouse Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing
141 amino acids (205-324 a.a.) and having a total molecular mass of 16.3kDa. Mouse VEGF is fused to
20 amino acid His Tag at N-terminus

Order Hotline 1-800-777-4779 502-266-8787 503

 PRODUCT Code Qty PRICE
Recombinant proteins

rVEGF CYT-392 2 µg 50
Recombinant Rat Vascular Endothelial Growth Factor -20 °C 10 µg 130
Vascular endothelial growth factor A, VEGF-A, Vascular 1 mg 3,510
permeability factor, VPF, VEGF, MGC70609
MAPTTEGEQK AHEVVKFMDV YQRSYCRPIE TLVDIFQEYP DEIEYIFKPS CVPLMRCAGC
CNDEALECVP TSESNVTMQI MRIKPHQSQH IGEMSFLQHS RCECRPKKDR TKPEKHCEPC
SERRKHLFVQ DPQTCKCSCK NTDSRCKARQ LELNERTCRC DKPRR
Vascular Endothelial Growth Factor Rat Recombinant produced in E.Coli is a double, non-glycosylated,
polypeptide chain containing 165 amino acids and having a molecular mass of 38,750 Dalton.

VEGFB CYT-628 5 µg 505

Recombinant Human Vascular Endothelial Growth Factor B -20 °C 20 µg 130
Vascular endothelial growth factor B, VEGF-B, VRF, VEGFL, 1 mg 3,510
VEGF-related factor, VEGFB
MGSSHHHHHH SSGLVPRGSH MPVSQPDAPG HQRKVVSWID VYTRATCQPR EVVVPLTVEL MGT-
VAKQLVP SCVTVQRCGG CCPDDGLECV PTGQHQVRMQ ILMIRYPSSQ LGEMSLEEHS QCECRPK-
KKD SAVKPDRAAT PHHRPQPRSV PGWDSAPGAP SPADITHPTP APGPSAHAAP STTSALTPGP
AAAAADAAAS SVAKGGA
VEGFB Human Recombinant produced in E.Coli is a double, non-glycosylated, polypeptide chain contain-
ing 207 amino acids (22-207) and having a molecular mass of 21.6 kDa (molecular weight on SDS-PAGE
will appear higher). The VEGFB is fused to a 20 amino acid His Tag at N-terminus.

VEGFC CYT-527 2 µg 50
Recombinant Human Vascular Endothelial Growth Factor C -20 °C 10 µg 130
VEGF-C, Vascular endothelial growth factor C, VRP, Flt4 ligand, 1 mg 2,700
Flt4-L, Vascular endothelial growth factor-related Protein,
PEPTIDES INTERNATIONAL

VEGFC
VEGF-C Human Recombinant- contains 129 amino acids residues and was fused to a His- tag (6x His) at
the C-terminal end. As a result of glycosylation VEGF-C migrates as an 18-24 kDa protein in SDS-PAGE
under reducing conditions.

VEGFC HEK CYT-784 5 µg 50

Recombinant Human Vascular Endothelial Growth Factor -20 °C 20 µg 130
C HEK, VEGF-C, Vascular endothelial growth factor C, VRP, 1 mg 2,700
Flt4 ligand, Flt4-L, Vascular endothelial growth factor-related
Protein, VEGFC
FESGLDLSDAEPDAGEATAYASKDLEEQLRSVSSVDELMTVLYPEYWKMYK
CQLRKGGWQHNREQANLNSRTEETIKFAAAHYNTEILKSIDNEWRKTQCMP
REVCIDVGKEFGVATNTFFKPPCVSVYRCGGCCNSEGQCMNTSTSYLSKTLF
EITVPLSQGPKPVTISFANHTSCRCMSKLDVYRQVHSIIRRVDHHHHHH
VEGFC Human Recombinant produced by transfected human cells is a single polypeptide chain contain-
ing 204 amino acids (32-227). VEGFC is fused to an 8 amino acid His-tag at C-terminus.
Please prevent freeze-thaw cycles.

504 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
rVEGFC CYT-262 2 µg 50
Recombinant Rat Vascular Endothelial Growth Factor Related -20 °C 10 µg 130
Protein, VEGF-C, Vascular endothelial growth factor C, VRP, 1 mg 5,100
Flt4 ligand, Flt4-L
Vascular Endothelial Growth Factor C Rat Recombinant contains 129 amino acids residues and was fused
to a His- tag (6x His) at the C-terminal end. As a result of glycosylation VEGF-C migrates as an 18-24 kDa
protein in SDS-PAGE under reducing conditions.

rVEGFC (152a.a.) CYT-284 2 µg 50

Recombinant Rat Vascular Endothelial Growth Factor-C (152) -20 °C 10 µg 130
VEGF-C152, Vascular endothelial growth factor C 152, VRP, Flt4 1 mg 5,100
ligand, Flt4-L
Vascular Endothelial Growth Factor -C 152 Rat Recombinant contains 152 amino acids residues and was
fused to a His-tag (6x His) at the C-terminal end. As a result of glycosylation, VEGF-C migrates as an
18-24 kDa protein in SDS-PAGE under reducing conditions.

VEGF D CYT-045 2 µg 50
Recombinant Human Vascular Endothelial Growth Factor D -20 °C 10 µg 130
c-fos induced growth factor (vascular endothelial growth factor 1 mg 4,680
D), FIGF, VEGFD
VEGFD Human Recombinant produced in HEK-293 cells is a secreted protein (amino acids Phe93-
Ser201) fused to a polyhistidine tag at the C-terminus.

VEGF E (Orf Virus) CYT-263 2 µg 50

Recombinant Vascular Endothelial Growth Factor-E (Orf Virus) -20 °C 10 µg 130
1 mg 5,100

PEPTIDES INTERNATIONAL
A DNA sequence encoding the mature variant of ovVEGF-E isolate D1701 (Dehio, et al., 1999; GenBank
accession No. AF106020) was expressed in E. coli as a 132 amino acid residue fusion protein with an
N-terminal His-tag sequence and a thrombin cleavage site. Recombinant VEGF-E homodimer was dimer-
ized in vitro and has a predicted mass of approximately 35 kDa. Based on sequence similarity to VEGF-A,
a gene encoding a VEGF homologue has recently been discovered in the genome of Orf virus (OV) (Lyttle,
et al., 1994). Different isolates of Orf virus show significant amino acid sequence similarity to VEGF-A and
described as a viral virulence factor that appears to be derived from captured host genes. All eight cysteine
residues of the central cysteine knot motif characteristic of members of the VEGF family are conserved
among other residues in the VEGF-E proteins (Dehio, et al., 1999; Wise et al., 1999). Alignment of all
mammalian VEGF sequences indicated that VEGF-E is distinct from the previously described VEGFs
but most closely related to VEGF-A. Like VEGF-A, VEGF-E was found to bind with high affinity to VEGF
receptor-2 (KDR) resulting in receptor autophosphorylation, whilst in contrast to VEGF-A, VEGF-E can
not bind to VEGF receptor-1 (Flt-1). Furthermore, VEGF-E can also not bind to VEGF receptor-3 (FLT-4).
Therefor,e VEGF-E is a potent angiogenic factor selectively binding to VEGF receptor –2/KDR

VEGI CYT-517 2 µg 50
Recombinant Human Vascular Endothelial Growth Inhibitor -20 °C 10 µg 130
Tumor necrosis factor ligand superfamily member 15, 1 mg 3,000
TNFSF-15, TNFSF15, TNF ligand-related molecule 1, VEGI, TL-
1, TL1, TL1A, VEGI192A, VEGI-192, MGC129934, MGC129935
MQLTKGRLHFSHPLSHTKHISPFVTDAPLRADGDKPRAHL
TVVRQTPTQHFKNQFPALHWEHEL-
GLAFTKNRMNYTNKF
LLIPESGDYFIYSQVTFRGMTSECSEIRQAGRPNKPDSIT
VVITKVTDSYPEP-
TQLLMGTKSVCEVGSNWFQPIYLGAM
FSLQEGDKLMVNVSDISLVDYTKEDKTFFGAFLL
TNFSF15 Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain
containing 180 amino acids and having a molecular mass of 20.5kDa.

Order Hotline 1-800-777-4779 502-266-8787 505

 PRODUCT Code Qty PRICE
Recombinant proteins

VEGI His CYT-589 5 µg 50

Recombinant Human Vascular Endothelial Growth Inhibitor, -20 °C 20 µg 130
His Tag 1 mg 2,700
Tumor necrosis factor ligand superfamily member 15,
TNFSF-15, TNFSF15, TNF ligand-related molecule 1, VEGI, TL-
1, TL1, TL1A, VEGI192A, VEGI-192, MGC129934, MGC129935
MGSSHHHHHH SSGLVPRGSH MLKGQEFAPS HQQVYAPLRA DGDKPRAHLT VVRQTPTQHF KNQF-
PALHWE HELGLAFTKN RMNYTNKFLL IPESGDYFIY SQVTFRGMTS ECSEIRQAGR PNKPDSITVV
ITKVTDSYPE PTQLLMGTKS VCEVGSNWFQ PIYLGAMFSL QEGDKLMVNV SDISLVDYTK EDKTFF-
GAFL L
VEGI Human Recombinant fused with a 21 amino acid His tag at N-terminus produced in E.Coli is a single,
non-glycosylated, polypeptide chain containing 201 amino acids (72-251a.a.) and having a molecular mass
of 22.7kDa.
Please prevent freeze-thaw cycles.

Visfatin CYT-318 5 µg 50
Recombinant Human Visfatin -20 °C 25 µg 130
PBEF, Pre-B cell colony-enhancing factor, Nicotinamide 1 mg 2,950
phosphoribosyltransferase NAmPRTase, Nampt, MGC117256,
DKFZP666B131, 1110035O14Rik
MPPNTSKVYS YFECREKKTE NSKLRKVKYE ETVFYGLQYI LNKYLKGKVV TKEKIQEAKD VYKE-
HFQDDV FNEKGWNYIL EKYDGHLPIE IKAVPEGFVI PRGNVLFTVE NTDPECYWLT NWIETILVQS
WYPITVATNS REQKKILAKY LLETSGNLDG LEYKLHDFGY RGVSSQETAG IGASAHLVNF KGTDTVA-
GLA LIKKYYGTKD PVPGYSVPAA EHSTITAWGK DHEKDAFEHI VTQFSSVPVS VVSDSYDIYN ACEKI-
WGEDL RHLIVSRSTQ APLIIRPDSG NPLDTVLKVL EILGKKFPVT ENSKGYKLLP PYLRVIQGDG VD-
INTLQEIV EGMKQKMWSI ENIAFGSGGG LLQKLTRDLL NCSFKCSYVV TNGLGINVFK DPVADPNKRS
PEPTIDES INTERNATIONAL

KKGRLSLHRT PAGNFVTLEE GKGDLEEYGQ DLLHTVFKNG KVTKSYSFDE IRKNAQLNIE LEAAHH

Visfatin Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing
466 amino acids. The total molecular mass is 52.6kDa (calculated). The Visfatin is purified by Flag-affinity
chromatography.

Visfatin His CYT-563 5 µg 50

Recombinant Human Visfatin, His Tag -20 °C 25 µg 130
PBEF, Pre-B cell colony-enhancing factor, Nicotinamide 1 mg 4,500
phosphoribosyltransferase NAmPRTase, Nampt, MGC117256,
DKFZP666B131, 1110035O14Rik
MGSSHHHHHH SSGLVPRGSH MNPAAEAEFN ILLATDSYKV THYKQYPPNT SKVYSYFECR EKKTEN-
SKLR KVKYEETVFY GLQYILNKYL KGKVVTKEKI QEAKDVYKEH FQDDVFNEKG WNYILEKYDG
HLPIEIKAVP EGFVIPRGNV LFTVENTDPE CYWLTNWIET ILVQSWYPIT VATNSREQKK ILAKYL-
LETS GNLDGLEYKL HDFGYRGVSS QETAGIGASA HLVNFKGTDT VAGLALIKKY YGTKDPVPGY
SVPAAEHSTI TAWGKDHEKD AFEHIVTQFS SVPVSVVSDS YDIYNACEKI WGEDLRHLIV SRSTQAPLII
RPDSGNPLDT VLKVLEILGK KFPVTENSKG YKLLPPYLRV IQGDGVDINT LQEIVEGMKQ KMWSIE-
NIAF GSGGGLLQKL TRDLLNCSFK CSYVVTNGLG INVFKDPVAD PNKRSKKGRL SLHRTPAGNF
VTLEEGKGDL EEYGQDLLHT VFKNGKVTKS YSFDEIRKNA QLNIELEAAH H
Visfatin Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing
511 amino acids and having a molecular mass of 57 kDa. The recombinant human Visfatin is fused to His
tag at N-Terminus.

506 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
mVisfatin CYT-447 5 µg 50
Recombinant Mouse Visfatin, PBEF, Pre-B cell colony- -20 °C 25 µg 130
enhancing factor, Nicotinamide phosphoribosyltransferase 1 mg 3,600
NAmPRTase, Nampt, MGC117256, DKFZP666B131,
1110035O14Rik
MGSSHHHHHH SSGLVPRGSH MNAAAEAEFN ILLATDSYKV THYKQYPPNT SKVYSYFECREK-
KTENSKVR KVKYEETVFY GLQYILNKYL KGKVVTKEKI QEAKEVYREH FQDDVFNERGWNYILEKYDG
HLPIEVKAVP EGSVIPRGNV LFTVENTDPE CYWLTNWIET ILVQSWYPITVATNSREQKK ILAKYL-
LETS GNLDGLEYKL HDFGYRGVSS QETAGIGASA HLVNFKGTDT VAGIALIKKY YGTKDPVPGY
SVPAAEHSTI TAWGKDHEKD AFEHIVTQFS SVPVSVVSDS YDIYNACEKI WGEDLRHLIV SRSTEAPLII
RPDSGNPLDT VLKVLDILGK KFPVTENSKG YKLLPPYLRV IQGDGVDINT LQEIVEGMKQ KKWSIEN-
VSF GSGGALLQKL TRDLLNCSFK CSYVVTNGLG VNVFKDPVAD PNKRSKKGRL SLHRTPAGNF
VTLEEGKGDL EEYGHDLLHTVFKNGKVTKS YSFDEVRKNA QLNIEQDVAP H
Visfatin Mouse Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain (aa 1-491)
containing a 20 aa His tag and having 511 amino acids. The total molecular mass is 57kDa. T

WNT7A CYT-795 5 µg 50
Recombinant Human Wingless-Type MmTV Integration Site -20 °C 20 µg 130
Family, Member 7A 1 mg 2,700

PEPTIDES INTERNATIONAL

Order Hotline 1-800-777-4779 502-266-8787 507

 PRODUCT Code Qty PRICE
Recombinant proteins

Chemokines
BCA 1 CHM-348 5 µg 50
Recombinant Human BCA-1/ BLC (CXCL13) -20 °C 20 µg 130
1 mg 2,700

BRAK His CHM-239 5 µg 50

Recombinant Human BRAK (CXCL14), His Tag -20 °C 20 µg 130
1 mg 3,000

BRAK CHM-001 5 µg 50
Recombinant Human BRAK (CXCL14) -20 °C 20 µg 130
1 mg 2,700

mBRAK CHM-007 5 µg 50
Recombinant Mouse BRAK (CXCL14) -20 °C 20 µg 130
1 mg 2,700

rBRAK CHM-021 5 µg 50
Recombinant Rat BRAK (CXCL14) 20 µg 130
1 mg 2,700

mC 10 CHM-307 2 µg 50
Recombinant Mouse C-10 (CCL6) 10 µg 130
1 mg 2,700

rC 10 CHM-268 2 µg 50
Recombinant Rat C-10 (CCL6) 10 µg 130
1 mg 2,700
PEPTIDES INTERNATIONAL

CCL16 CHM-237 5 µg 50
Recombinant Human LEC/NCC-4 (CCL16) 20 µg 130
1 mg 2,700

CCL3L1 His CHM-251 5 µg 50

Recombinant Human LD78-β (CCL3L1), His Tag 20 µg 130
1 mg 2,700

CCL3L1 CHM-263 5 µg 50
Recombinant Human LD78-β (CCL3L1) 20 µg 130
1 mg 2,700

CTACK CHM-373 5 µg 50
Recombinant Human CTACK (CCL27) 20 µg 130
1 mg 2,250

mCTACK CHM-013 5 µg 50
Recombinant Mouse CTACK (CCL27) 20 µg 130
1 mg 2,700

mCXCL16 CHM-363 5 µg 50
Recombinant Mouse CXCL16 25 µg 130
1 mg 2,700

CXCL17 CHM-019 5 µg 50
Recombinant Human VEGF Co-regulated Chemokine 1 25 µg 130
1 mg 2,700

508 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
rCXCL17 CHM-281 5 µg 50
Recombinant Rat VEGF Co-regulated Chemokine 1 25 µg 130
1 mg 2,700

ENA 78 CHM-331 5 µg 50
Recombinant Human Epithelial Neutrophil-Activating Protein 20 µg 130
78 (CXCL5) 1 mg 2,700

mENA 78 CHM-365 5 µg 50
Recombinant Mouse Epithelial Neutrophil-Activating Protein 20 µg 130
78 (CXCL5) 1 mg 2,700

ENA 78 (8-78 a.a.) CHM-265 5 µg 50

Recombinant Human Epithelial Neutrophil-Activating Protein 20 µg 130
78 (CXCL5), 8-78 a.a. 1 mg 2,700

rENA 78 CHM-267 5 µg 50
Recombinant Rat Epithelial Neutrophil-Activating Protein 78 20 µg 130
(CXCL5) 1 mg 2,700

Eotaxin CHM-256 5 µg 50
Recombinant Human Eotaxin (CCL11) 20 µg 130
1 mg 2,700

Eotaxin, His CHM-344 5 µg 50

Recombinant Human Eotaxin (CCL11), His Tag 20 µg 130

PEPTIDES INTERNATIONAL
1 mg 2,000

mEotaxin CHM-308 5 µg 50
Recombinant Mouse Eotaxin (CCL11) 20 µg 130
1 mg 2,700

rEotaxin CHM-260 5 µg 50
Recombinant Rat Eotaxin (CCL11) 20 µg 130
1 mg 2,700

rmEotaxin CHM-022 5 µg 50
Recombinant Rhesus Macaque Eotaxin (CCL11) 20 µg 130
1 mg 2,700

Eotaxin 2 CHM-238 5 µg 50
Recombinant Human Eotaxin-2 (CCL24) 20 µg 130
1 mg 2,700

mEotaxin 2 CHM-368 5 µg 50
Recombinant Mouse Eotaxin-2 (CCL24) 20 µg 130
1 mg 2,700

rEotaxin 2 CHM-282 5 µg 50
Recombinant Rat Eotaxin-2 (CCL24) 20 µg 130
1 mg 2,700

Eotaxin 3 CHM-362 10 µg 50
Recombinant Human Eotaxin-3 (CCL26) 50 µg 130
1 mg 1,800

Order Hotline 1-800-777-4779 502-266-8787 509

 PRODUCT Code Qty PRICE
Recombinant proteins

Exodus 2 CHM-332 5 µg 50
Recombinant Human Exodus-2 (CCL21) 20 µg 130
1 mg 2,700

mExodus 2 CHM-371 5 µg 50
Recombinant Mouse Exodus-2 (CCL21) 20 µg 130
1 mg 2,700

Fractalkine CHM-235 5 µg 50
Recombinant Human Fractalkine (CX3CL1) 20 µg 130
1 mg 2,700

Fractalkine His CHM-360 2 µg 50

Recombinant Human Fractalkine (CX3CL1) His Tag 10 µg 130
1 mg 4,800

rFractalkine CHM-005 5 µg 50
Recombinant Rat Fractalkine (CX3CL1) 20 µg 130
1 mg 2,700

mFractalkine CHM-017 5 µg 50
Recombinant Mouse Fractalkine (CX3CL1) 20 µg 130
1 mg 2,700

GRO a CHM-329 5 µg 50
Recombinant Human GRO-α (CXCL1) 25 µg 130
1 mg 2,700

GRO a, His CHM-242 10 µg 50

PEPTIDES INTERNATIONAL

Recombinant Human GRO-α (CXCL1), His Tag 50 µg 130

1 mg 1,800

mGRO1/KC CHM-335 5 µg 50
Recombinant Mouse GRO/KC (CXCL1) 20 µg 130
1 mg 2,700

mGRO1/KC, His CHM-002 5 µg 50

Recombinant Mouse GRO/KC (CXCL1), His Tag 20 µg 130
1 mg 3,600

rGRO a CHM-375 5 µg 50
Recombinant Rat GRO-α (CXCL1) 25 µg 130
1 mg 2,700

GRO b CHM-309 2 µg 50
Recombinant Human GRO-β/mIP-2 (CXCL2) 10 µg 130
1 mg 2,700

GRO b His CHM-356 2 µg 50

Recombinant Human GRO-β/mIP-2 (CXCL2) His 10 µg 130
1 mg 2,700

mGRO b CHM-338 5 µg 50
Recombinant Mouse GRO-β/mIP-2 (CXCL2) 20 µg 130
1 mg 2,700

510 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
rGRO b CHM-372 5 µg 50
Recombinant Rat GRO-β/mIP-2 (CXCL2) 20 µg 130
1 mg 2,700

vmIP2 CHM-376 10 µg 50
Recombinant Viral Macrophage inflammatory Protein-2 50 µg 130
1 mg 1,350

GRO g CHM-310 2 µg 50
Recombinant Human GRO-gamma (CXCL3) 10 µg 130
1 mg 2,700

GRO g His CHM-244 2 µg 50

Recombinant Human GRO-gamma (CXCL3), His Tag 10 µg 130
1 mg 5,200

mGRO g CHM-255 2 µg 50
Recombinant Mouse GRO-gamma (CXCL3) 10 µg 130
1 mg 2,700

mGRO g His CHM-283 2 µg 50

Recombinant Mouse GRO-gamma (CXCL3), His Tag 10 µg 130
1 mg 2,700

rGRO g/CINC-2a CHM-258 2 µg 50

Recombinant Rat GRO-gamma (CXCL3), CINC-2 α 10 µg 130
1 mg 2,700

rGRO g/CINC-2b CHM-273 2 µg 50

PEPTIDES INTERNATIONAL
Recombinant Rat GRO-gamma (CXCL3), CINC-2 β 10 µg 130
1 mg 2,700

HCC 1 CHM-311 2 µg 50
Recombinant Human HCC-1 (CCL14) 10 µg 130
1 mg 2,700

HCC 1 (66 a.a.) CHM-006 2 µg 50

Recombinant Human HCC-1 (CCL14) (66 a.a.) 10 µg 130
1 mg 2,700

HCC 1 His CHM-253 2 µg 50

Recombinant Human HCC-1 (CCL14) His Tag 10 µg 130
1 mg 2,700

I 309 CHM-312 2 µg 50
Recombinant Human I-309 (CCL1) 10 µg 130
1 mg 2,700

I 309 His CHM-254 2 µg 50

Recombinant Human I-309 (CCL1) His Tag 10 µg 130
1 mg 5,200

IL 8 (1-72) CHM-231 5 µg 50
Recombinant Human Interleukin-8 (1-72) (CXCL8) 25 µg 130
1 mg 2,700

Order Hotline 1-800-777-4779 502-266-8787 511

 PRODUCT Code Qty PRICE
Recombinant proteins

pIL 8 CHM-340 5 µg 50
Recombinant Porcine Interleukin-8 (1-72) (CXCL8) 20 µg 130
1 mg 2,700

IL 8 (1-77) CHM-327 5 µg 50
Recombinant Human Interleukin-8 (1-77) (CXCL8) 25 µg 130
1 mg 2,700

IL 8 Pichia CHM-349 5 µg 50
Recombinant Human Interleukin-8 (1-77) (CXCL8) Pichia 25 µg 130
1 mg 2,700

IL 8 (1-77), His CHM-345 10 µg 50

Recombinant Human Interleukin-8 (1-77) (CXCL8), His Tag 50 µg 130
1 mg 2,200

rIL 8 CHM-261 5 µg 50
Recombinant Rabbit Interleukin-8 20 µg 130
1 mg 3,600

rmIL8 CHM-004 5 µg 50
Recombinant Rhesus Macaque Interleukin-8 25 µg 130
1 mg 2,700

k9IL8 CHM-009 5 µg 50
Recombinant Canine Interleukin-8 20 µg 130
1 mg 2,700

IP 10 CHM-330 5 µg 50
PEPTIDES INTERNATIONAL

Recombinant Human IP-10 (CXCL10) 25 µg 130

1 mg 2,700

IP 10 His CHM-346 5 µg 50
Recombinant Human IP-10 (CXCL10), His Tag 25 µg 130
1 mg 2,600

mIP 10 CHM-336 5 µg 50
Recombinant Mouse IP-10 (CXCL10) 25 µg 130
1 mg 2,700

rIP 10 CHM-264 5 µg 50
Recombinant Rat IP-10 (CXCL10) 25 µg 130
1 mg 2,700

rmIP10 CHM-010 5 µg 50
Recombinant Rhesus Macaque IP-10 (CXCL10) 25 µg 130
1 mg 2,700

I TAC CHM-334 5 µg 50
Recombinant Human I-TAC (CXCL11) 20 µg 130
1 mg 2,700

I TAC, His CHM-232 5 µg 50

Recombinant Human I-TAC (CXCL11), His Tag 20 µg 130
1 mg 2,700

512 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
LAG-1 His CHM-272 5 µg 50
Recombinant Human LAG-1 (CCL4L1), His Tag 20 µg 130
1 mg 2,700

LAG-1 CHM-018 5 µg 50
Recombinant Human LAG-1 (CCL4L1) 20 µg 130
1 mg 2,700

Lymphotactin CHM-314 3x2 µg 50

Recombinant Human Lymphotactin (XCL1) 2x10 µg 130
1 mg 2,700

Lymphotactin His CHM-357 2 µg 50

Recombinant Human Lymphotactin (XCL1) His Tag 10 µg 130
1 mg 5,200

mCP 1 CHM-271 5 µg 50
Recombinant Human Monocyte Chemotactic Protein-1/mCAF 20 µg 130
(CCL2) 1 mg 2,700

mCP 1 His CHM-246 10 µg 50

Recombinant Human Monocyte Chemotactic Protein-1/mCAF 50 µg 130
(CCL2), His Tag 1 mg 1,800

mmCP 1 CHM-313 2 µg 50
Recombinant Mouse Monocyte Chemotactic Protein-1 (CCL2) 10 µg 130
1 mg 2,700

PEPTIDES INTERNATIONAL
mmCP 1 His CHM-014 5 µg 50
Recombinant Mouse Monocyte Chemotactic Protein-1 (CCL2) 20 µg 130
His Tag 1 mg 4,500

rmCP 1 CHM-315 2 µg 50
Recombinant Rat Monocyte Chemotactic Protein-1 (CCL2) 10 µg 130
1 mg 2,700

mCP 2 CHM-316 2 µg 25
Recombinant Human Monocyte Chemotactic Protein-2 (CCL8) 10 µg 70
1 mg 2,700

mmCP-2 CHM-355 2 µg 50
Recombinant Mouse Monocyte Chemotactic Protein-2 (CCL8) 10 µg 130
1 mg 2,700

mCP 3 CHM-317 2 µg 50
Recombinant Human Monocyte Chemotactic Protein-3 (CCL7) 10 µg 130
1 mg 2,700

mmCP 3 CHM-318 2 µg 50
Recombinant Mouse Monocyte Chemotactic Protein-3 (CCL7) 10 µg 130
1 mg 2,700

rmCP 3 CHM-280 2 µg 50
Recombinant Rat Monocyte Chemotactic Protein-3 (CCL7) 10 µg 130
1 mg 2,700

Order Hotline 1-800-777-4779 502-266-8787 513

 PRODUCT Code Qty PRICE
Recombinant proteins

mCP 4 CHM-319 2 µg 25
Recombinant Human Monocyte Chemotactic Protein-4 (CCL13) 10 µg 70
1 mg 2,700

mCP 4, His CHM-275 1 µg 50

Recombinant Human Monocyte Chemotactic Protein-4 5 µg 130
(CCL13), His Tag 50 µg 1,200

mCP 5 CHM-266 5 µg 50
Recombinant Mouse Monocyte Chemotactic Protein-5 (CCL12) 20 µg 130
1 mg 2,700

mDC CHM-250 5 µg 50
Recombinant Human Macrophage-Derived Chemokine (CCL22) 20 µg 130
1 mg 2,700

mDC His CHM-367 5 µg 50

Recombinant Human Macrophage-Derived Chemokine (CCL22) 20 µg 130
His Tag 1 mg 1,800

mmDC CHM-370 5 µg 50
Recombinant Mouse Macrophage-Derived Chemokine (CCL22) 20 µg 130
1 mg 2,700

rmDC CHM-279 5 µg 50
Recombinant Rat Macrophage-Derived Chemokine (CCL22) 20 µg 130
1 mg 2,700
PEPTIDES INTERNATIONAL

mEC CHM-353 5 µg 50
Recombinant Human Mucosae-Associated Epithelial 20 µg 130
Chemokine (CCL28) 1 mg 2,700

mEC His CHM-366 5 µg 50

Recombinant Human Mucosae-Associated Epithelial 20 µg 130
Chemokine (CCL28) His Tag 1 mg 3,600

mmEC CHM-369 5 µg 50
Recombinant Mouse Mucosae-Associated Epithelial 20 µg 130
Chemokine (CCL28) 1 mg 2,700

rmEC CHM-278 5 µg 50
Recombinant Rat Mucosae-Associated Epithelial Chemokine 20 µg 130
(CCL28) 1 mg 2,700

mIG CHM-333 5 µg 50
Recombinant Human MIG (CXCL9) 20 µg 130
1 mg 2,700

mIG His CHM-016 5 µg 50

Recombinant Human MIG (CXCL9) His Tag 20 µg 130
1 mg 3,600

rmmIG CHM-337 5 µg 50
Recombinant Mouse MIG (CXCL9) 20 µg 130
1 mg 2,700

514 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
mIP 1a CHM-233 5 µg 50
Recombinant Human Macrophage Inflammatory Protein-1 α 20 µg 130
(CCL3) 1 mg 2,700

mIP 1a, His CHM-347 2 µg 50

Recombinant Human Macrophage Inflammatory Protein-1 α 10 µg 130
(CCL3), His Tag 1 mg 2,600

mmIP 1a CHM-320 2 µg 50
Recombinant Mouse Macrophage Inflammatory Protein-1 α 10 µg 130
(CCL3) 1 mg 2,700

rmIP 1a CHM-343 5 µg 50
Recombinant Rat Macrophage Inflammatory Protein-1 α (CCL3) 20 µg 130
1 mg 2,700

mmIP 1a, His CHM-008 2 µg 50

Recombinant Mouse Macrophage Inflammatory Protein-1 α 10 µg 130
(CCL3), His Tag 1 mg 5,200

mIP 1b CHM-276 2 µg 50
Recombinant Human Macrophage Inflammatory Protein-1 β 10 µg 130
(CCL4) 1 mg 2,700

mmIP 1b CHM-321 2 µg 50
Recombinant Mouse Macrophage Inflammatory Protein-1 β 10 µg 130
(CCL4) 1 mg 2,700

PEPTIDES INTERNATIONAL
rmIP 1b CHM-003 5 µg 50
Recombinant Rat Macrophage Inflammatory Protein-1 β (CCL4) 20 µg 130
1 mg 2,700

mmIP-1g CHM-257 5 µg 50
Recombinant Mouse Macrophage Inflammatory Protein-1 20 µg 130
gamma (CCL9) 1 mg 2,700

mIP 3 CHM-358 5 µg 50
Recombinant Human Macrophage Inflammatory Protein-3 20 µg 130
(CCL23) 1 mg 2,700

mIP 3b CHM-287 5 µg 50
Recombinant Human Macrophage Inflammatory Protein-3 β 20 µg 130
(CCL19) 1 mg 2,700

mIP 3, T7 CHM-374 5 µg 50
Recombinant Human Macrophage Inflammatory Protein-3 20 µg 130
(CCL23), T7 Tag 1 mg 2,250

mmIP 3b CHM-341 5 µg 50
Recombinant Mouse Macrophage Inflammatory Protein-3 β 20 µg 130
(CCL19) 1 mg 2,700

mIP 3α CHM-351 5 µg 50
Recombinant Human Macrophage Inflammatory Protein-3 α 20 µg 130
(CCL20) 1 mg 2,700

Order Hotline 1-800-777-4779 502-266-8787 515

 PRODUCT Code Qty PRICE
Recombinant proteins

mIP 3α His CHM-252 2 µg 50

Recombinant Human Macrophage Inflammatory Protein-3 α 10 µg 130
(CCL20), His Tag 1 mg 5,200

mmIP 3α CHM-236 5 µg 50
Recombinant Mouse Macrophage Inflammatory Protein-3 α 20 µg 130
(CCL20) 1 mg 2,700

mIP 4 CHM-322 2 µg 50
Recombinant Human Macrophage Inflammatory Protein-4 10 µg 130
(CCL18) 1 mg 2,700

mIP 4 His CHM-339 1 µg 50

Recombinant Human Macrophage Inflammatory Protein-4 5 µg 130
(CCL18), His-Tag 50 µg 1,100

mIP 5 CHM-230 5 µg 50
Recombinant Human Macrophage Inflammatory Protein-5 25 µg 130
(CCL15) 1 mg 2,700

mIP 5 (68 a.a.) CHM-011 5 µg 50

Recombinant Human Macrophage Inflammatory Protein-5 25 µg 130
(CCL15) 68 a.a 1 mg 2,700

NAP 2 CHM-274 2 µg 50
Recombinant Human Neutrophil Activating Protein-2 (CXCL7) 10 µg 130
1 mg 2,700
PEPTIDES INTERNATIONAL

NAP 2 95 a.a. CHM-277 2 µg 50

Recombinant Human Neutrophil Activating Protein-2 (CXCL7), 10 µg 130
95 a.a. 1 mg 2,700

rNAP 2 CHM-269 2 µg 50
Recombinant Rat Neutrophil Activating Protein-2 (CXCL7) 10 µg 130
1 mg 2,700

PF 4 CHM-234 5 µg 50
Human Platelet Factor-4 (CXCL4) 20 µg 130
1 mg 2,700

PF 4 CHM-350 5 µg 50
Recombinant Human Platelet Factor-4 (CXCL4) 20 µg 130
1 mg 2,700

PF 4 Variant-1 CHM-243 1 µg 50
Recombinant Human Platelet Factor-4 (CXCL4V1) Variant-1 5 µg 130
50 µg 1,100

PF4 His CHM-015 2 µg 50

Recombinant Human Platelet Factor-4 (CXCL4), His Tag 10 µg 130
100 µg 1,200

mPF 4 CHM-245 5 µg 50
Recombinant Mouse Platelet Factor-4 (CXCL4) 20 µg 130
1 mg 2,700

516 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
Rantes CHM-328 5 µg 50
Recombinant Human Rantes (CCL5) 20 µg 130
1 mg 2,700

Rantes His CHM-361 2 µg 50

Recombinant Human Rantes (CCL5) His Tag 10 µg 130
1 mg 4,800

rmRantes CHM-342 5 µg 50
Recombinant Mouse Rantes (CCL5) 20 µg 130
1 mg 2,700

rRantes CHM-352 5 µg 50
Recombinant Rat Rantes (CCL5) 20 µg 130
1 mg 2,700

SDF 1a CHM-262 2 µg 50
Recombinant Human Stromal Cell-Derived Factor-1 α (CXCL12) 10 µg 130
1 mg 2,700

SDF 1a, His CHM-241 2 µg 50

Recombinant Human Stromal Cell-Derived Factor-1 α (CXCL12) 10 µg 130
His-Tag 1 mg 2,900

mSDF 1a CHM-324 2 µg 50
Recombinant Mouse Stromal Cell-Derived Factor-1 α (CXCL12) 10 µg 130
1 mg 2,700

rSDF 1a CHM-354

PEPTIDES INTERNATIONAL
2 µg 50
Recombinant Rat Stromal Cell-Derived Factor-1 α (CXCL12) 10 µg 130
1 mg 2,700

SDF 1b CHM-325 2 µg 50
Recombinant Human Stromal Cell-Derived Factor-1 β (CXCL12) 10 µg 130
1 mg 2,700

SDF 1b His CHM-249 2 µg 50

Recombinant Human Stromal Cell-Derived Factor-1 β (CXCL12) 10 µg 130
His Tag 1 mg 5,200

mSDF 1b CHM-326 2 µg 50
Recombinant Mouse Stromal Cell-Derived Factor-1 β (CXCL12) 10 µg 130
1 mg 2,700

fSDF 1b CHM-247 2 µg 50
Recombinant Feline Stromal Cell-Derived Factor-1 β (CXCL12) 10 µg 130
1 mg 2,700

rSDF 1b CHM-248 2 µg 50
Recombinant Rat Stromal Cell-Derived Factor-1 β (CXCL12) 10 µg 130
1 mg 2,700

SDF 1g CHM-020 2 µg 50
Recombinant Human Stromal Cell-Derived Factor-1 gamma 10 µg 130
(CXCL12) 1 mg 2,700

Order Hotline 1-800-777-4779 502-266-8787 517

 PRODUCT Code Qty PRICE
Recombinant proteins

TARC CHM-240 5 µg 50
Recombinant Human Thymus and Activation Regulated 20 µg 130
Chemokine (CCL17) 1 mg 2,700

TARC His CHM-359 2 µg 50

Recombinant Human Thymus and Activation Regulated 10 µg 130
Chemokine (CCL17) His Tag 1 mg 5,200

mTARC CHM-270 5 µg 50
Recombinant Mouse Thymus and Activation Regulated 20 µg 130
Chemokine (CCL17) 1 mg 2,700

rTARC CHM-012 5 µg 50
Recombinant Rat Thymus and Activation Regulated 20 µg 130
Chemokine (CCL17) 1 mg 2,700

TECK CHM-364 5 µg 50
Recombinant Human Thymus Expressed Chemokine (CCL25) 20 µg 130
1 mg 2,700

mTECK CHM-259 5 µg 50
Recombinant Mouse Thymus Expressed Chemokine (CCL25) 20 µg 130
1 mg 2,700
PEPTIDES INTERNATIONAL

518 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
PEPTIDES INTERNATIONAL

Order Hotline 1-800-777-4779 502-266-8787 519

 Recombinant proteins

Hormones
ACTH hor-279 2 mg 50
Adrenocorticotropic Hormone 10 mg 130
50 mg 490

AGRP hor-283 2 µg 50
Recombinant Human Agouti–Related Protein 10 µg 130
1 mg 3,600

Alarelin hor-291 2 mg 50
Alarelin 10 mg 130
100 mg 390

Antide hor-242 1 mg 50
Antide 5 mg 130
25 mg 490

Atosiban hor-239 10 mg 50
Human Atosiban 50 mg 150
1gra m 2,250

Buserelin hor-255 1 mg 60
Human Buserelin 5 mg 260
20 mg 780

Cetrorelix hor-277 250 µg 50

Cetrorelix 1 mg 130
10 mg 800
PEPTIDES INTERNATIONAL

CGB hor-007 5 µg 50
Recombinant Human Chorionic Gonadotropin Β 20 µg 130
1 mg 2,700

CRHBP hor-267 2 µg 50
Recombinant Human Corticotropin Releasing Hormone 10 µg 130
Binding Protein 1 mg 5,200

DDAVP hor-270 5 mg 130

Desmopressin 25 mg 520
100 mg 1,560

Deslorelin hor-240 5 mg 50
Deslorelin 25 mg 200
100 mg 600

EDN1 hor-307 1 mg 130

Human Endothelin-1 5 mg 520
25 mg 1,950

EDN2 hor-308 1 mg 130

Human Endothelin-2 5 mg 520
25 mg 1,950

EDN2 His hor-006 5 µg 50

Recombinant Human Endothelin-2, His 20 µg 130
1 mg 2,700

520 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
EDN3 hor-309 1 mg 130
Human Endothelin-3 5 mg 520
25 mg 1,950

Elcatonin hor-302 0.2 mg 50

Elcatonin 1 mg 130
100 mg 2,700

Exenatide hor-246 1 mg 200

Exenatide 10 mg 900
50 mg 2,300

Exendin 4 hor-269 20 µg 50
Recombinant Exendin-4 100 µg 130
1 mg 450

FSH hor-249 100IU 90

Human Follicle Stimulating Hormone 500IU 220
5000IU 385

FSH hor-253 2 µg 50
Recombinant Human Follicle Stimulating Hormone 10 µg 130
1 mg 5,200

Ganirelix hor-276 50 µg 150

Ganirelix 150 µg 250
0.5 mg 650

GHRH hor-235 250 µg 50

PEPTIDES INTERNATIONAL
Human Growth Hormone Releasing Hormone 1 mg 130
5 mg 400

GHRL hor-297 1 mg 50
Human Ghrelin 10 mg 400
20 mg 700

GHRL hor-294 5 µg 50
Recombinant Human Ghrelin 25 µg 130
1 mg 2,250

GHRP 2 hor-271 2 mg 50
Human Growth Hormone Releasing Peptide-2 10 mg 130
50 mg 390

GHRP 6 hor-298 2 µg 50
Growth Hormone Releasing Peptide-6 10 µg 130
1 mg 390

GLP1 (31 a.a.) hor-236 2 mg 50

Recombinant Human Glucagon Like Peptide-1 (31 a.a.) 10 mg 130
100 mg 1,350

GLP1 (37 a.a.) hor-009 1 mg 50

Human Glucagon Like Peptide-1 (37 a.a.) 5 mg 130
25 mg 5,200

Order Hotline 1-800-777-4779 502-266-8787 521

 Recombinant proteins

GLP 1 hor-284 10 mg 50
Human Glucagon Like Peptide-1 (7-36) 50 mg 130
1gra m 1,950

GLP 2 hor-305 1 mg 50
Human Glucagon Like Peptide-2 5 mg 130
20 mg 1,950

Glucagon hor-286 250 µg 350

Glucagon 1 mg 500
10 mg 900

Glucagon hor-237 5 µg 50
Recombinant Human Glucagon 20 µg 130
1 mg 250

Glucagon, His Tag hor-301 2 µg 50

Recombinant Human Glucagon, His Tag 10 µg 130
1 mg 2,700

Goserelin hor-256 5 mg 80
Human Goserelin 25 mg 320
100 mg 970

GPHA2 hor-258 5 mg 50
Recombinant Human Thyrostimulin Α 25 mg 130
100 mg 4,600

GPHB5 hor-257 1 mg 50
PEPTIDES INTERNATIONAL

Recombinant Human Thyrostimulin Β 5 mg 130

25 mg 4,600

GUCA2B hor-245 1 mg 50
Recombinant Human Prouroguanylin 5 mg 130
25 mg 3,600

hCG hor-250 5 µg 65
Human Chorionic Gonadotropin 20 µg 110
1 mg 175

Hexarelin hor-288 1 mg 300

Hexarelin 5 mg 700
25 mg 3,000

Histrelin hor-244 0.2 mg 50

Histrelin 1 mg 130
100 mg 520

Inhibin a hor-303 1 mg 50
Recombinant Human Inhibin-Α 10 mg 130
50 mg 4,800

Inhibin α A Chain hor-293 20 µg 50

Recombinant Human Inhibin-Α A Chain 100 µg 130
1 mg 4,800

522 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
INHBC hor-010 100IU 50
Recombinant Human Inhibin-Β C Chain 500IU 130
5000IU 1,200

Lanreotide hor-282 2 µg 50
Lanreotide 10 µg 130
1 mg 1,200

Leuprorelin hor-260 50 µg 55
Human Leuprolide 150 µg 220
0.5 mg 650

LHRH hor-268 250 µg 50

Recombinant Human Leutenizing hormone Releasing Hormone 1 mg 130
(Gonadorelin) 5 mg 1,300

LHRH hor-261 1 mg 50
Human Leutenizing hormone Releasing Hormone 10 mg 110
(Gonadorelin) 20 mg 325

Lypressin hor-278 5 µg 50
Lypressin 25 µg 130
1 mg 400

mG hor-251 2 mg 75
Human Menopausal Gonadotropin 10 mg 255
50 mg 425

PEPTIDES INTERNATIONAL
mT I hor-306 2 µg 300
melanotan-I 10 µg 700
1 mg 2,000

mT II hor-289 2 mg 300
melanotan-II 10 mg 700
100 mg 2,000

NAF hor-248 1 mg 250

Human Nafarelin 5 mg 450
25 mg 750

OCT hor-265 10 mg 50
Human Octreotide 50 mg 210
1gra m 900

OT hor-254 1 mg 50
Human Oxytocin 5 mg 130
20 mg 390

pFSH hor-285 250 µg 90

Porcine Follicle Stimulating Hormone 1 mg 220
10 mg 385

pLH hor-310 5 µg 50
Porcine Leutenizing hormone (Gonadorelin) 20 µg 130
1 mg 700

Order Hotline 1-800-777-4779 502-266-8787 523

 Recombinant proteins

PmSG hor-272 2 µg 50
Pregnant Mare Serum Gonadotropin 10 µg 130
1 mg 1,500

pOXm hor-292 5 mg 50
Recombinant Porcine Oxyntomodulin 25 mg 130
100 mg 1,400

Pramlintide hor-300 5 mg 50
Pramlintide 25 mg 130
100 mg 500

Procalcitonin hor-304 1 mg 50
Recombinant Human Procalcitonin 5 mg 130
25 mg 5,200

Procalcitonin His hor-295 1 mg 50

Recombinant Human Procalcitonin His Tag 5 mg 130
25 mg 4,800

Proguanylin hor-281 5 µg 50
Recombinant Human Proguanylin 20 µg 130
1 mg 3,600

PTH (1-34) hor-247 1 mg 200

Recombinant Human Parathyroid Hormone (1-34) 5 mg 500
25 mg 800

PTH (1-34) hor-290 0.2 mg 50

PEPTIDES INTERNATIONAL

Human Parathyroid Hormone (1-34) 1 mg 130

100 mg 450

PTH (1-84) hor-263 1 mg 200

Recombinant Human Parathyroid Hormone (1-84) 10 mg 500
50 mg 800

PTH (1-84) N15 hor-002 20 µg 50

Recombinant Human Parathyroid Hormone (1-84) N15 Labeled 100 µg 130
1 mg 2,100

PTH (7-84) hor-011 100IU 200

Recombinant Human Parathyroid Hormone (7-84) 500IU 500
5000IU 800

PTH (7-34) hor-266 2 µg 200

Recombinant Human Parathyroid Hormone (7-34) 10 µg 500
1 mg 800

PTHrP hor-004 50 µg 50
Recombinant Human Parathyroid Hormone Related Protein 150 µg 130
0.5 mg 1,350

PTHrP N15 hor-005 250 µg 50

Recombinant Human Parathyroid Hormone Related Protein 1 mg 130
N15 Labeled 5 mg 3,000

524 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
sCalcitonin hor-262 1 mg 80
Salmon Calcitonin Acetate 10 mg 320
20 mg 1,290

Secretin hor-273 5 µg 50
Human Secretin 25 µg 130
1 mg 390

Sincalide hor-274 2 mg 50
Sincalide 10 mg 130
50 mg 500

SST hor-299 2 µg 50
Somatostatin 10 µg 130
1 mg 350

STC 1 hor-259 2 mg 50
Recombinant Human Stanniocalcin-1 10 mg 130
100 mg 1,100

STC 2 hor-296 1 mg 50
Recombinant Human Stanniocalcin-2 5 mg 130
25 mg 1,100

STC 2, His hor-008 10 mg 50

Recombinant Human Stanniocalcin-2, His Tag 50 mg 130
1gra m 2,700

Terlipressin hor-287 1 mg 300

PEPTIDES INTERNATIONAL
Terlipressin 5 mg 700
20 mg 2,000

Thymosin α1 hor-243 250 µg 130

Thymosin-a1 1 mg 540
10 mg 1,900

Thymosin β4 hor-275 5 µg 130

Thymosin-b4 20 µg 540
1 mg 1,900

Thymosin β4 hor-003 2 µg 50
Recombinant Human Thymosin-b4 10 µg 130
1 mg 600

TP 5 hor-241 5 mg 50
Thymopentin 25 mg 130
100 mg 1,100

TRH hor-264 5 mg 250

Human Protirelin (Thyrotropin Releasing Hormone) 25 mg 500
100 mg 750

Trp hor-238 1 mg 100

Triptorelin 5 mg 175
25 mg 300

Order Hotline 1-800-777-4779 502-266-8787 525

 Recombinant proteins

TSH hor-001 1 mg 50
Human Thyroid Stimulating Hormone 5 mg 130
25 mg 5,200

Vasopressin hor-280 5 µg 50
Vasopressin 20 µg 130
1 mg 400

Enzymes
AASDHPPT enz-008 5 µg 50
Recombinant Human Aminoadipate-Semialdehyde 20 µg 130
Dehydrogenase-Phosphopantetheinyl Transferase 1 mg 2,700

ABHD10 enz-612 2 µg 50
Recombinant Human Abhydrolase Domain Containing 10 10 µg 130
100 µg 1,200

ABHD14B enz-240 1 µg 50
Recombinant Human Abhydrolase Domain Containing 14B 5 µg 130
50 µg 1,200

ABO enz-167 2 µg 50
Recombinant Human ABO Blood Group 10 µg 130
1 mg 5,200

ACAA1 enz-251 5 µg 50
Recombinant Human Acetyl-COA Acyltransferase 20 µg 130
PEPTIDES INTERNATIONAL

1 mg 2,700

ACAA2 enz-697 2 µg 50
Recombinant Human Acetyl-COA Acyltransferase 2 10 µg 130
1 mg 5,200

ACAD8 enz-294 2 µg 50
Recombinant Human Acyl-Coenzyme A Dehydrogenase 8 10 µg 130
1 mg 4,800

ACADL enz-190 2 µg 50
Recombinant Human Acyl-CoA Dehydrogenase, Long Chain 10 µg 130
1 mg 5,200

ACADm enz-529 2 µg 50
Recombinant Human Acyl-Coenzyme A Dehydrogenase, C-4 10 µg 130
to C-12 1 mg 5,200

ACADS enz-467 2 µg 50
Recombinant Human Acyl-Coenzyme A Dehydrogenase, C-2 10 µg 130
to C-3 1 mg 5,200

ACADSB enz-643 2 µg 50
Recombinant Human Acyl-CoA Dehydrogenase, Short Chain 10 µg 130
1 mg 5,200

ACADVL enz-250 2 µg 50
Recombinant Human Acyl-CoA Dehydrogenase, Very Long 10 µg 130
Chain 1 mg 5,200

526 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
ACAT1 enz-665 5 µg 50
Recombinant Human Acetyl-Coenzyme A acetyltransferase 1 20 µg 130
1 mg 2,700

ACAT2 enz-295 5 µg 50
Recombinant Human Acetyl-Coenzyme A acetyltransferase 2 20 µg 130
1 mg 2,700

ACO1 enz-056 1 µg 50
Recombinant Human Aconitase-1 5 µg 130
50 µg 1,200

ACOT8 enz-712 5 µg 50
Recombinant Human Acyl-CoA Thioesterase 8 20 µg 130
1 mg 2,700

ACOT13 enz-004 2 µg 50
Recombinant Human Acyl-CoA Thioesterase 13 10 µg 130
1 mg 5,200

ACOT7 enz-214 5 µg 50
Recombinant Human Acyl-CoA Thioesterase 7 20 µg 130
1 mg 2,700

ACP1 enz-408 5 µg 50
Recombinant Human Acid Phosphatase-1 20 µg 130
1 mg 3,600

ACY1 enz-296 2 µg 50

PEPTIDES INTERNATIONAL
Recombinant Human AminoAcylase-1 10 µg 130
1 mg 5,200

ACY3 enz-153 2 µg 50
Recombinant Human AminoAcylase-3 10 µg 130
1 mg 5,200

ACYP1 enz-078 5 µg 50
Recombinant Human Acylphosphatase 1 20 µg 130
1 mg 2,700

ADA enz-147 2 µg 50
Recombinant Human Adenosine Deaminase 10 µg 130
1 mg 5,200

ADAT1 enz-307 2 µg 50
Recombinant Human Adenosine Deaminase tRNA-Specific 1 10 µg 130
1 mg 4,800

ADAT2 enz-561 2 µg 50
Recombinant Human Adenosine Deaminase, tRNA-specific 2 10 µg 130
1 mg 5,200

ADH1A enz-580 5 µg 50
Recombinant Human Alcohol Dehydrogenase 1A 20 µg 130
1 mg 2,700

Order Hotline 1-800-777-4779 502-266-8787 527

 Recombinant proteins

ADH1C enz-622 5 µg 50
Recombinant Human Alcohol Dehydrogenase 1C 20 µg 130
1 mg 3,600

ADH5 enz-595 5 µg 50
Recombinant Human Alcohol Dehydrogenase 5 20 µg 130
1 mg 2,700

ADH6 enz-619 5 µg 50
Recombinant Human Alcohol Dehydrogenase 6 20 µg 130
1 mg 2,700

ADI1 enz-700 5 µg 50
Recombinant Human Acireductone Dioxygenase 1 20 µg 130
1 mg 2,700

ADPRH enz-631 5 µg 50
Recombinant Human ADP-Ribosylarginine Hydrolase 20 µg 130
1 mg 2,700

ADPRHL2 enz-638 5 µg 50
Recombinant Human ADP-Ribosylhydrolase Like 2 20 µg 130
1 mg 2,700

ADSL enz-188 5 µg 50
Recombinant Human Adenylosuccinate Lyase 20 µg 130
1 mg 2,700

AHCY enz-532 5 µg 50
PEPTIDES INTERNATIONAL

Recombinant Human Adenosylhomocysteinase 20 µg 130

1 mg 2,250

AICDA enz-651 5 µg 50
Recombinant Human Activation-Induced Cytidine Deaminase 20 µg 130
1 mg 2,700

AKR1A1 enz-464 5 µg 50
Recombinant Human Aldo-Keto Reductase Family 1 Member 20 µg 130
A1 1 mg 2,250

AKR1B1 enz-390 10 µg 50
Recombinant Human Aldose Reductase 50 µg 130
1 mg 1,800

AKR1B10 enz-416 5 µg 50
Recombinant Human Aldo-Keto Reductase Family 1 Member 20 µg 130
B10 1 mg 3,000

AKR1C1 enz-496 5 µg 50
Recombinant Human Aldo-Keto Reductase Family 1 Member 20 µg 130
C1 1 mg 2,250

AKR1C3 enz-406 5 µg 50
Recombinant Human Aldo-Keto Reductase Family 1 Member 20 µg 130
C3 1 mg 3,600

528 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
AKR1C4 enz-145 2 µg 50
Recombinant Human Aldo-Keto Reductase Family 1 Member 10 µg 130
C4 1 mg 5,200

AKR1D1 enz-098 5 µg 50
Recombinant Human Aldo-Keto Reductase Family 1 Member 20 µg 130
D1 1 mg 2,700

AKR7A2 enz-485 5 µg 50
Recombinant Human Aldo-Keto Reductase Family 7 Member 20 µg 130
A2 1 mg 3,600

AKR7A3 enz-484 2 µg 50
Recombinant Human Aldo-Keto Reductase Family 7 Member 10 µg 130
A3 1 mg 5,200

ALAD enz-586 2 µg 50
Recombinant Human Aminolevulinate Dehydratase 10 µg 130
1 mg 5,200

ALDH1A1 enz-453 5 µg 50
Recombinant Human Aldehyde Dehydrogenase 1A1 20 µg 130
1 mg 2,250

ALDH2 enz-401 10 µg 50
Recombinant Human Aldehyde Dehydrogenase 2 50 µg 130
1 mg 1,800

PEPTIDES INTERNATIONAL
ALDH3A1 enz-479 2 µg 50
Recombinant Human Aldehyde Dehydrogenase 3 A1 10 µg 130
1 mg 5,200

ALDH5A1 enz-567 2 µg 50
Recombinant Human Aldehyde Dehydrogenase 5 A1 10 µg 130
1 mg 5,200

ALDOA enz-486 5 µg 50
Recombinant Human Aldolase-A 20 µg 130
1 mg 2,250

ALDOB enz-245 5 µg 50
Recombinant Human Aldolase B Fructose-Bisphosphate 20 µg 130
1 mg 2,700

ALDOC enz-085 5 µg 50
Recombinant Human Aldolase C Fructose-Bisphosphate 20 µg 130
1 mg 2,700

ALKBH2 enz-112 5 µg 50
Recombinant Human ALKB Alkylation Repair Homolog 2 20 µg 130
1 mg 2,700

ALKBH3 enz-101 5 µg 50
Recombinant Human ALKB Alkylation Repair Homolog 3 20 µg 130
1 mg 2,700

Order Hotline 1-800-777-4779 502-266-8787 529

 Recombinant proteins

AmD1 enz-624 1 µg 50
Recombinant Human Adenosylmethionine Decarboxylase 1 5 µg 130
50 µg 1,200

Aminopeptidase enz-275 100U 95

Recombinant Aeromonas Aminopeptidase 250U 270
500U 410

Angiotensin enz-283 1 mg 130

Angiotensin 10 mg 450
200 mg 2,000

ANSA enz-119 5 µg 50
Recombinant E.Coli Cytoplasmic L-asparaginase I 20 µg 130
1 mg 2,700

APEX1 enz-059 2 µg 50
Recombinant Human APEX nuclease-1 10 µg 130
1 mg 5,200

APRT enz-487 5 µg 50
Recombinant Human Adenine Phosphoribosyltransferase 20 µg 130
1 mg 2,250

ARG1 enz-517 5 µg 50
Recombinant Human Arginase, Liver 25 µg 130
1 mg 2,250

ARG2 enz-526 2 µg 50
PEPTIDES INTERNATIONAL

Recombinant Human Arginase Type II 10 µg 130

1 mg 5,200

ARSA enz-706 5 µg 50
Recombinant Human Arylsulfatase A 20 µg 130
1 mg 2,700

ARSG enz-677 5 µg 50
Recombinant Human Arylsulfatase G 20 µg 130
1 mg 2,700

AS3mT enz-615 5 µg 50
Recombinant Human Arsenic Methyltransferase 20 µg 130
1 mg 2,700

ASL enz-185 5 µg 50
Recombinant Human Argininosuccinate Lyase 20 µg 130
1 mg 2,700

ASmT enz-664 5 µg 50
Recombinant Human Acetylserotonin O-methyltransferase 20 µg 130
1 mg 3,600

ASPA enz-572 5 µg 50
Recombinant Human Aspartoacylase 20 µg 130
1 mg 3,600

530 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
ASPH enz-488 5 µg 50
Recombinant Human Aspartate Β-Hydroxylase 20 µg 130
1 mg 3,600

ASPRV1 enz-659 5 µg 50
Recombinant Human Aspartic Peptidase, Retroviral-Like 1 20 µg 130
1 mg 2,700

ASS1 enz-548 2 µg 50
Recombinant Human Argininosuccinate Synthase 1 10 µg 130
1 mg 5,200

ATP sulfurylase Yeast enz-353 10IU 60

Recombinant Yeast Adenosine 5" Triphosphate Sulfurylase 50IU 240
100IU 450

ATP5D enz-143 1 µg 50
Recombinant Human ATP Synthase Subunit D, Mitochondrial 5 µg 130
50 µg 1,100

ATP5O enz-043 5 µg 50
Recombinant Human ATP Synthase Subunit O, Mitochondrial 20 µg 130
1 mg 2,700

AUH enz-046 5 µg 50
Recombinant Human AU RNA Binding Protein/Enoyl-CoA 20 µg 130
Hydratase 1 mg 2,700

bAlkaline Phosphatase enz-322

PEPTIDES INTERNATIONAL
1 mg 50
Alkaline Phosphatase 5 mg 200
35 mg 1,200

B3GAT3 enz-711 5 µg 50
Recombinant Human Β-1,3-Glucuronyltransferase 3 20 µg 130
1 mg 2,700

BAT1 enz-563 2 µg 50
Recombinant Human HLA-B Associated Transcript 1 10 µg 130
1 mg 5,200

BCAT1 enz-597 5 µg 50
Recombinant Human Branched Chain Amino-Acid 20 µg 130
Transaminase 1 1 mg 2,700

BCAT2 enz-606 2 µg 50
Recombinant Human Branched Chain Amino-Acid 10 µg 130
Transaminase 2 1 mg 5,200

BCKDHA enz-090 1 µg 50
Recombinant Human Branched Chain keto Acid 5 µg 130
Dehydrogenase E1, Α 50 µg 1,200

BCOADC-E2 enz-084 2 µg 50
Recombinant Human 2-Oxo-Acid Dehydrogenase Complex E2 10 µg 130
1 mg 4,100

Order Hotline 1-800-777-4779 502-266-8787 531

 Recombinant proteins

BDH1 enz-215 1 µg 50
Recombinant Human 3-Hydroxybutyrate Dehydrogenase, Type 5 µg 130
1 50 µg 1,200

BDH2 enz-060 5 µg 50
Recombinant Human 3-Hydroxybutyrate Dehydrogenase, Type 20 µg 130
2 1 mg 2,700

bDNase enz-417 20 mg 50
Bovine Deoxyribonuclease I 100 mg 130
1gr 700

bEnterokinase enz-311 20IU 100

Recombinant Bovine Enteropeptidase/Enterokinase 100IU 350
500IU 1,155

bEnterokinase His enz-655 20IU 100

Recombinant Bovine Enteropeptidase/Enterokinase His Tag 100IU 350
500IU 1,155

pEnterokinase enz-267 100IU 250

Porcine Enteropeptidase/Enterokinase 500IU 900
1,000IU 1,500

BHmT enz-292 10 µg 50
Recombinant Human Βine-Homocysteine Methyltransferase 50 µg 130
1 mg 1,800
PEPTIDES INTERNATIONAL

BLmH enz-018 5 µg 50
Recombinant Human Bleomycin Hydrolase 20 µg 130
1 mg 2,700

BLVRA enz-446 10 µg 50
Recombinant Human Biliverdin Reductase A 50 µg 130
1 mg 1,800

BLVRB enz-387 10 µg 50
Recombinant Human Biliverdin Reductase B 50 µg 130
1 mg 1,800

BPGm enz-505 5 µg 50
Recombinant Human 2,3-Bisphosphoglycerate Mutase 20 µg 130
1 mg 2,250

BPHL enz-055 5 µg 50
Recombinant Human Biphenyl Hydrolase-Like 20 µg 130
1 mg 2,700

BPNT1 enz-061 2 µg 50
Recombinant Human 3(2) 5-Bisphosphate Nucleotidase 1 10 µg 130
1 mg 5,200

bTOP1 enz-656 5 µg 50
Bovine DNA Topoisomerase-I 20 µg 130
1 mg 3,900

532 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
C1GALT1 enz-721 2 µg 50
Recombinant Human Core 1 Β3-Gal-T1 10 µg 130
1 mg 5,200

CA3 enz-500 5 µg 50
Recombinant Human Carbonic Anhydrase III 20 µg 130
1 mg 2,250

CA3 His enz-270 5 µg 50

Recombinant Human Carbonic Anhydrase III, His Tag 20 µg 130
1 mg 3,600

CA8 enz-235 5 µg 50
Recombinant Human Carbonic Anhydrase 8 20 µg 130
1 mg 2,700

Carbonic Anhydrase 2 enz-373 5 µg 50

Recombinant E.Coli Carbonic Anhydrase 2 25 µg 130
1 mg 2,800

Carbonic Anhydrase 2 enz-420 5 µg 50

Recombinant Human Carbonic Anhydrase 2 20 µg 130
1 mg 3,600

Carbonic Anhydrase-1 enz-462 5 µg 50

Recombinant Human Carbonic Anhydrase-1 25 µg 130
1 mg 2,250

CA11 enz-726 5 µg 50

PEPTIDES INTERNATIONAL
Recombinant Human Carbonic Anhydrase XI 20 µg 130
1 mg 2,700

rCarboxypeptidase-B enz-475 5 mg 50
Recombinant Rat Carboxypeptidase-B 15 mg 130
50 mg 450

CPE enz-687 5 µg 50
Recombinant Human Carboxypeptidase-E 20 µg 130
1 mg 2,700

CAT enz-629 5 µg 50
Recombinant Human Catalase 20 µg 130
1 mg 2,700

CBR1 enz-415 5 µg 50
Recombinant Human Carbonyl Reductase-1 20 µg 130
1 mg 2,700

CBR3 enz-428 5 µg 50
Recombinant Human Carbonyl Reductase-3 20 µg 130
1 mg 2,700

CBR4 enz-022 2 µg 50
Recombinant Human Carbonyl Reductase-4 10 µg 130
1 mg 5,200

Order Hotline 1-800-777-4779 502-266-8787 533

 Recombinant proteins

CDA enz-007 5 µg 50
Recombinant Human Cytidine Deaminase 20 µg 130
1 mg 2,700

CDC25A enz-091 1 µg 50
Recombinant Human Cell Division Cycle 25A 5 µg 130
50 µg 1,200

CDC34 enz-355 5 µg 50
Recombinant Cell Division Cycle 34 20 µg 130
1 mg 2,700

CDO1 enz-449 10 µg 50
Recombinant Human Cysteine Dioxygenase 50 µg 130
1 mg 1,800

CEL enz-728 2 µg 50
Human Carboxyl Ester Lipase 10 µg 130
100 µg 1,200

Chitinase enz-031 20 µg 170

Recombinant Clostridium Paraputrificum Chitinase 100 µg 350
1 mg 2,700

CHI3L1 enz-688 1 µg 50
Recombinant Human Chitinase 3-Like 1 5 µg 130
50 µg 1,200

Chitodextrinase enz-032 20 µg 170

PEPTIDES INTERNATIONAL

Recombinant Clostridium Botulinum Chitodextrinase 100 µg 350

1 mg 2,700

CLPP enz-115 2 µg 50
Recombinant Human ClpP Caseinolytic Peptidase 10 µg 130
1 mg 5,200

CmBL enz-634 5 µg 50
Recombinant Human Carboxymethylenebutenolidase  20 µg 130
1 mg 2,700

CNDP2 enz-681 5 µg 50
Recombinant Human CNDP Dipeptidase 2 20 µg 130
1 mg 2,700

COmT enz-400 2 µg 50
Recombinant Human Catechol-O-methyltransferase 10 µg 130
1 mg 5,200

CPOX enz-701 5 µg 50
Recombinant Human Coproporphyrinogen Oxidase 20 µg 130
1 mg 2,700

CRYZL1 enz-481 5 µg 50
Recombinant Human Quinone Oxidoreductase-like Protein 1 25 µg 130
1 mg 2,250

534 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
CTDSP1 enz-110 2 µg 50
Recombinant Human CTD Small Phosphatase 1 10 µg 130
1 mg 5,200

CTDSPL enz-569 5 µg 50
Recombinant Human CTD Small Phosphatase-Like 20 µg 130
1 mg 2,700

CTH enz-212 5 µg 50
Recombinant Human Cystathionase 20 µg 130
1 mg 2,700

CTSD enz-378 2 µg 175

Recombinant Human Cathepsin-D 5 µg 270
10 µg 490

CTSF enz-738 5 µg 50
Recombinant Human Cathepsin-F 20 µg 130
1 mg 2,700

CTSL1 enz-377 2 µg 175

Recombinant Human Cathepsin-L 5 µg 270
10 µg 490

CTSS enz-686 5 µg 50
Recombinant Human Cathepsin-S 20 µg 130
1 mg 2,700

CTSZ enz-748 5 µg 50

PEPTIDES INTERNATIONAL
Recombinant Human Cathepsin-Z 20 µg 130
1 mg 2,700

CYB5R1 enz-727 5 µg 50
Recombinant Human Cytochrome B5 Reductase 1 20 µg 130
1 mg 2,700

Cyclophilin A enz-359 10 µg 50
Recombinant Human Cyclophilin-A 50 µg 130
1 mg 2,400

Cyclophilin B enz-313 10 µg 50
Recombinant Human Cyclophilin-B 50 µg 130
1 mg 1,800

Cyclophilin D enz-367 5 µg 50
Recombinant Human Cyclophilin-D 20 µg 130
1 mg 3,600

Cyclophilin E enz-383 5 µg 50
Recombinant Human Cyclophilin-E 25 µg 130
1 mg 2,800

Cyclophilin G enz-463 5 µg 50
Recombinant Human Cyclophilin-G 25 µg 130
1 mg 2,250

Order Hotline 1-800-777-4779 502-266-8787 535

 Recombinant proteins

CYP2D6 enz-316 5 µg 50
Recombinant Human Cytochrome P450 2D6 20 µg 130
1 mg 3,500

CYSH enz-131 5 µg 50
Recombinant E.Coli Phosphoadenosine phosphosulfate 20 µg 130
reductase 1 mg 2,700

DAAO enz-425 2 µg 50
Recombinant Human D-Amino Acid Oxidase 10 µg 130
1 mg 5,200

DARS enz-591 5 µg 50
Recombinant Human Aspartyl-tRNA Synthetase 20 µg 130
1 mg 2,700

DCPS enz-159 2 µg 50
Recombinant Human Decapping Enzyme, Scavenger 10 µg 130
1 mg 5,200

DCTD enz-538 5 µg 50
Recombinant Human dCmP Deaminase 25 µg 130
1 mg 2,250

DCTPP1 enz-234 5 µg 50
Recombinant Human dCTP Pyrophosphatase 1 20 µg 130
1 mg 2,700

DCXR enz-540 5 µg 50
PEPTIDES INTERNATIONAL

Recombinant Human Dicarbonyl/L-Xylulose Reductase 20 µg 130

1 mg 2,700

DDAH1 enz-014 5 µg 50
Recombinant Human Dimethylarginine 20 µg 130
Dimethylaminohydrolase 1 1 mg 2,700

DDT enz-527 5 µg 50
Recombinant Human D-Dopachrome Tautomerase 25 µg 130
1 mg 2,250

DECR1 enz-102 2 µg 50
Recombinant Human 2,4-Dienoyl CoA Reductase 1 10 µg 130
1 mg 5,200

DECR2 enz-211 2 µg 50
Recombinant Human 2,4-Dienoyl CoA Reductase 2 10 µg 130
1 mg 5,200

DERA enz-118 5 µg 50
Recombinant E.Coli Deoxyribose-Phosphate Aldolase 20 µg 130
1 mg 2,700

DERA enz-170 2 µg 50
Recombinant Human Deoxyribose-Phosphate Aldolase 10 µg 130
1 mg 5,200

536 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
DERA 1-259 a.a. enz-127 5 µg 50
Recombinant E.Coli Deoxyribose-Phosphate Aldolase 1-259 a.a. 20 µg 130
1 mg 2,700

DESI1 enz-734 2 µg 50
Recombinant Human Desumoylating Isopeptidase 1 10 µg 130
0.1 mg 1,200

DHFR enz-443 10 µg 50
Recombinant Human Dihydrofolate Reductase 50 µg 130
1 mg 1,800

mDHFR enz-069 5 µg 50
Recombinant Mouse Dihydrofolate Reductase 20 µg 130
1 mg 2,700

DHODH enz-642 1 µg 50
Recombinant Human Dihydroorotate Dehydrogenase 5 µg 130
50 µg 1,200

DHPS enz-498 5 µg 50
Recombinant Human Deoxyhypusine Synthase 25 µg 130
1 mg 2,250

DHRS4 enz-207 1 µg 50
Recombinant Human Dehydrogenase/Reductase Member 4 5 µg 130
50 µg 1,100

DHRS9 enz-216 2 µg 50

PEPTIDES INTERNATIONAL
Recombinant Human Dehydrogenase/Reductase Member 9 10 µg 130
1 mg 5,200

DImT1 enz-628 5 µg 50
Recombinant Human DIm1 Dimethyladenosine Transferase 1 20 µg 130
1 mg 3,600

DLAT enz-082 2 µg 50
Recombinant Human Dihydrolipoamide S-Acetyltransferase 10 µg 130
1 mg 4,100

DLD enz-502 5 µg 50
Recombinant Human Dihydrolipoamide Dehydrogenase 25 µg 130
1 mg 2,250

DLST enz-083 2 µg 50
Recombinant Human Dihydrolipoamide S-Succinyltransferase 10 µg 130
1 mg 4,100

DmGO enz-318 10 µg 50
Recombinant Dimethylglycine oxidase 50 µg 130
1 mg 1,800

DNase enz-319 500IU 50

Recombinant Human Deoxyribonuclease I 1500IU 130
10,000IU 600

Order Hotline 1-800-777-4779 502-266-8787 537

 Recombinant proteins

Dopa Decarboxylase enz-413 5 µg 50

Recombinant Human Dopa Decarboxylase 20 µg 130
1 mg 3,000

DPP4 enz-375 2 µg 50
Recombinant Human Dipeptidyl-Peptidase 4 10 µg 130
1 mg 4,000

DPP4 enz-382 2ng 50

Human Dipeptidyl-Peptidase 4 10ng 130
700ng 5,200

DsbA enz-276 10 µg 50
Recombinant Disulfide Oxidoreductase 50 µg 130
1 mg 1,400

DsbC enz-291 10 µg 50
Recombinant Disulfide Bond Isomerase 50 µg 130
1 mg 1,400

DTD1 enz-671 2 µg 50
Recombinant Human D-Tyrosyl-tRNA Deacylase 1 10 µg 130
100 µg 1,200

DUSP10 enz-238 5 µg 50
Recombinant Human Dual Specificity Phosphatase 10 20 µg 130
1 mg 3,600

DUSP13 enz-635 2 µg 50
PEPTIDES INTERNATIONAL

Recombinant Human Dual Specificity Phosphatase 13 10 µg 130

1 mg 5,200

DUSP18 enz-582 5 µg 50
Recombinant Human Dual Specificity Phosphatase 18 20 µg 130
1 mg 3,600

DUSP19 enz-201 2 µg 50
Recombinant Human Dual Specificity Phosphatase 19 10 µg 130
1 mg 5,200

DUSP21 enz-239 2 µg 50
Recombinant Human Dual Specificity Phosphatase 21 10 µg 130
1 mg 5,200

DUSP23 enz-195 2 µg 50
Recombinant Human Dual Specificity Phosphatase 23 10 µg 130
1 mg 5,200

DUSP26 enz-747 5 µg 50
Recombinant Human Dual Specificity Phosphatase 26 20 µg 130
1 mg 2,700

DUSP3 enz-176 5 µg 50
Recombinant Human Dual Specificity Phosphatase 3 20 µg 130
1 mg 2,700

538 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
DUT enz-568 5 µg 50
Recombinant Human Deoxyuridine Triphosphatase 20 µg 130
1 mg 2,700

DUT enz-281 500IU 250

Recombinant Pyrococcus Fruriosus Deoxyuridine 1000IU 390
Triphosphatase 2000IU 750

ECH1 enz-562 5 µg 50
Recombinant Human Enoyl CoA Hydratase 1, Peroxisomal 20 µg 130
1 mg 2,700

ECHDC1 enz-573 5 µg 50
Recombinant Human Enoyl CoA Hydratase Domain Containing 20 µg 130
1 1 mg 2,700

ECHS1 enz-556 5 µg 50
Recombinant Human Enoyl CoA Hydratase, Short chain, 1, 20 µg 130
Mitochondrial 1 mg 2,700

ECOTIN enz-058 2 µg 50
Recombinant E.Coli Ecotin 10 µg 130
1 mg 5,200

Endonuclease enz-675 7KU 50

Recombinant Serratia Marcescens Endonuclease 25KU 130
500KU 1,500

PEPTIDES INTERNATIONAL
ENO1 enz-452 5 µg 50
Recombinant Human Enolase-1 25 µg 130
1 mg 2,250

ENO2 enz-324 5 µg 50
Recombinant Human Neuronal Specific Enolase 25 µg 130
1 mg 2,700

ENO2 enz-371 5 µg 50
Human Neurone Specific Enolase 20 µg 130
1 mg 3,600

ENO2, His enz-298 2 µg 50

Recombinant Human Neuronal Specific Enolase, His Tag 10 µg 130
1 mg 4,800

ENO3 enz-183 2 µg 50
Recombinant Human Enolase-3 10 µg 130
1 mg 5,200

ENOPH1 enz-077 5 µg 50
Recombinant Human Enolase-Phosphatase-1 20 µg 130
1 mg 3,600

ENPP1 enz-729 2 µg 50
Recombinant Human Ectonucleotide Pyrophosphatase 10 µg 130
1 mg 5,200

Order Hotline 1-800-777-4779 502-266-8787 539

 Recombinant proteins

Enterokinase enz-260 20IU 100

Recombinant Human Enteropeptidase/Enterokinase, Light 100IU 350
Chain 500IU 1,155

Esterase-D enz-447 10 µg 50
Recombinant Human Esterase D,S-Formylglutathione 50 µg 130
Hydrolase 1 mg 1,800

FAHD1 enz-067 5 µg 50
Recombinant Human Fumarylacetoacetate Hydrolase Domain 20 µg 130
Containing 1 1 mg 2,700

FARS2 enz-111 2 µg 50
Recombinant Human Phenylalanyl-tRNA Synthetase 2 10 µg 130
1 mg 5,200

FBL enz-566 1 µg 50
Recombinant human Fibrillarin 5 µg 130
50 µg 1,100

FBP1 enz-454 5 µg 50
Recombinant Human Fructose-1,6-Bisphosphatase 1 25 µg 130
1 mg 2,250

FBP2 enz-667 5 µg 50
Recombinant Human Fructose-1,6-Bisphosphatase 2 20 µg 130
1 mg 2,700
PEPTIDES INTERNATIONAL

FEN1 enz-468 5 µg 50
Recombinant Human Flap Structure-Specific Endonuclease 1 20 µg 130
1 mg 3,600

FKBP14 enz-530 5 µg 50
Recombinant Human FK506 Binding Protein 14 25 µg 130
1 mg 2,250

FKBP1A enz-374 2 µg 50
Recombinant Human FK506 Binding Protein 1A 10 µg 130
100 µg 400

FKBP1B enz-194 5 µg 50
Recombinant Human FK506 Binding Protein 1B 20 µg 130
1 mg 2,700

FKBP2 enz-503 2 µg 50
Recombinant Human FK506 Binding Protein 2 10 µg 130
1 mg 5,200

FKBP3 enz-495 5 µg 50
Recombinant Human FK506 Binding Protein 3 25 µg 130
1 mg 2,250

FKBP4 enz-412 10 µg 50
Recombinant Human FK506 Binding Protein 4 50 µg 130
1 mg 1,800

540 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
FKBP6 enz-516 2 µg 50
Recombinant Human FK506 Binding Protein 6 10 µg 130
1 mg 5,200

FKBPL enz-543 1 µg 50
Recombinant Human FK506 Binding Protein Like 5 µg 130
50 µg 1,100

FTCD enz-302 5 µg 50
Recombinant Human Formiminotransferase Cyclodeaminase 20 µg 130
1 mg 3,300

Fumarase enz-395 10 µg 50
Recombinant Human Fumarate Hydratase 50 µg 130
1 mg 1,800

FUT3 enz-745 2 µg 50
Recombinant Human Fucosyltransferase 3 10 µg 130
1 mg 5,200

GARS enz-717 2 µg 50
Recombinant Human Glycyl-TRNA Synthetase 10 µg 130
1 mg 5,200

G3BP1 enz-048 2 µg 50
Recombinant Human GTPase Activating Protein (SH3 domain) 10 µg 130
Binding Protein 1 1 mg 5,200

G3BP2 enz-217

PEPTIDES INTERNATIONAL
5 µg 50
Recombinant Human GTPase Activating Protein (SH3 domain) 20 µg 130
Binding Protein 2 1 mg 2,700

G6PD enz-399 10 µg 50
Recombinant E.Coli Glucose-6-Phosphate Dehydrogenase 50 µg 130
1 mg 1,800

G6PD enz-608 5 µg 50
Recombinant Human Glucose-6-Phosphate Dehydrogenase 20 µg 130
1 mg 2,700

GALE enz-537 5 µg 50
Recombinant Human UDP-Galactose-4-Epimerase 25 µg 130
1 mg 2,250

GALm enz-541 5 µg 50
Recombinant Human Galactose Mutarotase 20 µg 130
1 mg 2,700

GALT enz-358 2 µg 50
Recombinant Human Galactose-1-Phosphate 10 µg 130
Uridylyltransferase 100 µg 1,200

GAmT enz-460 5 µg 50
Recombinant Human Guanidinoacetate N-methyltransferase 25 µg 130
1 mg 2,250

Order Hotline 1-800-777-4779 502-266-8787 541

 Recombinant proteins

GAPDH enz-350 5 µg 50
Recombinant Human Glyceraldehyde-3-Phosphate 20 µg 130
Dehydrogenase 1 mg 2,800

GATC enz-722 2 µg 50
Recombinant Human Glutamyl-TRNA Amidotransferase, 10 µg 130
Subunit C 100 µg 1,200

GATm enz-583 2 µg 50
Recombinant Human Glycine Amidinotransferase 10 µg 130
1 mg 5,200

GCAT enz-705 5 µg 50
Recombinant Human Glycine C-Acetyltransferase 20 µg 130
1 mg 2,700

GCDH enz-542 2 µg 50
Recombinant Human Glutaryl-Coenzyme A Dehydrogenase 10 µg 130
1 mg 5,200

GCLm enz-636 5 µg 50
Recombinant Human Glutamate-Cysteine Ligase, Modifier 20 µg 130
Subunit 1 mg 2,700

GDA enz-682 5 µg 50
Recombinant Human Guanine Deaminase 20 µg 130
1 mg 2,700
PEPTIDES INTERNATIONAL

GGCT enz-062 5 µg 50
Recombinant Human Gamma-Glutamylcyclotransferase 20 µg 130
1 mg 2,700

GGH enz-242 5 µg 50
Recombinant Human Gamma-Glutamyl Hydrolase 20 µg 130
1 mg 2,700

GGPS1 enz-555 5 µg 50
Recombinant Human Geranylgeranyl Diphosphate Synthase 1 20 µg 130
1 mg 2,700

GLB1 enz-041 10 µg 50
Recombinant E.Coli Galactosidase-Β 1 50 µg 130
1 mg 1,800

GLO1 enz-398 10 µg 50
Recombinant Human Glyoxalase-I 50 µg 130
1 mg 1,800

glpE enz-714 5 µg 50
Recombinant E.Coli Thiosulfate sulfurtransferase 20 µg 130
1 mg 2,700

GLRX1 enz-391 10 µg 50
Recombinant Human Glutaredoxin 1 50 µg 130
1 mg 1,800

542 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
GLRX1 Yeast enz-361 10 µg 50
Recombinant Yeast Glutaredoxin 1 50 µg 130
1 mg 1,500

GLRX2 enz-466 5 µg 50
Recombinant Human Glutaredoxin 2 25 µg 130
1 mg 2,250

GLRX2 enz-360 10 µg 50
Recombinant Yeast Glutaredoxin 2 50 µg 130
1 mg 1,500

GLRX3 enz-482 5 µg 50
Recombinant Human Glutaredoxin 3 25 µg 130
1 mg 2,250

GLRX5 enz-480 5 µg 50
Recombinant Human Glutaredoxin 5 25 µg 130
1 mg 2,250

GLSA1 enz-133 5 µg 50
Recombinant E.Coli Glutaminase 1 20 µg 130
1 mg 2,700

GLUL enz-544 5 µg 50
Recombinant Human Glutamine Synthetase 20 µg 130
1 mg 2,700

GLYAT enz-148 2 µg 50

PEPTIDES INTERNATIONAL
Recombinant Human Glycine-N-Acyltransferase 10 µg 130
1 mg 5,200

GmDS enz-191 5 µg 50
Recombinant Human GDP-mannose 4,6-Dehydratase 20 µg 130
1 mg 2,700

GmPR enz-570 5 µg 50
Recombinant Human Guanosine Monophosphate Reductase 20 µg 130
1 mg 2,700

GmPR2 enz-557 2 µg 50
Recombinant Human Guanosine Monophosphate Reductase 2 10 µg 130
1 mg 5,200

GmPS enz-244 2 µg 50
Recombinant Human Guanine Monphosphate Synthetase 10 µg 130
1 mg 5,200

GNmT enz-386 10 µg 50
Recombinant Human Glycine N-methyltransferase 50 µg 130
1 mg 1,800

GNPDA1 enz-554 5 µg 50
Recombinant Human Glucosamine-6-Phosphate Deaminase 1 20 µg 130
1 mg 3,600

Order Hotline 1-800-777-4779 502-266-8787 543

 Recombinant proteins

GNPNAT1 enz-037 2 µg 50
Recombinant Human Glucosamine-Phosphate 10 µg 130
N-Acetyltransferase 1 1 mg 5,200

GOR enz-574 5 µg 50
Recombinant E.Coli Glutathione Oxidoreductase 20 µg 130
1 mg 2,700

GOT1 enz-528 5 µg 50
Recombinant Human Glutamic-Oxaloacetic Transaminase 1 25 µg 130
1 mg 2,250

GOT2 enz-684 5 µg 50
Recombinant Human Glutamic-Oxaloacetic Transaminase 2 20 µg 130
1 mg 2,700

GPBB enz-282 5 µg 50
Recombinant Human Glycogen Phosphorylase 20 µg 130
1 mg 3,600

GPD1 enz-489 5 µg 50
Recombinant Human Glycerol-3-Phosphate Dehydrogenase 1 25 µg 130
1 mg 2,250

GPD1L enz-171 5 µg 50
Recombinant Human Glycerol-3-Phosphate Dehydrogenase 20 µg 130
1 Like 1 mg 2,700
PEPTIDES INTERNATIONAL

GPD2 enz-437 2 µg 50
Recombinant Human Glycerol-3-Phosphate Dehydrogenase 2 10 µg 130
1 mg 4,800

GPI enz-430 5 µg 50
Recombinant Human Glucose-6-Phosphate Isomerase 20 µg 130
1 mg 2,700

GPT enz-192 2 µg 50
Recombinant Human Glutamic-Pyruvate Transaminase 10 µg 130
1 mg 5,200

GPT2 enz-680 2 µg 50
Recombinant Human Glutamic-Pyruvate Transaminase 2 10 µg 130
1 mg 5,200

GPT Active enz-280 1U 50

Recombinant Human Glutamic-Pyruvate Transaminase 3U 130
50U 1,800

GPX1 enz-186 5 µg 50
Recombinant Human Glutathione Peroxidase 1 20 µg 130
1 mg 2,700

GPX2 enz-206 1 µg 50
Recombinant Human Glutathione Peroxidase 2 5 µg 130
50 µg 1,100

544 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
GPX3 enz-579 2 µg 50
Recombinant Human Glutathione Peroxidase 3 10 µg 130
1 mg 5,200

GPX7 enz-237 5 µg 50
Recombinant Human Glutathione Peroxidase 7 20 µg 130
1 mg 2,700

GRHPR enz-521 5 µg 50
Recombinant Human Glyoxylate Reductase/Hydroxypyruvate 25 µg 130
Reductase 1 mg 2,250

GRXB enz-130 5 µg 50
Recombinant E.Coli Glutaredoxin-2 20 µg 130
1 mg 2,700

GSR enz-202 2 µg 50
Recombinant Human Glutathione Reductase 10 µg 130
1 mg 5,200

GSS enz-021 5 µg 50
Recombinant Human Glutathione Synthetase 20 µg 130
1 mg 2,700

GST enz-393 10 µg 50
Recombinant Glutathione S-Transferase 50 µg 130
1 mg 1,800

GST His

PEPTIDES INTERNATIONAL
enz-451 10 µg 50
Recombinant Glutathione S-Transferase His Tag 50 µg 130
1 mg 2.25

GSTA1 enz-469 10 µg 50
Recombinant Human Glutathione S-Transferase Α 1 50 µg 130
1 mg 2.25

GSTA4 enz-600 5 µg 50
Recombinant Human Glutathione S-Transferase Α 4 20 µg 130
1 mg 2,700

GSTK1 enz-476 10 µg 50
Recombinant Human Glutathione S-Transferase Kappa 1 50 µg 130
1 mg 2.25

GSTm2 enz-003 5 µg 50
Recombinant Human Glutathione S-Transferase MU 2 20 µg 130
1 mg 2,700

mGSTm1 enz-397 10 µg 50
Recombinant Mouse Glutathione S-Transferase M1 50 µg 130
1 mg 1,800

mGSTm1 His enz-456 5 µg 50

Recombinant Mouse Glutathione S-Transferase M1 His-Tag 25 µg 130
1 mg 2,250

Order Hotline 1-800-777-4779 502-266-8787 545

 Recombinant proteins

GSTm3 enz-592 5 µg 50
Recombinant Human Glutathione S-Transferase MU 3 20 µg 130
1 mg 2,700

GSTm4 enz-492 5 µg 50
Recombinant Human Glutathione S-Transferase MU 4 20 µg 130
1 mg 2,700

GSTm5 enz-623 5 µg 50
Recombinant Human Glutathione S-Transferase MU 5 20 µg 130
1 mg 2,700

GSTO1 enz-434 2 µg 50
Recombinant Human Glutathione S-Transferase Omega 1 10 µg 130
1 mg 4,500

GSTO1 Mutant enz-435 2 µg 50

Recombinant Human Glutathione S-Transferase Omega 1 10 µg 130
Mutant 1 mg 4,500

GSTO2 enz-605 2 µg 50
Recombinant Human Glutathione S-Transferase Omega 2 10 µg 130
1 mg 5,200

GSTP1 enz-427 5 µg 50
Recombinant Human Glutathione S-Transferase pi 1 20 µg 130
1 mg 3,600

GSTT1 enz-429 5 µg 50
PEPTIDES INTERNATIONAL

Recombinant Human Glutathione S-Transferase Theta-1 20 µg 130

1 mg 3,000

GSTT2 enz-593 5 µg 50
Recombinant Human Glutathione S-Transferase Theta-2 20 µg 130
1 mg 2,700

GSTZ1 enz-494 5 µg 50
Recombinant Human Glutathione S-Transferase Zeta-1 25 µg 130
1 mg 2,250

GYG1 enz-431 5 µg 50
Recombinant Human Glycogenin-1 20 µg 130
1 mg 3,000

GZmK enz-741 5 µg 50
Recombinant Human Granzyme-K 20 µg 130
1 mg 2,700

HAAO enz-617 2 µg 50
Recombinant Human 3-Hydroxyanthranilate 3,4-Dioxygenase 10 µg 130
1 mg 5,200

HADH enz-499 5 µg 50
Recombinant Human Hydroxyacyl-Coenzyme A 25 µg 130
Dehydrogenase 1 mg 2,250

546 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
HAGH enz-034 2 µg 50
Recombinant Human Hydroxyacylglutathione Hydrolase 10 µg 130
1 mg 5,200

HAO1 enz-162 5 µg 50
Recombinant Human Hydroxyacid Oxidase 1 20 µg 130
1 mg 2,700

HARS enz-268 10 µg 50
Recombinant Human Histidyl-tRNA Synthetase 50 µg 130
1 mg 1,600

HARS His enz-001 2 µg 50

Recombinant Human Histidyl-tRNA Synthetase, His Tag 10 µg 130
1 mg 5,200

HARS Sf9 enz-335 5 µg 50

Recombinant Human Histidyl-tRNA Synthetase Sf9 25 µg 130
1 mg 3,900

HAT1 enz-504 2 µg 50
Recombinant Human Histone Acetyltransferase 1 10 µg 130
1 mg 5,200

HDAC2 enz-157 2 µg 50
Recombinant Human Histone Deacetylase 2 10 µg 130
1 mg 5,200

HDAC8 enz-210 2 µg 50

PEPTIDES INTERNATIONAL
Recombinant Human Histone Deacetylase 8 10 µg 130
1 mg 5,200

HDDC3 enz-184 5 µg 50
Recombinant Human HD domain containing 3 20 µg 130
1 mg 2,700

HDHD1 enz-028 5 µg 50
Recombinant Human Haloacid Dehalogenase-Like Hydrolase 20 µg 130
Domain Containing 1 1 mg 2,700

HDHD2 enz-038 5 µg 50
Recombinant Human Haloacid Dehalogenase-Like Hydrolase 20 µg 130
Domain Containing 2 1 mg 2,700

HDHD3 enz-089 2 µg 50
Recombinant Human Haloacid Dehalogenase-Like Hydrolase 10 µg 130
Domain Containing 3 1 mg 5,200

HEXA enz-683 5 µg 50
Recombinant Human Hexosaminidase A 20 µg 130
1 mg 2,700

HIBCH enz-594 2 µg 50
Recombinant Human 3-Hydroxyisobutyryl-CoA Hydrolase 10 µg 130
1 mg 5,200

Order Hotline 1-800-777-4779 502-266-8787 547

 Recombinant proteins

HmBS enz-581 5 µg 50
Recombinant Human Hydroxymethylbilane Synthase 20 µg 130
1 mg 2,700

HmGCL enz-218 5 µg 50
Recombinant Human 3-Hydroxymethyl-3-methylglutaryl-CoA 20 µg 130
Lyase 1 mg 2,700

HmOX1 enz-392 10 µg 50
Recombinant Human Heme Oxygenase 1 50 µg 130
1 mg 1,800

HmOX2 enz-478 5 µg 50
Recombinant Human Heme Oxygenase 2 25 µg 130
1 mg 2,250

HNmT enz-402 5 µg 50
Recombinant Human Histamine N-methyltransferase 20 µg 130
1 mg 3,600

HPA1 enz-261 100ng 450

Recombinant Human Heparanase-1 200ng 900
300ng 1,350

HPD enz-015 2 µg 50
Recombinant Human 4-Hydroxyphenylpyruvate Dioxygenase 10 µg 130
1 mg 5,200

HPGD enz-564 2 µg 50
PEPTIDES INTERNATIONAL

Recombinant Human Hydroxyprostaglandin Dehydrogenase 10 µg 130

15-(NAD) 1 mg 5,200

HPGDS enz-616 5 µg 50
Recombinant Human Hematopoietic Prostaglandin D Synthase 20 µg 130
1 mg 2,700

HPRT1 enz-524 5 µg 50
Recombinant Human Hypoxanthine-Guanine 25 µg 130
Phosphoribosyltransferase 1 mg 2,250

HRASLS3 enz-336 10 µg 50
Recombinant Human HRAS-Like Suppressor 3 (PLA2G16) 50 µg 130
1 mg 1,800

HRP enz-321 20 mg 50
Horseradish Peroxidase 60 mg 130
1gra m 1,500

HS3T1 enz-744 2 µg 50
Recombinant Human Heparan Sulfate 3-O-Sulfotransferase 1 10 µg 130
1 mg 5,200

HSD17B1 enz-709 2 µg 50
Recombinant Human Hydroxysteroid (17-β) Dehydrogenase 1 10 µg 130
1 mg 5,200

548 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
HSD17B11 enz-049 5 µg 50
Recombinant Human Hydroxysteroid (17-β) Dehydrogenase 11 20 µg 130
1 mg 3,600

HSD17B14 enz-029 5 µg 50
Recombinant Human Hydroxysteroid (17-β) Dehydrogenase 14 20 µg 130
1 mg 2,700

HSD17B8 enz-108 5 µg 50
Recombinant Human Hydroxysteroid (17-β) Dehydrogenase 8 20 µg 130
1 mg 3,600

HTATIP2 enz-546 5 µg 50
Recombinant Human HIV-1 Tat Interactive Protein 2 20 µg 130
1 mg 2,700

HTRA2 enz-332 10 µg 50
Recombinant Human HTRA2 50 µg 130
1 mg 1,800

IDH1 enz-289 1 mg 50
Recombinant Yeast Isocitrate Dehydrogenase-1 5 mg 130
50 mg 980

IDH1 enz-193 5 µg 50
Recombinant Human Isocitrate Dehydrogenase-1 20 µg 130
1 mg 2,700

IDH3G enz-205 2 µg 50

PEPTIDES INTERNATIONAL
Recombinant Human Isocitrate Dehydrogenase 3 (NAD+) 10 µg 130
Gamma 1 mg 5,200

IdhA enz-632 5 µg 50
Recombinant E.Coli Fermentative D-lactate Dehydrogenase, 20 µg 130
NAD-Dependent 1 mg 2,700

IDI1 enz-189 2 µg 50
Recombinant Human Isopentenyl-Diphosphate Delta 10 µg 130
Isomerase 1 1 mg 5,200

IDI2 enz-107 5 µg 50
Recombinant Human Isopentenyl-Diphosphate Delta 20 µg 130
Isomerase 2 1 mg 3,600

ImPA1 enz-006 5 µg 50
Recombinant Human Inositol Monophosphatase 1 20 µg 130
1 mg 2,700

ImPA2 enz-070 2 µg 50
Recombinant Human Inositol Monophosphatase 2 10 µg 130
1 mg 5,200

ImPDH1 enz-525 2 µg 50
Recombinant Human ImP Dehydrogenase 1 10 µg 130
1 mg 5,200

Order Hotline 1-800-777-4779 502-266-8787 549

 Recombinant proteins

ImPDH2 enz-187 2 µg 50
Recombinant Human ImP Dehydrogenase 2 10 µg 130
1 mg 5,200

ITPA enz-549 5 µg 50
Recombinant Human Inosine Triphosphatase 20 µg 130
1 mg 2,700

IVD enz-490 5 µg 50
Recombinant Human Isovaleryl Coenzyme A Dehydrogenase 25 µg 130
1 mg 2,250

KARS enz-161 5 µg 50
Recombinant Human Lysyl-tRNA Synthetase 20 µg 130
1 mg 2,700

KAT2A enz-166 5 µg 50
Recombinant Human K (lysine) Acetyltransferase 2A 20 µg 130
1 mg 2,700

KDSR enz-092 5 µg 50
Recombinant Human 3-Ketodihydrosphingosine Reductase 20 µg 130
1 mg 2,700

KLK1 enz-293 20 µg 50
Recombinant Human Kallikrein-1 100 µg 130
1 mg 1,100

KLK1 His enz-690 2 µg 50

PEPTIDES INTERNATIONAL

Recombinant Human Kallikrein-1, His Tag 10 µg 130

100 µg 1,200

KLK2 enz-719 5 µg 50
Recombinant Human Kallikrein-2 20 µg 130
1 mg 2,700

KLK3 enz-620 5 µg 50
Recombinant Human Kallikrein-3 20 µg 130
1 mg 2,700

KLK3 enz-731 2 µg 50
Human Kallikrein-3 10 µg 130
100 µg 1,100

KLK5 enz-630 2 µg 50
Recombinant Human Kallikrein-5 10 µg 130
100 µg 1,200

KLK7 enz-510 5 µg 50
Recombinant Human Kallikrein-7 20 µg 130
1 mg 2,700

KLOTHO enz-369 5 µg 50
Recombinant Human Klotho 20 µg 130
0.5 mg 2,200

550 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
LACTB enz-351 1 mg 130
Recombinant Β Lactamase 10 mg 900
50 mg 3,600

LACTB, His enz-088 5 µg 50

Recombinant E.Coli Β Lactamase, His Tag 20 µg 130
1 mg 2,700

L-Asparaginase enz-287 500IU 50

L-Asparaginase 2500IU 130
10,000IU 520

Latexin enz-407 5 µg 50
Recombinant Human Latexin 20 µg 130
1 mg 3,600

LCAT enz-380 5 µg 50
Recombinant Human Lecithin-Cholesterol Acyltransferase 20 µg 130
1 mg 2,700

LCAT HEK enz-254 2 µg 50

Recombinant Human Lecithin-Cholesterol Acyltransferase, 10 µg 130
HEK 1 mg 5,200

LCmT1 enz-219 5 µg 50
Recombinant Human Leucine Carboxyl Methyltransferase 1 20 µg 130
1 mg 2,700

LCN2

PEPTIDES INTERNATIONAL
enz-297 2 µg 50
Recombinant Human Neutrophil Gelatinase Associated 10 µg 130
Lipocalin/Lipocalin-2 1 mg 4,800

LCN2 Pichia enz-064 5 µg 50

Recombinant Human Neutrophil Gelatinase Associated 20 µg 130
Lipocalin/Lipocalin-2, Pichia 1 mg 3,000

LDHA enz-491 5 µg 50
Recombinant Human Lactate Dehydrogenase A 25 µg 130
1 mg 2,250

LDHB enz-279 1 mg 50
Recombinant Lactate Dehydrogenase B 3 mg 130
30 mg 980

LDHB enz-539 5 µg 50
Recombinant Human Lactate Dehydrogenase B 25 µg 130
1 mg 2,250

LHPP enz-575 2 µg 50
Recombinant Human Phospholysine Phosphohistidine 10 µg 130
Inorganic Pyrophosphate Phosphatase 1 mg 5,200

Lipase-A enz-473 10 mg 50
Recombinant Lipase-A 100 mg 130
1gr 700

Order Hotline 1-800-777-4779 502-266-8787 551

 Recombinant proteins

lldD enz-618 2 µg 50
Recombinant E.Coli L-Lactate Dehydrogenase 10 µg 130
100 µg 1,200

LPCAT1 enz-695 2 µg 50
Recombinant Human Lysophosphatidylcholine Acyltransferase  10 µg 130
100 µg 1,200

LPL enz-086 2 µg 50
Recombinant Human LipoProtein Lipase 10 µg 130
1 mg 5,200

LPL, HEK enz-087 2 µg 50

Recombinant Human LipoProtein Lipase, HEK 10 µg 130
1 mg 5,200

Luciferase enz-553 5 µg 50
Recombinant Firefly Luciferin 4-monooxygenase 20 µg 130
1 mg 2,700

LYPLA2 enz-076 5 µg 50
Recombinant Human Lysophospholipase II 20 µg 130
1 mg 3,600

LYPLAL1 enz-644 5 µg 50
Recombinant Human Lysophospholipase Like I 20 µg 130
1 mg 2,700

mLYPLA1 enz-565 5 µg 50
PEPTIDES INTERNATIONAL

Recombinant Mouse Lysophospholipase I 25 µg 130

1 mg 2,700

Lysostaphin enz-269 1 mg 50
Recombinant Lysostaphin 5 mg 200
10 mg 350

LY6G6F enz-737 5 µg 50
Recombinant Human Lymphocyte Antigen 6 Complex Locus 20 µg 130
G6F 1 mg 2,700

m2 enz-072 5 µg 50
Recombinant Human DLAT/DLST/BCOADC 20 µg 130
1 mg 3,900

mAO-B enz-440 2 µg 50
Recombinant Human Monoamine Oxidase B 10 µg 130
1 mg 4,800

mAP enz-123 5 µg 50
Recombinant E.Coli Methionine Aminopeptidase 20 µg 130
1 mg 2,700

mAT1A enz-493 2 µg 50
Recombinant Human Methionine Adenosyltransferase I, Α 10 µg 130
1 mg 5,200

552 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
mAT2A enz-320 5 µg 50
Recombinant Human Methionine Adenosyltransferase II, Α 20 µg 130
1 mg 2,700

mAT2B enz-461 5 µg 50
Recombinant Human Methionine Adenosyltransferase II, Β 20 µg 130
1 mg 3,600

mCEE enz-013 5 µg 50
Recombinant Human Methylmalonyl CoA Epimerase 20 µg 130
1 mg 2,700

mDH enz-598 5 µg 50
Recombinant Malate Dehydrogenase 20 µg 130
1 mg 2,700

mDH1 enz-256 5 µg 50
Recombinant Human Malate Dehydrogenase 1 25 µg 130
1 mg 2,700

mDH1 enz-273 1000IU 50

Recombinant Malate Dehydrogenase 1 5000IU 130
50,000IU 990

mDH2 enz-247 2 µg 50
Recombinant Human Malate Dehydrogenase 2 10 µg 130
1 mg 5,200

mDP1 enz-044 5 µg 50

PEPTIDES INTERNATIONAL
Recombinant Human Magnesium-Dependent Phosphatase 1 20 µg 130
1 mg 2,700

mE2 enz-376 5 µg 50
Recombinant Human Malic Enzyme 2 25 µg 130
1 mg 2,400

mECR enz-533 2 µg 50
Recombinant Human Mitochondrial Trans-2-Enoyl-CoA 10 µg 130
Reductase 1 mg 5,200

melA enz-609 2 µg 50
Recombinant E.Coli Α-Galactosidase 10 µg 130
1 mg 5,200

mETAP1 enz-604 5 µg 50
Recombinant Human Methionyl Aminopeptidase 1 20 µg 130
1 mg 2,700

mETTL1 enz-054 2 µg 50
Recombinant Human Methyltransferase Like 1 10 µg 130
1 mg 5,200

mETTL21A enz-718 2 µg 50
Recombinant Human Methyltransferase Like 21A 10 µg 130
100 µg 1,200

Order Hotline 1-800-777-4779 502-266-8787 553

 Recombinant proteins

mGLL enz-019 2 µg 50
Recombinant Human Monoglyceride Lipase 10 µg 130
1 mg 5,200

mGmT enz-389 5 µg 50
Recombinant Human O-6-methylguanine-DNA 20 µg 130
Methyltransferase 1 mg 3,600

mmAB enz-248 5 µg 50
Recombinant Human Methylmalonic Aciduria Type B 25 µg 130
1 mg 2,700

mmLV RT enz-310 2,500U 50

Recombinant Moloney Mouse Leukemia Virus Reverse 10,000U 130
Trancscriptase 50,000U 600

mmP 1 enz-099 2 µg 50
Recombinant Human Matrix MetalloProteinase-1 10 µg 130
1 mg 4,680

mmP 13 enz-317 1 µg 130

Recombinant Human Matrix MetalloProteinase-13 2.5 µg 250
10 µg 900

mmP 2 enz-100 2 µg 50
Recombinant Human Matrix MetalloProteinase-2 10 µg 130
1 mg 4,680
PEPTIDES INTERNATIONAL

mmP 3 enz-284 2 µg 50
Recombinant Human Matrix MetalloProteinase-3 10 µg 130
1 mg 4,680

mmP 3 GST enz-455 2 µg 175

Recombinant Human Matrix MetalloProteinase-3 GST-Tag 5 µg 270
10 µg 490

mmP 7 enz-271 5 µg 50
Recombinant Human Matrix MetalloProteinase-7 20 µg 130
1 mg 5,200

mmP 8 enz-301 1U 130

Recombinant Human Matrix MetalloProteinase-8 2.5U 250
10U 900

mmP 9 enz-438 2 µg 50
Recombinant Human Matrix MetalloProteinase-9 10 µg 130
1 mg 4,800

mPG enz-151 2 µg 50
Recombinant Human N-methylpurine-DNA Glycosylase 10 µg 130
1 mg 5,200

mPI enz-169 5 µg 50
Recombinant Human Mannose Phosphate Isomerase 25 µg 130
1 mg 2,700

554 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
mPO enz-074 5 µg 50
Human Myeloperoxidase 25 µg 130
1 mg 2,500

mPST enz-676 5 µg 50
Recombinant Human Mercaptopyruvate Sulfurtransferase 20 µg 130
1 mg 2,700

mSRA enz-129 1 µg 50
Recombinant E.Coli Methionine Sulfoxide Reductase A 5 µg 130
50 µg 1,100

mSRA enz-621 5 µg 50
Recombinant Human Methionine Sulfoxide Reductase A 20 µg 130
1 mg 2,700

mSRB enz-124 5 µg 50
Recombinant E.Coli Methionine Sulfoxide Reductase B 20 µg 130
1 mg 2,700

mSRB2 enz-036 5 µg 50
Recombinant Human Methionine Sulfoxide Reductase B2 25 µg 130
1 mg 2,700

mSRB3 enz-093 2 µg 50
Recombinant Human Methionine Sulfoxide Reductase B3 10 µg 130
1 mg 5,200

mTHFS enz-096 5 µg 50

PEPTIDES INTERNATIONAL
Recombinant Human 5,10-methenyltetrahydrofolate Synthetase 25 µg 130
1 mg 2,700

mUG enz-703 2 µg 50
Recombinant E.Coli G/U Mismatch-Specific DNA Glycosylase 10 µg 130
1 mg 5,200

mUTm enz-589 2 µg 50
Recombinant E.Coli Formamidopyrimidine-DNA Glycosylase 10 µg 130
1 mg 5,200

mutY enz-702 1 µg 50
Recombinant E.Coli Adenine DNA Glycosylase 5 µg 130
50 µg 1,100

mVD enz-226 2 µg 50
Recombinant Human Mevalonate Decarboxylase 10 µg 130
1 mg 5,200

NAA10 enz-158 5 µg 50
Recombinant Human N Α-Acetyltransferase 10, NatA Catalytic 20 µg 130
Subunit 1 mg 3.60

NAA30 enz-720 2 µg 50
Recombinant Human N Α-Acetyltransferase 30, NatA Catalytic 10 µg 130
Subunit 100 µg 1,200

Order Hotline 1-800-777-4779 502-266-8787 555

 Recombinant proteins

NAA50 enz-424 5 µg 50
Recombinant Human N Α-Acetyltransferase 50, NatA Catalytic 20 µg 130
Subunit 1 mg 2,700

NAE1 enz-227 2 µg 50
Recombinant Human NEDD8 Activating Enzyme E1 Subunit 1 10 µg 130
1 mg 5,200

NANA enz-128 5 µg 50
Recombinant E.Coli N-Acetylneuraminate Lyase 20 µg 130
1 mg 2,700

NANP enz-009 5 µg 50
Recombinant Human N-Acetylneuraminic Acid Phosphatase 20 µg 130
1 mg 2,700

NANS enz-024 5 µg 50
Recombinant Human N-acetylneuraminic acid synthase 20 µg 130
1 mg 2,700

NARS enz-716 2 µg 50
Recombinant Human Asparaginyl-TRNA Synthetase 10 µg 130
1 mg 5,200

NAT1 enz-144 5 µg 50
Recombinant Human N-Acetyltransferase 6 20 µg 130
1 mg 5,200

NAT6 enz-410 2 µg 175

PEPTIDES INTERNATIONAL

Recombinant Human N-Acetyltransferase 6 5 µg 250

10 µg 360

NDUFA2 enz-660 2 µg 50
Recombinant Human NADH Dehydrogenase 1 Α Subcomplex 2 10 µg 130
1 mg 5,200

NDUFA5 enz-657 2 µg 50
Recombinant Human NADH Dehydrogenase1 Α Subcomplex 5 10 µg 130
100 µg 1,200

NDUFAF1 enz-661 5 µg 50
Recombinant Human NADH Dehydrogenase 1 Α Subcomplex, 20 µg 130
Assembly Factor 1 1 mg 3.60

NDUFAF2 enz-150 2 µg 50
Recombinant Human NADH Dehydrogenase 1 Α Subcomplex, 10 µg 130
Assembly Factor 2 1 mg 5,200

NDUFAF4 enz-658 1 µg 50
Recombinant Human NADH Dehydrogenase 1 Α Subcomplex, 5 µg 130
Assembly Factor 4 50 µg 1,200

NDUFB4 enz-699 5 µg 50
Recombinant Human NADH Dehydrogenase 1 Β Subcomplex 4 20 µg 130
1 mg 2,700

556 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
NDUFB9 enz-740 2 µg 50
Recombinant Human NADH Dehydrogenase 1 Β Subcomplex 9 10 µg 130
1 mg 5,200

NDUFS3 enz-662 1 µg 50
Recombinant Human Histidine NADH Dehydrogenase Fe-S 5 µg 130
Protein 3 50 µg 1,200

NDUFS4 enz-421 5 µg 50
Recombinant Human Histidine NADH Dehydrogenase Fe-S 25 µg 130
Protein 4 1 mg 2,700

NDUFS6 enz-725 5 µg 50
Recombinant Human Histidine NADH Dehydrogenase Fe-S 20 µg 130
Protein 6 1 mg 2,700

NDUFV2 enz-743 5 µg 50
Recombinant Human NADH Dehydrogenase FlavoProtein 2 20 µg 130
1 mg 2,700

NDUFV3 enz-749 5 µg 50
Recombinant Human NADH Dehydrogenase FlavoProtein 3 20 µg 130
1 mg 2,700

NEDD8 enz-396 5 µg 50
Recombinant Human Neural Precursor Cell Expressed, 25 µg 130
Developmentally Down-Regulated 8 1 mg 2,700

PEPTIDES INTERNATIONAL
NEIL1 enz-220 1 µg 50
Recombinant Human Nei Endonuclease VIII-Like 1 5 µg 130
50 µg 1,200

NEIL2 enz-607 2 µg 50
Recombinant Human Nei Endonuclease VIII-Like 2 10 µg 130
1 mg 5,200

NEU1 enz-645 5 µg 50
Recombinant Human Sialidase 1 20 µg 130
1 mg 3.60

NFNB enz-423 5 µg 50
Recombinant E.Coli Dihydropteridine Reductase 20 µg 130
1 mg 2,700

NIT2 enz-039 2 µg 50
Recombinant Human Nitrilase Family Member 2 10 µg 130
1 mg 5,200

NmNAT1 enz-384 5 µg 50
Recombinant Human Nicotinamide Nucleotide 20 µg 130
Adenylyltransferase 1 1 mg 2,700

NmNAT2 enz- 2 µg 50
Recombinant Human Nicotinamide Nucleotide 10 µg 130
Adenylyltransferase 2 100 µg 1,200

Order Hotline 1-800-777-4779 502-266-8787 557

 Recombinant proteins

NmT2 enz-068 5 µg 50
Recombinant Human N-myristoyltransferase 2 20 µg 130
1 mg 2,700

NNmT enz-418 5 µg 50
Recombinant Human Nicotinamide N-methyltransferase 25 µg 130
1 mg 2,700

NPL enz-125 5 µg 50
Recombinant Human N-acetylneuraminate Pyruvate Lyase 20 µg 130
1 mg 2,700

NQO1 enz-448 2 µg 50
Recombinant Human NAD(P)H Dehydrogenase Quinone 1 10 µg 130
1 mg 5,200

NQO2 enz-515 5 µg 50
Recombinant Human NAD(P)H Dehydrogenase Quinone 2 25 µg 130
1 mg 2,250

NT5C2 enz-173 5 µg 50
Recombinant Human 5'-Nucleotidase, Cytosolic II 20 µg 130
1 mg 2,700

NT5m enz-160 1 µg 50
Recombinant Human 5',3'-Nucleotidase, Mitochondrial 5 µg 130
50 µg 1,200

NTH enz-132 2 µg 50
PEPTIDES INTERNATIONAL

Recombinant E.Coli Endonuclease-III 10 µg 130

1 mg 5,200

NTHL1 enz-172 2 µg 50
Recombinant Human nth Endonuclease III-Like 1 10 µg 130
1 mg 5,200

NUDT1 enz-010 5 µg 50
Recombinant Human Nudix Type Motif 1 20 µg 130
1 mg 2,700

NUDT4 enz-708 2 µg 50
Recombinant Human Nudix Type Motif 4 10 µg 130
1 mg 5,200

NUDT10 enz-126 5 µg 50
Recombinant Human Nudix Type Motif 10 20 µg 130
1 mg 3.60

NUDT14 enz-691 5 µg 50
Recombinant Human Nudix Type Motif 14 20 µg 130
1 mg 2,700

NUDT16 enz-053 5 µg 50
Recombinant Human Nudix Type Motif 16 20 µg 130
1 mg 2,700

558 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
NUDT16L1 enz-079 5 µg 50
Recombinant Human Nudix Type Motif 16 Like-1 20 µg 130
1 mg 3.60

NUDT2 enz-063 5 µg 50
Recombinant Human Nudix Type Motif 2 20 µg 130
1 mg 2,700

NUDT21 enz-080 5 µg 50
Recombinant Human Nudix Type Motif 21 20 µg 130
1 mg 2,700

NUDT3 enz-071 2 µg 50
Recombinant Human Nudix Type Motif 3 10 µg 130
1 mg 5,200

NUDT5 enz-547 5 µg 50
Recombinant Human Nudix Type Motif 5 20 µg 130
1 mg 2,700

NUDT9 enz-137 5 µg 50
Recombinant Human Nudix Type Motif 9 20 µg 130
1 mg 2,700

OAS1 enz-445 2 µg 50
Recombinant Human 2’-5’ Oligoadenylate Synthetase 1 10 µg 130
1 mg 5,200

ODC1 enz-181 2 µg 50

PEPTIDES INTERNATIONAL
Recombinant Human Ornithine Decarboxylase 1 10 µg 130
1 mg 5,200

OGG1 enz-253 5 µg 50
Recombinant Human 8-Oxoguanine DNA Glycosylase 25 µg 130
1 mg 2,700

oHYAL 1 enz-323 1,500IU 50

Hyaluronidase 4,500IU 130
15,000IU 300

OLA1 enz-637 5 µg 50
Recombinant Human Obg-Like ATPase 1 20 µg 130
1 mg 3.60

Ornithine enz-472 5 µg 50
Recombinant Human Ornithine Aminotransferase 25 µg 130
1 mg 2,250

OTC enz-596 2 µg 50
Recombinant Human Ornithine Carbamoyltransferase 10 µg 130
1 mg 5,200

OXSm enz-751 2 µg 50
Recombinant Human 3-Oxoacyl-ACP Synthase, Mitochondrial 10 µg 130
1 mg 5,200

Order Hotline 1-800-777-4779 502-266-8787 559

 Recombinant proteins

P4HB enz-252 5 µg 50
Recombinant Human Prolyl 4-Hydroxylase Β 25 µg 130
1 mg 2,700

PAFAH1B3 enz-641 5 µg 50
Recombinant Human Platelet-activating Factor Acetylhydrolase 20 µg 130
1b, Catalytic Subunit 3 1 mg 2,700

PAPP-A enz-441 2 µg 50
Recombinant Human Pregnancy-Associated Plasma Protein-1 10 µg 130
1 mg 4,800

PAPSS1 enz-236 5 µg 50
Recombinant Human 3'-Phosphoadenosine 5'-Phosphosulfate 20 µg 130
Synthase 1 1 mg 3.60

PARP1 enz-477 5 µg 50
Recombinant Human Poly (ADP-Ribose) Polymerase 1 25 µg 130
1 mg 2,250

PARP2 enz-694 5 µg 50
Recombinant Human Poly (ADP-Ribose) Polymerase 2 20 µg 130
1 mg 2,700

PCBD1 enz-552 5 µg 50
Recombinant Human Pterin-4-Α-Carbinolamine Dehydratase 25 µg 130
1 mg 2,700
PEPTIDES INTERNATIONAL

PCmT1 enz-522 5 µg 50
Recombinant Human Protein-L-Isoaspartate 25 µg 130
O-methyltransferase 1 mg 2,250

PCYT2 enz-221 1 µg 50
Recombinant Human Phosphate Cytidylyltransferase 2 5 µg 130
50 µg 1,200

PDE6D enz-483 5 µg 50
Recombinant Human Phosphodiesterase 6D cGmP-Specific 20 µg 130
Rod Delta 1 mg 3.60

PDI enz-262 100 µg 160

Recombinant Human Protein Disulfide Isomerase 0.5 mg 640
1 mg 1,050

PDIA3 enz-474 5 µg 50
Recombinant Human Protein Disulfide Isomerase A3 25 µg 130
1 mg 2,250

PDIA4 enz-246 2 µg 50
Recombinant Human Protein Disulfide Isomerase A4 10 µg 130
1 mg 5,200

PDIA6 enz-020 5 µg 50
Recombinant Human Protein Disulfide Isomerase A6 20 µg 130
1 mg 2,700

560 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
PDXP enz-551 2 µg 50
Recombinant Human Pyridoxal Phosphatase 10 µg 130
1 mg 5,200

PECI enz-531 5 µg 50
Recombinant Human Peroxisomal D3,D2-Enoyl-CoA Isomerase 25 µg 130
1 mg 2,250

PECR enz-177 5 µg 50
Recombinant Human Peroxisomal Trans-2-enoyl-CoA 20 µg 130
Reductase 1 mg 2,700

Pfu DNA Polymerase enz-265 100U 130

Recombinant Pfu DNA Polymerase 500U 230
2500U 920

PGAm1 enz-337 5 µg 50
Recombinant Human Phosphoglycerate Mutase 1 25 µg 130
1 mg 2,700

mPGAm1 enz-627 5 µg 50
Recombinant Mouse Phosphoglycerate Mutase 1 25 µg 130
1 mg 2,700

PGAm2 enz-578 5 µg 50
Recombinant Human Phosphoglycerate Mutase 2 25 µg 130
1 mg 2,700

PGD

PEPTIDES INTERNATIONAL
enz-501 5 µg 50
Recombinant Human Phosphogluconate Dehydrogenase 25 µg 130
1 mg 2,250

PGLS enz-016 2 µg 50
Recombinant Human 6-Phosphogluconolactonase 10 µg 130
1 mg 5,200

PGP enz-692 5 µg 50
Recombinant Human Phosphoglycolate Phosphatase 20 µg 130
1 mg 2,700

PGPEP1 enz-672 5 µg 50
Recombinant Human Pyroglutamyl-Peptidase I 20 µg 130
1 mg 2,700

PHOSPHO1 enz-363 2 µg 50
Recombinant Human Phosphatase Orphan-1 10 µg 130
1 mg 5,200

PHOSPHO2 enz-231 2 µg 50
Recombinant Human Phosphatase Orphan-2 10 µg 130
1 mg 5,200

PHPT1 enz-012 5 µg 50
Recombinant Human Phosphohistidine Phosphatase 1 25 µg 130
1 mg 2,700

Order Hotline 1-800-777-4779 502-266-8787 561

 Recombinant proteins

phrB enz-362 2 µg 50
Recombinant E.Coli Deoxyribodipyrimidine photo-lyase 10 µg 130
100 µg 1,200

PI16 enz-113 2 µg 50
Recombinant Human Peptidase Inhibitor 16 10 µg 130
1 mg 5,200

PIN1 enz-331 5 µg 50
Recombinant Human Peptidyl-Prolyl Cis/Trans Isomerase 20 µg 130
NImA-Interacting 1 1 mg 2,800

PIN4 enz-106 5 µg 50
Recombinant Human Peptidyl-Prolyl Cis/Trans Isomerase 20 µg 130
NImA-Interacting 4 1 mg 3.60

PL 12 enz-305 5 µg 50
Recombinant Human Alanyl t-RNA Synthetase 20 µg 130
1 mg 3,900

PL 7 enz-304 5 µg 50
Recombinant Human Threonyl t-RNA Synthetase 20 µg 130
1 mg 3,900

PLA2G10 enz-329 2 µg 50
Recombinant Human Secreted Phospholipase A2-X 10 µg 130
1 mg 3,900
PEPTIDES INTERNATIONAL

PLA2G12 enz-330 2 µg 50
Recombinant Human Secreted Phospholipase A2-XII 10 µg 130
1 mg 3,900

PLA2G1B enz-325 2 µg 50
Recombinant Human Secreted Phospholipase A2-IB 10 µg 130
1 mg 3,900

PLA2G2A enz-290 2 µg 50
Recombinant Human Secreted Phospholipase A2-IIA 10 µg 130
1 mg 3,900

PLA2G2D enz-326 2 µg 50
Recombinant Human Secreted Phospholipase A2-IID 10 µg 130
1 mg 3,900

PLA2G2E enz-327 2 µg 50
Recombinant Human Secreted Phospholipase A2-IIE 10 µg 130
1 mg 3,900

PLA2G5 enz-328 2 µg 50
Recombinant Human Secreted Phospholipase A2-V 10 µg 130
1 mg 3,900

PLA2G7 enz-436 5 µg 50
Recombinant Human Secreted Phospholipase A2-VII 20 µg 130
1 mg 2,700

562 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
PLA2G7 HEK enz-736 5 µg 50
Recombinant Human Secreted Phospholipase A2-VII HEK 20 µg 130
1 mg 2,700

PLAP enz-333 2 µg 175

Recombinant Human Placental Alkaline Phosphatase 5 µg 270
10 µg 490

Pmm1 enz-023 2 µg 50
Recombinant Human Phosphomannomutase 1 10 µg 130
1 mg 5,200

Pmm2 enz-002 5 µg 50
Recombinant Human Phosphomannomutase 2 20 µg 130
1 mg 2,700

PNmT enz-457 5 µg 50
Recombinant Human Phenylethanolamine-N-methyltransferase 25 µg 130
1 mg 2,250

PNP enz-025 5 µg 50
Recombinant Human Purine Nucleoside Phosphorylase 20 µg 130
1 mg 2,700

PNPO enz-030 5 µg 50
Recombinant Human Pyridoxamine 5'-Phosphate Oxidase 20 µg 130
1 mg 2,700

POFUT1 enz-679 5 µg 50

PEPTIDES INTERNATIONAL
Recombinant Human Protein O-Fucosyltransferase 1 20 µg 130
1 mg 2,700

POLB enz-168 5 µg 50
Recombinant Human Polymerase (DNA directed), Β 20 µg 130
1 mg 2,700

POLL enz-182 2 µg 50
Recombinant Human Polymerase (DNA directed), Lambda 10 µg 130
1 mg 5,200

POLR2D enz-739 5 µg 50
Recombinant Human Polymerase II Polypeptide D 20 µg 130
1 mg 2,700

POLR2E enz-673 5 µg 50
Recombinant Human Polymerase II Polypeptide E 20 µg 130
1 mg 2,700

POLR3F enz-650 5 µg 50
Recombinant Human Polymerase III Polypeptide F 20 µg 130
1 mg 2,700

POLR2I enz-669 2 µg 50
Recombinant Human Polymerase II Polypeptide I 10 µg 130
1 mg 5,200

Order Hotline 1-800-777-4779 502-266-8787 563

 Recombinant proteins

POLR2J2 enz-689 2 µg 50
Recombinant Human Polymerase II Polypeptide J2 10 µg 130
1 mg 5,200

POLR2J3 enz-654 2 µg 50
Recombinant Human Polymerase II Polypeptide J3 10 µg 130
1 mg 5,200

PON1 enz-299 2 µg 50
Recombinant Human Paraoxonase-1 10 µg 130
1 mg 4,800

PON2 enz-300 2 µg 50
Recombinant Human Paraoxonase-2 10 µg 130
1 mg 4,800

PPA enz-149 5 µg 50
Recombinant E.Coli Inorganic Pyrophosphatase 20 µg 130
1 mg 2,700

PPA1 enz-241 5 µg 50
Recombinant Human Pyrophosphatase-1 20 µg 130
1 mg 2,700

PPCDC enz-011 5 µg 50
Recombinant Human Phosphopantothenoylcysteine 20 µg 130
Decarboxylase 1 mg 2,700

PPCS enz-139 5 µg 50
PEPTIDES INTERNATIONAL

Recombinant Human Phosphopantothenoylcysteine 20 µg 130

Synthetase 1 mg 2,700

PPIF enz-385 10 µg 50
Recombinant Human Cyclophilin-F 50 µg 130
1 mg 1,800

PPIH enz-379 5 µg 50
Recombinant Human Cyclophilin-H 20 µg 130
1 mg 3,600

PPIH His enz-730 2 µg 50

Recombinant Human Cyclophilin-H, His Tag 10 µg 130
1 mg 5,200

PPIL1 enz-388 10 µg 50
Recombinant Human Peptidylprolyl Isomerase (Cyclophilin)- 50 µg 130
Like 1 1 mg 1,800

PPIL2 enz-497 2 µg 50
Recombinant Human Peptidylprolyl Isomerase (Cyclophilin)- 10 µg 130
Like 2 1 mg 5,200

PPIL3 enz-174 5 µg 50
Recombinant Human Cyclophilin-J 20 µg 130
1 mg 2,700

564 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
PPIL4 enz-026 2 µg 50
Recombinant Human Peptidylprolyl Isomerase (Cyclophilin)- 10 µg 130
Like 4 1 mg 5,200

PPm1F enz-122 5 µg 50
Recombinant Human Protein Phosphatase 1F 20 µg 130
1 mg 2,700

PPm1G enz-368 10 µg 50
Recombinant Human Protein Phosphatase 1G 50 µg 130
1 mg 1,800

PPm1G, 546 a.a. enz-156 2 µg 50

Recombinant Human Protein Phosphatase 1G 546 a.a. 10 µg 130
1 mg 5,200

PPmE1 enz-155 5 µg 50
Recombinant Human Protein Phosphatase Methylesterase 1 20 µg 130
1 mg 2,700

PPP1CA enz-165 1 µg 50
Recombinant Human Protein Phosphatase 1, Catalytic Subunit 5 µg 130
Α 50 µg 1,200

PPP1CC enz-613 2 µg 50
Recombinant Human Protein Phosphatase 1, Catalytic Subunit 10 µg 130
Gamma 100 µg 1,200

PEPTIDES INTERNATIONAL
PPP1R14A enz-370 5 µg 50
Recombinant Human Protein Phosphatase-1, Regulatory 20 µg 130
Subunit-14A 1 mg 3,600

PPP1R1A enz-366 5 µg 50
Recombinant Human Protein Phosphatase Inhibitor-1 20 µg 130
1 mg 3,600

PPP1R8 enz-648 2 µg 50
Recombinant Human Protein Phosphatase 1, Regulatory 10 µg 130
Subunit 8 1 mg 5,200

PPP3CA enz-051 1 µg 50
Recombinant Human Protein Phosphatase 3, Catalytic subunit, 5 µg 130
Α Isozyme 50 µg 1,200

PPP3R1 enz-066 5 µg 50
Recombinant Human Protein Phosphatase 3, Regulatory 20 µg 130
subunit, Α Isozyme 1 mg 2,700

PPP3R2 enz-103 5 µg 50
Recombinant Human Protein Phosphatase 3, Regulatory 20 µg 130
subunit, Β Isozyme 1 mg 5,200

PPP4C enz-266 5 µg 50
Recombinant Human Protein Phosphatase 4 Catalytic subunit 20 µg 130
1 mg 2,700

Order Hotline 1-800-777-4779 502-266-8787 565

 Recombinant proteins

PRDX1 enz-372 5 µg 50
Recombinant Human Peroxiredoxin-1 20 µg 130
1 mg 2,700

PRDX2 enz-414 5 µg 50
Recombinant Human Peroxiredoxin-2 20 µg 130
1 mg 3,000

PRDX3 enz-419 5 µg 50
Recombinant Human Peroxiredoxin-3 20 µg 130
1 mg 3,600

PRDX4 enz-513 5 µg 50
Recombinant Human Peroxiredoxin-4 25 µg 130
1 mg 2,250

PRDX5 enz-426 5 µg 50
Recombinant Human Peroxiredoxin-5 20 µg 130
1 mg 2,700

PRDX6 enz-432 5 µg 50
Recombinant Human Peroxiredoxin-6 20 µg 130
1 mg 2,700

PRmT1 enz-364 10 µg 50
Recombinant Human Protein Arginine Methyltransferase 1 50 µg 130
1 mg 1,800

mPRmT1 enz-365 10 µg 50
PEPTIDES INTERNATIONAL

Recombinant Mouse Protein Arginine Methyltransferase 1 50 µg 130

1 mg 1,800

Promatrilysin enz-272 5 µg 50
Recombinant Promatrix MetalloProteinase-7 20 µg 130
1 mg 5,200

PrommP 9 enz-439 2 µg 50
Recombinant Human Promatrix MetalloProteinase-9 10 µg 130
1 mg 4,800

Protease enz-354 50IU 50

Recombinant Protease 150IU 130
1,000IU 400

PRSS3 enz-735 5 µg 50
Recombinant Human Protease Serine 3 20 µg 130
1 mg 2,700

PRTFDC1 enz-142 5 µg 50
Recombinant Human Phosphoribosyl Transferase Domain 20 µg 130
Containing 1 1 mg 2,700

PRTN3 enz-075 2 µg 50
Human Proteinase-3 10 µg 130
1 mg 5,200

566 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
PSAT1 enz-209 5 µg 50
Recombinant Human Phosphoserine Aminotransferase 1 20 µg 130
1 mg 2,700

PSmA1 enz-178 5 µg 50
Recombinant Human Proteasome Subunit Α Type 1 20 µg 130
1 mg 2,700

PSmA2 enz-175 5 µg 50
Recombinant Human Proteasome Subunit Α Type 2 20 µg 130
1 mg 2,700

PSmA3 enz-196 5 µg 50
Recombinant Human Proteasome Subunit Α Type 3 20 µg 130
1 mg 2,700

PSmA4 enz-222 5 µg 50
Recombinant Human Proteasome Subunit Α Type 4 20 µg 130
1 mg 2,700

PSmA5 enz-213 1 µg 50
Recombinant Human Proteasome Subunit Α type 5 5 µg 130
50 µg 1,100

PSmA6 enz-198 2 µg 50
Recombinant Human Proteasome Subunit Α Type 6 10 µg 130
1 mg 5,200

PSmA7 enz-403 10 µg 50

PEPTIDES INTERNATIONAL
Recombinant Human Proteasome Subunit Α Type 7 50 µg 130
1 mg 1,800

PSmA8 enz-203 2 µg 50
Recombinant Human Proteasome Subunit Α Type 8 10 µg 130
1 mg 5,200

PSmB1 enz-405 2 µg 50
Recombinant Human Proteasome Subunit Β Type 1 10 µg 130
1 mg 5,200

PSmB2 enz-204 2 µg 50
Recombinant Human Proteasome Subunit Β Type 2 10 µg 130
1 mg 5,200

PSmB3 enz-200 5 µg 50
Recombinant Human Proteasome Subunit Β Type 3 20 µg 130
1 mg 3,600

PSmB4 enz-197 2 µg 50
Recombinant Human Proteasome Subunit Β Type 4 10 µg 130
1 mg 5,200

PSmB5 enz-050 2 µg 50
Recombinant Human Proteasome Subunit Β Type 5 10 µg 130
1 mg 5,200

Order Hotline 1-800-777-4779 502-266-8787 567

 Recombinant proteins

PSmB6 enz-223 2 µg 50
Recombinant Human Proteasome Subunit Β Type 6 10 µg 130
1 mg 5,200

PSmB7 enz-577 1 µg 50
Recombinant Human Proteasome Subunit Β Type 7 5 µg 130
50 µg 1,100

PSmB8 enz-670 5 µg 50
Recombinant Human Proteasome Subunit Β Type 8 20 µg 130
1 mg 2,700

PSmB9 enz-105 2 µg 50
Recombinant Human Proteasome Subunit Β Type 9 10 µg 130
1 mg 5,200

PSmD10 enz-404 5 µg 50
Recombinant Human Gankyrin 25 µg 130
1 mg 2,700

PSmD9 enz-666 5 µg 50
Recombinant Human Proteasome 26S Subunit, Non-ATPase 9 20 µg 130
1 mg 2,700

PSmF1 enz-224 5 µg 50
Recombinant Human Proteasome Inhibitor Subunit 1 20 µg 130
1 mg 3,600

PTGDS enz-109 2 µg 50
PEPTIDES INTERNATIONAL

Recombinant Human Prostaglandin D2 Synthase 10 µg 130

1 mg 5,200

PTGES2 enz-136 5 µg 50
Recombinant Human Prostaglandin E Synthase 2 20 µg 130
1 mg 2,700

PTGES3 enz-458 5 µg 50
Recombinant Human Prostaglandin E Synthase 3 20 µg 130
1 mg 3,600

PTGR1 enz-633 5 µg 50
Recombinant Human Prostaglandin Reductase 1 20 µg 130
1 mg 2,700

PTGR2 enz-601 2 µg 50
Recombinant Human Prostaglandin Reductase 2 10 µg 130
1 mg 5,200

PTP4A1 enz-052 5 µg 50
Recombinant Human Protein Tyrosine Phosphatase Type IVA 20 µg 130
Member 1 1 mg 2,700

PTP4A2 enz-558 5 µg 50
Recombinant Human Protein Tyrosine Phosphatase Type IVA 20 µg 130
Member 3 1 mg 5,200

568 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
PTP4A3 enz-450 10 µg 50
Recombinant Human Protein Tyrosine Phosphatase Type IVA 50 µg 130
Member 3 1 mg 1,800

PTPmT1 enz-225 5 µg 50
Recombinant Human Protein Tyrosine Phosphatase, 20 µg 130
Mitochondrial 1 1 mg 3,600

PTPS enz-471 5 µg 50
Recombinant Human 6-Pyruvoyltetrahydropterin Synthase 25 µg 130
1 mg 2,250

PTRH2 enz-045 5 µg 50
Recombinant Human Peptidyl-tRNA Hydrolase 2 20 µg 130
1 mg 3,600

PYCR1 enz-035 2 µg 50
Recombinant Human Pyrroline-5-Carboxylate Reductase 1 10 µg 130
1 mg 5,200

PYCRL enz-678 2 µg 50
Recombinant Human Pyrroline-5-Carboxylate Reductase Like 10 µg 130
1 mg 5,200

QDPR enz-163 5 µg 50
Recombinant Human Quinoid Dihydropteridine Reductase 20 µg 130
1 mg 3,600

PEPTIDES INTERNATIONAL
QPRT enz-559 5 µg 50
Recombinant Human Quinolinate Phosphoribosyltransferase 20 µg 130
1 mg 2,700

RDH12 enz-233 2 µg 50
Recombinant Human Retinol Dehydrogenase 12 10 µg 130
1 mg 5,200

REXO2 enz-715 5 µg 50
Recombinant Human RNA Exonuclease 2 20 µg 130
1 mg 2,700

Rhodanese enz-459 5 µg 50
Recombinant Human Thiosulfate Sulfurtransferase 20 µg 130
1 mg 3,600

rmmP 9 enz-121 2 µg 50
Recombinant Rabbit Matrix MetalloProteinase-9 10 µg 130
100 µg 1,000

RNASE3 enz-668 5 µg 50
Recombinant Human Ribonuclease 3 20 µg 130
1 mg 2,700

RNASEH1 enz-164 5 µg 50
Recombinant E.Coli Ribonuclease H1 20 µg 130
1 mg 2,700

Order Hotline 1-800-777-4779 502-266-8787 569

 Recombinant proteins

RNASEH2A enz-713 5 µg 50
Recombinant E.Coli Ribonuclease H2A 20 µg 130
1 mg 3,600

RNASE7 enz-704 2 µg 50
Recombinant Human Ribonuclease 7 10 µg 130
1 mg 5,200

RNLS enz-653 5 µg 50
Recombinant Human Renalase 20 µg 130
1 mg 2,700

RNmT enz-114 2 µg 50
Recombinant Human RNA (guanine-7-) Methyltransferase 10 µg 130
1 mg 5,200

RPE enz-584 5 µg 50
Recombinant Human Ribulose-5-Phosphate-3-Epimerase 20 µg 130
1 mg 2,700

RPIA enz-228 2 µg 50
Recombinant Human Ribose 5-Phosphate Isomerase A 10 µg 130
1 mg 5,200

RPL12 enz-693 2 µg 50
Recombinant Human Ribosomal Protein L12 10 µg 130
1 mg 5,200

RPN2 enz-349 5 µg 50
PEPTIDES INTERNATIONAL

Recombinant Human Ribophorin II 20 µg 130

1 mg 3,600

RPP30 enz-040 5 µg 50
Recombinant Human Ribonuclease P/mRP 30kDa Subunit 20 µg 130
1 mg 2,700

RRm2 enz-523 5 µg 50
Recombinant Human Ribonucleotide Reductase M2 25 µg 130
1 mg 2,250

SAE1 enz-534 2 µg 50
Recombinant Human SUmO1 Activating Enzyme Subunit 1 10 µg 130
1 mg 5,200

SARS enz-229 2 µg 50
Recombinant Human Seryl-tRNA Synthetase 10 µg 130
1 mg 5,200

SAT1 enz-433 5 µg 50
Recombinant Human Spermidine/Spermine N1- 20 µg 130
Acetyltransferase 1 1 mg 3,000

SAT2 enz-587 5 µg 50
Recombinant Human Spermidine/Spermine N1- 20 µg 130
Acetyltransferase 2 1 mg 2,700

570 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
SDSL enz-180 2 µg 50
Recombinant Human Serine Dehydratase-Like 10 µg 130
1 mg 5,200

SENP8 enz-146 5 µg 50
Recombinant Human Sentrin Specific Peptidase Family 20 µg 130
Member 8 1 mg 2,700

Seprase enz-465 2 µg 175

Recombinant Human Fibroblast Activation Protein Α 5 µg 270
10 µg 490

SEPSECS enz-033 5 µg 50
Recombinant Human Selenocysteinyl-tRNA(Sec) synthase 20 µg 130
1 mg 2,700

SERPINE1 enz-356 2 µg 50
Human Plasminogen Activator Inhibitor-1 10 µg 130
1 mg 3,600

SERPINE1 enz-357 5 µg 50
Recombinant Human Plasminogen Activator Inhibitor-1 25 µg 130
1 mg 3,000

SETD7 enz-314 20 µg 50
Recombinant Human Set7/9 Histone Methyltransferase 100 µg 130
1 mg 1,000

SHmT1 enz-199

PEPTIDES INTERNATIONAL
5 µg 50
Recombinant Human Serine Hydroxymethyltransferase 1 20 µg 130
1 mg 2,700

SIAH1 enz-640 2 µg 50
Recombinant Human Siah E3 Ubiquitin Protein Ligase 1 10 µg 130
1 mg 5,200

SlyD E.Coli enz-338 5 µg 50

Recombinant E.Coli KBP-Type Peptidyl-Prolyl Cis-Trans 20 µg 130
Isomerase 1 mg 2,700

SmS enz-230 2 µg 50
Recombinant Human Spermine Synthase 10 µg 130
1 mg 5,200

SmUG1 enz-674 5 µg 50
Recombinant Human Single-Strand-Selective Monofunctional 20 µg 130
Uracil-DNA Glycosylase 1 1 mg 2,700

SORD enz-520 5 µg 50
Recombinant Human Sorbitol Dehydrogenase 25 µg 130
1 mg 2,250

SPINK1 enz-724 5 µg 50
Recombinant Human Serine Peptidase Inhibitor Kazal Type 1 20 µg 130
1 mg 3,600

Order Hotline 1-800-777-4779 502-266-8787 571

 Recombinant proteins

SPR enz-411 5 µg 50
Recombinant Human Sepiapterin Reductase 20 µg 130
1 mg 2,700

SRm enz-027 5 µg 50
Recombinant Human Spermidine Synthase 20 µg 130
1 mg 2,700

SRR enz-232 1 µg 50
Recombinant Human Serine Racemase 5 µg 130
50 µg 1,100

SSU72 enz-243 5 µg 50
Recombinant Human SSU72 RNA Polymerase II CTD 20 µg 130
Phosphatase 1 mg 2,700

Staphylokinase enz-288 20 µg 50
Recombinant Staphylokinase 100 µg 130
1 mg 715

Streptokinase enz-315 250,000IU 210

Recombinant Streptokinase 750,000IU 400
1.5 mIU 725

STYX enz-585 2 µg 50
Recombinant Human Serine/Threonine/Tyrosine Interacting 10 µg 130
Protein 1 mg 5,200
PEPTIDES INTERNATIONAL

STYX (26-223) enz-590 1 µg 50

Recombinant Human Serine/Threonine/Tyrosine Interacting 5 µg 130
Protein (26-223 a.a.) 50 µg 1,100

SULT1A2 enz-152 5 µg 50
Recombinant Human Sulfotransferase Family, Cytosolic, 1A, 20 µg 130
Member 2 1 mg 2,700

SULT1B1 enz-610 5 µg 50
Recombinant Human Sulfotransferase Family, Cytosolic, 1B, 20 µg 130
Member 1 1 mg 2,700

SULT1C2 enz-047 5 µg 50
Recombinant Human Sulfotransferase Family, Cytosolic 1C, 25 µg 130
Member 2 1 mg 2,700

SULT1C4 enz-710 5 µg 50
Recombinant Human Sulfotransferase Family, Cytosolic 1C, 25 µg 130
Member 4 1 mg 2,700

SULT1E1 enz-409 5 µg 50
Recombinant Human Estrogen Sulfotransferase 25 µg 130
1 mg 2,700

SULT2A1 enz-141 5 µg 50
Recombinant Human Sulfotransferase Family, Cytosolic, 2A, 20 µg 130
Member 1 1 mg 2,700

572 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
SULT2B1 enz-512 5 µg 50
Recombinant Human Sulfotransferase Family, Cytosolic, 2B, 25 µg 130
Member 1 1 mg 2,250

SURA enz-257 5 µg 50
Recombinant E.Coli Chaperone SURA 20 µg 130
1 mg 2,700

T4 DNA enz-286 20,000IU 65

Recombinant T4 DNA Ligase 100,000IU 255
500,000IU 990

TAF9 enz-065 5 µg 50
Recombinant Human TAF9 RNA Polymerase II 20 µg 130
1 mg 2,700

TAF10 enz-750 2 µg 50
Recombinant Human TAF10 RNA Polymerase II 10 µg 130
1 mg 5,200

TALDO1 enz-255 5 µg 50
Recombinant Human Transaldolase 25 µg 130
1 mg 2,700

Taq Plus DNA enz-309 250U 50

Recombinant Taq Plus DNA Polymerase 750U 130
2,500U 350

TaqDNA enz-308 1,000U 50

PEPTIDES INTERNATIONAL
Recombinant Taq DNA Polymerase 3,000U 130
10,000U 350

TARS enz-571 2 µg 50
Recombinant Human Threonyl-tRNA Synthetase 10 µg 130
1 mg 5,200

TATDN3 enz-611 5 µg 50
Recombinant Human TatD DNase Domain Containing 3 20 µg 130
1 mg 3,600

TDG enz-649 5 µg 50
Recombinant Human Thymine-DNA Glycosylase 20 µg 130
1 mg 2,700

TDO2 enz-081 1 µg 50
Recombinant Human Tryptophan 2,3-Dioxygenase 5 µg 130
50 µg 1,200

TDP1 enz-685 5 µg 50
Recombinant Human Tyrosyl-DNA Phosphodiesterase 1 20 µg 130
1 mg 2,700

TDP2 enz-698 2 µg 50
Recombinant Human Tyrosyl-DNA Phosphodiesterase 2 10 µg 130
1 mg 5,200

Order Hotline 1-800-777-4779 502-266-8787 573

 Recombinant proteins

TGm2 enz-394 5 µg 50
Recombinant Human Tissue Transglutaminase 20 µg 130
1 mg 3,500

TGm2 Sf9 enz-303 5 µg 50

Recombinant Human Tissue Transglutaminase, Sf9 20 µg 130
1 mg 4,500

THG1L enz-639 2 µg 50
Recombinant Human tRNA-Histidine Guanylyltransferase 10 µg 130
1-Like 100 µg 1,200

THTPA enz-249 5 µg 50
Recombinant Human Thiamine Triphosphatase 25 µg 130
1 mg 2,700

TImP1 enz-442 2 µg 50
Recombinant Human Tissue Inhibitor of Metalloprotease 1 10 µg 130
1 mg 4,680

TImP1 HEK enz-508 2 µg 50

Recombinant Human Tissue Inhibitor of Metalloprotease 1, 10 µg 130
HEK 1 mg 4,680

TImP2 enz-646 5 µg 50
Recombinant Human Tissue Inhibitor of Metalloprotease 2 20 µg 130
1 mg 2,700

TImP2 HEK
PEPTIDES INTERNATIONAL

enz-120 2 µg 50
Recombinant Human Tissue Inhibitor of Metalloprotease 2, 10 µg 130
HEK 1 mg 4,680

TKT enz-588 2 µg 50
Recombinant Human Transketolase 10 µg 130
1 mg 5,200

TOP1 enz-306 5 µg 50
Recombinant Human DNA Topoisomerase-I 20 µg 130
1 mg 3,900

TOP1 70kDa enz-073 5 µg 50

Recombinant Human DNA Topoisomerase-I 70kDa 20 µg 130
1 mg 3,900

TP53I3 enz-519 5 µg 50
Recombinant Human Tumor Protein p53 Inducible Protein 3 25 µg 130
1 mg 2,250

tPA enz-263 20 µg 50
Recombinant Human Tissue Plasminogen Activator 100 µg 175
1 mg 1,050

TPI1 enz-017 5 µg 50
Recombinant Human Triosephosphate Isomerase 1 25 µg 130
1 mg 2,700

574 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
TPO enz-285 5 µg 50
Recombinant Human Thyroid Peroxidase 20 µg 130
1 mg 4,900

TPSAB1 enz-652 2 µg 50
Recombinant Human Tryptase Α/Β 1 10 µg 130
1 mg 5,200

TPST2 enz-707 2 µg 50
Recombinant Human TyrosylProtein Sulfotransferase 2 10 µg 130
1 mg 5,200

TPX enz-135 5 µg 50
Recombinant E.Coli Thiol Peroxidase 20 µg 130
1 mg 2,700

TRDmT1 enz-599 2 µg 50
Recombinant Human tRNA Aspartic Acid Methyltransferase 1 10 µg 130
1 mg 5,200

TREX2 enz-095 5 µg 50
Recombinant Human Three Prime Repair Exonuclease 2 25 µg 130
1 mg 2,700

TRPT1 enz-208 2 µg 50
Recombinant Human tRNA Phosphotransferase 1 10 µg 130
1 mg 5,200

TRXR enz-507 5 µg 50

PEPTIDES INTERNATIONAL
Recombinant E.Coli Thioredoxin Reductase 25 µg 130
1 mg 2,250

TRXR enz-278 5 µg 50
Recombinant Yeast Thioredoxin Reductase 20 µg 130
1 mg 3,200

TSTA3 enz-259 5 µg 50
Recombinant Human Tissue Specific Transplantation Antigen 25 µg 130
P35B 1 mg 2,700

TSTD1 enz-094 2 µg 50
Recombinant Human Thiosulfate Sulfurtransferase Like 10 µg 130
Domain Containing 1 1 mg 5,200

TSTD3 enz-723 5 µg 50
Recombinant Human Thiosulfate Sulfurtransferase Like 20 µg 130
Domain Containing 3 1 mg 3,600

TXNRD1 enz-518 5 µg 50
Recombinant Human Thioredoxin Reductase 1 25 µg 130
1 mg 2,250

TXNRD1 161-649 enz-042 2 µg 50

Recombinant Human Thioredoxin Reductase 1 161-649 a.a. 10 µg 130
1 mg 5,200

Order Hotline 1-800-777-4779 502-266-8787 575

 Recombinant proteins

TXNRD3NB enz-753 2 µg 50
Recombinant Human Thioredoxin Reductase 3 Neighbor 10 µg 130
0.1 mg 1,200

TYmP enz-005 5 µg 50
Recombinant Human Thymidine Phosphorylase 20 µg 130
1 mg 3,600

TYmS enz-470 5 µg 50
Recombinant Human Thymidylate Synthetase 25 µg 130
1 mg 2,250

UBA3 enz-576 5 µg 50
Recombinant Human Ubiquitin-Like Modifier Activating 20 µg 130
Enzyme 3 1 mg 2,700

UBA5 enz-602 2 µg 50
Recombinant Human Ubiquitin-Like Modifier Activating 10 µg 130
Enzyme 5 1 mg 5,200

UBE2A enz-514 5 µg 50
Recombinant Human Ubiquitin Conjugating Enzyme E2A 25 µg 130
1 mg 2,250

UBE2B enz-340 2 µg 50
Recombinant Human Ubiquitin Conjugating Enzyme E2B 10 µg 130
1 mg 5,200

UBE2C enz-346
PEPTIDES INTERNATIONAL

5 µg 50
Recombinant Human Ubiquitin Conjugating Enzyme E2C 20 µg 130
mg 2,700

UBE2D1 enz-116 5 µg 50
Recombinant Human Ubiquitin Conjugating Enzyme E2D1 20 µg 130
1 mg 2,700

UBE2D2 enz-154 5 µg 50
Recombinant Human Ubiquitin Conjugating Enzyme E2D2 20 µg 130
1 mg 2,700

UBE2D3 enz-343 2 µg 50
Recombinant Human Ubiquitin Conjugating Enzyme E2D3 10 µg 130
1 mg 5,200

UBE2D4 enz-179 5 µg 50
Recombinant Human Ubiquitin Conjugating Enzyme E2D4 20 µg 130
1 mg 2,700

UBE2E1 enz-647 5 µg 50
Recombinant Human Ubiquitin Conjugating Enzyme E2E1 20 µg 130
1 mg 2,700

UBE2F enz-625 5 µg 50
Recombinant Human Ubiquitin-Conjugating Enzyme E2F 20 µg 130
1 mg 2,700

576 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
UBE2H enz-603 5 µg 50
Recombinant Human Ubiquitin-Conjugating Enzyme E2H 20 µg 130
1 mg 2,700

UBE2I enz-341 10 µg 50
Recombinant Human Ubiquitin-Conjugating Enzyme E2I 50 µg 130
1 mg 1,800

UBE2I His enz-274 10 µg 50

Recombinant Human Ubiquitin-Conjugating Enzyme E2I , His 50 µg 130
tag mg 1,950

UBE2J2 enz-626 5 µg 50
Recombinant Human Ubiquitin-Conjugating Enzyme E2, J2 20 µg 130
1 mg 2,700

UBE2K enz-339 2 µg 50
Recombinant Human Ubiquitin-Conjugating Enzyme E2K 10 µg 130
1 mg 5,200

UBE2L3 enz-342 10 µg 50
Recombinant Human Ubiquitin-Conjugating Enzyme E2L 3 50 µg 130
1 mg 1,800

UBE2L3 His enz-344 10 µg 50

Recombinant Human Ubiquitin-Conjugating Enzyme E2L 3, 50 µg 130
His Tag mg 1,950

PEPTIDES INTERNATIONAL
UBE2L6 enz-347 5 µg 50
Recombinant Human Ubiquitin Conjugating Enzyme E2L 6 25 µg 130
1 mg 3,600

UBE2m enz-345 5 µg 50
Recombinant Human Ubiquitin Conjugating Enzyme E2m 20 µg 130
mg 2,700

UBE2N enz-104 5 µg 50
Recombinant Human Ubiquitin Conjugating Enzyme E2N 20 µg 130
1 mg 2,700

UBE2R2 enz-511 2 µg 50
Recombinant Human Ubiquitin Conjugating Enzyme E2R 2 10 µg 130
1 mg 5,200

UBE2S enz-444 10 µg 50
Recombinant Human Ubiquitin Conjugating Enzyme E2S 50 µg 130
1 mg 1,800

UBE2T enz-506 5 µg 50
Recombinant Human Ubiquitin Conjugating Enzyme E2T 25 µg 130
1 mg 2,250

UBE2V2 enz-550 5 µg 50
Recombinant Human Ubiquitin-Conjugating Enzyme E2 Variant 20 µg 130
2 1 mg 2,700

Order Hotline 1-800-777-4779 502-266-8787 577

 Recombinant proteins

UBE2W enz-117 5 µg 50
Recombinant Human Ubiquitin Conjugating Enzyme E2W 20 µg 130
1 mg 2,700

UCHL3 enz-057 5 µg 50
Recombinant Human Ubiquitin Carboxyl-Terminal Esterase L3 20 µg 130
1 mg 2,700

UCHL5 enz-097 5 µg 50
Recombinant Human Ubiquitin Carboxyl-Terminal Esterase L5 20 µg 130
1 mg 2,700

UFC1 enz-138 5 µg 50
Recombinant Human Ubiquitin Fold Modifier Conjugating 20 µg 130
Enzyme 1 1 mg 2,700

UGDH enz-535 2 µg 50
Recombinant Human UDP-Glucose Dehydrogenase 10 µg 130
1 mg 5,200

UmOD enz-381 2 µg 50
Human Uromodulin 10 µg 130
1 mg 5,200

cUmOD enz-334 2 µg 50
Canine Uromodulin 10 µg 130
1 mg 5,200

fUmOD enz-732 2 µg 50
PEPTIDES INTERNATIONAL

Feline Uromodulin 10 µg 130

0.1 mg 1,200

pUmOD enz-733 2 µg 50
Porcine Uromodulin 10 µg 130
1 mg 5,200

UmPS enz-663 5 µg 50
Recombinant Human Uridine Monophosphate Synthetase 20 µg 130
1 mg 2,700

UNG enz-352 2,000U 200

Uracil DNA Glycosylase 10,000U 800
20,000U 1,400

UNG enz-752 2 µg 50
Recombinant E.Coli Uracil DNA Glycosylase 10 µg 130
1 mg 5,200

UPP1 enz-560 2 µg 50
Recombinant Human Typhimurium Uridine phosphorylase 10 µg 130
1 mg 5,200

UPP1 enz-348 10 µg 50
Recombinant Salmonella Typhimurium Uridine phosphorylase 50 µg 130
1 mg 1,400

578 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
UPP1 enz-258 5 µg 50
Recombinant E.Coli Uridine phosphorylase 25 µg 130
1 mg 2,700

UPRT enz-742 2 µg 50
Recombinant Human Uracil Phosphoribosyltransferase 10 µg 130
1 mg 5,200

UQCRQ enz-746 2 µg 50
Recombinant Human Ubiquinol-Cytochrome C Reductase 10 µg 130
1 mg 5,200

Urease enz-277 1 mg 50
Recombinant Urease 5 mg 130
50 mg 980

Uricase enz-312 100 µg 50

Recombinant Urate Oxidase 0.5 mg 130
1 mg 215

UROD enz-536 5 µg 50
Recombinant Human Uroporphyrinogen Decarboxylase 25 µg 130
1 mg 2,250

Urokinase enz-264 100 µg 56

Human Urokinase 1 mg 112
5 mg 500

UROS enz-140 5 µg 50

PEPTIDES INTERNATIONAL
Recombinant Human Uroporphyrinogen III Synthase 25 µg 130
1 mg 2,700

WARS enz-545 5 µg 50
Recombinant Human Tryptophanyl-tRNA Synthetase 25 µg 130
1 mg 2,700

WWOX enz-422 2 µg 50
Recombinant Human WW Domain Containing Oxidoreductase 10 µg 130
1 mg 5,200

YARS enz-134 2 µg 50
Recombinant Human Tyrosyl-tRNA Synthetase 10 µg 130
1 mg 5,200

YARS2 enz-614 2 µg 50
Recombinant Human Tyrosyl-tRNA Synthetase 2 10 µg 130
100 µg 1,200

YOD1 enz-696 2 µg 50
Recombinant Human YOD1 10 µg 130
100 µg 1,200

Protein Kinases
ADK pka-367 2 µg 50
Recombinant Human Adenosine Kinase 10 µg 130
1 mg 5,200

Order Hotline 1-800-777-4779 502-266-8787 579

 Recombinant proteins

AK1 pka-316 5 µg 50
Recombinant Human Adenylate Kinase 1 25 µg 130
1 mg 2,700

AK2 pka-260 2 µg 50
Recombinant Human Adenylate Kinase 2 10 µg 130
1 mg 4,500

AK3L1 pka-346 5 µg 50
Recombinant Human Adenylate Kinase 3 Like 1 20 µg 130
1 mg 3,600

AK4 pka-267 5 µg 50
Recombinant Human Adenylate Kinase 4 20 µg 130
1 mg 2,700

AK5 pka-011 2 µg 50
Recombinant Human Adenylate Kinase 5 10 µg 130
1 mg 5,200

AKAP7 pka-030 2 µg 50
Recombinant Human A Kinase Anchor Protein 7 10 µg 130
1 mg 5,200

ATF1 pka-019 2 µg 50
Recombinant Human Activating Transcription Factor-1 10 µg 130
1 mg 5,200

ATF3 pka-270 5 µg 50
PEPTIDES INTERNATIONAL

Recombinant Human Activating Transcription Factor-3 20 µg 130

1 mg 2,700

ATF4 pka-006 2 µg 50
Recombinant Human Activating Transcription Factor-4 10 µg 130
1 mg 5,200

AURKA pka-350 2 µg 50
Recombinant Human Aurora Kinase A 10 µg 130
1 mg 5,200

AURKB pka-355 2 µg 50
Recombinant Human Aurora Kinase B 10 µg 130
1 mg 5,200

BLK pka-271 2 µg 50
Recombinant Human B lymphoid tyrosine kinase 10 µg 130
1 mg 5,200

bP85a pka-328 2 µg 150

Recombinant bovine Phosphoinositide 3-kinase a, regulatory 10 µg 400
subunit 20 µg 700

bPI3Ka pka-327 1 µg 130

Recombinant bovine Phosphoinositide 3-kinase α p110a/p85a 2.5 µg 250
5 µg 450

580 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
CAmK4 pka-021 2 µg 50
Recombinant Human Calcium/Calmodulin-Dependent Protein 10 µg 130
Kinase IV 1 mg 5,200

CCNA2 pka-033 5 µg 50
Recombinant Human Cyclin-A2 20 µg 130
1 mg 2,700

CCNB1 pka-037 2 µg 50
Recombinant Human Cyclin-B1 10 µg 130
100 µg 1,200

CCNB2 pka-035 2 µg 50
Recombinant Human Cyclin-B2 10 µg 130
1 mg 5,200

CCNH pka-364 5 µg 50
Recombinant Human Cyclin-H 25 µg 130
1 mg 2,250

CCNI pka-318 5 µg 50
Recombinant Human Cyclin-I 20 µg 130
1 mg 2,700

CDK2 pka-008 2 µg 50
Recombinant Human cyclin-dependent kinase 2 10 µg 130
1 mg 5,200

CDK2AP1 pka-362

PEPTIDES INTERNATIONAL
5 µg 50
Recombinant Human Cyclin-Dependent Kinase 2 Associated 25 µg 130
Protein 1 1 mg 2,250

CDK2AP2 pka-048 5 µg 50
Recombinant Human Cyclin-Dependent Kinase 2 Associated 20 µg 130
Protein 2 1 mg 2,700

CDK3 pka-055 2 µg 50
Recombinant Human cyclin-dependent kinase 3 10 µg 130
1 mg 5,200

CDK4 pka-325 2 µg 50
Recombinant Human cyclin-dependent kinase 4 10 µg 130
1 mg 4,800

CDK5 pka-047 5 µg 50
Recombinant Human cyclin-dependent kinase 5 20 µg 130
1 mg 2,700

CDKN1A pka-043 2 µg 50
Recombinant Human Cyclin-Dependent Kinase Inhibitor 1A 10 µg 130
100 µg 1,200

CDKN1B pka-012 5 µg 50
Recombinant Human Cyclin-Dependent Kinase Inhibitor 1B 20 µg 130
1 mg 2,700

Order Hotline 1-800-777-4779 502-266-8787 581

 Recombinant proteins

CDKN2C pka-020 5 µg 50
Recombinant Human Cyclin-Dependent Kinase Inhibitor 2C 20 µg 130
1 mg 2,700

CDKN3 pka-336 5 µg 50
Recombinant Human Cyclin-Dependent Kinase Inhibitor 3 20 µg 130
1 mg 3,600

c-erbB-2 pka-340 2 µg 175

Recombinant Human C-erbB2 5 µg 270
10 µg 490

CIB1 pka-345 5 µg 50
Recombinant Human Calcium and Integrin Binding 1 25 µg 130
1 mg 2,700

CIB2 pka-268 5 µg 50
Recombinant Human Calcium and Integrin Binding 2 25 µg 130
1 mg 2,700

CINP pka-269 5 µg 50
Recombinant Human Cyclin-Dependent Kinase 2 Interacting 20 µg 130
Protein 1 mg 2,700

C-JUN pka-323 2 µg 50
Recombinant Human Jun Proto-Oncogene 10 µg 130
1 mg 4,800

C-JUN (241 a.a.) pka-001

PEPTIDES INTERNATIONAL

1 µg 50
Recombinant Human Jun Proto-Oncogene (1-241 a.a.) 5 µg 130
50 µg 1,200

CK2b pka-223 2 µg 50
Recombinant Human Casein Kinase 2 β 10 µg 130
1 mg 5,200

CK2b Active pka-209 3 µg 400

Recombinant Human Casein Kinase 2 β Active 10 µg 800
20 µg 1,500

CK2h pka-211 3 µg 400

Recombinant Human Casein Kinase 2 Holoenzyme 10 µg 800
20 µg 1,500

CKB cki-268 10 µg 50
Recombinant Human Creatine Kinase Brain 50 µg 130
1 mg 945

CKB His cki-274 5 µg 50

Recombinant Human Creatine Kinase Brain, His Tag 20 µg 130
1 mg 2,700

CKm cki-273 200 µg 200

Human Creatine Kinase Muscle 1 mg 600
10 mg 4,750

582 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
CKm Type-1 cki-271 10 µg 50
Recombinant Human Creatine Kinase Muscle Type-1 50 µg 130
1 mg 945

CKm Type-3 cki-272 10 µg 50

Recombinant Human Creatine Kinase Muscle Type-3 50 µg 130
1 mg 945

CKmB Type-1 cki-269 10 µg 50

Recombinant Human Creatine Kinase MB Isoenzyme Type-1 50 µg 130
1 mg 945

CKmB Type-2 cki-270 10 µg 50

Recombinant Human Creatine Kinase MB Isoenzyme Type-2 50 µg 130
1 mg 945

CKmT1A cki-275 5 µg 50
Recombinant Human Creatine Kinase, Mitochondrial 1A 20 µg 130
1 mg 2,700

CKmT2 cki-276 5 µg 50
Recombinant Human Creatine Kinase, Mitochondrial 2 20 µg 130
1 mg 2,700

CKS2 pka-258 5 µg 50
Recombinant Human CDC28 Protein kinase 2 25 µg 130
1 mg 2,700

CmPK1 pka-002 5 µg 50

PEPTIDES INTERNATIONAL
Recombinant Human Cytidine Monophosphate Kinase 1 20 µg 130
1 mg 3,600

COAA pka-022 5 µg 50
Recombinant E.Coli Pantothenate Kinase 20 µg 130
1 mg 2,700

CSNK1A1 pka-056 5 µg 50
Recombinant Human Casein Kinase 1 α 1 20 µg 130
1 mg 2,700

CSNK2A1 pka-208 3 µg 400

Recombinant Human Casein Kinase 2 α 1 10 µg 800
20 µg 1,500

CSNK2A1 His pka-225 2 µg 50

Recombinant Human Protein kinase Casein Kinase 2 α 1, His 10 µg 130
Tag 1 mg 5,200

CSNK2A2 pka-042 2 µg 50
Recombinant Human Casein Kinase 2, Α 2 Prime 10 µg 130
1 mg 5,200

DCK pka-313 5 µg 50
Recombinant Human Deoxycytidine Kinase 20 µg 130
1 mg 3,600

Order Hotline 1-800-777-4779 502-266-8787 583

 Recombinant proteins

DTYmK pka-005 5 µg 50
Recombinant Human Deoxythymidylate Kinase 20 µg 130
1 mg 2,700

EGFR Sf9 pka-344 2 µg 50

Recombinant Human Epidermal Growth Factor Receptor-Sf9 10 µg 130
(ErbB1) 100 µg 700

EGFR Sf9 pka-335 1 µg 50

Recombinant Human Epidermal Growth Factor Receptor-Sf9 5 µg 130
(ErbB1), Active 50 µg 1,100

ELK-1 pka-309 2 µg 50
Recombinant Human ELK-1 10 µg 130
1 mg 4,800

ErbB2 pka-343 5 µg 50
Recombinant Human Tyrosine Kinase ErbB-2 20 µg 130
1 mg 4,300

ErbB3 pka-342 5 µg 50
Recombinant Human Tyrosine Kinase ErbB-3 20 µg 130
1 mg 3,600

FGFR1 pka-230 2 µg 50
Recombinant Human Fibroblast Growth Factor Receptor-1 10 µg 130
1 mg 5,200

FGFR1OP
PEPTIDES INTERNATIONAL

pka-031 2 µg 50
Recombinant Human FGFR1 Oncogene Partner 10 µg 130
1 mg 5,200

FGFR2 pka-231 2 µg 50
Recombinant Human Fibroblast Growth Factor Receptor-2 10 µg 130
1 mg 5,200

FGFR3 pka-232 2 µg 50
Recombinant Human Fibroblast Growth Factor Receptor-3 10 µg 130
1 mg 5,200

FGFR4 pka-233 2 µg 50
Recombinant Human Fibroblast Growth Factor Receptor-4 10 µg 130
1 mg 5,200

Flavokinase pka-352 5 µg 50
Recombinant Human Riboflavin Kinase 20 µg 130
1 mg 3,000

FLT1 pka-240 2 µg 50
Recombinant Human Vascular Endothelial Growth Factor 10 µg 130
receptor-1 100 µg 990

FLT1 D3 pka-234 2 µg 50
Recombinant Human Vascular Endothelial Growth Factor 10 µg 130
receptor-1 D1-3 100 µg 990

584 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
FLT1 D3 His pka-338 2 µg 50
Recombinant Human Vascular Endothelial Growth Factor 10 µg 130
receptor-1 D1-3, His Tag 1 mg 3,600

FLT1 D4 pka-235 2 µg 50
Recombinant Human Vascular Endothelial Growth Factor 10 µg 130
receptor-1 D1-4 100 µg 990

FLT1 D5 pka-239 2 µg 50
Recombinant Human Vascular Endothelial Growth Factor 10 µg 130
receptor-1 D1-5 100 µg 990

FLT1 D7 pka-241 2 µg 50
Recombinant Human Vascular Endothelial Growth Factor 10 µg 130
receptor-1 D1-7 1 mg 5,000

FLT1 His pka-354 2 µg 50

Recombinant Human Vascular Endothelial Growth Factor 10 µg 130
receptor-1 His Tag 1 mg 4,800

FLT4 pka-244 2 µg 50
Recombinant Human Vascular Endothelial Growth Factor 10 µg 130
receptor-3 1 mg 5,200

FLT4 Fc pka-245 2 µg 50
Recombinant Human Vascular Endothelial Growth Factor 10 µg 130
1 mg 5,000

PEPTIDES INTERNATIONAL
receptor-3 Fc Chimera

FN3K pka-049 2 µg 50
Recombinant Human Fructosamine 3 Kinase 10 µg 130
1 mg 5,200

FN3KRP pka-051 5 µg 50
Recombinant Human Fructosamine 3 Kinase Related Protein 20 µg 130
1 mg 2,700

GALK1 pka-264 5 µg 50
Recombinant Human Galactokinase 1 20 µg 130
1 mg 3,600

GCK pka-236 2 µg 50
Recombinant Human Hexokinase-4 10 µg 130
1 mg 5,200

GUK1 pka-266 5 µg 50
Recombinant Human Guanylate Kinase 1 20 µg 130
1 mg 2,700

HK-1 pka-226 2 µg 50
Recombinant Human Hexokinase-1 10 µg 130
1 mg 5,200

HK-2 pka-227 2 µg 50
Recombinant Human Hexokinase-2 10 µg 130
1 mg 5,200

Order Hotline 1-800-777-4779 502-266-8787 585

 Recombinant proteins

HK-3 pka-229 2 µg 50
Recombinant Human Hexokinase-3 10 µg 130
1 mg 5,200

IGF-IR pka-237 2 µg 175

Recombinant Human Insulin Like Growth Factor-I Receptor 5 µg 270
10 µg 490

ILK1 pka-353 2 µg 50
Recombinant Human Integrin Linked Kinase 10 µg 130
1 mg 4,800

ITPK1 pka-040 5 µg 50
Recombinant Human Inositol-Tetrakisphosphate 1-Kinase 20 µg 130
1 mg 3,600

JNK2/SAPK1 pka-216 1 µg 50
Recombinant Human JNK2/SAPK1 5 µg 130
200 µg 2,250

Ketohexokinase pka-359 5 µg 50
Recombinant Human Ketohexokinase 25 µg 130
1 mg 2,250

LYVE-1 pka-252 2 µg 175

Recombinant Human Lymphatic Endothelial Hyluronan 5 µg 270
Receptor-1 10 µg 490
PEPTIDES INTERNATIONAL

LYVE-1 (25-235) pka-349 2 µg 50

Recombinant Human Lymphatic Vessel Endothelial Hyaluronic 10 µg 130
Acid Receptor 1 (25-235) 100 µg 1,100

LYVE-1 Sf9 pka-250 2 µg 50

Recombinant Human Lymphatic Vessel Endothelial Hyaluronic 10 µg 130
Acid Receptor 1, Sf9 1 mg 5,200

mLYVE-1 Sf9 pka-251 2 µg 50

Recombinant Mouse Lymphatic Vessel Endothelial Hyaluronic 10 µg 130
Acid Receptor 1, Sf9 1 mg 5,200

mAP2K2 pka-029 1 µg 50
Recombinant Human Mitogen-Activated Protein Kinase Kinase 5 µg 130
2 50 µg 1,200

mAP2K3 pka-004 1 µg 50
Recombinant Human Mitogen-Activated Protein Kinase Kinase 5 µg 130
3 50 µg 1,200

mAPK1 pka-215 2 µg 50
Recombinant Human Mitogen-Activated Protein Kinase 1 10 µg 130
100 µg 1,100

mAPK1 Active pka-214 2 µg 50

Recombinant Human Mitogen-Activated Protein Kinase 1, 10 µg 130
Active 100 µg 1,100

586 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
mAPK1 His pka-360 5 µg 50
Recombinant Human Mitogen-Activated Protein Kinase 1 His 25 µg 130
Tag 1 mg 2,250

mAPK11 pka-013 1 µg 50
Recombinant Human Mitogen-Activated Protein Kinase 11 5 µg 130
50 µg 1,100

mAPK12 pka-015 5 µg 50
Recombinant Human Mitogen-Activated Protein Kinase 12 20 µg 130
1 mg 2,700

mAPK13 pka-273 5 µg 50
Recombinant Human Mitogen-Activated Protein Kinase 13 20 µg 130
1 mg 2,700

mAPK14 pka-014 5 µg 50
Recombinant Human Mitogen-Activated Protein Kinase 14 20 µg 130
1 mg 3,600

mAPK3 pka-213 3 µg 400

Recombinant Human Mitogen-Activated Protein Kinase 3 10 µg 800
20 µg 1,500

mAPK3 Active pka-212 3 µg 400

Recombinant Human Mitogen-Activated Protein Kinase 3, 10 µg 800
Active 20 µg 1,750

PEPTIDES INTERNATIONAL
mAPK3 His pka-265 5 µg 50
Recombinant Human Mitogen-Activated Protein Kinase 3 His 25 µg 130
Tag 1 mg 2,700

mAPK9 pka-039 5 µg 50
Recombinant Human Mitogen-Activated Protein Kinase 9 20 µg 130
1 mg 2,700

mAPKAPK3 pka-045 5 µg 50
Recombinant Human Mitogen-Activated Protein Kinase- 20 µg 130
Activated Protein Kinase 3 1 mg 2,700

mEK1 pka-256 1 µg 50
Recombinant Human Mitogen Activated Kinase Kinase 1 5 µg 130
50 µg 900

mOB1B pka-054 5 µg 50
Recombinant Human MOB Kinase Activator 1B 20 µg 130
1 mg 2,700

mVK pka-052 5 µg 50
Recombinant Human Mevalonate Kinase 20 µg 130
1 mg 2,700

NAGK pka-027 5 µg 50
Recombinant Human N-Acetylglucosamine Kinase 20 µg 130
1 mg 2,700

Order Hotline 1-800-777-4779 502-266-8787 587

 Recombinant proteins

NDK pka-034 5 µg 50
Recombinant E.Coli Nucleoside Diphosphate Kinase 20 µg 130
1 mg 2,700

NEK7 pka-044 5 µg 50
Recombinant Human NImA-related kinase 7 20 µg 130
1 mg 3,600

NmE2 pka-363 5 µg 50
Recombinant Human Non-metastatic Cells 2 25 µg 130
1 mg 2,250

p16-INK4a pka-341 5 µg 50
Recombinant Human Cyclin-Dependent Kinase Inhibitor 2A 20 µg 130
1 mg 3,510

p16-INK4a-TAT pka-337 5 µg 50
Recombinant Human Cyclin-Dependent Kinase Inhibitor 2A 25 µg 130
TAT 1 mg 2,700

p38a/SAPK2a pka-217 1 µg 130

Recombinant Human p38 α/SAPK2 α 5 µg 400
20 µg 1,050

PAK4 pka-259 5 µg 50
Recombinant Human p21 Activated Kinase 4 25 µg 130
1 mg 2,900

PBK pka-024
PEPTIDES INTERNATIONAL

5 µg 50
Recombinant Human PDZ Binding Kinase 20 µg 130
1 mg 3,600

PCK1 pka-018 2 µg 50
Recombinant Human Phosphoenolpyruvate Carboxykinase 1 10 µg 130
1 mg 5,200

PDK1 pka-263 10 µg 50
Recombinant Human Pyruvate Dehydrogenase Kinase Isozyme 50 µg 130
1 1 mg 1,800

PDXK pka-326 2 µg 50
Recombinant Human Pyridoxal Kinase 10 µg 130
1 mg 5,200

PFKm pka-365 5 µg 50
Recombinant Human Phosphofructokinase, Muscle 20 µg 130
1 mg 3,600

PGK1 pka-351 5 µg 50
Recombinant Human Phosphoglycerate Kinase 1 25 µg 130
1 mg 2,700

PGK2 pka-017 2 µg 50
Recombinant Human Phosphoglycerate Kinase 2 10 µg 130
1 mg 5,200

588 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
PI3Kb pka-333 1 µg 130
Recombinant Human Phosphoinositide 3-kinase β P110β/p85a 2.5 µg 250
5ug 450

PI3KdGST pka-330 1 µg 200

Recombinant Human Phosphoinositide 3-kinase p110d/p85a 5 µg 600
10 µg 1,000

PI3KgHis pka-329 1 µg 200

Recombinant Human Phosphoinositide 3-kinase p110g 5 µg 400
10 µg 600

PI3KγD946GST pka-331 1 µg 130

Recombinant Human Phosphoinositide 3-kinase p110g 2.5 µg 250
inactive Mutant 5 µg 450

PINK1 pka-010 5 µg 50
Recombinant Human PTEN Induced Putative Kinase 1 20 µg 130
1 mg 2,700

PIP4K2B pka-053 2 µg 50
Recombinant Human Phosphatidylinositol-5-Phosphate 10 µg 130
4-Kinase, Type II, Β 1 mg 5,200

PKACa2/RIa2 pka-203 1 µg 50
Recombinant Protein Kinase A Inactive holoenzyme type 1 α 3 µg 130
100 µg 3,700

PEPTIDES INTERNATIONAL
PKACa2/RIIa2 pka-205 1 µg 50
Recombinant Protein Kinase A Inactive holoenzyme type 2 α 3 µg 130
100 µg 3,700

PKAkt1/PKBa pka-206 5 µg 390

Recombinant Human Protein Kinase Akt1/PKB α Active 20 µg 900
Enzyme 40 µg 1,900

PKAkt1/PKBa pka-207 5 µg 390

Recombinant Human Protein Kinase Akt1/PKB α Inactive 20 µg 900
Enzyme 40 µg 1,900

PKAR-1a pka-202 5 µg 310

Recombinant Human Protein Kinase A regulatory subunit-1 α 25 µg 890
50 µg 1,530

PKAr-1a pka-204 1 µg 50
Recombinant C-AmP dependant Protein Kinase A regulatory 3 µg 130
subunit 2 α 100 µg 3,700

PKC-a pka-218 2 µg 50
Recombinant Human Protein Kinase C α 10 µg 130
0.1 mg 1,100

PKC-e pka-322 2 µg 50
Recombinant Human Protein Kinase C e 10 µg 130
1 mg 4,800

Order Hotline 1-800-777-4779 502-266-8787 589

 Recombinant proteins

PKIB pka-003 5 µg 50
Recombinant Human Protein Kinase Inhibitor Β 25 µg 130
1 mg 2,700

PKLR pka-307 2 µg 50
Recombinant Human Pyruvate Kinase, Liver and RBC 10 µg 130
1 mg 5,200

PKm2 pka-339 2 µg 50
Recombinant Human Tumour Type M2 Pyruvate Kinase 10 µg 130
1 mg 4,800

PmVK pka-308 5 µg 50
Recombinant Human Phosphomevalonate Kinase 20 µg 130
1 mg 2,700

PPARG pka-228 2 µg 50
Recombinant Human Peroxisome Proliferator Activated 10 µg 130
Receptor Gamma 1 mg 4,800

PPARG (1-477) pka-334 2 µg 175

Recombinant Human Peroxisome Proliferator Activated 5 µg 270
Receptor Gamma (1-477) 10 µg 490

PPm1A pka-222 10 µg 50
Recombinant Human Protein Phosphatase 1A Α Isoform 50 µg 130
1 mg 1,800
PEPTIDES INTERNATIONAL

PRKA1RA pka-201 1 µg 50
Recombinant C-AmP dependant Protein Kinase A regulatory 3 µg 130
subunit-1 α 100 µg 3,700

PRKAB1 pka-026 1 µg 50
Recombinant Human Protein Kinase, AmP-Activated, Β 1 non- 5 µg 130
Catalytic Subunit 50 µg 1,200

PRKAB2 pka-046 5 µg 50
Recombinant Human Protein Kinase, AmP-Activated, Β 2 non- 20 µg 130
Catalytic Subunit 1 mg 2,700

PRKACA pka-200 1 µg 50
Recombinant C-AmP dependant Protein Kinase A catalytic 5 µg 130
subunit α 100 µg 2,150

PRKAG1 pka-305 2 µg 50
Recombinant Human Protein Kinase, AmP-Activated, Gamma 1 10 µg 130
1 mg 5,200

PRPS1 pka-361 5 µg 50
Recombinant Human Phosphoribosyl Pyrophosphate 25 µg 130
Synthetase 1 1 mg 2,250

PSPH pka-224 5 µg 50
Recombinant Human Phosphoserine Phosphatase 20 µg 130
1 mg 2,800

590 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
PTPN1 pka-219 10 µg 50
Recombinant Human Protein Tyrosine Phosphatase Non 50 µg 130
Receptor Type-1 1 mg 1,800

PTPN6 pka-221 5 µg 50
Recombinant Human Protein Tyrosine Phosphatase Non 20 µg 130
Receptor Type-6 1 mg 2,800

PTPN7 pka-025 1 µg 50
Recombinant Human Protein Tyrosine Phosphatase Non 5 µg 130
Receptor Type-7 50 µg 1,100

pykF pka-028 5 µg 50
Recombinant E.Coli Pyruvate Kinase I 20 µg 130
1 mg 2,700

RBKS pka-358 2 µg 50
Recombinant Human Ribokinase 10 µg 130
1 mg 5,200

SGK1 pka-272 2 µg 50
Recombinant Human Serum/Glucocorticoid Regulated Kinase 10 µg 130
1 1 mg 5,200

SKP1 pka-356 5 µg 50
Recombinant Human S-phase Kinase-Associated Protein 1 25 µg 130
Isoform A 1 mg 2,250

PEPTIDES INTERNATIONAL
STAT1 pka-315 2 µg 50
Recombinant Human Signal Transducer and Activator of 10 µg 130
Transcription 1 1 mg 5,200

STK16 pka-032 5 µg 50
Recombinant Human Serine/Threonine Kinase 16 20 µg 130
1 mg 2,700

STK17B pka-050 2 µg 50
Recombinant Human Serine/Threonine Kinase 17B 10 µg 130
100 µg 1,200

Stratifin pka-357 5 µg 50
Recombinant Human Tyr-3/trp-5 Monooxygenase Activation 25 µg 130
Protein, Sigma 1 mg 2,250

SYK pka-007 2 µg 50
Recombinant Human Spleen Tyrosine Kinase 10 µg 130
100 µg 1,000

TGFBR2 pka-261 2 µg 50
Recombinant Human Transforming Growth Factor Β Receptor 10 µg 130
II 1 mg 5,200

TIE-1 Fc pka-246 2 µg 50
Recombinant Human TIE-1 Fc Chimera 10 µg 130
1 mg 3,800

Order Hotline 1-800-777-4779 502-266-8787 591

 Recombinant proteins

TIE-2 Fc pka-248 2 µg 50
Recombinant Human TIE-2 Fc Chimera 10 µg 130
1 mg 3,800

mTIE-1 Fc pka-247 2 µg 50
Recombinant Mouse TIE-1 Fc Chimera 10 µg 130
1 mg 3,800

mTIE-2 Fc pka-249 2 µg 50
Recombinant Mouse TIE-2 Fc Chimera 10 µg 130
1 mg 3,800

TK1 pka-036 5 µg 50
Recombinant Human Thymidine Kinase 1 20 µg 130
1 mg 2,700

TK2 pka-041 2 µg 50
Recombinant Human Thymidine Kinase 2 10 µg 130
1 mg 5,200

TPK1 pka-023 5 µg 50
Recombinant Human Thiamin Pyrophosphokinase 1 20 µg 130
1 mg 2,700

TPmT pka-255 5 µg 50
Recombinant Human Thiopurine S-methyltransferase 20 µg 130
1 mg 3,600

TSSK2 pka-057 2 µg 50
PEPTIDES INTERNATIONAL

Recombinant Human Testis Specific Serine Kinase 2 10 µg 130

100 µg 1,200

UCK2 pka-332 5 µg 50
Recombinant Human Uridine-Cytidine Kinase 2 25 µg 130
1 mg 2,700

VEGFR2 pka-242 2 µg 50
Recombinant Human Vascular Endothelial Growth Factor 10 µg 130
receptor-2 1 mg 5,200

VEGFR2 Fc pka-243 2 µg 50
Recombinant Human Vascular Endothelial Growth Factor 10 µg 130
receptor-2 Fc Chimera 1 mg 5,000

YWHAB pka-348 5 µg 50
Recombinant Human Tyr-3/Trp-5 Monooxygenase Activation 25 µg 130
Protein, Β 1 mg 3,600

YWHAE pka-253 5 µg 50
Recombinant Human Tyr-3/Trp-5 Monooxygenase Activation 20 µg 130
Protein, Epsilon 1 mg 3,600

YWHAG pka-238 5 µg 50
Recombinant Human Tyr-3/Trp-5 Monooxygenase Activation 25 µg 130
Protein, Gamma 1 mg 3,600

592 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
YWHAG His pka-262 2 µg 50
Recombinant Human Tyr-3/Trp-5 Monooxygenase Activation 10 µg 130
Protein, Gamma His Tag 1 mg 4,500

YWHAH pka-347 5 µg 50
Recombinant Human Tyr-3/Trp-5 Monooxygenase Activation 25 µg 130
Protein, ETA 1 mg 2,700

YWHAQ pka-254 5 µg 50
Recombinant Human Tyr-3/trp-5 Monooxygenase Activation 20 µg 130
Protein, Tau 1 mg 3,600

YWHAZ pka-257 5 µg 50
Recombinant Human Tyr- 3/Trp-5 Mmonooxygenase Activation 20 µg 130
Protein, Zeta 1 mg 3,600

ZmCK2a pka-210 3 µg 400

Recombinant Zea Mays Casein Kinase 2 α 10 µg 800
20 µg 1,500

Recombinant and Natural Proteins

AAGAB pro-1479 5 µg 50
Recombinant Human Α and Gamma-Adaptin Binding Protein 20 µg 130
1 mg 2,700

ABI3 pro-1227 2 µg 50

PEPTIDES INTERNATIONAL
Recombinant Human ABI Family, Member 3 10 µg 130
100 µg 1,200

ABRACL pro-1466 5 µg 50
Recombinant Human ABRA C-Terminal Like 20 µg 130
1 mg 2,700

A2LD1 pro-172 2 µg 50
Recombinant Human AIG2-Like Domain 1 10 µg 130
1 mg 5,200

A2m pro-551 200 µg 50

Human Α-2 Macroglobulin Protein 1 mg 130
10 mg 1,000

ACTA2 pro-1220 2 µg 50
Recombinant Human Actin, Α 2, Smooth Muscle, Aorta 10 µg 130
1 mg 5,200

ACTG1 pro-377 2 µg 50
Recombinant Human Actin Gamma 1 10 µg 130
1 mg 4,800

Order Hotline 1-800-777-4779 502-266-8787 593

 Recombinant proteins

Actin pro-517 10 µg 50
Actin 50 µg 130
1 mg 1,800

ACTL6A pro-379 2 µg 50
Recombinant Human Actin-Like 6A 10 µg 130
1 mg 4,800

ADAm10 pro-476 2 µg 50
Recombinant Human A Disintegrin and MetalloProteinase 10 µg 130
Domain 10 1 mg 4,800

ADAm12 pro-474 2 µg 50
Recombinant Human A Disintegrin and MetalloProteinase 10 µg 130
Domain 12 S Isoform 1 mg 4,800

ADFP pro-405 2 µg 50
Recombinant Human Adipose Differentiation-Related Protein 10 µg 130
1 mg 5,200

Adipsin pro-1360 5 µg 50
Recombinant Human Complement Factor D 20 µg 130
1 mg 2,700

ADRm1 pro-1079 2 µg 50
Recombinant Human Adhesion Regulating Molecule 1 10 µg 130
1 mg 5,200
PEPTIDES INTERNATIONAL

AES pro-169 2 µg 50
Recombinant Human Amino-Terminal Enhancer of Split 10 µg 130
1 mg 5,200

AFP pro-406 5 µg 50
Human Α FetoProtein 25 µg 130
1 mg 2,200

Ag85A pro-1076 2 µg 50
Recombinant Mycobacterium Tuberculosis Major secretory 10 µg 130
Protein Antigen 85A 1 mg 5,200

Ag85B pro-589 2 µg 50
Recombinant Mycobacterium Tuberculosis Major secretory 10 µg 130
Protein Antigen 85B 100 µg 1,000

AGR2 pro-580 5 µg 50
Recombinant Human Anterior Gradient Protein 2 Homolog 20 µg 130
1 mg 2,700

AGR3 pro-242 5 µg 50
Recombinant Human Anterior Gradient Protein 3 Homolog 20 µg 130
1 mg 2,700

AHSG pro-1450 2 µg 50
Recombinant Human Α-2-HS-GlycoProtein 10 µg 130
1 mg 5,200

594 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
AHSG pro-418 10 µg 50
Human Α-2-HS-GlycoProtein 50 µg 130
1 mg 2,400

AHSG HEK pro-1644 2 µg 50

Recombinant Human Α-2-HS-GlycoProtein HEK 10 µg 130
1 mg 5,200

AHSP pro-720 10 µg 50
Recombinant Human Α Hemoglobin Stabilizing Protein 50 µg 130
1 mg 1,800

AIDA pro-1370 2 µg 50
Recombinant Human Axin Interactor Dorsalization Associated 10 µg 130
100 µg 1,200

AIP pro-886 5 µg 50
Recombinant Human Aryl Hydrocarbon Receptor Interacting 20 µg 130
Protein 1 mg 2,700

ALK/P80 pro-455 2 µg 175

Recombinant Human ALK-P80 5 µg 270
10 µg 490

Α Actinin pro-518 10 µg 50
Α Actinin 50 µg 130
1 mg 2,500

AmBP pro-407

PEPTIDES INTERNATIONAL
20 µg 50
Human Α-1 Microglobulin 100 µg 130
1 mg 450

AmBP pro-957 2 µg 50
Recombinant Human Α-1 Microglobulin 10 µg 130
1 mg 5,200

AmELX pro-1324 2 µg 50
Recombinant Human Amelogenin, X-Linked 10 µg 130
100 µg 1,200

AmN pro-1330 1 µg 50
Recombinant Human Amnion Associated Transmembrane 5 µg 130
Protein 50 µg 1,100

AmTN pro-1301 5 µg 50
Recombinant Human Amelotin 20 µg 130
1 mg 2,700

ANAPC13 pro-1037 2 µg 50
Recombinant Human Anaphase Promoting Complex Subunit 10 µg 130
13 1 mg 5,200

Angiostatin K1-3 pro-284 20 µg 50

Recombinant Human Angiostatin Kringles 1-3 100 µg 130
1 mg 990

Order Hotline 1-800-777-4779 502-266-8787 595

 Recombinant proteins

Angiostatin K1-4 pro-604 2 µg 50

Human Angiostatin Kringles 1-4 10 µg 130
1 mg 4,800

ANKRD1 pro-1219 2 µg 50
Recombinant Human Ankyrin Repeat Domain 1 10 µg 130
100 µg 1,200

ANKRD54 pro-1480 2 µg 50
Recombinant Human Ankyrin Repeat Domain 54 10 µg 130
100 µg 1,200

ANP32A pro-252 2 µg 50
Recombinant Human Acidic Nuclear PhosphoProtein 32 10 µg 130
Family, Member A 1 mg 5,200

ANXA1 pro-679 2 µg 170

Recombinant Human Annexin A1 10 µg 360
100 µg 1,800

ANXA10 pro-1045 5 µg 50
Recombinant Human Annexin A10 20 µg 130
1 mg 2,700

ANXA11 pro-278 5 µg 50
Recombinant Human Annexin A11 20 µg 130
1 mg 3,600

ANXA13 pro-197 5 µg 50
PEPTIDES INTERNATIONAL

Recombinant Human Annexin A13 20 µg 130

1 mg 2,700

ANXA2 pro-777 5 µg 50
Recombinant Human Annexin A2 20 µg 130
1 mg 2,250

ANXA2 pro-1573 1 µg 50
Human Annexin A2 5 µg 130
50 µg 1,200

ANXA3 pro-765 5 µg 50
Recombinant Human Annexin A3 20 µg 130
1 mg 2,250

ANXA4 pro-766 2 µg 50
Recombinant Human Annexin A4 10 µg 130
1 mg 5,200

ANXA5 pro-732 5 µg 50
Recombinant Human Annexin A5 20 µg 130
1 mg 2,250

ANXA5 Sf9 pro-137 2 µg 50

Recombinant Human Annexin A5, Sf9 10 µg 130
1 mg 5,200

596 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
ANXA6 pro-767 2 µg 50
Recombinant Human Annexin A6 10 µg 130
1 mg 5,200

ANXA7 pro-449 5 µg 50
Recombinant Human Annexin A7 20 µg 130
1 mg 2,700

ANXA8 pro-548 5 µg 50
Recombinant Human Annexin A8 20 µg 130
1 mg 2,700

ANXA8L2 pro-1138 1 µg 50
Recombinant Human Annexin A8 Like-2 5 µg 130
50 µg 1,200

ANXA9 pro-450 2 µg 50
Recombinant Human Annexin A9 10 µg 130
1 mg 4,800

AP1AR pro-1696 2 µg 50
Recombinant Human Adaptor-Related Protein Complex 1 10 µg 130
Associated Regulatory Protein 100 µg 1,200

AP1S2 pro-234 2 µg 50
Recombinant Human Adaptor-Related Protein Complex 1, 10 µg 130
Sigma 2 1 mg 5,200

PEPTIDES INTERNATIONAL
AP2m1 pro-451 2 µg 50
Recombinant Human Assembly Protein Complex 2 10 µg 130
1 mg 4,800

AP3S1 pro-1280 5 µg 50
Recombinant Human Assembly Protein Complex 3 Subunit-1 20 µg 130
1 mg 2,700

AP3S2 pro-452 2 µg 50
Recombinant Human Assembly Protein Complex 3 Subunit-2 10 µg 130
1 mg 4,800

APCS pro-453 2 µg 50
Recombinant Human Amyloid P Component 10 µg 130
1 mg 4,800

APIP pro-1186 5 µg 50
Recombinant Human APAF1 interacting Protein 20 µg 130
1 mg 2,700

Apo Transferrin pro-325 500 mg 250

Human Apo Transferrin 1gra m 400
5gra m 1,600

APP pro-1080 5 µg 50
Recombinant Human Amyloid β (A4) Precursor Protein 20 µg 130
1 mg 2,700

Order Hotline 1-800-777-4779 502-266-8787 597

 Recombinant proteins

bApo Transferrin pro-511 500 mg 300

Bovine Apo Transferrin 1gra m 500
5gra m 2,200

bAprotinin pro-285 100 mg 135

Bovine Aprotinin 250 mg 270
1gra m 900

bAprotinin pro-414 1 mg 50
Recombinant Bovine Aprotinin 20 mg 130
100 mg 650

APTX pro-790 2 µg 50
Recombinant Human Aprataxin 10 µg 130
1 mg 5,200

ARC pro-1403 1 µg 50
Recombinant Human Activity-Regulated Cytoskeleton- 5 µg 130
Associated Protein 50 µg 1,200

ARF1 pro-867 5 µg 50
Recombinant Human ADP-Ribosylation Factor 1 20 µg 130
1 mg 2,700

ARF3 pro-933 5 µg 50
Recombinant Human ADP-Ribosylation Factor 3 20 µg 130
1 mg 2,700

ARF4 pro-066
PEPTIDES INTERNATIONAL

5 µg 50
Recombinant Human ADP-Ribosylation Factor 4 20 µg 130
1 mg 3,600

ARF5 pro-245 5 µg 50
Recombinant Human ADP-Ribosylation Factor 5 20 µg 130
1 mg 2,700

ARF6 pro-032 5 µg 50
Recombinant Human ADP-Ribosylation Factor 6 20 µg 130
1 mg 2,700

ARFIP2 pro-1201 5 µg 50
Recombinant Human ADP-Ribosylation Factor Interacting 20 µg 130
Protein 2 1 mg 3,600

ARHGDIA pro-002 5 µg 50
Recombinant Human Rho GDP Dissociation Inhibitor (GDI) Α 20 µg 130
1 mg 2,700

ARHGDIB pro-1067 1 µg 50
Recombinant Human Rho GDP Dissociation Inhibitor (GDI) Β 5 µg 130
50 µg 1,100

ARL1 pro-508 5 µg 50
Recombinant Human ADP-Ribosylation Factor-Like 1 20 µg 130
1 mg 2,700

598 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
ARL11 pro-884 5 µg 50
Recombinant Human ADP-Ribosylation Factor-Like 11 20 µg 130
1 mg 2,700

ARL14 pro-936 5 µg 50
Recombinant Human ADP-Ribosylation Factor-Like 14 20 µg 130
1 mg 2,700

ARL15 pro-956 5 µg 50
Recombinant Human ADP-Ribosylation Factor-Like 15 20 µg 130
1 mg 3,600

ARL2 pro-074 5 µg 50
Recombinant Human ADP-Ribosylation Factor-Like 2 20 µg 130
1 mg 2,700

ARL2BP pro-274 5 µg 50
Recombinant Human ADP-Ribosylation Factor-Like 2 Binding 20 µg 130
Protein 1 mg 2,700

ARL3 pro-939 5 µg 50
Recombinant Human ADP-Ribosylation Factor-Like 3 20 µg 130
1 mg 2,700

ARL4A pro-895 2 µg 50
Recombinant Human ADP-Ribosylation Factor-Like 4A 10 µg 130
1 mg 5,200

ARL4D pro-953

PEPTIDES INTERNATIONAL
5 µg 50
Recombinant Human ADP-Ribosylation Factor-Like 4D 20 µg 130
1 mg 2,700

ARL5A pro-040 2 µg 50
Recombinant Human ADP-Ribosylation Factor-Like 5A 10 µg 130
1 mg 5,200

ARL5B pro-897 5 µg 50
Recombinant Human ADP-Ribosylation Factor-Like 5B 20 µg 130
1 mg 2,700

ARL6 pro-232 2 µg 50
Recombinant Human ADP-Ribosylation Factor-Like 6 10 µg 130
1 mg 5,200

ARL9 pro-1009 2 µg 50
Recombinant Human ADP-Ribosylation Factor-Like 9 10 µg 130
1 mg 5,200

ARmC10 pro-1453 2 µg 50
Recombinant Human Armadillo Repeat Containing 10 10 µg 130
1 mg 5,200

ARPC2 pro-1418 2 µg 50
Recombinant Human Actin Related Protein 2/3 Complex, 10 µg 130
Subunit 2 100 µg 1,200

Order Hotline 1-800-777-4779 502-266-8787 599

 Recombinant proteins

ARPC5 pro-145 5 µg 50
Recombinant Human Actin Related Protein 2/3 Complex, 20 µg 130
Subunit 5 1 mg 2,700

ARPC3 pro-1413 5 µg 50
Recombinant Human Actin Related Protein 2/3 Complex, 20 µg 130
Subunit 3 1 mg 2,700

ASB8 pro-1709 2 µg 50
Recombinant Human Ankyrin Repeat And SOCS Box 10 µg 130
Containing 8 100 µg 1,200

ASCC1 pro-1682 2 µg 50
Recombinant Human Activating Signal Cointegrator 1 Complex 10 µg 130
Subunit 1 1 mg 5,200

ASF1A pro-682 5 µg 50
Recombinant Human ASF1 Anti-Silencing Function 1 Homolog 20 µg 130
A 1 mg 3,600

ASF1B pro-1163 5 µg 50
Recombinant Human ASF1 Anti-Silencing Function 1 Homolog 20 µg 130
B 1 mg 2,700

ASGR2 pro-1261 5 µg 50
Recombinant Human AsialoglycoProtein Receptor 2 20 µg 130
1 mg 2,700
PEPTIDES INTERNATIONAL

ASNA1 pro-1247 5 µg 50
Recombinant Human arsA Arsenite Transporter, ATP-Binding, 20 µg 130
Homolog 1 1 mg 2,700

ASPSCR1 pro-1519 2 µg 50
Recombinant Human Alveolar Soft Part Sarcoma Chromosome 10 µg 130
Region, Candidate 1 100 µg 1,200

ATG10 pro-1234 5 µg 50
Recombinant Human Autophagy Related 10 20 µg 130
1 mg 2,700

ATG4B pro-1048 5 µg 50
Recombinant Human ATG4 Autophagy Related 4 Homolog B 20 µg 130
1 mg 3,600

ATG5 pro-454 2 µg 50
Recombinant Human Autophagy Related 5 10 µg 130
1 mg 5,200

ATOH1 pro-1073 5 µg 50
Recombinant Human Atonal Homolog 1 20 µg 130
1 mg 2,700

600 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
ATOX1 pro-754 5 µg 50
Recombinant Human Copper Transport Protein ATOX1 20 µg 130
1 mg 2,250

ATPIF1 pro-1154 5 µg 50
Recombinant Human ATPase Inhibitory Factor 1 20 µg 130
1 mg 2,700

ATP1B1 pro-1665 5 µg 50
Recombinant Human ATPaseTransporting Β 1 20 µg 130
1 mg 2,700

ATP1B2 pro-1647 5 µg 50
Recombinant Human ATPaseTransporting Β 2 20 µg 130
1 mg 2,700

ATP5C1 pro-1494 5 µg 50
Recombinant Human ATP Synthase Gamma Chain, 20 µg 130
Mitochondria 1 mg 2,700

ATP5H pro-1631 2 µg 50
Recombinant Human ATP Synthase Mitochondrial Fo Complex 10 µg 130
Subunit D 1 mg 5,200

ATP6AP2 pro-1599 2 µg 50
Recombinant Human ATPase Transporting Lysosomal 10 µg 130
Accessory Protein 2 1 mg 5,200

PEPTIDES INTERNATIONAL
ATXN3 pro-708 2 µg 50
Recombinant Human Ataxin-3 10 µg 130
1 mg 5,200

Avidin pro-500 5 mg 50
Avidin 25 mg 130
100 mg 400

Avidin-Biotin pro-446 2 mg 50
modified Affinity Purified Avidin 10 mg 130
100 mg 990

APOH sf9 pro-388 5 µg 50

Recombinant Human ApolipoProtein-H, Sf9 20 µg 130
1 mg 2,800

APOH pro-552 100 µg 130

Human ApolipoProtein-H 1 mg 750
5 mg 3,300

bAPOH pro-1504 10 µg 50
Bovine ApolipoProtein-H 50 µg 130
1 mg 2,000

B2m pro-337 10 µg 50
Recombinant Human Β 2 Microglobulin 50 µg 130
1 mg 1,200

Order Hotline 1-800-777-4779 502-266-8787 601

 Recombinant proteins

B2m pro-553 200 µg 50

Human Β 2 Microglobulin 1 mg 150
10 mg 1,350

B2m His pro-859 1 µg 50

Recombinant Human Β 2 Microglobulin, His Tag 5 µg 130
50 µg 1,100

BAALC pro-758 2 µg 50
Recombinant Human Brain and Acute Leukemia, 10 µg 130
Cytoplasmatic 1 mg 5,200

BAD pro-458 2 µg 175

Recombinant Human BAD 5 µg 270
10 µg 490

BAG1 pro-817 5 µg 50
Recombinant Human BCL2-Associated Athanogene 1 20 µg 130
1 mg 2,250

BAG2 pro-168 5 µg 50
Recombinant Human BCL2-Associated Athanogene 2 20 µg 130
1 mg 2,700

BAG3 pro-760 2 µg 50
Recombinant Human BCL2-Associated Athanogene 3 10 µg 130
1 mg 5,200

BAIAP2
PEPTIDES INTERNATIONAL

pro-1022 5 µg 50
Recombinant Human BAI1-Associated Protein 2 20 µg 130
1 mg 2,700

BASP1 pro-1355 2 µg 50
Recombinant Human Brain Abundant Membrane Attached 10 µg 130
Signal Protein 1 100 µg 1,200

BATF pro-119 5 µg 50
Recombinant Human Basic Leucine Zipper Transcription 20 µg 130
Factor 1 mg 2,700

Batroxobin pro-607 10 µg 50
Recombinant Batroxobin 50 µg 130
1 mg 1,950

mBAX pro-412 2 µg 50
Recombinant Mouse Bax 10 µg 130
1 mg 4,800

mBAX GST pro-647 2 µg 50

Recombinant Mouse Bax GST Tag 10 µg 130
1 mg 4,800

bCAPN2 pro-330 2 µg 175

Bovine Calpain-2 Catalytic Subunit 5 µg 270
10 µg 490

602 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
BCAS2 pro-116 1 µg 50
Recombinant Human Breast Carcinoma Amplified Sequence 2 5 µg 130
50 µg 1,200

BCDIN3D pro-1262 2 µg 50
Recombinant Human BCDIN3D 10 µg 130
1 mg 5,200

BCL10 pro-1058 1 µg 50
Recombinant Human B-cell CLL/Lymphoma 10 5 µg 130
50 µg 1,100

BCL2 pro-1574 5 µg 50
Recombinant Human B-Cell Leukemia/Lymphoma 2 20 µg 130
1 mg 2,700

Bcl-2 (1-206 a.a.) pro-630 2 µg 50

Recombinant Human B-Cell Leukemia/Lymphoma 2, (1-206 10 µg 130
a.a.) 1 mg 4,800

Bcl-2 -BH1 pro-631 2 µg 50

Recombinant Human B-Cell Leukemia/Lymphoma 2 -BH1 10 µg 130
1 mg 4,800

Bcl-2 -BH2 pro-632 2 µg 50

Recombinant Human B-Cell Leukemia/Lymphoma 2 -BH2 10 µg 130
1 mg 4,800

Bcl-2 -BH3 pro-633

PEPTIDES INTERNATIONAL
2 µg 50
Recombinant Human B-Cell Leukemia/Lymphoma 2 -BH3 10 µg 130
1 mg 4,800

Bcl-2 -BH4 pro-411 2 µg 50

Recombinant Human B-Cell Leukemia/Lymphoma 2 -BH4 10 µg 130
1 mg 4,800

BCL2 His pro-683 5 µg 50

Recombinant Human B-Cell Lymphoma Protein 2 Α, His Tag 20 µg 130
1 mg 3,600

Bcl-2 -NWGR pro-634 2 µg 50

Recombinant Human B-Cell Leukemia/Lymphoma 2 -NWGR 10 µg 130
1 mg 4,800

BCL2A1 pro-1102 2 µg 50
Recombinant Human BCL2-Related Protein A1 10 µg 130
100 µg 1,200

BCL2L10 pro-1321 5 µg 50
Recombinant Human BCL2 Like 10 20 µg 130
1 mg 2,700

BCL2L11 pro-1171 2 µg 50
Recombinant Human BCL2 Like 11 10 µg 130
1 mg 5,200

Order Hotline 1-800-777-4779 502-266-8787 603

 Recombinant proteins

BCL2L2 pro-1577 5 µg 50
Recombinant Human BCL2 Like 2 20 µg 130
1 mg 2,700

BCL2L2, His pro-768 5 µg 50

Recombinant Human BCL2 Like 2, His Tag 25 µg 130
1 mg 2,250

BCL6 pro-460 2 µg 175

Recombinant Human B-cell CLL/lymphoma 6 5 µg 270
10 µg 490

BCL7A pro-1318 2 µg 50
Recombinant Human B-cell CLL/lymphoma 7A 10 µg 130
100 µg 1,200

Bcl-XL pro-639 10 µg 50
Recombinant Human B-Cell Leukemia/Lymphoma XL 50 µg 130
1 mg 1,800

Bcl-XL GST pro-640 2 µg 50

Recombinant Human B-Cell Leukemia/Lymphoma XL GST Tag 10 µg 130
1 mg 4,800

Bcl-XL His pro-641 2 µg 50

Recombinant Human B-Cell Leukemia/Lymphoma His Tag 10 µg 130
1 mg 4,800

mBcl-XL pro-1362 10 µg 50
PEPTIDES INTERNATIONAL

Recombinant Mouse B-Cell Leukemia/Lymphoma XL 50 µg 130

1 mg 1,800

bECGS pro-603 5 mg 50
Bovine Endothelial Mitogen 20 mg 130
100 mg 700

BECN1 pro-1289 2 µg 50
Recombinant Human Beclin 1, Autophagy Related 10 µg 130
100 µg 1,200

BEX1 pro-1530 2 µg 50
Recombinant Human Brain Expressed X-Linked 1 10 µg 130
100 µg 1,200

BGN pro-1382 5 µg 50
Recombinant Human Biglycan 20 µg 130
1 mg 2,700

bFibronectin pro-059 200 µg 50

Bovine Fibronectin 1 mg 130
10 mg 950

bHolo Transferrin pro-510 500 mg 300

Bovine Holo Transferrin 1gra m 500
5gra m 2,200

604 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
BID pro-627 2 µg 50
Recombinant Human BH3 Interacting Domain Death Agonist 10 µg 130
1 mg 5,200

mBID pro-642 2 µg 50
Recombinant Mouse BH3 Interacting Domain Death Agonist 10 µg 130
1 mg 4,800

mBID GST pro-643 2 µg 50

Recombinant Mouse BH3 Interacting Domain Death Agonist 10 µg 130
GST 1 mg 4,800

mtBID pro-644 2 µg 50
Recombinant Mouse BH3 Interacting Domain Death Agonist 10 µg 130
p15 1 mg 4,800

BIN1 pro-546 5 µg 50
Recombinant Human Bridging Integrator 1 20 µg 130
1 mg 2,700

BIRC5 pro-613 5 µg 50
Recombinant Human Baculoviral IAP Repeat-Containing 5 25 µg 130
1 mg 2,700

BIRC7 pro-612 5 µg 50
Recombinant Human Baculoviral IAP Repeat-Containing 7 20 µg 130
1 mg 3,600

PEPTIDES INTERNATIONAL
BIRC7 (1-280) pro-1042 2 µg 50
Recombinant Human Baculoviral IAP Repeat-Containing 7 10 µg 130
(1-280 a.a.) 1 mg 5,200

Bivalirudin pro-357 1 mg 50
Human Bivalirudin 5 mg 130
100 mg 500

BLNK pro-102 5 µg 50
Recombinant Human B-Cell Linker 20 µg 130
1 mg 2,700

BLOC1S2 pro-1094 5 µg 50
Recombinant Human Biogenesis of Lysosomal Organelles 20 µg 130
Complex-1, Subunit 2 1 mg 2,700

BmF pro-700 5 µg 50
Recombinant Human Bcl2 Modifying Factor, Isoform 3 20 µg 130
1 mg 3,600

bNEFm pro-523 2 µg 50
Bovine Neurofilament Medium Polypeptide 10 µg 130
1 mg 3,600

BOLA1 pro-302 5 µg 50
Recombinant Human BolA Homolog 1  20 µg 130
1 mg 2,700

Order Hotline 1-800-777-4779 502-266-8787 605

 Recombinant proteins

BP-1 pro-463 2 µg 175

Recombinant Human BP-1 5 µg 270
10 µg 490

BPI pro-129 2 µg 50
Human Bactericidal/Permeability-Increasing Protein 10 µg 130
1 mg 5,200

BPIFA1 pro-404 5 µg 50
Recombinant Human BPI fold containing family A Member 1 20 µg 130
1 mg 2,700

BSA pro-422 10gr 140

Bovine Serum Albumin 50gr 285
100gr 430

bSNRPD pro-998 2 µg 50
Bovine Small Nuclear RibonucleoProtein Polypeptide 10 µg 130
1 mg 5,200

BSND pro-1551 2 µg 50
Recombinant Human Bartter Syndrome Infantile with 10 µg 130
Sensorineural Deafness 100 µg 1,200

BTF3 pro-1333 2 µg 50
Recombinant Human Basic Transcription Factor 3 10 µg 130
100 µg 1,200

BUB3 pro-023 5 µg 50
PEPTIDES INTERNATIONAL

Recombinant Human BUB3 20 µg 130

1 mg 2,700

BUD31 pro-1492 2 µg 50
Recombinant Human BUD31 10 µg 130
100 µg 1,200

bTROVE2 pro-111 2 µg 50
Bovine TROVE Domain Family, Member 2 10 µg 130
1 mg 4,200

bVimentin pro-525 2 µg 50
Bovine Vimentin 10 µg 130
1 mg 3,600

C7ORF49 pro-1415 2 µg 50
Recombinant Human Chromosome 7 Open Reading Frame 49 10 µg 130
100 µg 1,200

C12ORF5 pro-051 2 µg 50
Recombinant Human Chromosome 12 Open Reading Frame 5 10 µg 130
1 mg 5,200

C14ORF129 pro-193 5 µg 50
Recombinant Human Chromosome 14 Open Reading Frame 25 µg 130
129 1 mg 2,700

606 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
C16ORF53 pro-225 5 µg 50
Recombinant Human Chromosome 16 Open Reading Frame 53 20 µg 130
1 mg 2,700

C17ORF49 pro-1192 2 µg 50
Recombinant Human Chromosome 17 Open Reading Frame 49 10 µg 130
1 mg 5,200

C19ORF80 pro-1575 2 µg 50
Recombinant Human Chromosome 19 Open Reading Frame 80 10 µg 130
1 mg 5,200

mC19ORF80 pro-1576 2 µg 50
Recombinant Mouse Chromosome 19 Open Reading Frame 80 10 µg 130
1 mg 5,200

C17ORF103 pro-1619 5 µg 50
Recombinant Human Chromosome 19 Open Reading Frame 80 20 µg 130
1 mg 2,700

C1D pro-1499 2 µg 50
Recombinant Human C1D 10 µg 130
1 mg 5,200

C1q pro-554 200 µg 200

Human Complement Component C1q 1 mg 600
10 mg 4,000

C1QBP pro-636 5 µg 50

PEPTIDES INTERNATIONAL
Recombinant Human Complement Component 1 25 µg 130
1 mg 2,700

C1QTNF1 pro-654 2 µg 50
Recombinant Human Complement C1q Tumor Necrosis Factor- 10 µg 130
Related Protein 1 1 mg 5,200

C1QTNF2 pro-133 2 µg 50
Recombinant Human Complement C1q Tumor Necrosis Factor- 10 µg 130
Related Protein 2 1 mg 5,200

C1QTNF3 pro-653 2 µg 50
Recombinant Human Complement C1q Tumor Necrosis Factor- 10 µg 130
Related Protein 3 1 mg 5,200

C1QTNF6 pro-655 2 µg 50
Recombinant Human Complement C1q Tumor Necrosis Factor- 10 µg 130
Related Protein 6 1 mg 5,200

C1QTNF7 pro-514 2 µg 50
Recombinant Human Complement C1q Tumor Necrosis Factor- 10 µg 130
Related Protein 7 1 mg 5,200

C1QTNF8 pro-134 2 µg 50
Recombinant Human Complement C1q Tumor Necrosis Factor- 10 µg 130
Related Protein 8 1 mg 5,200

Order Hotline 1-800-777-4779 502-266-8787 607

 Recombinant proteins

C1QTNF9 pro-135 2 µg 50
Recombinant Human Complement C1q Tumor Necrosis Factor- 10 µg 130
Related Protein 9 1 mg 5,200

C20ORF20 pro-1000 2 µg 50
Recombinant Human Chromosome 20 Open Reading Frame 20 10 µg 130
1 mg 5,200

C3c pro-555 200 µg 50

Human Complement Component C3c 1 mg 130
10 mg 1,100

C4BPB pro-1174 5 µg 50
Recombinant Human Complement Component 4 Binding 25 µg 130
Protein, Β 1 mg 2,700

C4c pro-556 200 µg 150

Human Complement Component C4c 1 mg 450
10 mg 3,500

mC5a pro-085 2 µg 50
Recombinant Mouse Complement Component C5a 10 µg 130
1 mg 5,200

C6ORF108 pro-249 5 µg 50
Recombinant Human Chromosome 6 Open Reading Frame 108 25 µg 130
1 mg 2,700
PEPTIDES INTERNATIONAL

C8G pro-947 5 µg 50
Recombinant Human Complement Component 8, Gamma 20 µg 130
1 mg 2,700

C9ORF103 pro-1025 2 µg 50
Recombinant Human Chromosome 9 Open Reading Frame 103 10 µg 130
1 mg 5,200

C9ORF95 pro-1116 5 µg 50
Recombinant Human Chromosome 9 Open Reading Frame 95 20 µg 130
1 mg 2,700

CAB39 pro-857 2 µg 50
Recombinant Human Calcium Binding Protein 39 10 µg 130
1 mg 5,200

CAB39L pro-020 5 µg 50
Recombinant Human Calcium Binding Protein 39 Like 20 µg 130
1 mg 2,700

CABP7 pro-211 1 µg 50
Recombinant Human Calcium Binding Protein 7 5 µg 130
50 µg 1,200

CACYBP pro-831 5 µg 50
Recombinant Human Calcyclin Binding Protein 25 µg 130
1 mg 2,250

608 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
Cadherin-E pro-461 2 µg 175
Recombinant Human Cadherin-E 5 µg 270
10 µg 490

CALB1 pro-721 10 µg 50
Recombinant Human Calbindin-1 50 µg 130
1 mg 1,800

CALB2 pro-401 5 µg 50
Recombinant Human Calbindin-2 25 µg 130
1 mg 2,700

mCALB2 pro-290 2 µg 175

Recombinant Mouse Calbindin-2 5 µg 270
10 µg 490

CALm2 pro-618 5 µg 50
Recombinant Human Calmodulin-2 25 µg 130
1 mg 3,600

CALm2 135 a.a. pro-370 10 µg 50

Recombinant Human Calmodulin-2 135 a.a. 50 µg 130
mg 1,350

CALmL3 pro-1323 5 µg 50
Recombinant Human Calmodulin Like 3 20 µg 130
1 mg 2,700

CALN1 pro-279 1 µg 50

PEPTIDES INTERNATIONAL
Recombinant Human Calnueron-1 5 µg 130
50 µg 1,100

CALR pro-813 5 µg 50
Recombinant Human Calreticulin 25 µg 130
1 mg 3,600

Calumenin pro-696 5 µg 50
Recombinant Human Calumenin 25 µg 130
1 mg 2,700

CAmLG pro-1612 5 µg 50
Recombinant Human Calcium Modulating Ligand 20 µg 130
1 mg 2,700

CAmP pro-1405 2 µg 50
Recombinant Human Cathelicidin Antimicrobial Peptide 10 µg 130
100 µg 1,200

CANT1 pro-1010 2 µg 50
Recombinant Human Calcium Activated Nucleotidase 1 10 µg 130
1 mg 5,200

CANX pro-725 10 µg 50
Recombinant Human Calnexin 50 µg 130
1 mg 1,800

Order Hotline 1-800-777-4779 502-266-8787 609

 Recombinant proteins

CAPG pro-759 5 µg 50
Recombinant Human Capping Protein Gelsolin-Like 25 µg 130
1 mg 2,250

CAPN1 pro-363 2 µg 175

Human Calpain-1 Catalytic Subunit 5 µg 270
10 µg 490

CAPS pro-117 5 µg 50
Recombinant Human Calcyphosine 20 µg 130
1 mg 2,700

CAPSL pro-185 5 µg 50
Recombinant Human Calcyphosine-Like 20 µg 130
1 mg 3,600

CAPZA2 pro-1721 5 µg 50
Recombinant Human Capping Protein (Actin Filament) Muscle 20 µg 130
Z-Line, Α 2 1 mg 2,700

CARD17 pro-1688 5 µg 50
Recombinant Human Caspase Recruitment Domain Family, 20 µg 130
Member 17 1 mg 2,700

CARD18 pro-1061 2 µg 50
Recombinant Human Caspase Recruitment Domain Family, 10 µg 130
Member 18 1 mg 5,200
PEPTIDES INTERNATIONAL

Cardiac Actin pro-519 2 µg 50

Cardiac Actin 10 µg 130
1 mg 4,800

CARHSP1 pro-257 2 µg 50
Recombinant Human Calcium Regulated Heat Stable Protein 1 10 µg 130
1 mg 5,200

CASQ2 pro-799 5 µg 50
Recombinant Human Calsequestrin 25 µg 130
1 mg 2,250

CBFB pro-534 2 µg 50
Recombinant Human Core Binding Factor Β 10 µg 130
1 mg 5,200

CBX1 pro-876 5 µg 50
Recombinant Human Chromobox Homolog 1 20 µg 130
1 mg 2,700

CBX3 pro-1057 5 µg 50
Recombinant Human Chromobox Homolog 3 20 µg 130
1 mg 2,700

CBX5 pro-1062 5 µg 50
Recombinant Human Chromobox Homolog 5 20 µg 130
1 mg 2,700

610 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
CCDC25 pro-1655 5 µg 50
Recombinant Human Coiled-Coil Domain Containing 25 20 µg 130
1 mg 2,700

CCDC43 pro-1419 2 µg 50
Recombinant Human Coiled-Coil Domain Containing 43 10 µg 130
1 mg 5,200

CCDC90B pro-1478 2 µg 50
Recombinant Human Coiled-Coil Domain Containing 90B 10 µg 130
100 µg 1,200

CCDC101 pro-1063 2 µg 50
Recombinant Human Coiled-Coil Domain Containing 101 10 µg 130
1 mg 5,200

CCDC104 pro-1728 5 µg 50
Recombinant Human Coiled-Coil Domain Containing 104 20 µg 130
1 mg 2,700

CCND2 pro-1012 5 µg 50
Recombinant Human Cyclin D2 20 µg 130
1 mg 2,700

CCNG1 pro-1005 2 µg 50
Recombinant Human Cyclin G1 10 µg 130
1 mg 5,200

CCS pro-251 5 µg 50

PEPTIDES INTERNATIONAL
Recombinant Human Copper Chaperone for Superoxide 25 µg 130
Dismutase 1 mg 2,700

CD11b pro-472 2 µg 175

Recombinant Human CD11b 5 µg 270
10 µg 490

CD14 CHO pro-536 10 µg 50

Recombinant Human CD14 CHO 50 µg 130
1 mg 1,800

CD14 HEK pro-1642 10 µg 50

Recombinant Human CD14, HEK 50 µg 130
1 mg 1,800

mCD14 pro-537 2 µg 175

Recombinant Mouse CD14 5 µg 270
10 µg 520

CD1B pro-1267 2 µg 50
Recombinant Human CD1B 10 µg 130
100 µg 1,200

CD2 pro-1337 5 µg 50
Recombinant Human CD2 20 µg 130
1 mg 2,700

Order Hotline 1-800-777-4779 502-266-8787 611

 Recombinant proteins

CD2 GST pro-468 2 µg 175

Recombinant Human CD2, GST Tag 5 µg 270
10 µg 490

CD5L pro-1578 2 µg 50
Recombinant Human CD5 Molecule-Like 10 µg 130
1 mg 5,200

CD7 pro-1673 5 µg 50
Recombinant Human CD7 20 µg 130
1 mg 2,700

CD23 pro-470 2 µg 175

Recombinant Human CD23 5 µg 270
10 µg 490

CD226 pro-1353 5 µg 50
Recombinant Human CD226 20 µg 130
1 mg 2,700

CD244 pro-1173 2 µg 50
Recombinant Human CD244 10 µg 130
1 mg 5,200

CD247 pro-1335 2 µg 50
Recombinant Human CD247 10 µg 130
1 mg 5,200

CD27 pro-1213 5 µg 50
PEPTIDES INTERNATIONAL

Recombinant Human CD27 20 µg 130

1 mg 2,700

CD74 pro-1467 5 µg 50
Recombinant Human CD74 20 µg 130
1 mg 2,700

CD274 pro-1103 2 µg 50
Recombinant Human CD274 10 µg 130
100 µg 1,200

mCD274 pro-1164 5 µg 50
Recombinant Mouse CD274 20 µg 130
1 mg 2,700

CD300C pro-273 5 µg 50
Recombinant Human CD300C 20 µg 130
1 mg 2,700

CD30 pro-1369 2 µg 50
Recombinant Human CD30 10 µg 130
1 mg 5,200

CD3G pro-1392 5 µg 50
Recombinant Human CD3 Gamma 20 µg 130
1 mg 2,700

612 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
CD34 GST pro-292 2 µg 175
Recombinant Human CD34 GST Tag 5 µg 270
10 µg 490

CD34 pro-1363 5 µg 50
Recombinant Human CD34 20 µg 130
1 mg 3,000

CD3e pro-1317 2 µg 50
Recombinant Human CD3e 10 µg 130
1 mg 5,200

CD43 pro-1687 5 µg 50
Recombinant Human CD43 20 µg 130
1 mg 3,600

CD46 pro-1414 5 µg 50
Recombinant Human CD46 20 µg 130
1 mg 2,700

CD56 pro-483 2 µg 175

Recombinant Human CD56 5 µg 270
10 µg 490

CD59 pro-1648 2 µg 50
Recombinant Human CD59 10 µg 130
100 µg 1,200

CD68 pro-1209 2 µg 50

PEPTIDES INTERNATIONAL
Recombinant Human CD68 10 µg 130
1 mg 5,200

CD68, 38 kda pro-293 2 µg 175

Recombinant Human CD68, 38kda 5 µg 270
10 µg 490

CD72 pro-486 2 µg 175

Recombinant Human CD72 5 µg 270
10 µg 490

CD79B pro-1304 5 µg 50
Recombinant Human CD79B 20 µg 130
1 mg 2,700

CD83 pro-019 2 µg 50
Recombinant Human CD83 10 µg 130
1 mg 5,200

CD84 pro-1229 5 µg 50
Recombinant Human CD84 20 µg 130
1 mg 2,700

CD95 His pro-594 5 µg 50

Recombinant Human CD95, His Tag 20 µg 130
1 mg 3,000

Order Hotline 1-800-777-4779 502-266-8787 613

 Recombinant proteins

CD99 pro-294 2 µg 175

Recombinant Human CD99 5 µg 270
10 µg 490

CD100 pro-1640 2 µg 50
Recombinant Human CD100 10 µg 130
1 mg 3,900

CD300A pro-1618 2 µg 50
Recombinant Human CD300A 10 µg 130
1 mg 5,200

CDC26 pro-241 5 µg 50
Recombinant Human Cell Division Cycle 26 20 µg 130
1 mg 2,700

CDC37 pro-464 5 µg 50
Recombinant Human Cell Division Cycle 37 25 µg 130
1 mg 2,700

CDC37, His pro-140 2 µg 50

Recombinant Human Cell Division Cycle 37, His Tag 10 µg 130
1 mg 5,200

CDC42 pro-727 10 µg 50
Recombinant Human Cell Division Cycle 42 50 µg 130
1 mg 1,800

CDCA8 pro-222 2 µg 50
PEPTIDES INTERNATIONAL

Recombinant Human Cell Division Cycle Associated 8 10 µg 130

1 mg 5,200

CDC123 pro-1463 5 µg 50
Recombinant Human Cell Division Cycle 123 20 µg 130
1 mg 2,700

CDH11 pro-1368 2 µg 50
Recombinant Human Cadherin 11 10 µg 130
1 mg 5,200

CEA pro-287 2 µg 50
Recombinant Human Carcinoembryonic Antigen 10 µg 130
1 mg 2,800

CEACAm7 pro-1483 2 µg 50
Recombinant Human Carcinoembryonic Antigen-Related Cell 10 µg 130
Adhesion Molecule 7 1 mg 5,200

CEACAm21 pro-1637 5 µg 50
Recombinant Human Carcinoembryonic Antigen-Related Cell 20 µg 130
Adhesion Molecule 21 1 mg 3,600

CEBP-a pro-433 10 µg 50
Recombinant Human CCAAT/enhancer binding Protein(C/ 50 µg 130
EBP) Α 1 mg 1,800

614 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
CEBP-g pro-434 10 µg 50
Recombinant Human CCAAT/enhancer binding Protein(C/EBP) 50 µg 130
Gamma 1 mg 1,800

CENPA pro-389 5 µg 50
Recombinant Human Centromere Protein-A 20 µg 130
1 mg 3,900

CENPB pro-390 5 µg 50
Recombinant Human Centromere Protein-B 20 µg 130
1 mg 3,900

CENPH pro-966 5 µg 50
Recombinant Human Centromere Protein-H 20 µg 130
1 mg 2,700

CENPm pro-1626 5 µg 50
Recombinant Human Centromere Protein-m 20 µg 130
1 mg 2,700

CETN1 pro-1104 2 µg 50
Recombinant Human Centrin-1 10 µg 130
1 mg 5,200

CETN2 pro-060 2 µg 50
Recombinant Human Centrin-2 10 µg 130
1 mg 5,200

PEPTIDES INTERNATIONAL
CETN3 pro-533 5 µg 50
Recombinant Human Centrin-3 20 µg 130
1 mg 3,600

CFL1 pro-591 5 µg 50
Recombinant Human Cofilin-1 20 µg 130
1 mg 3,600

CFL2 pro-912 5 µg 50
Recombinant Human Cofilin-2 20 µg 130
1 mg 2,700

CFLAR pro-920 5 µg 50
Recombinant Human CASP8 and FADD-Like Apoptosis 20 µg 130
Regulator 1 mg 2,700

CHCHD3 pro-815 2 µg 50
Recombinant Human Coiled-Coil-Helix-Coiled-Coil-Helix 10 µg 130
Domain Containing 3 100 µg 1,200

CHD4 pro-112 5 µg 50
Recombinant Human Chromodomain Helicase DNA Binding 20 µg 130
Protein 4 1 mg 3,900

CHGA pro-692 5 µg 50
Recombinant Human Chromogranin A 20 µg 130
1 mg 2,700

Order Hotline 1-800-777-4779 502-266-8787 615

 Recombinant proteins

CHGA GST pro-491 2 µg 175

Recombinant Human Chromogranin A GST Tag 5 µg 270
10 µg 490

CHGA His pro-699 2 µg 50

Recombinant Human Chromogranin A His Tag 10 µg 130
1 mg 5,200

CHGB pro-824 2 µg 50
Recombinant Human Chromogranin B 10 µg 130
1 mg 5,200

CHmP1A pro-1308 2 µg 50
Recombinant Human Chromatin Modifying Protein 1A 10 µg 130
100 µg 1,200

CHmP1B pro-1117 2 µg 50
Recombinant Human Charged Multivesicular Body Protein 1B 10 µg 130
100 µg 1,200

CHmP2A pro-503 5 µg 50
Recombinant Human Chromatin Modifying Protein 2A 20 µg 130
1 mg 3,600

CHmP2B pro-877 5 µg 50
Recombinant Human Chromatin Modifying Protein 2B 20 µg 130
1 mg 3,600

CHmP4A pro-1024 1 µg 50
PEPTIDES INTERNATIONAL

Recombinant Human Chromatin Modifying Protein 4A 5 µg 130

50 µg 1,100

CHmP5 pro-1232 5 µg 50
Recombinant Human Charged Multivesicular Body Protein 5 20 µg 130
1 mg 2,700

CHmP6 pro-1085 5 µg 50
Recombinant Human Charged Multivesicular Body Protein 6 20 µg 130
1 mg 2,700

CHP1 pro-847 5 µg 50
Recombinant Human Calcium Binding Protein P22 25 µg 130
1 mg 2,250

CHRAC1 pro-1391 5 µg 50
Recombinant Human Chromatin Accessibility Complex 1 20 µg 130
1 mg 2,700

CIAO1 pro-1396 5 µg 50
Recombinant Human Cytosolic Iron-Sulfur Protein Assembly 1 20 µg 130
1 mg 2,700

616 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
CIAPIN1 pro-024 5 µg 50
Recombinant Human Cytokine Induced Apoptosis Inhibitor 1 20 µg 130
1 mg 2,700

CIRBP pro-746 5 µg 50
Recombinant Human Cold Inducible RNA Binding Protein 20 µg 130
1 mg 2,700

CISD1 pro-1221 5 µg 50
Recombinant Human CDGSH Iron Sulfur Domain 1 20 µg 130
1 mg 2,700

CITED2 pro-701 5 µg 50
Recombinant Human Cbp/p300-Interacting Transactivator 2 20 µg 130
1 mg 3,000

CLDN4 pro-203 2 µg 50
Recombinant Human Claudin-4 10 µg 130
1 mg 5,200

CLEC2B pro-526 5 µg 50
Recombinant Human C-type Lectin Domain Family 2, Member 20 µg 130
B 1 mg 2,700

CLIC1 pro-833 5 µg 50
Recombinant Human Chloride Intracellular Channel 1 25 µg 130
1 mg 2,250

CLIC2 pro-198

PEPTIDES INTERNATIONAL
5 µg 50
Recombinant Human Chloride Intracellular Channel 2 20 µg 130
1 mg 2,700

CLIC4 pro-173 5 µg 50
Recombinant Human Chloride Intracellular Channel 4 20 µg 130
1 mg 3,600

CLNS1A pro-1277 5 µg 50
Recombinant Human Chloride Channel, Nucleotide-Sensitive, 20 µg 130
1A 1 mg 2,700

CLTA pro-1144 5 µg 50
Recombinant Human Clathrin, Light Chain A 20 µg 130
1 mg 2,700

CLTB pro-1172 5 µg 50
Recombinant Human Clathrin, Light Chain B 20 µg 130
1 mg 3,600

CmC1 pro-1651 5 µg 50
Recombinant Human COX Assembly Mitochondrial Protein 1  20 µg 130
1 mg 2,700

CNBP pro-1371 5 µg 50
Recombinant Human Cellular Nucleic Acid Binding Protein 20 µg 130
1 mg 2,700

Order Hotline 1-800-777-4779 502-266-8787 617

 Recombinant proteins

CNN1 pro-1129 5 µg 50
Recombinant Human Calponin 1, Basic, Smooth Muscle 20 µg 130
1 mg 2,700

CNPY3 pro-1386 5 µg 50
Recombinant Human Canopy 3 Homolog  20 µg 130
1 mg 2,700

CNOT8 pro-1517 5 µg 50
Recombinant Human CCR4-NOT Transcription Complex, 20 µg 130
Subunit 8 1 mg 3,600

mCNOT7 pro-908 5 µg 50
Recombinant Mouse CCR4-NOT Transcription Complex, 20 µg 130
Subunit 7 1 mg 2,700

CNRIP1 pro-1214 5 µg 50
Recombinant Human Cannabinoid Receptor Interacting Protein 20 µg 130
1 1 mg 2,700

COL4A3 pro-387 2 µg 50
Recombinant Human Collagen Type IV Α 3 10 µg 130
1 mg 5,200

COL4A3BP pro-837 5 µg 50
Recombinant Human Collagen Type IV Α 3 Binding Protein 25 µg 130
1 mg 2,250
PEPTIDES INTERNATIONAL

Collagen-3 pro-480 10 mg 215

Recombinant Human Collagen-3 50 mg 860
100 mg 1,400

COmmD1 pro-862 2 µg 50
Recombinant Human Copper Metabolism Domain Containing 1 10 µg 130
1 mg 5,200

COmmD9 pro-1244 2 µg 50
Recombinant Human COmm Domain Containing 9 10 µg 130
1 mg 5,200

COmmD7 pro-1481 5 µg 50
Recombinant Human COmm Domain Containing 7 20 µg 130
1 mg 2,700

COmP HEK pro-132 2 µg 50

Recombinant Human Cartilage Oligomeric Matrix Protein, HEK 10 µg 130
1 mg 5,200

COPS6 pro-1650 5 µg 50
Recombinant Human COP9 Constitutive Photomorphogenic 6 20 µg 130
1 mg 3,600

COPS8 pro-983 5 µg 50
Recombinant Human COP9 Constitutive Photomorphogenic 8 20 µg 130
1 mg 2,700

618 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
COPZ1 pro-221 2 µg 50
Recombinant Human Coatomer Protein Complex, Subunit Zeta 10 µg 130
1 1 mg 5,200

COTL1 pro-064 5 µg 50
Recombinant Human Coactosin-Like 1 20 µg 130
1 mg 2,700

COX4NB pro-917 5 µg 50
Recombinant Human COX4NB 20 µg 130
1 mg 2,700

COX5A pro-1331 5 µg 50
Recombinant Human Cytochrome C Oxidase Subunit Va 20 µg 130
1 mg 2,700

COX5B pro-1513 2 µg 50
Recombinant Human Cytochrome C Oxidase Subunit Vb 10 µg 130
100 µg 1,200

CPLX1 pro-645 10 µg 50
Recombinant Human Complexin-1 50 µg 130
1 mg 1,800

CPPED1 pro-1500 5 µg 50
Recombinant Human Calcineurin-Like Phosphoesterase 20 µg 130
Domain Containing 1 1 mg 2,700

PEPTIDES INTERNATIONAL
CPSF4 pro-1406 5 µg 50
Recombinant Human Cleavage And Polyadenylation Specific 20 µg 130
Factor 4 1 mg 2,700

CRABP1 pro-710 5 µg 50
Recombinant Human Cellular Retinoic Acid Binding Protein 1 20 µg 130
1 mg 3,000

CRABP2 pro-637 5 µg 50
Recombinant Human Cellular Retinoic Acid binding Protein 2 20 µg 130
1 mg 3,600

CRADD pro-465 5 µg 50
Recombinant Human Caspase and RIP Adapter with Death 25 µg 130
Domain 1 mg 2,800

CRCP pro-919 5 µg 50
Recombinant Human CGRP Receptor Component 20 µg 130
1 mg 2,700

CREG1 pro-1196 5 µg 50
Recombinant Human Cellular Repressor of E1A-Stimulated 20 µg 130
Genes 1 1 mg 2,700

CRIP1 pro-1563 5 µg 50
Recombinant Human Cysteine-Rich Protein 1  20 µg 130
1 mg 2,700

Order Hotline 1-800-777-4779 502-266-8787 619

 Recombinant proteins

CRIPT pro-1105 2 µg 50
Recombinant Human Cysteine-Rich PDZ-Binding Protein 10 µg 130
1 mg 5,200

CRISP1 pro-473 2 µg 50
Recombinant Human Cysteine-Rich Secretory Protein 1 10 µg 130
1 mg 5,200

CRK pro-275 1 µg 50
Recombinant Human V-crk Sarcoma Virus CT10 Oncogene 5 µg 130
50 µg 1,100

CRKL pro-063 5 µg 50
Recombinant Human V-crk Sarcoma Virus CT10 Oncogene 20 µg 130
Homolog (Avian)-Like 1 mg 2,700

CRmP-1 pro-493 2 µg 175

Recombinant Human Collapsin Response Mediator Protein-1 5 µg 270
10 µg 490

CRNN pro-797 5 µg 50
Recombinant Human Cornulin 25 µg 130
1 mg 2,250

CRP pro-335 0.5 mg 210

Recombinant Human C-Reactive Protein 1 mg 325
5 mg 1,350

CRP pro-557 200 µg 50

PEPTIDES INTERNATIONAL

Human C-Reactive Protein 1 mg 130

10 mg 850

CRP (19-224 a.a.) pro-914 5 µg 50

Recombinant Human C-Reactive Protein (19-224 a.a.) 20 µg 130
1 mg 2,700

CRYGC pro-1095 5 µg 50
Recombinant Human Crystallin, Gamma C 20 µg 130
1 mg 2,700

CRYGD pro-913 5 µg 50
Recombinant Human Crystallin, Gamma D 20 µg 130
1 mg 2,700

CRYGN pro-1152 5 µg 50
Recombinant Human Crystallin, Gamma N 20 µg 130
1 mg 2,700

CRYGS pro-963 5 µg 50
Recombinant Human Crystallin, Gamma S 20 µg 130
1 mg 2,700

CSDC2 pro-1439 2 µg 50
Recombinant Human Cold Shock Domain Containing C2 10 µg 130
1 mg 5,200

620 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
CSN2 pro-1047 2 µg 50
Recombinant Human Casein Β 10 µg 130
1 mg 5,200

CSRP2 pro-1096 2 µg 50
Recombinant Human Cysteine and Glycine-rich Protein 2 10 µg 130
1 mg 5,200

CST1 pro-1006 5 µg 50
Recombinant Human Cystatin SN 20 µg 130
1 mg 2,700

CST3 pro-656 5 µg 50
Recombinant Human Cystatin C 25 µg 130
1 mg 2,400

CST3 pro-413 20 µg 50
Human Cystatin C 100 µg 130
1 mg 1,400

mCST3 pro-597 2 µg 50
Recombinant Mouse Cystatin-C 10 µg 130
1 mg 5,200

rCST3 pro-438 2 µg 50
Recombinant Rat Cystatin C 10 µg 130
1 mg 5,200

CST3 Active pro-961 2 µg 50

PEPTIDES INTERNATIONAL
Recombinant Human Cystatin C Active 10 µg 130
1 mg 5,200

k9Cystatin-C pro-138 2 µg 50
Recombinant Canine Cystatin-C 10 µg 130
1 mg 5,200

CST4 pro-1097 5 µg 50
Recombinant Human Cystatin 4 20 µg 130
1 mg 2,700

CST6 pro-892 2 µg 50
Recombinant Human Cystatin E/m 10 µg 130
1 mg 5,200

CST9 pro-955 5 µg 50
Recombinant Human Cystatin 9 20 µg 130
1 mg 2,700

CST11 pro-1475 5 µg 50
Recombinant Human Cystatin 11 20 µg 130
1 mg 2,700

CSTA pro-086 2 µg 50
Recombinant Human Cystatin-A 10 µg 130
1 mg 5,200

Order Hotline 1-800-777-4779 502-266-8787 621

 Recombinant proteins

CSTA GST pro-543 2 µg 175

Recombinant Human Cystatin-A, GST tag 5 µg 270
10 µg 490

CSTA His pro-504 5 µg 50

Recombinant Human Cystatin-A His Tag 20 µg 130
1 mg 2,700

CSTB pro-609 5 µg 50
Recombinant Human Cystatin-B 20 µg 130
1 mg 3,600

CSTF1 pro-1170 5 µg 50
Recombinant Human Cleavage Stimulation Factor 1 20 µg 130
1 mg 2,700

CTBP1 pro-796 5 µg 50
Recombinant Human C-Terminal Binding Protein 1 25 µg 130
1 mg 2,250

CTNNBIP1 pro-850 5 µg 50
Recombinant Human Catenin, Β Interacting Protein 1 25 µg 130
1 mg 2,250

CUEDC2 pro-1680 5 µg 50
Recombinant Human CUE Domain Containing 2 20 µg 130
1 mg 2,700

CUL1 pro-268 2 µg 50
PEPTIDES INTERNATIONAL

Recombinant Human Cullin-1 10 µg 130

1 mg 5,200

CUTA pro-812 5 µg 50
Recombinant Human CutA Divalent Cation Tolerance Homolog 25 µg 130
1 mg 2,250

CUTC pro-911 5 µg 50
Recombinant Human cutC Copper Transporter Homolog 20 µg 130
1 mg 2,700

CXADR pro-1548 5 µg 50
Recombinant Human Coxsackie Virus And Adenovirus 20 µg 130
Receptor 1 mg 2,700

CYB5A pro-910 5 µg 50
Recombinant Human Cytochrome B5 Type A 20 µg 130
1 mg 2,700

CYB5R3 pro-1026 5 µg 50
Recombinant Human Cytochrome B5 Reductase 3 20 µg 130
1 mg 2,700

Cyclosporin-A pro-408 1gra m 50

Cyclosporin-A 4gra m 130
100gra m 1,200

622 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
CYGB pro-842 2 µg 50
Recombinant Human Cytoglobin 10 µg 130
1 mg 5,200

Cys-Protein-G His pro-1238 1 mg 50

Recombinant Cys-Protein G His Tag 10 mg 250
100 mg 1,500

CYTH2 pro-1248 5 µg 50
Recombinant Human Cytohesin 2 20 µg 130
1 mg 2,700

D4GDI pro-296 2 µg 175

Recombinant Human D4-GDI 5 µg 270
10 µg 490

DAG1 pro-1571 2 µg 50
Recombinant Human Dystroglycan 1 10 µg 130
1 mg 5,200

DBI pro-832 5 µg 50
Recombinant Human Diazepam Binding Inhibitor 25 µg 130
1 mg 2,250

DBNDD1 pro-1162 5 µg 50
Recombinant Human Dysbindin (Dystrobrevin Binding Protein 20 µg 130
1) Domain Containing 1 1 mg 2,700

DBNDD2 pro-1167

PEPTIDES INTERNATIONAL
2 µg 50
Recombinant Human Dysbindin (Dystrobrevin Binding Protein 10 µg 130
1) Domain Containing 2 1 mg 5,200

DBR1 pro-1708 2 µg 50
Recombinant Human Debranching RNA Lariats 1 10 µg 130
1 mg 5,200

DCAF7 pro-909 5 µg 50
Recombinant Human DDB1 and CUL4 Associated Factor 7 20 µg 130
1 mg 2,700

dCASQ2 pro-410 2 µg 175

Dog Calsequestrin-2 5 µg 270
10 µg 490

DCN pro-1583 2 µg 50
Recombinant Human Decorin 10 µg 130
1 mg 5,200

DCUN1D1 pro-078 5 µg 50
Recombinant Human DCN1 Defective in Cullin Neddylation 1 20 µg 130
Domain Containing 1 1 mg 2,700

DCUN1D2 pro-899 5 µg 50
Recombinant Human DCN1 Defective in Cullin Neddylation 1 20 µg 130
Domain Containing 2 1 mg 2,700

Order Hotline 1-800-777-4779 502-266-8787 623

 Recombinant proteins

DCUN1D4 pro-1715 2 µg 50
Recombinant Human DCN1 Defective in Cullin Neddylation 1 10 µg 130
Domain Containing 4 1 mg 5,200

DDIT3 pro-638 5 µg 50
Recombinant Human DNA Damage Inducible Transcript 3 20 µg 130
1 mg 3,600

DDIT4 pro-094 2 µg 50
Recombinant Human DNA Damage Inducible Transcript 4 10 µg 130
1 mg 5,200

DDX56 pro-1723 5 µg 50
Recombinant Human DEAD Box Protein 56 20 µg 130
1 mg 2,700

DEDD pro-1349 2 µg 50
Recombinant Human Death Effector Domain Containing 10 µg 130
1 mg 5,200

DENR pro-926 5 µg 50
Recombinant Human Density-Regulated Protein 20 µg 130
1 mg 2,700

Desmin pro-520 5 µg 50
Recombinant Human Desmin 20 µg 130
1 mg 3,600

DFFA pro-718 5 µg 50
PEPTIDES INTERNATIONAL

Recombinant Human DNA Fragmentation Factor Subunit Α 25 µg 130

1 mg 3,000

DGCR6 pro-1372 5 µg 50
Recombinant Human DiGeorge Syndrome Critical Region Gene 20 µg 130
6 1 mg 3,600

DGCR6L pro-1454 2 µg 50
Recombinant Human DiGeorge Syndrome Critical Region Gene 10 µg 130
6-Like 100 µg 1,200

DIRAS1 pro-256 2 µg 50
Recombinant Human DIRAS family, GTP-binding RAS-like 1 10 µg 130
1 mg 5,200

DKK1 pro-673 2 µg 180

Recombinant Human Dickkopf-Related Protein 1 5 µg 300
10 µg 480

DKK1 pro-1566 5 µg 50
Recombinant Human Dickkopf-Related Protein 1 20 µg 130
1 mg 2,700

DKK2 pro-1205 2 µg 50
Recombinant Human Dickkopf-Related Protein 2 10 µg 130
100 µg 1,200

624 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
DKK3 pro-1175 5 µg 50
Recombinant Human Dickkopf-Related Protein 3 20 µg 130
1 mg 2,700

DKK3 HEK pro-1638 2 µg 50

Recombinant Human Dickkopf-Related Protein 3, HEK 10 µg 130
1 mg 3,900

DNAL1 pro-1357 5 µg 50
Recombinant Human Dynein Axonemal Light Chain 1 20 µg 130
1 mg 2,700

DNAL4 pro-227 5 µg 50
Recombinant Human Dynein Axonemal Light Chain 4 20 µg 130
1 mg 2,700

DNTTIP1 pro-1706 5 µg 50
Recombinant Human Deoxynucleotidyltransferase Terminal 20 µg 130
Interacting Protein 1 1 mg 2,700

DPPA3 pro-1291 2 µg 50
Recombinant Human Developmental Pluripotency Associated 3 10 µg 130
1 mg 5,200

DPPA4 pro-1546 5 µg 50
Recombinant Human Developmental Pluripotency Associated 4 20 µg 130
1 mg 3,600

DR1

PEPTIDES INTERNATIONAL
pro-542 5 µg 50
Recombinant Human Down-Regulator of Transcription 1 25 µg 130
1 mg 2,700

DRG1 pro-885 2 µg 50
Recombinant Human Developmentally Regulated GTP Binding 10 µg 130
Protein 1 1 mg 5,200

DSTN pro-1137 5 µg 50
Recombinant Human Destrin 20 µg 130
1 mg 2,700

DTNBP1 pro-675 5 µg 50
Recombinant Human Dystrobrevin-Binding Protein 1 Isoform C 20 µg 130
1 mg 3,600

DYNLL1 pro-262 5 µg 50
Recombinant Human Dynein Light Chain LC8 Type-1 20 µg 130
1 mg 2,700

DYNLL2 pro-235 5 µg 50
Recombinant Human Dynein Light Chain LC8 Type-2 20 µg 130
1 mg 2,700

DYNLRB1 pro-489 2 µg 50
Recombinant Human Dynein Light Chain Roadblock-Type 1 10 µg 130
1 mg 5,200

Order Hotline 1-800-777-4779 502-266-8787 625

 Recombinant proteins

DYNLRB2 pro-174 5 µg 50
Recombinant Human Dynein Light Chain Roadblock-Type 2 20 µg 130
1 mg 2,700

DYNLT1 pro-757 5 µg 50
Recombinant Human Dynein, Light Chain, Tctex-Type 1 20 µg 130
1 mg 2,700

DYNLT3 pro-1197 2 µg 50
Recombinant Human Dynein, Light Chain, Tctex-Type 3 10 µg 130
1 mg 5,200

EBAG9 pro-343 10 µg 50
Recombinant Human Estrogen Receptor Binding Site 50 µg 130
Associated Antigen 9 1 mg 1,800

ECSIT pro-1241 2 µg 50
Recombinant Human ECSIT homolog  10 µg 130
1 mg 5,200

EDF1 pro-494 5 µg 50
Recombinant Human Endothelial Differentiation-Related Factor 25 µg 130
1 1 mg 2,700

EED pro-1503 5 µg 50
Recombinant Human Embryonic Ectoderm Development 20 µg 130
1 mg 2,700

EEF1B2
PEPTIDES INTERNATIONAL

pro-167 1 µg 50
Recombinant Human Eukaryotic Translation Elongation Factor 5 µg 130
1Β2 50 µg 1,200

EEF1D pro-170 2 µg 50
Recombinant Human Eukaryotic Translation Elongation Factor 10 µg 130
1 Delta 1 mg 5,200

EEF1E1 pro-199 5 µg 50
Recombinant Human Eukaryotic Translation Elongation Factor 20 µg 130
1 Epsilon 1 1 mg 2,700

EGFP pro-1606 5 µg 50
Recombinant Enhanced Green Fluorescent Protein 25 µg 130
1 mg 1,900

EFNA1 pro-971 5 µg 50
Recombinant Human Ephrin A1 20 µg 130
1 mg 3,600

EFNA3 pro-1460 5 µg 50
Recombinant Human Ephrin A3 20 µg 130
1 mg 2,700

EFNA4 pro-498 2 µg 175

Recombinant Human Ephrin A4 5 µg 270
10 µg 490

626 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
EFNB1 pro-918 5 µg 50
Recombinant Human Ephrin- B1 20 µg 130
1 mg 2,700

EFNB2 pro-937 5 µg 50
Recombinant Human Ephrin- B2 20 µg 130
1 mg 2,700

EFNB3 pro-1169 5 µg 50
Recombinant Human Ephrin- B3 20 µg 130
1 mg 2,700

EGLN3 pro-1143 2 µg 50
Recombinant Human Egl Nine Homolog 3 10 µg 130
100 µg 1,200

EHF pro-1436 2 µg 50
Recombinant Human Ets Homologous Factor 10 µg 130
1 mg 5,200

EIF1 pro-773 2 µg 50
Recombinant Human Eukaryotic Translation Initiation Factor 1 10 µg 130
1 mg 5,200

EIF1AX pro-253 5 µg 50
Recombinant Human Eukaryotic Translation Initiation Factor 20 µg 130
1A X-linked 1 mg 2,700

EIF1AY pro-098

PEPTIDES INTERNATIONAL
2 µg 50
Recombinant Human Eukaryotic Translation Initiation Factor 10 µg 130
1A Y-linked 1 mg 5,200

EIF1B pro-175 5 µg 50
Recombinant Human Eukaryotic Translation Initiation Factor 25 µg 130
1B 1 mg 2,700

EIF2B1 pro-209 1 µg 50
Recombinant Human Eukaryotic Translation Initiation Factor 5 µg 130
2B Subunit 1 Α 50 µg 1,200

EIF2S1 pro-845 2 µg 50
Recombinant Human Eukaryotic Translation Initiation Factor 2 10 µg 130
Subunit 1 Α 1 mg 5,200

EIF3F pro-1722 5 µg 50
Recombinant Human Eukaryotic Translation Initiation Factor 20 µg 130
3F 1 mg 2,700

EIF3J pro-970 2 µg 50
Recombinant Human Eukaryotic Translation Initiation Factor 3J 10 µg 130
1 mg 5,200

EIF3K pro-179 2 µg 50
Recombinant Human Eukaryotic Translation Initiation Factor 10 µg 130
3K 1 mg 5,200

Order Hotline 1-800-777-4779 502-266-8787 627

 Recombinant proteins

EIF4A3 pro-1007 5 µg 50
Recombinant Human Eukaryotic Translation Initiation Factor 20 µg 130
4A3 1 mg 2,700

EIF4E pro-530 2 µg 50
Recombinant Human Eukaryotic Translation Initiation Factor 10 µg 130
4E 1 mg 5,200

EIF4EBP1 pro-532 10 µg 50
Recombinant Human Eukaryotic Translation Initiation Factor 50 µg 130
4E-Binding Protein 1 1 mg 1,800

EIF4EBP2 pro-176 5 µg 50
Recombinant Human Eukaryotic Translation Initiation Factor 20 µg 130
4E-Binding Protein 2 1 mg 2,700

EIF4H pro-1114 5 µg 50
Recombinant Human Eukaryotic Translation Initiation Factor 20 µg 130
4H 1 mg 3,600

EIF5A pro-674 5 µg 50
Recombinant Human Eukaryotic Translation Initiation Factor 20 µg 130
5A 1 mg 3,600

EIF5A2 pro-846 2 µg 50
Recombinant Human Eukaryotic Translation Initiation Factor 10 µg 130
1 mg 5,200
PEPTIDES INTERNATIONAL

5A2

Eledoisin pro-281 5 mg 50
Eledoisin 20 mg 130
100 mg 400

ELP5 pro-1660 2 µg 50
Recombinant Human Elongator Acetyltransferase Complex 10 µg 130
Subunit 5 1 mg 5,200

EmC2 pro-1613 5 µg 50
Recombinant Human ER Membrane Protein Complex Subunit 2 20 µg 130
1 mg 2,700

EmCN pro-1156 2 µg 50
Recombinant Human Endomucin 10 µg 130
100 µg 1,200

EmG1 pro-1122 5 µg 50
Recombinant Human EmG1 Nucleolar Protein 20 µg 130
1 mg 2,700

Endostatin pro-248 20 µg 50
Recombinant Human Endostatin 100 µg 130
1 mg 990

Enfuvirtide pro-376 90 mg 195

Enfuvirtide T-20 900 mg 1,600
1.8gra m 2,700

628 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
ENHO pro-1569 2 µg 50
Recombinant Human Energy Homeostasis Associated 10 µg 130
1 mg 5,200

ENSA pro-772 5 µg 50
Recombinant Human Endosulfine Α 25 µg 130
1 mg 2,250

EPCAm pro-1322 5 µg 50
Recombinant Human Epithelial Cell Adhesion Molecule 20 µg 130
1 mg 2,700

Eptifibatide pro-358 5 mg 50
Human Eptifibatide 25 mg 130
100 mg 390

ER-a pro-499 2 µg 175

Recombinant Human Estrogen Receptor Α 5 µg 270
10 µg 490

ERCC1 pro-1106 2 µg 50
Recombinant Human Excision Repair Cross-Complementing 1 10 µg 130
1 mg 5,200

ERCC1, GST pro-496 2 µg 175

Recombinant Human Excision Repair Cross-Complementing 5 µg 270
1, GST Tag 10 µg 490

ERH pro-121

PEPTIDES INTERNATIONAL
5 µg 50
Recombinant Human Enhancer of Rudimentary 20 µg 130
1 mg 2,700

ERLIN2 pro-1266 5 µg 50
Recombinant Human ER Lipid Raft Associated 2 20 µg 130
1 mg 2,700

ERP27 pro-046 2 µg 50
Recombinant Human Endoplasmic Reticulum Protein 27 10 µg 130
1 mg 5,200

ERP44 pro-547 5 µg 50
Recombinant Human Endoplasmic Reticulum Protein 44 25 µg 130
1 mg 2,700

ESAT6 pro-291 2 µg 50
Recombinant Early Secretory Target Mycobacterium 10 µg 130
Tuberculosis 1 mg 5,200

ESm1 pro-1328 5 µg 50
Recombinant Human Endothelial Cell-Specific Molecule 1 20 µg 130
1 mg 2,700

ETFB pro-220 2 µg 50
Recombinant Human Electron-Transfer-FlavoProtein Β 10 µg 130
Polypeptide 1 mg 5,200

Order Hotline 1-800-777-4779 502-266-8787 629

 Recombinant proteins

ETHE1 pro-1027 5 µg 50
Recombinant Human Ethylmalonic Encephalopathy 1 20 µg 130
1 mg 3,600

ETS1 pro-501 2 µg 175

Recombinant Human C-ets-1 Protein 5 µg 270
10 µg 490

EXOSC10 pro-444 5 µg 50
Recombinant Human Exosome Component 10 20 µg 130
1 mg 3,500

EXOSC5 pro-1059 5 µg 50
Recombinant Human Exosome Component 5 25 µg 130
1 mg 2,700

EXOSC9 pro-126 2 µg 50
Recombinant Human Exosome Component 9 10 µg 130
1 mg 4,100

EYA2 pro-1071 2 µg 50
Recombinant Human Eyes Absent Homolog 2 10 µg 130
1 mg 5,200

F11R pro-1112 5 µg 50
Recombinant Human F11 Receptor 20 µg 130
1 mg 2,700

F3 pro-312 2 µg 50
PEPTIDES INTERNATIONAL

Recombinant Human Coagulation Factor III 10 µg 130

1 mg 4,800

F7 pro-331 10 µg 130
Recombinant Human Coagulation Factor VIIa 50 µg 315
1 mg 2,800

F8 pro-317 200IU 490

Human Coagulation Factor VIII 400IU 890
600IU 1,200

F8 pro-318 250IU 1,200

Recombinant Human Coagulation Factor VIII 500IU 2,200
1000IU 3,750

F9 pro-353 100IU 900

Human Coagulation Factor IX 500IU 3,600
1000IU 6,500

FABP1 pro-1593 2 µg 50
Recombinant Human Fatty Acid Binding Protein-1 10 µg 130
1 mg 5,200

FABP1 His pro-588 5 µg 50

Recombinant Human Fatty Acid Binding Protein-1 His Tag 25 µg 130
1 mg 2,800

630 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
mFABP1 pro-1121 5 µg 50
Recombinant Mouse Fatty Acid Binding Protein-1 25 µg 130
1 mg 2,700

FABP12 pro-738 2 µg 50
Recombinant Human Fatty Acid Binding Protein-12 10 µg 130
1 mg 5,200

FABP2 pro-1579 5 µg 50
Recombinant Human Fatty Acid Binding Protein-2 25 µg 130
1 mg 2,700

FABP2 His pro-669 5 µg 50

Recombinant Human Fatty Acid Binding Protein-2, His Tag 25 µg 130
1 mg 2,500

FABP3 pro-340 5 µg 50
Recombinant Human Fatty Acid Binding Protein-3 20 µg 130
1 mg 3,600

FABP3 His pro-668 5 µg 50

Recombinant Human Fatty Acid Binding Protein-3, His Tag 25 µg 130
1 mg 2,500

FABP4 pro-416 2 µg 50
Recombinant Human Fatty Acid Binding Protein-4 10 µg 130
1 mg 3,600

FABP4 His pro-566 5 µg 50

PEPTIDES INTERNATIONAL
Recombinant Human Fatty Acid Binding Protein-4, His Tag 25 µg 130
1 mg 2,500

FABP4 pro-1568 2 µg 50
Human Fatty Acid Binding Protein-4 10 µg 130
100 µg 1,200

FABP5 pro-417 2 µg 50
Recombinant Human Fatty Acid Binding Protein-5 10 µg 130
1 mg 3,600

FABP5 His pro-666 5 µg 50

Recombinant Human Fatty Acid Binding Protein-5, His Tag 25 µg 130
1 mg 2,500

FABP6 pro-649 5 µg 50
Recombinant Human Fatty Acid Binding Protein-6 25 µg 130
1 mg 3,600

FABP6 His pro-667 5 µg 50

Recombinant Human Fatty Acid Binding Protein-6, His Tag 25 µg 130
1 mg 2,500

FABP7 pro-628 5 µg 50
Recombinant Human Fatty Acid Binding Protein-7 25 µg 130
1 mg 2,800

Order Hotline 1-800-777-4779 502-266-8787 631

 Recombinant proteins

FABP7 His pro-661 5 µg 50

Recombinant Human Fatty Acid Binding Protein-7, His Tag 25 µg 130
1 mg 2,500

FABP9 pro-1088 5 µg 50
Recombinant Human Fatty Acid Binding Protein-9 20 µg 130
1 mg 2,700

FADD pro-733 2 µg 50
Recombinant Human Fas-Associated Death Domain 10 µg 130
1 mg 5,200

FAm3A pro-1584 2 µg 50
Recombinant Human Family with Sequence Similarity 3, 10 µg 130
Member A 1 mg 5,200

FAm3B pro-139 2 µg 50
Recombinant Human Family with Sequence Similarity 3, 10 µg 130
Member B 1 mg 5,200

FAm3C pro-952 2 µg 50
Recombinant Human Family with Sequence Similarity 3, 10 µg 130
Member C 1 mg 5,200

FAm3D pro-1585 2 µg 50
Recombinant Human Family with Sequence Similarity 3, 10 µg 130
Member D 1 mg 5,200

FAm49B pro-1411
PEPTIDES INTERNATIONAL

5 µg 50
Recombinant Human Family with Sequence Similarity 49, 20 µg 130
Member B 1 mg 2,700

FAm50A pro-1477 5 µg 50
Recombinant Human Family with Sequence Similarity 50, 20 µg 130
Member A 1 mg 2,700

FAm84A pro-1610 5 µg 50
Recombinant Human Family with Sequence Similarity 84, 20 µg 130
Member A 1 mg 2,700

FAm107B pro-1691 5 µg 50
Recombinant Human Family with Sequence Similarity 107, 20 µg 130
Member B 1 mg 2,700

FBLIm1 pro-1473 2 µg 50
Recombinant Human Filamin Binding LIm Protein 1 10 µg 130
100 µg 1,200

FBXO6 pro-1522 5 µg 50
Recombinant Human F-Box Protein 6 20 µg 130
1 mg 2,700

FCGR1A pro-1228 2 µg 50
Recombinant Human CD64 10 µg 130
100 µg 1,200

632 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
FCGR2A pro-029 2 µg 50
Recombinant Human CD32a 10 µg 130
100 µg 1,200

FCGR2B pro-1295 2 µg 50
Recombinant Human CD32 10 µg 130
100 µg 1,200

FCGR3A pro-1150 5 µg 50
Recombinant Human CD16a 20 µg 130
1 mg 2,700

FDCSP pro-1339 5 µg 50
Recombinant Human Follicular Dendritic Cell Secreted Protein 20 µg 130
1 mg 2,700

FDX1 pro-713 5 µg 50
Recombinant Human Ferredoxin-1 25 µg 130
1 mg 3,000

Ferritin pro-564 200 µg 100

Human Liver Ferritin 1 mg 400
10 mg 2,000

Ferritin Heavy pro-658 5 µg 50

Recombinant Human Ferritin Heavy Chain 25 µg 130
1 mg 3,600

Ferritin Light pro-650 5 µg 50

PEPTIDES INTERNATIONAL
Recombinant Human Ferritin Light Chain 25 µg 130
1 mg 3,600

FETUB pro-1586 2 µg 50
Recombinant Human Fetuin-B 10 µg 130
1 mg 5,200

FHIT pro-828 5 µg 50
Recombinant Human Fragile Histidine Triad 25 µg 130
1 mg 2,250

FHIT, GST pro-297 2 µg 175

Recombinant Human Fragile Histidine Triad, GST Tag 5 µg 270
10 µg 490

Fibrinogen pro-1421 10 µg 390

Recombinant Human Fibrinogen 50 µg 1,500
100 µg 2,550

Fibronectin pro-448 200 µg 50

Human Fibronectin 1 mg 130
10 mg 950

Filamin pro-521 10 µg 50
Filamin 50 µg 130
1 mg 1,400

Order Hotline 1-800-777-4779 502-266-8787 633

 Recombinant proteins

FImC pro-120 5 µg 50
Recombinant E.Coli Chaperone Protein fimC 25 µg 130
1 mg 2,700

FIS1 pro-829 10 µg 50
Recombinant Human Fission-1 25 µg 130
1 mg 2,250

Flagellin pro-1240 20 µg 50
Recombinant Flagellin 100 µg 130
1 mg 1,200

FNDC5 pro-1589 2 µg 50
Recombinant Human Fibronectin Type III Domain Containing 5 10 µg 130
1 mg 5,200

FNDC5 Yeast pro-1663 2 µg 50

Recombinant Human Fibronectin Type III Domain Containing 10 µg 130
5, Yeast 1 mg 5,200

FOPNL pro-1195 5 µg 50
Recombinant Human FGFR1OP N-terminal like 25 µg 130
1 mg 3,600

FOS-B pro-505 2 µg 175

Recombinant Human FOS-B 5 µg 270
10 µg 490

Frataxin pro-761 5 µg 50
PEPTIDES INTERNATIONAL

Recombinant Human Frataxin 25 µg 130

1 mg 3,600

FRZB pro-1345 5 µg 50
Recombinant Human Frizzled-Related Protein 20 µg 130
1 mg 2,700

FSCN1 pro-527 5 µg 50
Recombinant Human Fascin 25 µg 130
1 mg 2,700

FSBP pro-1493 2 µg 50
Recombinant Human Fibrinogen Silencer Binding Protein 10 µg 130
1 mg 5,200

FTSJ2 pro-1207 2 µg 50
Recombinant Human FtsJ RNA Methyltransferase Homolog 2 10 µg 130
1 mg 5,200

FUBP1 pro-1132 5 µg 50
Recombinant Human Far Upstream Element Binding Protein 20 µg 130
1 mg 2,700

FUR pro-622 5 µg 50
Recombinant E.Coli Ferric Uptake Regulator 25 µg 130
1 mg 2,700

634 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
FXYD5 pro-1366 5 µg 50
Recombinant Human FXYD5 20 µg 130
1 mg 2,700

Fyn-p59 pro-506 2 µg 175

Recombinant Human Fyn-p59 5 µg 270
10 µg 490

GABARAP pro-775 10 µg 50
Recombinant Human GABA(A) Receptor-Associated Protein 50 µg 130
1 mg 2,250

GABARAPL1 pro-048 5 µg 50
Recombinant Human GABA(A) Receptor-Associated Protein 20 µg 130
Like 1 1 mg 3,600

GABARAPL2 pro-079 2 µg 50
Recombinant Human GABA(A) Receptor-Associated Protein 10 µg 130
Like 2 1 mg 5,200

GADD45A pro-783 5 µg 50
Recombinant Human Growth Arrest and DNA-Damage- 25 µg 130
Inducible Α 1 mg 2,250

GADD45B pro-563 10 µg 50
Recombinant Human Growth Arrest and DNA-Damage- 50 µg 130
Inducible Β 1 mg 1,800

GADD45G

PEPTIDES INTERNATIONAL
pro-570 10 µg 50
Recombinant Human Growth Arrest and DNA-Damage- 50 µg 130
Inducible Gamma 1 mg 1,800

GADD45GIP1 pro-972 2 µg 50
Recombinant Human Growth Arrest and DNA-Damage- 10 µg 130
Inducible Gamma Interacting Protein 1 1 mg 5,200

GAGA-POZ pro-435 10 µg 50
Recombinant Drosophila Melanogaster GAGA-POZ 50 µg 130
1 mg 1,800

GAGE2A pro-1705 5 µg 50
Recombinant Human G Antigen 2A 20 µg 130
1 mg 2,700

GAGE2D pro-1726 2 µg 50
Recombinant Human G Antigen 2D 10 µg 130
1 mg 5,200

GAL pro-1433 2 µg 50
Recombinant Human Galanin Prepropeptide 10 µg 130
1 mg 5,200

GAP43 pro-1126 2 µg 50
Recombinant Human Growth Associated Protein 43 10 µg 130
100 µg 1,200

Order Hotline 1-800-777-4779 502-266-8787 635

 Recombinant proteins

GAS7 pro-680 10 µg 50
Recombinant Human Growth Arrest-Specific 7, Isoform b 50 µg 130
1 mg 2,400

GCA pro-080 2 µg 50
Recombinant Human Grancalcin 10 µg 130
1 mg 5,200

GCSAm pro-1282 5 µg 50
Recombinant Human Germinal Center-Associated, Signaling 20 µg 130
and Motility 1 mg 2,700

GCSH pro-973 5 µg 50
Recombinant Human Glycine Cleavage System Protein H 20 µg 130
1 mg 2,700

GCV syn-001 100 mg 100

Ganciclovir 500 mg 300
1000 mg 500

Gelatin pro-481 10 mg 200

Recombinant Human Gelatin 50 mg 500
100 mg 750

GEmIN6 pro-1394 2 µg 50
Recombinant Human Gem-Associated Protein 6 10 µg 130
1 mg 5,200

GFER pro-1326 2 µg 50
PEPTIDES INTERNATIONAL

Recombinant Human Growth Factor, Augmenter of Liver 10 µg 130

Regeneration 1 mg 5,200

GFP pro-522 2 µg 50
Glial Filament Protein 10 µg 130
1 mg 3,600

GImAP5 pro-1695 2 µg 50
Recombinant Human GTPase, ImAP Family Member 5 10 µg 130
1 mg 5,200

GImAP6 pro-1628 5 µg 50
Recombinant Human GTPase, ImAP Family Member 6 20 µg 130
1 mg 3,600

GINS4 pro-1270 2 µg 50
Recombinant Human GINS Complex Subunit 4 10 µg 130
100 µg 1,200

GIP pro-1438 2 µg 50
Recombinant Human Gastric Inhibitory Polypeptide 10 µg 130
1 mg 5,200

GIPC1 pro-855 2 µg 50
Recombinant Human GIPC PDZ Domain Member 1 10 µg 130
1 mg 5,200

636 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
GIPC2 pro-1035 5 µg 50
Recombinant Human GIPC PDZ Domain Member 2 20 µg 130
1 mg 2,700

GKN1 pro-1206 2 µg 50
Recombinant Human Gastrokine 1 10 µg 130
100 µg 1,200

GKN2 pro-1588 2 µg 50
Recombinant Human Gastrokine 2 10 µg 130
1 mg 5,200

GLC8 pro-540 10 µg 50
Recombinant Yeast GLC8 50 µg 130
1 mg 1,800

Gliadin pro-114 5 µg 50
Recombinant Wheat Gliadin 20 µg 130
1 mg 3,900

GLIPR2 pro-550 5 µg 50
Recombinant Human GLI Pathogenesis-Related 2 25 µg 130
1 mg 2,700

GLOD4 pro-894 5 µg 50
Recombinant Human Glyoxalase Domain Containing 4 20 µg 130
1 mg 2,700

GLTP pro-1313 2 µg 50

PEPTIDES INTERNATIONAL
Recombinant Human Glycolipid Transfer Protein 10 µg 130
1 mg 5,200

Gm2A pro-1587 2 µg 50
Recombinant Human Gm2 Ganglioside Activator 10 µg 130
1 mg 5,200

GmNN pro-579 5 µg 50
Recombinant Human Geminin 20 µg 130
1 mg 2,800

GNAI1 pro-940 2 µg 50
Recombinant Human Guanine Nucleotide Binding Protein Α 10 µg 130
Inhibiting Activity 1 1 mg 5,200

GNAI2 pro-1310 5 µg 50
Recombinant Human Guanine Nucleotide Binding Protein-G Α 20 µg 130
Inhibiting Activity Polypeptide 2 1 mg 3,600

GNAI3 pro-1074 2 µg 50
Recombinant Human Guanine Nucleotide Binding Protein Α 10 µg 130
Inhibiting Activity 3 1 mg 5,200

GNAZ pro-1225 5 µg 50
Recombinant Human Guanine Nucleotide Binding Protein Α Z 20 µg 130
Polypeptide 1 mg 2,700

Order Hotline 1-800-777-4779 502-266-8787 637

 Recombinant proteins

GNB2L1 pro-1023 2 µg 50
Recombinant Human Guanine Nucleotide Binding Protein Β 10 µg 130
Polypeptide 2-like 1 1 mg 5,200

GNB3 pro-332 5 µg 50
Recombinant Human Guanine Nucleotide Binding Protein Β 20 µg 130
Polypeptide 3 1 mg 3,600

GNLY pro-852 2 µg 50
Recombinant Human Granulysin 10 µg 130
1 mg 4,100

GOLGA7 pro-1445 5 µg 50
Recombinant Human Golgin A7 20 µg 130
1 mg 2,700

GOPC pro-793 5 µg 50
Recombinant Human Golgi-Associated PDZ and Coiled-Coil 25 µg 130
Motif Containing 1 mg 2,250

GOSR2 pro-1399 2 µg 50
Recombinant Human Golgi SNAP Receptor Complex Member 2 10 µg 130
100 µg 1,200

GP2 pro-115 2 µg 50
Recombinant Human GlycoProtein-2 10 µg 130
1 mg 4,500
PEPTIDES INTERNATIONAL

GP9 pro-055 5 µg 50
Recombinant Human GlycoProtein-9 20 µg 130
1 mg 2,700

GPN1 pro-1140 5 µg 50
Recombinant Human GPN-loop GTPase 1 25 µg 130
1 mg 2,700

GPNmB pro-1666 5 µg 50
Recombinant Human GlycoProtein Nmb 20 µg 130
1 mg 2,700

GPNmB HEK pro-1596 2 µg 50

Recombinant Human GlycoProtein Nmb, HEK 10 µg 130
1 mg 5,200

GRAP2 pro-081 2 µg 50
Recombinant Human GRB2-Related Adaptor Protein 2 10 µg 130
1 mg 5,200

GRB2 pro-678 5 µg 50
Recombinant Human Growth Factor Receptor-Bound Protein 2 25 µg 130
1 mg 2,700

GREm1 pro-1359 5 µg 50
Recombinant Human GREm1 20 µg 130
1 mg 2,700

638 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
GREm2 pro-1428 5 µg 50
Recombinant Human GREm2 20 µg 130
1 mg 2,700

GRPEL1 pro-263 2 µg 50
Recombinant Human GrpE-Like 1 10 µg 130
1 mg 5,200

GTF2B pro-762 5 µg 50
Recombinant Human General Transcription Factor IIB 25 µg 130
1 mg 2,250

GTF2E2 pro-1107 2 µg 50
Recombinant Human General Transcription Factor IIE, 10 µg 130
Polypeptide 2 1 mg 5,200

GTF2F2 pro-1093 5 µg 50
Recombinant Human General Transcription Factor IIF, 20 µg 130
Polypeptide 2 1 mg 3,600

GULP1 pro-1398 5 µg 50
Recombinant Human GULP1 20 µg 130
1 mg 2,700

HAND1 pro-1231 5 µg 50
Recombinant Human Heart and Neural Crest Derivatives 20 µg 130
Expressed 1 1 mg 2,700

PEPTIDES INTERNATIONAL
Haptoglobin pro-567 5 µg 50
Recombinant Human Haptoglobin 20 µg 130
1 mg 2,400

Haptoglobin pro-558 200 µg 100

Human Haptoglobin 1 mg 200
10 mg 1,620

H3F3A pro-1452 5 µg 50
Recombinant Human H3 Histone Family 3A 20 µg 130
1 mg 2,700

HAUS1 pro-1077 2 µg 50
Recombinant Human HAUS Augmin-Like Complex, Subunit 1 10 µg 130
1 mg 5,200

HAX1 pro-1417 2 µg 50
Recombinant Human HCLS1 Associated Protein X-1 10 µg 130
1 mg 5,200

HbA1c pro-299 100 µg 50

Human Hemoglobin A1c 0.5 mg 130
10 mg 2,200

HBA2 pro-1183 2 µg 50
Recombinant Human Hemoglobin, Α 2 10 µg 130
1 mg 5,200

Order Hotline 1-800-777-4779 502-266-8787 639

 Recombinant proteins

HBG1 pro-1502 5 µg 50
Recombinant Human Hemoglobin Gamma A 20 µg 130
1 mg 2,700

HBG2 pro-021 5 µg 50
Recombinant Human Hemoglobin Gamma G 20 µg 130
1 mg 2,700

HBQ1 pro-1616 5 µg 50
Recombinant Human Hemoglobin Theta 1 20 µg 130
1 mg 2,700

HBZ pro-803 5 µg 50
Recombinant Human Hemoglobin-Zeta 25 µg 130
1 mg 2,250

HDL pro-559 10 mg 130

Human High Density LipoProtein 100 mg 600
1gra m 5,000

HEBP1 pro-1316 2 µg 50
Recombinant Human Heme Binding Protein 1 10 µg 130
1 mg 5,200

Hemopexin pro-560 10 µg 50
Human Hemopexin 50 µg 130
1 mg 1,600

HEPACAm2 pro-1672 2 µg 50
PEPTIDES INTERNATIONAL

Recombinant Human HEPACAm2 10 µg 130

1 mg 5,200

HES2 pro-1649 2 µg 50
Recombinant Human Hairy and Enhancer of Split 2 10 µg 130
1 mg 5,200

HES7 pro-1306 5 µg 50
Recombinant Human Hairy and Enhancer of Split 7 20 µg 130
1 mg 2,700

HEXIm1 pro-789 2 µg 50
Recombinant Human Hexamethylene Bis-Acetamide Inducible 10 µg 130
1 1 mg 5,200

HFE pro-1332 5 µg 50
Recombinant Human Hemochromatosis 20 µg 130
1 mg 2,700

HHEX pro-1624 2 µg 50
Recombinant Human Hematopoietically Expressed Homeobox 10 µg 130
0.1 mg 1,200

HIF1A pro-477 10 µg 50
Recombinant Human Hypoxia-Inducible Factor-1 Α 50 µg 130
1 mg 1,800

640 Order Hotline 1-800-777-4779 502-266-8787

 PRODUCT Code Qty PRICE

Recombinant proteins
HIF1A (85 a.a.) pro-258 1 µg 50
Recombinant Human Hypoxia-Inducible Factor-1 Α (85 a.a.) 5 µg 130
50 µg 1,100

HIF1A His pro-415 2 µg 50

Recombinant Human Hypoxia-Inducible Factor-1 Α His Tag 10 µg 130
1 mg 5,200

HIF1AN pro-662 10 µg 50
Recombinant Human Hypoxia-Inducible Factor-1 Α Inhibitor 50 µg 130
1 mg 1,800

HINT1 pro-702 5 µg 50
Recombinant Human Histidine Triad Nucleotide Binding 20 µg 130
Protein 1 1 mg 3,000

HINT2 pro-1455 2 µg 50
Recombinant Human Histidine Triad Nucleotide Binding 10 µg 130
Protein 2 1 mg 5,200

Hirudin pro-362 2 µg 50
Recombinant Hirudin 10 µg 130
1 mg 4,080

HLA-C pro-1562 5 µg 50
Recombinant Human Major Histocompatibility Complex Class 20 µg 130
IC 1 mg 2,700

PEPTIDES INTERNATIONAL
HLA-DOA pro-1535 5 µg 50
Recombinant Human Major Histocompatibility Complex Class 20 µg 130
II DO Α 1 mg 2,700

HLF pro-904 1 µg 50
Recombinant Human Hepatic Leukemia Factor 5 µg 130
50 µg 1,100

HmGA1 pro-887 2 µg 50
Recombinant Human High Mobility Group AT-Hook 1 10 µg 130
1 mg 5,200

HmGA2 pro-1469 2 µg 50
Recombinant Human High Mobility Group AT-Hook 2 10 µg 130
100 µg 1,200

HmGB1 pro-581 10 µg 50
Recombinant Human High-mobility Group Box 1 50 µg 130
1 mg 1,800

HmGB1 Hi-5 pro-610 5 µg 50

Recombinant Human High-mobility Group Box 1 Hi-5 Insect 20 µg 130
Cells 1 mg 3,600

HmGB2 pro-888 5 µg 50
Recombinant Human High-mobility Group Box 2 20 µg 130
1 mg 3,600

641 Order Hotline 1-800-777-4779 502-266-8787 Order Hotline 1-800-777-4779 502-266-8787 641
 Recombinant proteins

HmGB3 pro-1623 5 µg 50
Recombinant Human High-mobility Group Box 3 20 µg 130
1 mg 2,700

HmGN1 pro-821 2 µg 50
Recombinant Human High-mobility Group Nucleosome 10 µg 130
Binding Domain 1 1 mg 5,200

HN1 pro-1434 2 µg 50
Recombinant Human Hematological And Neurological 10 µg 130
Expressed 1 1 mg 5,200

HN1L pro-027 5 µg 50
Recombinant Human Hematological and Neurological 20 µg 130
Expressed 1-Like 1 mg 2,700

HNRNPA1 pro-1038 5 µg 50
Recombinant Human Heterogeneous Nuclear 20 µg 130
RibonucleoProtein A1 1 mg 3,600

HNRNPAB pro-1731 2 µg 50
Recombinant Human Heterogeneous Nuclear 10 µg 130
RibonucleoProtein A/B 1 mg 5,200

HNRNPC pro-177 1 µg 50
Recombinant Human Heterogeneous Nuclear 5 µg 130
RibonucleoProtein C 50 µg 1,200
PEPTIDES INTERNATIONAL

HNRNPK pro-1539 5 µg 50
Recombinant Human Heterogeneous Nuclear 20 µg 130
RibonucleoProtein K 1 mg 2,700

Holo Transferrin pro-315 500 mg 250

Human Holo Transferrin 1gra m 400
5gra m 1,600

HOmER1 pro-695 5 µg 50
Recombinant Human Homer Homolog-1 20 µg 130
1 mg 3,000

HOmER2 pro-1072 2 µg 50
Recombinant Human Homer Homolog-2 10 µg 130
1 mg 5,200

HOmER3 pro-1108 5 µg 50
Recombinant Human Homer Homolog-3 20 µg 130
1 mg 2,700

HOPX pro-1158 5 µg 50
Recombinant Human HOP homeobox 20 µg 130
1 mg 2,700

HOXC11 pro-1658 5 µg 50
Recombinant Human Homeobox C11 20 µg 130
1 mg 3,600

642 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
HPCAL1 pro-254 2 µg 50
Recombinant Human Hippocalcin-Like 1 10 µg 130
1 mg 5,200

HRAS pro-822 5 µg 50
Recombinant Human V-Ha-ras Harvey Rat Sarcoma Viral 25 µg 130
Oncogene Homolog 1 mg 2,250

HRSP12 pro-052 5 µg 50
Recombinant Human Heat-Responsive Protein 12 20 µg 130
1 mg 2,700

HSA pro-354 100 mg 50

Human Serum Albumin 500 mg 130
5gra m 750

HSCB pro-1142 5 µg 50
Recombinant Human HscB Iron-Sulfur Cluster Co-Chaperone 20 µg 130
1 mg 2,700

HSD17B10 pro-823 5 µg 50
Recombinant Human Hydroxysteroid (17-β) Dehydrogenase 10 25 µg 130
1 mg 2,250

HUS1 pro-039 1 µg 50
Recombinant Human HUS1 Checkpoint Homolog 5 µg 130
50 µg 1,100

ICAm1

PEPTIDES INTERNATIONAL
pro-383 2 µg 50
Recombinant Human Intercellular Adhesion Molecule-1 10 µg 130
1 mg 3,200

ICAm1 HEK pro-1643 10 µg 50

Recombinant Human Intercellular Adhesion Molecule-1, HEK 50 µg 130
1 mg 1,800

ICT1 pro-1303 5 µg 50
Recombinant Human Immature Colon Carcinoma Transcript 1 20 µg 130
1 mg 2,700

ID1 pro-1426 2 µg 50
Recombinant Human Inhibitor of DNA Binding 1 10 µg 130
1 mg 5,200

ID2 pro-1383 5 µg 50
Recombinant Human Inhibitor of DNA Binding 2 20 µg 130
1 mg 2,700

IER3 pro-1490 2 µg 50
Recombinant Human Immediate Early Response 3 10 µg 130
100 µg 1,200

IFIH1 pro-1505 2 µg 50
Recombinant Human Interferon Induced With Helicase C 10 µg 130
Domain 1 1 mg 5,200

Order Hotline 1-800-777-4779 502-266-8787 643

 Recombinant proteins

IFT20 pro-1222 5 µg 50
Recombinant Human Intraflagellar Transport 20 Homolog 20 µg 130
1 mg 2,700

IGFLR1 pro-1432 2 µg 50
Recombinant Human IGF-Like Family Receptor 1 10 µg 130
1 mg 5,200

IGLL1 pro-1390 5 µg 50
Recombinant Human Immunoglobulin Lambda-Like 20 µg 130
Polypeptide 1 1 mg 2,700

IGJ pro-1420 5 µg 50
Recombinant Human Immunoglobulin J 20 µg 130
1 mg 2,700

ImPACT pro-1653 5 µg 50
Recombinant Human Impact RWD Domain Protein 20 µg 130
1 mg 2,700

ImP3 pro-015 5 µg 50
Recombinant Human ImP3 20 µg 130
1 mg 2,700

ImPAD1 pro-1346 5 µg 50
Recombinant Human Inositol Monophosphatase Domain 20 µg 130
Containing 1 1 mg 2,700

mIgG pro-1087
PEPTIDES INTERNATIONAL

2 µg 50
Recombinant Mouse Immunoglobulin Heavy Chain Constant 10 µg 130
Region Gamma 2a 1 mg 5,200

mIgG His pro-1086 5 µg 50

Recombinant Mouse Immunoglobulin Heavy Chain Constant 20 µg 130
Region Gamma 2a, His Tag 1 mg 3,600

Intein pro-958 5 µg 50
Recombinant Bacillus Circulans Intein 20 µg 130
1 mg 2,700

Internalin pro-031 20 µg 170

Recombinant Listeria Monocytogenes Internalin  100 µg 350
1 mg 2,700

Intrinsic Factor pro-375 2 µg 50

Recombinant Human Intrinsic Factor 10 µg 130
1 mg 4,400

Involucrin pro-512 2 µg 175

Recombinant Human Involucrin 5 µg 270
10 µg 490

IPP-POZ pro-436 10 µg 50
Recombinant Human IPP-POZ 50 µg 130
1 mg 1,800

644 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
IRGm pro-1302 5 µg 50
Recombinant Human Immunity-Related GTPase Family, M 20 µg 130
1 mg 2,700

ISCU pro-072 1 µg 50
Recombinant Human Iron-sulfur Cluster Scaffold Homolog 5 µg 130
50 µg 1,200

ISG15 pro-611 10 µg 50
Recombinant Human Interferon Stimulated Gene 15 50 µg 130
1 mg 1,800

ISOC2 pro-1669 2 µg 50
Recombinant Human Isochorismatase Domain Containing 2 10 µg 130
1 mg 5,200

ITGB1BP3 pro-1177 2 µg 50
Recombinant Human Integrin Β 1 Binding Protein 3 10 µg 130
100 µg 1,200

ITGB3BP pro-1435 2 µg 50
Recombinant Human Integrin Β 3 Binding Protein 10 µg 130
100 µg 1,200

JAm2 pro-1336 5 µg 50
Recombinant Human Junctional Adhesion Molecule 2 20 µg 130
1 mg 2,700

JAm3 pro-1223 2 µg 50

PEPTIDES INTERNATIONAL
Recombinant Human Junctional Adhesion Molecule 3 10 µg 130
100 µg 1,200

JAZF1 pro-1444 5 µg 50
Recombinant Human JAZF zinc finger 1 20 µg 130
1 mg 2,700

JDP2 pro-1441 1 µg 50
Recombinant Human Jun Dimerization Protein 2 5 µg 130
50 µg 1,100

JOSD1 pro-1251 5 µg 50
Recombinant Human Josephin Domain Containing 1 20 µg 130
1 mg 2,700

JSRP1 pro-1707 2 µg 50
Recombinant Human Junctional Sarcoplasmic Reticulum 10 µg 130
Protein 1 100 µg 1,200

KAAG1 pro-192 1 µg 50
Recombinant Human Kidney Associated Antigen 1 5 µg 130
50 µg 1,200

KCNIP3 pro-009 5 µg 50
Recombinant Human Kv Channel Interacting Protein 3 20 µg 130
1 mg 2,700

Order Hotline 1-800-777-4779 502-266-8787 645

 Recombinant proteins

KCTD5 pro-1276 2 µg 50
Recombinant Human Potassium Channel Tetramerisation 10 µg 130
Domain Containing 5 100 µg 1,200

KCTD11 pro-1376 2 µg 50
Recombinant Human Potassium Channel Tetramerisation 10 µg 130
Domain Containing 11 1 mg 5,200

KCTD15 pro-1002 5 µg 50
Recombinant Human Potassium Channel Tetramerisation 20 µg 130
Domain Containing 15 1 mg 2,700

KHDC1L pro-1720 5 µg 50
Recombinant Human KH Homology Domain Containing 1-Like 20 µg 130
1 mg 3,600

KIAA0101 pro-1683 2 µg 50
Recombinant Human KIAA0101 10 µg 130
1 mg 5,200

KIN pro-1275 5 µg 50
Recombinant Human KIN 20 µg 130
1 mg 2,700

KIR2DL1 pro-428 5 µg 50
Recombinant Human Killer Cell Immunoglobulin-Like Receptor, 20 µg 130
2 Domains Long Cytoplasmic Tail 1 1 mg 3,600
PEPTIDES INTERNATIONAL

KIR2DL3 pro-429 5 µg 50
Recombinant Human Killer Cell Immunoglobulin-Like Receptor, 20 µg 130
2 Domains Long Cytoplasmic Tail 3 1 mg 3,600

KIR2DS4 pro-430 5 µg 50
Recombinant Human Killer Cell Immunoglobulin-Like Receptor, 20 µg 130
2 Domains Short Cytoplasmic Tail 4 1 mg 3,600

KIR3DL1 pro-427 5 µg 50
Recombinant Human Killer Cell Immunoglobulin-Like Receptor, 20 µg 130
3 Domains Long Cytoplasmic Tail 1 1 mg 3,600

KISS1 pro-419 2 µg 50
Recombinant Human KISS-1 Metastasis-Suppressor 10 µg 130
1 mg 4,000

KLF3 pro-1632 5 µg 50
Recombinant Human Kruppel-Like Factor 3 20 µg 130
1 mg 2,700

KLF4 pro-891 2 µg 50
Recombinant Human Kruppel-Like Factor 4 10 µg 130
1 mg 5,200

KLF7 pro-1527 5 µg 50
Recombinant Human Kruppel-Like Factor 7 20 µg 130
1 mg 2,700

646 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
KLRB1 pro-1189 5 µg 50
Recombinant Human Killer Cell Lectin-Like Receptor Subfamily 20 µg 130
B, Member 1 1 mg 2,700

KLRC2 pro-1190 2 µg 50
Recombinant Human Killer Cell Lectin-Like Receptor Subfamily 10 µg 130
C, Member 2 1 mg 5,200

KLRC3 pro-1230 5 µg 50
Recombinant Human Killer Cell Lectin-Like Receptor Subfamily 20 µg 130
C, Member 3 1 mg 2,700

KLRG1 pro-1344 2 µg 50
Recombinant Human Killer Cell lectin-like Receptor Subfamily 10 µg 130
G, Member 1 1 mg 5,200

KLRK1 pro-1290 5 µg 50
Recombinant Human Killer Cell lectin-Like Receptor Subfamily 20 µg 130
K, Member 1 1 mg 2,700

KPNA2 pro-1032 2 µg 50
Recombinant Human karyopherin Α 2 10 µg 130
1 mg 5,200

KPNB1 pro-1001 2 µg 50
Recombinant Human karyopherin Β 1 10 µg 130
1 mg 5,200

PEPTIDES INTERNATIONAL
KRAS 2B pro-854 5 µg 50
Recombinant Human Kirsten Rat Sarcoma Viral Oncogene, 25 µg 130
Isoform 2B 1 mg 2,250

KRAS 2A pro-1446 5 µg 50
Recombinant Human Kirsten Rat Sarcoma Viral Oncogene, 20 µg 130
Isoform 2A 1 mg 2,700

KRT14 pro-348 5 µg 50
Recombinant Human Cytokeratin 14 20 µg 130
1 mg 5,200

KRT14 His pro-941 5 µg 50

Recombinant Human Cytokeratin 14 His Tag 20 µg 130
1 mg 3,600

KRT18 pro-349 5 µg 50
Recombinant Human Cytokeratin 18 20 µg 130
1 mg 3,600

KRT18 His pro-484 2 µg 50

Recombinant Human Cytokeratin 18 His Tag 10 µg 130
1 mg 4,800

KRT19 pro-350 5 µg 50
Recombinant Human Cytokeratin 19 20 µg 130
1 mg 2,800

Order Hotline 1-800-777-4779 502-266-8787 647

 Recombinant proteins

KRT19 His pro-1347 5 µg 50

Recombinant Human Cytokeratin 19 His Tag 20 µg 130
1 mg 2,700

KRT20 pro-351 5 µg 50
Recombinant Human Cytokeratin 20 20 µg 130
1 mg 3,600

KRT20 His pro-1358 5 µg 50

Recombinant Human Cytokeratin 20 His Tag 20 µg 130
1 mg 3,600

KRT8 pro-347 5 µg 50
Recombinant Human Cytokeratin 8 20 µg 130
1 mg 3,600

KRT8 GST pro-298 2 µg 175

Recombinant Human Cytokeratin 8 GST-Tag 5 µg 270
10 µg 490

KRT8 His pro-1567 5 µg 50

Recombinant Human Cytokeratin 8 His Tag 20 µg 130
1 mg 2,700

Ku P70/P80 pro-397 5 µg 50
Recombinant Human Ku P70/P80 20 µg 130
1 mg 3,500

KXD1 pro-1656 2 µg 50
PEPTIDES INTERNATIONAL

Recombinant Human KxDL Motif Containing 1 10 µg 130

100 µg 1,200

LA/SS-B pro-327 5 µg 50
Recombinant Human LA / SS-B 20 µg 130
1 mg 3,500

LAGE3 pro-1424 2 µg 50
Recombinant Human L Antigen Family Member 3 10 µg 130
100 µg 1,200

LAIR1 pro-431 5 µg 50
Recombinant Human Leukocyte-Associated Ig-Like Receptor 1 20 µg 130
1 mg 2,800

LAIR2 pro-1081 5 µg 50
Recombinant Human Leukocyte-Associated Ig-Like Receptor 2 20 µg 130
1 mg 3,600

Lamin-A pro-690 2 µg 50
Recombinant Human Lamin-A 10 µg 130
100 µg 900

LAmP2 pro-130 2 µg 50
Recombinant Human Lysosomal-Associated Membrane 10 µg 130
Protein 2 1 mg 5,200

648 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
LAmTOR2 pro-1440 2 µg 50
Recombinant Human LAmTOR2  10 µg 130
1 mg 5,200

LASP1 pro-1031 1ug 50

Recombinant Human LIm and SH3 Protein 1 5ug 130
50 µg 1,100

LAT pro-948 2 µg 50
Recombinant Human Linker for Activation of T Cells 10 µg 130
1 mg 5,200

LAYN pro-1629 5 µg 50
Recombinant Human Layilin 20 µg 130
1 mg 2,700

LBH pro-423 2 µg 50
Recombinant Human Limb Bud And Heart Development 10 µg 130
100 µg 1,200

LBP pro-538 2 µg 175

Recombinant Human Lipopolysaccarid Binding Protein 5 µg 270
10 µg 490

mLBP pro-539 2 µg 175

Recombinant Mouse Lipopolysaccarid Binding Protein 5 µg 270
10 µg 490

LDL pro-562 10 mg 100

PEPTIDES INTERNATIONAL
Low Density LipoProtein 100 mg 400
1gra m 2,400

LDLRAP1 pro-1033 5 µg 50
Recombinant Human Low Density LipoProtein Receptor 20 µg 130
Adaptor Protein 1 1 mg 3,600

LDOC1L pro-1153 5 µg 50
Recombinant Human Leucine Zipper, Down-Regulated in 20 µg 130
Cancer 1-Like 1 mg 2,700

LEFTY1 pro-962 1ug 50

Recombinant Human Left-Right Determination Factor 1 5ug 130
50 µg 1,100

LGALS10 pro-744 5 µg 50
Recombinant Human Charcot-Leyden Crystal Protein 20 µg 130
1 mg 2,700

LGALSL pro-1374 2 µg 50
Recombinant Human Lectin Galactoside-Binding-Like 10 µg 130
1 mg 5,200

LImD2 pro-1620 5 µg 50
Recombinant Human LIm Domain Containing 2 20 µg 130
1 mg 2,700

Order Hotline 1-800-777-4779 502-266-8787 649

 Recombinant proteins

LIN28A pro-743 2 µg 50
Recombinant Human LIN28 10 µg 130
1 mg 5,200

LIN28B pro-1249 1ug 50

Recombinant Human LIN28B 5ug 130
50 µg 1,200

LIN7A pro-1252 2 µg 50
Recombinant Human LIN7A 10 µg 130
1 mg 5,200

LIN7B pro-1298 2 µg 50
Recombinant Human LIN7B 10 µg 130
1 mg 5,200

LIN7C pro-1305 5 µg 50
Recombinant Human LIN7C 20 µg 130
1 mg 2,700

LITAF pro-1350 5 µg 50
Recombinant Human Lipopolysaccharide-Induced TNF Factor 20 µg 130
1 mg 2,700

LLC pro-561 200 µg 200

Human Lambda Light Chain 1 mg 400
10 mg 2,750

LLO pro-320 10 µg 160

PEPTIDES INTERNATIONAL

Recombinant Listeriolysin-O 50 µg 400

100 µg 660

LLO-pest pro-373 10 µg 160

Recombinant Listeriolysin-O PEST-free 50 µg 400
100 µg 660

LmO1 pro-1457 2 µg 50
Recombinant Human LIm Domain Only 1  10 µg 130
100 µg 1,200

LRG1 pro-1676 5 µg 50
Recombinant Human Leucine-Rich Α-2-GlycoProtein 1 20 µg 130
1 mg 2,700

LRG1 pro-141 2 µg 50
Human Leucine-Rich Α-2-GlycoProtein 1 10 µg 130
1 mg 5,200

cLRG1 pro-1592 2 µg 50
Canine Leucine-Rich Α-2-GlycoProtein 1 10 µg 130
100 µg 1,000

LRPAP1 pro-1029 5 µg 50
Recombinant Human Low Density LipoProtein Receptor- 20 µg 130
Related Protein Associated Protein 1 1 mg 2,700

650 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
LRRC59 pro-1714 2 µg 50
Recombinant Human Leucine Rich Repeat Containing 59 10 µg 130
1 mg 5,200

L-Selectin pro-381 2 µg 50
Recombinant Human L-Selectin 10 µg 130
1 mg 4,800

LSm1 pro-259 5 µg 50
Recombinant Human LSm1 Homolog, U6 Small Nuclear RNA 20 µg 130
Associated 1 mg 2,700

LSm12 pro-1329 2 µg 50
Recombinant Human LSm12 Homolog, U6 Small Nuclear RNA 10 µg 130
Associated 100 µg 1,200

LSm2 pro-1069 5 µg 50
Recombinant Human LSm2 Homolog, U6 Small Nuclear RNA 20 µg 130
Associated 1 mg 2,700

LSm3 pro-1060 5 µg 50
Recombinant Human LSm3 Homolog, U6 Small Nuclear RNA 20 µg 130
Associated 1 mg 2,700

LSm4 pro-065 5 µg 50
Recombinant Human LSm4 Homolog, U6 Small Nuclear RNA 20 µg 130
Associated 1 mg 2,700

PEPTIDES INTERNATIONAL
LSm5 pro-795 5 µg 50
Recombinant Human LSm5 Homolog, U6 Small Nuclear RNA 20 µg 130
Associated 1 mg 3,600

LTF Holo pro-592 10 mg 50

Recombinant Human Lactoferrin Holo 100 mg 130
1gra m 600

LTF pro-1590 50 µg 50
Human Lactoferrin (Breast Milk) 200 µg 130
10 mg 4,800

LTF S.Plasma pro-1591 2 µg 50

Human Lactoferrin (Seminal Plasma) 10 µg 130
1 mg 5,200

LY86 pro-1559 5 µg 50
Recombinant Human Lymphocyte Antigen 86 20 µg 130
1 mg 2,700

LYG2 pro-1245 2 µg 50
Recombinant Human Lysozyme G-Like 2 10 µg 130
1 mg 5,200

LYN pro-136 5 µg 50
Recombinant Human v-yes-1 Yamaguchi Sarcoma Viral Related 20 µg 130
Oncogene 1 mg 2,700

Order Hotline 1-800-777-4779 502-266-8787 651

 Recombinant proteins

m.Pneumoniae pro-801 100 µg 150

Recombinant Mycoplasma Pneumoniae P1-C 0.5 mg 600
1 mg 1,200

m.Pneumoniae P116 pro-513 100 µg 150

Recombinant Mycoplasma Pneumoniae P116 0.5 mg 600
1 mg 1,200

m.Pneumoniae P36 pro-471 100 µg 150

Recombinant Mycoplasma Pneumoniae P36 0.5 mg 600
1 mg 1,200

mAD2L1 pro-934 1 µg 50
Recombinant Human MAD2 Mitotic Arrest Deficient-Like 1 5 µg 130
50 µg 1,100

mAD2L1BP pro-1052 2 µg 50
Recombinant Human MAD2L1 Binding Protein 10 µg 130
1 mg 5,200

mAEA pro-1634 2 µg 50
Recombinant Human Macrophage Erythroblast Attacher 10 µg 130
1 mg 5,200

mAF1 pro-921 5 µg 50
Recombinant Human MAF1 20 µg 130
1 mg 2,700

mAFF pro-1565 5 µg 50
PEPTIDES INTERNATIONAL

Recombinant Human V-maf Musculoaponeurotic Fibrosarcoma 20 µg 130

Oncogene F 1 mg 2,700

mAFG pro-968 2 µg 50
Recombinant Human V-maf Musculoaponeurotic Fibrosarcoma 10 µg 130
Oncogene G 1 mg 5,200

mAFK pro-025 5 µg 50
Recombinant Human V-maf Musculoaponeurotic Fibrosarcoma 20 µg 130
Oncogene K 1 mg 3,600

mAGEA1 pro-311 2 µg 175

Recombinant Human Melanoma Antigen Family A, 1 5 µg 270
10 µg 490

mAGEA3 pro-502 2 µg 50
Recombinant Human Melanoma Antigen Family A, 3 10 µg 130
1 mg 5,200

mAGEA4 pro-843 5 µg 50
Recombinant Human Melanoma Antigen Family A, 4 25 µg 130
1 mg 2,250

mAGEA5 pro-1070 2 µg 50
Recombinant Human Melanoma Antigen Family A, 5 10 µg 130
1 mg 5,200

652 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
mAGEA6 pro-1113 2 µg 50
Recombinant Human Melanoma Antigen Family A, 6 10 µg 130
100 µg 1,200

mAGOH pro-810 5 µg 50
Recombinant Human Mago-Nashi Homolog 25 µg 130
1 mg 2,250

mAGOHB pro-1488 2 µg 50
Recombinant Human Mago-Nashi Homolog B 10 µg 130
1 mg 5,200

mAP1LC3A pro-495 5 µg 50
Recombinant Human Microtubule-Associated Protein 1 Light 20 µg 130
Chain 3 Α 1 mg 3,600

mAP1LC3B pro-076 5 µg 50
Recombinant Human Microtubule-Associated Protein 1 Light 20 µg 130
Chain 3 Β 1 mg 2,700

mAP1LC3B2 pro-215 5 µg 50
Recombinant Human Microtubule-Associated Protein 1 Light 20 µg 130
Chain 3 Β 2 1 mg 2,700

mAPKSP1 pro-034 5 µg 50
Recombinant Human MAPK Scaffold Protein 1 20 µg 130
1 mg 2,700

mAPRE1 pro-058

PEPTIDES INTERNATIONAL
5 µg 50
Recombinant Human Microtubule-Associated Protein, RP/EB 20 µg 130
Family, Member 1 1 mg 2,700

mAPRE2 pro-932 5 µg 50
Recombinant Human Microtubule-Associated Protein, RP/EB 20 µg 130
Family, Member 2 1 mg 2,700

mAPRE3 pro-264 5 µg 50
Recombinant Human Microtubule-Associated Protein, RP/EB 20 µg 130
Family, Member 3 1 mg 2,700

mAPT pro-295 2 µg 50
Recombinant Human Microtubule-Associated Protein Tau 10 µg 130
1 mg 5,200

mAPT 381a.a. pro-042 2 µg 50

Recombinant Human Microtubule-Associated Protein Tau 381 10 µg 130
a.a. 1 mg 5,200

mAPT 383a.a. pro-012 2 µg 50

Recombinant Human Microtubule-Associated Protein Tau 383 10 µg 130
a.a. 1 mg 5,200

mAPT 412a.a. pro-210 1 µg 50

Recombinant Human Microtubule-Associated Protein Tau 412 5 µg 130
a.a. 50 µg 1,200

Order Hotline 1-800-777-4779 502-266-8787 653

 Recombinant proteins

mARCKSL1 pro-1423 2 µg 50
Recombinant Human MARCKS-Like 1 10 µg 130
100 µg 1,200

mAVS pro-1351 1 µg 50
Recombinant Human Mitochondrial Antiviral Signaling Protein 5 µg 130
50 µg 1,200

mAX pro-811 5 µg 50
Recombinant Human MYC Associated Factor X 25 µg 130
1 mg 2,250

mBD3 pro-1243 2 µg 50
Recombinant Human Methyl-CpG Binding Domain Protein 3 10 µg 130
1 mg 5,200

mBL2 pro-1285 5 µg 50
Recombinant Human Mannose-Binding Lectin 2 20 µg 130
1 mg 2,700

mBP pro-616 50 µg 50
Recombinant E.Coli Maltose Binding Protein 200 µg 130
1 mg 550

mBP pro-1524 5 µg 50
Recombinant E.Coli Myelin Basic Protein 20 µg 130
1 mg 2,700

mBP pro-1713 2 µg 50
PEPTIDES INTERNATIONAL

Recombinant Human Myelin Basic Protein 10 µg 130

1 mg 3,600

mCFD2 pro-769 5 µg 50
Recombinant Human Multiple Coagulation Factor Deficiency 2 25 µg 130
1 mg 2,250

mCL1 pro-1202 2 µg 50
Recombinant Human Myeloid Cell Leukemia Sequence 1 10 µg 130
1 mg 5,200

mCTS1 pro-1387 5 µg 50
Recombinant Human Malignant T-Cell-Amplified Sequence 1 20 µg 130
1 mg 2,700

mECP2 pro-212 2 µg 50
Recombinant Human Methyl CpG Binding Protein 2 10 µg 130
0.1 mg 1,000

mED20 pro-1204 5 µg 50
Recombinant Human Mediator Complex Subunit 20 20 µg 130
1 mg 2,700

mED4 pro-785 5 µg 50
Recombinant Human Mediator Complex Subunit 4 25 µg 130
1 mg 2,250

654 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
mED7 pro-1319 2 µg 50
Recombinant Human Mediator Complex Subunit 7 10 µg 130
1 mg 5,200

mED21 pro-1476 2 µg 50
Recombinant Human Mediator Complex Subunit 21 10 µg 130
1 mg 5,200

melanoma pro-509 2 µg 175

Recombinant Human Melanoma (gp100) 5 µg 270
10 µg 490

mEmO1 pro-1148 5 µg 50
Recombinant Human Mediator of Cell Motility 1 20 µg 130
1 mg 2,700

mEOX2 pro-1542 2 µg 50
Recombinant Human Mesenchyme Homeobox 2 10 µg 130
1 mg 5,200

mESDC2 pro-122 2 µg 50
Recombinant Human Mesoderm Development Candidate 2 10 µg 130
1 mg 3,600

mET pro-207 2 µg 50
Recombinant Human Met Proto-Oncogene 10 µg 130
100 µg 1,000

mET, GST pro-497 2 µg 175

PEPTIDES INTERNATIONAL
Recombinant Human Met Proto-Oncogene, GST Tag 5 µg 270
10 µg 490

mFAP2 pro-1265 2 µg 50
Recombinant Human Microfibrillar-associated Protein 2 10 µg 130
1 mg 5,200

mFAP4 pro-1210 5 µg 50
Recombinant Human Microfibrillar-associated Protein 4 20 µg 130
1 mg 2,700

mGP pro-922 5 µg 50
Recombinant Human Matrix Gla Protein 20 µg 130
1 mg 2,700

mICA pro-367 2 µg 50
Recombinant Human MHC class I chain-related gene A 10 µg 130
1 mg 4,080

mICB pro-368 2 µg 50
Recombinant Human MHC class I chain-related gene B 10 µg 130
1 mg 4,080

mIEN1 pro-1657 5 µg 50
Recombinant Human Migration And Invasion Enhancer 1 20 µg 130
1 mg 2,700

Order Hotline 1-800-777-4779 502-266-8787 655

 Recombinant proteins

mIS12 pro-022 5 µg 50
Recombinant Human MIS12 20 µg 130
1 mg 2,700

mLANA pro-1498 5 µg 50
Recombinant Human Melan-A 20 µg 130
1 mg 2,700

mLEC pro-1614 2 µg 50
Recombinant Human Malectin 10 µg 130
1 mg 5,200

mLF1 pro-100 5 µg 50
Recombinant Human Myeloid Leukemia Factor 1 20 µg 130
1 mg 2,700

mmACHC pro-1119 5 µg 50
Recombinant Human Methylmalonic Aciduria cblC type, with 20 µg 130
Homocystinuria 1 mg 2,700

mNDA pro-763 2 µg 50
Recombinant Human Myeloid Cell Nuclear Differentiation 10 µg 130
Antigen 1 mg 5,200

mOBKL1B pro-068 5 µg 50
Recombinant Human MOB1, Mps One Binder Kinase Activator- 20 µg 130
Like 1B 1 mg 2,700

mOBLK3 pro-049 2 µg 50
PEPTIDES INTERNATIONAL

Recombinant Human MOB1, Mps One Binder Kinase Activator- 10 µg 130

Like 3 1 mg 5,200

mOCS2 pro-1281 2 µg 50
Recombinant Human Molybdenum Cofactor Synthesis 2 10 µg 130
100 µg 1,200

mOG pro-371 5 mg 130

myelin Oligodendrocyte GlycoProtein 25 mg 520
100 mg 1,560

mOG pro-466 10 µg 50
Recombinant Human Myelin Oligodendrocyte GlycoProtein 50 µg 130
1 mg 1,500

mORF4L1 pro-1078 5 µg 50
Recombinant Human Mortality Factor 4 Like 1 20 µg 130
1 mg 2,700

mORF4L2 pro-475 5 µg 50
Recombinant Human Mortality Factor 4 Like 2 20 µg 130
1 mg 2,700

mPZL1 pro-1611 2 µg 50
Recombinant Human Myelin Protein Zero-Like 1 10 µg 130
1 mg 5,200

656 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
mRAS pro-1008 5 µg 50
Recombinant Human Muscle RAS Oncogene Homolog 20 µg 130
1 mg 3,600

mRm1 pro-1416 2 µg 50
Recombinant Human Mitochondrial RRNA Methyltransferase 1 10 µg 130
1 mg 5,200

mRRF pro-1299 5 µg 50
Recombinant Human Mitochondrial Ribosome Recycling 20 µg 130
Factor 1 mg 2,700

mRTO4 pro-1233 2 µg 50
Recombinant Human MRNA Turnover 4 10 µg 130
1 mg 5,200

mRPL1 pro-1431 5 µg 50
Recombinant Human Mitochondrial Ribosomal Protein L1 20 µg 130
1 mg 3,600

mRPL28 pro-1279 2 µg 50
Recombinant Human Mitochondrial Ribosomal Protein L28 10 µg 130
1 mg 5,200

mRPL13 pro-1404 5 µg 50
Recombinant Human Mitochondrial Ribosomal Protein L13 20 µg 130
1 mg 2,700

mRPS2 pro-1681 5 µg 50

PEPTIDES INTERNATIONAL
Recombinant Human Mitochondrial Ribosomal Protein S2 20 µg 130
1 mg 2,700

mRPS25 pro-1558 5 µg 50
Recombinant Human Mitochondrial Ribosomal Protein S25 20 µg 130
1 mg 2,700

mSH6 pro-745 2 µg 175

Recombinant Human MutS Homolog 6 5 µg 270
10 µg 490

mSI2 pro-1531 2 µg 50
Recombinant Human Musashi RNA-Binding Protein 2 10 µg 130
100 µg 1,200

mXD3 pro-1356 5 µg 50
Recombinant Human MAX Dimerization Protein 3 20 µg 130
1 mg 2,700

mUP1 pro-1437 5 µg 50
Recombinant Mouse Major Urinary Protein 1 20 µg 130
1 mg 2,700

mUTED pro-1155 2 µg 50
Recombinant Human MUTED 10 µg 130
100 µg 1,200

Order Hotline 1-800-777-4779 502-266-8787 657

 Recombinant proteins

bmX1 pro-1662 5 µg 50
Recombinant Bovine Myxoma Resistance Protein 1 20 µg 130
1 mg 2,700

mYC pro-087 2 µg 50
Recombinant Human V-myc Myelocytomatosis Viral Oncogene 10 µg 130
1 mg 5,200

mYCBP pro-942 5 µg 50
Recombinant Human C-myc Binding Protein 20 µg 130
1 mg 2,700

mYD88 pro-1377 5 µg 50
Recombinant Human Myeloid Differentiation Primary Response 20 µg 130
88 1 mg 2,700

mYL1 pro-365 2 µg 50
Recombinant Human Myosin Light Chain 1 10 µg 130
1 mg 3,000

mYL12A pro-902 5 µg 50
Recombinant Human Myosin Light Chain 12A 20 µg 130
1 mg 2,700

mYL12B pro-1124 5 µg 50
Recombinant Human Myosin Light Chain 12B 20 µg 130
1 mg 2,700

mYL2 pro-524 5 µg 50
PEPTIDES INTERNATIONAL

Recombinant Human Myosin Light Chain 2 25 µg 130

1 mg 3,000

mYL4 pro-992 5 µg 50
Recombinant Human Myosin Light Chain 4 20 µg 130
1 mg 2,700

mYL5 pro-916 5 µg 50
Recombinant Human Myosin Light Chain 5 20 µg 130
1 mg 3,600

mYL5 (1-173 a.a.) pro-943 2 µg 50

Recombinant Human Myosin Light Chain 5 (1-173 a.a.) 10 µg 130
1 mg 5,200

mYL6 pro-171 2 µg 50
Recombinant Human Myosin Light Chain 6 10 µg 130
1 mg 5,200

mYL6B pro-964 5 µg 50
Recombinant Human Myosin Light Chain 6B 20 µg 130
1 mg 2,700

mYL7 pro-1109 5 µg 50
Recombinant Human Myosin Light Chain 7 20 µg 130
1 mg 3,600

658 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
mYL9 pro-107 2 µg 50
Recombinant Human Myosin Light Chain 9 10 µg 130
1 mg 5,200

mYLPF pro-243 2 µg 50
Recombinant Human Myosin Light chain, Phosphorylatable, 10 µg 130
Fast Skeletal Muscle 1 mg 5,200

myoglobin pro-336 10 µg 50
Recombinant Human Myoglobin 50 µg 130
1 mg 1,300

myoglobin pro-565 200 µg 100

Human Myoglobin 1 mg 400
10 mg 2,000

myoglobin heme free pro-374 20 µg 50

Recombinant Human Myoglobin Heme free 100 µg 130
1 mg 900

myoglobin His pro-071 5 µg 50

Recombinant Human Myoglobin, His Tag 20 µg 130
1 mg 3,600

mYOZ1 pro-1652 5 µg 50
Recombinant Human Myozenin 1 20 µg 130
1 mg 2,700

NABP1 pro-1718

PEPTIDES INTERNATIONAL
5 µg 50
Recombinant Human Nucleic Acid Binding Protein 1 20 µg 130
1 mg 2,700

NACA pro-974 5 µg 50
Recombinant Human Nascent Polypeptide-Associated 20 µg 130
Complex Α 1 mg 2,700

NANOG pro-896 5 µg 50
Recombinant Human Nanog 20 µg 130
1 mg 2,700

NANOG, His pro-881 5 µg 50

Recombinant Human Nanog, His Tag 20 µg 130
1 mg 3,510

NANOG-TAT pro-090 5 µg 50
Recombinant Human Nanog-TAT 20 µg 130
1 mg 3,510

NANOGP8 pro-1553 2 µg 50
Recombinant Human Nanog Homeobox Pseudogene 8 10 µg 130
100 µg 1,200

NAP1L1 pro-985 5 µg 50
Recombinant Human Nucleosome Assembly Protein 1-Like 1 20 µg 130
1 mg 2,700

Order Hotline 1-800-777-4779 502-266-8787 659

 Recombinant proteins

NAP1L4 pro-1693 5 µg 50
Recombinant Human Nucleosome Assembly Protein 1-Like 4 20 µg 130
1 mg 2,700

NAPA pro-250 5 µg 50
Recombinant Human N-Ethylmaleimide-Sensitive Factor 20 µg 130
Attachment Protein, Α 1 mg 2,700

NAPG pro-944 5 µg 50
Rcombinant Human N-ethylmaleimide-Sensitive Factor 20 µg 130
Attachment Protein, Gamma 1 mg 2,700

NBL1 pro-1365 5 µg 50
Recombinant Human Neuroblastoma 1 20 µg 130
1 mg 2,700

NCALD pro-093 5 µg 50
Recombinant Human Neurocalcin Delta 20 µg 130
1 mg 2,700

NCBP2 pro-265 5 µg 50
Recombinant Human Nuclear Cap Binding Protein Subunit 2 20 µg 130
1 mg 2,700

NCEH1 pro-1393 5 µg 50
Recombinant Human Neutral Cholesterol Ester Hydrolase 1 20 µg 130
1 mg 2,700

NCF1 pro-488 2 µg 50
PEPTIDES INTERNATIONAL

Recombinant Human Neutrophil Cytosolic Factor 1 10 µg 130

1 mg 5,200

NCF4 pro-1258 5 µg 50
Recombinant Human Neutrophil Cytosolic Factor 4 20 µg 130
1 mg 3,600

NCK1 pro-839 5 µg 50
Recombinant Human NCK Adaptor Protein 1 25 µg 130
1 mg 2,250

NCK2 pro-1621 2 µg 50
Recombinant Human NCK Adaptor Protein 2 10 µg 130
1 mg 5,200

NCL pro-1508 2 µg 50
Recombinant Human Nucleolin 10 µg 130
1 mg 5,200

NCS1 pro-802 5 µg 50
Recombinant Human Neuronal Calcium Sensor 1 25 µg 130
1 mg 2,250

NDE1 pro-204 5 µg 50
Recombinant Human nudE Nuclear Distribution Gene E 20 µg 130
Homolog 1 1 mg 2,700

660 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
NDP pro-1674 2 µg 50
Recombinant Human Norrie Disease 10 µg 130
1 mg 5,200

NDRG1 pro-724 10 µg 50
Recombinant Human N-myc Downstream Regulated 1 50 µg 130
1 mg 1,800

NDRG2 pro-1198 5 µg 50
Recombinant Human N-myc Downstream Regulated 2 20 µg 130
1 mg 2,700

NECAP2 pro-180 5 µg 50
Recombinant Human NECAP Endocytosis Associated 2 20 µg 130
1 mg 2,700

NEURL2 pro-1678 2 µg 50
Recombinant Human Neuralized Homolog 2 10 µg 130
1 mg 5,200

NFKBIA pro-960 2 µg 50
Recombinant Human NF-kappa-B Inhibitor Α 10 µg 130
1 mg 5,200

NFKBIB pro-1046 5 µg 50
Recombinant Human NF-kappa-B Inhibitor Β 20 µg 130
1 mg 2,700

NFKBID pro-1684 5 µg 50

PEPTIDES INTERNATIONAL
Recombinant Human NF-kappa-B Inhibitor Delta 20 µg 130
1 mg 2,700

NHEJ1 pro-1193 2 µg 50
Recombinant Human Nonhomologous End-Joining Factor 1 10 µg 130
100 µg 1,200

NHLH1 pro-1547 1 µg 50
Recombinant Human Nescient Helix Loop Helix 1 5 µg 130
50 µg 1,100

NHLH2 pro-1487 2 µg 50
Recombinant Human Nescient Helix Loop Helix 2 10 µg 130
1 mg 5,200

NHP2 pro-067 5 µg 50
Recombinant Human NHP2 RibonucleoProtein Homolog 20 µg 130
1 mg 3,600

NHP2L1 pro-038 2 µg 50
Recombinant Human NHP2 Non-Histone Chromosome Protein 10 µg 130
2-Like 1 mg 5,200

NIP7 pro-780 5 µg 50
Recombinant Human Nuclear Import 7 Homolog 25 µg 130
1 mg 2,250

Order Hotline 1-800-777-4779 502-266-8787 661

 Recombinant proteins

NKIRAS1 pro-1039 1 µg 50
Recombinant Human NFKB Inhibitor Interacting Ras-Like 1 5 µg 130
50 µg 1,200

NKIRAS2 pro-1091 2 µg 50
Recombinant Human NFKB Inhibitor Interacting Ras-Like 2 10 µg 130
1 mg 5,200

NKp46 pro-432 5 µg 50
Recombinant Human Natural Cytotoxicity Receptor NKp46 20 µg 130
1 mg 2,800

NKX3-1 pro-1341 5 µg 50
Recombinant Human NK3 Homeobox 1 20 µg 130
1 mg 2,700

NmB pro-1518 2 µg 50
Recombinant Human Neuromedin B 10 µg 130
1 mg 5,200

NmE1 pro-715 5 µg 50
Recombinant Human Non-metastatic Cells 1 20 µg 130
1 mg 2,700

NmE3 pro-082 5 µg 50
Recombinant Human Non-metastatic Cells 3 20 µg 130
1 mg 2,700

NmE4 pro-219 5 µg 50
PEPTIDES INTERNATIONAL

Recombinant Human Non-metastatic Cells 4 20 µg 130

1 mg 2,700

NmI pro-070 5 µg 50
Recombinant Human N-myc Interactor 20 µg 130
1 mg 2,700

Nmm pro-366 2 µg 50
Recombinant Human Non-muscle Myosin-II Regulatory Light 10 µg 130
Chain 1 mg 4,080

NmRAL1 pro-1131 5 µg 50
Recombinant Human NmrA-Like Family Domain Containing 1 20 µg 130
1 mg 2,700

NOB1 pro-1701 5 µg 50
Recombinant Human NIN1/RPN12 Binding Protein 1 20 µg 130
1 mg 2,700

NOL3 pro-1178 5 µg 50
Recombinant Human Nucleolar Protein 3 20 µg 130
1 mg 2,700

NOP16 pro-1340 2 µg 50
Recombinant Human NOP16 10 µg 130
100 µg 1,200

662 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
NPm1 pro-1120 5 µg 50
Recombinant Human Nucleophosmin 20 µg 130
1 mg 2,700

NPm2 pro-1182 2 µg 50
Recombinant Human Nucleophosmin 2 10 µg 130
1 mg 5,200

NR1H2 pro-869 2 µg 175

Recombinant Human Nuclear Receptor Subfamily 1 Group H, 5 µg 270
Member 2 10 µg 490

NRAS pro-794 2 µg 50
Recombinant Human Neuroblastoma RAS Viral Oncogene 10 µg 130
Homolog 1 mg 5,200

NRBF2 pro-1692 2 µg 50
Recombinant Human Nuclear Receptor Binding Factor 2 10 µg 130
100 µg 1,200

NRIP3 pro-1384 2 µg 50
Recombinant Human Nuclear Receptor-Interacting Protein 3 10 µg 130
1 mg 5,200

NSL1 pro-1557 5 µg 50
Recombinant Human NSL1 20 µg 130
1 mg 2,700

NSmCE1 pro-1617

PEPTIDES INTERNATIONAL
5 µg 50
Recombinant Human Non-SmC Element 1 20 µg 130
1 mg 2,700

NTAL pro-827 5 µg 50
Recombinant Human Non-T-cell Activation Linker 25 µg 130
1 mg 2,250

NTS pro-1311 5 µg 50
Recombinant Human Neurotensin 20 µg 130
1 mg 2,700

NUCB2 pro-492 20 µg 50
Recombinant Human Nucleobindin-2 100 µg 130
1 mg 990

NUCB2, His pro-142 2 µg 50

Recombinant Human Nucleobindin-2, His Tag 10 µg 130
1 mg 5,200

mNUCB2 pro-605 5 µg 50
Recombinant Mouse Nucleobindin-2 25 µg 130
1 mg 2,700

NUP210 pro-109 5 µg 50
Recombinant Human Nucleopurin 210kDa 20 µg 130
1 mg 3,900

Order Hotline 1-800-777-4779 502-266-8787 663

 Recombinant proteins

NUP62 pro-999 5 µg 50
Recombinant Human Nucleopurin 62kDa 20 µg 130
1 mg 3,900

NusA pro-623 20 µg 50
Recombinant E.Coli Transcription Termination/Antitermination 100 µg 130
L Factor 1 mg 900

NUTF2 pro-844 5 µg 50
Recombinant Human Nuclear Transport Factor 2 25 µg 130
1 mg 2,250

NXT1 pro-218 2 µg 50
Recombinant Human NTF2-like Export Factor 1 10 µg 130
1 mg 5,200

NXT2 pro-1051 5 µg 50
Recombinant Human NTF2-like Export Factor 2 25 µg 130
1 mg 2,700

NY-ESO-1 pro-531 2 µg 175

Recombinant Human New York Esophageal Squamous Cell 5 µg 270
Carcinoma 10 µg 490

OAZ1 pro-1200 2 µg 50
Recombinant Human Ornithine Decarboxylase Antizyme 1 10 µg 130
1 mg 5,200
PEPTIDES INTERNATIONAL

OBFC1 pro-028 2 µg 50
Recombinant Human Oligonucleotide Binding Fold Containing 10 µg 130
1 1 mg 5,200

OCIAD2 pro-1456 5 µg 50
Recombinant Human OCIA Domain Containing 2 20 µg 130
1 mg 2,700

OCm pro-143 2 µg 50
Recombinant Human Oncomodulin-1 10 µg 130
1 mg 5,200

OLFm1 pro-1491 2 µg 50
Recombinant Human Olfactomedin 1 10 µg 130
1 mg 5,200

OLR1 pro-923 5 µg 50
Recombinant Human Oxidized Low Density LipoProtein 20 µg 130
Receptor 1 1 mg 2,700

OmP pro-1412 5 µg 50
Recombinant Human Olfactory Marker Protein 20 µg 130
1 mg 3,600

Omp Pylori pro-369 100 µg 150

Recombinant Helicobacter Pylori Outer Membrane Protein 0.5 mg 600
1 mg 1,200

664 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
OmpA pro-571 100 µg 255
Recombinant Bacterial Outer Membrane Protein-A 200 µg 340
1 mg 1,350

ORAOV1 pro-1092 2 µg 50
Recombinant Human Oral Cancer Overexpressed 1 10 µg 130
1 mg 5,200

ORC6 pro-1716 2 µg 50
Recombinant Human Origin Recognition Complex, Subunit 6 10 µg 130
100 µg 1,200

ORm1 pro-889 5 µg 50
Recombinant Human Orosomucoid 1 20 µg 130
1 mg 2,700

ORm1 pro-1570 2 µg 50
Human Orosomucoid 1 10 µg 130
100 µg 1,200

ORm2 pro-1560 5 µg 50
Recombinant Human Orosomucoid 2 20 µg 130
1 mg 2,700

OSCAR pro-1486 5 µg 50
Recombinant Human Osteoclast Associated, Immunoglobulin- 20 µg 130
Like Receptor 1 mg 2,700

Osteocrin

PEPTIDES INTERNATIONAL
pro-420 2 µg 50
Recombinant Human Osteocrin 10 µg 130
1 mg 3,900

OTUB1 pro-711 5 µg 50
Recombinant Human Ubiquitin Aldehyde Binding 1 25 µg 130
1 mg 2,700

OTUB2 pro-214 5 µg 50
Recombinant Human Ubiquitin Aldehyde Binding 2 25 µg 130
1 mg 2,700

OVCA2 pro-1123 1 µg 50
Recombinant Human Ovarian Tumor Suppressor Candidate 2 5 µg 130
50 µg 1,200

p53 pro-742 2 µg 175

Recombinant Human p53 5 µg 270
10 µg 490

p53 Mutant pro-301 2 µg 175

Recombinant Human p53 Mutant 5 µg 270
10 µg 490

PA2G4 pro-782 5 µg 50
Recombinant Human Proliferation-associated Protein 2G4 25 µg 130
1 mg 2,250

Order Hotline 1-800-777-4779 502-266-8787 665

 Recombinant proteins

PAEP pro-1397 2 µg 50
Recombinant Human Progesterone-Associated Endometrial 10 µg 130
Protein 1 mg 5,200

PAIP2 pro-748 5 µg 50
Recombinant Human Polyadenylate-Binding Protein- 25 µg 130
Interacting Protein 2 1 mg 2,250

PARD6B pro-1307 2 µg 50
Recombinant Human Par-6 Partitioning Defective 6 Homolog Β 10 µg 130
100 µg 1,200

PARK7 pro-575 5 µg 50
Recombinant Human Parkinson Disease Protein 7 20 µg 130
1 mg 3,000

PARVA pro-1257 5 µg 50
Recombinant Human Parvin Α 20 µg 130
1 mg 3,600

PAX9 pro-1724 2 µg 50
Recombinant Human Paired Box 9 10 µg 130
1 mg 5,200

PBLD pro-010 5 µg 50
Recombinant Human Phenazine Biosynthesis-Like Protein 20 µg 130
Domain Containing 1 mg 2,700
PEPTIDES INTERNATIONAL

PCBP1 pro-1690 5 µg 50
Recombinant Human Poly (RC) Binding Protein 1 20 µg 130
1 mg 2,700

pCD163 pro-856 10 µg 50
Recombinant Porcine CD163 50 µg 130
1 mg 1,800

PCNA pro-615 5 µg 50
Recombinant Human Proliferating Cell Antigen 25 µg 130
1 mg 2,700

PCNA GST pro-741 2 µg 175

Recombinant Human Proliferating Cell Antigen, GST Tag 5 µg 270
10 µg 490

PCNA Sf9 pro-303 5 µg 50

Recombinant Human Proliferating Cell Antigen, S9 20 µg 130
1 mg 3,500

PCNP pro-906 5 µg 50
Recombinant Human PEST proteolytic Signal Containing 20 µg 130
Nuclear Protein 1 mg 3,600

PDAP1 pro-490 5 µg 50
Recombinant Human PDGFA Associated Protein 1 20 µg 130
1 mg 3,600

666 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
PDCD4 pro-606 2 µg 50
Recombinant Human ProgrammedCell Death 4 10 µg 130
1 mg 5,200

PDCD5 pro-624 5 µg 50
Recombinant Human Programmed Cell Death 5 20 µg 130
1 mg 3,600

PDCD6 pro-184 2 µg 50
Recombinant Human Programmed Cell Death 6 10 µg 130
1 mg 5,200

PDCD6IP pro-792 5 µg 50
Recombinant Human ProgrammedCell Death 6 Interacting 25 µg 130
Protein 1 mg 2,250

PDCL pro-1141 2 µg 50
Recombinant Human Phosducin-Like 10 µg 130
100 µg 1,200

PDCL3 pro-1028 5 µg 50
Recombinant Human Phosducin-Like 3 20 µg 130
1 mg 3,600

PDPN pro-626 5 µg 50
Recombinant Human Podoplanin 25 µg 130
1 mg 2,700

PDRG1 pro-007

PEPTIDES INTERNATIONAL
5 µg 50
Recombinant Human p53 and DNA-Damage Regulated 1 20 µg 130
1 mg 2,700

PDZD11 pro-1263 2 µg 50
Recombinant Human PDZ Domain Containing 11 10 µg 130
1 mg 5,200

PDZK1 pro-1447 5 µg 50
Recombinant Human PDZ Domain Containing 1 20 µg 130
1 mg 2,700

PEA15 pro-729 2 µg 50
Recombinant Human PhosphoProtein Enriched in Astrocytes 10 µg 130
15 1 mg 5,200

PEBP1 pro-722 10 µg 50
Recombinant Human Phosphatidylethanolamine Binding 50 µg 130
Protein 1 1 mg 1,800

PEF1 pro-099 2 µg 50
Recombinant Human Penta-EF-Hand Domain Containing 1 10 µg 130
1 mg 5,200

PET117 pro-1686 2 µg 50
Recombinant Human PET117 10 µg 130
1 mg 5,200

Order Hotline 1-800-777-4779 502-266-8787 667

 Recombinant proteins

PEX pro-360 2 µg 50
Recombinant Human C-terminal hemopexin-like domain of 10 µg 130
MmP-2 (445-635 a.a.) 1 mg 4,080

PEX19 pro-925 5 µg 50
Recombinant Human Peroxisomal Biogenesis Factor 19 20 µg 130
1 mg 2,700

PEX26 pro-1544 5 µg 50
Recombinant Human Peroxisomal Biogenesis Factor 26 20 µg 130
1 mg 3,600

PFDN1 pro-277 1 µg 50
Recombinant Human Prefoldin Subunit 1 5 µg 130
50 µg 1,100

PFDN2 pro-001 2 µg 50
Recombinant Human Prefoldin Subunit 2 10 µg 130
1 mg 5,200

PFDN4 pro-092 2 µg 50
Recombinant Human Prefoldin Subunit 4 10 µg 130
1 mg 5,200

PFDN5 pro-901 5 µg 50
Recombinant Human Prefoldin Subunit 5 20 µg 130
1 mg 2,700

PFDN6
PEPTIDES INTERNATIONAL

pro-178 2 µg 50
Recombinant Human Prefoldin Subunit 6 10 µg 130
1 mg 5,200

PFN1 pro-528 10 µg 50
Recombinant Human Profilin-1 50 µg 130
1 mg 1,800

PFN2 pro-809 2 µg 50
Recombinant Human Profilin-2 10 µg 130
1 mg 5,200

PFN4 pro-818 5 µg 50
Recombinant Human Profilin-4 25 µg 130
1 mg 2,250

PGLYRP1 pro-1597 2 µg 50
Recombinant Human Peptidoglycan Recognition Protein 1 10 µg 130
1 mg 5,200

PGP9.5 pro-576 5 µg 50
Recombinant Human Ubiquitin Carboxyl-Terminal Hydrolase L1 25 µg 130
1 mg 2,700

PGP9.5 GST pro-304 2 µg 175

Recombinant Human Ubiquitin Carboxyl-Terminal Hydrolase 5 µg 270
L1 GST tag 10 µg 490

668 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
PGR pro-535 2 µg 175
Recombinant Human Progesterone Receptor 5 µg 270
10 µg 490

PHB pro-1381 2 µg 50
Recombinant Human Prohibitin 10 µg 130
1 mg 5,200

PHB2 pro-1533 5 µg 50
Recombinant Human Prohibitin 2 20 µg 130
1 mg 2,700

PHF5A pro-1521 2 µg 50
Recombinant Human PHD Finger Protein 5A 10 µg 130
100 µg 1,200

PHF11 pro-1268 5 µg 50
Recombinant Human PHD Finger Protein 11 20 µg 130
1 mg 2,700

PHF13 pro-1532 1 µg 50
Recombinant Human PHD Finger Protein 13 5 µg 130
50 µg 1,100

PHLDA2 pro-781 2 µg 50
Recombinant Human Pleckstrin Homology-Like Domain Family 10 µg 130
A Member 2 1 mg 5,200

PI3 pro-1627

PEPTIDES INTERNATIONAL
2 µg 50
Recombinant Human Peptidase Inhibitor 3 10 µg 130
1 mg 5,200

PIm1 pro-1389 2 µg 50
Recombinant Human PIm1 10 µg 130
1 mg 5,200

PINX1 pro-693 5 µg 50
Recombinant Human PIN2-Interacting Protein 1 20 µg 130
1 mg 3,600

PIR pro-1040 5 µg 50
Recombinant Human Pirin 25 µg 130
1 mg 2,700

PITPNA pro-044 5 µg 50
Recombinant Human Phosphatidylinositol Transfer Protein, Α 25 µg 130
1 mg 2,700

PITPNB pro-003 5 µg 50
Recombinant Human Phosphatidylinositol Transfer Protein, Β 25 µg 130
1 mg 2,700

PLAC8 pro-1725 5 µg 50
Recombinant Human Placenta-Specific 8 25 µg 130
1 mg 2,700

Order Hotline 1-800-777-4779 502-266-8787 669

 Recombinant proteins

PLDN pro-1068 2 µg 50
Recombinant Human Pallidin Homolog 10 µg 130
1 mg 5,200

PLSCR1 pro-1271 2 µg 50
Recombinant Human Phospholipid Scramblase 1 10 µg 130
1 mg 5,200

PmP2 pro-651 5 µg 50
Recombinant Human Peripheral Myelin Protein-2 25 µg 130
1 mg 3,600

PmP2 His pro-671 5 µg 50

Recombinant Human Peripheral Myelin Protein-2, His Tag 25 µg 130
1 mg 2,500

PNOC pro-1442 5 µg 50
Recombinant Human Prepronociceptin 20 µg 130
1 mg 2,700

PNRC pro-1534 5 µg 50
Recombinant Human Proline-Rich Nuclear Receptor 20 µg 130
Coactivator 2 1 mg 2,700

POLD4 pro-1667 2 µg 50
Recombinant Human Polymerase Delta 4 10 µg 130
100 µg 1,200

POLE3 pro-1496 5 µg 50
PEPTIDES INTERNATIONAL

Recombinant Human Polymerase (DNA Directed), Epsilon 3 20 µg 130

1 mg 2,700

POLR2J pro-1260 2 µg 50
Recombinant Human Polymerase (RNA) II (DNA directed) 10 µg 130
Polypeptide J 1 mg 5,200

POLR2H pro-1443 5 µg 50
Recombinant Human Polymerase (RNA) II (DNA directed) 20 µg 130
Polypeptide H  1 mg 2,700

POLR3H pro-1250 5 µg 50
Recombinant Human Polymerase (RNA) III (DNA directed) 20 µg 130
Polypeptide H  1 mg 2,700

POmC pro-236 2 µg 50
Recombinant Human Proopiomelanocortin 10 µg 130
1 mg 5,200

POP4 pro-1407 5 µg 50
Recombinant Human Processing Of Precursor 4 20 µg 130
1 mg 2,700

POU2AF1 pro-880 2 µg 50
Recombinant Human POU class 2 associating factor 1 10 µg 130
1 mg 5,200

670 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
POU5F1 pro-088 5 µg 50
Recombinant Human POU Class 5 Homeobox 1 20 µg 130
1 mg 3,600

POU5F1 PolyR pro-091 2 µg 50

Recombinant Human POU Class 5 Homeobox 1 Polyarginine- 10 µg 130
Tag 1 mg 5,200

POU6F1 pro-1484 5 µg 50
Recombinant Human POU Class 6 Homeobox 1 20 µg 130
1 mg 2,700

PPP1R3B pro-1700 5 µg 50
Recombinant Human Protein Phosphatase 1, Regulatory 20 µg 130
Subunit 3B 1 mg 2,700

PPP1R11 pro-1526 2 µg 50
Recombinant Human Protein Phosphatase 1, Regulatory 10 µg 130
Subunit 11 1 mg 5,200

PQBP1 pro-1101 5 µg 50
Recombinant Human Polyglutamine Binding Protein 1 20 µg 130
1 mg 2,700

PRAP1 pro-1598 2 µg 50
Recombinant Human Proline-Rich Acidic Protein 1 10 µg 130
1 mg 5,200

PEPTIDES INTERNATIONAL
Prealbumin pro-771 5 µg 50
Recombinant Human Transthyretin 25 µg 130
1 mg 2,250

Prelamin-A pro-689 2 µg 50
Recombinant Prelamin-A 10 µg 130
100 µg 900

PRH1 pro-1552 2 µg 50
Recombinant Human Proline-Rich Protein HaeIII Subfamily 1 10 µg 130
1 mg 5,200

PRND pro-018 2 µg 50
Recombinant Human Prion Protein 2  10 µg 130
100 µg 1,200

PRNP pro-1400 2 µg 50
Recombinant Human Prion Protein 10 µg 130
100 µg 1,200

PROC pro-485 2 µg 50
Recombinant Human Protein-c 10 µg 130
100 µg 1.10

PRRX1 pro-1729 2 µg 50
Recombinant Human Paired Related Homeobox 1 10 µg 130
1 mg 5,200

Order Hotline 1-800-777-4779 502-266-8787 671

 Recombinant proteins

PSAP pro-1600 2 µg 50
Recombinant Human Prosaposin 10 µg 130
1 mg 5,200

Protein-A/G pro-646 1 mg 50
Recombinant Protein A/G 10 mg 130
100 mg 500

Protein-G pro-402 1 mg 50
Recombinant Protein G 10 mg 130
100 mg 500

Protein-G His pro-1237 1 mg 50

Recombinant Protein G His Tag 10 mg 250
100 mg 1,500

Prothrombin pro-439 10IU 50

Human Prothrombin Complex 50IU 130
300IU 700

P-Selectin pro-382 2 µg 50
Recombinant Human P-Selectin 10 µg 130
1 mg 4,800

PSG5 pro-1633 5 µg 50
Recombinant Human Pregnancy Specific Β-1-GlycoProtein 5 20 µg 130
1 mg 2,700

PSmA pro-740 2 µg 175

PEPTIDES INTERNATIONAL

Recombinant Human Prostate Specific Membrane Antigen 5 µg 270

10 µg 490

PSmB10 pro-931 1 µg 50
Recombinant Human Proteasome Β Type 10 5 µg 130
50 µg 1,100

PSmE1 pro-266 2 µg 50
Recombinant Human Proteasome Activator Subunit 1 10 µg 130
1 mg 5,200

PSmE2 pro-975 2 µg 50
Recombinant Human Proteasome Activator Subunit 2 10 µg 130
1 mg 5,200

PSmE3 pro-987 2 µg 50
Recombinant Human Proteasome Activator Subunit 3 10 µg 130
1 mg 5,200

PSmG2 pro-930 2 µg 50
Recombinant Human Proteasome Assembly Chaperone 2 10 µg 130
1 mg 5,200

PSmG3 pro-261 1 µg 50
Recombinant Human Proteasome Assembly Chaperone 3 5 µg 130
50 µg 1,100

672 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
PSmG4 pro-989 5 µg 50
Recombinant Human Proteasome Assembly Chaperone 4 20 µg 130
1 mg 2,700

mSmB pro-598 2 µg 50
Recombinant Human Β-microseminoProtein 10 µg 130
1 mg 5,200

PSTPIP1 pro-1515 5 µg 50
Recombinant Human Proline-Serine-Threonine Phosphatase 20 µg 130
Interacting Protein 1 1 mg 2,700

PTEN pro-305 2 µg 175

Recombinant Human Phosphatase and Tensin Homolog 5 µg 270
10 µg 490

PTEN His pro-712 1 µg 50

Recombinant Human Phosphatase and Tensin homolog His 5 µg 130
Tag 100 µg 1,350

PTGDS pro-316 2 µg 50
Recombinant Human Β-Trace 10 µg 130
1 mg 4,800

PTmA pro-1694 2 µg 50
Recombinant Human Prothymosin Α 10 µg 130
1 mg 5,200

PEPTIDES INTERNATIONAL
PTTG1 pro-717 5 µg 50
Recombinant Human Pituitary Tumor-Transforming Protein 1 20 µg 130
1 mg 3,600

PTX3 pro-694 5 µg 50
Recombinant Human Pentraxin-3 20 µg 130
1 mg 3,600

PVALB pro-004 5 µg 50
Recombinant Human Parvalbumin 25 µg 130
1 mg 2,700

QKI pro-816 2 µg 50
Recombinant Human QKI 10 µg 130
1 mg 5,200

RAB8 pro-1528 5 µg 50
Recombinant Human RAB8, Member RAS Oncogene Family 20 µg 130
1 mg 2,700

RAB10 pro-1361 2 µg 50
Recombinant Human RAB10, Member RAS Oncogene Family 10 µg 130
1 mg 5,200

RAB11A pro-826 5 µg 50
Recombinant Human RAB11A, Member RAS Oncogene Family 25 µg 130
1 mg 2,250

Order Hotline 1-800-777-4779 502-266-8787 673

 Recombinant proteins

RAB13 pro-882 2 µg 50
Recombinant Human RAB13, Member RAS Oncogene Family 10 µg 130
1 mg 5,200

RAB14 pro-873 2 µg 50
Recombinant Human RAB14, Member RAS Oncogene Family 10 µg 130
1 mg 5,200

RAB17 pro-874 5 µg 50
Recombinant Human RAB17, Member RAS Oncogene Family 20 µg 130
1 mg 2,700

RAB18 pro-976 2 µg 50
Recombinant Human RAB18, Member RAS Oncogene Family 10 µg 130
1 mg 5,200

RAB1A pro-097 2 µg 50
Recombinant Human RAB1A, Member RAS Oncogene Family 10 µg 130
1 mg 5,200

RAB1B pro-045 2 µg 50
Recombinant Human RAB1B, Member RAS Oncogene Family 10 µg 130
1 mg 5,200

RAB21 pro-101 2 µg 50
Recombinant Human RAB21, Member RAS Oncogene Family 10 µg 130
1 mg 5,200

RAB22A pro-929 1 µg 50
PEPTIDES INTERNATIONAL

Recombinant Human RAB22, Member RAS Oncogene Family 5 µg 130

50 µg 1,200

RAB23 pro-977 5 µg 50
Recombinant Human RAB23, Member RAS Oncogene Family 20 µg 130
1 mg 2,700

RAB24 pro-951 5 µg 50
Recombinant Human RAB24, Member RAS Oncogene Family 20 µg 130
1 mg 2,700

RAB27A pro-825 5 µg 50
Recombinant Human RAB27A, Member RAS Oncogene Family 25 µg 130
1 mg 2,250

RAB27B pro-075 5 µg 50
Recombinant Human RAB27B, Member RAS Oncogene Family 20 µg 130
1 mg 2,700

RAB2A pro-244 5 µg 50
Recombinant Human RAB2A, Member RAS Oncogene Family 20 µg 130
1 mg 3,600

RAB2B pro-1013 5 µg 50
Recombinant Human RAB2B, Member RAS Oncogene Family 20 µg 130
1 mg 2,700

674 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
RAB31 pro-1090 5 µg 50
Recombinant Human RAB31, Member RAS Oncogene Family 20 µg 130
1 mg 2,700

RAB32 pro-950 5 µg 50
Recombinant Human RAB32, Member RAS Oncogene Family 20 µg 130
1 mg 2,700

RAB34 pro-978 2 µg 50
Recombinant Human RAB34, Member RAS Oncogene Family 10 µg 130
1 mg 5,200

RAB35 pro-935 2 µg 50
Recombinant Human RAB35, Member RAS Oncogene Family 10 µg 130
1 mg 5,200

RAB3A pro-870 5 µg 50
Recombinant Human RAB3A, Member RAS Oncogene Family 20 µg 130
1 mg 2,700

RAB3B pro-875 5 µg 50
Recombinant Human RAB3B, Member RAS Oncogene Family 20 µg 130
1 mg 2,700

RAB3D pro-247 5 µg 50
Recombinant Human RAB3D, Member RAS Oncogene Family 20 µg 130
1 mg 2,700

RAB4A pro-871 2 µg 50

PEPTIDES INTERNATIONAL
Recombinant Human RAB4A, Member RAS Oncogene Family 10 µg 130
1 mg 5,200

RAB5A pro-590 5 µg 50
Recombinant Human RAB5A, Member RAS Oncogene Family 20 µg 130
1 mg 3,600

RAB5B pro-056 5 µg 50
Recombinant Human RAB5B, Member RAS Oncogene Family 20 µg 130
1 mg 2,700

RAB5C pro-1427 5 µg 50
Recombinant Human RAB5C, Member RAS Oncogene Family 20 µg 130
1 mg 2,700

RAB6A pro-047 2 µg 50
Recombinant Human RAB6A, Member RAS Oncogene Family 10 µg 130
1 mg 5,200

RAB6B pro-103 5 µg 50
Recombinant Human RAB6B, Member RAS Oncogene Family 20 µg 130
1 mg 2,700

RAB7A pro-077 5 µg 50
Recombinant Human RAB7A, Member RAS Oncogene Family 20 µg 130
1 mg 2,700

Order Hotline 1-800-777-4779 502-266-8787 675

 Recombinant proteins

RABIF pro-300 2 µg 50
Recombinant Human RAB Interacting Factor 10 µg 130
1 mg 5,200

RABL5 pro-1472 2 µg 50
Recombinant Human RAB, Member RAS Oncogene Family- 10 µg 130
Like 5 100 µg 1,200

RAC1 pro-572 10 µg 50
Recombinant Human Ras-Related C3 Botulinum Toxin 50 µg 130
substrate 1 1 mg 1,800

RAC1 His pro-731 10 µg 50

Recombinant Human Ras-Related C3 Botulinum Toxin 50 µg 130
substrate 1 His Tag 1 mg 1,800

RAC2 pro-619 5 µg 50
Recombinant Human Ras-Related C3 Botulinum Toxin 20 µg 130
Substrate 2 1 mg 3,600

RAC2 (189) pro-719 5 µg 50

Recombinant Human Ras-Related C3 Botulinum Toxin 20 µg 130
Substrate 2 (1-189) 1 mg 2,700

RAC3 pro-073 5 µg 50
Recombinant Human Ras-Related C3 Botulinum Toxin 20 µg 130
Substrate 3 1 mg 2,700
PEPTIDES INTERNATIONAL

RAD1 pro-868 2 µg 50
Recombinant Human RAD1 10 µg 130
1 mg 5,200

RAET1E pro-1293 5 µg 50
Recombinant Human Retinoic Acid Early Transcript 1E 20 µg 130
1 mg 2,700

RAET1G pro-1608 2 µg 50
Recombinant Human Retinoic Acid Early Transcript 1G 10 µg 130
1 mg 5,200

RALA pro-043 5 µg 50
Recombinant Human V-ral Simian Leukemia Viral Oncogene 25 µg 130
Homolog A 1 mg 2,700

RALB pro-053 2 µg 50
Recombinant Human V-ral Simian Leukemia Viral Oncogene 10 µg 130
Homolog B 1 mg 5,200

RAmP3 pro-1367 2 µg 50
Recombinant Human Receptor Activity-modifying Protein 3 10 µg 130
100 µg 1,200

RAN pro-841 2 µg 50
Recombinant Human RAN, Member RAS Oncogene Family 10 µg 130
1 mg 5,200

676 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
RANBP1 pro-1064 5 µg 50
Recombinant Human RAN Binding Protein 1 25 µg 130
1 mg 2,700

RANGRF pro-1149 5 µg 50
Recombinant Human RAN Guanine Nucleotide Release Factor 20 µg 130
1 mg 2,700

RAP1A pro-848 2 µg 50
Recombinant Human RAP1A, Member RAS Oncogene Family 10 µg 130
1 mg 5,200

RAP1B pro-083 2 µg 50
Recombinant Human RAP1B, Member RAS Oncogene Family 10 µg 130
1 mg 5,200

RAP2B pro-1364 5 µg 50
Recombinant Human RAP2B, Member RAS Oncogene Family 20 µg 130
1 mg 2,700

RAP2A pro-061 2 µg 50
Recombinant Human RAP2A, Member RAS Oncogene Family 10 µg 130
1 mg 5,200

RARA pro-596 5 µg 50
Recombinant Retnoid Acid Receptor Α 25 µg 130
1 mg 2,700

RARRES1 pro-1514 5 µg 50

PEPTIDES INTERNATIONAL
Recombinant Human Retinoic Acid Receptor Responder 1 25 µg 130
1 mg 2,700

RARRES2 pro-788 5 µg 50
Recombinant Human Retinoic Acid Receptor Responder 2 25 µg 130
1 mg 2,700

RARRES2, His pro-1458 5 µg 50

Recombinant Human Retinoic Acid Receptor Responder 2 His 25 µg 130
Tag 1 mg 2,700

RASSF1A pro-1288 5 µg 50
Recombinant Human Ras association domain-containing 25 µg 130
Protein 1 1 mg 2,700

RASSF3 pro-1378 5 µg 50
Recombinant Human Ras Association Domain-Containing 20 µg 130
Protein 3 1 mg 2,700

RB1 pro-584 10 µg 50
Recombinant Human Retinoblastoma Associated Protein 50 µg 130
1 mg 1,800

RBBP4 pro-1168 5 µg 50
Recombinant Human Retinoblastoma Binding Protein 4 20 µg 130
1 mg 2,700

Order Hotline 1-800-777-4779 502-266-8787 677

 Recombinant proteins

RBBP9 pro-991 5 µg 50
Recombinant Human Retinoblastoma Binding Protein 9 20 µg 130
1 mg 2,700

RBm3 pro-1462 5 µg 50
Recombinant Human RNA Binding Motif Protein 3 20 µg 130
1 mg 2,700

RBm8A pro-186 2 µg 50
Recombinant Human RNA Binding Motif Protein 8A 10 µg 130
1 mg 5,200

rCALB1 pro-400 1 µg 50
Recombinant Rat Calbindin-1 5 µg 130
100 µg 2,500

RCAN1 pro-319 5 µg 50
Recombinant Human Regulator of Calcineurin 1 20 µg 130
1 mg 3,600

RCAN2 pro-990 5 µg 50
Recombinant Human Regulator of Calcineurin 2 20 µg 130
1 mg 2,700

RCAN3 pro-1284 2 µg 50
Recombinant Human Regulator of Calcineurin 3 10 µg 130
1 mg 5,200

RCHY1 pro-1536 5 µg 50
PEPTIDES INTERNATIONAL

Recombinant Human Ring Finger and CHY Zinc Finger Domain 20 µg 130
Containing 1 1 mg 3,600

RCN1 pro-544 2 µg 50
Recombinant Human Reticulocalbin 1 10 µg 130
1 mg 5,200

RCN2 pro-189 2 µg 50
Recombinant Human Reticulocalbin 2 10 µg 130
1 mg 5,200

RCN3 pro-1049 5 µg 50
Recombinant Human Reticulocalbin 3 20 µg 130
1 mg 2,700

RCVRN pro-441 10 µg 50
Recombinant Human Recoverin 50 µg 130
1 mg 2,100

RDBP pro-181 5 µg 50
Recombinant Human RD RNA Binding Protein 25 µg 130
1 mg 2,700

REG1A pro-289 2 µg 50
Recombinant Human Regenerating Islet-Derived 1 Α 10 µg 130
1 mg 3,900

678 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
REG1B pro-391 2 µg 50
Recombinant Human Regenerating Islet-Derived 1 Β 10 µg 130
1 mg 3,900

REG3A pro-421 2 µg 50
Recombinant Human Regenerating Islet-Derived 3 Α 10 µg 130
1 mg 3,900

REG4 pro-424 2 µg 50
Recombinant Human Regenerating Islet-Derived 4 10 µg 130
1 mg 3,900

REN pro-1529 5 µg 50
Recombinant Human Renin 25 µg 130
1 mg 2,700

RERG pro-106 2 µg 50
Recombinant Human RAS-like, Estrogen-Regulated, Growth 10 µg 130
Inhibitor 1 mg 5,200

REXANK pro-1537 2 µg 50
Recombinant Human Regulatory Factor X-Associated Ankyrin- 10 µg 130
Containing Protein 100 µg 1,200

rFibronectin pro-131 20 µg 50
Rat Fibronectin 100 µg 130
1 mg 600

PEPTIDES INTERNATIONAL
rGFP pro-687 10 µg 50
Recombinant Green Fluorescent Protein 50 µg 130
1 mg 2,400

RGN pro-915 5 µg 50
Recombinant Human Regucalcin 20 µg 130
1 mg 2,700

RGS1 pro-1118 5 µg 50
Recombinant Human Regulator of G-Protein Signaling 1 20 µg 130
1 mg 3,600

RGS10 pro-890 5 µg 50
Recombinant Human Regulator of G-Protein Signaling 10 25 µg 130
1 mg 2,700

RGS14 pro-1151 2 µg 50
Recombinant Human Regulator of G-Protein Signaling 14 10 µg 130
100 µg 1,200

RGS16 pro-798 2 µg 50
Recombinant Human Regulator of G-Protein Signaling 16 10 µg 130
1 mg 5,200

RGS17 pro-924 5 µg 50
Recombinant Human Regulator of G-Protein Signaling 17 25 µg 130
1 mg 2,700

Order Hotline 1-800-777-4779 502-266-8787 679

 Recombinant proteins

RGS19 pro-037 5 µg 50
Recombinant Human Regulator of G-Protein Signaling 19 20 µg 130
1 mg 2,700

RGS2 pro-182 1 µg 50
Recombinant Human Regulator of G-Protein Signaling 2 5 µg 130
50 µg 1,200

RGS21 pro-898 5 µg 50
Recombinant Human Regulator of G-Protein Signaling 21 20 µg 130
1 mg 2,700

RGS4 pro-900 2 µg 50
Recombinant Human Regulator of G-Protein Signaling 4 10 µg 130
1 mg 5,200

RGS5 pro-905 5 µg 50
Recombinant Human Regulator of G-Protein Signaling 5 25 µg 130
1 mg 2,700

RHEB pro-308 10 µg 50
Recombinant Human Ras Homolog Enriched in Brain 50 µg 130
1 mg 1,800

RHOA pro-057 5 µg 50
Recombinant Human Ras Homolog Gene Family Member A 20 µg 130
1 mg 2,700

RHOB pro-224 2 µg 50
PEPTIDES INTERNATIONAL

Recombinant Human Ras Homolog Gene Family Member B 10 µg 130

1 mg 5,200

RHOC pro-865 2 µg 50
Recombinant Human Ras Homolog Gene Family Member C 10 µg 130
1 mg 5,200

RHOD pro-190 1 µg 50
Recombinant Human Ras Homolog Gene Family Member D 5 µg 130
50 µg 1,200

RHOG pro-1136 5 µg 50
Recombinant Human Ras Homolog Gene Family Member G 20 µg 130
1 mg 2,700

RHOQ pro-1451 2 µg 50
Recombinant Human Ras Homolog Gene Family Member Q 10 µg 130
1 mg 5,200

RHOV pro-1199 5 µg 50
Recombinant Human Ras Homolog Gene Family Member V 20 µg 130
1 mg 3,600

rHSA HEK pro-967 20 µg 50

Recombinant Human Serum Albumin, HEK 100 µg 130
2 mg 1,200

680 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
rHSA Plant pro-595 10 mg 100
Recombinant Human Serum Albumin, Plant 50 mg 300
100 mg 500

RLN2 pro-1327 5 µg 50
Recombinant Human Relaxin-2 25 µg 130
1 mg 2,700

rmS100b pro-1236 5 µg 50
Recombinant Rhesus Macaque S100 Calcium Binding Protein 20 µg 130
B 1 mg 2,700

RND1 pro-893 5 µg 50
Recombinant Human Rho Family GTPase 1 20 µg 130
1 mg 2,700

RND3 pro-487 5 µg 50
Recombinant Human Rho Family GTPase 3 20 µg 130
1 mg 2,700

RNF181 pro-1218 5 µg 50
Recombinant Human Ring Finger Protein 181 20 µg 130
1 mg 2,700

RNF4 pro-1255 5 µg 50
Recombinant Human Ring Finger Protein 4 20 µg 130
1 mg 2,700

RNF7 pro-1671

PEPTIDES INTERNATIONAL
5 µg 50
Recombinant Human Ring Finger Protein 7 20 µg 130
1 mg 2,700

ROBLD3 pro-050 5 µg 50
Recombinant Human Roadblock Domain Containing 3 20 µg 130
1 mg 3,600

RORC pro-206 5 µg 50
Recombinant Human RAR-Related Orphan Receptor C 20 µg 130
1 mg 3,600

RP9 pro-1314 5 µg 50
Recombinant Human Retinitis Pigmentosa 9 20 µg 130
1 mg 2,700

RPAIN pro-1661 2 µg 50
Recombinant Human RPA Interacting Protein 10 µg 130
1 mg 5,200

RPA2 pro-011 2 µg 50
Recombinant Human Replication Protein A2 10 µg 130
1 mg 5,200

RPL26L1 pro-1242 2 µg 50
Recombinant Human Ribosomal Protein L26-Like 1 10 µg 130
100 µg 1,200

RPL8 pro-1053 2 µg 50
Recombinant Human Ribosomal Protein L8 10 µg 130
1 mg 5,200

Order Hotline 1-800-777-4779 502-266-8787 681

 Recombinant proteins

RPL11 pro-1561 5 µg 50
Recombinant Human Ribosomal Protein L11 20 µg 130
1 mg 2,700

RPL22 pro-1549 2 µg 50
Recombinant Human Ribosomal Protein L22 10 µg 130
1 mg 5,200

RPL23A pro-1465 2 µg 50
Recombinant Human Ribosomal Protein L23A 10 µg 130
1 mg 5,200

RPL26 pro-1538 5 µg 50
Recombinant Human Ribosomal Protein L26 20 µg 130
1 mg 2,700

RPL30 pro-1659 2 µg 50
Recombinant Human Ribosomal Protein L30 10 µg 130
100 µg 1,200

RPL34 pro-1704 5 µg 50
Recombinant Human Ribosomal Protein L34 20 µg 130
1 mg 2,700

RPL35A pro-1703 5 µg 50
Recombinant Human Ribosomal Protein L35A 20 µg 130
1 mg 2,700

RPLP0 pro-392 5 µg 50
PEPTIDES INTERNATIONAL

Recombinant Human Ribosomal PhosphoProtein P0 20 µg 130

1 mg 3,500

RPLP1 pro-127 2 µg 50
Recombinant Human Ribosomal PhosphoProtein P1 10 µg 130
1 mg 4,200

RPLP2 pro-128 5 µg 50
Recombinant Human Ribosomal PhosphoProtein P2 20 µg 130
1 mg 2,700

RPS3 pro-954 2 µg 50
Recombinant Human Ribosomal Protein S3 10 µg 130
1 mg 5,200

RPS3A pro-1125 5 µg 50
Recombinant Human Ribosomal Protein S3A 20 µg 130
1 mg 2,700

RPS5 pro-1300 2 µg 50
Recombinant Human Ribosomal Protein S5 10 µg 130
1 mg 5,200

RPS7 pro-993 2 µg 50
Recombinant Human Ribosomal Protein S7 10 µg 130
1 mg 5,200

682 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
RPS10 pro-1409 5 µg 50
Recombinant Human Ribosomal Protein S10 20 µg 130
1 mg 2,700

RPS12 pro-1482 5 µg 50
Recombinant Human Ribosomal Protein S12 20 µg 130
1 mg 2,700

RPS13 pro-1449 5 µg 50
Recombinant Human Ribosomal Protein S13 20 µg 130
1 mg 3,600

RPS14 pro-118 1 µg 50
Recombinant Human Ribosomal Protein S14 5 µg 130
50 µg 1,200

RPS16 pro-1555 2 µg 50
Recombinant Human Ribosomal Protein S16 10 µg 130
1 mg 5,200

RPS18 pro-984 5 µg 50
Recombinant Human Ribosomal Protein S18 20 µg 130
1 mg 3,600

RPS19 pro-1541 2 µg 50
Recombinant Human Ribosomal Protein S19 10 µg 130
100 µg 1,200

RPS24 pro-1554 2 µg 50

PEPTIDES INTERNATIONAL
Recombinant Human Ribosomal Protein S24 10 µg 130
100 µg 1,200

rPVALB pro-398 2 µg 50
Recombinant Rat Parvalbumin 10 µg 270
100 µg 2,400

RQCD1 pro-008 5 µg 50
Recombinant Human RCD1 Required for Cell Differentiation1 20 µg 130
1 mg 2,700

RRAGC pro-1050 5 µg 50
Recombinant Human Ras-Related GTP Binding C 20 µg 130
1 mg 2,700

rRAP pro-352 5 µg 50
Recombinant Rat Receptor Associated Protein 20 µg 130
1 mg 2,800

RRAS pro-808 2 µg 50
Recombinant Human Related RAS Viral (r-ras) Oncogene 10 µg 130
Homolog 1 mg 5,200

RRAS2 pro-728 10 µg 50
Recombinant Human Related RAS Viral (r-ras) Oncogene 50 µg 130
Homolog 2 1 mg 1,800

Order Hotline 1-800-777-4779 502-266-8787 683

 Recombinant proteins

RSG1 pro-1334 1 µg 50
Recombinant Human REm2 and RAB-Like Small GTPase 1 5 µg 130
50 µg 1,200

RSPO3 pro-1646 5 µg 50
Recombinant Human R-Spondin-3 20 µg 130
1 mg 2,700

RTN4IP1 pro-1014 5 µg 50
Recombinant Human Reticulon 4 Interacting Protein 1 20 µg 130
1 mg 2,700

rTpc1808 pro-587 10 µg 50
Recombinant Rat Tropic 1808 50 µg 130
1 mg 1,800

rTroponin-C pro-323 1 mg 130

Rabbit Skeletal Muscle Troponin-C 5 mg 550
10 mg 1,000

RUNX3 pro-836 2 µg 50
Recombinant Human Runt-Related Transcription Factor 3 10 µg 130
1 mg 5,200

RUVBL1 pro-861 5 µg 50
Recombinant Human RuvB-Like 1 20 µg 130
1 mg 2,700

RWDD1 pro-1309 2 µg 50
PEPTIDES INTERNATIONAL

Recombinant Human RWD Domain Containing 1 10 µg 130

1 mg 5,200

RXRA pro-437 10 µg 50
Recombinant Human Retinoid X Receptor Α 50 µg 130
1 mg 1,800

RYBP pro-1139 2 µg 50
Recombinant Human RING1 and YY1 Binding Protein 10 µg 130
100 µg 1,200

S100A1 pro-364 5 µg 175

Recombinant Human S100 Calcium Binding Protein A1 10 µg 270
25 µg 490

mS100A1 pro-237 5 µg 50
Recombinant Mouse S100 Calcium Binding Protein A1 20 µg 130
1 mg 2,700

S100A10 pro-384 2 µg 50
Recombinant Human S100 Calcium Binding Protein A10 10 µg 130
1 mg 4,800

S100A11 pro-385 2 µg 50
Recombinant Human S100 Calcium Binding Protein A11 10 µg 130
1 mg 4,800

684 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
S100A12 pro-152 2 µg 50
Recombinant Human S100 Calcium Binding Protein A12 10 µg 130
1 mg 5,200

S100A13 pro-153 2 µg 50
Recombinant Human S100 Calcium Binding Protein A13 10 µg 130
1 mg 5,200

S100A14 pro-154 2 µg 50
Recombinant Human S100 Calcium Binding Protein A14 10 µg 130
1 mg 5,200

S100A16 pro-155 5 µg 50
Recombinant Human S100 Calcium Binding Protein A16 20 µg 130
1 mg 2,700

S100A2 pro-146 5 µg 50
Recombinant Human S100 Calcium Binding Protein A2 20 µg 130
1 mg 2,700

S100A3 pro-755 2 µg 50
Recombinant Human S100 Calcium Binding Protein A3 10 µg 130
1 mg 4,800

mS100A3 pro-1166 5 µg 50
Recombinant Mouse S100 Calcium Binding Protein A3 20 µg 130
1 mg 2,700

S100A4 pro-307 2 µg 175

PEPTIDES INTERNATIONAL
Recombinant Human S100 Calcium Binding Protein A4 5 µg 270
10 µg 490

S100A4 His pro-698 5 µg 50

Recombinant Human S100 Calcium Binding Protein A4 His Tag 20 µg 130
1 mg 3,000

mS100A4 pro-229 5 µg 50
Recombinant Mouse S100 Calcium Binding Protein A4 20 µg 130
1 mg 2,700

S100A5 pro-147 5 µg 50
Recombinant Human S100 Calcium Binding Protein A5 20 µg 130
1 mg 3,600

mS100A5 pro-1084 5 µg 50
Recombinant Mouse S100 Calcium Binding Protein A5 20 µg 130
1 mg 2,700

S100A6 pro-148 5 µg 50
Recombinant Human S100 Calcium Binding Protein A6 20 µg 130
1 mg 2.70

mS100A6 pro-409 2 µg 175

Mouse S100 Calcium Binding Protein A6 5 µg 270
10 µg 490

Order Hotline 1-800-777-4779 502-266-8787 685

 Recombinant proteins

mS100A6 pro-240 5 µg 50
Recombinant Mouse S100 Calcium Binding Protein A6 20 µg 130
1 mg 2,700

S100A7 pro-149 5 µg 50
Recombinant Human S100 Calcium Binding Protein A7 20 µg 130
1 mg 2.70

S100A7A pro-756 2 µg 50
Recombinant Human S100 Calcium Binding Protein A7A 10 µg 130
1 mg 4,800

S100A8 pro-800 5 µg 50
Recombinant Human S100 Calcium Binding Protein A8 20 µg 130
1 mg 3,600

S100A8, His pro-150 2 µg 50

Recombinant Human S100 Calcium Binding Protein A8, His Tag 10 µg 130
1 mg 5,200

mS100A8 pro-233 5 µg 50
Recombinant Mouse S100 Calcium Binding Protein A8 20 µg 130
1 mg 2.70

S100A9 pro-814 5 µg 50
Recombinant Human S100 Calcium Binding Protein A9 25 µg 130
1 mg 2,250

S100A9, His pro-151 2 µg 50

PEPTIDES INTERNATIONAL

Recombinant Human S100 Calcium Binding Protein A9, His Tag 10 µg 130
1 mg 5,200

mS100A9 pro-878 2 µg 50
Recombinant Mouse S100 Calcium Binding Protein A9 10 µg 130
1 mg 5,200

S100b pro-306 5 µg 50
Recombinant Human S100 Calcium Binding Protein B 20 µg 130
1 mg 2,700

mS100b pro-853 5 µg 50
Recombinant Mouse S100 Calcium Binding Protein B 25 µg 130
1 mg 2,250

S100b GST pro-737 2 µg 175

Recombinant Human S100 Calcium Binding Protein B, GST 5 µg 270
Tag 10 µg 490

S100G pro-399 1 µg 50
Recombinant Rat S100 Calcium Binding Protein G 5 µg 130
100 µg 2,200

S100G pro-156 2 µg 50
Recombinant Human S100 Calcium Binding Protein G 10 µg 130
1 mg 5,200

686 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
S100P pro-425 2 µg 50
Recombinant Human S100 Calcium Binding Protein P 10 µg 130
1 mg 3,900

S100P His pro-830 5 µg 50

Recombinant Human S100 Calcium Binding Protein P, His Tag 25 µg 130
1 mg 2,250

S100Z pro-840 5 µg 50
Recombinant HumanS100 Calcium Binding Protein Z 25 µg 130
1 mg 2,250

mS100A15 pro-1145 2 µg 50
Recombinant Mouse S100 Calcium Binding Protein A15 10 µg 130
1 mg 5,200

SAmD13 pro-355 5 µg 50
Recombinant Human Sterile Α Motif Domain Containing 13 20 µg 130
1 mg 2,700

SAP18 pro-707 5 µg 50
Recombinant Human Sin3A-Associated Protein, 18kDa 20 µg 130
1 mg 3,000

SAR1A pro-709 5 µg 50
Recombinant Human GTP-Binding Protein SAR1A 20 µg 130
1 mg 2,700

SAR1B pro-310 5 µg 50

PEPTIDES INTERNATIONAL
Recombinant Human GTP-Binding Protein SAR1B 20 µg 130
1 mg 2,700

SBDS pro-272 5 µg 50
Recombinant Human Shwachman-Bodian-Diamond Syndrome 20 µg 130
1 mg 2,700

SCAND1 pro-269 2 µg 50
Recombinant Human SCAN domain containing 1 10 µg 130
1 mg 5,200

SCG3 pro-1556 5 µg 50
Recombinant Human Secretogranin III 20 µg 130
1 mg 2,700

SCG5 pro-467 2 µg 50
Recombinant Human Secretogranin V 10 µg 130
1 mg 5,200

SCGB1D1 pro-1602 2 µg 50
Recombinant Human Secretoglobin Family 1D Member 1 10 µg 130
1 mg 5,200

SCGB2A2 pro-515 2 µg 175

Recombinant Human Mammaglobin-A 5 µg 270
10 µg 490

Order Hotline 1-800-777-4779 502-266-8787 687

 Recombinant proteins

SCGN pro-599 2 µg 50
Recombinant Human Secretagogin 10 µg 130
1 mg 5,200

rSCGN pro-657 2 µg 50
Recombinant Rat Secretagogin 10 µg 130
1 mg 5,200

SCO2 pro-054 2 µg 50
Recombinant Human SCO Cytochrome Oxidase Deficient 10 µg 130
Homolog 2 1 mg 5,200

SDC1 pro-1065 5 µg 50
Recombinant Human Syndecan-1 20 µg 130
1 mg 2,700

SDC1, GST pro-516 2 µg 175

Recombinant Human Syndecan-1, GST tag 5 µg 270
10 µg 490

SDC4 pro-778 2 µg 50
Recombinant Human Syndecan-4 10 µg 130
1 mg 5,200

SDC4, His pro-583 10 µg 50

Recombinant Human Syndecan-4, His Tag 50 µg 130
1 mg 1,800

SDCBP pro-036 5 µg 50
PEPTIDES INTERNATIONAL

Recombinant Human Syndecan Binding Protein 20 µg 130

1 mg 2,700

SDCBP2 pro-1297 2 µg 50
Recombinant Human Syndecan Binding Protein 2 10 µg 130
1 mg 5,200

SDHAF2 pro-593 5 µg 50
Recombinant Human Succinate Dehydrogenase Complex 20 µg 130
Assembly Factor 2 1 mg 2,700

SDR16C5 pro-1385 5 µg 50
Recombinant Human Short Chain Dehydrogenase/Reductase 20 µg 130
Family 16C, Member 5 1 mg 2,700

SEC13 pro-194 5 µg 50
Recombinant Human SEC13 20 µg 130
1 mg 2,700

SEC22B pro-1212 5 µg 50
Recombinant Human SEC22 Homolog B 20 µg 130
1 mg 2,700

SecB pro-697 5 µg 50
Recombinant Protein Export Protein SecB 25 µg 130
1 mg 2,700

688 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
SELE pro-380 2 µg 50
Recombinant Human E-Selectin 10 µg 130
1 mg 3,200

SELE HEK pro-1645 2 µg 50

Recombinant Human E-Selectin HEK 10 µg 130
1 mg 2,000

SEmG1 pro-1732 5 µg 50
Recombinant Human Semenogelin I 20 µg 130
1 mg 2,700

SEP15 pro-1468 5 µg 50
Recombinant Human 15 KDa SelenoProtein 20 µg 130
1 mg 2,700

SEPT2 pro-255 2 µg 50
Recombinant Human Septin-2 10 µg 130
1 mg 5,200

SEPT5 pro-879 5 µg 50
Recombinant Human Septin-5 20 µg 130
1 mg 2,700

SEPT6 pro-949 5 µg 50
Recombinant Human Septin-6 20 µg 130
1 mg 2,700

SEPX1 pro-260 2 µg 50

PEPTIDES INTERNATIONAL
Recombinant Human SelenoProtein X 1 10 µg 130
1 mg 5,200

SERF2 pro-1730 2 µg 50
Recombinant Human Small EDRK-Rich Factor 2 10 µg 130
1 mg 5,200

SERPINA1 pro-456 100 µg 50

Human Α-1 Antitrypsin 0.5 mg 130
5 mg 700

SERPINA1 pro-529 5 µg 50
Recombinant Human Α-1 Antitrypsin 25 µg 130
1 mg 2,700

SERPINA1, Active pro-907 20 µg 50

Recombinant Human Α-1 Antitrypsin, Active 100 µg 130
1 mg 1,050

SERPINA3 pro-750 5 µg 50
Recombinant Human Α-1 AntiChymotrypsin 25 µg 130
1 mg 2,250

SERPINA3 pro-378 20 µg 50
Human Α-1 AntiChymotrypsin 100 µg 130
1 mg 450

Order Hotline 1-800-777-4779 502-266-8787 689

 Recombinant proteins

SERPINA5 pro-749 2 µg 50
Recombinant Human Serpin Peptidase Inhibitor, Clade A 10 µg 130
Member 5 1 mg 5,200

SERPINA8 pro-1572 2 µg 50
Recombinant Human Serpin Peptidase Inhibitor, Clade A 10 µg 130
Member 8 1 mg 5,200

SERPINB5 pro-202 5 µg 50
Recombinant Human Serpin Peptidase Inhibitor, Clade B 20 µg 130
Member 5 1 mg 2,700

SERPINB5 His pro-704 5 µg 50

Recombinant Human Serpin Peptidase Inhibitor, Clade B 25 µg 130
Member 5, His Tag 1 mg 2,700

SERPING1 pro-1401 10 µg 50
Recombinant Human Serpin Peptidase Inhibitor, Clade G 50 µg 130
Member 1 1 mg 2,400

SERPING1 HEK pro-1639 10 µg 50

Recombinant Human Serpin Peptidase Inhibitor, Clade G 50 µg 130
Member 1, HEK 1 mg 2,000

SERPINI1 pro-213 5 µg 50
Recombinant Human Serpin Peptidase Inhibitor, Clade I 20 µg 130
Member 1 1 mg 2,700
PEPTIDES INTERNATIONAL

SERPINI1 His pro-1595 2 µg 50

Recombinant Human Serpin Peptidase Inhibitor, Clade I 10 µg 130
Member 1, His Tag 1 mg 5,200

SERTAD1 pro-1157 2 µg 50
Recombinant Human SERTA Domain Containing 1 10 µg 130
100 µg 1,200

SET pro-1540 5 µg 50
Recombinant Human SET 20 µg 130
1 mg 2,700

SFRP4 pro-1604 2 µg 50
Recombinant Human Secreted Frizzled-Related Protein 4 10 µg 130
1 mg 5,200

SF3B14 pro-105 2 µg 50
Recombinant Human Splicing Factor 3B, 14 kDa Subunit 10 µg 130
1 mg 5,200

SGCD pro-1373 5 µg 50
Recombinant Human Sarcoglycan Delta  20 µg 130
1 mg 2,700

SCN3B pro-1670 2 µg 50
Recombinant Human Sodium Channel Voltage-Gated, Type III Β 10 µg 130
1 mg 5,200

690 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
SGTA pro-807 5 µg 50
Recombinant Human Small Glutamine-Rich Tetratricopeptide 25 µg 130
Repeat-Containing Protein Α 1 mg 2,250

SHBG pro-1603 2 µg 50
Recombinant Human Sex Hormone-Binding Globulin 10 µg 130
1 mg 5,200

SH2D1A pro-006 5 µg 50
Recombinant Human SH2 domain containing 1A 25 µg 130
1 mg 2,700

SH3BGRL pro-1159 5 µg 50
Recombinant Human SH3 Domain Binding Glutamic Acid-Rich 20 µg 130
Protein Like 1 mg 2,700

SH3BGRL2 pro-1215 5 µg 50
Recombinant Human SH3 Domain Binding Glutamic Acid-Rich 20 µg 130
Protein Like 2 1 mg 3,600

SH3BGRL3 pro-1216 5 µg 50
Recombinant Human SH3 Domain Binding Glutamic Acid-Rich 20 µg 130
Protein Like 3 1 mg 2,700

PEPTIDES INTERNATIONAL
SH3GL2 pro-1083 5 µg 50
Recombinant Human SH3-domain GRB2-like 2 20 µg 130
1 mg 2,700

SH3GLB1 pro-1278 5 µg 50
Recombinant Human SH3-domain GRB2-like endophilin B1 20 µg 130
1 mg 2,700

SH3GLB2 pro-1287 5 µg 50
Recombinant Human SH3-domain GRB2-like endophilin B2 20 µg 130
1 mg 2,700

SHC1 pro-883 5 µg 50
Recombinant Human SHC-Transforming Protein 1 20 µg 130
1 mg 2,700

SIL1 pro-1187 2 µg 50
Recombinant Human SIL1 10 µg 130
100 µg 1,200

SIRT2 pro-033 1 µg 50
Recombinant Human SIrtuin-2 5 µg 130
50 µg 1,200

SIRT3 pro-462 2 µg 50
Recombinant Human SIrtuin-3 10 µg 130
1 mg 5,200

Order Hotline 1-800-777-4779 502-266-8787 691

 Recombinant proteins

SIRT6 pro-282 2 µg 50
Recombinant Human SIrtuin-6 10 µg 130
1 mg 5,200

SIT1 pro-928 1 µg 50
Recombinant Human Signaling Threshold Regulating 5 µg 130
Transmembrane Adaptor 1 50 µg 1,200

SIX1 pro-1226 5 µg 50
Recombinant Human SIX Homeobox 1 20 µg 130
1 mg 2,700

SIX6 pro-1253 5 µg 50
Recombinant Human SIX Homeobox 6 20 µg 130
1 mg 2,700

SLAmF1 pro-1342 2 µg 50
Recombinant Human SLAmF1 10 µg 130
100 µg 1,200

SLAmF6 pro-1286 5 µg 50
Recombinant Human SLAmF6 20 µg 130
1 mg 2,700

SLC4A4 pro-688 5 µg 50
Recombinant Human Solute Carrier Family 4, Sodium 20 µg 130
Bicarbonate Cotransporter, Member 4 1 mg 2,700
PEPTIDES INTERNATIONAL

SLC51B pro-1727 2 µg 50
Recombinant Human Solute Carrier Family 51 Β 10 µg 130
1 mg 5,200

SLPI pro-849 2 µg 50
Recombinant Human Secretory Leukocyte Peptidase Inhibitor 10 µg 130
1 mg 5,200

SmAC/DIABLO pro-614 5 µg 50
Recombinant Human SmAC/DIABLO 20 µg 130
1 mg 3,600

SmAD2 pro-691 2 µg 50
Recombinant Human SmAD Family Member 2 10 µg 130
1 mg 5,200

SmAD3 pro-751 5 µg 50
Recombinant Human Mothers Against Decapentaplegic 25 µg 130
Homolog 3 1 mg 2,250

SmAD4 pro-459 10 µg 50
Recombinant Human Mothers Against Decapentaplegic 50 µg 130
Homolog 4 1 mg 1,800

SmCP pro-1719 2 µg 50
Recombinant Human Sperm Mitochondria-Associated 10 µg 130
Cysteine-Rich Protein 1 mg 5,200

692 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
SmNDC1 pro-035 2 µg 50
Recombinant Human Survival Motor Neuron Domain 10 µg 130
Containing 1 1 mg 5,200

SNAP23 pro-659 5 µg 50
Recombinant Human Synaptosomal-associated Protein 23kDa 25 µg 130
1 mg 2,900

SNAP25 pro-573 10 µg 50
Recombinant Human Synaptosomal-associated Protein 25kDa 50 µg 130
1 mg 1,800

SNAP-25 pro-396 10 µg 50
Recombinant Synaptosomal-associated Protein 25kDa, 50 µg 130
C.elegans 1 mg 1,800

SNAP25B pro-635 5 µg 50
Recombinant Human Synaptosomal-associated Protein 25B 20 µg 130
1 mg 2,800

SNAPIN pro-663 10 µg 50
Recombinant Human SNAP Associated Protein 50 µg 130
1 mg 1,800

SNCA pro-393 20 µg 50
Recombinant Human Α-Synuclein 100 µg 130
1 mg 1,000

PEPTIDES INTERNATIONAL
SNCA 1-60 pro-165 10 µg 50
Recombinant Human Α-Synuclein 1-60 50 µg 130
1 mg 1,800

SNCA 61-140 pro-163 10 µg 50

Recombinant Human Α-Synuclein 61-140 50 µg 130
1 mg 1,800

SNCA 96-140 pro-164 10 µg 50

Recombinant Human Α-Synuclein 96-140 50 µg 130
1 mg 1,800

SNCA A30P pro-158 10 µg 50

Recombinant Human Α-Synuclein A30P 50 µg 130
1 mg 1,800

SNCA A30P/A53T pro-160 10 µg 50

Recombinant Human Α-Synuclein A30P/A53T 50 µg 130
1 mg 1,800

SNCA A53T pro-159 10 µg 50

Recombinant Human Α-Synuclein A53T 50 µg 130
1 mg 1,800

Order Hotline 1-800-777-4779 502-266-8787 693

 Recombinant proteins

SNCA Delta-NAC pro-161 10 µg 50

Recombinant Human Α-Synuclein Delta-NAC 50 µg 130
1 mg 1,800

SNCA NACP112 pro-162 10 µg 50

Recombinant Human Α-Synuclein NACP112 50 µg 130
1 mg 1,800

mSNCA pro-858 5 µg 50
Recombinant Mouse Α-Synuclein 20 µg 130
1 mg 2,700

SNCB pro-394 10 µg 50
Recombinant Human Β-Synuclein 50 µg 130
1 mg 1,900

SNCG pro-395 20 µg 50
Recombinant Human Gamma-Synuclein 100 µg 130
1 mg 1,000

SNF8 pro-1135 5 µg 50
Recombinant Human SNF8, ESCRT-II Complex Subunit 20 µg 130
1 mg 3,600

SNIP1 pro-201 5 µg 50
Recombinant Human Smad Nuclear Interacting Protein 1 20 µg 130
1 mg 2,700

SNPH pro-545 10 µg 50
PEPTIDES INTERNATIONAL

Recombinant Human Syntaphilin 50 µg 130

1 mg 1,800

SNRNP25 pro-226 5 µg 50
Recombinant Human Small Nuclear RibonucleoProtein 25kDa 20 µg 130
1 mg 3,600

SNRNP70 pro-445 5 µg 50
Recombinant Human Small Nuclear RibonucleoProtein 70kDa 20 µg 130
1 mg 3,500

SNRPA pro-1509 2 µg 50
Recombinant Human Small Nuclear RibonucleoProtein 10 µg 130
Polypeptide A 1 mg 5,200

SNRPA1 pro-1015 1 µg 50
Recombinant Human Small Nuclear RibonucleoProtein 5 µg 130
Polypeptide A 50 µg 1,200

SNRPB pro-1511 2 µg 50
Recombinant Human Small Nuclear RibonucleoProtein 10 µg 130
Polypeptides B and B1 1 mg 5,200

SNRPB2 pro-217 2 µg 50
Recombinant Human Small Nuclear RibonucleoProtein 10 µg 130
Polypeptide B 1 mg 5,200

694 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
SNRPC pro-1004 1 µg 50
Recombinant Human Small Nuclear RibonucleoProtein 5 µg 130
Polypeptide C 50 µg 1,200

SNRPC sf9 pro-1510 2 µg 50

Recombinant Human Small Nuclear RibonucleoProtein 10 µg 130
Polypeptide C, sf9 1 mg 5,200

SNRPD pro-997 2 µg 50
Recombinant Human Small Nuclear RibonucleoProtein 10 µg 130
Polypeptide D1, D2, D3 1 mg 5,200

SNRPD1 pro-994 2 µg 50
Recombinant Human Small Nuclear RibonucleoProtein 10 µg 130
Polypeptide D1 1 mg 5,200

SNRPD2 pro-123 5 µg 50
Recombinant Human Small Nuclear RibonucleoProtein 20 µg 130
Polypeptide D2 1 mg 3,600

SNRPD2, Sf9 pro-995 2 µg 50

Recombinant Human Small Nuclear RibonucleoProtein 10 µg 130
Polypeptide D2, Sf9 1 mg 5,200

SNRPD3 pro-945 2 µg 50
Recombinant Human Small Nuclear RibonucleoProtein 10 µg 130
Polypeptide D3 1 mg 5,200

PEPTIDES INTERNATIONAL
SNRPD3, Sf9 pro-996 2 µg 50
Recombinant Human Small Nuclear RibonucleoProtein 10 µg 130
Polypeptide D3, Sf9 1 mg 5,200

SNRPE pro-104 1 µg 50
Recombinant Human Small Nuclear RibonucleoProtein 5 µg 130
Polypeptide E 50 µg 1,200

SNRPF pro-041 5 µg 50
Recombinant Human Small Nuclear RibonucleoProtein 20 µg 130
Polypeptide F 1 mg 3,600

SNRPG pro-196 2 µg 50
Recombinant Human Small Nuclear RibonucleoProtein 10 µg 130
Polypeptide G 1 mg 5,200

SNTA1 pro-1016 2 µg 50
Recombinant Human Syntrophin, Α 1 10 µg 130
1 mg 5,200

SNTN pro-216 5 µg 50
Recombinant Human Sentan Cilia Apical Structure Protein 20 µg 130
1 mg 2,700

SNUPN pro-866 5 µg 50
Recombinant Human Snurportin 1 20 µg 130
1 mg 2,700

Order Hotline 1-800-777-4779 502-266-8787 695

 Recombinant proteins

SNX1 pro-665 1 µg 50
Recombinant Human Sorting Nexin 1 5 µg 130
50 µg 1,200

SNX3 pro-246 5 µg 50
Recombinant Human Sorting Nexin 3 20 µg 130
1 mg 2,700

SOD pro-286 20 µg 50
Recombinant Human Superoxide Dismutase 100 µg 130
1 mg 600

SOD His pro-1239 20 µg 50

Recombinant Human Superoxide Dismutase His Tag 100 µg 130
1 mg 600

SOD1 pro-648 5 µg 50
Recombinant Human Superoxide Dismutase-1 25 µg 130
1 mg 2,700

SOD2 pro-819 5 µg 50
Recombinant Human Superoxide Dismutase-2 25 µg 130
1 mg 2,250

SODA pro-208 5 µg 50
Recombinant E.Coli Superoxide Dismutase 20 µg 130
1 mg 2,700

SOSTDC1 pro-426 5 µg 50
PEPTIDES INTERNATIONAL

Recombinant Human Sclerostin Domain Containing 1 20 µg 130

1 mg 2,700

SOST pro-1601 2 µg 50
Recombinant Human Sclerostin 10 µg 130
1 mg 5,200

SOX2 pro-820 5 µg 50
Recombinant Human SRY (sex determining region Y)-box 2 25 µg 130
1 mg 2,250

SOX2 PolyR pro-089 2 µg 50

Recombinant Human SRY (sex determining region Y)-box 2 10 µg 130
Polyarginine-Tag 1 mg 5,200

Sox2-TAT pro-1343 5 µg 50
Recombinant Human SRY (sex determining region Y)-box 2 25 µg 130
TAT 1 mg 2,700

SOX9 pro-739 2 µg 175

Recombinant Human SOX9 5 µg 270
10 µg 490

SP100 pro-108 5 µg 50
Recombinant Human SP100 20 µg 130
1 mg 3,900

696 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
SPA pro-356 10 mg 40
Recombinant Staphylococcal Protein-A 100 mg 350
1gra m 1,400

SPA 41kDa pro-774 10 mg 40

Recombinant Staphylococcal Protein-A 41kDa 100 mg 350
1gra m 1,400

SPA 434a.a. pro-686 10 µg 50

Recombinant Staphylococcal Protein A 434 a.a 50 µg 130
1 mg 2,400

SPA17 pro-1425 2 µg 50
Recombinant Human Sperm Autoantigenic Protein 17 10 µg 130
1 mg 5,200

SPAG7 pro-1654 5 µg 50
Recombinant Human Sperm Associated Antigen 7 25 µg 130
1 mg 2,700

SPARC pro-582 10 µg 50
Recombinant Human Secreted Protein Acidic and Rich in 50 µg 130
Cysteine 1 mg 1,350

SPG21 pro-677 5 µg 50
Recombinant Human Spastic Paraplegia 21 20 µg 130
1 mg 3,600

PEPTIDES INTERNATIONAL
SPIN1 pro-1184 1 µg 50
Recombinant Human Spindlin-1 5 µg 130
50 µg 1,200

SPINT2 pro-1296 2 µg 50
Recombinant Human Serine Peptidase Inhibitor, Kunitz Type 2 10 µg 130
1 mg 5,200

SPINK7 pro-1507 2 µg 50
Recombinant Human Serine Peptidase Inhibitor Kazal Type 7  10 µg 130
1 mg 5,200

SPOP pro-195 2 µg 50
Recombinant Human Speckle-Type POZ Protein 10 µg 130
1 mg 5,200

SPRR1B pro-1582 2 µg 50
Recombinant Human Small Proline-Rich Protein 1B 10 µg 130
1 mg 5,200

SPRY pro-1698 5 µg 50
Recombinant Human Sprouty Homolog 4 25 µg 130
1 mg 2,700

SPSB1 pro-223 2 µg 50
Recombinant Human SPRY Domain-Containing SOCS Cox 10 µg 130
Protein 1 1 mg 5,200

Order Hotline 1-800-777-4779 502-266-8787 697

 Recombinant proteins

SPSB2 pro-1264 5 µg 50
Recombinant Human SPRY Domain-Containing SOCS Cox 20 µg 130
Protein 2 1 mg 2,700

SQSTm1 pro-806 5 µg 50
Recombinant Human Sequestosome 1 25 µg 130
1 mg 2,250

SRA1 pro-1274 2 µg 50
Recombinant Human Steroid Receptor RNA Activator 1 10 µg 130
100 µg 1,200

sRAGE pro-600 2 µg 50
Recombinant Human Advanced Glycosylation End Product- 10 µg 130
Specific Receptor 1 mg 5,200

sRAGE HEK pro-601 2 µg 50

Recombinant Human Advanced Glycosylation End Product- 10 µg 130
Specific Receptor, HEK 100 µg 990

SRSF1 pro-1352 5 µg 50
Recombinant Human Serine/arginine-Rich Splicing Factor 1 20 µg 130
1 mg 2,700

SRGN pro-965 5 µg 50
Recombinant Human Serglycin 20 µg 130
1 mg 2,700
PEPTIDES INTERNATIONAL

SRI pro-166 5 µg 50
Recombinant Human Sorcin 20 µg 130
1 mg 2,700

SRP14 pro-013 5 µg 50
Recombinant Human Signal Recognition Particle 14kDa 20 µg 130
1 mg 2,700

SRP54 pro-113 5 µg 50
Recombinant Human Signal Recognition Particle 54kDa 20 µg 130
1 mg 3,900

SRP19 pro-1474 2 µg 50
Recombinant Human Signal Recognition Particle 19kDa 10 µg 130
1 mg 5,200

SSBP1 pro-1408 5 µg 50
Recombinant Human Single-Stranded DNA Binding Protein 1 20 µg 130
1 mg 2,700

SSBP1 pro-359 5 µg 50
Recombinant Single-Stranded DNA Binding Protein 1 20 µg 130
1 mg 2,700

SSR2 pro-1380 5 µg 50
Recombinant Human Signal Sequence Receptor, Β 20 µg 130
1 mg 2,700

698 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
SSR4 pro-1294 5 µg 50
Recombinant Human Signal Sequence Receptor, Delta 20 µg 130
1 mg 2,700

SSX1 pro-1379 2 µg 50
Recombinant Human Synovial Sarcoma, X Breakpoint 1 10 µg 130
1 mg 5,200

STAmBP pro-017 5 µg 50
Recombinant Human STAm Binding Protein 20 µg 130
1 mg 2,700

STAmBPL1 pro-1354 2 µg 50
Recombinant Human STAm Binding Protein Like 1 10 µg 130
1 mg 5,200

STAP1 pro-1110 5 µg 50
Recombinant Human Signal Transducing Adaptor Family 20 µg 130
Member 1 1 mg 2,700

STAR pro-979 5 µg 50
Recombinant Human Steroidogenic Acute Regulatory Protein 20 µg 130
1 mg 2,700

STBD1 pro-1545 5 µg 50
Recombinant Human Starch Binding Domain 1 20 µg 130
1 mg 3,600

PEPTIDES INTERNATIONAL
STIm1 pro-620 5 µg 50
Recombinant Human Stromal Interaction Molecule 1 25 µg 130
1 mg 2,700

STIP1 pro-753 2 µg 50
Recombinant Human Stress-Induced-PhosphoProtein 1 10 µg 130
1 mg 5,200

STmN1 pro-676 5 µg 50
Recombinant Human Stathmin-1 25 µg 130
1 mg 2,700

STmN2 pro-752 2 µg 50
Recombinant Human Stathmin Like-2 10 µg 130
1 mg 5,200

STmN3 pro-838 2 µg 50
Recombinant Human Stathmin Like-3 10 µg 130
1 mg 5,200

STmN4 pro-1497 5 µg 50
Recombinant Human Stathmin Like-4 20 µg 130
1 mg 3,600

STOm pro-1525 5 µg 50
Recombinant Human Stomatin 25 µg 130
1 mg 2,700

Order Hotline 1-800-777-4779 502-266-8787 699

 Recombinant proteins

Streptavidin pro-283 2 mg 50
Streptavidin 10 mg 130
100 mg 990

Streptavidin pro-791 5 mg 50
Recombinant Streptavidin 20 mg 130
1gr 3,300

Streptavidin, His pro-621 5 µg 50

Recombinant Streptavidin, His Tag 20 µg 130
1 mg 2,700

Streptavidin (37-159), His pro-1495 5 µg 50

Recombinant Streptavidin (37-159 a.a), His Tag 20 µg 130
1 mg 2,700

Streptavidin-NC pro-338 20 µg 50
Recombinant Streptavidin-NC 100 µg 130
1 mg 700

STX11 pro-1111 5 µg 50
Recombinant Human Syntaxin-11 20 µg 130
1 mg 2,700

STX12 pro-1099 2 µg 50
Recombinant Human Syntaxin-12 10 µg 130
100 µg 1,200

STX1A pro-574 5 µg 50
PEPTIDES INTERNATIONAL

Recombinant Human Syntaxin-1A 25 µg 130

1 mg 2,700

STX2 pro-1146 2 µg 50
Recombinant Human Syntaxin-2 10 µg 130
1 mg 5,200

STX3 pro-1082 5 µg 50
Recombinant Human Syntaxin-3 20 µg 130
1 mg 2,700

STX4 pro-1176 5 µg 50
Recombinant Human Syntaxin-4 20 µg 130
1 mg 2,700

STX6 pro-1711 5 µg 50
Recombinant Human Syntaxin-6 20 µg 130
1 mg 2,700

STX17 pro-1712 2 µg 50
Recombinant Human Syntaxin-17 10 µg 130
1 mg 5,200

SUB1 pro-835 2 µg 50
Recombinant Human SUB1 Homolog 10 µg 130
1 mg 5,200

700 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
SUFU pro-938 5 µg 50
Recombinant Human Suppressor of Fused Homolog 20 µg 130
1 mg 2,700

SUGT1 pro-096 5 µg 50
Recombinant Human SGT1 20 µg 130
1 mg 2,700

SUmF1 pro-986 2 µg 50
Recombinant Human Sulfatase Modifying Factor 1 10 µg 130
1 mg 5,200

SUmO1 pro-326 10 µg 50
Recombinant Human Small Ubiquitin-Related Modifier 1 50 µg 130
1 mg 1,200

SUmO1 His pro-980 5 µg 50

Recombinant Human Small Ubiquitin-Related Modifier 1, His 20 µg 130
Tag 1 mg 2,700

SUmO2 pro-586 10 µg 50
Recombinant Human Small Ubiquitin-Related Modifier 2 50 µg 130
1 mg 1,800

SUmO2 GST pro-541 2 µg 175

Recombinant Human Small Ubiquitin-Related Modifier 2, GST 5 µg 270
10 µg 490

SUmO3 pro-267

PEPTIDES INTERNATIONAL
5 µg 50
Recombinant Human Small Ubiquitin-Related Modifier 3 20 µg 130
1 mg 2,700

SURF1 pro-764 5 µg 50
Recombinant Human Surfeit-1 25 µg 130
1 mg 2,250

SURF2 pro-1470 5 µg 50
Recombinant Human Surfeit-2 20 µg 130
1 mg 2,700

SYCE3 pro-1179 2 µg 50
Recombinant Human Synaptonemal Complex Central Element 10 µg 130
Protein 3 100 µg 1,200

SYF2 pro-969 1 µg 50
Recombinant Human SYF2 RNA splicing factor 5 µg 130
50 µg 1,100

SYT1 pro-239 1 µg 50
Recombinant Human Synaptotagmin I 5 µg 130
50 µg 1,100

SYT4 pro-1375 2 µg 50
Recombinant Human Synaptotagmin IV 10 µg 130
100 µg 1,200

Order Hotline 1-800-777-4779 502-266-8787 701

 Recombinant proteins

SYT13 pro-1550 5 µg 50
Recombinant Human Synaptotagmin XIII 20 µg 130
1 mg 3,600

TAC1 pro-1338 5 µg 50
Recombinant Human Tachykinin-1 25 µg 130
1 mg 2,700

TAC3 pro-716 5 µg 50
Recombinant Human Tachykinin-3 25 µg 130
1 mg 2,700

TACSTD2 pro-157 5 µg 50
Recombinant Human Tumor-Associated Calcium Signal 25 µg 130
Transducer 2 1 mg 2,700

TADA3 pro-1689 2 µg 50
Recombinant Human Transcriptional Adaptor 3 10 µg 130
1 mg 5,200

TAGLN pro-851 5 µg 50
Recombinant Human Transgelin 25 µg 130
1 mg 2,250

TAGLN2 pro-124 5 µg 50
Recombinant Human Transgelin-2 20 µg 130
1 mg 2,700

TAGLN3 pro-946
PEPTIDES INTERNATIONAL

5 µg 50
Recombinant Human Transgelin-3 20 µg 130
1 mg 2,700

TANK pro-1348 5 µg 50
Recombinant Human TRAF Family Member-Associated NFKB 20 µg 130
Activator 1 mg 2,700

TARDBP pro-1410 2 µg 50
Recombinant Human TAR DNA Binding Protein 10 µg 130
100 µg 1,200

TARDBP (1-414) pro-1459 5 µg 50

Recombinant Human TAR DNA Binding Protein, (1-414 a.a.) 20 µg 130
1 mg 2,700

TAX1BP3 pro-981 5 µg 50
Recombinant Human Tax1 Binding Protein 3 25 µg 130
1 mg 2,700

TBC1D13 pro-1679 5 µg 50
Recombinant Human TBC1 Domain Family, Member 13 20 µg 130
1 mg 2,700

TBCA pro-705 5 µg 50
Recombinant Human Tubulin Folding Cofactor A 25 µg 130
1 mg 2,700

702 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
TBCB pro-1127 5 µg 50
Recombinant Human Tubulin Folding Cofactor B 25 µg 130
1 mg 2,700

TBCC pro-1180 2 µg 50
Recombinant Human Tubulin Folding Cofactor C 10 µg 130
100 µg 1,200

TBPL1 pro-736 2 µg 50
Recombinant Human TBP-Like 1 10 µg 130
1 mg 5,200

TBCEL pro-030 5 µg 50
Recombinant Human Tubulin Folding Cofactor E-Like 20 µg 130
1 mg 2,700

TCEA1 pro-1098 5 µg 50
Recombinant Human Transcription Elongation Factor A (SII)- 1 20 µg 130
1 mg 2,700

TCEA2 pro-1489 2 µg 50
Recombinant Human Transcription Elongation Factor A (SII)- 2 10 µg 130
1 mg 5,200

TCEAL1 pro-507 5 µg 50
Recombinant Human Transcription Elongation Factor A (SII)- 20 µg 130
Like 1 1 mg 2,700

TCEAL3 pro-1128 2 µg 50

PEPTIDES INTERNATIONAL
Recombinant Human Transcription Elongation Factor A (SII)- 10 µg 130
Like 3 1 mg 5,200

TCEAL7 pro-1147 5 µg 50
Recombinant Human Transcription Elongation Factor A (SII)- 20 µg 130
Like 7 1 mg 2,700

TCEAL8 pro-1188 2 µg 50
Recombinant Human Transcription Elongation Factor A (SII)- 10 µg 130
Like 8 1 mg 5,200

TCEB1 pro-1017 5 µg 50
Recombinant Human Transcription Elongation Factor B 20 µg 130
Polypeptide 1 1 mg 2,700

TCEB2 pro-664 10 µg 50
Recombinant Human Transcription Elongation Factor B 50 µg 130
Polypeptide 2 1 mg 1,800

TCL1A pro-726 10 µg 50
Recombinant Human T-cell Leukemia/Lymphoma 1A 50 µg 130
1 mg 1,800

TCP1 pro-276 2 µg 50
Recombinant Human T-Complex 1 10 µg 130
1 mg 5,200

Order Hotline 1-800-777-4779 502-266-8787 703

 Recombinant proteins

TEF pro-1523 2 µg 50
Recombinant Human Thyrotrophic Embryonic Factor 10 µg 130
100 µg 1,200

TEN1 pro-1520 2 µg 50
Recombinant Human TEN1 10 µg 130
1 mg 5,200

TES pro-549 2 µg 50
Recombinant Human Testis Derived Transcript 10 µg 130
1 mg 5,200

TEV pro-585 100IU 50

Recombinant Tobacco Etch Virus Protease 500IU 130
1,000IU 250

TFAm pro-095 1 µg 50
Recombinant Human Transcription Factor-A 5 µg 130
50 µg 1,200

TFB1m pro-903 2 µg 50
Recombinant Human Transcription Factor B1, Mitochondrial 10 µg 130
1 mg 5,200

TFB2m pro-1259 2 µg 50
Recombinant Human Transcription Factor B2, Mitochondrial 10 µg 130
1 mg 5,200

TFPI pro-1702 5 µg 50
PEPTIDES INTERNATIONAL

Recombinant Human Tissue Factor Pathway Inhibitor 20 µg 130

1 mg 2,700

TFPI2 pro-860 2 µg 175

Recombinant Human Tissue Factor Pathway Inhibitor 2 5 µg 270
10 µg 490

TGFBI pro-568 5 µg 50
Recombinant Human Transforming Growth Factor Β Induced 20 µg 130
1 mg 2,800

TGFBI 182 pro-672 10 µg 50

Recombinant Human Transforming Growth Factor Β Induced 50 µg 130
182 a.a. 1 mg 1,800

THAP1 pro-1089 5 µg 50
Recombinant Human THAP Domain Containing, Apoptosis 20 µg 130
Associated Protein 1 1 mg 3,600

THAP3 pro-1630 2 µg 50
Recombinant Human THAP Domain Containing, Apoptosis 10 µg 130
Associated Protein 3 1 mg 5,200

THBS1 pro-288 2 µg 50
Recombinant Human Thrombospondin 10 µg 200
100 µg 1,800

704 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
Thrombin pro-339 0.5 mg 400
Human Thrombin 1 mg 700
5 mg 3,300

Thrombin pro-1422 10 µg 200

Recombinant Human Thrombin 50 µg 750
100 µg 1,300

pThrombin pro-617 500U 300

Porcine Thrombin 1000U 500
2000U 700

bThrombin pro-447 50U 65

Bovine Thrombin 100U 100
250U 200

THRSP pro-1485 5 µg 50
Recombinant Human Thyroid Hormone Responsive 20 µg 130
1 mg 2,700

THYN1 pro-270 5 µg 50
Recombinant Human Thymocyte Nuclear Protein 1 20 µg 130
1 mg 2,700

Thyroglobulin pro-443 20 µg 50
Human Thyroglobulin 100 µg 130
1 mg 1,200

TIAF1 pro-1211 2 µg 50

PEPTIDES INTERNATIONAL
Recombinant Human TGFB1-Induced Anti-Apoptotic Factor 1 10 µg 130
1 mg 5,200

TICAm2 pro-1036 2 µg 50
Recombinant Human Toll-Like Receptor Adaptor Molecule 2 10 µg 130
1 mg 5,200

TIFA pro-1041 2 µg 50
Recombinant Human TRAF-Interacting Protein with Forkhead- 10 µg 130
Associated Domain 1 mg 5,200

TIGAR-TAT pro-1580 5 µg 50
Recombinant Human TIGAR-TAT (C12ORF5) 25 µg 130
1 mg 2,700

TINAGL1 pro-1675 2 µg 50
Recombinant Human Tubulointerstitial Nephritis Antigen Like 1 10 µg 130
1 mg 5,200

TIPIN pro-1710 2 µg 50
Recombinant Human TImELESS Interacting Protein 10 µg 130
1 mg 5,200

TIRAP pro-1181 2 µg 50
Recombinant Human Toll-Interleukin 1 Receptor (TIR) Domain 10 µg 130
Containing Adaptor Protein 1 mg 5,200

Order Hotline 1-800-777-4779 502-266-8787 705

 Recombinant proteins

TmED10 pro-1636 2 µg 50
Recombinant Human Transmembrane Emp24-Like Trafficking 10 µg 130
Protein 10 0.1 mg 1,200

TmEFF1 pro-1429 5 µg 50
Recombinant Human TmEFF1 20 µg 130
1 mg 2,700

TmEm27 pro-1581 2 µg 50
Recombinant Human Transmembrane Protein 27 10 µg 130
1 mg 5,200

TmOD3 pro-1165 2 µg 50
Recombinant Human Tropomodulin 3 10 µg 130
1 mg 5,200

TNIP1 pro-005 1 µg 50
Recombinant Human TNFAIP3 Interacting Protein 1 5 µg 130
50 µg 1,100

TNNI1 pro-1269 5 µg 50
Recombinant Human Troponin I Type 1 20 µg 130
1 mg 2,700

TNNI2 His pro-1283 2 µg 50

Recombinant Human Troponin I Type 2, His Tag 10 µg 130
100 µg 1,200

TNNI2 pro-341 5 µg 50
PEPTIDES INTERNATIONAL

Recombinant Human Troponin I Type 2 20 µg 130

1 mg 3,000

TNNT2 pro-703 5 µg 50
Recombinant Human Troponin T Type 2, Cardiac Isoform 3 20 µg 130
1 mg 3,600

TOLLIP pro-228 2 µg 50
Recombinant Human Toll Interacting Protein 10 µg 130
1 mg 5,200

TOmm20 pro-1471 2 µg 50
Recombinant Human Translocase Of Outer Mitochondrial 10 µg 130
Membrane 20 1 mg 5,200

TOmm34 pro-1501 5 µg 50
Recombinant Human Translocase Of Outer Mitochondrial 20 µg 130
Membrane 34 1 mg 2,700

TOR1A pro-1430 5 µg 50
Recombinant Human Torsin Family 1 Member A 20 µg 130
1 mg 2,700

TP53AIP1 pro-1664 5 µg 50
Recombinant Human Tumor Protein P53 Regulated Apoptosis 20 µg 130
Inducing Protein 1 1 mg 2,700

706 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
TPD52L1 pro-442 5 µg 50
Recombinant Human Tumor Protein D52 L1 20 µg 130
1 mg 3,600

TPGS2 pro-1668 2 µg 50
Recombinant Human Tubulin Polyglutamylase Complex 10 µg 130
Subunit 2 100 µg 1,200

TPm1 pro-469 2 µg 50
Recombinant Human Tropomyosin-1 10 µg 130
1 mg 4,800

TPm2 pro-069 1 µg 50
Recombinant Human Tropomyosin-2 5 µg 130
50 µg 1,200

TPm3 pro-1020 2 µg 50
Recombinant Human Tropomyosin-3 10 µg 130
1 mg 5,200

TPm4 pro-187 2 µg 50
Recombinant Human Tropomyosin-4 10 µg 130
1 mg 5,200

TPPP pro-1607 2 µg 50
Recombinant Human Tubulin Polymerization Promoting 10 µg 130
Protein 1 mg 5,200

PEPTIDES INTERNATIONAL
TPPP3 pro-1615 5 µg 50
Recombinant Human Tubulin Polymerization-Promoting 20 µg 130
Protein Family Member 3 1 mg 2,700

TPRKB pro-1185 2 µg 50
Recombinant Human TP53RK Binding Protein 10 µg 130
1 mg 5,200

TPT1 pro-776 5 µg 50
Recombinant Human Tumor Protein Translationally-Controlled 25 µg 130
1 1 mg 2,250

TRAF1 pro-834 5 µg 50
Recombinant Human TNF receptor-Associated Factor 1 25 µg 130
1 mg 2,250

TRAF2 pro-685 10 µg 50
Recombinant Human TNF receptor-Associated Factor 2 50 µg 130
1 mg 2,400

Transferrin pro-747 100 mg 50

Recombinant Human Transferrin 1gr 350
10gr 3,000

TRAPPC2 pro-1272 2 µg 50
Recombinant Human Trafficking Protein Particle Complex 2 10 µg 130
100 µg 1,200

Order Hotline 1-800-777-4779 502-266-8787 707

 Recombinant proteins

TRAPPC2L pro-1543 5 µg 50
Recombinant Human Trafficking Protein Particle Complex 20 µg 130
2-Like 1 mg 2,700

TRAPPC3 pro-1056 5 µg 50
Recombinant Human Trafficking Protein Particle Complex 3 20 µg 130
1 mg 2,700

TRAPPC4 pro-1273 2 µg 50
Recombinant Human Trafficking Protein Particle Complex 4 10 µg 130
100 µg 1,200

TREm1 pro-457 2 µg 50
Recombinant Human Triggering Receptor Expressed on 10 µg 130
Myeloid Cells 1 1 mg 4,800

TRIm21 pro-328 5 µg 50
Recombinant Human Tripartite Motif Containing 21 (RO52) 20 µg 130
1 mg 3,600

TRIm28 pro-1697 5 µg 50
Recombinant Human Tripartite Motif Containing 28 20 µg 130
1 mg 2,700

TRIm33 pro-1506 2 µg 50
Recombinant Human Tripartite Motif Containing 33 10 µg 130
1 mg 5,200
PEPTIDES INTERNATIONAL

Troponin I-C pro-344 2 µg 50

Recombinant Human Cardiac Troponin I-C Complex 10 µg 130
1 mg 5,200

Troponin I-C pro-345 2 µg 50

Recombinant Single Chain Cardiac Troponin I-C 10 µg 130
1 mg 5,200

Troponin I-C pro-346 2 µg 50

Recombinant Single Chain Cardiac Troponin I-C 2nd 10 µg 130
generation 1 mg 5,200

Troponin-C pro-322 20 µg 50
Recombinant Human Cardiac Troponin-C 100 µg 130
1 mg 900

Troponin-C His pro-959 2 µg 50

Recombinant Human Cardiac Troponin-C His 10 µg 130
1 mg 5,200

Troponin-I pro-324 10 µg 50
Recombinant Human Cardiac Troponin-I 50 µg 130
1 mg 1,350

Troponin-T pro-342 10 µg 50
Human Cardiac Troponin-T 50 µg 130
1 mg 1,600

708 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
TROVE2 pro-329 10 µg 50
Recombinant Human TROVE Domain Family Member 2 50 µg 130
1 mg 1,350

TROVE2 His pro-110 5 µg 50

Recombinant Human TROVE Domain Family Member 2 His Tag 20 µg 130
1 mg 3,500

Trypsin pro-770 1 mg 50
Recombinant Human Trypsin 5 mg 130
50 mg 500

Trypsin Yeast pro-786 1 mg 50

Recombinant Human Trypsin, Yeast 5 mg 130
50 mg 1,150

pTrypsin pro-787 1 mg 50
Recombinant Porcine Trypsin 2.5 mg 130
50 mg 2,000

bTrypsin pro-313 1 mg 50
Recombinant Bovine Trypsin 5 mg 130
50 mg 900

TSC22D3 pro-1254 2 µg 50
Recombinant Human TSC22 Domain Family, Member 3 10 µg 130
1 mg 5,200

TSEN15 pro-144 2 µg 50

PEPTIDES INTERNATIONAL
Recombinant Human tRNA Splicing Endonuclease 15 10 µg 130
1 mg 5,200

TSG101 pro-805 2 µg 50
Recombinant Human Tumor Susceptibility Gene 101 10 µg 130
1 mg 5,200

TSN pro-271 5 µg 50
Recombinant Human Translin 20 µg 130
1 mg 3,600

TSNAX pro-1292 5 µg 50
Recombinant Human Translin-Associated Factor X 20 µg 130
1 mg 3,600

TSSC4 pro-1021 5 µg 50
Recombinant Human Tumor Suppressing Subtransferable 20 µg 130
Candidate 4 1 mg 3,600

TTC1 pro-1160 5 µg 50
Recombinant Human Tetratricopeptide Repeat Domain 1 20 µg 130
1 mg 3,600

TTC32 pro-1246 5 µg 50
Recombinant Human Tetratricopeptide Repeat Domain 32 20 µg 130
1 mg 3,600

Order Hotline 1-800-777-4779 502-266-8787 709

 Recombinant proteins

TTC33 pro-1217 2 µg 50
Recombinant Human Tetratricopeptide Repeat Domain 33 10 µg 130
100 µg 1,200

TUBB3 pro-1388 2 µg 50
Recombinant Human Tubulin, Β 3 Class III 10 µg 130
1 mg 5,200

TUBG1 pro-982 5 µg 50
Recombinant Human Tubulin Gamma 1 20 µg 130
1 mg 2,700

TULP1 pro-1191 5 µg 50
Recombinant Human Tubby Like Protein 1 20 µg 130
1 mg 2,700

TUSC2 pro-1677 5 µg 50
Recombinant Human Tumor Suppressor Candidate 2 20 µg 130
1 mg 3,600

TWF1 pro-1003 2 µg 50
Recombinant Human Twinfilin-1 10 µg 130
1 mg 5,200

TXN1 pro-334 20 µg 50
Recombinant E.Coli Thioredoxin 100 µg 130
1 mg 900

TXN1 pro-569 10 µg 50
PEPTIDES INTERNATIONAL

Recombinant Human Thioredoxin 50 µg 130

1 mg 1,800

TXN1, His pro-784 2 µg 50

Recombinant E.Coli Thioredoxin, His 10 µg 130
1 mg 5,200

TXN1, His pro-804 5 µg 50

Recombinant Human Thioredoxin His Tag 25 µg 130
1 mg 2,250

TXN2 pro-625 5 µg 50
Recombinant Human Thioredoxin-2 20 µg 130
1 mg 3,600

TXNDC12 pro-1133 2 µg 50
Recombinant Human Thioredoxin Domain Containing 12 10 µg 130
100 µg 1,200

TXNDC17 pro-1055 5 µg 50
Recombinant Human Thioredoxin Domain Containing 17 20 µg 130
1 mg 2,700

TXNL1 pro-084 5 µg 50
Recombinant Human Thioredoxin-Like 1 20 µg 130
1 mg 3,600

710 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
TXNL4A pro-1100 2 µg 50
Recombinant Human Thioredoxin-Like 4A 10 µg 130
1 mg 5,200

TXNL4B pro-238 2 µg 50
Recombinant Human Thioredoxin-Like 4B 10 µg 130
1 mg 5,200

TYW5 pro-1315 5 µg 50
Recombinant Human tRNA-yW Synthesizing Protein 5 20 µg 130
1 mg 2,700

WFDC2 pro-1609 2 µg 50
Recombinant Human WAP Four-Disulfide Core Domain 2 10 µg 130
1 mg 5,200

U2AF1 pro-1461 5 µg 50
Recombinant Human U2 Small Nuclear RNA Auxiliary Factor 1 20 µg 130
1 mg 2,700

U. Urealyticum pro-670 100 µg 150

Recombinant Ureaplasma Urealyticum Parvum 0.5 mg 600
1 mg 1,200

UBD pro-927 1 µg 50
Recombinant Human Ubiquitin-D 5 µg 130
50 µg 1,200

Ubiquitin pro-314 10 µg 50

PEPTIDES INTERNATIONAL
Recombinant Human Ubiquitin 50 µg 130
1 mg 1,800

Ubiquitin Biotin pro-629 2 µg 50

Recombinant Human Ubiquitin Biotin 10 µg 130
100 µg 800

Ubiquitin G76A pro-280 5 µg 50

Recombinant Human Ubiquitin Gly76 to Ala76 Mutation 20 µg 130
1 mg 2,800

Ubiquitin GST pro-735 2 µg 175

Recombinant Human Ubiquitin, GST Tag 5 µg 270
10 µg 490

Ubiquitin K48R pro-372 5 µg 50

Recombinant Human Ubiquitin Lys 48 to Arg 48 Mutation 20 µg 130
1 mg 2,800

UBL3 pro-230 5 µg 50
Recombinant Human Ubiquitin-Like 3 20 µg 130
1 mg 2,700

UBL4A pro-1043 5 µg 50
Recombinant Human Ubiquitin-Like 4A 20 µg 130
1 mg 2,700

Order Hotline 1-800-777-4779 502-266-8787 711

 Recombinant proteins

UBL5 pro-231 5 µg 50
Recombinant Human Ubiquitin-Like 5 20 µg 130
1 mg 3,600

UBTD2 pro-1203 5 µg 50
Recombinant Human Ubiquitin Domain Containing 2 20 µg 130
1 mg 2,700

UBXN2B pro-1512 2 µg 50
Recombinant Human UBX Domain Protein 2B 10 µg 130
1 mg 5,200

UFD1L pro-1625 2 µg 50
Recombinant Human Ubiquitin Fusion Degradation 1 Like 10 µg 130
1 mg 5,200

UFm1 pro-125 5 µg 50
Recombinant Human Ubiquitin-Fold Modifier 1 20 µg 130
1 mg 2,700

UFSP1 pro-1320 2 µg 50
Recombinant Human UFm1-Specific Peptidase 1 10 µg 130
1 mg 5,200

ULBP2 pro-1134 5 µg 50
Recombinant Human UL16 Binding Protein 2 20 µg 130
1 mg 2,700

Ulinastatin pro-608 20 µg 50
PEPTIDES INTERNATIONAL

Recombinant Human Urinary Trypsin Inhibitor (UTI) 100 µg 130

1 mg 1,100

Ulinastatin pro-321 2.5 mg 50

Human Urinary Trypsin Inhibitor (UTI) 5 mg 90
10 mg 140

UNC119B pro-1034 5 µg 50
Recombinant Human UNC-119 Homolog B 20 µg 130
1 mg 3,600

UPK2 pro-479 5 µg 50
Recombinant Human Uroplakin 2 20 µg 130
1 mg 2,700

UPK3A pro-988 2 µg 50
Recombinant Human Uroplakin 3A 10 µg 130
1 mg 5,200

UQCRC2 pro-1224 2 µg 50
Recombinant Human Ubiquinol-Cytochrome C Reductase Core 10 µg 130
Protein II 1 mg 5,200

URm1 pro-188 5 µg 50
Recombinant Human Ubiquitin Related Modifier 1 20 µg 130
1 mg 2,700

712 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
USE1 pro-1464 2 µg 50
Recombinant Human Unconventional SNARE In The ER 1 10 µg 130
100 µg 1,200

USH1C pro-706 5 µg 50
Recombinant Human Usher Syndrome 1C 20 µg 130
1 mg 2,700

USP14 pro-016 5 µg 50
Recombinant Human Ubiquitin Specific Peptidase 14 20 µg 130
1 mg 2,700

USP16 pro-1622 2 µg 50
Recombinant Human Ubiquitin Specific Peptidase 15 10 µg 130
1 mg 5,200

UTP23 pro-1235 5 µg 50
Recombinant Human UTP23, Small Subunit Processome 20 µg 130
Component 1 mg 3,600

UXT pro-1312 5 µg 50
Recombinant Human Ubiquitously-Expressed, Prefoldin-Like 20 µg 130
Chaperone 1 mg 2,700

VAmP1 pro-577 20 µg 50
Recombinant Human Synaptobrevin-1 100 µg 130
1 mg 990

PEPTIDES INTERNATIONAL
VAmP2 pro-578 5 µg 50
Recombinant Human Synaptobrevin-2 20 µg 130
1 mg 3,000

VAmP3 pro-652 5 µg 50
Recombinant Human Synaptobrevin-3 25 µg 130
1 mg 3,600

VAmP4 pro-714 2 µg 50
Recombinant Human Vesicle-Associated Membrane Protein 4 10 µg 130
1 mg 5,200

VAmP5 pro-681 5 µg 50
Recombinant Human Synaptobrevin-5 20 µg 130
1 mg 3,600

VAmP7 pro-1194 5 µg 50
Recombinant Human Vesicle-Associated Membrane Protein 7 20 µg 130
1 mg 2,700

VAmP8 pro-660 5 µg 50
Recombinant Human Synaptobrevin-8 25 µg 130
1 mg 3,600

VAPA pro-779 5 µg 50
Recombinant Human VAmP Associated Protein A, 33kDa 25 µg 130
1 mg 2,250

Order Hotline 1-800-777-4779 502-266-8787 713

 PRODUCT Code Qty PRICE
Recombinant proteins

VAPB pro-014 5 µg 50
Recombinant Human VAmP Associated Protein B and C 20 µg 130
1 mg 2,700

VASP pro-191 2 µg 50
Recombinant Human Vasodilator-Stimulated PhosphoProtein 10 µg 130
1 mg 5,200

VAT1 pro-1011 2 µg 50
Recombinant Human Vesicle Amine Transport Protein 1 10 µg 130
Homolog 1 mg 5,200

VBP1 pro-1325 5 µg 50
Recombinant Human Von Hippel-Lindau Binding Protein 1 20 µg 130
1 mg 2,700

VCAm1 pro-386 2 µg 50
Recombinant Human Vascular cell adhesion Molecule 1 10 µg 130
1 mg 3,200

VCAm1 HEK pro-1641 10 µg 50

Recombinant Human Vascular cell adhesion Molecule 1, HEK 50 µg 130
1 mg 1,900

rVCAm1 pro-361 2 µg 50
Recombinant Rabbit Vascular cell adhesion Molecule 1 10 µg 130
0.1 mg 1,000

VDR pro-205 5 µg 50
PEPTIDES INTERNATIONAL

Recombinant Human Vitamin D Receptor 20 µg 130

1 mg 3,600

VHL pro-440 10 µg 50
Recombinant Human Von Hippel-Lindau Protein 50 µg 130
1 mg 1,800

Vimentin pro-309 2 µg 35
Recombinant Human Vimentin 10 µg 90
1 mg 990

Vimentin GST pro-734 2 µg 175

Recombinant Human Vimentin, GST Tag 5 µg 270
10 µg 490

VOPP1 pro-200 2 µg 50
Recombinant Human Vesicular Overexpressed in Cancer, 10 µg 130
Prosurvival Protein 1 1 mg 5,200

VPS4B pro-1717 2 µg 50
Recombinant Human Vacuolar Protein Sorting 4 Homolog B 10 µg 130
1 mg 5,200

VPS24 pro-872 5 µg 50
Recombinant Human Vacuolar Protein Sorting 24 20 µg 130
1 mg 2,700

714 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
VPS25 pro-1054 5 µg 50
Recombinant Human Vacuolar Protein Sorting 25 20 µg 130
1 mg 2,700

VPS26A pro-1161 2 µg 50
Recombinant Human Vacuolar Protein Sorting 26A 10 µg 130
100 µg 1,200

VPS28 pro-730 10 µg 50
Recombinant Human Vacuolar Protein Sorting 28 50 µg 130
1 mg 1,800

VPS29 pro-1075 1 µg 50
Recombinant Human Vacuolar Protein Sorting 29 5 µg 130
50 µg 1,100

mVPS29 pro-1066 2 µg 50
Recombinant Mouse Vacuolar Protein Sorting 29 10 µg 130
1 mg 5,200

VRK3 pro-1130 2 µg 50
Recombinant Human Vaccinia Related Kinase 3 10 µg 130
1 mg 5,200

VSNL1 pro-723 10 µg 50
Recombinant Human Visinin-Like Protein-1 50 µg 130
1 mg 1,800

VSNL1 His pro-602 2 µg 50

PEPTIDES INTERNATIONAL
Recombinant Human Visinin-Like Protein-1 His Tag 10 µg 130
1 mg 5,200

VSTm2L pro-1018 2 µg 50
Recombinant Human V-Set and Transmembrane Domain 10 µg 130
Containing 2 Like 100 µg 1,100

VTA1 pro-1044 5 µg 50
Recombinant Human Vps20-Associated 1 Homolog 20 µg 130
1 mg 2,700

VTI1B pro-1115 2 µg 50
Recombinant Human Vesicle Transport Through Interaction 10 µg 130
with t-SNAREs Homolog 1B 100 µg 1,200

WBP2 pro-1208 2 µg 50
Recombinant Human WW Domain Binding Protein 2 10 µg 130
1 mg 5,200

WDR5 pro-863 5 µg 50
Recombinant Human WD Repeat Domain 5 20 µg 130
1 mg 2,700

WHSC2 pro-062 2 µg 50
Recombinant Human Wolf-Hirschhorn Syndrome Candidate 2 10 µg 130
1 mg 5,200

Order Hotline 1-800-777-4779 502-266-8787 715

 PRODUCT Code Qty PRICE
Recombinant proteins

WIBG pro-864 2 µg 50
Recombinant Human within BCGN Homolog 10 µg 130
1 mg 5,200

WIF1 pro-684 2 µg 175

Recombinant Human WNT Inhibitory Factor 1 5 µg 250
10 µg 350

WLS pro-1402 2 µg 50
Recombinant Human Wntless  10 µg 130
1 mg 5,200

XAGE1A pro-1256 1 µg 50
Recombinant Human X Antigen Family, Member 1A 5 µg 130
50 µg 1,200

XG pro-1395 2 µg 50
Recombinant Human XG Blood Group 10 µg 130
100 µg 1,200

XPA pro-026 5 µg 50
Recombinant Human Xeroderma Pigmentosum, 20 µg 130
Complementation Group A 1 mg 2,700

YAE1D1 pro-1516 5 µg 50
Recombinant Human Yae1 Domain Containing 1 20 µg 130
1 mg 2,700

YEATS4 pro-1019
PEPTIDES INTERNATIONAL

2 µg 50
Recombinant Human YEATS Domain Containing 4 10 µg 130
1 mg 5,200

yTXN1 pro-333 5 µg 50
Recombinant Yeast Thioredoxin 20 µg 130
1 mg 2,400

ZA2G pro-403 2 µg 50
Recombinant Human Zinc-Α 2 GlycoProtein 10 µg 130
100 µg 800

ZA2G pro-1605 1 µg 50
Human Zinc-Α 2 GlycoProtein 5 µg 130
50 µg 1,100

ZC4H2 pro-482 5 µg 50
Recombinant Human Zinc Finger, C4H2 Domain Containing 20 µg 130
1 mg 2,700

ZCCHC17 pro-183 2 µg 50
Recombinant Human Zinc Finger, CCHC Domain Containing 17 10 µg 130
1 mg 5,200

ZFAND1 pro-1564 2 µg 50
Recombinant Human Zinc Finger, AN1-Type Domain 1 10 µg 130
1 mg 5,200

716 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
ZFAND3 pro-1030 2 µg 50
Recombinant Human Zinc Finger, AN1-Type Domain 3 10 µg 130
1 mg 5,200

ZmAT pro-1635 2 µg 50
Recombinant Huma Zinc Finger, Matrin-Type 3 10 µg 130
0.1 mg 1,200

ZG16 pro-478 2 µg 50
Recombinant Human Zymogen Granule Protein 16 Homolog 10 µg 130
1 mg 5,200

ZNF346 pro-1685 5 µg 50
Recombinant Human Zinc Finger Protein 346 20 µg 130
1 mg 2,700

ZNF514 pro-1594 5 µg 50
Recombinant Human Zinc Finger Protein 514 20 µg 130
1 mg 2,700

ZNHIT3 pro-1699 5 µg 50
Recombinant Human Zinc Finger HIT-Type Containing 3 20 µg 130
1 mg 2,700

Heat Shock Proteins

AHA1 hsp-013 10 µg 50
Recombinant Human Activator of HSP90 ATPase-1 50 µg 130
1 mg 1,500

PEPTIDES INTERNATIONAL
CRYAA hsp-002 20 µg 50
Recombinant Human Crystallin Α A 100 µg 130
1 mg 1,000

CRYAB hsp-003 20 µg 50
Recombinant Human Crystallin Α B 100 µg 130
1 mg 1,000

mCRYAB hsp-018 5 µg 50
Recombinant Mouse Crystallin Α B 20 µg 130
1 mg 2,700

CRYBA4 hsp-048 5 µg 50
Recombinant Human Crystallin Β A4 20 µg 130
1 mg 2,700

CRYBB1 hsp-033 5 µg 50
Recombinant Human Crystallin Β B1 25 µg 130
1 mg 2,250

DnaJ hsp-007 20 µg 50
Recombinant E.Coli DnaJ (HSP40) 100 µg 130
1 mg 1,000

DnaJ hsp-012 5 µg 50
Recombinant Human DnaJ (HSP40) 25 µg 130
1 mg 3,600

Order Hotline 1-800-777-4779 502-266-8787 717

 PRODUCT Code Qty PRICE
Recombinant proteins

DNAJB11 hsp-042 1 µg 50
Recombinant Human DnaJ (Hsp40) Homolog, Subfamily B, 5 µg 130
Member 11 50 µg 1,200

DNAJB2 hsp-035 2 µg 50
Recombinant Human DnaJ (Hsp40) Homolog, Subfamily B, 10 µg 130
Member 2 1 mg 5,200

DNAJB4 hsp-054 2 µg 50
Recombinant Human DnaJ (Hsp40) Homolog, Subfamily B, 10 µg 130
Member 4 1 mg 5,200

DNAJB6 hsp-038 1 µg 50
Recombinant Human DnaJ (Hsp40) Homolog, Subfamily B, 5 µg 130
Member 6 50 µg 1,200

DNAJB8 hsp-050 5 µg 50
Recombinant Human DnaJ (Hsp40) Homolog, Subfamily B, 25 µg 130
Member 8 1 mg 2,700

DNAJC12 hsp-053 2 µg 50
Recombinant Human DnaJ (Hsp40) Homolog, Subfamily C, 10 µg 130
Member 12 1 mg 5,200

DNAJC15 hsp-057 2 µg 50
Recombinant Human DnaJ (Hsp40) Homolog, Subfamily C, 10 µg 130
Member 15 100 µg 1,200
PEPTIDES INTERNATIONAL

DNAJC19 hsp-039 5 µg 50
Recombinant Human DnaJ (Hsp40) Homolog, Subfamily C, 25 µg 130
Member 19 1 mg 2,700

DNAJC24 hsp-056 2 µg 50
Recombinant Human DnaJ (Hsp40) Homolog, Subfamily C, 10 µg 130
Member 24 1 mg 5,200

Dnak hsp-006 10 µg 50
Recombinant E.Coli Dnak (HSP70) 50 µg 130
1 mg 1,800

Dnak hsp-070 2 µg 50
Recombinant Myobacterium Tuberculosis DnaK (HSP70) 10 µg 130
100 µg 1,250

Dnak ATPase BD hsp-010 10 µg 50

Recombinant E.Coli Dnak ATPase Binding Domain 50 µg 130
1 mg 1,800

Dnak His hsp-170 10 µg 50

Recombinant Human Dnak (HSP70), His Tag 50 µg 130
1 mg 1,900

Dnak LCS hsp-011 20 µg 50

Recombinant E.Coli Dnak Lid Covering Substrate 100 µg 130
1 mg 1,000

718 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
Dnak SBD hsp-008 20 µg 50
Recombinant E.Coli Dnak Substrate Binding Domain 100 µg 130
1 mg 1,000

Dnak SBD C-terminal hsp-009 20 µg 50

Recombinant E.Coli Dnak Substrate Binding Domain C-terminal 100 µg 130
1 mg 1,000

DsbE hsp-025 5 µg 50
Recombinant E.Coli Thiol Disulfide Interchange Protein 25 µg 130
1 mg 2,700

DsbG hsp-024 5 µg 50
Recombinant E.Coli Thiol Disulfide Interchange Protein 25 µg 130
1 mg 2,700

GroEL hsp-004 10 µg 50
Recombinant E.Coli GroEL (HSP60) 50 µg 130
1 mg 1,800

GroEL hsp-016 5 µg 50
Recombinant Human GroEL (HSP60) 20 µg 130
1 mg 2,700

GROEL (27-573) hsp-055 2 µg 50

Recombinant Human GroEL (HSP60) (27-573 a.a.) 10 µg 130
1 mg 5,200

GroES hsp-005 20 µg 50

PEPTIDES INTERNATIONAL
Recombinant E.Coli GroES (HSP10) 100 µg 130
1 mg 1,000

GroES hsp-015 5 µg 50
Recombinant Human GroES (HSP10) 20 µg 130
1 mg 2,700

GroES His hsp-040 2 µg 50

Recombinant Human GroES (HSP10), His Tag 10 µg 130
1 mg 5,200

GrpE hsp-014 5 µg 50
Recombinant E.Coli Heat Shock Protein Cofactor 70 (HSP24) 25 µg 130
1 mg 2,800

hchA hsp-043 5 µg 50
Recombinant E.Coli Chaperone Protein hchA 20 µg 130
1 mg 2,700

HSBP-1 hsp-001 10 µg 50
Recombinant Human Heat Shock Factor Binding Protein- 1 50 µg 130
1 mg 1,800

HSF1 hsp-017 5 µg 50
Recombinant Human Heat Shock Transcription Factor-1 25 µg 130
1 mg 3,600

Order Hotline 1-800-777-4779 502-266-8787 719

 PRODUCT Code Qty PRICE
Recombinant proteins

HSP104 hsp-104 10 µg 50
Recombinant Saccharomyces cerevisiae Heat Shock Protein 50 µg 130
104 1 mg 1,400

HSP105 hsp-105 5 µg 50
Recombinant Human Heat Shock Protein 105 25 µg 130
1 mg 2,700

HSP20 hsp-020 2 µg 50
Recombinant Human Heat Shock Protein 20 10 µg 130
100 µg 1,250

HSP27 hsp-027 10 µg 50
Recombinant Human Heat Shock Protein 27 50 µg 130
1 mg 1,900

HSP27 His hsp-029 5 µg 50

Recombinant Human Heat Shock Protein 27, His Tag 25 µg 130
1 mg 2,250

HSP47 hsp-047 10 µg 50
Recombinant Human Heat Shock Protein 47 50 µg 130
1 mg 1,800

HSP65 hsp-065 2 µg 50
Recombinant Myobacterium Tuberculosis Heat Shock Protein 10 µg 130
65 100 µg 1,250

HSP90 hsp-090 5 µg 50
PEPTIDES INTERNATIONAL

Recombinant Human Heat Shock Protein 90 Α 20 µg 130

1 mg 3,600

HSP90B1 hsp-091 2 µg 50
Recombinant Human Heat Shock Protein 90kDa Β (GRP94) 10 µg 130
Member 1 1 mg 5,200

HSPA1B hsp-021 2 µg 50
Recombinant Human Heat Shock 70kDa Protein 1B 10 µg 130
1 mg 5,200

HSPA5 hsp-044 5 µg 50
Recombinant Human Heat Shock 70kDa Protein 5 25 µg 130
1 mg 3,600

HSPA5 Hi-5 hsp-037 5 µg 50

Recombinant Human Heat Shock 70kDa Protein 5, Hi-5 20 µg 130
1 mg 2,700

HSPA5 (19-654) hsp-058 5 µg 50

Recombinant Human Heat Shock 70kDa Protein 5 (19-654 a.a.) 20 µg 130
1 mg 2,700

HSPA6 hsp-028 5 µg 50
Recombinant Human heat Shock 70kDa Protein 6 25 µg 130
1 mg 2,250

720 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
HSPA8 hsp-026 2 µg 50
Recombinant Human Heat Shock 70kDa Protein-8 10 µg 130
1 mg 5,200

HSPA9 hsp-023 10 µg 50
Recombinant Human Heat Shock 70kDa Protein 9 50 µg 130
1 mg 1,800

HSPA13 hsp-041 5 µg 50
Recombinant Human Heat Shock 70kDa Protein 13 20 µg 130
1 mg 2,700

HSPB11 hsp-046 5 µg 50
Recombinant Human Heat Shock Protein Family B Member 11 20 µg 130
1 mg 2,700

HSPB2 hsp-052 5 µg 50
Recombinant Human Heat Shock 27kDa Protein 2 20 µg 130
1 mg 2,700

HSPB3 hsp-049 5 µg 50
Recombinant Human Heat Shock 27kDa Protein 3 20 µg 130
1 mg 2,700

HSPB7 hsp-032 2 µg 50
Recombinant Human Heat Shock 27kDa Protein Family, 10 µg 130
Member 7 1 mg 5,200

HSPB8 hsp-022 2 µg 50

PEPTIDES INTERNATIONAL
Recombinant Human Heat Shock 22 kDa Protein-8 10 µg 130
100 µg 1,250

HSPB8 His hsp-031 2 µg 50

Recombinant Human Heat Shock 22 kDa Protein-8, His Tag 10 µg 130
1 mg 5,200

HSPB9 hsp-051 2 µg 50
Recombinant Human Heat Shock Protein B9 10 µg 130
1 mg 5,200

HSPBAP1 hsp-045 1 µg 50
Recombinant Human HSPB Associated Protein 1 5 µg 130
50 µg 1,100

HSPBP1 hsp-030 2 µg 50
Recombinant Human Heat Shock Protein-Binding Protein 1 10 µg 130
1 mg 5,200

SKP hsp-034 5 µg 50
Recombinant E.Coli Chaperone Protein SKP 25 µg 130
1 mg 2,250

ST13 hsp-130 10 µg 50
Recombinant Human HSP70 Interacting Protein 50 µg 130
1 mg 1,800

STUB1 hsp-019 10 µg 50
Recombinant Human STIP1 Homology and U-Box Containing 50 µg 130
Protein 1 1 mg 1,800

Order Hotline 1-800-777-4779 502-266-8787 721

 PRODUCT Code Qty PRICE
Recombinant proteins

Allergy Proteins
PA2-BVP alr-001 100 µg 150
Recombinant Phospholipase A2 P00630 Bee Venom Protein 0.5 mg 600
1 mg 1,000

Soy Bean P34 alr-002 100 µg 150

Recombinant Soy Bean P34 Protein 0.5 mg 600
1 mg 1,200

Soy Bean P34, GST alr-005 100 µg 150

Recombinant Soy Bean P34 Protein, GST Tag 0.5 mg 600
1 mg 1,200

Der-1 alr-003 100 µg 150

Recombinant Der P1 Protein 0.5 mg 600
1 mg 1,000

Der-F1 alr-004 100 µg 150

Recombinant Der F1 Protein 0.5 mg 600
1 mg 1,200

malaria Proteins
malaria HSP mal-001 100 µg 150
Recombinant Malaria Protein HSP 0.5 mg 600
1 mg 1,200

malaria Mosaic mal-002 100 µg 150

PEPTIDES INTERNATIONAL

Recombinant Malaria Cs Mosaic 0.5 mg 600

1 mg 1,200

mumps Protein
mumps m mp-001 100 µg 150
Recombinant Mumps Virus NucleoProtein 0.5 mg 600
1 mg 1,200

Shiga Like Protein

Shiga Like Toxin 1 stx-001 100 µg 150
Recombinant Shiga Like Toxin-1 Subunit B 0.5 mg 600
1 mg 1,200

Shiga Like Toxin 2 stx-002 100 µg 150

Recombinant Shiga Like Toxin-2 Subunit B 0.5 mg 600
1 mg 1,200

Viral Antigens SARS Proteins

SARS S(N) sars-258 100 µg $150
Recombinant SARS Associated Spike Mosaic S(N) 0.5 mg $600
1 mg $1,000

SARS S(m) sars-256 100 µg $150

Recombinant SARS Associated Spike Mosaic S(m) 0.5 mg $600
1 mg $1,000

722 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
SARS S(C) sars-257 100 µg $150
Recombinant SARS Associated Spike Mosaic S© 0.5 mg $600
1 mg $1,000

SARS Nucleocaspid sars-254 100 µg $150

Recombinant SARS Associated Coronavirus Nucleocaspid 0.5 mg $600
(340-390) 1 mg $1,000

SARS Nucleocaspid sars-253 100 µg $150

Recombinant SARS Associated Coronavirus Nucleocaspid 0.5 mg $600
(1-49) 1 mg $1,000

SARS Nucleocaspid sars-255 100 µg $150

Recombinant SARS Associated Coronavirus Nucleocaspid 0.5 mg $600
(1-49,192-220) 1 mg $1,000

SARS Nucleocaspid sars-250 5 µg $50

Recombinant SARS Coronavirus Nucleocapsid (1-422) 20 µg $130
1 mg $3,900

SARS Matrix sars-251 100 µg $150

Recombinant SARS Associated Coronavirus Matrix 0.5 mg $600
1 mg $1,000

SARS Envelope sars-252 100 µg $150

Recombinant SARS Associated Coronavirus Envelope 0.5 mg $600
1 mg $1,000

PEPTIDES INTERNATIONAL
Viral Antigens Borrelia Protein
Borrelia p41 bor-001 100 µg 150
Recombinant Borrelia Burgdorferi p41 0.5 mg 600
1 mg 1,200

Borrelia p41, Sf9 bor-002 5 µg 50

Recombinant Borrelia Burgdorferi p41, Sf9 20 µg 130
1 mg 3,600

Borrelia p100 bor-003 5 µg 50

Recombinant Borrelia Burgdorferi p100 20 µg 130
1 mg 3,600

Borrelia OspC bor-004 5 µg 50

Recombinant Borrelia Burgdorferi Outer Surface Protein C 20 µg 130
1 mg 3,600

Borrelia DbpA bor-005 5 µg 50

Recombinant Borrelia Burgdorferi Decorin Binding Protein A 20 µg 130
1 mg 3,600

Borrelia BmpA bor-006 5 µg 50

Recombinant Borrelia Burgdorferi Basic Membrane Protein A 20 µg 130
1 mg 3,600

Borrelia DbpB bor-007 5 µg 50

Recombinant Borrelia Burgdorferi Decorin Binding Protein B 20 µg 130
1 mg 3,600

Order Hotline 1-800-777-4779 502-266-8787 723

 PRODUCT Code Qty PRICE
Recombinant proteins

Borrelia OspA bor-015 5 µg 50

Recombinant Borrelia Burgdorferi Outer Surface Protein A 20 µg 130
1 mg 3,600

Borrelia NapA bor-014 5 µg 50

Recombinant Borrelia Burgdorferi Neutrophil Activating 20 µg 130
Protein A 1 mg 3,600

Borrelia Garinii VlsE1 bor-013 2 µg 50

Recombinant Borrelia Garinii VlsE1 10 µg 130
1 mg 5,200

Borrelia Garinii p58 bor-008 5 µg 50

Recombinant Borrelia Garinii p58 20 µg 130
1 mg 3,600

Borrelia Spielmanii OspC bor-009 5 µg 50

Recombinant Borrelia Spielmanii Outer Surface Protein C 20 µg 130
1 mg 3,600

Borrelia Afzelii DbpA bor-010 5 µg 50

Recombinant Borrelia Afzelii Decorin Binding Protein A 20 µg 130
1 mg 3,600

Borrelia OspA bor-011 5 µg 50

Recombinant Borrelia Afzelii Outer Surface Protein A 20 µg 130
1 mg 3,600

Borrelia Afzelii BmpA bor-012 5 µg 50

PEPTIDES INTERNATIONAL

Recombinant Borrelia Afzelii Basic Membrane Protein A 20 µg 130

1 mg 3,600

Viral Antigens - Chagas Protein

Chimeric Chagas cch-001 5 µg 100
Recombinant Chimeric Chagas Multiantigen 15 µg 250
100 µg 950

1F8 Chagas cch-002 5 µg 50

Recombinant 1F8 Chagas 20 µg 130
1 mg 3,600

Viral Antigens - Herpes Simplex Virus

HSV-1 gD hsv-221 100 µg 150
Recombinant Herpes Simplex Virus-1 gD  0.5 mg 600
1 mg 1,000

HSV-1 gG hsv-224 100 µg 150

Recombinant Herpes Simplex Virus-1 gG 0.5 mg 600
1 mg 1,000

HSV-2 gD hsv-222 100 µg 150

Recombinant Herpes Simplex Virus-2 gD  0.5 mg 600
1 mg 1,000

724 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
HSV-2 gG hsv-223 100 µg 150
Recombinant Herpes Simplex Virus-2 gG 0.5 mg 600
1 mg 1,000

HSV-2 gG hsv-220 100 µg 150

Herpes Simplex Virus-2 gG 0.5 mg 600
1 mg 1,000

HSV-8 Mosaic hsv-225 100 µg 150

Recombinant Herpes Simplex Virus-8 Mosaic 0.5 mg 600
1 mg 1,200

Viral Antigens - Chlamydia Trachomatis

Chlamydia W2 cht-001 100 µg 150
Recombinant Chlamydia Trachomatis W2 0.5 mg 600
1 mg 1,200

Chlamydia W4 cht-002 100 µg 150

Recombinant Chlamydia Trachomatis W4 0.5 mg 600
1 mg 1,200

Chlamydia W5 cht-003 100 µg 150

Recombinant Chlamydia Trachomatis W5 0.5 mg 600
1 mg 1,200

Chlamydia W4-5 cht-004 100 µg 150

Recombinant Chlamydia Trachomatis W4-W5 0.5 mg 600
1 mg 1,200

PEPTIDES INTERNATIONAL
Chlamydia W5-6 cht-005 100 µg 150
Recombinant Chlamydia Trachomatis W5-W6 0.5 mg 600
1 mg 1,200

Chlamydia W3-6 cht-006 100 µg 150

Recombinant Chlamydia Trachomatis W3-W6 0.5 mg 600
1 mg 1,200

Chlamydia PGP-3D cht-007 100 µg 150

Recombinant Chlamydia Trachomatis PGP3-D 0.5 mg 600
1 mg 1,200

Chlamydia HSP70 cht-008 100 µg 150

Recombinant Chlamydia Trachomatis HSP70 (462-503) 0.5 mg 600
1 mg 1,200

Chlamydia HSP70 cht-009 100 µg 150

Recombinant Chlamydia Trachomatis HSP70 (549-660) 0.5 mg 600
1 mg 1,200

Chlamydia Pneumonia cht-010 100 µg 150

Recombinant Chlamydia Pneumonia 0.5 mg 600
1 mg 1,200

Order Hotline 1-800-777-4779 502-266-8787 725

 PRODUCT Code Qty PRICE
Recombinant proteins

Viral Antigens - Hepatitis C Virus

HCV Genotype-1 hcv-213 100 µg 150
Recombinant Hepatitis C Virus Nucleocapsid (core) Genotype-1 0.5 mg 600
1 mg 1,000

HCV Genotype-1a hcv-203 100 µg 150

Recombinant Hepatitis C Virus Nucleocapsid (core) Genotype- 0.5 mg 600
1a 1 mg 1,200

HCV Genotype-1b hcv-245 100 µg 150

Recombinant Hepatitis C Virus Nucleocapsid (core) Genotype- 0.5 mg 600
1b 1 mg 1,200

HCV Genotype-2a hcv-214 100 µg 150

Recombinant Hepatitis C Virus Nucleocapsid (core) Genotype- 0.5 mg 600
2a 1 mg 1,200

HCV Genotype-2b hcv-237 100 µg 150

Recombinant Hepatitis C Virus Nucleocapsid (core) Genotype- 0.5 mg 600
2b 1 mg 1,200

HCV Genotype-3a hcv-215 100 µg 150

Recombinant Hepatitis C Virus Nucleocapsid (core) Genotype- 0.5 mg 600
3a 1 mg 1,200

HCV Genotype-3b hcv-238 100 µg 150

Recombinant Hepatitis C Virus Nucleocapsid (core) Genotype- 0.5 mg 600
PEPTIDES INTERNATIONAL

3b 1 mg 1,200

HCV Genotype-4 hcv-216 100 µg 150

Recombinant Hepatitis C Virus Nucleocapsid (core) Genotype-4 0.5 mg 600
1 mg 1,200

HCV Genotype-5 hcv-217 100 µg 150

Recombinant Hepatitis C Virus Nucleocapsid (core) Genotype-5 0.5 mg 600
1 mg 1,200

HCV Genotype-6a hcv-218 100 µg 150

Recombinant Hepatitis C Virus Nucleocapsid (core) Genotype- 0.5 mg 600
6a 1 mg 1,200

HCV Genotype-3/10 hcv-201 100 µg 150

Recombinant Hepatitis C Virus Nucleocapsid (core) 0.5 mg 600
Genotype-3/10 1 mg 1,200

HCV Core-Biotin hcv-242 100 µg 250

Recombinant Hepatitis C Virus Nucleocapsid (core), Biotin 0.5 mg 900
Labeled 1 mg 1,500

HCV Core-HRP hcv-243 100 µg 250

Recombinant Hepatitis C Virus Nucleocapsid (core), 0.5 mg 900
Horseradish Peroxidase Labled 1 mg 1,500

HCV Core-24 hcv-240 100 µg 150

Recombinant Hepatitis C Virus Nucleocapsid (core) 24 0.5 mg 600
1 mg 1,200

726 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
HCV Combined hcv-207 100 µg 150
Recombinant Hepatitis C Virus Combined    0.5 mg 600
1 mg 1,000

HCV 22kDa hcv-241 100 µg 150

Recombinant Hepatitis C Virus Nucleocapsid (core) 22kDa 0.5 mg 600
1 mg 1,200

HCV 22kDa Biotin hcv-225 100 µg 250

Recombinant Hepatitis C Virus Nucleocapsid (core) 22kDa, 0.5 mg 900
Biotin 1 mg 1,500

HCV 22kDa Fluorescein hcv-261 100 µg 250

Recombinant Hepatitis C Virus Nucleocapsid (core) 22kDa, 0.5 mg 900
Fluorescein Labeled 1 mg 1,500

HCV 22kDa Rhodamine hcv-262 100 µg 250

Recombinant Hepatitis C Virus Nucleocapsid (core) 22kDa, 0.5 mg 900
Rhodamine Labeled 1 mg 1,500

HCV Mosaic-A hcv-001 100 µg 150

Recombinant Hepatitis C Virus mosaic Antigen-A 0.5 mg 600
1 mg 1,200

HCV Mosaic-B hcv-002 100 µg 150

Recombinant Hepatitis C Virus mosaic Antigen-B 0.5 mg 600
1 mg 1,200

HCV NS3 Genotype-1a hcv-246

PEPTIDES INTERNATIONAL
100 µg 150
Recombinant Hepatitis C Virus NS3 Genotype-1a (1192-1459) 0.5 mg 600
1 mg 1,200

HCV NS3 Genotype-1a hcv-248 100 µg 150

Recombinant Hepatitis C Virus NS3 Genotype-1a (1356-1459) 0.5 mg 600
1 mg 1,200

HCV NS3 Genotype-1b hcv-247 100 µg 150

Recombinant Hepatitis C Virus NS3 Genotype-1b (1192-1459) 0.5 mg 600
1 mg 1,200

HCV NS3 Genotype-1b hcv-204 100 µg 150

Recombinant Hepatitis C Virus NS3 Genotype-1b 0.5 mg 600
1 mg 1,000

HCV NS3 Genotype-1b hcv-249 100 µg 150

Recombinant Hepatitis C Virus NS3 Genotype-1b (1356-1459) 0.5 mg 600
1 mg 1,200

HCV NS3 Genotype-1c hcv-208 100 µg 150

Recombinant Hepatitis C Virus NS3 Genotype-1c  0.5 mg 600
1 mg 1,000

HCV NS3 Genotype-2c hcv-209 100 µg 150

Recombinant Hepatitis C Virus NS3 Genotype-2c (1192-1459) 0.5 mg 600
1 mg 1,200

Order Hotline 1-800-777-4779 502-266-8787 727

 PRODUCT Code Qty PRICE
Recombinant proteins

HCV NS3 Genotype-2b hcv-210 100 µg 150

Recombinant Hepatitis C Virus NS3 Genotype-2b (1192-1459) 0.5 mg 600
1 mg 1,200

HCV NS3 Genotype-2b hcv-250 100 µg 150

Recombinant Hepatitis C Virus NS3 Genotype-2b (1356-1459) 0.5 mg 600
1 mg 1,200

HCV NS3 Genotype-2c hcv-265 100 µg 150

Recombinant Hepatitis C Virus NS3 Genotype-2c (1356-1459) 0.5 mg 600
1 mg 1,200

HCV NS3 Genotype-3 hcv-251 100 µg 150

Recombinant Hepatitis C Virus NS3 Genotype-3 (1356-1459) 0.5 mg 600
1 mg 1,200

HCV NS3 Genotype-4c hcv-252 100 µg 150

Recombinant Hepatitis C Virus NS3 Genotype-4c (1356-1459) 0.5 mg 600
1 mg 1,200

HCV NS3 Genotype-5 hcv-253 100 µg 150

Recombinant Hepatitis C Virus NS3 Genotype-5 (1356-1459) 0.5 mg 600
1 mg 1,200

HCV NS3 Genotype-5 hcv-266 100 µg 150

Recombinant Hepatitis C Virus NS3 Genotype-5 (1192-1459) 0.5 mg 600
1 mg 1,200

HCV NS3 Genotype-5a hcv-212 100 µg 150

PEPTIDES INTERNATIONAL

Recombinant Hepatitis C Virus NS3 Genotype-5a  0.5 mg 600

1 mg 1,000

HCV NS3 Genotype-6 hcv-254 100 µg 150

Recombinant Hepatitis C Virus NS3 Genotype-6 (1356-1459) 0.5 mg 600
1 mg 1,200

HCV NS3 Genotype-6a hcv-211 100 µg 150

Recombinant Hepatitis C Virus NS3 Genotype-6a (1192-1459) 0.5 mg 600
1 mg 1,200

HCV NS3 hcv-255 100 µg 150

Recombinant Hepatitis C Virus NS3 (1450-1643) 0.5 mg 600
1 mg 1,200

HCV NS3-Biotin hcv-244 100 µg 250

Recombinant Hepatitis C Virus NS3 (1450-1643), Biotin Labeled 0.5 mg 900
1 mg 1,500

HCV NS3-HRP hcv-256 100 µg 250

Recombinant Hepatitis C Virus NS3 (1450-1643), Horseradish 0.5 mg 900
Peroxidase Labeled 1 mg 1,500

HCV NS3 His hcv-267 20 µg 150

Recombinant Hepatitis C Virus NS3, His Tag 100 µg 600
1 mg 3,600

728 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
HCV NS4 Mosaic hcv-205 100 µg 150
Recombinant Hepatitis C Virus NS4 mosaic  0.5 mg 600
1 mg 1,000

HCV NS4 Genotype-1 hcv-257 100 µg 150

Recombinant Mosaic Hepatitis C Virus NS4 Genotype-1        0.5 mg 600
1 mg 1,200

HCV NS4 Genotype-2 hcv-258 100 µg 150

Recombinant Mosaic Hepatitis C Virus NS4 Genotype-2          0.5 mg 600
1 mg 1,200

HCV NS4 Genotype-3 hcv-259 100 µg 150

Recombinant Mosaic Hepatitis C Virus NS4 Genotype-3          0.5 mg 600
1 mg 1,200

HCV NS4 Genotype-5 hcv-260 100 µg 150

Recombinant Mosaic Hepatitis C Virus NS4 Genotype-5         0.5 mg 600
1 mg 1,200

HCV NS4 hcv-202 100 µg 150

Recombinant Hepatitis C Virus NS4 0.5 mg 600
1 mg 1,200

HCV NS4 HRP hcv-220 100 µg 250

Recombinant Hepatitis C Virus NS4, Horseradish Peroxidase 0.5 mg 900
Labeled 1 mg 1,500

HCV NS4 a+b hcv-264

PEPTIDES INTERNATIONAL
100 µg 150
Recombinant Hepatitis C Virus NS4 a+b 0.5 mg 600
1 mg 1,200

HCV NS4 a+b Fluorescein hcv-268 100 µg 250

Recombinant Hepatitis C Virus NS4 a+b, Fluorescein Labeled 0.5 mg 900
1 mg 1,500

HCV NS4 a+b Rhodamine hcv-226 100 µg 250

Recombinant Hepatitis C Virus NS4 a+b, Rhodamine Labeled 0.5 mg 900
1 mg 1,500

HCV NS4 a+b Biotin hcv-200 100 µg 250

Recombinant Hepatitis C Virus NS4 a+b, Biotin Labeled 0.5 mg 900
1 mg 1,500

HCV NS5 Genotype-1 hcv-219 100 µg 150

Recombinant Hepatitis C Virus NS5 Genotype-1  0.5 mg 600
1 mg 1,000

HCV NS5 Genotype-1a hcv-206 100 µg 150

Recombinant Hepatitis C Virus NS5 Genotype-1a (2322-2423) 0.5 mg 600
1 mg 1,000

HCV NS5 Genotype-1a hcv-227 100 µg 150

Recombinant Hepatitis C Virus NS5 Genotype-1a 0.5 mg 600
1 mg 1,200

Order Hotline 1-800-777-4779 502-266-8787 729

 PRODUCT Code Qty PRICE
Recombinant proteins

HCV NS5 Genotype-1b hcv-228 100 µg 150

Recombinant Hepatitis C Virus NS5 Genotype-1b 0.5 mg 600
1 mg 1,200

HCV NS5 Genotype-2 hcv-229 100 µg 150

Recombinant Hepatitis C Virus NS5 Genotype-2  0.5 mg 600
1 mg 1,000

HCV NS5 Genotype-2a hcv-230 100 µg 150

Recombinant Hepatitis C Virus NS5 Genotype-2a  0.5 mg 600
1 mg 1,200

HCV NS5 Genotype-2b hcv-231 100 µg 150

Recombinant Hepatitis C Virus NS5 Genotype-2b 0.5 mg 600
1 mg 1,200

HCV NS5 Genotype-3 hcv-221 100 µg 150

Recombinant Hepatitis C Virus NS5 Genotype-3  0.5 mg 600
1 mg 1,000

HCV NS5 Genotype-3a hcv-232 100 µg 150

Recombinant Hepatitis C Virus NS5 Genotype-3a  0.5 mg 600
1 mg 1,200

HCV NS5 Genotype-3b hcv-233 100 µg 150

Recombinant Hepatitis C Virus NS5 Genotype-3b  0.5 mg 600
1 mg 1,200

HCV NS5 Genotype-4 hcv-222 100 µg 150

PEPTIDES INTERNATIONAL

Recombinant Hepatitis C Virus NS5 Genotype-4  0.5 mg 600

1 mg 1,200

HCV NS5 Genotype-5 hcv-223 100 µg 150

Recombinant Hepatitis C Virus NS5 Genotype-5  0.5 mg 600
1 mg 1,200

HCV NS5 Genotype-6 hcv-224 100 µg 150

Recombinant Hepatitis C Virus NS5 Genotype-6  0.5 mg 600
1 mg 1,000

HCV NS5 Genotype-6a hcv-234 100 µg 150

Recombinant Hepatitis C Virus NS5 Genotype-6a 0.5 mg 600
1 mg 1,200

HCV NS5 hcv-235 100 µg 150

Recombinant Hepatitis C Virus NS5 0.5 mg 600
1 mg 1,200

HCV NS5B hcv-269 100 µg 150

Recombinant Hepatitis C Virus NS5B 0.5 mg 600
1 mg 1,200

HCV NS5 Biotin hcv-236 100 µg 250

Recombinant Hepatitis C Virus NS5, Biotin Labled 0.5 mg 900
1 mg 1,500

730 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
HCVNS5 HRP hcv-263 100 µg 250
Recombinant Hepatitis C Virus NS5, Horseradish Peroxidase 0.5 mg 900
Labled 1 mg 1,500

HCV 4th Generation hcv-239 100 µg 150

Recombinant Hepatitis C Virus 4th Generation 0.5 mg 600
1 mg 1,200

HCV 4th Generation 1b hcv-270 100 µg 150

Recombinant Hepatitis C Virus 4th Generation Genotypes 1b 0.5 mg 600
1 mg 1,200

Viral Antigens - Hepatitis A Virus

HAV VP1 hav-227 100 µg 150
Recombinant Hepatitis A Virus VP1 0.5 mg 600
1 mg 1,000

HAV VP1-P2A hav-228 100 µg 150

Recombinant Hepatitis A Virus VP1-P2A (722-830) 0.5 mg 600
1 mg 1,000

HAV VP1-P2A hav-265 100 µg 150

Recombinant Hepatitis A Virus VP1-P2A (669-782) 0.5 mg 600
1 mg 1,200

HAV P2C hav-229 100 µg 150

Recombinant Hepatitis A Virus P2C  0.5 mg 600

PEPTIDES INTERNATIONAL
1 mg 1,000

HAV P2C-P3B hav-230 100 µg 150

Recombinant Hepatitis A Virus P2C-P3B 0.5 mg 600
1 mg 1,200

HAV P2C-P3A hav-266 100 µg 150

Recombinant Hepatitis A Virus P2C-P3A  0.5 mg 600
1 mg 1,000

HAV P3C hav-231 100 µg 150

Recombinant Hepatitis A Virus P3C 0.5 mg 600
1 mg 1,000

HAV VP3 hav-226 100 µg 150

Recombinant Hepatitis A Virus VP3 0.5 mg 600
1 mg 1,000

HAV VP4-VP2 hav-225 100 µg 150

Recombinant Hepatitis A Virus VP4-VP2 0.5 mg 600
1 mg 1,000

HAVCR2 hav-224 5 µg 50
Recombinant Human Hepatitis A Virus Cellular Receptor 2 20 µg 130
1 mg 2,700

Order Hotline 1-800-777-4779 502-266-8787 731

 PRODUCT Code Qty PRICE
Recombinant proteins

Viral Antigens - Hepatitis B Virus

HBcAg hbv-232 100 µg 150
Recombinant Hepatitis B Virus Core (1-186)    0.5 mg 600
1 mg 1,000

HBcAg hbv-269 100 µg 150

Recombinant Hepatitis B Virus Core (1-183) 0.5 mg 600
1 mg 1,200

HBcAg Delta hbv-270 100 µg 150

Recombinant Hepatitis B Virus Core Delta 0.5 mg 600
1 mg 1,200

HBV X hbv-271 5 µg 50
Recombinant Hepatitis B Virus x 25 µg 130
1 mg 3,700

HBXIP hbv-235 5 µg 50
Recombinant Human Hepatitis B Virus x Interacting Protein 20 µg 130
1 mg 2,700

HBeAg hbv-272 5 µg 50
Recombinant Hepatitis B Virus e-Antigen 25 µg 130
1 mg 2,700

HBV HBe hbv-233 100 µg 150

Recombinant Hepatitis B Virus HBe     0.5 mg 600
1 mg 1,000
PEPTIDES INTERNATIONAL

Viral Antigens - Hantaan Virus

HTNV htv-001 100 µg 150
Recombinant Hantavirus 0.5 mg 600
1 mg 1,200

Viral Antigens -Feline Leukemia Virus

FeLV flv-001 100 µg 150
Recombinant Feline Leukemia Virus p27 0.5 mg 600
1 mg 1,200

Viral Antigens - Hepatitis D Virus

HDV hdv-234 100 µg 150
Recombinant Hepatitis D Virus   0.5 mg 600
1 mg 1,200

Viral Antigens - Hepatitis E Virus

HEV ORF2/ORF3 hev-274 100 µg 150
Recombinant Hepatitis E Virus mosaic-S ORF2/ORF3 33kDa 0.5 mg 600
1 mg 1,000

HEV ORF2/ORF3 hev-235 100 µg 150

Recombinant Hepatitis E Virus mosaic ORF2/ORF3 38.5 kDa 0.5 mg 600
1 mg 1,000

732 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
HEV ORF2 hev-271 100 µg 150
Recombinant Hepatitis E Virus ORF2  (633-659) 0.5 mg 600
1 mg 1,200

HEV ORF2 hev-272 100 µg 150

Recombinant Hepatitis E Virus ORF2  (403-461) 0.5 mg 600
1 mg 1,200

HEV ORF2 hev-236 100 µg 150

Recombinant Hepatitis E Virus ORF2  (452-617) 0.5 mg 600
1 mg 1,000

HEV ORF3 hev-273 100 µg 150

Recombinant Hepatitis E Virus ORF3  0.5 mg 600
1 mg 1,200

Viral Antigens - Hepatitis B Surface Antigens

HBsAg ayw hbs-870 10 µg 50
Recombinant Hepatitis B Surface Antigen ayw subtype, 50 µg 130
Saccharomyces 1 mg 1,200

HBsAg ayw hbs-877 10 µg 50

Recombinant Hepatitis B Surface Antigen ayw subtype 50 µg 130
1 mg 1,200

HBsAg ayw G-145-R hbs-878 10 µg 50

Recombinant Hepatitis B Surface Antigen ayw subtype, Mutant 50 µg 130

PEPTIDES INTERNATIONAL
G-145-R 1 mg 1,200

HBsAg adr hbs-873 10 µg 50

Recombinant Hepatitis B Surface Antigen adr subtype, 50 µg 130
Saccharomyces 1 mg 1,850

HBsAg adr CHO hbs-875 20 µg 50

Recombinant Hepatitis B Surface Antigen adr subtype, CHO 100 µg 130
1 mg 850

HBsAg adw hbs-872 20 µg 50

Recombinant Hepatitis B Surface Antigen Adw subtype 100 µg 130
1 mg 850

HBsAg adw Saccharomyces hbs-876 10 µg 50

Recombinant Hepatitis B Surface Antigen Adw subtype, 50 µg 130
Saccharomyces 1 mg 2,400

HBsAg adw G-145-R hbs-879 10 µg 50

Recombinant Hepatitis B Surface Antigen adw subtype, Mutant 50 µg 130
G-145-R 1 mg 1,200

HBsAg adw K-141-E hbs-883 10 µg 50

Recombinant Hepatitis B Surface Antigen adw subtype, Mutant 50 µg 130
K-141-E 1 mg 1,200

HBsAg adw M-133-L hbs-884 10 µg 50

Recombinant Hepatitis B Surface Antigen adw subtype, Mutant 50 µg 130
K-133-L 1 mg 1,200

Order Hotline 1-800-777-4779 502-266-8787 733

 PRODUCT Code Qty PRICE
Recombinant proteins

HBsAg adw M-133-H hbs-885 10 µg 50

Recombinant Hepatitis B Surface Antigen adw subtype, Mutant 50 µg 130
M-133-H 1 mg 1,200

HBsAg adw P-142-S hbs-886 10 µg 50

Recombinant Hepatitis B Surface Antigen adw subtype, Mutant 50 µg 130
P-142-S 1 mg 1,200

HBsAg adw Q-129-H hbs-881 10 µg 50

Recombinant Hepatitis B Surface Antigen adw subtype, Mutant 50 µg 130
Q-129-H 1 mg 1,200

HBsAg adw Q-129-L hbs-882 10 µg 50

Recombinant Hepatitis B Surface Antigen adw subtype, Mutant 50 µg 130
Q-129-L 1 mg 1,200

HBsAg adw T-126-N hbs-887 10 µg 50

Recombinant Hepatitis B Surface Antigen adw subtype, Mutant 50 µg 130
T-126-N 1 mg 1,200

HBsAg adw T-143-K hbs-888 10 µg 50

Recombinant Hepatitis B Surface Antigen adw subtype, Mutant 50 µg 130
T-143-K 1 mg 1,200

HBsAg preS1 hbs-871 10 µg 50

Recombinant Hepatitis B Surface Antigen preS1 50 µg 130
1 mg 1,850
PEPTIDES INTERNATIONAL

HBsAg preS2 hbs-874 10 µg 50

Recombinant Hepatitis B Surface Antigen preS2 50 µg 130
1 mg 1,850

Viral Antigens - Cytomegalo Virus

CmV gB c mv-211 100 µg 150
Recombinant Cytomegalo Virus gB 0.5 mg 600
1 mg 1,000

CmV Pp28 c mv-212 100 µg 150

Recombinant Cytomegalo Virus Pp28 (UL99) 0.5 mg 600
1 mg 1,000

CmV Pp38 c mv-213 100 µg 150

Recombinant Cytomegalo Virus Pp38 (UL80a) 0.5 mg 600
1 mg 1,000

CmV Pp52 c mv-214 100 µg 150

Recombinant Cytomegalo Virus Pp52 (UL44) 0.5 mg 600
1 mg 1,000

CmV Pp65 c mv-215 100 µg 150

Recombinant Cytomegalo Virus Pp65(UL83) 0.5 mg 600
1 mg 1,000

CmV Pp150 c mv-216 100 µg 150

Recombinant Cytomegalo Virus Pp150(UL32) 0.5 mg 600
1 mg 1,000

734 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
Viral Antigens - Varizella Zoster Virus
VZV gE vzv-231 100 µg 150
Recombinant Varicella Zoster Virus gE  0.5 mg 600
1 mg 1,000

VZV ORF9 vzv-232 100 µg 150

Recombinant Varicella Zoster Virus ORF9 0.5 mg 600
1 mg 1,000

VZV ORF26 vzv-233 100 µg 150

Recombinant Varicella Zoster Virus ORF26  0.5 mg 600
1 mg 1,000

Viral Antigens - Toxoplasma Gondii Proteins

Toxoplasma MIC3 tox-261 100 µg 150
Recombinant Toxoplasma Gondii MIC3 0.5 mg 600
1 mg 1,000

Toxoplasma P24 tox-262 100 µg 150

Recombinant Toxoplasma Gondii P24 (GRA 1) 0.5 mg 600
1 mg 1,000

Toxoplasma P29 tox-263 100 µg 150

Recombinant Toxoplasma Gondii P29 (GRA 7) 0.5 mg 600
1 mg 1,000

Toxoplasma P30 tox-264 100 µg 150

PEPTIDES INTERNATIONAL
Recombinant Toxoplasma Gondii P30 (SAG 1) 0.5 mg 600
1 mg 1,000

Toxoplasma P30 (78-339) tox-265 100 µg 150

Recombinant Toxoplasma Gondii P30 (SAG 1), 78-339 a.a. 0.5 mg 600
1 mg 1,000

Toxoplasma ROP4 RH2 tox-266 100 µg 150

Recombinant Toxoplasma Gondii ROP4 RH2 0.5 mg 600
1 mg 1,200

Viral Antigens - Treponema Pallidum Proteins

Treponema p15 trp-275 100 µg 150
Recombinant Treponema pallidum p15 (partial) 0.5 mg 600
1 mg 1,200

Treponema p15 trp-246 100 µg 150

Recombinant Treponema pallidum p15 0.5 mg 600
1 mg 1,200

Treponema p15 His trp-247 100 µg 150

Recombinant Treponema pallidum p15 (Partial), His Tag 0.5 mg 600
1 mg 1,200

Treponema p17 trp-241 100 µg 150

Recombinant Treponema pallidum p17 0.5 mg 600
1 mg 1,000

Order Hotline 1-800-777-4779 502-266-8787 735

 PRODUCT Code Qty PRICE
Recombinant proteins

Treponema p17 trp-248 100 µg 150

Recombinant Treponema pallidum p17 (Partial) 0.5 mg 600
1 mg 1,200

Treponema p41 trp-242 100 µg 150

Recombinant Treponema pallidum p41 0.5 mg 600
1 mg 1,000

Treponema p41 Mosaic trp-244 100 µg 150

Recombinant Treponema pallidum p41 Mosaic 0.5 mg 600
1 mg 1,000

Treponema p47 trp-243 100 µg 150

Recombinant Treponema pallidum p47 0.5 mg 600
1 mg 1,000

Treponema p47 trp-249 100 µg 150

Recombinant Treponema pallidum p47 (Partial) 0.5 mg 600
1 mg 1,200

Treponema TmpA trp-245 100 µg 150

Recombinant Treponema pallidum TmpA (Partial) 0.5 mg 600
1 mg 1,200

Treponema TmpA trp-250 100 µg 150

Recombinant Treponema pallidum TmpA 0.5 mg 600
1 mg 1,200

Viral Antigens - Human Immunodeficiency Virus

PEPTIDES INTERNATIONAL

HIV-1 Envelope hiv-101 100 µg 150

Recombinant HIV-1 Envelope (233) 0.5 mg 600
1 mg 1,000

HIV-1 nef hiv-124 100 µg 150

Recombinant HIV-1 nef 0.5 mg 600
1 mg 1,200

HIV-1 nef Clade B hiv-156 2 µg 50

Recombinant HIV-1 nef , Clade B 10 µg 130
100 µg 1,100

HIV-1 p24c hiv-103 100 µg 150

Recombinant HIV-1 p24 Core 0.5 mg 600
1 mg 1,000

HIV-1 p24c Sf9 hiv-153 2 µg 50

Recombinant HIV-1 p24 Core, Sf9 10 µg 200
100 µg 1,800

HIV-1 p24 His hiv-159 5 µg 50

Recombinant HIV-1 p24 His Tag 20 µg 130
1 mg 3,600

rHIV-1 p24 Biotin hiv-106 100 µg 250

Recombinant HIV-1 p24, Biotin Labeled 0.5 mg 900
1 mg 1,500

736 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
HIV-1 24 HRP hiv-109 100 µg 250
Recombinant HIV-1 p24, Horseradish Peroxidase Labeled 0.5 mg 900
1 mg 1.50

HIV-1 p24 gag hiv-123 100 µg 150

Recombinant HIV-I p24 gag 0.5 mg 600
1 mg 1,200

HIV-1 p24 24kDa hiv-155 2 µg 50

Recombinant HIV-1 p24 , 24kDa 10 µg 130
100 µg 950

HIV-1 gp41 hiv-112 100 µg 150

Recombinant HIV-1 gp41 0.5 mg 600
1 mg 1,200

HIV-1 gp41 Biotin hiv-117 100 µg 250

Recombinant HIV-1 gp41, Biotin Labeled 0.5 mg 900
1 mg 1,500

HIV-1 gp41 HRP hiv-118 100 µg 250

Recombinant HIV-1 gp41, Horseradish Peroxidase Labeled 0.5 mg 900
1 mg 1.50

HIV-1 gp41 Long hiv-113 100 µg 150

Recombinant HIV-1 gp41 Long (466-753 a.a.) 0.5 mg 600
1 mg 1,200

HIV-1 gp41 L-Biotin hiv-119 100 µg 250

PEPTIDES INTERNATIONAL
Recombinant HIV-1 gp41 Long, Biotin Labeled 0.5 mg 900
1 mg 1,500

HIV-1 gp41 L-HRP hiv-120 100 µg 250

Recombinant HIV-1 gp41 Long, Horseradish peroxidase 0.5 mg 900
Labeled 1 mg 1.50

HIV-1 gp41/120 hiv-158 100 µg 150

Recombinant HIV-1 gp41,gp120 0.5 mg 600
1 mg 1,200

HIV-1 p55 gag hiv-130 2 µg 50

Recombinant HIV-1 p55 gag 10 µg 200
100 µg 1,800

HIV-1 p66 pol hiv-127 2 µg 50

Recombinant HIV-1 p66 pol 10 µg 200
100 µg 1,800

HIV-1 gp120 hiv-102 100 µg 150

Recombinant HIV-1 gp120 nef Mosaic 0.5 mg 600
1 mg 1,200

HIV-1 gp120 LAV hiv-146 2 µg 50

Recombinant HIV-1 gp120 LAV 10 µg 200
100 µg 1,800

Order Hotline 1-800-777-4779 502-266-8787 737

 PRODUCT Code Qty PRICE
Recombinant proteins

HIV-1 gp120 MN hiv-114 2 µg 50

Recombinant HIV-1 gp120 MN 10 µg 200
100 µg 1,800

HIV-1 gp120 Cm hiv-154 2 µg 50

Recombinant HIV-1 gp120 Cm 10 µg 200
100 µg 1,800

HIV-1 p17/24 hiv-121 100 µg 150

Recombinant HIV-1 gag p17, p24 0.5 mg 600
1 mg 1,200

HIV-1 p17/24/120 hiv-111 100 µg 150

Recombinant HIV-1 gag p17, p24, gp120 0.5 mg 600
1 mg 1,200

HIV-1 p17-24,41-120 hiv-110 100 µg 150

Recombinant HIV-1 gag p17-p24, gp41-gp120 0.5 mg 600
1 mg 1,200

HIV-1 Integrase hiv-122 100 µg 150

Recombinant HIV-1 pol Integrase 0.5 mg 600
1 mg 1,200

HIV-1 Integrase hiv-145 100 µg 150

Recombinant HIV-1 p31 Integrase 0.5 mg 600
1 mg 1,200

HIV-1 Protease hiv-001 2 µg 50

PEPTIDES INTERNATIONAL

Recombinant HIV-1 Protease 10 µg 130

1 mg 5,200

HIV-1 TAT Clade-A hiv-105 2 µg 50

Recombinant HIV-1 TAT Clade-A 10 µg 130
100 µg 1,200

HIV-1 TAT Clade-B hiv-129 2 µg 50

Recombinant HIV-1 TAT Clade-B 10 µg 130
100 µg 1,000

HIV-1 TAT Clade-C hiv-116 2 µg 50

Recombinant HIV-1 TAT Clade-C 10 µg 130
100 µg 1,100

HIV-1 TAT Clade-D hiv-157 2 µg 50

Recombinant HIV-1 TAT Clade-D 10 µg 130
100 µg 1,100

HIV-1 TAT Biotin hiv-128 1 µg 50

Recombinant HIV-1 TAT, Biotin Labeled 5 µg 130
50 µg 1,000

rHIV-1 TAT Cys22 hiv-136 2 µg 50

Recombinant HIV-1 TAT Cys22 10 µg 130
100 µg 1,000

738 Order Hotline 1-800-777-4779 502-266-8787

 PRODUCT Code Qty PRICE
Recombinant proteins

HIV-1,2 hiv-131 100 µg 150

Recombinant HIV-1 Envelope conjugated to HIV-2 gp39 0.5 mg 600
1 mg 1,000

HIV Type-O Envelope hiv-132 100 µg 150

Recombinant HIV Type-O Envelope 0.5 mg 600
1 mg 1,000

HIV Type-O gp41 hiv-133 100 µg 150

Recombinant HIV Type-O gp41 0.5 mg 600
1 mg 1,200

HIV-2 gp32 hiv-134 100 µg 150

Recombinant HIV-2 gp32 0.5 mg 600
1 mg 1,200

HIV-2 gp32 Biotin hiv-135 100 µg 250

Recombinant HIV-2 gp32, Biotin Labeled 0.5 mg 900
1 mg 1,500

HIV-2 gp32 HRP hiv-137 100 µg 250

Recombinant HIV-2 gp32, Horseradish Peroxidase Labled 0.5 mg 900
1 mg 1,500

HIV-2 gp36 hiv-138 100 µg 150

Recombinant HIV-2 gp36 0.5 mg 600
1 mg 1,000

HIV-2 gp36 hiv-104 100 µg 75

PEPTIDES INTERNATIONAL

Synthetic HIV-2 gp36 0.5 mg 300

1 mg 500

HIV-2 gp36 (390-702) hiv-139 100 µg 150

Recombinant HIV-2 gp36 (390-702) 0.5 mg 600
1 mg 1,200

HIV-2 Envelope hiv-140 100 µg 150

Recombinant HIV-2 Envelope 0.5 mg 600
1 mg 1,000

HIV-2 Protease hiv-002 2 µg 50

Recombinant HIV-2 Protease 10 µg 130
1 mg 5,200

SIV p55 siv-114 2 µg 50

Recombinant SIV p55 10 µg 200
100 µg 1,800

Viral Antigens - Human T-Lymphotrophic Virus

HTLV-1 Envelope hiv-107 100 µg 150
Recombinant HTLV-1 Envelope 0.5 mg 600
1 mg 1,000

HTLV-1 p24c hiv-108 100 µg 150

Recombinant HTLV-1 p24 Core 0.5 mg 600
1 mg 1,000

739 Order Hotline 1-800-777-4779 502-266-8787

 PRODUCT Code Qty PRICE
Recombinant proteins

HTLV-1 p24 hiv-003 100 µg 150

Recombinant HTLV-1 p24 0.5 mg 600
1 mg 1,200

rHTLV-I+II hiv-115 5 µg 50
Recombinant HTLV-I+II 20 µg 130
1 mg 3,600

HTLV-1 gp21 hiv-141 100 µg 150

Recombinant HTLV-1 gp21 0.5 mg 600
1 mg 1,200

HTLV-1 gp46 hiv-142 100 µg 150

Recombinant HTLV-1 gp46 0.5 mg 600
1 mg 1,200

HTLV-1 Mosaic hiv-144 100 µg 150

Recombinant HTLV-1 Mosaic 0.5 mg 600
1 mg 1,200

Viral Antigens - Human Papillomavirus Virus

HPV 16 hpv-001 100 µg 150
Recombinant Human Papillomavirus 16 0.5 mg 600
1 mg 1,200

HPV 18 hpv-002 100 µg 150

Recombinant Human Papillomavirus 18 0.5 mg 600
1 mg 1,200
PEPTIDES INTERNATIONAL

HPV 6 hpv-003 100 µg 150

Recombinant Human Papillomavirus 6 0.5 mg 600
1 mg 1,200

HPV 11 hpv-004 100 µg 150

Recombinant Human Papillomavirus 11 0.5 mg 600
1 mg 1,200

Viral Antigens - Epstein-Barr Virus

EBV EBNA1 ebv-271 100 µg 150
Recombinant Epstein-Barr Virus (HHV-4) Mosaic EBNA1 0.5 mg 600
1 mg 1,000

EBV EBNA1 His ebv-276 100 µg 250

Recombinant Epstein-Barr Virus (HHV-4) EBNA1, His Tag 0.5 mg 800
1 mg 1,500

EBV EA ebv-272 100 µg 150

Recombinant Epstein-Barr Virus (HHV-4) Early Antigen 0.5 mg 600
1 mg 1,000

EBV p18 ebv-273 100 µg 150

Recombinant Epstein-Barr Virus (HHV-4) p18 0.5 mg 600
1 mg 1,000

740 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
EBV p18 GST ebv-277 100 µg 250
Recombinant Epstein-Barr Virus (HHV-4) p18 GST 0.5 mg 800
1 mg 1,500

EBV Mosaic ebv-275 100 µg 150

Recombinant Epstein-Barr Virus (HHV-4) Mosaic p18 0.5 mg 600
1 mg 1,200

EBV p23 ebv-274 100 µg 150

Recombinant Epstein-Barr Virus (HHV-4) p23 0.5 mg 600
1 mg 1,000

EBV p23 His ebv-278 100 µg 250

Recombinant Epstein-Barr Virus (HHV-4) p23 His 0.5 mg 800
1 mg 1,500

EBNA1BP2 ebv-279 5 µg 50
Recombinant Human EBNA1 Binding Protein 2 20 µg 130
1 mg 2,700

Viral Antigens - Encephalitis Virus

Encephalitis gE tbe-281 100 µg 150
Recombinant Tick-Borne Encephalitis Virus gE 0.5 mg 600
1 mg 1,000

Encephalitis NE/gE tbe-282 100 µg 150

Recombinant Tick-Borne Encephalitis Virus NE/gE 0.5 mg 600
1 mg 1,000

PEPTIDES INTERNATIONAL
Encephalitis gE Middle tbe-283 100 µg 150
Recombinant Tick-Borne Encephalitis Virus gE Middle (50-250) 0.5 mg 600
1 mg 1,000

Encephalitis C-end tbe-284 100 µg 150

Recombinant Tick-Borne Encephalitis Virus gE C-end (296-414) 0.5 mg 600
1 mg 1,000

Encephalitis Japanese tbe-290 100 µg 150

Recombinant Japanese Encephalitis Virus 0.5 mg 600
1 mg 1,000

Encephalitis Core tbe-285 100 µg 150

Recombinant Tick-Borne Encephalitis Virus Core 0.5 mg 600
1 mg 1,000

Encephalitis NS3 tbe-286 100 µg 150

Recombinant Tick-Borne Encephalitis Virus NS3 0.5 mg 600
1 mg 1,000

Encephalitis Prem tbe-287 100 µg 150

Recombinant Tick-Borne Encephalitis Virus prem 0.5 mg 600
1 mg 1,000

Order Hotline 1-800-777-4779 502-266-8787 741

 PRODUCT Code Qty PRICE
Recombinant proteins

Viral Antigens - Measles Virus

Measles Polymerase mev-001 100 µg 150
Recombinant Measles Virus Large Polymerase (58-149) 0.5 mg 600
1 mg 1,200

Measles Polymerase mev-003 100 µg 150

Recombinant Measles Virus Large Polymerase (2059-2183) 0.5 mg 600
1 mg 1,200

Measles Mosaic mev-005 100 µg 150

Recombinant Measles Virus Hemagglutinin Mosaic (1-30,115- 0.5 mg 600
150,379-410) 1 mg 1,200

Viral Antigens - Rubella Virus

Rubella Mosaic rub-291 100 µg 150
Recombinant Rubella Virus E1 Mosaic 0.5 mg 600
1 mg 1,200

Rubella E2 rub-292 100 µg 150

Recombinant Rubella Virus E2 0.5 mg 600
1 mg 1,000

Rubella Capsid rub-293 100 µg 150

Recombinant Rubella Virus Capsid C 0.5 mg 600
1 mg 1,000

Viral Antigens - Chikungunya Virus

PEPTIDES INTERNATIONAL

CHIKV E1 chi-001 2 µg 50
Recombinant Chikungunya Wild Type E1 10 µg 130
1 mg 5,200

CHIKV Mutant chi-002 2 µg 50

Recombinant Chikungunya Mutant (A226V) E1 10 µg 130
1 mg 5,200

Viral Antigens - Parvovirus

Parvovirus B19 VLP VP2 prv-001 5 µg 50
Recombinant Parvovirus B19 VLP VP2 20 µg 130
1 mg 3,600

Parvovirus B19 VLP VP1/VP2 prv-002 5 µg 50

Recombinant Parvovirus VLP VP1/VP2 Co-Capsid 20 µg 130
1 mg 3,600

Viral Antigens - Influenza Virus

Caledonia 20/99 iha-001 2 µg 50
Recombinant Hemagglutinin-Influenza A Virus H1N1 New 10 µg 200
Caledonia 20/99 100 µg 1,800

Solomon Island 03/06 iha-031 2 µg 50

Recombinant Hemagglutinin-Influenza A Virus H1N1 Solomon 10 µg 200
Island 03/2006 100 µg 1,800

742 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
California 04/2009 iha-014 2 µg 50
Recombinant Hemagglutinin-Influenza A Virus H1N1 California 10 µg 200
04/2009 100 µg 1,800

New York 3571/2009 iha-019 2 µg 50

Recombinant Hemagglutinin-Influenza A Virus H1N1 New York 10 µg 200
3571/2009 100 µg 1,800

Netherlands 219/03 iha-009 2 µg 50

Recombinant Hemagglutinin-Influenza A Virus H7N7 10 µg 200
Netherlands 219/03 100 µg 1,800

Vietnam 1203/04 iha-010 2 µg 50

Recombinant Hemagglutinin-Influenza A Virus H5N1 Vietnam 10 µg 200
1203/04 100 µg 1,800

Vietnam HN31242/2007 iha-035 2 µg 50

Recombinant Hemagglutinin-Influenza A Virus H5N1 Vietnam 10 µg 200
HN31242/2007 100 µg 1,800

Indonesia 05/05 iha-032 2 µg 50

Recombinant Hemagglutinin-Influenza A Virus H5N1 Indonesia 10 µg 200
05/2005 100 µg 1,800

New York 55/04 iha-011 2 µg 50

Recombinant Hemagglutinin-Influenza A Virus H3N2 New York 10 µg 200
55/04 100 µg 1,800

PEPTIDES INTERNATIONAL
Wyoming 3/03 iha-012 2 µg 50
Recombinant Hemagglutinin-Influenza A Virus H3N2 Wyoming 10 µg 200
3/03 100 µg 1,800

Wisconsin 67/05 iha-020 2 µg 50

Recombinant Hemagglutinin-Influenza A Virus H3N2 Wisconsin 10 µg 200
67/05 100 µg 1,800

Perth 16/09 iha-008 1 µg 50

Recombinant Hemagglutinin-Influenza A Virus H3N2 Perth 5 µg 130
16/09 50 µg 1,100

Canine iha-034 5 µg 50
Recombinant Hemagglutinin-Influenza A Virus H3N2 Canine 20 µg 130
1 mg 2,700

Hong Kong 1073/99 iha-013 2 µg 50

Recombinant Hemagglutinin-Influenza A Virus H9N2 Hong 10 µg 200
Kong 1073/99 100 µg 1,800

Ohio 01/05 iha-015 2 µg 50

Recombinant Hemagglutinin-Influenza B Virus Ohio 01/05 10 µg 200
100 µg 1,800

Jilin 20/03 iha-021 2 µg 50

Recombinant Hemagglutinin-Influenza B Virus Jilin 20/03 10 µg 200
100 µg 1,800

Order Hotline 1-800-777-4779 502-266-8787 743

 PRODUCT Code Qty PRICE
Recombinant proteins

malaysia 2506/04 iha-033 2 µg 50

Recombinant Hemagglutinin-Influenza B Virus Malaysia 10 µg 200
2506/04 100 µg 1,800

Qingdao 102/91 iha-016 10 µg 50

Influenza B Virus Qingdao 102/91 50 µg 130
1 mg 2,000

Tokio 53/99 iha-017 10 µg 50

Influenza B Virus Tokio 53/99 50 µg 130
1 mg 2,000

Victoria 504/00 iha-018 10 µg 50

Influenza B Virus Victoria 504/00 50 µg 130
1 mg 2,000

malaysia 2506/04 iha-025 10 µg 50

Influenza B Virus Malaysia 2506/04 50 µg 130
1 mg 2,000

Florida 07/04 iha-026 10 µg 50

Influenza B Virus Florida 07/04 50 µg 130
1 mg 2,000

Florida 04/06 iha-027 10 µg 50

Influenza B Virus Florida 04/06 50 µg 130
1 mg 2,000

Beijing 262/95 iha-002 10 µg 50

PEPTIDES INTERNATIONAL

Influenza A Virus H1N1 Beijing 262/95 50 µg 130

1 mg 2,000

Caledonia 20/99 iha-003 10 µg 50

Influenza A Virus H1N1 New Caledonia 20/99 IV 116 50 µg 130
1 mg 2,000

Taiwan 1/86 iha-007 10 µg 50

Influenza A Virus H1N1 Taiwan 1/86 50 µg 130
1 mg 2,000

Solomon Island 03/06 iha-022 10 µg 50

Influenza A Virus H1N1 Solomon Island 03/06 50 µg 130
1 mg 2,000

Shangdong 9/93 iha-004 10 µg 50

Influenza A Virus H3N2 Shangdong 9/93 50 µg 130
1 mg 2,000

Kiev 301/94 iha-005 10 µg 50

Influenza A Virus H3N2 Kiev 301/94 like /Johannesburg 33/94 50 µg 130
1 mg 2,000

Panama 2007/99 iha-006 10 µg 50

Influenza A Virus H3N2 Panama 2007/99 50 µg 130
1 mg 2,000

744 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
Wisconsin 67/05 iha-023 10 µg 50
Influenza A Virus H3N2 Wisconsin 67/05 50 µg 130
1 mg 2,000

Brisbane 10/07 iha-024 10 µg 50

Influenza A Virus H3N2 Brisbane 10/07 50 µg 130
1 mg 2,000

Parainfluenza Type-1 iha-028 10 µg 50

Parainfluenza Virus Type-1 50 µg 130
1 mg 2,000

Parainfluenza Type-2 iha-029 10 µg 50

Parainfluenza Virus Type-2 50 µg 130
1 mg 2,000

Parainfluenza Type-3 iha-030 10 µg 50

Parainfluenza Virus Type-3 50 µg 130
1 mg 2,000

Viral Antigens - West-Nile Virus

WNV Envelope wnv-001 100 µg 150
Recombinant West Nile Envelope Virus 0.5 mg 600
1 mg 1,200

WNV Pre-m wnv-002 100 µg 150

Recombinant West Nile Pre-m Virus 0.5 mg 600
1 mg 1,200

PEPTIDES INTERNATIONAL
Viral Antigens - Dengue Virus
Dengue Envelope-1 22kDa den-005 100 µg 150
Recombinant Dengue Virus Subtype-1 Envelope 22kDa 0.5 mg 600
1 mg 1,200

Dengue Envelope-2 22kDa den-007 100 µg 150

Recombinant Dengue Virus Subtype-2 Envelope 22kDa 0.5 mg 600
1 mg 1,200

Dengue Envelope-3 22kDa den-008 100 µg 150

Recombinant Dengue Virus Subtype-3 Envelope 22kDa 0.5 mg 600
1 mg 1,200

Dengue Envelope-4 22kDa den-009 100 µg 150

Recombinant Dengue Virus Subtype-4 Envelope 22kDa 0.5 mg 600
1 mg 1,200

Dengue Polyvalent den-010 100 µg 150

Recombinant Polyvalent Dengue Antigen 0.5 mg 600
1 mg 1,200

Dengue Polyvalent ELISA den-027 100 µg 150

Recombinant Polyvalent Dengue Antigen-I for ELISA 0.5 mg 600
1 mg 1,200

Order Hotline 1-800-777-4779 502-266-8787 745

 PRODUCT Code Qty PRICE
Recombinant proteins

Dengue Envelope-1 32kDa den-014 100 µg 150

Recombinant Dengue Virus Subtype 1 Envelope 32kDa 0.5 mg 600
1 mg 1,200

Dengue Envelope-2 32kDa den-018 100 µg 150

Recombinant Dengue Virus Subtype 2 Envelope 32kDa 0.5 mg 600
1 mg 1,200

Dengue Envelope-3 32kDa den-019 100 µg 150

Recombinant Dengue Virus Subtype 3 Envelope 32kDa 0.5 mg 600
1 mg 1,200

Dengue Envelope-4 32kDa den-020 100 µg 150

Recombinant Dengue Virus Subtype 4 Envelope 32kDa 0.5 mg 600
1 mg 1,200

Dengue Envelope-1 45kDa den-021 100 µg 150

Recombinant Dengue Virus Subtype 1 Envelope 45kDa 0.5 mg 600
1 mg 1,200

Dengue Envelope-2 45kDa den-022 100 µg 150

Recombinant Dengue Virus Subtype 2 Envelope 45kDa 0.5 mg 600
1 mg 1,200

Dengue Envelope-3 45kDa den-023 100 µg 150

Recombinant Dengue Virus Subtype 3 Envelope 45kDa 0.5 mg 600
1 mg 1,200

Dengue Envelope-4 45kDa den-024 100 µg 150

PEPTIDES INTERNATIONAL

Recombinant Dengue Virus Subtype 4 Envelope 45kDa 0.5 mg 600

1 mg 1,200

Dengue Envelope-1 and 3 den-001 100 µg 150

Recombinant Dengue Virus Subtype 1 and 3 fused Envelope 0.5 mg 600
58kDa 1 mg 1,200

Dengue Envelope-1 and 4 den-025 100 µg 150

Recombinant Dengue Virus Subtype 1 and 4 fused Envelope 0.5 mg 600
55kDa 1 mg 1,200

Dengue Envelope-2 and 4 den-026 100 µg 150

Recombinant Dengue Virus Subtype 2 and 4 fused Envelope 0.5 mg 600
52kDa 1 mg 1,200

Dengue Envelope-1 15kDa den-011 100 µg 150

Recombinant Dengue Virus Subtype 1 Envelope 15kDa, 0.5 mg 600
C-Terminal (Domain III) 1 mg 1,200

Dengue Envelope-2 15kDa den-006 100 µg 150

Recombinant Dengue Virus Subtype 2 Envelope 15 kDa, 0.5 mg 600
C-Terminal (Domain III) 1 mg 1,200

Dengue Envelope-3 15kDa den-013 100 µg 150

Recombinant Dengue Virus Subtype 3 Envelope 15kDa, 0.5 mg 600
C-Terminal (Domain III) 1 mg 1,200

746 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
Dengue Envelope-4 15kDa den-012 100 µg 150
Recombinant Dengue Virus Subtype 4 Envelope 15kDa, 0.5 mg 600
C-Terminal (Domain III) 1 mg 1,200

Dengue Envelope-1 Insect den-033 2 µg 50

Recombinant Dengue Virus Subtype 1, Insect Cells 10 µg 130
1 mg 4,800

Dengue Envelope-2 Insect den-034 2 µg 50

Recombinant Dengue Virus Subtype 2, Insect Cells 10 µg 130
1 mg 4,800

Dengue Envelope-3 Insect den-035 2 µg 50

Recombinant Dengue Virus Subtype 3, Insect Cells 10 µg 130
1 mg 4,800

Dengue Envelope-4 Insect den-036 2 µg 50

Recombinant Dengue Virus Subtype 4, Insect Cells 10 µg 130
1 mg 4,800

Dengue Premembrane den-028 100 µg 150

Recombinant Dengue Virus Subtype 2, Premembrane 0.5 mg 600
1 mg 1,200

Dengue NS1 den-004 100 µg 150

Recombinant Dengue Virus NS1 Type 2 0.5 mg 600
1 mg 1,200

Dengue NS1c den-002 100 µg 150

PEPTIDES INTERNATIONAL
Recombinant Dengue Virus NS1 C-end Type 2 0.5 mg 600
1 mg 1,000

Dengue NS1n den-003 100 µg 150

Recombinant Dengue Virus NS1 N-end Type 2 0.5 mg 600
1 mg 1,000

Dengue NS1 ST1 den-015 100 µg 150

Recombinant Dengue Virus NS1 Subtype 1 0.5 mg 600
1 mg 1,200

Dengue Epitopes 10 den-037 100 µg 150

Recombinant Dengue Mutiple Epitopes 10 0.5 mg 600
1 mg 1,200

Dengue Epitopes 13 den-038 100 µg 150

Recombinant Dengue Mutiple Epitopes 13 0.5 mg 600
1 mg 1,200

Dengue NS1 ST1, Insect den-029 2 µg 50

Recombinant Dengue Virus NS1 Subtype 1, Insect Cells 10 µg 130
1 mg 4,800

Dengue NS1 ST2 den-030 2 µg 50

Recombinant Dengue Virus NS1 Subtype 2 10 µg 130
1 mg 4,800

Order Hotline 1-800-777-4779 502-266-8787 747

 PRODUCT Code Qty PRICE
Recombinant proteins

Dengue NS1 ST3 den-016 100 µg 150

Recombinant Dengue Virus NS1 Subtype 3 0.5 mg 600
1 mg 1,200

Dengue NS1 ST3, Insect den-031 2 µg 50

Recombinant Dengue Virus NS1 Subtype 3, Insect Cells 10 µg 130
1 mg 4,800

Dengue NS1 ST4 den-017 100 µg 150

Recombinant Dengue Virus NS1 Subtype 4 0.5 mg 600
1 mg 1,200

Dengue NS1 ST4, Insect den-032 2 µg 50

Recombinant Dengue Virus NS1 Subtype 4, Insect Cells 10 µg 130
1 mg 4,800

Anti - Human Cytokines

Acrp30 ant-232 5 µg 50
Mouse Anti Human Adiponectin 20 µg 130
100 µg 450

Activin-A ant-029 5 µg 50
Polyclonal Rabbit Anti Human Activin-A 20 µg 130
100 µg 450

ANGPTL3 ant-310 5 µg 50
Mouse Anti Human Angiopoietin Like Protein 3 20 µg 130
100 µg 450
PEPTIDES INTERNATIONAL

APOA1 ant-065 5 µg 50
Mouse Anti Human ApolipoProtein A-I 20 µg 130
100 µg 450

BAFF ant-367 5 µg 50
Mouse Anti Human B-cell Activating Factor 20 µg 130
100 µg 450

BD 3 ant-050 0.5 mg 155

Mouse Anti Human Β Defensin -3 1 mg 290

BDNF ant-128 0.5 mg 155

Mouse Anti Human Brain-Derived Neurotrophic Factor 1 mg 290

BmP-2 ant-183 100 µg 155

Mouse Anti Human Bone Morphogenetic Protein-2 250 µg 290

BmP-7 ant-312 5 µg 50
Mouse Anti Human Bone Morphogenetic Protein-7 20 µg 130
100 µg 450

BmP-7 ant-037 5 µg 50
Polyclonal Rabbit Anti Human Bone Morphogenetic Protein-7 20 µg 130
100 µg 450

748 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
Clusterin ant-314 5 µg 50
Mouse Anti Human Clusterin 20 µg 130
100 µg 450

CYR61 ant-423 5 µg 50
Mouse Anti Human Cysteine-Rich Angiogenic Inducer 61 20 µg 130
100 µg 450

EGF ant-169 0.5 mg 155

Mouse Anti Human Epidermal Growth Factor 1 mg 290

EPO ant-187 50 µg 50
Mouse Anti Human Erythropoietin 150 µg 130
0.5 mg 400

EPO ant-196 0.5 mg 155

Mouse Anti Human Erythropoietin clone NYRhEPO 1 mg 290

FAS ant-204 0.5 mg 155

Mouse Anti Human FAS (CD95) Blocking/Activating 1 mg 290

FAS ant-205 0.5 mg 155

Mouse Anti Human FAS (CD95) Blocking 1 mg 290

FGF 2 ant-239 0.5 mg 155

PEPTIDES INTERNATIONAL
Mouse Anti Human Fibroblast Growth Factor Basic 1 mg 290

GH ant-197 0.5 mg 155

Mouse Anti Human Growth Hormone 1 mg 290

GH ant-230 5 µg 50
Mouse Anti Human Growth Hormone IgG2b 20 µg 130
100 µg 450

HGH ant-036 5 µg 50
Polyclonal Rabbit Anti Human Growth Hormone 20 µg 130
100 µg 450

GmCSF ant-129 0.5 mg 155

Mouse Anti Human Granulocyte Macrophage-Colony 1 mg 290
Stimulating Factor

GCSF ant-184 0.5 mg 155

Mouse Anti Human Granulocyte Colony Stimulating Factor 1 mg 290

GCSF Biotin ant-240 0.5 mg 250

Mouse Anti Human Granulocyte Colony Stimulating Factor 1 mg 400
Biotinylated

Order Hotline 1-800-777-4779 502-266-8787 749

 PRODUCT Code Qty PRICE
Recombinant proteins

GCSF FITC ant-241 0.5 mg 250

Mouse Anti Human Granulocyte Colony Stimulating Factor 1 mg 400
FITC

IFN-a Neut ant-122 0.5 mg 155

Mouse Anti Human Interferon-α Neutralizing 1 mg 290

IFN-a WB ant-208 0.5 mg 155

Mouse Anti Human Interferon-α Western Blot 1 mg 290

IFNA2A ant-034 5 µg 50
Polyclonal Rabbit Anti Human Interferon-Α 2a 20 µg 130
100 µg 450

IFN-b ant-185 0.5 mg 155

Mouse Anti Human Interferon-β 1 mg 290

IFN-g ant-123 0.5 mg 155

Mouse Anti Human Interferon-gamma 1 mg 290

IGF1 ant-062 0.5 mg 155

Mouse Anti Human Insulin-Like Growth Factor-1 1 mg 290
PEPTIDES INTERNATIONAL

IL-1RA ant-238 0.5 mg 155

Mouse Anti Human Interleukin-1 Receptor Anatagonsit 1 mg 290

IL-1b ant-248 0.5 mg 155

Mouse Anti Human IL-1 β 1 mg 290

IL-1b Biotin ant-249 0.5 mg 250

Mouse Anti Human IL-1 β Biotinylated 1 mg 400

IL-1b FITC ant-250 0.5 mg 250

Mouse Anti Human IL-1 β FITC 1 mg 400

IL-2 ant-102 0.5 mg 155

Mouse Anti Human Interleukin-2 1 mg 290

IL-2r ant-104 0.5 mg 155

Mouse Anti Human Interleukin-2 receptor 1 mg 290

IL-2r Biotin ant-071 0.5 mg 250

Mouse Anti Human Interleukin-2 receptor Biotinylated 1 mg 400

750 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
IL-2r FITC ant-072 0.5 mg 250
Mouse Anti Human Interleukin-2 receptor FITC 1 mg 400

IL-3 ant-106 0.5 mg 155

Mouse Anti Human Interleukin-3 1 mg 290

IL-4 ant-107 0.5 mg 155

Mouse Anti Human Interleukin-4 1 mg 290

IL-6 ant-109 0.5 mg 155

Mouse Anti Human Interleukin-6 1 mg 290

IL-7 ant-110 0.5 mg 155

Mouse Anti Human Interleukin-7 1 mg 290

IL-8 ant-111 0.5 mg 155

Mouse Anti Human Interleukin-8 1 mg 290

IL-10 ant-112 0.5 mg 155

Mouse Anti Human Interleukin-10 1 mg 290

IL12B ant-435 5 µg 50

PEPTIDES INTERNATIONAL
Mouse Anti Human Interleukin-12 subunit β 20 µg 130
100 µg 450

IL-15 ant-115 0.5 mg 155

Mouse Anti Human Interleukin-15 1 mg 290

IL16 ant-370 5 µg 50
Mouse Anti Human Interleukin-16 20 µg 130
100 µg 450

IL17E ant-048 0.5 mg 155

Mouse Anti Human IL17E 1 mg 290

IL-18 ant-212 0.5 mg 155

Mouse Anti Human Interleukin-18 1 mg 290

IL32 ant-007 5 µg 50
Mouse Anti Human Interleukin-32 20 µg 130
100 µg 450

IL33 ant-369 5 µg 50
Mouse Anti Human Interleukin-33 20 µg 130
100 µg 450

Order Hotline 1-800-777-4779 502-266-8787 751

 PRODUCT Code Qty PRICE
Recombinant proteins

IRF3 ant-365 5 µg 50
Mouse Anti Human Interferon Regulatory Factor-3 20 µg 130
100 µg 450

IRF5 ant-407 5 µg 50
Mouse Anti Human Interferon Regulatory Factor-5 20 µg 130
100 µg 450

IRF7 ant-418 5 µg 50
Mouse Anti Human Interferon Regulatory Factor-7 20 µg 130
100 µg 450

Leptin ant-172 0.5 mg 155

Mouse Anti Human Leptin 1 mg 290

LITAF ant-443 5 µg 50
Mouse Anti Human Lipopolysaccharide-induced TNF factor 20 µg 130
100 µg 450

LTA ant-014 5 µg 50
Mouse Anti Human Lymphotoxin-α 20 µg 130
100 µg 450

mIF ant-311 5 µg 50
Mouse Anti Human Macrophage Migration Inhibitory Factor 20 µg 130
100 µg 450

myostatin ant-041 5 µg 50
PEPTIDES INTERNATIONAL

Polyclonal Rabbit Anti Human Myostatin 20 µg 130

100 µg 450

NRG1 (HRG-β3) ant-458 5 µg 50

Mouse Anti Human Neuregulin1 isoform HRG-β3 20 µg 130
100 µg 450

NT-4 ant-117 0.5 mg 155

Mouse Anti Human Neurotrophin-4 1 mg 290

OSTF1 ant-056 5 µg 50
Mouse Anti Human Osteoclast Stimulating Factor-1 20 µg 130
100 µg 450

PEDF ant-313 5 µg 50
Mouse Anti Human Pigment Epithelium-Derived Factor 20 µg 130
100 µg 450

RBP4 ant-371 5 µg 50
Mouse Anti Human Retinol Binding Protein-4 20 µg 130
100 µg 450

TNF-a ant-124 0.5 mg 155

Mouse Anti Human Tumor Necrosis Factor-α 1 mg 290

752 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
TGFB ant-168 0.5 mg 155
Mouse Anti Human Transforming Growth Factor-β 1 mg 290

TGFB2 ant-035 5 µg 50
Polyclonal Rabbit Anti Human Transforming Growth Factor-β 2 20 µg 130
100 µg 450

TGFB3 ant-040 5 µg 50
Polyclonal Rabbit Anti Human Transforming Growth Factor-β 3 20 µg 130
100 µg 450

Vaspin ant-366 5 µg 50
Mouse Anti Human Vaspin 20 µg 130
100 µg 450

VEGF ant-125 0.5 mg 155

Mouse Anti Human Vascular Endothelial Growth Factor 1 mg 290

Visfatin ant-368 5 µg 50
Mouse Anti Human Visfatin 20 µg 130
100 µg 450

Monoclonal Antibodies, Anti-Human Chemokines

CCR6 ant-416 5 µg 50
Mouse Anti Human C-C chemokine receptor type 6 20 µg 130
100 µg 450

PEPTIDES INTERNATIONAL
Eotaxin-1 ant-126 0.5 mg 155
Mouse Anti Human Eotaxin-1 (CCL11) 1 mg 290

Eotaxin-2 ant-127 0.5 mg 155

Mouse Anti Human Eotaxin-2 1 mg 290

mCP-1 ant-119 0.5 mg 155

Mouse Anti Human Macrophage/monocyte Chemotactic and 1 mg 290
Activating Factor

mCP-3 ant-120 0.5 mg 155

Mouse Anti Human Macrophage/monocyte Chemotactic 1 mg 290
Protein-3/mARC

mIP-1 a ant-118 0.5 mg 155

Mouse Anti-Human Macrophage Inflammatory Protein-1a 1 mg 290
(CCL3)

mIP-3 ant-121 0.5 mg 155

Mouse Anti-Human Macrophage Inflammatory Protein-3 1 mg 290

mIP-3b ant-213 0.5 mg 155

Mouse Anti-Human Macrophage Inflammatory Protein-3 β 1 mg 290
(CCL19)

NAP-2 ant-170 0.5 mg 155

Mouse Anti Human Neutrophil Activating Protein-2 (CXCL7) 1 mg 290

Order Hotline 1-800-777-4779 502-266-8787 753

 PRODUCT Code Qty PRICE
Recombinant proteins

Monoclonal Antibodies, Anti-Human Lymphocytes

CD1A ant-206 0.5 mg 155
Mouse Anti Human CD1A (T6, LEU6) 1 mg 290

CD2 ant-207 0.5 mg 155

Mouse Anti Human CD2 (T11, LFA-2) 1 mg 290

CD2 FITC ant-188 0.5 mg 250

Mouse Anti Human CD2 (T11, LFA-2) FITC 1 mg 400

CD3 ant-144 0.5 mg 155

Mouse Anti Human CD3 1 mg 290

CD3 FITC ant-137 0.5 mg 250

Mouse Anti Human CD3-FITC 1 mg 400

CD3 Biotin ant-138 0.5 mg 250

Mouse Anti Human CD3-Biotinylated 1 mg 400

CD4 ant-145 0.5 mg 155

Mouse Anti Human CD4 1 mg 290

CD4 FITC ant-132 0.5 mg 250

Mouse Anti Human CD4-FITC 1 mg 400
PEPTIDES INTERNATIONAL

CD4 Biotin ant-167 0.5 mg 250

Mouse Anti Human CD4-Biotinylated 1 mg 400

CD5 ant-171 0.5 mg 155

Mouse Anti Human CD5 1 mg 290

CD8 ant-148 0.5 mg 155

Mouse Anti Human CD8 1 mg 290

CD8 FITC ant-131 0.5 mg 250

Mouse Anti Human CD8-FITC 1 mg 400

CD8 Biotin ant-134 0.5 mg 250

Mouse Anti Human CD8-Biotinylated 1 mg 400

CD11b ant-274 0.5 mg 155

Mouse Anti Human CD11b 1 mg 290

CD11b Biotin ant-275 0.5 mg 250

Mouse Anti Human CD11b Biotinylated 1 mg 400

CD11b FITC ant-276 0.5 mg 250

Mouse Anti Human CD11b FITC 1 mg 400

CD14 ant-251 0.5 mg 155

Mouse Anti Human CD14 1 mg 290

754 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
CD14 Biotin ant-252 0.5 mg 250
Mouse Anti Human CD14 Biotinylated 1 mg 400

CD14 FITC ant-253 0.5 mg 250

Mouse Anti Human CD14 FITC 1 mg 400

CD21 ant-257 0.5 mg 155

Mouse Anti Human CD21 1 mg 290

CD21 Biotin ant-258 0.5 mg 250

Mouse Anti Human CD21 Biotinylated 1 mg 400

CD21 FITC ant-259 0.5 mg 250

Mouse Anti Human CD21 FITC 1 mg 400

CD29 ant-340 5 µg 50
Mouse Anti Human CD29 20 µg 130
100 µg 450

CD31 ant-051 0.5 mg 155

Mouse Anti Human CD31 1 mg 290

CD31 FITC ant-052 0.5 mg 250

Mouse Anti Human CD31-FITC 1 mg 400

PEPTIDES INTERNATIONAL
CD31 Biotin ant-053 0.5 mg 250
Mouse Anti Human CD31-Biotinylated 1 mg 400

CD34 ant-360 5 µg 50
Mouse Anti Human CD34 20 µg 130
100 µg 450

CD40 ant-263 0.5 mg 155

Mouse Anti Human CD40 1 mg 290

CD40 Biotin ant-264 0.5 mg 250

Mouse Anti Human CD40 Biotinylated 1 mg 400

CD40 FITC ant-265 0.5 mg 250

Mouse Anti Human CD40 FITC 1 mg 400

CD44 ant-242 0.5 mg 155

Mouse Anti Human CD44 1 mg 290

CD44 Biotin ant-243 0.5 mg 250

Mouse Anti Human CD44 Biotinylated 1 mg 400

CD44 FITC ant-244 0.5 mg 250

Mouse Anti Human CD44 FITC 1 mg 400

CD44 ant-453 5 µg 50
Mouse Anti Human CD44 20 µg 130
100 µg 450

Order Hotline 1-800-777-4779 502-266-8787 755

 PRODUCT Code Qty PRICE
Recombinant proteins

CD45 ant-260 0.5 mg 155

Mouse Anti Human CD45 1 mg 290

CD45 Biotin ant-261 0.5 mg 250

Mouse Anti Human CD45 Biotinylated 1 mg 400

CD45 FITC ant-262 0.5 mg 250

Mouse Anti Human CD45 FITC 1 mg 400

CD45 ant-452 5 µg 50
Mouse Anti Human CD45 20 µg 130
100 µg 450

CD57 ant-287 0.5 mg 155

Mouse Anti Human CD57 1 mg 290

CD57 Biotin ant-288 0.5 mg 250

Mouse Anti Human CD57 Biotin 1 mg 400

CD57 FITC ant-289 0.5 mg 250

Mouse Anti Human CD57 FITC 1 mg 400

CD58 ant-277 0.5 mg 155

Mouse Anti Human CD58 1 mg 290

CD58 Biotin ant-278 0.5 mg 250

Mouse Anti Human CD58 Biotin 1 mg 400
PEPTIDES INTERNATIONAL

CD58 FITC ant-279 0.5 mg 250

Mouse Anti Human CD58 FITC 1 mg 400

CD62E ant-237 0.5 mg 155

Mouse Anti Human E-Selectin 1 mg 290

CD73 ant-414 5 µg 50
Mouse Anti Human CD73 20 µg 130
100 µg 450

Monoclonal Antibodies, Anti-Mouse Cytokine

CTLA-4 ant-116 0.5 mg 250
Hamster Anti Mouse CTLA-4 (CD152) 1 mg 400

IL-2 ant-105 0.5 mg 155

Rat Anti Mouse Interleukin-2 1 mg 290

IL-2r ant-103 0.5 mg 155

Rat Anti Mouse Interleukin-2 receptor 1 mg 290

IL-4 ant-108 0.5 mg 155

Rat Anti Mouse Interleukin-4 1 mg 290

IL-10 ant-113 0.5 mg 155

Rat Anti Mouse Interleukin-10 1 mg 290

756 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
IL-12p40 ant-114 0.5 mg 155
Rat Anti Mouse Interleukin-12p40 1 mg 290

IL-12p75 ant-209 0.5 mg 155

Rat Anti Mouse Interleukin-12p75 1 mg 290

IFN-g ant-166 0.5 mg 155

Rat Anti Mouse IFN-gamma 1 mg 290

Monoclonal Antibodies, Anti-Mouse Lymphocytes

CD3 ant-175 0.5 mg 155
Rat Anti Mouse CD3 1 mg 290

CD4 ant-165 0.5 mg 155

Rat Anti Mouse CD4 1 mg 290

CD4 Biotin ant-291 0.5 mg 250

Rat Anti Mouse CD4 Biotinylated 1 mg 400

CD4 FITC ant-292 0.5 mg 250

Rat Anti Mouse CD4 FITC 1 mg 400

CD11b FITC ant-136 0.5 mg 250

Rat Anti Mouse CD11b FITC 1 mg 400

CD11a ant-135 0.5 mg 155

PEPTIDES INTERNATIONAL
Rat Anti Mouse CD11a 1 mg 290

CD8 ant-280 0.5 mg 155

Rat Anti Mouse CD8 1 mg 290

CD8 Biotin ant-281 0.5 mg 250

Rat Anti Mouse CD8 Biotinylated 1 mg 400

CD8 FITC ant-282 0.5 mg 250

Rat Anti Mouse CD8 FITC 1 mg 400

CD28 ant-271 0.5 mg 155

Hamster Anti Mouse CD28 1 mg 290

CD28 Biotin ant-272 0.5 mg 250

Hamster Anti Mouse CD28 Biotinylated 1 mg 400

CD28 FITC ant-273 0.5 mg 250

Hamster Anti Mouse CD28 FITC 1 mg 400

CD44 ant-293 0.5 mg 155

Rat Anti Mouse CD44 1 mg 290

CD44 Biotin ant-294 0.5 mg 250

Rat Anti Mouse CD44 Biotinylated 1 mg 400

CD44 FITC ant-295 0.5 mg 250

Rat Anti Mouse CD44 FITC 1 mg 400

Order Hotline 1-800-777-4779 502-266-8787 757

 PRODUCT Code Qty PRICE
Recombinant proteins

CD86 ant-283 0.5 mg 155

Rat Anti Mouse CD86 1 mg 290

CD86 Biotin ant-284 0.5 mg 250

Rat Anti Mouse CD86 Biotinylated 1 mg 400

CD86 FITC ant-285 0.5 mg 250

Rat Anti Mouse CD86 FITC 1 mg 400

CD80 ant-133 0.5 mg 155

Rat Anti Mouse CD80 1 mg 290

CD90Thy-1 ant-142 0.5 mg 155

Rat Anti Mouse CD90 Thy-1 1 mg 290

CD90Thy-1.1 ant-140 0.5 mg 155

Rat Anti Mouse CD90 Thy-1.1 1 mg 290

CD90Thy-1.2 ant-141 0.5 mg 155

Rat Anti Mouse CD90 Thy-1.2 1 mg 290

B220 ant-139 0.5 mg 155

Rat Anti Mouse B220 (CD45R) 1 mg 290

Monoclonal Antibodies, Anti-Viral

Dengue type 2 ant-143 0.5 mg 155
PEPTIDES INTERNATIONAL

Mouse Anti Dengue Type 2 (envelop) 1 mg 290

HBV ant-150 0.5 mg 155

Mouse Anti Hepatitis B Virus (AD and AY Antigens) 1 mg 290

HBV AG-1 ant-038 0.5 mg 155

Mouse Anti Hepatitis B Virus (AD and AY Antigens) AG-1 for 1 mg 290
Capture ELISA

HBV AG-2 ant-039 0.5 mg 155

Mouse Anti Hepatitis B Virus (AD and AY Antigens) AG-2 for 1 mg 290
Capture ELISA

HBV Core ant-097 100 µg 150

Mouse Anti Hepatitis B Virus Core 0.5 mg 600
1 mg 1,200

HCV Core ant-286 0.5 mg 155

Mouse Anti Hepatitis C Virus Core 1 mg 290

HCV NS3 ant-156 100 µg 130

Mouse Anti Hepatitis C Virus NS3 200 µg 200
500 µg 350

HIV-1 p24 ant-152 0.5 mg 155

Mouse Anti HIV-1 p24 1 mg 290

HIV-1 gp41 ant-159 0.5 mg 155

Mouse Anti HIV-1 gp41 1 mg 290

758 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
HIV-1 gp120 ant-151 0.5 mg 155
Mouse Anti HIV-1 gp120 (PND) 1 mg 290

HIV-2 gp39 ant-153 0.5 mg 155

Mouse Anti HIV-2 gp39 1 mg 290

HTLV-1 TAX ant-290 0.5 mg 155

Mouse Anti HTLV-1 TAX 1 mg 290

Influenza-A H5N1 ant-073 5 µg 50

Mouse Anti-Human H5N1/HA1 20 µg 130
100 µg 450

Influenza-A H3N2 ant-080 5 µg 50

Mouse Anti-Human H3N2/HA1 20 µg 130
100 µg 450

Influenza-A H1N1 ant-214 10 µg 50

Mouse Anti Influenza-A Hemagglutinin H1N1 50 µg 130
1 mg 1,350

Influenza-A H3N2 ant-215 10 µg 50

Mouse Anti Influenza-A Hemagglutinin H3N2 50 µg 130
1 mg 1,350

Influenza-A H5N1 ant-216 10 µg 50

Mouse Anti Influenza-A Hemagglutinin H5N1 50 µg 130
1 mg 1,350

PEPTIDES INTERNATIONAL
Influenza-B ant-217 10 µg 50
Mouse Anti Influenza-B 50 µg 130
1 mg 1,350

Reovirus ant-348 0.5 mg 155

Mouse Anti Respiratory Enteric Orphan Virus 1 mg 290

ORF73 ant-459 5 µg 50
Mouse Anti Human Herpesvirus 8 20 µg 130
100 µg 450

SARS Nucleocapsid ant-178 100 µg 690

Mouse Anti SARS Nucleocapsid Protein 200 µg 1,100
300 µg 1,500

SARS Spike ant-179 100 µg 690

Mouse Anti SARS Spike 200 µg 1,100
300 µg 1,300

Polyclonal Antibodies, Anti-Human

AnthraxPA ant-182 200 µl 590
Polyclonal Anti Anthrax PA 400 µl 1,000
600 µl 1,200

AnthraxLF ant-181 200 µl 590

Polyclonal Anti Anthrax LF 400 µl 1,000
600 µl 1,200

Order Hotline 1-800-777-4779 502-266-8787 759

 PRODUCT Code Qty PRICE
Recombinant proteins

HBsAgA ant-163 ml 140

Polyclonal Goat Anti Hepatitis B Surface Antigen A 5 ml 700
10 ml 1,200

HIV-1 gp41 ant-160 ml 140

Polyclonal Rabbit Anti HIV-1 gp41 5 ml 700
10 ml 1,200

HIV-1 gp120 ant-210 0.1 ml 300

Polyclonal Rabbit Anti HIV-1 gp120 0.25 ml 600
0.5 ml 990

HIV-1 gp120 ant-236 2 µg 50

Polyclonal Rabbit Anti HIV-1 gp120, Purified 10 µg 130
100 µg 780

HIV-2 gp39 ant-161 ml 140

Polyclonal Rabbit Anti HIV-1 gp39 5 ml 700
10 ml 1,200

Influenza-A H1N1 ant-254 5 µg 50

Polyclonal Rabbit Anti Influenza-A Hemagglutinin H1N1 15 µg 130
100 µg 640

Influenza-A H3N2 ant-255 5 µg 50

Polyclonal Rabbit Anti Influenza-A Hemagglutinin H3N2 15 µg 130
100 µg 640

Influenza-B Jiangsu ant-256 5 µg 50

PEPTIDES INTERNATIONAL

Polyclonal Rabbit Anti Influenza B Jiangsu/10/2003 15 µg 130

100 µg 640

SARS Nucleocapsid ant-180 100 µg 590

Polyclonal Rabbit Anti SARS Nucleocapsid Protein 200 µg 1,000
300 µg 1,200

SARS Spike ant-157 100 µg 590

Polyclonal Rabbit Anti SARS Spike Protein 200 µg 1,000
300 µg 1,200

Dengue 1 NS1 ant-083 100 µg 150

Polyclonal Rabbit Anti Dengue 1 NS1 0.5 mg 600
1 mg 1,200

Dengue 2 NS1 ant-084 100 µg 150

Polyclonal Rabbit Anti Dengue 2 NS1 0.5 mg 600
1 mg 1,200

Dengue 3 NS1 ant-085 100 µg 150

Polyclonal Rabbit Anti Dengue 3 NS1 0.5 mg 600
1 mg 1,200

Dengue 4 NS1 ant-086 100 µg 150

Polyclonal Rabbit Anti Dengue 4 NS1 0.5 mg 600
1 mg 1,200

760 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
Monoclonal Antibodies, Anti-Human Heat Shock Proteins
CRYAA ant-305 5 µg 50
Mouse Anti Human Crystallin Α A 20 µg 130
100 µg 450

CRYAB ant-306 5 µg 50
Mouse Anti Human Crystallin Α B 20 µg 130
100 µg 450

DnaJ ant-326 5 µg 50
Mouse Anti Human DnaJ (HSP40) 20 µg 130
100 µg 450

GroEL ant-327 5 µg 50
Mouse Anti Human GroEL (HSP60) 20 µg 130
100 µg 450

HSF1 ant-328 5 µg 50
Mouse Anti Human Heat Shock Transcription Factor-1 20 µg 130
100 µg 450

HSP27 ant-307 5 µg 50
Mouse Anti Human Heat Shock Protein 27 20 µg 130
100 µg 450

HSP70 ant-397 5 µg 50
Mouse Anti Human Heat shock 70 kDa Protein 20 µg 130
100 µg 450

PEPTIDES INTERNATIONAL
HSP90 Alpaha ant-398 5 µg 50
Mouse Anti Human Heat shock Protein HSP 90-α 20 µg 130
100 µg 450

HSP90B1 ant-325 5 µg 50
Mouse Anti Human Heat Shock Protein 90kDa Β (GRP94) 20 µg 130
Member 1 100 µg 450

HSPH1 ant-329 5 µg 50
Mouse Anti Human Heat Shock Protein 105 20 µg 130
100 µg 450

ST13 ant-330 5 µg 50
Mouse Anti Human HSP70 Interacting Protein 20 µg 130
100 µg 450

Monoclonal Antibodies, Anti-Human Enzymes

ACAT1 ant-101 5 µg 50
Mouse Anti Human Acetyl-Coenzyme A acetyltransferase 1 20 µg 130
100 µg 450

ACOT7 ant-462 5 µg 50
Mouse Anti Human Acyl-Coenzyme A Thioesterase 7 20 µg 130
100 µg 450

Order Hotline 1-800-777-4779 502-266-8787 761

 PRODUCT Code Qty PRICE
Recombinant proteins

ACOT11 ant-424 5 µg 50
Mouse Anti Human Acyl-Coenzyme A Thioesterase 11 20 µg 130
100 µg 450

ADK ant-057 5 µg 50
Mouse Anti Human Adenosine Kinase 20 µg 130
100 µg 450

AGXT ant-449 5 µg 50
Mouse Anti Human Serine-Pyruvate Aminotransferase 20 µg 130
100 µg 450

AICDA ant-411 5 µg 50
Mouse Anti Human Activation-induced cytidine deaminase 20 µg 130
100 µg 450

AK3L1 ant-320 5 µg 50
Mouse Anti Human Adenylate Kinase-3 Like 1 20 µg 130
100 µg 450

AKR7A3 ant-066 5 µg 50
Mouse Anti Human Aldo-Keto Reductase Family 7 Member A3 20 µg 130
100 µg 450

AURKB ant-017 5 µg 50
Mouse Anti Human Aurora Kinase B 20 µg 130
100 µg 450

BHmT ant-373 5 µg 50
PEPTIDES INTERNATIONAL

Mouse Anti Human Βine Homocysteine S-methyltransferase 20 µg 130

100 µg 450

BRCC3 ant-448 5 µg 50
Mouse Anti Human Lys-63-specific deubiquitinase BRCC36 20 µg 130
100 µg 450

CASP2 ant-409 5 µg 50
Mouse Anti Human Caspase-2 20 µg 130
100 µg 450

Cathepsin H ant-405 5 µg 50
Mouse Anti Human Cathepsin H 20 µg 130
100 µg 450

CBR3 ant-393 5 µg 50
Mouse Anti Human Carbonyl Reductase-3 20 µg 130
100 µg 450

CDK4 ant-465 5 µg 50
Mouse Anti Human Cyclin-Dependent Kinase 4 20 µg 130
100 µg 450

CHI3L1 ant-439 5 µg 50
Mouse Anti Human Chitinase-3-like Protein 1 20 µg 130
100 µg 450

762 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
CIB1 ant-377 5 µg 50
Mouse Anti Human Calcium and Integrin Binding 1 20 µg 130
100 µg 450

CmBL ant-093 5 µg 50
Mouse Anti Human Carboxymethylenebutenolidase  20 µg 130
100 µg 450

CNDP2 ant-096 5 µg 50
Mouse Anti Human CNDP Dipeptidase 2 20 µg 130
100 µg 450

CSNK1A1 ant-442 5 µg 50
Mouse Anti Human Casein kinase I isoform α 20 µg 130
100 µg 450

CSNK2A1 ant-372 5 µg 50
Mouse Anti Human Casein Kinase 2 α 20 µg 130
100 µg 450

CTSD ant-324 5 µg 50
Mouse Anti Human Cathepsin D 20 µg 130
100 µg 450

CTSL1 ant-384 5 µg 50
Mouse Anti Human Cathepsin L 20 µg 130
100 µg 450

Cyclophilin-B ant-380 5 µg 50

PEPTIDES INTERNATIONAL
Mouse Anti Human Cyclophilin-B 20 µg 130
100 µg 450

EGFR ant-042 5 µg 50
Mouse Anti Human Epidermal Growth Factor Receptor 20 µg 130
100 µg 450

EPHX1 ant-440 5 µg 50
Mouse Anti Human Epoxide hydrolase 1 20 µg 130
100 µg 450

ERBB2 ant-033 5 µg 50
Mouse Anti Human Herstatin 15 µg 130
100 µg 600

ERBB2 ant-043 2 µg 50
Polyclonal Rabbit Anti Human Herstatin 10 µg 130
50 µg 600

FBP2 ant-095 5 µg 50
Mouse Anti Human Fructose-1,6-Bisphosphatase 2 20 µg 130
100 µg 450

FKBP4 ant-390 5 µg 50
Mouse Anti Human FK506 Binding Protein 4 20 µg 130
100 µg 450

Order Hotline 1-800-777-4779 502-266-8787 763

 PRODUCT Code Qty PRICE
Recombinant proteins

FKBP14 ant-020 5 µg 50
Mouse Anti Human FK506 Binding Protein 14 20 µg 130
100 µg 450

GAPDH ant-005 5 µg 50
Mouse Anti Human Glyceraldehyde-3-Phosphate 20 µg 130
Dehydrogenase 100 µg 450

GCLm ant-089 5 µg 50
Mouse Anti Human Glutamate-Cysteine Ligase, Modifier 20 µg 130
Subunit 100 µg 450

G6PD ant-391 5 µg 50
Mouse Anti Human Glucose-6-Phosphate Dehydrogenase 20 µg 130
100 µg 450

GSK3B ant-404 5 µg 50
Mouse Anti Human Glycogen synthase kinase-3 β 20 µg 130
100 µg 450

HK1 ant-375 5 µg 50
Mouse Anti Human Hexokinase-1 20 µg 130
100 µg 450

HK2 ant-378 5 µg 50
Mouse Anti Human Hexokinase-2 20 µg 130
100 µg 450

HK3 ant-376 5 µg 50
PEPTIDES INTERNATIONAL

Mouse Anti Human Hexokinase-3 20 µg 130

100 µg 450

HTRA2 ant-321 5 µg 50
Mouse Anti Human HTRA2 20 µg 130
100 µg 450

HPRT ant-046 5 µg 50
Mouse Anti Human Hypoxanthine-Guanine 20 µg 130
Phosphoribosyltransferase 100 µg 450

KAT2A ant-011 5 µg 50
Mouse Anti Human Histone acetyltransferase KAT2A 20 µg 130
100 µg 450

KLK3 ant-088 5 µg 50
Mouse Anti Human Kallikrein-3 20 µg 130
100 µg 450

LDHA ant-004 5 µg 50
Mouse Anti Human Lactate Dehydrogenase A 20 µg 130
100 µg 450

LSm2 ant-082 5 µg 50
Mouse Anti Human LSm2 Homolog, U6 Small Nuclear RNA 20 µg 130
Associated 100 µg 450

764 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
LYVE1 ant-322 5 µg 50
Mouse Anti Human Lymphatic Vessel Endothelial Hyaluronic 20 µg 130
Acid Receptor 1 100 µg 450

mAPK1 ant-006 5 µg 50
Mouse Anti Human Mitogen-Activated Protein Kinase 1 20 µg 130
100 µg 450

mAPK3 ant-023 5 µg 50
Mouse Anti Human Mitogen-Activated Protein Kinase 3 20 µg 130
100 µg 450

mAT2A ant-388 5 µg 50
Mouse Anti Human Methionine Adenosyltransferase II Α 20 µg 130
100 µg 450

NAGK ant-092 5 µg 50
Mouse Anti Human N-Acetylglucosamine Kinase 20 µg 130
100 µg 450

NANS ant-054 5 µg 50
Mouse Anti Human N-acetylneuraminic acid synthase 20 µg 130
100 µg 450

NAT6 ant-395 5 µg 50
Mouse Anti Human N-Acetyltransferase 6 20 µg 130
100 µg 450

PEPTIDES INTERNATIONAL
NmNAT1 ant-018 5 µg 50
Mouse Anti Human Nicotinamide Nucleotide 20 µg 130
Adenylyltransferase 1 100 µg 450

NQO2 ant-024 5 µg 50
Mouse Anti Human NAD(P)H Dehydrogenase Quinone 2 20 µg 130
100 µg 450

PDK1 ant-392 5 µg 50
Mouse Anti Human Pyruvate Dehydrogenase Kinase Isozyme 1 20 µg 130
100 µg 450

PFKm ant-100 5 µg 50
Mouse Anti Human Phosphofructokinase Muscle 20 µg 130
100 µg 450

PIN1 ant-323 5 µg 50
Mouse Anti Human PIN1 20 µg 130
100 µg 450

PKLR ant-060 5 µg 50
Mouse Anti Human Pyruvate Kinase, Liver and RBC 20 µg 130
100 µg 450

PKm2 ant-009 5 µg 50
Mouse Anti Human Tumor Type M2 Pyruvate Kinase 20 µg 130
100 µg 450

Order Hotline 1-800-777-4779 502-266-8787 765

 PRODUCT Code Qty PRICE
Recombinant proteins

PNmT ant-064 5 µg 50
Mouse Anti Human Phenylethanolamine-N-methyltransferase 20 µg 130
100 µg 450

PNPLA2 ant-437 5 µg 50
Mouse Anti Human Patatin-like phospholipase domain- 20 µg 130
containing Protein 2 100 µg 450

PNPO ant-063 5 µg 50
Mouse Anti Human Pyridoxamine 5'-Phosphate Oxidase 20 µg 130
100 µg 450

PPIC ant-069 5 µg 50
Mouse Anti Human Peptidylprolyl Isomerase C 20 µg 130
100 µg 450

PPIF ant-389 5 µg 50
Mouse Anti Human Cyclophilin-F 20 µg 130
100 µg 450

PPm1A ant-309 5 µg 50
Mouse Anti Human Protein Phosphatase 1A Α Isoform 20 µg 130
100 µg 450

PPm1B ant-419 5 µg 50
Mouse Anti Human Protein phosphatase 1B 20 µg 130
100 µg 450

PPm1G
PEPTIDES INTERNATIONAL

ant-383 5 µg 50
Mouse Anti Human Protein Phosphatase 1G 20 µg 130
100 µg 450

PPP1CA ant-415 5 µg 50
Mouse Anti Human Protein Phosphatase 1 Catalytic Subunit Α 20 µg 130
100 µg 450

PPP1R14A ant-381 5 µg 50
Mouse Anti Human Protein Phosphatase-1 Regulatory Subunit- 20 µg 130
14A 100 µg 450

PRDX1 ant-394 5 µg 50
Mouse Anti Human Peroxiredoxin-1 20 µg 130
100 µg 450

PSmD11 ant-444 5 µg 50
Mouse Anti Human 26S proteasome non-ATPase regulatory 20 µg 130
subunit 11 100 µg 450

PSPH ant-399 5 µg 50
Mouse Anti Human Phosphoserine Phosphatase 20 µg 130
100 µg 450

PTPS ant-026 5 µg 50
Mouse Anti Human 6-Pyruvoyltetrahydropterin Synthase 20 µg 130
100 µg 450

766 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
RNH1 ant-445 5 µg 50
Mouse Anti Human Ribonuclease inhibitor 20 µg 130
100 µg 450

SETD7 ant-308 5 µg 50
Mouse Anti Human Set7/9 Histone Methyltransferase 20 µg 130
100 µg 450

STEAP1 ant-426 5 µg 50
Mouse Anti Human Metalloreductase STEAP1 20 µg 130
100 µg 450

TDP1 ant-447 5 µg 50
Mouse Anti Human Tyrosyl-DNA phosphodiesterase 1 20 µg 130
100 µg 450

TGm4 ant-438 5 µg 50
Mouse Anti Human Transglutaminase-4 20 µg 130
100 µg 450

TP53I3 ant-087 5 µg 50
Mouse Anti Human Tumor Protein p53 Inducible Protein 3 20 µg 130
100 µg 450

TPmT ant-055 5 µg 50
Mouse Anti Human Thiopurine S-methyltransferase 20 µg 130
100 µg 450

TYmS ant-002 5 µg 50

PEPTIDES INTERNATIONAL
Mouse Anti Human Thymidylate Synthetase 20 µg 130
100 µg 450

UBE2L6 ant-386 5 µg 50
Mouse Anti Human Ubiquitin Conjugating Enzyme E2L 6 20 µg 130
100 µg 450

UBE2S ant-396 5 µg 50
Mouse Anti Human Ubiquitin Conjugating Enzyme E2S 20 µg 130
100 µg 450

UNG ant-374 5 µg 50
Mouse Anti Human Uracil DNA Glycosilase 20 µg 130
100 µg 450

WHSC1L1 ant-412 5 µg 50
Mouse Anti Human Histone-lysine N-methyltransferase NSD3 20 µg 130
100 µg 450

YWHAB ant-382 5 µg 50
Mouse Anti Human Tyr-3/trp-5 Monooxygenase Activation 20 µg 130
Protein Β 100 µg 450

YWHAE ant-379 5 µg 50
Mouse Anti Human Tyr-3/trp-5 Monooxygenase Activation 20 µg 130
Protein Epsilon 100 µg 450

Order Hotline 1-800-777-4779 502-266-8787 767

 PRODUCT Code Qty PRICE
Recombinant proteins

YWHAG ant-385 5 µg 50
Mouse Anti Human Tyr-3/Trp-5 Monooxygenase Activation 20 µg 130
Protein Gamma 100 µg 450

YWHAQ ant-387 5 µg 50
Mouse Anti Human Tyr-3/trp-5 Monooxygenase Activation 20 µg 130
Protein Theta 100 µg 450

Monoclonal / Polyclonal Antibodies, Miscellaneous Antibodies

ALK/P80 ant-331 5 µg 50
Mouse Anti Human ALK/P80 Protein 20 µg 130
100 µg 450

AKR1C1 ant-044 5 µg 50
Mouse Anti Human Aldo-Keto Reductase Family 1 Member C1 20 µg 130
100 µg 450

APP ant-421 5 µg 50
Mouse Anti Human Amyloid Β A4 Protein 20 µg 130
100 µg 450

ARF1 ant-058 5 µg 50
Mouse Anti Human ADP-Ribosylation Factor 1 20 µg 130
100 µg 450

AXIN1 ant-021 5 µg 50
Mouse Anti Human Axin-1 20 µg 130
100 µg 450
PEPTIDES INTERNATIONAL

BAK1 ant-015 5 µg 50
Mouse Anti Human Bcl-2 homologous antagonist/killer 20 µg 130
100 µg 450

BCL2 ant-022 5 µg 50
Mouse Anti Human B-Cell Leukemia/Lymphoma 2 20 µg 130
100 µg 450

BID ant-353 5 µg 50
Mouse Anti Human BH3 Interacting Domain Death Agonist 20 µg 130
100 µg 450

BrdU ant-049 0.5 mg 155

Mouse Anti BrdU (5-bromo-2-deoxyuridine) 1 mg 290

Calmodulin ant-342 5 µg 50
Mouse Anti Human Calmodulin 20 µg 130
100 µg 450

CASQ2 ant-045 5 µg 50
Mouse Anti Human Calsequestrin 20 µg 130
100 µg 450

CAV1 ant-027 5 µg 50
Mouse Anti Human Caveolin-1 20 µg 130
100 µg 450

768 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
CBR1 ant-032 5 µg 50
Mouse Anti Human Carbonyl Reductase-1 20 µg 130
100 µg 450

CD20 ant-191 50 µg 140

Recombinant Anti Human CD20 Antibody 0.5 mg 1,300
1 mg 2,400

CEBPB ant-406 5 µg 50
Mouse Anti Human CCAAT/enhancer-binding Protein β 20 µg 130
100 µg 450

CFL1 ant-354 5 µg 50
Mouse Anti Human Cofilin-1 20 µg 130
100 µg 450

CFLAR ant-433 5 µg 50
Mouse Anti Human CASP8 and FADD-like apoptosis regulator 20 µg 130
100 µg 450

CHGA ant-351 5 µg 50
Mouse Anti Human Chromogranin-A 20 µg 130
100 µg 450

CISD1 ant-061 5 µg 50
Mouse Anti Human CDGSH Iron Sulfur Domain 1 20 µg 130
100 µg 450

Chlamydia LPS ant-130 0.5 mg 155

PEPTIDES INTERNATIONAL
Mouse Anti Chlamydia LPS 1 mg 290

CLEC4E ant-012 5 µg 50
Mouse Anti Human C-type lectin domain family 4 Member E 20 µg 130
100 µg 450

c-myc ant-211 0.5 mg 155

Mouse Anti Human C-myc 1 mg 290

CRABP1 ant-363 5 µg 50
Mouse Anti Human Cellular Retinoic Acid binding Protein 1 20 µg 130
100 µg 450

CRABP2 ant-356 5 µg 50
Mouse Anti Human Cellular Retinoic Acid binding Protein 2 20 µg 130
100 µg 450

CRP ant-332 5 µg 50
Mouse Anti Human C-Reactive Protein 20 µg 130
100 µg 450

CSTB ant-339 5 µg 50
Mouse Anti Human Cystatin B 20 µg 130
100 µg 450

Order Hotline 1-800-777-4779 502-266-8787 769

 PRODUCT Code Qty PRICE
Recombinant proteins

CTBP1 ant-031 5 µg 50
Mouse Anti Human C-Terminal Binding Protein 1 20 µg 130
100 µg 450

DACT3 ant-432 5 µg 50
Mouse Anti Human Dapper homolog 3 20 µg 130
100 µg 450

EGLN1 ant-001 5 µg 50
Mouse Anti Human Egl nine homolog 1 20 µg 130
100 µg 450

EIF2S1 ant-059 5 µg 50
Mouse Anti Human Eukaryotic Translation Initiation Factor 2 20 µg 130
Subunit 1 Α 100 µg 450

EIF5A ant-010 5 µg 50
Mouse Anti Human Eukaryotic Translation Initiation Factor 5A 20 µg 130
100 µg 450

EPHA2 ant-425 5 µg 50
Mouse Anti Human EPH receptor A2 20 µg 130
100 µg 450

EPm2A ant-427 5 µg 50
Mouse Anti Human Laforin 20 µg 130
100 µg 450

FABP1 ant-346 5 µg 50
PEPTIDES INTERNATIONAL

Mouse Anti Human Fatty Acid Binding Protein-1 20 µg 130

100 µg 450

FABP4 ant-350 5 µg 50
Mouse Anti Human Fatty Acid Binding Protein 4 20 µg 130
100 µg 450

FABP7 ant-355 5 µg 50
Mouse Anti Human Fatty Acid Binding Protein-7 20 µg 130
100 µg 450

Factor-IX ant-229 0.5 mg 155

Mouse Anti Factor IX 1 mg 290

FADD ant-344 5 µg 50
Mouse Anti Human Fas-Associated Death Domain 20 µg 130
100 µg 450

FLAG peptide ant-222 100 µg 155

Mouse Anti FLAG peptide 0.2 mg 290
0.5 mg 650

FLAG peptide ant-146 0.5 mg 155

Mouse Anti FLAG peptide 1 mg 290

FLAG peptide HRP ant-221 100 µl 315

Mouse Anti FLAG peptide Peroxidase Conjugated 200 µl 580
500 µl 1,300

770 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
GAS7 ant-358 5 µg 50
Mouse Anti Human Growth Arrest-Specific 7 Isoform b 20 µg 130
100 µg 450

GFP ant-359 5 µg 50
Mouse Anti Green Fluorescent Protein 20 µg 130
100 µg 450

GIPC2 ant-079 5 µg 50
Mouse Anti Human GIPC PDZ Domain Member 2 20 µg 130
100 µg 450

GmNN ant-319 5 µg 50
Mouse Anti Human Geminin 20 µg 130
100 µg 450

Gonorrhea ant-186 0.5 mg 155

Mouse Anti Neisseria Gonorrhea 1 mg 290

GPC4 ant-008 5 µg 50
Mouse Anti Human Glypican-4 20 µg 130
100 µg 450

GPS2 ant-410 5 µg 50
Mouse Anti Human G-Protein pathway suppressor 2 20 µg 130
100 µg 450

GST ant-219 100 µg 155

0.2 mg 290

PEPTIDES INTERNATIONAL
Mouse Anti Glutathione-S-transferase (GST)
0.5 mg 650

GST ant-164 0.5 mg 250

Mouse Anti Glutathione-S-transferase (GST) 1 mg 400

GST ant-456 5 µg 50
Mouse Anti Glutathione-S-transferase (GST) 20 µg 130
100 µg 450

GST ant-189 30 µg 130

Polyclonal Rabbit Anti Glutathione-S-transferase (GST) 60 µg 250
250 µg 1,000

GST AfP ant-190 5 µg 50

Polyclonal Rabbit Anti Glutathione-S-transferase (GST) Affinity 20 µg 130
Purified 100 µg 550

GST HRP ant-220 100 µl 315

Mouse Anti Glutathione-S-transferase (GST) Peroxidase 200 µl 580
Conjugated 500 µl 1,300

GYPA ant-231 0.5 mg 155

Mouse Anti Human Glycophorin A (type M and type N) 1 mg 290

HA HRP ant-226 100 µl 315

Mouse Anti HA-tag peptide Peroxidase Conjugated 200 µl 580
500 µl 1,300

Order Hotline 1-800-777-4779 502-266-8787 771

 PRODUCT Code Qty PRICE
Recombinant proteins

HA-tag Peptide ant-101 0.5 mg 155

Mouse Anti HA-tag peptide 1 mg 290

HA-tag Peptide ant-225 100 µg 155

Mouse Anti HA-tag peptide clone PHASHG 0.2 mg 290
0.5 mg 650

HA-tag Peptide ant-234 100 µl 315

Polyclonal Rabbit Anti HA-tag peptide 200 µl 580
500 µl 1,300

HAX1 ant-446 5 µg 50
Mouse Anti Human HCLS1-associated Protein X-1 20 µg 130
100 µg 450

HBsAg ant-194 2 µg 50
Recombinant Anti Hepatitis B Virus Surface Antigen Ck 10 µg 130
1 mg 4,800

HCG-b core ant-147 0.5 mg 155

Mouse Anti hCG β core 1 mg 290

HEL ant-149 0.5 mg 155

Mouse Anti Hen Egg Lysozyme 1 mg 290

HEP-1 130 ant-193

Mouse Anti Human Heparanase-1 130 850 µg 435
PEPTIDES INTERNATIONAL

HEP-1 3/17 ant-154 50 µg 300

Mouse Anti Human Heparanase-1 3/17 100 µg 435
150 µg 600

His tag ant-227 100 µg 155

Mouse Anti Polyhistidine Tag 0.2 mg 290
0.5 mg 650

HmGB1 ant-347 5 µg 50
Mouse Anti Human High-mobility Group Box 1 20 µg 130
100 µg 450

HOmER1 ant-357 5 µg 50
Mouse Anti Human Homer Homolog-1 20 µg 130
100 µg 450

HPA-1 ant-155 290 µg 450

Polyclonal Rabbit Anti Human Heparanase-1 570 µg 750

Ig Kappa ant-202 0.5 mg 155

Mouse Anti Human Ig Kappa Light Chain 1 mg 290

Ig Lambda ant-203 0.5 mg 155

Mouse Anti Human Ig Lambda Light Chain 1 mg 290

IgA 1and2 ant-201 0.5 mg 155

Mouse Anti Human IgA 1and2 1 mg 290

772 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
IgA Sec ant-174 0.5 mg 155
Mouse Anti Human IgA Sec Component 1 mg 290

IgG-Fc ant-173 0.5 mg 155

Mouse Anti Human IgG-Fc 1 mg 290

Insulin ant-100 200 µg 175

Mouse Anti Human Insulin 0.5 mg 300
1 mg 550

ISG15 ant-333 5 µg 50
Mouse Anti Human Interferon stimulated gene 15 20 µg 130
100 µg 450

KCTD15 ant-028 5 µg 50
Mouse Anti Human Potassium channel tetramerisation domain 20 µg 130
containing 15 100 µg 450

KIR2DL1 ant-318 5 µg 50
Mouse Anti Human Killer Cell Immunoglobulin-Like Receptor, 2 20 µg 130
Domains Long Cytoplasmic Tail 1 100 µg 450

KIR2DL3 ant-300 5 µg 50
Mouse Anti Human Killer Cell Immunoglobulin-Like Receptor, 2 20 µg 130
Domains Long Cytoplasmic Tail 3 100 µg 450

KIR2DS4 ant-304

PEPTIDES INTERNATIONAL
5 µg 50
Mouse Anti Human Killer Cell Immunoglobulin-Like Receptor, 2 20 µg 130
Domains Short Cytoplasmic Tail 4 100 µg 450

KLF4 ant-434 5 µg 50
Mouse Anti Human Krueppel-like factor 4 20 µg 130
100 µg 450

KRT18 ant-025 5 µg 50
Mouse Anti Human Cytokeratin 18 20 µg 130
100 µg 450

KRT23 ant-081 5 µg 50
Mouse Anti Human Cytokeratin 23 20 µg 130
100 µg 450

LAIR1 ant-301 5 µg 50
Mouse Anti Human Leukocyte-Associated Ig-Like Receptor 1 20 µg 130
100 µg 450

LY6C/G ant-075 0.5 mg 155

Rat Anti Mouse LY6C/G 1 mg 290

LY6C/G Biotin ant-077 0.5 mg 250

Rat Anti Mouse LY6C/G Biotin 1 mg 400

LY6C/G FITC ant-076 0.5 mg 250

Rat Anti Mouse LY6C/G FITC 1 mg 400

Order Hotline 1-800-777-4779 502-266-8787 773

 PRODUCT Code Qty PRICE
Recombinant proteins

LY6G ant-158 0.5 mg 155

Rat Anti Mouse LY6G 1 mg 290

LY6G Biotin ant-074 0.5 mg 250

Rat Anti Mouse LY6G Biotin 1 mg 400

LY6G FITC ant-099 0.5 mg 250

Rat Anti Mouse LY6G FITC 1 mg 400

mAFK ant-463 5 µg 50
Mouse Anti Human V-maf Musculoaponeurotic Fibrosarcoma 20 µg 130
Oncogene K 100 µg 450

mBP ant-177 20 µg 250

Mouse Anti Maltose-Binding Protein 50 µg 400
100 µg 700

mBP ant-451 5 µg 50
Mouse Anti Maltose-Binding Protein 20 µg 130
100 µg 450

mEmO1 ant-090 5 µg 50
Mouse Anti Human Mediator of Cell Motility 1 20 µg 130
100 µg 450

mHC Class I ant-176

PEPTIDES INTERNATIONAL

0.5 mg 155
Mouse Anti MHC Class I (H-2K) 1 mg 290

mHC Class I Biotin ant-266 0.5 mg 250

Mouse Anti MHC Class I (H-2K) Biotin 1 mg 400

mHC Class I FITC ant-267 0.5 mg 250

Mouse Anti MHC Class I (H-2K) FITC 1 mg 400

mHC Class II ant-268 0.5 mg 155

Mouse Anti MHC Class II (I-A) 1 mg 290

mHC Class II ant-296 0.5 mg 155

Mouse Anti Human MHC Class II 1 mg 290

mHC Class II (I-E) ant-297 0.5 mg 155

Mouse Anti MHC Class II (I-E) 1 mg 290

mHC Class II (I-E) Biotin ant-298 0.5 mg 250

Mouse Anti MHC Class II (I-E) Biotin 1 mg 400

mHC Class II (I-E) FITC ant-299 0.5 mg 250

Mouse Anti MHC Class II (I-E) FITC 1 mg 400

774 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
mHC Class II Biotin ant-269 0.5 mg 250
Mouse Anti MHC Class II (I-A) Biotin 1 mg 400

mHC Class II FITC ant-270 0.5 mg 250

Mouse Anti MHC Class II (I-A) FITC 1 mg 400

mOG ant-199 0.5 mg 250

Mouse Anti Myelin Oligodendrocyte GlycoProtein 1 mg 400

mRRF ant-098 5 µg 50
Mouse Anti Human Mitochondrial Ribosome Recycling Factor 20 µg 130
100 µg 450

mRSA ant-198 0.5 mg 250

Mouse Anti Methicillin-Resistant Staphylococcus Aureus 1 mg 400

myc ant-223 100 µg 155

Mouse Anti Myc 0.2 mg 290
0.5 mg 650

myc ant-235 100 µl 315

Polyclonal Rabbit Anti Myc 200 µl 580
500 µl 1,300

myc HRP ant-224 100 µl 315

Mouse Anti Myc Peroxidase Conjugated 200 µl 580

PEPTIDES INTERNATIONAL
500 µl 1,300

mYD88 ant-464 5 µg 50
Mouse Anti Human Myeloid Differentiation Primary Response 20 µg 130
88 100 µg 450

mYL2 ant-361 5 µg 50
Mouse Anti Human Myosin Light Chain 2 20 µg 130
100 µg 450

myoglobin ant-068 5 µg 50
Mouse Anti Human Myoglobin 20 µg 130
100 µg 450

NANOG ant-422 5 µg 50
Mouse Anti Human Homeobox Protein NANOG 20 µg 130
100 µg 450

NCSTN ant-441 5 µg 50
Mouse Anti Human Nicastrin 20 µg 130
100 µg 450

NDE1 ant-078 5 µg 50
Mouse Anti Human nudE Nuclear Distribution Gene E Homolog 20 µg 130
1 100 µg 450

NELL2 ant-030 5 µg 50
Mouse Anti Human NEL-Like 2 20 µg 130
100 µg 450

Order Hotline 1-800-777-4779 502-266-8787 775

 PRODUCT Code Qty PRICE
Recombinant proteins

NFATC1 ant-436 5 µg 50
Mouse Anti Human Nuclear factor of activated T-cells 20 µg 130
cytoplasmic 1 100 µg 450

NKp30 ant-402 5 µg 50
Mouse Anti Human Natural killer cell p30-related Protein 20 µg 130
100 µg 450

NKp44 ant-401 5 µg 50
Mouse Anti Human Natural killer cell p44-related Protein 20 µg 130
100 µg 450

NKp46 ant-303 5 µg 50
Mouse Anti Human Natural Cytotoxicity Receptor NKp46 20 µg 130
100 µg 450

NRAS ant-047 5 µg 50
Mouse Anti Human Neuroblastoma RAS Viral Oncogene 20 µg 130
Homolog 100 µg 450

OAT ant-013 5 µg 50
Mouse Anti Human Ornithine aminotransferase 20 µg 130
100 µg 450

p53 ant-192 2 µg 50
Recombinant Anti p53 scFv 10 µg 130
1 mg 4,800
PEPTIDES INTERNATIONAL

p53 ant-228 100 µg 315

Mouse Anti p53 0.2 mg 580
0.5 mg 1,300

REG3A ant-218 2 µg 50
Polyclonal Rabbit Anti Human Regenerating Islet-Derived 3 Α 10 µg 130
100 µg 990

PAIP2 ant-094 5 µg 50
Mouse Anti Human Polyadenylate-Binding Protein-Interacting 20 µg 130
Protein 2 100 µg 450

PARK7 ant-317 5 µg 50
Mouse Anti Human Parkinson Disease Protein 7 20 µg 130
100 µg 450

PCNA ant-341 5 µg 50
Mouse Anti Human Proliferating Cell Nuclear Antigen 20 µg 130
100 µg 450

PDCD1 ant-417 5 µg 50
Mouse Anti Human Programmed Cell Death 1 20 µg 130
100 µg 450

PDCD12 ant-457 5 µg 50
Mouse Anti Human Programmed Cell Death 12 20 µg 130
100 µg 450

776 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
PDCD4 ant-338 5 µg 50
Mouse Anti Human Programmed Cell Death 4 20 µg 130
100 µg 450

PDPN ant-343 5 µg 50
Mouse Anti Human Podoplanin 20 µg 130
100 µg 450

PDX-1 ant-162 10 µl 50
Polyclonal Rabbit Anti Pancreas Duodenum Homeobox-1 50 µl 130
100 µl 240

PDZK1 ant-460 5 µg 50
Mouse Anti Human PDZ Domain Containing 1 20 µg 130
100 µg 450

PGP9.5 ant-335 5 µg 50
Mouse Anti Human PGP9.5 20 µg 130
100 µg 450

PLP ant-200 0.5 mg 250

Mouse Anti Porteolipid Protein of Myelin 1 mg 400

PSmA ant-450 5 µg 50
Mouse Anti Human Prostate Specific Cancer Antigen 20 µg 130
100 µg 450

RAB5A ant-337 5 µg 50

PEPTIDES INTERNATIONAL
Mouse Anti Human RAB5A 20 µg 130
100 µg 450

Rac2 ant-067 5 µg 50
Mouse Anti Human Ras-Related C3 Botulinum Toxin Substrate 20 µg 130
2 100 µg 450

RASSF1A ant-400 5 µg 50
Mouse Anti Human Ras association domain-containing Protein 20 µg 130
1 100 µg 450

REXO1 ant-413 5 µg 50
Mouse Anti Human RNA exonuclease 1 homolog 20 µg 130
100 µg 450

SAR1B ant-233 5 µg 50
Mouse Anti Human GTP-Binding Protein SAR1B 20 µg 130
100 µg 450

SBDS ant-091 5 µg 50
Mouse Anti Human Shwachman-Bodian-Diamond Syndrome 20 µg 130
100 µg 450

SERPINB5 ant-364 5 µg 50
Mouse Anti Human Serpin Peptidase Inhibitor, Clade B Member 20 µg 130
5 100 µg 450

SNAP25 ant-336 5 µg 50
Mouse Anti Human Synaptosomal-associated Protein 25 20 µg 130
100 µg 450

Order Hotline 1-800-777-4779 502-266-8787 777

 PRODUCT Code Qty PRICE
Recombinant proteins

SNCA ant-315 5 µg 50
Mouse Anti Human Α-Synuclein 20 µg 130
100 µg 450

SNCA (1-140) ant-461 5 µg 50

Mouse Anti Human Α-Synuclein (Immunogen 1-140 a.a.) 20 µg 130
100 µg 450

SNCB ant-454 5 µg 50
Polyclonal Rabbit Anti Human Β-Synuclein 20 µg 130
100 µg 450

SNCG ant-455 5 µg 50
Polyclonal Rabbit Anti Human Gamma-Synuclein 20 µg 130
100 µg 450

Streptavidin ant-345 5 µg 50
Mouse Anti Streptavidin 20 µg 130
100 µg 450

SUmO2/3 ant-016 5 µg 50
Mouse Anti Human Small Ubiquitin-Related Modifier 2/3 20 µg 130
100 µg 450

TARDBP ant-420 5 µg 50
Mouse Anti Human TAR DNA-binding Protein 43 20 µg 130
100 µg 450

TBCA ant-362 5 µg 50
PEPTIDES INTERNATIONAL

Mouse Anti Human Tubulin Folding Cofactor A 20 µg 130

100 µg 450

Tetanus ant-195 2 µg 50
Recombinant Anti-Tetanus Toxoid scFv 10 µg 130
1 mg 4,800

TGFBI ant-349 5 µg 50
Mouse Anti Human Transforming Growth Factor Β Induced 20 µg 130
100 µg 450

TLR2 ant-408 5 µg 50
Mouse Anti Human Toll-like receptor 2 20 µg 130
100 µg 450

TLR7 ant-403 5 µg 50
Mouse Anti Human Toll-like receptor 7 20 µg 130
100 µg 450

TmEFF2 ant-428 5 µg 50
Mouse Anti Human Tomoregulin-2 20 µg 130
100 µg 450

TNNI1 ant-099 5 µg 50
Mouse Anti Human Troponin I Type 1 20 µg 130
100 µg 450

778 Order Hotline 1-800-777-4779 502-266-8787

PRODUCT Code Qty PRICE

Recombinant proteins
TOLLIP ant-430 5 µg 50
Mouse Anti Human Toll-interacting Protein 20 µg 130
100 µg 450

TPD52L1 ant-302 5 µg 50
Mouse Anti Human Tumor Protein D52 L1 20 µg 130
100 µg 450

TREm2 ant-429 5 µg 50
Mouse Anti Human Triggering receptor expressed on Myeloid 20 µg 130
cells 2 100 µg 450

TTR ant-003 5 µg 50
Mouse Anti Human Transthyretin 20 µg 130
100 µg 450

TUBB2b ant-019 5 µg 50
Mouse Anti Human Tubulin β-2B chain 20 µg 130
100 µg 450

VAmP2 ant-334 5 µg 50
Mouse Anti Human Synaptobrevin-2 20 µg 130
100 µg 450

VAmP3 ant-352 5 µg 50
Mouse Anti Human Synaptobrevin-3 20 µg 130
100 µg 450

VHL ant-316

PEPTIDES INTERNATIONAL
5 µg 50
Mouse Anti Human Von Hippel-Lindau Protein 20 µg 130
100 µg 450

Vimentin ant-245 0.5 mg 250

Mouse Anti Human Vimentin 1 mg 400

Vimentin Biotin ant-246 0.5 mg 350

Mouse Anti Human Vimentin Biotinylated 1 mg 500

Vimentin FITC ant-247 0.5 mg 350

Mouse Anti Human Vimentin FITC 1 mg 500

WNT3A ant-431 5 µg 50
Mouse Anti Human Protein Wnt-3a 20 µg 130
100 µg 450

Order Hotline 1-800-777-4779 502-266-8787 779

 PRODUCT Code Qty PRICE
Recombinant proteins
PEPTIDES INTERNATIONAL

780 Order Hotline 1-800-777-4779 502-266-8787

Peptides International, Inc.
11621 Electron Drive
Louisville, KY 40299 USA
Phone: +1-502-266-8787
Phone: +1-800-777-4779
Fax: +1- 502-267-1329
Email: peptides@pepnet.com
Web: PEPNET.

CATALOG PRODUCTS
Including:
• RGD Platform
• ProTx-II & Other Toxins
• Biologically Active Peptides
• Substrates & Inhibitors
• dPEGs and Linkers

CUSTOM CHEMISTRY SERVICES

Made in USA
• Design Consultation
• Chemistry Development
• Process Scale-up
• Pilot-Scale Synthesis
• Click Chemistry
• Solution & Solid Phase
• Substrates by DesignTM

EXCELLENCE COMPOUNDED
• High Purity, Quality and Value
• Strict Con.dentiality
• Friendly Service
• Proactive Project Management